Citrus Sinensis ID: 000889
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1237 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ZWC8 | 1166 | Serine/threonine-protein | yes | no | 0.833 | 0.884 | 0.746 | 0.0 | |
| Q9LJF3 | 1164 | Receptor-like protein kin | no | no | 0.907 | 0.964 | 0.702 | 0.0 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.892 | 0.914 | 0.503 | 0.0 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.892 | 0.914 | 0.504 | 0.0 | |
| O22476 | 1196 | Protein BRASSINOSTEROID I | no | no | 0.898 | 0.929 | 0.489 | 0.0 | |
| Q9ZPS9 | 1143 | Serine/threonine-protein | no | no | 0.763 | 0.825 | 0.516 | 0.0 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.892 | 0.926 | 0.358 | 1e-164 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.834 | 0.937 | 0.337 | 1e-147 | |
| Q9ZVR7 | 1008 | Phytosulfokine receptor 1 | no | no | 0.700 | 0.860 | 0.342 | 1e-144 | |
| Q9FN37 | 1036 | Phytosulfokine receptor 2 | no | no | 0.721 | 0.861 | 0.346 | 1e-142 |
| >sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1586 bits (4107), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 773/1036 (74%), Positives = 885/1036 (85%), Gaps = 5/1036 (0%)
Query: 203 LDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSG 262
LDLS N ISD +++ Y S C NL +N S+NKL GKL + +S++T+DLSYN+LS
Sbjct: 130 LDLSSNSISDYSMVDYVFSKCSNLVSVNISNNKLVGKLGFAPSSLQSLTTVDLSYNILSD 189
Query: 263 EIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKN 322
+IP SF++D SLKYLDL+HNN +G FS+L FG CGNL+ +LSQN LSG +FP +L N
Sbjct: 190 KIPESFISDFPASLKYLDLTHNNLSGDFSDLSFGICGNLTFFSLSQNNLSGDKFPITLPN 249
Query: 323 CQLLETLNMSHNALQGGIP-GFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDL 381
C+ LETLN+S N L G IP G GSF+NLKQLSLAHN+ +GEIPPEL C TL LDL
Sbjct: 250 CKFLETLNISRNNLAGKIPNGEYWGSFQNLKQLSLAHNRLSGEIPPELSLLCKTLVILDL 309
Query: 382 SSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPL 441
S N +GELPS F +C L +LNLG+N LSG+FLNTVVSKI+ + YLYV +NNISG VP+
Sbjct: 310 SGNTFSGELPSQFTACVWLQNLNLGNNYLSGDFLNTVVSKITGITYLYVAYNNISGSVPI 369
Query: 442 SLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLK 501
SLTNC+ LRVLDLSSNGFTG +PSGFCS + P LEKI++ NNYLSGTVP+ELG CK+LK
Sbjct: 370 SLTNCSNLRVLDLSSNGFTGNVPSGFCSLQSSPVLEKILIANNYLSGTVPMELGKCKSLK 429
Query: 502 TIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTG 561
TIDLSFN L GP+P EIW LPNLSDLVMWANNLTG IPEG+CV GGNLETLILNNN LTG
Sbjct: 430 TIDLSFNELTGPIPKEIWMLPNLSDLVMWANNLTGTIPEGVCVKGGNLETLILNNNLLTG 489
Query: 562 AIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSL 621
+IP+SI+ CTNM+W+SLSSN+LTG+IP+GIGNL KLAILQLGNNSL+G VP+ LG C+SL
Sbjct: 490 SIPESISRCTNMIWISLSSNRLTGKIPSGIGNLSKLAILQLGNNSLSGNVPRQLGNCKSL 549
Query: 622 VWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRP 681
+WLDLNSNNL+G LP ELA+QAG+VMPG VSGKQFAFVRNEGGT CRGAGGLVEFEGIR
Sbjct: 550 IWLDLNSNNLTGDLPGELASQAGLVMPGSVSGKQFAFVRNEGGTDCRGAGGLVEFEGIRA 609
Query: 682 ERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLN 741
ERLE PMVHSCP+TRIY+GMTMYTF+ NGS+IY D+SYN++SG +P +G++ YLQVLN
Sbjct: 610 ERLERLPMVHSCPATRIYSGMTMYTFSANGSMIYFDISYNAVSGFIPPGYGNMGYLQVLN 669
Query: 742 LGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPS 801
LGHN++TG IPDSFGGLKAIGVLDLSHNN QG +PGSLG LSFLSDLDVSNNNL+G IP
Sbjct: 670 LGHNRITGTIPDSFGGLKAIGVLDLSHNNLQGYLPGSLGSLSFLSDLDVSNNNLTGPIPF 729
Query: 802 GGQLTTFPASRYENNSGLCGLPLLPCSSG-NHAATVHPHENKQNVETGVVIGIAFFLLII 860
GGQLTTFP SRY NNSGLCG+PL PC S T H KQ V T V+ GIAF +
Sbjct: 730 GGQLTTFPVSRYANNSGLCGVPLRPCGSAPRRPITSRIHAKKQTVATAVIAGIAFSFMCF 789
Query: 861 LGLTLALYRVKKDQKKDEQREKYIESLPTSGSSSWKLSSVPEPLSINVATFEKPLRKLTF 920
+ L +ALYRV+K QKK+++REKYIESLPTSGS SWKLSSVPEPLSINVATFEKPLRKLTF
Sbjct: 790 VMLVMALYRVRKVQKKEQKREKYIESLPTSGSCSWKLSSVPEPLSINVATFEKPLRKLTF 849
Query: 921 AHLLEATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGK 980
AHLLEATNGFSA++M+GSGGFGEVYKAQLRDGSVVAIKKLI +TGQGDREFMAEMETIGK
Sbjct: 850 AHLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKKLIRITGQGDREFMAEMETIGK 909
Query: 981 IKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDR-AKGGGTKLDWAARKKIAIGSA 1039
IKHRNLVPLLGYCK+GEERLLVYEYMKWGSLE+VLH++ +K GG L+WAARKKIAIG+A
Sbjct: 910 IKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKSSKKGGIYLNWAARKKIAIGAA 969
Query: 1040 RGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPG 1099
RGLAFLHHSCIPHIIHRDMKSSNVLLDE+FEARVSDFGMARLV+ALDTHLSVSTLAGTPG
Sbjct: 970 RGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDFGMARLVSALDTHLSVSTLAGTPG 1029
Query: 1100 YVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRIN 1159
YVPPEYYQSFRCT KGDVYSYGVILLELLSGK+PIDP EFG+DNNLVGWAKQL+REKR
Sbjct: 1030 YVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPGEFGEDNNLVGWAKQLYREKRGA 1089
Query: 1160 EILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGD-SLDS 1218
EILDPEL S + EL+ YL+I+ +CLDDRPFKRPTMIQ+MAMFKE++ DTE D SLD
Sbjct: 1090 EILDPELVTDKSGDVELFHYLKIASQCLDDRPFKRPTMIQLMAMFKEMKADTEEDESLDE 1149
Query: 1219 FSLKDT-VIEELRERE 1233
FSLK+T ++EE R++E
Sbjct: 1150 FSLKETPLVEESRDKE 1165
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 1544 bits (3998), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 800/1138 (70%), Positives = 928/1138 (81%), Gaps = 15/1138 (1%)
Query: 107 NLNNSGLSGSLNLTTLTALPYLEHLNLQGN-SFSAG-DLSTSKTSSCS----LVTMDLSS 160
++N++ L + T++ + P N GN + +G D T + SCS ++ +DL +
Sbjct: 30 DVNDTALLTAFKQTSIKSDPT----NFLGNWRYGSGRDPCTWRGVSCSSDGRVIGLDLRN 85
Query: 161 NNITGSLPGRSFL-LSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYS 219
+TG+L + LS R Y+ ++ S S G SL LDLS N ++DS+++ Y
Sbjct: 86 GGLTGTLNLNNLTALSNLRSLYLQGNNFSSGDSSSSSGCSLEVLDLSSNSLTDSSIVDYV 145
Query: 220 LSNCQNLNLLNFSDNKLPGKLNAT-SVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKY 278
S C NL +NFS NKL GKL ++ S + K I+T+DLS N S EIP +F+AD SLK+
Sbjct: 146 FSTCLNLVSVNFSHNKLAGKLKSSPSASNKRITTVDLSNNRFSDEIPETFIADFPNSLKH 205
Query: 279 LDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQG 338
LDLS NN TG FS L FG C NL+V +LSQN +SG FP SL NC+LLETLN+S N+L G
Sbjct: 206 LDLSGNNVTGDFSRLSFGLCENLTVFSLSQNSISGDRFPVSLSNCKLLETLNLSRNSLIG 265
Query: 339 GIPGF-LLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASC 397
IPG G+F+NL+QLSLAHN ++GEIPPEL C TL LDLS N LTG+LP +F SC
Sbjct: 266 KIPGDDYWGNFQNLRQLSLAHNLYSGEIPPELSLLCRTLEVLDLSGNSLTGQLPQSFTSC 325
Query: 398 SSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSN 457
SL SLNLG+N LSG+FL+TVVSK+S + LY+PFNNISG VP+SLTNC+ LRVLDLSSN
Sbjct: 326 GSLQSLNLGNNKLSGDFLSTVVSKLSRITNLYLPFNNISGSVPISLTNCSNLRVLDLSSN 385
Query: 458 GFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSE 517
FTG +PSGFCS + LEK+++ NNYLSGTVP+ELG CK+LKTIDLSFN+L G +P E
Sbjct: 386 EFTGEVPSGFCSLQSSSVLEKLLIANNYLSGTVPVELGKCKSLKTIDLSFNALTGLIPKE 445
Query: 518 IWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVS 577
IW+LP LSDLVMWANNLTG IPE ICV+GGNLETLILNNN LTG++P+SI+ CTNMLW+S
Sbjct: 446 IWTLPKLSDLVMWANNLTGGIPESICVDGGNLETLILNNNLLTGSLPESISKCTNMLWIS 505
Query: 578 LSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPS 637
LSSN LTGEIP GIG L KLAILQLGNNSLTG +P LG C++L+WLDLNSNNL+G LP
Sbjct: 506 LSSNLLTGEIPVGIGKLEKLAILQLGNNSLTGNIPSELGNCKNLIWLDLNSNNLTGNLPG 565
Query: 638 ELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTR 697
ELA+QAG+VMPG VSGKQFAFVRNEGGT CRGAGGLVEFEGIR ERLE FPMVHSCP TR
Sbjct: 566 ELASQAGLVMPGSVSGKQFAFVRNEGGTDCRGAGGLVEFEGIRAERLEHFPMVHSCPKTR 625
Query: 698 IYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGG 757
IY+GMTMY F++NGS+IYLDLSYN++SG++P +G++ YLQVLNLGHN LTG IPDSFGG
Sbjct: 626 IYSGMTMYMFSSNGSMIYLDLSYNAVSGSIPLGYGAMGYLQVLNLGHNLLTGTIPDSFGG 685
Query: 758 LKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNS 817
LKAIGVLDLSHN+ QG +PGSLGGLSFLSDLDVSNNNL+G IP GGQLTTFP +RY NNS
Sbjct: 686 LKAIGVLDLSHNDLQGFLPGSLGGLSFLSDLDVSNNNLTGPIPFGGQLTTFPLTRYANNS 745
Query: 818 GLCGLPLLPCSSGNHAATVHPHENKQNVETGVVIGIAFFLLIILGLTLALYRVKKDQKKD 877
GLCG+PL PCSSG+ H H KQ++ TG+ GI F + I+ L +ALYR +K QKK+
Sbjct: 746 GLCGVPLPPCSSGSRPTRSHAHPKKQSIATGMSAGIVFSFMCIVMLIMALYRARKVQKKE 805
Query: 878 EQREKYIESLPTSGSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIG 937
+QREKYIESLPTSGSSSWKLSSV EPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIG
Sbjct: 806 KQREKYIESLPTSGSSSWKLSSVHEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIG 865
Query: 938 SGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGE 997
SGGFG+VYKA+L DGSVVAIKKLI VTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGE
Sbjct: 866 SGGFGDVYKAKLADGSVVAIKKLIQVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGE 925
Query: 998 ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRD 1057
ERLLVYEYMK+GSLE+VLH++ K GG LDW+ARKKIAIG+ARGLAFLHHSCIPHIIHRD
Sbjct: 926 ERLLVYEYMKYGSLETVLHEKTKKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRD 985
Query: 1058 MKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDV 1117
MKSSNVLLD++F ARVSDFGMARLV+ALDTHLSVSTLAGTPGYVPPEYYQSFRCT KGDV
Sbjct: 986 MKSSNVLLDQDFVARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDV 1045
Query: 1118 YSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELY 1177
YSYGVILLELLSGK+PIDP EFG+DNNLVGWAKQL+REKR EILDPEL S + EL
Sbjct: 1046 YSYGVILLELLSGKKPIDPEEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELL 1105
Query: 1178 QYLRISFECLDDRPFKRPTMIQVMAMFKEL-QVDTEGDSLDSFSLKDT-VIEELRERE 1233
YL+I+ +CLDDRPFKRPTMIQVM MFKEL QVDTE DSLD F LK+T ++EE R++E
Sbjct: 1106 HYLKIASQCLDDRPFKRPTMIQVMTMFKELVQVDTENDSLDEFLLKETPLVEESRDKE 1163
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 1053 bits (2722), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 585/1162 (50%), Positives = 761/1162 (65%), Gaps = 58/1162 (4%)
Query: 79 LANWTADALTPCSWQGVSCSLNSHVTSLNLNNSGLSGSLNLTTLTALPY--LEHLNLQGN 136
L NW + + PCS+ GVSC NS V+S++L+N+ LS +L T LP LE L L+
Sbjct: 61 LQNWLS-STDPCSFTGVSCK-NSRVSSIDLSNTFLSVDFSLVTSYLLPLSNLESLVLKNA 118
Query: 137 SFSAGDLSTSKTSSC--SLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSIS--GG 192
+ S G L+++ S C +L ++DL+ N I+G + S C L +NLS N + G
Sbjct: 119 NLS-GSLTSAAKSQCGVTLDSIDLAENTISGPISDISSFGVCSNLKSLNLSKNFLDPPGK 177
Query: 193 SLHIGP--SLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSI 250
+ G SL LDLS N IS L + +S+ +
Sbjct: 178 EMLKGATFSLQVLDLSYNNISGFNLFPW-----------------------VSSMGFVEL 214
Query: 251 STIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNG 310
+ N L+G IP + L YLDLS NNF+ F + F C NL + LS N
Sbjct: 215 EFFSIKGNKLAGSIPELDFKN----LSYLDLSANNFSTVFPS--FKDCSNLQHLDLSSNK 268
Query: 311 LSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELG 370
G + +SL +C L LN+++N G +P +L+ L L N F G P +L
Sbjct: 269 FYG-DIGSSLSSCGKLSFLNLTNNQFVGLVPKL---PSESLQYLYLRGNDFQGVYPNQLA 324
Query: 371 QACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYV 430
C T+ ELDLS N +G +P + CSSL +++ +N SG + K+S++ + +
Sbjct: 325 DLCKTVVELDLSYNNFSGMVPESLGECSSLELVDISNNNFSGKLPVDTLLKLSNIKTMVL 384
Query: 431 PFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTV 490
FN G +P S +N +L LD+SSN TG IPSG C P L+ + L NN G +
Sbjct: 385 SFNKFVGGLPDSFSNLPKLETLDMSSNNLTGIIPSGICKDP-MNNLKVLYLQNNLFKGPI 443
Query: 491 PLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLE 550
P L +C L ++DLSFN L G +PS + SL L DL++W N L+GEIP+ + LE
Sbjct: 444 PDSLSNCSQLVSLDLSFNYLTGSIPSSLGSLSKLKDLILWLNQLSGEIPQELMYLQA-LE 502
Query: 551 TLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQ 610
LIL+ N LTG IP S+++CT + W+SLS+NQL+GEIPA +G L LAIL+LGNNS++G
Sbjct: 503 NLILDFNDLTGPIPASLSNCTKLNWISLSNNQLSGEIPASLGRLSNLAILKLGNNSISGN 562
Query: 611 VPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGA 670
+P LG C+SL+WLDLN+N L+G +P L Q+G + +++GK++ +++N+G C GA
Sbjct: 563 IPAELGNCQSLIWLDLNTNFLNGSIPPPLFKQSGNIAVALLTGKRYVYIKNDGSKECHGA 622
Query: 671 GGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPEN 730
G L+EF GIR E+L+ H C TR+Y G+T TF NGS+I+LDLSYN L G++P+
Sbjct: 623 GNLLEFGGIRQEQLDRISTRHPCNFTRVYRGITQPTFNHNGSMIFLDLSYNKLEGSIPKE 682
Query: 731 FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDV 790
G++ YL +LNLGHN L+G IP GGLK + +LDLS+N F G+IP SL L+ L ++D+
Sbjct: 683 LGAMYYLSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLGEIDL 742
Query: 791 SNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPL-LPCSSGNHA-ATVH--PHENKQNVE 846
SNNNLSG+IP TFP R+ NNS LCG PL LPCSSG + A H H + ++
Sbjct: 743 SNNNLSGMIPESAPFDTFPDYRFANNS-LCGYPLPLPCSSGPKSDANQHQKSHRRQASLA 801
Query: 847 TGVVIGIAFFLLIILGLTLALYRVKKDQKKDEQR-EKYIE--SLPTSGSSSWKLSSVPEP 903
V +G+ F L I GL + KK ++K E E Y++ S + +S+WK +S E
Sbjct: 802 GSVAMGLLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMDGHSHSATANSAWKFTSAREA 861
Query: 904 LSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHV 963
LSIN+A FEKPLRKLTFA LLEATNGF DS++GSGGFG+VYKAQL+DGSVVAIKKLIHV
Sbjct: 862 LSINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHV 921
Query: 964 TGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGG 1023
+GQGDREF AEMETIGKIKHRNLVPLLGYCK+GEERLLVYEYMK+GSLE VLHDR K G
Sbjct: 922 SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKK-TG 980
Query: 1024 TKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083
KL+W AR+KIAIG+ARGLAFLHH+CIPHIIHRDMKSSNVLLDEN EARVSDFGMARL++
Sbjct: 981 IKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMS 1040
Query: 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDN 1143
A+DTHLSVSTLAGTPGYVPPEYYQSFRC+TKGDVYSYGV+LLELL+GK+P D ++FG DN
Sbjct: 1041 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFG-DN 1099
Query: 1144 NLVGWAKQLHREKRINEILDPELTMQ-TSDETELYQYLRISFECLDDRPFKRPTMIQVMA 1202
NLVGW K LH + +I ++ D EL + S E EL Q+L+++ CLDDR +KRPTMIQVMA
Sbjct: 1100 NLVGWVK-LHAKGKITDVFDRELLKEDASIEIELLQHLKVACACLDDRHWKRPTMIQVMA 1158
Query: 1203 MFKELQVDTEGDSLDSFSLKDT 1224
MFKE+Q + DS + D
Sbjct: 1159 MFKEIQAGSGMDSTSTIGADDV 1180
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 1051 bits (2717), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 586/1162 (50%), Positives = 765/1162 (65%), Gaps = 58/1162 (4%)
Query: 79 LANWTADALTPCSWQGVSCSLNSHVTSLNLNNSGLSGSLNLTTLTALPY--LEHLNLQGN 136
L NW + + PCS+ GVSC NS V+S++L+N+ LS +L T LP LE L L+
Sbjct: 61 LQNWLS-STGPCSFTGVSCK-NSRVSSIDLSNTFLSVDFSLVTSYLLPLSNLESLVLKNA 118
Query: 137 SFSAGDLSTSKTSSC--SLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSL 194
+ S G L+++ S C +L ++DL+ N I+G + S C L +NLS N
Sbjct: 119 NLS-GSLTSAAKSQCGVTLDSIDLAENTISGPISDISSFGVCSNLKSLNLSKNF------ 171
Query: 195 HIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLN----ATSVNCKSI 250
LD G ++ +A T+SL +L+ S N + G N +S+ +
Sbjct: 172 --------LDPPGKEMLKAA--TFSL------QVLDLSYNNISG-FNLFPWVSSMGFVEL 214
Query: 251 STIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNG 310
L N L+G IP + L YLDLS NNF+ F + F C NL + LS N
Sbjct: 215 EFFSLKGNKLAGSIPELDFKN----LSYLDLSANNFSTVFPS--FKDCSNLQHLDLSSNK 268
Query: 311 LSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELG 370
G + +SL +C L LN+++N G +P +L+ L L N F G P +L
Sbjct: 269 FYG-DIGSSLSSCGKLSFLNLTNNQFVGLVPKL---PSESLQYLYLRGNDFQGVYPNQLA 324
Query: 371 QACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYV 430
C T+ ELDLS N +G +P + CSSL +++ N SG +SK+S++ + +
Sbjct: 325 DLCKTVVELDLSYNNFSGMVPESLGECSSLELVDISYNNFSGKLPVDTLSKLSNIKTMVL 384
Query: 431 PFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTV 490
FN G +P S +N +L LD+SSN TG IPSG C P L+ + L NN G +
Sbjct: 385 SFNKFVGGLPDSFSNLLKLETLDMSSNNLTGVIPSGICKDP-MNNLKVLYLQNNLFKGPI 443
Query: 491 PLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLE 550
P L +C L ++DLSFN L G +PS + SL L DL++W N L+GEIP+ + LE
Sbjct: 444 PDSLSNCSQLVSLDLSFNYLTGSIPSSLGSLSKLKDLILWLNQLSGEIPQELMYLQA-LE 502
Query: 551 TLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQ 610
LIL+ N LTG IP S+++CT + W+SLS+NQL+GEIPA +G L LAIL+LGNNS++G
Sbjct: 503 NLILDFNDLTGPIPASLSNCTKLNWISLSNNQLSGEIPASLGRLSNLAILKLGNNSISGN 562
Query: 611 VPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGA 670
+P LG C+SL+WLDLN+N L+G +P L Q+G + +++GK++ +++N+G C GA
Sbjct: 563 IPAELGNCQSLIWLDLNTNFLNGSIPPPLFKQSGNIAVALLTGKRYVYIKNDGSKECHGA 622
Query: 671 GGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPEN 730
G L+EF GIR E+L+ H C TR+Y G+T TF NGS+I+LDLSYN L G++P+
Sbjct: 623 GNLLEFGGIRQEQLDRISTRHPCNFTRVYRGITQPTFNHNGSMIFLDLSYNKLEGSIPKE 682
Query: 731 FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDV 790
G++ YL +LNLGHN L+G IP GGLK + +LDLS+N F G+IP SL L+ L ++D+
Sbjct: 683 LGAMYYLSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLGEIDL 742
Query: 791 SNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPL-LPCSSGNHA-ATVH--PHENKQNVE 846
SNNNLSG+IP TFP R+ NNS LCG PL +PCSSG + A H H + ++
Sbjct: 743 SNNNLSGMIPESAPFDTFPDYRFANNS-LCGYPLPIPCSSGPKSDANQHQKSHRRQASLA 801
Query: 847 TGVVIGIAFFLLIILGLTLALYRVKKDQKKDEQR-EKYIE--SLPTSGSSSWKLSSVPEP 903
V +G+ F L I GL + KK ++K E E Y++ S + +S+WK +S E
Sbjct: 802 GSVAMGLLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMDGHSHSATANSAWKFTSAREA 861
Query: 904 LSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHV 963
LSIN+A FEKPLRKLTFA LLEATNGF DS++GSGGFG+VYKAQL+DGSVVAIKKLIHV
Sbjct: 862 LSINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHV 921
Query: 964 TGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGG 1023
+GQGDREF AEMETIGKIKHRNLVPLLGYCK+GEERLLVYEYMK+GSLE VLHDR K G
Sbjct: 922 SGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKK-IG 980
Query: 1024 TKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083
KL+W AR+KIAIG+ARGLAFLHH+CIPHIIHRDMKSSNVLLDEN EARVSDFGMARL++
Sbjct: 981 IKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMS 1040
Query: 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDN 1143
A+DTHLSVSTLAGTPGYVPPEYYQSFRC+TKGDVYSYGV+LLELL+GK+P D ++FG DN
Sbjct: 1041 AMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFG-DN 1099
Query: 1144 NLVGWAKQLHREKRINEILDPELTMQ-TSDETELYQYLRISFECLDDRPFKRPTMIQVMA 1202
NLVGW K LH + +I ++ D EL + S E EL Q+L+++ CLDDR +KRPTMIQVMA
Sbjct: 1100 NLVGWVK-LHAKGKITDVFDRELLKEDASIEIELLQHLKVACACLDDRHWKRPTMIQVMA 1158
Query: 1203 MFKELQVDTEGDSLDSFSLKDT 1224
MFKE+Q + DS + D
Sbjct: 1159 MFKEIQAGSGMDSTSTIGADDV 1180
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 986 bits (2549), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 577/1179 (48%), Positives = 765/1179 (64%), Gaps = 67/1179 (5%)
Query: 58 EELTILMAFKQSSIGSDPNGYLANWTADALTPCSWQGVSCSLNSHVTSLNLNNSGLS-GS 116
E+ L++FK + D N L +W+++ PC++ GV+C + VTS++L++ L+ G
Sbjct: 34 REIHQLISFKD--VLPDKN-LLPDWSSNK-NPCTFDGVTCR-DDKVTSIDLSSKPLNVGF 88
Query: 117 LNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSC 176
+++ NS G +S K S+ SL ++DLS N+++G + + L SC
Sbjct: 89 SAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSA-SLTSLDLSRNSLSGPVTTLTSLGSC 147
Query: 177 DRLSYVNLSHNSIS-----GGSLHIGPSLLQLDLSGNQISDSALLTYSLSN-CQNLNLLN 230
L ++N+S N++ G L + SL LDLS N IS + ++ + LS+ C L L
Sbjct: 148 SGLKFLNVSSNTLDFPGKVSGGLKLN-SLEVLDLSANSISGANVVGWVLSDGCGELKHLA 206
Query: 231 FSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKF 290
S NK+ G ++ + C ++ +D+S N S IP F+ D S +L++LD+S N +G F
Sbjct: 207 ISGNKISGDVDVS--RCVNLEFLDVSSNNFSTGIP--FLGDCS-ALQHLDISGNKLSGDF 261
Query: 291 SNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRN 350
S ++ C L+ LN+S N G IP L ++
Sbjct: 262 SR--------------------------AISTCTELKLLNISSNQFVGPIPPLPL---KS 292
Query: 351 LKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNML 410
L+ LSLA N+F GEIP L AC TL LDLS N G +P F SCS L SL L SN
Sbjct: 293 LQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNF 352
Query: 411 SGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCT-QLRVLDLSSNGFTGTIPSGFCS 469
SG + K+ L L + FN SG +P SLTN + L LDLSSN F+G I C
Sbjct: 353 SGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQ 412
Query: 470 PPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVM 529
P L+++ L NN +G +P L +C L ++ LSFN L+G +PS + SL L DL +
Sbjct: 413 NPK-NTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKL 471
Query: 530 WANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPA 589
W N L GEIP+ + + LETLIL+ N LTG IP +++CTN+ W+SLS+N+LTGEIP
Sbjct: 472 WLNMLEGEIPQEL-MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK 530
Query: 590 GIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPG 649
IG L LAIL+L NNS +G +P LG CRSL+WLDLN+N +G +P+ + Q+G +
Sbjct: 531 WIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAAN 590
Query: 650 IVSGKQFAFVRNEG-GTACRGAGGLVEFEGIRPERLEGFPMVHSCPST-RIYTGMTMYTF 707
++GK++ +++N+G C GAG L+EF+GIR E+L + C T R+Y G T TF
Sbjct: 591 FIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF 650
Query: 708 TTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLS 767
NGS+++LD+SYN LSG +P+ GS+ YL +LNLGHN ++G IPD G L+ + +LDLS
Sbjct: 651 DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLS 710
Query: 768 HNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPLLPC 827
N G IP ++ L+ L+++D+SNNNLSG IP GQ TFP +++ NN GLCG PL C
Sbjct: 711 SNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRC 770
Query: 828 SSGNHAATVHPHENK----QNVETGVVIGIAFFLLIILGLTLA-LYRVKKDQKKDEQREK 882
N H + ++ V +G+ F + I GL L K+ +KK+ + E
Sbjct: 771 DPSNADGYAHHQRSHGRRPASLAGSVAMGLLFSFVCIFGLILVGREMRKRRRKKEAELEM 830
Query: 883 YIESLPTSG-----SSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIG 937
Y E SG +++WKL+ V E LSIN+A FEKPLRKLTFA LL+ATNGF DS+IG
Sbjct: 831 YAEGHGNSGDRTANNTNWKLTGVKEALSINLAAFEKPLRKLTFADLLQATNGFHNDSLIG 890
Query: 938 SGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGE 997
SGGFG+VYKA L+DGS VAIKKLIHV+GQGDREFMAEMETIGKIKHRNLVPLLGYCK+G+
Sbjct: 891 SGGFGDVYKAILKDGSAVAIKKLIHVSGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGD 950
Query: 998 ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRD 1057
ERLLVYE+MK+GSLE VLHD K G KL+W+ R+KIAIGSARGLAFLHH+C PHIIHRD
Sbjct: 951 ERLLVYEFMKYGSLEDVLHD-PKKAGVKLNWSTRRKIAIGSARGLAFLHHNCSPHIIHRD 1009
Query: 1058 MKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDV 1117
MKSSNVLLDEN EARVSDFGMARL++A+DTHLSVSTLAGTPGYVPPEYYQSFRC+TKGDV
Sbjct: 1010 MKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDV 1069
Query: 1118 YSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSD-ETEL 1176
YSYGV+LLELL+GKRP D +FG DNNLVGW KQ H + RI+++ DPEL + E EL
Sbjct: 1070 YSYGVVLLELLTGKRPTDSPDFG-DNNLVGWVKQ-HAKLRISDVFDPELMKEDPALEIEL 1127
Query: 1177 YQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGDS 1215
Q+L+++ CLDDR ++RPTM+QVMAMFKE+Q + DS
Sbjct: 1128 LQHLKVAVACLDDRAWRRPTMVQVMAMFKEIQAGSGIDS 1166
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZPS9|BRL2_ARATH Serine/threonine-protein kinase BRI1-like 2 OS=Arabidopsis thaliana GN=BRL2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 952 bits (2462), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 510/988 (51%), Positives = 654/988 (66%), Gaps = 44/988 (4%)
Query: 252 TIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLD--FGRCGNLSVITLSQN 309
+I LSYN +G++P SS L+ LDLS+NN TG S L C +++ + S N
Sbjct: 156 SITLSYNNFTGKLPNDLFL-SSKKLQTLDLSYNNITGPISGLTIPLSSCVSMTYLDFSGN 214
Query: 310 GLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPEL 369
+SG SL NC L++LN+S+N G IP G + L+ L L+HN+ G IPPE+
Sbjct: 215 SISGY-ISDSLINCTNLKSLNLSYNNFDGQIPKSF-GELKLLQSLDLSHNRLTGWIPPEI 272
Query: 370 GQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLY 429
G C +L+ L LS N TG +P + +SCS L SL+L +N +SG F NT++ SL L
Sbjct: 273 GDTCRSLQNLRLSYNNFTGVIPESLSSCSWLQSLDLSNNNISGPFPNTILRSFGSLQILL 332
Query: 430 VPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGT 489
+ N ISG P S++ C LR+ D SSN F+G IP C P +LE++ LP+N ++G
Sbjct: 333 LSNNLISGDFPTSISACKSLRIADFSSNRFSGVIPPDLC--PGAASLEELRLPDNLVTGE 390
Query: 490 VPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNL 549
+P + C L+TIDLS N L G +P EI +L L + W NN+ GEIP I NL
Sbjct: 391 IPPAISQCSELRTIDLSLNYLNGTIPPEIGNLQKLEQFIAWYNNIAGEIPPEIG-KLQNL 449
Query: 550 ETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTG 609
+ LILNNN LTG IP +C+N+ WVS +SN+LTGE+P G L +LA+LQLGNN+ TG
Sbjct: 450 KDLILNNNQLTGEIPPEFFNCSNIEWVSFTSNRLTGEVPKDFGILSRLAVLQLGNNNFTG 509
Query: 610 QVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAG-VVMPGIVSGKQFAFVRNEGGTACR 668
++P LGKC +LVWLDLN+N+L+G +P L Q G + G++SG AFVRN G +C+
Sbjct: 510 EIPPELGKCTTLVWLDLNTNHLTGEIPPRLGRQPGSKALSGLLSGNTMAFVRNVG-NSCK 568
Query: 669 GAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLP 728
G GGLVEF GIRPERL P + SC TR+Y+G + FT ++ YLDLSYN L G +P
Sbjct: 569 GVGGLVEFSGIRPERLLQIPSLKSCDFTRMYSGPILSLFTRYQTIEYLDLSYNQLRGKIP 628
Query: 729 ENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDL 788
+ G + LQVL L HN+L+G IP + G LK +GV D S N QG IP S LSFL +
Sbjct: 629 DEIGEMIALQVLELSHNQLSGEIPFTIGQLKNLGVFDASDNRLQGQIPESFSNLSFLVQI 688
Query: 789 DVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPLLPCSSGNHAATVHPHENKQ----- 843
D+SNN L+G IP GQL+T PA++Y NN GLCG+PL C +GN+ E K+
Sbjct: 689 DLSNNELTGPIPQRGQLSTLPATQYANNPGLCGVPLPECKNGNNQLPAGTEEGKRAKHGT 748
Query: 844 -------NVETGVVIGIA-FFLLIILGLTLALYRVKKDQKKDEQREKYIESLPTSGSSSW 895
++ GV+I A +LI+ + + R D K + + S +++W
Sbjct: 749 RAASWANSIVLGVLISAASVCILIVWAIAVRARRRDADDAKMLHSLQAVNS-----ATTW 803
Query: 896 KLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQLRDGSVV 955
K+ EPLSINVATF++ LRKL F+ L+EATNGFSA SMIG GGFGEV+KA L+DGS V
Sbjct: 804 KIEKEKEPLSINVATFQRQLRKLKFSQLIEATNGFSAASMIGHGGFGEVFKATLKDGSSV 863
Query: 956 AIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVL 1015
AIKKLI ++ QGDREFMAEMET+GKIKHRNLVPLLGYCKIGEERLLVYE+M++GSLE VL
Sbjct: 864 AIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMQYGSLEEVL 923
Query: 1016 HDRAKGGGTK-LDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVS 1074
H G + L W RKKIA G+A+GL FLHH+CIPHIIHRDMKSSNVLLD++ EARVS
Sbjct: 924 HGPRTGEKRRILGWEERKKIAKGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDQDMEARVS 983
Query: 1075 DFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPI 1134
DFGMARL++ALDTHLSVSTLAGTPGYVPPEYYQSFRCT KGDVYS GV++LE+LSGKRP
Sbjct: 984 DFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSIGVVMLEILSGKRPT 1043
Query: 1135 DPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDET--------------ELYQYL 1180
D EFG D NLVGW+K RE + E++D +L + S E+ E+ +YL
Sbjct: 1044 DKEEFG-DTNLVGWSKMKAREGKHMEVIDEDLLKEGSSESLNEKEGFEGGVIVKEMLRYL 1102
Query: 1181 RISFECLDDRPFKRPTMIQVMAMFKELQ 1208
I+ C+DD P KRP M+QV+A +EL+
Sbjct: 1103 EIALRCVDDFPSKRPNMLQVVASLRELR 1130
|
Receptor with a serine/threonine-protein kinase activity, which may transduce extracellular spatial and temporal signals into downstream cell differentiation responses in provascular and procambial cells. In contrast to BRI1, BRL1 and BRL3, it does not bind brassinolide. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 578 bits (1491), Expect = e-164, Method: Compositional matrix adjust.
Identities = 435/1212 (35%), Positives = 634/1212 (52%), Gaps = 108/1212 (8%)
Query: 59 ELTILMAFKQSSIGSDPNGYLANWTADALTPCSWQGVSCSLNSHVTSLNLNNSGLSGSLN 118
E T L++FK+S +P+ + + + + C W GV+C L V SL+L + L G +
Sbjct: 26 ETTSLISFKRSL--ENPSLLSSWNVSSSASHCDWVGVTCLL-GRVNSLSLPSLSLRGQIP 82
Query: 119 LTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDR 178
+++L L L L GN FS G + + L T+DLS N++TG LP L +
Sbjct: 83 -KEISSLKNLRELCLAGNQFS-GKIPPEIWNLKHLQTLDLSGNSLTGLLP--RLLSELPQ 138
Query: 179 LSYVNLSHNSISGG---SLHIG-PSLLQLDLSGNQISDSALLTY-SLSNCQNLNL-LNFS 232
L Y++LS N SG S I P+L LD+S N +S LSN NL + LN
Sbjct: 139 LLYLDLSDNHFSGSLPPSFFISLPALSSLDVSNNSLSGEIPPEIGKLSNLSNLYMGLNSF 198
Query: 233 DNKLPGKL-------NATSVNC-------------KSISTIDLSYNLLSGEIPASFVADS 272
++P ++ N + +C K ++ +DLSYN L IP SF
Sbjct: 199 SGQIPSEIGNISLLKNFAAPSCFFNGPLPKEISKLKHLAKLDLSYNPLKCSIPKSF--GE 256
Query: 273 SGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMS 332
+L L+L G + G C +L + LS N LSG P L LL T +
Sbjct: 257 LHNLSILNLVSAELIGLIPP-ELGNCKSLKSLMLSFNSLSGP-LPLELSEIPLL-TFSAE 313
Query: 333 HNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPS 392
N L G +P ++ G ++ L L LA+N+F+GEIP E+ + C L+ L L+SN L+G +P
Sbjct: 314 RNQLSGSLPSWM-GKWKVLDSLLLANNRFSGEIPHEI-EDCPMLKHLSLASNLLSGSIPR 371
Query: 393 TFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVL 452
SL +++L N+LSG + V SSL L + N I+G +P L L L
Sbjct: 372 ELCGSGSLEAIDLSGNLLSGT-IEEVFDGCSSLGELLLTNNQINGSIPEDLWKLP-LMAL 429
Query: 453 DLSSNGFTGTIPSGFCSPPNF--------------PA-------LEKIVLPNNYLSGTVP 491
DL SN FTG IP N PA L+++VL +N L+G +P
Sbjct: 430 DLDSNNFTGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGEIP 489
Query: 492 LELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLET 551
E+G +L ++L+ N G +P E+ +L+ L + +NNL G+IP+ I L+
Sbjct: 490 REIGKLTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALA-QLQC 548
Query: 552 LILNNNHLTGAIPKSIASCTNMLWV------------SLSSNQLTGEIPAGIGNLVKLAI 599
L+L+ N+L+G+IP ++ + + + LS N+L+G IP +G + L
Sbjct: 549 LVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVE 608
Query: 600 LQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFV 659
+ L NN L+G++P L + +L LDL+ N L+G +P E+ N + + + + +
Sbjct: 609 ISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHI 668
Query: 660 RNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLS 719
G G LV+ + +L+G P+ S + + L ++DLS
Sbjct: 669 PESFGLL----GSLVKL-NLTKNKLDG-PVPASLGNLK--------------ELTHMDLS 708
Query: 720 YNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSL 779
+N+LSG L ++ L L + NK TG IP G L + LD+S N G IP +
Sbjct: 709 FNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKI 768
Query: 780 GGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPLLPCSSGNHAATVHPH 839
GL L L+++ NNL G +PS G + N LCG + G+
Sbjct: 769 CGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVV-----GSDCKIEGTK 823
Query: 840 ENKQNVETGVVIG---IAFFLLIILGLTLALYRVKKDQKKDEQREKYIESLPTSGSSSWK 896
G+++G I F + L RVK+ + E ++
Sbjct: 824 LRSAWGIAGLMLGFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLS 883
Query: 897 LSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQLRDGSVVA 956
S EPLSIN+A FE+PL K+ ++EAT+ FS ++IG GGFG VYKA L VA
Sbjct: 884 GSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVA 943
Query: 957 IKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLH 1016
+KKL QG+REFMAEMET+GK+KH NLV LLGYC EE+LLVYEYM GSL+ L
Sbjct: 944 VKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLR 1003
Query: 1017 DRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDF 1076
++ G LDW+ R KIA+G+ARGLAFLHH IPHIIHRD+K+SN+LLD +FE +V+DF
Sbjct: 1004 NQT-GMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADF 1062
Query: 1077 GMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDP 1136
G+ARL++A ++H+S + +AGT GY+PPEY QS R TTKGDVYS+GVILLEL++GK P P
Sbjct: 1063 GLARLISACESHVS-TVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGP 1121
Query: 1137 S-EFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRP 1195
+ + NLVGWA Q + + +++DP L ++L + L+I+ CL + P KRP
Sbjct: 1122 DFKESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQL-RLLQIAMLCLAETPAKRP 1180
Query: 1196 TMIQVMAMFKEL 1207
M+ V+ KE+
Sbjct: 1181 NMLDVLKALKEI 1192
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 523 bits (1347), Expect = e-147, Method: Compositional matrix adjust.
Identities = 394/1168 (33%), Positives = 588/1168 (50%), Gaps = 136/1168 (11%)
Query: 57 NEELTILMAFKQSSIGSDPNGYLANWTADALTPCSWQGVSCSLNSHVTSLNLNNSGLSGS 116
NEE +L+ FK + +D NGYLA+W PC+W G++C+ VTS++LN LSG+
Sbjct: 25 NEEGRVLLEFK--AFLNDSNGYLASWNQLDSNPCNWTGIACTHLRTVTSVDLNGMNLSGT 82
Query: 117 LNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSC 176
L+ + L L LN+ N F +G + + SL +DL +N G +P + ++
Sbjct: 83 LS-PLICKLHGLRKLNVSTN-FISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMIIT 140
Query: 177 DRLSYVNLSHNSISGG-SLHIG--PSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSD 233
+ Y L N + G IG SL +L + N ++ ++ S++ + L ++
Sbjct: 141 LKKLY--LCENYLFGSIPRQIGNLSSLQELVIYSNNLT--GVIPPSMAKLRQLRIIRAGR 196
Query: 234 NKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNL 293
N G + + C+S+ + L+ NLL G +P K L+
Sbjct: 197 NGFSGVIPSEISGCESLKVLGLAENLLEGSLP-----------KQLE------------- 232
Query: 294 DFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQ 353
+ NL+ + L QN LSG E P S+ N LE L + N G IP + G +K+
Sbjct: 233 ---KLQNLTDLILWQNRLSG-EIPPSVGNISRLEVLALHENYFTGSIPREI-GKLTKMKR 287
Query: 354 LSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGN 413
L L NQ GEIP E+G E+D S N+LTG +P F H LNL
Sbjct: 288 LYLYTNQLTGEIPREIGNLIDA-AEIDFSENQLTGFIPKEFG-----HILNL-------- 333
Query: 414 FLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNF 473
L++L+ N + GP+P L T L LDLS N GTIP
Sbjct: 334 ----------KLLHLFE--NILLGPIPRELGELTLLEKLDLSINRLNGTIPQEL---QFL 378
Query: 474 PALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANN 533
P L + L +N L G +P +G N +D+S NSL+GP+P+ L L + +N
Sbjct: 379 PYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNK 438
Query: 534 LTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGN 593
L+G IP + +L L+L +N LTG++P + + N+ + L N L+G I A +G
Sbjct: 439 LSGNIPRDL-KTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGK 497
Query: 594 LVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSG 653
L L L+L NN+ TG++P +G +V +++SN L+G +P EL + + + SG
Sbjct: 498 LKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDL-SG 556
Query: 654 KQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSL 713
+F+ G + G LV E +R S TG ++F L
Sbjct: 557 NKFS------GYIAQELGQLVYLEILRL-------------SDNRLTGEIPHSFGDLTRL 597
Query: 714 IYLDLSYNSLSGTLPENFGSLNYLQV-LNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQ 772
+ L L N LS +P G L LQ+ LN+ HN L+G IPDS G L+ + +L L+ N
Sbjct: 598 MELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLS 657
Query: 773 GSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCG------LPLLP 826
G IP S+G L L ++SNNNL G +P +S + N GLC PL+P
Sbjct: 658 GEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVP 717
Query: 827 CSSGNHAATVHPHENKQNVE-TGVVIGIAFFLLIILGLTLALYRVKKDQKKDEQREKYIE 885
S ++ + ++ + T +VIG + FL+ LGL + R RE
Sbjct: 718 HSDSKLNWLINGSQRQKILTITCIVIG-SVFLITFLGLCWTIKR----------REPAFV 766
Query: 886 SLPTSGSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVY 945
+L + P+ + ++ P + T+ L++AT FS D ++G G G VY
Sbjct: 767 ALEDQ--------TKPDVMD----SYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVY 814
Query: 946 KAQLRDGSVVAIKKLIHVTGQG---DREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLV 1002
KA++ G V+A+KKL + G+G D F AE+ T+GKI+HRN+V L G+C LL+
Sbjct: 815 KAEMSGGEVIAVKKL-NSRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLL 873
Query: 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSN 1062
YEYM GSL L K LDW AR +IA+G+A GL +LHH C P I+HRD+KS+N
Sbjct: 874 YEYMSKGSLGEQLQRGEKN--CLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNN 931
Query: 1063 VLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGV 1122
+LLDE F+A V DFG+A+L++ L S+S +AG+ GY+ PEY + + T K D+YS+GV
Sbjct: 932 ILLDERFQAHVGDFGLAKLID-LSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGV 990
Query: 1123 ILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRIN-EILDPELTMQTSDETELYQ--- 1178
+LLEL++GK P+ P E G D LV W ++ R E+ D L T+D+ +++
Sbjct: 991 VLLELITGKPPVQPLEQGGD--LVNWVRRSIRNMIPTIEMFDARL--DTNDKRTVHEMSL 1046
Query: 1179 YLRISFECLDDRPFKRPTMIQVMAMFKE 1206
L+I+ C + P RPTM +V+AM E
Sbjct: 1047 VLKIALFCTSNSPASRPTMREVVAMITE 1074
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZVR7|PSKR1_ARATH Phytosulfokine receptor 1 OS=Arabidopsis thaliana GN=PSKR1 PE=2 SV=4 | Back alignment and function description |
|---|
Score = 512 bits (1318), Expect = e-144, Method: Compositional matrix adjust.
Identities = 345/1008 (34%), Positives = 514/1008 (50%), Gaps = 141/1008 (13%)
Query: 270 ADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETL 329
++++G + L+L + +GK S G+ + V+ LS+N + + P S+ N + L+TL
Sbjct: 72 SNNTGRVIRLELGNKKLSGKLSE-SLGKLDEIRVLNLSRNFIKDS-IPLSIFNLKNLQTL 129
Query: 330 NMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGE 389
++S N L GGIP + + L+ L+ N+F G +P + +R + L+ N G
Sbjct: 130 DLSSNDLSGGIPTSI--NLPALQSFDLSSNKFNGSLPSHICHNSTQIRVVKLAVNYFAGN 187
Query: 390 LPSTFASCSSLHSLNLGSNMLSGNF-----------------------LNTVVSKISSLI 426
S F C L L LG N L+GN L+ + +SSL+
Sbjct: 188 FTSGFGKCVLLEHLCLGMNDLTGNIPEDLFHLKRLNLLGIQENRLSGSLSREIRNLSSLV 247
Query: 427 YLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPN-------------- 472
L V +N SG +P QL+ +NGF G IP + P+
Sbjct: 248 RLDVSWNLFSGEIPDVFDELPQLKFFLGQTNGFIGGIPKSLANSPSLNLLNLRNNSLSGR 307
Query: 473 -------FPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSL---- 521
AL + L N +G +P L CK LK ++L+ N+ G VP +
Sbjct: 308 LMLNCTAMIALNSLDLGTNRFNGRLPENLPDCKRLKNVNLARNTFHGQVPESFKNFESLS 367
Query: 522 ----------------------PNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHL 559
NL+ LV+ N +P+ ++ L+ L++ N L
Sbjct: 368 YFSLSNSSLANISSALGILQHCKNLTTLVLTLNFHGEALPDDSSLHFEKLKVLVVANCRL 427
Query: 560 TGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCR 619
TG++P+ ++S + + LS N+LTG IP+ IG+ L L L NNS TG++P+ L K
Sbjct: 428 TGSMPRWLSSSNELQLLDLSWNRLTGAIPSWIGDFKALFYLDLSNNSFTGEIPKSLTKLE 487
Query: 620 SLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGI 679
SL +++ N S P F RNE A +
Sbjct: 488 SLTSRNISVNEPSPDFP-------------------FFMKRNESARA------------L 516
Query: 680 RPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQV 739
+ ++ GFP P+ ++L +N+LSG + E FG+L L V
Sbjct: 517 QYNQIFGFP-----PT--------------------IELGHNNLSGPIWEEFGNLKKLHV 551
Query: 740 LNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGII 799
+L N L+G IP S G+ ++ LDLS+N GSIP SL LSFLS V+ NNLSG+I
Sbjct: 552 FDLKWNALSGSIPSSLSGMTSLEALDLSNNRLSGSIPVSLQQLSFLSKFSVAYNNLSGVI 611
Query: 800 PSGGQLTTFPASRYENNSGLCGLPLLPCSSGNHAATVHPHENKQNVETGVVIGIAFFLLI 859
PSGGQ TFP S +E+N LCG PCS G +A + + + G+ IGIAF
Sbjct: 612 PSGGQFQTFPNSSFESNH-LCGEHRFPCSEGTESALIKRSRRSRGGDIGMAIGIAFG--S 668
Query: 860 ILGLTLALYRVKKDQKKDEQREKYIESLPTSGSSSWKLSSVPEPLSINVATFEKPLRKLT 919
+ LTL V + +++ + + IE S S + E S V F+ ++L+
Sbjct: 669 VFLLTLLSLIVLRARRRSGEVDPEIEE-----SESMNRKELGEIGSKLVVLFQSNDKELS 723
Query: 920 FAHLLEATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIG 979
+ LL++TN F ++IG GGFG VYKA L DG VAIKKL GQ +REF AE+ET+
Sbjct: 724 YDDLLDSTNSFDQANIIGCGGFGMVYKATLPDGKKVAIKKLSGDCGQIEREFEAEVETLS 783
Query: 980 KIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSA 1039
+ +H NLV L G+C +RLL+Y YM+ GSL+ LH+R G L W R +IA G+A
Sbjct: 784 RAQHPNLVLLRGFCFYKNDRLLIYSYMENGSLDYWLHERNDGPAL-LKWKTRLRIAQGAA 842
Query: 1040 RGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPG 1099
+GL +LH C PHI+HRD+KSSN+LLDENF + ++DFG+ARL++ +TH+S + L GT G
Sbjct: 843 KGLLYLHEGCDPHILHRDIKSSNILLDENFNSHLADFGLARLMSPYETHVS-TDLVGTLG 901
Query: 1100 YVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRIN 1159
Y+PPEY Q+ T KGDVYS+GV+LLELL+ KRP+D + +L+ W ++ E R +
Sbjct: 902 YIPPEYGQASVATYKGDVYSFGVVLLELLTDKRPVDMCKPKGCRDLISWVVKMKHESRAS 961
Query: 1160 EILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207
E+ DP L ++ E+++ L I+ CL + P +RPT Q+++ ++
Sbjct: 962 EVFDP-LIYSKENDKEMFRVLEIACLCLSENPKQRPTTQQLVSWLDDV 1008
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis, somatic embryogenesis, cellular proliferation and plant growth. Not involved in PSY perception. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FN37|PSKR2_ARATH Phytosulfokine receptor 2 OS=Arabidopsis thaliana GN=PSKR2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 507 bits (1305), Expect = e-142, Method: Compositional matrix adjust.
Identities = 354/1023 (34%), Positives = 516/1023 (50%), Gaps = 131/1023 (12%)
Query: 270 ADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETL 329
+D SG + L L G S G L V+ LS+N L G E PA + + L+ L
Sbjct: 60 SDVSGRVTKLVLPEKGLEGVISK-SLGELTELRVLDLSRNQLKG-EVPAEISKLEQLQVL 117
Query: 330 NMSHNALQGGIPGFL----------------------LGSFRNLKQLSLAHNQFAGEIPP 367
++SHN L G + G + +G F L L++++N F GEI P
Sbjct: 118 DLSHNLLSGSVLGVVSGLKLIQSLNISSNSLSGKLSDVGVFPGLVMLNVSNNLFEGEIHP 177
Query: 368 ELGQACGTLRELDLS------------------------SNRLTGELPSTFASCSSLHSL 403
EL + G ++ LDLS SNRLTG+LP S L L
Sbjct: 178 ELCSSSGGIQVLDLSMNRLVGNLDGLYNCSKSIQQLHIDSNRLTGQLPDYLYSIRELEQL 237
Query: 404 NLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTI 463
+L N LSG L+ +S +S L L + N S +P N TQL LD+SSN F+G
Sbjct: 238 SLSGNYLSGE-LSKNLSNLSGLKSLLISENRFSDVIPDVFGNLTQLEHLDVSSNKFSGRF 296
Query: 464 PSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPN 523
P L+ L NN LSG++ L +L +DL+ N +GP+P + P
Sbjct: 297 PPSLSQCSKLRVLD---LRNNSLSGSINLNFTGFTDLCVLDLASNHFSGPLPDSLGHCPK 353
Query: 524 LSDLVMWANNLTGEIPE-------------------------GICVNGGNLETLILNNNH 558
+ L + N G+IP+ + + NL TLIL+ N
Sbjct: 354 MKILSLAKNEFRGKIPDTFKNLQSLLFLSLSNNSFVDFSETMNVLQHCRNLSTLILSKNF 413
Query: 559 LTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKC 618
+ IP ++ N+ ++L + L G+IP+ + N KL +L L N G +P +GK
Sbjct: 414 IGEEIPNNVTGFDNLAILALGNCGLRGQIPSWLLNCKKLEVLDLSWNHFYGTIPHWIGKM 473
Query: 619 RSLVWLDLNSNNLSGPLP---SELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVE 675
SL ++D ++N L+G +P +EL N +R G + +
Sbjct: 474 ESLFYIDFSNNTLTGAIPVAITELKN----------------LIRLNGTASQMTDSSGIP 517
Query: 676 FEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLN 735
R + G P Y ++ + + IYL+ N L+GT+ G L
Sbjct: 518 LYVKRNKSSNGLP----------YNQVSRFPPS-----IYLN--NNRLNGTILPEIGRLK 560
Query: 736 YLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNL 795
L +L+L N TG IPDS GL + VLDLS+N+ GSIP S L+FLS V+ N L
Sbjct: 561 ELHMLDLSRNNFTGTIPDSISGLDNLEVLDLSYNHLYGSIPLSFQSLTFLSRFSVAYNRL 620
Query: 796 SGIIPSGGQLTTFPASRYENNSGLCGLPLLPCSSGNHAATVHPHENKQNVETG------- 848
+G IPSGGQ +FP S +E N GLC PC +++N G
Sbjct: 621 TGAIPSGGQFYSFPHSSFEGNLGLCRAIDSPCDVLMSNMLNPKGSSRRNNNGGKFGRSSI 680
Query: 849 VVIGIAFFLLIILGLTLALYRVKKDQKKDEQREKYIESLPTSGSSSWKLSSVPEPLSINV 908
VV+ I+ + I L L++ L R+ + K + R ++ SG +S P I V
Sbjct: 681 VVLTISLAIGITLLLSVILLRISR--KDVDDRINDVDEETISG-----VSKALGPSKI-V 732
Query: 909 ATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGD 968
+ L+ LL++TN FS ++IG GGFG VYKA DGS A+K+L GQ +
Sbjct: 733 LFHSCGCKDLSVEELLKSTNNFSQANIIGCGGFGLVYKANFPDGSKAAVKRLSGDCGQME 792
Query: 969 REFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDW 1028
REF AE+E + + +H+NLV L GYCK G +RLL+Y +M+ GSL+ LH+R G T L W
Sbjct: 793 REFQAEVEALSRAEHKNLVSLQGYCKHGNDRLLIYSFMENGSLDYWLHERVDGNMT-LIW 851
Query: 1029 AARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088
R KIA G+ARGLA+LH C P++IHRD+KSSN+LLDE FEA ++DFG+ARL+ DTH
Sbjct: 852 DVRLKIAQGAARGLAYLHKVCEPNVIHRDVKSSNILLDEKFEAHLADFGLARLLRPYDTH 911
Query: 1089 LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGW 1148
++ + L GT GY+PPEY QS T +GDVYS+GV+LLEL++G+RP++ + +LV
Sbjct: 912 VT-TDLVGTLGYIPPEYSQSLIATCRGDVYSFGVVLLELVTGRRPVEVCKGKSCRDLVSR 970
Query: 1149 AKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208
Q+ EKR E++D + ++ T L + L I+ +C+D P +RP + +V+ ++L
Sbjct: 971 VFQMKAEKREAELIDTTIRENVNERTVL-EMLEIACKCIDHEPRRRPLIEEVVTWLEDLP 1029
Query: 1209 VDT 1211
+++
Sbjct: 1030 MES 1032
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1237 | ||||||
| 224122062 | 1193 | predicted protein [Populus trichocarpa] | 0.962 | 0.997 | 0.783 | 0.0 | |
| 224061673 | 1186 | predicted protein [Populus trichocarpa] | 0.957 | 0.999 | 0.762 | 0.0 | |
| 359494370 | 1187 | PREDICTED: receptor-like protein kinase | 0.941 | 0.981 | 0.753 | 0.0 | |
| 46804805 | 1212 | putative leucine rich repeat-type serine | 0.955 | 0.975 | 0.706 | 0.0 | |
| 13620226 | 1192 | hypothetical protein [Solanum lycopersic | 0.959 | 0.995 | 0.674 | 0.0 | |
| 13620169 | 1166 | hypothetical protein [Capsella rubella] | 0.932 | 0.988 | 0.674 | 0.0 | |
| 15222751 | 1166 | serine/threonine-protein kinase BRI1-lik | 0.833 | 0.884 | 0.746 | 0.0 | |
| 297853266 | 1173 | hypothetical protein ARALYDRAFT_892562 [ | 0.833 | 0.878 | 0.745 | 0.0 | |
| 297829874 | 1167 | hypothetical protein ARALYDRAFT_478719 [ | 0.835 | 0.886 | 0.752 | 0.0 | |
| 15231225 | 1164 | receptor-like protein kinase BRI1-like 3 | 0.907 | 0.964 | 0.702 | 0.0 |
| >gi|224122062|ref|XP_002330531.1| predicted protein [Populus trichocarpa] gi|222872089|gb|EEF09220.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1891 bits (4899), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 939/1199 (78%), Positives = 1049/1199 (87%), Gaps = 9/1199 (0%)
Query: 40 MPS--YARELSSSSRQSGGNEELTILMAFKQSSIGSDPNGYLANWTADALTPCSWQGVSC 97
MPS ARELSS Q N E+ L+AFK+SS+ SDP LANW+ ++ TPCSW G+SC
Sbjct: 1 MPSSSQARELSS---QQSSNNEVVGLLAFKKSSVQSDPKNLLANWSPNSATPCSWSGISC 57
Query: 98 SLNSHVTSLNLNNSGLSGSLNLTTLT-ALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTM 156
SL HVT+LNL +GL G+LNL LT AL L+HL LQGNSFSA DLS S SC L T+
Sbjct: 58 SL-GHVTTLNLAKAGLIGTLNLHDLTGALQSLKHLYLQGNSFSATDLSASP--SCVLETI 114
Query: 157 DLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALL 216
DLSSNN++ LP SFL SC LSYVNLSHNSISGG+L GPSLLQLDLS N ISDS L
Sbjct: 115 DLSSNNLSDPLPRNSFLESCIHLSYVNLSHNSISGGTLRFGPSLLQLDLSRNTISDSTWL 174
Query: 217 TYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSL 276
TYSLS CQNLNLLNFSDNKL GKL AT +CKS+S +DLSYN SGEIP +FVADS SL
Sbjct: 175 TYSLSTCQNLNLLNFSDNKLTGKLGATPSSCKSLSILDLSYNPFSGEIPPTFVADSPPSL 234
Query: 277 KYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNAL 336
KYLDLSHNNF+G FS+LDFG C NL+ ++LSQN LSG FP SL+NC LL+TLN+S N L
Sbjct: 235 KYLDLSHNNFSGSFSSLDFGHCSNLTWLSLSQNRLSGNGFPFSLRNCVLLQTLNLSRNEL 294
Query: 337 QGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFAS 396
+ IPG LLGS NL+QLSLAHN F G+IPPELGQAC TL+ELDLS+N+LTG LP TFAS
Sbjct: 295 KFKIPGSLLGSLTNLRQLSLAHNLFYGDIPPELGQACRTLQELDLSANKLTGGLPQTFAS 354
Query: 397 CSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSS 456
CSS+ SLNLG+N+LSG+FL+TVVSK+ SL YLYVPFNNI+G VPLSLT CTQL VLDLSS
Sbjct: 355 CSSMRSLNLGNNLLSGDFLSTVVSKLQSLKYLYVPFNNITGTVPLSLTKCTQLEVLDLSS 414
Query: 457 NGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPS 516
N FTG +PS CS N AL+K++L +NYLSG VP ELGSCKNL++IDLSFN+L GP+P
Sbjct: 415 NAFTGDVPSKLCSSSNPTALQKLLLADNYLSGNVPPELGSCKNLRSIDLSFNNLIGPIPM 474
Query: 517 EIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWV 576
E+W+LPNL DLVMWANNLTGEIPEGICVNGGNLETLILNNN +TG+IP+SI +CTNM+WV
Sbjct: 475 EVWTLPNLLDLVMWANNLTGEIPEGICVNGGNLETLILNNNLITGSIPQSIGNCTNMIWV 534
Query: 577 SLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLP 636
SLSSN+LTGEIPAGIGNLV LA+LQ+GNNSLTGQ+P LGKCRSL+WLDLNSNNL+GPLP
Sbjct: 535 SLSSNRLTGEIPAGIGNLVDLAVLQMGNNSLTGQIPPELGKCRSLIWLDLNSNNLTGPLP 594
Query: 637 SELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPST 696
ELA+QAG+V+PGIVSGKQFAFVRNEGGT+CRGAGGLVEF+GIR ERLE PM HSC +T
Sbjct: 595 PELADQAGLVVPGIVSGKQFAFVRNEGGTSCRGAGGLVEFQGIRAERLENLPMAHSCSTT 654
Query: 697 RIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFG 756
RIY+GMT+YTFTTNGS+I+LDL+YNSLSG +P+NFGS++YLQVLNLGHNKLTG+IPDSFG
Sbjct: 655 RIYSGMTVYTFTTNGSMIFLDLAYNSLSGDIPQNFGSMSYLQVLNLGHNKLTGNIPDSFG 714
Query: 757 GLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENN 816
GLKAIGVLDLSHN+ QG +PGSLG LSFLSDLDVSNNNL+G IPSGGQLTTFP SRYENN
Sbjct: 715 GLKAIGVLDLSHNDLQGFLPGSLGTLSFLSDLDVSNNNLTGPIPSGGQLTTFPQSRYENN 774
Query: 817 SGLCGLPLLPCSSGNHAATVHPHENKQNVETGVVIGIAFFLLIILGLTLALYRVKKDQKK 876
SGLCG+PL PCSSG+H +++ KQ+VE G+VIGI FF+L + GL+LALYRVKK Q+K
Sbjct: 775 SGLCGVPLPPCSSGDHPQSLNTRRKKQSVEVGMVIGITFFILCVFGLSLALYRVKKYQQK 834
Query: 877 DEQREKYIESLPTSGSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMI 936
+EQREKYIESLPTSGSSSWKLS VPEPLSIN+ATFEKPLRKLTFAHLLEATNGFSADS+I
Sbjct: 835 EEQREKYIESLPTSGSSSWKLSGVPEPLSINIATFEKPLRKLTFAHLLEATNGFSADSLI 894
Query: 937 GSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIG 996
GSGGFGEVYKAQL DG VVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIG
Sbjct: 895 GSGGFGEVYKAQLGDGCVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIG 954
Query: 997 EERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHR 1056
EERLLVYEYMKWGSLESVLHDR+KGG ++LDWAARKKIAIGSARGLAFLHHSCIPHIIHR
Sbjct: 955 EERLLVYEYMKWGSLESVLHDRSKGGCSRLDWAARKKIAIGSARGLAFLHHSCIPHIIHR 1014
Query: 1057 DMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGD 1116
DMKSSNVLLDENFEARVSDFGMARLVNAL+THLSVSTLAGTPGYVPPEYYQSFRCT+KGD
Sbjct: 1015 DMKSSNVLLDENFEARVSDFGMARLVNALETHLSVSTLAGTPGYVPPEYYQSFRCTSKGD 1074
Query: 1117 VYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETEL 1176
VYSYGVILLELLSGK+PID +EFGDDNNLVGWAKQL+REKR NEILDPEL QTS E +L
Sbjct: 1075 VYSYGVILLELLSGKKPIDSAEFGDDNNLVGWAKQLYREKRCNEILDPELMTQTSGEAKL 1134
Query: 1177 YQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGDSLDSFSLKDTVIEELRERESS 1235
YQYLRI+FECLDDRPF+RPTMIQVMAMFKELQVD+E D LD SLKD I+E +E SS
Sbjct: 1135 YQYLRIAFECLDDRPFRRPTMIQVMAMFKELQVDSESDILDGLSLKDASIDEFKEESSS 1193
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224061673|ref|XP_002300597.1| predicted protein [Populus trichocarpa] gi|222847855|gb|EEE85402.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1832 bits (4745), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 927/1216 (76%), Positives = 1041/1216 (85%), Gaps = 31/1216 (2%)
Query: 21 IMGIFGFVLWLLLLCHLLIMPSYARELSSSSRQSGGNEELTILMAFKQSSIGSDPNGYLA 80
++ IFG+VL L LL MPS ++ SS+QS N E+ L+AFK+SS+ SDPN LA
Sbjct: 1 MIRIFGYVL----LLLLLFMPSSSQTRELSSQQST-NNEVVGLLAFKKSSVQSDPNNLLA 55
Query: 81 NWTADALTPCSWQGVSCSLNSHVTSLNLNNSGLSGSLNLTTLT-ALPYLEHLNLQGNSFS 139
NW+ ++ TPCSW G+SCSL+SHVT+LNL N GL G+LNL LT ALP L+HL LQGNSFS
Sbjct: 56 NWSPNSATPCSWSGISCSLDSHVTTLNLTNGGLIGTLNLYNLTGALPSLKHLYLQGNSFS 115
Query: 140 AGDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPS 199
A S +SSC L ++DLSSNNI+ LP +SF SC+ LSYVNLSHNSI GGSL PS
Sbjct: 116 A--SDLSASSSCVLESLDLSSNNISDPLPRKSFFESCNHLSYVNLSHNSIPGGSLRFSPS 173
Query: 200 LLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNL 259
LLQLDLS N ISDS L YSLS CQNLNLLNFSDNKL GKL T ++C
Sbjct: 174 LLQLDLSRNTISDSTWLAYSLSTCQNLNLLNFSDNKLAGKLAVTPLSC------------ 221
Query: 260 LSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPAS 319
++S SLKYLDLSHNNF+ FS+LDFG NL+ ++LSQN LSG FP S
Sbjct: 222 -----------NNSPSLKYLDLSHNNFSANFSSLDFGHYCNLTWLSLSQNRLSGIGFPLS 270
Query: 320 LKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLREL 379
L+NC LL+TLN+S N LQ IPG LGSF NL+QLSLAHN F G+IP ELGQ CGTL+EL
Sbjct: 271 LRNCVLLQTLNLSRNELQLKIPGNFLGSFTNLRQLSLAHNLFYGDIPLELGQTCGTLQEL 330
Query: 380 DLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPV 439
DLS+N+LTG LP TFASCSS+ SLNLG+N+LSG+FL TVVS + SLIYLYVPFNNI+G V
Sbjct: 331 DLSANKLTGGLPLTFASCSSMQSLNLGNNLLSGDFLTTVVSNLQSLIYLYVPFNNITGTV 390
Query: 440 PLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKN 499
PLSL NCT L+VLDLSSNGFTG +PS CS N AL+K++L +NYLSG VP ELGSCKN
Sbjct: 391 PLSLANCTHLQVLDLSSNGFTGDVPSKLCSSSNPTALQKLLLADNYLSGKVPSELGSCKN 450
Query: 500 LKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHL 559
L++IDLSFNSL GP+P E+W+LPNL DLVMWANNLTGEIPEGICVNGGNLETLILNNN +
Sbjct: 451 LRSIDLSFNSLNGPIPLEVWTLPNLLDLVMWANNLTGEIPEGICVNGGNLETLILNNNLI 510
Query: 560 TGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCR 619
TG+IP+SI +CTNM+WVSLSSN+LTGEIPAG+GNLV LA+LQ+GNNSLTG++P +G CR
Sbjct: 511 TGSIPQSIGNCTNMIWVSLSSNRLTGEIPAGVGNLVNLAVLQMGNNSLTGKIPPEIGNCR 570
Query: 620 SLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGI 679
SL+WLDLNSNNLSGPLP ELA+QAG+V+PGIVSGKQFAFVRNEGGT+CRGAGGLVEF+GI
Sbjct: 571 SLIWLDLNSNNLSGPLPPELADQAGLVVPGIVSGKQFAFVRNEGGTSCRGAGGLVEFQGI 630
Query: 680 RPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQV 739
R ERLE PMVHSCP+TRIY+GMT+YTF TNGS+I+LDL+YNSLSGT+P+NFGS++YLQV
Sbjct: 631 RAERLENLPMVHSCPTTRIYSGMTVYTFVTNGSMIFLDLAYNSLSGTIPQNFGSMSYLQV 690
Query: 740 LNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGII 799
LNLGHNKLTG+IPDSFGGLKAIGVLDLSHN+ QG +PGSLG LSFLSDLDVSNNNL+G I
Sbjct: 691 LNLGHNKLTGNIPDSFGGLKAIGVLDLSHNDLQGFLPGSLGTLSFLSDLDVSNNNLTGPI 750
Query: 800 PSGGQLTTFPASRYENNSGLCGLPLLPCSSGNHAATVHPHENKQNVETGVVIGIAFFLLI 859
PSGGQLTTFP SRYENNSGLCG+PL PCSSG H + KQ+VE GVVIGI FF+L
Sbjct: 751 PSGGQLTTFPQSRYENNSGLCGVPLPPCSSGGHPQSFTTGGKKQSVEVGVVIGITFFVLC 810
Query: 860 ILGLTLALYRVKKDQKKDEQREKYIESLPTSGSSSWKLSSVPEPLSINVATFEKPLRKLT 919
+ GLTLALYRVK+ Q+K+EQREKYI+SLPTSGSSSWKLS VPEPLSIN+ATFEKPLRKLT
Sbjct: 811 LFGLTLALYRVKRYQRKEEQREKYIDSLPTSGSSSWKLSGVPEPLSINIATFEKPLRKLT 870
Query: 920 FAHLLEATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIG 979
FAHLLEATNGFSADS+IGSGGFGEVYKAQL+DG VVAIKKLIHVTGQGDREFMAEMETIG
Sbjct: 871 FAHLLEATNGFSADSLIGSGGFGEVYKAQLKDGCVVAIKKLIHVTGQGDREFMAEMETIG 930
Query: 980 KIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSA 1039
KIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDR+KGG ++LDWAARKKIAIGSA
Sbjct: 931 KIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRSKGGCSRLDWAARKKIAIGSA 990
Query: 1040 RGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPG 1099
RGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPG
Sbjct: 991 RGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPG 1050
Query: 1100 YVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRIN 1159
YVPPEYYQSFRCT+KGDVYSYGVILLELLSGK+PID +EFGDDNNLVGWAKQL+REKR N
Sbjct: 1051 YVPPEYYQSFRCTSKGDVYSYGVILLELLSGKKPIDSAEFGDDNNLVGWAKQLYREKRSN 1110
Query: 1160 EILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGDSLDSF 1219
ILDPEL Q S E ELYQYLRI+FECLDDRPF+RPTMIQVMAMFKELQVD+E D LD F
Sbjct: 1111 GILDPELMTQKSGEAELYQYLRIAFECLDDRPFRRPTMIQVMAMFKELQVDSESDILDGF 1170
Query: 1220 SLKDTVIEELRERESS 1235
SLKD I+ELRE+ESS
Sbjct: 1171 SLKDASIDELREKESS 1186
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359494370|ref|XP_002265525.2| PREDICTED: receptor-like protein kinase BRI1-like 3-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1761 bits (4561), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 883/1172 (75%), Positives = 1008/1172 (86%), Gaps = 7/1172 (0%)
Query: 63 LMAFKQSSIGSDPNGYLANWTADALTPCSWQGVSCSLNSHVTSLNLNNSGLSGSLNLTTL 122
L+AFK SS+ SDP G+L++W+ D+ PC+W+GVSCS + V +L+L N+GL GSL L+ L
Sbjct: 18 LLAFKSSSVVSDPTGFLSDWSHDSPRPCAWRGVSCSSSGRVVALDLTNAGLVGSLQLSRL 77
Query: 123 TALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYV 182
AL L H++ GN FS GDLS S SC L T+DLS+NN+T L G LL C RL+ +
Sbjct: 78 LALENLRHVHFHGNHFSEGDLSRSYRGSCKLETLDLSANNLTLPLAGPPLLLGCQRLASL 137
Query: 183 NLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNA 242
NLS N I GGSL GPSLLQLDLS N+ISDSA + + LSNCQNLNL N SDNKL KL+A
Sbjct: 138 NLSRNFIPGGSLAFGPSLLQLDLSRNKISDSAFVDHFLSNCQNLNLFNLSDNKLAAKLSA 197
Query: 243 TSVN-CKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNL 301
+S++ CK++ST+DLSYNLLSGE+P S SL+ LDLSHNNF+ K S+++FG CGNL
Sbjct: 198 SSLSPCKNLSTLDLSYNLLSGEMPVGH--SSPPSLRLLDLSHNNFSAKLSSIEFGECGNL 255
Query: 302 SVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQF 361
+V+ LS N SGT+FP SL+NC+LLETL++SHN L+ IPG LLG+ RNL+ LSLAHN+F
Sbjct: 256 TVLDLSHNDFSGTDFPPSLRNCELLETLDLSHNVLEYKIPGDLLGNLRNLRWLSLAHNRF 315
Query: 362 AGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSK 421
GEIPPEL CGTL+ LDLS+N L+G P TFASCSSL SLNLG+N LSG+FL V+S
Sbjct: 316 MGEIPPELAATCGTLQGLDLSANNLSGGFPLTFASCSSLVSLNLGNNRLSGDFLTMVIST 375
Query: 422 ISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVL 481
+ SL YLYVPFNN++G VPLSLTNCTQL+VLDLSSN FTGT P GFCS + LEKI+L
Sbjct: 376 LPSLKYLYVPFNNLTGSVPLSLTNCTQLQVLDLSSNAFTGTFPPGFCSDASQSVLEKILL 435
Query: 482 PNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEG 541
+N+LSGTVPLELG+C+ L++IDLSFN+L+GP+P EIW+LPNLSDLVMWANNLTGEIPEG
Sbjct: 436 ADNFLSGTVPLELGNCQKLRSIDLSFNNLSGPIPYEIWTLPNLSDLVMWANNLTGEIPEG 495
Query: 542 ICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQ 601
IC+ GGNLETLILNNN + G IP S+A+CTN++WVSL+SNQLTGEIPAGIGNL LA+LQ
Sbjct: 496 ICIKGGNLETLILNNNRINGTIPLSLANCTNLIWVSLASNQLTGEIPAGIGNLHNLAVLQ 555
Query: 602 LGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRN 661
LGNN+L G++P LGKC++L+WLDLNSN SG +PSELA++AG+V PG+VSGKQFAFVRN
Sbjct: 556 LGNNTLNGRIPSELGKCQNLIWLDLNSNGFSGSVPSELASEAGLVTPGLVSGKQFAFVRN 615
Query: 662 EGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYN 721
EGGTACRGAGGLVEFEGIR ERL FPMVHSCPSTRIY+G+T+YTF++NGS+IYLDLSYN
Sbjct: 616 EGGTACRGAGGLVEFEGIRSERLASFPMVHSCPSTRIYSGVTVYTFSSNGSMIYLDLSYN 675
Query: 722 SLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGG 781
SLSGT+P++FGSLNYLQVLNLGHN+LTG+IPDS GGLKAIGVLDLSHNN QG IPG+LG
Sbjct: 676 SLSGTIPQSFGSLNYLQVLNLGHNQLTGNIPDSLGGLKAIGVLDLSHNNLQGYIPGALGS 735
Query: 782 LSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPLLPCSS--GNH--AATVH 837
LSFLSDLDVSNNNL+G IPSGGQLTTFPASRY+NNSGLCG+PL PC S G+H A++
Sbjct: 736 LSFLSDLDVSNNNLTGPIPSGGQLTTFPASRYDNNSGLCGVPLPPCGSDAGDHPQASSYS 795
Query: 838 PHENKQNVETGVVIGIAFFLLIILGLTLALYRVKKDQKKDEQREKYIESLPTSGSSSWKL 897
+Q V +VIGI L I GLTLALYR++K+Q+ +EQR+KYIESLPTSGSSSWKL
Sbjct: 796 RKRKQQAVAAEMVIGITVSLFCIFGLTLALYRMRKNQRTEEQRDKYIESLPTSGSSSWKL 855
Query: 898 SSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQLRDGSVVAI 957
SSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSA+S+IGSGGFGEVYKAQLRDG VVAI
Sbjct: 856 SSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSAESLIGSGGFGEVYKAQLRDGCVVAI 915
Query: 958 KKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHD 1017
KKLIHVTGQGDREFMAEMETIGK+KHRNLVPLLGYCKIGEERLLVYEYMKWGSLE+VLHD
Sbjct: 916 KKLIHVTGQGDREFMAEMETIGKVKHRNLVPLLGYCKIGEERLLVYEYMKWGSLEAVLHD 975
Query: 1018 RAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFG 1077
RAKGG + LDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFG
Sbjct: 976 RAKGGVSNLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFG 1035
Query: 1078 MARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPS 1137
MARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGV+LLELLSGKRPID
Sbjct: 1036 MARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVVLLELLSGKRPIDSL 1095
Query: 1138 EFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTM 1197
EFGDDNNLVGWAKQL REKR NEILDPEL Q S E EL+QYL I+FECLDDRPF+RPTM
Sbjct: 1096 EFGDDNNLVGWAKQLQREKRSNEILDPELMTQKSGEAELFQYLNIAFECLDDRPFRRPTM 1155
Query: 1198 IQVMAMFKELQVDTEGDSLDSFSLKDTVIEEL 1229
IQVMAMFKEL VDTE D LD FSLKDTV+EEL
Sbjct: 1156 IQVMAMFKELHVDTESDILDGFSLKDTVVEEL 1187
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|46804805|dbj|BAD16810.1| putative leucine rich repeat-type serine/threonine receptor-like kinase [Daucus carota] | Back alignment and taxonomy information |
|---|
Score = 1650 bits (4273), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 842/1192 (70%), Positives = 976/1192 (81%), Gaps = 10/1192 (0%)
Query: 42 SYARELSSSSRQSGGNEELTILMAFKQSSIGSDPNGYLANW-TADALTPCSWQGVSCSLN 100
S +R+LS + G E+ L FK+ S+ + PNG+L W ++ + +PCSW+G+ CSL
Sbjct: 24 SESRKLSGQVKDQG--NEVEGLANFKKFSVDAGPNGFLKTWDSSSSSSPCSWKGIGCSLE 81
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTA-LPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLS 159
VT LNL +GL G L L+ L LP L L L GNSF G+LS S SSCS +DLS
Sbjct: 82 GAVTVLNLTGAGLVGHLQLSELMDNLPSLSQLYLSGNSF-YGNLS-STASSCSFEVLDLS 139
Query: 160 SNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYS 219
+NN + L +S LL+CD L NLS N IS GSL GPSLLQ DLS N+ISD LLT S
Sbjct: 140 ANNFSEPLDAQSLLLTCDHLMIFNLSRNLISAGSLKFGPSLLQPDLSRNRISDLGLLTDS 199
Query: 220 LSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYL 279
LSNCQNLNLLNFSDNKL GKL + +CK++ST+DLSYN S +I +FVA+S SLK+L
Sbjct: 200 LSNCQNLNLLNFSDNKLTGKLTSFLSSCKNLSTVDLSYNFFS-QIHPNFVANSPASLKFL 258
Query: 280 DLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGG 339
DLSHNNFTG NL+ G C NL+V+ LS N LSGTEFPASL NCQ LETL+M HN
Sbjct: 259 DLSHNNFTGNLVNLELGTCHNLTVLNLSHNSLSGTEFPASLANCQFLETLDMGHNDFHLK 318
Query: 340 IPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSS 399
IPG LLG+ + L+ LSLA N F GEIPPELG AC TL LDLS N+L + P+ F+ C+S
Sbjct: 319 IPGDLLGNLKKLRHLSLAQNSFFGEIPPELGNACRTLEVLDLSGNQLIEQFPTEFSLCTS 378
Query: 400 LHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGF 459
L +LN+ N LSG+FL +V+S + SL YLY+ FNNI+G VP SLTN TQL+VLDLSSN F
Sbjct: 379 LVTLNVSKNQLSGDFLTSVLSPLPSLKYLYLSFNNITGSVPPSLTNATQLQVLDLSSNAF 438
Query: 460 TGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIW 519
TGTIP+GFCS + +LEK++L NNYL G +P ELG+CKNLKTIDLSFNSL GPVPSEIW
Sbjct: 439 TGTIPTGFCSTSSSFSLEKLLLANNYLKGRIPSELGNCKNLKTIDLSFNSLIGPVPSEIW 498
Query: 520 SLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLS 579
+LP ++D+VMW N LTGEIPEGIC++GGNL+TLILNNN ++G+IP+S CTN++WVSLS
Sbjct: 499 TLPYIADIVMWGNGLTGEIPEGICIDGGNLQTLILNNNFISGSIPQSFVKCTNLIWVSLS 558
Query: 580 SNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSEL 639
SNQL G IPAGIGNL+ LAILQLGNNSLTG++P GLGKC+SL+WLDLNSN L+G +P EL
Sbjct: 559 SNQLRGTIPAGIGNLLNLAILQLGNNSLTGEIPPGLGKCKSLIWLDLNSNALTGSIPPEL 618
Query: 640 ANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIY 699
++Q+G+V PG VSGKQFAFVRNEGGTACRGAGGL+E+EGIR ERLE FPMV +CPSTRIY
Sbjct: 619 SSQSGLVSPGPVSGKQFAFVRNEGGTACRGAGGLLEYEGIRAERLEKFPMVLACPSTRIY 678
Query: 700 TGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLK 759
+G T+YTF +NGS+IY DLSYN+LSGT+PE+FGSLN +QV+NLGHN LTG IP SFGGLK
Sbjct: 679 SGRTVYTFASNGSIIYFDLSYNALSGTIPESFGSLNSVQVMNLGHNNLTGSIPSSFGGLK 738
Query: 760 AIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGL 819
IGVLDLS+NN QG+IPGSLGGLSFLSDLDVSNNNLSG +PSGGQLTTFP+SRYENN+GL
Sbjct: 739 YIGVLDLSYNNLQGAIPGSLGGLSFLSDLDVSNNNLSGSVPSGGQLTTFPSSRYENNAGL 798
Query: 820 CGLPLLPCSS--GNHAATVHPHENKQNVETGVVIGIAFFLLIILGLTLALYRVKKDQKKD 877
CG+PL PC S G H + K +V TGV+IGI L I L ALYR++K Q+K+
Sbjct: 799 CGVPLPPCGSENGRHPLRSNSQGKKTSVTTGVMIGIGVSLFSIFILLCALYRIRKYQQKE 858
Query: 878 EQREKYIESLPTSGSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIG 937
E R+KYI SLPTSGSSSWKLSSVPEPLSINVATFEKPL+KLTFAHLLEATNGFSA+S+IG
Sbjct: 859 ELRDKYIGSLPTSGSSSWKLSSVPEPLSINVATFEKPLQKLTFAHLLEATNGFSANSLIG 918
Query: 938 SGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGE 997
SGGFG+VYKAQL DG VVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGE
Sbjct: 919 SGGFGDVYKAQLGDGRVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGE 978
Query: 998 ERLLVYEYMKWGSLESVLHDRAK-GGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHR 1056
ERLLVYEYMKWGSLES +HDR K GGG ++DW ARKKIAIGSARGLAFLHHS IPHIIHR
Sbjct: 979 ERLLVYEYMKWGSLESFIHDRPKVGGGLRIDWPARKKIAIGSARGLAFLHHSRIPHIIHR 1038
Query: 1057 DMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGD 1116
DMKSSNVLLDENFEARVSDFGMARLVNA DTHLSVSTLAGTPGYVPPEYYQSFRCT KGD
Sbjct: 1039 DMKSSNVLLDENFEARVSDFGMARLVNAFDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGD 1098
Query: 1117 VYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETEL 1176
VYSYGV+LLELLSGKRPIDP++FGDDNNLVGWAKQLH+EKR EILD EL + S E EL
Sbjct: 1099 VYSYGVVLLELLSGKRPIDPAQFGDDNNLVGWAKQLHKEKRDLEILDSELLLHQSSEAEL 1158
Query: 1177 YQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGDSLDSFSLKDTVIEE 1228
Y YL+I+FECLD++ ++RPTMIQVMAMFKELQ+D+E D LD S+K++VI+E
Sbjct: 1159 YHYLQIAFECLDEKAYRRPTMIQVMAMFKELQMDSETDILDGLSVKNSVIDE 1210
|
Source: Daucus carota Species: Daucus carota Genus: Daucus Family: Apiaceae Order: Apiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|13620226|emb|CAC36401.1| hypothetical protein [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 1632 bits (4225), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 828/1228 (67%), Positives = 981/1228 (79%), Gaps = 41/1228 (3%)
Query: 10 LSQDQQQQGKGIMGIFGFVLWLLLL--CHLLIMPSYARELSSSSRQSGGNEELTILMAFK 67
+S + + + G+ V+++++L L++ S AR+L+ N+++ L+AFK
Sbjct: 1 MSHKRCHEYFSLNGVLKNVVFMIILLSSSFLVVVSNARKLAE-------NDQVGRLLAFK 53
Query: 68 QSSIGSDPNGYLANWTADALTPCSWQGVSCSLNSHVTSLNLNNSGLSGSLNLTTLTALPY 127
+SS+ SDPNG+L WT + +PC+W G+SCS N V LNL++ GLSG L+LT L ALP
Sbjct: 54 KSSVESDPNGFLNEWTLSSSSPCTWNGISCS-NGQVVELNLSSVGLSGLLHLTDLMALPT 112
Query: 128 LEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHN 187
L +N GN F G+LS S SSCS +DLS+NN + L L SCD + Y+N+S N
Sbjct: 113 LLRVNFSGNHF-YGNLS-SIASSCSFEFLDLSANNFSEVLVLEPLLKSCDNIKYLNVSGN 170
Query: 188 SISGGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNC 247
SI G L GPSLLQLDLS N ISD +L+Y+LSNCQNLNLLNFS NK+ GKL ++ +C
Sbjct: 171 SIKGVVLKFGPSLLQLDLSSNTISDFGILSYALSNCQNLNLLNFSSNKIAGKLKSSISSC 230
Query: 248 KSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLS 307
KS+S +D LS NN TG+ ++LD G C NL+V+ LS
Sbjct: 231 KSLSVLD--------------------------LSRNNLTGELNDLDLGTCQNLTVLNLS 264
Query: 308 QNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPP 367
N L+ EFP SL NCQ L TLN++HN+++ IP LL ++LK+L LAHNQF +IP
Sbjct: 265 FNNLTSVEFPPSLANCQSLNTLNIAHNSIRMEIPVELLVKLKSLKRLVLAHNQFFDKIPS 324
Query: 368 ELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIY 427
ELGQ+C TL ELDLS NRLTGELPSTF CSSL SLNLG+N LSG+FLNTV+S +++L Y
Sbjct: 325 ELGQSCSTLEELDLSGNRLTGELPSTFKLCSSLFSLNLGNNELSGDFLNTVISSLTNLRY 384
Query: 428 LYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLS 487
LY+PFNNI+G VP SL NCT+L+VLDLSSN F G +PS FC + LE ++L +NYL+
Sbjct: 385 LYLPFNNITGYVPKSLVNCTKLQVLDLSSNAFIGNVPSEFCFAASGFPLETMLLASNYLT 444
Query: 488 GTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGG 547
GTVP +LG C+NL+ IDLSFN+L G +P EIW+LPNLS+LVMWANNLTGEIPEGIC+NGG
Sbjct: 445 GTVPKQLGHCRNLRKIDLSFNNLVGSIPLEIWNLPNLSELVMWANNLTGEIPEGICINGG 504
Query: 548 NLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSL 607
NL+TLILNNN ++G +P+SI+ CTN++WVSLSSN+L+GEIP GIGNL LAILQLGNNSL
Sbjct: 505 NLQTLILNNNFISGTLPQSISKCTNLVWVSLSSNRLSGEIPQGIGNLANLAILQLGNNSL 564
Query: 608 TGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTAC 667
TG +P+GLG CR+L+WLDLNSN L+G +P ELA+QAG V PG+ SGKQFAFVRNEGGT C
Sbjct: 565 TGPIPRGLGSCRNLIWLDLNSNALTGSIPLELADQAGHVNPGMASGKQFAFVRNEGGTEC 624
Query: 668 RGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTL 727
RGAGGLVEFEGIR ERL PMVH CPSTRIY+G TMYTFT+NGS+IYLDLSYNSLSGT+
Sbjct: 625 RGAGGLVEFEGIREERLAILPMVHFCPSTRIYSGRTMYTFTSNGSMIYLDLSYNSLSGTI 684
Query: 728 PENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSD 787
P+N GSL++LQVLNLGHN TG IP +FGGLK +GVLDLSHN+ QG IP SLGGLSFLSD
Sbjct: 685 PDNLGSLSFLQVLNLGHNNFTGTIPFNFGGLKIVGVLDLSHNSLQGFIPPSLGGLSFLSD 744
Query: 788 LDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPLLPCSSGN--HAATVHPHENKQNV 845
LDVSNNNLSG IPSGGQLTTFPASRYENNSGLCG+PL PC SGN H+++++ H NK+
Sbjct: 745 LDVSNNNLSGTIPSGGQLTTFPASRYENNSGLCGVPLPPCGSGNGHHSSSIYHHGNKKPT 804
Query: 846 ETGVVIGIAFFLLIILGLTLALYRVKKDQKKDEQREKYIESLPTSGSSSWKLSSVPEPLS 905
G+V+GI + I+ L +ALY++KK Q ++E+R+KYI+SLPTSGSSSWKLS+VPEPLS
Sbjct: 805 TIGMVVGIMVSFICIILLVIALYKIKKTQNEEEKRDKYIDSLPTSGSSSWKLSTVPEPLS 864
Query: 906 INVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTG 965
INVATFEKPLRKLTF HLLEATNGFS++SMIGSGGFGEVYKAQLRDGS VAIKKL+HVTG
Sbjct: 865 INVATFEKPLRKLTFGHLLEATNGFSSESMIGSGGFGEVYKAQLRDGSTVAIKKLVHVTG 924
Query: 966 QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTK 1025
QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHD K GG
Sbjct: 925 QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDGGK-GGMF 983
Query: 1026 LDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085
LDW ARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL
Sbjct: 984 LDWPARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1043
Query: 1086 DTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNL 1145
DTHLSVSTLAGTPGYVPPEYYQSFRCT KGDVYSYGVILLELLSGKRPIDP FGDDNNL
Sbjct: 1044 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKRPIDPRVFGDDNNL 1103
Query: 1146 VGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFK 1205
VGWAKQLH +K+ +EILDPEL S + ELY YL+++FECLD++ +KRPTMIQVM FK
Sbjct: 1104 VGWAKQLHNDKQSHEILDPELITNLSGDAELYHYLKVAFECLDEKSYKRPTMIQVMTKFK 1163
Query: 1206 ELQVDTEGDSLDSFSLKDTVIEELRERE 1233
E+Q D+E D LD S+K +++EE +ERE
Sbjct: 1164 EVQTDSESDILDGISVKGSILEESQERE 1191
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|13620169|emb|CAC36390.1| hypothetical protein [Capsella rubella] | Back alignment and taxonomy information |
|---|
Score = 1621 bits (4197), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 817/1212 (67%), Positives = 955/1212 (78%), Gaps = 59/1212 (4%)
Query: 29 LWLLLLCHLLIMPSYARELSSSSRQSGGNEELTILMAFKQSSIGSDPNGYLANWTADA-L 87
L++L+LC + + + L +S +E +LMAFKQ S+ SDPN L NW ++
Sbjct: 6 LFVLILCFFTALGIHGKRLINSDF-----DETALLMAFKQFSVKSDPNNVLGNWIYESGR 60
Query: 88 TPCSWQGVSCSLNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSK 147
CSW+GVSCS + + L+L N G++G+LNL LTALP L++L LQGN FS+ S
Sbjct: 61 GSCSWRGVSCSDDGRIVGLDLRNGGVTGTLNLANLTALPNLQNLYLQGNYFSSSSGGDSS 120
Query: 148 TSS-CSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLS 206
+ S C L +DLSSN I+ C L VN S+N + G L PS L+
Sbjct: 121 SGSYCYLQVLDLSSNLISDYSLVDYVFSKCSNLVSVNFSNNKLV-GKLGFAPSSLK---- 175
Query: 207 GNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPA 266
S++T+D SYN+LS +IP
Sbjct: 176 ------------------------------------------SLTTVDFSYNILSEKIPE 193
Query: 267 SFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLL 326
SF+++ SLKYLDL+HNNF+G FS+L FG CGNLS +LSQN +SG +FP SL NC+ L
Sbjct: 194 SFISEFPASLKYLDLTHNNFSGDFSDLSFGMCGNLSFFSLSQNNISGVKFPISLPNCRFL 253
Query: 327 ETLNMSHNALQGGIP-GFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNR 385
ETLN+S N L G IP G GSF+NLKQLSLAHN+F+GEIPPEL C TL LDLS N
Sbjct: 254 ETLNISRNNLAGKIPGGEYWGSFQNLKQLSLAHNRFSGEIPPELSLLCKTLETLDLSGNA 313
Query: 386 LTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTN 445
L+GELPS F +C L +LN+G+N LSG+FL+TVVSKI+ + YLYV FNNISG VP+SLTN
Sbjct: 314 LSGELPSQFTACVWLQNLNIGNNYLSGDFLSTVVSKITRITYLYVAFNNISGSVPISLTN 373
Query: 446 CTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDL 505
CT LRVLDLSSNGFTG +PSG CS + P LEK+++ NNYLSGTVP+ELG CK+LKTIDL
Sbjct: 374 CTNLRVLDLSSNGFTGNVPSGLCSQQSSPVLEKLLIANNYLSGTVPVELGKCKSLKTIDL 433
Query: 506 SFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPK 565
SFN L GP+P ++W LPNLSDLVMWANNLTG IPEG+CV GG LET+ILNNN LTG+IP+
Sbjct: 434 SFNELTGPIPKDVWMLPNLSDLVMWANNLTGSIPEGVCVKGGKLETIILNNNLLTGSIPQ 493
Query: 566 SIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLD 625
SI+ CTNM+W+SLSSN+LTG+IP GIGNL KLAILQLGNNSL+G VP+ LG C+SL+WLD
Sbjct: 494 SISRCTNMIWISLSSNRLTGKIPTGIGNLSKLAILQLGNNSLSGNVPRQLGNCKSLIWLD 553
Query: 626 LNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLE 685
LNSNNL+G LP ELA+QAG+VMPG VSGKQFAFVRNEGGT CRGAGGLVEFEGIR ERLE
Sbjct: 554 LNSNNLTGDLPGELASQAGLVMPGSVSGKQFAFVRNEGGTDCRGAGGLVEFEGIRAERLE 613
Query: 686 GFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHN 745
FPMVHSCP+TRIY+GMTMYTF+ NGS+IY D+SYN++SG +P +G++ YLQVLNLGHN
Sbjct: 614 RFPMVHSCPATRIYSGMTMYTFSANGSMIYFDISYNAVSGLIPPGYGNMGYLQVLNLGHN 673
Query: 746 KLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQL 805
++TG+IPDS GGLKAIGVLDLSHN+ QG +PGSLG LSFLSDLDVSNNNL+G IP GGQL
Sbjct: 674 RITGNIPDSLGGLKAIGVLDLSHNDLQGYLPGSLGSLSFLSDLDVSNNNLTGPIPFGGQL 733
Query: 806 TTFPASRYENNSGLCGLPLLPCSSG-NHAATVHPHENKQNVETGVVIGIAFFLLIILGLT 864
TTFP SRY NNSGLCG+PL PC S T H KQ + T V+ GIAF + ++ L
Sbjct: 734 TTFPVSRYANNSGLCGVPLRPCGSAPRRPITSSVHAKKQTLATAVIAGIAFSFMCLVMLF 793
Query: 865 LALYRVKKDQKKDEQREKYIESLPTSGSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLL 924
+ALYRV+K QKK+ +REKYIESLPTSGS SWKLSSVPEPLSINVATFEKPLRKLTFAHLL
Sbjct: 794 MALYRVRKVQKKELKREKYIESLPTSGSCSWKLSSVPEPLSINVATFEKPLRKLTFAHLL 853
Query: 925 EATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHR 984
EATNGFSA++M+GSGGFGEVYKAQLRDGSVVAIKKLI +TGQGDREFMAEMETIGKIKHR
Sbjct: 854 EATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKKLIRITGQGDREFMAEMETIGKIKHR 913
Query: 985 NLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDR-AKGGGTKLDWAARKKIAIGSARGLA 1043
NLVPLLGYCK+GEERLLVYEYMKWGSLE+VLH++ +K GG L+W ARKKIAIG+ARGLA
Sbjct: 914 NLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKSSKKGGIFLNWTARKKIAIGAARGLA 973
Query: 1044 FLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPP 1103
FLHHSCIPHIIHRDMKSSNVLLDE+FEARVSDFGMARLV+ALDTHLSVSTLAGTPGYVPP
Sbjct: 974 FLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDFGMARLVSALDTHLSVSTLAGTPGYVPP 1033
Query: 1104 EYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163
EYYQSFRCT KGDVYSYGVILLELLSGK+PIDP EFG+DNNLVGWAKQL+REK EILD
Sbjct: 1034 EYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPGEFGEDNNLVGWAKQLYREKSGTEILD 1093
Query: 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGD-SLDSFSLK 1222
PEL + S + EL+ YL+I+ +CLDDRPFKRPTMIQVMAMFKEL+ DTE D SLD FSLK
Sbjct: 1094 PELVTEKSGDAELFHYLKIASQCLDDRPFKRPTMIQVMAMFKELKADTEEDESLDEFSLK 1153
Query: 1223 DT-VIEELRERE 1233
+T ++EE R++E
Sbjct: 1154 ETPLVEESRDKE 1165
|
Source: Capsella rubella Species: Capsella rubella Genus: Capsella Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15222751|ref|NP_175957.1| serine/threonine-protein kinase BRI1-like 1 [Arabidopsis thaliana] gi|186491196|ref|NP_001117501.1| serine/threonine-protein kinase BRI1-like 1 [Arabidopsis thaliana] gi|57012628|sp|Q9ZWC8.1|BRL1_ARATH RecName: Full=Serine/threonine-protein kinase BRI1-like 1; AltName: Full=BRASSINOSTEROID INSENSITIVE 1-like protein 1; Flags: Precursor gi|8778502|gb|AAF79510.1|AC002328_18 F20N2.4 [Arabidopsis thaliana] gi|224589444|gb|ACN59256.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332195150|gb|AEE33271.1| serine/threonine-protein kinase BRI1-like 1 [Arabidopsis thaliana] gi|332195151|gb|AEE33272.1| serine/threonine-protein kinase BRI1-like 1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1586 bits (4107), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 773/1036 (74%), Positives = 885/1036 (85%), Gaps = 5/1036 (0%)
Query: 203 LDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSG 262
LDLS N ISD +++ Y S C NL +N S+NKL GKL + +S++T+DLSYN+LS
Sbjct: 130 LDLSSNSISDYSMVDYVFSKCSNLVSVNISNNKLVGKLGFAPSSLQSLTTVDLSYNILSD 189
Query: 263 EIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKN 322
+IP SF++D SLKYLDL+HNN +G FS+L FG CGNL+ +LSQN LSG +FP +L N
Sbjct: 190 KIPESFISDFPASLKYLDLTHNNLSGDFSDLSFGICGNLTFFSLSQNNLSGDKFPITLPN 249
Query: 323 CQLLETLNMSHNALQGGIP-GFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDL 381
C+ LETLN+S N L G IP G GSF+NLKQLSLAHN+ +GEIPPEL C TL LDL
Sbjct: 250 CKFLETLNISRNNLAGKIPNGEYWGSFQNLKQLSLAHNRLSGEIPPELSLLCKTLVILDL 309
Query: 382 SSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPL 441
S N +GELPS F +C L +LNLG+N LSG+FLNTVVSKI+ + YLYV +NNISG VP+
Sbjct: 310 SGNTFSGELPSQFTACVWLQNLNLGNNYLSGDFLNTVVSKITGITYLYVAYNNISGSVPI 369
Query: 442 SLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLK 501
SLTNC+ LRVLDLSSNGFTG +PSGFCS + P LEKI++ NNYLSGTVP+ELG CK+LK
Sbjct: 370 SLTNCSNLRVLDLSSNGFTGNVPSGFCSLQSSPVLEKILIANNYLSGTVPMELGKCKSLK 429
Query: 502 TIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTG 561
TIDLSFN L GP+P EIW LPNLSDLVMWANNLTG IPEG+CV GGNLETLILNNN LTG
Sbjct: 430 TIDLSFNELTGPIPKEIWMLPNLSDLVMWANNLTGTIPEGVCVKGGNLETLILNNNLLTG 489
Query: 562 AIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSL 621
+IP+SI+ CTNM+W+SLSSN+LTG+IP+GIGNL KLAILQLGNNSL+G VP+ LG C+SL
Sbjct: 490 SIPESISRCTNMIWISLSSNRLTGKIPSGIGNLSKLAILQLGNNSLSGNVPRQLGNCKSL 549
Query: 622 VWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRP 681
+WLDLNSNNL+G LP ELA+QAG+VMPG VSGKQFAFVRNEGGT CRGAGGLVEFEGIR
Sbjct: 550 IWLDLNSNNLTGDLPGELASQAGLVMPGSVSGKQFAFVRNEGGTDCRGAGGLVEFEGIRA 609
Query: 682 ERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLN 741
ERLE PMVHSCP+TRIY+GMTMYTF+ NGS+IY D+SYN++SG +P +G++ YLQVLN
Sbjct: 610 ERLERLPMVHSCPATRIYSGMTMYTFSANGSMIYFDISYNAVSGFIPPGYGNMGYLQVLN 669
Query: 742 LGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPS 801
LGHN++TG IPDSFGGLKAIGVLDLSHNN QG +PGSLG LSFLSDLDVSNNNL+G IP
Sbjct: 670 LGHNRITGTIPDSFGGLKAIGVLDLSHNNLQGYLPGSLGSLSFLSDLDVSNNNLTGPIPF 729
Query: 802 GGQLTTFPASRYENNSGLCGLPLLPCSSG-NHAATVHPHENKQNVETGVVIGIAFFLLII 860
GGQLTTFP SRY NNSGLCG+PL PC S T H KQ V T V+ GIAF +
Sbjct: 730 GGQLTTFPVSRYANNSGLCGVPLRPCGSAPRRPITSRIHAKKQTVATAVIAGIAFSFMCF 789
Query: 861 LGLTLALYRVKKDQKKDEQREKYIESLPTSGSSSWKLSSVPEPLSINVATFEKPLRKLTF 920
+ L +ALYRV+K QKK+++REKYIESLPTSGS SWKLSSVPEPLSINVATFEKPLRKLTF
Sbjct: 790 VMLVMALYRVRKVQKKEQKREKYIESLPTSGSCSWKLSSVPEPLSINVATFEKPLRKLTF 849
Query: 921 AHLLEATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGK 980
AHLLEATNGFSA++M+GSGGFGEVYKAQLRDGSVVAIKKLI +TGQGDREFMAEMETIGK
Sbjct: 850 AHLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKKLIRITGQGDREFMAEMETIGK 909
Query: 981 IKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDR-AKGGGTKLDWAARKKIAIGSA 1039
IKHRNLVPLLGYCK+GEERLLVYEYMKWGSLE+VLH++ +K GG L+WAARKKIAIG+A
Sbjct: 910 IKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKSSKKGGIYLNWAARKKIAIGAA 969
Query: 1040 RGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPG 1099
RGLAFLHHSCIPHIIHRDMKSSNVLLDE+FEARVSDFGMARLV+ALDTHLSVSTLAGTPG
Sbjct: 970 RGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDFGMARLVSALDTHLSVSTLAGTPG 1029
Query: 1100 YVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRIN 1159
YVPPEYYQSFRCT KGDVYSYGVILLELLSGK+PIDP EFG+DNNLVGWAKQL+REKR
Sbjct: 1030 YVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPGEFGEDNNLVGWAKQLYREKRGA 1089
Query: 1160 EILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGD-SLDS 1218
EILDPEL S + EL+ YL+I+ +CLDDRPFKRPTMIQ+MAMFKE++ DTE D SLD
Sbjct: 1090 EILDPELVTDKSGDVELFHYLKIASQCLDDRPFKRPTMIQLMAMFKEMKADTEEDESLDE 1149
Query: 1219 FSLKDT-VIEELRERE 1233
FSLK+T ++EE R++E
Sbjct: 1150 FSLKETPLVEESRDKE 1165
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297853266|ref|XP_002894514.1| hypothetical protein ARALYDRAFT_892562 [Arabidopsis lyrata subsp. lyrata] gi|297340356|gb|EFH70773.1| hypothetical protein ARALYDRAFT_892562 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1582 bits (4097), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 772/1036 (74%), Positives = 885/1036 (85%), Gaps = 5/1036 (0%)
Query: 203 LDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSG 262
LDLS N ISD +++ Y S C NL +N S+NKL GKL + KS++T+DLSYN+LS
Sbjct: 137 LDLSSNSISDYSMVDYVFSKCSNLVSVNISNNKLVGKLGFAPSSLKSLTTVDLSYNILSE 196
Query: 263 EIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKN 322
+IP SF++D SLKYLDL+HNN +G FS+L FG CGNLS ++LSQN +SG + P +L N
Sbjct: 197 KIPESFISDLPSSLKYLDLTHNNLSGDFSDLSFGFCGNLSFLSLSQNNISGDKLPITLPN 256
Query: 323 CQLLETLNMSHNALQGGIPGF-LLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDL 381
C+ LETLN+S N L G IPG GSF+NLK LSLAHN+ +GEIPPEL C TL LDL
Sbjct: 257 CKFLETLNISRNNLAGKIPGGGYWGSFQNLKHLSLAHNRLSGEIPPELSLLCKTLVVLDL 316
Query: 382 SSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPL 441
S N +GELP F +C SL +LNLG+N LSG+FL+TVVSKI+ + YLYV +NNISG VP+
Sbjct: 317 SGNAFSGELPPQFTACVSLKNLNLGNNFLSGDFLSTVVSKITGITYLYVAYNNISGSVPI 376
Query: 442 SLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLK 501
SLTNC+ LRVLDLSSNGFTG +PSGFCS + P LEKI++ NNYLSGTVP+ELG CK+LK
Sbjct: 377 SLTNCSNLRVLDLSSNGFTGNVPSGFCSLQSSPVLEKILIANNYLSGTVPMELGKCKSLK 436
Query: 502 TIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTG 561
TIDLSFN L GP+P EIW LPNLSDLVMWANNLTG IPEG+CV GGNLETLILNNN LTG
Sbjct: 437 TIDLSFNELTGPIPKEIWMLPNLSDLVMWANNLTGRIPEGVCVKGGNLETLILNNNLLTG 496
Query: 562 AIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSL 621
+IPKSI+ CTNM+W+SLSSN+LTG+IP+GIGNL KLAILQLGNNSL+G VP+ LG C+SL
Sbjct: 497 SIPKSISRCTNMIWISLSSNRLTGKIPSGIGNLSKLAILQLGNNSLSGNVPRELGNCKSL 556
Query: 622 VWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRP 681
+WLDLNSNNL+G LP ELA+QAG+VMPG VSGKQFAFVRNEGGT CRGAGGLVEFEGIR
Sbjct: 557 IWLDLNSNNLTGDLPGELASQAGLVMPGSVSGKQFAFVRNEGGTDCRGAGGLVEFEGIRA 616
Query: 682 ERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLN 741
ERLE PMVHSCP+TRIY+GMTMYTF+ NGS+IY D+SYN++SG +P +G++ YLQVLN
Sbjct: 617 ERLERLPMVHSCPATRIYSGMTMYTFSANGSMIYFDISYNAVSGFIPPGYGNMGYLQVLN 676
Query: 742 LGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPS 801
LGHN++TG IPD+ GGLKAIGVLDLSHNN QG +PGSLG LSFLSDLDVSNNNL+G IP
Sbjct: 677 LGHNRITGTIPDNLGGLKAIGVLDLSHNNLQGYLPGSLGSLSFLSDLDVSNNNLTGPIPF 736
Query: 802 GGQLTTFPASRYENNSGLCGLPLLPCSSG-NHAATVHPHENKQNVETGVVIGIAFFLLII 860
GGQLTTFP SRY NNSGLCG+PL PC S T H KQ V T V+ GIAF +
Sbjct: 737 GGQLTTFPVSRYANNSGLCGVPLRPCGSAPRRPITSRVHAKKQTVATAVIAGIAFSFMCF 796
Query: 861 LGLTLALYRVKKDQKKDEQREKYIESLPTSGSSSWKLSSVPEPLSINVATFEKPLRKLTF 920
+ L +ALYRV+K QKK+++REKYIESLPTSGS SWKLSSVPEPLSINVATFEKPLRKLTF
Sbjct: 797 VMLVMALYRVRKVQKKEQKREKYIESLPTSGSCSWKLSSVPEPLSINVATFEKPLRKLTF 856
Query: 921 AHLLEATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGK 980
AHLLEATNGFSA++MIGSGGFGEVYKAQLRDGSVVAIKKLI +TGQGDREFMAEMETIGK
Sbjct: 857 AHLLEATNGFSAETMIGSGGFGEVYKAQLRDGSVVAIKKLIRITGQGDREFMAEMETIGK 916
Query: 981 IKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDR-AKGGGTKLDWAARKKIAIGSA 1039
IKHRNLVPLLGYCK+GEERLLVYEYMKWGSLE+VLH++ +K GG L+WA+RKKIAIG+A
Sbjct: 917 IKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKSSKKGGIFLNWASRKKIAIGAA 976
Query: 1040 RGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPG 1099
RGLAFLHHSCIPHIIHRDMKSSNVLLDE+FEARVSDFGMARLV+ALDTHLSVSTLAGTPG
Sbjct: 977 RGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDFGMARLVSALDTHLSVSTLAGTPG 1036
Query: 1100 YVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRIN 1159
YVPPEYYQSFRCT KGDVYSYGVILLELLSGK+PIDP EFG+DNNLVGWAKQL+REKR
Sbjct: 1037 YVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPGEFGEDNNLVGWAKQLYREKRGA 1096
Query: 1160 EILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGD-SLDS 1218
EILDPEL ++ S + EL+ YL+I+ +CLDDRPFKRPTMIQVMAMFKEL+ DTE D SLD
Sbjct: 1097 EILDPELVIEKSGDVELFHYLKIASQCLDDRPFKRPTMIQVMAMFKELKADTEEDESLDE 1156
Query: 1219 FSLKDT-VIEELRERE 1233
FSLK+T ++EE R++E
Sbjct: 1157 FSLKETPLVEESRDKE 1172
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297829874|ref|XP_002882819.1| hypothetical protein ARALYDRAFT_478719 [Arabidopsis lyrata subsp. lyrata] gi|297328659|gb|EFH59078.1| hypothetical protein ARALYDRAFT_478719 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1559 bits (4037), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 781/1038 (75%), Positives = 884/1038 (85%), Gaps = 4/1038 (0%)
Query: 200 LLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNC-KSISTIDLSYN 258
L LD+S N I+DS+++ Y S+C NL +NFS NKL GKL ++ + K I+T+DLS N
Sbjct: 129 LEALDISSNSITDSSMVEYVFSSCLNLVSVNFSHNKLAGKLKSSPLTSNKRITTVDLSNN 188
Query: 259 LLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPA 318
S EIP +F+AD SLK+LDLS +NFTG FS L FG CGNL+V +LSQN +SG FP
Sbjct: 189 RFSDEIPETFIADFPTSLKHLDLSGSNFTGDFSRLSFGLCGNLTVFSLSQNSISGDRFPV 248
Query: 319 SLKNCQLLETLNMSHNALQGGIPG-FLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLR 377
SL NC+LLETLN+S N+L G IPG G+F+NLKQLSLAHN ++GEIPPEL C TL
Sbjct: 249 SLSNCKLLETLNLSRNSLTGKIPGDEYWGNFQNLKQLSLAHNLYSGEIPPELSLLCRTLE 308
Query: 378 ELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISG 437
LDLS N LTG+LP +F SC SL SLNLG+N LSG+FL+TVVSK+S + LY+PFNNISG
Sbjct: 309 VLDLSGNSLTGQLPQSFTSCGSLQSLNLGNNKLSGDFLSTVVSKLSRISNLYLPFNNISG 368
Query: 438 PVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSC 497
VP SLTNCT LRVLDLSSN FTG +PSGFCS LEK ++ NNYLSGTVP+ELG C
Sbjct: 369 SVPSSLTNCTNLRVLDLSSNEFTGEVPSGFCSLQRSSVLEKFLIANNYLSGTVPVELGKC 428
Query: 498 KNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNN 557
K+LKTIDLSFN+L GP+P EIW+LPNLSDLVMWANNLTG IPE ICV+GGNLETLILNNN
Sbjct: 429 KSLKTIDLSFNALTGPIPKEIWTLPNLSDLVMWANNLTGGIPESICVDGGNLETLILNNN 488
Query: 558 HLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGK 617
LTG++P+SI+ CTNMLW+SLSSN LTGEIP GIG L KLAILQLGNNSLTG +P+ LG
Sbjct: 489 LLTGSVPESISKCTNMLWISLSSNLLTGEIPVGIGKLEKLAILQLGNNSLTGNIPRELGN 548
Query: 618 CRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFE 677
C++L+WLDLNSNNL+G LP ELA+QAG+VMPG VSGKQFAFVRNEGGT CRGAGGLVEFE
Sbjct: 549 CKNLIWLDLNSNNLTGNLPGELASQAGLVMPGSVSGKQFAFVRNEGGTDCRGAGGLVEFE 608
Query: 678 GIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYL 737
GIR ERLE FPMVHSCP TRIY+GMTMY F+ NGS+IYLDLSYN++SG++P +G++ YL
Sbjct: 609 GIRAERLEHFPMVHSCPKTRIYSGMTMYMFSGNGSMIYLDLSYNAVSGSIPLGYGAMGYL 668
Query: 738 QVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSG 797
QVLNLGHN LTG IPDSFGGLKAIGVLDLSHNN QG +PGSLGGLSFLSDLDVSNNNL+G
Sbjct: 669 QVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHNNLQGFLPGSLGGLSFLSDLDVSNNNLTG 728
Query: 798 IIPSGGQLTTFPASRYENNSGLCGLPLLPCSSGNHAATVHPHENKQNVETGVVIGIAFFL 857
IP GGQLTTFP +RY NNSGLCG+PL PC SG+ H H KQ++ TG++ GI F
Sbjct: 729 PIPFGGQLTTFPVTRYANNSGLCGVPLPPCGSGSRPTRSHAHPKKQSIATGMITGIVFSF 788
Query: 858 LIILGLTLALYRVKKDQKKDEQREKYIESLPTSGSSSWKLSSVPEPLSINVATFEKPLRK 917
+ I+ L +ALYRV+K QKK++QREKYIESLPTSGSSSWKLSSV EPLSINVATFEKPLRK
Sbjct: 789 MCIVMLIMALYRVRKVQKKEKQREKYIESLPTSGSSSWKLSSVHEPLSINVATFEKPLRK 848
Query: 918 LTFAHLLEATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMET 977
LTFAHLLEATNGFSADSMIGSGGFG+VYKAQL DGSVVAIKKLI VTGQGDREFMAEMET
Sbjct: 849 LTFAHLLEATNGFSADSMIGSGGFGDVYKAQLADGSVVAIKKLIQVTGQGDREFMAEMET 908
Query: 978 IGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIG 1037
IGKIKHRNLVPLLGYCKIGEERLLVYEYMK+GSLE+VLH++ K GG LDW+ARKKIAIG
Sbjct: 909 IGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKKGGIFLDWSARKKIAIG 968
Query: 1038 SARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGT 1097
+ARGLAFLHHSCIPHIIHRDMKSSNVLLD++F ARVSDFGMARLV+ALDTHLSVSTLAGT
Sbjct: 969 AARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVSALDTHLSVSTLAGT 1028
Query: 1098 PGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKR 1157
PGYVPPEYYQSFRCT KGDVYSYGVILLELLSGK+PIDP EFG+DNNLVGWAKQL+REKR
Sbjct: 1029 PGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPEEFGEDNNLVGWAKQLYREKR 1088
Query: 1158 INEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL-QVDTEGDSL 1216
EILDPEL S + EL YL+I+ +CLDDRPFKRPTMIQVM MFKEL QVDTE DSL
Sbjct: 1089 GAEILDPELVTDKSGDVELLHYLKIASQCLDDRPFKRPTMIQVMTMFKELVQVDTENDSL 1148
Query: 1217 DSFSLKDT-VIEELRERE 1233
D FSLK+T ++EE R++E
Sbjct: 1149 DEFSLKETPLVEESRDKE 1166
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15231225|ref|NP_187946.1| receptor-like protein kinase BRI1-like 3 [Arabidopsis thaliana] gi|57012617|sp|Q9LJF3.1|BRL3_ARATH RecName: Full=Receptor-like protein kinase BRI1-like 3; AltName: Full=BRASSINOSTEROID INSENSITIVE 1-like protein 3; Flags: Precursor gi|9280288|dbj|BAB01743.1| receptor protein kinase [Arabidopsis thaliana] gi|22135805|gb|AAM91089.1| AT3g13380/MRP15_1 [Arabidopsis thaliana] gi|224589563|gb|ACN59315.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332641819|gb|AEE75340.1| receptor-like protein kinase BRI1-like 3 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1544 bits (3998), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 800/1138 (70%), Positives = 928/1138 (81%), Gaps = 15/1138 (1%)
Query: 107 NLNNSGLSGSLNLTTLTALPYLEHLNLQGN-SFSAG-DLSTSKTSSCS----LVTMDLSS 160
++N++ L + T++ + P N GN + +G D T + SCS ++ +DL +
Sbjct: 30 DVNDTALLTAFKQTSIKSDPT----NFLGNWRYGSGRDPCTWRGVSCSSDGRVIGLDLRN 85
Query: 161 NNITGSLPGRSFL-LSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYS 219
+TG+L + LS R Y+ ++ S S G SL LDLS N ++DS+++ Y
Sbjct: 86 GGLTGTLNLNNLTALSNLRSLYLQGNNFSSGDSSSSSGCSLEVLDLSSNSLTDSSIVDYV 145
Query: 220 LSNCQNLNLLNFSDNKLPGKLNAT-SVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKY 278
S C NL +NFS NKL GKL ++ S + K I+T+DLS N S EIP +F+AD SLK+
Sbjct: 146 FSTCLNLVSVNFSHNKLAGKLKSSPSASNKRITTVDLSNNRFSDEIPETFIADFPNSLKH 205
Query: 279 LDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQG 338
LDLS NN TG FS L FG C NL+V +LSQN +SG FP SL NC+LLETLN+S N+L G
Sbjct: 206 LDLSGNNVTGDFSRLSFGLCENLTVFSLSQNSISGDRFPVSLSNCKLLETLNLSRNSLIG 265
Query: 339 GIPGF-LLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASC 397
IPG G+F+NL+QLSLAHN ++GEIPPEL C TL LDLS N LTG+LP +F SC
Sbjct: 266 KIPGDDYWGNFQNLRQLSLAHNLYSGEIPPELSLLCRTLEVLDLSGNSLTGQLPQSFTSC 325
Query: 398 SSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSN 457
SL SLNLG+N LSG+FL+TVVSK+S + LY+PFNNISG VP+SLTNC+ LRVLDLSSN
Sbjct: 326 GSLQSLNLGNNKLSGDFLSTVVSKLSRITNLYLPFNNISGSVPISLTNCSNLRVLDLSSN 385
Query: 458 GFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSE 517
FTG +PSGFCS + LEK+++ NNYLSGTVP+ELG CK+LKTIDLSFN+L G +P E
Sbjct: 386 EFTGEVPSGFCSLQSSSVLEKLLIANNYLSGTVPVELGKCKSLKTIDLSFNALTGLIPKE 445
Query: 518 IWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVS 577
IW+LP LSDLVMWANNLTG IPE ICV+GGNLETLILNNN LTG++P+SI+ CTNMLW+S
Sbjct: 446 IWTLPKLSDLVMWANNLTGGIPESICVDGGNLETLILNNNLLTGSLPESISKCTNMLWIS 505
Query: 578 LSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPS 637
LSSN LTGEIP GIG L KLAILQLGNNSLTG +P LG C++L+WLDLNSNNL+G LP
Sbjct: 506 LSSNLLTGEIPVGIGKLEKLAILQLGNNSLTGNIPSELGNCKNLIWLDLNSNNLTGNLPG 565
Query: 638 ELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTR 697
ELA+QAG+VMPG VSGKQFAFVRNEGGT CRGAGGLVEFEGIR ERLE FPMVHSCP TR
Sbjct: 566 ELASQAGLVMPGSVSGKQFAFVRNEGGTDCRGAGGLVEFEGIRAERLEHFPMVHSCPKTR 625
Query: 698 IYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGG 757
IY+GMTMY F++NGS+IYLDLSYN++SG++P +G++ YLQVLNLGHN LTG IPDSFGG
Sbjct: 626 IYSGMTMYMFSSNGSMIYLDLSYNAVSGSIPLGYGAMGYLQVLNLGHNLLTGTIPDSFGG 685
Query: 758 LKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNS 817
LKAIGVLDLSHN+ QG +PGSLGGLSFLSDLDVSNNNL+G IP GGQLTTFP +RY NNS
Sbjct: 686 LKAIGVLDLSHNDLQGFLPGSLGGLSFLSDLDVSNNNLTGPIPFGGQLTTFPLTRYANNS 745
Query: 818 GLCGLPLLPCSSGNHAATVHPHENKQNVETGVVIGIAFFLLIILGLTLALYRVKKDQKKD 877
GLCG+PL PCSSG+ H H KQ++ TG+ GI F + I+ L +ALYR +K QKK+
Sbjct: 746 GLCGVPLPPCSSGSRPTRSHAHPKKQSIATGMSAGIVFSFMCIVMLIMALYRARKVQKKE 805
Query: 878 EQREKYIESLPTSGSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIG 937
+QREKYIESLPTSGSSSWKLSSV EPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIG
Sbjct: 806 KQREKYIESLPTSGSSSWKLSSVHEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIG 865
Query: 938 SGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGE 997
SGGFG+VYKA+L DGSVVAIKKLI VTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGE
Sbjct: 866 SGGFGDVYKAKLADGSVVAIKKLIQVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGE 925
Query: 998 ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRD 1057
ERLLVYEYMK+GSLE+VLH++ K GG LDW+ARKKIAIG+ARGLAFLHHSCIPHIIHRD
Sbjct: 926 ERLLVYEYMKYGSLETVLHEKTKKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRD 985
Query: 1058 MKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDV 1117
MKSSNVLLD++F ARVSDFGMARLV+ALDTHLSVSTLAGTPGYVPPEYYQSFRCT KGDV
Sbjct: 986 MKSSNVLLDQDFVARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDV 1045
Query: 1118 YSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELY 1177
YSYGVILLELLSGK+PIDP EFG+DNNLVGWAKQL+REKR EILDPEL S + EL
Sbjct: 1046 YSYGVILLELLSGKKPIDPEEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELL 1105
Query: 1178 QYLRISFECLDDRPFKRPTMIQVMAMFKEL-QVDTEGDSLDSFSLKDT-VIEELRERE 1233
YL+I+ +CLDDRPFKRPTMIQVM MFKEL QVDTE DSLD F LK+T ++EE R++E
Sbjct: 1106 HYLKIASQCLDDRPFKRPTMIQVMTMFKELVQVDTENDSLDEFLLKETPLVEESRDKE 1163
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1237 | ||||||
| TAIR|locus:2020457 | 1166 | BRL1 "BRI1 like" [Arabidopsis | 0.890 | 0.944 | 0.683 | 0.0 | |
| TAIR|locus:2092810 | 1164 | BRL3 "BRI1-like 3" [Arabidopsi | 0.890 | 0.945 | 0.682 | 0.0 | |
| TAIR|locus:2005498 | 1196 | BRI1 "BRASSINOSTEROID INSENSIT | 0.268 | 0.277 | 0.732 | 6.1e-260 | |
| TAIR|locus:2041150 | 1143 | BRL2 "BRI1-like 2" [Arabidopsi | 0.869 | 0.940 | 0.471 | 1.3e-249 | |
| UNIPROTKB|Q942F3 | 1121 | P0480C01.18-1 "cDNA clone:J033 | 0.792 | 0.874 | 0.487 | 1.8e-238 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.244 | 0.254 | 0.543 | 3.6e-152 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.383 | 0.379 | 0.364 | 1.5e-134 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.838 | 0.801 | 0.336 | 1.8e-133 | |
| TAIR|locus:2154709 | 1036 | PSKR2 "phytosylfokine-alpha re | 0.236 | 0.282 | 0.469 | 3.6e-126 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.481 | 0.524 | 0.320 | 5.4e-126 |
| TAIR|locus:2020457 BRL1 "BRI1 like" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3871 (1367.7 bits), Expect = 0., P = 0.
Identities = 762/1115 (68%), Positives = 877/1115 (78%)
Query: 132 NLQGN-SFSAGDLSTS-KTSSCS----LVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLS 185
N+ GN + +G S S + SCS +V +DL ++ +TG+L L + L + L
Sbjct: 52 NVLGNWKYESGRGSCSWRGVSCSDDGRIVGLDLRNSGLTGTL-NLVNLTALPNLQNLYLQ 110
Query: 186 HNSISGGSLHIGPSL-LQ-LDLSGNQISDSALLTYXXXXXXXXXXXXXXDNKLPGKLNAT 243
N S G G LQ LDLS N ISD +++ Y +NKL GKL
Sbjct: 111 GNYFSSGGDSSGSDCYLQVLDLSSNSISDYSMVDYVFSKCSNLVSVNISNNKLVGKLGFA 170
Query: 244 SVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSV 303
+ +S++T+DLSYN+LS +IP SF++D SLKYLDL+HNN +G FS+L FG CGNL+
Sbjct: 171 PSSLQSLTTVDLSYNILSDKIPESFISDFPASLKYLDLTHNNLSGDFSDLSFGICGNLTF 230
Query: 304 ITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIP-GFLLGSFRNLKQLSLAHNQFA 362
+LSQN LSG +FP +L NC+ LETLN+S N L G IP G GSF+NLKQLSLAHN+ +
Sbjct: 231 FSLSQNNLSGDKFPITLPNCKFLETLNISRNNLAGKIPNGEYWGSFQNLKQLSLAHNRLS 290
Query: 363 GEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKI 422
GEIPPEL C TL LDLS N +GELPS F +C L +LNLG+N LSG+FLNTVVSKI
Sbjct: 291 GEIPPELSLLCKTLVILDLSGNTFSGELPSQFTACVWLQNLNLGNNYLSGDFLNTVVSKI 350
Query: 423 SSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLP 482
+ + YLYV +NNISG VP+SLTNC+ LRVLDLSSNGFTG +PSGFCS + P LEKI++
Sbjct: 351 TGITYLYVAYNNISGSVPISLTNCSNLRVLDLSSNGFTGNVPSGFCSLQSSPVLEKILIA 410
Query: 483 NNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGI 542
NNYLSGTVP+ELG CK+LKTIDLSFN L GP+P EIW LPNLSDLVMWANNLTG IPEG+
Sbjct: 411 NNYLSGTVPMELGKCKSLKTIDLSFNELTGPIPKEIWMLPNLSDLVMWANNLTGTIPEGV 470
Query: 543 CVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQL 602
CV GGNLETLILNNN LTG+IP+SI+ CTNM+W+SLSSN+LTG+IP+GIGNL KLAILQL
Sbjct: 471 CVKGGNLETLILNNNLLTGSIPESISRCTNMIWISLSSNRLTGKIPSGIGNLSKLAILQL 530
Query: 603 GNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNE 662
GNNSL+G VP+ LG C+SL+WLDLNSNNL+G LP ELA+QAG+VMPG VSGKQFAFVRNE
Sbjct: 531 GNNSLSGNVPRQLGNCKSLIWLDLNSNNLTGDLPGELASQAGLVMPGSVSGKQFAFVRNE 590
Query: 663 GGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNS 722
GGT CRGAGGLVEFEGIR ERLE PMVHSCP+TRIY+GMTMYTF+ NGS+IY D+SYN+
Sbjct: 591 GGTDCRGAGGLVEFEGIRAERLERLPMVHSCPATRIYSGMTMYTFSANGSMIYFDISYNA 650
Query: 723 LSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQXXXXXXXXXX 782
+SG +P +G++ YLQVLNLGHN++TG IPDSFGGLKAIGVLDLSHNN Q
Sbjct: 651 VSGFIPPGYGNMGYLQVLNLGHNRITGTIPDSFGGLKAIGVLDLSHNNLQGYLPGSLGSL 710
Query: 783 XXXXXXDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPLLPCSSG-NHAATVHPHEN 841
DVSNNNL+G IP GGQLTTFP SRY NNSGLCG+PL PC S T H
Sbjct: 711 SFLSDLDVSNNNLTGPIPFGGQLTTFPVSRYANNSGLCGVPLRPCGSAPRRPITSRIHAK 770
Query: 842 KQNVETGVVXXXXXXXXXXXXXXXXXYXXXXXXXXXXXXXXYIESLPTSGSSSWKLSSVP 901
KQ V T V+ Y YIESLPTSGS SWKLSSVP
Sbjct: 771 KQTVATAVIAGIAFSFMCFVMLVMALYRVRKVQKKEQKREKYIESLPTSGSCSWKLSSVP 830
Query: 902 EPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLI 961
EPLSINVATFEKPLRKLTFAHLLEATNGFSA++M+GSGGFGEVYKAQLRDGSVVAIKKLI
Sbjct: 831 EPLSINVATFEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKKLI 890
Query: 962 HVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRA-K 1020
+TGQGDREFMAEMETIGKIKHRNLVPLLGYCK+GEERLLVYEYMKWGSLE+VLH+++ K
Sbjct: 891 RITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKSSK 950
Query: 1021 GGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1080
GG L+WAARKKIAIG+ARGLAFLHHSCIPHIIHRDMKSSNVLLDE+FEARVSDFGMAR
Sbjct: 951 KGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDFGMAR 1010
Query: 1081 LVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFG 1140
LV+ALDTHLSVSTLAGTPGYVPPEYYQSFRCT KGDVYSYGVILLELLSGK+PIDP EFG
Sbjct: 1011 LVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPGEFG 1070
Query: 1141 DDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQV 1200
+DNNLVGWAKQL+REKR EILDPEL S + EL+ YL+I+ +CLDDRPFKRPTMIQ+
Sbjct: 1071 EDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELFHYLKIASQCLDDRPFKRPTMIQL 1130
Query: 1201 MAMFKELQVDTEGD-SLDSFSLKDT-VIEELRERE 1233
MAMFKE++ DTE D SLD FSLK+T ++EE R++E
Sbjct: 1131 MAMFKEMKADTEEDESLDEFSLKETPLVEESRDKE 1165
|
|
| TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3831 (1353.6 bits), Expect = 0., P = 0.
Identities = 760/1114 (68%), Positives = 872/1114 (78%)
Query: 132 NLQGN-SFSAG-DLSTSKTSSCS----LVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLS 185
N GN + +G D T + SCS ++ +DL + +TG+L + L + L + L
Sbjct: 51 NFLGNWRYGSGRDPCTWRGVSCSSDGRVIGLDLRNGGLTGTL-NLNNLTALSNLRSLYLQ 109
Query: 186 HNSISGG--SLHIGPSLLQLDLSGNQISDSALLTYXXXXXXXXXXXXXXDNKLPGKLNAT 243
N+ S G S G SL LDLS N ++DS+++ Y NKL GKL ++
Sbjct: 110 GNNFSSGDSSSSSGCSLEVLDLSSNSLTDSSIVDYVFSTCLNLVSVNFSHNKLAGKLKSS 169
Query: 244 -SVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLS 302
S + K I+T+DLS N S EIP +F+AD SLK+LDLS NN TG FS L FG C NL+
Sbjct: 170 PSASNKRITTVDLSNNRFSDEIPETFIADFPNSLKHLDLSGNNVTGDFSRLSFGLCENLT 229
Query: 303 VITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGF-LLGSFRNLKQLSLAHNQF 361
V +LSQN +SG FP SL NC+LLETLN+S N+L G IPG G+F+NL+QLSLAHN +
Sbjct: 230 VFSLSQNSISGDRFPVSLSNCKLLETLNLSRNSLIGKIPGDDYWGNFQNLRQLSLAHNLY 289
Query: 362 AGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSK 421
+GEIPPEL C TL LDLS N LTG+LP +F SC SL SLNLG+N LSG+FL+TVVSK
Sbjct: 290 SGEIPPELSLLCRTLEVLDLSGNSLTGQLPQSFTSCGSLQSLNLGNNKLSGDFLSTVVSK 349
Query: 422 ISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVL 481
+S + LY+PFNNISG VP+SLTNC+ LRVLDLSSN FTG +PSGFCS + LEK+++
Sbjct: 350 LSRITNLYLPFNNISGSVPISLTNCSNLRVLDLSSNEFTGEVPSGFCSLQSSSVLEKLLI 409
Query: 482 PNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEG 541
NNYLSGTVP+ELG CK+LKTIDLSFN+L G +P EIW+LP LSDLVMWANNLTG IPE
Sbjct: 410 ANNYLSGTVPVELGKCKSLKTIDLSFNALTGLIPKEIWTLPKLSDLVMWANNLTGGIPES 469
Query: 542 ICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQ 601
ICV+GGNLETLILNNN LTG++P+SI+ CTNMLW+SLSSN LTGEIP GIG L KLAILQ
Sbjct: 470 ICVDGGNLETLILNNNLLTGSLPESISKCTNMLWISLSSNLLTGEIPVGIGKLEKLAILQ 529
Query: 602 LGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRN 661
LGNNSLTG +P LG C++L+WLDLNSNNL+G LP ELA+QAG+VMPG VSGKQFAFVRN
Sbjct: 530 LGNNSLTGNIPSELGNCKNLIWLDLNSNNLTGNLPGELASQAGLVMPGSVSGKQFAFVRN 589
Query: 662 EGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYN 721
EGGT CRGAGGLVEFEGIR ERLE FPMVHSCP TRIY+GMTMY F++NGS+IYLDLSYN
Sbjct: 590 EGGTDCRGAGGLVEFEGIRAERLEHFPMVHSCPKTRIYSGMTMYMFSSNGSMIYLDLSYN 649
Query: 722 SLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQXXXXXXXXX 781
++SG++P +G++ YLQVLNLGHN LTG IPDSFGGLKAIGVLDLSHN+ Q
Sbjct: 650 AVSGSIPLGYGAMGYLQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHNDLQGFLPGSLGG 709
Query: 782 XXXXXXXDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPLLPCSSGNHAATVHPHEN 841
DVSNNNL+G IP GGQLTTFP +RY NNSGLCG+PL PCSSG+ H H
Sbjct: 710 LSFLSDLDVSNNNLTGPIPFGGQLTTFPLTRYANNSGLCGVPLPPCSSGSRPTRSHAHPK 769
Query: 842 KQNVETGVVXXXXXXXXXXXXXXXXXYXXXXXXXXXXXXXXYIESLPTSGSSSWKLSSVP 901
KQ++ TG+ Y YIESLPTSGSSSWKLSSV
Sbjct: 770 KQSIATGMSAGIVFSFMCIVMLIMALYRARKVQKKEKQREKYIESLPTSGSSSWKLSSVH 829
Query: 902 EPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLI 961
EPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFG+VYKA+L DGSVVAIKKLI
Sbjct: 830 EPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLI 889
Query: 962 HVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKG 1021
VTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMK+GSLE+VLH++ K
Sbjct: 890 QVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKK 949
Query: 1022 GGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081
GG LDW+ARKKIAIG+ARGLAFLHHSCIPHIIHRDMKSSNVLLD++F ARVSDFGMARL
Sbjct: 950 GGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARL 1009
Query: 1082 VNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGD 1141
V+ALDTHLSVSTLAGTPGYVPPEYYQSFRCT KGDVYSYGVILLELLSGK+PIDP EFG+
Sbjct: 1010 VSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPEEFGE 1069
Query: 1142 DNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVM 1201
DNNLVGWAKQL+REKR EILDPEL S + EL YL+I+ +CLDDRPFKRPTMIQVM
Sbjct: 1070 DNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELLHYLKIASQCLDDRPFKRPTMIQVM 1129
Query: 1202 AMFKEL-QVDTEGDSLDSFSLKDT-VIEELRERE 1233
MFKEL QVDTE DSLD F LK+T ++EE R++E
Sbjct: 1130 TMFKELVQVDTENDSLDEFLLKETPLVEESRDKE 1163
|
|
| TAIR|locus:2005498 BRI1 "BRASSINOSTEROID INSENSITIVE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1285 (457.4 bits), Expect = 6.1e-260, Sum P(2) = 6.1e-260
Identities = 247/337 (73%), Positives = 290/337 (86%)
Query: 889 TSGSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQ 948
T+ +++WKL+ V E LSIN+A FEKPLRKLTFA LL+ATNGF DS+IGSGGFG+VYKA
Sbjct: 842 TANNTNWKLTGVKEALSINLAAFEKPLRKLTFADLLQATNGFHNDSLIGSGGFGDVYKAI 901
Query: 949 LRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKW 1008
L+DGS VAIKKLIHV+GQGDREFMAEMETIGKIKHRNLVPLLGYCK+G+ERLLVYE+MK+
Sbjct: 902 LKDGSAVAIKKLIHVSGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGDERLLVYEFMKY 961
Query: 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDEN 1068
GSLE VLHD K G KL+W+ R+KIAIGSARGLAFLHH+C PHIIHRDMKSSNVLLDEN
Sbjct: 962 GSLEDVLHDPKKAG-VKLNWSTRRKIAIGSARGLAFLHHNCSPHIIHRDMKSSNVLLDEN 1020
Query: 1069 FEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELL 1128
EARVSDFGMARL++A+DTHLSVSTLAGTPGYVPPEYYQSFRC+TKGDVYSYGV+LLELL
Sbjct: 1021 LEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELL 1080
Query: 1129 SGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSD-ETELYQYLRISFECL 1187
+GKRP D +FGD NNLVGW KQ H + RI+++ DPEL + E EL Q+L+++ CL
Sbjct: 1081 TGKRPTDSPDFGD-NNLVGWVKQ-HAKLRISDVFDPELMKEDPALEIELLQHLKVAVACL 1138
Query: 1188 DDRPFKRPTMIQVMAMFKELQVDTEGDSLDSF-SLKD 1223
DDR ++RPTM+QVMAMFKE+Q + DS + S++D
Sbjct: 1139 DDRAWRRPTMVQVMAMFKEIQAGSGIDSQSTIRSIED 1175
|
|
| TAIR|locus:2041150 BRL2 "BRI1-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2404 (851.3 bits), Expect = 1.3e-249, P = 1.3e-249
Identities = 532/1128 (47%), Positives = 688/1128 (60%)
Query: 128 LEHLNLQGNSFSAGDLSTSKTSSCSLVTM--DLSSNNITGSLPGRS---FL-LSC--DRL 179
L HL+ Q +S L T S S TM D +N ++ P +S F ++C R+
Sbjct: 22 LTHLS-QSSSSDQSSLKTDSLSLLSFKTMIQDDPNNILSNWSPRKSPCQFSGVTCLGGRV 80
Query: 180 SYVNLSHNSISG----GSLHIGPSLLQLDLSGN--QISDSALLTYXXXXXXXXXXXXXXD 233
+ +NLS + +SG + SL L LS N ++ ++LL
Sbjct: 81 TEINLSGSGLSGIVSFNAFTSLDSLSVLKLSENFFVLNSTSLLLLPLTLTHLELSSSGLI 140
Query: 234 NKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNL 293
LP + N SI+ LSYN +G++P SS L+ LDLS+NN TG S L
Sbjct: 141 GTLPENFFSKYSNLISIT---LSYNNFTGKLPNDLFL-SSKKLQTLDLSYNNITGPISGL 196
Query: 294 DF--GRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNL 351
C +++ + S N +SG SL NC L++LN+S+N G IP G + L
Sbjct: 197 TIPLSSCVSMTYLDFSGNSISGY-ISDSLINCTNLKSLNLSYNNFDGQIPKSF-GELKLL 254
Query: 352 KQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLS 411
+ L L+HN+ G IPPE+G C +L+ L LS N TG +P + +SCS L SL+L +N +S
Sbjct: 255 QSLDLSHNRLTGWIPPEIGDTCRSLQNLRLSYNNFTGVIPESLSSCSWLQSLDLSNNNIS 314
Query: 412 GNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPP 471
G F NT++ SL L + N ISG P S++ C LR+ D SSN F+G IP C P
Sbjct: 315 GPFPNTILRSFGSLQILLLSNNLISGDFPTSISACKSLRIADFSSNRFSGVIPPDLC--P 372
Query: 472 NFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWA 531
+LE++ LP+N ++G +P + C L+TIDLS N L G +P EI +L L + W
Sbjct: 373 GAASLEELRLPDNLVTGEIPPAISQCSELRTIDLSLNYLNGTIPPEIGNLQKLEQFIAWY 432
Query: 532 NNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGI 591
NN+ GEIP I NL+ LILNNN LTG IP +C+N+ WVS +SN+LTGE+P
Sbjct: 433 NNIAGEIPPEIG-KLQNLKDLILNNNQLTGEIPPEFFNCSNIEWVSFTSNRLTGEVPKDF 491
Query: 592 GNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGV-VMPGI 650
G L +LA+LQLGNN+ TG++P LGKC +LVWLDLN+N+L+G +P L Q G + G+
Sbjct: 492 GILSRLAVLQLGNNNFTGEIPPELGKCTTLVWLDLNTNHLTGEIPPRLGRQPGSKALSGL 551
Query: 651 VSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTN 710
+SG AFVRN G + C+G GGLVEF GIRPERL P + SC TR+Y+G + FT
Sbjct: 552 LSGNTMAFVRNVGNS-CKGVGGLVEFSGIRPERLLQIPSLKSCDFTRMYSGPILSLFTRY 610
Query: 711 GSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNN 770
++ YLDLSYN L G +P+ G + LQVL L HN+L+G IP + G LK +GV D S N
Sbjct: 611 QTIEYLDLSYNQLRGKIPDEIGEMIALQVLELSHNQLSGEIPFTIGQLKNLGVFDASDNR 670
Query: 771 FQXXXXXXXXXXXXXXXXDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPLLPCSSG 830
Q D+SNN L+G IP GQL+T PA++Y NN GLCG+PL C +G
Sbjct: 671 LQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQLSTLPATQYANNPGLCGVPLPECKNG 730
Query: 831 NHAATVHPHENKQNVE-------TGVVXXXXXXXXXXXXXXXXXYXXXXXXXXXXXXXXY 883
N+ E K+ +
Sbjct: 731 NNQLPAGTEEGKRAKHGTRAASWANSIVLGVLISAASVCILIVWAIAVRARRRDADDAKM 790
Query: 884 IESLPTSGSSS-WKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFG 942
+ SL S++ WK+ EPLSINVATF++ LRKL F+ L+EATNGFSA SMIG GGFG
Sbjct: 791 LHSLQAVNSATTWKIEKEKEPLSINVATFQRQLRKLKFSQLIEATNGFSAASMIGHGGFG 850
Query: 943 EVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLV 1002
EV+KA L+DGS VAIKKLI ++ QGDREFMAEMET+GKIKHRNLVPLLGYCKIGEERLLV
Sbjct: 851 EVFKATLKDGSSVAIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLV 910
Query: 1003 YEYMKWGSLESVLHDRAKGGGTK-LDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSS 1061
YE+M++GSLE VLH G + L W RKKIA G+A+GL FLHH+CIPHIIHRDMKSS
Sbjct: 911 YEFMQYGSLEEVLHGPRTGEKRRILGWEERKKIAKGAAKGLCFLHHNCIPHIIHRDMKSS 970
Query: 1062 NVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYG 1121
NVLLD++ EARVSDFGMARL++ALDTHLSVSTLAGTPGYVPPEYYQSFRCT KGDVYS G
Sbjct: 971 NVLLDQDMEARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSIG 1030
Query: 1122 VILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDET------- 1174
V++LE+LSGKRP D EFGD NLVGW+K RE + E++D +L + S E+
Sbjct: 1031 VVMLEILSGKRPTDKEEFGD-TNLVGWSKMKAREGKHMEVIDEDLLKEGSSESLNEKEGF 1089
Query: 1175 -------ELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGDS 1215
E+ +YL I+ C+DD P KRP M+QV+A +EL+ +E +S
Sbjct: 1090 EGGVIVKEMLRYLEIALRCVDDFPSKRPNMLQVVASLRELR-GSENNS 1136
|
|
| UNIPROTKB|Q942F3 P0480C01.18-1 "cDNA clone:J033069J12, full insert sequence" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 2299 (814.3 bits), Expect = 1.8e-238, P = 1.8e-238
Identities = 492/1009 (48%), Positives = 642/1009 (63%)
Query: 238 GKLNATS-VNCKS-ISTIDLSYNL-LSGEIP-ASFVADSSGSLKYLDLSHNNFTGKFSNL 293
G L+A C S + +DLS N L G + + +A + G LK L+LS + G
Sbjct: 105 GALSAAGGARCGSKLQALDLSGNAALRGSVADVAALASACGGLKTLNLS-GDAVGAAKVG 163
Query: 294 DFGRCG--NLSVITLSQNGLSGTEFPASLKNCQL--LETLNMSHNALQGGIPGFLLGSFR 349
G G L + LS N ++ + + + + L+++ N + G +P F S
Sbjct: 164 GGGGPGFAGLDSLDLSNNKITDDSDLRWMVDAGVGAVRWLDLALNRISG-VPEFTNCS-- 220
Query: 350 NLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNM 409
L+ L L+ N GE+P C L+ L+LS N L G P A +SL++LNL +N
Sbjct: 221 GLQYLDLSGNLIVGEVPGGALSDCRGLKVLNLSFNHLAGVFPPDIAGLTSLNALNLSNNN 280
Query: 410 LSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCS 469
SG +K+ L L + FN+ +G +P ++ + +L+ LDLSSN F+GTIPS C
Sbjct: 281 FSGELPGEAFAKLQQLTALSLSFNHFNGSIPDTVASLPELQQLDLSSNTFSGTIPSSLCQ 340
Query: 470 PPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVM 529
PN L + L NNYL+G +P + +C +L ++DLS N + G +P+ + L NL DL++
Sbjct: 341 DPN-SKLHLLYLQNNYLTGGIPDAVSNCTSLVSLDLSLNYINGSIPASLGDLGNLQDLIL 399
Query: 530 WANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPA 589
W N L GEIP + G LE LIL+ N LTG+IP +A CT + W+SL+SN+L+G IP+
Sbjct: 400 WQNELEGEIPASLSRIQG-LEHLILDYNGLTGSIPPELAKCTKLNWISLASNRLSGPIPS 458
Query: 590 GIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPG 649
+G L LAIL+L NNS +G +P LG C+SLVWLDLNSN L+G +P ELA Q+G + G
Sbjct: 459 WLGKLSYLAILKLSNNSFSGPIPPELGDCQSLVWLDLNSNQLNGSIPKELAKQSGKMNVG 518
Query: 650 IVSGKQFAFVRN-EGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFT 708
++ G+ + ++RN E + CRG G L+EF IRP+ L P C TR+Y G T YTF
Sbjct: 519 LIVGRPYVYLRNDELSSECRGKGSLLEFTSIRPDDLSRMPSKKLCNFTRMYVGSTEYTFN 578
Query: 709 TNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSH 768
NGS+I+LDLSYN L +P G + YL ++NLGHN L+G IP K + VLDLS+
Sbjct: 579 KNGSMIFLDLSYNQLDSAIPGELGDMFYLMIMNLGHNLLSGTIPSRLAEAKKLAVLDLSY 638
Query: 769 NNFQXXXXXXXXXXXXXXXXDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPLLPCS 828
N + ++SNN L+G IP G L TFP S+YENN+GLCG PL PC
Sbjct: 639 NQLEGPIPNSFSALSLSEI-NLSNNQLNGTIPELGSLATFPKSQYENNTGLCGFPLPPCD 697
Query: 829 -SGNHAATVHPHENKQ-----NVETGVVXXXXXXXXXXXXXXXXXYXXXXXXXXXXXXXX 882
S ++ H +Q ++ G++
Sbjct: 698 HSSPRSSNDHQSHRRQASMASSIAMGLLFSLFCIIVIIIAIGSKR-RRLKNEEASTSRDI 756
Query: 883 YIESLPTSGS--SSWKLS-SVPEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSG 939
YI+S S + S W+ + S LSIN+A FEKPL+ LT A L+EATNGF IGSG
Sbjct: 757 YIDSRSHSATMNSDWRQNLSGTNLLSINLAAFEKPLQNLTLADLVEATNGFHIACQIGSG 816
Query: 940 GFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEER 999
GFG+VYKAQL+DG VVAIKKLIHV+GQGDREF AEMETIGKIKHRNLVPLLGYCK GEER
Sbjct: 817 GFGDVYKAQLKDGKVVAIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKAGEER 876
Query: 1000 LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMK 1059
LLVY+YMK+GSLE VLHDR K G KL+W AR+KIA+G+ARGLAFLHH+CIPHIIHRDMK
Sbjct: 877 LLVYDYMKFGSLEDVLHDRKKIG-KKLNWEARRKIAVGAARGLAFLHHNCIPHIIHRDMK 935
Query: 1060 SSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYS 1119
SSNVL+DE EARVSDFGMARL++ +DTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYS
Sbjct: 936 SSNVLIDEQLEARVSDFGMARLMSVVDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYS 995
Query: 1120 YGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQT-SDETELYQ 1178
YGV+LLELL+GK P D ++FG+DNNLVGW KQ H + +I ++ DPEL + S E EL +
Sbjct: 996 YGVVLLELLTGKPPTDSADFGEDNNLVGWVKQ-HTKLKITDVFDPELLKEDPSVELELLE 1054
Query: 1179 YLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGDSLDSFSLKDTVIE 1227
+L+I+ CLDDRP +RPTM++VMAMFKE+Q + DS S + ++ E
Sbjct: 1055 HLKIACACLDDRPSRRPTMLKVMAMFKEIQAGSTVDSKTSSAAAGSIDE 1103
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 830 (297.2 bits), Expect = 3.6e-152, Sum P(2) = 3.6e-152
Identities = 167/307 (54%), Positives = 220/307 (71%)
Query: 902 EPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLI 961
EPLSIN+A FE+PL K+ ++EAT+ FS ++IG GGFG VYKA L VA+KKL
Sbjct: 889 EPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLS 948
Query: 962 HVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKG 1021
QG+REFMAEMET+GK+KH NLV LLGYC EE+LLVYEYM GSL+ L ++ G
Sbjct: 949 EAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQT-G 1007
Query: 1022 GGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081
LDW+ R KIA+G+ARGLAFLHH IPHIIHRD+K+SN+LLD +FE +V+DFG+ARL
Sbjct: 1008 MLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARL 1067
Query: 1082 VNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPS-EFG 1140
++A ++H+S + +AGT GY+PPEY QS R TTKGDVYS+GVILLEL++GK P P +
Sbjct: 1068 ISACESHVS-TVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKES 1126
Query: 1141 DDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQV 1200
+ NLVGWA Q + + +++DP L ++L + L+I+ CL + P KRP M+ V
Sbjct: 1127 EGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQL-RLLQIAMLCLAETPAKRPNMLDV 1185
Query: 1201 MAMFKEL 1207
+ KE+
Sbjct: 1186 LKALKEI 1192
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 724 (259.9 bits), Expect = 1.5e-134, Sum P(2) = 1.5e-134
Identities = 183/502 (36%), Positives = 270/502 (53%)
Query: 712 SLIY-LDLSYNSLSGTLPENFGSLNYLQ-VLNLGHNKLTGHIPDSFGGLKAIGVLDLSHN 769
S +Y L LS NSL+G +P G L LQ L+L +N TG IP + G L + LDLSHN
Sbjct: 743 SKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHN 802
Query: 770 NFQXXXXXXXXXXXXXXXXDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPLLPCSS 829
+VS NNL G + Q + +PA + N+GLCG PL C
Sbjct: 803 QLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKK--QFSRWPADSFLGNTGLCGSPLSRC-- 858
Query: 830 GNHAATVHPHENKQNVETGVVXXXXXXXXXXXXXXXXXYXXXXXXXXXXXXXXYIESLPT 889
N + + + + + V+ + + T
Sbjct: 859 -NRVRSNNKQQGL-SARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYT 916
Query: 890 SGSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQL 949
S SSS + + +PL N A+ + +R + ++EAT+ S + MIGSGG G+VYKA+L
Sbjct: 917 SSSSSSQATH--KPLFRNGAS-KSDIR---WEDIMEATHNLSEEFMIGSGGSGKVYKAEL 970
Query: 950 RDGSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEE--RLLVYEYM 1006
+G VA+KK++ ++ F E++T+G+I+HR+LV L+GYC E LL+YEYM
Sbjct: 971 ENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYM 1030
Query: 1007 KWGSLESVLH-DRAKGGGTK--LDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNV 1063
K GS+ LH D+ K LDW AR +IA+G A+G+ +LHH C+P I+HRD+KSSNV
Sbjct: 1031 KNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNV 1090
Query: 1064 LLDENFEARVSDFGMAR-LVNALDTHLSVST-LAGTPGYVPPEYYQSFRCTTKGDVYSYG 1121
LLD N EA + DFG+A+ L DT+ +T A + GY+ PEY S + T K DVYS G
Sbjct: 1091 LLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMG 1150
Query: 1122 VILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE---KRINEILDPELT-MQTSDETELY 1177
++L+E+++GK P D S FG + ++V W + H E ++++DP+L + +E
Sbjct: 1151 IVLMEIVTGKMPTD-SVFGAEMDMVRWV-ETHLEVAGSARDKLIDPKLKPLLPFEEDAAC 1208
Query: 1178 QYLRISFECLDDRPFKRPTMIQ 1199
Q L I+ +C P +RP+ Q
Sbjct: 1209 QVLEIALQCTKTSPQERPSSRQ 1230
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1308 (465.5 bits), Expect = 1.8e-133, P = 1.8e-133
Identities = 383/1139 (33%), Positives = 560/1139 (49%)
Query: 124 ALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNITGSL-PGRSFLLSCDRLSYV 182
+L LE L+++ N+F+ +T SC L+ D S NN+TGS+ PG + S L +
Sbjct: 183 SLKNLELLDIKMNTFNGSIPATFGNLSC-LLHFDASQNNLTGSIFPG---ITSLTNLLTL 238
Query: 183 NLSHNSISGG-SLHIGP--SLLQLDLSGNQISDSALLTYXXXXXXXXXXXXXXDNKLPGK 239
+LS NS G IG +L L L N ++ + + + GK
Sbjct: 239 DLSSNSFEGTIPREIGQLENLELLILGKNDLTGR--IPQEIGSLKQLKLLHLEECQFTGK 296
Query: 240 LNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCG 299
+ + S++ +D+S N E+P+S G+L L + +G + G C
Sbjct: 297 IPWSISGLSSLTELDISDNNFDAELPSSM--GELGNLTQLIAKNAGLSGNMPK-ELGNCK 353
Query: 300 NLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHN 359
L+VI LS N L G P + + + + + N L G +P ++ ++N + + L N
Sbjct: 354 KLTVINLSFNALIGP-IPEEFADLEAIVSFFVEGNKLSGRVPDWIQ-KWKNARSIRLGQN 411
Query: 360 QFAG----------------------EIPPELGQACGTLRELDLSSNRLTGELPSTFASC 397
+F+G IP + QA +L L L N LTG + F C
Sbjct: 412 KFSGPLPVLPLQHLLSFAAESNLLSGSIPSHICQA-NSLHSLLLHHNNLTGTIDEAFKGC 470
Query: 398 SSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSN 457
++L LNL N + G + ++++ L+ L + N +G +P L L + LS+N
Sbjct: 471 TNLTELNLLDNHIHGE-VPGYLAELP-LVTLELSQNKFAGMLPAELWESKTLLEISLSNN 528
Query: 458 GFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSE 517
TG IP S L+++ + NN L G +P +G +NL + L N L+G +P
Sbjct: 529 EITGPIPE---SIGKLSVLQRLHIDNNLLEGPIPQSVGDLRNLTNLSLRGNRLSGIIPLA 585
Query: 518 IWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIA--------S 569
+++ L+ L + NNLTG IP I + L++LIL++N L+G+IP I
Sbjct: 586 LFNCRKLATLDLSYNNLTGNIPSAIS-HLTLLDSLILSSNQLSGSIPAEICVGFENEAHP 644
Query: 570 CTNMLW----VSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLD 625
+ L + LS NQLTG+IP I N + +L L N L G +P LG+ +L ++
Sbjct: 645 DSEFLQHHGLLDLSYNQLTGQIPTSIKNCAMVMVLNLQGNLLNGTIPVELGELTNLTSIN 704
Query: 626 LNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERL- 684
L+ N GP+ +P SG V+ +G +G P ++
Sbjct: 705 LSFNEFVGPM-----------LPW--SGP---LVQLQGLILSNN-----HLDGSIPAKIG 743
Query: 685 EGFPMVHSCP-STRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTL----PENFGSLNYLQV 739
+ P + S+ TG + N L +LD+S N LSG + P+ + L
Sbjct: 744 QILPKIAVLDLSSNALTGTLPQSLLCNNYLNHLDVSNNHLSGHIQFSCPDGKEYSSTLLF 803
Query: 740 LNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQXXXXXXXXXXXXXXXXDVSNNNLSGII 799
N N +G + +S + LD+ +N+ D+S+NNL G I
Sbjct: 804 FNSSSNHFSGSLDESISNFTQLSTLDIHNNSLTGRLPSALSDLSSLNYLDLSSNNLYGAI 863
Query: 800 PSGGQLTTFPASRYENNSG--LCGLPLLPCSSGNHAAT-------VHPHENKQNVETGVV 850
P G F S + N SG + L C++G +T +HP+ + T
Sbjct: 864 PCG-ICNIFGLS-FANFSGNYIDMYSLADCAAGGICSTNGTDHKALHPYHRVRRAITICA 921
Query: 851 XXXXXXXXXXXXXXXXXYXXXXXXXXXXXXXXYIESL--PTSGSSSWKLSSVPEPLSINV 908
++ PTS S EPLSIN+
Sbjct: 922 FTFVIIIVLVLLAVYLRRKLVRSRPLAFESASKAKATVEPTSTDELLGKKS-REPLSINL 980
Query: 909 ATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLI--HVTGQ 966
ATFE L ++T +L+AT FS +IG GGFG VYKA L +G VAIK+L H Q
Sbjct: 981 ATFEHALLRVTADDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRLHGGHQF-Q 1039
Query: 967 GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKL 1026
GDREF+AEMETIGK+KH NLVPLLGYC G+ER L+YEYM+ GSLE L +RA L
Sbjct: 1040 GDREFLAEMETIGKVKHPNLVPLLGYCVCGDERFLIYEYMENGSLEMWLRNRADALEA-L 1098
Query: 1027 DWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086
W R KI +GSARGLAFLHH +PHIIHRDMKSSN+LLDENFE RVSDFG+AR+++A +
Sbjct: 1099 GWPDRLKICLGSARGLAFLHHGFVPHIIHRDMKSSNILLDENFEPRVSDFGLARIISACE 1158
Query: 1087 THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLV 1146
TH+S +AGT GY+PPEY + + TTKGDVYS+GV++LELL+G+ P E NLV
Sbjct: 1159 THVSTD-IAGTFGYIPPEYGLTMKSTTKGDVYSFGVVMLELLTGRPPTGQEEVQGGGNLV 1217
Query: 1147 GWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFK 1205
GW + + + NE+ DP L + + ++ + L I+ +C D PFKRPTM++V+ K
Sbjct: 1218 GWVRWMIARGKQNELFDPCLPVSSVWREQMARVLAIARDCTADEPFKRPTMLEVVKGLK 1276
|
|
| TAIR|locus:2154709 PSKR2 "phytosylfokine-alpha receptor 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 700 (251.5 bits), Expect = 3.6e-126, Sum P(2) = 3.6e-126
Identities = 139/296 (46%), Positives = 201/296 (67%)
Query: 916 RKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEM 975
+ L+ LL++TN FS ++IG GGFG VYKA DGS A+K+L GQ +REF AE+
Sbjct: 740 KDLSVEELLKSTNNFSQANIIGCGGFGLVYKANFPDGSKAAVKRLSGDCGQMEREFQAEV 799
Query: 976 ETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIA 1035
E + + +H+NLV L GYCK G +RLL+Y +M+ GSL+ LH+R G T L W R KIA
Sbjct: 800 EALSRAEHKNLVSLQGYCKHGNDRLLIYSFMENGSLDYWLHERVDGNMT-LIWDVRLKIA 858
Query: 1036 IGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLA 1095
G+ARGLA+LH C P++IHRD+KSSN+LLDE FEA ++DFG+ARL+ DTH++ L
Sbjct: 859 QGAARGLAYLHKVCEPNVIHRDVKSSNILLDEKFEAHLADFGLARLLRPYDTHVTTD-LV 917
Query: 1096 GTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE 1155
GT GY+PPEY QS T +GDVYS+GV+LLEL++G+RP++ + +LV Q+ E
Sbjct: 918 GTLGYIPPEYSQSLIATCRGDVYSFGVVLLELVTGRRPVEVCKGKSCRDLVSRVFQMKAE 977
Query: 1156 KRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDT 1211
KR E++D + ++ T L + L I+ +C+D P +RP + +V+ ++L +++
Sbjct: 978 KREAELIDTTIRENVNERTVL-EMLEIACKCIDHEPRRRPLIEEVVTWLEDLPMES 1032
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 727 (261.0 bits), Expect = 5.4e-126, Sum P(2) = 5.4e-126
Identities = 198/618 (32%), Positives = 307/618 (49%)
Query: 233 DNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSN 292
+ L G +++ +C + IDLS N L GEIP+S +L+ L L+ N TGK
Sbjct: 115 NTNLTGAISSEIGDCSELIVIDLSSNSLVGEIPSSL--GKLKNLQELCLNSNGLTGKIPP 172
Query: 293 LDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNA-LQGGIPGFLLGSFRNL 351
+ G C +L + + N LS P L LE++ N+ L G IP + G+ RNL
Sbjct: 173 -ELGDCVSLKNLEIFDNYLS-ENLPLELGKISTLESIRAGGNSELSGKIPEEI-GNCRNL 229
Query: 352 KQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLS 411
K L LA + +G +P LGQ L+ L + S L+GE+P +CS L +L L N LS
Sbjct: 230 KVLGLAATKISGSLPVSLGQL-SKLQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLS 288
Query: 412 GNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPP 471
G L + K+ +L + + NN+ GP+P + L +DLS N F+GTIP F
Sbjct: 289 GT-LPKELGKLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSF---G 344
Query: 472 NFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWA 531
N L++++L +N ++G++P L +C L + N ++G +P EI L L+ + W
Sbjct: 345 NLSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQ 404
Query: 532 NNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGI 591
N L G IP+ + NL+ L L+ N+LTG++P + N+ + L SN ++G IP I
Sbjct: 405 NKLEGNIPDELA-GCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEI 463
Query: 592 GNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIV 651
GN L L+L NN +TG++P+G+G ++L +LDL+ NNLSGP+P E++N + M +
Sbjct: 464 GNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLS 523
Query: 652 SGKQFAFVRNEGGTACRGAGGLV---EFEGIRPERLEGFPMVHSCP-STRIYTGMTMYTF 707
+ ++ + + V + G P+ L ++ S + G +
Sbjct: 524 NNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSL 583
Query: 708 TTNGSLIYLDLSYNSLSGTLPENFGSLNYLQV-LNLGHNKLTGHIPDSFGGLKAIGVLDL 766
+L LDLS N++SGT+PE + L + LNL N L G IP+ L + VLD+
Sbjct: 584 GHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIPERISALNRLSVLDI 643
Query: 767 SHNNFQXXXXXXXXXXXXXXXXDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPLLP 826
SHN ++S+N SG +P + E N+GLC
Sbjct: 644 SHNMLSGDLSALSGLENLVSL-NISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCSKGFRS 702
Query: 827 C--SSGNHAAT---VHPH 839
C S+ + T VH H
Sbjct: 703 CFVSNSSQLTTQRGVHSH 720
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8GUQ5 | BRI1_SOLLC | 2, ., 7, ., 1, 1, ., 1 | 0.5043 | 0.8924 | 0.9146 | N/A | no |
| Q8L899 | BRI1_SOLPE | 2, ., 7, ., 1, 1, ., 1 | 0.5034 | 0.8924 | 0.9146 | N/A | no |
| Q9ZWC8 | BRL1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7461 | 0.8334 | 0.8842 | yes | no |
| Q9LJF3 | BRL3_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7029 | 0.9078 | 0.9647 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | grail3.0140000501 | hypothetical protein (1193 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1237 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-116 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-79 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-49 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-46 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-46 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-32 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-27 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-25 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-24 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-23 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-23 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-21 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-20 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-19 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-18 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-14 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 8e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-09 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 2e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-09 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 2e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-09 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-08 | |
| COG5238 | 388 | COG5238, RNA1, Ran GTPase-activating protein (RanG | 3e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 8e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-06 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 5e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.002 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.003 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 385 bits (990), Expect = e-116
Identities = 295/1002 (29%), Positives = 458/1002 (45%), Gaps = 145/1002 (14%)
Query: 203 LDLSGNQISDS-ALLTYSLSNCQNLNLLNFSDNKLPGKL-NATSVNCKSISTIDLSYNLL 260
+DLSG IS + + L Q +NL S+N+L G + + S+ ++LS N
Sbjct: 74 IDLSGKNISGKISSAIFRLPYIQTINL---SNNQLSGPIPDDIFTTSSSLRYLNLSNNNF 130
Query: 261 SGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASL 320
+G IP + +L+ LDLS+N +G+ N D G +L V+ L N L G + P SL
Sbjct: 131 TGSIPRGSIP----NLETLDLSNNMLSGEIPN-DIGSFSSLKVLDLGGNVLVG-KIPNSL 184
Query: 321 KNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELD 380
N LE L ++ N L G IP LG ++LK + L +N +GEIP E+G +L LD
Sbjct: 185 TNLTSLEFLTLASNQLVGQIPR-ELGQMKSLKWIYLGYNNLSGEIPYEIGGLT-SLNHLD 242
Query: 381 LSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVP 440
L N LTG +PS+ + +L L L N LSG ++ S + LI L + N++SG +P
Sbjct: 243 LVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS-LQKLISLDLSDNSLSGEIP 301
Query: 441 LSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNL 500
+ L +L L SN FTG IP S P L+ + L +N SG +P LG NL
Sbjct: 302 ELVIQLQNLEILHLFSNNFTGKIPVALTS---LPRLQVLQLWSNKFSGEIPKNLGKHNNL 358
Query: 501 KTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLT 560
+DLS NNLTGEIPEG+C + GNL LIL +N L
Sbjct: 359 TVLDLS------------------------TNNLTGEIPEGLC-SSGNLFKLILFSNSLE 393
Query: 561 GAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRS 620
G IPKS+ +C ++ V L N +GE+P+ L + L + NN+L G++ S
Sbjct: 394 GEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPS 453
Query: 621 LVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIR 680
L L L N G LP +
Sbjct: 454 LQMLSLARNKFFGGLP----------------------------------------DSFG 473
Query: 681 PERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVL 740
+RLE + S ++G + L+ L LS N LSG +P+ S L L
Sbjct: 474 SKRLENLDL-----SRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSL 528
Query: 741 NLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIP 800
+L HN+L+G IP SF + + LDLS N G IP +LG + L +++S+N+L G +P
Sbjct: 529 DLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588
Query: 801 SGGQLTTFPASRYENNSGLCGLPLLPCSSGNHAATVHPHENKQNVETG----VVIGIAFF 856
S G AS N LCG G+ + + P + + + AF
Sbjct: 589 STGAFLAINASAVAGNIDLCG--------GDTTSGLPPCKRVRKTPSWWFYITCTLGAFL 640
Query: 857 LLIILGLTLALYRVKK--DQKKDEQREKYIESLPTSGSSSWKLSSVPEPLSINVATFEKP 914
+L ++ R + + K+ E + +W+L +S
Sbjct: 641 VLALVAFGFVFIRGRNNLELKRVENED-----------GTWELQFFDSKVS--------- 680
Query: 915 LRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAE 974
+ +T +L + +++I G G YK + + + K I+ +A+
Sbjct: 681 -KSITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD 736
Query: 975 METIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKI 1034
M GK++H N+V L+G C+ + L++EY++ +L VL + L W R+KI
Sbjct: 737 M---GKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKI 785
Query: 1035 AIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTL 1094
AIG A+ L FLH C P ++ ++ +++D E + + L+ DT +S+
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL-CTDTKCFISS- 842
Query: 1095 AGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR 1154
YV PE ++ T K D+Y +G+IL+ELL+GK P D EFG ++V WA+ +
Sbjct: 843 ----AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA-EFGVHGSIVEWARYCYS 897
Query: 1155 EKRINEILDPELTMQTS-DETELYQYLRISFECLDDRPFKRP 1195
+ ++ +DP + S ++ E+ + + ++ C P RP
Sbjct: 898 DCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP 939
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 280 bits (719), Expect = 4e-79
Identities = 208/583 (35%), Positives = 313/583 (53%), Gaps = 25/583 (4%)
Query: 58 EELTILMAFKQSSIGSDPNGYLANWTADALTPCSWQGVSCSLNSHVTSLNLNNSGLSGSL 117
EEL +L++FK SSI +DP YL+NW + A C WQG++C+ +S V S++L+ +SG +
Sbjct: 29 EELELLLSFK-SSI-NDPLKYLSNWNSSA-DVCLWQGITCNNSSRVVSIDLSGKNISGKI 85
Query: 118 NLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSCD 177
+ LPY++ +NL N S T+S SL ++LS+NN TGS+P S
Sbjct: 86 SSAIF-RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPN--- 141
Query: 178 RLSYVNLSHNSISGG-SLHIG--PSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDN 234
L ++LS+N +SG IG SL LDL GN + + SL+N +L L + N
Sbjct: 142 -LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK--IPNSLTNLTSLEFLTLASN 198
Query: 235 KLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLD 294
+L G++ KS+ I L YN LSGEIP + SL +LDL +NN TG +
Sbjct: 199 QLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLT--SLNHLDLVYNNLTGPIPS-S 255
Query: 295 FGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQL 354
G NL + L QN LSG P S+ + Q L +L++S N+L G IP L+ +NL+ L
Sbjct: 256 LGNLKNLQYLFLYQNKLSG-PIPPSIFSLQKLISLDLSDNSLSGEIPE-LVIQLQNLEIL 313
Query: 355 SLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNF 414
L N F G+IP L + L+ L L SN+ +GE+P ++L L+L +N L+G
Sbjct: 314 HLFSNNFTGKIPVAL-TSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEI 372
Query: 415 LNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFP 474
+ S +L L + N++ G +P SL C LR + L N F+G +PS F P
Sbjct: 373 PEGLCSS-GNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVY 431
Query: 475 ALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNL 534
L+ + NN L G + +L+ + L+ N G +P S L +L + N
Sbjct: 432 FLD---ISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQF 487
Query: 535 TGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNL 594
+G +P + + L L L+ N L+G IP ++SC ++ + LS NQL+G+IPA +
Sbjct: 488 SGAVPRKL-GSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEM 546
Query: 595 VKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPS 637
L+ L L N L+G++P+ LG SLV ++++ N+L G LPS
Sbjct: 547 PVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPS 589
|
Length = 968 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 3e-49
Identities = 80/287 (27%), Positives = 132/287 (45%), Gaps = 47/287 (16%)
Query: 933 DSMIGSGGFGEVYKAQLRDGSV-----VAIKKL-IHVTGQGDREFMAEMETIGKIKHRNL 986
+G G FGEVYK L+ VA+K L + Q EF+ E + K+ H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 987 VPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLH 1046
V LLG C E ++V EYM G L L +L + A+ ARG+ +L
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN---RPKELSLSDLLSFALQIARGMEYLE 120
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP---- 1102
+ IHRD+ + N L+ EN ++SDFG++R + D + G +P
Sbjct: 121 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKV------KGGKLPIRWM 171
Query: 1103 -PEYYQSFRCTTKGDVYSYGVILLELLS-GKRP---IDPSEFGDDNNLVGWAKQLHREKR 1157
PE + + T+K DV+S+GV+L E+ + G+ P + +E ++ + K+ +R +
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE------VLEYLKKGYRLPK 225
Query: 1158 INEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204
P + ELY+ + +C + P RPT +++ +
Sbjct: 226 ------PP-----NCPPELYKLML---QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 2e-48
Identities = 80/287 (27%), Positives = 129/287 (44%), Gaps = 48/287 (16%)
Query: 933 DSMIGSGGFGEVYKAQLRDGSV-----VAIKKLIHVTGQGDR-EFMAEMETIGKIKHRNL 986
+G G FGEVYK +L+ VA+K L + EF+ E + K+ H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 987 VPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLH 1046
V LLG C E +V EYM+ G L S L KL + A+ ARG+ +L
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP----KLSLSDLLSFALQIARGMEYLE 119
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP---- 1102
+ IHRD+ + N L+ EN ++SDFG++R + G +P
Sbjct: 120 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLY------DDDYYRKRGGKLPIRWM 170
Query: 1103 -PEYYQSFRCTTKGDVYSYGVILLELLS-GKRP---IDPSEFGDDNNLVGWAKQLHREKR 1157
PE + + T+K DV+S+GV+L E+ + G++P + E ++ + K +R +
Sbjct: 171 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE------VLEYLKNGYRLPQ 224
Query: 1158 INEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204
P + ELY + +C + P RPT +++ +
Sbjct: 225 ------PP-----NCPPELYDLML---QCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 2e-46
Identities = 86/270 (31%), Positives = 129/270 (47%), Gaps = 27/270 (10%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLVPLLGYC 993
+G G FG+VY A+ + G +VAIK + + DRE + E++ + K+KH N+V L
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHI 1053
+ ++ LV EY + G L +L R G D A + L +LH I
Sbjct: 67 EDEDKLYLVMEYCEGGDLFDLLKKR---GRLSEDEA--RFYLRQILSALEYLHSK---GI 118
Query: 1054 IHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTT 1113
+HRD+K N+LLDE+ +++DFG+AR LD ++T GTP Y+ PE
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQ---LDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 1114 KGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDE 1173
D++S GVIL ELL+GK P F D+ L+ K++ + K P S
Sbjct: 176 AVDIWSLGVILYELLTGKPP-----FPGDDQLLELFKKIGKPK----PPFPPPEWDISP- 225
Query: 1174 TELYQYLRISFECLDDRPFKRPTMIQVMAM 1203
E +R + L P KR T + +
Sbjct: 226 -EAKDLIR---KLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 5e-46
Identities = 82/283 (28%), Positives = 124/283 (43%), Gaps = 46/283 (16%)
Query: 936 IGSGGFGEVYKAQLRDGS----VVAIKKLIHVTGQGDR-EFMAEMETIGKIKHRNLVPLL 990
+G G FGEVYK +L+ VA+K L + +R +F+ E + K+ H N+V LL
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 991 GYCKIGEERLLVYEYMKWGSLESVL----HDRAKGGGTKLDWAARKKIAIGSARGLAFLH 1046
G C E LV EYM+ G L L + L AI A+G+ +L
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP---- 1102
+HRD+ + N L+ E+ ++SDFG++R V D + T G +P
Sbjct: 123 SK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRK-----KTGGKLPIRWM 174
Query: 1103 -PEYYQSFRCTTKGDVYSYGVILLELLS-GKRP---IDPSEFGDDNNLVGWAKQLHREKR 1157
PE + T+K DV+S+GV+L E+ + G P + E + L + R
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV---------LEYLRKGYR 225
Query: 1158 INEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQV 1200
+ PE D ELY+ + C P RPT ++
Sbjct: 226 LP---KPEY---CPD--ELYELML---SCWQLDPEDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 1e-45
Identities = 86/291 (29%), Positives = 128/291 (43%), Gaps = 56/291 (19%)
Query: 936 IGSGGFGEVYKAQLRDGS-----VVAIKKL-IHVTGQGDREFMAEMETIGKIKHRNLVPL 989
+G G FGEVYK L+ VA+K L + + EF+ E + K+ H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC 1049
LG C GE +V EYM G L L G KL ++A+ A+G+ +L
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKH----GEKLTLKDLLQMALQIAKGMEYLESK- 121
Query: 1050 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP-----PE 1104
+ +HRD+ + N L+ EN ++SDFG++R + D G +P PE
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY-----YRKRGGGKLPIKWMAPE 174
Query: 1105 YYQSFRCTTKGDVYSYGVILLELLS-GKRP---IDPSEFGDDNNLVGWAKQLHREKRINE 1160
+ + T+K DV+S+GV+L E+ + G++P + E + L R
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV---------LELLEDGYR--- 222
Query: 1161 ILD-PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVD 1210
L PE ELY+ + +C P RPT F EL D
Sbjct: 223 -LPRPENCPD-----ELYELML---QCWAYDPEDRPT-------FSELVED 257
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 2e-45
Identities = 91/275 (33%), Positives = 132/275 (48%), Gaps = 35/275 (12%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKLI--HVTGQGDREFMAEMETIGKIKHRNLVPLLGY 992
+GSG FG VYKA+ + G +VA+K L + D+ E+ + ++ H N+V L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 993 CKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPH 1052
+ + LV EY + G L L G L KKIA+ RGL +LH +
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSR-----GGPLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 1053 IIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE------YY 1106
IIHRD+K N+LLDEN +++DFG+A+ + + L +T GTP Y+ PE Y
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL--TTFVGTPWYMAPEVLLGGNGY 176
Query: 1107 QSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166
K DV+S GVIL ELL+GK P D QL R + E
Sbjct: 177 -----GPKVDVWSLGVILYELLTGKPPFSGENILDQ-------LQLIRRILGPPLEFDEP 224
Query: 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVM 1201
+ E E ++ +CL+ P KRPT +++
Sbjct: 225 KWSSGSE-EAKDLIK---KCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 4e-45
Identities = 68/196 (34%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLVPLLGYC 993
+G GGFG VY A+ + G VAIK + E + E+E + K+ H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHI 1053
+ LV EY + GSL+ +L + KL +I + GL +LH + I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG----KLSEDEILRILLQILEGLEYLHSN---GI 113
Query: 1054 IHRDMKSSNVLLDE-NFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQS-FRC 1111
IHRD+K N+LLD N + +++DFG+++L+ + T+ GTP Y+ PE
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLT--SDKSLLKTIVGTPAYMAPEVLLGKGYY 171
Query: 1112 TTKGDVYSYGVILLEL 1127
+ K D++S GVIL EL
Sbjct: 172 SEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 82/272 (30%), Positives = 128/272 (47%), Gaps = 42/272 (15%)
Query: 934 SMIGSGGFGEVYKA-QLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLG- 991
IG GGFGEVYKA R G VAIK + + + + + E++ + K KH N+V G
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 992 -YCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCI 1050
K +E +V E+ GSL+ +L ++ A + +GL +LH +
Sbjct: 66 YLKK--DELWIVMEFCSGGSLKDLL--KSTNQTLTESQIA--YVCKELLKGLEYLHSN-- 117
Query: 1051 PHIIHRDMKSSNVLLDENFEARVSDFGMA-RLVNALDTHLSVSTLAGTPGYVPPEYYQSF 1109
IIHRD+K++N+LL + E ++ DFG++ +L + + T+ GTP ++ PE
Sbjct: 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN----TMVGTPYWMAPEVINGK 172
Query: 1110 RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD---PEL 1166
K D++S G+ +EL GK P +L K + +I P L
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPY---------------SELPPMKALFKIATNGPPGL 217
Query: 1167 --TMQTSDETELYQYLRISFECLDDRPFKRPT 1196
+ SD E +L+ +CL P KRPT
Sbjct: 218 RNPEKWSD--EFKDFLK---KCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 15/205 (7%)
Query: 935 MIGSGGFGEVYKAQLRD-GSVVAIKK--LIHVTGQGDREFMAEMETIGKIKHRNLVPLLG 991
++G G FG VY A +D G ++A+K L + + E+ + ++H N+V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 992 YCKIGEERLLVY---EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHS 1048
+ EE+ + EY+ GSL S+L K G KL +K GLA+LH +
Sbjct: 67 -SERDEEKNTLNIFLEYVSGGSLSSLLK---KFG--KLPEPVIRKYTRQILEGLAYLHSN 120
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQS 1108
I+HRD+K +N+L+D + +++DFG A+ + ++T ++ GTP ++ PE +
Sbjct: 121 ---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 1109 FRCTTKGDVYSYGVILLELLSGKRP 1133
D++S G ++E+ +GK P
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 5e-32
Identities = 112/339 (33%), Positives = 159/339 (46%), Gaps = 26/339 (7%)
Query: 497 CKN---LKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLI 553
C N + +IDLS +++G + S I+ LP + + + N L+G IP+ I +L L
Sbjct: 65 CNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLN 124
Query: 554 LNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQ 613
L+NN+ TG+IP+ L LS+N L+GEIP IG+ L +L LG N L G++P
Sbjct: 125 LSNNNFTGSIPRGSIPNLETL--DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182
Query: 614 GLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGL 673
L SL +L L SN L G +P EL + I G N G GGL
Sbjct: 183 SLTNLTSLEFLTLASNQLVGQIPRELGQMKS--LKWIYLG-----YNNLSGEIPYEIGGL 235
Query: 674 VEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGS 733
L +V++ + I + + +L YL L N LSG +P + S
Sbjct: 236 TS--------LNHLDLVYNNLTGPIPSSLGNLK-----NLQYLFLYQNKLSGPIPPSIFS 282
Query: 734 LNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNN 793
L L L+L N L+G IP+ L+ + +L L NNF G IP +L L L L + +N
Sbjct: 283 LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSN 342
Query: 794 NLSGIIPSG-GQLTTFPASRYENNSGLCGLPLLPCSSGN 831
SG IP G+ N+ +P CSSGN
Sbjct: 343 KFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGN 381
|
Length = 968 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 82/266 (30%), Positives = 126/266 (47%), Gaps = 30/266 (11%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGD--REFMAEMETIGKIKHRNLVPLLG- 991
+G G G VYK + + G + A+KK IHV G + ++ + E++T+ + +V G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKK-IHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 992 YCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIP 1051
+ K GE + V EYM GSL +L K L IA +GL +LH
Sbjct: 68 FYKEGEISI-VLEYMDGGSLADLLKKVGKIPEPVL-----AYIARQILKGLDYLHT--KR 119
Query: 1052 HIIHRDMKSSNVLLDENFEARVSDFGMAR-LVNALDTHLSVSTLAGTPGYVPPEYYQSFR 1110
HIIHRD+K SN+L++ E +++DFG+++ L N LD +T GT Y+ PE Q
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC---NTFVGTVTYMSPERIQGES 176
Query: 1111 CTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQT 1170
+ D++S G+ LLE GK P P + + + + I + P L +
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFLPPGQPS------FFELM---QAICDGPPPSLPAEE 227
Query: 1171 SDETELYQYLRISFECLDDRPFKRPT 1196
E ++ CL P KRP+
Sbjct: 228 FSP-EFRDFISA---CLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 73/284 (25%), Positives = 124/284 (43%), Gaps = 50/284 (17%)
Query: 935 MIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDRE---FMAEMETIGKIKHRNLVPLL 990
IG G FG+VY + DG + +K+ I ++ ++E + E++ + K+ H N++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKE-IDLSNMSEKEREDALNEVKILKKLNHPNII--- 62
Query: 991 GYCK--IGEERLL-VYEYMKWGSLESVLHDRAKGGG-----TKLDWAARKKIAIGSARGL 1042
Y + + +L V EY G L + + K G LDW ++ + L
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV--QLCLA----L 116
Query: 1043 AFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP 1102
+LH I+HRD+K N+ L N ++ DFG++++++ T T+ GTP Y+
Sbjct: 117 KYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLS--STVDLAKTVVGTPYYLS 171
Query: 1103 PEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDN--NLVGWAKQLHRE-KRIN 1159
PE Q+ K D++S G +L EL + K P F +N L K L + I
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHP-----FEGENLLELAL--KILKGQYPPIP 224
Query: 1160 EILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203
EL + L P +RP++ Q++
Sbjct: 225 SQYSSELR-------------NLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (310), Expect = 3e-30
Identities = 77/313 (24%), Positives = 123/313 (39%), Gaps = 24/313 (7%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIH---VTGQGDREFMAEMETIGKIKH-RNLVPLLG 991
+G G FGEVY A RD +VA+K L + F+ E++ + + H N+V L
Sbjct: 8 LGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 992 YCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIP 1051
+ + LV EY+ GSLE +L + G A I L +LH
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEA--LFILAQILSALEYLHSK--- 120
Query: 1052 HIIHRDMKSSNVLLDEN-FEARVSDFGMARLVNALDTHLSV----STLAGTPGYVPPEYY 1106
IIHRD+K N+LLD + ++ DFG+A+L+ + S+ ST GTPGY+ PE
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 1107 QSFRC---TTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163
++ D++S G+ L ELL+G P + + + K + +
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEG--EKNSSATSQTLKIILELPTPSLASP 238
Query: 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGDSLDSFSLKD 1223
+ L+ + L P R + ++ + + L D
Sbjct: 239 LSPSNPELISKAASDLLK---KLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPD 295
Query: 1224 TVIEELRERESSS 1236
S
Sbjct: 296 DSAPLRLSLPPSL 308
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 60/203 (29%), Positives = 105/203 (51%), Gaps = 17/203 (8%)
Query: 936 IGSGGFGEVYKA-QLRDGSVVAIKKLIHVTGQGD--REFMAEMETIGKIKHRNLVPLLGY 992
IG G FG VYK L G VAIK++ + + + M E++ + +KH N+V +G
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67
Query: 993 CKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAAR--KKIAIGSARGLAFLHHSCI 1050
+ + ++ EY + GSL ++ K G A ++ +GLA+LH
Sbjct: 68 IETSDSLYIILEYAENGSLRQIIK---KFGPFPESLVAVYVYQV----LQGLAYLHEQ-- 118
Query: 1051 PHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFR 1110
+IHRD+K++N+L ++ +++DFG+A D +++ GTP ++ PE +
Sbjct: 119 -GVIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIEMSG 175
Query: 1111 CTTKGDVYSYGVILLELLSGKRP 1133
+T D++S G ++ELL+G P
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 34/222 (15%)
Query: 936 IGSGGFGEVYKAQLR------DGSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLVP 988
+G G FG+V+ + D +VA+K L R+ F E E + +H N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVL--HDR----AKGGGTK---LDWAARKKIAIGSA 1039
G C G+ ++V+EYM+ G L L H K + L + +IA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 1040 RGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD-------THLSVS 1092
G+ +L H +HRD+ + N L+ + ++ DFGM+R V D T L +
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 1093 TLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRP 1133
++PPE + TT+ DV+S+GV+L E+ + GK+P
Sbjct: 190 -------WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 29/215 (13%)
Query: 935 MIGSGGFGEVYKAQLR-DGS----VVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVP 988
++GSG FG VYK +G VAIK L T + ++E + E + + H ++V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTK--LDWAARKKIAIGSARGLAFLH 1046
LLG C + + L+ + M G L + + G++ L+W + A+G+++L
Sbjct: 74 LLGIC-LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP---- 1102
++HRD+ + NVL+ +++DFG+A+L++ + G VP
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEG-----GKVPIKWM 178
Query: 1103 -PEYYQSFRCTTKGDVYSYGVILLELLS-GKRPID 1135
E T K DV+SYGV + EL++ G +P +
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 66/206 (32%), Positives = 100/206 (48%), Gaps = 24/206 (11%)
Query: 934 SMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYC 993
+ IG G FG+V R G VA+K L + F+AE + ++H NLV LLG
Sbjct: 12 ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVV 69
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHI 1053
G +V EYM GSL L R G + A + A+ G+ +L +
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLEEK---NF 123
Query: 1054 IHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP-----PEYYQS 1108
+HRD+ + NVL+ E+ A+VSDFG+A+ + G +P PE +
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEAS--------QGQDS--GKLPVKWTAPEALRE 173
Query: 1109 FRCTTKGDVYSYGVILLELLS-GKRP 1133
+ +TK DV+S+G++L E+ S G+ P
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 9e-27
Identities = 86/275 (31%), Positives = 128/275 (46%), Gaps = 36/275 (13%)
Query: 936 IGSGGFGEVYKA-QLRDGSVVAIKKLIHVTGQGD--REFMAEMETIGKIKHRNLVPLLGY 992
IG G FG+VY A L G ++A+K++ +E EM+ + +KH NLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG- 66
Query: 993 CKIGEERLLVY-EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIP 1051
++ E++ ++ EY G+LE +L G LD + + GLA+LH
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLE-----HGRILDEHVIRVYTLQLLEGLAYLHSH--- 118
Query: 1052 HIIHRDMKSSNVLLDENFEARVSDFGMA-RLVNALDT-HLSVSTLAGTPGYVPPEYYQSF 1109
I+HRD+K +N+ LD N ++ DFG A +L N T V +LAGTP Y+ PE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 1110 RCTTKG---DVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166
+ G D++S G ++LE+ +GKRP SE DN + H +
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPW--SEL--DNE---FQIMFH--------VGAGH 223
Query: 1167 TMQTSDETELYQYLRISF--ECLDDRPFKRPTMIQ 1199
D +L F CL+ P KRPT +
Sbjct: 224 KPPIPDSLQLSP-EGKDFLDRCLESDPKKRPTASE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 75/279 (26%), Positives = 123/279 (44%), Gaps = 37/279 (13%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLVPLLGYCK 994
IG G FG+VYK L+ + VA+K + F+ E E + + H N+V L+G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 995 IGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHII 1054
+ +V E + GSL + L R K + ++++ +A G+ +L I
Sbjct: 63 QKQPIYIVMELVPGGSLLTFL--RKKKNRLTVK--KLLQMSLDAAAGMEYLESKNC---I 115
Query: 1055 HRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP-----PEYYQSF 1109
HRD+ + N L+ EN ++SDFGM+R + + T++ +P PE
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-----EEEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 1110 RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQ 1169
R T++ DV+SYG++L E S D G + Q RE+ ++ M
Sbjct: 171 RYTSESDVWSYGILLWETFS----------LGDTPYPGMSNQQTRER-----IESGYRMP 215
Query: 1170 TSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208
Y R+ +C P RP+ ++ + ELQ
Sbjct: 216 APQLCPEEIY-RLMLQCWAYDPENRPSFSEI---YNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 83/274 (30%), Positives = 128/274 (46%), Gaps = 36/274 (13%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI 995
+GSG FG V+ + R VAIK +I + +F+ E + + K+ H NLV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIK-MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 996 GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIH 1055
+V EYM G L + L +R GT+ + + +L + IH
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVC----EAMEYLESNGF---IH 123
Query: 1056 RDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP-GYVPPEYYQSFRCTTK 1114
RD+ + N L+ E+ +VSDFG+AR V LD + S P + PPE + R ++K
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYV--LDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181
Query: 1115 GDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDE 1173
DV+S+GV++ E+ S GK P + N+ V + + R+ P+L
Sbjct: 182 SDVWSFGVLMWEVFSEGKMPYE----RFSNSEV--VESVSAGYRLYR---PKLA-----P 227
Query: 1174 TELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207
TE+Y I + C ++P RP FK+L
Sbjct: 228 TEVYT---IMYSCWHEKPEDRPA-------FKKL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 83/264 (31%), Positives = 124/264 (46%), Gaps = 30/264 (11%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLVPLLGYCK 994
+G+G FGEV+ + VA+K L G E F+ E + + K++H LV L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTL--KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 995 IGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHII 1054
E +V EYM GSL L G G KL +A A G+A+L + I
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKS---GEGKKLRLPQLVDMAAQIAEGMAYLESR---NYI 125
Query: 1055 HRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP-GYVPPEYYQSFRCTT 1113
HRD+ + N+L+ EN +++DFG+ARL+ D + A P + PE R T
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIE--DDEYTAREGAKFPIKWTAPEAANYGRFTI 183
Query: 1114 KGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSD 1172
K DV+S+G++L E+++ G+ P G N V +Q+ R R + +
Sbjct: 184 KSDVWSFGILLTEIVTYGRVPYP----GMTNREV--LEQVERGYR--------MPRPPNC 229
Query: 1173 ETELYQYLRISFECLDDRPFKRPT 1196
ELY + +C D P +RPT
Sbjct: 230 PEELYDLML---QCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 86/286 (30%), Positives = 127/286 (44%), Gaps = 51/286 (17%)
Query: 936 IGSGGFGEVYKA--QLRDGSV--VAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLL 990
+G G FG V K ++ G VA+K L G +EF+ E + ++ H +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 991 GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCI 1050
G CK GE +LV E G L L R + + L K++A A G+A+L
Sbjct: 63 GVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYLESK-- 114
Query: 1051 PHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP-----PE- 1104
H +HRD+ + NVLL +A++SDFGM+R + A + A T G P PE
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR----ATTAGRWPLKWYAPEC 169
Query: 1105 -YYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEI- 1161
Y F ++K DV+SYGV L E S G +P + E + E+
Sbjct: 170 INYGKF--SSKSDVWSYGVTLWEAFSYGAKP-------------------YGEMKGAEVI 208
Query: 1162 --LDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFK 1205
L+ + +E Y I C RP RPT ++ + F+
Sbjct: 209 AMLESGERLPRPEECPQEIY-SIMLSCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 69/271 (25%), Positives = 119/271 (43%), Gaps = 25/271 (9%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTG--QGDREFMAEMETIGKIKHRNLVPLLGYC 993
+G+G G V K R + K I + ++ + E++ + K +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHI 1053
+ + EYM GSL+ +L K ++ KIA+ +GL +LH I
Sbjct: 69 YNNGDISICMEYMDGGSLDKIL----KEVQGRIPERILGKIAVAVLKGLTYLHEKH--KI 122
Query: 1054 IHRDMKSSNVLLDENFEARVSDFGMA-RLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCT 1112
IHRD+K SN+L++ + ++ DFG++ +LVN+L T GT Y+ PE Q +
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL-----AKTFVGTSSYMAPERIQGNDYS 177
Query: 1113 TKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSD 1172
K D++S G+ L+EL +G+ P P D + L I++ S
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYPPENDPPDGIF----ELLQY------IVNEPPPRLPSG 227
Query: 1173 ETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203
+ ++ CL P +RP+ +++
Sbjct: 228 KFSPDFQDFVN-LCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 934 SMIGSGGFGEVYKA-QLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGY 992
IG G GEVYKA G VAIKK + + Q + E+ + KH N+V
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKK-MRLRKQNKELIINEILIMKDCKHPNIVDYYDS 83
Query: 993 CKIGEERLLVYEYMKWGSLESVL--HDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCI 1050
+G+E +V EYM GSL ++ + +++ + +GL +LH
Sbjct: 84 YLVGDELWVVMEYMDGGSLTDIITQNF------VRMNEPQIAYVCREVLQGLEYLHSQ-- 135
Query: 1051 PHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFR 1110
++IHRD+KS N+LL ++ +++DFG A + +++ GTP ++ PE +
Sbjct: 136 -NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE--KSKRNSVVGTPYWMAPEVIKRKD 192
Query: 1111 CTTKGDVYSYGVILLELLSGKRP 1133
K D++S G++ +E+ G+ P
Sbjct: 193 YGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 65/206 (31%), Positives = 112/206 (54%), Gaps = 11/206 (5%)
Query: 930 FSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPL 989
F+ + +GSG FGEV++ ++ VAIK L ++F E++ + +++H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC 1049
C +GE ++ E M+ GSL + L G L A+ +A A G+A+L
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPE---GQVLPVASLIDMACQVAEGMAYLEEQ- 123
Query: 1050 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP-GYVPPEYYQS 1108
+ IHRD+ + N+L+ E+ +V+DFG+ARL+ D +LS P + PE
Sbjct: 124 --NSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDK--KIPYKWTAPEAASH 178
Query: 1109 FRCTTKGDVYSYGVILLELLS-GKRP 1133
+TK DV+S+G++L E+ + G+ P
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 65/200 (32%), Positives = 105/200 (52%), Gaps = 11/200 (5%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI 995
+G+G FGEV++ + + VA+K L T +F+AE + + K++H L+ L C +
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 996 GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIH 1055
E +V E MK+GSL L G G L +A A G+A+L + IH
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQ---GGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIH 126
Query: 1056 RDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP-GYVPPEYYQSFRCTTK 1114
RD+ + NVL+ EN +V+DFG+AR++ + A P + PE R + K
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIK--EDIYEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 1115 GDVYSYGVILLELLS-GKRP 1133
DV+S+G++L E+++ G+ P
Sbjct: 185 SDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 70/202 (34%), Positives = 103/202 (50%), Gaps = 12/202 (5%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI 995
IGSG FG V+ + VAIK I + +F+ E + + K+ H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKT-IREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 996 GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIH 1055
LV+E+M+ G L L RA+ G K + + G+A+L S + IH
Sbjct: 71 RSPICLVFEFMEHGCLSDYL--RAQRG--KFSQETLLGMCLDVCEGMAYLESSNV---IH 123
Query: 1056 RDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP-GYVPPEYYQSFRCTTK 1114
RD+ + N L+ EN +VSDFGM R V LD + ST P + PE + + ++K
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFV--LDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181
Query: 1115 GDVYSYGVILLELLS-GKRPID 1135
DV+S+GV++ E+ S GK P +
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 22/215 (10%)
Query: 936 IGSGGFGEVYKAQL------RDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPL 989
+G G FG+V+ A+ +D +VA+K L + ++F E E + ++H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGG----------TKLDWAARKKIAIGSA 1039
G C G+ ++V+EYMK G L L RA G +L + IA A
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFL--RAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 1040 RGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPG 1099
G+ +L H +HRD+ + N L+ EN ++ DFGM+R V + D +
Sbjct: 131 AGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 1100 YVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRP 1133
++PPE + TT+ DV+S GV+L E+ + GK+P
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 16/209 (7%)
Query: 934 SMIGSGGFGEVYKAQ---LRD--GSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLV 987
+G G FG+V + L D G VA+K L H Q +F E+E + + H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 988 PLLGYC--KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFL 1045
G C G L+ EY+ GSL L +++ + +G+ +L
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGMDYL 125
Query: 1046 HHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPG-YVPPE 1104
IHRD+ + N+L++ ++SDFG+A+++ + V +P + PE
Sbjct: 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182
Query: 1105 YYQSFRCTTKGDVYSYGVILLELLSGKRP 1133
++ + ++ DV+S+GV L EL + P
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDP 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 66/223 (29%), Positives = 109/223 (48%), Gaps = 28/223 (12%)
Query: 936 IGSGGFGEVYKAQL------RDGSVVAIKKLIH-VTGQGDREFMAEMETIGKIKHRNLVP 988
IG G FG V++A+ ++VA+K L + +F E + + H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDR---------------AKGGGTKLDWAARKK 1033
LLG C +G+ L++EYM +G L L R K G L + ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 1034 IAIGS--ARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSV 1091
+ I A G+A+L +HRD+ + N L+ EN +++DFG++R + + D + +
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 1092 STLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRP 1133
A ++PPE R TT+ DV++YGV+L E+ S G +P
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 75/238 (31%), Positives = 109/238 (45%), Gaps = 25/238 (10%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKL----IHVTGQGDREFMAEMETIGKIKHRNLVPLL 990
+G G FG+V + +D G + A+K L I + + + E + +I H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEH-TLTERNILSRINHPFIVKLH 59
Query: 991 GYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIA-IGSARGLAFLHHS 1048
Y EE+L LV EY G L S L G + AR A I A L +LH
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGELFSHLSKE----GRFSEERARFYAAEIVLA--LEYLHSL 112
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQS 1108
II+RD+K N+LLD + +++DFG+A+ + +T GTP Y+ PE
Sbjct: 113 ---GIIYRDLKPENILLDADGHIKLTDFGLAKEL--SSEGSRTNTFCGTPEYLAPEVLLG 167
Query: 1109 FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166
D +S GV+L E+L+GK P F ++ + K L R E L PE
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKPP-----FYAEDRKEIYEKILKDPLRFPEFLSPEA 220
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-23
Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 28/219 (12%)
Query: 936 IGSGGFGEVYKAQL------RDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPL 989
+G G FG+V+ A+ +D +VA+K L + ++F E E + ++H+++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGS----------- 1038
G C G L+V+EYM+ G L L R+ G K+ A + +A G
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFL--RSHGPDAKI-LAGGEDVAPGQLTLGQMLAIAS 129
Query: 1039 --ARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAG 1096
A G+ +L H +HRD+ + N L+ + ++ DFGM+R + + D + V
Sbjct: 130 QIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-YYRVGGRTM 185
Query: 1097 TP-GYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRP 1133
P ++PPE + TT+ D++S+GV+L E+ + GK+P
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 64/214 (29%), Positives = 108/214 (50%), Gaps = 27/214 (12%)
Query: 933 DSMIGSGGFGEVYKAQLRDGS----VVAIKKL-IHVTGQGDREFMAEMETIGKIKHRNLV 987
+ +IG G FGEV + +L+ VAIK L + + +F+ E +G+ H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 988 PLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH 1047
L G +++ EYM+ GSL+ L R G K + G A G+ +L
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFL--RENDG--KFTVGQLVGMLRGIASGMKYLSE 124
Query: 1048 SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP----- 1102
+HRD+ + N+L++ N +VSDFG++R + + + T G G +P
Sbjct: 125 MNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE---ATYTTKG--GKIPIRWTA 176
Query: 1103 PEY--YQSFRCTTKGDVYSYGVILLELLS-GKRP 1133
PE Y+ F T+ DV+S+G+++ E++S G+RP
Sbjct: 177 PEAIAYRKF--TSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 75/280 (26%), Positives = 131/280 (46%), Gaps = 39/280 (13%)
Query: 936 IGSGGFGEVYKAQL------RDGSVVAIKKLI-HVTGQGDREFMAEMETIGKIKHRNLVP 988
+G G FG+VYK +L + VAIK L + + +EF E E + ++H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDRA-----------KGGGTKLDWAARKKIAIG 1037
LLG C + +++EY+ G L L + + + LD + IAI
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 1038 SARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGT 1097
A G+ +L H +HRD+ + N L+ E ++SDFG++R + + D + S
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 1098 PGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREK 1156
++PPE + TT+ D++S+GV+L E+ S G +P +G N V ++ R +
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY----YGFSNQEV---IEMIRSR 242
Query: 1157 RINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPT 1196
++ + ++ Y + EC ++ P +RP
Sbjct: 243 QL---------LPCPEDCPARVY-ALMIECWNEIPARRPR 272
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 87/306 (28%), Positives = 131/306 (42%), Gaps = 65/306 (21%)
Query: 931 SADSMIGSGGFGEVYKAQLRD------GSVVAIKKL-IHVTGQGDREFMAEMETIGKI-K 982
+ +G G FG+V KA+ S VA+K L T + + ++EME + I K
Sbjct: 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 74
Query: 983 HRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGG-----------GTKLDWAAR 1031
H+N++ LLG C +V EY G+L L R G L
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 1032 KKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD----- 1086
A ARG+ FL IHRD+ + NVL+ E+ +++DFG+AR ++ +D
Sbjct: 135 VSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 1087 --THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPID--PSEFGD 1141
L V +A PE T + DV+S+GV+L E+ + G P P E
Sbjct: 192 TNGRLPVKWMA-------PEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--- 241
Query: 1142 DNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVM 1201
L K+ +R ++ P+ Q ELY +R +C + P +RPT
Sbjct: 242 --ELFKLLKEGYRMEK------PQNCTQ-----ELYHLMR---DCWHEVPSQRPT----- 280
Query: 1202 AMFKEL 1207
FK+L
Sbjct: 281 --FKQL 284
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 7e-23
Identities = 85/300 (28%), Positives = 136/300 (45%), Gaps = 49/300 (16%)
Query: 923 LLEATNGFSADSMIGSGGFGEVYKA-QLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKI 981
L + T F +IG G +G+VYKA + G +VAIK ++ + + E E + K
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKY 59
Query: 982 -KHRNLVPLLG-YCK----IGEERL-LVYEYMKWGSL-ESVLHDRAKGGGTKLDWAARKK 1033
H N+ G + K +++L LV E GS+ + V R KG K +W A
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY-- 117
Query: 1034 IAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVST 1093
I + RGLA+LH + +IHRD+K N+LL +N E ++ DFG++ +++ T +T
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS--TLGRRNT 172
Query: 1094 LAGTPGYVPPE---------YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144
GTP ++ PE R DV+S G+ +EL GK P D
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARS----DVWSLGITAIELADGKPP-----LCD--- 220
Query: 1145 LVGWAKQLHREKRINEIL--DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMA 1202
+H + + +I P + ++ + IS ECL +RP M +++
Sbjct: 221 -------MHPMRALFKIPRNPPPTLKSPENWSKKFNDF-IS-ECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 9e-23
Identities = 77/269 (28%), Positives = 126/269 (46%), Gaps = 29/269 (10%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI 995
+G+G FG V + R VAIK +I + EF+ E + + K+ H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 996 GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIH 1055
+V EYM G L + L + G + + ++ G+A+L IH
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLRE----HGKRFQPSQLLEMCKDVCEGMAYLESK---QFIH 123
Query: 1056 RDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP-GYVPPEYYQSFRCTTK 1114
RD+ + N L+D+ +VSDFG++R V LD + S + P + PPE + ++K
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 1115 GDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDE 1173
DV+++GV++ E+ S GK P E +++ V Q R R P L +
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPY---ERFNNSETVEKVSQGLRLYR------PHLASEK--- 229
Query: 1174 TELYQYLRISFECLDDRPFKRPTMIQVMA 1202
+Y I + C ++ +RPT Q+++
Sbjct: 230 --VYA---IMYSCWHEKAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 1e-22
Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 21/216 (9%)
Query: 936 IGSGGFGEVYKAQ------LRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPL 989
+G G FG+V+ A+ +D +VA+K L T ++F E E + ++H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKK-----------IAIGS 1038
G C G+ ++V+EYMK G L L +D R+ IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 1039 ARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP 1098
A G+ +L H +HRD+ + N L+ N ++ DFGM+R V + D +
Sbjct: 133 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 1099 GYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRP 1133
++PPE + TT+ DV+S+GVIL E+ + GK+P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 2e-22
Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 32/213 (15%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDRE-----FMAEMETIGKIKHRNLVPL 989
IG G +G+VYKA+ + G +VA+KK+ + ++E + E++ + K++H N+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 990 LGYC--KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH 1047
K +V+EYM L +L K + K GL +LH
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDH-DLTGLLDS----PEVKFTESQIKCYMKQLLEGLQYLHS 118
Query: 1048 SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPG-----YVP 1102
+ I+HRD+K SN+L++ + +++DFG+AR ++ T Y P
Sbjct: 119 N---GILHRDIKGSNILINNDGVLKLADFGLARPYT------KRNSADYTNRVITLWYRP 169
Query: 1103 PE-YYQSFRCTTKGDVYSYGVILLELLSGKRPI 1134
PE + R + D++S G IL EL GK PI
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLGK-PI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDRE---------FMAEMETIGKIKHRN 985
IG G FG V+K + D V A+K+ I ++ RE +A++++ I++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQ-IDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 986 LVPLLGYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAF 1044
+ + +L +V EY + G L +L G L + I GLA
Sbjct: 67 -------SFLDKGKLNIVMEYAENGDLHKLLK---MQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 1045 LHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE 1104
LH I+HRD+KS N+ LD ++ D G+A+L++ D +T+ GTP Y+ PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS--DNTNFANTIVGTPYYLSPE 171
Query: 1105 YYQSFRCTTKGDVYSYGVILLELLSGKRPID 1135
+ K DV++ GV+L E +GK P D
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 6e-22
Identities = 67/202 (33%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 933 DSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGY 992
D +G G FGEV+ + VAIK L T F+ E + + K++H LVPL Y
Sbjct: 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPL--Y 67
Query: 993 CKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIP 1051
+ EE + +V E+M GSL L + G G L +A A G+A++
Sbjct: 68 AVVSEEPIYIVTEFMGKGSLLDFLKE---GDGKYLKLPQLVDMAAQIADGMAYIERM--- 121
Query: 1052 HIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP-GYVPPEYYQSFR 1110
+ IHRD++++N+L+ +N +++DFG+ARL+ D + A P + PE R
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 1111 CTTKGDVYSYGVILLELLSGKR 1132
T K DV+S+G++L EL++ R
Sbjct: 180 FTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 7e-22
Identities = 71/280 (25%), Positives = 120/280 (42%), Gaps = 34/280 (12%)
Query: 929 GFSADSMIGSGGFGEVYKAQ-LRDGSVVAIKKL-IHVTGQGDRE-FMAEMETIGKIKHRN 985
F +G G +G VYK + L D A+K++ + Q +RE + E+ + + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 986 LVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGG---TKLDWAARKKIAIGSARGL 1042
++ G + +V EY +G L + R K + W +I I RGL
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRGL 116
Query: 1043 AFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP 1102
LH I+HRD+KS+N+LL N ++ D G+++++ T GTP Y+
Sbjct: 117 QALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMA 169
Query: 1103 PEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162
PE ++ + K D++S G +L E+ + P + D V Q + I I
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV----QRGKYPPIPPIY 225
Query: 1163 DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMA 1202
+L ++R L +P RP +++A
Sbjct: 226 SQDLQ----------NFIR---SMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 1e-21
Identities = 65/220 (29%), Positives = 99/220 (45%), Gaps = 24/220 (10%)
Query: 928 NGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGD--REFMAEMETIGKIKHRN 985
S +G G G V K +L++ ++ K I D ++ + E+E K
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 986 LVPLLGY------CKIGEERLLVYEYMKWGSLESVLHD-RAKGGGTKLDWAARKKIAIGS 1038
+V G IG + EY + GSL+S+ + +GG KIA
Sbjct: 61 IVKYYGAFLDESSSSIG----IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG--KIAESV 114
Query: 1039 ARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA-RLVNALDTHLSVSTLAGT 1097
+GL++LH IIHRD+K SN+LL + ++ DFG++ LVN+L T GT
Sbjct: 115 LKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA-----GTFTGT 166
Query: 1098 PGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPS 1137
Y+ PE Q + DV+S G+ LLE+ + P P
Sbjct: 167 SFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 73/276 (26%), Positives = 131/276 (47%), Gaps = 35/276 (12%)
Query: 935 MIGSGGFGEVYKA-QLRDGSVVAIKK--LIHVTGQGDREFM--------AEMETIGKIKH 983
+IG G +G VY A + G ++A+K+ L +E+ET+ + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 984 RNLVPLLGYCKIGEERLLVY-EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGL 1042
N+V LG+ EE L ++ EY+ GS+ S L R G + + + GL
Sbjct: 68 LNIVQYLGFET-TEEYLSIFLEYVPGGSIGSCL--RTYG---RFEEQLVRFFTEQVLEGL 121
Query: 1043 AFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP 1102
A+LH I+HRD+K+ N+L+D + ++SDFG+++ + + + ++ G+ ++
Sbjct: 122 AYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178
Query: 1103 PEYYQSFRC--TTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINE 1160
PE S+ + K D++S G ++LE+ +G+RP + D+ + K L ++
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-----WSDEEAIAAMFK-LGNKRSAPP 232
Query: 1161 ILDPELTMQTSDETELYQYLRISFECLDDRPFKRPT 1196
I P+++M S +L C P RPT
Sbjct: 233 I-PPDVSMNLSPVA--LDFLN---ACFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 76/276 (27%), Positives = 129/276 (46%), Gaps = 36/276 (13%)
Query: 935 MIGSGGFGEVYKA-QLRDGSVVAIKK-LIHVTGQGDREFMAEMET----IGKIKHRNLVP 988
++GSG FG VY+ L DG A+K+ + GQ +E + ++E + K++H N+V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 989 LLGYCKIGEERLLVY-EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH 1047
LG + E+ L ++ E + GSL +L + R+ + GL +LH
Sbjct: 67 YLGTER-EEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLHD 120
Query: 1048 SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYY- 1106
+ +HRD+K +N+L+D N +++DFGMA+ V S G+P ++ PE
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK---GSPYWMAPEVIA 174
Query: 1107 QSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166
Q D++S G +LE+ +GK P E V ++ R K + I D L
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELPPIPD-HL 227
Query: 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMA 1202
+ + D ++ +CL P RPT +++
Sbjct: 228 SDEAKD------FIL---KCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-21
Identities = 69/205 (33%), Positives = 108/205 (52%), Gaps = 26/205 (12%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIH-VTGQGDREFMAEMETIGKIKHRNLVPLLGYCK 994
IG G FG+V R G+ VA+K + + T Q F+AE + +++H NLV LLG
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGV-- 67
Query: 995 IGEER---LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIP 1051
I EE+ +V EYM GSL L R G + L K ++ + +L +
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEAN--- 121
Query: 1052 HIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL-DT-HLSVSTLAGTPGYVPPEYYQSF 1109
+ +HRD+ + NVL+ E+ A+VSDFG+ + ++ DT L V + PE +
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-------WTAPEALREK 174
Query: 1110 RCTTKGDVYSYGVILLELLS-GKRP 1133
+ +TK DV+S+G++L E+ S G+ P
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 3e-21
Identities = 68/285 (23%), Positives = 122/285 (42%), Gaps = 36/285 (12%)
Query: 936 IGSGGFGEVYKAQLR------DGSVVAIKKLIHVTGQG-DREFMAEMETIGKIKHRNLVP 988
+G G FGEV+ A+ + ++V +K L + EF E++ K+ H+N+V
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTK----LDWAARKKIAIGSARGLAF 1044
LLG C+ E ++ EY G L+ L L + + A G+
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 1045 LHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP-GYVPP 1103
L ++ +HRD+ + N L+ E +VS +++ V + + + L P ++ P
Sbjct: 133 LSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI--PLRWLAP 187
Query: 1104 EYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGW-AKQLHREKRINEI 1161
E Q +TK DV+S+GV++ E+ + G+ P D+ L A +L
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF--YGLSDEEVLNRLQAGKL--------- 236
Query: 1162 LDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206
EL + + LY ++ C P RP+ ++++ E
Sbjct: 237 ---ELPVPEGCPSRLY---KLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 3e-21
Identities = 69/223 (30%), Positives = 117/223 (52%), Gaps = 27/223 (12%)
Query: 924 LEATNGFSADSMIGSGGFGEVYKAQLRDGS----VVAIKKL-IHVTGQGDREFMAEMETI 978
++A+ + +IG+G FGEV +L+ VAIK L T + R+F++E +
Sbjct: 1 IDASC-IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIM 59
Query: 979 GKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVL--HDRAKGGGTKLDWAARKKIAI 1036
G+ H N++ L G + ++V EYM+ GSL++ L HD G T + +
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD---GQFTVIQLVGMLR--- 113
Query: 1037 GSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAG 1096
G A G+ +L +HRD+ + N+L++ N +VSDFG++R++ D + T G
Sbjct: 114 GIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE--DDPEAAYTTRG 168
Query: 1097 TPGYVP-----PEYYQSFRCTTKGDVYSYGVILLELLS-GKRP 1133
G +P PE + T+ DV+SYG+++ E++S G+RP
Sbjct: 169 --GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-21
Identities = 59/155 (38%), Positives = 87/155 (56%), Gaps = 23/155 (14%)
Query: 716 LDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSI 775
L L L G +P + L +LQ +NL N + G+IP S G + ++ VLDLS+N+F GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 776 PGSLGGLSFLSDLDVSNNNLSGIIPS--GGQLTTFPASRYENNSGLCGLP-LLPCSSGNH 832
P SLG L+ L L+++ N+LSG +P+ GG+L + + +N+GLCG+P L C
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG---- 538
Query: 833 AATVHPHENKQNVETGVVIGIAFFLLIILGLTLAL 867
PH + G IGIAF G+++A
Sbjct: 539 -----PH-----LSVGAKIGIAF------GVSVAF 557
|
Length = 623 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 56/193 (29%), Positives = 100/193 (51%), Gaps = 9/193 (4%)
Query: 936 IGSGGFGEVYKAQL-RDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCK 994
+G G +GEVY+ + VA+K L T + + EF+ E + +IKH NLV LLG C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 995 IGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHII 1054
++ E+M +G+L L + + +++ +A + + +L + I
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNR---QEVNAVVLLYMATQISSAMEYLEKK---NFI 126
Query: 1055 HRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTK 1114
HRD+ + N L+ EN +V+DFG++RL+ DT+ + + + PE + + K
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIK 185
Query: 1115 GDVYSYGVILLEL 1127
DV+++GV+L E+
Sbjct: 186 SDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 4e-21
Identities = 64/217 (29%), Positives = 114/217 (52%), Gaps = 22/217 (10%)
Query: 928 NGFSADSMIGSGGFGEVYKAQL----RDGSVVAIKKL-IHVTGQGDREFMAEMETIGKIK 982
+ + +IG+G FGEV++ L R VAIK L T + ++F++E +G+
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 983 HRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGL 1042
H N++ L G + +++ EYM+ G+L+ L D G + + G A G+
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDH-DGEFSSYQLVGMLR---GIAAGM 120
Query: 1043 AFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP 1102
+L + +HRD+ + N+L++ N E +VSDFG++R++ D T +G G +P
Sbjct: 121 KYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE--DDPEGTYTTSG--GKIP 173
Query: 1103 -----PEYYQSFRCTTKGDVYSYGVILLELLS-GKRP 1133
PE + T+ DV+S+G+++ E++S G+RP
Sbjct: 174 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 16/208 (7%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLIHV---TGQGDREFMAEMETIGKIKHRNLVPLLG 991
IG G G V+KA+ R+ G VA+KK + + G + + E++ + +H +V LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKK-VALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 992 YCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIP 1051
G +LV EYM L VL D + L A K +G+A++H +
Sbjct: 67 VFPHGSGFVLVMEYM-PSDLSEVLRDEER----PLPEAQVKSYMRMLLKGVAYMHAN--- 118
Query: 1052 HIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE-YYQSFR 1110
I+HRD+K +N+L+ + +++DFG+ARL + + S T Y PE Y + +
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSE-EEPRLYSHQVATRWYRAPELLYGARK 177
Query: 1111 CTTKGDVYSYGVILLELLSGKRPIDPSE 1138
D+++ G I ELL+G P+ P E
Sbjct: 178 YDPGVDLWAVGCIFAELLNG-SPLFPGE 204
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 25/211 (11%)
Query: 936 IGSGGFGEVYK---AQLRDGSV---VAIKKLIHVTGQGDR-EFMAEMETIGKIKHRNLVP 988
+G G FG VY+ + G VAIK + +R EF+ E + + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLH-----DRAKGGGTKLDWAARKKIAIGSARGLA 1043
LLG G+ L+V E M G L+S L G ++A A G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 1044 FLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP- 1102
+L +HRD+ + N ++ E+ ++ DFGM R + D + G G +P
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK-----GGKGLLPV 185
Query: 1103 ----PEYYQSFRCTTKGDVYSYGVILLELLS 1129
PE + TTK DV+S+GV+L E+ +
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 6e-21
Identities = 68/204 (33%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIK---KLIHVTGQGDREFMAEMETIGKIKHRNLVPLLG 991
IG G FG+V Q RD + A+K K V R + E + ++ H LV L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 992 YCKIGEERLLVYEYMKWGSLESVLHDRAK--GGGTKLDWAARKKIAIGSARGLAFLHHSC 1049
+ E LV + + G L L + K K W I A L +LH
Sbjct: 68 SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-WICE----IVLA--LEYLHSK- 119
Query: 1050 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSF 1109
IIHRD+K N+LLDE ++DF +A V L+ ST +GTPGY+ PE
Sbjct: 120 --GIIHRDIKPDNILLDEQGHVHITDFNIATKVT--PDTLTTST-SGTPGYMAPEVLCRQ 174
Query: 1110 RCTTKGDVYSYGVILLELLSGKRP 1133
+ D +S GV E L GKRP
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 8e-21
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 930 FSADSMIGSGGFGEVYKA-QLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVP 988
F +G G +G VYKA G VVAIK + V +E + E+ + + +V
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKV-VPVEE-DLQEIIKEISILKQCDSPYIVK 62
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHS 1048
G + +V EY GS+ ++ K L I + +GL +LH +
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK----TLTEEEIAAILYQTLKGLEYLHSN 118
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQS 1108
IHRD+K+ N+LL+E +A+++DFG++ + DT +T+ GTP ++ PE Q
Sbjct: 119 ---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLT--DTMAKRNTVIGTPFWMAPEVIQE 173
Query: 1109 FRCTTKGDVYSYGVILLELLSGKRP 1133
K D++S G+ +E+ GK P
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-20
Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI 995
+G+G FGEV+ + VA+K L T F+ E + + K++H LV L Y +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQL--YAVV 70
Query: 996 GEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHII 1054
EE + +V EYM GSL L D G G L +A A G+A++ + I
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKD---GEGRALKLPNLVDMAAQVAAGMAYIERM---NYI 124
Query: 1055 HRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP-GYVPPEYYQSFRCTT 1113
HRD++S+N+L+ + +++DFG+ARL+ D + A P + PE R T
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 1114 KGDVYSYGVILLELLSGKR 1132
K DV+S+G++L EL++ R
Sbjct: 183 KSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 1e-20
Identities = 65/216 (30%), Positives = 111/216 (51%), Gaps = 28/216 (12%)
Query: 933 DSMIGSGGFGEVYKAQL----RDGSVVAIKKL-IHVTGQGDREFMAEMETIGKIKHRNLV 987
+ +IG+G FGEV + +L + VAIK L T + R+F++E +G+ H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 988 PLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGG---TKLDWAARKKIAIGSARGLAF 1044
L G +++ E+M+ G+L+S L R G +L R G A G+ +
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVIQLVGMLR-----GIAAGMKY 121
Query: 1045 LHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPG----- 1099
L + +HRD+ + N+L++ N +VSDFG++R L+ S T + G
Sbjct: 122 LSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRF---LEDDTSDPTYTSSLGGKIPI 175
Query: 1100 -YVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRP 1133
+ PE + T+ DV+SYG+++ E++S G+RP
Sbjct: 176 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-20
Identities = 81/307 (26%), Positives = 136/307 (44%), Gaps = 53/307 (17%)
Query: 933 DSMIGSGGFGEVYKAQL-----RDG-SVVAIKKLIHVTGQGD-REFMAEMETIGKIKHRN 985
+G G FG+V KA R G + VA+K L + R+ ++E + ++ H +
Sbjct: 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPH 64
Query: 986 LVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGG-----------GTKLDWAARKKI 1034
++ L G C LL+ EY K+GSL S L + K G + LD + +
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 1035 AIGS--------ARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086
+G +RG+ +L ++HRD+ + NVL+ E + ++SDFG++R V D
Sbjct: 125 TMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181
Query: 1087 THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRP---IDPSEFGDD 1142
+++ S ++ E TT+ DV+S+GV+L E+++ G P I P
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE----- 236
Query: 1143 NNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMA 1202
L K +R +R PE + E+Y + C P KRPT +
Sbjct: 237 -RLFNLLKTGYRMER------PE-----NCSEEMY---NLMLTCWKQEPDKRPTFADISK 281
Query: 1203 MFKELQV 1209
+++ V
Sbjct: 282 ELEKMMV 288
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 76/268 (28%), Positives = 129/268 (48%), Gaps = 29/268 (10%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI 995
+GSG FG V+ + R VAIK I+ + +F+ E + + K+ H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKA-INEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 996 GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIH 1055
+ +V E+M+ G L + L R +G KL + G+ +L + IH
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQR-QG---KLSKDMLLSMCQDVCEGMEYLERN---SFIH 123
Query: 1056 RDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP-GYVPPEYYQSFRCTTK 1114
RD+ + N L+ +VSDFGM R V LD + S+ A P + PPE + + ++K
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYV--LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 1115 GDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDE 1173
DV+S+GV++ E+ + GK P + + ++ +L+R P+L T
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR---------PKLASMT--- 229
Query: 1174 TELYQYLRISFECLDDRPFKRPTMIQVM 1201
+Y+ + + C ++P RPT +++
Sbjct: 230 --VYE---VMYSCWHEKPEGRPTFAELL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 2e-20
Identities = 82/300 (27%), Positives = 138/300 (46%), Gaps = 54/300 (18%)
Query: 933 DSMIGSGGFGEVYKAQLR-DGSVV--AIKKLIHVTGQGD-REFMAEMETIGKI-KHRNLV 987
+ +IG G FG+V +A ++ DG + AIK L + D R+F E+E + K+ H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 988 PLLGYCKIGEERLLVY---EYMKWGSLESVLHDR---------AKGGGTKLDWAARK--K 1033
LLG C E R +Y EY +G+L L AK GT +++ +
Sbjct: 67 NLLGAC---ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 1034 IAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR----LVNALDTHL 1089
A A G+ +L IHRD+ + NVL+ EN ++++DFG++R V L
Sbjct: 124 FASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL 180
Query: 1090 SVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGW 1148
V +A + Y + TTK DV+S+GV+L E++S G P + +
Sbjct: 181 PVRWMA-----IESLNYSVY--TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233
Query: 1149 AKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208
++ + + ++ E+Y+ +R +C DRP++RP Q+ +
Sbjct: 234 GYRMEKPRNCDD--------------EVYELMR---QCWRDRPYERPPFAQISVQLSRML 276
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 27/211 (12%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMA--EMETIGKIKHRNLVPLLGY 992
IG G +G VYKA+ G +VAIKK+ A E++ + ++ H N++ LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 993 CKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPH 1052
+ + LV+E+M L ++ DR +G L + K +GLAF H
Sbjct: 67 FRHKGDLYLVFEFMD-TDLYKLIKDRQRG----LPESLIKSYLYQLLQGLAFCHSH---G 118
Query: 1053 IIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRC- 1111
I+HRD+K N+L++ +++DFG+AR T YV +Y++
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARS-------FGSPVRPYTH-YVVTRWYRAPELL 170
Query: 1112 ------TTKGDVYSYGVILLELLSGKRPIDP 1136
+T D++S G I ELLS RP+ P
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSR-RPLFP 200
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 66/199 (33%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI 995
+G G FGEV+ + VAIK L T F+ E + + K++H LV L Y +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQL--YAVV 70
Query: 996 GEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHII 1054
EE + +V EYM GSL L G L +A A G+A++ + +
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVERM---NYV 124
Query: 1055 HRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP-GYVPPEYYQSFRCTT 1113
HRD++++N+L+ EN +V+DFG+ARL+ D + A P + PE R T
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 1114 KGDVYSYGVILLELLSGKR 1132
K DV+S+G++L EL + R
Sbjct: 183 KSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 3e-20
Identities = 77/284 (27%), Positives = 133/284 (46%), Gaps = 24/284 (8%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGD--REFMAEMETIGKIKHRNLVPLLGYC 993
+G+G G V K + V KK++H+ + ++ + E++ + + + +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHI 1053
+ E+M GSL+ + KGG ++ KIA+ GL +L++ + I
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYK---KGGPIPVEILG--KIAVAVVEGLTYLYN--VHRI 125
Query: 1054 IHRDMKSSNVLLDENFEARVSDFGMA-RLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCT 1112
+HRD+K SN+L++ + ++ DFG++ L+N++ T GT Y+ PE Q + T
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-----ADTFVGTSTYMSPERIQGGKYT 180
Query: 1113 TKGDVYSYGVILLELLSGKRPIDPSEFGDDNNL--VGWAKQLHREKRINEILDPELTMQT 1170
K DV+S G+ ++EL GK P S DD +G L + + E P + +
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ--IVQE---PPPRLPS 235
Query: 1171 SDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGD 1214
SD E + CL P +RPT Q+ AM +Q +
Sbjct: 236 SDFPEDLR--DFVDACLLKDPTERPTPQQLCAMPPFIQALRASN 277
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 11/197 (5%)
Query: 935 MIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDR-EFMAEMETIGKIKHRNLVPLLGYC 993
++G G FGEV+K L+D + VA+K Q + +F++E + + H N+V L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHI 1053
+ +V E + G S L + TK K A+ +A G+A+L +
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTK----QLVKFALDAAAGMAYLESK---NC 114
Query: 1054 IHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 1112
IHRD+ + N L+ EN ++SDFGM+R + D S S L P + PE R +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQED--DGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 1113 TKGDVYSYGVILLELLS 1129
++ DV+SYG++L E S
Sbjct: 173 SESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 5e-20
Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 34/229 (14%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKL--IHVTGQGDREF-MAEMETIGKIK-HRNLVPLL 990
IG G F V A+ + AIK L + + ++ E E + ++ H ++ L
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68
Query: 991 GYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC 1049
Y EE L V EY G L + LD + A L +LH S
Sbjct: 69 -YTFQDEENLYFVLEYAPNGELLQYIRKYGS-----LDEKCTRFYAAEILLALEYLH-SK 121
Query: 1050 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSV------------------ 1091
IIHRD+K N+LLD++ +++DFG A++++ + S
Sbjct: 122 --GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 1092 STLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPI-DPSEF 1139
++ GT YV PE D+++ G I+ ++L+GK P +E+
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY 228
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 6e-20
Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 34/219 (15%)
Query: 934 SMIGSGGFGEVYKAQLRD-GSVVAIKKL--IHVTGQGDREFMAEMETIGKIKHRNLVPLL 990
++G G +G V K + + G +VAIKK + + E++ + +++H N+V L
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 991 GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCI 1050
+ LV+EY++ LE L + + GG L A + + +A+ H
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLE--LLEASPGG---LPPDAVRSYIWQLLQAIAYCHSH-- 119
Query: 1051 PHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA-LDTHLS--VST--------LAGTPG 1099
+IIHRD+K N+L+ E+ ++ DFG AR + A + L+ V+T L G
Sbjct: 120 -NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 1100 YVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSE 1138
Y P DV++ G I+ ELL G P+ P +
Sbjct: 179 YGKPV-----------DVWAIGCIMAELLDG-EPLFPGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 65/271 (23%), Positives = 117/271 (43%), Gaps = 33/271 (12%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKL--IHVTGQGDREFMAEMETIGKIKHRNLVPLLGY 992
IG G FG V K + DG ++ K++ ++T + ++ ++E+ + ++KH N+V Y
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV---RY 64
Query: 993 CK--IGEERLLVYEYMKW---GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH 1047
I +Y M++ G L ++ + K ++ +I L H+
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQ-KCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 1048 SCIPH--IIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEY 1105
P ++HRD+K +N+ LD N ++ DFG+A+++ T GTP Y+ PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG--HDSSFAKTYVGTPYYMSPEQ 181
Query: 1106 YQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPE 1165
K D++S G ++ EL + P QL +I E
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ----------LQLAS--KIKEGKFRR 229
Query: 1166 LTMQTSDETELYQYLRISFECLDDRPFKRPT 1196
+ + S EL + ++ L+ P KRP+
Sbjct: 230 IPYRYSS--ELNEVIK---SMLNVDPDKRPS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 76/287 (26%), Positives = 131/287 (45%), Gaps = 48/287 (16%)
Query: 935 MIGSGGFGEVYKAQLRDGSV---VAIKKLIHVTGQGD-REFMAEMETIGKIKHR-NLVPL 989
+IG G FG+V KA+++ + AIK++ + D R+F E+E + K+ H N++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDR---------AKGGGTKLDWAARK--KIAIGS 1038
LG C+ L EY G+L L A T ++++ A
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 1039 ARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR----LVNALDTHLSVSTL 1094
ARG+ +L IHRD+ + N+L+ EN+ A+++DFG++R V L V +
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 178
Query: 1095 AGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLH 1153
A + Y + TT DV+SYGV+L E++S G P + + +L
Sbjct: 179 A-----IESLNYSVY--TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 231
Query: 1154 REKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQV 1200
+ ++ E+Y +R +C ++P++RP+ Q+
Sbjct: 232 KPLNCDD--------------EVYDLMR---QCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 22/202 (10%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKL-IHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCK 994
IG G FG V + + G VA+K + VT Q F+ E + K+ H+NLV LLG
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI- 68
Query: 995 IGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHII 1054
+ +V E M G+L + L R G + + ++ A G+ +L ++
Sbjct: 69 LHNGLYIVMELMSKGNLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLESK---KLV 122
Query: 1055 HRDMKSSNVLLDENFEARVSDFGMARL-VNALD-THLSVSTLAGTPGYVPPEYYQSFRCT 1112
HRD+ + N+L+ E+ A+VSDFG+AR+ +D + L V + PE + + +
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-------WTAPEALKHKKFS 175
Query: 1113 TKGDVYSYGVILLELLS-GKRP 1133
+K DV+SYGV+L E+ S G+ P
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-19
Identities = 76/287 (26%), Positives = 133/287 (46%), Gaps = 46/287 (16%)
Query: 935 MIGSGGFGEVYKAQLRDGSV---VAIKKLIHVTGQGD-REFMAEMETIGKI-KHRNLVPL 989
+IG G FG+V KA+++ + AIK++ + D R+F E+E + K+ H N++ L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDR---------AKGGGTKLDWAARKKIAIGS-- 1038
LG C+ L EY G+L L A T ++++ + +
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 1039 ARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR----LVNALDTHLSVSTL 1094
ARG+ +L IHRD+ + N+L+ EN+ A+++DFG++R V L V +
Sbjct: 134 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 190
Query: 1095 AGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR 1154
A + Y + TT DV+SYGV+L E++S G +L+
Sbjct: 191 A-----IESLNYSVY--TTNSDVWSYGVLLWEIVS---------LGGTPYCGMTCAELYE 234
Query: 1155 EKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVM 1201
+ L+ L + E+Y +R +C ++P++RP+ Q++
Sbjct: 235 KLPQGYRLEKPLNC----DDEVYDLMR---QCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 2e-19
Identities = 65/218 (29%), Positives = 102/218 (46%), Gaps = 34/218 (15%)
Query: 936 IGSGGFGEVYKA-QLRDGSVVAIKK--LIHVTGQGD-------RE--FMAEMETIGKIKH 983
+G G + VYKA G +VAIKK L D RE + E +KH
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQE------LKH 61
Query: 984 RNLVPLLG-YCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARG 1041
N++ LL + + + LV+E+M+ LE V+ D++ L A K + + RG
Sbjct: 62 PNIIGLLDVFGH--KSNINLVFEFMET-DLEKVIKDKS----IVLTPADIKSYMLMTLRG 114
Query: 1042 LAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV 1101
L +LH + I+HRD+K +N+L+ + +++DFG+AR + + + + T Y
Sbjct: 115 LEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM--THQVVTRWYR 169
Query: 1102 PPEYYQSFRCTTKG-DVYSYGVILLELLSGKRPIDPSE 1138
PE R G D++S G I ELL P P +
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRV-PFLPGD 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 62/206 (30%), Positives = 109/206 (52%), Gaps = 21/206 (10%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMA-EMETIGKIKHRNLVPLLGYC 993
IGSG +G+VYKA+ + G +VAIK +I + D E + E+ + + +H N+V G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIK-VIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY 69
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHI 1053
++ +V EY GSL+ + +G ++L A + + +GLA+LH +
Sbjct: 70 LRRDKLWIVMEYCGGGSLQDIYQ-VTRGPLSELQIAY---VCRETLKGLAYLHET---GK 122
Query: 1054 IHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVS---TLAGTPGYVPPEYYQ--- 1107
IHRD+K +N+LL E+ + +++DFG V+A T +++ + GTP ++ PE
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFG----VSAQLTA-TIAKRKSFIGTPYWMAPEVAAVER 177
Query: 1108 SFRCTTKGDVYSYGVILLELLSGKRP 1133
K D+++ G+ +EL + P
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 63/210 (30%), Positives = 107/210 (50%), Gaps = 27/210 (12%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLVPLL-GYC 993
+G G FG+VYKAQ ++ + A K+I + + + E FM E++ + + KH N+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY- 71
Query: 994 KIGEERLLVY-EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPH 1052
E +L + E+ G+L+S++ + +G L + + L FLH
Sbjct: 72 -FYENKLWILIEFCDGGALDSIMLELERG----LTEPQIRYVCRQMLEALNFLHSH---K 123
Query: 1053 IIHRDMKSSNVLLDENFEARVSDFGM-ARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRC 1111
+IHRD+K+ N+LL + + +++DFG+ A+ + L T GTP ++ PE C
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR---DTFIGTPYWMAPEV---VAC 177
Query: 1112 TT--------KGDVYSYGVILLELLSGKRP 1133
T K D++S G+ L+EL + P
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 10/203 (4%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMA-EMETIGKIKHRNLVPLLGYC 993
IG G VY A L + VAIK++ Q + + E++ + + H N+V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHI 1053
+G+E LV Y+ GSL ++ GG LD A + +GL +LH +
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGG--LDEAIIATVLKEVLKGLEYLHSN---GQ 123
Query: 1054 IHRDMKSSNVLLDENFEARVSDFGMARLV--NALDTHLSVSTLAGTPGYVPPEYYQSFR- 1110
IHRD+K+ N+LL E+ +++DFG++ + T T GTP ++ PE +
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183
Query: 1111 CTTKGDVYSYGVILLELLSGKRP 1133
K D++S+G+ +EL +G P
Sbjct: 184 YDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 5e-19
Identities = 69/222 (31%), Positives = 103/222 (46%), Gaps = 33/222 (14%)
Query: 935 MIGSGGFGEVYKAQLRD-------GSVVAIKKLIH-VTGQGDREFMAEMETIGKIKHRNL 986
+GSG FGEVY+ D VA+K L T Q +EF+ E + H N+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 987 VPLLGYCKIGEERLLVYEYMKWGSLESVLHD--RAKGGGTKLDWAARKKIAIGSARGLAF 1044
V LLG C + E + ++ E M+ G L S L D + G L I + A+G +
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 1045 LHHSCIPHIIHRDMKSSNVLLDENFEAR-----VSDFGMARLVNALDTH-------LSVS 1092
L H IHRD+ + N L+ E + DFG+AR + D + L V
Sbjct: 122 LEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 1093 TLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRP 1133
+A PE + TT+ DV+S+GV++ E+L+ G++P
Sbjct: 179 WMA-------PESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 6e-19
Identities = 70/238 (29%), Positives = 115/238 (48%), Gaps = 28/238 (11%)
Query: 913 KPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREF 971
+ L + + L + F ++G+G +G+VYK + ++ G + AIK ++ VT + E
Sbjct: 1 RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEI 59
Query: 972 MAEMETIGKIKH-RNLVPLLG-YCKIG-----EERLLVYEYMKWGSLESVLHDRAKGGGT 1024
E+ + K H RN+ G + K ++ LV E+ GS+ ++ + KG
Sbjct: 60 KLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKN-TKGNAL 118
Query: 1025 KLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084
K DW A I RGLA LH +IHRD+K NVLL EN E ++ DFG++ ++
Sbjct: 119 KEDWIAY--ICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173
Query: 1085 LDTHLSVSTLAGTPGYVPPEYYQSFRCTT--------KGDVYSYGVILLELLSGKRPI 1134
T +T GTP ++ PE C + D++S G+ +E+ G P+
Sbjct: 174 --TVGRRNTFIGTPYWMAPEV---IACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 7e-19
Identities = 68/207 (32%), Positives = 108/207 (52%), Gaps = 23/207 (11%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGD---REFMAEMETIGKIKHRNLVPLLG 991
IG G FG VY A+ +R VVAIKK+ + Q + ++ + E+ + +++H N + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 992 YCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCI 1050
C + E LV EY GS +L + K +++ AA I G+ +GLA+LH
Sbjct: 83 -CYLREHTAWLVMEYC-LGSASDIL-EVHKKPLQEVEIAA---ICHGALQGLAYLHSHER 136
Query: 1051 PHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSF- 1109
IHRD+K+ N+LL E +++DFG A LV+ ++ GTP ++ PE +
Sbjct: 137 ---IHRDIKAGNILLTEPGTVKLADFGSASLVS------PANSFVGTPYWMAPEVILAMD 187
Query: 1110 --RCTTKGDVYSYGVILLELLSGKRPI 1134
+ K DV+S G+ +EL K P+
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (218), Expect = 1e-18
Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 38/212 (17%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREF----MAEMETIGKIKHRNLVPLL 990
+G G +G VYKA+ + G +VA+KK+ + + E+ + ++KH N+V LL
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRL--DNEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 991 GYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC 1049
E +L LV+EY L+ L R L K I RGLA+ H
Sbjct: 65 DVI-HTERKLYLVFEYCDM-DLKKYLDKRPG----PLSPNLIKSIMYQLLRGLAYCHSH- 117
Query: 1050 IPHIIHRDMKSSNVLLDENFEARVSDFGMARL----VNALDTHLSVSTLAGTPGYVPPE- 1104
I+HRD+K N+L++ + +++DFG+AR + TH V TL Y PE
Sbjct: 118 --RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-TH-EVVTLW----YRAPEI 169
Query: 1105 -----YYQSFRCTTKGDVYSYGVILLELLSGK 1131
+Y +T D++S G I E+++GK
Sbjct: 170 LLGSKHY-----STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 68/217 (31%), Positives = 104/217 (47%), Gaps = 30/217 (13%)
Query: 936 IGSGGFGEVYKAQL-RDGSVVAIKKLI--HVTGQGDRE-FMAEMETIGKIKHRNLVPLLG 991
+G GGFG V ++ A+K + H+ G +E +E E + + H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 992 YCKIGEERLLVY---EYMKWGSLESVLHDRAKGGGTKLDWAARKKIA-IGSARGLAFLHH 1047
K ++ +Y EY G L ++L DR ++ AR IA + A +LH+
Sbjct: 61 TFK---DKKYIYMLMEYCLGGELWTILRDRGLFD----EYTARFYIACVVLA--FEYLHN 111
Query: 1048 SCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR-LVNALDTHLSVSTLAGTPGYVPPEYY 1106
II+RD+K N+LLD N ++ DFG A+ L + T T GTP YV PE
Sbjct: 112 R---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW----TFCGTPEYVAPEII 164
Query: 1107 QSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDN 1143
+ D +S G++L ELL+G+ P FG+D+
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGRPP-----FGEDD 196
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 81/265 (30%), Positives = 132/265 (49%), Gaps = 33/265 (12%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI 995
+G+G FGEV+ + VAIK L + + F+AE + +++H LV L Y +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRL--YAVV 70
Query: 996 GEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHII 1054
+E + ++ EYM+ GSL L G KL +A A G+AF+ + I
Sbjct: 71 TQEPIYIITEYMENGSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIERK---NYI 124
Query: 1055 HRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP-GYVPPEY--YQSFRC 1111
HRD++++N+L+ E +++DFG+ARL+ D + A P + PE Y +F
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINYGTF-- 180
Query: 1112 TTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTS 1171
T K DV+S+G++L E+++ R P G N V + L R R+ P+ +
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIPYP---GMTNPEV--IQNLERGYRMPR---PDNCPE-- 230
Query: 1172 DETELYQYLRISFECLDDRPFKRPT 1196
ELY+ +R C ++P +RPT
Sbjct: 231 ---ELYELMR---LCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 67/207 (32%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 936 IGSGGFGEVYKAQL--RDGSV----VAIKKLIHV-TGQGDREFMAEMETIGKIKHRNLVP 988
+G G FGEVY+ RDG VA+K L + Q + +F+ E + K H+N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVL-HDRAKGGG-TKLDWAARKKIAIGSARGLAFLH 1046
L+G R ++ E M G L+S L +R + + L A A+G +L
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARV---SDFGMARLVNALDTHLSVSTLAGTP-GYVP 1102
+ H IHRD+ + N LL RV +DFGMAR + + A P ++P
Sbjct: 134 EN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRAS-YYRKGGRAMLPIKWMP 189
Query: 1103 PEYYQSFRCTTKGDVYSYGVILLELLS 1129
PE + T+K DV+S+GV+L E+ S
Sbjct: 190 PEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 72/274 (26%), Positives = 121/274 (44%), Gaps = 34/274 (12%)
Query: 935 MIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMA---EMETIGKIKHRNLVPLLG 991
++G G FG V+ + + + I K I V E +A E + + + H N++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 992 YCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIP 1051
+ ++V EY G+L + R + LD I + L LHH
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKR---CNSLLD---EDTILHFFVQILLALHHVHTK 120
Query: 1052 HIIHRDMKSSNVLLDEN-FEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFR 1110
I+HRD+K+ N+LLD++ ++ DFG++++ L + T+ GTP Y+ PE +
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKI---LSSKSKAYTVVGTPCYISPELCEGKP 177
Query: 1111 CTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKR--INEILDPELTM 1168
K D+++ G +L EL S KR + + NL ++ I++ P+L
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFEAA------NLPALVLKIMSGTFAPISDRYSPDLRQ 231
Query: 1169 QTSDETELYQYLRISFECLDDRPFKRPTMIQVMA 1202
L +S LD P KRP + Q+MA
Sbjct: 232 -----------LILSMLNLD--PSKRPQLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 76/265 (28%), Positives = 126/265 (47%), Gaps = 32/265 (12%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI 995
+G+G FGEV+ + + VA+K L T + F+ E + ++H LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 996 GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIH 1055
E ++ EYM GSL L G K+ + A G+A++ + IH
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIERK---NYIH 126
Query: 1056 RDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP-GYVPPEY--YQSFRCT 1112
RD++++NVL+ E+ +++DFG+AR++ D + A P + PE + SF T
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIE--DNEYTAREGAKFPIKWTAPEAINFGSF--T 182
Query: 1113 TKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTS 1171
K DV+S+G++L E+++ GK P G N+ V A L R R+ M+
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPYP----GMSNSDVMSA--LQRGYRMPR-------MENC 229
Query: 1172 DETELYQYLRISFECLDDRPFKRPT 1196
+ ELY ++ C ++ +RPT
Sbjct: 230 PD-ELYDIMK---TCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 72/278 (25%), Positives = 126/278 (45%), Gaps = 42/278 (15%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLVPLLGYCK 994
+G G FG+VYKA+ ++ +A K+I + + E +M E+E + H +V LLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 995 IGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHII 1054
+ ++ E+ G++++++ + +G L + I L +LH II
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVICRQMLEALQYLHSM---KII 132
Query: 1055 HRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTT- 1113
HRD+K+ NVLL + + +++DFG++ + T + GTP ++ PE C T
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVM---CETM 187
Query: 1114 -------KGDVYSYGVILLELLSGKRPIDPS--EFGDDNNLVGWAKQLHREKRINEILDP 1164
K D++S G+ L+E+ I+P E L+ AK +P
Sbjct: 188 KDTPYDYKADIWSLGITLIEMAQ----IEPPHHELNPMRVLLKIAKS-----------EP 232
Query: 1165 ELTMQTSD-ETELYQYLRISFECLDDRPFKRPTMIQVM 1201
Q S E +L+ + LD P RP+ Q++
Sbjct: 233 PTLSQPSKWSMEFRDFLKTA---LDKHPETRPSAAQLL 267
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 4e-18
Identities = 65/223 (29%), Positives = 96/223 (43%), Gaps = 53/223 (23%)
Query: 936 IGSGGFGEVYKA-QLRDGSVVAIKKLIHVTGQGDREFMA-----EMETIGKIKHRNLVPL 989
IGSG +G V A R G VAIKK+ +V D A E++ + ++H N++ L
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVF---DDLIDAKRILREIKLLRHLRHENIIGL 64
Query: 990 LG-------------YCKIGEERLLVYEYMKWGS-LESVLHDRAKGGGTKLDWAARKKIA 1035
L Y +V E M + L V+ L +
Sbjct: 65 LDILRPPSPEDFNDVY--------IVTELM--ETDLHKVIKSP-----QPLTDDHIQYFL 109
Query: 1036 IGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLA 1095
RGL +LH S ++IHRD+K SN+L++ N + ++ DFG+AR V+ + T
Sbjct: 110 YQILRGLKYLH-SA--NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT-- 164
Query: 1096 GTPGYVPPEYY-------QSFRCTTKGDVYSYGVILLELLSGK 1131
YV +Y S R T D++S G I ELL+ K
Sbjct: 165 ---EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 4e-18
Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 936 IGSGGFGEVYKA-QLRDGSVVAIKKLIHVTGQGDREFMA-EMETIGKIKHRNLVPLLGYC 993
IG G G VY A + G VAIK+ +++ Q +E + E+ + + KH N+V L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQ-MNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHI 1053
+G+E +V EY+ GSL V+ + T +D + + L FLH + +
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSN---QV 136
Query: 1054 IHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTT 1113
IHRD+KS N+LL + +++DFG + + ST+ GTP ++ PE
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 1114 KGDVYSYGVILLELLSGKRP 1133
K D++S G++ +E++ G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 6e-18
Identities = 84/290 (28%), Positives = 133/290 (45%), Gaps = 49/290 (16%)
Query: 936 IGSGGFGEVYKAQL----RDGSV--VAIKKLIHVTGQGDRE-FMAEMETIGKI-KHRNLV 987
+G+G FG+V +A + +V VA+K L +RE M+E++ + + H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 988 PLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFL-H 1046
LLG C IG L++ EY +G L + L + + + L + A+G+AFL
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP-GYVPPEY 1105
+CI HRD+ + NVLL ++ DFG+AR + D++ V A P ++ PE
Sbjct: 160 KNCI----HRDLAARNVLLTHGKIVKICDFGLARDIMN-DSNYVVKGNARLPVKWMAPE- 213
Query: 1106 YQSFRC--TTKGDVYSYGVILLELLS-GKRP-----IDPSEFGDDNNLVGWAKQLHREKR 1157
F C T + DV+SYG++L E+ S G P +D + A+ H
Sbjct: 214 -SIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAE 272
Query: 1158 INEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207
I +I M+T C D P KRPT Q++ + +
Sbjct: 273 IYDI------MKT---------------CWDADPLKRPTFKQIVQLIGKQ 301
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 8e-18
Identities = 68/221 (30%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 930 FSADSMIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKH-RNLV 987
F ++G+G +G+VYK + ++ G + AIK ++ VTG + E E+ + K H RN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIA 66
Query: 988 PLLG-YCK-----IGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARG 1041
G + K + ++ LV E+ GS+ ++ + KG K +W A I RG
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAY--ICREILRG 123
Query: 1042 LAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV 1101
L+ LH +IHRD+K NVLL EN E ++ DFG++ ++ T +T GTP ++
Sbjct: 124 LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR--TVGRRNTFIGTPYWM 178
Query: 1102 PPEYYQSFRCTT--------KGDVYSYGVILLELLSGKRPI 1134
PE C K D++S G+ +E+ G P+
Sbjct: 179 APEV---IACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 9e-18
Identities = 82/283 (28%), Positives = 122/283 (43%), Gaps = 49/283 (17%)
Query: 935 MIGSGGFGEVYKAQLRDGSV----VAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLVPL 989
+IG G FG VY L D A+K L +T + E F+ E + H N++ L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 990 LGYCKIGE-ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIG--SARGLAFLH 1046
LG C E L+V YMK G L + + K I G A+G+ +L
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVK------DLIGFGLQVAKGMEYLA 115
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV---------NALDTHLSVSTLAGT 1097
+HRD+ + N +LDE+F +V+DFG+AR + N L V +A
Sbjct: 116 SK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA-- 170
Query: 1098 PGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKR 1157
E Q+ + TTK DV+S+GV+L EL++ R P D ++ + Q R
Sbjct: 171 -----LESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVDSFDITVYLLQGRR--- 220
Query: 1158 INEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQV 1200
+L PE LY+ + C +P RPT ++
Sbjct: 221 ---LLQPEYCPDP-----LYE---VMLSCWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-17
Identities = 59/212 (27%), Positives = 108/212 (50%), Gaps = 15/212 (7%)
Query: 930 FSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQG--DREFMAEMETIGKIKHRNLV 987
F S +G+G G V K Q + ++ +KLIH+ + + + E++ + + +V
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 988 PLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH 1047
G E + E+M GSL+ VL + ++ K++I RGLA+L
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKE-----AKRIPEEILGKVSIAVLRGLAYLRE 121
Query: 1048 SCIPHIIHRDMKSSNVLLDENFEARVSDFGMA-RLVNALDTHLSVSTLAGTPGYVPPEYY 1106
I+HRD+K SN+L++ E ++ DFG++ +L++++ ++ GT Y+ PE
Sbjct: 122 K--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSPERL 174
Query: 1107 QSFRCTTKGDVYSYGVILLELLSGKRPIDPSE 1138
Q + + D++S G+ L+EL G+ PI P +
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-17
Identities = 77/287 (26%), Positives = 127/287 (44%), Gaps = 32/287 (11%)
Query: 936 IGSGGFGEV----YKAQLRD-GSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLVPL 989
+G G FG+V Y G +VA+K L GQ + + E+ + + H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 990 LGYCKIGEER--LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH 1047
G C + L+ EY+ GSL L KL+ A A G+A+LH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHS 125
Query: 1048 SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGY-VPPEYY 1106
H IHRD+ + NVLLD + ++ DFG+A+ V + V +P + E
Sbjct: 126 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182
Query: 1107 QSFRCTTKGDVYSYGVILLELL----SGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162
+ + + DV+S+GV L ELL S + P P +F + ++G + R+ E+L
Sbjct: 183 KENKFSYASDVWSFGVTLYELLTHCDSKQSP--PKKFEE---MIGPKQGQMTVVRLIELL 237
Query: 1163 DPELTMQTSDET--ELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207
+ + + E+Y ++ C + RPT ++ + KE+
Sbjct: 238 ERGMRLPCPKNCPQEVYILMK---NCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 26/220 (11%)
Query: 930 FSADSMIGSGGFGEVYKA-QLRDGSVVAIKKLIHV--TGQGDREFMAEMETIGKIKHRNL 986
+ IGSG +G V A R G VAIKK+ H + + E++ + KH N+
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNI 66
Query: 987 VPLLGYCK----IGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARK---KIAIGSA 1039
+ + + ++ +V + M ES LH + R ++
Sbjct: 67 IAIRDILRPPGADFKDVYVVMDLM-----ESDLHHIIHSDQPLTEEHIRYFLYQLL---- 117
Query: 1040 RGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR-LVNALDTHLSVST-LAGT 1097
RGL ++H + + IHRD+K SN+L++E+ E R+ DFGMAR L ++ H T T
Sbjct: 118 RGLKYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 1098 PGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDP 1136
Y PE S TT D++S G I E+L G+R + P
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFP 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-17
Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 935 MIGSGGFGEVYKA-QLRDGSVV----AIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVP 988
++GSG FG VYK + +G V AIK L TG + + EFM E + + H +LV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKL--DWAARKKIAIGSARGLAFLH 1046
LLG C + LV + M G L +H+ G++L +W + A+G+ +L
Sbjct: 74 LLGVC-LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLE 126
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYY 1106
++HRD+ + NVL+ +++DFG+ARL+ + + ++ E
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 1107 QSFRCTTKGDVYSYGVILLELLS-GKRPID 1135
+ T + DV+SYGV + EL++ G +P D
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 75/283 (26%), Positives = 138/283 (48%), Gaps = 41/283 (14%)
Query: 934 SMIGSGGFGEVYKA-QLRDGSVVAIKKLIHVTGQGDRE---------FMAEMETIGKIKH 983
++IGSG FG VY G ++A+K++ + + E+ + +++H
Sbjct: 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 984 RNLVPLLGYCKIGEERLLVY-EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGL 1042
N+V LG + + L ++ EY+ GS+ ++L++ + + +GL
Sbjct: 66 ENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGA-----FEETLVRNFVRQILKGL 119
Query: 1043 AFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV--NALDTHLSVS--TLAGTP 1098
+LH+ IIHRD+K +N+L+D ++SDFG+++ + N+L T + + +L G+
Sbjct: 120 NYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 1099 GYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158
++ PE + T K D++S G +++E+L+GK P F D QL +I
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP-----FPDCT-------QLQAIFKI 224
Query: 1159 NEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVM 1201
E PE+ S E +L +FE +D KRPT +++
Sbjct: 225 GENASPEIPSNISSEAI--DFLEKTFE-IDHN--KRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 4e-17
Identities = 71/226 (31%), Positives = 108/226 (47%), Gaps = 42/226 (18%)
Query: 936 IGSGGFGEVYKA-QLRDGSVVAIKKLI-HVTGQGDREF----MAEMETIGKIKHRNLVPL 989
+G G FGEVYKA Q++ G VVA+KK++ H G F + E++ + K+KH N+VPL
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKLKHPNVVPL 72
Query: 990 LGYC-----KIGEERLLVY---EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARG 1041
+ K +R VY YM L +L + + KL + K + G
Sbjct: 73 IDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPS----VKLTESQIKCYMLQLLEG 127
Query: 1042 LAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPG-- 1099
+ +LH + HI+HRD+K++N+L+D +++DFG+AR D G G
Sbjct: 128 INYLHEN---HILHRDIKAANILIDNQGILKIADFGLARP---YDGPPPNPKGGGGGGTR 181
Query: 1100 ----------YVPPEY-YQSFRCTTKGDVYSYGVILLELLSGKRPI 1134
Y PPE R TT D++ G + E+ + RPI
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 5e-17
Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 14/200 (7%)
Query: 936 IGSGGFGEVYKA-QLRDGSVVAIKKLIHVTGQGDREFMA-EMETIGKIKHRNLVPLLGYC 993
IG G G V+ A + G VAIK+ I++ Q +E + E+ + ++K+ N+V L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQ-INLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHI 1053
+G+E +V EY+ GSL V+ + T +D A + + L FLH + +
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHAN---QV 136
Query: 1054 IHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTT 1113
IHRD+KS NVLL + +++DFG + + ST+ GTP ++ PE
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 1114 KGDVYSYGVILLELLSGKRP 1133
K D++S G++ +E++ G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 8e-17
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLIHV---TGQGDREFMAEMETIGKIKHRNLVPLLG 991
+G GGFGEV Q++ G + A KKL +G++ + E + + K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 992 YCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIP 1051
+ ++ LV M G L+ +++ + G A A GL LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPG---FPEARAIFYAAQIICGLEHLHQR--- 114
Query: 1052 HIIHRDMKSSNVLLDENFEARVSDFGMA-RLVNALDTHLSVSTLAGTPGYVPPEYYQSFR 1110
I++RD+K NVLLD++ R+SD G+A L AGTPGY+ PE Q
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR----AGTPGYMAPEVLQGEV 170
Query: 1111 CTTKGDVYSYGVILLELLSGKRP 1133
D ++ G L E+++G+ P
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 8e-17
Identities = 66/212 (31%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMA---EMETIGKIKHRNLVPLLGY 992
IG G FG++Y A+ + S + K I +T +E A E+ + K+KH N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 993 CKIGEERLLVYEYMKWGSLESVLHDRAKG----GGTKLDWAARKKIAIGSARGLAFLHHS 1048
+ +V EY G L + +R +G L W +I++G L H
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFV--QISLG-------LKHI 117
Query: 1049 CIPHIIHRDMKSSNVLLDEN-FEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQ 1107
I+HRD+KS N+ L +N A++ DFG+AR +N D+ T GTP Y+ PE Q
Sbjct: 118 HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN--DSMELAYTCVGTPYYLSPEICQ 175
Query: 1108 SFRCTTKGDVYSYGVILLELLSGKRPIDPSEF 1139
+ K D++S G +L EL + K P + +
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 9e-17
Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 930 FSADSMIGSGGFGEVYKA-QLRDGSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLV 987
F+ IG G FGEV+K R VVAIK + + + E E+ + + +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 988 PLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH 1047
G G + ++ EY+ GS +L RA G + A K + +GL +LH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLL--RA-GPFDEFQIATMLKEIL---KGLDYLHS 119
Query: 1048 SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQ 1107
IHRD+K++NVLL E + +++DFG+A + DT + +T GTP ++ PE Q
Sbjct: 120 E---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIQ 174
Query: 1108 SFRCTTKGDVYSYGVILLELLSGKRP 1133
+K D++S G+ +EL G+ P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 77/292 (26%), Positives = 132/292 (45%), Gaps = 41/292 (14%)
Query: 935 MIGSGGFGEVYKAQLR--DGSV--VAIK--KLIHVTGQGDREFMAEMETIGKIKHRNLVP 988
++G G FG V + QL DGS VA+K KL T EF++E + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 989 LLGYCKIGEER------LLVYEYMKWGSLES-VLHDRAKGGGTKLDWAARKKIAIGSARG 1041
L+G C +++ +MK G L S +L+ R G KL K + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 1042 LAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP-GY 1100
+ +L + + IHRD+ + N +L E+ V+DFG+++ + + D + +A P +
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQ-GRIAKMPVKW 181
Query: 1101 VPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINE 1160
+ E T+K DV+++GV + E+ + R P +++ + + + +R K+ +
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIAT--RGQTPYPGVENHEIYDYLRHGNRLKQPED 239
Query: 1161 ILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTE 1212
LD ELY + + C P RPT F +L+ E
Sbjct: 240 CLD-----------ELYD---LMYSCWRADPKDRPT-------FTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 935 MIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDRE-------FMAEMETIGKIKHRNL 986
++G G FG VY D G +A+K++ E E++ + ++H +
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQV--PFDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 987 VPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARK---KIAIGSARGLA 1043
V G + E + EYM GS+ D+ K G + RK +I G+
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSV----KDQLKAYGALTETVTRKYTRQIL----EGVE 118
Query: 1044 FLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLS-VSTLAGTPGYVP 1102
+LH + I+HRD+K +N+L D ++ DFG ++ + + + + + ++ GTP ++
Sbjct: 119 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175
Query: 1103 PEYYQSFRCTTKGDVYSYGVILLELLSGKRP 1133
PE K DV+S G ++E+L+ K P
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 70/273 (25%), Positives = 127/273 (46%), Gaps = 32/273 (11%)
Query: 936 IGSGGFGE--VYKAQLRDGSVVAIKK--LIHVTGQGDREFMAEMETIGKIKHRNLVPLLG 991
+G G FGE +Y+ + D S+V K+ L ++ + R+ + E+ + ++H N++
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 992 YCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIP 1051
+ L+ EY G+L + R KG + + I SA ++++H +
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWYLFQIVSA--VSYIHKA--- 120
Query: 1052 HIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRC 1111
I+HRD+K+ N+ L + ++ DFG+++++ + T+ GTP Y+ PE Q +
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILG--SEYSMAETVVGTPYYMSPELCQGVKY 178
Query: 1112 TTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTS 1171
K D+++ G +L ELL+ KR D + + NLV +I+ T S
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTFDAT---NPLNLV------------VKIVQGNYTPVVS 223
Query: 1172 DET-ELYQYLRISFECLDDRPFKRPTMIQVMAM 1203
+ EL + L P KRPT +V+
Sbjct: 224 VYSSELISLVH---SLLQQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 1e-16
Identities = 81/306 (26%), Positives = 132/306 (43%), Gaps = 46/306 (15%)
Query: 936 IGSGGFGEVYKAQL--------RDGSVVAIKKLI-HVTGQGDREFMAEMETIGKI-KHRN 985
+G G FG+V +A+ VA+K L + T + + ++EME + I KH+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 986 LVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGG------GTK-----LDWAARKKI 1034
++ LLG C ++ EY G+L L R G TK L +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 1035 AIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTL 1094
A ARG+ +L IHRD+ + NVL+ E+ +++DFG+AR V+ +D + S
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 1095 AGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS---GKRPIDPSEFGDDNNLVGWAKQ 1151
++ PE T + DV+S+G+++ E+ + P P E L ++
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE-----ELFKLLRE 251
Query: 1152 LHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDT 1211
HR + T ELY +R EC P +RPT Q++ ++
Sbjct: 252 GHRMDK-----PSNCT------HELYMLMR---ECWHAVPTQRPTFKQLVEALDKVLAAV 297
Query: 1212 EGDSLD 1217
+ LD
Sbjct: 298 SEEYLD 303
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-16
Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 23/207 (11%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGD---REFMAEMETIGKIKHRNLVPLLG 991
IG G FG VY A+ +R+ VVAIKK+ + Q + ++ + E+ + K++H N + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 992 YCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCI 1050
C + E LV EY GS +L K L + G+ +GLA+LH
Sbjct: 83 -CYLREHTAWLVMEYC-LGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSH-- 134
Query: 1051 PHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSF- 1109
++IHRD+K+ N+LL E ++ DFG A ++ + GTP ++ PE +
Sbjct: 135 -NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVGTPYWMAPEVILAMD 187
Query: 1110 --RCTTKGDVYSYGVILLELLSGKRPI 1134
+ K DV+S G+ +EL K P+
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 2e-16
Identities = 68/228 (29%), Positives = 101/228 (44%), Gaps = 43/228 (18%)
Query: 933 DSMIGSGGFGEV-YKAQLRDGSVVAIKKLIHVTGQGDREFM---AEM------------- 975
++GSG G V ++ DG A+K ++ + G + + AE+
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVK-VVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK 95
Query: 976 --ETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKK 1033
E K RN +L LV +Y G L + RAK T + A
Sbjct: 96 CHEDFAKKDPRNPENVLMIA-------LVLDYANAGDLRQEIKSRAKTNRTFREHEA--- 145
Query: 1034 IAIGSARGLAFL------HHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDT 1087
GL F+ HH H+IHRD+KS+N+LL N ++ DFG +++ A +
Sbjct: 146 -------GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVS 198
Query: 1088 HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPID 1135
T GTP YV PE ++ + K D++S GV+L ELL+ KRP D
Sbjct: 199 DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 61/249 (24%), Positives = 95/249 (38%), Gaps = 48/249 (19%)
Query: 936 IGSGGFGEVYKAQ------------LRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKH 983
I G FG VY A+ L+ ++A ++ +V + M + E+
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAE-RAIMMIQGES------ 56
Query: 984 RNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLA 1043
+ L + + LV EY+ G S++ GG DWA K+ G+
Sbjct: 57 PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIK---TLGGLPEDWA--KQYIAEVVLGVE 111
Query: 1044 FLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPP 1103
LH IIHRD+K N+L+D+ +++DFG++R L GTP Y+ P
Sbjct: 112 DLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAP 162
Query: 1104 EYYQSFRCTTKGDVYSYGVILLELLSGKRPID---PSEFGDDNNLVGWAKQLHRE----K 1156
E D +S G ++ E L G P P + L R +
Sbjct: 163 ETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV--------FDNILSRRINWPE 214
Query: 1157 RINEILDPE 1165
+ E PE
Sbjct: 215 EVKEFCSPE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 2e-16
Identities = 68/213 (31%), Positives = 108/213 (50%), Gaps = 23/213 (10%)
Query: 930 FSADSMIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGD---REFMAEMETIGKIKHRN 985
F+ IG G FG VY A+ +R VVAIKK+ + Q + ++ + E++ + +IKH N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 986 LVPLLGYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAF 1044
+ G C + E LV EY GS +L K L I G+ +GLA+
Sbjct: 87 SIEYKG-CYLREHTAWLVMEYC-LGSASDLLEVHKK----PLQEVEIAAITHGALQGLAY 140
Query: 1045 LHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE 1104
LH ++IHRD+K+ N+LL E + +++DFG A + + ++ GTP ++ PE
Sbjct: 141 LHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIAS------PANSFVGTPYWMAPE 191
Query: 1105 YYQSF---RCTTKGDVYSYGVILLELLSGKRPI 1134
+ + K DV+S G+ +EL K P+
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 935 MIGSGGFGEVYKAQLRDG----SVVAIKKLIHVTGQGDRE-FMAEMETIG-KIKHRNLVP 988
++G G FG+V A+L+ ++ A+KK + V D E M E + +H L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDV-VLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHS 1048
L + E V EY+ G L + H ++ G + D A + A GL FLH
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDL--MFHIQSSG---RFDEARARFYAAEIICGLQFLHKK 115
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQS 1108
II+RD+K NVLLD++ +++DFGM + + ST GTP Y+ PE +
Sbjct: 116 ---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTFCGTPDYIAPEILKG 170
Query: 1109 FRCTTKGDVYSYGVILLELLSGKRP 1133
+ D +S+GV+L E+L G+ P
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 66/239 (27%), Positives = 114/239 (47%), Gaps = 53/239 (22%)
Query: 935 MIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREF----MAEMETIGKIKHRNLVPL 989
++G G +G V K + ++ G +VAIKK + + D+ M E+ + +++H NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLE--SEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHD--RAKGGGTKLDWAARKKIAIGSARGLAFLHH 1047
+ + + LV+E++ +VL D + G LD + +K RG+ F H
Sbjct: 66 IEVFRRKKRLYLVFEFVD----HTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHS 118
Query: 1048 SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPG-----YVP 1102
+IIHRD+K N+L+ ++ ++ DFG AR TLA PG YV
Sbjct: 119 H---NIIHRDIKPENILVSQSGVVKLCDFGFAR------------TLAA-PGEVYTDYVA 162
Query: 1103 PEYYQSFRC----TTKG---DVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR 1154
+Y++ T G D+++ G ++ E+L+G+ P+ P + D QL+
Sbjct: 163 TRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE-PLFPGDSDID--------QLYH 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 42/215 (19%)
Query: 934 SMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGD----REFMAEMETIGKIKHRNLVP 988
S IG G +G V+K + R+ G +VAIKK V + D + + E+ + ++KH NLV
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKF--VESEDDPVIKKIALREIRMLKQLKHPNLVN 64
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLH--DRAKGGGTKLDWAARKKIAIGSARGLAFLH 1046
L+ + + LV+EY +VL+ ++ G + KKI + + + F H
Sbjct: 65 LIEVFRRKRKLHLVFEYCD----HTVLNELEKNPRG---VPEHLIKKIIWQTLQAVNFCH 117
Query: 1047 -HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLS--VST--------LA 1095
H+CI HRD+K N+L+ + + ++ DFG AR++ + V+T L
Sbjct: 118 KHNCI----HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLV 173
Query: 1096 GTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSG 1130
G Y PP DV++ G + ELL+G
Sbjct: 174 GDTQYGPPV-----------DVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 29/221 (13%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKL----IHVTGQGDREFMAEMETIGKIKHRNLVPLL 990
I G +G V+ A+ G + AIK + + Q D+ + E + + + + +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQ-VLTERDILSQAQSPYVVKLY 59
Query: 991 GYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIA-IGSARGLAFLHHS 1048
Y G++ L LV EY+ G L S+L + G+ + AR IA I L +LH +
Sbjct: 60 -YSFQGKKNLYLVMEYLPGGDLASLLENV----GSLDEDVARIYIAEI--VLALEYLHSN 112
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFG------MARLVNALDTHLSVSTLAGTPGYVP 1102
IIHRD+K N+L+D N +++DFG + R +N D + GTP Y+
Sbjct: 113 ---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 1103 PEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDN 1143
PE + D +S G IL E L G P F +
Sbjct: 170 PEVILGQGHSKTVDWWSLGCILYEFLVGIPP-----FHGET 205
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 2e-16
Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 30/211 (14%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLIHVTG-QGD-----RE--FMAEMETIGKIKHRNL 986
+G G +G V+KA R VVA+KK+ D RE F+ E+ H N+
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-----DHPNI 69
Query: 987 VPLLGYCKIGEER--LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAF 1044
V LL K ++ LV+EYM E+ LH + L+ ++ I + L +
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRAN--ILEDVHKRYIMYQLLKALKY 122
Query: 1045 LHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLA---GTPGYV 1101
+H ++IHRD+K SN+LL+ + +++DFG+AR ++ L+ + L T Y
Sbjct: 123 IHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYR 179
Query: 1102 PPEYYQSFRCTTKG-DVYSYGVILLELLSGK 1131
PE TKG D++S G IL E+L GK
Sbjct: 180 APEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-16
Identities = 71/225 (31%), Positives = 111/225 (49%), Gaps = 36/225 (16%)
Query: 930 FSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDRE-----FMAEMETIGKIKH 983
F IG G +G+VYKA+ +D G +VA+KK V ++E + E++ + ++ H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKK---VRLDNEKEGFPITAIREIKILRQLNH 65
Query: 984 RNLVPL----------LGYCKIGEERLLVYEYMK---WGSLESVLHDRAKGGGTKLDWAA 1030
RN+V L L + K LV+EYM G LES L ++
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF---- 121
Query: 1031 RKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLS 1090
K++ GL + H + +HRD+K SN+LL+ + +++DFG+ARL N+ ++
Sbjct: 122 MKQLL----EGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174
Query: 1091 VSTLAGTPGYVPPE-YYQSFRCTTKGDVYSYGVILLELLSGKRPI 1134
+ + T Y PPE R DV+S G IL EL + K+PI
Sbjct: 175 TNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 3e-16
Identities = 69/222 (31%), Positives = 107/222 (48%), Gaps = 29/222 (13%)
Query: 934 SMIGSGGFGEVYKAQ---LRD--GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVP 988
+G G FG V + L+D G VVA+KKL H T + R+F E+E + ++H N+V
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 989 LLGYC-KIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGS--ARGLAF 1044
G C G L LV EY+ +GSL L + +LD RK + S +G+ +
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE----RLD--HRKLLLYASQICKGMEY 123
Query: 1045 LHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP-- 1102
L +HRD+ + N+L++ ++ DFG+ +++ + V PG P
Sbjct: 124 LG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVR----EPGESPIF 176
Query: 1103 ---PEYYQSFRCTTKGDVYSYGVILLELL--SGKRPIDPSEF 1139
PE + + DV+S+GV+L EL S K P+EF
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-16
Identities = 81/302 (26%), Positives = 132/302 (43%), Gaps = 53/302 (17%)
Query: 930 FSADSM-----IGSGGFGEVYKAQL--------RDGSVVAIKKLIHVTGQGD-REFMAEM 975
FS D + +G G FG+V A+ ++ VA+K L + D + ++EM
Sbjct: 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 71
Query: 976 ETIGKI-KHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVL-----------HDRAKGGG 1023
E + I KH+N++ LLG C ++ EY G+L L +D A+
Sbjct: 72 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPD 131
Query: 1024 TKLDWAARKKIAIGSARGLAFL-HHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082
++ + ARG+ +L CI HRD+ + NVL+ EN +++DFG+AR V
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDV 187
Query: 1083 NALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPID--PSEF 1139
N +D + + ++ PE T + DV+S+GV++ E+ + G P P E
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE- 246
Query: 1140 GDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQ 1199
L K+ HR + + ELY +R +C P RPT Q
Sbjct: 247 ----ELFKLLKEGHR-----------MDKPANCTNELYMMMR---DCWHAIPSHRPTFKQ 288
Query: 1200 VM 1201
++
Sbjct: 289 LV 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 72/288 (25%), Positives = 119/288 (41%), Gaps = 50/288 (17%)
Query: 936 IGSGGFGEVYKAQLRD--GSV--VAIKKL--IHVTGQGDREFMAEMETIGKIKHRNLVPL 989
+G G FG V + + G V VA+K L ++ D +F+ E + + H NL+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMD-DFLKEAAIMHSLDHENLIRL 61
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGG---GTKLDWAARKKIAIGSARGLAFLH 1046
G + ++V E GSL L A G T D+A + I A G+ +L
Sbjct: 62 YGVV-LTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYA----VQI--ANGMRYLE 114
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP-GYVPPEY 1105
IHRD+ + N+LL + + ++ DFG+ R + + H + P + PE
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171
Query: 1106 YQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWA-----KQLHREKRIN 1159
++ + DV+ +GV L E+ + G+ P WA + L + +
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGEEP--------------WAGLSGSQILKKIDKEG 217
Query: 1160 EILD-PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206
E L+ PE Q ++Y + +C P RPT + E
Sbjct: 218 ERLERPEACPQ-----DIYNVML---QCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 930 FSADSMIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMA-EMETIGKIKHRNLV 987
F+ IG G FGEVYKA R VVAIK + + + E + E++ + + + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 988 PLLGYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAI---GSARGLA 1043
G + +L ++ EY GS +L K G KLD IA GL
Sbjct: 63 KYYG-SFLKGSKLWIIMEYCGGGSCLDLL----KPG--KLD---ETYIAFILREVLLGLE 112
Query: 1044 FLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPP 1103
+LH IHRD+K++N+LL E + +++DFG++ + T +T GTP ++ P
Sbjct: 113 YLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLT--STMSKRNTFVGTPFWMAP 167
Query: 1104 EYYQSFRCTTKGDVYSYGVILLELLSGKRP 1133
E + K D++S G+ +EL G+ P
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 5e-16
Identities = 62/220 (28%), Positives = 104/220 (47%), Gaps = 41/220 (18%)
Query: 934 SMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREF--------MAEMETIGKIK-H 983
+G G FG VY A+ ++ G +VAIKK+ ++F + E++++ K+ H
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEH 57
Query: 984 RNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLA 1043
N+V L + +E V+EYM+ G+L ++ DR G + + I +GLA
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRK---GKPFSESVIRSIIYQILQGLA 113
Query: 1044 FLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLS-VSTLAGTPGYVP 1102
+H HRD+K N+L+ +++DFG+AR + + + VS T Y
Sbjct: 114 HIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVS----TRWYRA 166
Query: 1103 PE------YYQSFRCTTKGDVYSYGVILLELLSGKRPIDP 1136
PE Y S D+++ G I+ EL + RP+ P
Sbjct: 167 PEILLRSTSYSS-----PVDIWALGCIMAELYTL-RPLFP 200
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 6e-16
Identities = 68/214 (31%), Positives = 104/214 (48%), Gaps = 31/214 (14%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMA-----EMETIGKIKHRNLVPL 989
IG G +G VY+A+ G +VA+KK V +R+ + E+ + ++H N+V L
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKK---VRMDNERDGIPISSLREITLLLNLRHPNIVEL 71
Query: 990 LGYC--KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH 1047
K + LV EY + L S+L + T + K + + RGL +LH
Sbjct: 72 KEVVVGKHLDSIFLVMEYCE-QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHE 126
Query: 1048 SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLS--VSTLAGTPGYVPPEY 1105
+ I IHRD+K SN+LL + +++DFG+AR ++ V TL Y PE
Sbjct: 127 NFI---IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTL----WYRAPEL 179
Query: 1106 YQSFRC---TTKGDVYSYGVILLELLSGKRPIDP 1136
C TT D+++ G IL ELL+ K P+ P
Sbjct: 180 L--LGCTTYTTAIDMWAVGCILAELLAHK-PLLP 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 56/197 (28%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKLIH-VTGQGDREFMAEMETIGKIKHRNLVPLLGYC 993
IG G FGEV+ +LR D + VA+K + +F+ E + + H N+V L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHI 1053
+ +V E ++ G + L G +L ++ +A G+ +L H
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTE----GPRLKVKELIQMVENAAAGMEYLESK---HC 115
Query: 1054 IHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP-GYVPPEYYQSFRCT 1112
IHRD+ + N L+ E ++SDFGM+R + S + P + PE R +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 1113 TKGDVYSYGVILLELLS 1129
++ DV+S+G++L E S
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 7e-16
Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 930 FSADSMIGSGGFGEVYKA-QLRDGS----VVAIKKLIHVTG-QGDREFMAEMETIGKIKH 983
F ++GSG FG VYK + +G VAIK+L T + ++E + E + + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 984 RNLVPLLGYCKIGEERLLVYEYMKWGSLESVL--HDRAKGGGTKLDWAARKKIAIGSARG 1041
++ LLG C + L+ + M +G L + H G L+W + A+G
Sbjct: 69 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 121
Query: 1042 LAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV 1101
+ +L ++HRD+ + NVL+ +++DFG+A+L+ A + ++
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 1102 PPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPID 1135
E T + DV+SYGV + EL++ G +P D
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 8e-16
Identities = 66/220 (30%), Positives = 98/220 (44%), Gaps = 38/220 (17%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIK-----KLI------HVTGQGDREFMAEMETIGKIKH 983
+G+G FG V + + G A+K K++ HV + E + I+H
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHV--------LNEKRILQSIRH 60
Query: 984 RNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLA 1043
LV L G + LV EY+ G L S L K G A + A L
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR---KSGRFPEPVA--RFYAAQVVLALE 115
Query: 1044 FLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPP 1103
+LH I++RD+K N+LLD + +++DFG A+ V T+ TL GTP Y+ P
Sbjct: 116 YLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV-KGRTY----TLCGTPEYLAP 167
Query: 1104 EYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDN 1143
E S D ++ G+++ E+L+G P F DDN
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAGYPP-----FFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 8e-16
Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 936 IGSGGFGEVYKA-QLRDGSVVAIKKLIHVTGQGDREFMA-EMETIGKIKHRNLVPLLGYC 993
IG G G VY A + G VAIK++ ++ Q +E + E+ + + K+ N+V L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHI 1053
+G+E +V EY+ GSL V+ + T +D + + L FLH + +
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHSN---QV 136
Query: 1054 IHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTT 1113
IHRD+KS N+LL + +++DFG + + ST+ GTP ++ PE
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 1114 KGDVYSYGVILLELLSGKRP 1133
K D++S G++ +E++ G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 9e-16
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 930 FSADSMIGSGGFGEVYKA-QLRDGSVVAIKKLIHVTGQGDR--EFMAEMETIGKIKHRNL 986
F+ IG G FGEVYK R VVAIK +I + D + E+ + + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSPYI 64
Query: 987 VPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLH 1046
G G + ++ EY+ GS +L K G L+ I +GL +LH
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGSALDLL----KPG--PLEETYIATILREILKGLDYLH 118
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYY 1106
IHRD+K++NVLL E + +++DFG+A + DT + +T GTP ++ PE
Sbjct: 119 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 173
Query: 1107 QSFRCTTKGDVYSYGVILLELLSGKRP 1133
+ K D++S G+ +EL G+ P
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 56/211 (26%), Positives = 104/211 (49%), Gaps = 29/211 (13%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLVPLLGYCK 994
+G G FG+VYKAQ ++ V+A K+I + + E +M E++ + H N+V LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 995 IGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHII 1054
++ E+ G++++V+ + + L + + + L +LH + II
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELER----PLTEPQIRVVCKQTLEALNYLHEN---KII 125
Query: 1055 HRDMKSSNVLLDENFEARVSDFGMA----RLVNALDTHLSVSTLAGTPGYVPPEYYQSFR 1110
HRD+K+ N+L + + +++DFG++ R + D+ + GTP ++ PE
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI------GTPYWMAPEVVM--- 176
Query: 1111 CTT--------KGDVYSYGVILLELLSGKRP 1133
C T K DV+S G+ L+E+ + P
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 936 IGSGGFGEVYKA-QLRDGSVVAIKKLIHVTGQGDREFM-AEMETIGKIKHRNLVPLLGYC 993
IG G G V A G VA+KK+ + Q RE + E+ + +H N+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM-DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHI 1053
+G+E +V E+++ G+L ++ T+++ + + + L+FLH +
Sbjct: 86 LVGDELWVVMEFLEGGALTDIVTH------TRMNEEQIATVCLAVLKALSFLHAQ---GV 136
Query: 1054 IHRDMKSSNVLLDENFEARVSDFGM-ARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCT 1112
IHRD+KS ++LL + ++SDFG A++ + S L GTP ++ PE
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS---LVGTPYWMAPEVISRLPYG 193
Query: 1113 TKGDVYSYGVILLELLSGKRP 1133
T+ D++S G++++E++ G+ P
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-15
Identities = 57/212 (26%), Positives = 108/212 (50%), Gaps = 15/212 (7%)
Query: 930 FSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQG--DREFMAEMETIGKIKHRNLV 987
F S +G+G G V+K + ++ +KLIH+ + + + E++ + + +V
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 988 PLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH 1047
G E + E+M GSL+ VL K G ++ K++I +GL +L
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLK---KAG--RIPEQILGKVSIAVIKGLTYLRE 121
Query: 1048 SCIPHIIHRDMKSSNVLLDENFEARVSDFGMA-RLVNALDTHLSVSTLAGTPGYVPPEYY 1106
I+HRD+K SN+L++ E ++ DFG++ +L++++ ++ GT Y+ PE
Sbjct: 122 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSPERL 174
Query: 1107 QSFRCTTKGDVYSYGVILLELLSGKRPIDPSE 1138
Q + + D++S G+ L+E+ G+ PI P +
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 76/274 (27%), Positives = 127/274 (46%), Gaps = 39/274 (14%)
Query: 936 IGSGGFGEVYKA-QLRDGSVVAIKKLIHVTGQGD---REFMAEMETIGKIKHRNLVPLLG 991
IG G FG VY A VVA+KK+ + Q + ++ + E++ + ++KH N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 992 YCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCI 1050
C + E LV EY GS +L K L I G+ +GLA+LH +
Sbjct: 89 -CYLKEHTAWLVMEYC-LGSASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHSHNM 142
Query: 1051 PHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSF- 1109
IHRD+K+ N+LL E + +++DFG A + ++ GTP ++ PE +
Sbjct: 143 ---IHRDIKAGNILLTEPGQVKLADFGSASKSS------PANSFVGTPYWMAPEVILAMD 193
Query: 1110 --RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELT 1167
+ K DV+S G+ +EL K P+ N+ + H I + P T
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERKPPL--------FNMNAMSALYH----IAQNDSP--T 239
Query: 1168 MQTSDETELYQYLRISFECLDDRPFKRPTMIQVM 1201
+Q+++ T+ ++ CL P +RP +++
Sbjct: 240 LQSNEWTDSFR--GFVDYCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 74/286 (25%), Positives = 124/286 (43%), Gaps = 30/286 (10%)
Query: 930 FSADSMIGSGGFGEVYKAQ-LRDGSVVAIKKLI---HVTGQGDREFMAEMETIGKIKHRN 985
F + IG G F EVY+A L DG VA+KK+ + + + + E++ + ++ H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 986 LVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGG---GTKLDWAARKKIAIGSARGL 1042
++ E +V E G L ++ K K W + + + SA
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW--KYFVQLCSA--- 118
Query: 1043 AFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP 1102
L H ++HRD+K +NV + ++ D G+ R ++ T + +L GTP Y+
Sbjct: 119 --LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMS 174
Query: 1103 PEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162
PE K D++S G +L E+ + + P +GD NL K+I +
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLYSLC------KKIEQCD 224
Query: 1163 DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208
P L E EL Q + + C++ P KRP + V + K +
Sbjct: 225 YPPLPSDHYSE-ELRQLVNM---CINPDPEKRPDITYVYDVAKRMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 18/210 (8%)
Query: 935 MIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGD------REFMAEMETIGKIKHRNLVP 988
++G G +G VY G ++A+K++ T + E++ + +KH N+V
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHS 1048
LG C + E++ GS+ S+L G + K G+A+LH++
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSIL----NRFGPLPEPVFCKYTK-QILDGVAYLHNN 121
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVS----TLAGTPGYVPPE 1104
C ++HRD+K +NV+L N ++ DFG AR + + H + S ++ GTP ++ PE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 1105 YYQSFRCTTKGDVYSYGVILLELLSGKRPI 1134
K D++S G + E+ +GK P+
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 936 IGSGGFGEVYKAQL-----RDGSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPL 989
+G FG++YK L +VAIK L + Q EF E + ++ H N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRA----------KGGGTK--LDWAARKKIAIG 1037
LG + +++EY+ G L L R+ + G K LD IAI
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 1038 SARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGT 1097
A G+ +L +H+D+ + N+L+ E ++SD G++R + + D +
Sbjct: 133 IAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 1098 PGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRP 1133
++PPE + ++ D++S+GV+L E+ S G +P
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-15
Identities = 80/291 (27%), Positives = 126/291 (43%), Gaps = 48/291 (16%)
Query: 936 IGSGGFGEVYKAQL--------RDGSVVAIKKLIH-VTGQGDREFMAEMETIGKI-KHRN 985
+G G FG+V A+ VA+K L T + + ++EME + I KH+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 986 LVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGG-----------GTKLDWAARKKI 1034
++ LLG C ++ EY G+L L R G +L +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 1035 AIGSARGLAFL-HHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVST 1093
A ARG+ +L CI HRD+ + NVL+ E+ +++DFG+AR V+ +D + +
Sbjct: 140 AYQVARGMEYLASQKCI----HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 1094 LAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPID--PSEFGDDNNLVGWAK 1150
++ PE T + DV+S+GV+L E+ + G P P E L K
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-----ELFKLLK 250
Query: 1151 QLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVM 1201
+ HR + + ELY +R EC P +RPT Q++
Sbjct: 251 EGHR-----------MDKPANCTHELYMIMR---ECWHAVPSQRPTFKQLV 287
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 4e-15
Identities = 93/329 (28%), Positives = 137/329 (41%), Gaps = 66/329 (20%)
Query: 888 PTSGSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKA 947
P S SSS SS S + + K L +L E N IGSG G VYK
Sbjct: 49 PPSSSSSSSSSSSA---SGSAPSAAKSLSEL------ERVN------RIGSGAGGTVYKV 93
Query: 948 QLRDGSVVAIKKLIHVTGQGD----REFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003
R + K+I+ G + R+ E+E + + H N+V E ++
Sbjct: 94 IHRPTGRLYALKVIY--GNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151
Query: 1004 EYMKWGSLESVLHDRAKGGGTKL-DWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSN 1062
E+M GSLE GT + D +A G+A+LH HI+HRD+K SN
Sbjct: 152 EFMDGGSLE----------GTHIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSN 198
Query: 1063 VLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTK-------- 1114
+L++ +++DFG++R++ T ++ GT Y+ PE R T
Sbjct: 199 LLINSAKNVKIADFGVSRILA--QTMDPCNSSVGTIAYMSPE-----RINTDLNHGAYDG 251
Query: 1115 --GDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSD 1172
GD++S GV +LE G+ P GD WA + I PE S
Sbjct: 252 YAGDIWSLGVSILEFYLGRFPFGVGRQGD------WASLMC---AICMSQPPEAPATASR 302
Query: 1173 ETELYQYLRISFECLDDRPFKRPTMIQVM 1201
E + IS CL P KR + +Q++
Sbjct: 303 EFRHF----ISC-CLQREPAKRWSAMQLL 326
|
Length = 353 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 14/223 (6%)
Query: 927 TNGFSADSMIGSGGFGEVYKAQ-LRDGSVVAIKK--LIHVTGQGDRE-FMAEMETIGKIK 982
F + IG G F VYKA L DG VVA+KK + + R+ + E++ + ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 983 HRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGL 1042
H N++ L E +V E G L S + K + K + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 1043 AFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP 1102
+H I+HRD+K +NV + ++ D G+ R ++ T + +L GTP Y+
Sbjct: 120 EHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMS 174
Query: 1103 PEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNL 1145
PE K D++S G +L E+ + + P +GD NL
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 75/269 (27%), Positives = 123/269 (45%), Gaps = 35/269 (13%)
Query: 933 DSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGY 992
+ +G+G FGEV+ A + VA+K + + F+AE + ++H LV L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 993 CKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPH 1052
E ++ E+M GSL L G+K + A G+AF+ +
Sbjct: 70 VT-KEPIYIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQR---N 122
Query: 1053 IIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP-GYVPPEY--YQSF 1109
IHRD++++N+L+ + +++DFG+AR++ D + A P + PE + SF
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIE--DNEYTAREGAKFPIKWTAPEAINFGSF 180
Query: 1110 RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQ 1169
T K DV+S+G++L+E+++ R P G N V + L R R M
Sbjct: 181 --TIKSDVWSFGILLMEIVTYGRIPYP---GMSNPEV--IRALERGYR----------MP 223
Query: 1170 TSDE--TELYQYLRISFECLDDRPFKRPT 1196
+ ELY I C +RP +RPT
Sbjct: 224 RPENCPEELYN---IMMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 935 MIGSGGFGEVYKA-QLRDGSVVAIKKLIHVTGQGD-REFMAEMETIGKIKH---RNLVPL 989
+IG G +G VY+ + G VVA+K + T D + E+ + +++ N+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAA---RKKIAIGSARGLAFLH 1046
G G ++ EY + GS+ +++ K G + + R+ + L ++H
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLV-----ALKYIH 118
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYY 1106
+IHRD+K++N+L+ ++ DFG+A L+N ST GTP ++ PE
Sbjct: 119 KV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ--NSSKRSTFVGTPYWMAPEVI 173
Query: 1107 QSFRC-TTKGDVYSYGVILLELLSGKRP 1133
+ TK D++S G+ + E+ +G P
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 7e-15
Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 936 IGSGGFGEVYKA-QLRDGSVVAIKKLIHVTGQGDREFMA-EMETIGKIKHRNLVPLLGYC 993
IG G G VY A + G VAI+++ ++ Q +E + E+ + + K+ N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHI 1053
+G+E +V EY+ GSL V+ + T +D + + L FLH + +
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 1054 IHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTT 1113
IHRD+KS N+LL + +++DFG + + ST+ GTP ++ PE
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 1114 KGDVYSYGVILLELLSGKRP 1133
K D++S G++ +E++ G+ P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 8e-15
Identities = 69/220 (31%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 935 MIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLV-----P 988
++G G FG+V A+L+ G A+K L + D + + ++ R L P
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKAL-----KKDVVLIDDDVECTMVEKRVLALAWENP 56
Query: 989 LLG--YC--KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAF 1044
L YC + E V E++ G L + H + KG + D A GL F
Sbjct: 57 FLTHLYCTFQTKEHLFFVMEFLNGGDL--MFHIQDKG---RFDLYRATFYAAEIVCGLQF 111
Query: 1045 LHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE 1104
LH II+RD+K NV+LD + +++DFGM + N + ST GTP Y+ PE
Sbjct: 112 LHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCK-ENVFGDN-RASTFCGTPDYIAPE 166
Query: 1105 YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144
Q + T D +S+GV+L E+L G+ P GDD +
Sbjct: 167 ILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH----GDDED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-15
Identities = 72/275 (26%), Positives = 124/275 (45%), Gaps = 47/275 (17%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCK 994
+GSG +G+VYKA+ L G + A+K + G E+ + + KH N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 995 IGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHII 1054
E+ + EY GSL+ + H ++ + R+ + +GLA+LH +
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGK---M 128
Query: 1055 HRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEY--------Y 1106
HRD+K +N+LL +N + +++DFG+A + A T + GTP ++ PE Y
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITA--TIAKRKSFIGTPYWMAPEVAAVEKNGGY 186
Query: 1107 QSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI-----NEI 1161
C D+++ G+ +EL + P F LH + + +
Sbjct: 187 NQL-C----DIWAVGITAIELAE----LQPPMF-----------DLHPMRALFLMSKSNF 226
Query: 1162 LDPELTMQTSDETELYQYLRISFECLDDRPFKRPT 1196
P+L +T + + +++IS L P KRPT
Sbjct: 227 QPPKLKDKTKWSSTFHNFVKIS---LTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 9e-15
Identities = 57/215 (26%), Positives = 103/215 (47%), Gaps = 21/215 (9%)
Query: 935 MIGSGGFGEVYKA-QLRDGSVVAIKKL-IHVTGQGDREFMAEMETIGKIKHRNLVPLLGY 992
++G G G VYKA L ++A+K + + +T + ++ M+E+E + K ++ G
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 993 CKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPH 1052
+ + E+M GSL+ K+ +IA+ +GL +L
Sbjct: 68 FFVENRISICTEFMDGGSLDVY---------RKIPEHVLGRIAVAVVKGLTYLWSL---K 115
Query: 1053 IIHRDMKSSNVLLDENFEARVSDFGMAR-LVNALDTHLSVSTLAGTPGYVPPEYYQSFRC 1111
I+HRD+K SN+L++ + ++ DFG++ LVN++ T GT Y+ PE +
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAK-----TYVGTNAYMAPERISGEQY 170
Query: 1112 TTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLV 1146
DV+S G+ +EL G+ P P + +L+
Sbjct: 171 GIHSDVWSLGISFMELALGRFPY-PQIQKNQGSLM 204
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 9e-15
Identities = 65/203 (32%), Positives = 91/203 (44%), Gaps = 12/203 (5%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKLIH---VTGQGDREFMAEMETIGKIKHRNLVPLLG 991
+G GGFGEV Q+R G + A KKL +G M E + K+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 992 YCKIGEERLLVYEYMKWGSLESVLHD-RAKGGGTKLDWAARKKIAIGSARGLAFLHHSCI 1050
+ + LV M G L +++ + G A I S GL LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIIS--GLEHLHQR-- 116
Query: 1051 PHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFR 1110
II+RD+K NVLLD + R+SD G+A V D AGTPG++ PE Q
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQGEE 173
Query: 1111 CTTKGDVYSYGVILLELLSGKRP 1133
D ++ GV L E+++ + P
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 72/233 (30%), Positives = 111/233 (47%), Gaps = 27/233 (11%)
Query: 918 LTFAHLLEATNGFSADSMIGSGGFGEVYK-AQLRDGSVVAIKKLIHVTGQGDREFMAEME 976
L L + T+ + IG G +G+VYK +DGS+ A+K L ++ D E AE
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-DEEIEAEYN 70
Query: 977 TIGKI-KHRNLVPLLG-YCK----IGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAA 1030
+ + H N+V G + K +G + LV E GS+ ++ G +LD A
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG-QRLDEAM 129
Query: 1031 RKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLS 1090
I G+ GL LH++ IIHRD+K +N+LL ++ DFG++ + + T L
Sbjct: 130 ISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS--TRLR 184
Query: 1091 VSTLAGTPGYVPPE---------YYQSFRCTTKGDVYSYGVILLELLSGKRPI 1134
+T GTP ++ PE Y RC DV+S G+ +EL G P+
Sbjct: 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARC----DVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 935 MIGSGGFGEVYKA-QLRDGSV----VAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVP 988
++GSG FG V+K + +G VAIK + +G Q +E M +G + H +V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTK--LDWAARKKIAIGSARGLAFLH 1046
LLG C G LV + GSL + + L+W + A+G+ +L
Sbjct: 74 LLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLE 126
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYY 1106
+ +HR++ + N+LL + +++DFG+A L+ D S ++ E
Sbjct: 127 EHRM---VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 1107 QSFRCTTKGDVYSYGVILLELLS-GKRP 1133
R T + DV+SYGV + E++S G P
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 78/286 (27%), Positives = 128/286 (44%), Gaps = 61/286 (21%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMA---EMETIGKIKHRNLVP--- 988
+G G +GEV + R DG IKKL ++ RE A E + + ++KH N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKL-NLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 989 -----------LLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIG 1037
++G+C+ G+ +Y +K + + ++ ++W + +A
Sbjct: 67 SWEGEDGLLYIVMGFCEGGD----LYHKLKEQKGKLLPENQV------VEWFVQIAMA-- 114
Query: 1038 SARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSV-STLAG 1096
L +LH HI+HRD+K+ NV L +V D G+AR+ L+ + STL G
Sbjct: 115 ----LQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARV---LENQCDMASTLIG 164
Query: 1097 TPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREK 1156
TP Y+ PE + + K DV++ G + E+ + K + D N+LV
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK---DMNSLV---------Y 212
Query: 1157 RINEILDPELTMQTSDE-TELYQYLRISFECLDDRPFKRPTMIQVM 1201
RI E P + S E EL + L RP KRP++ ++
Sbjct: 213 RIIEGKLPPMPKDYSPELGELIATM------LSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 53/200 (26%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFM-AEMETIGKIKHRNLVPLLGYC 993
IG G G V A ++ G +VA+KK+ + Q RE + E+ + +H N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHI 1053
+G+E +V E+++ G+L ++ T+++ + + + L+ LH +
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLKALSVLHAQ---GV 137
Query: 1054 IHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTT 1113
IHRD+KS ++LL + ++SDFG V+ +L GTP ++ PE
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KSLVGTPYWMAPELISRLPYGP 195
Query: 1114 KGDVYSYGVILLELLSGKRP 1133
+ D++S G++++E++ G+ P
Sbjct: 196 EVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 37/221 (16%)
Query: 930 FSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIH------VTGQGDREFMAEMETIGKIKH 983
F +G+G G V K R ++ +KLIH + Q RE K+ H
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIREL--------KVLH 54
Query: 984 RNLVPLL-----GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGS 1038
P + + GE + + E+M GSL+ VL +A ++ KI+I
Sbjct: 55 ECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLK-KAG----RIPENILGKISIAV 108
Query: 1039 ARGLAFLH--HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA-RLVNALDTHLSVSTLA 1095
RGL +L H I+HRD+K SN+L++ E ++ DFG++ +L++++ ++
Sbjct: 109 LRGLTYLREKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFV 159
Query: 1096 GTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDP 1136
GT Y+ PE Q T + D++S G+ L+E+ G+ PI P
Sbjct: 160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 11/203 (5%)
Query: 935 MIGSGGFGEVYKAQLRDGSV-VAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYC 993
++G G +G VY A+ V +AIK++ + + E+ +KHRN+V LG
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHI 1053
+ E + GSL ++L R+K G K + GL +LH + I
Sbjct: 75 SENGFFKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QI 129
Query: 1054 IHRDMKSSNVLLDE-NFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYY-QSFRC 1111
+HRD+K NVL++ + ++SDFG ++ + ++ T GT Y+ PE + R
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRG 187
Query: 1112 TTK-GDVYSYGVILLELLSGKRP 1133
D++S G ++E+ +GK P
Sbjct: 188 YGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 15/207 (7%)
Query: 930 FSADSMIGSGGFGEVYKA-QLRDGSVVAIKKLIHVTGQGDR--EFMAEMETIGKIKHRNL 986
F+ IG G FGEV+K R VVAIK +I + D + E+ + + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 987 VPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLH 1046
G + ++ EY+ GS +L LD I +GL +LH
Sbjct: 65 TKYYGSYLKDTKLWIIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLH 118
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYY 1106
IHRD+K++NVLL E+ E +++DFG+A + DT + +T GTP ++ PE
Sbjct: 119 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 173
Query: 1107 QSFRCTTKGDVYSYGVILLELLSGKRP 1133
+ +K D++S G+ +EL G+ P
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 930 FSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHV---TGQGDREFMAEMETIGKIKHRN 985
F ++G GGFGEV Q+R G + A KKL +G+ + E + + K+ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 986 LVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSAR---GL 1042
+V L + + LV M G L+ ++ + G + + +A GL
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEE------GRAVFYAAEICCGL 115
Query: 1043 AFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP 1102
LH I++RD+K N+LLD++ R+SD G+A V T + GT GY+
Sbjct: 116 EDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMA 169
Query: 1103 PEYYQSFRCTTKGDVYSYGVILLELLSGKRP 1133
PE ++ R T D ++ G +L E+++G+ P
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 936 IGSGGFGEVYKA--QLRDGSV-VAIKKLIHVTGQGDR-EFMAEMETIGKIKHRNLVPLLG 991
+GSG FG V K ++R + VAIK L + + R E M E E + ++ + +V ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 992 YCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAI---GSARGLAFLHHS 1048
C+ E +LV E G L L K D + + G+ +L
Sbjct: 63 VCE-AEALMLVMEMASGGPLNKFL-------SGKKDEITVSNVVELMHQVSMGMKYLEGK 114
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP-GYVPPEYYQ 1107
+ +HRD+ + NVLL A++SDFG+++ + A D++ + P + PE
Sbjct: 115 ---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171
Query: 1108 SFRCTTKGDVYSYGVILLELLS-GKRP 1133
+ +++ DV+SYG+ + E S G++P
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 3e-14
Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 935 MIGSGGFGEVYKAQLR-DGSVVAIKKLIH-VTGQGD--REFMAEMETIGKIKHRNLVPLL 990
++G G FG+V A+L+ G + A+K L V Q D M E + ++ + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 991 GYCKIGEERLL-VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC 1049
C +RL V E++ G L + H + + D A + A L FLH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDL--MFHIQKS---RRFDEARARFYAAEITSALMFLHDK- 115
Query: 1050 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSF 1109
II+RD+K NVLLD +++DFGM + + + ST GTP Y+ PE Q
Sbjct: 116 --GIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEM 171
Query: 1110 RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDD 1142
D ++ GV+L E+L G P + +E DD
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFE-AENEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 936 IGSGGFGEVY----KAQLRDG--SVVAIKKLIHVTGQGDR-EFMAEMETIGKIKHRNLVP 988
+G G FG VY K ++D + VAIK + +R EF+ E + + ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHD---RAKGGGTKLDWAARKKIAIGS--ARGLA 1043
LLG G+ L++ E M G L+S L + + + +K I + A G+A
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 1044 FLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP- 1102
+L+ + +HRD+ + N ++ E+F ++ DFGM R + D + G G +P
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK-----GGKGLLPV 185
Query: 1103 ----PEYYQSFRCTTKGDVYSYGVILLEL 1127
PE + TT DV+S+GV+L E+
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 44/225 (19%)
Query: 934 SMIGSGGFGEVYKAQLRDGS------------VVAIKKLIHVTGQGDREFMAEMETIGKI 981
+G+G FG V+ + R V+ +K+ HV ++ + E +
Sbjct: 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHV--HNEKRVLKE------V 58
Query: 982 KHRNLVPLLGYCKIGEERLL--VYEYMKWGSLESVLHDRAK-GGGTKLDWAARKKIAIGS 1038
H ++ L + ++R L + EY+ G L S L + + T L +A+ I
Sbjct: 59 SHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE----IVC 112
Query: 1039 ARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP 1098
A L +LH I++RD+K N+LLD+ +++DFG A+ + TL GTP
Sbjct: 113 A--LEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKL-----RDRTWTLCGTP 162
Query: 1099 GYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDN 1143
Y+ PE QS D ++ G+++ E+L G P F DDN
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP-----FFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-14
Identities = 77/290 (26%), Positives = 127/290 (43%), Gaps = 46/290 (15%)
Query: 936 IGSGGFGEVYKAQL--------RDGSVVAIKKLIHVTGQGD-REFMAEMETIGKI-KHRN 985
+G G FG+V A+ + VA+K L + D + ++EME + I KH+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 986 LVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGG-----------GTKLDWAARKKI 1034
++ LLG C ++ EY G+L L R G +L +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 1035 AIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTL 1094
A ARG+ +L IHRD+ + NVL+ E+ +++DFG+AR ++ +D + +
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 1095 AGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPID--PSEFGDDNNLVGWAKQ 1151
++ PE T + DV+S+GV+L E+ + G P P E L K+
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-----ELFKLLKE 257
Query: 1152 LHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVM 1201
HR + ++ ELY +R +C P +RPT Q++
Sbjct: 258 GHRMDK-----------PSNCTNELYMMMR---DCWHAVPSQRPTFKQLV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 71/286 (24%), Positives = 115/286 (40%), Gaps = 65/286 (22%)
Query: 936 IGSGGFGEVYKAQLR-------DGSVVAIKKLIHVTGQGDREFMAEMETIG---KIKHRN 985
+G G F +YK LR G + ++ V G R+ +A ET ++ H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 986 LVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGT---KLDWAARKKIAIGSARGL 1042
LV L G C + +E ++V EY+K+G L+ LH R K + KLD +A A L
Sbjct: 63 LVKLYGVC-VRDENIMVEEYVKFGPLDVFLH-REKNNVSLHWKLD------VAKQLASAL 114
Query: 1043 AFLHHSCIPHIIHRDMKSSNVLL---DENFE----ARVSDFGMARLVNALDTHLSVSTLA 1095
+L ++H ++ N+L+ N ++SD G+ V LS
Sbjct: 115 HYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV------LSREERV 165
Query: 1096 GTPGYVPPEYYQ--SFRCTTKGDVYSYGVILLELLS-GKRP---IDPSEFGDDNNLVGWA 1149
++ PE + T D +S+G LLE+ S G+ P + SE
Sbjct: 166 ERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE----------- 214
Query: 1150 KQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRP 1195
+ + + + P D EL + +C P KRP
Sbjct: 215 -KERFYQDQHRLPMP-------DCAELANLIN---QCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 71/280 (25%), Positives = 123/280 (43%), Gaps = 34/280 (12%)
Query: 936 IGSGGFGEVYKAQLRDGSVVA---IKKL-IHVTGQGDREFMAEMETIGKIKHRNLVPLLG 991
IG+G FG+V + G A +K+L T F+ E++ ++ H N++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 992 YCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAAR--KKIAIGSARGLAFLHHSC 1049
C LLV E+ G L++ L R+ G +++A A GL +LH +
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYL--RSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA- 119
Query: 1050 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSF 1109
IH D+ N L + ++ D+G+A D +++ A ++ PE +
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 1110 -------RCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161
T K +++S GV + EL + +P + D+ L KQ+ RE+ I ++
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY--PDLSDEQVL----KQVVREQDI-KL 230
Query: 1162 LDPELTMQTSDE-TELYQYLRISFECLDDRPFKRPTMIQV 1200
P+L ++ SD E+ Q+ + P RPT +V
Sbjct: 231 PKPQLDLKYSDRWYEVMQFCWLD-------PETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 69/236 (29%), Positives = 112/236 (47%), Gaps = 42/236 (17%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKL-IHVTGQGD-----REFMAEMETIGKIKHRNLVP 988
IG G +G VYKA+ L G VA+KK+ + ++ +G RE +A ++ + +H N+V
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLRE-IALLKQLESFEHPNIVR 65
Query: 989 LLGYCKIGE-ER----LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLA 1043
LL C +R LV+E++ L + L K G L K + RG+
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPG---LPPETIKDLMRQLLRGVD 121
Query: 1044 FLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPP 1103
FLH I +HRD+K N+L+ + + +++DFG+AR+ ++++++ T Y P
Sbjct: 122 FLHSHRI---VHRDLKPQNILVTSDGQVKIADFGLARI---YSFEMALTSVVVTLWYRAP 175
Query: 1104 E-----YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR 1154
E Y T D++S G I EL +RP+ G A QL +
Sbjct: 176 EVLLQSSY-----ATPVDMWSVGCIFAELFR-RRPLFR---GTSE-----ADQLDK 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 55/200 (27%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 936 IGSGGFGEVYKA-QLRDGSVVAIKKLIHVTGQGDREFM-AEMETIGKIKHRNLVPLLGYC 993
IG G G V A + G VA+KK+ + Q RE + E+ + H N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKM-DLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHI 1053
+G+E +V E+++ G+L ++ T+++ + + R L++LH+ +
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTH------TRMNEEQIATVCLSVLRALSYLHNQ---GV 139
Query: 1054 IHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTT 1113
IHRD+KS ++LL + ++SDFG V+ +L GTP ++ PE T
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVS--KEVPKRKSLVGTPYWMAPEVISRLPYGT 197
Query: 1114 KGDVYSYGVILLELLSGKRP 1133
+ D++S G++++E++ G+ P
Sbjct: 198 EVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 4e-14
Identities = 69/224 (30%), Positives = 107/224 (47%), Gaps = 27/224 (12%)
Query: 930 FSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIH--VTGQGDRE-FMAEMETIGKIKHRN 985
F+ ++G G FG+V A+ + + AIK L V D E M E +
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 986 LVPLLGYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAF 1044
+ L C +RL V EY+ G L + K + + A +I++G L F
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYA-AEISVG----LFF 116
Query: 1045 LHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR--LVNALDTHLSVSTLAGTPGYVP 1102
LH II+RD+K NV+LD +++DFGM + +V+ + T T GTP Y+
Sbjct: 117 LHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR----TFCGTPDYIA 169
Query: 1103 PEY--YQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144
PE YQ + + D ++YGV+L E+L+G+ P D G+D +
Sbjct: 170 PEIIAYQPYGKSV--DWWAYGVLLYEMLAGQPPFD----GEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 5e-14
Identities = 64/209 (30%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 935 MIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLV-----P 988
M+G G FG+V+ A+L+ AIK L + D M + ++ R L P
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKAL-----KKDVVLMDDDVECTMVEKRVLSLAWEHP 56
Query: 989 LLG--YC--KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAF 1044
L YC + E V EY+ G L + H ++ K D A GL F
Sbjct: 57 FLTHLYCTFQTKENLFFVMEYLNGGDL--MFHIQS---CHKFDLPRATFYAAEIICGLQF 111
Query: 1045 LHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE 1104
LH I++RD+K N+LLD + +++DFGM + + T GTP Y+ PE
Sbjct: 112 LHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPE 166
Query: 1105 YYQSFRCTTKGDVYSYGVILLELLSGKRP 1133
+ T D +S+GV+L E+L G+ P
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 69/245 (28%), Positives = 119/245 (48%), Gaps = 27/245 (11%)
Query: 936 IGSGGFGEVYKAQL-RDGSV--VAIKKL-IHVTGQGDRE-FMAEMETIGKIKHRNLVPLL 990
+G G FG V + QL +D S+ VA+K + I + + + E F++E + + H N++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 991 GYCKIGEER------LLVYEYMKWGSLES-VLHDRAKGGGTKLDWAARKKIAIGSARGLA 1043
G C E +++ +MK G L S +L+ R L K A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 1044 FLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP-GYVP 1102
+L IHRD+ + N +L+EN V+DFG+++ + D + +A P ++
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQ-GRIAKMPVKWIA 182
Query: 1103 PEYYQSFRCTTKGDVYSYGVILLELLS-GKRP---IDPSEFGDDNNLVGWAKQLHREKRI 1158
E TTK DV+S+GV + E+ + G+ P ++ SE D + +Q +R K+
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYD------YLRQGNRLKQP 236
Query: 1159 NEILD 1163
+ LD
Sbjct: 237 PDCLD 241
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 18/205 (8%)
Query: 935 MIGSGGFGEVYKAQLRDGSVVAIKKLIH--VTGQGDREFMAEMETIGKIKHRNLVPLLGY 992
++G G FG Q + K I + + E + K+KH N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 993 CKIGEERLLVYEYMKWGSLESVLHDRAKGG----GTKLDWAARKKIAIGSARGLAFLHHS 1048
+ +V EY G L + + +G T L W + + + H
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGV---------QHI 116
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQS 1108
++HRD+KS N+ L +N + ++ DFG ARL+ + + T GTP YVPPE +++
Sbjct: 117 HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY--ACTYVGTPYYVPPEIWEN 174
Query: 1109 FRCTTKGDVYSYGVILLELLSGKRP 1133
K D++S G IL EL + K P
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-14
Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 20/206 (9%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCK 994
IGSG +G+VYKA+ + G + AIK + G+ E+ + KH N+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 995 IGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHII 1054
++ + E+ GSL+ + H +++ + +R+ + +GL +LH +
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSK---GKM 128
Query: 1055 HRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTK 1114
HRD+K +N+LL +N +++DFG++ + A T + GTP ++ PE R K
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVER---K 183
Query: 1115 G------DVYSYGVILLELLSGKRPI 1134
G D+++ G+ +EL + P+
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 6e-14
Identities = 58/235 (24%), Positives = 97/235 (41%), Gaps = 40/235 (17%)
Query: 933 DSMIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDRE--------------FMAEMET 977
+ +G G +G+V KA G +VAIKK+ + D + E++
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 978 IGKIKHRNLVPLLG-YCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAI 1036
+ +IKH N++ L+ Y + G+ LV + M L+ V+ + +L + K I +
Sbjct: 74 MNEIKHENIMGLVDVYVE-GDFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILL 126
Query: 1037 GSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR-------LVNALDTHL 1089
GL LH + +HRD+ +N+ ++ +++DFG+AR
Sbjct: 127 QILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183
Query: 1090 SVSTLAGTPG-----YVPPEYYQSFRCTTKG-DVYSYGVILLELLSGKRPIDPSE 1138
T Y PE D++S G I ELL+GK P+ P E
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK-PLFPGE 237
|
Length = 335 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 7e-14
Identities = 65/232 (28%), Positives = 107/232 (46%), Gaps = 41/232 (17%)
Query: 920 FAHLLEATNGFSADSMIGSGGFGEVYKA--QLRDGSVVAIKKLIH--VTGQGDREFMAEM 975
F + E TN + +G G FG V A QL G VAIKK++ T + E+
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYREL 60
Query: 976 ETIGKIKHRNLVPLLGYCKI----GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAAR 1031
+ + ++H N++ L I E+ V E + L +L R L+
Sbjct: 61 KLLKHLRHENIISL---SDIFISPLEDIYFVTELLG-TDLHRLLTSR------PLEKQFI 110
Query: 1032 KKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSV 1091
+ RGL ++H + ++HRD+K SN+L++EN + ++ DFG+AR+ D ++
Sbjct: 111 QYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI---QDPQMT- 163
Query: 1092 STLAGTPGYVPPEYYQS-------FRCTTKGDVYSYGVILLELLSGKRPIDP 1136
GYV YY++ + + D++S G I E+L GK P+ P
Sbjct: 164 -------GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK-PLFP 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 8e-14
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 27/217 (12%)
Query: 936 IGSGGFGEVYKAQL---RDGSVVAIKKLIHVTGQGD-------REFMAEMETIGKIKHRN 985
IG G +G VYKA+ +DG AIKK Q RE E +KH N
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRE----LKHEN 63
Query: 986 LVPLLGYCKIGEERL--LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLA 1043
+V L+ ++ L+++Y + + + R + + K + G+
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQA-KRVSIPPSMVKSLLWQILNGVH 122
Query: 1044 FLHHSCIPHIIHRDMKSSNVLL----DENFEARVSDFGMARLVNA-LDTHLSVSTLAGTP 1098
+LH + ++HRD+K +N+L+ E ++ D G+ARL NA L + + T
Sbjct: 123 YLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI 179
Query: 1099 GYVPPEYYQSFRCTTKG-DVYSYGVILLELLSGKRPI 1134
Y PE R TK D+++ G I ELL+ PI
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 9e-14
Identities = 55/213 (25%), Positives = 105/213 (49%), Gaps = 26/213 (12%)
Query: 935 MIGSGGFGEVYKAQ-LRDGSVVAIKKLIHV-TGQGDRE-----FMAEMETIGKIKHRNLV 987
+G+G F Y+A+ ++ G+++A+K++ +V ++E E+ + ++ H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 988 PLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSA----RGLA 1043
+LG L E+M GS+ +L A ++ + I RGL+
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG---------AFKEAVIINYTEQLLRGLS 117
Query: 1044 FLHHSCIPHIIHRDMKSSNVLLDENFE-ARVSDFGMARLVNALDTH--LSVSTLAGTPGY 1100
+LH + IIHRD+K +N+L+D + R++DFG A + A T L GT +
Sbjct: 118 YLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAF 174
Query: 1101 VPPEYYQSFRCTTKGDVYSYGVILLELLSGKRP 1133
+ PE + + DV+S G +++E+ + K P
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 70/218 (32%), Positives = 103/218 (47%), Gaps = 29/218 (13%)
Query: 935 MIGSGGFGEVYKAQLRD-GSVVAIKKLIH--VTGQGDREF-MAE---METIGKIKHRNLV 987
++G G FG+V A+L+ + A+K L + D E M E + GK H L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK--HPFLT 59
Query: 988 PLLGYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLH 1046
L C ++RL V EY+ G L + H + G + D + A GL FLH
Sbjct: 60 QLHS-CFQTKDRLFFVMEYVNGGDL--MFHIQRSG---RFDEPRARFYAAEIVLGLQFLH 113
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR--LVNALDTHLSVSTLAGTPGYVPPE 1104
II+RD+K NVLLD +++DFGM + ++ + T ST GTP Y+ PE
Sbjct: 114 ER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT----STFCGTPDYIAPE 166
Query: 1105 YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDD 1142
D ++ GV+L E+L+G+ P + GDD
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQSPFE----GDD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 1e-13
Identities = 73/262 (27%), Positives = 111/262 (42%), Gaps = 62/262 (23%)
Query: 936 IGSGGFGEVYKAQLRDGSV-VAIKKL-------IHVTGQGDREFMAEMETIGKIKHRNLV 987
+GSG +G+V A VAIKKL IH R + E+ + + H N++
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIH----AKRTYR-ELRLLKHMDHENVI 77
Query: 988 PLLGYCKIGEER------LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARG 1041
LL LV M L +++ + KL + + RG
Sbjct: 78 GLLDVFTPASSLEDFQDVYLVTHLMG-ADLNNIVKCQ------KLSDDHIQFLVYQILRG 130
Query: 1042 LAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV 1101
L ++H S IIHRD+K SN+ ++E+ E ++ DFG+AR + T GYV
Sbjct: 131 LKYIH-SA--GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT-----------GYV 176
Query: 1102 PPEYYQS-------FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR 1154
+Y++ D++S G I+ ELL+GK + P G D+ QL
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK-TLFP---GSDHI-----DQL-- 225
Query: 1155 EKRINEIL---DPELTMQTSDE 1173
KRI ++ D EL + S E
Sbjct: 226 -KRIMNLVGTPDEELLQKISSE 246
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 73/282 (25%), Positives = 114/282 (40%), Gaps = 41/282 (14%)
Query: 933 DSMIGSGGFGEVYKA---QLRDGSV-VAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLV 987
IG G FG+VY+ + + VA+K + T RE F+ E + + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 988 PLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH 1047
L+G +V E G L S L LD A+ + + LA+L
Sbjct: 71 KLIGVITE-NPVWIVMELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLES 125
Query: 1048 SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQ 1107
+HRD+ + NVL+ ++ DFG++R + +++ S ++ PE
Sbjct: 126 K---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED-ESYYKASKGKLPIKWMAPESIN 181
Query: 1108 SFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPE- 1165
R T+ DV+ +GV + E+L G +P G NN V I I + E
Sbjct: 182 FRRFTSASDVWMFGVCMWEILMLGVKPF----QGVKNNDV-----------IGRIENGER 226
Query: 1166 LTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207
L M + LY + +C P KRP F EL
Sbjct: 227 LPMPPNCPPTLYSLMT---KCWAYDPSKRPR-------FTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-13
Identities = 55/201 (27%), Positives = 104/201 (51%), Gaps = 16/201 (7%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFM-AEMETIGKIKHRNLVPLLGYC 993
IG G G V A+ + G VA+K ++ + Q RE + E+ + +H+N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHI 1053
+GEE ++ E+++ G+L ++ T+L+ + + L +LH +
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQ------TRLNEEQIATVCESVLQALCYLHSQ---GV 138
Query: 1054 IHRDMKSSNVLLDENFEARVSDFGM-ARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCT 1112
IHRD+KS ++LL + ++SDFG A++ + S L GTP ++ PE
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS---LVGTPYWMAPEVISRTPYG 195
Query: 1113 TKGDVYSYGVILLELLSGKRP 1133
T+ D++S G++++E++ G+ P
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 23/208 (11%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGD------REFMAEMETIGKIKHRNLVP 988
IG G +G VYKA+ G VA+K + T + RE +A ++ + H N+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVRE-VALLKRLEAFDHPNIVR 66
Query: 989 LLGYCKIG----EERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLA 1043
L+ C E ++ LV+E++ L + L D+ G + K + RGL
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVD-QDLRTYL-DKVPPPGLPAE--TIKDLMRQFLRGLD 122
Query: 1044 FLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPP 1103
FLH +CI +HRD+K N+L+ + +++DFG+AR+ + ++++ + T Y P
Sbjct: 123 FLHANCI---VHRDLKPENILVTSGGQVKLADFGLARIYSC---QMALTPVVVTLWYRAP 176
Query: 1104 EYYQSFRCTTKGDVYSYGVILLELLSGK 1131
E T D++S G I E+ K
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDRE-----FMAEMETIGKIKHRNLVPL 989
IG G +G V+KA+ R+ +VA+K+ V D E + E+ + ++KH+N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKR---VRLDDDDEGVPSSALREICLLKELKHKNIVRL 64
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC 1049
++ LV+EY L+ D G +D K +GLAF H
Sbjct: 65 YDVLHSDKKLTLVFEYCD-QDLKKYF-DSCNG---DIDPEIVKSFMFQLLKGLAFCHSH- 118
Query: 1050 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLS--VSTLAGTPGYVPPEYYQ 1107
+++HRD+K N+L+++N E +++DFG+AR S V TL Y PP+
Sbjct: 119 --NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTL----WYRPPDVLF 172
Query: 1108 SFRC-TTKGDVYSYGVILLELLSGKRPIDPSEFGDD 1142
+ +T D++S G I EL + RP+ P DD
Sbjct: 173 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 69/279 (24%), Positives = 115/279 (41%), Gaps = 39/279 (13%)
Query: 936 IGSGGFGEVYKAQL------RDGSVVAIKKLI-HVTGQGDREFMAEMETIGKIKHRNLVP 988
+G FG+VYK L VAIK L G EF E +++H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDRAKG---GGTKLDWAARKK--------IAIG 1037
LLG + +++ Y L L R+ G T D + I
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 1038 SARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGT 1097
A G+ FL H++H+D+ + NVL+ + ++SD G+ R V A D + +
Sbjct: 133 IAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 1098 PGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREK 1156
++ PE + + D++SYGV+L E+ S G +P G++ Q
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-----------YCGYSNQ----- 233
Query: 1157 RINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRP 1195
+ E++ + D+ + Y + EC ++ P +RP
Sbjct: 234 DVIEMIRNRQVLPCPDDCPAWVY-TLMLECWNEFPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 935 MIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDR------EFMA--EMETIGKIKHRN 985
++G GGFGEV Q+R G + A KKL + R E MA E + + K+ R
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKL-----EKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 986 LVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFL 1045
+V L + + LV M G L+ +++ G D A GL L
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG---FDEERAVFYAAEITCGLEDL 118
Query: 1046 HHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEY 1105
H I++RD+K N+LLD+ R+SD G+A + +T + GT GY+ PE
Sbjct: 119 HRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEV 172
Query: 1106 YQSFRCTTKGDVYSYGVILLELLSGKRP 1133
++ R T D + G ++ E++ GK P
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 29/215 (13%)
Query: 935 MIGSGGFGEVYKA-QLRDGSVVAIKKLIHV-----TGQGDREFMAEMETIGKIKHRNLVP 988
++GSG FG VYK + DG V I I V + + ++E + E + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 989 LLGYCKIGEERLLVYEYMKWGSL-ESVLHDRAKGGGTKL-DWAARKKIAIGSARGLAFLH 1046
LLG C + LV + M +G L + V ++ + G L +W + A+G+++L
Sbjct: 74 LLGIC-LTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLE 126
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYY 1106
++HRD+ + NVL+ +++DFG+ARL++ +T G VP ++
Sbjct: 127 EV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG-----GKVPIKWM 178
Query: 1107 --QSF---RCTTKGDVYSYGVILLELLS-GKRPID 1135
+S R T + DV+SYGV + EL++ G +P D
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-13
Identities = 76/287 (26%), Positives = 126/287 (43%), Gaps = 44/287 (15%)
Query: 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIH--VTGQGDREFMAEMETIGKIKHR 984
F S++G G FGEV + + G + A+K + + Q F E I I +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 985 NLVPLLGYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLD------WAARKKIAIG 1037
+P L Y ++ L LV EY G L S+L +R + + D + A +AI
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL-NRYED---QFDEDMAQFYLAELVLAIH 116
Query: 1038 SARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGT 1097
S + + +HRD+K NVL+D +++DFG A + A + ++ GT
Sbjct: 117 SVHQMGY---------VHRDIKPENVLIDRTGHIKLADFGSAARLTA-NKMVNSKLPVGT 166
Query: 1098 PGYVPPEYYQSFRCTTKG------DVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQ 1151
P Y+ PE + KG D +S GVI E++ G+ P F + + +
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP-----FHEGTSAKTYNNI 221
Query: 1152 LHREKRINEILDPELTMQTSDETELYQYL------RISFECLDDRPF 1192
++ ++ + DP++ +SD +L Q L R+ +E L PF
Sbjct: 222 MNFQRFLKFPEDPKV---SSDFLDLIQSLLCGQKERLGYEGLCCHPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 13/208 (6%)
Query: 930 FSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHV---TGQGDREFMAEMETIGKIKHRN 985
F ++G GGFGEV Q+R G + A K+L +G+ + E + + K+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 986 LVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFL 1045
+V L + + LV M G L+ +++ G ++ +A L L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG------FEEERALFYAAEILCGL 115
Query: 1046 HHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEY 1105
+ ++RD+K N+LLD+ R+SD G+A + + S+ GT GY+ PE
Sbjct: 116 EDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEV 172
Query: 1106 YQSFRCTTKGDVYSYGVILLELLSGKRP 1133
+ R T D + G ++ E++ G+ P
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 71/290 (24%), Positives = 127/290 (43%), Gaps = 45/290 (15%)
Query: 936 IGSGGFGEVYKAQLRD------GSVVAIKKLIHVTGQGDR-EFMAEMETIGKIKHRNLVP 988
+G G FG VY+ RD + VA+K + +R EF+ E + ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHD---RAKGGGTKLDWAARKKIAIGS--ARGLA 1043
LLG G+ L+V E M G L+S L A+ + ++ I + + A G+A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 1044 FLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP- 1102
+L+ +HRD+ + N ++ +F ++ DFGM R + D + G G +P
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK-----GGKGLLPV 185
Query: 1103 ----PEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKR 1157
PE + TT D++S+GV+L E+ S ++P + L E+
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY---------------QGLSNEQV 230
Query: 1158 INEILDPELTMQTSD-ETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206
+ ++D Q + + +R+ C P RPT ++++ + K+
Sbjct: 231 LKFVMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-13
Identities = 39/112 (34%), Positives = 60/112 (53%), Gaps = 7/112 (6%)
Query: 552 LILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQV 611
L L+N L G IP I+ ++ ++LS N + G IP +G++ L +L L NS G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 612 PQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEG 663
P+ LG+ SL L+LN N+LSG +P+ L + ++ F F N G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGR-------LLHRASFNFTDNAG 527
|
Length = 623 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 72/289 (24%), Positives = 130/289 (44%), Gaps = 51/289 (17%)
Query: 936 IGSGGFGEVYKAQLRDG--SVVAIKKLIHVT----GQGDRE-------FMAEMETIGK-I 981
+GSG FG VYK + ++ +++A+K+ I+V G+ RE ++E+ I + +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKE-INVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 982 KHRNLVPLLGYCKIGEERLLVYEYMKW------GSLESVLHDRAKGGGTKLDWAARKKIA 1035
+H N+V Y K E +Y M G + L ++ + + W I
Sbjct: 67 RHPNIVR---YYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW----NIF 119
Query: 1036 IGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLA 1095
+ L +LH I+HRD+ +N++L E+ + ++DFG+A+ SV
Sbjct: 120 VQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSV---V 174
Query: 1096 GTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE 1155
GT Y PE ++ K DV+++G IL ++ + + P + N++ A ++
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT----LQPPFY--STNMLSLATKI--- 225
Query: 1156 KRINEILDP-ELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203
+ + +P M + D T++ CL RP +IQV AM
Sbjct: 226 --VEAVYEPLPEGMYSEDVTDVIT------SCLTPDAEARPDIIQVSAM 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 63/216 (29%), Positives = 108/216 (50%), Gaps = 23/216 (10%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMA--EMETIGKIKHRNLVPLLGY 992
+G G + VYK + R G +VA+K+ IH+ + A E+ + ++KH N+V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKE-IHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66
Query: 993 CKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPH 1052
+ +LV+EYM L+ + G LD K +G+AF H +
Sbjct: 67 IHTENKLMLVFEYMD-KDLKKYMDTHGVRGA--LDPNTVKSFTYQLLKGIAFCHEN---R 120
Query: 1053 IIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAG---TPGYVPPEYYQSF 1109
++HRD+K N+L+++ E +++DFG+AR + V+T + T Y P+
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFG-----IPVNTFSNEVVTLWYRAPDVLLGS 175
Query: 1110 RC-TTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144
R +T D++S G I+ E+++G RP+ P G +N
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITG-RPLFP---GTNNE 207
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 5e-13
Identities = 70/217 (32%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 930 FSADSMIGSGGFGEVYKAQLRDGS--VVAIKKLIH-VTGQGD--REFMAEMETIGKIKHR 984
F+ ++G G FG+V A+ R G+ + AIK L V Q D M E +
Sbjct: 2 FNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 985 NLVPLLGYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAA--RKKIAIGSARG 1041
+ L C +RL V EY+ G L ++ + G K A +IAIG
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGKFKEPHAVFYAAEIAIG---- 113
Query: 1042 LAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL-VNALDTHLSVSTLAGTPGY 1100
L FLH II+RD+K NV+LD +++DFGM + + T T GTP Y
Sbjct: 114 LFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDY 167
Query: 1101 VPPEY--YQSFRCTTKGDVYSYGVILLELLSGKRPID 1135
+ PE YQ + + D +++GV+L E+L+G+ P D
Sbjct: 168 IAPEIIAYQPYGKSV--DWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 8e-13
Identities = 84/267 (31%), Positives = 129/267 (48%), Gaps = 21/267 (7%)
Query: 377 RELDLSSNRLTGELPSTFASCSSLHSLN---LGSNMLSGNFLNTVVSKISSLIYLYVPFN 433
L+LSSN L LPS+ + SL L+ + S S N LN + L
Sbjct: 50 LALNLSSNTLL-LLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLN------L 102
Query: 434 NISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLE 493
N L T L LDL +N T P N L+++ L +N + ++P
Sbjct: 103 NRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSN---LKELDLSDNKIE-SLPSP 158
Query: 494 LGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLI 553
L + NLK +DLSFN L+ +P + +L NL++L + + N ++P I + LE L
Sbjct: 159 LRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDL-SGNKISDLPPEIELL-SALEELD 215
Query: 554 LNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQ 613
L+NN + + S+++ N+ + LS+N+L ++P IGNL L L L NN ++ +
Sbjct: 216 LSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SIS- 271
Query: 614 GLGKCRSLVWLDLNSNNLSGPLPSELA 640
LG +L LDL+ N+LS LP
Sbjct: 272 SLGSLTNLRELDLSGNSLSNALPLIAL 298
|
Length = 394 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 8e-13
Identities = 71/265 (26%), Positives = 106/265 (40%), Gaps = 54/265 (20%)
Query: 928 NGFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKL----IHVTGQGDREFMAEMETIGKIK 982
+ F +IG G FGEV+ + +D G V A+K L + Q AE + +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADAD 59
Query: 983 HRNLVPLLGYCKIGEERL-LVYEYMKWGSLESVL--HDRAKGGGTKLDWAARKKIAIGSA 1039
+V L Y EE L LV EYM G L ++L D + + A +A+ S
Sbjct: 60 SPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARF-YIAELVLALDSV 117
Query: 1040 RGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA--------------RLVNAL 1085
L F IHRD+K N+L+D + +++DFG+ N L
Sbjct: 118 HKLGF---------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 1086 DT--------------HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGK 1131
+ ST GTP Y+ PE + + D +S GVIL E+L G
Sbjct: 169 FRDNVLVRRRDHKQRRVRANST-VGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227
Query: 1132 RPIDPSEFGDDNNLVGWAKQLHREK 1156
P F D + K ++ ++
Sbjct: 228 PP-----FYSDTLQETYNKIINWKE 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 9e-13
Identities = 66/285 (23%), Positives = 124/285 (43%), Gaps = 26/285 (9%)
Query: 930 FSADSMIGSGGFGEVYKAQ-LRDGSVVAIKKLI---HVTGQGDREFMAEMETIGKIKHRN 985
F + IG G F EVY+A L D VA+KK+ + + ++ + E++ + ++ H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 986 LVPLLGYCKIGEERLLVYEYMKWGSL-ESVLHDRAKGGGTKLDWAARKKIAIGSARGLAF 1044
++ L E +V E G L + + + + + + + + SA
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA----- 118
Query: 1045 LHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE 1104
+ H ++HRD+K +NV + ++ D G+ R ++ T + +L GTP Y+ PE
Sbjct: 119 VEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPE 176
Query: 1105 YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDP 1164
K D++S G +L E+ + + P +GD NL ++I + P
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLFSLC------QKIEQCDYP 226
Query: 1165 ELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQV 1209
L + E + + C+ P +RP + V + K++ V
Sbjct: 227 PLPTEHYSE----KLRELVSMCIYPDPDQRPDIGYVHQIAKQMHV 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 56/208 (26%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 935 MIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTG--QGDREFMA---EMETIGKIKHRNLVP 988
++G G FGEVY D G +A+K++ + +E A E++ + ++H +V
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 989 LLGYCKIGEERLL--VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLH 1046
G + EE+ L EYM GS++ L +A G T+ ++ +G+++LH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTE---NVTRRYTRQILQGVSYLH 123
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL-DTHLSVSTLAGTPGYVPPEY 1105
+ I +HRD+K +N+L D ++ DFG ++ + + + + ++ GTP ++ PE
Sbjct: 124 SNMI---VHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180
Query: 1106 YQSFRCTTKGDVYSYGVILLELLSGKRP 1133
K DV+S ++E+L+ K P
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-12
Identities = 58/193 (30%), Positives = 89/193 (46%), Gaps = 20/193 (10%)
Query: 952 GSVVAIKKL--IHVTGQGDR-EFMAEMETIGKIKHRNLVPLLGYCKIGEERLL-VYEYMK 1007
G VAIK L + R F E ++ H N+V LL + L V+EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 1008 WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLL-- 1065
+L VL A G L ++ + LA H+ I+HRD+K N+++
Sbjct: 63 GRTLREVL--AADGA---LPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQ 114
Query: 1066 -DENFEARVSDFGMARLV----NALDTHLSVST-LAGTPGYVPPEYYQSFRCTTKGDVYS 1119
A+V DFG+ L+ +A L+ +T + GTP Y PE + T D+Y+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 1120 YGVILLELLSGKR 1132
+G+I LE L+G+R
Sbjct: 175 WGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-12
Identities = 60/232 (25%), Positives = 109/232 (46%), Gaps = 47/232 (20%)
Query: 936 IGSGGFGEVYKAQ---------------LRDGS--VVAIKKLIHVTGQGDR-EFMAEMET 977
+G G FGEV+ + +R G +VA+K L + R +F+ E++
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 978 IGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLES-----VLHDRAKGG---------G 1023
+ ++K N++ LLG C + ++ EYM+ G L L D+ + G
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 1024 TKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083
+ +++ +A+ A G+ +L + +HRD+ + N L+ EN +++DFGM+R +
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRC------TTKGDVYSYGVILLELLS 1129
A D + + A V P + ++ C TT DV+++GV L E+L
Sbjct: 190 AGD-YYRIQGRA-----VLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 68/303 (22%), Positives = 124/303 (40%), Gaps = 56/303 (18%)
Query: 936 IGSGGFGEVY------------KAQLRDGSV-----VAIKKL-IHVTGQGDREFMAEMET 977
+G G FGEV+ KA + + VA+K L + +F+ E++
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 978 IGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDR------AKGGGTKLDWAAR 1031
+ ++ N+ LLG C + ++ EYM+ G L L L ++
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 1032 KKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSV 1091
+A A G+ +L + +HRD+ + N L+ +N+ +++DFGM+R + + D
Sbjct: 133 LYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD----Y 185
Query: 1092 STLAGTPGYVPPEYYQSFRC------TTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNN 1144
+ G P + ++ TTK DV+++GV L E+L+ + P E D
Sbjct: 186 YRVQGRA--PLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ--PYEHLTDQQ 241
Query: 1145 LVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204
++ A R+ L + ++Y+ + EC RPT F
Sbjct: 242 VIENAGHFFRDDGRQIYLP----RPPNCPKDIYELML---ECWRRDEEDRPT-------F 287
Query: 1205 KEL 1207
+E+
Sbjct: 288 REI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 44/229 (19%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDRE---FMAEMETIGKIKHRNLVPLLGY 992
IG G FG+ + ++ + K I+++ +E E+ + +KH N+V Y
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ---Y 64
Query: 993 CKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAF-------- 1044
+ EE +Y M D +GG D + I + RG+ F
Sbjct: 65 QESFEENGNLYIVM----------DYCEGG----DLYKK----INAQRGVLFPEDQILDW 106
Query: 1045 -------LHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGT 1097
L H I+HRD+KS N+ L ++ ++ DFG+AR++N+ T T GT
Sbjct: 107 FVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS--TVELARTCIGT 164
Query: 1098 PGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLV 1146
P Y+ PE ++ K D+++ G +L E+ + K E G+ NLV
Sbjct: 165 PYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF---EAGNMKNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-12
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 935 MIGSGGFGEVYKAQLR-DGSVVAIKKLIH-VTGQGDRE--FMAEMETIG-KIKHRNLVPL 989
++G G FG+V A+L+ V AIK L V Q D M E + KH L L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC 1049
+ + V EY+ G L + R++ K D + A L FLH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQ-RSR----KFDEPRSRFYAAEVTLALMFLHRH- 115
Query: 1050 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSF 1109
+I+RD+K N+LLD +++DFGM + + ++ +T GTP Y+ PE Q
Sbjct: 116 --GVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQEL 171
Query: 1110 RCTTKGDVYSYGVILLELLSGKRPID 1135
D ++ GV++ E+++G+ P +
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 935 MIGSGGFGEVYKAQLRD-GSVVAIKKLIH--VTGQGDREFMA---EMETIGKIKHRNLVP 988
++G G FG VY D G +A K++ + + +E A E++ + ++H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 989 LLGYCKIGEERLLV--YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLH 1046
G + E+ L EYM GS++ L +A G T+ + +K G+++LH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTE---SVTRKYTRQILEGMSYLH 123
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA-RLVNALDTHLSVSTLAGTPGYVPPEY 1105
+ I +HRD+K +N+L D ++ DFG + RL + + ++ GTP ++ PE
Sbjct: 124 SNMI---VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 1106 YQSFRCTTKGDVYSYGVILLELLSGKRP 1133
K DV+S G ++E+L+ K P
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 933 DSMIGSGGFGEVYKAQLRDGS----VVAIKKL-IHVTGQGDREFMAEMETIGKIKHRNLV 987
+ ++G+G FGE+ + L+ S VAI L + + R F+AE T+G+ H N+V
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 988 PLLGYCKIGEERLLVYEYMKWGSLESVL--HDRAKGGGTKLDWAARKKIAIGSARGLAFL 1045
L G G ++V EYM G+L+S L H+ G + + G A G+ +L
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMG------MLPGLASGMKYL 123
Query: 1046 HHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL----VNALDTHLSVSTLAGTPGYV 1101
+H+ + + VL++ + ++S F RL A+ T +S + +
Sbjct: 124 SEM---GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPV---LWA 175
Query: 1102 PPEYYQSFRCTTKGDVYSYGVILLELLS-GKRP 1133
PE Q ++ DV+S+G+++ E++S G+RP
Sbjct: 176 APEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 51/191 (26%), Positives = 89/191 (46%), Gaps = 33/191 (17%)
Query: 1033 KIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA-RLVNALDTHLSV 1091
KIA+ + L +LH +IHRD+K SNVL++ N + ++ DFG++ LV+++
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-----A 159
Query: 1092 STL-AGTPGYVPPEY------YQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144
T+ AG Y+ PE + + K DV+S G+ ++EL +G+ P D
Sbjct: 160 KTIDAGCKPYMAPERINPELNQKGY--DVKSDVWSLGITMIELATGRFPYD--------- 208
Query: 1145 LVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM- 1203
W + K++ E P+L + E ++ +CL +RP +++
Sbjct: 209 --SWKTPFQQLKQVVEEPSPQLPAEKFSP-EFQDFVN---KCLKKNYKERPNYPELLQHP 262
Query: 1204 FKELQVDTEGD 1214
F EL + D
Sbjct: 263 FFELHLSKNTD 273
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKL-IHVTGQG-DREFMAEMETIGKIKHRNLVPLLGY 992
IG G +G VYKA+ G VVA+KK+ + +G + E+ + ++ H N+V LL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 993 CKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPH 1052
+ LV+E++ L+ + D + G L K +GLAF H
Sbjct: 68 IHTENKLYLVFEFLH-QDLKKFM-DASPLSGIPL--PLIKSYLFQLLQGLAFCHSH---R 120
Query: 1053 IIHRDMKSSNVLLDENFEARVSDFGMARLVNA---LDTHLSVSTLAGTPGYVPPE----- 1104
++HRD+K N+L++ +++DFG+AR TH V TL Y PE
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-EVVTL----WYRAPEILLGC 175
Query: 1105 -YYQSFRCTTKGDVYSYGVILLELLSGK 1131
YY +T D++S G I E+++ +
Sbjct: 176 KYY-----STAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 8e-12
Identities = 37/99 (37%), Positives = 58/99 (58%), Gaps = 6/99 (6%)
Query: 1040 RGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVST-LAGTP 1098
RGL ++H + +++HRD+K SN+LL+ N + ++ DFG+AR+ + H T T
Sbjct: 117 RGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 1099 GYVPPEYYQSFRCTTKG-DVYSYGVILLELLSGKRPIDP 1136
Y PE + + TK D++S G IL E+LS RP+ P
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLFP 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 9e-12
Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 13/203 (6%)
Query: 935 MIGSGGFGEVYKAQLR-DGSVVAIKKLIHV---TGQGDREFMAEMETIGKIKHRNLVPLL 990
++G GGFGEV Q+R G + A KKL +G+ + E + K+ R +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 991 GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCI 1050
+ + LV M G L+ +++ G D A GL L
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPG---FDEQRAIFYAAELCCGLEDLQRE-- 121
Query: 1051 PHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFR 1110
I++RD+K N+LLD+ R+SD G+A + +T V GT GY+ PE + +
Sbjct: 122 -RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMAPEVINNEK 177
Query: 1111 CTTKGDVYSYGVILLELLSGKRP 1133
T D + G ++ E++ G+ P
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-11
Identities = 71/220 (32%), Positives = 107/220 (48%), Gaps = 29/220 (13%)
Query: 935 MIGSGGFGEVYKAQLRDGS--VVAIKKLIH--VTGQGDRE-FMAEMETIGKIKHRNLVPL 989
++G G FG+V A+ R G+ + AIK L V D E M E + +
Sbjct: 7 VLGKGSFGKVMLAE-RKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQ 65
Query: 990 LGYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAA--RKKIAIGSARGLAFLH 1046
L C +RL V EY+ G L ++ + G K A +IAIG L FLH
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIG----LFFLH 118
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEY- 1105
II+RD+K NV+LD +++DFGM + N D ++ T GTP Y+ PE
Sbjct: 119 SK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDG-VTTKTFCGTPDYIAPEII 173
Query: 1106 -YQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144
YQ + + D +++GV+L E+L+G+ P + G+D +
Sbjct: 174 AYQPYGKSV--DWWAFGVLLYEMLAGQAPFE----GEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 69/289 (23%), Positives = 124/289 (42%), Gaps = 43/289 (14%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAI----KKLIHVTGQGDREFMAEMETIGKIKHRNLVPLL 990
+G GG+G+V+ A+ +D G +VA+ K L+ + R + E + + K LV LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNE-VRHVLTERDILTTTKSEWLVKLL 67
Query: 991 GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKI-----AIGSARGLAFL 1045
+ E L EY+ G ++L++ G + AR + A+ + L
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHELG-- 121
Query: 1046 HHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEY 1105
IHRD+K N L+D + +++DFG+++ + +++ G+P Y+ PE
Sbjct: 122 -------YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY-----ANSVVGSPDYMAPEV 169
Query: 1106 YQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDD-NNLVGWAKQLHREKRINEILDP 1164
+ D +S G +L E L G P S + NL W + L R DP
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYD----DP 225
Query: 1165 ELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM--FKELQVDT 1211
+ SDE + + + ++D + ++ + FKE+ +
Sbjct: 226 RFNL--SDEA--WDLIT---KLINDPSRRFGSLEDIKNHPFFKEVDWNE 267
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 56/218 (25%), Positives = 105/218 (48%), Gaps = 28/218 (12%)
Query: 936 IGSGGFGEVYKAQ-------LRDGS--------VVAIKKL-IHVTGQGDREFMAEMETIG 979
+G G FGEV+ + L +G+ +VA+K L VT +F+ E++ +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 980 KIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDR------AKGGGT-KLDWAARK 1032
++K+ N++ LLG C + ++ EYM+ G L L R + A
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 1033 KIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVS 1092
+A+ A G+ +L + +HRD+ + N L+ ++ +++DFGM+R + + D + +
Sbjct: 133 YMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD-YYRIQ 188
Query: 1093 TLAGTP-GYVPPEYYQSFRCTTKGDVYSYGVILLELLS 1129
A P ++ E + TT DV+++GV L E+ +
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 67/231 (29%), Positives = 104/231 (45%), Gaps = 59/231 (25%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGD-------RE--FMAEMETIGKIKHRN 985
IG G +G VYKA+ G +VA+KK I + + + RE + E+ H N
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKK-IRLETEDEGVPSTAIREISLLKEL------NHPN 59
Query: 986 LVPLLGYCKIGEERL-LVYEYM-----KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSA 1039
+V LL E +L LV+E++ K+ ++S LD K
Sbjct: 60 IVRLLDVV-HSENKLYLVFEFLDLDLKKY--MDSSPLT-------GLDPPLIKSYLYQLL 109
Query: 1040 RGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA---LDTHLSVSTLAG 1096
+G+A+ H ++HRD+K N+L+D +++DFG+AR TH V TL
Sbjct: 110 QGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH-EVVTL-- 163
Query: 1097 TPGYVPPE------YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGD 1141
Y PE Y +T D++S G I E+++ +RP+ P GD
Sbjct: 164 --WYRAPEILLGSRQY-----STPVDIWSIGCIFAEMVN-RRPLFP---GD 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 56/219 (25%), Positives = 103/219 (47%), Gaps = 27/219 (12%)
Query: 939 GGFGEVYKAQLRDGSV-----VAIKKLIHVTGQGDREFM-AEMETIGKIKHRNLVPLLGY 992
G FG ++ L D V +K + + + E + + H+N++P+L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 993 C-KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKI---AIGSARGLAFLHHS 1048
C + GE ++Y YM WG+L+ L G + +++ AI A G+++LH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR 136
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP-----P 1103
+IH+D+ + N ++DE + +++D ++R + +D H G P
Sbjct: 137 ---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH-----CLGDNENRPVKWMAL 188
Query: 1104 EYYQSFRCTTKGDVYSYGVILLELLS-GKRP---IDPSE 1138
E + ++ DV+S+GV+L EL++ G+ P IDP E
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE 227
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 66/213 (30%), Positives = 97/213 (45%), Gaps = 26/213 (12%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKL----IHVTGQGDREFMAEMETIGKIKHRNLVPLL 990
+G+G FG V A+ + G AIK L I Q E + ++ H +V ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQ-HVAQEKSILMELSHPFIVNMM 84
Query: 991 -GYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLH-H 1047
+ E R+ + E++ G L + H R K G D A + LAF + H
Sbjct: 85 CSF--QDENRVYFLLEFVVGGELFT--HLR-KAGRFPNDVAKFYHAELV----LAFEYLH 135
Query: 1048 SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQ 1107
S II+RD+K N+LLD +V+DFG A+ V TL GTP Y+ PE Q
Sbjct: 136 SK--DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGTPEYLAPEVIQ 188
Query: 1108 SFRCTTKGDVYSYGVILLELLSGKRPI-DPSEF 1139
S D ++ GV+L E ++G P D + F
Sbjct: 189 SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF 221
|
Length = 329 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 2e-11
Identities = 60/209 (28%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKL-IHVTGQGDREF----MAEMETIGKIKHRNLVPL 989
I G +G VY+A+ + G +VA+KKL + +G F + E+ + K++H N+V +
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQHPNIVTV 69
Query: 990 ----LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFL 1045
+G ++ +V EY++ L+S++ + K + + K + + G+A L
Sbjct: 70 KEVVVG--SNLDKIYMVMEYVE-HDLKSLM-ETMKQPFLQ---SEVKCLMLQLLSGVAHL 122
Query: 1046 HHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLS--VSTLAGTPGYVPP 1103
H + I+HRD+K+SN+LL+ ++ DFG+AR + + V TL Y P
Sbjct: 123 HDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTL----WYRAP 175
Query: 1104 EYYQSFRC-TTKGDVYSYGVILLELLSGK 1131
E + +T D++S G I ELL+ K
Sbjct: 176 ELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-11
Identities = 66/246 (26%), Positives = 100/246 (40%), Gaps = 42/246 (17%)
Query: 935 MIGSGGFGEVYKAQLRDGSVVAIKKLI---HVTGQGDREFMAEMETIGKIKHRNLVPLLG 991
+IG G FGEV + + V KL+ + + D F E I + V L
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 992 YCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCI 1050
Y + L +V EYM G L +++ + + A +A+ + + F
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF------ 163
Query: 1051 PHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFR 1110
IHRD+K N+LLD++ +++DFG +N + + T GTP Y+ PE +S
Sbjct: 164 ---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCDTAVGTPDYISPEVLKS-- 217
Query: 1111 CTTKGDVY--------SYGVILLELLSGKRPI----------------DPSEFGDDNNLV 1146
GD Y S GV L E+L G P + F DDN++
Sbjct: 218 --QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 275
Query: 1147 GWAKQL 1152
AK L
Sbjct: 276 KEAKNL 281
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 32/213 (15%)
Query: 935 MIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLL--G 991
+IG GGFGEVY + D G + A+K L R M + ET+ + R ++ L+ G
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCL-----DKKRIKMKQGETLA-LNERIMLSLVSTG 54
Query: 992 YCKI----------GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARG 1041
C ++ + + M G L L ++ + A + I G
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL-----G 109
Query: 1042 LAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV 1101
L +H+ +++RD+K +N+LLDE+ R+SD G+A + H SV GT GY+
Sbjct: 110 LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYM 162
Query: 1102 PPEYYQSFRC-TTKGDVYSYGVILLELLSGKRP 1133
PE Q + D +S G +L +LL G P
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 68/253 (26%), Positives = 108/253 (42%), Gaps = 42/253 (16%)
Query: 935 MIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLL--G 991
+IG GGFGEVY + D G + A+K L R M + ET+ + R ++ L+ G
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCL-----DKKRIKMKQGETLA-LNERIMLSLVSTG 54
Query: 992 YC----------KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARG 1041
C ++ + + M G L L ++ + A + I G
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIIL-----G 109
Query: 1042 LAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV 1101
L +H+ +++RD+K +N+LLDE+ R+SD G+A + H SV GT GY+
Sbjct: 110 LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYM 162
Query: 1102 PPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINE 1160
PE Q + D +S G +L +LL G P + D + + R+
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----------DRMTL 212
Query: 1161 ILDPELTMQTSDE 1173
+ EL S E
Sbjct: 213 TMAVELPDSFSPE 225
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 63/232 (27%), Positives = 113/232 (48%), Gaps = 34/232 (14%)
Query: 936 IGSGGFGEVYKAQ-LRDGS-VVAIKKLIHVTGQGDREFM--------AEMETIGKIKHRN 985
IG G +G+V+KA+ L++G VA+K+ V Q E M A + + +H N
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKR---VRVQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 986 LVPLLGYCKIG----EERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSAR 1040
+V L C + E +L LV+E++ L + L D+ G + K + R
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYL-DKVPEPGVPTE--TIKDMMFQLLR 121
Query: 1041 GLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGY 1100
GL FLH ++HRD+K N+L+ + + +++DFG+AR+ + ++++++ T Y
Sbjct: 122 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWY 175
Query: 1101 VPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPI-----DPSEFGDDNNLVG 1147
PE T D++S G I E+ ++P+ D + G +++G
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKILDVIG 226
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-11
Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 25/159 (15%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMA--EMETIGKIKHRNLVPLLGY 992
IG G FGEV+KA+ + +VA+KK++ + A E++ + +KH N+V L+
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 993 C---KIGEER-----LLVYEYMKWGSLESVLHDRA---KGGGTKLDWAARKKIAIGSARG 1041
C R LV+E+ + HD A K + KK+ G
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCE--------HDLAGLLSNKNVKFTLSEIKKVMKMLLNG 131
Query: 1042 LAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1080
L ++H + I+HRDMK++N+L+ ++ +++DFG+AR
Sbjct: 132 LYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQ---GDREFMAEMETIGKIKHRNLVPLLG 991
+G GGFGEV Q+++ G + A KKL + G++ + E E + K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 992 YCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIP 1051
+ LV M G L+ +++ + G L+ + G+ LH
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERG---LEMERVIHYSAQITCGILHLHSM--- 114
Query: 1052 HIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRC 1111
I++RDMK NVLLD+ R+SD G+A L +++ AGT GY+ PE +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNGYMAPEILKEEPY 171
Query: 1112 TTKGDVYSYGVILLELLSGKRP 1133
+ D ++ G + E+++G+ P
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 62/229 (27%), Positives = 98/229 (42%), Gaps = 15/229 (6%)
Query: 935 MIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDRE----FMAEMETIGKIKHRNLVPLL 990
+IG G + +V +L+ + K++ D E E + + L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 991 GYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC 1049
C RL LV EY+ G L + H + + KL + A L FLH
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDL--MFHMQRQ---RKLPEEHARFYAAEICIALNFLHER- 115
Query: 1050 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSF 1109
II+RD+K NVLLD + +++D+GM + L + ST GTP Y+ PE +
Sbjct: 116 --GIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGE 171
Query: 1110 RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158
D ++ GV++ E+++G+ P D D N + Q+ EK I
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI 220
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 935 MIGSGGFGEVYKAQLRD-GSVVAIKKLIH--VTGQGDREFMA---EMETIGKIKHRNLVP 988
++G G FG VY D G +A+K++ + + +E A E++ + + H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 989 LLGYCKIGEERLL--VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLH 1046
G + ER L E+M GS++ D+ K G + RK G+++LH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTRK-YTRQILEGVSYLH 123
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA-RLVNALDTHLSVSTLAGTPGYVPPEY 1105
+ I +HRD+K +N+L D ++ DFG + RL + + ++ GTP ++ PE
Sbjct: 124 SNMI---VHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180
Query: 1106 YQSFRCTTKGDVYSYGVILLELLSGKRP 1133
K D++S G ++E+L+ K P
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-11
Identities = 66/211 (31%), Positives = 97/211 (45%), Gaps = 29/211 (13%)
Query: 935 MIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDRE---FMAEMETIGK-IKHRNLVPL 989
+IG G FG+V A+ + DGS A+K L T +E MAE + K +KH LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 990 LGYCKIGEERLLVYEYMKWGSL-------ESVLHDRAKGGGTKLDWAARKKIAIGSARGL 1042
+ E+ V +Y+ G L L RA+ +AA AIG
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF------YAAEVASAIG----- 110
Query: 1043 AFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP 1102
+LH +II+RD+K N+LLD ++DFG+ + ++ + ST GTP Y+
Sbjct: 111 -YLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLA 164
Query: 1103 PEYYQSFRCTTKGDVYSYGVILLELLSGKRP 1133
PE + D + G +L E+L G P
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-11
Identities = 74/273 (27%), Positives = 117/273 (42%), Gaps = 40/273 (14%)
Query: 930 FSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNL--- 986
F +IG G FGEV +++ + K+++ E + ET + RN+
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILN-----KWEMLKRAETACFREERNVLVN 57
Query: 987 -----VPLLGYCKIGEERL-LVYEYMKWGSLESVL---HDRAKGGGTKLDWAARKKIAIG 1037
+ L Y E L LV +Y G L ++L DR + + A +AI
Sbjct: 58 GDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF-YIAEMVLAIH 116
Query: 1038 SARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGT 1097
S L H +HRD+K NVLLD N R++DFG +N D + S GT
Sbjct: 117 SIHQL---------HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ-DGTVQSSVAVGT 166
Query: 1098 PGYVPPEYYQSF-----RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQL 1152
P Y+ PE Q+ + + D +S GV + E+L G+ P F ++ + + K +
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP-----FYAESLVETYGKIM 221
Query: 1153 HREKRINEILDPELTMQTSDETELYQYLRISFE 1185
+ E+R +T + + +L Q L S E
Sbjct: 222 NHEERFQ--FPSHITDVSEEAKDLIQRLICSRE 252
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 5e-11
Identities = 64/222 (28%), Positives = 98/222 (44%), Gaps = 35/222 (15%)
Query: 930 FSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNL--- 986
F +IG G FGEV +L++ V K+++ E + ET + R++
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILN-----KWEMLKRAETACFREERDVLVN 57
Query: 987 -----VPLLGYCKIGEERL-LVYEYMKWGSLESVL---HDRAKGGGTKLDWAARKKIAIG 1037
+ L Y E L LV +Y G L ++L DR + + A IAI
Sbjct: 58 GDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF-YLAEMVIAID 116
Query: 1038 SARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA-RLVNALDTHLSVSTLAG 1096
S L H +HRD+K N+L+D N R++DFG +L+ D + S G
Sbjct: 117 SVHQL---------HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME--DGTVQSSVAVG 165
Query: 1097 TPGYVPPEYYQSF-----RCTTKGDVYSYGVILLELLSGKRP 1133
TP Y+ PE Q+ + + D +S GV + E+L G+ P
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 5e-11
Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMA--EMETIGKIKHRNLVPLLGY 992
+G G + VYK + + +G +VA+K +I + + F A E + +KH N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALK-VIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 993 CKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPH 1052
E LV+EY+ + + D+ GG L K RGL+++H +
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYM--DKHPGG---LHPENVKLFLFQLLRGLSYIHQR---Y 123
Query: 1053 IIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE-YYQSFRC 1111
I+HRD+K N+L+ + E +++DFG+AR ++ +H + S T Y PP+ S
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSH-TYSNEVVTLWYRPPDVLLGSTEY 181
Query: 1112 TTKGDVYSYGVILLELLSG 1130
+T D++ G I +E++ G
Sbjct: 182 STCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 5e-11
Identities = 66/237 (27%), Positives = 103/237 (43%), Gaps = 41/237 (17%)
Query: 906 INVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKA-QLRDGSVVAIKKLIHVT 964
+N +E P R + +GSG +G V A R G VAIKKL
Sbjct: 6 VNKTVWELPERYTSLKQ-------------VGSGAYGSVCSAIDKRTGEKVAIKKL-SRP 51
Query: 965 GQGD---REFMAEMETIGKIKHRNLVPLLGY---CKIGEER---LLVYEYMKWGSLESVL 1015
Q + + E+ + ++H N++ LL G+E LV YM+
Sbjct: 52 FQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-------- 103
Query: 1016 HDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSD 1075
D K G L + + GL ++H + IIHRD+K N+ ++E+ E ++ D
Sbjct: 104 TDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILD 160
Query: 1076 FGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKG-DVYSYGVILLELLSGK 1131
FG+AR +A T V T Y PE ++ + D++S G I+ E+L+GK
Sbjct: 161 FGLARHADAEMTGYVV-----TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 17/218 (7%)
Query: 930 FSADSMIGSGGFGEVYKAQLR--DGSV--VAIKKL-IHVTGQGD-REFMAEMETIGKIKH 983
F+ M+G G FG V +AQL+ DGS VA+K L + D EF+ E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 984 RNLVPLLGYC--KIGEERL----LVYEYMKWGSLES-VLHDRAKGGGTKLDWAARKKIAI 1036
N++ L+G + RL ++ +MK G L + +L R L + I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 1037 GSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAG 1096
A G+ +L + IHRD+ + N +L+EN V+DFG+++ + + D +
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 1097 TPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRP 1133
++ E TT DV+++GV + E+++ G+ P
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 18/210 (8%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGD--REFMAEMETIGKIKHRNLVPLLGYC 993
+G G +G VYK R V K I + + + E++ + K +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHI 1053
I + EYM GSL+ + G D R I +GL FL +I
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRR--ITYAVVKGLKFLKEE--HNI 124
Query: 1054 IHRDMKSSNVLLDENFEARVSDFGMA-RLVNALDTHLSVSTLAGTPGYVPPEYYQSFRC- 1111
IHRD+K +NVL++ N + ++ DFG++ LV +L T G Y+ PE +S
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-----AKTNIGCQSYMAPERIKSGGPN 179
Query: 1112 -----TTKGDVYSYGVILLELLSGKRPIDP 1136
T + DV+S G+ +LE+ G+ P P
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYPYPP 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 6e-11
Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 29/210 (13%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIK---KLIHVTGQGDREFMAEMETIGK-IKHRNLVPLL 990
IG G FG+V A+ + DG A+K K + + + MAE + K +KH LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 991 GYCKIGEERLLVYEYMKWGSL-------ESVLHDRAKGGGTKLDWAARKKIAIGSARGLA 1043
+ ++ V +Y+ G L S RA+ +AA A+G
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF------YAAEIASALG------ 110
Query: 1044 FLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPP 1103
+LH +II+RD+K N+LLD ++DFG+ + ++ + ST GTP Y+ P
Sbjct: 111 YLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAP 165
Query: 1104 EYYQSFRCTTKGDVYSYGVILLELLSGKRP 1133
E + D + G +L E+L G P
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 8e-11
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 15/210 (7%)
Query: 936 IGSGGFGEVYKAQLRDG---SVVAIKKL-IHVTGQGDREFMAEMETIGKIKHRNLVPLLG 991
IG+G FG+V ++ G + V +K+L + + Q +F+ E + ++H NL+ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 992 YCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIP 1051
C LLV E+ G L+ L K D +++A A GL LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 1052 HIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRC 1111
+ IH D+ N LL + ++ D+G++ D +++ L ++ PE
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 1112 -------TTKGDVYSYGVILLELLS-GKRP 1133
T + +V+S GV + EL G +P
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 8e-11
Identities = 68/234 (29%), Positives = 105/234 (44%), Gaps = 25/234 (10%)
Query: 916 RKLTFAHLLEATNGFSADSMIGSGGFGEVYKA-QLRDGSVVAIKKL--IHVTGQGDREFM 972
+ + F + ++ + IG G +G+V+K ++GS A+K L IH D E
Sbjct: 6 KTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI---DEEIE 62
Query: 973 AEMETIGKIK-HRNLVPLLGY-----CKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKL 1026
AE + + H N+V G K G++ LV E GS+ D KG +
Sbjct: 63 AEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVT----DLVKGFLKRG 118
Query: 1027 DWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGM-ARLVNAL 1085
+ IA L L H + IHRD+K +N+LL ++ DFG+ A+L +
Sbjct: 119 ERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS-- 176
Query: 1086 DTHLSVSTLAGTPGYVPPEYY---QSFRCT--TKGDVYSYGVILLELLSGKRPI 1134
T L +T GTP ++ PE Q T + DV+S G+ +EL G P+
Sbjct: 177 -TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 8e-11
Identities = 60/231 (25%), Positives = 105/231 (45%), Gaps = 49/231 (21%)
Query: 930 FSADSM-----IGSGGFGEVYKAQLRD-GSVVAIKKL-IHVTGQGDREFMAEMETIGK-- 980
F+A+ + IG G FG V K + G+++A+K++ V + + + +++ + +
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60
Query: 981 -----IKHRNLVPLLGYCKIGEERL---------LVYEYMKWGSLESVLHDRAKGGGTKL 1026
+K + G C I E + VYE +K E +L
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEIL----------- 109
Query: 1027 DWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA-RLVNAL 1085
KIA+ + + L +L IIHRD+K SN+LLD N ++ DFG++ +LV++
Sbjct: 110 -----GKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS- 161
Query: 1086 DTHLSVSTLAGTPGYVPPEYYQSFRCT---TKGDVYSYGVILLELLSGKRP 1133
++ + AG Y+ PE + DV+S G+ L E+ +GK P
Sbjct: 162 ---IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 16/205 (7%)
Query: 936 IGSGGFGEVYKA---QLRDGSVVAIKKLIHVTGQG--DREFMAEMETIGKIKHRNLVPLL 990
+GSG FG V K + VA+K L + E + E + ++ + +V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 991 GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCI 1050
G C+ E +LV E + G L L + ++ + G+ +L +
Sbjct: 63 GICE-AESWMLVMELAELGPLNKFLQKNKHVTEKNI-----TELVHQVSMGMKYLEET-- 114
Query: 1051 PHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP-GYVPPEYYQSF 1109
+ +HRD+ + NVLL A++SDFG+++ + A + + T P + PE +
Sbjct: 115 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 1110 RCTTKGDVYSYGVILLELLS-GKRP 1133
+ ++K DV+S+GV++ E S G++P
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 21/207 (10%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKL-IHVTGQG-DREFMAEMETIGKIKHRNLVPLLGY 992
IG G +G VYK + + G +VA+KK+ + +G + E+ + +++H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 993 CKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIP 1051
+ E RL L++E++ S++ + + G +D K +G+ F H
Sbjct: 68 L-MQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR--- 120
Query: 1052 HIIHRDMKSSNVLLDENFEARVSDFGMARLVNA---LDTHLSVSTLAGTPGYVPPE-YYQ 1107
++HRD+K N+L+D +++DFG+AR + TH V TL Y PE
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH-EVVTL----WYRAPEVLLG 175
Query: 1108 SFRCTTKGDVYSYGVILLELLSGKRPI 1134
S R +T D++S G I E+ + K+P+
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-10
Identities = 76/261 (29%), Positives = 114/261 (43%), Gaps = 60/261 (22%)
Query: 936 IGSGGFGEV---YKAQLRDGSVVAIKKL-------IHVTGQGDREFMAEMETIGKIKHRN 985
+GSG +G V Y +LR VA+KKL IH R E+ + +KH N
Sbjct: 23 VGSGAYGSVCSAYDTRLRQK--VAVKKLSRPFQSLIHA-----RRTYRELRLLKHMKHEN 75
Query: 986 LVPLLGY---CKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGL 1042
++ LL E VY + + + L++ K KL + + RGL
Sbjct: 76 VIGLLDVFTPATSIENFNEVY--LVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGL 131
Query: 1043 AFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP 1102
++H + IIHRD+K SNV ++E+ E R+ DFG+AR ++ T Y
Sbjct: 132 KYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRA 183
Query: 1103 PE-------YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE 1155
PE Y Q+ D++S G I+ ELL GK +++ D QL
Sbjct: 184 PEIMLNWMHYNQTV------DIWSVGCIMAELLKGKALFPGNDYID---------QL--- 225
Query: 1156 KRINEIL---DPELTMQTSDE 1173
KRI E++ PE+ + S E
Sbjct: 226 KRIMEVVGTPSPEVLKKISSE 246
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-10
Identities = 63/223 (28%), Positives = 93/223 (41%), Gaps = 49/223 (21%)
Query: 933 DSMIGSGGFGEVYK-AQLRDGSVVAIKKLIHVTGQ--GDREFMAEMETIGKIKHRNLVPL 989
D IG G FG V+ RDG VA+KK+ +V + E++ + KH N++
Sbjct: 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSA 64
Query: 990 LGYCKIG-----EERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSA----- 1039
L + EE +V E M +S LH KI +
Sbjct: 65 LDILQPPHIDPFEEIYVVTELM-----QSDLH----------------KIIVSPQPLSSD 103
Query: 1040 ----------RGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHL 1089
RGL +LH + I+HRD+K N+L++ N ++ DFG+AR V D
Sbjct: 104 HVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESK 159
Query: 1090 SVSTLAGTPGYVPPEYYQ-SFRCTTKGDVYSYGVILLELLSGK 1131
++ T Y PE S T+ D++S G I ELL +
Sbjct: 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-10
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 27/207 (13%)
Query: 936 IGSGGFGEV-YKAQLRDGSVVAIKKLIHVTGQGD---REFMAEMETIGKIKHRNLVPLLG 991
+GSG +G V R G+ VAIKKL + Q + + E+ + +KH N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMKHENVIGLLD 81
Query: 992 YCKIGE------ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFL 1045
+ LV +M G+ L K ++ + + + +GL ++
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQML-----KGLKYI 134
Query: 1046 HHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEY 1105
H + IIHRD+K N+ ++E+ E ++ DFG+AR ++ T V T Y PE
Sbjct: 135 HAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV-----TRWYRAPEV 186
Query: 1106 YQSF-RCTTKGDVYSYGVILLELLSGK 1131
++ T D++S G I+ E+L+GK
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 34/215 (15%)
Query: 935 MIGSGGFGEVYKAQLRDGS-VVAIKKL--IHVTGQGDREFMAEMETIGKIKHRN---LVP 988
+IG G FGEV + + V A+K L + + D F E I + H N +V
Sbjct: 50 VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI--MAHANSEWIVQ 107
Query: 989 LLGYCKIGEERLL--VYEYMKWGSLESVLHDRAKGGGTKLDWA----ARKKIAIGSARGL 1042
L + +++ L V EYM G L +++ + WA A +A+ + +
Sbjct: 108 L--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYD----IPEKWARFYTAEVVLALDAIHSM 161
Query: 1043 AFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP 1102
F IHRD+K N+LLD++ +++DFG ++A + + T GTP Y+
Sbjct: 162 GF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDA-NGMVRCDTAVGTPDYIS 211
Query: 1103 PEYYQSFRCTT----KGDVYSYGVILLELLSGKRP 1133
PE +S + D +S GV L E+L G P
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 19/212 (8%)
Query: 936 IGSGGFGEVYKAQLRDGSVV----AIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLG 991
IG G FG+V + + RD + I+K V+ +AE + ++ +VPL
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 992 YCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIP 1051
+ E+ LV ++ G L H + G + D +R + +A L L +
Sbjct: 61 SFQSPEKLYLVLAFINGGEL---FHHLQREG--RFD-LSRARFY--TAELLCALENLHKF 112
Query: 1052 HIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRC 1111
++I+RD+K N+LLD + DFG+ +L N D +T GTP Y+ PE
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDD-KTNTFCGTPEYLAPELLLGHGY 170
Query: 1112 TTKGDVYSYGVILLELLSGKRPIDPSEFGDDN 1143
T D ++ GV+L E+L+G P F D+N
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPP-----FYDEN 197
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-10
Identities = 65/217 (29%), Positives = 97/217 (44%), Gaps = 35/217 (16%)
Query: 935 MIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNL------- 986
+IG G FGEV ++++ G V A+K L E + ET + R++
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKIL------NKWEMLKRAETACFREERDVLVNGDRR 61
Query: 987 -VPLLGYCKIGEERL-LVYEYMKWGSLESVL---HDRAKGGGTKLDWAARKKIAIGSARG 1041
+ L Y E L LV +Y G L ++L DR + + A +AI S
Sbjct: 62 WITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF-YLAEMVLAIDSVHQ 120
Query: 1042 LAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV 1101
L +HRD+K NVLLD+N R++DFG + A D + + GTP Y+
Sbjct: 121 L---------GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA-DGTVQSNVAVGTPDYI 170
Query: 1102 PPEYYQSF-----RCTTKGDVYSYGVILLELLSGKRP 1133
PE Q+ R + D +S GV + E+L G+ P
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 80/341 (23%), Positives = 130/341 (38%), Gaps = 88/341 (25%)
Query: 935 MIGSGGFGEVYKAQL------RDGSVVAIKKLIH-VTGQGDREFMAEMETIGKI-KHRNL 986
++G G FG+V +A + VA+K L T + M+E++ + I H N+
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV 73
Query: 987 VPLLGYCKIGEERLLV-YEYMKWGSL-----------------------------ESVLH 1016
V LLG C L+V E+ K+G+L E
Sbjct: 74 VNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRV 133
Query: 1017 DRAKGGGTKLDWAARKKIAIGS----------------------------ARGLAFL-HH 1047
DR G +R + + ARG+ FL
Sbjct: 134 DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR 193
Query: 1048 SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQ 1107
CI HRD+ + N+LL EN ++ DFG+AR + ++ + ++ PE
Sbjct: 194 KCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIF 249
Query: 1108 SFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166
TT+ DV+S+GV+L E+ S G P + ++ + ++L R+ PE
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-----FCQRLKDGTRMRA---PEN 301
Query: 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207
E+Y RI C P +RPT ++ + +L
Sbjct: 302 A-----TPEIY---RIMLACWQGDPKERPTFSALVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMA--EMETIGKIKHRNLVPLLGY 992
+G G + VYK R +G +VA+K +I + + F A E + +KH N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALK-VISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 993 CKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPH 1052
E V+EYM L + G L + RGLA++H H
Sbjct: 72 IHTKETLTFVFEYMH-TDLAQYMIQHPGG----LHPYNVRLFMFQLLRGLAYIHGQ---H 123
Query: 1053 IIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQ-SFRC 1111
I+HRD+K N+L+ E +++DFG+AR + S + T Y PP+ +
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDY 181
Query: 1112 TTKGDVYSYGVILLELLSGKRPIDP 1136
++ D++ G I +E+L G+ P P
Sbjct: 182 SSALDIWGAGCIFIEMLQGQ-PAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIK--KLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGY 992
+G G + V+K + + ++VA+K +L H G + E+ + +KH N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-APCTAIREVSLLKNLKHANIVTLHDI 71
Query: 993 CKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPH 1052
LV+EY L+S L G + K RGL++ H
Sbjct: 72 IHTERCLTLVFEY-----LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---K 123
Query: 1053 IIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE-YYQSFRC 1111
I+HRD+K N+L++E E +++DFG+AR ++ T + S T Y PP+ S
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTK-TYSNEVVTLWYRPPDVLLGSTEY 181
Query: 1112 TTKGDVYSYGVILLELLSGKRPIDP 1136
+T D++ G IL E+ +G RP+ P
Sbjct: 182 STPIDMWGVGCILYEMATG-RPMFP 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 69/287 (24%), Positives = 125/287 (43%), Gaps = 30/287 (10%)
Query: 936 IGSGGFGEVYKAQL-----RDGSVVAIKKLIHVTGQGD-REFMAEMETIGKIKHRNLVPL 989
+G G FG+V + G VA+K L +G + E+E + + H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 990 LGYCKIGEER--LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH 1047
G C L+ E++ GSL+ L R K K++ + K A+ +G+ +L
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNK---NKINLKQQLKYAVQICKGMDYLGS 127
Query: 1048 SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGY-VPPEYY 1106
+HRD+ + NVL++ + ++ DFG+ + + + +V +P + PE
Sbjct: 128 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 1107 QSFRCTTKGDVYSYGVILLELL----SGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162
+ DV+S+GV L ELL S P+ + F ++G R+ +L
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLTYCDSESSPM--TLF---LKMIGPTHGQMTVTRLVRVL 239
Query: 1163 DPELTMQTSDE--TELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207
+ + E+YQ +R +C + +P KR T ++ F+ +
Sbjct: 240 EEGKRLPRPPNCPEEVYQLMR---KCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-10
Identities = 62/261 (23%), Positives = 113/261 (43%), Gaps = 51/261 (19%)
Query: 912 EKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVY-----------------KAQLRDGSV 954
E P ++LTF L G G FGEV+ +
Sbjct: 1 EFPRKRLTFKEKL------------GEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVL 48
Query: 955 VAIKKLIHVTGQGDR-EFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLES 1013
VA+K L + R +F+ E++ + ++K N++ LL C + ++ EYM+ G L
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 1014 VL------HDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE 1067
L K + ++ +A A G+ +L + +HRD+ + N L+ +
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGK 165
Query: 1068 NFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSF------RCTTKGDVYSYG 1121
N+ +++DFGM+R + + D + + G V P + S+ + TT DV+++G
Sbjct: 166 NYTIKIADFGMSRNLYSGDYY----RIQGRA--VLPIRWMSWESILLGKFTTASDVWAFG 219
Query: 1122 VILLELLSGKRPIDPSEFGDD 1142
V L E+L+ + S+ D+
Sbjct: 220 VTLWEILTLCKEQPYSQLSDE 240
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-10
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIK--KLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGY 992
+G G + V+K + + ++VA+K +L H G + E+ + +KH N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDI 72
Query: 993 CKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPH 1052
+ LV+EY L+ L G + K RGLA+ H
Sbjct: 73 VHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---K 124
Query: 1053 IIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE-YYQSFRC 1111
++HRD+K N+L++E E +++DFG+AR ++ T + S T Y PP+ S
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTK-TYSNEVVTLWYRPPDVLLGSSEY 182
Query: 1112 TTKGDVYSYGVILLELLSGKRPIDPSEFGDD 1142
+T+ D++ G I E+ SG RP+ P +D
Sbjct: 183 STQIDMWGVGCIFFEMASG-RPLFPGSTVED 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-10
Identities = 52/173 (30%), Positives = 85/173 (49%), Gaps = 28/173 (16%)
Query: 1039 ARGLAFL-HHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGT 1097
A+G++FL +CI HRD+ + N+LL ++ DFG+AR + D++ V A
Sbjct: 224 AKGMSFLASKNCI----HRDLAARNILLTHGRITKICDFGLARDIRN-DSNYVVKGNARL 278
Query: 1098 P-GYVPPEYYQSFRC--TTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLH 1153
P ++ PE F C T + DV+SYG++L E+ S G P D+ K+ +
Sbjct: 279 PVKWMAPE--SIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV--DSKFYKMIKEGY 334
Query: 1154 REKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206
R +L PE +E+Y ++ C D P KRPT Q++ + ++
Sbjct: 335 R------MLSPECA-----PSEMYDIMK---SCWDADPLKRPTFKQIVQLIEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 5e-10
Identities = 64/232 (27%), Positives = 105/232 (45%), Gaps = 19/232 (8%)
Query: 935 MIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKI-----KHRNLVPL 989
+IG G + +V +L+ + K++ D E + ++T + H LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 990 LGYCKIGEERLL-VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHS 1048
C E RL V EY+ G L + H + + KL + + + L +LH
Sbjct: 62 HS-CFQTESRLFFVIEYVNGGDL--MFHMQRQ---RKLPEEHARFYSAEISLALNYLHER 115
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQS 1108
II+RD+K NVLLD +++D+GM + L + ST GTP Y+ PE +
Sbjct: 116 ---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRG 170
Query: 1109 FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGD--DNNLVGWAKQLHREKRI 1158
D ++ GV++ E+++G+ P D D D N + Q+ EK+I
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 5e-10
Identities = 72/266 (27%), Positives = 108/266 (40%), Gaps = 75/266 (28%)
Query: 928 NGFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKIK-HRN 985
+ F + +IG G FGEV Q +D G + A+KKL + M E E + ++ R+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKL-------RKSEMLEKEQVAHVRAERD 53
Query: 986 L---------VPLLGYCKIGEER--LLVYEYMKWGSLESVL--HDRAKGGGTKLDWAARK 1032
+ V L Y +E L+ EY+ G + ++L D T+ + A
Sbjct: 54 ILAEADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRF-YIAET 110
Query: 1033 KIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGM-------------- 1078
+AI S L + IHRD+K N+LLD ++SDFG+
Sbjct: 111 ILAIDSIHKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYR 161
Query: 1079 ----ARLVNALDT-------------------HLSVSTLAGTPGYVPPEYYQSFRCTTKG 1115
A N LD L+ ST+ GTP Y+ PE + +
Sbjct: 162 ILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTV-GTPDYIAPEVFLQTGYNKEC 220
Query: 1116 DVYSYGVILLELLSGKRPI---DPSE 1138
D +S GVI+ E+L G P +P E
Sbjct: 221 DWWSLGVIMYEMLVGYPPFCSDNPQE 246
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-10
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 22/210 (10%)
Query: 936 IGSGGFGEVYKAQLRDGSV--VAIKKL----IHVTGQGDREFMAEMETIGKIKHRNLVPL 989
+G+G FG V A ++ VAIK+ I Q D F +E + + I H V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYINHPFCVNL 96
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAK-GGGTKLDWAARKKIAIGSARGLAFLHHS 1048
G K LV E++ G + L + +AA+ + + L
Sbjct: 97 YGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL------ 150
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQS 1108
+I++RD+K N+LLD++ +++DFG A++V+ TL GTP Y+ PE +
Sbjct: 151 ---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-----RTYTLCGTPEYIAPEILLN 202
Query: 1109 FRCTTKGDVYSYGVILLELLSGKRPIDPSE 1138
D ++ G+ + E+L G P +E
Sbjct: 203 VGHGKAADWWTLGIFIYEILVGCPPFYANE 232
|
Length = 340 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 6e-10
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 20/217 (9%)
Query: 935 MIGSGGFGEVYKAQL-RDGSVVAIK---KLIHVTGQGDREFMAEMETIGK-IKHRNLVPL 989
+IG G FG+V A+ DG A+K K I + + + MAE + K +KH LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGS-ARGLAFLHHS 1048
+ E+ V +++ G L H + + + R + A L +LH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPE----PRARFYAAEIASALGYLHSI 115
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQS 1108
+I++RD+K N+LLD ++DFG+ + + + +T GTP Y+ PE +
Sbjct: 116 ---NIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRK 170
Query: 1109 FRCTTKGDVYSYGVILLELLSGKRPI---DPSEFGDD 1142
D + G +L E+L G P D +E D+
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDN 207
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 6e-10
Identities = 64/224 (28%), Positives = 98/224 (43%), Gaps = 38/224 (16%)
Query: 934 SMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGD-------REFMAE---METIGKIK 982
+++G G FG+V A+ + G + AIK L +GD M E ET +
Sbjct: 5 AVLGRGHFGKVLLAEYKKTGELYAIKAL----KKGDIIARDEVESLMCEKRIFETANSER 60
Query: 983 HRNLVPLLGYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSAR- 1040
H LV L C E+ + V EY G L +H D + + +A
Sbjct: 61 HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHT---------DVFSEPRAVFYAACV 110
Query: 1041 --GLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP 1098
GL +LH + I++RD+K N+LLD +++DFG+ + + ST GTP
Sbjct: 111 VLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTP 165
Query: 1099 GYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDD 1142
++ PE T D + GV++ E+L G+ P GDD
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFP----GDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 6e-10
Identities = 39/133 (29%), Positives = 63/133 (47%), Gaps = 17/133 (12%)
Query: 1053 IIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCT 1112
II+RD+K N+LLDE +++DFG+++ ++D + GT Y+ PE T
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 176
Query: 1113 TKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSD 1172
D +S+GV++ E+L+G P G D R++ + IL +L M
Sbjct: 177 QSADWWSFGVLMFEMLTGSLPFQ----GKD-----------RKETMTMILKAKLGMPQFL 221
Query: 1173 ETELYQYLRISFE 1185
E LR F+
Sbjct: 222 SPEAQSLLRALFK 234
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-10
Identities = 29/68 (42%), Positives = 41/68 (60%)
Query: 549 LETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLT 608
L+++ L+ N + G IP S+ S T++ + LS N G IP +G L L IL L NSL+
Sbjct: 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLS 503
Query: 609 GQVPQGLG 616
G+VP LG
Sbjct: 504 GRVPAALG 511
|
Length = 623 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 7e-10
Identities = 36/100 (36%), Positives = 58/100 (58%), Gaps = 11/100 (11%)
Query: 1040 RGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPG 1099
RGL ++H + +++HRD+K SN+LL+ N + ++ DFG+AR + + ++ T
Sbjct: 119 RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTS--EKGDFMTEYVVTRW 173
Query: 1100 YVPPEYYQSFRC---TTKGDVYSYGVILLELLSGKRPIDP 1136
Y PE + C TT DV+S G I ELL G++P+ P
Sbjct: 174 YRAPELLLN--CSEYTTAIDVWSVGCIFAELL-GRKPLFP 210
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-10
Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 936 IGSGGFGEVYK--AQLRDGSVVAIK--KLIHVTGQGDREFMAEMETIGKIKHRNLVPLLG 991
+G G + VYK ++L D ++VA+K +L H G + E+ + +KH N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHD 71
Query: 992 YCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIP 1051
+ LV+EY+ L+ L D G ++ K RGL + H
Sbjct: 72 IIHTEKSLTLVFEYLD-KDLKQYLDD----CGNSINMHNVKLFLFQLLRGLNYCHRR--- 123
Query: 1052 HIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE-YYQSFR 1110
++HRD+K N+L++E E +++DFG+AR ++ T + S T Y PP+ S
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTK-TYSNEVVTLWYRPPDILLGSTD 181
Query: 1111 CTTKGDVYSYGVILLELLSGKRPIDP 1136
+T+ D++ G I E+ +G RP+ P
Sbjct: 182 YSTQIDMWGVGCIFYEMSTG-RPLFP 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 9e-10
Identities = 50/179 (27%), Positives = 81/179 (45%), Gaps = 29/179 (16%)
Query: 973 AEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARK 1032
+E+ + H +V K ++ LL+ EY G L + R K ++
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEV-- 171
Query: 1033 KIAIGSARGLAF---------LHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083
GL F +H + +HRD+KS+N+ L ++ DFG ++ +
Sbjct: 172 --------GLLFYQIVLALDEVHSRKM---MHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220
Query: 1084 ---ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPID-PSE 1138
+LD S+ GTP Y+ PE ++ R + K D++S GVIL ELL+ RP PS+
Sbjct: 221 DSVSLDV---ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ 276
|
Length = 478 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-09
Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 1042 LAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV 1101
L FLH II+RD+K NVLLD +++D+GM + + + ST GTP Y+
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYI 163
Query: 1102 PPEYYQSFRCTTKGDVYSYGVILLELLSGKRPID 1135
PE + D ++ GV++ E+++G+ P D
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 70/276 (25%), Positives = 118/276 (42%), Gaps = 37/276 (13%)
Query: 911 FEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLI---HVTGQG 967
+EK +RK+ L + +IG G FGEV + + V KL+ + +
Sbjct: 28 YEKIVRKIR--KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRS 85
Query: 968 DREFMAEMETIGKIKHRNLVPLLGYCKIGEERLL--VYEYMKWGSLESVLHDRAKGGGTK 1025
D F E I + V L +C +++ L V EYM G L +++ +
Sbjct: 86 DSAFFWEERDIMAFANSPWVVQL-FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWA 144
Query: 1026 LDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085
+ A +A+ + + +IHRD+K N+LLD++ +++DFG ++
Sbjct: 145 KFYTAEVVLALDAIHSMG---------LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195
Query: 1086 DTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVY--------SYGVILLELLSGKRPIDPS 1137
+ T GTP Y+ PE +S GD Y S GV L E+L G P
Sbjct: 196 GM-VRCDTAVGTPDYISPEVLKS----QGGDGYYGRECDWWSVGVFLFEMLVGDTPF--- 247
Query: 1138 EFGDDNNLVG-WAKQLHREKRINEILDPELTMQTSD 1172
+ D +LVG ++K + + +N D E++ +
Sbjct: 248 -YAD--SLVGTYSKIMDHKNSLNFPEDVEISKHAKN 280
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-09
Identities = 34/87 (39%), Positives = 53/87 (60%), Gaps = 3/87 (3%)
Query: 306 LSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEI 365
L GL G P + + L+++N+S N+++G IP LGS +L+ L L++N F G I
Sbjct: 425 LDNQGLRG-FIPNDISKLRHLQSINLSGNSIRGNIP-PSLGSITSLEVLDLSYNSFNGSI 482
Query: 366 PPELGQACGTLRELDLSSNRLTGELPS 392
P LGQ +LR L+L+ N L+G +P+
Sbjct: 483 PESLGQLT-SLRILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-09
Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 16/211 (7%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQG-DREFMAEMETIGKIKHRNLVPLLGYCK 994
+G G +G VYKA+ +DG L + G G E+ + ++KH N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 995 IGEER--LLVYEYMK---WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC 1049
+R L+++Y + W ++ +A +L + K + G+ +LH +
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128
Query: 1050 IPHIIHRDMKSSNVLL----DENFEARVSDFGMARLVNA-LDTHLSVSTLAGTPGYVPPE 1104
++HRD+K +N+L+ E +++D G ARL N+ L + + T Y PE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 1105 YYQSFRCTTKG-DVYSYGVILLELLSGKRPI 1134
R TK D+++ G I ELL+ + PI
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE-PI 215
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 64/248 (25%), Positives = 111/248 (44%), Gaps = 34/248 (13%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCK 994
+G G G V+ A D VA+KK++ Q + + E++ I ++ H N+V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 995 IGEERL--------------LVYEYMKWGSLESVL-HDRAKGGGTKLDWAARKKIAIGSA 1039
L +V EYM+ L +VL +L
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARL-------FMYQLL 124
Query: 1040 RGLAFLHHSCIPHIIHRDMKSSNVLLD-ENFEARVSDFGMARLVNALDTH---LSVSTLA 1095
RGL ++H + +++HRD+K +NV ++ E+ ++ DFG+AR+V+ +H LS +
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV- 180
Query: 1096 GTPGYVPPEYYQSFRCTTKG-DVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR 1154
T Y P S TK D+++ G I E+L+GK + + L+ + + R
Sbjct: 181 -TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239
Query: 1155 EKRINEIL 1162
E+ NE+L
Sbjct: 240 EEDRNELL 247
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-09
Identities = 19/42 (45%), Positives = 28/42 (66%), Gaps = 1/42 (2%)
Query: 57 NEELTILMAFKQSSIGSDPNGYLANWTADALTPCSWQGVSCS 98
N++ L+AFK SS+ DP+G L++W + PCSW GV+C
Sbjct: 2 NDDRDALLAFK-SSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 16/211 (7%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQG-DREFMAEMETIGKIKHRNLVPLLGYCK 994
+G G +G VYKA+ +DG L + G G E+ + ++KH N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 995 IGEER--LLVYEYMK---WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC 1049
+R L+++Y + W ++ +A +L K + G+ +LH +
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128
Query: 1050 IPHIIHRDMKSSNVLL----DENFEARVSDFGMARLVNA-LDTHLSVSTLAGTPGYVPPE 1104
++HRD+K +N+L+ E +++D G ARL N+ L + + T Y PE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 1105 YYQSFRCTTKG-DVYSYGVILLELLSGKRPI 1134
R TK D+++ G I ELL+ + PI
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE-PI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 73/317 (23%), Positives = 114/317 (35%), Gaps = 50/317 (15%)
Query: 125 LPYLEHLNLQGNSFSAG---DLSTSKTSSCSLVTMDLSSNNITGSLPG----RSFLLSCD 177
L L+ L L+GN+ L+++ SL + LS N G L
Sbjct: 22 LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81
Query: 178 RLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLP 237
L ++LS N++ + SLL+ + SL Q L L N
Sbjct: 82 GLQELDLSDNALGPDGCGVLESLLR--------------SSSL---QELKLNNNGLGDRG 124
Query: 238 GKLNATSV--NCKSISTIDLSYNLLSGE--IPASFVADSSGSLKYLDLSHNNFTGK-FSN 292
+L A + ++ + L N L G + ++ LK L+L++N
Sbjct: 125 LRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRA 184
Query: 293 L--DFGRCGNLSVITLSQNGLSGTE---FPASLKNCQLLETLNMSHNAL-QGGIPGF--- 343
L NL V+ L+ NGL+ +L + + LE LN+ N L G
Sbjct: 185 LAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASA 244
Query: 344 LLGSFRNLKQLSLAHNQFAGEIPPELGQACG---TLRELDLSSNRLTGELPSTFASCSSL 400
LL +L LSL+ N + +L + +L ELDL N+ E SL
Sbjct: 245 LLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEE--GAQLLAESL 302
Query: 401 H-------SLNLGSNML 410
SL + +
Sbjct: 303 LEPGNELESLWVKDDSF 319
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-09
Identities = 41/120 (34%), Positives = 59/120 (49%), Gaps = 17/120 (14%)
Query: 82 WTADALTPCS-----WQGVSCSLNSH-----VTSLNLNNSGLSGSLNLTTLTALPYLEHL 131
W D PC W G C +S + L L+N GL G + ++ L +L+ +
Sbjct: 392 WNGD---PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIP-NDISKLRHLQSI 447
Query: 132 NLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISG 191
NL GNS G++ S S SL +DLS N+ GS+P L+ L +NL+ NS+SG
Sbjct: 448 NLSGNSIR-GNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLT--SLRILNLNGNSLSG 504
|
Length = 623 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 5e-09
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 16/205 (7%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMA--EMETIGKIKHRNLVPLLGY 992
+G G + VYK + + G +VA+K+ I + + F A E + +KH N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKE-IRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 993 CKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPH 1052
+ LV+EY+ L+ + D GGG + + RGLA+ H
Sbjct: 72 IHTKKTLTLVFEYLD-TDLKQYMDDC--GGGLSMHNV--RLFLFQLLRGLAYCHQR---R 123
Query: 1053 IIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRC- 1111
++HRD+K N+L+ E E +++DFG+AR ++ + + S T Y PP+
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSK-TYSNEVVTLWYRPPDVLLGSTEY 181
Query: 1112 TTKGDVYSYGVILLELLSGKRPIDP 1136
+T D++ G I E+ +G RP+ P
Sbjct: 182 STSLDMWGVGCIFYEMATG-RPLFP 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 6e-09
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 25/209 (11%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKL--IHVTGQGDREFMAEMETIGKIKHR--NLVPLL 990
IGSG G+VYK + + G V+A+K++ + R M +++ + K H +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILM-DLDVVLK-SHDCPYIVKCY 80
Query: 991 GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCI 1050
GY + + E M L+ +L + G D + +AI A LH+
Sbjct: 81 GYFITDSDVFICMELMS-TCLDKLL--KRIQGPIPEDILGKMTVAIVKA-----LHYLKE 132
Query: 1051 PH-IIHRDMKSSNVLLDENFEARVSDFGMA-RLVNALDTHLSVSTLAGTPGYVPPEYYQS 1108
H +IHRD+K SN+LLD + ++ DFG++ RLV++ + + AG Y+ PE
Sbjct: 133 KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS----KAKTRSAGCAAYMAPERIDP 188
Query: 1109 FRCTTK----GDVYSYGVILLELLSGKRP 1133
K DV+S G+ L+EL +G+ P
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 6e-09
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 32/214 (14%)
Query: 936 IGSGGFGEVYKAQ---LRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIK-------HRN 985
+G G +G V A+ + VAIKK +T ++ +A+ + ++K H+N
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKK---ITNVFSKKILAK-RALRELKLLRHFRGHKN 63
Query: 986 LVPLLG-----YCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSAR 1040
+ L E L +YE + L ++ G L A +
Sbjct: 64 ITCLYDMDIVFPGNFNE--LYLYEELMEADLHQIIRS-----GQPLTDAHFQSFIYQILC 116
Query: 1041 GLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR--LVNALDTHLSVSTLAGTP 1098
GL ++H + +++HRD+K N+L++ + E ++ DFG+AR N + ++ T
Sbjct: 117 GLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 1099 GYVPPEYYQSFRCTTKG-DVYSYGVILLELLSGK 1131
Y PE SF+ TK DV+S G IL ELL K
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-09
Identities = 49/210 (23%), Positives = 91/210 (43%), Gaps = 28/210 (13%)
Query: 935 MIGSGGFGEVY----KAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLL 990
++G G FG+V KA + ++ +KK + + + E + +H L L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 991 GYCKIGEERLLVYEYMKWGSL------ESVL-HDRAKGGGTKLDWAARKKIAIGSARGLA 1043
+ + V EY+ G L E V DR + G ++ L
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEI------------VSALD 109
Query: 1044 FLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPP 1103
+LH I++RD+K N++LD++ +++DFG+ + + ++ T GTP Y+ P
Sbjct: 110 YLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAP 164
Query: 1104 EYYQSFRCTTKGDVYSYGVILLELLSGKRP 1133
E + D + GV++ E++ G+ P
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 7e-09
Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 27/217 (12%)
Query: 934 SMIGSGGFGEVYKA-QLRDGSVVAIKKLI----HVTGQGDREFMAEMETIGKIKHRNLVP 988
+IG G +G V A G VAIKK+ HV+ + E++ + ++H ++V
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDA--TRILREIKLLRLLRHPDIVE 63
Query: 989 LLGYCKIGEER-----LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLA 1043
+ R +V+E M ES LH K L + R L
Sbjct: 64 IKHIMLPPSRREFKDIYVVFELM-----ESDLHQVIKAN-DDLTPEHHQFFLYQLLRALK 117
Query: 1044 FLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSV--STLAGTPGYV 1101
++H + ++ HRD+K N+L + + + ++ DFG+AR V DT ++ + T Y
Sbjct: 118 YIHTA---NVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATRWYR 173
Query: 1102 PPEYYQSF--RCTTKGDVYSYGVILLELLSGKRPIDP 1136
PE SF + T D++S G I E+L+GK P+ P
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFP 209
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 52.9 bits (128), Expect = 7e-09
Identities = 26/60 (43%), Positives = 34/60 (56%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
+L LDLS N L+ F L L+VL+L N LT P++F GL ++ LDLS NN
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 9e-09
Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 3/88 (3%)
Query: 452 LDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLA 511
L L + G G IP+ L+ I L N + G +P LGS +L+ +DLS+NS
Sbjct: 423 LGLDNQGLRGFIPNDI---SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 512 GPVPSEIWSLPNLSDLVMWANNLTGEIP 539
G +P + L +L L + N+L+G +P
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-08
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 29/211 (13%)
Query: 935 MIGSGGFGEVYKAQLRDG----SVVAIKKLIHVTGQGDREFMAEMETIGK-IKHRNLVPL 989
+IG G FG+V A+ + +V ++K + + ++ M+E + K +KH LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 990 LGYCKIGEERLLVYEYMKWGSL-------ESVLHDRAKGGGTKLDWAARKKIAIGSARGL 1042
+ ++ V +Y+ G L L RA+ +AA I SA L
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF------YAAE----IASA--L 109
Query: 1043 AFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP 1102
+LH +I++RD+K N+LLD ++DFG+ + ++ + + ST GTP Y+
Sbjct: 110 GYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLA 164
Query: 1103 PEYYQSFRCTTKGDVYSYGVILLELLSGKRP 1133
PE D + G +L E+L G P
Sbjct: 165 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-08
Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 37/214 (17%)
Query: 934 SMIGSGGFGEVYKA-QLRDGSVVAIKKL-------IHVTGQGDREFMAEMETIGKIKHRN 985
S +GSG +G V A + G VA+KKL IH + E+ + +KH N
Sbjct: 23 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-----KRTYRELRLLKHMKHEN 77
Query: 986 LVPLLGY---CKIGEERLLVY--EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSAR 1040
++ LL + EE VY ++ L +++ + KL + + R
Sbjct: 78 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ------KLTDDHVQFLIYQILR 131
Query: 1041 GLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGY 1100
GL ++H + IIHRD+K SN+ ++E+ E ++ DFG+AR T ++ T Y
Sbjct: 132 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWY 183
Query: 1101 VPPEY---YQSFRCTTKGDVYSYGVILLELLSGK 1131
PE + + T D++S G I+ ELL+G+
Sbjct: 184 RAPEIMLNWMHYNQTV--DIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 47/250 (18%)
Query: 934 SMIGSGGFGEVYKAQLRDGS-------VVAIKKLIHVTGQGDREFM-AEMETIGKIKHRN 985
++G GG+G+V++ + G+ + +KK V Q D AE + +KH
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 986 LVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKG---GGTKLDWAARKKIAIGSARGL 1042
+V L+ + G + L+ EY+ G L +H +G T + + +A+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLALEH---- 115
Query: 1043 AFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR--LVNALDTHLSVSTLAGTPGY 1100
LH II+RD+K N+LLD +++DFG+ + + TH T GT Y
Sbjct: 116 --LHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH----TFCGTIEY 166
Query: 1101 VPPEYYQSFRCTTKGDV--YSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158
+ PE R V +S G ++ ++L+G P F +N R+K I
Sbjct: 167 MAPEILM--RSGHGKAVDWWSLGALMYDMLTGAPP-----FTAEN----------RKKTI 209
Query: 1159 NEILDPELTM 1168
++IL +L +
Sbjct: 210 DKILKGKLNL 219
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 50/167 (29%), Positives = 74/167 (44%), Gaps = 36/167 (21%)
Query: 1039 ARGLAFL-HHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR-------LVNALDTHLS 1090
ARG+ FL CI HRD+ + N+LL EN ++ DFG+AR V D L
Sbjct: 183 ARGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 1091 VSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWA 1149
+ +A PE TT+ DV+S+GV+L E+ S G P + ++ +
Sbjct: 239 LKWMA-------PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-----FC 286
Query: 1150 KQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPT 1196
++L R+ PE E+Y I +C + P RPT
Sbjct: 287 RRLKEGTRMRA---PEYATP-----EIYS---IMLDCWHNNPEDRPT 322
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-08
Identities = 36/106 (33%), Positives = 52/106 (49%), Gaps = 10/106 (9%)
Query: 315 EFPASLKNCQL--------LETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIP 366
+ P S +CQ ++ L + + L+G IP + R+L+ ++L+ N G IP
Sbjct: 401 QHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPN-DISKLRHLQSINLSGNSIRGNIP 459
Query: 367 PELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSG 412
P LG L LDLS N G +P + +SL LNL N LSG
Sbjct: 460 PSLGSITS-LEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSG 504
|
Length = 623 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 51/226 (22%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKL--------IHVTGQGDREFMAEMETIGKIKHRNL 986
IG G +G VYKA+ R +A+KK+ + T + + EM +H N+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM------QHGNI 63
Query: 987 VPL--LGYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGS----- 1038
V L + + E+RL LV+EY+ D K + D+A ++ I +
Sbjct: 64 VRLQDVVHS---EKRLYLVFEYLDL--------DLKKHMDSSPDFAKNPRL-IKTYLYQI 111
Query: 1039 ARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEA-RVSDFGMARL----VNALDTHLSVST 1093
RG+A+ H ++HRD+K N+L+D A +++DFG+AR V TH V T
Sbjct: 112 LRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF-TH-EVVT 166
Query: 1094 LAGTPGYVPPEYYQSFRC-TTKGDVYSYGVILLELLSGKRPIDPSE 1138
L Y PE R +T D++S G I E+++ ++P+ P +
Sbjct: 167 L----WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPLFPGD 207
|
Length = 294 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-08
Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 10/106 (9%)
Query: 1040 RGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL-VNALDTHLSVSTLAGTP 1098
GL +LH IIHRD+K+ N+ +++ + + D G A+ V A LAGT
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL----GLAGTV 220
Query: 1099 GYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPI--DPSEFGDD 1142
PE + +K D++S G++L E+L+ I DP ++
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEE 266
|
Length = 357 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-08
Identities = 66/251 (26%), Positives = 100/251 (39%), Gaps = 65/251 (25%)
Query: 930 FSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRN--- 985
F + +IG G FGEV Q +D G V A+K L + M E E +G I+
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKIL-------RKADMLEKEQVGHIRAERDIL 55
Query: 986 -------LVPLLGYCKIGEERLLVYEYMKWGSLESVL--HDRAKGGGTKLDWAARKKIAI 1036
+V + + L+ E++ G + ++L D T+ + A +AI
Sbjct: 56 VEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQF-YIAETVLAI 114
Query: 1037 GSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA-------------RLVN 1083
S L F IHRD+K N+LLD ++SDFG+ L +
Sbjct: 115 DSIHQLGF---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNH 165
Query: 1084 ALDT---------------------HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGV 1122
+L + L+ ST+ GTP Y+ PE + D +S GV
Sbjct: 166 SLPSDFTFQNMNSKRKAETWKRNRRQLAFSTV-GTPDYIAPEVFMQTGYNKLCDWWSLGV 224
Query: 1123 ILLELLSGKRP 1133
I+ E+L G P
Sbjct: 225 IMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 935 MIGSGGFGEVY----KAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLL 990
++G G FG+V KA R ++ +KK + V + E + +H L L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 991 GYCKIGEERLLVYEYMKWGSL------ESVL-HDRAKGGGTKLDWAARKKIAIGSARGLA 1043
+ + V EY G L E V DRA+ G ++ L
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI------------VSALD 109
Query: 1044 FLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPP 1103
+LH ++++RD+K N++LD++ +++DFG+ + + ++ T GTP Y+ P
Sbjct: 110 YLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAP 165
Query: 1104 EYYQSFRCTTKGDVYSYGVILLELLSGKRP 1133
E + D + GV++ E++ G+ P
Sbjct: 166 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-08
Identities = 74/321 (23%), Positives = 129/321 (40%), Gaps = 74/321 (23%)
Query: 935 MIGSGGFGEVYKA-QLRDGSVVAIKK---------LIHVTGQGDREFMAEMETIGKIKHR 984
+IG GG GEVY A VA+KK L+ + F+ E + + H
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLK------KRFLREAKIAADLIHP 62
Query: 985 NLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDW---AARKKIAIGSARG 1041
+VP+ C G+ Y++ +L+S+L K W + K++A ++ G
Sbjct: 63 GIVPVYSICSDGDPVYYTMPYIEGYTLKSLL---------KSVWQKESLSKELAEKTSVG 113
Query: 1042 LAFL---HHSCIP----H---IIHRDMKSSNVLLDENFEARVSDFGMARLVNA-LDTHLS 1090
AFL H C H ++HRD+K N+LL E + D+G A + L
Sbjct: 114 -AFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 1091 VST---------------LAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPID 1135
+ + GTP Y+ PE + D+Y+ GVIL ++L+ P
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232
Query: 1136 PSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYL-RISFECLDDRPFKR 1194
+ +++ IL P + + E+ +L +I+ + L P +R
Sbjct: 233 RKKG----------RKISYRDV---ILSPI---EVAPYREIPPFLSQIAMKALAVDPAER 276
Query: 1195 PTMIQVMAMFKELQVDTEGDS 1215
+ +Q + ++L+ +G
Sbjct: 277 YSSVQ--ELKQDLEPHLQGSP 295
|
Length = 932 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-08
Identities = 70/298 (23%), Positives = 109/298 (36%), Gaps = 82/298 (27%)
Query: 930 FSADSMIGSGGFGEVYKAQLRDGSVV-AIKKL-----------IHVTGQGDREFMAEMET 977
F IG G FGEV + D + + A+K L HV + +R+ +AE +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHV--KAERDILAEADN 60
Query: 978 IGKIKHRNLVPLLGYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWA----ARK 1032
V L Y ++ L V +Y+ G + S+L + G + D A A
Sbjct: 61 -------EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL---IRLGIFEEDLARFYIAEL 110
Query: 1033 KIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGM-------------- 1078
AI S + F IHRD+K N+L+D + +++DFG+
Sbjct: 111 TCAIESVHKMGF---------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161
Query: 1079 ----AR--------LVNALD---------------THLSVSTLAGTPGYVPPEYYQSFRC 1111
R + +D +L GTP Y+ PE
Sbjct: 162 KGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY 221
Query: 1112 TTKGDVYSYGVILLELLSGKRP-IDPSEFGDDNNLVGWAKQLHREKRINEILDPELTM 1168
T D +S GVIL E+L G+ P + + ++ W LH + L E +
Sbjct: 222 TQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAK--LSREASD 277
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-08
Identities = 40/117 (34%), Positives = 50/117 (42%), Gaps = 28/117 (23%)
Query: 379 LDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGP 438
L L + L G +P+ + L S+NL SGN I G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINL-----SGNS--------------------IRGN 457
Query: 439 VPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELG 495
+P SL + T L VLDLS N F G+IP S +L + L N LSG VP LG
Sbjct: 458 IPPSLGSITSLEVLDLSYNSFNGSIPE---SLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 64/280 (22%), Positives = 120/280 (42%), Gaps = 35/280 (12%)
Query: 936 IGSGGFGEVYKAQLRDGSVVA---IKKLIHVTGQGDR-EFMAEMETIGKIKHRNLVPLLG 991
IG+G FG+V +++ + VA +K+L ++ EF+ + + ++H N++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 992 YCKIGEERLLVYEYMKWGSLESVL--HDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC 1049
C LLV+EY + G L+S L + L +++A A G+ +H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLL---QRMACEIAAGVTHMHKH- 118
Query: 1050 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSF 1109
+ +H D+ N L + +V D+G+ D + ++ PE F
Sbjct: 119 --NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176
Query: 1110 R-------CTTKGDVYSYGVILLELL-SGKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161
T +V++ GV L EL + +P S D L + +++++ ++
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELFENAAQPY--SHLSDREVL----NHVIKDQQV-KL 229
Query: 1162 LDPELTMQTSDE-TELYQYLRISFECLDDRPFKRPTMIQV 1200
P+L + S+ E+ Q+ +S P KR T +V
Sbjct: 230 FKPQLELPYSERWYEVLQFCWLS-------PEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-08
Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLV------- 987
IG G FG+VY+ + +D + A+K L +E +A+ E I RN++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERNILVRTLLDE 54
Query: 988 -PLLGYCKIG----EERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGL 1042
P + K + LV +YM G L H + +G ++ R K I A +
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFSE----DRAKFYI--AELV 106
Query: 1043 AFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP 1102
L H I++RD+K N+LLD + DFG+++ L + + +T GT Y+
Sbjct: 107 LALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLA 164
Query: 1103 PEYYQSFRCTTKG-DVYSYGVILLELLSGKRP 1133
PE + TK D +S GV++ E+ G P
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|227563 COG5238, RNA1, Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-08
Identities = 75/315 (23%), Positives = 118/315 (37%), Gaps = 55/315 (17%)
Query: 199 SLLQLDLSGNQISDSAL--LTYSLSNCQNLNLLNFSD-------NKLPGKLNATS---VN 246
L+++DLSGN I A+ L ++N +NL ++NFSD ++L L +
Sbjct: 31 ELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLK 90
Query: 247 CKSISTIDLSYNLLSGEIP---ASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSV 303
C + +DLS N E P ++ SS L +L L +NN G + G+ ++
Sbjct: 91 CPRLQKVDLSDNAFGSEFPEELGDLIS-SSTDLVHLKL-NNNGLGPIAGGRIGK----AL 144
Query: 304 ITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGG---IPGFLLGSFRNLKQLSLAHNQ 360
L+ N + LE + N L+ G + LL S NLK++ + N
Sbjct: 145 FHLAYN--------KKAADKPKLEVVICGRNRLENGSKELSAALLESHENLKEVKIQQNG 196
Query: 361 FAGEIPPEL----GQACGTLRELDLSSNRLTGE----LPSTFASCSSLHSLNLGSNMLSG 412
E L +L LDL N T E L + L L L +LS
Sbjct: 197 IRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCLLSN 256
Query: 413 NFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPN 472
+ +V+ + + F P+P +LD+S N F
Sbjct: 257 EGVKSVLRRFNEK------FVPNLMPLPGDYNERRGGIILDISLNEF---------EQDA 301
Query: 473 FPALEKIVLPNNYLS 487
P L + N +
Sbjct: 302 VPLLVDLERNGNRIK 316
|
Length = 388 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-08
Identities = 54/177 (30%), Positives = 84/177 (47%), Gaps = 34/177 (19%)
Query: 1039 ARGLAFL-HHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR-LVNALDTHLSVSTLAG 1096
A+G+ FL +CI HRD+ + NVLL + A++ DFG+AR ++N D++ V A
Sbjct: 222 AQGMDFLASKNCI----HRDVAARNVLLTDGRVAKICDFGLARDIMN--DSNYVVKGNAR 275
Query: 1097 TP-GYVPPEYYQSFRC--TTKGDVYSYGVILLELLS-GKRPIDPSEFGDDN--NLVGWAK 1150
P ++ PE F C T + DV+SYG++L E+ S GK P P + +V
Sbjct: 276 LPVKWMAPE--SIFDCVYTVQSDVWSYGILLWEIFSLGKSPY-PGILVNSKFYKMVKRGY 332
Query: 1151 QLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207
Q+ R P+ E+Y I C + P +RPT Q+ + +
Sbjct: 333 QMSR---------PDFAPP-----EIY---SIMKMCWNLEPTERPTFSQISQLIQRQ 372
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 51/211 (24%), Positives = 93/211 (44%), Gaps = 30/211 (14%)
Query: 935 MIGSGGFGEVY----KAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLL 990
++G G FG+V KA R ++ ++K + + + E + +H L L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL- 60
Query: 991 GYCKIGEERL-LVYEYMKWGSL------ESVL-HDRAKGGGTKLDWAARKKIAIGSARGL 1042
Y +RL V EY G L E V +RA+ G ++ L
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI------------VSAL 108
Query: 1043 AFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP 1102
+LH +++RD+K N++LD++ +++DFG+ + + ++ T GTP Y+
Sbjct: 109 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLA 163
Query: 1103 PEYYQSFRCTTKGDVYSYGVILLELLSGKRP 1133
PE + D + GV++ E++ G+ P
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 6e-08
Identities = 61/229 (26%), Positives = 98/229 (42%), Gaps = 48/229 (20%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMAEMETIG----KIKHRNLVPLL 990
IG G +G+VYKA+ G +VA+KK EM+ G ++ +L+ +L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKT-----------RLEMDEEGIPPTALREISLLQML 57
Query: 991 GYC--------------KIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIA 1035
K G+ L LV+EY+ L+ + +G G L K
Sbjct: 58 SESIYIVRLLDVEHVEEKNGKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFM 116
Query: 1036 IGSARGLAFLH-HSCIPHIIHRDMKSSNVLLDENFEA-RVSDFGMARLVN---ALDTHLS 1090
+G+A H H ++HRD+K N+L+D+ +++D G+ R + TH
Sbjct: 117 YQLLKGVAHCHKHG----VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEI 172
Query: 1091 VSTLAGTPGYVPPE-YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSE 1138
V T Y PE S +T D++S G I E+ K+P+ P +
Sbjct: 173 V-----TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPLFPGD 215
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 30/88 (34%), Positives = 50/88 (56%), Gaps = 8/88 (9%)
Query: 1041 GLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR-LVNALDTHLSVSTLAGTPG 1099
G+ ++H I+HRD+K+ N+ L N ++ DFG++R L+ + D +T GTP
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDL---ATTFTGTPY 170
Query: 1100 YVPPEYYQSFRCTTKGDVYSYGVILLEL 1127
Y+ PE + +K D++S G IL E+
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 7e-08
Identities = 67/280 (23%), Positives = 113/280 (40%), Gaps = 59/280 (21%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGD-----REFMAEMETIGKIKHRNLVPL 989
IG G F EV KAQ + G AIK + + RE A + + H N++ L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQA-LRRLSP--HPNILRL 63
Query: 990 LGYCKIGEERL-----LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAF 1044
++ +R LV+E M + L++ KG L K + L
Sbjct: 64 ---IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 1045 LHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE 1104
+H + I HRD+K N+L+ ++ +++DFG R + + + T Y PE
Sbjct: 116 MHRN---GIFHRDIKPENILIKDD-ILKLADFGSCR---GIYSKPPYTEYISTRWYRAPE 168
Query: 1105 ------YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158
YY K D+++ G + E+LS P+ P N L Q+ +I
Sbjct: 169 CLLTDGYY-----GPKMDIWAVGCVFFEILS-LFPLFPGT----NEL----DQIA---KI 211
Query: 1159 NEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMI 1198
+++L + + E+ + R S + P K+ T +
Sbjct: 212 HDVLG-------TPDAEVLKKFRKSRHMNYNFPSKKGTGL 244
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 8e-08
Identities = 90/336 (26%), Positives = 142/336 (42%), Gaps = 24/336 (7%)
Query: 75 PNGYLANWTADALTPCSWQGVSCSLNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQ 134
N Y + L S + V L LN S + L ++L+ L L+ L+
Sbjct: 23 SNTYHTTPQSINLN----FPDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPS 78
Query: 135 GNSFSAGDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSL 194
G S + D S + + L ++DL+ N + ++ L + L N + I
Sbjct: 79 GIS--SLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIG 136
Query: 195 HIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTID 254
+ +L +LDLS N+I L L N NL L+ S N L L N +++ +D
Sbjct: 137 LLKSNLKELDLSDNKIES---LPSPLRNLPNLKNLDLSFNDL-SDLPKLLSNLSNLNNLD 192
Query: 255 LSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGT 314
LS N +S ++P + +L+ LDLS+N+ NLS + LS N
Sbjct: 193 LSGNKIS-DLPPE--IELLSALEELDLSNNS--IIELLSSLSNLKNLSGLELSNN--KLE 245
Query: 315 EFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACG 374
+ P S+ N LETL++S+N + LGS NL++L L+ N + +P A
Sbjct: 246 DLPESIGNLSNLETLDLSNNQISSISS---LGSLTNLRELDLSGNSLSNALPL---IALL 299
Query: 375 TLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNML 410
L L + LT + S L + N+ SN
Sbjct: 300 LLLLELLLNLLLTLKAL-ELKLNSILLNNNILSNGE 334
|
Length = 394 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 8e-08
Identities = 47/148 (31%), Positives = 66/148 (44%), Gaps = 31/148 (20%)
Query: 1000 LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLH-HSCIPHIIHRDM 1058
+L+ +Y+K G L +L KL A KKI L LH H +IIH D+
Sbjct: 85 VLIMDYIKDGDLFDLLKKE-----GKLSEAEVKKIIRQLVEALNDLHKH----NIIHNDI 135
Query: 1059 KSSNVLLDENFEARV--SDFGMARLVNALDTHLSVSTLAGTPGYVPPE------YYQSFR 1110
K NVL D + R+ D+G+ +++ + S GT Y PE Y SF
Sbjct: 136 KLENVLYDR-AKDRIYLCDYGLCKIIG------TPSCYDGTLDYFSPEKIKGHNYDVSF- 187
Query: 1111 CTTKGDVYSYGVILLELLSGKRPIDPSE 1138
D ++ GV+ ELL+GK P E
Sbjct: 188 -----DWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-08
Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 29/222 (13%)
Query: 928 NGFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREF----MAEMETIGKIK 982
N F ++G G +G V K + ++ +VAIKK + + E + E++ + +K
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLK 58
Query: 983 HRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGL 1042
N+V L + + LV+EY++ LE +L + G +K+ + +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLE-LLEEMPNG-------VPPEKVRSYIYQLI 110
Query: 1043 AFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP 1102
+H I+HRD+K N+L+ N ++ DFG AR +LS + A YV
Sbjct: 111 KAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFAR-------NLSEGSNANYTEYVA 163
Query: 1103 PEYYQSFRCTTKG------DVYSYGVILLELLSGKRPIDPSE 1138
+Y+S D++S G IL EL G+ P+ P E
Sbjct: 164 TRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ-PLFPGE 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 1e-07
Identities = 26/59 (44%), Positives = 34/59 (57%)
Query: 737 LQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNL 795
L+ L+L +N+LT +F GL + VLDLS NN P + GL L LD+S NNL
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 30/211 (14%)
Query: 935 MIGSGGFGEVY----KAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLL 990
++G G FG+V KA + ++ +KK + + + E + +H L L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL- 60
Query: 991 GYCKIGEERL-LVYEYMKWGSL------ESVL-HDRAKGGGTKLDWAARKKIAIGSARGL 1042
Y +RL V EY G L E V DRA+ G + I SA L
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE----------IVSA--L 108
Query: 1043 AFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP 1102
+LH SC +++RD+K N++LD++ +++DFG+ + + ++ T GTP Y+
Sbjct: 109 GYLH-SC--DVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLA 163
Query: 1103 PEYYQSFRCTTKGDVYSYGVILLELLSGKRP 1133
PE + D + GV++ E++ G+ P
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 49/178 (27%), Positives = 79/178 (44%), Gaps = 36/178 (20%)
Query: 1039 ARGLAFL-HHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR-------LVNALDTHLS 1090
A+G+ FL CI HRD+ + N+LL EN ++ DFG+AR V D L
Sbjct: 189 AKGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 1091 VSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWA 1149
+ +A PE T + DV+S+GV+L E+ S G P + ++ +
Sbjct: 245 LKWMA-------PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FC 292
Query: 1150 KQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207
++L R+ P+ T E+YQ + +C P +RPT +++ L
Sbjct: 293 RRLKEGTRMRA---PDYT-----TPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 67/251 (26%), Positives = 100/251 (39%), Gaps = 65/251 (25%)
Query: 930 FSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRN--L 986
F + +IG G FGEV Q +D G + A+K L + M E E + I+ L
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKIL-------RKADMLEKEQVAHIRAERDIL 55
Query: 987 VPLLG------YCKIGEER--LLVYEYMKWGSLESVL--HDRAKGGGTKLDWAARKKIAI 1036
V G + ++R L+ E++ G + ++L D T+ + A +AI
Sbjct: 56 VEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQF-YIAETVLAI 114
Query: 1037 GSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR-LVNALDT-------- 1087
+ L F IHRD+K N+LLD ++SDFG+ L A T
Sbjct: 115 DAIHQLGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTH 165
Query: 1088 -------------------------HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGV 1122
L+ ST+ GTP Y+ PE + D +S GV
Sbjct: 166 NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTV-GTPDYIAPEVFMQTGYNKLCDWWSLGV 224
Query: 1123 ILLELLSGKRP 1133
I+ E+L G P
Sbjct: 225 IMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-07
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 21/207 (10%)
Query: 934 SMIGSGGFGEVYKAQLRDGS-VVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGY 992
++IG+G FG VY+A D S VAIKK++ +RE + + + H N++ L Y
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINIIFLKDY 127
Query: 993 -----CKIGEERLLVYEYMKWGSLESVLHDRAK---GGGTKLDWAARKKIAIGSARGLAF 1044
K E+ + + M++ + +H K L K + R LA+
Sbjct: 128 YYTECFKKNEKNIFLNVVMEF--IPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185
Query: 1045 LHHSCIPHIIHRDMKSSNVLLDENFEA-RVSDFGMARLVNALDTHLSVSTLAGTPGYVPP 1103
+H I HRD+K N+L+D N ++ DFG A+ N L SVS + P
Sbjct: 186 IHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAK--NLLAGQRSVSYICSRFYRAPE 240
Query: 1104 EYYQSFRCTTKGDVYSYGVILLELLSG 1130
+ TT D++S G I+ E++ G
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-07
Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 28/213 (13%)
Query: 936 IGSGGFGEVYKAQLR----DGSVVAIK---KLIHVTGQGDREF-MAEMETIGKIKHRNLV 987
+G+G +G+V+ + G + A+K K V E E + + ++ +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 988 PLLGYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGS-ARGLAFL 1045
L Y + +L L+ +Y+ G L + L+ R + ++ I L L
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFT------ESEVRVYIAEIVLALDHL 121
Query: 1046 HHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEY 1105
H II+RD+K N+LLD ++DFG+++ A + + S GT Y+ PE
Sbjct: 122 HQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEV 177
Query: 1106 YQSFRCTTKG-----DVYSYGVILLELLSGKRP 1133
R + G D +S GV+ ELL+G P
Sbjct: 178 ---IRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 7e-07
Identities = 62/259 (23%), Positives = 108/259 (41%), Gaps = 45/259 (17%)
Query: 928 NGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDRE---FMAEMETIGKIKHR 984
N + IG+G FGEV+ + + K I G +RE + E+ + ++KH+
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 985 NLVPLLG--YCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGL 1042
N+V + K ++ ++ E+ G L + K G K++ A I L
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFG-KIEEHAIVDITRQLLHAL 131
Query: 1043 AFLHH----SCIPHIIHRDMKSSNVLLDENFE-----------------ARVSDFGMARL 1081
A+ H+ ++HRD+K N+ L A++ DFG+++
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK- 190
Query: 1082 VNALDTHLSVSTLA----GTPGYVPPEY--YQSFRCTTKGDVYSYGVILLELLSGKRPID 1135
++ + ++A GTP Y PE +++ K D+++ G I+ EL SGK P
Sbjct: 191 ------NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP-- 242
Query: 1136 PSEFGDDNNLVGWAKQLHR 1154
F NN +L R
Sbjct: 243 ---FHKANNFSQLISELKR 258
|
Length = 1021 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-07
Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 930 FSADSMIGSGGFGEVY---KAQLRD-GSVVAIKKLIHVT----GQGDREFMAEMETIGKI 981
F ++G+G +G+V+ K D G + A+K L T + E + + I
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 982 KHRNLVPLLGYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSAR 1040
+ + L Y + +L L+ +Y+ G L + L R + +++ I S
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER--------FKEQEVQIYSGE 113
Query: 1041 GLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGY 1100
+ L H II+RD+K N+LLD N ++DFG+++ + + + S GT Y
Sbjct: 114 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEY 172
Query: 1101 VPPEYYQSFRCTTKG-----DVYSYGVILLELLSGKRP 1133
+ P+ R G D +S GV++ ELL+G P
Sbjct: 173 MAPDI---VRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-06
Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 5/115 (4%)
Query: 229 LNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTG 288
L + L G + + + +I+LS N + G IP S S SL+ LDLS+N+F G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSL--GSITSLEVLDLSYNSFNG 480
Query: 289 KFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLET-LNMSHNALQGGIPG 342
G+ +L ++ L+ N LSG PA+L L N + NA GIPG
Sbjct: 481 SIPE-SLGQLTSLRILNLNGNSLSG-RVPAALGGRLLHRASFNFTDNAGLCGIPG 533
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-06
Identities = 32/92 (34%), Positives = 46/92 (50%), Gaps = 3/92 (3%)
Query: 279 LDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQG 338
L L + G N D + +L I LS N + G P SL + LE L++S+N+ G
Sbjct: 423 LGLDNQGLRGFIPN-DISKLRHLQSINLSGNSIRG-NIPPSLGSITSLEVLDLSYNSFNG 480
Query: 339 GIPGFLLGSFRNLKQLSLAHNQFAGEIPPELG 370
IP LG +L+ L+L N +G +P LG
Sbjct: 481 SIPE-SLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-06
Identities = 37/127 (29%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSN 1062
Y+ ++++L D G T LD + ARG+ FL + +HRD+ + N
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLS---FTYQVARGMEFLASK---NCVHRDLAARN 267
Query: 1063 VLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGV 1122
VLL + ++ DFG+AR + ++S + ++ PE TT DV+SYG+
Sbjct: 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 1123 ILLELLS 1129
+L E+ S
Sbjct: 328 LLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 56/213 (26%), Positives = 101/213 (47%), Gaps = 32/213 (15%)
Query: 936 IGSGGFGEVYKAQLRD----GSVVAIKKLIHVTGQGDREFM------AEMETIGKIKHRN 985
+G G F +++K R+ G + + L+ V + R + A M + ++ H++
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASM--MSQLSHKH 60
Query: 986 LVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAF- 1044
LV G C G+E ++V EY+K+GSL++ L + + W K+ + A+ LA+
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISW----KLEV--AKQLAWA 112
Query: 1045 LHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAG------TP 1098
LH + H ++ + NVLL E R + G + D +S++ L P
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLLIRE-EDRKT--GNPPFIKLSDPGISITVLPKEILLERIP 169
Query: 1099 GYVPPEYYQSFR-CTTKGDVYSYGVILLELLSG 1130
+VPPE ++ + + D +S+G L E+ SG
Sbjct: 170 -WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 8e-06
Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 481 LPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPE 540
L N L G +P ++ ++L++I+LS NS+ G +P + S+ +L L + N+ G IPE
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484
Query: 541 GICVNG--GNLETLILNNNHLTGAIPKSI 567
+ G +L L LN N L+G +P ++
Sbjct: 485 SL---GQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 1e-05
Identities = 54/215 (25%), Positives = 85/215 (39%), Gaps = 25/215 (11%)
Query: 443 LTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGT-VPL---ELGSCK 498
LT L+ LDLS N S +L+++ L NN L + L L
Sbjct: 77 LTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLP 136
Query: 499 -NLKTIDLSFNSLAG----PVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNG---GNLE 550
L+ + L N L G + + + +L +L + N + + NLE
Sbjct: 137 PALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLE 196
Query: 551 TLILNNNHLT----GAIPKSIASCTNMLWVSLSSNQLTGEI-----PAGIGNLVKLAILQ 601
L LNNN LT A+ +++AS ++ ++L N LT A + + L L
Sbjct: 197 VLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLS 256
Query: 602 LGNNSLT----GQVPQGLGKCRSLVWLDLNSNNLS 632
L N +T + + L + SL+ LDL N
Sbjct: 257 LSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-05
Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 23/204 (11%)
Query: 936 IGSGGFGEVYKA-QLRDGSVVAIKKL---IHVTGQGDREFMAEMETIGKIKHRNLVPLLG 991
IGSG G V A G VA+KKL R + E+ + + H+N++ LL
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 87
Query: 992 YC---KIGEERLLVYEYMKW--GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLH 1046
K EE VY M+ +L V+H +LD + G+ LH
Sbjct: 88 VFTPQKSLEEFQDVYLVMELMDANLCQVIH-------MELDHERMSYLLYQMLCGIKHLH 140
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYY 1106
+ IIHRD+K SN+++ + ++ DFG+AR T+ ++ T Y PE
Sbjct: 141 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVVTRYYRAPEVI 194
Query: 1107 QSFRCTTKGDVYSYGVILLELLSG 1130
D++S G I+ EL+ G
Sbjct: 195 LGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-05
Identities = 32/103 (31%), Positives = 46/103 (44%), Gaps = 7/103 (6%)
Query: 1042 LAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV 1101
LA+LH IIHRD+K+ N+ LDE A + DFG A ++A +GT
Sbjct: 198 LAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETN 254
Query: 1102 PPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144
PE K D++S G++L E+ + FG
Sbjct: 255 SPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL----FGKQVK 293
|
Length = 392 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 5e-05
Identities = 21/61 (34%), Positives = 32/61 (52%), Gaps = 1/61 (1%)
Query: 523 NLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQ 582
NL L + N LT IP+G NL+ L L+ N+LT P++ + ++ + LS N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 583 L 583
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 6e-05
Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 16/173 (9%)
Query: 936 IGSGGFGEVYKAQLRDGS----VVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLG 991
I G FG+VY + ++ S V +KK + + AE + + K +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 992 YCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLH-HSCI 1050
+ LV EY+ G ++S+LH G + A K I+ A L +LH H
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIY----GYFDEEMAVKYIS-EVALALDYLHRHG-- 124
Query: 1051 PHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPP 1103
IIHRD+K N+L+ +++DFG++++ L+ L++ + TP P
Sbjct: 125 --IIHRDLKPDNMLISNEGHIKLTDFGLSKV--TLNRELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 7e-05
Identities = 21/60 (35%), Positives = 29/60 (48%), Gaps = 1/60 (1%)
Query: 376 LRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNI 435
L+ LDLS+NRLT F +L L+L N L+ S + SL L + NN+
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTS-ISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 7e-05
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 19/214 (8%)
Query: 930 FSADSMIGSGGFGEVY---KAQLRD-GSVVAIKKL----IHVTGQGDREFMAEMETIGKI 981
F ++G+G +G+V+ K D G + A+K L + + E + +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 982 KHRNLVPLLGYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSAR 1040
+ + L Y E +L L+ +Y+ G + + L+ R D + ++ S
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR--------DNFSEDEVRFYSGE 113
Query: 1041 GLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGY 1100
+ L H I++RD+K N+LLD ++DFG+++ + + + S GT Y
Sbjct: 114 IILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEY 172
Query: 1101 VPPEYYQSFRCTTKG-DVYSYGVILLELLSGKRP 1133
+ PE + K D +S G+++ ELL+G P
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 8e-05
Identities = 31/102 (30%), Positives = 46/102 (45%), Gaps = 17/102 (16%)
Query: 1053 IIHRDMKSSNVLLDENFEARVSDFG------MARLVNALDTHLSVST-------LAGTPG 1099
I+HRD+K N+L+ +++DFG M+ N + H+ T + GTP
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181
Query: 1100 YVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGD 1141
Y+ PE D ++ G+IL E L G P FGD
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF----FGD 219
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 9e-05
Identities = 66/270 (24%), Positives = 106/270 (39%), Gaps = 87/270 (32%)
Query: 928 NGFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLI-----------HVTGQGDREFMAEM 975
F +IG G FGEV Q +D G + A+K L+ HV + +R+ +AE
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHV--KAERDVLAES 58
Query: 976 ETIGKIKHRNLVPLLGYCKIGEERL-LVYEYMKWGSLESVL--HDRAKGGGTKLDWAARK 1032
++ + L Y + L L+ E++ G L ++L +D T+ + A
Sbjct: 59 DSPWVVS-------LYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAEC 110
Query: 1033 KIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA------------- 1079
+AI + L F IHRD+K N+L+D ++SDFG++
Sbjct: 111 VLAIEAVHKLGF---------IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ 161
Query: 1080 --------------RLVNALDT-HLSVSTLA-----------------GTPGYVPPEYY- 1106
R A+D+ +L++S+ GTP Y+ PE +
Sbjct: 162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL 221
Query: 1107 ---QSFRCTTKGDVYSYGVILLELLSGKRP 1133
C D +S G I+ E L G P
Sbjct: 222 QQGYGQEC----DWWSLGAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-04
Identities = 27/91 (29%), Positives = 49/91 (53%), Gaps = 3/91 (3%)
Query: 1039 ARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP 1098
A G+ FL + +HRD+ + NVL+ E ++ DFG+AR + ++S +
Sbjct: 249 ANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305
Query: 1099 GYVPPEYYQSFRCTTKGDVYSYGVILLELLS 1129
++ PE + TT DV+S+G++L E+ +
Sbjct: 306 KWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-04
Identities = 34/112 (30%), Positives = 51/112 (45%), Gaps = 3/112 (2%)
Query: 709 TNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSH 768
+L LDLS N + +LP +L L+ L+L N L+ +P L + LDLS
Sbjct: 138 LKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSG 195
Query: 769 NNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLC 820
N +P + LS L +LD+SNN++ ++ S L NN
Sbjct: 196 NKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED 246
|
Length = 394 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-04
Identities = 59/210 (28%), Positives = 89/210 (42%), Gaps = 33/210 (15%)
Query: 936 IGSGGFGEVYKA-QLRDGSVVAIKKL----IHVT--GQGDREFMAEMETIGKIKHRNLVP 988
IGSG G V A G VAIKKL +VT + RE + M+ + H+N++
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVL-MKLV---NHKNIIG 79
Query: 989 LLGYCKIGEERL-------LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARG 1041
LL ++ L LV E M +L V+ LD + G
Sbjct: 80 LLN-VFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ-------MDLDHERMSYLLYQMLCG 130
Query: 1042 LAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV 1101
+ LH + IIHRD+K SN+++ + ++ DFG+AR T ++ T Y
Sbjct: 131 IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYR 184
Query: 1102 PPEYYQSFRCTTKGDVYSYGVILLELLSGK 1131
PE D++S G I+ E++ G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 39/178 (21%), Positives = 80/178 (44%), Gaps = 28/178 (15%)
Query: 969 REFMAEMETIGKIKHRNLVPLLGY--------CKIGEERLLVYEYMKWGSLESVLHDRAK 1020
E++ + +I N++ + G+ ++ L+ EY G L VL D+ K
Sbjct: 63 DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRL----SLILEYCTRGYLREVL-DKEK 117
Query: 1021 GGGTKLDWAARKKIAIGSARGLAFLHHSC-IPHIIHRDMKSSNVLLDENFEARVSDFGMA 1079
L + + +AI +GL L+ P+ +++ S + L+ EN++ ++ G+
Sbjct: 118 ----DLSFKTKLDMAIDCCKGLYNLYKYTNKPY---KNLTSVSFLVTENYKLKIICHGLE 170
Query: 1080 RLVNALDTHLSVSTLAGTPGYVPPEYYQSF--RCTTKGDVYSYGVILLELLSGKRPID 1135
+++ + +V+ + Y + T K D+YS GV+L E+ +GK P +
Sbjct: 171 KIL-SSPPFKNVNFMV----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE 223
|
Length = 283 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 3e-04
Identities = 27/91 (29%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 1041 GLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGY 1100
G+ LH + IIHRD+K SN+++ + ++ DFG+AR T ++ T Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 1101 VPPEYYQSFRCTTKGDVYSYGVILLELLSGK 1131
PE D++S G I+ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-04
Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 27/207 (13%)
Query: 936 IGSGGFGEV---YKAQLRDGSVVAIKKL---IHVTGQGDREFMAEMETIGKIKHRNLVPL 989
IGSG G V Y A L VAIKKL R + E+ + + H+N++ L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 990 LGYC---KIGEERLLVYEYMKW--GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAF 1044
L K EE VY M+ +L V+ +LD + G+
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ-------MELDHERMSYLLYQMLCGIKH 134
Query: 1045 LHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE 1104
LH + IIHRD+K SN+++ + ++ DFG+AR T ++ T Y PE
Sbjct: 135 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPE 188
Query: 1105 YYQSFRCTTKGDVYSYGVILLELLSGK 1131
D++S G I+ E++ K
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 5e-04
Identities = 57/251 (22%), Positives = 93/251 (37%), Gaps = 36/251 (14%)
Query: 933 DSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAE------METIGKI----K 982
D +IG GGFG VY+ Q + + + + + + E + I KI
Sbjct: 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKN 76
Query: 983 HRNL----VPLLGYCKIGEERLLVYEYMKWGSL---ESVLHDRAKGGGTKLDWAARKKIA 1035
N+ +P C + + Y ++ L + R K KL K I
Sbjct: 77 IHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKL----IKNIM 132
Query: 1036 IGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLA 1095
L ++H I H D+K N+++D N + D+G+A H+ S
Sbjct: 133 KDMLTTLEYIHEHGISH---GDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQ 189
Query: 1096 -----GTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWA- 1149
GT Y + + T +GD+ S G +L+ + FG + NL+ A
Sbjct: 190 KDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKW--AGIKLPWKGFGHNGNLIHAAK 247
Query: 1150 ----KQLHREK 1156
K+LH K
Sbjct: 248 CDFIKRLHEGK 258
|
Length = 294 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 43/117 (36%), Positives = 57/117 (48%), Gaps = 4/117 (3%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
+L LDLS NS+ L + +L L L L +NKL +P+S G L + LDLS+N
Sbjct: 210 ALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETLDLSNN-- 265
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPLLPCS 828
Q S SLG L+ L +LD+S N+LS +P L L L L S
Sbjct: 266 QISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNS 322
|
Length = 394 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.001
Identities = 21/60 (35%), Positives = 28/60 (46%)
Query: 548 NLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSL 607
NL++L L+NN LT + N+ + LS N LT P L L L L N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.001
Identities = 25/61 (40%), Positives = 32/61 (52%), Gaps = 1/61 (1%)
Query: 350 NLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNM 409
NLK L L++N+ IP + L+ LDLS N LT P F+ SL SL+L N
Sbjct: 1 NLKSLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 410 L 410
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 33/116 (28%), Positives = 55/116 (47%), Gaps = 20/116 (17%)
Query: 911 FEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQ----LRDGSV--VAIKKLIHVT 964
+E P +L+F L G+G FG+V +A + + VA+K L
Sbjct: 30 WEFPRNRLSFGKTL------------GAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA 77
Query: 965 GQGDRE-FMAEMETIGKI-KHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDR 1018
+RE M+E++ + + H N+V LLG C +G L++ EY +G L + L +
Sbjct: 78 HLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRK 133
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 17/62 (27%), Positives = 26/62 (41%), Gaps = 2/62 (3%)
Query: 300 NLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHN 359
NL + LS N L+ + K L+ L++S N L I +L+ L L+ N
Sbjct: 1 NLKSLDLSNNRLTVIP-DGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGN 58
Query: 360 QF 361
Sbjct: 59 NL 60
|
Length = 60 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.002
Identities = 40/147 (27%), Positives = 61/147 (41%), Gaps = 23/147 (15%)
Query: 878 EQREKYIESLPTSGSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIG 937
E R K IES+ + G + + P + +E P L L G
Sbjct: 2 EIRWKVIESVSSDGHEYIYVDPMQLPYD---SAWEMPRDNLVLGRTL------------G 46
Query: 938 SGGFGEVYKAQLRDGS------VVAIKKLIHVTGQGDRE-FMAEMETIGKI-KHRNLVPL 989
SG FG V +A S VA+K L +++ M+E++ + + H N+V L
Sbjct: 47 SGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNL 106
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLH 1016
LG C G ++ EY ++G L LH
Sbjct: 107 LGACTKGGPIYIITEYCRYGDLVDYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 27/138 (19%), Positives = 53/138 (38%), Gaps = 19/138 (13%)
Query: 934 SMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQG-DREFMAE-METIGKIKHRNLVP-LL 990
++ G VY +D V K+ +G DRE ++ + + VP +L
Sbjct: 4 KLLKGGLTNRVYLLGTKDEDYVL--KINPSREKGADREREVAILQLLAR--KGLPVPKVL 59
Query: 991 GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCI 1050
+ L+ E+++ G + + K + A + + LA LH +
Sbjct: 60 ASGESDGWSYLLMEWIE-GETLDEVSEEEK------EDIAEQ---LAEL--LAKLHQLPL 107
Query: 1051 PHIIHRDMKSSNVLLDEN 1068
+ H D+ N+L+D+
Sbjct: 108 LVLCHGDLHPGNILVDDG 125
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.003
Identities = 20/62 (32%), Positives = 31/62 (50%), Gaps = 5/62 (8%)
Query: 178 RLSYVNLSHN---SISGGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDN 234
L ++LS+N I G+ P+L LDLSGN ++ + + S +L L+ S N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTS--ISPEAFSGLPSLRSLDLSGN 58
Query: 235 KL 236
L
Sbjct: 59 NL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.003
Identities = 24/62 (38%), Positives = 35/62 (56%), Gaps = 5/62 (8%)
Query: 152 SLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHN---SISGGSLHIGPSLLQLDLSGN 208
+L ++DLS+N +T +P +F L ++LS N SIS + PSL LDLSGN
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFK-GLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
Query: 209 QI 210
+
Sbjct: 59 NL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.003
Identities = 21/59 (35%), Positives = 28/59 (47%)
Query: 476 LEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNL 534
L+ + L NN L+ NLK +DLS N+L P LP+L L + NNL
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.003
Identities = 22/62 (35%), Positives = 30/62 (48%), Gaps = 2/62 (3%)
Query: 275 SLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHN 334
+LK LDLS+N T F NL V+ LS N L+ P + L +L++S N
Sbjct: 1 NLKSLDLSNNRLTVIPDGA-FKGLPNLKVLDLSGNNLTSIS-PEAFSGLPSLRSLDLSGN 58
Query: 335 AL 336
L
Sbjct: 59 NL 60
|
Length = 60 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.003
Identities = 25/74 (33%), Positives = 36/74 (48%), Gaps = 3/74 (4%)
Query: 1093 TLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRP-IDPSEFGDDNNLVGWAKQ 1151
+L GTP Y+ PE T D +S GVIL E+L G+ P + P+ ++ W
Sbjct: 207 SLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENT 266
Query: 1152 LHREKRINEILDPE 1165
LH ++ L PE
Sbjct: 267 LHIPPQVK--LSPE 278
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.004
Identities = 30/93 (32%), Positives = 53/93 (56%), Gaps = 8/93 (8%)
Query: 936 IGSGGFGEVYKAQL----RDGSV--VAIKKLIHVTGQGDRE-FMAEMETIGKI-KHRNLV 987
+G+G FG+V +A ++ +V VA+K L +RE M+E++ + + +H+N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 988 PLLGYCKIGEERLLVYEYMKWGSLESVLHDRAK 1020
LLG C G L++ EY +G L + L +A+
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRKKAE 138
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1237 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.98 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.98 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.98 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.98 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.98 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.98 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.98 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.88 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.72 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.71 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.71 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.71 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.68 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.66 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.65 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.63 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.62 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.62 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.62 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.61 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.58 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.51 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.5 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.49 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.47 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.47 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.46 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.4 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.35 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.34 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.34 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.31 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.29 | |
| KOG4341 | 483 | consensus F-box protein containing LRR [General fu | 99.29 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.28 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.26 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.25 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.24 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.17 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.16 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.12 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.06 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.05 | |
| KOG4341 | 483 | consensus F-box protein containing LRR [General fu | 99.05 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.04 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.03 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.01 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.99 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.97 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.96 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.92 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.91 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.9 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.89 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.85 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 98.83 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 98.81 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.72 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.68 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.68 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.65 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.65 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.64 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.63 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.61 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.61 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.56 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.54 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.53 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-109 Score=1094.80 Aligned_cols=921 Identities=32% Similarity=0.576 Sum_probs=636.4
Q ss_pred chhHHHHHHhhccccCCCCCCCcccccCCCCCCceeeeeecCCCCceeEEecCCCCCCCccccccccCCCCCCeEEccCC
Q 000889 57 NEELTILMAFKQSSIGSDPNGYLANWTADALTPCSWQGVSCSLNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGN 136 (1237)
Q Consensus 57 ~~~~~aLl~~k~~~~~~~~~~~l~sW~~~~~~~c~W~gv~c~~~~~v~~L~L~~~~l~~~~~~~~l~~l~~L~~L~Ls~n 136 (1237)
++|+.||++||+++ .||.+.+++|+. ..+||.|.||+|+..++|+.|+|++++++|.+. ..+..+++|+.|+|++|
T Consensus 28 ~~~~~~l~~~~~~~--~~~~~~~~~w~~-~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~-~~~~~l~~L~~L~Ls~n 103 (968)
T PLN00113 28 AEELELLLSFKSSI--NDPLKYLSNWNS-SADVCLWQGITCNNSSRVVSIDLSGKNISGKIS-SAIFRLPYIQTINLSNN 103 (968)
T ss_pred HHHHHHHHHHHHhC--CCCcccCCCCCC-CCCCCcCcceecCCCCcEEEEEecCCCccccCC-hHHhCCCCCCEEECCCC
Confidence 57999999999985 578888999986 469999999999977899999999999998774 57888999999988888
Q ss_pred CCCcccchhhhhcCcccceecccCCcccCCcccccccccCCccceEEccCCccCCCccccCCcccEEEcCCCCCCCchhh
Q 000889 137 SFSAGDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALL 216 (1237)
Q Consensus 137 ~l~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~~~~~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~Ls~N~i~~~~~~ 216 (1237)
+++..-...+...+.+|++|+|++|.++|.+|.
T Consensus 104 ~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~----------------------------------------------- 136 (968)
T PLN00113 104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR----------------------------------------------- 136 (968)
T ss_pred ccCCcCChHHhccCCCCCEEECcCCccccccCc-----------------------------------------------
Confidence 875322222333455555555555555544331
Q ss_pred hccccCCCCCCEEEccCCCCCchhhhhcccCCCccEEEcccccccCccchhhhhccCCCccEEeCCCCcCCCCccccccc
Q 000889 217 TYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFG 296 (1237)
Q Consensus 217 ~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~ 296 (1237)
..+++|++|+|++|.+++..+..+..+++|++|+|++|.+.+.+|..+ ..+++|++|+|++|++++.
T Consensus 137 ----~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~--~~l~~L~~L~L~~n~l~~~------- 203 (968)
T PLN00113 137 ----GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL--TNLTSLEFLTLASNQLVGQ------- 203 (968)
T ss_pred ----cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhh--hhCcCCCeeeccCCCCcCc-------
Confidence 223455555555555555555555555556666666555554444432 1223333444433333321
Q ss_pred CCCCCceeeccCccccCcccchhhcccccceEEEecCCccCCCCchhhhccCCCCcEEecCCCcCCCCCchhHhhhcCCC
Q 000889 297 RCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTL 376 (1237)
Q Consensus 297 ~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~l~~L 376 (1237)
+|..+.++++|++|+|++|.+++.+|.. ++.+++|++|+|++|++++.+|..+.. +++|
T Consensus 204 -------------------~p~~l~~l~~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~L~~n~l~~~~p~~l~~-l~~L 262 (968)
T PLN00113 204 -------------------IPRELGQMKSLKWIYLGYNNLSGEIPYE-IGGLTSLNHLDLVYNNLTGPIPSSLGN-LKNL 262 (968)
T ss_pred -------------------CChHHcCcCCccEEECcCCccCCcCChh-HhcCCCCCEEECcCceeccccChhHhC-CCCC
Confidence 3344444444444444444444444432 244444555555544444444444332 2445
Q ss_pred cEEEcccCcCCCCCCcCcccccccceeeccCccccCcccchhccccccceEEeccCCCCCCCCCccCCCCCCCcEEEccC
Q 000889 377 RELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSS 456 (1237)
Q Consensus 377 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~ 456 (1237)
++|+|++|++.+..|..+.++++|+.|+|++|.+.+. .+..+..+++|++|++++|.+++..|..+..+++|+.|++++
T Consensus 263 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~-~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~ 341 (968)
T PLN00113 263 QYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGE-IPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWS 341 (968)
T ss_pred CEEECcCCeeeccCchhHhhccCcCEEECcCCeeccC-CChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcC
Confidence 5555555555444444444444444444444444321 112222233333333333333334444455555555555555
Q ss_pred CcCcccCCCCCCCCCCCcccceecccCceeeecccccccccccccEecccCCccccCCCccccCCcCcceeecccccccC
Q 000889 457 NGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTG 536 (1237)
Q Consensus 457 N~l~~~~p~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 536 (1237)
|.++ +.+|..++.+++|+.|++++|++++.+|..+..+++|+.|++++|++.+
T Consensus 342 n~l~---------------------------~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~ 394 (968)
T PLN00113 342 NKFS---------------------------GEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEG 394 (968)
T ss_pred CCCc---------------------------CcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecc
Confidence 5554 4445555666666777777777766667666667777777777777766
Q ss_pred cccccccccCCCccEEEccccccccccccccccCCCccEEEeecccccccCCccccCccccceEEecCCccccCCCCCCC
Q 000889 537 EIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLG 616 (1237)
Q Consensus 537 ~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~l~ 616 (1237)
.+|..+ ..+++|+.|+|++|++++.+|..|..+++|+.|+|++|++++.+|..+..+++|+.|+|++|++.+.+|..++
T Consensus 395 ~~p~~~-~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~ 473 (968)
T PLN00113 395 EIPKSL-GACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG 473 (968)
T ss_pred cCCHHH-hCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc
Confidence 666543 4567888888888888888898999999999999999999999999999999999999999999988888764
Q ss_pred CCCCCCEEECCCCccccCCChhHHhhcccccCccccCccceeeccCCCccccCCCCcccccCCCccccCCCccccCCCCc
Q 000889 617 KCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPST 696 (1237)
Q Consensus 617 ~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (1237)
.++|+.|+|++|+++|.+|..+.++.
T Consensus 474 -~~~L~~L~ls~n~l~~~~~~~~~~l~----------------------------------------------------- 499 (968)
T PLN00113 474 -SKRLENLDLSRNQFSGAVPRKLGSLS----------------------------------------------------- 499 (968)
T ss_pred -cccceEEECcCCccCCccChhhhhhh-----------------------------------------------------
Confidence 58999999999999998887665432
Q ss_pred ceeccceeeeeccCCceeEEEccCCcCCccCCccccCCCCCcEEEecCcccccccccccccccCCcEEeCCCCccCCCCC
Q 000889 697 RIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIP 776 (1237)
Q Consensus 697 ~~~~~~~~~~f~~~~~L~~LdLs~N~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~P~~~~~L~~L~~L~Ls~N~l~~~~p 776 (1237)
+|++|+|++|+++|.+|+.++++++|++|+|++|+++|.+|..|+++++|+.|||++|+++|.+|
T Consensus 500 ---------------~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 564 (968)
T PLN00113 500 ---------------ELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIP 564 (968)
T ss_pred ---------------ccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCC
Confidence 68899999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccCcccccceecccccccccCCCCCCCCccCCCcccCCCCCCCCCC----CCCCCCCCCCccCCCCCccccccceehh
Q 000889 777 GSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPL----LPCSSGNHAATVHPHENKQNVETGVVIG 852 (1237)
Q Consensus 777 ~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~~~~~p~----~~c~~~~~~~~~~~~~~~~~~~~~i~~~ 852 (1237)
..+..+++|+.|++++|+++|.+|+.+++.++.+..+.+|+++||.+. ++|... .......+.++++++
T Consensus 565 ~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~-------~~~~~~~~~~~~~~~ 637 (968)
T PLN00113 565 KNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV-------RKTPSWWFYITCTLG 637 (968)
T ss_pred hhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccc-------cccceeeeehhHHHH
Confidence 999999999999999999999999999999999999999999999753 345321 011111111111111
Q ss_pred hHHHHHHHHhhhhheehhccccchhhhhhhhhccCCCCCCCCCccCCCCCCCcccccccc-ccccccCHHHHHHHhCCCC
Q 000889 853 IAFFLLIILGLTLALYRVKKDQKKDEQREKYIESLPTSGSSSWKLSSVPEPLSINVATFE-KPLRKLTFAHLLEATNGFS 931 (1237)
Q Consensus 853 i~~~l~iil~l~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 931 (1237)
+ +++++++++++ ++++++++.+.+.. +. ..+ .+.. ..+. ...+.+++.++ ...|.
T Consensus 638 ~-~~~~~~~~~~~-~~~~~~~~~~~~~~----~~--~~~--~~~~-----------~~~~~~~~~~~~~~~~---~~~~~ 693 (968)
T PLN00113 638 A-FLVLALVAFGF-VFIRGRNNLELKRV----EN--EDG--TWEL-----------QFFDSKVSKSITINDI---LSSLK 693 (968)
T ss_pred H-HHHHHHHHHHH-HHHHhhhccccccc----cc--ccc--cccc-----------cccccccchhhhHHHH---HhhCC
Confidence 1 11112222222 22222211111000 00 000 0100 0000 11122333333 34577
Q ss_pred CCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCCC
Q 000889 932 ADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGS 1010 (1237)
Q Consensus 932 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 1010 (1237)
..++||+|+||.||+|++. ++..||||++...... ..+|++++++++|||||+++++|.+.+..++||||+++|+
T Consensus 694 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~ 769 (968)
T PLN00113 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKN 769 (968)
T ss_pred cccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCc
Confidence 8889999999999999984 6889999988643221 2356889999999999999999999999999999999999
Q ss_pred HHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCccee
Q 000889 1011 LESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLS 1090 (1237)
Q Consensus 1011 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~ 1090 (1237)
|.++++ .++|..+.+++.|+|+|++|||..+.++|+||||||+||+++.++.+++. ||.+......
T Consensus 770 L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----- 835 (968)
T PLN00113 770 LSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----- 835 (968)
T ss_pred HHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----
Confidence 999985 37899999999999999999996656699999999999999999888875 6665433211
Q ss_pred eeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCC
Q 000889 1091 VSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQT 1170 (1237)
Q Consensus 1091 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1170 (1237)
....+++.|||||++.+..++.++|||||||++|||++|+.||+... ........|.+..........++|+......
T Consensus 836 -~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 836 -TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred -CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence 22367899999999999999999999999999999999999996533 3344566666655544445555665553322
Q ss_pred -CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccccc
Q 000889 1171 -SDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDT 1211 (1237)
Q Consensus 1171 -~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~~ 1211 (1237)
....+..++.+++.+||+.+|++||||.++++.|+++....
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 23456678889999999999999999999999999886543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-57 Score=594.87 Aligned_cols=518 Identities=38% Similarity=0.609 Sum_probs=411.7
Q ss_pred CCCEEEccCCCCCchhhhhcccCCCccEEEcccccccCccchhhhhccCCCccEEeCCCCcCCCCcccccccCCCCCcee
Q 000889 225 NLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVI 304 (1237)
Q Consensus 225 ~L~~L~Ls~n~l~~~~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L 304 (1237)
.++.|+|++|.+++..+..+..+++|+.|+|++|.+.+.+|.... ..+.+|++|+|++|++++.++. +.+++|++|
T Consensus 70 ~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~-~~l~~L~~L~Ls~n~l~~~~p~---~~l~~L~~L 145 (968)
T PLN00113 70 RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIF-TTSSSLRYLNLSNNNFTGSIPR---GSIPNLETL 145 (968)
T ss_pred cEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHh-ccCCCCCEEECcCCccccccCc---cccCCCCEE
Confidence 344444444444444444455555555555555555544444321 1344555555555555543332 345566666
Q ss_pred eccCccccCcccchhhcccccceEEEecCCccCCCCchhhhccCCCCcEEecCCCcCCCCCchhHhhhcCCCcEEEcccC
Q 000889 305 TLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSN 384 (1237)
Q Consensus 305 ~L~~n~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~l~~L~~L~Ls~N 384 (1237)
+|++|.+++ .+|..+.++++|++|+|++|.+.+.+|.. ++.+++|++|+|++|++++.+|..+.. +++|++|+|++|
T Consensus 146 ~Ls~n~~~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~L~~n~l~~~~p~~l~~-l~~L~~L~L~~n 222 (968)
T PLN00113 146 DLSNNMLSG-EIPNDIGSFSSLKVLDLGGNVLVGKIPNS-LTNLTSLEFLTLASNQLVGQIPRELGQ-MKSLKWIYLGYN 222 (968)
T ss_pred ECcCCcccc-cCChHHhcCCCCCEEECccCcccccCChh-hhhCcCCCeeeccCCCCcCcCChHHcC-cCCccEEECcCC
Confidence 666666654 24666677777777777777776666654 456777777777777777666666554 367777777777
Q ss_pred cCCCCCCcCcccccccceeeccCccccCcccchhccccccceEEeccCCCCCCCCCccCCCCCCCcEEEccCCcCcccCC
Q 000889 385 RLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIP 464 (1237)
Q Consensus 385 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p 464 (1237)
++++.+|..|+++++|++|++++|.+++. .+..+..+++|++|++++|.+++..|..+.++++|++|+|++|.+.+.+|
T Consensus 223 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p 301 (968)
T PLN00113 223 NLSGEIPYEIGGLTSLNHLDLVYNNLTGP-IPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301 (968)
T ss_pred ccCCcCChhHhcCCCCCEEECcCceeccc-cChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCC
Confidence 77777777777777777777777777643 34456677777777777777777888888888999999999999988888
Q ss_pred CCCCCCCCCcccceecccCceeeecccccccccccccEecccCCccccCCCccccCCcCcceeecccccccCcccccccc
Q 000889 465 SGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICV 544 (1237)
Q Consensus 465 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~ 544 (1237)
..+ ..+++|+.|++++|.+.+..|..+..+++|+.|++++|.+++.+|..++.+++|+.|++++|++++.+|..++
T Consensus 302 ~~~---~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~- 377 (968)
T PLN00113 302 ELV---IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLC- 377 (968)
T ss_pred hhH---cCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHh-
Confidence 776 4678889999999999888999999999999999999999999999999999999999999999998988764
Q ss_pred cCCCccEEEccccccccccccccccCCCccEEEeecccccccCCccccCccccceEEecCCccccCCCCCCCCCCCCCEE
Q 000889 545 NGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWL 624 (1237)
Q Consensus 545 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 624 (1237)
.+++|+.|++++|++.+.+|..+..+++|+.|+|++|++++.+|..+..+++|+.|+|++|++++.+|..+..+++|+.|
T Consensus 378 ~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 457 (968)
T PLN00113 378 SSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQML 457 (968)
T ss_pred CcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEE
Confidence 57899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ECCCCccccCCChhHHhhcccccCccccCccceeeccCCCccccCCCCcccccCCCccccCCCccccCCCCcceecccee
Q 000889 625 DLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTM 704 (1237)
Q Consensus 625 ~L~~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (1237)
+|++|++.|.+|..++
T Consensus 458 ~L~~n~~~~~~p~~~~---------------------------------------------------------------- 473 (968)
T PLN00113 458 SLARNKFFGGLPDSFG---------------------------------------------------------------- 473 (968)
T ss_pred ECcCceeeeecCcccc----------------------------------------------------------------
Confidence 9999999987775321
Q ss_pred eeeccCCceeEEEccCCcCCccCCccccCCCCCcEEEecCcccccccccccccccCCcEEeCCCCccCCCCCCcccCccc
Q 000889 705 YTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSF 784 (1237)
Q Consensus 705 ~~f~~~~~L~~LdLs~N~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~P~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~ 784 (1237)
..+|+.|||++|+++|.+|..|+++++|+.|+|++|+++|.+|+.|+++++|++|+|++|+++|.+|..+..+++
T Consensus 474 -----~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 548 (968)
T PLN00113 474 -----SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPV 548 (968)
T ss_pred -----cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCccc
Confidence 126899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccceecccccccccCCCC-CCCCccCCCcccCCCCCCCCC
Q 000889 785 LSDLDVSNNNLSGIIPSG-GQLTTFPASRYENNSGLCGLP 823 (1237)
Q Consensus 785 L~~l~l~~N~l~g~~p~~-~~~~~~~~~~~~~n~~~~~~p 823 (1237)
|+.|||++|+++|.+|.. ..++.+....+.+|.-.+..|
T Consensus 549 L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p 588 (968)
T PLN00113 549 LSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588 (968)
T ss_pred CCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence 999999999999999963 456667777777887665555
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=444.26 Aligned_cols=292 Identities=50% Similarity=0.847 Sum_probs=257.4
Q ss_pred cccccCHHHHHHHhCCCCCCceecccCCeEEEEEEECCCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceE
Q 000889 914 PLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYC 993 (1237)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 993 (1237)
+.+.|++.++..||++|....+||+|+||.||+|...++..||||++........++|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 57889999999999999999999999999999999999999999988654432156799999999999999999999999
Q ss_pred EeCC-eEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceE
Q 000889 994 KIGE-ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEAR 1072 (1237)
Q Consensus 994 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vk 1072 (1237)
.+.+ +.++|||||++|+|+++++..... +++|..|.+||.++|+||+|||+.+.++||||||||+|||+|+++++|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 9988 599999999999999999875321 889999999999999999999999888999999999999999999999
Q ss_pred EeecccceeeccCCcceeeecc-ccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHH
Q 000889 1073 VSDFGMARLVNALDTHLSVSTL-AGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQ 1151 (1237)
Q Consensus 1073 l~DfGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 1151 (1237)
|+|||+|+........ .... .||.+|+|||+...+..+.|+|||||||++.|+++|+.|.+.........+..|...
T Consensus 218 lsDFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP 295 (361)
T ss_pred ccCccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence 9999999655431211 1222 899999999999999999999999999999999999999987665556668999988
Q ss_pred HhhhcccccccCccccCCCCC-HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccc
Q 000889 1152 LHREKRINEILDPELTMQTSD-ETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVD 1210 (1237)
Q Consensus 1152 ~~~~~~~~~~~~~~l~~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~ 1210 (1237)
......+.+++|+.+...... ..++.++..++.+|++.+|.+||+|.+|+++|+.+...
T Consensus 296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 888889999999998743333 36888899999999999999999999999999776654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=383.50 Aligned_cols=253 Identities=27% Similarity=0.431 Sum_probs=205.9
Q ss_pred CCCCceecccCCeEEEEEEEC-CCCEEEEEEecc-ccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCC-eEEEEEEec
Q 000889 930 FSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIH-VTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGE-ERLLVYEYM 1006 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~ 1006 (1237)
.+..+.||+|+.|+||+++++ +++.+|+|++.. ......+++.+|++++++++||+||++||.|.... +..++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 344578999999999999998 577899998843 23334568999999999999999999999999888 599999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
++|+|++++... +.+++....+|+.+|++||.|||+.+ +||||||||+|||+...|+|||||||.++.+...
T Consensus 161 DgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 161 DGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred CCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 999999999764 46899999999999999999999732 9999999999999999999999999999876543
Q ss_pred cceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
...+++||..|||||.+.+..|+.++||||||++++|+.+|+.||.+.... ..+..........+. .|.+
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~~~~~Ll~~Iv~~p------pP~l 302 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YLDIFELLCAIVDEP------PPRL 302 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CCCHHHHHHHHhcCC------CCCC
Confidence 346789999999999999999999999999999999999999999865211 112222222111111 1222
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
+.. ....+|..++..|+++||.+|||+.++++|=
T Consensus 303 P~~----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 303 PEG----EFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred Ccc----cCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 221 1234566777799999999999999999883
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=376.70 Aligned_cols=200 Identities=34% Similarity=0.534 Sum_probs=180.1
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccc--cCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHV--TGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
.++|.+.+.||+|+||+||+|+++ ++.+||||++... .....+.+..|+++++.++|||||++++++..++..|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 457888888999999999999987 5789999999765 3333455788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCC------CceEEeecc
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDEN------FEARVSDFG 1077 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~------~~vkl~DfG 1077 (1237)
|||.||+|.+|++.+ +.+++..++.++.|+|.|+++||++ +||||||||+|||++.. -.+||+|||
T Consensus 89 EyC~gGDLs~yi~~~-----~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR-----GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 999999999999875 4789999999999999999999999 99999999999999864 568999999
Q ss_pred cceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCC
Q 000889 1078 MARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPS 1137 (1237)
Q Consensus 1078 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~ 1137 (1237)
+|+.+.... ...+.||++-|||||++..++|+.|+|+||+|+++|+|++|+.||+..
T Consensus 161 fAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 161 FARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 999887433 236789999999999999999999999999999999999999999854
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=392.80 Aligned_cols=248 Identities=27% Similarity=0.456 Sum_probs=209.7
Q ss_pred CCCCCCceecccCCeEEEEEEE-CCCCEEEEEEeccc---cCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQL-RDGSVVAIKKLIHV---TGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
.+|...+.||+|+|+.||.+++ ..|+.||+|++.+. .....+.+.+|+++.++++|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 3588899999999999999998 78999999998652 3344567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
|+|+.++|..+++.+ +++++.+++.++.||+.|+.|||+. +|+|||||..|++++++.+|||+|||+|..+.
T Consensus 98 ELC~~~sL~el~Krr-----k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR-----KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EecCCccHHHHHHhc-----CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeec
Confidence 999999999999843 5899999999999999999999999 99999999999999999999999999999887
Q ss_pred cCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccC
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
..++. ..+.||||.|.|||++....++..+||||+||+||-|+.|++||+.....+ ....+..
T Consensus 170 ~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke---------------ty~~Ik~ 232 (592)
T KOG0575|consen 170 YDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE---------------TYNKIKL 232 (592)
T ss_pred Ccccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH---------------HHHHHHh
Confidence 54333 467899999999999999999999999999999999999999997543211 1111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.+...+..-. .+..++|.++++.+|.+|||+++|+.+
T Consensus 233 ~~Y~~P~~ls---~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 233 NEYSMPSHLS---AEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred cCcccccccC---HHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1222222222 234577789999999999999999987
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=391.39 Aligned_cols=257 Identities=31% Similarity=0.520 Sum_probs=208.2
Q ss_pred CCceecccCCeEEEEEEECCCCEEEEEEeccccCcC--HHHHHHHHHHHHhcCCCCcccccceEEeCC-eEEEEEEeccC
Q 000889 932 ADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQG--DREFMAEMETIGKIKHRNLVPLLGYCKIGE-ERLLVYEYMKW 1008 (1237)
Q Consensus 932 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~ 1008 (1237)
..+.||+|+||+||+|.++....||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ..++||||+++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 344599999999999999855559999987533222 458999999999999999999999998877 79999999999
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCC-eeecCCCCCCeeeCCCC-ceEEeecccceeeccCC
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPH-IIHRDMKSSNVLLDENF-EARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-ivHrDikp~NIll~~~~-~vkl~DfGla~~~~~~~ 1086 (1237)
|+|.++++.. ....+++..+.+|+.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++......
T Consensus 125 GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 125 GSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999875 136899999999999999999999999 7 99999999999999997 99999999998765322
Q ss_pred cceeeeccccCCCcCCccccC--ccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQ--SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDP 1164 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1164 (1237)
...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||..... ...+....... ..+
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~-----~Rp 265 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGG-----LRP 265 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcC-----CCC
Confidence 2334478999999999999 56899999999999999999999999975432 11111111111 111
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccccC
Q 000889 1165 ELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTE 1212 (1237)
Q Consensus 1165 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~~~ 1212 (1237)
.+ +.. ....+..++.+||+.||+.||++.+++..|+.+.....
T Consensus 266 ~~--p~~---~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 266 PI--PKE---CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CC--Ccc---CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 11 111 33456678889999999999999999999998866443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=376.59 Aligned_cols=253 Identities=27% Similarity=0.384 Sum_probs=203.4
Q ss_pred HhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCc-------CHHHHHHHHHHHHhcCCCCcccccceEEeCC
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQ-------GDREFMAEMETIGKIKHRNLVPLLGYCKIGE 997 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 997 (1237)
..+.|.+.+.||+|+||.|-+|..+ +|+.||||.+.+.... ......+|+++|++++|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3456888999999999999999865 6999999988643221 1234579999999999999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCC---CceEEe
Q 000889 998 ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDEN---FEARVS 1074 (1237)
Q Consensus 998 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~---~~vkl~ 1074 (1237)
..||||||++||+|.+++-.. +.+.+...+.+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n-----k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN-----KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc-----cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEec
Confidence 999999999999999998764 4677888899999999999999999 99999999999999765 789999
Q ss_pred ecccceeeccCCcceeeeccccCCCcCCccccCcccc---CcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHH
Q 000889 1075 DFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRC---TTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQ 1151 (1237)
Q Consensus 1075 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 1151 (1237)
|||+|+..+. ...+.+.||||.|.|||++.+..+ ..++|+||+||++|-+++|.+||..+.... .+ .++
T Consensus 322 DFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl---~eQ 393 (475)
T KOG0615|consen 322 DFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SL---KEQ 393 (475)
T ss_pred ccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cH---HHH
Confidence 9999997753 234578999999999999986543 347899999999999999999998654221 11 111
Q ss_pred HhhhcccccccCccccCC-CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1152 LHREKRINEILDPELTMQ-TSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1152 ~~~~~~~~~~~~~~l~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
. ...++... .....-..+.+++|.+|+..||++|||++|++++
T Consensus 394 I---------~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 394 I---------LKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred H---------hcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1 11111111 1223334566788889999999999999999987
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=386.92 Aligned_cols=256 Identities=30% Similarity=0.466 Sum_probs=212.9
Q ss_pred CCceecccCCeEEEEEEECCCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCCCH
Q 000889 932 ADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSL 1011 (1237)
Q Consensus 932 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 1011 (1237)
..+.||+|.||+||.|.++....||+|.++.. ....++|.+|+++|++++|++||+++++|..++..+||||||+.|+|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 34679999999999999998879999998754 45567899999999999999999999999998899999999999999
Q ss_pred HHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcceee
Q 000889 1012 ESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSV 1091 (1237)
Q Consensus 1012 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~~ 1091 (1237)
.+|++.. .+..+...+...++.|||+|++||+++ ++|||||.++||||+++..+||+|||+|+.... +.+...
T Consensus 289 l~yLr~~---~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d-~~Y~~~ 361 (468)
T KOG0197|consen 289 LDYLRTR---EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD-DEYTAS 361 (468)
T ss_pred HHHhhhc---CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC-Cceeec
Confidence 9999873 246788999999999999999999999 999999999999999999999999999994433 333233
Q ss_pred eccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCC
Q 000889 1092 STLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQT 1170 (1237)
Q Consensus 1092 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1170 (1237)
....-+..|.|||++....++.|||||||||+||||+| |+.||.... .........+.. +++.+.
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms------n~ev~~~le~Gy--------Rlp~P~ 427 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS------NEEVLELLERGY--------RLPRPE 427 (468)
T ss_pred CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC------HHHHHHHHhccC--------cCCCCC
Confidence 34445778999999999999999999999999999999 888876432 222333333333 333344
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccccC
Q 000889 1171 SDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTE 1212 (1237)
Q Consensus 1171 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~~~ 1212 (1237)
.+++++ .+++..||+.+|++|||+..+...++++....+
T Consensus 428 ~CP~~v---Y~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 428 GCPDEV---YELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred CCCHHH---HHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 455554 457779999999999999999999998876554
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=358.09 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=206.1
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccc-eEEeCCe-EEEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLG-YCKIGEE-RLLVY 1003 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv~ 1003 (1237)
+|++.++||+|+||+||+++.. +|..+|.|++.... ....++...|+.++++++|||||++++ .+.+..+ .++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 4677789999999999999865 79999999987322 223456889999999999999999999 5555555 89999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCC-CeeecCCCCCCeeeCCCCceEEeecccceee
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIP-HIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDikp~NIll~~~~~vkl~DfGla~~~ 1082 (1237)
|||.+|+|...++...+ .++.+++..+++++.|++.||+.+|+.... .|+||||||.||+++.+|.||++|||+++.+
T Consensus 100 E~c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999987654 357899999999999999999999994321 3999999999999999999999999999988
Q ss_pred ccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccccccc
Q 000889 1083 NALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162 (1237)
Q Consensus 1083 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1162 (1237)
....+. ..+.+|||.||+||.+.+..|+.+|||||+||++|||+.-++||.+. ++.......... ..
T Consensus 179 ~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~qg-d~---- 245 (375)
T KOG0591|consen 179 SSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQG-DY---- 245 (375)
T ss_pred cchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHcC-CC----
Confidence 754332 34688999999999999999999999999999999999999999754 333333322222 11
Q ss_pred CccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1163 DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1163 ~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
+++ ...-...++..+|..|+.+||+.||+...+++.+
T Consensus 246 -~~~----p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 246 -PPL----PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred -CCC----cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 111 1233556788889999999999999865444443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=405.13 Aligned_cols=269 Identities=28% Similarity=0.492 Sum_probs=221.4
Q ss_pred hCCCCCCceecccCCeEEEEEEEC------CCCEEEEEEeccccCc-CHHHHHHHHHHHHhcCCCCcccccceEEeCCeE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR------DGSVVAIKKLIHVTGQ-GDREFMAEMETIGKIKHRNLVPLLGYCKIGEER 999 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 999 (1237)
..+.+..+.||+|+||+||+|+.. +...||||.++..... ..++|.+|++.+..++|||||+++|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 344566778999999999999864 3457999999876665 567899999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHhhhhcCC-----CC----ccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCc
Q 000889 1000 LLVYEYMKWGSLESVLHDRAKGG-----GT----KLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFE 1070 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~~~~-----~~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~ 1070 (1237)
+||+|||..|||.+||+.+.... +. +++..+.+.||.|||.||+||-++ .+|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceE
Confidence 99999999999999998754321 22 388999999999999999999999 9999999999999999999
Q ss_pred eEEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHH
Q 000889 1071 ARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWA 1149 (1237)
Q Consensus 1071 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~ 1149 (1237)
|||+|||+++..-..+.+.......-+.+|||||.+..++|+++||||||||++||+++ |+.||.+..-+ .....
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~---EVIe~- 717 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ---EVIEC- 717 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH---HHHHH-
Confidence 99999999998877676655445666889999999999999999999999999999998 99998754321 11111
Q ss_pred HHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccccCCCC
Q 000889 1150 KQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGDS 1215 (1237)
Q Consensus 1150 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~~~~~~ 1215 (1237)
.+.+++ +..+..++. ++..++..||+..|.+||+++|+-..|+....+.+...
T Consensus 718 ---i~~g~l-------L~~Pe~CP~---~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~~ 770 (774)
T KOG1026|consen 718 ---IRAGQL-------LSCPENCPT---EVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKYS 770 (774)
T ss_pred ---HHcCCc-------ccCCCCCCH---HHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcccc
Confidence 111211 223333444 55677779999999999999999999999877665543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=359.47 Aligned_cols=250 Identities=25% Similarity=0.352 Sum_probs=203.2
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC---cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG---QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 1002 (1237)
.++|++.++||+|+||.||.++.+ +++.+|.|++.+..- .+.+...+|..++.+++||+||+++..|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 346899999999999999999876 478899998875332 3356788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceee
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~ 1082 (1237)
+||+.||.|..++++. ..+++..++.++.+|+.||.|||+. +|||||+||+|||+|.+|+++|+|||+++..
T Consensus 104 ld~~~GGeLf~hL~~e-----g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE-----GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EeccCCccHHHHHHhc-----CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 9999999999999864 5789999999999999999999999 9999999999999999999999999999854
Q ss_pred ccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccccccc
Q 000889 1083 NALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162 (1237)
Q Consensus 1083 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1162 (1237)
...+. ...+.+||+.|||||++.+..|+.++|+||+|+++|||++|.+||.... ...+.+.....+.
T Consensus 176 ~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------~~~~~~~I~~~k~----- 242 (357)
T KOG0598|consen 176 LKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------VKKMYDKILKGKL----- 242 (357)
T ss_pred ccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------HHHHHHHHhcCcC-----
Confidence 43222 2356899999999999999999999999999999999999999997532 2233333332220
Q ss_pred CccccCCCCCHHHHHHHHHHHHhccccCCCCCC----CHHHHHHH
Q 000889 1163 DPELTMQTSDETELYQYLRISFECLDDRPFKRP----TMIQVMAM 1203 (1237)
Q Consensus 1163 ~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP----t~~ell~~ 1203 (1237)
...+..... +..+++.+.+..+|++|. ++.++.++
T Consensus 243 ---~~~p~~ls~---~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 243 ---PLPPGYLSE---EARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred ---CCCCccCCH---HHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 111111122 344666789999999995 45554443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=343.96 Aligned_cols=264 Identities=24% Similarity=0.337 Sum_probs=203.0
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCc--CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQ--GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
+.|+...++|+|+||+||+++++ +|+.||||++...... -.+-.++|++++++++|||+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35777889999999999999988 4899999999753321 12446899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
||+..-|.+ ++... ..++...+.++++|+++|+.|+|++ ++|||||||+|||++.+|.+|+||||+|+....
T Consensus 82 ~~dhTvL~e-Le~~p----~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDHTVLHE-LERYP----NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecchHHHHH-HHhcc----CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 998544443 44432 4578889999999999999999999 999999999999999999999999999998874
Q ss_pred CCcceeeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHH-----------
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQL----------- 1152 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----------- 1152 (1237)
... .++..+.|..|+|||.+.+ .+|+.++||||+||++.||++|.+-|.+.+. .+.+.......
T Consensus 154 pgd--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD--iDQLy~I~ktLG~L~prhq~iF 229 (396)
T KOG0593|consen 154 PGD--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD--IDQLYLIRKTLGNLIPRHQSIF 229 (396)
T ss_pred Ccc--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch--HHHHHHHHHHHcccCHHHHHHh
Confidence 332 2356778999999999987 7899999999999999999999999987542 22222211111
Q ss_pred hhhcccccccCccccCCCC----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1153 HREKRINEILDPELTMQTS----DETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1153 ~~~~~~~~~~~~~l~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.....+..+.-|....... .+....-+++++..|++.||++|++.++++.+
T Consensus 230 ~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 230 SSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1111111111111111110 11122356789999999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=329.75 Aligned_cols=264 Identities=26% Similarity=0.352 Sum_probs=206.5
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCc--CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQ--GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
.+|...+++|+|.||.||+|++. +|+.||||+++..... -.....+|++.++.++||||+.++++|.+.+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 35777889999999999999876 6899999999743222 23467899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
||+ .+|+.++++.. ..+.....+.++.++++|++|||++ .|+||||||.|+|++.+|.+||+|||+|+.+..
T Consensus 82 fm~-tdLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred ecc-ccHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 998 79999998764 4789999999999999999999999 999999999999999999999999999998876
Q ss_pred CCcceeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhh--cccccc
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE--KRINEI 1161 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 1161 (1237)
.+.... ..+-|..|+|||.+.|. .|+..+||||.|||+.||+-|.+-|.+.. +.+.+....+.+... +...++
T Consensus 154 p~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s--DidQL~~If~~LGTP~~~~WP~~ 229 (318)
T KOG0659|consen 154 PNRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS--DIDQLSKIFRALGTPTPDQWPEM 229 (318)
T ss_pred CCcccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc--hHHHHHHHHHHcCCCCcccCccc
Confidence 554432 33678899999998875 69999999999999999999988776542 112222222211111 000000
Q ss_pred ---c-------CccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1162 ---L-------DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1162 ---~-------~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
- -|......-.+.+..+.++++.+|+..+|.+|+|++|++++
T Consensus 230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0 01111111122334556889999999999999999999987
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=363.66 Aligned_cols=250 Identities=26% Similarity=0.384 Sum_probs=209.1
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
..|+...+||+|+.|.||.|+.. .++.||||++........+-+.+|+.+|+..+|+|||.+++.|..+++.|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 45777789999999999999765 68899999998766666667899999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
+||+|.+++... .+++.+...|+.++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+....
T Consensus 353 ~ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 353 EGGSLTDVVTKT------RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred CCCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 999999998763 589999999999999999999999 99999999999999999999999999998776543
Q ss_pred cceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
. +..+.+|||.|||||++....|+.++||||||++++||+.|.+||-... .+... ..+...-.+.+
T Consensus 424 ~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~-----PlrAl-------yLIa~ng~P~l 489 (550)
T KOG0578|consen 424 S--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN-----PLRAL-------YLIATNGTPKL 489 (550)
T ss_pred C--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC-----hHHHH-------HHHhhcCCCCc
Confidence 3 3467889999999999999999999999999999999999999986421 11111 11111122333
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
........ .|.+++.+|+..||++||++.|++++
T Consensus 490 k~~~klS~---~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 KNPEKLSP---ELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCccccCH---HHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 33322333 45566669999999999999999987
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=378.71 Aligned_cols=282 Identities=26% Similarity=0.449 Sum_probs=221.6
Q ss_pred ccccccccccccccCHHHHHHHhCCCCCCceecccCCeEEEEEEECC----CCEEEEEEeccc-cCcCHHHHHHHHHHHH
Q 000889 905 SINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQLRD----GSVVAIKKLIHV-TGQGDREFMAEMETIG 979 (1237)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~ 979 (1237)
.+++.++|+|.+-...-.-+.......+.++||.|.||+||+|+++. ...||||.++.- .....++|..|+.||.
T Consensus 606 YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMG 685 (996)
T KOG0196|consen 606 YIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMG 685 (996)
T ss_pred ecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcc
Confidence 35556666664322111111112345678899999999999999872 457999999743 3445678999999999
Q ss_pred hcCCCCcccccceEEeCCeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 000889 980 KIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMK 1059 (1237)
Q Consensus 980 ~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDik 1059 (1237)
+++||||+++-|+.......+||.|||++|+|+.||+.+. .++.+.+..-++++||.|+.||.+. ++|||||.
T Consensus 686 QFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D----GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLA 758 (996)
T KOG0196|consen 686 QFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND----GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLA 758 (996)
T ss_pred cCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC----CceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhh
Confidence 9999999999999999999999999999999999998763 5699999999999999999999999 99999999
Q ss_pred CCCeeeCCCCceEEeecccceeeccCCcceeeecccc--CCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCC
Q 000889 1060 SSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAG--TPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDP 1136 (1237)
Q Consensus 1060 p~NIll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~ 1136 (1237)
++|||++.+..+|++|||+++..+... ....++..| +.+|.|||.+..++++.+|||||||++|||.++ |.+||-.
T Consensus 759 ARNILVNsnLvCKVsDFGLSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd 837 (996)
T KOG0196|consen 759 ARNILVNSNLVCKVSDFGLSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 837 (996)
T ss_pred hhheeeccceEEEeccccceeecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc
Confidence 999999999999999999999876533 222233333 568999999999999999999999999999887 9999754
Q ss_pred CCCCCCchHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccccc
Q 000889 1137 SEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDT 1211 (1237)
Q Consensus 1137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~~ 1211 (1237)
... ++. +..... +.+++.+.+++ ..+-++++.||++|-.+||++.+++.+|.++..++
T Consensus 838 mSN---QdV---IkaIe~--------gyRLPpPmDCP---~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 838 MSN---QDV---IKAIEQ--------GYRLPPPMDCP---AALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred cch---HHH---HHHHHh--------ccCCCCCCCCc---HHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 321 111 111111 23344333444 45668888999999999999999999999886654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=359.64 Aligned_cols=254 Identities=25% Similarity=0.363 Sum_probs=208.4
Q ss_pred HHhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccc---cCcCHHHHHHHHHHHHhc-CCCCcccccceEEeCCeE
Q 000889 925 EATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHV---TGQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEER 999 (1237)
Q Consensus 925 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 999 (1237)
+..++|...+.||+|+|++||+|+.+ .++.+|||++.+. .....+-+..|-.+|.+| .||.|++++..|++....
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 34567889999999999999999876 5889999988532 222334567899999999 899999999999999999
Q ss_pred EEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccc
Q 000889 1000 LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1079 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla 1079 (1237)
|+|+||+++|+|.+++++. +.+++.-++.++.+|+.|++|||++ |||||||||+|||+|+|+++||+|||.|
T Consensus 150 YFvLe~A~nGdll~~i~K~-----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY-----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred EEEEEecCCCcHHHHHHHh-----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence 9999999999999999886 5789999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcc-----------eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHH
Q 000889 1080 RLVNALDTH-----------LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGW 1148 (1237)
Q Consensus 1080 ~~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~ 1148 (1237)
+.+...... .....++||..|.+||++.....+..+|+|+|||++|+|+.|.+||.+.. .+..+
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N-----eyliF 296 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN-----EYLIF 296 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc-----HHHHH
Confidence 987543221 11245899999999999999999999999999999999999999997532 12222
Q ss_pred HHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1149 AKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1149 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
.+ |++-.+..+...++ ...+++.+.+..||.+|+|..++.+|-
T Consensus 297 qk----------I~~l~y~fp~~fp~---~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 297 QK----------IQALDYEFPEGFPE---DARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HH----------HHHhcccCCCCCCH---HHHHHHHHHHccCccccccHHHHhhCc
Confidence 22 22222222222333 345677799999999999999998874
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=332.78 Aligned_cols=236 Identities=28% Similarity=0.372 Sum_probs=197.8
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
++|+..+.||.|+||+|.+++.+ +|..+|.|.+.+.. ..+.++..+|.++++.+.||+++++++.+.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 35788899999999999999987 58889999886432 233456788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||++||.|.+++++. +++++..++.+|.+|+.|++|||+. +|++||+||+|||+|++|++||+|||+|+++.
T Consensus 124 eyv~GGElFS~Lrk~-----~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS-----GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred eccCCccHHHHHHhc-----CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999875 5789999999999999999999999 99999999999999999999999999999875
Q ss_pred cCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccC
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
.. ..+.||||.|+|||++....|..++|.|||||++|||+.|.+||..... +..+ .+|+.
T Consensus 196 ~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-----~~iY----------~KI~~ 255 (355)
T KOG0616|consen 196 GR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-----IQIY----------EKILE 255 (355)
T ss_pred Cc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-----HHHH----------HHHHh
Confidence 32 3578999999999999999999999999999999999999999975432 2222 22333
Q ss_pred ccccCCCCCHHHHHHHHHHHHhccccCCCCC
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKR 1194 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~R 1194 (1237)
..+..+.....+ +.+++...+++|-.+|
T Consensus 256 ~~v~fP~~fs~~---~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 256 GKVKFPSYFSSD---AKDLLKKLLQVDLTKR 283 (355)
T ss_pred CcccCCcccCHH---HHHHHHHHHhhhhHhh
Confidence 333333333333 3456668888888888
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=353.90 Aligned_cols=260 Identities=27% Similarity=0.437 Sum_probs=202.5
Q ss_pred CCCCCCceecccCCeEEEEEEECC-CCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCC--eEEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGE--ERLLVYE 1004 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e 1004 (1237)
.+|...+.||+|+||+||++...+ |...|||.+........+.+.+|++++++++|||||+++|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 346677899999999999999875 8899999886543333566889999999999999999999855544 6899999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCC-CCceEEeecccceeec
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE-NFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~-~~~vkl~DfGla~~~~ 1083 (1237)
|+++|+|.+++.... + .+++..+++++.||++||+|||++ +||||||||+|||++. ++.+||+|||+++...
T Consensus 97 y~~~GsL~~~~~~~g---~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYG---G-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred ccCCCcHHHHHHHcC---C-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 999999999998642 2 699999999999999999999999 9999999999999999 7999999999998776
Q ss_pred cCC-cceeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccc
Q 000889 1084 ALD-THLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161 (1237)
Q Consensus 1084 ~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1161 (1237)
... .........||+.|||||++..+ ....++||||+||++.||+||++||... .....+.-........
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~--- 241 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSL--- 241 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCC---
Confidence 411 11223457899999999999953 3335999999999999999999999743 1111112222222211
Q ss_pred cCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 000889 1162 LDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQV 1209 (1237)
Q Consensus 1162 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~ 1209 (1237)
|.+ +..-++ +..+++.+|+..+|++||||.+++++....+.
T Consensus 242 --P~i--p~~ls~---~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 242 --PEI--PDSLSD---EAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred --CCC--CcccCH---HHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 111 112222 34466679999999999999999999755443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=356.07 Aligned_cols=264 Identities=23% Similarity=0.324 Sum_probs=209.0
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHH--HHHHHHHHHhcC-CCCcccccceEEeCC-eEEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDRE--FMAEMETIGKIK-HRNLVPLLGYCKIGE-ERLL 1001 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l 1001 (1237)
-++|.+.++||.|.||.||+|+.. +++.||||+++..-.. .++ =.+|++.+++++ |||||++.+++.+.+ ..++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 357888899999999999999865 6889999999754322 333 368999999998 999999999999888 9999
Q ss_pred EEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeeccccee
Q 000889 1002 VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~ 1081 (1237)
|||||+ .+|++.++++. +.+++..++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+||.
T Consensus 88 VfE~Md-~NLYqLmK~R~----r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDRN----RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eHHhhh-hhHHHHHhhcC----CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccc
Confidence 999997 89999998873 5899999999999999999999999 999999999999999888999999999997
Q ss_pred eccCCcceeeeccccCCCcCCccccC-ccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhc----
Q 000889 1082 VNALDTHLSVSTLAGTPGYVPPEYYQ-SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREK---- 1156 (1237)
Q Consensus 1082 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 1156 (1237)
+..... ++..+.|..|+|||++. ...|+.++||||+|||++|+.+-++-|.+.. +.+.+......+....
T Consensus 160 v~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s--E~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 160 VRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS--EIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred cccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc--HHHHHHHHHHHhCCCccccc
Confidence 765443 46678899999999874 5679999999999999999999999998653 2233333222221110
Q ss_pred ----ccccccCccccCCC------CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1157 ----RINEILDPELTMQT------SDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1157 ----~~~~~~~~~l~~~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
.+...+.-.++.-. --+....+.++++.+|+++||.+||||.+++++-
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 01111111111000 0112445778899999999999999999999883
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=355.88 Aligned_cols=247 Identities=27% Similarity=0.427 Sum_probs=205.8
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCc--CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQ--GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
++|-+.+.||+|+||+||||+.+ +.+.||+|.+.+.... +.+.+.+|++++++++|||||.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 45777788999999999999887 5778999988654332 34568899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
|+.| +|..++... ..++++.++.|+.+++.||.|||+. +|.|||+||+||+++..|++|+||||+|+.+..
T Consensus 82 ~a~g-~L~~il~~d-----~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD-----GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred hhhh-hHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 9986 999999874 5799999999999999999999999 999999999999999999999999999997654
Q ss_pred CCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCc
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDP 1164 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1164 (1237)
.....+...|||-|||||+..++.|+..+|+||+||++|||++|++||...+ +....+....+
T Consensus 153 --~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d--------- 215 (808)
T KOG0597|consen 153 --NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKD--------- 215 (808)
T ss_pred --CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcC---------
Confidence 2233467889999999999999999999999999999999999999996432 12222221111
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1165 ELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1165 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
+... .......+..++...+.+||..|.|-.+++.+
T Consensus 216 ~v~~---p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 216 PVKP---PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CCCC---cccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1111 11334467777889999999999999999876
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=342.06 Aligned_cols=262 Identities=25% Similarity=0.353 Sum_probs=206.3
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcC-HHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQG-DREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
..|++..+||.|..++||+|+.. .++.||||++.-..... .+.+.+|+..|+.++||||++++.+|..+...|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 46888999999999999999865 57999999997444333 47789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
|.+|++.+.++..... .+++..+..|++++++||.|||.+ |.||||||+.|||++.+|.|||+|||.+..+...
T Consensus 106 Ma~GS~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPD---GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hcCCcHHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999887653 489999999999999999999999 9999999999999999999999999998655443
Q ss_pred Cccee--eeccccCCCcCCccccCc--cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccc
Q 000889 1086 DTHLS--VSTLAGTPGYVPPEYYQS--FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161 (1237)
Q Consensus 1086 ~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1161 (1237)
..... .....||+.|||||++.. ..|+.|+||||||++..|+.+|..||..-... ......+.... ...
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-----kvLl~tLqn~p--p~~ 252 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-----KVLLLTLQNDP--PTL 252 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-----HHHHHHhcCCC--CCc
Confidence 32222 256789999999999643 46999999999999999999999999743311 11111111111 000
Q ss_pred cCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1162 LDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1162 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.-..+ ...........|.+++..|+.+||++|||+++++++
T Consensus 253 ~t~~~-~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 253 LTSGL-DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ccccC-ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 00000 000001122467788889999999999999999976
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=353.32 Aligned_cols=240 Identities=26% Similarity=0.477 Sum_probs=199.4
Q ss_pred CceecccCCeEEEEEEECCCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCCCHH
Q 000889 933 DSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLE 1012 (1237)
Q Consensus 933 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 1012 (1237)
.+-||.|+.|.||+|+++ ++.|||||+.... ..+++-+++++||||+.+.|+|.....+|||||||..|.|.
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 357999999999999997 7889999885322 24788899999999999999999999999999999999999
Q ss_pred HHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcceeee
Q 000889 1013 SVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVS 1092 (1237)
Q Consensus 1013 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~~~ 1092 (1237)
.+++.. .++.......|..+||.|+.|||.+ .|||||+|.-||||+.+..|||+|||-++......+ ..
T Consensus 201 ~VLka~-----~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST---kM 269 (904)
T KOG4721|consen 201 EVLKAG-----RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST---KM 269 (904)
T ss_pred HHHhcc-----CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhh---hh
Confidence 999864 5788888899999999999999999 999999999999999999999999999987765433 35
Q ss_pred ccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCCC
Q 000889 1093 TLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSD 1172 (1237)
Q Consensus 1093 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 1172 (1237)
.++||..|||||++.....+.|+||||||||+|||+||..||..-.... ..| +.-.. .-.++.+..+
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIw-------GVGsN--sL~LpvPstc 336 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIW-------GVGSN--SLHLPVPSTC 336 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEE-------eccCC--cccccCcccC
Confidence 6899999999999999999999999999999999999999986421100 000 00001 1223343334
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 000889 1173 ETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207 (1237)
Q Consensus 1173 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l 1207 (1237)
+ ..|.-++.+||+..|..||++.+++.+|+-.
T Consensus 337 P---~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 337 P---DGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred c---hHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 4 4566677799999999999999999999644
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=368.08 Aligned_cols=498 Identities=29% Similarity=0.370 Sum_probs=381.2
Q ss_pred cCCCCCCEEEccCCCCCchhhhhcccCCCccEEEcccccccCccchhhhhccCCCccEEeCCCCcCCCCcccccccCCCC
Q 000889 221 SNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGN 300 (1237)
Q Consensus 221 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~l~~ 300 (1237)
..-..|+.|++++|.++. +...+.++..|++|++++|.+... |.+. ..+..++.|+.++|++...+. ....+.+
T Consensus 42 W~qv~l~~lils~N~l~~-l~~dl~nL~~l~vl~~~~n~l~~l-p~ai--g~l~~l~~l~vs~n~ls~lp~--~i~s~~~ 115 (565)
T KOG0472|consen 42 WEQVDLQKLILSHNDLEV-LREDLKNLACLTVLNVHDNKLSQL-PAAI--GELEALKSLNVSHNKLSELPE--QIGSLIS 115 (565)
T ss_pred hhhcchhhhhhccCchhh-ccHhhhcccceeEEEeccchhhhC-CHHH--HHHHHHHHhhcccchHhhccH--HHhhhhh
Confidence 455678999999999863 455677888999999999999844 4433 234578889999998874333 4567888
Q ss_pred CceeeccCccccCcccchhhcccccceEEEecCCccCCCCchhhhccCCCCcEEecCCCcCCCCCchhHhhhcCCCcEEE
Q 000889 301 LSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELD 380 (1237)
Q Consensus 301 L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~l~~L~~L~ 380 (1237)
|..|+.++|.+. +++..++.+..|+.|+..+|+++. .|+. +..+.+|..|++.+|+++ ..|+.... .+.|++||
T Consensus 116 l~~l~~s~n~~~--el~~~i~~~~~l~dl~~~~N~i~s-lp~~-~~~~~~l~~l~~~~n~l~-~l~~~~i~-m~~L~~ld 189 (565)
T KOG0472|consen 116 LVKLDCSSNELK--ELPDSIGRLLDLEDLDATNNQISS-LPED-MVNLSKLSKLDLEGNKLK-ALPENHIA-MKRLKHLD 189 (565)
T ss_pred hhhhhcccccee--ecCchHHHHhhhhhhhcccccccc-CchH-HHHHHHHHHhhccccchh-hCCHHHHH-HHHHHhcc
Confidence 999999999884 477888889999999999999984 4443 356788889999999998 77777666 48899999
Q ss_pred cccCcCCCCCCcCcccccccceeeccCccccCcccchhccccccceEEeccCCCCCCCCCccCCCCCCCcEEEccCCcCc
Q 000889 381 LSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFT 460 (1237)
Q Consensus 381 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~ 460 (1237)
...|-++ .+|..++.+.+|+-|+|.+|+|.. .+ .|.+++.|++|+++.|.|.-...+...++++|.+|||.+|+++
T Consensus 190 ~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~--lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk 265 (565)
T KOG0472|consen 190 CNSNLLE-TLPPELGGLESLELLYLRRNKIRF--LP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK 265 (565)
T ss_pred cchhhhh-cCChhhcchhhhHHHHhhhccccc--CC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc
Confidence 9999888 678889999999999999999872 33 6788888899999988888444444558888999999999888
Q ss_pred ccCCCCCCCCCCCcccceecccCceeeecccccccccccccEecccCCccccCCCccccCCcC---cceeec--cccccc
Q 000889 461 GTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPN---LSDLVM--WANNLT 535 (1237)
Q Consensus 461 ~~~p~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L--~~N~l~ 535 (1237)
..|+.+|- +.+|+.|++++|.|+ ..|..++++ .|+.|-+.+|.+.. +-.++-+-.. |++|.= ..-.++
T Consensus 266 -e~Pde~cl---LrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrT-iRr~ii~~gT~~vLKyLrs~~~~dglS 338 (565)
T KOG0472|consen 266 -EVPDEICL---LRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRT-IRREIISKGTQEVLKYLRSKIKDDGLS 338 (565)
T ss_pred -cCchHHHH---hhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHH-HHHHHHcccHHHHHHHHHHhhccCCCC
Confidence 67777763 567888888888888 567788888 78888888888863 2222211111 111110 000111
Q ss_pred ---------Ccccccccc---cCCCccEEEccccccccccccccccCCC---ccEEEeecccccccCCccccCccccce-
Q 000889 536 ---------GEIPEGICV---NGGNLETLILNNNHLTGAIPKSIASCTN---MLWVSLSSNQLTGEIPAGIGNLVKLAI- 599 (1237)
Q Consensus 536 ---------~~ip~~~~~---~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~~~p~~~~~L~~L~~- 599 (1237)
+..|.+.|. ...+.+.|++++=+++ .+|+....-.. ....+++.|++. ++|..+..+..+..
T Consensus 339 ~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~ 416 (565)
T KOG0472|consen 339 QSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTD 416 (565)
T ss_pred CCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHH
Confidence 122333332 2356788999999998 67766555444 778999999999 89999999888654
Q ss_pred EEecCCccccCCCCCCCCCCCCCEEECCCCccccCCChhHHhhcccccCccccCccceeeccCCCccccCCCCcccccCC
Q 000889 600 LQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGI 679 (1237)
Q Consensus 600 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (1237)
+.+++|.+. .+|..++.+++|..|+|++|.+. .+|.+++.+.
T Consensus 417 l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv------------------------------------ 458 (565)
T KOG0472|consen 417 LVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLV------------------------------------ 458 (565)
T ss_pred HHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhh------------------------------------
Confidence 566666666 89999999999999999999997 8888876542
Q ss_pred CccccCCCccccCCCCcceeccceeeeeccCCceeEEEccCCcCCccCCccccCCCCCcEEEecCccccccccccccccc
Q 000889 680 RPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLK 759 (1237)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~L~~LdLs~N~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~P~~~~~L~ 759 (1237)
.|+.||+|.|+|. .+|+.+..+..|+.+-.++|++....|+.+.+|.
T Consensus 459 --------------------------------~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~ 505 (565)
T KOG0472|consen 459 --------------------------------RLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMR 505 (565)
T ss_pred --------------------------------hhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhh
Confidence 4899999999998 8999999999999999999999966666699999
Q ss_pred CCcEEeCCCCccCCCCCCcccCcccccceecccccccccCCCCCCC-CccCCCcccCC
Q 000889 760 AIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQL-TTFPASRYENN 816 (1237)
Q Consensus 760 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~-~~~~~~~~~~n 816 (1237)
+|..|||.+|.+. .+|+.+++|++|++|+|++|+|. .||....+ .|....+|.++
T Consensus 506 nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr-~Pr~~iLmkgT~aiL~ylrd 561 (565)
T KOG0472|consen 506 NLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR-QPRHQILMKGTAAILSYLRD 561 (565)
T ss_pred hcceeccCCCchh-hCChhhccccceeEEEecCCccC-CCHHHHhccChHHHHHHhcc
Confidence 9999999999998 89999999999999999999999 44432222 34444444444
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=346.48 Aligned_cols=295 Identities=25% Similarity=0.337 Sum_probs=215.7
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeC--CeEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIG--EERLLV 1002 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 1002 (1237)
+.|+..++||+|.||.||+|++. +|+.||+||+.... .....-..+|+.+|++++||||+++.+...+. ...|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 34667788999999999999875 68999999997544 33445678999999999999999999988776 689999
Q ss_pred EEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceee
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~ 1082 (1237)
+|||+ -+|..++... +..+++.+++.++.|++.||+|+|++ +|+|||||.+|||||.+|.+||+|||+|+++
T Consensus 197 FeYMd-hDL~GLl~~p----~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 197 FEYMD-HDLSGLLSSP----GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred Eeccc-chhhhhhcCC----CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 99998 5788777642 45789999999999999999999999 9999999999999999999999999999988
Q ss_pred ccCCcceeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHh---hhc--
Q 000889 1083 NALDTHLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLH---REK-- 1156 (1237)
Q Consensus 1083 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~-- 1156 (1237)
..... ...+..+-|..|+|||.+.|. .|+.++|+||.|||+.||+.|++.|.+.... ..+....+... ...
T Consensus 269 ~~~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv--eQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 269 TPSGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV--EQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred cCCCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH--HHHHHHHHHhCCCChhccc
Confidence 65443 235677889999999999875 6999999999999999999999999865321 11111111000 000
Q ss_pred --ccc--cccCccccCCCCCHHH----HHHHHHHHHhccccCCCCCCCHHHHHHH--HHhcccccCCCCCCccCchhhHH
Q 000889 1157 --RIN--EILDPELTMQTSDETE----LYQYLRISFECLDDRPFKRPTMIQVMAM--FKELQVDTEGDSLDSFSLKDTVI 1226 (1237)
Q Consensus 1157 --~~~--~~~~~~l~~~~~~~~~----~~~l~~li~~cl~~dP~~RPt~~ell~~--L~~l~~~~~~~~~~~~~~~~~~~ 1226 (1237)
.+. ..+.+...-.....+. ....++++..++..||.+|.|+.++++. +..-....+...+..+.-.+.+.
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p~~Lp~y~~s~E~~ 425 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDPSSLPKYPPSHELD 425 (560)
T ss_pred cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCcccCCCCCcchhHH
Confidence 000 0011000000000010 1345677789999999999999999865 33333334444455555555555
Q ss_pred HHHHHhh
Q 000889 1227 EELRERE 1233 (1237)
Q Consensus 1227 ~~~~~~~ 1233 (1237)
...|..+
T Consensus 426 ~K~r~e~ 432 (560)
T KOG0600|consen 426 AKRRREQ 432 (560)
T ss_pred HHHHHHH
Confidence 5555443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=355.34 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=204.8
Q ss_pred CCCCceecccCCeEEEEEEECCCCEEEEEEeccccC--cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEecc
Q 000889 930 FSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTG--QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMK 1007 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 1007 (1237)
+.+...||+|+||+||+|+|. ..||||++..... +..+.|+.|+.++++-+|.||+-+.|||..... .||..+|+
T Consensus 394 v~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCe 470 (678)
T KOG0193|consen 394 VLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCE 470 (678)
T ss_pred hhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhcc
Confidence 456778999999999999997 4599999875433 345679999999999999999999999987666 99999999
Q ss_pred CCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCc
Q 000889 1008 WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDT 1087 (1237)
Q Consensus 1008 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~ 1087 (1237)
|-+|+.+++... ..++..+.+.||.|||+|+.|||.+ +|||||+|..||++.+++.|||+|||++..-.....
T Consensus 471 GsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 471 GSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred Cchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 999999998764 4789999999999999999999999 999999999999999999999999999976554444
Q ss_pred ceeeeccccCCCcCCccccCcc---ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCc
Q 000889 1088 HLSVSTLAGTPGYVPPEYYQSF---RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDP 1164 (1237)
Q Consensus 1088 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1164 (1237)
........|...|||||+++.+ .|++.+||||||+|+|||++|..||..... +.+ +....+..- ..|.
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~---dqI---ifmVGrG~l---~pd~ 614 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR---DQI---IFMVGRGYL---MPDL 614 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh---hhe---EEEeccccc---Cccc
Confidence 4444556688899999999743 689999999999999999999999972211 110 000111100 0010
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 000889 1165 ELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQV 1209 (1237)
Q Consensus 1165 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~ 1209 (1237)
.... ..+..++.+++..||..++++||.+.+++..|+.+..
T Consensus 615 -s~~~---s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 615 -SKIR---SNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred -hhhh---ccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 1111 2233456677779999999999999999999988766
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=348.70 Aligned_cols=266 Identities=24% Similarity=0.382 Sum_probs=215.1
Q ss_pred HhCCCCCCceecccCCeEEEEEEECCCCEEEEEEeccccCcC-HHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEE
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQG-DREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
......++++||+|-||.|.+++...+..||||+++...... ..+|.+|+++|.+++||||++++|+|..++..++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 445567889999999999999999888999999998655444 4789999999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
||++|+|.+|+...... ........+|+.|||.|++||.+. .+||||+.++|+|+|.++++||+|||+++-+-.
T Consensus 616 YmEnGDLnqFl~aheap---t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELP---TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHhcCcHHHHHHhccCc---ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccccc
Confidence 99999999999875432 235556678999999999999999 999999999999999999999999999997776
Q ss_pred CCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc--CCCCCCCCCCCCCchHHHHHHHHhhhccccccc
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS--GKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1162 (1237)
.+.+......+-+.+|||||.+..+++++++|||+||+++||+++ ...||.... +++.+.-.....+.... ..+
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt---~e~vven~~~~~~~~~~-~~~ 765 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT---DEQVVENAGEFFRDQGR-QVV 765 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh---HHHHHHhhhhhcCCCCc-cee
Confidence 676666666778899999999999999999999999999999876 778876422 12222222222111111 111
Q ss_pred CccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 000889 1163 DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207 (1237)
Q Consensus 1163 ~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l 1207 (1237)
- .. .+.+...+.+++.+||+.+.++||+++++...|++.
T Consensus 766 l---~~---P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 L---SR---PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred c---cC---CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1 11 122445677899999999999999999999998764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=338.07 Aligned_cols=268 Identities=30% Similarity=0.400 Sum_probs=209.6
Q ss_pred CCCceecccCCeEEEEEEECCCCEEEEEEeccccCcCHHHHHHHHHHHHh--cCCCCcccccceEEeCC----eEEEEEE
Q 000889 931 SADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGK--IKHRNLVPLLGYCKIGE----ERLLVYE 1004 (1237)
Q Consensus 931 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~e 1004 (1237)
+..++||+|.||.||+|++. ++.||||++.. ++.+.|.+|-++++. |+|+||++++++-..++ ++++|+|
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 34567999999999999997 69999998843 456678888888665 58999999999887666 8999999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcC------CCCeeecCCCCCCeeeCCCCceEEeeccc
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC------IPHIIHRDMKSSNVLLDENFEARVSDFGM 1078 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~ivHrDikp~NIll~~~~~vkl~DfGl 1078 (1237)
|.+.|+|.+|+... .++|....+|+..+++||+|||+.. +|+|+|||||++|||+..|+++.|+|||+
T Consensus 289 fh~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 289 FHPKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eccCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 99999999999864 7899999999999999999999763 57899999999999999999999999999
Q ss_pred ceeeccCCcceeeeccccCCCcCCccccCccc-cC-----cccchHHHHHHHHHHHcCCCCCCCCCCCC-----------
Q 000889 1079 ARLVNALDTHLSVSTLAGTPGYVPPEYYQSFR-CT-----TKGDVYSYGVILLELLSGKRPIDPSEFGD----------- 1141 (1237)
Q Consensus 1079 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDvwSlGv~l~el~tg~~p~~~~~~~~----------- 1141 (1237)
|.++.........-..+||.+|||||++.+.- +. .+.||||+|.|+|||++....+++.+..+
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 99988665555445588999999999997642 11 35899999999999998665553211111
Q ss_pred CchHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccccCC
Q 000889 1142 DNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEG 1213 (1237)
Q Consensus 1142 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~~~~ 1213 (1237)
.-.+..+.....++ ..+|.++..+..-+.+..+.+.+..||..||+.|.|+.=|.+.+.++...++.
T Consensus 443 hPt~e~mq~~VV~k-----K~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 443 HPTLEEMQELVVRK-----KQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CCCHHHHHHHHHhh-----ccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 11111222222222 22333333333335666788889999999999999999999999988777754
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=357.89 Aligned_cols=390 Identities=23% Similarity=0.279 Sum_probs=258.6
Q ss_pred cCC-ccceEEccCCccCCCcc-----ccCCcccEEEcCCCCCCCchhhhccccCCCCCCEEEccCCCCCchhhhhcccCC
Q 000889 175 SCD-RLSYVNLSHNSISGGSL-----HIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCK 248 (1237)
Q Consensus 175 ~~~-~L~~L~ls~n~l~~~~~-----~~~~~L~~L~Ls~N~i~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~ 248 (1237)
.|+ +-..|+|++++|..... ..++..+.||+++|.|.+..+ ..|.++++|+.+++..|.++. +|.......
T Consensus 49 ~c~c~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~--~~f~nl~nLq~v~l~~N~Lt~-IP~f~~~sg 125 (873)
T KOG4194|consen 49 TCPCNTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDF--EFFYNLPNLQEVNLNKNELTR-IPRFGHESG 125 (873)
T ss_pred cCCCCceeeecCccccccccccccCCcCccceeeeeccccccccCcH--HHHhcCCcceeeeeccchhhh-ccccccccc
Confidence 455 34567888887766321 223455667777777776543 234677777777777777753 344344445
Q ss_pred CccEEEcccccccCccchhhhhccCCCccEEeCCCCcCCCCcccccccCCCCCceeeccCccccCcccchhhcccccceE
Q 000889 249 SISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLET 328 (1237)
Q Consensus 249 ~L~~LdLs~N~l~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~ 328 (1237)
+|+.|+|.+|.|+..-...+ ..++.|+.||||.|.|+ .++...|..-.++++|+|++|+|+..+ ...|.++.+|..
T Consensus 126 hl~~L~L~~N~I~sv~se~L--~~l~alrslDLSrN~is-~i~~~sfp~~~ni~~L~La~N~It~l~-~~~F~~lnsL~t 201 (873)
T KOG4194|consen 126 HLEKLDLRHNLISSVTSEEL--SALPALRSLDLSRNLIS-EIPKPSFPAKVNIKKLNLASNRITTLE-TGHFDSLNSLLT 201 (873)
T ss_pred ceeEEeeeccccccccHHHH--HhHhhhhhhhhhhchhh-cccCCCCCCCCCceEEeeccccccccc-cccccccchhee
Confidence 57777777777764333332 22456777777777776 444455666667777777777776654 345677777777
Q ss_pred EEecCCccCCCCchhhhccCCCCcEEecCCCcCCCCCchhHhhhcCCCcEEEcccCcCCCCCCcCcccccccceeeccCc
Q 000889 329 LNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSN 408 (1237)
Q Consensus 329 L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 408 (1237)
|.|+.|.++ .+|...|.++++|+.|+|..|+|. .+.--.|+++++|+.|.|..|.|......+|..+.++++|+|+.|
T Consensus 202 lkLsrNrit-tLp~r~Fk~L~~L~~LdLnrN~ir-ive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N 279 (873)
T KOG4194|consen 202 LKLSRNRIT-TLPQRSFKRLPKLESLDLNRNRIR-IVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETN 279 (873)
T ss_pred eecccCccc-ccCHHHhhhcchhhhhhcccccee-eehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccc
Confidence 777777777 566666777777777777777776 444455666777777777777777666667777777777777777
Q ss_pred cccCcccchhccccccceEEeccCCCCCCCCCccCCCCCCCcEEEccCCcCcccCCCCCCCCCCCcccceecccCceeee
Q 000889 409 MLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSG 488 (1237)
Q Consensus 409 ~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~L~~N~l~~ 488 (1237)
+++ .....++.++++|+.|+|++|.|..+.+.++.-+++|++|+|++|+|+...+..| ..+..|++|.|++|++..
T Consensus 280 ~l~-~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf---~~L~~Le~LnLs~Nsi~~ 355 (873)
T KOG4194|consen 280 RLQ-AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSF---RVLSQLEELNLSHNSIDH 355 (873)
T ss_pred hhh-hhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHH---HHHHHhhhhcccccchHH
Confidence 776 3455666677777777777777777777777777777777777777775555544 456667777777777776
Q ss_pred cccccccccccccEecccCCccccCCCc---cccCCcCcceeecccccccCcccccccccCCCccEEEcccccccccccc
Q 000889 489 TVPLELGSCKNLKTIDLSFNSLAGPVPS---EIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPK 565 (1237)
Q Consensus 489 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~ 565 (1237)
+-...|..+++|++|||++|.|+..+.+ .|.+|++|+.|++.+|++. .||...|.++..|++|||.+|.|..+-|.
T Consensus 356 l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~krAfsgl~~LE~LdL~~NaiaSIq~n 434 (873)
T KOG4194|consen 356 LAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIPKRAFSGLEALEHLDLGDNAIASIQPN 434 (873)
T ss_pred HHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee-ecchhhhccCcccceecCCCCcceeeccc
Confidence 6666777777777777777777654432 4566777777777777776 66766667777777777777777666666
Q ss_pred ccccCCCccEEEee
Q 000889 566 SIASCTNMLWVSLS 579 (1237)
Q Consensus 566 ~~~~l~~L~~L~Ls 579 (1237)
+|..+ .|++|.+.
T Consensus 435 AFe~m-~Lk~Lv~n 447 (873)
T KOG4194|consen 435 AFEPM-ELKELVMN 447 (873)
T ss_pred ccccc-hhhhhhhc
Confidence 66666 66665543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=357.06 Aligned_cols=252 Identities=27% Similarity=0.400 Sum_probs=205.6
Q ss_pred HHhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccc----cC-cCHHHHHHHHHHHHhcC-CCCcccccceEEeCC
Q 000889 925 EATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHV----TG-QGDREFMAEMETIGKIK-HRNLVPLLGYCKIGE 997 (1237)
Q Consensus 925 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 997 (1237)
...++|.+.+.||+|+||+|+.|++. ++..||+|.+.+. .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34568999999999999999999876 6799999966542 11 23445678999999999 999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCC-CceEEeec
Q 000889 998 ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDEN-FEARVSDF 1076 (1237)
Q Consensus 998 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~-~~vkl~Df 1076 (1237)
..++||||+.||+|.+++... .++.+..+.+++.|++.|++|+|+. +|+||||||+||+++.+ +.+||+||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~-----g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK-----GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecc
Confidence 999999999999999999873 4788899999999999999999999 99999999999999999 99999999
Q ss_pred ccceeeccCCcceeeeccccCCCcCCccccCccc-cC-cccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhh
Q 000889 1077 GMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFR-CT-TKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR 1154 (1237)
Q Consensus 1077 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1154 (1237)
|++.... .........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+... .......
T Consensus 166 G~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------~~~l~~k--- 234 (370)
T KOG0583|consen 166 GLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------VPNLYRK--- 234 (370)
T ss_pred ccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------HHHHHHH---
Confidence 9998774 2223446789999999999999877 75 78999999999999999999998521 1111111
Q ss_pred hcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1155 EKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1155 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
+....+..+.... ..++..++.+|+..+|.+|+|+.+++++
T Consensus 235 ------i~~~~~~~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 235 ------IRKGEFKIPSYLL--SPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred ------HhcCCccCCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 1222222222220 2355678889999999999999999944
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=381.06 Aligned_cols=271 Identities=27% Similarity=0.448 Sum_probs=218.3
Q ss_pred CCCCCceecccCCeEEEEEEECC--CC----EEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLRD--GS----VVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLL 1001 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~~--~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 1001 (1237)
+.+..+.||+|+||.||.|...+ +. .||+|++.+... +...+|.+|..+|+.++|||||+++|.|.+....++
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 44567789999999999998763 43 489998876543 445679999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHhhhhcC--CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccc
Q 000889 1002 VYEYMKWGSLESVLHDRAKG--GGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1079 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla 1079 (1237)
++|||+||+|..|+++.+.. ....+...+...++.|||+|+.||+++ ++|||||.++|+|+++...|||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999876332 234678899999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhccc
Q 000889 1080 RLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158 (1237)
Q Consensus 1080 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1158 (1237)
+.....+.+.......-+..|||||.+..+.++.|+|||||||++||++| |..||..... . ........+
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-----~-~v~~~~~~g--- 920 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-----F-EVLLDVLEG--- 920 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-----H-HHHHHHHhC---
Confidence 96655554444333345679999999999999999999999999999999 8999874321 1 111112222
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccccCCCCCCcc
Q 000889 1159 NEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGDSLDSF 1219 (1237)
Q Consensus 1159 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~~~~~~~~~~ 1219 (1237)
.++..+.++++. +.+++.+||+.+|++||++..+++.+..+..+........+
T Consensus 921 -----gRL~~P~~CP~~---ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~~~ 973 (1025)
T KOG1095|consen 921 -----GRLDPPSYCPEK---LYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYGPL 973 (1025)
T ss_pred -----CccCCCCCCChH---HHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCccccc
Confidence 244445555554 45788899999999999999999998887766655554433
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=343.93 Aligned_cols=248 Identities=27% Similarity=0.377 Sum_probs=203.5
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
.|+..+.||+|+||.||+|.+. .++.||+|.+.-... ....++.+|+.++.+++++||.++|+.+..+...|++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 4666678999999999999876 588999999874433 33567889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
.||++.+.++.. ..+.+.....++.++..|+.|||.+ +.+|||||+.||++..+|.||++|||.+.......
T Consensus 94 ~gGsv~~lL~~~-----~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 94 GGGSVLDLLKSG-----NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred cCcchhhhhccC-----CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 999999998753 3447777778899999999999999 99999999999999999999999999998776433
Q ss_pred cceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
.+..+++||+.|||||++....|+.|+||||||++.+||.+|.+|+....... ..-.+.+-..|.+
T Consensus 166 --~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr------------vlflIpk~~PP~L 231 (467)
T KOG0201|consen 166 --KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR------------VLFLIPKSAPPRL 231 (467)
T ss_pred --hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce------------EEEeccCCCCCcc
Confidence 23378899999999999998899999999999999999999999986432100 0011122222222
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.. .....+.+++..|+.++|+.||+|.+++++
T Consensus 232 ~~-----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 232 DG-----DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cc-----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 22 233456777889999999999999999986
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=355.77 Aligned_cols=394 Identities=26% Similarity=0.287 Sum_probs=256.3
Q ss_pred CccEEeCCCCcCCCCcccccccC-C-CCCceeeccCccccCcccchhhcccccceEEEecCCccCCCCchhhhccCCCCc
Q 000889 275 SLKYLDLSHNNFTGKFSNLDFGR-C-GNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLK 352 (1237)
Q Consensus 275 ~L~~L~Ls~N~l~~~~~~~~~~~-l-~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~ 352 (1237)
.-..||++++.+.. +....+.+ + +.-+.|++++|+|+.+. +..|.++++|++++|.+|.++ .||.+ .+...+|+
T Consensus 53 ~~~lldcs~~~lea-~~~~~l~g~lp~~t~~LdlsnNkl~~id-~~~f~nl~nLq~v~l~~N~Lt-~IP~f-~~~sghl~ 128 (873)
T KOG4194|consen 53 NTRLLDCSDRELEA-IDKSRLKGFLPSQTQTLDLSNNKLSHID-FEFFYNLPNLQEVNLNKNELT-RIPRF-GHESGHLE 128 (873)
T ss_pred CceeeecCcccccc-ccccccCCcCccceeeeeccccccccCc-HHHHhcCCcceeeeeccchhh-hcccc-ccccccee
Confidence 34567777777652 11111111 1 12334555555555543 334555555555555555555 44442 12223355
Q ss_pred EEecCCCcCCCCCchhHhhhcCCCcEEEcccCcCCCCCCcCcccccccceeeccCccccCcccchhccccccceEEeccC
Q 000889 353 QLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPF 432 (1237)
Q Consensus 353 ~L~L~~n~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~ 432 (1237)
.|+|.+|.|+ ++..+-...++.|+.||||.|.|+.+.-..|..-.++++|+|++|+|
T Consensus 129 ~L~L~~N~I~-sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~I---------------------- 185 (873)
T KOG4194|consen 129 KLDLRHNLIS-SVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRI---------------------- 185 (873)
T ss_pred EEeeeccccc-cccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccc----------------------
Confidence 5555555555 33333333445555555555555544334444444455555555544
Q ss_pred CCCCCCCCccCCCCCCCcEEEccCCcCcccCCCCCCCCCCCcccceecccCceeeecccccccccccccEecccCCcccc
Q 000889 433 NNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAG 512 (1237)
Q Consensus 433 N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~ 512 (1237)
+..-...|.++.+|..|.|+.|+|+...+..| +++++|+.|+|..|+|....-.+|.++++|+.|.|..|.|..
T Consensus 186 ---t~l~~~~F~~lnsL~tlkLsrNrittLp~r~F---k~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~k 259 (873)
T KOG4194|consen 186 ---TTLETGHFDSLNSLLTLKLSRNRITTLPQRSF---KRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISK 259 (873)
T ss_pred ---cccccccccccchheeeecccCcccccCHHHh---hhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCccc
Confidence 44444555555555555555555553333333 345555555555555554445567778888888888888887
Q ss_pred CCCccccCCcCcceeecccccccCcccccccccCCCccEEEccccccccccccccccCCCccEEEeecccccccCCcccc
Q 000889 513 PVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIG 592 (1237)
Q Consensus 513 ~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 592 (1237)
.....|+.+.++++|+|..|++. .+.++...+++.|+.|+||+|.|..+-++++.-+++|++|+|++|+|+...+..|.
T Consensus 260 L~DG~Fy~l~kme~l~L~~N~l~-~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~ 338 (873)
T KOG4194|consen 260 LDDGAFYGLEKMEHLNLETNRLQ-AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFR 338 (873)
T ss_pred ccCcceeeecccceeecccchhh-hhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHH
Confidence 77778888888888888888887 67777777888899999999998888888888899999999999999977788899
Q ss_pred CccccceEEecCCccccCCCCCCCCCCCCCEEECCCCccccCCChhHHhhcccccCccccCccceeeccCCCccccCCCC
Q 000889 593 NLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGG 672 (1237)
Q Consensus 593 ~L~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (1237)
.|..|+.|+|++|+++..--..|..+++|+.|||++|.|++.|-..
T Consensus 339 ~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDa---------------------------------- 384 (873)
T KOG4194|consen 339 VLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDA---------------------------------- 384 (873)
T ss_pred HHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecc----------------------------------
Confidence 9999999999999998666677888899999999999888544321
Q ss_pred cccccCCCccccCCCccccCCCCcceeccceeeeeccCCceeEEEccCCcCCccCCccccCCCCCcEEEecCcccccccc
Q 000889 673 LVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIP 752 (1237)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~L~~LdLs~N~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~P 752 (1237)
...|.++.+|+.|+|.+|+|....-..|.+|.+|++|||.+|.+...-|
T Consensus 385 -------------------------------a~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~ 433 (873)
T KOG4194|consen 385 -------------------------------AVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQP 433 (873)
T ss_pred -------------------------------hhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecc
Confidence 0124445577888888888874444678888888888888888876667
Q ss_pred cccccccCCcEEeCCC
Q 000889 753 DSFGGLKAIGVLDLSH 768 (1237)
Q Consensus 753 ~~~~~L~~L~~L~Ls~ 768 (1237)
..|..+ .|++|.+..
T Consensus 434 nAFe~m-~Lk~Lv~nS 448 (873)
T KOG4194|consen 434 NAFEPM-ELKELVMNS 448 (873)
T ss_pred cccccc-hhhhhhhcc
Confidence 777777 777776643
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=357.78 Aligned_cols=260 Identities=26% Similarity=0.424 Sum_probs=207.0
Q ss_pred CCCCceecccCCeEEEEEEECC--C--CE-EEEEEecc---ccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEE
Q 000889 930 FSADSMIGSGGFGEVYKAQLRD--G--SV-VAIKKLIH---VTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLL 1001 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 1001 (1237)
....++||+|+||.||+|+++. + .. ||||.... .......+|.+|+++|++++|||||++||++......++
T Consensus 159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i 238 (474)
T KOG0194|consen 159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML 238 (474)
T ss_pred ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence 3445899999999999998763 2 23 89998874 234456789999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeeccccee
Q 000889 1002 VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~ 1081 (1237)
|||+|.||+|++|+++.. ..++..+..+++.+.|.||+|||++ +++||||.++|+|++.++.+||+|||+++.
T Consensus 239 vmEl~~gGsL~~~L~k~~----~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 239 VMELCNGGSLDDYLKKNK----KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEecCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccC
Confidence 999999999999998753 3699999999999999999999999 999999999999999999999999999875
Q ss_pred eccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhccccc
Q 000889 1082 VNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINE 1160 (1237)
Q Consensus 1082 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1160 (1237)
.. ..........-+..|+|||.+....|+.++|||||||++||+++ |..||.+.... .........
T Consensus 312 ~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~v~~kI~~~----- 378 (474)
T KOG0194|consen 312 GS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------EVKAKIVKN----- 378 (474)
T ss_pred Cc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------HHHHHHHhc-----
Confidence 43 11111112235679999999999999999999999999999999 88898754321 111111011
Q ss_pred ccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccccCCC
Q 000889 1161 ILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGD 1214 (1237)
Q Consensus 1161 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~~~~~ 1214 (1237)
..+.+.+...+. .+..++.+||..+|++||+|.++.+.++.+....+..
T Consensus 379 --~~r~~~~~~~p~---~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 379 --GYRMPIPSKTPK---ELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred --CccCCCCCCCHH---HHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 111222223333 4456666999999999999999999999988877654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=357.21 Aligned_cols=264 Identities=26% Similarity=0.430 Sum_probs=203.8
Q ss_pred hCCCCCCceecccCCeEEEEEEEC------CCCEEEEEEeccccC-cCHHHHHHHHHHHHhc-CCCCcccccceEEeC-C
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR------DGSVVAIKKLIHVTG-QGDREFMAEMETIGKI-KHRNLVPLLGYCKIG-E 997 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 997 (1237)
.++|++.++||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+++++++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 457899999999999999999752 356799998864322 2235688999999999 899999999988754 4
Q ss_pred eEEEEEEeccCCCHHHHHhhhhcC--------------------------------------------------------
Q 000889 998 ERLLVYEYMKWGSLESVLHDRAKG-------------------------------------------------------- 1021 (1237)
Q Consensus 998 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 1021 (1237)
..++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 578999999999999999753210
Q ss_pred -CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcceeeeccccCCCc
Q 000889 1022 -GGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGY 1100 (1237)
Q Consensus 1022 -~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y 1100 (1237)
....+++..+.+++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...............+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 013578888999999999999999999 9999999999999999999999999999865433322222344567889
Q ss_pred CCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCCCHHHHHHH
Q 000889 1101 VPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQY 1179 (1237)
Q Consensus 1101 ~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l 1179 (1237)
||||++.+..++.++|||||||++|||++ |..||...... .. +......... ... +.. ....+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~---~~~~~~~~~~------~~~--~~~---~~~~l 306 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EE---FCQRLKDGTR------MRA--PEN---ATPEI 306 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HH---HHHHHhcCCC------CCC--CCC---CCHHH
Confidence 99999998899999999999999999997 99998753221 11 1111111110 011 111 12356
Q ss_pred HHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 000889 1180 LRISFECLDDRPFKRPTMIQVMAMFKELQV 1209 (1237)
Q Consensus 1180 ~~li~~cl~~dP~~RPt~~ell~~L~~l~~ 1209 (1237)
.+++.+||+.+|++|||+.++++.|+++..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 788899999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=340.68 Aligned_cols=254 Identities=23% Similarity=0.319 Sum_probs=202.1
Q ss_pred HhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEE
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLL 1001 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 1001 (1237)
..++|++.+.||+|+||.||+|+-+ +|..+|.|++.+.. ..+.+++..|-.+|...++|.||++|..|++.+..|+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4568999999999999999999876 58999999997543 3345678899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeeccccee
Q 000889 1002 VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~ 1081 (1237)
||||++||++..+|... ..+++..++.++.+++-|++.+|+. |+|||||||+|+|||..|++||+|||++.-
T Consensus 219 iMEylPGGD~mTLL~~~-----~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRK-----DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEecCCccHHHHHHhc-----CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccch
Confidence 99999999999999764 5899999999999999999999999 999999999999999999999999999852
Q ss_pred ecc----------------------CCcc-----ee------------------eeccccCCCcCCccccCccccCcccc
Q 000889 1082 VNA----------------------LDTH-----LS------------------VSTLAGTPGYVPPEYYQSFRCTTKGD 1116 (1237)
Q Consensus 1082 ~~~----------------------~~~~-----~~------------------~~~~~gt~~y~aPE~~~~~~~~~~sD 1116 (1237)
... .+.. .. ....+|||.|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 211 0000 00 12467999999999999999999999
Q ss_pred hHHHHHHHHHHHcCCCCCCCCCCCCC-chHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCC
Q 000889 1117 VYSYGVILLELLSGKRPIDPSEFGDD-NNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRP 1195 (1237)
Q Consensus 1117 vwSlGv~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1195 (1237)
+||+|||||||+.|.+||..+...+. ..+..|...+. . +...... .+..++|.+|+. ||++|.
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~------f------P~~~~~s---~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK------F------PEEVDLS---DEAKDLITRLLC-DPENRL 434 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc------C------CCcCccc---HHHHHHHHHHhc-CHHHhc
Confidence 99999999999999999986543221 11222221111 1 0011111 345577778888 999998
Q ss_pred C---HHHHHHH
Q 000889 1196 T---MIQVMAM 1203 (1237)
Q Consensus 1196 t---~~ell~~ 1203 (1237)
- +.||.+|
T Consensus 435 G~~G~~EIK~H 445 (550)
T KOG0605|consen 435 GSKGAEEIKKH 445 (550)
T ss_pred CcccHHHHhcC
Confidence 5 6666655
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=352.52 Aligned_cols=242 Identities=27% Similarity=0.376 Sum_probs=197.2
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcC-CCCcccccceEEeCCeEEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIK-HRNLVPLLGYCKIGEERLL 1001 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 1001 (1237)
-++|...++||+|+||.|++|..+ +++.+|||.+++.. ..+.+..+.|.+++.... ||.++.++.+|++.++.|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 457899999999999999999988 57899999987543 344556788999988875 9999999999999999999
Q ss_pred EEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeeccccee
Q 000889 1002 VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~ 1081 (1237)
||||+.||++..+.+. ..+++..+..++..|+.||.|||++ +|||||||.+|||+|.+|++||+|||+++.
T Consensus 447 vmey~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEecCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccc
Confidence 9999999994443332 5799999999999999999999999 999999999999999999999999999985
Q ss_pred eccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccc
Q 000889 1082 VNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161 (1237)
Q Consensus 1082 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1161 (1237)
.- ......++.||||.|||||++.+..|+.++|+|||||+||||+.|..||.+...+ +....|
T Consensus 518 ~m--~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---------------e~FdsI 580 (694)
T KOG0694|consen 518 GM--GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---------------EVFDSI 580 (694)
T ss_pred cC--CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH---------------HHHHHH
Confidence 43 2233567899999999999999999999999999999999999999999854311 111111
Q ss_pred cCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 000889 1162 LDPELTMQTSDETELYQYLRISFECLDDRPFKRPTM 1197 (1237)
Q Consensus 1162 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1197 (1237)
+..+..-+.. ...+.+.|+.+++.++|++|.-+
T Consensus 581 ~~d~~~yP~~---ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 581 VNDEVRYPRF---LSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred hcCCCCCCCc---ccHHHHHHHHHHhccCcccccCC
Confidence 1111111111 22345677789999999999865
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=324.70 Aligned_cols=248 Identities=27% Similarity=0.409 Sum_probs=208.9
Q ss_pred CCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccC
Q 000889 930 FSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
|.++.+||+|+||.||+|.++ .|..+|+|++.. ..+.+++..|+.+|++++.|+||++||.+......|+|||||.-
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 556778999999999999887 589999998853 34678899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
|+..+.++.++ +++.+.+...++.+.++||+|||.. .-+|||||+.|||+..+|++|++|||.|..+. ++-
T Consensus 113 GSiSDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT--DTM 183 (502)
T KOG0574|consen 113 GSISDIMRARR----KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLT--DTM 183 (502)
T ss_pred CcHHHHHHHhc----CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhh--hhH
Confidence 99999998775 4799999999999999999999999 88999999999999999999999999997654 333
Q ss_pred eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccC
Q 000889 1089 LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTM 1168 (1237)
Q Consensus 1089 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1168 (1237)
.+.++..|||.|||||++..-.|..++||||+|++..||..|++||..-.. ...+.-+-....+.
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP---------------MRAIFMIPT~PPPT 248 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP---------------MRAIFMIPTKPPPT 248 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc---------------cceeEeccCCCCCC
Confidence 445778999999999999999999999999999999999999999863211 11111111111111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1169 QTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1169 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
....+....+|-+++++|+-+.|++|.|+.++.++
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 12234456678889999999999999999999886
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=328.10 Aligned_cols=248 Identities=22% Similarity=0.375 Sum_probs=208.2
Q ss_pred hCCCCCCceecccCCeEEEEEEE-CCCCEEEEEEeccccCcCHH---HHHHHHHHHHhcCCCCcccccceEEeCCeEEEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQL-RDGSVVAIKKLIHVTGQGDR---EFMAEMETIGKIKHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 1002 (1237)
.++|++.+.||+|.||.|-+|+. ..|+.||||.+.+....+.+ .+.+|+++|..++||||+.+|.+|+..+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45788888999999999999976 57999999999876655554 467899999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceee
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~ 1082 (1237)
|||..+|.|++|+.++ +.+++.+++.++.||+.|+.|+|.+ +|||||+|.+|||+|.++.+||+|||++-.+
T Consensus 132 MEYaS~GeLYDYiSer-----~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 132 MEYASGGELYDYISER-----GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEecCCccHHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhh
Confidence 9999999999999876 5799999999999999999999999 9999999999999999999999999999776
Q ss_pred ccCCcceeeeccccCCCcCCccccCccccC-cccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccc
Q 000889 1083 NALDTHLSVSTLAGTPGYVPPEYYQSFRCT-TKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161 (1237)
Q Consensus 1083 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1161 (1237)
.... -..++||++-|.+||.+.+..|. ..+|.||+||++|-++.|..||++... ....+ ++
T Consensus 204 ~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh------k~lvr---------QI 265 (668)
T KOG0611|consen 204 ADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH------KRLVR---------QI 265 (668)
T ss_pred cccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH------HHHHH---------Hh
Confidence 5322 23578999999999999998885 679999999999999999999986431 11122 22
Q ss_pred cCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1162 LDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1162 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
-...+..+.... ....+|++|+.++|++|.|+.++..+-
T Consensus 266 s~GaYrEP~~PS----dA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 266 SRGAYREPETPS----DASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred hcccccCCCCCc----hHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 222222222222 334677899999999999999999884
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=325.64 Aligned_cols=271 Identities=25% Similarity=0.405 Sum_probs=215.6
Q ss_pred hCCCCCCceecccCCeEEEEEEECCCCEEEEEEeccccCcCHHHHHHHHHHHHhc--CCCCcccccceEEeC----CeEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKI--KHRNLVPLLGYCKIG----EERL 1000 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~~~~ 1000 (1237)
..+.++.+.||+|.||+||+|.++ |+.||||.+.. .+++.+.+|.++++.. +|+||..+++.-..+ .+.|
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 345677889999999999999998 89999999864 4566788888887764 999999999986544 3679
Q ss_pred EEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCCeeeCCCCceEEee
Q 000889 1001 LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHS-----CIPHIIHRDMKSSNVLLDENFEARVSD 1075 (1237)
Q Consensus 1001 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivHrDikp~NIll~~~~~vkl~D 1075 (1237)
+|.+|.+.|+|.||+.. ..++...+.+++..+|.||++||.. .+|.|+|||||+.|||+.+++.+.|+|
T Consensus 286 LvTdYHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EeeecccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 99999999999999986 3789999999999999999999965 467899999999999999999999999
Q ss_pred cccceeeccCCc--ceeeeccccCCCcCCccccCccc----c-C-cccchHHHHHHHHHHHc----------CCCCCCCC
Q 000889 1076 FGMARLVNALDT--HLSVSTLAGTPGYVPPEYYQSFR----C-T-TKGDVYSYGVILLELLS----------GKRPIDPS 1137 (1237)
Q Consensus 1076 fGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~-~-~~sDvwSlGv~l~el~t----------g~~p~~~~ 1137 (1237)
+|+|........ ....+..+||.+|||||++...- + + ..+||||||.|+||+.. -+.||..-
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 999987765432 23346688999999999996431 1 1 35899999999999975 24566543
Q ss_pred CCCCCchHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccccCC
Q 000889 1138 EFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEG 1213 (1237)
Q Consensus 1138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~~~~ 1213 (1237)
-..++ .+..+ ++-.-.+.+.|..+..+...+.+..+.+++..||..+|..|-|+-.+.+.|.++....++
T Consensus 440 Vp~DP-s~eeM-----rkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~ek 509 (513)
T KOG2052|consen 440 VPSDP-SFEEM-----RKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDEK 509 (513)
T ss_pred CCCCC-CHHHH-----hcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChhh
Confidence 22211 11111 111122334566777777788999999999999999999999999999999998864433
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=335.54 Aligned_cols=264 Identities=25% Similarity=0.291 Sum_probs=206.4
Q ss_pred HHHHHhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC--------------cCHHHHHHHHHHHHhcCCCCc
Q 000889 922 HLLEATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG--------------QGDREFMAEMETIGKIKHRNL 986 (1237)
Q Consensus 922 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~ni 986 (1237)
+-.+..+.|++.+.||+|.||.|-+|+.. +++.||+|.+.+... ...+...+|+.+|++++||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 33445678999999999999999999987 688999998853221 112467899999999999999
Q ss_pred ccccceEEe--CCeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 000889 987 VPLLGYCKI--GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVL 1064 (1237)
Q Consensus 987 v~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIl 1064 (1237)
|+++++..+ .+..|||+|||..|.+...-.. ...+.+.++++++.+++.||+|||.+ +||||||||+|+|
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d-----~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLL 242 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPD-----KPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLL 242 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCCCC-----cccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheE
Confidence 999999865 4678999999999887543211 12389999999999999999999999 9999999999999
Q ss_pred eCCCCceEEeecccceeeccCC---cceeeeccccCCCcCCccccCccc----cCcccchHHHHHHHHHHHcCCCCCCCC
Q 000889 1065 LDENFEARVSDFGMARLVNALD---THLSVSTLAGTPGYVPPEYYQSFR----CTTKGDVYSYGVILLELLSGKRPIDPS 1137 (1237)
Q Consensus 1065 l~~~~~vkl~DfGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGv~l~el~tg~~p~~~~ 1137 (1237)
++++|+|||+|||.+....... ........+|||.|||||...++. .+.+.||||+||++|.|+.|+.||...
T Consensus 243 l~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 243 LSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred EcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 9999999999999998663221 122233478999999999987632 356889999999999999999999643
Q ss_pred CCCCCchHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 000889 1138 EFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQV 1209 (1237)
Q Consensus 1138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~ 1209 (1237)
.. .+...+|+...+..+.. ++...++.++|.+++.+||+.|.+..+|..+..--..
T Consensus 323 ~~---------------~~l~~KIvn~pL~fP~~-pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 323 FE---------------LELFDKIVNDPLEFPEN-PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred hH---------------HHHHHHHhcCcccCCCc-ccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 21 11223344444443332 2344567788999999999999999999988755443
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=345.66 Aligned_cols=266 Identities=23% Similarity=0.380 Sum_probs=202.1
Q ss_pred CCCCCCceecccCCeEEEEEEECC-----------------CCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccc
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD-----------------GSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPL 989 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l 989 (1237)
++|++.++||+|+||.||+|++++ +..||+|.+..... ....++.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578889999999999999998642 23699998864322 224568899999999999999999
Q ss_pred cceEEeCCeEEEEEEeccCCCHHHHHhhhhcC--------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 000889 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKG--------------GGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIH 1055 (1237)
Q Consensus 990 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH 1055 (1237)
++++.+.+..++||||+++|+|.+++...... ....+++..+.+++.|++.||+|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 99999999999999999999999998653211 113568888999999999999999999 9999
Q ss_pred cCCCCCCeeeCCCCceEEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc--CCCC
Q 000889 1056 RDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS--GKRP 1133 (1237)
Q Consensus 1056 rDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t--g~~p 1133 (1237)
|||||+||+++.++.+||+|||+++.....+.........++..|||||++.+..++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986654333222234456789999999988889999999999999999987 5566
Q ss_pred CCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 000889 1134 IDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206 (1237)
Q Consensus 1134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 1206 (1237)
|.... ................ ..... ..+ +.....+.+++.+||+.+|++|||+.++.+.|++
T Consensus 242 ~~~~~---~~~~~~~~~~~~~~~~-~~~~~---~~~---~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELT---DEQVIENAGEFFRDQG-RQVYL---FRP---PPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCC---HHHHHHHHHHHhhhcc-ccccc---cCC---CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 65322 1111111111111110 00000 000 1122457788899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=308.48 Aligned_cols=250 Identities=26% Similarity=0.388 Sum_probs=206.3
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 1002 (1237)
.++|++.+.||+|.||.||.|+.+ ++-.||+|++.+.. ..-.+++.+|+++-..++||||.++|++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 346889999999999999999876 57789999987543 23456789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceee
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~ 1082 (1237)
+||.++|++...++... ..++++.....+..|+|.|+.|+|.. +|+||||||+|+|++.++.+||+|||.+..-
T Consensus 101 lEya~~gel~k~L~~~~---~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGR---MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEecCCchHHHHHHhcc---cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999998643 35788888899999999999999999 9999999999999999999999999999644
Q ss_pred ccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccccccc
Q 000889 1083 NALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162 (1237)
Q Consensus 1083 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1162 (1237)
. ..+..+.|||..|.|||+..+..++.++|+|++|++.||++.|.+||...... ..+. ++.
T Consensus 175 p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-----etYk----------rI~ 235 (281)
T KOG0580|consen 175 P----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-----ETYK----------RIR 235 (281)
T ss_pred C----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-----HHHH----------HHH
Confidence 3 22346789999999999999999999999999999999999999999753310 0111 111
Q ss_pred CccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1163 DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1163 ~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
..++..+...+ ....++|.+|+..+|.+|.+..|++++-
T Consensus 236 k~~~~~p~~is---~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 236 KVDLKFPSTIS---GGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred HccccCCcccC---hhHHHHHHHHhccCccccccHHHHhhhH
Confidence 11111111122 2445788899999999999999999873
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=345.36 Aligned_cols=249 Identities=27% Similarity=0.352 Sum_probs=207.3
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 1002 (1237)
.+.|++.+.||.|+.|.|.+|++. +|+.+|||.+.+.. ......+.+|+-+|+-+.||||+++|+++....++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 356888899999999999999876 69999999887542 22244578999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceee
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~ 1082 (1237)
.||++||.|.+++..+ +++++.++.+++.||+.|+.|+|.. +|+|||+||+|+|+|..+.+||+|||+|..-
T Consensus 91 lEyv~gGELFdylv~k-----G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe 162 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRK-----GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLE 162 (786)
T ss_pred EEecCCchhHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecc
Confidence 9999999999999864 5789999999999999999999999 9999999999999999999999999999743
Q ss_pred ccCCcceeeeccccCCCcCCccccCccccC-cccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccc
Q 000889 1083 NALDTHLSVSTLAGTPGYVPPEYYQSFRCT-TKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161 (1237)
Q Consensus 1083 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1161 (1237)
.. ..-..+.||.|.|.|||++.|..|. .++||||.|||+|.|++|+.||+. +++.....+..++
T Consensus 163 ~~---gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD------dNir~LLlKV~~G------ 227 (786)
T KOG0588|consen 163 VP---GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD------DNIRVLLLKVQRG------ 227 (786)
T ss_pred cC---CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC------ccHHHHHHHHHcC------
Confidence 32 2234678999999999999998874 789999999999999999999973 3444333332222
Q ss_pred cCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1162 LDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1162 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
.+.++...+. +..+++.+|+.+||++|.|+.||++|-
T Consensus 228 ---~f~MPs~Is~---eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 228 ---VFEMPSNISS---EAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred ---cccCCCcCCH---HHHHHHHHHhccCccccccHHHHhhCc
Confidence 2223322333 345677799999999999999999984
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=326.82 Aligned_cols=253 Identities=23% Similarity=0.307 Sum_probs=205.9
Q ss_pred CCCCCceecccCCeEEEEEEECC-CCEEEEEEeccccCcC---HHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQG---DREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
.|+..+.||+|.-|+||+++.++ +..+|+|++.+..... ..+...|-+|++.++||.++.+|+.++.+...|+|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 35667889999999999999885 5889999997544332 3346679999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
||+||+|..+++++. ++.+++..++.++.+++-||+|||.. |||+||+||+||||.++|++.++||.++..+..
T Consensus 158 yCpGGdL~~LrqkQp---~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQP---GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred cCCCccHHHHHhhCC---CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 999999999988754 46899999999999999999999999 999999999999999999999999999764311
Q ss_pred CC---------------------------------c---------------------ceeeeccccCCCcCCccccCccc
Q 000889 1085 LD---------------------------------T---------------------HLSVSTLAGTPGYVPPEYYQSFR 1110 (1237)
Q Consensus 1085 ~~---------------------------------~---------------------~~~~~~~~gt~~y~aPE~~~~~~ 1110 (1237)
.. . ..+...++||..|.|||++.|..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 00 0 01123467999999999999999
Q ss_pred cCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccC
Q 000889 1111 CTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDR 1190 (1237)
Q Consensus 1111 ~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~d 1190 (1237)
++.++|+|+|||++|||+.|..||.+..- ...+..++..++..+... .......++|++.+.+|
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~---------------~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNN---------------KETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCc---------------hhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccC
Confidence 99999999999999999999999986532 122233333333333222 23345678888999999
Q ss_pred CCCCCC----HHHHHHH
Q 000889 1191 PFKRPT----MIQVMAM 1203 (1237)
Q Consensus 1191 P~~RPt----~~ell~~ 1203 (1237)
|.+|.- ++||.++
T Consensus 376 P~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhhhccccchHHhhcC
Confidence 999998 8888877
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=350.44 Aligned_cols=472 Identities=29% Similarity=0.434 Sum_probs=327.8
Q ss_pred CccEEeCCCCcCCCCcccccccCCCCCceeeccCccccCcccchhhcccccceEEEecCCccCCCCchhhhccCCCCcEE
Q 000889 275 SLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQL 354 (1237)
Q Consensus 275 ~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L 354 (1237)
.|+.|.+++|.++... .++.++..|.+|++++|+++ ..|++++.+..++.|+.++|+++ .+|.. .+.+.+|+.|
T Consensus 46 ~l~~lils~N~l~~l~--~dl~nL~~l~vl~~~~n~l~--~lp~aig~l~~l~~l~vs~n~ls-~lp~~-i~s~~~l~~l 119 (565)
T KOG0472|consen 46 DLQKLILSHNDLEVLR--EDLKNLACLTVLNVHDNKLS--QLPAAIGELEALKSLNVSHNKLS-ELPEQ-IGSLISLVKL 119 (565)
T ss_pred chhhhhhccCchhhcc--HhhhcccceeEEEeccchhh--hCCHHHHHHHHHHHhhcccchHh-hccHH-Hhhhhhhhhh
Confidence 4666677777665322 24566777777777777774 46777888888888888888887 55554 4677788888
Q ss_pred ecCCCcCCCCCchhHhhhcCCCcEEEcccCcCCCCCCcCcccccccceeeccCccccCcccchhccccccceEEeccCCC
Q 000889 355 SLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNN 434 (1237)
Q Consensus 355 ~L~~n~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~ 434 (1237)
++++|++. ++|++++.. -.|+.|+..+|+++ ..|..+.++.+|..|++.+|++.. .++..+. ++.|++|++..|.
T Consensus 120 ~~s~n~~~-el~~~i~~~-~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~-l~~~~i~-m~~L~~ld~~~N~ 194 (565)
T KOG0472|consen 120 DCSSNELK-ELPDSIGRL-LDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKA-LPENHIA-MKRLKHLDCNSNL 194 (565)
T ss_pred hcccccee-ecCchHHHH-hhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhh-CCHHHHH-HHHHHhcccchhh
Confidence 88888887 778777764 57888888888887 567777778888888888888763 3333333 7777777777777
Q ss_pred CCCCCCccCCCCCCCcEEEccCCcCcccCCCCCCCCCCCcccceecccCceeeeccccccc-ccccccEecccCCccccC
Q 000889 435 ISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELG-SCKNLKTIDLSFNSLAGP 513 (1237)
Q Consensus 435 i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~-~l~~L~~L~Ls~N~l~~~ 513 (1237)
++ .+|..++.+.+|..|+|..|+|. ..| .| .+.+.|++|+++.|+|. .+|.+.+ ++.+|.+|||..|+++ .
T Consensus 195 L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef---~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e 266 (565)
T KOG0472|consen 195 LE-TLPPELGGLESLELLYLRRNKIR-FLP-EF---PGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-E 266 (565)
T ss_pred hh-cCChhhcchhhhHHHHhhhcccc-cCC-CC---CccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-c
Confidence 76 56667777777777777777776 455 34 45566777777777776 3444433 6777777777777777 6
Q ss_pred CCccccCCcCcceeecccccccCcccccccccCCCccEEEccccccccccccccccCC---CccEEE-------eeccc-
Q 000889 514 VPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCT---NMLWVS-------LSSNQ- 582 (1237)
Q Consensus 514 ~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~---~L~~L~-------Ls~N~- 582 (1237)
.|.++.-+.+|+.||+++|.++ .+|... .++ .|+.|-+.+|.+..+ -..+-+.. -|++|. +|.-.
T Consensus 267 ~Pde~clLrsL~rLDlSNN~is-~Lp~sL-gnl-hL~~L~leGNPlrTi-Rr~ii~~gT~~vLKyLrs~~~~dglS~se~ 342 (565)
T KOG0472|consen 267 VPDEICLLRSLERLDLSNNDIS-SLPYSL-GNL-HLKFLALEGNPLRTI-RREIISKGTQEVLKYLRSKIKDDGLSQSEG 342 (565)
T ss_pred CchHHHHhhhhhhhcccCCccc-cCCccc-ccc-eeeehhhcCCchHHH-HHHHHcccHHHHHHHHHHhhccCCCCCCcc
Confidence 7777777777777777777777 555554 344 666777777766522 22111111 111110 11100
Q ss_pred ---ccccCCc----cccCccccceEEecCCccccCCCCCCCCCCC---CCEEECCCCccccCCChhHHhhcccccCcccc
Q 000889 583 ---LTGEIPA----GIGNLVKLAILQLGNNSLTGQVPQGLGKCRS---LVWLDLNSNNLSGPLPSELANQAGVVMPGIVS 652 (1237)
Q Consensus 583 ---l~~~~p~----~~~~L~~L~~L~L~~N~l~~~~p~~l~~l~~---L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~ 652 (1237)
=++..|. ....+...+.|+++.=+++ .+|.....-.. .+..+++.|++. ++|..+..+..++..-..+
T Consensus 343 ~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~ls 420 (565)
T KOG0472|consen 343 GTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLS 420 (565)
T ss_pred cccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhh
Confidence 0001111 2334566778888888888 66665443333 677888888887 7888777665543322222
Q ss_pred CccceeeccCCCccccCCCCcccccCCCccccCCCccccCCCCcceeccceeeeeccCCceeEEEccCCcCCccCCcccc
Q 000889 653 GKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFG 732 (1237)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~L~~LdLs~N~l~g~~p~~~~ 732 (1237)
.+...|+ ....+..++|..|+|++|-+. .+|.+++
T Consensus 421 nn~isfv--------------------------------------------~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~ 455 (565)
T KOG0472|consen 421 NNKISFV--------------------------------------------PLELSQLQKLTFLDLSNNLLN-DLPEEMG 455 (565)
T ss_pred cCccccc--------------------------------------------hHHHHhhhcceeeecccchhh-hcchhhh
Confidence 2222111 112234458999999999998 8999999
Q ss_pred CCCCCcEEEecCcccccccccccccccCCcEEeCCCCccCCCCCCcccCcccccceecccccccccCCCCCCCCccCCCc
Q 000889 733 SLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASR 812 (1237)
Q Consensus 733 ~L~~L~~L~Ls~N~l~~~~P~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~ 812 (1237)
.+..|+.||+|+|+|. .+|..+-.+.-|+.+-.++|++....|..+.+|.+|..|||.+|.+..+||..|.++++....
T Consensus 456 ~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLe 534 (565)
T KOG0472|consen 456 SLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLE 534 (565)
T ss_pred hhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEE
Confidence 9999999999999999 999999999889988889999986556669999999999999999999999999999999998
Q ss_pred ccCCC
Q 000889 813 YENNS 817 (1237)
Q Consensus 813 ~~~n~ 817 (1237)
+.||+
T Consensus 535 L~gNp 539 (565)
T KOG0472|consen 535 LDGNP 539 (565)
T ss_pred ecCCc
Confidence 88886
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=329.50 Aligned_cols=267 Identities=29% Similarity=0.394 Sum_probs=201.5
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCe-----EEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEE-----RLLV 1002 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~lv 1002 (1237)
.|+..+++|.|+||.||+|... +++.||||++...... -.+|+++|++++|||||++..+|....+ ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4666789999999999999876 4689999998654332 2379999999999999999998865332 3589
Q ss_pred EEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCC-CceEEeeccccee
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDEN-FEARVSDFGMARL 1081 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~-~~vkl~DfGla~~ 1081 (1237)
||||+ .+|.++++..... +..++...++-+.+|+.+|++|||+. +|+||||||+|+|+|.+ |.+||||||.|+.
T Consensus 101 leymP-~tL~~~~r~~~~~-~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRA-NQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHhch-HHHHHHHHHHhhc-CCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 99998 7999999864332 35778888899999999999999998 99999999999999965 9999999999998
Q ss_pred eccCCcceeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhh--ccc
Q 000889 1082 VNALDTHLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE--KRI 1158 (1237)
Q Consensus 1082 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 1158 (1237)
....... .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+... .+.+....+..... +.+
T Consensus 176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~--~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS--VDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH--HHHHHHHHHHhCCCCHHHH
Confidence 8765554 235678899999998865 699999999999999999999999987432 23333333322111 111
Q ss_pred cc-------ccCccccCCC----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhccc
Q 000889 1159 NE-------ILDPELTMQT----SDETELYQYLRISFECLDDRPFKRPTMIQVMAM--FKELQV 1209 (1237)
Q Consensus 1159 ~~-------~~~~~l~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~--L~~l~~ 1209 (1237)
.. ...+.+.... .......+.++++.+++..+|.+|.++.+++++ +.++..
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 11 1111111111 111223456778889999999999999999977 444443
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=305.57 Aligned_cols=265 Identities=22% Similarity=0.317 Sum_probs=211.3
Q ss_pred hCCCCCCceecccCCeEEEEEEE-CCCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeC-----CeEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQL-RDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIG-----EERL 1000 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 1000 (1237)
..+|++.+.+|+|||+.||+++. .++..+|+|++.....++.+..++|++..++++||||++++++...+ .+.|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 45799999999999999999984 46889999999876667778889999999999999999999987443 3589
Q ss_pred EEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccce
Q 000889 1001 LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1080 (1237)
Q Consensus 1001 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~ 1080 (1237)
++++|...|+|.+.++.... ++..+++.+..+|+.++++||++||+.. ++++||||||.||++++.+.+++.|||.+.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEeehhccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 99999999999999987644 3568999999999999999999999982 359999999999999999999999999987
Q ss_pred eeccCCcce-------eeeccccCCCcCCccccC---ccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHH
Q 000889 1081 LVNALDTHL-------SVSTLAGTPGYVPPEYYQ---SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAK 1150 (1237)
Q Consensus 1081 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~ 1150 (1237)
...-.-... .-.....|..|+|||.+. +...+.++|||||||++|+|+.|..||+....
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~----------- 246 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ----------- 246 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----------
Confidence 543211100 012244688999999985 44568899999999999999999999974321
Q ss_pred HHhhhcccc-cccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 000889 1151 QLHREKRIN-EILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208 (1237)
Q Consensus 1151 ~~~~~~~~~-~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~ 1208 (1237)
+.+.+. .+..+.+..+... ...+.+.+++..|+++||.+||++.+++..++.+.
T Consensus 247 ---~GgSlaLAv~n~q~s~P~~~-~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 ---QGGSLALAVQNAQISIPNSS-RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---cCCeEEEeeeccccccCCCC-CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 222222 2223333322222 24557788899999999999999999999988753
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=324.02 Aligned_cols=280 Identities=24% Similarity=0.346 Sum_probs=209.5
Q ss_pred HhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecc--ccCcCHHHHHHHHHHHHhcCCCCcccccceEEe-----CC
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIH--VTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI-----GE 997 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~ 997 (1237)
....|...+.||+|+||.|+.|.++ +|+.||+||+.. ......++..+|+++++.++|+||+.+++.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3445666788999999999999887 689999999973 333445678899999999999999999998855 35
Q ss_pred eEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecc
Q 000889 998 ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFG 1077 (1237)
Q Consensus 998 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfG 1077 (1237)
..|+|+|+|+ .+|...++.. +.++...+..+++|+++|+.|+|+. +|+|||+||+|++++.+..+||+|||
T Consensus 100 DvYiV~elMe-tDL~~iik~~-----~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKSQ-----QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred eeEEehhHHh-hHHHHHHHcC-----ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence 7899999994 7899998763 4589999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcceeeeccccCCCcCCccccC-ccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHH--------
Q 000889 1078 MARLVNALDTHLSVSTLAGTPGYVPPEYYQ-SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGW-------- 1148 (1237)
Q Consensus 1078 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~-------- 1148 (1237)
+|+...........+..+.|..|.|||++. ...|+.++||||.|||+.||++|++-|.+........+...
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 999876543333446677899999999875 46799999999999999999999999987543221111000
Q ss_pred -HHHHh----hh--cccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhcccccCCCCC
Q 000889 1149 -AKQLH----RE--KRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM--FKELQVDTEGDSL 1216 (1237)
Q Consensus 1149 -~~~~~----~~--~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~--L~~l~~~~~~~~~ 1216 (1237)
..... +. ......-...+.. -.+......++++.+|+..||.+|+|++|++++ |.......+.+..
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~--~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~ 325 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSS--IFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVC 325 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHH--HcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCC
Confidence 00000 00 0000000000000 001112345677789999999999999999998 5666555544433
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=339.12 Aligned_cols=247 Identities=19% Similarity=0.293 Sum_probs=197.5
Q ss_pred ceecccCCeEEEEEEECCCCEEEEEEeccccCcC---HHHHHHHHHHHHhcCCCCcccccceEEe----CCeEEEEEEec
Q 000889 934 SMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQG---DREFMAEMETIGKIKHRNLVPLLGYCKI----GEERLLVYEYM 1006 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 1006 (1237)
..||+|++|.||+|.+ +|+.||||++....... .+.+.+|++++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 48899999987543333 3567899999999999999999999876 34679999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
++|+|.+++... ..+++....+++.+++.|++|||+.. +++||||||+||++++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 105 TRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 999999999753 46889999999999999999999842 78899999999999999999999999998654321
Q ss_pred cceeeeccccCCCcCCccccCc--cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQS--FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDP 1164 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1164 (1237)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... ........... .
T Consensus 178 -----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~------~~~~~~i~~~~-------~ 239 (283)
T PHA02988 178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT------KEIYDLIINKN-------N 239 (283)
T ss_pred -----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcC-------C
Confidence 23467899999999976 6789999999999999999999999975321 11111111110 0
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 000889 1165 ELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQV 1209 (1237)
Q Consensus 1165 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~ 1209 (1237)
+...+.. ....+.+++.+||+.||++|||+.++++.|+.++.
T Consensus 240 ~~~~~~~---~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 240 SLKLPLD---CPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCCCCCc---CcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1111111 22356788889999999999999999999988753
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=337.48 Aligned_cols=252 Identities=25% Similarity=0.316 Sum_probs=199.3
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
.|+..+.||+|+||.||+|.+. +++.||+|++.... ......+.+|++++++++|++|+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677889999999999999875 68899999886432 1223457889999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
|+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 81 IMNGGDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred ecCCCcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 999999998886432 23688999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCc
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDP 1164 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1164 (1237)
.. ......|++.|||||++.+..++.++||||+||++|||++|+.||........ ....... .. ..
T Consensus 155 ~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~-~~--------~~ 220 (285)
T cd05631 155 GE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--REEVDRR-VK--------ED 220 (285)
T ss_pred CC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--HHHHHHH-hh--------cc
Confidence 22 12345789999999999999999999999999999999999999975432110 0111110 00 00
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 000889 1165 ELTMQTSDETELYQYLRISFECLDDRPFKRPT-----MIQVMAM 1203 (1237)
Q Consensus 1165 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~~ 1203 (1237)
...... .....+.+++.+||+.+|++||+ +++++++
T Consensus 221 ~~~~~~---~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 221 QEEYSE---KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cccCCc---cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 000111 11235667888999999999997 7888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=311.14 Aligned_cols=253 Identities=24% Similarity=0.313 Sum_probs=199.7
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEec--cccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLI--HVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
.+.|++.+.||+|.|+.||+.... +|+.+|+|.+. +....+.+++.+|+++.+.++|||||++.+.+.+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 346777889999999999998765 57888888664 223446678899999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeC---CCCceEEeecccce
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLD---ENFEARVSDFGMAR 1080 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~---~~~~vkl~DfGla~ 1080 (1237)
|+|.|++|..-+-.+ ...++..+-..+.||++|+.|+|.+ +|||||+||+|+++. ...-+|++|||+|.
T Consensus 90 e~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred ecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence 999999998766554 3578888899999999999999999 999999999999995 34569999999999
Q ss_pred eeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccccc
Q 000889 1081 LVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINE 1160 (1237)
Q Consensus 1081 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1160 (1237)
.+.... ....++|||+|||||+++..+|+.++|||+.||++|-++.|++||.+... ..+ +......
T Consensus 162 ~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~---~rl--ye~I~~g------ 227 (355)
T KOG0033|consen 162 EVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRL--YEQIKAG------ 227 (355)
T ss_pred EeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH---HHH--HHHHhcc------
Confidence 887222 23567899999999999999999999999999999999999999975321 111 1111111
Q ss_pred ccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1161 ILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1161 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
.+|-..+.-....+ ...+++.+|+..||.+|.|+.|++++=
T Consensus 228 ~yd~~~~~w~~is~---~Ak~LvrrML~~dP~kRIta~EAL~Hp 268 (355)
T KOG0033|consen 228 AYDYPSPEWDTVTP---EAKSLIRRMLTVNPKKRITADEALKHP 268 (355)
T ss_pred ccCCCCcccCcCCH---HHHHHHHHHhccChhhhccHHHHhCCc
Confidence 11111111111122 334677799999999999999998763
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=356.98 Aligned_cols=260 Identities=26% Similarity=0.342 Sum_probs=214.0
Q ss_pred hCCCCCCceecccCCeEEEEEEECCC-CEEEEEEeccccCcCHHHHHHHHHHHHhcC-CCCcccccce-EEe------CC
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLRDG-SVVAIKKLIHVTGQGDREFMAEMETIGKIK-HRNLVPLLGY-CKI------GE 997 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~~ 997 (1237)
..++++.++|.+|||+.||.|++..+ ..||+|++........+.+.+|+++|++|+ |||||.+++. ... .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 45678889999999999999998876 999999998766666778899999999997 9999999993 221 23
Q ss_pred eEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecc
Q 000889 998 ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFG 1077 (1237)
Q Consensus 998 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfG 1077 (1237)
++++.||||.||.|-+++..+.. ..+++.++++|+.|+++|+++||.. .++|||||||-+|||++.+++.||||||
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence 67899999999999999998765 3599999999999999999999997 5679999999999999999999999999
Q ss_pred cceeeccCC-cceee------eccccCCCcCCcccc---CccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHH
Q 000889 1078 MARLVNALD-THLSV------STLAGTPGYVPPEYY---QSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVG 1147 (1237)
Q Consensus 1078 la~~~~~~~-~~~~~------~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~ 1147 (1237)
.|...-... ..... -...-|+.|+|||++ .+...+.|+|||+|||++|-++....||+...
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg--------- 262 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG--------- 262 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc---------
Confidence 996432211 11000 123468999999987 46778999999999999999999999997431
Q ss_pred HHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccc
Q 000889 1148 WAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVD 1210 (1237)
Q Consensus 1148 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~ 1210 (1237)
-..|++..+..+.. +.....+.+||..|++++|++||++.+|+..+.++...
T Consensus 263 ----------~laIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 263 ----------KLAILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ----------ceeEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 12345555544443 44667888999999999999999999999999888663
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=349.78 Aligned_cols=261 Identities=26% Similarity=0.435 Sum_probs=202.9
Q ss_pred hCCCCCCceecccCCeEEEEEEEC------CCCEEEEEEecccc-CcCHHHHHHHHHHHHhc-CCCCcccccceEEeCCe
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR------DGSVVAIKKLIHVT-GQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEE 998 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 998 (1237)
.++|++.+.||+|+||.||+|++. .+..||||++.... ....+.+.+|+++++.+ +||||+++++++..++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 346888899999999999999742 35689999886432 22345688999999999 89999999999999999
Q ss_pred EEEEEEeccCCCHHHHHhhhhc----------------------------------------------------------
Q 000889 999 RLLVYEYMKWGSLESVLHDRAK---------------------------------------------------------- 1020 (1237)
Q Consensus 999 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 1020 (1237)
.++||||+++|+|.++++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999975321
Q ss_pred ------------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1021 ------------GGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1021 ------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
.....+++..+.+++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 0123578889999999999999999999 9999999999999999999999999999866543322
Q ss_pred eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcccc
Q 000889 1089 LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELT 1167 (1237)
Q Consensus 1089 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1167 (1237)
.......++..|+|||++.+..++.++|||||||++|||++ |..||...... .....+ ...... ..
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~---~~~~~~------~~-- 337 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKM---IKEGYR------ML-- 337 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHH---HHhCcc------CC--
Confidence 22223345678999999999899999999999999999998 88888643211 111111 111100 00
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 000889 1168 MQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206 (1237)
Q Consensus 1168 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 1206 (1237)
.+.. ...++.+++.+||+.+|++||++.++++.|++
T Consensus 338 ~~~~---~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 338 SPEC---APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCC---CCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 0011 12357788899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=339.71 Aligned_cols=251 Identities=23% Similarity=0.409 Sum_probs=209.5
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC--cCHHHHHHHHHHHHhcCCCCcccccceEEeCCe-EEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG--QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEE-RLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 1003 (1237)
++|...+.+|+|+||.++.++++ ++..+++|++.-... ...+....|+.++++++|||||.+++.|..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46888899999999999999877 577899998874332 223457889999999999999999999998888 89999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
+||+||++.+.+.+.. +..+++....+|+.|++.|+.|||++ .|+|||||+.||+++.++.|||+|||+|+...
T Consensus 84 ~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 9999999999998765 46789999999999999999999998 99999999999999999999999999999887
Q ss_pred cCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccC
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
.... ...+..||+.||.||.+.+..|..|+||||+||++|||++-+++|..... ...+....+ ....
T Consensus 158 ~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m------~~Li~ki~~-----~~~~ 224 (426)
T KOG0589|consen 158 PEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM------SELILKINR-----GLYS 224 (426)
T ss_pred Cchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch------HHHHHHHhh-----ccCC
Confidence 6542 24578899999999999999999999999999999999999999986432 111111111 1111
Q ss_pred ccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
+ + ...+..++..++..|++.+|+.||++.+++.+
T Consensus 225 P-l-----p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 P-L-----PSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred C-C-----CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1 1 12234567788889999999999999999987
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=313.23 Aligned_cols=259 Identities=25% Similarity=0.278 Sum_probs=199.4
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcC--HHHHHHHHHHHHhcCCCCcccccceEEe--CCeEEEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQG--DREFMAEMETIGKIKHRNLVPLLGYCKI--GEERLLVY 1003 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 1003 (1237)
.|+....|++|+||.||+|+++ +++.||+|+++...... .---.+|+.++.+++|||||.+..+... -+..||||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 4777889999999999999987 57899999997543221 1235789999999999999999987754 35789999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
|||+ -+|..+++... +++...+++.+..|+++|++|||.+ .|+|||+|++|+|+...|.+||+|||+|+.++
T Consensus 157 e~~E-hDLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 157 EYVE-HDLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHH-hhHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 9998 68999998653 5889999999999999999999999 99999999999999999999999999999887
Q ss_pred cCCcceeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhh-cc-ccc
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE-KR-INE 1160 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~-~~~ 1160 (1237)
.. ....+..+-|..|+|||.+.+. .|++++|+||+|||+.||+++++-|.+... .+.+......+... +. ...
T Consensus 229 sp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE--~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 229 SP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE--IDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred CC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch--HHHHHHHHHHhCCCccccCCC
Confidence 54 2334567789999999998765 599999999999999999999999986532 12222211111100 00 000
Q ss_pred c------------------cCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1161 I------------------LDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1161 ~------------------~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
+ +.+.+.... -...-.+++..++..||.+|.|+.+.+++
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~----lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALS----LSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccc----cchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0 001111000 11233466778999999999999999987
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=348.69 Aligned_cols=262 Identities=26% Similarity=0.408 Sum_probs=202.8
Q ss_pred CCCCCCceecccCCeEEEEEEEC------CCCEEEEEEeccccCc-CHHHHHHHHHHHHhc-CCCCcccccceEEeCCeE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR------DGSVVAIKKLIHVTGQ-GDREFMAEMETIGKI-KHRNLVPLLGYCKIGEER 999 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 999 (1237)
++|++.+.||+|+||.||+|++. ++..||+|++...... ....+.+|+++++.+ +||||+++++++...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 36888999999999999999853 2357999988643322 234678899999999 899999999999999999
Q ss_pred EEEEEeccCCCHHHHHhhhhc-----------------------------------------------------------
Q 000889 1000 LLVYEYMKWGSLESVLHDRAK----------------------------------------------------------- 1020 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------- 1020 (1237)
++||||+++|+|.++++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 999999999999999865321
Q ss_pred ------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcceeeecc
Q 000889 1021 ------GGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTL 1094 (1237)
Q Consensus 1021 ------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~~~~~ 1094 (1237)
.....+++..+.+++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++..............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 0113478888999999999999999999 9999999999999999999999999999865433222222233
Q ss_pred ccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCCCH
Q 000889 1095 AGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDE 1173 (1237)
Q Consensus 1095 ~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 1173 (1237)
.++..|||||++.+..++.++|||||||++|||++ |+.||...... ..... ... .. .... .+...
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~--~~~~~---~~~-~~-----~~~~--~~~~~- 340 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN--SKFYK---MVK-RG-----YQMS--RPDFA- 340 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc--HHHHH---HHH-cc-----cCcc--CCCCC-
Confidence 45678999999998899999999999999999997 99998743211 11111 111 00 0000 01111
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 000889 1174 TELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208 (1237)
Q Consensus 1174 ~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~ 1208 (1237)
..++.+++.+||+.+|++|||+.++++.|+++.
T Consensus 341 --~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 341 --PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred --CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 235678888999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=338.35 Aligned_cols=245 Identities=22% Similarity=0.275 Sum_probs=199.3
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999987 58899999885422 123456788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 81 EYVPGGELFSYLRNS-----GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 999999999998753 4688899999999999999999999 99999999999999999999999999997654
Q ss_pred cCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccC
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
.. .....|++.|+|||++.+..++.++||||+||++|||++|+.||..... ..........
T Consensus 153 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~------~~~~~~i~~~-------- 213 (291)
T cd05612 153 DR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP------FGIYEKILAG-------- 213 (291)
T ss_pred CC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhC--------
Confidence 21 1235689999999999998899999999999999999999999974321 1111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPT-----MIQVMAM 1203 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~~ 1203 (1237)
....+... ...+.+++.+|++.||.+||+ +.+++++
T Consensus 214 -~~~~~~~~---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 214 -KLEFPRHL---DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -CcCCCccC---CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 11111111 124567888999999999995 8888876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=331.86 Aligned_cols=253 Identities=25% Similarity=0.430 Sum_probs=209.1
Q ss_pred CCCCceecccCCeEEEEEEECC---CC--EEEEEEecc-ccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 930 FSADSMIGSGGFGEVYKAQLRD---GS--VVAIKKLIH-VTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~~---~~--~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
.+..++||+|-||.||+|.+.+ |+ .||||..+. ....+.+.|..|..+|+.++||||++++|.|. ....|+||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQPMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-ccceeEEE
Confidence 4556789999999999998653 33 588898875 44556778999999999999999999999996 56889999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
|.++.|.|..|++.+. ..++......++.||..||+|||+. .+|||||..+|||+.....||++|||+++.++
T Consensus 470 EL~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred ecccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 9999999999998764 4688889999999999999999999 99999999999999999999999999999887
Q ss_pred cCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhccccccc
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1162 (1237)
.... ++.+...-+..|||||.+.-.+++.++|||-|||+|||++. |..||.+-...+ .+..+-
T Consensus 543 d~~y-YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD---------------VI~~iE 606 (974)
T KOG4257|consen 543 DDAY-YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD---------------VIGHIE 606 (974)
T ss_pred ccch-hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc---------------eEEEec
Confidence 6443 33345556779999999999999999999999999999886 999998643221 111111
Q ss_pred -CccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 000889 1163 -DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQV 1209 (1237)
Q Consensus 1163 -~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~ 1209 (1237)
..+++.+..+++. +..++.+||+++|.+||++.++...|.++..
T Consensus 607 nGeRlP~P~nCPp~---LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 607 NGERLPCPPNCPPA---LYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCCCCCCChH---HHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 2344555555554 4467789999999999999999999987654
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=343.79 Aligned_cols=245 Identities=24% Similarity=0.314 Sum_probs=199.3
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
++|++.+.||+|+||.||+|+++ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46888899999999999999987 57899999886432 223456889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 98 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 98 EFVVGGELFTHLRKA-----GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred cCCCCChHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 999999999998753 3678888999999999999999999 99999999999999999999999999998664
Q ss_pred cCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccC
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
... ....|++.|+|||++.+..++.++|||||||++|||++|+.||.... ....+ .... .
T Consensus 170 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-----~~~~~-~~i~-~-------- 229 (329)
T PTZ00263 170 DRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT-----PFRIY-EKIL-A-------- 229 (329)
T ss_pred CCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC-----HHHHH-HHHh-c--------
Confidence 321 23578999999999999899999999999999999999999996432 11111 1111 1
Q ss_pred ccccCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPT-----MIQVMAM 1203 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~~ 1203 (1237)
.....+.... ..+.+++.+|++.||.+||+ +.+++++
T Consensus 230 ~~~~~p~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 230 GRLKFPNWFD---GRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCcCCCCCCC---HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1111111111 24567888999999999997 6888766
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=342.30 Aligned_cols=259 Identities=25% Similarity=0.414 Sum_probs=213.7
Q ss_pred CCCceecccCCeEEEEEEEC-C----CCEEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEE
Q 000889 931 SADSMIGSGGFGEVYKAQLR-D----GSVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 931 ~~~~~lG~G~fg~Vy~~~~~-~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
+..++||+|+||+||+|.+- + ..+||+|++.... .+...++.+|+-+|.+++|||+++++++|.... ..+|++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 34678999999999999874 3 3468899886543 344678999999999999999999999998665 889999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
|+++|+|.+|++..+ ..+.....+.|..|||+||.|||.+ ++|||||..+|||+.+-.++||.|||+|+....
T Consensus 778 ~mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred hcccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 999999999998753 4788888999999999999999999 999999999999999999999999999998888
Q ss_pred CCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccC
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
++.........-.+.|||-|.+....|+.++|||||||++||++| |..|+++....+..++ +...+
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl------le~ge------- 917 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL------LEKGE------- 917 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH------Hhccc-------
Confidence 777766666667889999999999999999999999999999999 9999986553322111 11111
Q ss_pred ccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccccCCC
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGD 1214 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~~~~~ 1214 (1237)
++.. .+-+..++..++.+||..|+..||+++++...+.++..++...
T Consensus 918 -RLsq---PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqry 964 (1177)
T KOG1025|consen 918 -RLSQ---PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRY 964 (1177)
T ss_pred -cCCC---CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceE
Confidence 1222 2224456667888999999999999999999999887766443
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=336.94 Aligned_cols=245 Identities=29% Similarity=0.416 Sum_probs=199.8
Q ss_pred CCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCc---CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 930 FSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQ---GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
|+-.+.||.|+||.||.|++. +.++||||++.....+ ..+++..|++++++++|||++.+.|+|-.....|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 444567999999999999876 6789999999744333 346789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
|- |+-.|++.-.. +++.+..+..|..+.+.||+|||+. +.||||||+.|||+++.|.||++|||.|....+
T Consensus 108 Cl-GSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P- 178 (948)
T KOG0577|consen 108 CL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP- 178 (948)
T ss_pred Hh-ccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence 96 78888876543 4788999999999999999999999 999999999999999999999999999977654
Q ss_pred CcceeeeccccCCCcCCccccC---ccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccccccc
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQ---SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1162 (1237)
...++|||.|||||++. .+.|+-++||||+|++..|+...++|+.... .+..... +...-
T Consensus 179 -----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN-----AMSALYH-------IAQNe 241 (948)
T KOG0577|consen 179 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYH-------IAQNE 241 (948)
T ss_pred -----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch-----HHHHHHH-------HHhcC
Confidence 35689999999999984 5689999999999999999999999965321 1111111 11111
Q ss_pred CccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1163 DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1163 ~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
.|.+. ..+....|..++..|+++-|.+|||..+++++-
T Consensus 242 sPtLq----s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 242 SPTLQ----SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred CCCCC----CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 22222 234455677777799999999999999998874
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=341.96 Aligned_cols=242 Identities=20% Similarity=0.301 Sum_probs=194.6
Q ss_pred ceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCC
Q 000889 934 SMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWG 1009 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 1009 (1237)
+.||+|+||.||+|+.+ +++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999876 68899999886432 122345778999999999999999999999999999999999999
Q ss_pred CHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcce
Q 000889 1010 SLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHL 1089 (1237)
Q Consensus 1010 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~ 1089 (1237)
+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~ 150 (323)
T cd05571 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--A 150 (323)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--C
Confidence 999998753 4688999999999999999999999 99999999999999999999999999997532221 1
Q ss_pred eeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCC
Q 000889 1090 SVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQ 1169 (1237)
Q Consensus 1090 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 1169 (1237)
......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .......... +..++
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~~~~~-------~~~~p-- 215 (323)
T cd05571 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILME-------EIRFP-- 215 (323)
T ss_pred cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH------HHHHHHHHcC-------CCCCC--
Confidence 22346799999999999998999999999999999999999999964321 1111111110 01111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 000889 1170 TSDETELYQYLRISFECLDDRPFKRP-----TMIQVMAM 1203 (1237)
Q Consensus 1170 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 1203 (1237)
... ..++.+++.+|++.||++|| ++.+++++
T Consensus 216 ~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 216 RTL---SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCC---CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 111 23466788899999999999 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=342.76 Aligned_cols=253 Identities=22% Similarity=0.325 Sum_probs=202.1
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36889999999999999999987 47899999986432 123456788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 81 EYVPGGDFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 999999999999653 4678899999999999999999999 99999999999999999999999999997654
Q ss_pred cCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccC
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ... ......... ...
T Consensus 153 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~---~~i~~~~~~--~~~ 219 (333)
T cd05600 153 T-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN---ETW---ENLKYWKET--LQR 219 (333)
T ss_pred c-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH---HHH---HHHHhcccc--ccC
Confidence 3 223467999999999999989999999999999999999999999753311 111 111100000 000
Q ss_pred ccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
+... ........++.+++.+|+..+|.+||++.+++++
T Consensus 220 ~~~~--~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 PVYD--DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCC--ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1000 0001122356678889999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=335.93 Aligned_cols=265 Identities=22% Similarity=0.273 Sum_probs=199.8
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
++|++.+.||+|+||+||+|+++ +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999987 57889999886432 2234567889999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
|++++.+..+... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 9998776654432 24688899999999999999999999 999999999999999999999999999986643
Q ss_pred CCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHH-----------HHh
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAK-----------QLH 1153 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~-----------~~~ 1153 (1237)
... .......|++.|+|||++.+..++.++||||+||++|||++|+.||...... ........ ...
T Consensus 153 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 153 GSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI--DQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred ccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhhCCCCHHHHHhhh
Confidence 221 1223456899999999999888999999999999999999999999753211 11111000 000
Q ss_pred hhcccccccCccccCCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1154 REKRINEILDPELTMQTSD-----ETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1154 ~~~~~~~~~~~~l~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
..........+........ ......+.+++.+|++.+|++|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000000000000 0112457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=342.35 Aligned_cols=284 Identities=23% Similarity=0.354 Sum_probs=211.5
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
.++|++.+.||+|+||.||+|++. ++..+|+|.+.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 357899999999999999999987 57788888776432 1224568899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
|+++|+|.+++... ..+++..+..++.|++.|++|||+.+ +|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLKEA-----KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 99999999998753 35889999999999999999999862 699999999999999999999999999976532
Q ss_pred CCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhh--c------
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE--K------ 1156 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~------ 1156 (1237)
.. .....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.......... .
T Consensus 157 ~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 229 (331)
T cd06649 157 SM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA---KELEAIFGRPVVDGEEGEPHSI 229 (331)
T ss_pred cc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHhcccccccccCCcccc
Confidence 21 2345689999999999998999999999999999999999999964321 1111100000000 0
Q ss_pred --------------------------ccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccc
Q 000889 1157 --------------------------RINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVD 1210 (1237)
Q Consensus 1157 --------------------------~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~ 1210 (1237)
....+.....+ .........++.+++.+||+.+|++|||+.+++++----.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~-- 306 (331)
T cd06649 230 SPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPP-KLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR-- 306 (331)
T ss_pred CcccccccccccccccccccchhHHHHHHHHHhCCCc-CCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh--
Confidence 00000000000 0000112346778999999999999999999998743211
Q ss_pred cCCCCCCccCchhhHHHHHH
Q 000889 1211 TEGDSLDSFSLKDTVIEELR 1230 (1237)
Q Consensus 1211 ~~~~~~~~~~~~~~~~~~~~ 1230 (1237)
....+..++.-..++++
T Consensus 307 ---~~~~~~~~~~~~~~~~~ 323 (331)
T cd06649 307 ---SEVEEVDFAGWLCKTLR 323 (331)
T ss_pred ---cccccccHHHHHHHhhc
Confidence 22334555555555555
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=335.88 Aligned_cols=264 Identities=23% Similarity=0.316 Sum_probs=197.9
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
++|++.++||+|+||+||+|+.+ ++..||+|++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999886 57899999886432 22345678999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
++ |+|.+++... +..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 85 LD-SDLKQYLDNC----GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CC-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 98 5899888653 23578899999999999999999999 9999999999999999999999999999765432
Q ss_pred CcceeeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhh--hcc-----
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR--EKR----- 1157 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~----- 1157 (1237)
.. ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .+......... ...
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 157 TK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE--ELHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred Cc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhccc
Confidence 21 1234567899999999865 568999999999999999999999997543211 11110000000 000
Q ss_pred ----cccccCccccCCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1158 ----INEILDPELTMQT---SDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1158 ----~~~~~~~~l~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
......+...... ..+....+..+++.+|++.||.+|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000000 000012346688889999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=356.77 Aligned_cols=254 Identities=22% Similarity=0.283 Sum_probs=201.3
Q ss_pred CCCCCceecccCCeEEEEEEECC--CCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 929 GFSADSMIGSGGFGEVYKAQLRD--GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
.|.+.+.||+|+||.||+|.... +..||+|++..........+.+|+++++.++||||+++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 38888999999999999998653 5678888765433333445778999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
++|+|.+++..... ...++++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 148 ~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 148 SGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 99999999875432 234688999999999999999999999 99999999999999999999999999998765433
Q ss_pred cceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||..... .......... . .+ ..
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~~-~----~~-~~ 291 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLYG-K----YD-PF 291 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhC-C----CC-CC
Confidence 22223456799999999999998999999999999999999999999964321 1111111111 0 00 01
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
+.. ....+.+++.+|++.+|++||++.+++++
T Consensus 292 --~~~---~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 292 --PCP---VSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred --Ccc---CCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 111 12356788889999999999999999764
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=333.81 Aligned_cols=259 Identities=27% Similarity=0.472 Sum_probs=204.7
Q ss_pred CCCCCceecccCCeEEEEEEECCC------CEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLRDG------SVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLL 1001 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~~~------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 1001 (1237)
+|++.+.||+|+||.||+|..... ..||+|.+..... .....+.+|++++++++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 578889999999999999987532 4689998764322 223568899999999999999999999998899999
Q ss_pred EEEeccCCCHHHHHhhhhcCCC-----------CccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCc
Q 000889 1002 VYEYMKWGSLESVLHDRAKGGG-----------TKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFE 1070 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~~~~-----------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~ 1070 (1237)
+|||+++|+|.+++........ ..+++..+..++.|++.|++|||+. +++||||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCc
Confidence 9999999999999976432211 4678899999999999999999999 9999999999999999999
Q ss_pred eEEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHH
Q 000889 1071 ARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWA 1149 (1237)
Q Consensus 1071 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~ 1149 (1237)
+||+|||+++.....+.........+++.|+|||++.+..++.++|||||||++|||++ |..||..... ... .
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---~~~---~ 236 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---QEV---I 236 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---HHH---H
Confidence 99999999986544333223334556889999999988889999999999999999998 9999875321 111 1
Q ss_pred HHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 000889 1150 KQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207 (1237)
Q Consensus 1150 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l 1207 (1237)
.... ..... ..+ .....++.+++.+||+.+|.+||++.+++++|+.+
T Consensus 237 ~~i~-~~~~~-------~~~---~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 237 EMIR-SRQLL-------PCP---EDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHH-cCCcC-------CCc---ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1111 11110 011 11234677888899999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=341.62 Aligned_cols=245 Identities=24% Similarity=0.320 Sum_probs=198.3
Q ss_pred CCCCCCceecccCCeEEEEEEECC--CCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD--GSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 1002 (1237)
++|++.+.||+|+||.||+|+++. +..||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 368889999999999999998653 3589999886432 22345678899999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceee
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~ 1082 (1237)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 110 ~Ey~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN-----KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999753 4688999999999999999999999 9999999999999999999999999999865
Q ss_pred ccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccccccc
Q 000889 1083 NALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162 (1237)
Q Consensus 1083 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1162 (1237)
... .....||+.|||||++.+..++.++||||+||++|||++|+.||.... ....+.. ... .
T Consensus 182 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~~~~~~~-i~~-~------ 243 (340)
T PTZ00426 182 DTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE-----PLLIYQK-ILE-G------ 243 (340)
T ss_pred CCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC-----HHHHHHH-Hhc-C------
Confidence 432 134579999999999998889999999999999999999999997432 1111111 111 1
Q ss_pred CccccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 000889 1163 DPELTMQTSDETELYQYLRISFECLDDRPFKRP-----TMIQVMAM 1203 (1237)
Q Consensus 1163 ~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 1203 (1237)
....+.... ..+.+++.+|++.+|++|+ ++.+++++
T Consensus 244 --~~~~p~~~~---~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 244 --IIYFPKFLD---NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --CCCCCCCCC---HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 010111111 2356788899999999995 89998876
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=344.83 Aligned_cols=264 Identities=25% Similarity=0.422 Sum_probs=205.6
Q ss_pred hCCCCCCceecccCCeEEEEEEECC------CCEEEEEEeccccC-cCHHHHHHHHHHHHhcC-CCCcccccceEEeCCe
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLRD------GSVVAIKKLIHVTG-QGDREFMAEMETIGKIK-HRNLVPLLGYCKIGEE 998 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 998 (1237)
.++|++.++||+|+||.||+|++.. +..||||++..... ...+.+.+|+++++++. ||||+++++++.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4578889999999999999998642 34699998864332 22456889999999996 9999999999999999
Q ss_pred EEEEEEeccCCCHHHHHhhhhcC---------------------------------------------------------
Q 000889 999 RLLVYEYMKWGSLESVLHDRAKG--------------------------------------------------------- 1021 (1237)
Q Consensus 999 ~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------------- 1021 (1237)
.++||||+++|+|.+++......
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999999999998754210
Q ss_pred ----------------------------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCC
Q 000889 1022 ----------------------------------GGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE 1067 (1237)
Q Consensus 1022 ----------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~ 1067 (1237)
....+++..+.+++.|+++|++|||+. +|+||||||+||+++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 113477888899999999999999999 9999999999999999
Q ss_pred CCceEEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHH
Q 000889 1068 NFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLV 1146 (1237)
Q Consensus 1068 ~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~ 1146 (1237)
++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... ....
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~~~~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--STFY 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--HHHH
Confidence 99999999999986644333222234456788999999998889999999999999999997 99998643211 1111
Q ss_pred HHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 000889 1147 GWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQV 1209 (1237)
Q Consensus 1147 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~ 1209 (1237)
....... . .... ......+.+++.+||+.+|++|||+.++.++|+++..
T Consensus 351 ---~~~~~~~------~--~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 351 ---NKIKSGY------R--MAKP---DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ---HHHhcCC------C--CCCC---ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1111110 0 0011 1123457788899999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=331.45 Aligned_cols=264 Identities=26% Similarity=0.455 Sum_probs=208.2
Q ss_pred hCCCCCCceecccCCeEEEEEEEC------CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR------DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERL 1000 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 1000 (1237)
.++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 356888999999999999999852 24568888876544444567899999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHhhhhc--------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceE
Q 000889 1001 LVYEYMKWGSLESVLHDRAK--------GGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEAR 1072 (1237)
Q Consensus 1001 lv~e~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vk 1072 (1237)
+||||+++++|.+++..... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 99999999999999975421 1123589999999999999999999999 999999999999999999999
Q ss_pred EeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHH
Q 000889 1073 VSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQ 1151 (1237)
Q Consensus 1073 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 1151 (1237)
|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||..... .. ....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~---~~~~ 234 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NE---VIEC 234 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HH---HHHH
Confidence 999999986543332222233445778999999998889999999999999999998 8999864321 11 1111
Q ss_pred HhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccc
Q 000889 1152 LHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVD 1210 (1237)
Q Consensus 1152 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~ 1210 (1237)
.. ..... .. ... ....+.+++.+||+.+|.+|||+.++.+.|+.+...
T Consensus 235 i~-~~~~~-----~~--~~~---~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 IT-QGRVL-----QR--PRT---CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HH-cCCcC-----CC--CCC---CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11 11100 00 111 123577889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=337.00 Aligned_cols=242 Identities=21% Similarity=0.301 Sum_probs=193.7
Q ss_pred ceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCC
Q 000889 934 SMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWG 1009 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 1009 (1237)
+.||+|+||.||+|+.. ++..||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999976 58899999986432 223345778999999999999999999999999999999999999
Q ss_pred CHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcce
Q 000889 1010 SLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHL 1089 (1237)
Q Consensus 1010 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~ 1089 (1237)
+|..++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~ 150 (323)
T cd05595 81 ELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--A 150 (323)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--C
Confidence 999888653 4688999999999999999999999 99999999999999999999999999987532211 1
Q ss_pred eeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCC
Q 000889 1090 SVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQ 1169 (1237)
Q Consensus 1090 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 1169 (1237)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... . ......... +..++
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~---~~~~~~~~~-------~~~~p-- 215 (323)
T cd05595 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---E---RLFELILME-------EIRFP-- 215 (323)
T ss_pred ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH---H---HHHHHHhcC-------CCCCC--
Confidence 22346799999999999998999999999999999999999999964321 0 111111100 00111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 000889 1170 TSDETELYQYLRISFECLDDRPFKRP-----TMIQVMAM 1203 (1237)
Q Consensus 1170 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 1203 (1237)
... ...+.+++.+|++++|++|| ++.+++++
T Consensus 216 ~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 216 RTL---SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCC---CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 111 23456788899999999998 88888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=316.07 Aligned_cols=270 Identities=24% Similarity=0.310 Sum_probs=202.8
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCc--CHHHHHHHHHHHHhcCCCC-cccccceEEeCC------e
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQ--GDREFMAEMETIGKIKHRN-LVPLLGYCKIGE------E 998 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------~ 998 (1237)
.|+..++||+|+||+||+|+.+ +|+.||+|++.-...+ ......+|+.++++++|+| |+++++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 3555667999999999999876 6889999999754332 3345689999999999999 999999998877 7
Q ss_pred EEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeeccc
Q 000889 999 RLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1078 (1237)
Q Consensus 999 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGl 1078 (1237)
.++||||++ -+|..++....... ..++...++.++.|++.|++|||++ +|+||||||+||+++++|.+||+|||+
T Consensus 92 l~lvfe~~d-~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 92 LYLVFEFLD-RDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred EEEEEEeec-ccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 899999997 79999998765321 3466688899999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCcceeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhh--
Q 000889 1079 ARLVNALDTHLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE-- 1155 (1237)
Q Consensus 1079 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-- 1155 (1237)
|+...-... ..+..++|..|+|||++.+. .|+..+||||+||+++||++++.-|.+... .+.+....+.....
T Consensus 167 Ara~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 167 ARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRIFRLLGTPNE 242 (323)
T ss_pred HHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHHHcCCCCc
Confidence 986542221 24567789999999999876 699999999999999999999999876532 11111111111111
Q ss_pred cccccc---cCccccCCCCC-----HH----HHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhc
Q 000889 1156 KRINEI---LDPELTMQTSD-----ET----ELYQYLRISFECLDDRPFKRPTMIQVMAM--FKEL 1207 (1237)
Q Consensus 1156 ~~~~~~---~~~~l~~~~~~-----~~----~~~~l~~li~~cl~~dP~~RPt~~ell~~--L~~l 1207 (1237)
...+.. .+......... .. -.....+++.+|++.+|.+|.|+..++++ +.++
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 111110 01110000000 00 01256678889999999999999999987 5544
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=328.06 Aligned_cols=255 Identities=23% Similarity=0.377 Sum_probs=200.4
Q ss_pred CCCCCCceecccCCeEEEEEEEC----CCCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR----DGSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 1002 (1237)
++|++.+.||+|+||.||+|.++ .+..||+|.+..... ...+.+.+|+.++++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46888999999999999999864 356899998865322 2235688999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceee
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~ 1082 (1237)
|||+++|+|.+++... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+...
T Consensus 85 ~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 85 TEYMSNGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEeCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 9999999999998753 24689999999999999999999999 9999999999999999999999999987653
Q ss_pred ccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccc
Q 000889 1083 NALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161 (1237)
Q Consensus 1083 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1161 (1237)
.... ........++..|+|||++.+..++.++|||||||++||+++ |+.||..... . ..........
T Consensus 158 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~---~---~~~~~~~~~~----- 225 (266)
T cd05064 158 KSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---Q---DVIKAVEDGF----- 225 (266)
T ss_pred cccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH---H---HHHHHHHCCC-----
Confidence 2211 111112335678999999999899999999999999999875 9999864321 1 1111111110
Q ss_pred cCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 000889 1162 LDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207 (1237)
Q Consensus 1162 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l 1207 (1237)
. .+.+. .....+.+++.+||+.+|++||++.++.+.|.++
T Consensus 226 -~--~~~~~---~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 -R--LPAPR---NCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -C--CCCCC---CCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0 01111 1223567788899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=334.78 Aligned_cols=200 Identities=27% Similarity=0.438 Sum_probs=173.1
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
.++|++.++||+|+||.||+|++. ++..+|+|.+.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367999999999999999999987 57778888765432 2223568899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
|+++|+|.+++... ..+++..+..++.+++.|++|||+.+ +|+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 84 HMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred cCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 99999999998753 35788999999999999999999752 799999999999999999999999999875532
Q ss_pred CCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCC
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPS 1137 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~ 1137 (1237)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 157 SM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 11 13456899999999999888999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=329.10 Aligned_cols=259 Identities=25% Similarity=0.454 Sum_probs=204.2
Q ss_pred CCCCCCceecccCCeEEEEEEECC------CCEEEEEEeccccCc-CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD------GSVVAIKKLIHVTGQ-GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERL 1000 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 1000 (1237)
++|.+.+.||+|+||.||+|+..+ +..||+|++...... ..+.+.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457788899999999999998743 468999988654333 3467899999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHhhhh---------cCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCce
Q 000889 1001 LVYEYMKWGSLESVLHDRA---------KGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEA 1071 (1237)
Q Consensus 1001 lv~e~~~~gsL~~~l~~~~---------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~v 1071 (1237)
+||||+++++|.++++... ......+++..+..++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999997642 11234578999999999999999999999 99999999999999999999
Q ss_pred EEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHH
Q 000889 1072 RVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAK 1150 (1237)
Q Consensus 1072 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 1150 (1237)
||+|||+++...............+++.|+|||++.+..++.++||||+||++|||++ |..||..... ... ..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~~---~~ 235 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EEV---IE 235 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHH---HH
Confidence 9999999986543322222233446788999999999999999999999999999998 9999864321 111 11
Q ss_pred HHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 000889 1151 QLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206 (1237)
Q Consensus 1151 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 1206 (1237)
... ...... . . ......+.+++.+||..+|++||++.|+++.|++
T Consensus 236 ~~~-~~~~~~-----~--~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 236 CIT-QGRLLQ-----R--P---RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHH-cCCcCC-----C--C---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111 111100 0 0 1122356788889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=324.65 Aligned_cols=249 Identities=31% Similarity=0.532 Sum_probs=192.4
Q ss_pred CceecccCCeEEEEEEEC-----CCCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 933 DSMIGSGGFGEVYKAQLR-----DGSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 933 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
.+.||.|.||.||+|++. .+..|+||.+..... +..+.+.+|++.+++++||||++++|++...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 468999999999999987 256799998854322 23578999999999999999999999999888899999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
++|+|.+++.... ...+++..+..|+.|+++||+|||+. +++|+||+++||+++.++.+||+|||+++......
T Consensus 84 ~~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 84 PGGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp TTEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc---cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999998762 24789999999999999999999999 99999999999999999999999999998763333
Q ss_pred cceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPE 1165 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1165 (1237)
.............|+|||.+.+..++.++||||||+++||+++ |+.||... ....+...........
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~------~~~~~~~~~~~~~~~~------ 225 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY------DNEEIIEKLKQGQRLP------ 225 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS------CHHHHHHHHHTTEETT------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccccccccccce------
Confidence 3333344557789999999998889999999999999999999 67887532 1122222222222111
Q ss_pred ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1166 LTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1166 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
.+.. ....+.+++.+||+.+|++|||+.++++.|
T Consensus 226 --~~~~---~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 --IPDN---CPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --SBTT---SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --eccc---hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1111 123466788899999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=335.74 Aligned_cols=260 Identities=24% Similarity=0.400 Sum_probs=204.1
Q ss_pred CCCCCCceecccCCeEEEEEEECC-CC----EEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD-GS----VVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLL 1001 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 1001 (1237)
.+|+..+.||+|+||.||+|++.. +. .||+|++.... ....+++.+|+.+++.++||||+++++++.. +..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-~~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-CCcee
Confidence 468899999999999999998652 33 38899876432 2334578899999999999999999999875 45789
Q ss_pred EEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeeccccee
Q 000889 1002 VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~ 1081 (1237)
|+||+++|+|.+++.... ..+++..+.+++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 86 v~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 999999999999997642 3578889999999999999999999 999999999999999999999999999987
Q ss_pred eccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhccccc
Q 000889 1082 VNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINE 1160 (1237)
Q Consensus 1082 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1160 (1237)
..............++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~------~~~~~~~~~~~---- 228 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------SEISSILEKGE---- 228 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHhCCC----
Confidence 654433333233345678999999999899999999999999999998 9999864321 11111111110
Q ss_pred ccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccccC
Q 000889 1161 ILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTE 1212 (1237)
Q Consensus 1161 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~~~ 1212 (1237)
..+.+.. ....+.+++.+||+.+|++||++.++++.+..+..+..
T Consensus 229 ----~~~~~~~---~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 229 ----RLPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred ----CCCCCCC---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 0111111 12356788889999999999999999999998876553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=323.90 Aligned_cols=261 Identities=23% Similarity=0.373 Sum_probs=208.2
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC---cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG---QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999876 688999998753221 22346788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+++|+|.+++..... ....+++..+..++.|+++|++|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 99999999999875432 234678899999999999999999999 99999999999999999999999999998764
Q ss_pred cCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccC
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
.... ......|++.|+|||.+.+..++.++||||+|+++|||++|+.||..... ....+....... ..
T Consensus 158 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~~------~~ 225 (267)
T cd08228 158 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKIEQC------DY 225 (267)
T ss_pred chhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHHhcC------CC
Confidence 3221 11234688899999999888899999999999999999999999864321 111222211110 11
Q ss_pred ccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~ 1208 (1237)
+... .......+.+++.+||+.+|++||++.++++.+++++
T Consensus 226 ~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 226 PPLP----TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCCC----hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1111 1122346778889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=321.58 Aligned_cols=250 Identities=27% Similarity=0.455 Sum_probs=200.5
Q ss_pred CCCCCceecccCCeEEEEEEECCCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccC
Q 000889 929 GFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
+|++.+.||+|+||.||+|+++++..+|+|.+... ....+++.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 47788899999999999999988888999987532 33456789999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
|+|.++++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||.++........
T Consensus 84 ~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 84 GCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 99999987532 3588999999999999999999999 9999999999999999999999999999765332211
Q ss_pred eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcccc
Q 000889 1089 LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELT 1167 (1237)
Q Consensus 1089 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1167 (1237)
......++..|+|||++.+..++.++||||||+++|||++ |+.||..... ............ ...+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~------~~~~~~i~~~~~---~~~~~-- 224 (256)
T cd05114 157 -SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN------YEVVEMISRGFR---LYRPK-- 224 (256)
T ss_pred -ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHCCCC---CCCCC--
Confidence 1122335668999999998889999999999999999999 8999864321 111111111111 00111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1168 MQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1168 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
. ....+.+++.+||+.+|++||++.++++.|
T Consensus 225 ---~---~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 ---L---ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---C---CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1 123567889999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=340.33 Aligned_cols=261 Identities=19% Similarity=0.213 Sum_probs=197.1
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
..+|++.+.||+|+||.||+|++. +++.||+|+.. ...+.+|++++++++||||+++++++......++|||+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999986 57889999643 23567899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
+. ++|..++... ..+++..++.++.|++.||+|||+. +||||||||+||+++.++.+||+|||+|+.....
T Consensus 165 ~~-~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 165 YK-TDLYCYLAAK-----RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred CC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 95 7888887653 3578999999999999999999999 9999999999999999999999999999754322
Q ss_pred CcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCC-----chHHHHHHHHhhh-----
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDD-----NNLVGWAKQLHRE----- 1155 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~-----~~~~~~~~~~~~~----- 1155 (1237)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ..+..........
T Consensus 236 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 236 NA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred cc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 21 122346799999999999988999999999999999999999988754321110 0111111000000
Q ss_pred ----cccccc---------cCccccCCC-CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1156 ----KRINEI---------LDPELTMQT-SDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1156 ----~~~~~~---------~~~~l~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
...... ..+...... .......++.+++.+|++.||++|||+.|++++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 000000000 001123467788999999999999999999975
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=334.09 Aligned_cols=266 Identities=22% Similarity=0.299 Sum_probs=197.5
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367999999999999999999987 688999998864332 223457789999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
|++ ++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 84 YVH-TDLCQYMDKH----PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred CCC-cCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 996 6888887653 24578889999999999999999999 999999999999999999999999999975432
Q ss_pred CCcceeeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhh--hccc---
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR--EKRI--- 1158 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~--- 1158 (1237)
.. .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||...... ...+......... ....
T Consensus 156 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 156 PS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI-QDQLERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred CC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH-HHHHHHHHHHhCCCChhhccch
Confidence 22 12234568999999999865 45788999999999999999999999753210 0001000000000 0000
Q ss_pred ---ccccCccccC--CCCCH------HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1159 ---NEILDPELTM--QTSDE------TELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1159 ---~~~~~~~l~~--~~~~~------~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.......... +.... .....+.+++.+|++.||++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0000000000 00000 011346688889999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=335.98 Aligned_cols=242 Identities=21% Similarity=0.305 Sum_probs=194.4
Q ss_pred ceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCC
Q 000889 934 SMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWG 1009 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 1009 (1237)
+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999876 58899999886432 223456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcce
Q 000889 1010 SLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHL 1089 (1237)
Q Consensus 1010 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~ 1089 (1237)
+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~ 150 (328)
T cd05593 81 ELFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--A 150 (328)
T ss_pred CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--c
Confidence 999888653 4688999999999999999999999 99999999999999999999999999987532211 1
Q ss_pred eeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCC
Q 000889 1090 SVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQ 1169 (1237)
Q Consensus 1090 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 1169 (1237)
......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .......... +..++
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~------~~~~~~~~~~-------~~~~p-- 215 (328)
T cd05593 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILME-------DIKFP-- 215 (328)
T ss_pred ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH------HHHHHHhccC-------CccCC--
Confidence 22346799999999999988999999999999999999999999964321 1111111100 01111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 000889 1170 TSDETELYQYLRISFECLDDRPFKRP-----TMIQVMAM 1203 (1237)
Q Consensus 1170 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 1203 (1237)
... ..++.+++.+|++++|++|| ++.+++++
T Consensus 216 ~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 RTL---SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCC---CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 111 13456788899999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=324.29 Aligned_cols=255 Identities=24% Similarity=0.399 Sum_probs=204.6
Q ss_pred CCCCCCceecccCCeEEEEEEECCCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEecc
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMK 1007 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 1007 (1237)
++|++.++||+|+||.||+|...++..||+|++... ....+.+.+|+.++++++|+||+++++++...+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 468889999999999999999888888999987542 2345678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCc
Q 000889 1008 WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDT 1087 (1237)
Q Consensus 1008 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~ 1087 (1237)
+++|.+++.... ...+++..+..++.|+++|++|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~L~~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 85 KGSLLDFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 999999997542 24678889999999999999999999 999999999999999999999999999987643221
Q ss_pred ceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccc
Q 000889 1088 HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1088 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
. ......++..|+|||++.+..++.++|||||||++|||++ |+.||..... .... ....... ..
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~---~~~~~~~------~~-- 223 (261)
T cd05072 159 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---SDVM---SALQRGY------RM-- 223 (261)
T ss_pred e-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH---HHHH---HHHHcCC------CC--
Confidence 1 1123345678999999988889999999999999999998 9999864321 1111 1111110 00
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l 1207 (1237)
+.... ....+.+++.+|++.+|++||++.++.+.|+++
T Consensus 224 ~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 PRMEN---CPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCC---CCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 01111 123567888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=334.89 Aligned_cols=240 Identities=24% Similarity=0.350 Sum_probs=191.9
Q ss_pred ecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCCCH
Q 000889 936 IGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSL 1011 (1237)
Q Consensus 936 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 1011 (1237)
||+|+||.||+|++. +++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999987 47889999886422 22345678899999999999999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcceee
Q 000889 1012 ESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSV 1091 (1237)
Q Consensus 1012 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~~ 1091 (1237)
.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~ 150 (312)
T cd05585 81 FHHLQRE-----GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KT 150 (312)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cc
Confidence 9998753 3688999999999999999999999 999999999999999999999999999975432221 22
Q ss_pred eccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCC
Q 000889 1092 STLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTS 1171 (1237)
Q Consensus 1092 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 1171 (1237)
....||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......... .....+..
T Consensus 151 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~------~~~~~~~~~~---------~~~~~~~~ 215 (312)
T cd05585 151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN------VNEMYRKILQ---------EPLRFPDG 215 (312)
T ss_pred ccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC------HHHHHHHHHc---------CCCCCCCc
Confidence 34679999999999999899999999999999999999999997432 1111111111 11111111
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 000889 1172 DETELYQYLRISFECLDDRPFKRPT---MIQVMAM 1203 (1237)
Q Consensus 1172 ~~~~~~~l~~li~~cl~~dP~~RPt---~~ell~~ 1203 (1237)
.+ ..+.+++.+|++.+|++||+ +.+++++
T Consensus 216 ~~---~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 216 FD---RDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CC---HHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 11 34567888999999999985 6666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=325.04 Aligned_cols=256 Identities=25% Similarity=0.422 Sum_probs=211.4
Q ss_pred CCCCceecccCCeEEEEEEECC-CCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccC
Q 000889 930 FSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
.....+||-|.||.||.|.|+. .-.||||.++... ...++|.+|..+|+.++|||+|+++|+|..+..+|||+|||..
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 4456789999999999999985 5579999886533 4567899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
|+|.+|+++..+ ..++......++.||+.|++||..+ ++||||+.++|+|+.++..|||+|||+++.+.. +++
T Consensus 348 GNLLdYLRecnr---~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg-DTY 420 (1157)
T KOG4278|consen 348 GNLLDYLRECNR---SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTG-DTY 420 (1157)
T ss_pred ccHHHHHHHhch---hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcC-Cce
Confidence 999999998754 4677788899999999999999999 999999999999999999999999999998865 333
Q ss_pred eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcccc
Q 000889 1089 LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELT 1167 (1237)
Q Consensus 1089 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1167 (1237)
.......-+..|.|||.+....++.|+|||+|||++||+.| |..||.+ .++.+....+.... ++.
T Consensus 421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG------idlSqVY~LLEkgy--------RM~ 486 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQVYGLLEKGY--------RMD 486 (1157)
T ss_pred ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC------ccHHHHHHHHhccc--------ccc
Confidence 33334455778999999999999999999999999999998 8888764 23333333333222 233
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccc
Q 000889 1168 MQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVD 1210 (1237)
Q Consensus 1168 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~ 1210 (1237)
.+..+++ .+.++++.||++.|.+||++.|+-+.++.+..+
T Consensus 487 ~PeGCPp---kVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 487 GPEGCPP---KVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred CCCCCCH---HHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 3344444 455677799999999999999999999877543
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=322.75 Aligned_cols=256 Identities=27% Similarity=0.440 Sum_probs=205.2
Q ss_pred hCCCCCCceecccCCeEEEEEEECCCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
.++|++.+.||+|+||.||+|.+.+++.||+|.+... ....+++.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC-cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 3568889999999999999999887888999988643 234567899999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
++++|.+++.... +..+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 84 KYGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999997643 34689999999999999999999999 99999999999999999999999999998765321
Q ss_pred cceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPE 1165 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1165 (1237)
.. .......+..|+|||++.+..++.++||||||+++|||++ |+.||..... ... ........ .
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~---~~~~~~~~------~-- 222 (261)
T cd05068 158 YE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEV---LQQVDQGY------R-- 222 (261)
T ss_pred cc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHH---HHHHHcCC------C--
Confidence 11 1111223457999999998899999999999999999999 9999864321 111 11111110 0
Q ss_pred ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 000889 1166 LTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207 (1237)
Q Consensus 1166 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l 1207 (1237)
.... ......+.+++.+|++.+|++||++.++++.|+++
T Consensus 223 ~~~~---~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 MPCP---PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCC---CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0001 11224577888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=329.24 Aligned_cols=264 Identities=27% Similarity=0.446 Sum_probs=208.2
Q ss_pred CCCCCCceecccCCeEEEEEEEC------CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR------DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLL 1001 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 1001 (1237)
.+|.+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35778889999999999999753 245688888765444445678899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHhhhhc-----------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCc
Q 000889 1002 VYEYMKWGSLESVLHDRAK-----------GGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFE 1070 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~ 1070 (1237)
||||+++++|.+++..... .....+++..++.++.|++.|++|||++ +|+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 9999999999999975421 1123588999999999999999999999 9999999999999999999
Q ss_pred eEEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHH
Q 000889 1071 ARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWA 1149 (1237)
Q Consensus 1071 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~ 1149 (1237)
+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||..... .. ..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~---~~ 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN---TE---VI 235 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HH---HH
Confidence 99999999976544332222234456788999999998899999999999999999998 9999864321 11 11
Q ss_pred HHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccccc
Q 000889 1150 KQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDT 1211 (1237)
Q Consensus 1150 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~~ 1211 (1237)
.... ...... . . ......+.+++.+||+++|++|||+.++++.|+++....
T Consensus 236 ~~~~-~~~~~~-----~--~---~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 236 ECIT-QGRVLE-----R--P---RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred HHHh-CCCCCC-----C--C---ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence 1111 111110 0 0 112245778899999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=298.96 Aligned_cols=254 Identities=24% Similarity=0.341 Sum_probs=203.5
Q ss_pred HhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc----CcCHH----HHHHHHHHHHhc-CCCCcccccceEEe
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT----GQGDR----EFMAEMETIGKI-KHRNLVPLLGYCKI 995 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~----~~~~E~~~l~~l-~h~niv~l~~~~~~ 995 (1237)
..+.|...+.+|.|..++|.++.++ +|+.+|+|++.... .+... .-.+|+.+++++ .||+|+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456888889999999999998776 57889999886322 12222 345699999998 59999999999999
Q ss_pred CCeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEee
Q 000889 996 GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSD 1075 (1237)
Q Consensus 996 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~D 1075 (1237)
..-.++|+|.|+.|.|.+|+... ..+++...++|+.|+.+|++|||.. .|||||+||+|||+|++.++||+|
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEec
Confidence 99999999999999999999875 5789999999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCcceeeeccccCCCcCCccccCc------cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHH
Q 000889 1076 FGMARLVNALDTHLSVSTLAGTPGYVPPEYYQS------FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWA 1149 (1237)
Q Consensus 1076 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~ 1149 (1237)
||+|+...... +....||||+|.|||.+.. ..|+..+|+|++||+||-++.|.+||.... .-.+
T Consensus 167 FGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------QmlM 236 (411)
T KOG0599|consen 167 FGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------QMLM 236 (411)
T ss_pred cceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------HHHH
Confidence 99999876543 3467899999999999853 357888999999999999999999985321 1111
Q ss_pred HHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1150 KQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1150 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
-....++.... -.+ ...+......++|.+|++.||++|.|+.|++++=
T Consensus 237 LR~ImeGkyqF-~sp------eWadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 237 LRMIMEGKYQF-RSP------EWADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred HHHHHhccccc-CCc------chhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 11222221110 111 1123344567888999999999999999999873
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=333.52 Aligned_cols=242 Identities=23% Similarity=0.318 Sum_probs=193.3
Q ss_pred ceecccCCeEEEEEEEC----CCCEEEEEEecccc----CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 934 SMIGSGGFGEVYKAQLR----DGSVVAIKKLIHVT----GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
+.||+|+||.||+++.. .++.||+|.+.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999863 57889999886422 12234577899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
+++|+|.+++... ..+.+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 82 LSGGELFMHLERE-----GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 9999999998653 3578888889999999999999999 9999999999999999999999999999754322
Q ss_pred CcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcc
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPE 1165 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1165 (1237)
.. ......|++.|+|||++.+..++.++||||+||++|||++|+.||..... ........ ...
T Consensus 154 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~------~~~~~~~~---------~~~ 216 (323)
T cd05584 154 GT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------KKTIDKIL---------KGK 216 (323)
T ss_pred CC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH------HHHHHHHH---------cCC
Confidence 21 12345799999999999988899999999999999999999999974321 11111111 111
Q ss_pred ccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 000889 1166 LTMQTSDETELYQYLRISFECLDDRPFKRP-----TMIQVMAM 1203 (1237)
Q Consensus 1166 l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 1203 (1237)
...+... ...+.+++.+|++++|++|| ++.+++++
T Consensus 217 ~~~~~~~---~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 217 LNLPPYL---TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCC---CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1111111 13466788899999999999 88888875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=351.84 Aligned_cols=257 Identities=27% Similarity=0.361 Sum_probs=203.2
Q ss_pred HhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeCC-----
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGE----- 997 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 997 (1237)
..++|++.+.||+|+||+||+|++. +++.||+|++.... ......+.+|+..+..++|+||+++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 3568999999999999999999875 68999999886432 223345788999999999999999988775432
Q ss_pred ---eEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEe
Q 000889 998 ---ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVS 1074 (1237)
Q Consensus 998 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~ 1074 (1237)
..++||||+++|+|.+++..+... ...+++..+..++.|++.||+|+|+. +|+||||||+||+++.++.+||+
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~-~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKT-NRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence 368999999999999999765432 35789999999999999999999999 99999999999999999999999
Q ss_pred ecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhh
Q 000889 1075 DFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR 1154 (1237)
Q Consensus 1075 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1154 (1237)
|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..........
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~~~~~ 259 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMHKTLA 259 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHhc
Confidence 9999987654332223345679999999999999899999999999999999999999997432 1111111111
Q ss_pred hcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1155 EKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1155 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
. . .++ + +.. ....+.+++.+||+.+|.+||++.+++++
T Consensus 260 ~-~----~~~-~--~~~---~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 G-R----YDP-L--PPS---ISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred C-C----CCC-C--CCC---CCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1 0 010 1 111 12356788889999999999999999875
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=338.13 Aligned_cols=269 Identities=23% Similarity=0.332 Sum_probs=197.7
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeC-----CeEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIG-----EERL 1000 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 1000 (1237)
+|++.++||+|+||.||+|++. ++..||+|++.... ......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999976 58899999886422 22345688999999999999999999987543 2479
Q ss_pred EEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccce
Q 000889 1001 LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1080 (1237)
Q Consensus 1001 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~ 1080 (1237)
+||||+. ++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 81 VVFELME-SDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEecCC-CCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 9999995 7898888653 4689999999999999999999999 99999999999999999999999999997
Q ss_pred eeccCCc-ceeeeccccCCCcCCccccCc--cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHh----
Q 000889 1081 LVNALDT-HLSVSTLAGTPGYVPPEYYQS--FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLH---- 1153 (1237)
Q Consensus 1081 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~---- 1153 (1237)
....... ........|++.|+|||++.+ ..++.++||||+||++|||++|+.||....... .........
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~ 228 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH---QLDLITDLLGTPS 228 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCC
Confidence 5432221 112234578999999999875 578899999999999999999999996532110 000000000
Q ss_pred -------hhcc---cccccCccccCCC--CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhccc
Q 000889 1154 -------REKR---INEILDPELTMQT--SDETELYQYLRISFECLDDRPFKRPTMIQVMAM--FKELQV 1209 (1237)
Q Consensus 1154 -------~~~~---~~~~~~~~l~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~--L~~l~~ 1209 (1237)
.... ....+........ ..+.....+.+++.+|++.+|++|||+.+++++ +..+..
T Consensus 229 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 0000 0000000000000 000112346788899999999999999999987 444433
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=338.02 Aligned_cols=202 Identities=25% Similarity=0.370 Sum_probs=174.4
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
++|++.+.||+|+||+||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46889999999999999999876 57899999886432 122346788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 999999999999753 4689999999999999999999999 99999999999999999999999999997543
Q ss_pred cCCcc---------------------------------eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcC
Q 000889 1084 ALDTH---------------------------------LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSG 1130 (1237)
Q Consensus 1084 ~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg 1130 (1237)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 21100 001235799999999999998999999999999999999999
Q ss_pred CCCCCCC
Q 000889 1131 KRPIDPS 1137 (1237)
Q Consensus 1131 ~~p~~~~ 1137 (1237)
+.||...
T Consensus 233 ~~Pf~~~ 239 (363)
T cd05628 233 YPPFCSE 239 (363)
T ss_pred CCCCCCC
Confidence 9999743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=325.11 Aligned_cols=260 Identities=26% Similarity=0.395 Sum_probs=201.8
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCC----EEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGS----VVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLL 1001 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 1001 (1237)
++|++.+.||+|+||+||+|++. ++. .+++|++..... ....++..|+..+++++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 46788899999999999999875 344 367776643221 12346777888999999999999999875 456789
Q ss_pred EEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeeccccee
Q 000889 1002 VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~ 1081 (1237)
++||+++|+|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 86 i~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEeCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 999999999999997542 4689999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhccccc
Q 000889 1082 VNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINE 1160 (1237)
Q Consensus 1082 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1160 (1237)
..............++..|+|||++.+..++.++||||||+++||+++ |+.||..... ... ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~---~~~~~~~~~~-- 230 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP---HEV---PDLLEKGERL-- 230 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHH---HHHHHCCCcC--
Confidence 654333333344567789999999998899999999999999999998 9999864321 111 1111111110
Q ss_pred ccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccccC
Q 000889 1161 ILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTE 1212 (1237)
Q Consensus 1161 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~~~ 1212 (1237)
..+ ... ...+.+++.+||..+|++|||+.++++.|..+..+..
T Consensus 231 -~~~-----~~~---~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~ 273 (279)
T cd05111 231 -AQP-----QIC---TIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPP 273 (279)
T ss_pred -CCC-----CCC---CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCc
Confidence 011 111 1245678889999999999999999999999887663
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=321.16 Aligned_cols=256 Identities=25% Similarity=0.452 Sum_probs=203.6
Q ss_pred CCCCCCceecccCCeEEEEEEECC----CCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD----GSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 1002 (1237)
++|++.+.||+|+||+||+|+++. ...||+|++..... ....++.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 468889999999999999998753 35789998764322 2345688999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceee
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~ 1082 (1237)
|||+++++|.+++.... ..+++..+.+++.|++.|++|||+. +|+||||||+||++++++.+|++|||+++..
T Consensus 84 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 84 TEYMENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEcCCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 99999999999987532 3689999999999999999999999 9999999999999999999999999999877
Q ss_pred ccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccc
Q 000889 1083 NALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161 (1237)
Q Consensus 1083 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1161 (1237)
.............++..|+|||.+.+..++.++||||||+++|||++ |..||.... .... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~---~~~~---~~~~~~~~~~--- 227 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS---NQDV---IKAVEDGYRL--- 227 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC---HHHH---HHHHHcCCCC---
Confidence 53232222223345678999999998889999999999999999998 999985322 1111 1111111000
Q ss_pred cCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 000889 1162 LDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207 (1237)
Q Consensus 1162 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l 1207 (1237)
+... .....+.+++.+|++.+|++||++.+++++|+++
T Consensus 228 -----~~~~---~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 -----PPPM---DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----CCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011 1223567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=323.55 Aligned_cols=256 Identities=27% Similarity=0.462 Sum_probs=207.5
Q ss_pred hCCCCCCceecccCCeEEEEEEECCCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
..+|++.++||+|+||.||+|++.++..+|+|.+.........++.+|+++++.++||||+++++++...+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 34688889999999999999999888999999987655445667899999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
++++|.+++.... +..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+.......
T Consensus 85 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 85 EKGSLLAFLRSPE---GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred ccCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 9999999997642 34689999999999999999999999 99999999999999999999999999997654321
Q ss_pred cceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPE 1165 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1165 (1237)
. ......++..|+|||++.+..++.++||||||+++|+|++ |+.||..... ..... ...... .
T Consensus 159 ~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~---~~~~~~--------~ 222 (261)
T cd05148 159 Y--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYD---QITAGY--------R 222 (261)
T ss_pred c--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHH---HHHhCC--------c
Confidence 1 1123345678999999988889999999999999999998 8999864321 11111 111110 0
Q ss_pred ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 000889 1166 LTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207 (1237)
Q Consensus 1166 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l 1207 (1237)
...+.. ....+.+++.+|++.+|.+|||+.++++.|+.+
T Consensus 223 ~~~~~~---~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 MPCPAK---CPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCC---CCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 111111 223567888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=326.22 Aligned_cols=261 Identities=24% Similarity=0.370 Sum_probs=202.0
Q ss_pred HhCCCCCCceecccCCeEEEEEEEC------CCCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeCCe
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLR------DGSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEE 998 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 998 (1237)
+.++|++.+.||+|+||.||+|.+. .+..||+|++..... ....++.+|+.+++.++||||+++++++..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567999999999999999999864 245799998753221 223468899999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHHhhhhcC-----CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEE
Q 000889 999 RLLVYEYMKWGSLESVLHDRAKG-----GGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARV 1073 (1237)
Q Consensus 999 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl 1073 (1237)
.++||||+++|+|.++++..... .....++..+..++.|+++|++|||+. +++||||||+||++++++.+|+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 99999999999999999753221 123467888999999999999999999 9999999999999999999999
Q ss_pred eecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHH
Q 000889 1074 SDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQL 1152 (1237)
Q Consensus 1074 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 1152 (1237)
+|||+++...............+++.|||||++.+..++.++|||||||++|||++ |..||..... .......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~------~~~~~~~ 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN------EQVLRFV 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHH
Confidence 99999976543332222223345778999999998889999999999999999999 7888864321 1111111
Q ss_pred hhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 000889 1153 HREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206 (1237)
Q Consensus 1153 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 1206 (1237)
. ...... .+.. ....+.+++.+|++.+|++|||+.++++.|++
T Consensus 235 ~-~~~~~~-------~~~~---~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 M-EGGLLD-------KPDN---CPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred H-cCCcCC-------CCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1 111100 0111 22357788899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=324.96 Aligned_cols=254 Identities=25% Similarity=0.405 Sum_probs=207.4
Q ss_pred hCCCCCCceecccCCeEEEEEEECCCCEEEEEEecccc--CcCHHHHHHHHHHHHhcC-CCCcccccceEEeCCeEEEEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVT--GQGDREFMAEMETIGKIK-HRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
...|++.+.||+||.+.||++...+.+.+|+|++.... .+...-|..|+..+.+++ |.+||++++|-..++..||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 34588899999999999999999888899999886432 223456899999999995 999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||-+ .+|..+++++.. ....| .++.+..|++.|+.++|.. ||||.|+||.|+++-+ |.+||+|||.|..+.
T Consensus 440 E~Gd-~DL~kiL~k~~~---~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 440 ECGD-IDLNKILKKKKS---IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred eccc-ccHHHHHHhccC---CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 9865 799999987532 23334 7788999999999999999 9999999999999865 589999999999988
Q ss_pred cCCcceeeeccccCCCcCCccccCcc-----------ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHH
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSF-----------RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQL 1152 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 1152 (1237)
...+.......+||+.|||||.+... +.+.++||||+|||+|+|+.|++||.. +.
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~--------~~------ 576 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ--------II------ 576 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH--------HH------
Confidence 87788878889999999999998543 256789999999999999999999852 11
Q ss_pred hhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1153 HREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1153 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
....++..+.++.-.+++.......++++++..|+..||++|||+.+++++
T Consensus 577 n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 577 NQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 112234445555444444333333448899999999999999999999986
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=334.96 Aligned_cols=263 Identities=27% Similarity=0.440 Sum_probs=202.6
Q ss_pred CCCCCCceecccCCeEEEEEEEC------CCCEEEEEEeccccC-cCHHHHHHHHHHHHhc-CCCCcccccceEEe-CCe
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR------DGSVVAIKKLIHVTG-QGDREFMAEMETIGKI-KHRNLVPLLGYCKI-GEE 998 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~~ 998 (1237)
++|++.+.||+|+||.||+|+.. .++.||+|++..... ...+.+..|+.+++++ +||||+++++++.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46888999999999999999743 246899998864322 2234577899999999 89999999998764 456
Q ss_pred EEEEEEeccCCCHHHHHhhhhcC--------------------------------------------------------C
Q 000889 999 RLLVYEYMKWGSLESVLHDRAKG--------------------------------------------------------G 1022 (1237)
Q Consensus 999 ~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------------~ 1022 (1237)
.+++|||+++++|.+++...... .
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 78999999999999998643210 0
Q ss_pred CCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcceeeeccccCCCcCC
Q 000889 1023 GTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP 1102 (1237)
Q Consensus 1023 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 1102 (1237)
...+++..+.+++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++.+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 13678999999999999999999999 999999999999999999999999999987644333222334456778999
Q ss_pred ccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHH
Q 000889 1103 PEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLR 1181 (1237)
Q Consensus 1103 PE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~ 1181 (1237)
||++.+..++.++||||+||++|||++ |..||...... ..+. ........ ... + .....++.+
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--~~~~---~~~~~~~~------~~~--~---~~~~~~~~~ 307 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--EEFC---RRLKEGTR------MRA--P---EYATPEIYS 307 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--HHHH---HHHhccCC------CCC--C---ccCCHHHHH
Confidence 999999999999999999999999997 99998653221 1111 11111100 000 0 112245778
Q ss_pred HHHhccccCCCCCCCHHHHHHHHHhccc
Q 000889 1182 ISFECLDDRPFKRPTMIQVMAMFKELQV 1209 (1237)
Q Consensus 1182 li~~cl~~dP~~RPt~~ell~~L~~l~~ 1209 (1237)
++.+||+.+|++||++.+++++|+++..
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8899999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=338.71 Aligned_cols=247 Identities=28% Similarity=0.423 Sum_probs=191.3
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
+|+..++||+|+||.||+|++. +++.||+|++..... .....+.+|++++++++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4566788999999999999976 588999998854322 22356889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
++|+|.+. ....+..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 155 ~~~~L~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 155 DGGSLEGT---------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCccccc---------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 99998642 2345677788999999999999999 99999999999999999999999999998664322
Q ss_pred cceeeeccccCCCcCCccccCc-----cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQS-----FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1161 (1237)
. ......||..|+|||++.. ...+.++|||||||++|||++|+.||...... .+...........
T Consensus 223 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~~~----- 292 (353)
T PLN00034 223 D--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG---DWASLMCAICMSQ----- 292 (353)
T ss_pred c--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc---cHHHHHHHHhccC-----
Confidence 1 1234578999999998743 23456899999999999999999999743221 1111111110000
Q ss_pred cCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1162 LDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1162 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.+.. . .....++.+++.+||+.+|++|||+.|++++
T Consensus 293 -~~~~--~---~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 -PPEA--P---ATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -CCCC--C---CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0 1122357788889999999999999999987
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=329.38 Aligned_cols=264 Identities=23% Similarity=0.341 Sum_probs=193.9
Q ss_pred CCCCCCceecccCCeEEEEEEEC--CCCEEEEEEeccccC--cCHHHHHHHHHHHHhc---CCCCcccccceEEe-----
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR--DGSVVAIKKLIHVTG--QGDREFMAEMETIGKI---KHRNLVPLLGYCKI----- 995 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 995 (1237)
++|++.+.||+|+||+||+|++. ++..||+|++..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999874 367899998864322 2234566777777766 69999999998852
Q ss_pred CCeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEee
Q 000889 996 GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSD 1075 (1237)
Q Consensus 996 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~D 1075 (1237)
....++||||++ ++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcc
Confidence 456899999997 68999987542 24588999999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhh-
Q 000889 1076 FGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR- 1154 (1237)
Q Consensus 1076 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~- 1154 (1237)
||+++..... .......|++.|+|||++.+..++.++||||+||++|||++|++||...... ..+.........
T Consensus 154 fg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~--~~~~~i~~~~~~~ 228 (290)
T cd07862 154 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGLP 228 (290)
T ss_pred ccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCC
Confidence 9999865432 1224457899999999998888999999999999999999999999754211 111111110000
Q ss_pred -hcccc-------cccCccccCC--CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1155 -EKRIN-------EILDPELTMQ--TSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1155 -~~~~~-------~~~~~~l~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
..... ....+..... ...+.....+.+++.+|++.+|++|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00000 0000000000 0000112345688999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=340.71 Aligned_cols=253 Identities=24% Similarity=0.345 Sum_probs=202.2
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
++|++.+.||+|+||+||+|++. +++.||+|++.... ......+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999987 68899999986432 233456888999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 81 EYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 999999999999764 4688999999999999999999998 99999999999999999999999999998654
Q ss_pred cCC---------------------------cceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCC
Q 000889 1084 ALD---------------------------THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDP 1136 (1237)
Q Consensus 1084 ~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~ 1136 (1237)
... .........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 332 01122345689999999999999999999999999999999999999975
Q ss_pred CCCCCCchHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 000889 1137 SEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPT-MIQVMAM 1203 (1237)
Q Consensus 1137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~ell~~ 1203 (1237)
... ...+.......... ..+.... ....+.+++.+|+. +|.+||+ +.+++++
T Consensus 233 ~~~-----~~~~~~i~~~~~~~------~~p~~~~---~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 233 DTL-----QETYNKIINWKESL------RFPPDPP---VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCH-----HHHHHHHhccCCcc------cCCCCCC---CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 431 11111111000000 0111000 12356677889997 9999999 9999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=339.50 Aligned_cols=253 Identities=22% Similarity=0.266 Sum_probs=194.0
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
.|+..+.||+|+||+||+|++. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999876 57899999986432 1224568889999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
|+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++++||+|||+++.+..
T Consensus 82 ~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 82 YIPGGDMMSLLIRM-----EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 99999999998753 3578889999999999999999999 999999999999999999999999999864311
Q ss_pred CCc---------------------------------------------ceeeeccccCCCcCCccccCccccCcccchHH
Q 000889 1085 LDT---------------------------------------------HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYS 1119 (1237)
Q Consensus 1085 ~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 1119 (1237)
... .......+||+.|||||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 000 00012357999999999999888999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHh--ccccCCCCCCCH
Q 000889 1120 YGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFE--CLDDRPFKRPTM 1197 (1237)
Q Consensus 1120 lGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~--cl~~dP~~RPt~ 1197 (1237)
+||++|||++|+.||...... . .... ...... ....+....... ++.+++.+ |+..+|..||++
T Consensus 234 lG~il~elltG~~Pf~~~~~~---~--~~~~-i~~~~~-----~~~~~~~~~~s~---~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPT---E--TQLK-VINWEN-----TLHIPPQVKLSP---EAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHH---H--HHHH-HHcccc-----ccCCCCCCCCCH---HHHHHHHHHccCcccccCCCCH
Confidence 999999999999999753211 0 0000 000000 001111111122 34455555 556677779999
Q ss_pred HHHHHH
Q 000889 1198 IQVMAM 1203 (1237)
Q Consensus 1198 ~ell~~ 1203 (1237)
.+++++
T Consensus 300 ~~~l~h 305 (381)
T cd05626 300 DDIKAH 305 (381)
T ss_pred HHHhcC
Confidence 999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=333.98 Aligned_cols=252 Identities=20% Similarity=0.291 Sum_probs=196.8
Q ss_pred CCCCCceecccCCeEEEEEEEC----CCCEEEEEEecccc----CcCHHHHHHHHHHHHhc-CCCCcccccceEEeCCeE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR----DGSVVAIKKLIHVT----GQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEER 999 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 999 (1237)
+|++.+.||+|+||.||+|+.. ++..||+|++.... ....+.+..|+++++++ +||+|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788899999999999999863 57899999886422 12234577899999999 599999999999999999
Q ss_pred EEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccc
Q 000889 1000 LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1079 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla 1079 (1237)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 9999999999999998753 4688999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcceeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccc
Q 000889 1080 RLVNALDTHLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158 (1237)
Q Consensus 1080 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1158 (1237)
+........ ......||+.|||||++.+. .++.++|||||||++|||++|+.||........ ..........
T Consensus 153 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~---- 225 (332)
T cd05614 153 KEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT--QSEVSRRILK---- 225 (332)
T ss_pred ccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC--HHHHHHHHhc----
Confidence 865432221 12345799999999999865 478899999999999999999999974322211 1111111110
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 000889 1159 NEILDPELTMQTSDETELYQYLRISFECLDDRPFKRP-----TMIQVMAM 1203 (1237)
Q Consensus 1159 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 1203 (1237)
.++.++ ... ...+.+++.+|++.||++|| ++.+++++
T Consensus 226 ---~~~~~~--~~~---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 ---CDPPFP--SFI---GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ---CCCCCC--CCC---CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 111111 111 12456788899999999999 77788765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=334.64 Aligned_cols=242 Identities=20% Similarity=0.294 Sum_probs=193.3
Q ss_pred ceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCC
Q 000889 934 SMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWG 1009 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 1009 (1237)
+.||+|+||.||+|+.. ++..||+|.+.... ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999876 68899999886432 122345678999999999999999999999999999999999999
Q ss_pred CHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1010 SLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH-SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1010 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
+|.+++... ..+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~- 151 (325)
T cd05594 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA- 151 (325)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-
Confidence 999888653 468999999999999999999997 6 999999999999999999999999999875432221
Q ss_pred eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccC
Q 000889 1089 LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTM 1168 (1237)
Q Consensus 1089 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1168 (1237)
......||+.|||||++.+..++.++||||+||++|||++|+.||..... ........ .. ...+
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~------~~~~~~i~-~~------~~~~-- 215 (325)
T cd05594 152 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELIL-ME------EIRF-- 215 (325)
T ss_pred -ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH------HHHHHHHh-cC------CCCC--
Confidence 22345799999999999998999999999999999999999999964321 11111110 00 0011
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 000889 1169 QTSDETELYQYLRISFECLDDRPFKRP-----TMIQVMAM 1203 (1237)
Q Consensus 1169 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 1203 (1237)
+... ..++.+++.+|++.||++|+ ++.+++++
T Consensus 216 p~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 PRTL---SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCC---CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1111 12456788899999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=331.40 Aligned_cols=242 Identities=26% Similarity=0.367 Sum_probs=191.8
Q ss_pred ceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhc-CCCCcccccceEEeCCeEEEEEEeccC
Q 000889 934 SMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
++||+|+||+||+|+++ +++.||+|++.... ....+.+..|.++++.. +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999987 57899999886432 23345677888888876 699999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~~-----~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~- 151 (320)
T cd05590 81 GDLMFHIQKS-----RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK- 151 (320)
T ss_pred chHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-
Confidence 9999988753 4688999999999999999999999 999999999999999999999999999875432211
Q ss_pred eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccC
Q 000889 1089 LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTM 1168 (1237)
Q Consensus 1089 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1168 (1237)
......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .......... ....
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~---------~~~~ 215 (320)
T cd05590 152 -TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILND---------EVVY 215 (320)
T ss_pred -cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhcC---------CCCC
Confidence 22346799999999999988999999999999999999999999974321 1111111111 1111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 000889 1169 QTSDETELYQYLRISFECLDDRPFKRPTM------IQVMAM 1203 (1237)
Q Consensus 1169 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~ell~~ 1203 (1237)
+.. ....+.+++.+|++.||++||++ .+++++
T Consensus 216 ~~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 216 PTW---LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCC---CCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 111 12345678889999999999998 556554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=324.93 Aligned_cols=252 Identities=27% Similarity=0.346 Sum_probs=199.3
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
+|++.++||+|+||.||+|.+. +++.||+|++.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999976 58899999886422 1223457789999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
|+++|+|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 999999998886532 24689999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCc
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDP 1164 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1164 (1237)
... .....|++.|+|||++.+..++.++||||+||++|||++|+.||....... ....+..... .. ..
T Consensus 155 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~--~~~~~~~~~~-~~------~~ 222 (285)
T cd05605 155 GET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV--KREEVERRVK-ED------QE 222 (285)
T ss_pred CCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh--HHHHHHHHhh-hc------cc
Confidence 221 234578999999999998889999999999999999999999997532110 1111111100 00 00
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 000889 1165 ELTMQTSDETELYQYLRISFECLDDRPFKRP-----TMIQVMAM 1203 (1237)
Q Consensus 1165 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 1203 (1237)
.. .......+.+++.+|++.||++|| ++.+++++
T Consensus 223 ~~-----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 EY-----SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cc-----CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 00 111223567888899999999999 88888766
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=330.37 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=194.2
Q ss_pred ceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhc-CCCCcccccceEEeCCeEEEEEEeccC
Q 000889 934 SMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
++||+|+||.||+|++. +++.||+|.+.... ....+.+.+|..+++++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999986 57899999886432 12234577899999998 699999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-- 150 (329)
T cd05588 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-- 150 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC--
Confidence 9999888653 4689999999999999999999999 99999999999999999999999999987432211
Q ss_pred eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCC--CchHHHHHHHHhhhcccccccCccc
Q 000889 1089 LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGD--DNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1089 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||+.....+ ......+......... .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~ 222 (329)
T cd05588 151 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------I 222 (329)
T ss_pred CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--------C
Confidence 12234679999999999999899999999999999999999999997432211 1111112111111111 1
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCC------HHHHHHH
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPT------MIQVMAM 1203 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt------~~ell~~ 1203 (1237)
..+... ...+.+++.+|++.+|.+||+ +.+++++
T Consensus 223 ~~p~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 223 RIPRSL---SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCC---CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 111111 124567888999999999997 6777765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=339.36 Aligned_cols=253 Identities=24% Similarity=0.329 Sum_probs=198.5
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 1002 (1237)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.++...++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 457889999999999999999986 57899999886422 22334577899999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceee
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~ 1082 (1237)
|||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 122 ~Ey~~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 122 MEYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 999999999999864 2477888889999999999999999 9999999999999999999999999999865
Q ss_pred ccCCcceeeeccccCCCcCCccccCcc----ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccc
Q 000889 1083 NALDTHLSVSTLAGTPGYVPPEYYQSF----RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158 (1237)
Q Consensus 1083 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1158 (1237)
..... .......||+.|||||++.+. .++.++||||+||++|||++|+.||..... ...+.........
T Consensus 193 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~~i~~~~~~- 265 (370)
T cd05596 193 DANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYSKIMDHKNS- 265 (370)
T ss_pred cCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcCCCc-
Confidence 43221 122356799999999998653 478899999999999999999999975321 1111111110000
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 000889 1159 NEILDPELTMQTSDETELYQYLRISFECLDDRPFK--RPTMIQVMAM 1203 (1237)
Q Consensus 1159 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ell~~ 1203 (1237)
...+... .....+.+++.+|+..+|.+ ||++.+++++
T Consensus 266 -----~~~~~~~---~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 -----LTFPDDI---EISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -----CCCCCcC---CCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0111100 11235567888999999987 9999999887
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=339.13 Aligned_cols=254 Identities=23% Similarity=0.329 Sum_probs=196.4
Q ss_pred HhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEE
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLL 1001 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 1001 (1237)
..++|++.+.||+|+||.||+|++. +++.+|+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3567999999999999999999987 47789999885322 2234457889999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeeccccee
Q 000889 1002 VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~ 1081 (1237)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+|+.
T Consensus 121 v~Ey~~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 121 VMEYMPGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 9999999999999864 2578888999999999999999999 999999999999999999999999999987
Q ss_pred eccCCcceeeeccccCCCcCCccccCcc----ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcc
Q 000889 1082 VNALDTHLSVSTLAGTPGYVPPEYYQSF----RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKR 1157 (1237)
Q Consensus 1082 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1157 (1237)
..... ........||+.|||||++.+. .++.++||||+||++|||++|+.||..... ...+ ........
T Consensus 192 ~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-----~~~~-~~i~~~~~ 264 (370)
T cd05621 192 MDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-----VGTY-SKIMDHKN 264 (370)
T ss_pred cccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-----HHHH-HHHHhCCc
Confidence 64322 1222456799999999998754 378899999999999999999999974321 1111 11111100
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 000889 1158 INEILDPELTMQTSDETELYQYLRISFECLDDRPFK--RPTMIQVMAM 1203 (1237)
Q Consensus 1158 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ell~~ 1203 (1237)
....+... .....+.+++.+|+..++.+ ||++.+++++
T Consensus 265 -----~~~~p~~~---~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 -----SLNFPEDV---EISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -----ccCCCCcc---cCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 00111111 11224456677888755543 8999999988
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=330.12 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=192.5
Q ss_pred ceecccCCeEEEEEEEC-CCCEEEEEEeccccC---cCHHHHHHHHHHHHhc-CCCCcccccceEEeCCeEEEEEEeccC
Q 000889 934 SMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG---QGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999986 578899998875322 2234567888888777 799999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
|+|..++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~- 151 (329)
T cd05618 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD- 151 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-
Confidence 9999888653 4689999999999999999999999 999999999999999999999999999975322111
Q ss_pred eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCC--CchHHHHHHHHhhhcccccccCccc
Q 000889 1089 LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGD--DNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1089 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+......... .
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--------~ 222 (329)
T cd05618 152 -TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--------I 222 (329)
T ss_pred -ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--------C
Confidence 1234679999999999999999999999999999999999999996422111 1111111111111111 1
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCC------HHHHHHH
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPT------MIQVMAM 1203 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt------~~ell~~ 1203 (1237)
..+... ...+.+++.+|++.||++||+ +.+++++
T Consensus 223 ~~p~~~---~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 223 RIPRSL---SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCC---CHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 111111 234567888999999999998 4676655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=331.49 Aligned_cols=242 Identities=25% Similarity=0.356 Sum_probs=192.6
Q ss_pred ceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhc-CCCCcccccceEEeCCeEEEEEEeccC
Q 000889 934 SMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
++||+|+||.||+|++. +++.||+|++.... ....+.+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899999999999987 47899999886432 22334577889988876 799999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 151 (321)
T cd05591 81 GDLMFQIQRS-----RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV- 151 (321)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-
Confidence 9999988653 4688899999999999999999999 999999999999999999999999999975432221
Q ss_pred eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccC
Q 000889 1089 LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTM 1168 (1237)
Q Consensus 1089 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1168 (1237)
......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .......... ....
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~------~~~~~~i~~~---------~~~~ 215 (321)
T cd05591 152 -TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE------DDLFESILHD---------DVLY 215 (321)
T ss_pred -cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH------HHHHHHHHcC---------CCCC
Confidence 22346789999999999988999999999999999999999999974321 1111111111 1111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCC-------CHHHHHHH
Q 000889 1169 QTSDETELYQYLRISFECLDDRPFKRP-------TMIQVMAM 1203 (1237)
Q Consensus 1169 ~~~~~~~~~~l~~li~~cl~~dP~~RP-------t~~ell~~ 1203 (1237)
+... ..++.+++.+|++.+|++|| ++.+++++
T Consensus 216 p~~~---~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 216 PVWL---SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCC---CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1111 13466788899999999999 78888766
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=338.19 Aligned_cols=253 Identities=22% Similarity=0.287 Sum_probs=197.4
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
++|++.+.||+|+||+||+|++. +++.||+|++.... ......+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46889999999999999999986 58899999986432 223345778999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 999999999998753 3689999999999999999999999 99999999999999999999999999997543
Q ss_pred cCCcce------------------------------------eeeccccCCCcCCccccCccccCcccchHHHHHHHHHH
Q 000889 1084 ALDTHL------------------------------------SVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLEL 1127 (1237)
Q Consensus 1084 ~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el 1127 (1237)
...... .....+||+.|+|||++.+..++.++||||+||++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence 211100 01124699999999999998999999999999999999
Q ss_pred HcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 000889 1128 LSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPT---MIQVMAM 1203 (1237)
Q Consensus 1128 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~ell~~ 1203 (1237)
++|+.||..... ........... . ....+...... ..+.+++.+|+. +|.+|++ +.+++++
T Consensus 233 ~~G~~Pf~~~~~------~~~~~~i~~~~---~--~~~~~~~~~~s---~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 233 LVGYPPFCSDNP------QETYRKIINWK---E--TLQFPDEVPLS---PEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred hcCCCCCCCCCH------HHHHHHHHcCC---C--ccCCCCCCCCC---HHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999999974321 11111111000 0 00011111112 244567778886 8999998 9988875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=332.15 Aligned_cols=245 Identities=25% Similarity=0.345 Sum_probs=192.7
Q ss_pred CCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHH---HhcCCCCcccccceEEeCCeEEEE
Q 000889 930 FSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETI---GKIKHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 1002 (1237)
|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|.+++ ++++||||+++++++..++..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 667889999999999999876 58899999986432 22234566676655 566899999999999999999999
Q ss_pred EEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceee
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~ 1082 (1237)
|||+++|+|..+++. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 999999999888753 3689999999999999999999999 9999999999999999999999999998753
Q ss_pred ccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccccccc
Q 000889 1083 NALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162 (1237)
Q Consensus 1083 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1162 (1237)
.... .......|++.|||||++.+..++.++|||||||++|||++|+.||..... ..........
T Consensus 152 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~------~~~~~~i~~~------- 216 (324)
T cd05589 152 MGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE------EEVFDSIVND------- 216 (324)
T ss_pred CCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhC-------
Confidence 3222 122456799999999999998999999999999999999999999974321 1111111111
Q ss_pred CccccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 000889 1163 DPELTMQTSDETELYQYLRISFECLDDRPFKRP-----TMIQVMAM 1203 (1237)
Q Consensus 1163 ~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 1203 (1237)
....+... ...+.+++.+|++.||.+|| ++.+++++
T Consensus 217 --~~~~p~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 217 --EVRYPRFL---SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred --CCCCCCCC---CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 00111111 23456788899999999999 57777765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=325.11 Aligned_cols=261 Identities=27% Similarity=0.421 Sum_probs=203.3
Q ss_pred CCCCCceecccCCeEEEEEEECC------CCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLRD------GSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLL 1001 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 1001 (1237)
+|++.+.||+|+||.||+|+... ...+++|.+..... ...+++.+|+.++++++||||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47788999999999999998642 24678887754322 224568899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHhhhhc-------------------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 000889 1002 VYEYMKWGSLESVLHDRAK-------------------GGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSN 1062 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~N 1062 (1237)
||||+++|+|.+++..... .....+++..+..++.|++.|++|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 9999999999999875321 1124578999999999999999999999 99999999999
Q ss_pred eeeCCCCceEEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCC
Q 000889 1063 VLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGD 1141 (1237)
Q Consensus 1063 Ill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~ 1141 (1237)
|++++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 9999999999999999986543333222233456778999999988889999999999999999998 9999864321
Q ss_pred CchHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 000889 1142 DNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQV 1209 (1237)
Q Consensus 1142 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~ 1209 (1237)
..+..+ .... ..... +.. ...++.+++.+|++.+|++||++.++++.|+++..
T Consensus 236 -~~~~~~---~~~~------~~~~~--~~~---~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 -ERLFNL---LKTG------YRMER--PEN---CSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -HHHHHH---HhCC------CCCCC--CCC---CCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 111111 1110 01111 111 12357788899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=342.17 Aligned_cols=253 Identities=21% Similarity=0.285 Sum_probs=194.6
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
++|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888999999999999999876 68899999886432 122356788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 81 EFLPGGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999999998753 4678889999999999999999999 99999999999999999999999999996432
Q ss_pred cCCcc---------------------------------------------eeeeccccCCCcCCccccCccccCcccchH
Q 000889 1084 ALDTH---------------------------------------------LSVSTLAGTPGYVPPEYYQSFRCTTKGDVY 1118 (1237)
Q Consensus 1084 ~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvw 1118 (1237)
..... ......+||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 11000 000124699999999999998999999999
Q ss_pred HHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCC---C
Q 000889 1119 SYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKR---P 1195 (1237)
Q Consensus 1119 SlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~R---P 1195 (1237)
|+||++|||++|+.||..... ...+ ....... . ...++..... ...+.+++.+|+. +|.+| +
T Consensus 233 SlGvil~elltG~~Pf~~~~~-----~~~~-~~i~~~~---~--~~~~p~~~~~---s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENS-----HETY-RKIINWR---E--TLYFPDDIHL---SVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCH-----HHHH-HHHHccC---C--ccCCCCCCCC---CHHHHHHHHHHhc-CHhhcCCCC
Confidence 999999999999999964321 1111 1111000 0 0001110011 1245677778887 66665 6
Q ss_pred CHHHHHHH
Q 000889 1196 TMIQVMAM 1203 (1237)
Q Consensus 1196 t~~ell~~ 1203 (1237)
++.+++++
T Consensus 298 ~~~~~l~h 305 (377)
T cd05629 298 GAHEIKSH 305 (377)
T ss_pred CHHHHhcC
Confidence 99999887
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=324.72 Aligned_cols=259 Identities=24% Similarity=0.430 Sum_probs=201.5
Q ss_pred CCCCCCceecccCCeEEEEEEEC-----CCCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-----DGSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLL 1001 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 1001 (1237)
.+|++.+.||+|+||.||+|+.. .+..||+|.+..... .....+.+|++++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 35778899999999999999852 457899998864322 223568889999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHhhhhc------------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCC
Q 000889 1002 VYEYMKWGSLESVLHDRAK------------GGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENF 1069 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~ 1069 (1237)
||||+++++|.+++..... .....+++..+..++.|++.|++|||+. +++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999864321 0123578889999999999999999999 999999999999999999
Q ss_pred ceEEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHH
Q 000889 1070 EARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGW 1148 (1237)
Q Consensus 1070 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~ 1148 (1237)
.+|++|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||..... ...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~--- 235 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEV--- 235 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHH---
Confidence 999999999986644332222234456778999999988889999999999999999998 9889864321 111
Q ss_pred HHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 000889 1149 AKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206 (1237)
Q Consensus 1149 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 1206 (1237)
...... ... +...... ...+.+++.+|++.+|++||++.++.++|..
T Consensus 236 ~~~~~~-~~~-------~~~~~~~---~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 IEMVRK-RQL-------LPCSEDC---PPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHc-CCc-------CCCCCCC---CHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111 110 1111111 2356778889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=320.16 Aligned_cols=258 Identities=24% Similarity=0.415 Sum_probs=200.8
Q ss_pred CCCCceecccCCeEEEEEEECC----CCEEEEEEeccccC--cCHHHHHHHHHHHHhcCCCCcccccceEEeCCe-----
Q 000889 930 FSADSMIGSGGFGEVYKAQLRD----GSVVAIKKLIHVTG--QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEE----- 998 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 998 (1237)
|++.+.||+|+||.||+|.... +..||+|++..... .....+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998752 36799998864322 223568899999999999999999998866554
Q ss_pred -EEEEEEeccCCCHHHHHhhhhcC-CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeec
Q 000889 999 -RLLVYEYMKWGSLESVLHDRAKG-GGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDF 1076 (1237)
Q Consensus 999 -~~lv~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~Df 1076 (1237)
.++||||+++|+|..++...... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 79999999999999998664322 234689999999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhh
Q 000889 1077 GMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHRE 1155 (1237)
Q Consensus 1077 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1155 (1237)
|+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.... ... ........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~---~~~---~~~~~~~~ 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE---NHE---IYDYLRHG 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---HHH---HHHHHHcC
Confidence 99987654333222222345678999999988889999999999999999999 888886432 111 11111111
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 000889 1156 KRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207 (1237)
Q Consensus 1156 ~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l 1207 (1237)
.. ...+. .....+.+++.+|++.+|++|||+.++++.|+++
T Consensus 232 ~~--------~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NR--------LKQPE---DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC--------CCCCc---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10 00111 1223677888899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=318.80 Aligned_cols=251 Identities=26% Similarity=0.415 Sum_probs=200.7
Q ss_pred CCCCCceecccCCeEEEEEEECCCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccC
Q 000889 929 GFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
+|++.+.||+|+||.||+|++.++..+|+|.+... ......+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 57788899999999999999887778999987642 23456789999999999999999999999988899999999999
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
|+|.+++.... ..+++..++.++.|++.|++|||+. +++|+||||+||+++.++.+||+|||.++.......
T Consensus 84 ~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~- 155 (256)
T cd05113 84 GCLLNYLREHG----KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY- 155 (256)
T ss_pred CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce-
Confidence 99999987532 3689999999999999999999999 999999999999999999999999999986543221
Q ss_pred eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcccc
Q 000889 1089 LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELT 1167 (1237)
Q Consensus 1089 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1167 (1237)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||..... . ............ ...
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~---~~~~~~~~~~~~------~~~ 223 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---S---ETVEKVSQGLRL------YRP 223 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---H---HHHHHHhcCCCC------CCC
Confidence 11122345678999999988889999999999999999998 9999864321 1 111111111110 000
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 000889 1168 MQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFK 1205 (1237)
Q Consensus 1168 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 1205 (1237)
. .....+.+++.+||+.+|++|||+.++++.++
T Consensus 224 --~---~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 --H---LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --C---CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0 11246778889999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=327.47 Aligned_cols=252 Identities=25% Similarity=0.314 Sum_probs=207.2
Q ss_pred HhCCCCCCceecccCCeEEEEEEECC-CCEEEEEEeccccCcC---HHHHHHHHHHHHhcC-CCCcccccceEEeCCeEE
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQG---DREFMAEMETIGKIK-HRNLVPLLGYCKIGEERL 1000 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 1000 (1237)
....|++.+.||+|.||.||+++.+. |+.+|+|.+.+..... ...+.+|+.+|+++. |||||.+++++++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34568888999999999999999885 9999999997654433 357899999999998 999999999999999999
Q ss_pred EEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCC----CCceEEeec
Q 000889 1001 LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE----NFEARVSDF 1076 (1237)
Q Consensus 1001 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~----~~~vkl~Df 1076 (1237)
+|||++.||.|.+.+... .+++..+..++.|++.|+.|||+. +|||||+||+|+|+.. ++.+|++||
T Consensus 113 lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 999999999999999765 289999999999999999999999 9999999999999963 357999999
Q ss_pred ccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhc
Q 000889 1077 GMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREK 1156 (1237)
Q Consensus 1077 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1156 (1237)
|+|..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||....... .. . .....
T Consensus 184 Gla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~--~~---~--~i~~~ 253 (382)
T KOG0032|consen 184 GLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE--IF---L--AILRG 253 (382)
T ss_pred CCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH--HH---H--HHHcC
Confidence 99998765 334567899999999999999999999999999999999999999997543211 00 0 01111
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1157 RINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1157 ~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.. .+..+. .+.......+++..|+..||.+|+|+.+++++
T Consensus 254 ~~------~f~~~~-w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 254 DF------DFTSEP-WDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CC------CCCCCC-ccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11 111111 11223445577789999999999999999997
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=328.17 Aligned_cols=241 Identities=27% Similarity=0.378 Sum_probs=188.5
Q ss_pred ceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhc-CCCCcccccceEEeCCeEEEEEEeccC
Q 000889 934 SMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
++||+|+||.||+|++. +++.||+|++.... ....+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999986 47789999886432 22234456677777654 899999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-- 150 (316)
T cd05592 81 GDLMFHIQSS-----GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-- 150 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--
Confidence 9999988653 3688899999999999999999999 99999999999999999999999999997643322
Q ss_pred eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccC
Q 000889 1089 LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTM 1168 (1237)
Q Consensus 1089 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1168 (1237)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .......... .+.+
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~-------~~~~-- 215 (316)
T cd05592 151 GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE------DELFDSILND-------RPHF-- 215 (316)
T ss_pred CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcC-------CCCC--
Confidence 222456799999999999988899999999999999999999999974321 1111111100 0111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 000889 1169 QTSDETELYQYLRISFECLDDRPFKRPTMI-QVMA 1202 (1237)
Q Consensus 1169 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-ell~ 1202 (1237)
+... ..++.+++.+|++.+|++||++. ++++
T Consensus 216 ~~~~---~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 216 PRWI---SKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCC---CHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1111 12456778899999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=330.30 Aligned_cols=247 Identities=26% Similarity=0.336 Sum_probs=194.4
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCC-CcccccceEEeCCeEEEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHR-NLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 1003 (1237)
+|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+..|.++++.++|+ +|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999987 46789999886432 23345678899999999764 6888999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 81 EYVNGGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 999999999998653 3578899999999999999999999 99999999999999999999999999987532
Q ss_pred cCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccC
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ... ..... .
T Consensus 153 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~---~~~i~---------~ 215 (324)
T cd05587 153 FGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DEL---FQSIM---------E 215 (324)
T ss_pred CCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHH---HHHHH---------c
Confidence 2121 22346799999999999998999999999999999999999999974321 111 11111 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTM-----IQVMAM 1203 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~ell~~ 1203 (1237)
.....+... ...+.+++.+|++.+|.+|++. .++.++
T Consensus 216 ~~~~~~~~~---~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 216 HNVSYPKSL---SKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CCCCCCCCC---CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011111111 2345678889999999999986 566554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=350.46 Aligned_cols=264 Identities=23% Similarity=0.322 Sum_probs=203.0
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCc---CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQ---GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
++|++.++||+|+||.||+|++. +++.||+|++...... ..+.+.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999986 5889999998643222 2346889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcC------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecc
Q 000889 1004 EYMKWGSLESVLHDRAKG------GGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFG 1077 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfG 1077 (1237)
||++||+|.+++...... .....++..+.+++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998753211 123456778899999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcc----------------eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCC
Q 000889 1078 MARLVNALDTH----------------LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGD 1141 (1237)
Q Consensus 1078 la~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~ 1141 (1237)
+++........ .......||+.|||||++.+..++.++||||+||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99866211100 01123569999999999999999999999999999999999999997532110
Q ss_pred CchHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHhccc
Q 000889 1142 DNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRP-TMIQVMAMFKELQV 1209 (1237)
Q Consensus 1142 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~ell~~L~~l~~ 1209 (1237)
. .+. ... .++....+ .......+.+++.+|++.+|++|| ++.++++.|+....
T Consensus 239 ---i-~~~------~~i---~~P~~~~p--~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ---I-SYR------DVI---LSPIEVAP--YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred ---h-hhh------hhc---cChhhccc--cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0 000 000 00000000 011223566888899999999996 56777777877543
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=316.79 Aligned_cols=261 Identities=26% Similarity=0.415 Sum_probs=208.8
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999987 78899999875322 222457889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+++|+|.+++..... ....+++..+..++.++++|++|||+. +++||||+|+||+++.++.++++|||++....
T Consensus 82 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 99999999999875422 235689999999999999999999999 99999999999999999999999999987654
Q ss_pred cCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccC
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
..... .....+++.|+|||.+.+..++.++||||+||++|+|++|+.||.... ............. . .
T Consensus 158 ~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~-~-----~ 225 (267)
T cd08224 158 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEKC-D-----Y 225 (267)
T ss_pred CCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhhcC-C-----C
Confidence 32211 233468889999999998889999999999999999999999986432 1111111111110 0 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~ 1208 (1237)
+..+ .......+.+++.+|+..+|++|||+.++++.++++.
T Consensus 226 ~~~~----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 226 PPLP----ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCC----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1111 1122345678888999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=325.33 Aligned_cols=262 Identities=27% Similarity=0.425 Sum_probs=205.0
Q ss_pred hCCCCCCceecccCCeEEEEEEECC------CCEEEEEEecccc-CcCHHHHHHHHHHHHhc-CCCCcccccceEEeCCe
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLRD------GSVVAIKKLIHVT-GQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEE 998 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 998 (1237)
.++|++.+.||+|+||.||+|.... ...+|+|.+.... .....++.+|+++++++ +||||+++++++..++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 3468888999999999999998752 3578999876432 22334688899999999 79999999999999999
Q ss_pred EEEEEEeccCCCHHHHHhhhhc-----------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCC
Q 000889 999 RLLVYEYMKWGSLESVLHDRAK-----------GGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE 1067 (1237)
Q Consensus 999 ~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~ 1067 (1237)
.++||||+++|+|.++++.+.. .....+++..++.++.|++.|++|||+. +|+||||||+||+++.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence 9999999999999999975421 2245789999999999999999999999 9999999999999999
Q ss_pred CCceEEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHH
Q 000889 1068 NFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLV 1146 (1237)
Q Consensus 1068 ~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~ 1146 (1237)
++.+|++|||+++...............++..|+|||++.+..++.++|||||||++||+++ |..||..... .
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~ 241 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------E 241 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH------H
Confidence 99999999999987654332222223345678999999988889999999999999999997 9999864321 1
Q ss_pred HHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 000889 1147 GWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208 (1237)
Q Consensus 1147 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~ 1208 (1237)
........... ...+. .....+.+++.+|++.+|++|||+.++++.|+.+.
T Consensus 242 ~~~~~~~~~~~--------~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 ELFKLLKEGYR--------MEKPQ---NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHHcCCc--------CCCCC---CCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111111110 01111 12235778889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=324.89 Aligned_cols=265 Identities=22% Similarity=0.354 Sum_probs=199.9
Q ss_pred CCCCCCceecccCCeEEEEEEECC---------------CCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccc
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD---------------GSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLG 991 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~---------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~ 991 (1237)
++|++.+.||+|+||.||+++..+ ...||+|++..... .....+.+|++++++++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578899999999999999997642 22488998764322 22346889999999999999999999
Q ss_pred eEEeCCeEEEEEEeccCCCHHHHHhhhhcC-------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 000889 992 YCKIGEERLLVYEYMKWGSLESVLHDRAKG-------GGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVL 1064 (1237)
Q Consensus 992 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIl 1064 (1237)
++......++||||+++++|.+++...... ....+++..+.+++.|++.|++|||+. +++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 999999999999999999999999653211 112468889999999999999999999 9999999999999
Q ss_pred eCCCCceEEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc--CCCCCCCCCCCCC
Q 000889 1065 LDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS--GKRPIDPSEFGDD 1142 (1237)
Q Consensus 1065 l~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t--g~~p~~~~~~~~~ 1142 (1237)
++.++.+|++|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--- 238 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--- 238 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---
Confidence 99999999999999976543322222233445778999999988889999999999999999998 5667653221
Q ss_pred chHHHH-HHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 000889 1143 NNLVGW-AKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206 (1237)
Q Consensus 1143 ~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 1206 (1237)
...... ............... . +.....+.+++.+|++.+|++||++.++++.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~-----~---~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLSQ-----T---PLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHHHhhhhccccccCCC-----C---CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111111 111110000000000 0 0112367889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=324.84 Aligned_cols=264 Identities=26% Similarity=0.405 Sum_probs=206.6
Q ss_pred hCCCCCCceecccCCeEEEEEEEC--------CCCEEEEEEecccc-CcCHHHHHHHHHHHHhc-CCCCcccccceEEeC
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR--------DGSVVAIKKLIHVT-GQGDREFMAEMETIGKI-KHRNLVPLLGYCKIG 996 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 996 (1237)
.++|++.+.||+|+||.||+|++. ++..||+|+..... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 346788899999999999999742 24478999876432 23346788999999999 899999999999999
Q ss_pred CeEEEEEEeccCCCHHHHHhhhhcC-----------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 000889 997 EERLLVYEYMKWGSLESVLHDRAKG-----------GGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLL 1065 (1237)
Q Consensus 997 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll 1065 (1237)
...++||||+++|+|.+++...... ....+++..+..++.|+++|++|||+. +|+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 9999999999999999999864321 124578889999999999999999999 99999999999999
Q ss_pred CCCCceEEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCch
Q 000889 1066 DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNN 1144 (1237)
Q Consensus 1066 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~ 1144 (1237)
+.++.+||+|||.++...............+++.|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------ 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------ 244 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------
Confidence 9999999999999987654333322233456678999999988889999999999999999998 788876432
Q ss_pred HHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccc
Q 000889 1145 LVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVD 1210 (1237)
Q Consensus 1145 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~ 1210 (1237)
...+.......... .... .....+.+++.+||+.+|.+|||+.++++.|+++..-
T Consensus 245 ~~~~~~~~~~~~~~--------~~~~---~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 245 VEELFKLLKEGHRM--------DKPA---NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHHHHHcCCcC--------CCCC---CCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 11111211111110 0111 1234567888899999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=321.32 Aligned_cols=263 Identities=22% Similarity=0.401 Sum_probs=206.9
Q ss_pred hCCCCCCceecccCCeEEEEEEECC-----CCEEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEe-CCeE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLRD-----GSVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKI-GEER 999 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 999 (1237)
.++|++.+.||+|+||.||+|.+.. +..|++|++.... ......+.+|+.++++++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578889999999999999999875 6788888876432 2234568889999999999999999998765 5678
Q ss_pred EEEEEeccCCCHHHHHhhhhcC---CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeec
Q 000889 1000 LLVYEYMKWGSLESVLHDRAKG---GGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDF 1076 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~Df 1076 (1237)
++++||+++++|.+++...... .+..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999999764321 125689999999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhh
Q 000889 1077 GMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHRE 1155 (1237)
Q Consensus 1077 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1155 (1237)
|+++.+...+.........++..|+|||++.+..++.++||||||+++||+++ |+.||..... .. +.......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~---~~~~~~~~ 235 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FE---MAAYLKDG 235 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HH---HHHHHHcC
Confidence 99986654333322233446778999999998889999999999999999999 9999864321 11 11111111
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 000889 1156 KRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQV 1209 (1237)
Q Consensus 1156 ~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~ 1209 (1237)
... ..... ....+.+++.+||+.+|++|||+.++++.|+++..
T Consensus 236 ~~~--------~~~~~---~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 236 YRL--------AQPIN---CPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCC--------CCCCc---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 110 00111 12356788889999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=319.45 Aligned_cols=254 Identities=25% Similarity=0.354 Sum_probs=199.9
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 46899999999999999999975 57889999886544445566788999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
++++|.++++.. ..+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 89 ~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 89 GGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999998653 3678999999999999999999999 99999999999999999999999999998664322
Q ss_pred cceeeeccccCCCcCCccccC---ccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccC
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQ---SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
. ......|++.|+|||.+. ...++.++||||+||++|||++|+.||........ ...+ ... ....
T Consensus 161 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~~~-----~~~---~~~~ 228 (267)
T cd06646 161 A--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLM-----SKS---NFQP 228 (267)
T ss_pred c--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--heee-----ecC---CCCC
Confidence 1 123456888999999884 34578899999999999999999999853221100 0000 000 0000
Q ss_pred ccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
+.... .......+.+++.+||+.+|++|||+.++++++
T Consensus 229 ~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 229 PKLKD---KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCcc---ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11110 111224567888899999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=324.72 Aligned_cols=267 Identities=23% Similarity=0.392 Sum_probs=204.0
Q ss_pred hCCCCCCceecccCCeEEEEEEECC-----------------CCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCccc
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLRD-----------------GSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVP 988 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 988 (1237)
.++|++.+.||+|+||.||+|+... +..||+|++..... ...+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578899999999999999998653 24578888764322 23457889999999999999999
Q ss_pred ccceEEeCCeEEEEEEeccCCCHHHHHhhhhcC------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 000889 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDRAKG------GGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSN 1062 (1237)
Q Consensus 989 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~N 1062 (1237)
+++++..++..++||||+++++|.+++...... ....+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 999999999999999999999999999765321 123689999999999999999999999 99999999999
Q ss_pred eeeCCCCceEEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc--CCCCCCCCCCC
Q 000889 1063 VLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS--GKRPIDPSEFG 1140 (1237)
Q Consensus 1063 Ill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t--g~~p~~~~~~~ 1140 (1237)
|+++.++.++++|||+++.....+.........+++.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999999986544333222334556788999999988889999999999999999998 667775322
Q ss_pred CCchHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 000889 1141 DDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206 (1237)
Q Consensus 1141 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 1206 (1237)
..................... ... .....++.+++.+|++.+|++|||+.++++.|++
T Consensus 239 -~~~~~~~~~~~~~~~~~~~~~----~~~---~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 -DQQVIENAGHFFRDDGRQIYL----PRP---PNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred -hHHHHHHHHhccccccccccC----CCc---cCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111111111110000000000 001 1122467889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=319.00 Aligned_cols=256 Identities=24% Similarity=0.384 Sum_probs=191.8
Q ss_pred ceecccCCeEEEEEEECC---CCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCC
Q 000889 934 SMIGSGGFGEVYKAQLRD---GSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWG 1009 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 1009 (1237)
+.||+|+||.||+|.+.+ +..+|+|++..... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998753 35788998764332 22346888999999999999999999999889999999999999
Q ss_pred CHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcce
Q 000889 1010 SLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHL 1089 (1237)
Q Consensus 1010 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~ 1089 (1237)
+|.++++..........++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 999999765433334567788889999999999999999 99999999999999999999999999997544332222
Q ss_pred eeeccccCCCcCCccccCcc-------ccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccc
Q 000889 1090 SVSTLAGTPGYVPPEYYQSF-------RCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161 (1237)
Q Consensus 1090 ~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1161 (1237)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||..... .....+. . .......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~~~~~~---~-~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD---EQVLTYT---V-REQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHH---h-hcccCCC
Confidence 22334577889999998642 35789999999999999996 9999964321 1111110 0 1111111
Q ss_pred cCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 000889 1162 LDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFK 1205 (1237)
Q Consensus 1162 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 1205 (1237)
.++.... . ....+.+++.+|| .+|++|||+.++++.|+
T Consensus 231 ~~~~~~~--~---~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKL--P---LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCC--C---CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1222111 1 1224566778999 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=322.06 Aligned_cols=248 Identities=27% Similarity=0.334 Sum_probs=194.3
Q ss_pred ecccCCeEEEEEEEC-CCCEEEEEEeccccCc---CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCCCH
Q 000889 936 IGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQ---GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSL 1011 (1237)
Q Consensus 936 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 1011 (1237)
||+|+||+||++++. +++.||+|++...... ..+.+..|++++++++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999876 6789999988643221 224567899999999999999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcceee
Q 000889 1012 ESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSV 1091 (1237)
Q Consensus 1012 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~~ 1091 (1237)
.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......... .
T Consensus 81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~ 154 (280)
T cd05608 81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--T 154 (280)
T ss_pred HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--c
Confidence 988854322 235689999999999999999999999 9999999999999999999999999999866443221 2
Q ss_pred eccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCC
Q 000889 1092 STLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTS 1171 (1237)
Q Consensus 1092 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 1171 (1237)
....|++.|+|||++.+..++.++||||+||++|||++|+.||....... ........ +.......+
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~---------~~~~~~~~~-- 221 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQR---------ILNDSVTYP-- 221 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch--hHHHHHHh---------hcccCCCCc--
Confidence 34578999999999999999999999999999999999999997532111 01110110 111111111
Q ss_pred CHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 000889 1172 DETELYQYLRISFECLDDRPFKRP-----TMIQVMAM 1203 (1237)
Q Consensus 1172 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 1203 (1237)
......+.+++.+|++.+|++|| ++.+++++
T Consensus 222 -~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 222 -DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred -ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 11223566788899999999999 77788775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=317.72 Aligned_cols=254 Identities=24% Similarity=0.412 Sum_probs=202.6
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEecc
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMK 1007 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 1007 (1237)
+|++.+.||+|+||.||+|.++ .++.||+|++.. .....+++.+|++++++++||||+++++++...+..++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecC-CchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 4777889999999999999876 477899998754 23345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCc
Q 000889 1008 WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDT 1087 (1237)
Q Consensus 1008 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~ 1087 (1237)
+++|.+++.... ...+++..+..++.|+++|++|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 86 ~~~L~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 86 YGNLLDYLRECN---RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999987542 24689999999999999999999999 999999999999999999999999999986643221
Q ss_pred ceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccc
Q 000889 1088 HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1088 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
. ......++..|+|||++.+..++.++|||||||++|||++ |..||..... .......... .....
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------~~~~~~~~~~------~~~~~ 226 (263)
T cd05052 160 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELLEKG------YRMER 226 (263)
T ss_pred e-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHCC------CCCCC
Confidence 1 1122334668999999998899999999999999999998 9999864321 1111111111 01111
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l 1207 (1237)
+.. ....+.+++.+|++.+|++||++.++++.|+.+
T Consensus 227 --~~~---~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 227 --PEG---CPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred --CCC---CCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111 123567788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=332.55 Aligned_cols=253 Identities=22% Similarity=0.278 Sum_probs=199.6
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC---cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG---QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
++|++.+.||+|+||+||+|+.. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36889999999999999999886 588999999874322 23456788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+++|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 81 EYQPGGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred CCCCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 9999999999997642 3689999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCcceeeeccccCCCcCCccccC------ccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcc
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQ------SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKR 1157 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1157 (1237)
..... ......||+.|+|||++. +..++.++||||+||++|||++|+.||..... ...+ ........
T Consensus 154 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~-~~i~~~~~ 226 (330)
T cd05601 154 ANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-----AKTY-NNIMNFQR 226 (330)
T ss_pred CCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-----HHHH-HHHHcCCC
Confidence 43222 223457899999999986 45678899999999999999999999964321 1111 11111111
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1158 INEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1158 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.. ..+.. ......+.+++.+|++ +|.+|||+.+++++
T Consensus 227 ~~-----~~~~~---~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 227 FL-----KFPED---PKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred cc-----CCCCC---CCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00 01110 1112345677778997 99999999999876
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=318.80 Aligned_cols=258 Identities=24% Similarity=0.363 Sum_probs=197.1
Q ss_pred CCCCceecccCCeEEEEEEECCCC---EEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeC------Ce
Q 000889 930 FSADSMIGSGGFGEVYKAQLRDGS---VVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIG------EE 998 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~~~~---~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 998 (1237)
|.+.++||+|+||.||+|++.... .+|+|.+.... ....+.+.+|++++++++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 356788999999999999986433 58888775432 22345688899999999999999999987432 24
Q ss_pred EEEEEEeccCCCHHHHHhhhhc-CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecc
Q 000889 999 RLLVYEYMKWGSLESVLHDRAK-GGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFG 1077 (1237)
Q Consensus 999 ~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfG 1077 (1237)
.++||||+++|+|.+++..... .....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999998854322 1234589999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhc
Q 000889 1078 MARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREK 1156 (1237)
Q Consensus 1078 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1156 (1237)
+++...............+++.|+|||+..+..++.++||||||+++|||++ |+.||.... .. ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~---~~~~~~~~~~ 231 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE---NS---EIYDYLRQGN 231 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC---HH---HHHHHHHcCC
Confidence 9987644332212223346778999999999899999999999999999999 888886422 11 1111111111
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 000889 1157 RINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207 (1237)
Q Consensus 1157 ~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l 1207 (1237)
.. .... .....+.+++.+||+.+|++|||+.++++.|+++
T Consensus 232 ~~--------~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RL--------KQPP---DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC--------CCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 10 0111 1223567888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=323.02 Aligned_cols=260 Identities=27% Similarity=0.381 Sum_probs=201.0
Q ss_pred hCCCCCCceecccCCeEEEEEEECC------CCEEEEEEeccccCc-CHHHHHHHHHHHHhcCCCCcccccceEEeCCeE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLRD------GSVVAIKKLIHVTGQ-GDREFMAEMETIGKIKHRNLVPLLGYCKIGEER 999 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 999 (1237)
+++|++.+.||+|+||.||+|.+.. +..||+|.+...... ....+.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4568899999999999999998864 456888877543322 234688999999999999999999999988899
Q ss_pred EEEEEeccCCCHHHHHhhhhcC--CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCC---ceEEe
Q 000889 1000 LLVYEYMKWGSLESVLHDRAKG--GGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENF---EARVS 1074 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~---~vkl~ 1074 (1237)
++||||+++++|.+++...... ....+++..+.+++.||+.|++|||+. +++||||||+||+++.++ .+|++
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 9999999999999999765321 123589999999999999999999999 999999999999998654 69999
Q ss_pred ecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHh
Q 000889 1075 DFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLH 1153 (1237)
Q Consensus 1075 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 1153 (1237)
|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||...... . ......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~---~~~~~~ 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---E---VMEFVT 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---H---HHHHHH
Confidence 9999986643222211122334568999999998889999999999999999997 99998743211 1 111111
Q ss_pred hhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 000889 1154 REKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206 (1237)
Q Consensus 1154 ~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 1206 (1237)
.... ... +.. ....+.+++.+|++.+|++||++.+++++|++
T Consensus 236 ~~~~------~~~--~~~---~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 236 GGGR------LDP--PKG---CPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred cCCc------CCC--CCC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 1111 011 111 12356788889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=317.31 Aligned_cols=254 Identities=27% Similarity=0.420 Sum_probs=202.0
Q ss_pred CCCCCCceecccCCeEEEEEEECCCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEecc
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMK 1007 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 1007 (1237)
++|++.++||+|+||.||+|++.++..||+|++... ....+.+.+|++++++++||||+++++++. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 468899999999999999999887778999988642 234567899999999999999999999875 456799999999
Q ss_pred CCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCc
Q 000889 1008 WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDT 1087 (1237)
Q Consensus 1008 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~ 1087 (1237)
+|+|.+++.... ...+++..+..++.|+++||+|+|+. +++||||||+||++++++.+||+|||.++.......
T Consensus 84 ~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 84 KGSLLDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCcHHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 999999997532 24578999999999999999999999 999999999999999999999999999986643322
Q ss_pred ceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccc
Q 000889 1088 HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1088 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
. ......++..|+|||+..+..++.++||||||+++|||++ |..||..... . ......... .. .
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~---~---~~~~~~~~~------~~--~ 222 (262)
T cd05071 158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---R---EVLDQVERG------YR--M 222 (262)
T ss_pred c-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh---H---HHHHHHhcC------CC--C
Confidence 1 1123446678999999988889999999999999999999 8888864321 0 111111100 00 0
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l 1207 (1237)
.. .......+.+++.+|++.+|++||++.++++.|++.
T Consensus 223 ~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PC---PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CC---ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 00 112334677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=325.99 Aligned_cols=245 Identities=23% Similarity=0.402 Sum_probs=197.5
Q ss_pred eecccCCeEEEEEEECC-CCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCCCHHH
Q 000889 935 MIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLES 1013 (1237)
Q Consensus 935 ~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 1013 (1237)
++|+|.||+||-|++.+ ...+|||-+........+.+.+|+...++++|.|||+++|++.+++..-|.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999875 45688998865555556678899999999999999999999999999999999999999999
Q ss_pred HHhhhhcCCCCcc--CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeC-CCCceEEeecccceeeccCCccee
Q 000889 1014 VLHDRAKGGGTKL--DWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLD-ENFEARVSDFGMARLVNALDTHLS 1090 (1237)
Q Consensus 1014 ~l~~~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~-~~~~vkl~DfGla~~~~~~~~~~~ 1090 (1237)
+++..- +++ .+..+-.+..||++||.|||++ .|||||||-+|||+. -.|.+||+|||-+++...... .
T Consensus 662 LLrskW----GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~ 732 (1226)
T KOG4279|consen 662 LLRSKW----GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--C 732 (1226)
T ss_pred HHHhcc----CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCc--c
Confidence 998753 345 7778888999999999999999 999999999999996 689999999999998765432 2
Q ss_pred eeccccCCCcCCccccCcc--ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccC
Q 000889 1091 VSTLAGTPGYVPPEYYQSF--RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTM 1168 (1237)
Q Consensus 1091 ~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1168 (1237)
..++.||..|||||++..+ .|+.++|||||||++.||.||++||-... +. .. .+.+-+.. .+.|++
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg--sp---qA---AMFkVGmy--KvHP~i-- 800 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG--SP---QA---AMFKVGMY--KVHPPI-- 800 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC--Ch---hH---hhhhhcce--ecCCCC--
Confidence 3567899999999999764 58899999999999999999999996422 11 00 00111111 112222
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1169 QTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1169 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
+ .+...+...+|.+|+.+||.+||++.++++-
T Consensus 801 P---eelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 801 P---EELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred c---HHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 1 2334456678889999999999999999853
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=327.33 Aligned_cols=241 Identities=27% Similarity=0.404 Sum_probs=189.9
Q ss_pred ceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhc-CCCCcccccceEEeCCeEEEEEEeccC
Q 000889 934 SMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
++||+|+||.||+|+++ +++.||+|++.... ....+.+..|.+++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999987 57899999886432 22344567788888764 899999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 151 (316)
T cd05620 81 GDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN- 151 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-
Confidence 9999988653 4678899999999999999999999 999999999999999999999999999875322121
Q ss_pred eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccC
Q 000889 1089 LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTM 1168 (1237)
Q Consensus 1089 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1168 (1237)
......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .......... .+..+
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~------~~~~~~~~~~-------~~~~~- 216 (316)
T cd05620 152 -RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE------DELFESIRVD-------TPHYP- 216 (316)
T ss_pred -ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhC-------CCCCC-
Confidence 22456799999999999998999999999999999999999999964321 1111111100 11111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 000889 1169 QTSDETELYQYLRISFECLDDRPFKRPTMI-QVMA 1202 (1237)
Q Consensus 1169 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-ell~ 1202 (1237)
... ..++.+++.+|++.||++||++. ++.+
T Consensus 217 -~~~---~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 217 -RWI---TKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred -CCC---CHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 111 12456788899999999999985 5553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=317.30 Aligned_cols=261 Identities=25% Similarity=0.397 Sum_probs=207.4
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC---cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG---QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
++|++.+.||+|+||.||+|+.. ++..+|+|++..... ....++.+|+++++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46888899999999999999975 788999998754222 22346888999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+++++|.+++..... ....+++..++.++.|+++|++|||+. +++|+||||+||+++.++.++++|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 99999999999875332 235689999999999999999999999 99999999999999999999999999987654
Q ss_pred cCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccC
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
..... .....++..|+|||++.+..++.++||||+|+++|||++|..||..... ....+... +.....
T Consensus 158 ~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~------~~~~~~ 225 (267)
T cd08229 158 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKK------IEQCDY 225 (267)
T ss_pred cCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHhhh------hhcCCC
Confidence 32211 2345688899999999888899999999999999999999999864321 11111111 111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~ 1208 (1237)
+... .......+.+++.+||+.+|++|||+.+|++.++++.
T Consensus 226 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 226 PPLP----SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCC----cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1111 1112346778888999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=336.06 Aligned_cols=261 Identities=25% Similarity=0.416 Sum_probs=202.2
Q ss_pred CCCCCceecccCCeEEEEEEEC------CCCEEEEEEeccccCc-CHHHHHHHHHHHHhcC-CCCcccccceEEeCCeEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR------DGSVVAIKKLIHVTGQ-GDREFMAEMETIGKIK-HRNLVPLLGYCKIGEERL 1000 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 1000 (1237)
+|.+.++||+|+||.||+|+++ .+..||+|++...... ..+.+.+|++++.++. ||||+++++++...+..+
T Consensus 38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~ 117 (401)
T cd05107 38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIY 117 (401)
T ss_pred HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcE
Confidence 5777889999999999999864 2457999999753322 2346889999999997 999999999999999999
Q ss_pred EEEEeccCCCHHHHHhhhhc------------------------------------------------------------
Q 000889 1001 LVYEYMKWGSLESVLHDRAK------------------------------------------------------------ 1020 (1237)
Q Consensus 1001 lv~e~~~~gsL~~~l~~~~~------------------------------------------------------------ 1020 (1237)
+||||+++|+|.++++....
T Consensus 118 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (401)
T cd05107 118 IITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKG 197 (401)
T ss_pred EEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchh
Confidence 99999999999999975321
Q ss_pred ---------------------------------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCC
Q 000889 1021 ---------------------------------GGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE 1067 (1237)
Q Consensus 1021 ---------------------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~ 1067 (1237)
.....+++..+..++.|++.||+|||+. +|+||||||+||++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~ 274 (401)
T cd05107 198 TVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICE 274 (401)
T ss_pred hhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEeC
Confidence 0112467788899999999999999999 9999999999999999
Q ss_pred CCceEEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHH
Q 000889 1068 NFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLV 1146 (1237)
Q Consensus 1068 ~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~ 1146 (1237)
++.+|++|||+++...............+++.|||||++.+..++.++|||||||++|||++ |+.||...... .
T Consensus 275 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~--~--- 349 (401)
T cd05107 275 GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN--E--- 349 (401)
T ss_pred CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch--H---
Confidence 99999999999986543222222233456789999999998889999999999999999998 88898643211 0
Q ss_pred HHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 000889 1147 GWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208 (1237)
Q Consensus 1147 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~ 1208 (1237)
.......... +...+.. ...++.+++.+||+.+|++||++.++++.|+.+.
T Consensus 350 ~~~~~~~~~~--------~~~~p~~---~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 QFYNAIKRGY--------RMAKPAH---ASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHHcCC--------CCCCCCC---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0111111110 0111111 1235678888999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=326.11 Aligned_cols=241 Identities=27% Similarity=0.394 Sum_probs=190.1
Q ss_pred ceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhc-CCCCcccccceEEeCCeEEEEEEeccC
Q 000889 934 SMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
+.||+|+||+||+|++. +++.||+|++.... ....+.+..|..+++.. +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999987 47789999886432 23344566788888764 899999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 151 (316)
T cd05619 81 GDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA- 151 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-
Confidence 9999998753 3678899999999999999999999 999999999999999999999999999975322221
Q ss_pred eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccC
Q 000889 1089 LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTM 1168 (1237)
Q Consensus 1089 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1168 (1237)
......||+.|+|||++.+..++.++||||+||++|||++|+.||..... . ......... .+..+
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~---~~~~~i~~~-------~~~~~- 216 (316)
T cd05619 152 -KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---E---ELFQSIRMD-------NPCYP- 216 (316)
T ss_pred -ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---H---HHHHHHHhC-------CCCCC-
Confidence 22346789999999999998999999999999999999999999974321 1 111111100 01111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 000889 1169 QTSDETELYQYLRISFECLDDRPFKRPTMI-QVMA 1202 (1237)
Q Consensus 1169 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-ell~ 1202 (1237)
.. ....+.+++.+|++.+|++||++. ++.+
T Consensus 217 -~~---~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 -RW---LTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred -cc---CCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11 112456788899999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=321.29 Aligned_cols=267 Identities=21% Similarity=0.377 Sum_probs=201.3
Q ss_pred hCCCCCCceecccCCeEEEEEEECC-----------------CCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCccc
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLRD-----------------GSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVP 988 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 988 (1237)
.++|++.+.||+|+||.||+++..+ ...||+|++..... ....++.+|+++++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 3468899999999999999986432 33688888764322 23457889999999999999999
Q ss_pred ccceEEeCCeEEEEEEeccCCCHHHHHhhhhcC------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 000889 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDRAKG------GGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSN 1062 (1237)
Q Consensus 989 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~N 1062 (1237)
+++++...+..++||||+++|+|.+++...... ....+++..+..++.|++.|++|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 999999999999999999999999999764321 123578889999999999999999999 99999999999
Q ss_pred eeeCCCCceEEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc--CCCCCCCCCCC
Q 000889 1063 VLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS--GKRPIDPSEFG 1140 (1237)
Q Consensus 1063 Ill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t--g~~p~~~~~~~ 1140 (1237)
|+++.++.+|++|||+++.+.............++..|+|||+..++.++.++|||||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD- 239 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-
Confidence 9999999999999999986543322222223345678999999888889999999999999999998 7778754321
Q ss_pred CCchHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 000889 1141 DDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206 (1237)
Q Consensus 1141 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 1206 (1237)
............... .... .+.+.. ....+.+++.+||+.+|++||++.++.+.|++
T Consensus 240 --~~~~~~~~~~~~~~~-~~~~---~~~~~~---~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 --EQVIENTGEFFRDQG-RQVY---LPKPAL---CPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred --HHHHHHHHHHHhhcc-cccc---CCCCCC---CCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111111000000 0000 011111 12467788899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=329.04 Aligned_cols=247 Identities=25% Similarity=0.332 Sum_probs=194.1
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhc-CCCCcccccceEEeCCeEEEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
+|++.+.||+|+||.||+|++. +++.||+|.+.... ....+.+..|.+++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999887 46789999886432 12234566788888777 5899999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQV-----GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 999999999988653 3588899999999999999999999 99999999999999999999999999997543
Q ss_pred cCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccC
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ... ......
T Consensus 153 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~---~~~i~~--------- 215 (323)
T cd05616 153 WDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DEL---FQSIME--------- 215 (323)
T ss_pred CCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHH---HHHHHh---------
Confidence 2221 22356799999999999999999999999999999999999999974321 111 111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTM-----IQVMAM 1203 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~ell~~ 1203 (1237)
.....+.. ...++.+++.+|++.+|++|+++ .++.++
T Consensus 216 ~~~~~p~~---~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 216 HNVAYPKS---MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred CCCCCCCc---CCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 11111111 12345678889999999999984 555543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=320.03 Aligned_cols=259 Identities=25% Similarity=0.405 Sum_probs=202.7
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCC----EEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGS----VVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLL 1001 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 1001 (1237)
.+|+..++||+|+||+||+|++. ++. .||+|++.... ....+.+.+|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 46888899999999999999864 344 47888876432 2234568889999999999999999999864 45789
Q ss_pred EEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeeccccee
Q 000889 1002 VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~ 1081 (1237)
+|||+++|+|.++++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 86 ~~~~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEcCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 999999999999987532 4689999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhccccc
Q 000889 1082 VNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINE 1160 (1237)
Q Consensus 1082 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1160 (1237)
..............+++.|+|||...+..++.++|||||||++|||++ |..||..... .....+.. .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~---~~~~~-- 230 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDLLE---KGERL-- 230 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH---CCCcC--
Confidence 654333222223345678999999998899999999999999999998 8999864321 11111111 11100
Q ss_pred ccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccccc
Q 000889 1161 ILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDT 1211 (1237)
Q Consensus 1161 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~~ 1211 (1237)
. .. ......+.+++.+||+.+|++||++.++++.++++..++
T Consensus 231 ----~--~~---~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 231 ----P--QP---PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ----C--CC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 0 00 112235678888999999999999999999999887766
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=317.03 Aligned_cols=249 Identities=25% Similarity=0.390 Sum_probs=194.0
Q ss_pred ceecccCCeEEEEEEEC-CCCEEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCCCH
Q 000889 934 SMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSL 1011 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 1011 (1237)
+.||+|+||.||+|++. +++.||+|.+.... .+....+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999986 68889999875432 22345688999999999999999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcceee
Q 000889 1012 ESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSV 1091 (1237)
Q Consensus 1012 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~~ 1091 (1237)
.+++... +..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+|++|||++............
T Consensus 81 ~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 81 LTFLRTE----GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred HHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 9998643 23578999999999999999999999 9999999999999999999999999998754422111111
Q ss_pred eccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCC
Q 000889 1092 STLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQT 1170 (1237)
Q Consensus 1092 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1170 (1237)
.....+..|+|||.+.+..++.++||||+|+++|||++ |..||..... .. ........ ..... ..
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~---~~---~~~~~~~~------~~~~~--~~ 219 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN---QQ---TREAIEQG------VRLPC--PE 219 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH---HH---HHHHHHcC------CCCCC--cc
Confidence 11223457999999998889999999999999999998 8888853211 01 01111110 00011 11
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 000889 1171 SDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206 (1237)
Q Consensus 1171 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 1206 (1237)
.....+.+++.+|++.+|++|||+.++++.|++
T Consensus 220 ---~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 220 ---LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred ---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 112357788889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=316.81 Aligned_cols=250 Identities=27% Similarity=0.428 Sum_probs=199.2
Q ss_pred CCCCCceecccCCeEEEEEEECCCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccC
Q 000889 929 GFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
+|++.+.||+|+||.||+|+++++..+|+|.+... ......+.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 47788899999999999999887778999987532 23456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
++|.+++.... ..+++..+..++.|+++|++|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 84 ~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 84 GCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 99999987532 3689999999999999999999999 9999999999999999999999999999765422111
Q ss_pred eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcccc
Q 000889 1089 LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELT 1167 (1237)
Q Consensus 1089 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1167 (1237)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ... ....... .....
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~---~~~~~~~------~~~~~- 222 (256)
T cd05059 157 -SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SEV---VESVSAG------YRLYR- 222 (256)
T ss_pred -ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HHH---HHHHHcC------CcCCC-
Confidence 1112234457999999998899999999999999999999 8999864321 111 1111111 11111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1168 MQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1168 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
+. .....+.+++.+||+.+|++|||+.++++.|
T Consensus 223 -~~---~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 -PK---LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -CC---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11 1233677889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=337.32 Aligned_cols=201 Identities=25% Similarity=0.331 Sum_probs=171.7
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
.|+..++||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999876 57889999886432 1223467889999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 82 YIPGGDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 99999999998653 3578888999999999999999999 999999999999999999999999999753211
Q ss_pred CCc---------------------------------------------ceeeeccccCCCcCCccccCccccCcccchHH
Q 000889 1085 LDT---------------------------------------------HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYS 1119 (1237)
Q Consensus 1085 ~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 1119 (1237)
... .......+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 000 00012346899999999999989999999999
Q ss_pred HHHHHHHHHcCCCCCCCC
Q 000889 1120 YGVILLELLSGKRPIDPS 1137 (1237)
Q Consensus 1120 lGv~l~el~tg~~p~~~~ 1137 (1237)
+||++|||++|+.||...
T Consensus 234 lGvil~elltG~~Pf~~~ 251 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred chHHHHHHHhCCCCCCCC
Confidence 999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=321.25 Aligned_cols=268 Identities=25% Similarity=0.381 Sum_probs=199.1
Q ss_pred CCCCceecccCCeEEEEEEE-----CCCCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeC--CeEEE
Q 000889 930 FSADSMIGSGGFGEVYKAQL-----RDGSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIG--EERLL 1001 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 1001 (1237)
|+..+.||+|+||+||++.. .++..||+|.+..... .....+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988753 2577899998864322 2356788999999999999999999988653 45789
Q ss_pred EEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeeccccee
Q 000889 1002 VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~ 1081 (1237)
||||+++++|.+++.. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 86 v~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 86 IMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccc
Confidence 9999999999999865 2589999999999999999999999 999999999999999999999999999986
Q ss_pred eccCCccee-eeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccccc
Q 000889 1082 VNALDTHLS-VSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINE 1160 (1237)
Q Consensus 1082 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1160 (1237)
......... .....++..|+|||.+.+..++.++||||||+++|||++|..||....... ..................
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhh
Confidence 654222111 122345667999999988889999999999999999999999986432100 000000000000000111
Q ss_pred ccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 000889 1161 ILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208 (1237)
Q Consensus 1161 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~ 1208 (1237)
..+.....+ ........+.+++.+||+.+|++|||+.++++.|+++.
T Consensus 236 ~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLP-CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhcCCCCC-CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111110000 01112346778888999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=332.27 Aligned_cols=195 Identities=23% Similarity=0.287 Sum_probs=168.2
Q ss_pred hCCCCCCceecccCCeEEEEEEECC-CCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
..+|.+.+.||+|+||.||+|++.. ++.||+|... ...+.+|++++++++|||||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4479999999999999999999874 7789999542 23456899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
+. ++|.+++.... ..+++..+..++.|+++||+|||+. +||||||||+|||++.++.+||+|||+++.....
T Consensus 242 ~~-~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 242 YR-SDLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred cC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 95 78888886532 3689999999999999999999999 9999999999999999999999999999866432
Q ss_pred CcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCC
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPID 1135 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~ 1135 (1237)
..........||+.|||||++.+..++.++|||||||++|||++|..|+.
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 22222234579999999999999899999999999999999999887653
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=327.46 Aligned_cols=250 Identities=23% Similarity=0.382 Sum_probs=201.2
Q ss_pred CCCCceecccCCeEEEEEEECCCCEE-EEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccC
Q 000889 930 FSADSMIGSGGFGEVYKAQLRDGSVV-AIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~~~~~v-avK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
|.++..||.|+||.||+|..++.... |.|++.-...+...+|+-|++|+..++||+||++++.|-..+..||+.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 56677899999999999998865554 45555444555667899999999999999999999998889999999999999
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
|-.+.++-.. +..+.+.++..+++|++.||.|||++ .|||||+|+.|||++-+|.++++|||.+.... .+.
T Consensus 114 GAVDaimlEL----~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~ 184 (1187)
T KOG0579|consen 114 GAVDAIMLEL----GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STR 184 (1187)
T ss_pred chHhHHHHHh----ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch--hHH
Confidence 9999988765 35899999999999999999999999 99999999999999999999999999986433 233
Q ss_pred eeeeccccCCCcCCccccC-----ccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccC
Q 000889 1089 LSVSTLAGTPGYVPPEYYQ-----SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1089 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
.+...+.|||.|||||+.. ..+|++++||||||+++.||..+.+|..... .+......... -.
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln-----pMRVllKiaKS-------eP 252 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN-----PMRVLLKIAKS-------EP 252 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-----hHHHHHHHhhc-------CC
Confidence 3456789999999999874 4689999999999999999999999964321 11111111111 11
Q ss_pred ccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
|.+. ........|.+++.+|+.++|..||++++++++
T Consensus 253 PTLl---qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 253 PTLL---QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred Cccc---CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 2222 233344567777789999999999999999876
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=326.55 Aligned_cols=249 Identities=24% Similarity=0.321 Sum_probs=193.7
Q ss_pred ceecccCCeEEEEEEEC-CCCEEEEEEeccccC---cCHHHHHHHHHHHHhc-CCCCcccccceEEeCCeEEEEEEeccC
Q 000889 934 SMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG---QGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|..++.++ +||+|+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999986 578899999874322 2234577899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
|+|..++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 151 (327)
T cd05617 81 GDLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD- 151 (327)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-
Confidence 9999888653 4689999999999999999999999 999999999999999999999999999975322111
Q ss_pred eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccC
Q 000889 1089 LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTM 1168 (1237)
Q Consensus 1089 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1168 (1237)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||.............+......... ...
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~~~ 222 (327)
T cd05617 152 -TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--------IRI 222 (327)
T ss_pred -ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC--------CCC
Confidence 22456799999999999999999999999999999999999999975332222122222111111111 111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 000889 1169 QTSDETELYQYLRISFECLDDRPFKRPTM------IQVMAM 1203 (1237)
Q Consensus 1169 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~ell~~ 1203 (1237)
+...+ ..+.+++.+|++.||.+|+++ .+++++
T Consensus 223 p~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 223 PRFLS---VKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCC---HHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 11111 245678889999999999984 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=337.16 Aligned_cols=253 Identities=21% Similarity=0.247 Sum_probs=194.9
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
.+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999976 57899999885422 223456788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+|..+.
T Consensus 81 E~~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~ 152 (376)
T cd05598 81 DYIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (376)
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccc
Confidence 999999999999753 3578888899999999999999999 99999999999999999999999999985321
Q ss_pred cCC-----------------------------------------cceeeeccccCCCcCCccccCccccCcccchHHHHH
Q 000889 1084 ALD-----------------------------------------THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGV 1122 (1237)
Q Consensus 1084 ~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv 1122 (1237)
... .........||+.|||||++.+..++.++||||+||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 232 (376)
T cd05598 153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232 (376)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence 000 000012357999999999999989999999999999
Q ss_pred HHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCC---CHHH
Q 000889 1123 ILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRP---TMIQ 1199 (1237)
Q Consensus 1123 ~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~e 1199 (1237)
++|||++|+.||...... ........... ....+...... ..+.+++.+|+ .+|.+|+ ++.+
T Consensus 233 ilyell~G~~Pf~~~~~~------~~~~~i~~~~~-----~~~~~~~~~~s---~~~~~li~~l~-~~p~~R~~~~t~~e 297 (376)
T cd05598 233 ILYEMLVGQPPFLADTPA------ETQLKVINWET-----TLHIPSQAKLS---REASDLILRLC-CGAEDRLGKNGADE 297 (376)
T ss_pred eeeehhhCCCCCCCCCHH------HHHHHHhccCc-----cccCCCCCCCC---HHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence 999999999999754311 11111110000 00011111111 23445566665 4999999 8999
Q ss_pred HHHH
Q 000889 1200 VMAM 1203 (1237)
Q Consensus 1200 ll~~ 1203 (1237)
++++
T Consensus 298 ll~h 301 (376)
T cd05598 298 IKAH 301 (376)
T ss_pred HhCC
Confidence 9987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=322.29 Aligned_cols=250 Identities=26% Similarity=0.380 Sum_probs=201.7
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
.+|++.+.||+|+||.||+|+.. ++..||+|++..........+.+|+.++++++||||+++++++..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 46888899999999999999875 58899999887655455667889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
++++|.+++.. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 100 ~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 100 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred CCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 99999999864 3578889999999999999999999 99999999999999999999999999987654322
Q ss_pred cceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
. ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...... ..+... .... .+..
T Consensus 171 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-----~~~~~~-~~~~------~~~~ 236 (296)
T cd06654 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----RALYLI-ATNG------TPEL 236 (296)
T ss_pred c--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-----HhHHHH-hcCC------CCCC
Confidence 1 123356889999999999888999999999999999999999999643211 111110 0000 0011
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.. .......+.+++.+||.++|++|||+.+++++
T Consensus 237 ~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 QN---PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CC---ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 10 11122456788889999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=326.74 Aligned_cols=242 Identities=26% Similarity=0.356 Sum_probs=192.9
Q ss_pred ceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhc-CCCCcccccceEEeCCeEEEEEEeccC
Q 000889 934 SMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
+.||+|+||+||+|++. ++..||+|++.... ......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999987 47789999887432 22344567899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 151 (318)
T cd05570 81 GDLMFHIQRS-----GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV- 151 (318)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-
Confidence 9999888653 3689999999999999999999999 999999999999999999999999999975322221
Q ss_pred eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccC
Q 000889 1089 LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTM 1168 (1237)
Q Consensus 1089 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1168 (1237)
.....+|++.|+|||++.+..++.++||||+||++|||++|+.||..... .......... ....
T Consensus 152 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~------~~~~~~i~~~---------~~~~ 215 (318)
T cd05570 152 -TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE------DELFQSILED---------EVRY 215 (318)
T ss_pred -cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH------HHHHHHHHcC---------CCCC
Confidence 12345689999999999999999999999999999999999999974321 1111111110 1111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 000889 1169 QTSDETELYQYLRISFECLDDRPFKRPTM-----IQVMAM 1203 (1237)
Q Consensus 1169 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~ell~~ 1203 (1237)
+.. ....+.+++.+|++.||.+||++ .+++++
T Consensus 216 ~~~---~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 216 PRW---LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCc---CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 111 12356688889999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=313.13 Aligned_cols=253 Identities=27% Similarity=0.432 Sum_probs=201.3
Q ss_pred CCCCCCceecccCCeEEEEEEECCCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEecc
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMK 1007 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 1007 (1237)
++|++.+.||+|+||.||+|...++..+|+|++.... ...+.+.+|+.++++++||+++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 4688889999999999999998888889999886533 34567899999999999999999999875 456899999999
Q ss_pred CCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCc
Q 000889 1008 WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDT 1087 (1237)
Q Consensus 1008 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~ 1087 (1237)
+++|.++++... ...+++..+..++.+++.|++|||+. +++||||||+||++++++.+||+|||.+........
T Consensus 84 ~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 84 KGSLLDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 999999987532 24689999999999999999999999 999999999999999999999999999986643221
Q ss_pred ceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccc
Q 000889 1088 HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1088 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
. ......++..|+|||++.+..++.++||||||+++|||++ |..||..... ........... ..
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~~~------~~-- 222 (260)
T cd05070 158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN------REVLEQVERGY------RM-- 222 (260)
T ss_pred c-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCC------CC--
Confidence 1 1122345668999999988889999999999999999999 8889864321 11111111110 00
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 1206 (1237)
+.+. .....+.+++.+|+.++|++|||+.++.+.|+.
T Consensus 223 ~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQ---DCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCC---cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111 122357788899999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=323.47 Aligned_cols=263 Identities=25% Similarity=0.393 Sum_probs=204.0
Q ss_pred CCCCCCceecccCCeEEEEEEECC--------CCEEEEEEecccc-CcCHHHHHHHHHHHHhc-CCCCcccccceEEeCC
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD--------GSVVAIKKLIHVT-GQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGE 997 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 997 (1237)
++|.+.+.||+|+||.||+|++.. ...+|+|.+.... ......+.+|+++++++ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 468899999999999999998632 3469999886432 22345688899999999 7999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHhhhhcC-----------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeC
Q 000889 998 ERLLVYEYMKWGSLESVLHDRAKG-----------GGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLD 1066 (1237)
Q Consensus 998 ~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~ 1066 (1237)
..++||||+++|+|.+++...... ....+++..+.+++.|++.||+|||+. +++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 999999999999999999764321 123588999999999999999999999 999999999999999
Q ss_pred CCCceEEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchH
Q 000889 1067 ENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNL 1145 (1237)
Q Consensus 1067 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~ 1145 (1237)
.++.+||+|||.++...............+++.|+|||++.+..++.++||||+||++|||++ |..||.... .
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------~ 248 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------V 248 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC------H
Confidence 999999999999976543222111122234568999999998889999999999999999998 888885432 1
Q ss_pred HHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccc
Q 000889 1146 VGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVD 1210 (1237)
Q Consensus 1146 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~ 1210 (1237)
........... ...... .....+.+++.+|++.+|++|||+.++++.|+++...
T Consensus 249 ~~~~~~~~~~~--------~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 249 EELFKLLKEGH--------RMDKPS---NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHHHHcCC--------CCCCCC---cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 11111111111 001111 1223667888899999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=323.36 Aligned_cols=258 Identities=24% Similarity=0.353 Sum_probs=200.2
Q ss_pred CCCCCceecccCCeEEEEEEECC------CCEEEEEEeccccCc-CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLRD------GSVVAIKKLIHVTGQ-GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLL 1001 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 1001 (1237)
+|++.+.||+|+||.||+|++.+ +..||+|++...... ..+.+.+|+.++++++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 36667889999999999998642 467999988643322 23468889999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHhhhhc-----------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCc
Q 000889 1002 VYEYMKWGSLESVLHDRAK-----------GGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFE 1070 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~ 1070 (1237)
++||+++++|.+++..... .....+++..+.+++.|++.||+|+|+. +|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 9999999999999864321 1123578888999999999999999999 9999999999999999999
Q ss_pred eEEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHH
Q 000889 1071 ARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWA 1149 (1237)
Q Consensus 1071 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~ 1149 (1237)
+||+|||+++...............+++.|+|||++.+..++.++||||+|+++|||++ |..||..... ..+.
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~ 236 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QDVI 236 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------HHHH
Confidence 99999999886544332222234456789999999988889999999999999999998 8888764321 1111
Q ss_pred HHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 000889 1150 KQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206 (1237)
Q Consensus 1150 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 1206 (1237)
....... .. ..+.. ....+.+++.+||+.+|++||++.++++.|+.
T Consensus 237 ~~i~~~~-~~-------~~~~~---~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EMIRNRQ-VL-------PCPDD---CPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHcCC-cC-------CCCCC---CCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111111 00 11111 22346688889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=318.39 Aligned_cols=247 Identities=24% Similarity=0.318 Sum_probs=192.3
Q ss_pred ecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCCCH
Q 000889 936 IGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSL 1011 (1237)
Q Consensus 936 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 1011 (1237)
||+|+||.||+++.+ +|+.||+|++.... ....+.+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999876 58899999886322 12234456799999999999999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcceee
Q 000889 1012 ESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSV 1091 (1237)
Q Consensus 1012 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~~ 1091 (1237)
.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~ 151 (277)
T cd05607 81 KYHIYNVG---ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TI 151 (277)
T ss_pred HHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---ee
Confidence 98886532 24588999999999999999999999 99999999999999999999999999998664322 22
Q ss_pred eccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCC
Q 000889 1092 STLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTS 1171 (1237)
Q Consensus 1092 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 1171 (1237)
....|+..|+|||++.+..++.++||||+||++|||++|+.||...... ........... .......
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~--~~~~~~~~~~~---------~~~~~~~-- 218 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK--VAKEELKRRTL---------EDEVKFE-- 218 (277)
T ss_pred eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch--hhHHHHHHHhh---------ccccccc--
Confidence 3456899999999999888999999999999999999999998643211 11111111100 0011000
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1172 DETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1172 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
......++.+++.+|++.+|++||++.|+++..
T Consensus 219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred cccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 001123467888899999999999997766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=326.87 Aligned_cols=264 Identities=23% Similarity=0.325 Sum_probs=197.3
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
++|++.+.||+|+||.||+|+++ +++.||+|++..... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888999999999999999886 577899998864332 2334677899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
++ ++|.+++... +..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 ~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 86 LD-KDLKQYMDDC----GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred CC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 98 5888887653 23578899999999999999999999 9999999999999999999999999999764332
Q ss_pred CcceeeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhh--cccc---
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE--KRIN--- 1159 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~--- 1159 (1237)
.. ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+. ........... ....
T Consensus 158 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 158 TK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE--LHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred cc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHhhhc
Confidence 21 1233467899999998865 4688999999999999999999999975432111 11111000000 0000
Q ss_pred ---cccCccccCCC------CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1160 ---EILDPELTMQT------SDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1160 ---~~~~~~l~~~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
...+...+... ..+....++.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00000000000 000112345688889999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=320.84 Aligned_cols=259 Identities=25% Similarity=0.385 Sum_probs=203.3
Q ss_pred CCCCCCceecccCCeEEEEEEECC------CCEEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD------GSVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERL 1000 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 1000 (1237)
++|++.+.||+|+||.||+|.+++ +..||+|.+.... ......+.+|+.+++.++||||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 468888999999999999998753 3579999875332 122346889999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHhhhhcC-----CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEee
Q 000889 1001 LVYEYMKWGSLESVLHDRAKG-----GGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSD 1075 (1237)
Q Consensus 1001 lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~D 1075 (1237)
+||||+++|+|.+++...... ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECC
Confidence 999999999999999764321 123578899999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhh
Q 000889 1076 FGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHR 1154 (1237)
Q Consensus 1076 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 1154 (1237)
||+++.....+.........++..|+|||.+.+..++.++|||||||++||+++ |..||..... ..... ...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~---~~~- 235 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLK---FVI- 235 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHH---HHh-
Confidence 999986544332222234456789999999988889999999999999999998 8999864221 11111 111
Q ss_pred hcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 000889 1155 EKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206 (1237)
Q Consensus 1155 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 1206 (1237)
.... ... +... ...+.+++.+||+.+|++|||+.++++.|++
T Consensus 236 ~~~~-----~~~--~~~~---~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 DGGH-----LDL--PENC---PDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred cCCC-----CCC--CCCC---CHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1110 011 1111 3467788899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=326.59 Aligned_cols=263 Identities=25% Similarity=0.418 Sum_probs=201.0
Q ss_pred CCCCCCceecccCCeEEEEEEE------CCCCEEEEEEeccccC-cCHHHHHHHHHHHHhc-CCCCcccccceEEeC-Ce
Q 000889 928 NGFSADSMIGSGGFGEVYKAQL------RDGSVVAIKKLIHVTG-QGDREFMAEMETIGKI-KHRNLVPLLGYCKIG-EE 998 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~ 998 (1237)
++|++.+.||+|+||+||+|++ .+++.||||++..... ...+.+.+|+.++.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4688999999999999999974 2467899998864322 2235688899999999 689999999988654 46
Q ss_pred EEEEEEeccCCCHHHHHhhhhcC---------------------------------------------------------
Q 000889 999 RLLVYEYMKWGSLESVLHDRAKG--------------------------------------------------------- 1021 (1237)
Q Consensus 999 ~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------------- 1021 (1237)
.++||||+++|+|.++++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 78999999999999998753210
Q ss_pred -----CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcceeeecccc
Q 000889 1022 -----GGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAG 1096 (1237)
Q Consensus 1022 -----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~g 1096 (1237)
....+++..+.+++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++...............+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 012467888899999999999999999 999999999999999999999999999986543322222223445
Q ss_pred CCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCCCHHH
Q 000889 1097 TPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETE 1175 (1237)
Q Consensus 1097 t~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 1175 (1237)
+..|+|||++.+..++.++||||||+++|||++ |..||...... .. .......... ...+...
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~---~~~~~~~~~~--------~~~~~~~--- 307 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EE---FCRRLKEGTR--------MRAPDYT--- 307 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HH---HHHHHhccCC--------CCCCCCC---
Confidence 678999999988889999999999999999997 99998643211 11 1111111110 0001111
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 000889 1176 LYQYLRISFECLDDRPFKRPTMIQVMAMFKELQV 1209 (1237)
Q Consensus 1176 ~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~ 1209 (1237)
..++.+++.+||+.+|++|||+.+++++|+.+..
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1256788889999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=321.92 Aligned_cols=264 Identities=25% Similarity=0.425 Sum_probs=200.0
Q ss_pred CCCCCCceecccCCeEEEEEEEC-----CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEe--CCeEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-----DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI--GEERL 1000 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 1000 (1237)
.+|++.+.||+|+||.||+|..+ ++..||+|++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46888899999999999999753 478899999865544445678899999999999999999998754 34679
Q ss_pred EEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccce
Q 000889 1001 LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1080 (1237)
Q Consensus 1001 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~ 1080 (1237)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 84 lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence 9999999999999986532 3589999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCcceee-eccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcc--
Q 000889 1081 LVNALDTHLSV-STLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKR-- 1157 (1237)
Q Consensus 1081 ~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 1157 (1237)
........... ....++..|+|||++.+..++.++||||||+++|||++|..|+...... +.........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-------~~~~~~~~~~~~ 229 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-------FMRMMGNDKQGQ 229 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-------hhhhcccccccc
Confidence 76543322111 1122345699999999888999999999999999999988775432110 0000000000
Q ss_pred -----cccccC--ccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 000889 1158 -----INEILD--PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208 (1237)
Q Consensus 1158 -----~~~~~~--~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~ 1208 (1237)
+.+.+. ....... .....+.+++.+||+.+|++|||+.++++.|+.++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 230 MIVYHLIELLKNNGRLPAPP---GCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred cchHHHHHHHhcCCcCCCCC---CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 000000 0011111 12235778888999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=341.19 Aligned_cols=262 Identities=24% Similarity=0.308 Sum_probs=192.3
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeC--------C
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIG--------E 997 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~ 997 (1237)
..+|++.++||+|+||+||+|+.. +++.||||++... .....+|+.++++++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457999999999999999999986 5789999988532 22345799999999999999999876432 2
Q ss_pred eEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCC-ceEEeec
Q 000889 998 ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENF-EARVSDF 1076 (1237)
Q Consensus 998 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~-~vkl~Df 1076 (1237)
..++||||++ +++.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 4679999998 578777764322 235789999999999999999999999 999999999999999654 7999999
Q ss_pred ccceeeccCCcceeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhh
Q 000889 1077 GMARLVNALDTHLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE 1155 (1237)
Q Consensus 1077 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1155 (1237)
|+|+....... .....||+.|||||++.+. .++.++||||+||++|||++|++||.+.... ..+..........
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--~~~~~i~~~~~~p 290 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV--DQLVRIIQVLGTP 290 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCC
Confidence 99986643222 2345789999999998654 6899999999999999999999999753211 1111111110000
Q ss_pred --c-------cc-----ccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1156 --K-------RI-----NEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1156 --~-------~~-----~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
+ .. ..+....+... .......++.+++.+||+++|.+|||+.+++++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKV-FPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHH-hccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0 00 00000000000 000112356788889999999999999999977
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=318.84 Aligned_cols=259 Identities=25% Similarity=0.423 Sum_probs=201.9
Q ss_pred CCCCCCceecccCCeEEEEEEEC------CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR------DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLL 1001 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 1001 (1237)
.+|+..++||+|+||.||+|+.. ++..+|+|++..........+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 35777889999999999999743 355788888765544445678999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHhhhhc----------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCce
Q 000889 1002 VYEYMKWGSLESVLHDRAK----------GGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEA 1071 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~v 1071 (1237)
||||+++++|.+++..... .....+++..+..++.|++.|++|||+. +++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999999975421 0113578999999999999999999999 99999999999999999999
Q ss_pred EEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHH
Q 000889 1072 RVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAK 1150 (1237)
Q Consensus 1072 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 1150 (1237)
||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||...... . ...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~---~~~ 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT---E---AIE 235 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH---H---HHH
Confidence 9999999986543332222223345778999999998899999999999999999998 89998532210 1 111
Q ss_pred HHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 000889 1151 QLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206 (1237)
Q Consensus 1151 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 1206 (1237)
....... .. ..... ...+.+++.+||+.+|.+||++.++.+.|+.
T Consensus 236 ~~~~~~~------~~--~~~~~---~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 236 CITQGRE------LE--RPRTC---PPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHcCcc------CC--CCCCC---CHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1111100 00 01111 2346688889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=326.56 Aligned_cols=250 Identities=22% Similarity=0.346 Sum_probs=202.4
Q ss_pred CCCceecccCCeEEEEEEECC--CC--EEEEEEeccccCc-CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 931 SADSMIGSGGFGEVYKAQLRD--GS--VVAIKKLIHVTGQ-GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 931 ~~~~~lG~G~fg~Vy~~~~~~--~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
...++||+|.||+|++|.|.. |+ .||||.+...... ...+|.+|+.+|.+|+|||++++||...+ ....||||.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 345689999999999999873 33 5899999765443 56789999999999999999999999876 788999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
++.|+|.+.+++.. ...+.......++.|||.|+.||.++ ++||||+..+|+++-....|||+|||+.+-+...
T Consensus 192 aplGSLldrLrka~---~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAK---KAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred cccchHHHHHhhcc---ccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999998732 35788888899999999999999999 9999999999999999889999999999987765
Q ss_pred Ccceee-eccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccC
Q 000889 1086 DTHLSV-STLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1086 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
+..+.+ ....-...|+|||.+....++.++|||+|||++|||++ |..||.+-.. ....+.... .
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g------~qIL~~iD~--------~ 331 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG------IQILKNIDA--------G 331 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH------HHHHHhccc--------c
Confidence 544433 23445668999999999999999999999999999999 8889875431 111111111 1
Q ss_pred ccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
.++..+..+ .+++.+++.+||...|.+|||+..+.+.+
T Consensus 332 erLpRPk~c---sedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 332 ERLPRPKYC---SEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccCCCCCCC---hHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 233333334 44667788899999999999999998554
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=316.64 Aligned_cols=255 Identities=24% Similarity=0.341 Sum_probs=187.1
Q ss_pred eecccCCeEEEEEEECC---CCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCCC
Q 000889 935 MIGSGGFGEVYKAQLRD---GSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGS 1010 (1237)
Q Consensus 935 ~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 1010 (1237)
.||+|+||.||+|+... ...+|+|.+..... .....+.+|+++++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997653 34677776653222 223467889999999999999999999999999999999999999
Q ss_pred HHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCccee
Q 000889 1011 LESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLS 1090 (1237)
Q Consensus 1011 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~ 1090 (1237)
|.+++...........++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999775432233456788899999999999999999 999999999999999999999999999875433222222
Q ss_pred eeccccCCCcCCccccCc-------cccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhccccccc
Q 000889 1091 VSTLAGTPGYVPPEYYQS-------FRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162 (1237)
Q Consensus 1091 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1162 (1237)
.....++..|+|||++.. ..++.++||||+||++|||++ |..||..... ...... ..... ...+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~~~~-~~~~~-~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-----EQVLKQ-VVREQ-DIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHHHH-Hhhcc-CccCC
Confidence 233446678999998743 356789999999999999999 7788764321 111111 11111 11111
Q ss_pred CccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 000889 1163 DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFK 1205 (1237)
Q Consensus 1163 ~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 1205 (1237)
++.. .......+.+++..|| .||++|||+.+|++.|.
T Consensus 232 ~~~~-----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQL-----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcc-----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1111 1112234456777888 59999999999998863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=323.88 Aligned_cols=268 Identities=26% Similarity=0.416 Sum_probs=206.1
Q ss_pred CCCCCCceecccCCeEEEEEEEC--------CCCEEEEEEecccc-CcCHHHHHHHHHHHHhc-CCCCcccccceEEeCC
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR--------DGSVVAIKKLIHVT-GQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGE 997 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 997 (1237)
++|.+.+.||+|+||.||+|+.. ....+|+|++.... ......+..|+++++++ +||||+++++++....
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46778899999999999999752 24568888876432 22345688899999999 6999999999999889
Q ss_pred eEEEEEEeccCCCHHHHHhhhhc-----------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeC
Q 000889 998 ERLLVYEYMKWGSLESVLHDRAK-----------GGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLD 1066 (1237)
Q Consensus 998 ~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~ 1066 (1237)
..++||||+++|+|.+++..... .....+++..+.+++.|++.|++|||+. +++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 99999999999999999976431 1124588999999999999999999999 999999999999999
Q ss_pred CCCceEEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchH
Q 000889 1067 ENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNL 1145 (1237)
Q Consensus 1067 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~ 1145 (1237)
.++.+||+|||+++...............++..|||||++.+..++.++||||||+++|||++ |..||..... ...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~~ 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---EEL 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---HHH
Confidence 999999999999986643322211122234567999999988889999999999999999999 8888864321 111
Q ss_pred HHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccccCCCC
Q 000889 1146 VGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGDS 1215 (1237)
Q Consensus 1146 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~~~~~~ 1215 (1237)
. .... .... ...... ...++.+++.+|++.+|++|||+.++++.|.++........
T Consensus 246 ~---~~~~-~~~~-------~~~~~~---~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 301 (314)
T cd05099 246 F---KLLR-EGHR-------MDKPSN---CTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEY 301 (314)
T ss_pred H---HHHH-cCCC-------CCCCCC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcCCc
Confidence 1 1111 1100 011111 12356688889999999999999999999999877554433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=313.20 Aligned_cols=254 Identities=26% Similarity=0.437 Sum_probs=203.1
Q ss_pred hCCCCCCceecccCCeEEEEEEECCCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
.++|++.++||+|+||.||+|..++++.||+|++.... ....++.+|+.++++++||||+++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 35688899999999999999999889999999886433 34567899999999999999999999874 56789999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
++++|.+++.... +..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||++.......
T Consensus 83 ~~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 83 ENGSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 9999999986532 34689999999999999999999999 99999999999999999999999999997665322
Q ss_pred cceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPE 1165 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1165 (1237)
.. ......++..|+|||++.+..++.++||||||+++||+++ |+.||..... ... .........
T Consensus 157 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~---~~~~~~~~~-------- 221 (260)
T cd05067 157 YT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEV---IQNLERGYR-------- 221 (260)
T ss_pred cc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHH---HHHHHcCCC--------
Confidence 11 1123345678999999998889999999999999999999 9999864321 111 111111110
Q ss_pred ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 000889 1166 LTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206 (1237)
Q Consensus 1166 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 1206 (1237)
...... ...++.+++.+|++.+|++|||++++.+.|+.
T Consensus 222 ~~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 MPRPDN---CPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCC---CCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 011111 12357788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=329.46 Aligned_cols=238 Identities=23% Similarity=0.317 Sum_probs=189.8
Q ss_pred ceecccCCeEEEEEEE----CCCCEEEEEEeccccC--cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEecc
Q 000889 934 SMIGSGGFGEVYKAQL----RDGSVVAIKKLIHVTG--QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMK 1007 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 1007 (1237)
+.||+|+||.||+++. .+++.||+|++..... .....+..|++++++++||||+++++++...+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999975 2578999998864321 233456789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCc
Q 000889 1008 WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDT 1087 (1237)
Q Consensus 1008 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~ 1087 (1237)
+|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 82 GGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 99999998653 4689999999999999999999999 999999999999999999999999999976543211
Q ss_pred ceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcccc
Q 000889 1088 HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELT 1167 (1237)
Q Consensus 1088 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1167 (1237)
......|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......... ....
T Consensus 154 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~------~~~~~~i~~---------~~~~ 216 (318)
T cd05582 154 --KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR------KETMTMILK---------AKLG 216 (318)
T ss_pred --ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH------HHHHHHHHc---------CCCC
Confidence 22346789999999999988899999999999999999999999974321 111111110 0111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 000889 1168 MQTSDETELYQYLRISFECLDDRPFKRPTMIQ 1199 (1237)
Q Consensus 1168 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1199 (1237)
.+... ...+.+++.+|++.||++||++.+
T Consensus 217 ~p~~~---~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFL---SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCC---CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11111 134567888999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=330.62 Aligned_cols=256 Identities=23% Similarity=0.315 Sum_probs=196.8
Q ss_pred HHhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEE
Q 000889 925 EATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERL 1000 (1237)
Q Consensus 925 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 1000 (1237)
...++|++.+.||+|+||.||+|+++ +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..+...+
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34578999999999999999999987 57789999875322 122345778999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccce
Q 000889 1001 LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1080 (1237)
Q Consensus 1001 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~ 1080 (1237)
+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 120 lv~Ey~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 99999999999999864 2478888899999999999999999 99999999999999999999999999998
Q ss_pred eeccCCcceeeeccccCCCcCCccccCcc----ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhc
Q 000889 1081 LVNALDTHLSVSTLAGTPGYVPPEYYQSF----RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREK 1156 (1237)
Q Consensus 1081 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1156 (1237)
....... .......||+.|||||++.+. .++.++||||+||++|||++|+.||..... ...+ .......
T Consensus 191 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~-~~i~~~~ 263 (371)
T cd05622 191 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTY-SKIMNHK 263 (371)
T ss_pred EcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-----HHHH-HHHHcCC
Confidence 7643221 122456799999999998754 378899999999999999999999974321 1111 1111110
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHHH
Q 000889 1157 RINEILDPELTMQTSDETELYQYLRISFECLDDRPFK--RPTMIQVMAMF 1204 (1237)
Q Consensus 1157 ~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ell~~L 1204 (1237)
. ...++... .....+.+++.+|+..++.+ ||++.+++++.
T Consensus 264 ~-----~~~~~~~~---~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 264 N-----SLTFPDDN---DISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred C-----cccCCCcC---CCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0 00111111 11234557777899744433 78999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=323.40 Aligned_cols=258 Identities=28% Similarity=0.443 Sum_probs=202.4
Q ss_pred CCCCCCceecccCCeEEEEEEEC------CCCEEEEEEeccccC-cCHHHHHHHHHHHHhc-CCCCcccccceEEeCCeE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR------DGSVVAIKKLIHVTG-QGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEER 999 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 999 (1237)
++|++.+.||+|+||.||+|... .+..||+|++..... ...+.+.+|+++++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 46888999999999999999752 245789998764322 2235688999999999 799999999999999999
Q ss_pred EEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccc
Q 000889 1000 LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1079 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla 1079 (1237)
++||||+++|+|.++++.... ..+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.+|++|||++
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccc
Confidence 999999999999999975321 3489999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhccc
Q 000889 1080 RLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158 (1237)
Q Consensus 1080 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1158 (1237)
+...............++..|+|||++.+..++.++||||+||++|||++ |..||...... ... ..... .. .
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~~~---~~~~~-~~-~ 261 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--SKF---YKLIK-EG-Y 261 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--HHH---HHHHH-cC-C
Confidence 86543322222223446778999999998889999999999999999998 99998643211 111 11111 10 0
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 000889 1159 NEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207 (1237)
Q Consensus 1159 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l 1207 (1237)
... .+.. ....+.+++.+|++++|++|||+.++++.|+++
T Consensus 262 ----~~~--~~~~---~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 ----RMA--QPEH---APAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----cCC--CCCC---CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 000 0111 123577888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=312.64 Aligned_cols=250 Identities=27% Similarity=0.412 Sum_probs=201.7
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccc--cCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHV--TGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
+|++.+.||+|+||.||+|+.. +++.|++|.+... .....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777889999999999999986 5888999987532 223455788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
+++++|.++++... ...+++..++.++.+++.|+.|||+. +++||||||+||+++.++.+|++|||+++.....
T Consensus 81 ~~~~~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 99999999998642 24788999999999999999999999 9999999999999999999999999999866543
Q ss_pred CcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcc
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPE 1165 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1165 (1237)
... .....|++.|+|||+..+..++.++||||||+++|||++|+.||..... . ....... .... +.
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~---~~~~~~~-~~~~-----~~ 220 (256)
T cd08529 155 TNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---G---ALILKII-RGVF-----PP 220 (256)
T ss_pred cch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---H---HHHHHHH-cCCC-----CC
Confidence 221 2345688899999999988899999999999999999999999974321 0 1111111 1100 01
Q ss_pred ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1166 LTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1166 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.. ......+.+++.+||+.+|++||++.+++++
T Consensus 221 ~~-----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 VS-----QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred Cc-----cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 10 1122457788899999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=334.00 Aligned_cols=263 Identities=21% Similarity=0.245 Sum_probs=199.8
Q ss_pred hCCCCCCceecccCCeEEEEEEEC---CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR---DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
..+|++.+.||+|+||.||+|... .+..||+|.+... +...+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999764 3567888877532 34568999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+. ++|.+++... ..+++..++.++.|++.||+|||+. +||||||||+||+++.++.+||+|||+++...
T Consensus 166 e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 166 PKYK-CDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred hhcC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 9996 6888888432 4689999999999999999999999 99999999999999999999999999998665
Q ss_pred cCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCc-hHHHHHHHHhhh-------
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDN-NLVGWAKQLHRE------- 1155 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~------- 1155 (1237)
............||+.|+|||++.+..++.++||||+||++|||++|+.||.+....... .+..........
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 433333334567999999999999989999999999999999999999999765432211 111111110000
Q ss_pred ---------cccccccCccccCCCC--CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1156 ---------KRINEILDPELTMQTS--DETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1156 ---------~~~~~~~~~~l~~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
........+....+.. ......++.+++.+|++.+|++|||+.+++.+
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000110100000 00112356678889999999999999999987
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=327.48 Aligned_cols=237 Identities=26% Similarity=0.347 Sum_probs=186.2
Q ss_pred ceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHH-HHHhcCCCCcccccceEEeCCeEEEEEEeccC
Q 000889 934 SMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEME-TIGKIKHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
+.||+|+||+||+|++. +++.||+|++.... .....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999986 58899999886432 122234455544 56789999999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 150 (323)
T cd05575 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-- 150 (323)
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--
Confidence 9999988753 4688899999999999999999999 99999999999999999999999999987532211
Q ss_pred eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccC
Q 000889 1089 LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTM 1168 (1237)
Q Consensus 1089 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1168 (1237)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......... .....
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~~---------~~~~~ 215 (323)
T cd05575 151 KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNILN---------KPLRL 215 (323)
T ss_pred CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHHc---------CCCCC
Confidence 122345799999999999998999999999999999999999999974321 111111111 11111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 000889 1169 QTSDETELYQYLRISFECLDDRPFKRPTMI 1198 (1237)
Q Consensus 1169 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1198 (1237)
.... ...+.+++.+|++.+|.+||++.
T Consensus 216 ~~~~---~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNI---SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCC---CHHHHHHHHHHhhcCHHhCCCCC
Confidence 1111 23466788899999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=317.04 Aligned_cols=253 Identities=31% Similarity=0.481 Sum_probs=198.9
Q ss_pred CCCCceecccCCeEEEEEEECC-CCEEEEEEeccccCcCHH--HHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 930 FSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDR--EFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
|++.+.||+|+||+||+|+... ++.+|+|.+......... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5677899999999999999885 558999988754322222 2356999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
++++|.+++... ..+++..+..++.|+++||+|||+. +++|+||||+||++++++.++|+|||.+.... .
T Consensus 81 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~ 150 (260)
T PF00069_consen 81 PGGSLQDYLQKN-----KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS--E 150 (260)
T ss_dssp TTEBHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST--S
T ss_pred cccccccccccc-----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--c
Confidence 999999999832 4789999999999999999999999 99999999999999999999999999998642 2
Q ss_pred cceeeeccccCCCcCCccccC-ccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQ-SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPE 1165 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1165 (1237)
.........++..|+|||++. +..++.++||||+|+++|+|++|..||...... ............... . .
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~--~~~~~~~~~~~~~~~-~-----~ 222 (260)
T PF00069_consen 151 NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD--DQLEIIEKILKRPLP-S-----S 222 (260)
T ss_dssp TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH--HHHHHHHHHHHTHHH-H-----H
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccch--hhhhhhhhccccccc-c-----c
Confidence 222345667899999999998 888999999999999999999999998754110 111111111110100 0 0
Q ss_pred ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1166 LTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1166 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
... .......+.+++.+|++.+|++||++.+++++
T Consensus 223 ~~~---~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 223 SQQ---SREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TTS---HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccc---cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 00011567888999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=315.18 Aligned_cols=250 Identities=23% Similarity=0.356 Sum_probs=196.7
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
+|++.++||+|+||.||+|++. ++..||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 5788899999999999999875 67889999875432 223456889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
++++|..+. .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 82 DGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 999986542 467888889999999999999999 99999999999999999999999999997654322
Q ss_pred cceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCch-HHHHHHHHhhhcccccccCcc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN-LVGWAKQLHREKRINEILDPE 1165 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 1165 (1237)
.....|+..|+|||++.+..++.++||||+|+++|+|++|+.||.......... ........... ..+.
T Consensus 150 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------~~~~ 219 (279)
T cd06619 150 ----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE------DPPV 219 (279)
T ss_pred ----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc------CCCC
Confidence 234578999999999998889999999999999999999999997532111111 00111100000 0111
Q ss_pred ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1166 LTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1166 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
.... ....++.+++.+|++.+|++||++.+++++-
T Consensus 220 ~~~~----~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 220 LPVG----QFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred CCCC----cCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 1111 1123567888899999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=319.90 Aligned_cols=263 Identities=24% Similarity=0.363 Sum_probs=202.8
Q ss_pred hCCCCCCceecccCCeEEEEEEECC------CCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLRD------GSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEER 999 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 999 (1237)
.++|++.++||+|+||.||+|..++ +..||+|.+..... .....+.+|+.++++++||||+++++++.+.+..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 4678999999999999999997542 45799998753321 2234578899999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHhhhhcC-----CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEe
Q 000889 1000 LLVYEYMKWGSLESVLHDRAKG-----GGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVS 1074 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~ 1074 (1237)
++||||+++|+|.++++..... .....++..+..++.|++.|++|||++ +|+||||||+||+++.++.+|++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEEC
Confidence 9999999999999999764221 123456778899999999999999999 99999999999999999999999
Q ss_pred ecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHh
Q 000889 1075 DFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLH 1153 (1237)
Q Consensus 1075 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 1153 (1237)
|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..+.....
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~ 235 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN------EQVLKFVM 235 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHH
Confidence 9999986543332222223345678999999998889999999999999999998 7888864321 11111111
Q ss_pred hhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 000889 1154 REKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQV 1209 (1237)
Q Consensus 1154 ~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~ 1209 (1237)
..... .. ... ....+.+++.+|++.+|++|||+.++++.+++...
T Consensus 236 ~~~~~------~~--~~~---~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 236 DGGYL------DQ--PDN---CPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred cCCCC------CC--CCC---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 11100 00 111 12467788889999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=317.01 Aligned_cols=251 Identities=26% Similarity=0.336 Sum_probs=197.7
Q ss_pred CCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCc---CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 930 FSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQ---GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
|+..+.||+|+||.||+|.+. +++.||+|++...... ..+.+.+|+.++++++|++|+++++++.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677789999999999999887 5789999988643222 224567899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
+++++|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 82 ~~g~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 82 MNGGDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred cCCCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999999886532 24588999999999999999999999 9999999999999999999999999999765422
Q ss_pred CcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcc
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPE 1165 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1165 (1237)
.. .....|+..|+|||++.+..++.++||||+|+++|||++|+.||....... ........ ... .. ..
T Consensus 156 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~--~~~~~~~~-~~~--~~----~~ 223 (285)
T cd05630 156 QT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERL-VKE--VQ----EE 223 (285)
T ss_pred cc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc--hHHHHHhh-hhh--hh----hh
Confidence 21 234578999999999999899999999999999999999999997532111 11111110 000 00 00
Q ss_pred ccCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 000889 1166 LTMQTSDETELYQYLRISFECLDDRPFKRPT-----MIQVMAM 1203 (1237)
Q Consensus 1166 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~~ 1203 (1237)
.. . .....+.+++.+|++.+|++||| +.+++++
T Consensus 224 ~~--~---~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 224 YS--E---KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred cC--c---cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 11 0 11224667888999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=320.76 Aligned_cols=260 Identities=27% Similarity=0.443 Sum_probs=202.0
Q ss_pred hCCCCCCceecccCCeEEEEEEEC------CCCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR------DGSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEER 999 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 999 (1237)
.++|++.+.||+|+||.||+|.+. ++..||+|++..... ...+++.+|+.++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457889999999999999999864 367899998764322 2245688999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHhhhhc-----------------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 000889 1000 LLVYEYMKWGSLESVLHDRAK-----------------GGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSN 1062 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~N 1062 (1237)
++||||+++|+|.+++..... .....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 999999999999999975421 1123578889999999999999999999 99999999999
Q ss_pred eeeCCCCceEEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCC
Q 000889 1063 VLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGD 1141 (1237)
Q Consensus 1063 Ill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~ 1141 (1237)
|+++.++.+||+|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999876543322111222345667999999998899999999999999999997 8888753221
Q ss_pred CchHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 000889 1142 DNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206 (1237)
Q Consensus 1142 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 1206 (1237)
......... .... ..+. .....+.+++.+|++.+|++|||+.|+++.|++
T Consensus 239 ----~~~~~~~~~-~~~~-------~~~~---~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 ----EEVIYYVRD-GNVL-------SCPD---NCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ----HHHHHHHhc-CCCC-------CCCC---CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111111111 1100 0011 122457788899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=318.28 Aligned_cols=262 Identities=26% Similarity=0.433 Sum_probs=201.8
Q ss_pred CCCCCCceecccCCeEEEEEEECC-CC--EEEEEEecccc-CcCHHHHHHHHHHHHhc-CCCCcccccceEEeCCeEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD-GS--VVAIKKLIHVT-GQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 1002 (1237)
++|++.++||+|+||.||+|+.++ +. .+++|.+.... ....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 478899999999999999998764 32 46777765322 22345688999999999 799999999999999999999
Q ss_pred EEeccCCCHHHHHhhhhcC-----------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCce
Q 000889 1003 YEYMKWGSLESVLHDRAKG-----------GGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEA 1071 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~v 1071 (1237)
|||+++++|.++++..... ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 9999999999999753211 123588899999999999999999999 99999999999999999999
Q ss_pred EEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHH
Q 000889 1072 RVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAK 1150 (1237)
Q Consensus 1072 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 1150 (1237)
||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||..... .....
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~------~~~~~ 229 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC------AELYE 229 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------HHHHH
Confidence 99999998643211 11112233557999999998889999999999999999997 9999864321 11111
Q ss_pred HHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccccC
Q 000889 1151 QLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTE 1212 (1237)
Q Consensus 1151 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~~~ 1212 (1237)
..... ..... +.. ....+.+++.+|++.+|.+|||+.++++.|+.+.....
T Consensus 230 ~~~~~------~~~~~--~~~---~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 230 KLPQG------YRMEK--PRN---CDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HHhcC------CCCCC--CCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11111 01111 111 12356788889999999999999999999988876553
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=310.78 Aligned_cols=252 Identities=23% Similarity=0.371 Sum_probs=199.9
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCc-----CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQ-----GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLL 1001 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 1001 (1237)
++|++.+.||+|++|.||+|... ++..||+|.+...... ..+.+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46889999999999999999875 5889999987533211 23467889999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeeccccee
Q 000889 1002 VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~ 1081 (1237)
||||+++++|.+++... ..+++..+.+++.|++.|++|||+. +++||||+|+||+++.++.++|+|||+++.
T Consensus 82 v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEECCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 99999999999998753 3578889999999999999999999 999999999999999999999999999986
Q ss_pred eccCCccee-eeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccccc
Q 000889 1082 VNALDTHLS-VSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINE 1160 (1237)
Q Consensus 1082 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1160 (1237)
......... .....++..|+|||++.+..++.++||||+|+++|||++|+.||...+. ....... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~-~~~~---- 223 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-----MAAIFKI-ATQP---- 223 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-----HHHHHHH-hccC----
Confidence 543221111 1234578899999999998899999999999999999999999864321 1111111 0000
Q ss_pred ccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1161 ILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1161 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.....+ ......+.+++.+|+..+|++|||+.+++++
T Consensus 224 -~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 -TNPQLP-----SHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCCCCC-----ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 011111 1122356678889999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=312.61 Aligned_cols=253 Identities=27% Similarity=0.424 Sum_probs=200.1
Q ss_pred CCCCCCceecccCCeEEEEEEECCCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEecc
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMK 1007 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 1007 (1237)
++|++.+.||+|+||.||+|.+..+..+|+|++... ....+.+.+|++++++++|||++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 458888999999999999999887778999987542 234567889999999999999999999875 456899999999
Q ss_pred CCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCc
Q 000889 1008 WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDT 1087 (1237)
Q Consensus 1008 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~ 1087 (1237)
+++|.++++... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.++.......
T Consensus 84 ~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 84 KGSLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 999999997532 24578999999999999999999999 999999999999999999999999999986543221
Q ss_pred ceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccc
Q 000889 1088 HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1088 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
. ......++..|+|||+..+..++.++||||||+++|||++ |+.||..... ... ........ ..
T Consensus 158 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~---~~~~~~~~------~~-- 222 (260)
T cd05069 158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REV---LEQVERGY------RM-- 222 (260)
T ss_pred c-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHH---HHHHHcCC------CC--
Confidence 1 1122345678999999988889999999999999999999 8999864321 111 11111110 00
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 1206 (1237)
... ......+.+++.+|++++|++||++.++++.|++
T Consensus 223 ~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCP---QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCC---cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011 1122457788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=324.55 Aligned_cols=241 Identities=26% Similarity=0.351 Sum_probs=190.5
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcC-CCCcccccceEEeCCeEEEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIK-HRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
+|+..+.||+|+||+||+|+.. +++.||+|++.... ....+.+..|.++++.+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999876 58899999886432 223345778899988885 577888999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQV-----GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 999999999988653 4689999999999999999999999 99999999999999999999999999987543
Q ss_pred cCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccC
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ... ......
T Consensus 153 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~---~~~i~~--------- 215 (323)
T cd05615 153 VDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DEL---FQSIME--------- 215 (323)
T ss_pred CCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHH---HHHHHh---------
Confidence 2211 12345689999999999988899999999999999999999999975321 111 111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTM 1197 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1197 (1237)
.....+... ...+.+++.+|++.+|.+|++.
T Consensus 216 ~~~~~p~~~---~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 216 HNVSYPKSL---SKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCCCCccC---CHHHHHHHHHHcccCHhhCCCC
Confidence 011111111 1345678889999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=324.28 Aligned_cols=263 Identities=27% Similarity=0.400 Sum_probs=204.9
Q ss_pred CCCCCceecccCCeEEEEEEECC--------CCEEEEEEecccc-CcCHHHHHHHHHHHHhc-CCCCcccccceEEeCCe
Q 000889 929 GFSADSMIGSGGFGEVYKAQLRD--------GSVVAIKKLIHVT-GQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEE 998 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 998 (1237)
+|++.+.||+|+||.||+|++.. +..||+|.+.... ....+++.+|+++++++ +||||+++++++...+.
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 92 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCc
Confidence 58889999999999999997531 2368899776432 22345788999999999 79999999999999999
Q ss_pred EEEEEEeccCCCHHHHHhhhhc-----------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCC
Q 000889 999 RLLVYEYMKWGSLESVLHDRAK-----------GGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE 1067 (1237)
Q Consensus 999 ~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~ 1067 (1237)
.+++|||+++|+|.+++..... .....+++..+..++.|+++|++|||+. +++||||||+||+++.
T Consensus 93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~~ 169 (334)
T cd05100 93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTE 169 (334)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcC
Confidence 9999999999999999976431 1234588899999999999999999999 9999999999999999
Q ss_pred CCceEEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHH
Q 000889 1068 NFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLV 1146 (1237)
Q Consensus 1068 ~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~ 1146 (1237)
++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.... ..
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~~ 243 (334)
T cd05100 170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------VE 243 (334)
T ss_pred CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC------HH
Confidence 99999999999986654332222222334567999999999899999999999999999998 888886432 11
Q ss_pred HHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccccc
Q 000889 1147 GWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDT 1211 (1237)
Q Consensus 1147 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~~ 1211 (1237)
.+......... ..... .....+.+++.+|++.+|++|||+.++++.|+++....
T Consensus 244 ~~~~~~~~~~~--------~~~~~---~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 244 ELFKLLKEGHR--------MDKPA---NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHHHHcCCC--------CCCCC---CCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 11111111110 00111 12235778889999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=319.42 Aligned_cols=250 Identities=26% Similarity=0.374 Sum_probs=201.8
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
.+|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 57889999999999999999975 68999999887544445567889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
++++|.+++.. ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 99 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred CCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 99999999864 3578889999999999999999999 99999999999999999999999999997654322
Q ss_pred cceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
. ......+++.|+|||.+.+..++.++||||+||++|+|++|+.||........ .. .......+..
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~-----~~-------~~~~~~~~~~ 235 (297)
T cd06656 170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-----LY-------LIATNGTPEL 235 (297)
T ss_pred c--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh-----ee-------eeccCCCCCC
Confidence 1 12345688899999999988899999999999999999999999965321110 00 0000000011
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.. .......+.+++.+||+.+|++||++.+++++
T Consensus 236 ~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 236 QN---PERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01 11122345678889999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=324.33 Aligned_cols=193 Identities=23% Similarity=0.327 Sum_probs=165.2
Q ss_pred HHhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 925 EATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 925 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
....+|++.+.||+|+||.||+|+.. ++..||+|.... .....|+.++++++||||+++++++......++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34567999999999999999999987 466888886432 12356999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+. ++|.+++... ...+++..+..++.|++.||+|||+. +||||||||+||+++.++.+||+|||+++...
T Consensus 137 e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 137 PHYS-SDLYTYLTKR----SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EccC-CcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 9995 6888888653 24689999999999999999999999 99999999999999999999999999997533
Q ss_pred cCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCC
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPI 1134 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~ 1134 (1237)
... ......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 209 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 209 VAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 211 123456899999999999989999999999999999999866554
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=324.75 Aligned_cols=201 Identities=28% Similarity=0.371 Sum_probs=172.3
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccc---cCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHV---TGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
++|++.+.||+|+||+||+|+.. +++.||+|++... .....+.+.+|..+++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46889999999999999999976 5889999988642 1223445788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred ecCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 999999999999653 24688999999999999999999999 99999999999999999999999999997654
Q ss_pred cCCcceeeeccccCCCcCCccccCc-----cccCcccchHHHHHHHHHHHcCCCCCCC
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQS-----FRCTTKGDVYSYGVILLELLSGKRPIDP 1136 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGv~l~el~tg~~p~~~ 1136 (1237)
..... ......||+.|||||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 154 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 154 ADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 32221 1223468999999999863 4578899999999999999999999964
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=320.07 Aligned_cols=261 Identities=27% Similarity=0.459 Sum_probs=200.7
Q ss_pred CCCCCCceecccCCeEEEEEEECC-CC--EEEEEEecccc-CcCHHHHHHHHHHHHhc-CCCCcccccceEEeCCeEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD-GS--VVAIKKLIHVT-GQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 1002 (1237)
++|++.+.||+|+||.||+|+++. +. .+|+|++.... ....+.+.+|++++.++ +||||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 468888999999999999999763 43 45777665322 22345688899999999 899999999999999999999
Q ss_pred EEeccCCCHHHHHhhhhc-----------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCce
Q 000889 1003 YEYMKWGSLESVLHDRAK-----------GGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEA 1071 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~v 1071 (1237)
|||+++++|.++++.... .....+++..++.++.|+++|++|||+. +++||||||+||+++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 999999999999976431 1123578999999999999999999999 99999999999999999999
Q ss_pred EEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHH
Q 000889 1072 RVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAK 1150 (1237)
Q Consensus 1072 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 1150 (1237)
||+|||+++..... .......++..|+|||++.+..++.++|||||||++|||++ |..||...... ....
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~ 234 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYE 234 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------HHHH
Confidence 99999998633211 11112234667999999988889999999999999999998 99998643211 1111
Q ss_pred HHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccccc
Q 000889 1151 QLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDT 1211 (1237)
Q Consensus 1151 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~~ 1211 (1237)
..... ..... ... ....+.+++.+|++.+|++||++.++++.++++....
T Consensus 235 ~~~~~------~~~~~--~~~---~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 235 KLPQG------YRLEK--PLN---CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred HHhcC------CcCCC--CCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11110 01111 111 1234678888999999999999999999998775544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=318.38 Aligned_cols=251 Identities=23% Similarity=0.372 Sum_probs=196.2
Q ss_pred CCCCceecccCCeEEEEEEECC-CCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccC
Q 000889 930 FSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
|++.+.||+|+||.||+|++.. +..+++|.+........+.+.+|+++++.++||||+++++++..+...++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 5667889999999999999874 667788877544434456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
++|..++... ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.+|++|||++.......
T Consensus 87 ~~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-- 157 (282)
T cd06643 87 GAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 157 (282)
T ss_pred CcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc--
Confidence 9999987653 24689999999999999999999999 99999999999999999999999999987543221
Q ss_pred eeeeccccCCCcCCccccC-----ccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccC
Q 000889 1089 LSVSTLAGTPGYVPPEYYQ-----SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1089 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
.......+++.|+|||++. +..++.++||||+||++|||++|+.||.... ....... ..... .
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-----~~~~~~~-~~~~~------~ 225 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-----PMRVLLK-IAKSE------P 225 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-----HHHHHHH-HhhcC------C
Confidence 1223456889999999984 4457789999999999999999999986422 1111111 10000 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
+....+. .....+.+++.+||+.+|++||++.+++++-
T Consensus 226 ~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 226 PTLAQPS---RWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred CCCCCcc---ccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 1111111 1123567888899999999999999988664
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=326.74 Aligned_cols=240 Identities=24% Similarity=0.321 Sum_probs=186.0
Q ss_pred ceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHH-HHHhcCCCCcccccceEEeCCeEEEEEEeccC
Q 000889 934 SMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEME-TIGKIKHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
+.||+|+||+||+|++. +++.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999987 46789999886422 122234444444 56788999999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
|+|.+++... ..+.+..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-- 150 (325)
T cd05602 81 GELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-- 150 (325)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--
Confidence 9999998753 3577888889999999999999999 99999999999999999999999999997543211
Q ss_pred eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccC
Q 000889 1089 LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTM 1168 (1237)
Q Consensus 1089 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1168 (1237)
.......||+.|||||++.+..++.++||||+||++|||++|+.||..... .......... ....
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~---------~~~~ 215 (325)
T cd05602 151 GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNK---------PLQL 215 (325)
T ss_pred CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH------HHHHHHHHhC---------CcCC
Confidence 122456799999999999998999999999999999999999999974321 1111111111 1111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 000889 1169 QTSDETELYQYLRISFECLDDRPFKRPTMIQVM 1201 (1237)
Q Consensus 1169 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell 1201 (1237)
.... ...+.+++.+|++.+|.+||++.+.+
T Consensus 216 ~~~~---~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 216 KPNI---TNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCC---CHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 1111 22456788899999999999987443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=312.79 Aligned_cols=255 Identities=27% Similarity=0.463 Sum_probs=204.7
Q ss_pred hCCCCCCceecccCCeEEEEEEECCCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
.++|++.+.||+|+||.||+|..+++..||+|.+... ....+++.+|+.++++++||||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 4578899999999999999999888888999987643 344578999999999999999999999999888999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
++++|.+++.... +..+++..+..++.+++.|++|||+. +++|+||||+||+++.++.+|++|||.++......
T Consensus 84 ~~~~L~~~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 84 SKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred CCCCHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999997642 24689999999999999999999999 99999999999999999999999999998664321
Q ss_pred cceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPE 1165 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1165 (1237)
.. ......++..|+|||.+.+..++.++||||+|+++||+++ |+.||.... .. .......... .
T Consensus 158 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~---~~---~~~~~~~~~~--------~ 222 (261)
T cd05034 158 YT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT---NR---EVLEQVERGY--------R 222 (261)
T ss_pred hh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC---HH---HHHHHHHcCC--------C
Confidence 11 1122234568999999998889999999999999999998 999986432 11 1111111110 0
Q ss_pred ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 000889 1166 LTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206 (1237)
Q Consensus 1166 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 1206 (1237)
...+... ...+.+++.+|++.+|++||++.++.+.|+.
T Consensus 223 ~~~~~~~---~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 MPRPPNC---PEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCC---CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0111111 2356788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=309.25 Aligned_cols=249 Identities=21% Similarity=0.327 Sum_probs=208.4
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCc--CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQ--GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
.+-|.+.+.||+|.|++|-+|++- +|+.||||++.+.... ...++..|++.|+-++|||||++|++.......|+|+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 345788889999999999999864 7999999999765433 3457889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee-CCCCceEEeecccceee
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLL-DENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll-~~~~~vkl~DfGla~~~ 1082 (1237)
|.-++|+|.+|+.+.. ..+.+.-+.+++.||+.|+.|+|+. .|||||+||+||.+ .+-|-||+.|||++-.+
T Consensus 97 ELGD~GDl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EecCCchHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 9999999999998764 4688999999999999999999999 99999999999876 46789999999999776
Q ss_pred ccCCcceeeeccccCCCcCCccccCccccC-cccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccc
Q 000889 1083 NALDTHLSVSTLAGTPGYVPPEYYQSFRCT-TKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161 (1237)
Q Consensus 1083 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1161 (1237)
.+.. +..+.||...|-|||.+.+..|+ +++||||+|||+|-+++|+.||..... .+.+..|
T Consensus 170 ~PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND---------------SETLTmI 231 (864)
T KOG4717|consen 170 QPGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND---------------SETLTMI 231 (864)
T ss_pred CCcc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc---------------hhhhhhh
Confidence 5433 45778999999999999998886 579999999999999999999975331 2233344
Q ss_pred cCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1162 LDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1162 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
+|-.+..+.... .+..++|..|+..||.+|.+..+++..
T Consensus 232 mDCKYtvPshvS---~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 232 MDCKYTVPSHVS---KECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hcccccCchhhh---HHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 554444433333 456678889999999999999999865
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=319.56 Aligned_cols=250 Identities=27% Similarity=0.402 Sum_probs=202.0
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
.+|++.+.||.|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 35888899999999999999875 68899999887555455667889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
++++|.+++.. ..+++..+..++.+++.|++|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 99 AGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred CCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 99999998864 3578999999999999999999999 99999999999999999999999999987654322
Q ss_pred cceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
. ......++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ...... .... . .+.+
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~-----~~~~~~-~~~~-~-----~~~~ 235 (296)
T cd06655 170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-----LRALYL-IATN-G-----TPEL 235 (296)
T ss_pred c--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH-HHhc-C-----Cccc
Confidence 2 12345688899999999988899999999999999999999999965321 111110 0000 0 0011
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
..... ....+.+++.+||..+|++||++.+++++
T Consensus 236 ~~~~~---~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 236 QNPEK---LSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CCccc---CCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 11111 12346678889999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=320.32 Aligned_cols=262 Identities=24% Similarity=0.352 Sum_probs=199.4
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
++|++.+.||+|+||.||+|++. ++..+|+|.+..... ....++.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36889999999999999999876 467788887753221 2234588899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
+++++|.++++.. ..+++..+..++.|+++||+|||+.+ +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 81 MDGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 9999999999753 46788999999999999999999742 8999999999999999999999999998754322
Q ss_pred CcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhc---------
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREK--------- 1156 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 1156 (1237)
. .....++..|+|||++.+..++.++||||||+++|||++|+.||...... ....+........
T Consensus 154 ~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 154 M----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK---ELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred c----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh---hHHHhhcCccccccccCCcccc
Confidence 1 23457889999999998888999999999999999999999998643211 1111000000000
Q ss_pred ---------------ccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1157 ---------------RINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1157 ---------------~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
....+.....+. ........++.+++.+|++.+|++|||+.+++++-
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPK-LPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCcc-CcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000000000000 00001223577889999999999999999999884
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=327.38 Aligned_cols=198 Identities=27% Similarity=0.360 Sum_probs=167.4
Q ss_pred HhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeCC-----
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGE----- 997 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 997 (1237)
..++|++.+.||+|+||.||+|++. .+..||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3468999999999999999999876 58899999986432 223456788999999999999999999886443
Q ss_pred -eEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeec
Q 000889 998 -ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDF 1076 (1237)
Q Consensus 998 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~Df 1076 (1237)
..++||||+++ ++.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecC
Confidence 57999999974 56666532 478888899999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCC
Q 000889 1077 GMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPS 1137 (1237)
Q Consensus 1077 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~ 1137 (1237)
|+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 168 g~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 168 GLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred CCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 999754321 1123457899999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=329.54 Aligned_cols=263 Identities=25% Similarity=0.318 Sum_probs=196.0
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeCC-----eEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGE-----ERL 1000 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 1000 (1237)
+|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999975 68899999886432 123456889999999999999999999998776 789
Q ss_pred EEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccce
Q 000889 1001 LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1080 (1237)
Q Consensus 1001 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~ 1080 (1237)
+||||+. ++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEeeccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEecccccee
Confidence 9999997 6788877542 4689999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCcceeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHH--------
Q 000889 1081 LVNALDTHLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQ-------- 1151 (1237)
Q Consensus 1081 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-------- 1151 (1237)
....... .......+++.|+|||++.+. .++.++||||+||++|||++|+.||....... .+......
T Consensus 152 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~g~~~~~~ 228 (372)
T cd07853 152 VEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ--QLDLITDLLGTPSLEA 228 (372)
T ss_pred ecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHcCCCCHHH
Confidence 6543222 122345678999999998774 47899999999999999999999997543211 00000000
Q ss_pred ----H--hhhcccccccCcc-ccCC-CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1152 ----L--HREKRINEILDPE-LTMQ-TSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1152 ----~--~~~~~~~~~~~~~-l~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
. ...........+. .... ........++.+++.+|++.||++|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 0000000000000 0000 0000112356788889999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=311.93 Aligned_cols=247 Identities=23% Similarity=0.393 Sum_probs=193.2
Q ss_pred eecccCCeEEEEEEEC---CCCEEEEEEeccccC--cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCC
Q 000889 935 MIGSGGFGEVYKAQLR---DGSVVAIKKLIHVTG--QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWG 1009 (1237)
Q Consensus 935 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 1009 (1237)
.||+|+||.||+|.++ ++..+|+|++..... ...+++.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999763 467899998753322 22456889999999999999999999875 56779999999999
Q ss_pred CHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcce
Q 000889 1010 SLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHL 1089 (1237)
Q Consensus 1010 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~ 1089 (1237)
+|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 81 PLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 999998653 3688999999999999999999999 99999999999999999999999999998665433221
Q ss_pred e-eeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcccc
Q 000889 1090 S-VSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELT 1167 (1237)
Q Consensus 1090 ~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1167 (1237)
. .....++..|+|||.+....++.++|||||||++|||++ |+.||..... .. +......... +..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~---~~~~i~~~~~------~~~- 219 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NE---VTQMIESGER------MEC- 219 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HH---HHHHHHCCCC------CCC-
Confidence 1 122234578999999988889999999999999999998 9999864321 11 1111111110 111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 000889 1168 MQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207 (1237)
Q Consensus 1168 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l 1207 (1237)
+.. ...++.+++.+||+.+|++||++.+|++.|++.
T Consensus 220 -~~~---~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 220 -PQR---CPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred -CCC---CCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 111 123566888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=325.27 Aligned_cols=237 Identities=26% Similarity=0.351 Sum_probs=185.3
Q ss_pred ceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHH-HHHhcCCCCcccccceEEeCCeEEEEEEeccC
Q 000889 934 SMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEME-TIGKIKHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
++||+|+||.||+|++. +++.||+|++.... ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999986 57889999886432 122334555554 57889999999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
|+|..++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 150 (321)
T cd05603 81 GELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-- 150 (321)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--
Confidence 9998888643 4678888899999999999999999 99999999999999999999999999987532211
Q ss_pred eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccC
Q 000889 1089 LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTM 1168 (1237)
Q Consensus 1089 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1168 (1237)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ......... ......
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~---------~~~~~~ 215 (321)
T cd05603 151 ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------VSQMYDNIL---------HKPLQL 215 (321)
T ss_pred CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC------HHHHHHHHh---------cCCCCC
Confidence 12234678999999999998889999999999999999999999996432 111111111 111111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 000889 1169 QTSDETELYQYLRISFECLDDRPFKRPTMI 1198 (1237)
Q Consensus 1169 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1198 (1237)
+... ...+.+++.+|++.+|.+||++.
T Consensus 216 ~~~~---~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGK---TVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCC---CHHHHHHHHHHccCCHhhcCCCC
Confidence 1111 23466788899999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=308.90 Aligned_cols=252 Identities=29% Similarity=0.443 Sum_probs=202.2
Q ss_pred ceecccCCeEEEEEEECC----CCEEEEEEeccccCcC-HHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccC
Q 000889 934 SMIGSGGFGEVYKAQLRD----GSVVAIKKLIHVTGQG-DREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
+.||+|+||.||+|.... +..|++|.+....... .+.+.+|++++++++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999999864 7789999887543332 56788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhhcC----CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1009 GSLESVLHDRAKG----GGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1009 gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
++|.+++...... ....+++..++.++.|+++|++|||+. +++||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875211 125789999999999999999999999 999999999999999999999999999987765
Q ss_pred CCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccC
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
...........++..|+|||.+....++.++||||+|+++|||++ |..||.... ............
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~~~~~~~~~~~------- 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS------NEEVLEYLRKGY------- 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC------HHHHHHHHHcCC-------
Confidence 432223344567889999999988889999999999999999999 699987542 111111111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFK 1205 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 1205 (1237)
....+ .....++.+++.+|+..+|++|||+.+++++|+
T Consensus 225 -~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 -RLPKP---EYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -CCCCC---ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00011 111346778888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=313.09 Aligned_cols=256 Identities=25% Similarity=0.456 Sum_probs=201.1
Q ss_pred CCCCCCceecccCCeEEEEEEECC-C---CEEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD-G---SVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 1002 (1237)
++|+..+.||+|+||.||+|+... + ..+|+|++.... ....+.+..|++++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467788999999999999998763 3 268888875432 22345688999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceee
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~ 1082 (1237)
|||+++++|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||++...
T Consensus 85 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 85 TEYMENGALDKYLRDH----DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999998653 24689999999999999999999999 9999999999999999999999999999866
Q ss_pred ccCCcceee-eccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhccccc
Q 000889 1083 NALDTHLSV-STLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINE 1160 (1237)
Q Consensus 1083 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1160 (1237)
......... .....+..|+|||++.+..++.++|||||||++|||++ |+.||..... . .+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~---~~~~~i~~~~~--- 228 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---H---EVMKAINDGFR--- 228 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---H---HHHHHHhcCCC---
Confidence 543222111 11223457999999988889999999999999999997 9999864321 1 11111111100
Q ss_pred ccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 000889 1161 ILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207 (1237)
Q Consensus 1161 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l 1207 (1237)
.+.. ......+.+++.+||+.+|++||++.++++.|+++
T Consensus 229 -----~~~~---~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 -----LPAP---MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----CCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0001 11224567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=310.83 Aligned_cols=250 Identities=27% Similarity=0.415 Sum_probs=202.3
Q ss_pred CCCCCCceecccCCeEEEEEEECC-CCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
++|+..+.||+|+||.||+|+..+ +..+++|.+..... .+++.+|++++++++||||+++++++......+++|||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578889999999999999999875 78899998864322 668999999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
++++|.+++.... ..+++..+..++.|+++|+.|||+. +++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 81 GAGSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred CCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 9999999986532 4689999999999999999999999 99999999999999999999999999998664332
Q ss_pred cceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
. ......++..|+|||++.+..++.++||||||+++|+|++|+.||....... .... ......+..
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~-----~~~~-------~~~~~~~~~ 219 (256)
T cd06612 154 A--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-----AIFM-------IPNKPPPTL 219 (256)
T ss_pred c--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh-----hhhh-------hccCCCCCC
Confidence 1 1234557889999999998899999999999999999999999987432110 0000 000001111
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.. .......+.+++.+|++.+|++|||+.+++++
T Consensus 220 ~~---~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 220 SD---PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred Cc---hhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 11 11122457788899999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=314.65 Aligned_cols=251 Identities=24% Similarity=0.324 Sum_probs=196.7
Q ss_pred CCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC---cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 930 FSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG---QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
|+..+.||+|+||+||+|.+. +++.||+|++..... .....+.+|++++++++|++|+++++++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999886 588999998854321 2234577899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 82 MNGGDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred ccCccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999998886532 23689999999999999999999999 9999999999999999999999999999765432
Q ss_pred CcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcc
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPE 1165 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1165 (1237)
.. .....|+..|+|||++.+..++.++|+||+|+++|||++|+.||...... .....+..... . .....
T Consensus 156 ~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~--~~~~~~~~~~~-~--~~~~~--- 224 (285)
T cd05632 156 ES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK--VKREEVDRRVL-E--TEEVY--- 224 (285)
T ss_pred Cc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhhh-c--ccccc---
Confidence 21 23457899999999999888999999999999999999999999743211 00111111000 0 00001
Q ss_pred ccCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 000889 1166 LTMQTSDETELYQYLRISFECLDDRPFKRPT-----MIQVMAM 1203 (1237)
Q Consensus 1166 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~~ 1203 (1237)
.. .....+.+++.+|++.+|++||+ +.+++++
T Consensus 225 ---~~---~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 225 ---SA---KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ---Cc---cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 11 11224567888999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=317.44 Aligned_cols=252 Identities=23% Similarity=0.371 Sum_probs=198.6
Q ss_pred CCCCCCceecccCCeEEEEEEECC-CCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
+.|++.++||+|+||.||+|++.. +..+++|.+........+.+.+|++++++++||||+++++++..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 568889999999999999999874 7889999886544444567889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
++++|..++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 92 PGGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred CCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 9999998876532 3589999999999999999999999 99999999999999999999999999987543221
Q ss_pred cceeeeccccCCCcCCccccC-----ccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQ-----SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1161 (1237)
.......+++.|+|||++. ...++.++|||||||++|||++|+.||..... ... .......
T Consensus 165 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~-~~~~~~~------ 230 (292)
T cd06644 165 --QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRV-LLKIAKS------ 230 (292)
T ss_pred --cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-----HHH-HHHHhcC------
Confidence 1123456888999999984 34567899999999999999999999864221 111 1111100
Q ss_pred cCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1162 LDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1162 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
..+.... ......++.+++.+||+.+|++||++.+++++
T Consensus 231 ~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 231 EPPTLSQ---PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CCccCCC---CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0111111 11122356788889999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=313.68 Aligned_cols=239 Identities=21% Similarity=0.349 Sum_probs=186.4
Q ss_pred ceecccCCeEEEEEEECC-------------CCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEE
Q 000889 934 SMIGSGGFGEVYKAQLRD-------------GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERL 1000 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 1000 (1237)
+.||+|+||.||+|+... ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998542 2257888765443344456888999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCc-------eEE
Q 000889 1001 LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFE-------ARV 1073 (1237)
Q Consensus 1001 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~-------vkl 1073 (1237)
+||||+++|+|..++... ...+++..+.+++.|+++|++|||+. +|+||||||+||+++.++. +|+
T Consensus 81 lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK----SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEecccCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 999999999999988653 24689999999999999999999999 9999999999999986654 899
Q ss_pred eecccceeeccCCcceeeeccccCCCcCCccccC-ccccCcccchHHHHHHHHHHH-cCCCCCCCCCCCCCchHHHHHHH
Q 000889 1074 SDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQ-SFRCTTKGDVYSYGVILLELL-SGKRPIDPSEFGDDNNLVGWAKQ 1151 (1237)
Q Consensus 1074 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGv~l~el~-tg~~p~~~~~~~~~~~~~~~~~~ 1151 (1237)
+|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ .|..||......+ ...
T Consensus 154 ~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~- 220 (262)
T cd05077 154 SDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE------KER- 220 (262)
T ss_pred CCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH------HHH-
Confidence 999998754321 2345788999999886 466889999999999999998 5888876432111 000
Q ss_pred HhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1152 LHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1152 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
... . ...... +....+.+++.+||+.||++||++.++++++
T Consensus 221 ~~~-~--------~~~~~~---~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 221 FYE-G--------QCMLVT---PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHh-c--------CccCCC---CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000 0 000001 1123567888999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=309.32 Aligned_cols=250 Identities=28% Similarity=0.476 Sum_probs=202.8
Q ss_pred CCCCCCceecccCCeEEEEEEECCCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEecc
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMK 1007 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 1007 (1237)
++|++.+.||+|+||.||+|... ++.||+|++..... ..+++.+|+.++++++|+||+++++++...+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46888899999999999999886 78899999875433 45678999999999999999999999998999999999999
Q ss_pred CCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCc
Q 000889 1008 WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDT 1087 (1237)
Q Consensus 1008 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~ 1087 (1237)
+++|.+++..... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++......
T Consensus 84 ~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 84 KGSLVDYLRSRGR---AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred CCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 9999999976432 3689999999999999999999999 99999999999999999999999999998653211
Q ss_pred ceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccc
Q 000889 1088 HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1088 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
.....+..|+|||++.+..++.++||||+|+++|||++ |+.||..... ... ........ ....
T Consensus 157 ----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~---~~~~~~~~------~~~~ 220 (256)
T cd05039 157 ----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDV---VPHVEKGY------RMEA 220 (256)
T ss_pred ----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHH---HHHHhcCC------CCCC
Confidence 12334668999999988889999999999999999997 9999864321 111 11111110 0000
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l 1207 (1237)
.. .....+.+++.+|+..+|++|||+.+++++|+.+
T Consensus 221 --~~---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 221 --PE---GCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred --cc---CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11 1124567888899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=326.36 Aligned_cols=238 Identities=26% Similarity=0.358 Sum_probs=185.9
Q ss_pred ceecccCCeEEEEEEEC-CCCEEEEEEeccccC---cCHHHHHHHHH-HHHhcCCCCcccccceEEeCCeEEEEEEeccC
Q 000889 934 SMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG---QGDREFMAEME-TIGKIKHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
+.||+|+||.||+|+.. +++.||+|++..... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999876 588999998864321 22234555554 46778999999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 151 (325)
T cd05604 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD- 151 (325)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-
Confidence 9999888653 4688999999999999999999999 999999999999999999999999999875322111
Q ss_pred eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccC
Q 000889 1089 LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTM 1168 (1237)
Q Consensus 1089 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1168 (1237)
......|++.|||||++.+..++.++||||+||++|||++|+.||..... ......... .....
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~~~~---------~~~~~ 215 (325)
T cd05604 152 -TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV------AEMYDNILH---------KPLVL 215 (325)
T ss_pred -CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH------HHHHHHHHc---------CCccC
Confidence 22346799999999999998999999999999999999999999964321 111111111 11111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 000889 1169 QTSDETELYQYLRISFECLDDRPFKRPTMIQ 1199 (1237)
Q Consensus 1169 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 1199 (1237)
... ....+.+++.+|++.+|.+||++.+
T Consensus 216 ~~~---~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 216 RPG---ASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCC---CCHHHHHHHHHHhccCHHhcCCCCC
Confidence 111 1234567888999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=298.15 Aligned_cols=271 Identities=20% Similarity=0.280 Sum_probs=219.2
Q ss_pred HHHHHHHhCCCCCCceecccCCeEEEEEEECC------CCEEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccce
Q 000889 920 FAHLLEATNGFSADSMIGSGGFGEVYKAQLRD------GSVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGY 992 (1237)
Q Consensus 920 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~ 992 (1237)
..++.....+++...++.+|.||+||.|.+.+ .+.|.||.++... .-+...+..|...+..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 34555566778889999999999999997653 3456677665322 2234467889999999999999999998
Q ss_pred EEe-CCeEEEEEEeccCCCHHHHHhhhhc---CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCC
Q 000889 993 CKI-GEERLLVYEYMKWGSLESVLHDRAK---GGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDEN 1068 (1237)
Q Consensus 993 ~~~-~~~~~lv~e~~~~gsL~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~ 1068 (1237)
+.+ .+..+.+|.++..|+|..|++..+. ...+.++..+...++.|++.|++|||+. +|||.||.++|.+||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 865 4567889999999999999984331 2245677888899999999999999999 99999999999999999
Q ss_pred CceEEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHH
Q 000889 1069 FEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVG 1147 (1237)
Q Consensus 1069 ~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~ 1147 (1237)
.+|||+|=.+++..-+.+.+.-......+..||+||.+....|+.++|||||||++|||+| |+.||.. .+...
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae------IDPfE 506 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE------IDPFE 506 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc------cCHHH
Confidence 9999999999999988888877777778889999999999999999999999999999998 8999753 22333
Q ss_pred HHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccc
Q 000889 1148 WAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVD 1210 (1237)
Q Consensus 1148 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~ 1210 (1237)
+......+.++. .+..+++ ++..++.-||+.+|++||++++++..|.++...
T Consensus 507 m~~ylkdGyRla--------QP~NCPD---eLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 507 MEHYLKDGYRLA--------QPFNCPD---ELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred HHHHHhccceec--------CCCCCcH---HHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 444444444433 3334554 456777789999999999999999999987653
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=332.30 Aligned_cols=202 Identities=25% Similarity=0.385 Sum_probs=174.0
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
++|+..+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++.+++||+|+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999886 58899999886422 223456788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 999999999998753 4688999999999999999999999 99999999999999999999999999987543
Q ss_pred cCCcc---------------------------------eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcC
Q 000889 1084 ALDTH---------------------------------LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSG 1130 (1237)
Q Consensus 1084 ~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg 1130 (1237)
..... ......+||+.|+|||++.+..++.++||||+||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence 21100 001235799999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 000889 1131 KRPIDPS 1137 (1237)
Q Consensus 1131 ~~p~~~~ 1137 (1237)
+.||...
T Consensus 233 ~~Pf~~~ 239 (360)
T cd05627 233 YPPFCSE 239 (360)
T ss_pred CCCCCCC
Confidence 9999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=312.54 Aligned_cols=252 Identities=25% Similarity=0.407 Sum_probs=198.7
Q ss_pred CCCCCceecccCCeEEEEEEECCCCEEEEEEeccccCc------CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQ------GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 1002 (1237)
+|+..+.||+|+||+||+|...+++.+|+|.+...... ....+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47888999999999999999888999999987643211 124578899999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceee
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~ 1082 (1237)
|||+++++|.+++... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||++...
T Consensus 81 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999999653 3578899999999999999999999 9999999999999999999999999998755
Q ss_pred ccCCc----ceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccc
Q 000889 1083 NALDT----HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158 (1237)
Q Consensus 1083 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1158 (1237)
..... ........|+..|+|||++.+..++.++||||+|+++|||++|+.||..... ..............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~ 227 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-----LAAMFYIGAHRGLM 227 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh-----HHHHHHhhhccCCC
Confidence 32111 1112335688999999999988899999999999999999999999964321 11111100000111
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1159 NEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1159 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
+..+ . .....+.+++.+|++.+|++||++.+++++
T Consensus 228 -----~~~~--~---~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 228 -----PRLP--D---SFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred -----CCCC--C---CCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1111 1 122356778889999999999999998763
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=297.05 Aligned_cols=249 Identities=23% Similarity=0.323 Sum_probs=198.4
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCc---CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQ---GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 1002 (1237)
-++|...++||+|.||.|-+++-+ .++.+|+|.+++...- ...+-..|-++++..+||.+..+...|+..++.|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 356888899999999999999876 6889999988754322 233456799999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceee
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~ 1082 (1237)
|||+.||.|.-++... ..+++...+.+...|+.||.|||++ +||+||+|.+|.|+|++|++||+|||+++.-
T Consensus 247 MeyanGGeLf~HLsre-----r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRE-----RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEccCceEeeehhhh-----hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999888753 4688888899999999999999999 9999999999999999999999999999743
Q ss_pred ccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccccccc
Q 000889 1083 NALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162 (1237)
Q Consensus 1083 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1162 (1237)
- .......++||||.|.|||++....|+.++|+|.+||+||||++|+.||.... ...+.. -|.
T Consensus 319 I--~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d---h~kLFe------------LIl 381 (516)
T KOG0690|consen 319 I--KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD---HEKLFE------------LIL 381 (516)
T ss_pred c--cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc---hhHHHH------------HHH
Confidence 2 23344578999999999999999999999999999999999999999997432 111111 111
Q ss_pred CccccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 000889 1163 DPELTMQTSDETELYQYLRISFECLDDRPFKRP-----TMIQVMAM 1203 (1237)
Q Consensus 1163 ~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 1203 (1237)
-.++..+..-.++. ..+....+.+||.+|. ++.|+.++
T Consensus 382 ~ed~kFPr~ls~eA---ktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 382 MEDLKFPRTLSPEA---KTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred hhhccCCccCCHHH---HHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 11111121122232 2445578899999996 46666655
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=311.74 Aligned_cols=249 Identities=24% Similarity=0.383 Sum_probs=197.3
Q ss_pred ceecccCCeEEEEEEECC--C--CEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccC
Q 000889 934 SMIGSGGFGEVYKAQLRD--G--SVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
++||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|++++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998753 2 2689998875444 445678899999999999999999999987 889999999999
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
++|.+++..... ..+++..++.++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 999999976532 4689999999999999999999999 9999999999999999999999999999876543322
Q ss_pred ee-eeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccc
Q 000889 1089 LS-VSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1089 ~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
.. .....++..|+|||++.+..++.++|||||||++|||++ |+.||..... .. ......... ...
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~---~~~~~~~~~-------~~~ 220 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG---SQ---ILKKIDKEG-------ERL 220 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HH---HHHHHHhcC-------CcC
Confidence 11 123456789999999998899999999999999999998 9999863221 11 111111100 011
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFK 1205 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 1205 (1237)
.... .....+.+++.+|++.+|++||++.++++.|.
T Consensus 221 ~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPE---ACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCc---cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1111 12245778888999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=312.22 Aligned_cols=255 Identities=24% Similarity=0.450 Sum_probs=199.3
Q ss_pred CCCCCceecccCCeEEEEEEECC-C---CEEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLRD-G---SVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
.|++.+.||+|+||.||+|++.. + ..||+|++.... ....++|..|+.++++++||||+++++++..+...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 47788999999999999998763 3 359999876432 223457899999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+++++|.+++... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++...
T Consensus 85 e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 85 EFMENGALDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred ecCCCCcHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 999999999998753 24688999999999999999999999 99999999999999999999999999987654
Q ss_pred cCCcceeeeccc---cCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccc
Q 000889 1084 ALDTHLSVSTLA---GTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRIN 1159 (1237)
Q Consensus 1084 ~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1159 (1237)
............ .+..|+|||++.+..++.++||||+||++|||++ |..||..... .....+. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i---~~~~--- 228 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAI---EQDY--- 228 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHH---HcCC---
Confidence 322211111111 2357999999998899999999999999999886 9999864321 1111111 1110
Q ss_pred cccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 000889 1160 EILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207 (1237)
Q Consensus 1160 ~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l 1207 (1237)
..+.... ....+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 229 -----~~~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 -----RLPPPMD---CPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -----cCCCccc---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111111 123467888899999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=309.35 Aligned_cols=249 Identities=26% Similarity=0.415 Sum_probs=198.2
Q ss_pred CCCCCCceecccCCeEEEEEEECCCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEE-eCCeEEEEEEec
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCK-IGEERLLVYEYM 1006 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~ 1006 (1237)
.+|++.+.||+|+||.||+|... +..||+|..... ...+.+.+|+.++++++|+|++++++++. .++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 36888899999999999999876 778999987532 33567889999999999999999999764 456789999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
++++|.++++... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||+++......
T Consensus 83 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 83 AKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 9999999987642 23588999999999999999999999 99999999999999999999999999997554322
Q ss_pred cceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPE 1165 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1165 (1237)
....++..|+|||++.+..++.++||||||+++|||++ |+.||.... ............ .+.
T Consensus 157 -----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~~~~~------~~~ 219 (256)
T cd05082 157 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRVEKGY------KMD 219 (256)
T ss_pred -----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHhcCC------CCC
Confidence 22344668999999998889999999999999999997 999986322 111111111110 011
Q ss_pred ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 000889 1166 LTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207 (1237)
Q Consensus 1166 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l 1207 (1237)
. . ......+.+++.+|++.+|++|||+.++++.|+++
T Consensus 220 ~--~---~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 220 A--P---DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred C--C---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1 0 11223567888899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=316.75 Aligned_cols=261 Identities=23% Similarity=0.369 Sum_probs=200.0
Q ss_pred CCCCCceecccCCeEEEEEEEC-----CCCEEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEeC--CeEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-----DGSVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIG--EERL 1000 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 1000 (1237)
.|++.+.||+|+||.||+|++. ++..||+|.+.... ......+.+|++++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 4678899999999999999752 47789999886432 22345788999999999999999999998765 5689
Q ss_pred EEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccce
Q 000889 1001 LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1080 (1237)
Q Consensus 1001 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~ 1080 (1237)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 85 lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 9999999999999986532 3589999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCcce-eeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCC---------CCCchHHHHHH
Q 000889 1081 LVNALDTHL-SVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEF---------GDDNNLVGWAK 1150 (1237)
Q Consensus 1081 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~---------~~~~~~~~~~~ 1150 (1237)
......... ......++..|+|||++.+..++.++||||||+++|||++++.|+..... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 664432221 11234567789999999888899999999999999999998776432110 00001111111
Q ss_pred HHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 000889 1151 QLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207 (1237)
Q Consensus 1151 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l 1207 (1237)
...... ..+... .....+.+++.+|++.+|++|||+.++++.++.+
T Consensus 238 ~~~~~~--------~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGK--------RLPRPP---NCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCc--------cCCCCC---CCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111000 011111 1234677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=317.60 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=199.9
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
++|++.+.||+|+||.||+|++. ++..+|+|.+........+.+.+|++++++++||||+++++++..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 46888899999999999999986 57889999886544444567889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
++++|.+++.... ..+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 85 DGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred CCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 9999999987642 4689999999999999999999999 99999999999999999999999999987543322
Q ss_pred cceeeeccccCCCcCCccccC-----ccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQ-----SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1161 (1237)
. ......+++.|+|||++. ...++.++||||+|+++|||++|+.||..... . .........
T Consensus 158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-----~-~~~~~~~~~------ 223 (280)
T cd06611 158 Q--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-----M-RVLLKILKS------ 223 (280)
T ss_pred c--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-----H-HHHHHHhcC------
Confidence 1 223456889999999974 34567899999999999999999999864321 1 111111110
Q ss_pred cCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1162 LDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1162 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
..+.+..+ ......+.+++.+||+.+|.+||++.+++++
T Consensus 224 ~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 224 EPPTLDQP---SKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCCCcCCc---ccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00111111 1112356678889999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=315.59 Aligned_cols=253 Identities=27% Similarity=0.420 Sum_probs=197.6
Q ss_pred HhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhc-CCCCcccccceEEeC------C
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKI-KHRNLVPLLGYCKIG------E 997 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~ 997 (1237)
+.+.|++.+.||+|+||.||+|+.. +++.||+|++... ......+..|+.+++++ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567888899999999999999876 4778899987543 34456788999999998 699999999998753 4
Q ss_pred eEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecc
Q 000889 998 ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFG 1077 (1237)
Q Consensus 998 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfG 1077 (1237)
..++||||+++++|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence 6799999999999999987632 24688999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcceeeeccccCCCcCCccccC-----ccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHH
Q 000889 1078 MARLVNALDTHLSVSTLAGTPGYVPPEYYQ-----SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQL 1152 (1237)
Q Consensus 1078 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 1152 (1237)
+++....... ......|++.|+|||++. +..++.++||||+||++|||++|+.||..... .......
T Consensus 157 ~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-----~~~~~~~- 228 (272)
T cd06637 157 VSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-----MRALFLI- 228 (272)
T ss_pred Cceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-----HHHHHHH-
Confidence 9986543221 223467899999999986 34578899999999999999999999864221 1111110
Q ss_pred hhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1153 HREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1153 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.... ...... ......+.+++.+||..+|.+|||+.+++++
T Consensus 229 -~~~~-----~~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 229 -PRNP-----APRLKS----KKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred -hcCC-----CCCCCC----CCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 0000 111110 1112356788889999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=311.96 Aligned_cols=260 Identities=25% Similarity=0.409 Sum_probs=204.1
Q ss_pred CCCCCCceecccCCeEEEEEEECC-CC----EEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD-GS----VVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLL 1001 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 1001 (1237)
.+|++.+.||+|+||.||+|.+++ ++ .+|+|....... .....+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 467888999999999999998753 32 588887754332 234568899999999999999999999876 78899
Q ss_pred EEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeeccccee
Q 000889 1002 VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~ 1081 (1237)
||||+++|+|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.
T Consensus 86 v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEecCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 999999999999987542 3589999999999999999999998 999999999999999999999999999987
Q ss_pred eccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhccccc
Q 000889 1082 VNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINE 1160 (1237)
Q Consensus 1082 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1160 (1237)
..............++..|+|||.+....++.++||||||+++||+++ |+.||..... ..+.........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~~~--- 229 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA------VEIPDLLEKGER--- 229 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHHhCCCC---
Confidence 654333222222334568999999988889999999999999999998 9999864321 111111111110
Q ss_pred ccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccccC
Q 000889 1161 ILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTE 1212 (1237)
Q Consensus 1161 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~~~ 1212 (1237)
...+.. ....+.+++.+||..+|.+||++.++++.|.++..++.
T Consensus 230 -----~~~~~~---~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05057 230 -----LPQPPI---CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ 273 (279)
T ss_pred -----CCCCCC---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence 011111 11356678889999999999999999999999877554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=313.96 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=197.9
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
++|++.+.||+|+||.||+|+.. +++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 35777788999999999999876 57889999886544444456788999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
++++|.+++... ..+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 89 GGGSLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 999999998653 4688999999999999999999999 99999999999999999999999999997654321
Q ss_pred cceeeeccccCCCcCCccccC---ccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccC
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQ---SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
.......|+..|+|||++. ...++.++||||+||++|||++|+.||....... .... .. .... ..
T Consensus 161 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~~~~----~~-~~~~---~~ 228 (267)
T cd06645 161 --AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--ALFL----MT-KSNF---QP 228 (267)
T ss_pred --cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--hHHh----hh-ccCC---CC
Confidence 1223457899999999974 4458889999999999999999999985432110 0000 00 0000 00
Q ss_pred ccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
+...... .....+.+++.+|++.+|++||++.+++++
T Consensus 229 ~~~~~~~---~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 229 PKLKDKM---KWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CcccccC---CCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 1110000 112346678889999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=310.62 Aligned_cols=256 Identities=26% Similarity=0.451 Sum_probs=200.8
Q ss_pred CCCCCCceecccCCeEEEEEEEC-C---CCEEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-D---GSVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 1002 (1237)
++|++.+.||+|+||.||+|++. + +..+|+|.+.... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888899999999999999874 2 3378998875422 22345788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceee
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~ 1082 (1237)
|||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||++...
T Consensus 84 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 84 TEYMENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 99999999999997532 4679999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCccee-eeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhccccc
Q 000889 1083 NALDTHLS-VSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINE 1160 (1237)
Q Consensus 1083 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1160 (1237)
........ .....++..|+|||++.+..++.++||||||+++||+++ |+.||..... .... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~---~~~~---~~~~~~~~--- 227 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN---QDVI---KAIEEGYR--- 227 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH---HHHH---HHHhCCCc---
Confidence 54332211 112223568999999998889999999999999999886 9999864321 1111 11111100
Q ss_pred ccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 000889 1161 ILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207 (1237)
Q Consensus 1161 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l 1207 (1237)
.+.... ....+.+++.+|++.+|++||++.++++.|+++
T Consensus 228 -----~~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 -----LPAPMD---CPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -----CCCCCC---CCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 111111 123567888899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=310.30 Aligned_cols=254 Identities=25% Similarity=0.447 Sum_probs=201.6
Q ss_pred hCCCCCCceecccCCeEEEEEEECCCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
.++|++.+.||+|+||.||+|.+.++..+|+|.+... ....+.+.+|++++++++|+||+++++++.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 3578889999999999999999887888999987542 2334678899999999999999999999877 7789999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
++++|.+++.... ....++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+.......
T Consensus 83 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 83 AKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCcHHHHHHhCC---ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 9999999997642 24678889999999999999999999 99999999999999999999999999997654322
Q ss_pred cceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPE 1165 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1165 (1237)
.. ......++..|+|||++.+..++.++|+|||||++|++++ |+.||..... ..... .......
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~---~~~~~~~-------- 221 (260)
T cd05073 157 YT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIR---ALERGYR-------- 221 (260)
T ss_pred cc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHHH---HHhCCCC--------
Confidence 11 1123345678999999998889999999999999999998 8999864321 11111 1111100
Q ss_pred ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 000889 1166 LTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206 (1237)
Q Consensus 1166 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 1206 (1237)
.... ......+.+++.+|++++|++||++.++.+.|+.
T Consensus 222 ~~~~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 MPRP---ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCc---ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0001 1122457788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=307.67 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=200.4
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccc-cCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHV-TGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
+|++.+.||+|+||.||++++. ++..+|+|.+... .....+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999986 5888999987532 2233456788999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
++|+|.+++.... +..+++..+..++.|++.|+.|||+. +|+|+||||+||++++++.++++|||.++......
T Consensus 81 ~~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 81 DGGDLMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred CCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 9999999886532 24678899999999999999999999 99999999999999999999999999998664322
Q ss_pred cceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
. ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||..... ......... .... ..
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~-----~~ 220 (255)
T cd08219 155 A--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKVCQ-GSYK-----PL 220 (255)
T ss_pred c--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHHhc-CCCC-----CC
Confidence 2 12345688899999999988899999999999999999999999974321 111111111 1100 01
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
+ ......+.+++.+||+.+|++|||+.+++..
T Consensus 221 --~---~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 --P---SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --C---cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0 1112356788889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=307.31 Aligned_cols=248 Identities=24% Similarity=0.369 Sum_probs=192.6
Q ss_pred eecccCCeEEEEEEEC---CCCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCCC
Q 000889 935 MIGSGGFGEVYKAQLR---DGSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGS 1010 (1237)
Q Consensus 935 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 1010 (1237)
.||+|+||.||+|.+. .+..||+|.+..... ...+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999765 345689998764332 22356889999999999999999999885 457899999999999
Q ss_pred HHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCccee
Q 000889 1011 LESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLS 1090 (1237)
Q Consensus 1011 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~ 1090 (1237)
|.+++.... ..+++..+.+++.|++.|++|||++ +++||||||+||+++.++.+||+|||+++..........
T Consensus 81 L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 81 LNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 999987532 4689999999999999999999999 999999999999999999999999999986543332211
Q ss_pred -eeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccC
Q 000889 1091 -VSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTM 1168 (1237)
Q Consensus 1091 -~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1168 (1237)
.....++..|+|||++.+..++.++||||||+++||+++ |..||..... ..+......... .. .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~~~------~~--~ 219 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG------PEVMSFIEQGKR------LD--C 219 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH------HHHHHHHHCCCC------CC--C
Confidence 112233578999999988889999999999999999996 9999864321 111111111111 01 1
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 000889 1169 QTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207 (1237)
Q Consensus 1169 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l 1207 (1237)
+.. ...++.+++.+||..+|++||++.++.+.|+.+
T Consensus 220 ~~~---~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAE---CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 111 223566788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=323.77 Aligned_cols=255 Identities=23% Similarity=0.301 Sum_probs=195.0
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
++|++.+.||+|+||+||+++.. +++.||+|.+.... ......+.+|..+++.++|++|+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999987 57789999886421 122345778999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||++||+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 Ey~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred eCCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999997632 3688899999999999999999999 99999999999999999999999999998664
Q ss_pred cCCcceeeeccccCCCcCCccccCc-----cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccc
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQS-----FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1158 (1237)
.... .......|++.|||||++.+ ..++.++||||+||++|||++|+.||..... ...+.........
T Consensus 154 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~~~~~~i~~~~~~- 226 (331)
T cd05624 154 QDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHEER- 226 (331)
T ss_pred CCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-----HHHHHHHHcCCCc-
Confidence 3322 12234579999999999875 4678899999999999999999999964321 1111111111110
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 000889 1159 NEILDPELTMQTSDETELYQYLRISFECLDDRPFK--RPTMIQVMAM 1203 (1237)
Q Consensus 1159 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ell~~ 1203 (1237)
...+.........+.+++.+|+..++.+ |+++.+++++
T Consensus 227 -------~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 227 -------FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -------ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 1111111111234566777888765543 5688888876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=322.08 Aligned_cols=262 Identities=26% Similarity=0.328 Sum_probs=195.0
Q ss_pred HHhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC--cCHHHHHHHHHHHHhcCCCCcccccceEEeC-----
Q 000889 925 EATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG--QGDREFMAEMETIGKIKHRNLVPLLGYCKIG----- 996 (1237)
Q Consensus 925 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 996 (1237)
+..++|++.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 45678999999999999999999875 578899998864221 2234577899999999999999999987543
Q ss_pred -CeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEee
Q 000889 997 -EERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSD 1075 (1237)
Q Consensus 997 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~D 1075 (1237)
...+++||++ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcC
Confidence 3568999988 6899887753 3689999999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCcceeeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhh
Q 000889 1076 FGMARLVNALDTHLSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR 1154 (1237)
Q Consensus 1076 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1154 (1237)
||+++..... .....|++.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+..+......
T Consensus 162 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~ 234 (343)
T cd07878 162 FGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI--DQLKRIMEVVGT 234 (343)
T ss_pred CccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCC
Confidence 9999865432 234568999999999876 56889999999999999999999999653211 011111100000
Q ss_pred h--ccccccc-------CccccC-CCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1155 E--KRINEIL-------DPELTM-QTSD-----ETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1155 ~--~~~~~~~-------~~~l~~-~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
. .....+. ...+.. .... ......+.+++.+|++.||++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000000 000000 0000 0011245688899999999999999999987
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=317.93 Aligned_cols=199 Identities=24% Similarity=0.365 Sum_probs=162.1
Q ss_pred CceecccCCeEEEEEEEC---CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEe--CCeEEEEEEecc
Q 000889 933 DSMIGSGGFGEVYKAQLR---DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI--GEERLLVYEYMK 1007 (1237)
Q Consensus 933 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 1007 (1237)
.++||+|+||+||+|+.. ++..||+|++... .....+.+|++++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 357999999999999875 4578999988542 223457889999999999999999998854 456789999986
Q ss_pred CCCHHHHHhhhhc----CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee----CCCCceEEeecccc
Q 000889 1008 WGSLESVLHDRAK----GGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLL----DENFEARVSDFGMA 1079 (1237)
Q Consensus 1008 ~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll----~~~~~vkl~DfGla 1079 (1237)
++|.+++..... .....+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+|
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 688888764321 1123588999999999999999999999 99999999999999 46689999999999
Q ss_pred eeeccCCc-ceeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCC
Q 000889 1080 RLVNALDT-HLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPS 1137 (1237)
Q Consensus 1080 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~ 1137 (1237)
+....... ........||+.|+|||++.+. .++.++||||+||++|||++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 87643221 1122346789999999998764 5889999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=290.62 Aligned_cols=271 Identities=23% Similarity=0.391 Sum_probs=208.2
Q ss_pred CCceecccCCeEEEEEEEC-CCCEEEEEEeccccC-cCHHHHHHHHHHHHhcC-CCCcccccceEEeCCeEEEEEEeccC
Q 000889 932 ADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG-QGDREFMAEMETIGKIK-HRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 932 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
....||.|+.|.||+++++ .|...|||.+.+... +..+++...++++...+ +|.||+.+|||..+...++.||.|.
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs- 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS- 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence 3456999999999999987 478899999975432 33456777788777665 8999999999999999999999985
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
.-.+.+++... +++++..+-++...+++||.||.+++ +|+|||+||+|||+|+.|++|+||||.+.++-....
T Consensus 175 ~C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA- 247 (391)
T KOG0983|consen 175 TCAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA- 247 (391)
T ss_pred HHHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc-
Confidence 34555555432 47899989999999999999999997 999999999999999999999999999987654333
Q ss_pred eeeeccccCCCcCCccccCc---cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcc
Q 000889 1089 LSVSTLAGTPGYVPPEYYQS---FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPE 1165 (1237)
Q Consensus 1089 ~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1165 (1237)
.+..+|.+.|||||.+.- ..|+-.+||||||+.++|+.||+.||..-. .++......+..+ .|.
T Consensus 248 --htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~----tdFe~ltkvln~e-------PP~ 314 (391)
T KOG0983|consen 248 --HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK----TDFEVLTKVLNEE-------PPL 314 (391)
T ss_pred --cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC----ccHHHHHHHHhcC-------CCC
Confidence 255689999999999863 468889999999999999999999997522 1222222222211 122
Q ss_pred ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccccCCCCCCccCchhhHHHH
Q 000889 1166 LTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGDSLDSFSLKDTVIEE 1228 (1237)
Q Consensus 1166 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~~~~~~~~~~~~~~~~~~~ 1228 (1237)
++...... ..|.+++..|+++|+.+||...+++++ .+...+|..+.+.-+|..|++..
T Consensus 315 L~~~~gFS---p~F~~fv~~CL~kd~r~RP~Y~~Ll~h--~Fi~~ye~a~~dVa~WF~dV~~~ 372 (391)
T KOG0983|consen 315 LPGHMGFS---PDFQSFVKDCLTKDHRKRPKYNKLLEH--PFIKRYETAEVDVASWFKDVMAK 372 (391)
T ss_pred CCcccCcC---HHHHHHHHHHhhcCcccCcchHHHhcC--cceeecchhhccHHHHHHHHHhc
Confidence 32222222 356667779999999999999999886 45556666777777888877653
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=307.40 Aligned_cols=249 Identities=30% Similarity=0.476 Sum_probs=195.0
Q ss_pred ceecccCCeEEEEEEECC----CCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccC
Q 000889 934 SMIGSGGFGEVYKAQLRD----GSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
++||+|+||.||+|++.. +..+|+|.+..... ...+++.+|+++++++.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997642 26899998864332 23457889999999999999999999875 5578999999999
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
|+|.+++... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 80 GPLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 9999999764 3688999999999999999999999 9999999999999999999999999999866543322
Q ss_pred ee-eeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccc
Q 000889 1089 LS-VSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1089 ~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
.. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ......+.. .....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~---~~~~~~~~~---~~~~~-------- 217 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK---GAEVIAMLE---SGERL-------- 217 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC---HHHHHHHHH---cCCcC--------
Confidence 11 111223467999999998889999999999999999998 999986432 111211111 11110
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~ 1208 (1237)
..+.. ....+.+++.+|+..+|++||++.++++.|+.+.
T Consensus 218 ~~~~~---~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 PRPEE---CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCC---CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 01111 1235678899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=306.24 Aligned_cols=247 Identities=27% Similarity=0.404 Sum_probs=195.0
Q ss_pred ceecccCCeEEEEEEECCCCEEEEEEeccccCc-CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCCCHH
Q 000889 934 SMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQ-GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLE 1012 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 1012 (1237)
++||+|+||.||+|...++..+|+|++...... ....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 368999999999999888889999987643322 2346889999999999999999999999999999999999999999
Q ss_pred HHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcceeee
Q 000889 1013 SVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVS 1092 (1237)
Q Consensus 1013 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~~~ 1092 (1237)
+++.... ..+++..+..++.|++.|+.|+|+. +++||||||+||+++.++.+|++|||++......... ...
T Consensus 81 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~ 152 (250)
T cd05085 81 SFLRKKK----DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSG 152 (250)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccc-cCC
Confidence 9986532 3578999999999999999999999 9999999999999999999999999999754322111 111
Q ss_pred ccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCC
Q 000889 1093 TLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTS 1171 (1237)
Q Consensus 1093 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 1171 (1237)
...++..|+|||++.+..++.++||||||+++||+++ |..||..... ........... .... ..
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~------~~~~~~~~~~~------~~~~--~~- 217 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN------QQAREQVEKGY------RMSC--PQ- 217 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHHHcCC------CCCC--CC-
Confidence 2234567999999998889999999999999999998 9999864321 11111111110 0011 11
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 000889 1172 DETELYQYLRISFECLDDRPFKRPTMIQVMAMFK 1205 (1237)
Q Consensus 1172 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 1205 (1237)
.....+.+++.+|++.+|++||++.++++.|.
T Consensus 218 --~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 --KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred --CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 12246778889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=316.49 Aligned_cols=263 Identities=24% Similarity=0.321 Sum_probs=192.7
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC--cCHHHHHHHHHHHHhc---CCCCcccccceEEe-----CC
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG--QGDREFMAEMETIGKI---KHRNLVPLLGYCKI-----GE 997 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 997 (1237)
+|++.+.||+|+||+||+|++. +++.||+|.+..... .....+.+|+++++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4888899999999999999887 578899998864322 2234566777777665 69999999998764 34
Q ss_pred eEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecc
Q 000889 998 ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFG 1077 (1237)
Q Consensus 998 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfG 1077 (1237)
..++||||++ ++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccC
Confidence 5799999998 58988887542 23589999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhh--h
Q 000889 1078 MARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR--E 1155 (1237)
Q Consensus 1078 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~ 1155 (1237)
+++...... ......|+..|+|||++.+..++.++||||+||++|||++|++||..... ...+......... .
T Consensus 154 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~ 228 (288)
T cd07863 154 LARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE--ADQLGKIFDLIGLPPE 228 (288)
T ss_pred ccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH--HHHHHHHHHHhCCCCh
Confidence 998654322 12345678999999999988899999999999999999999999864321 1111111111000 0
Q ss_pred ccccc-------ccCccccCC--CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1156 KRINE-------ILDPELTMQ--TSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1156 ~~~~~-------~~~~~l~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
..... ...+..... ...+.....+.+++.+|+++||++|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 000000000 0001122356788899999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=309.18 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=203.3
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
++|++.+.||+|+||.||+|... +++.+++|.+........+.+.+|++++++++||||+++++++..+...+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888999999999999999886 47789999887555455678899999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
++++|.+++.... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||.+.......
T Consensus 83 ~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 83 GGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 9999999987642 3688999999999999999999999 99999999999999999999999999997654322
Q ss_pred cceeeeccccCCCcCCccccCcc---ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccC
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSF---RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
. ......++..|+|||.+.+. .++.++||||+|+++|||++|+.||..... ...... ...... ..
T Consensus 156 ~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~-----~~~~~~--~~~~~~---~~ 223 (262)
T cd06613 156 A--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP-----MRALFL--ISKSNF---PP 223 (262)
T ss_pred h--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH--HHhccC---CC
Confidence 1 12345688899999999876 788999999999999999999999864321 001000 000000 00
Q ss_pred ccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
... .........+.+++.+||..+|.+|||+.+++++
T Consensus 224 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 224 PKL---KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ccc---cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 011 0112233567889999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=326.90 Aligned_cols=262 Identities=23% Similarity=0.283 Sum_probs=195.8
Q ss_pred HhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC--cCHHHHHHHHHHHHhcCCCCcccccceEEeC------
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG--QGDREFMAEMETIGKIKHRNLVPLLGYCKIG------ 996 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 996 (1237)
..++|++.+.||+|+||.||+|.+. .++.||+|++..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4568999999999999999999876 578899998864322 2235677899999999999999999988643
Q ss_pred CeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeec
Q 000889 997 EERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDF 1076 (1237)
Q Consensus 997 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~Df 1076 (1237)
...++||||+++ ++.+++.. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence 357999999974 67666642 478888999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHh---
Q 000889 1077 GMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLH--- 1153 (1237)
Q Consensus 1077 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--- 1153 (1237)
|+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+........
T Consensus 164 g~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~ 238 (355)
T cd07874 164 GLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGTPC 238 (355)
T ss_pred cccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCC
Confidence 999865322 12234578999999999999899999999999999999999999997543111 0100000000
Q ss_pred ----------------hhccccccc------CccccCCC-CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1154 ----------------REKRINEIL------DPELTMQT-SDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1154 ----------------~~~~~~~~~------~~~l~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
......... +....... ........+.+++.+|++.||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 00000000 001112456788999999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=322.36 Aligned_cols=255 Identities=22% Similarity=0.274 Sum_probs=193.6
Q ss_pred CCCCCCceecccCCeEEEEEEECC-CCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
++|++.++||+|+||+||+++.+. ++.+|+|.+.... ......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 368889999999999999999874 6789999885321 222345788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+++|+|.+++.... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 ey~~~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred eccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 9999999999997532 3688899999999999999999999 99999999999999999999999999997653
Q ss_pred cCCcceeeeccccCCCcCCccccC-----ccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccc
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQ-----SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1158 (1237)
.... .......||+.|||||++. ...++.++|||||||++|||++|+.||..... ............
T Consensus 154 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~- 225 (332)
T cd05623 154 EDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKE- 225 (332)
T ss_pred cCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCCc-
Confidence 3222 1223457999999999986 34678899999999999999999999974321 111111111100
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHHhcccc--CCCCCCCHHHHHHH
Q 000889 1159 NEILDPELTMQTSDETELYQYLRISFECLDD--RPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1159 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~--dP~~RPt~~ell~~ 1203 (1237)
.... +.........+.+++.+|+.. ++..|+++.+++++
T Consensus 226 ----~~~~--p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 226 ----RFQF--PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ----cccC--CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0001 111111123455666677754 44447899999888
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=309.03 Aligned_cols=252 Identities=28% Similarity=0.470 Sum_probs=193.7
Q ss_pred ceecccCCeEEEEEEECC-CC--EEEEEEecccc-CcCHHHHHHHHHHHHhc-CCCCcccccceEEeCCeEEEEEEeccC
Q 000889 934 SMIGSGGFGEVYKAQLRD-GS--VVAIKKLIHVT-GQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
++||+|+||.||+|++++ +. .+++|.+.... ....+.+.+|+++++++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999864 33 46777775322 23345788999999999 799999999999999999999999999
Q ss_pred CCHHHHHhhhhc-----------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecc
Q 000889 1009 GSLESVLHDRAK-----------GGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFG 1077 (1237)
Q Consensus 1009 gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfG 1077 (1237)
|+|.+++..... .....+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999976431 1123578999999999999999999998 99999999999999999999999999
Q ss_pred cceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhc
Q 000889 1078 MARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREK 1156 (1237)
Q Consensus 1078 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1156 (1237)
++..... .........+..|+|||++.+..++.++||||||+++|||++ |..||..... ...........
T Consensus 158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~------~~~~~~~~~~~ 228 (270)
T cd05047 158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEKLPQGY 228 (270)
T ss_pred Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH------HHHHHHHhCCC
Confidence 9863221 111112234567999999988889999999999999999997 9999864321 11111111110
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 000889 1157 RINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208 (1237)
Q Consensus 1157 ~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~ 1208 (1237)
. ... ... ....+.+++.+|++.+|.+|||+.++++.|+++.
T Consensus 229 ~------~~~--~~~---~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 R------LEK--PLN---CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred C------CCC--CCc---CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0 011 111 1235678889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=305.50 Aligned_cols=251 Identities=27% Similarity=0.466 Sum_probs=200.3
Q ss_pred CCCCCCceecccCCeEEEEEEECCCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEecc
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMK 1007 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 1007 (1237)
.+|++.+.||+|+||.||+|.+.++..+|+|++... .....++.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 357778899999999999999887889999987542 3345678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCc
Q 000889 1008 WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDT 1087 (1237)
Q Consensus 1008 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~ 1087 (1237)
+++|.+++.... ..+++..+..++.+++.|++|||+. +++||||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 83 HGCLSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 999999987532 3578999999999999999999999 999999999999999999999999999976533211
Q ss_pred ceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccc
Q 000889 1088 HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1088 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
. ......++.+|+|||++.+..++.++||||+|+++|||++ |+.||..... .......... .....+..
T Consensus 156 ~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~---~~~~~~~~ 225 (256)
T cd05112 156 T-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN------SEVVETINAG---FRLYKPRL 225 (256)
T ss_pred c-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH------HHHHHHHhCC---CCCCCCCC
Confidence 1 1122335678999999998889999999999999999998 9999864321 1111111111 01111111
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
....+.+++.+||+.+|++|||+.+++++|
T Consensus 226 --------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 --------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred --------CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 124577889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=307.85 Aligned_cols=251 Identities=22% Similarity=0.367 Sum_probs=202.3
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccc--cCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHV--TGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
+|+..+.||+|+||.||.++.. +++.+++|++... .....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4888999999999999999875 5888999987543 233456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
+++++|.+++.... ...+++..+..++.|+++|++|||+. +++||||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 99999999987642 24689999999999999999999999 9999999999999999999999999999866443
Q ss_pred CcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcc
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPE 1165 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1165 (1237)
.. ......+++.|+|||++.+..++.++||||+|+++|||++|+.||..... .......... ....
T Consensus 155 ~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~~-~~~~----- 220 (256)
T cd08221 155 YS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKIVQG-NYTP----- 220 (256)
T ss_pred cc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcC-CCCC-----
Confidence 32 22345689999999999888889999999999999999999999864321 1111111111 0000
Q ss_pred ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1166 LTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1166 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
. ......++.+++.+|++.+|.+||++.+++++.
T Consensus 221 --~---~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 --V---VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred --C---ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 0 011223567888899999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=342.40 Aligned_cols=257 Identities=23% Similarity=0.369 Sum_probs=196.4
Q ss_pred HhCCCCCCceecccCCeEEEEEEECC-CCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEe--CCeEE
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKI--GEERL 1000 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 1000 (1237)
..++|++.+.||+|+||+||+|++.. +..||+|.+.... ......+..|+.++++++|||||+++++|.. ....|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 34579999999999999999999874 6678888775322 2234568899999999999999999998854 35689
Q ss_pred EEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCC----CCeeecCCCCCCeeeCC---------
Q 000889 1001 LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCI----PHIIHRDMKSSNVLLDE--------- 1067 (1237)
Q Consensus 1001 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~----~~ivHrDikp~NIll~~--------- 1067 (1237)
+||||+++|+|.+++...... ...+++..++.|+.||+.||+|||+... .+||||||||+|||++.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 999999999999999764321 2468999999999999999999998521 25999999999999964
Q ss_pred --------CCceEEeecccceeeccCCcceeeeccccCCCcCCccccCc--cccCcccchHHHHHHHHHHHcCCCCCCCC
Q 000889 1068 --------NFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQS--FRCTTKGDVYSYGVILLELLSGKRPIDPS 1137 (1237)
Q Consensus 1068 --------~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~tg~~p~~~~ 1137 (1237)
.+.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 3458999999998654322 1234578999999999854 45889999999999999999999999642
Q ss_pred CCCCCchHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1138 EFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
. ....+....... +.++... ....+.+++.+||+.+|.+||++.+++++
T Consensus 247 ~-----~~~qli~~lk~~--------p~lpi~~----~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 247 N-----NFSQLISELKRG--------PDLPIKG----KSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred C-----cHHHHHHHHhcC--------CCCCcCC----CCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 2 122222221111 1111111 12356788889999999999999999954
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=318.90 Aligned_cols=263 Identities=23% Similarity=0.334 Sum_probs=196.9
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
++|++.+.||+|+||.||+|+++ +++.||+|.+.... ......+.+|++++++++||||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888999999999999999886 57889999886432 23345678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
++ ++|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 86 ~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 86 LD-KDLKQYLDDC----GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred cc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 97 6898888654 23578899999999999999999999 9999999999999999999999999999754322
Q ss_pred CcceeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhh---hcccccc
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR---EKRINEI 1161 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 1161 (1237)
.. ......+++.|+|||++.+. .++.++||||+||++|||++|+.||...... ........... ......+
T Consensus 158 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 158 TK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE---EQLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred CC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCChhhchhh
Confidence 21 12234578899999998653 5788999999999999999999999754221 11100000000 0000000
Q ss_pred cC---------ccccCCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1162 LD---------PELTMQT---SDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1162 ~~---------~~l~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.. +...... ........+.+++.+|++.||.+|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 0000000 000112346688899999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=307.18 Aligned_cols=248 Identities=27% Similarity=0.429 Sum_probs=196.2
Q ss_pred ceecccCCeEEEEEEECCCCEEEEEEeccccCc-CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCCCHH
Q 000889 934 SMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQ-GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLE 1012 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 1012 (1237)
++||+|+||.||+|.+.+++.||+|++...... ....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 368999999999999877899999988654332 3457889999999999999999999999999999999999999999
Q ss_pred HHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcceeee
Q 000889 1013 SVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVS 1092 (1237)
Q Consensus 1013 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~~~ 1092 (1237)
+++.... ..+++..+..++.+++.|++|||++ +++||||||+||+++.++.+||+|||.++............
T Consensus 81 ~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 81 TFLRKKK----NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 9986532 3578889999999999999999999 99999999999999999999999999997654221111111
Q ss_pred ccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCC
Q 000889 1093 TLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTS 1171 (1237)
Q Consensus 1093 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 1171 (1237)
...++..|+|||.+.+..++.++||||+|+++|||++ |..||..... .... ....... ....+
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~---~~~~---~~~~~~~--------~~~~~-- 217 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN---QQTR---ERIESGY--------RMPAP-- 217 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH---HHHH---HHHhcCC--------CCCCC--
Confidence 2234567999999988889999999999999999999 8888864321 1111 1111000 01111
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 000889 1172 DETELYQYLRISFECLDDRPFKRPTMIQVMAMFK 1205 (1237)
Q Consensus 1172 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 1205 (1237)
......+.+++.+|+..+|.+|||+.++++.|+
T Consensus 218 -~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 -QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 112236778889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=310.22 Aligned_cols=255 Identities=23% Similarity=0.349 Sum_probs=197.8
Q ss_pred HHhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 925 EATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 925 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
.+++.+.....||+|+||.||+|++. ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++||
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 34556666778999999999999876 56789999876544445567899999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCcc--CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCC-CCceEEeecccce
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKL--DWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE-NFEARVSDFGMAR 1080 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~-~~~vkl~DfGla~ 1080 (1237)
||+++++|.+++.... ..+ ++..+..++.|++.|++|||+. +|+||||||+||+++. ++.+||+|||.+.
T Consensus 85 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 85 EQVPGGSLSALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred ecCCCCCHHHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 9999999999997542 234 7788889999999999999999 9999999999999986 6799999999997
Q ss_pred eeccCCcceeeeccccCCCcCCccccCccc--cCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccc
Q 000889 1081 LVNALDTHLSVSTLAGTPGYVPPEYYQSFR--CTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158 (1237)
Q Consensus 1081 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1158 (1237)
....... ......+++.|+|||++.+.. ++.++||||+|+++|+|++|+.||...... ....+......
T Consensus 158 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~---~~~~~~~~~~~---- 228 (268)
T cd06624 158 RLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP---QAAMFKVGMFK---- 228 (268)
T ss_pred ecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh---hhhHhhhhhhc----
Confidence 6543222 122345789999999986543 788999999999999999999998642210 11111110000
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1159 NEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1159 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
..+..+ .....++.+++.+||+.+|.+|||+.+++++
T Consensus 229 ---~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 ---IHPEIP-----ESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ---cCCCCC-----cccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 011111 1122356788889999999999999999865
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=312.81 Aligned_cols=263 Identities=23% Similarity=0.289 Sum_probs=196.5
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
+|++.+.||+|+||.||+|+.+ ++..||+|++.... ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999986 58899999886432 22245678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
++ ++|.+++..... +..+++..++.++.|+++||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 81 LS-MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred CC-CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 97 689888865432 35689999999999999999999999 9999999999999999999999999999765432
Q ss_pred CcceeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHh-----------
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLH----------- 1153 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~----------- 1153 (1237)
.. ......+++.|+|||++.+. .++.++||||+|+++|||++|+.||...... ...........
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 155 VR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI--DQLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred cc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhcch
Confidence 11 12334578899999988654 5788999999999999999999999743210 00000000000
Q ss_pred ----hhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1154 ----REKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1154 ----~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
................ ......++.+++.+|+..||++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSA--VKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhHHHHhhccccCcchhHHh--cCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000000000000 00012355688889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=324.83 Aligned_cols=262 Identities=23% Similarity=0.273 Sum_probs=195.6
Q ss_pred HhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeC------
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIG------ 996 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 996 (1237)
..++|++.+.||+|+||.||+|++. .++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3568999999999999999999876 57889999886432 22345678899999999999999999987543
Q ss_pred CeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeec
Q 000889 997 EERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDF 1076 (1237)
Q Consensus 997 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~Df 1076 (1237)
...++||||++ +++.+++.. .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeC
Confidence 35799999997 577777642 478888999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHh---
Q 000889 1077 GMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLH--- 1153 (1237)
Q Consensus 1077 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--- 1153 (1237)
|+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+........
T Consensus 171 G~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~ 245 (364)
T cd07875 171 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID--QWNKVIEQLGTPC 245 (364)
T ss_pred CCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCC
Confidence 9997653321 2234578999999999999999999999999999999999999997532110 0000000000
Q ss_pred ----------------hhcccccc----cCccccCCCC---CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1154 ----------------REKRINEI----LDPELTMQTS---DETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1154 ----------------~~~~~~~~----~~~~l~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
........ ..+....+.. .......+.+++.+|++.||.+|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 0000000000 00112356788999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=309.50 Aligned_cols=250 Identities=26% Similarity=0.429 Sum_probs=197.9
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcC---------HHHHHHHHHHHHhcCCCCcccccceEEeCCe
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQG---------DREFMAEMETIGKIKHRNLVPLLGYCKIGEE 998 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 998 (1237)
+|.+.+.||+|+||.||+|... ++..+|+|.+....... .+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778889999999999999875 57889999886432221 1457789999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeeccc
Q 000889 999 RLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1078 (1237)
Q Consensus 999 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGl 1078 (1237)
.++||||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~ 152 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGI 152 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCC
Confidence 99999999999999999753 3578888999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCc----ceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhh
Q 000889 1079 ARLVNALDT----HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR 1154 (1237)
Q Consensus 1079 a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1154 (1237)
++....... ........|+..|+|||.+.+..++.++||||+|+++|+|++|+.||.... .......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~---- 223 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT-----QLQAIFK---- 223 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc-----HHHHHHH----
Confidence 986652111 111123457889999999998889999999999999999999999997421 1111100
Q ss_pred hcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1155 EKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1155 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
......+..+ ......+.+++.+||+.+|++||++.+++++
T Consensus 224 ---~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 224 ---IGENASPEIP-----SNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ---HhccCCCcCC-----cccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0001111111 1122356678889999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=314.72 Aligned_cols=262 Identities=25% Similarity=0.372 Sum_probs=200.7
Q ss_pred HHHHHHhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhc-CCCCcccccceEE----
Q 000889 921 AHLLEATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKI-KHRNLVPLLGYCK---- 994 (1237)
Q Consensus 921 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~---- 994 (1237)
..+..+.++|++.+.||+|+||.||+|+.. +++.+|+|+.... .....++.+|+.+++++ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 344456778999999999999999999886 4778999977542 22345678899999999 6999999999874
Q ss_pred -eCCeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEE
Q 000889 995 -IGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARV 1073 (1237)
Q Consensus 995 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl 1073 (1237)
.++..++||||+++++|.+++..... ....+++..+..++.|+++|+.|||+. +++||||||+||+++.++.+|+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEE
Confidence 34568999999999999998865322 235688999999999999999999999 9999999999999999999999
Q ss_pred eecccceeeccCCcceeeeccccCCCcCCccccCc-----cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHH
Q 000889 1074 SDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQS-----FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGW 1148 (1237)
Q Consensus 1074 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~ 1148 (1237)
+|||+++....... ......|++.|+|||++.. ..++.++||||+||++|||++|+.||..... ....
T Consensus 166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~-----~~~~ 238 (286)
T cd06638 166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-----MRAL 238 (286)
T ss_pred ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-----hHHH
Confidence 99999986643221 1234568999999999853 4578899999999999999999999864321 1111
Q ss_pred HHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1149 AKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1149 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
.. . .....+....+.. ....+.+++.+||+.+|++|||+.+++++.
T Consensus 239 ~~-~------~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 239 FK-I------PRNPPPTLHQPEL---WSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hh-c------cccCCCcccCCCC---cCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 0 0000011111111 123577888899999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=314.58 Aligned_cols=260 Identities=27% Similarity=0.438 Sum_probs=200.7
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCC----EEEEEEeccccCc-CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGS----VVAIKKLIHVTGQ-GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLL 1001 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 1001 (1237)
++|+..+.||+|+||.||+|++. ++. .||+|.+...... ....+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-PTIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-CCcee
Confidence 45778889999999999999875 343 4677876543221 23367889999999999999999999865 45679
Q ss_pred EEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeeccccee
Q 000889 1002 VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~ 1081 (1237)
++||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 86 v~e~~~~g~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH----KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eehhcCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 99999999999998753 23578899999999999999999999 999999999999999999999999999987
Q ss_pred eccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhccccc
Q 000889 1082 VNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINE 1160 (1237)
Q Consensus 1082 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1160 (1237)
..............++..|+|||++.+..++.++||||||+++|||++ |+.||..... .....+ ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~~---~~~~~~--- 229 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPDL---LEKGER--- 229 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH---HHCCCC---
Confidence 654332222223445778999999998889999999999999999997 8999864321 111111 111111
Q ss_pred ccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccccC
Q 000889 1161 ILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTE 1212 (1237)
Q Consensus 1161 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~~~ 1212 (1237)
...... ....+.+++.+||..+|++||++.++++.+.++..+..
T Consensus 230 -----~~~~~~---~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 230 -----LPQPPI---CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred -----CCCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 111111 12356788889999999999999999999999876654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=311.35 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=198.1
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
++|++.+.||+|+||.||+|++. ++..||+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35788899999999999999987 68899999876432 22235688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
+++++|.++++.... ...+++..+..++.++++|+.|||+.+ +|+||||||+||+++.++.+||+|||.+......
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 81 MDAGSLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred cCCCCHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 999999998875321 246899999999999999999999742 8999999999999999999999999999765322
Q ss_pred CcceeeeccccCCCcCCccccCccc------cCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccc
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQSFR------CTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRIN 1159 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1159 (1237)
. .....+++.|+|||++.+.. ++.++||||+||++|||++|+.||...... ........... ..
T Consensus 157 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~-~~-- 226 (286)
T cd06622 157 L----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQLSAIVD-GD-- 226 (286)
T ss_pred c----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHHHHHHhh-cC--
Confidence 1 12346788999999985543 478999999999999999999999643211 11111110000 00
Q ss_pred cccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1160 EILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1160 ~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.+.. ......++.+++.+|++.+|++||++.+++++
T Consensus 227 ---~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 ---PPTL-----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ---CCCC-----CcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 0111 11123456688889999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=309.22 Aligned_cols=257 Identities=23% Similarity=0.371 Sum_probs=200.8
Q ss_pred CCCCCCceecccCCeEEEEEEECC----CCEEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD----GSVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 1002 (1237)
.+|++.+.||+|+||.||+|.+.+ ...||+|...... ....+.+.+|++++++++||||+++++++.. +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457888999999999999998753 2468888776433 2334578899999999999999999998865 567899
Q ss_pred EEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceee
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~ 1082 (1237)
|||+++|+|.+++.... ..+++..+..++.+++.|++|||+. +++||||||+||+++.++.+|++|||+++..
T Consensus 85 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 85 MELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEcCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence 99999999999997532 3589999999999999999999999 9999999999999999999999999999866
Q ss_pred ccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccc
Q 000889 1083 NALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161 (1237)
Q Consensus 1083 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1161 (1237)
...... ......++..|+|||.+.+..++.++||||||+++||+++ |..||...... .. ..........
T Consensus 158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~---~~~~~~~~~~--- 227 (270)
T cd05056 158 EDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DV---IGRIENGERL--- 227 (270)
T ss_pred ccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HH---HHHHHcCCcC---
Confidence 443221 1122334568999999988889999999999999999986 99999644211 11 1111111111
Q ss_pred cCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccc
Q 000889 1162 LDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVD 1210 (1237)
Q Consensus 1162 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~ 1210 (1237)
...... ...+.+++.+|+..+|.+|||+.++++.|+.+..+
T Consensus 228 -----~~~~~~---~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 -----PMPPNC---PPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred -----CCCCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 111111 23567788899999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=310.66 Aligned_cols=249 Identities=26% Similarity=0.378 Sum_probs=201.3
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
++|++.+.||.|+||.||+|++. +++.||+|.+.... ......+.+|++++++++||||+++++++..+...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999976 57889999876432 23345688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
+++++|.+++... .+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++++|||+++.....
T Consensus 81 ~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 81 CGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 9999999998752 688999999999999999999999 9999999999999999999999999999877543
Q ss_pred CcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcc
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPE 1165 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1165 (1237)
.. ......+++.|+|||++.+..++.++||||||+++|||++|+.||..... .. ...... .. ..+.
T Consensus 152 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~---~~---~~~~~~-~~-----~~~~ 217 (274)
T cd06609 152 MS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP---MR---VLFLIP-KN-----NPPS 217 (274)
T ss_pred cc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch---HH---HHHHhh-hc-----CCCC
Confidence 21 22345688899999999988899999999999999999999999964321 00 011000 11 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1166 LTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1166 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.... .....+.+++.+|+..+|++|||+.+++++
T Consensus 218 ~~~~----~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 218 LEGN----KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred Cccc----ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111 022356778889999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=306.38 Aligned_cols=254 Identities=22% Similarity=0.349 Sum_probs=186.5
Q ss_pred eecccCCeEEEEEEECCCC---EEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCCC
Q 000889 935 MIGSGGFGEVYKAQLRDGS---VVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGS 1010 (1237)
Q Consensus 935 ~lG~G~fg~Vy~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 1010 (1237)
.||+|+||.||+|+..++. .+++|.+.... ....+.+.+|+.+++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5899999999999765433 45566554322 2234678999999999999999999999999999999999999999
Q ss_pred HHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCccee
Q 000889 1011 LESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLS 1090 (1237)
Q Consensus 1011 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~ 1090 (1237)
|.++++..... ....++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 82 LKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred HHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999764321 23567777889999999999999999 999999999999999999999999999864322211112
Q ss_pred eeccccCCCcCCccccCc-------cccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhccccccc
Q 000889 1091 VSTLAGTPGYVPPEYYQS-------FRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162 (1237)
Q Consensus 1091 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1162 (1237)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||..... ........... .....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~~-~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIKDQ-QVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhhc-ccccC
Confidence 234567889999999753 245778999999999999997 5667753221 11111111111 11222
Q ss_pred CccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 000889 1163 DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFK 1205 (1237)
Q Consensus 1163 ~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 1205 (1237)
++..... ....+.+++..|| .+|++||++.++++.|.
T Consensus 231 ~~~~~~~-----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELP-----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCC-----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3332221 1234566777899 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=310.88 Aligned_cols=260 Identities=27% Similarity=0.390 Sum_probs=203.7
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
++|++.+.||+|+||+||+|+.. ++..||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46778889999999999999876 57889998775432 23346788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
+++++|.+++... ..+++..+..++.+++.|+.|||+.+ +++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 85 MDCGSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred CCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999988653 36899999999999999999999742 8999999999999999999999999998754322
Q ss_pred CcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCc-----hHHHHHHHHhhhccccc
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDN-----NLVGWAKQLHREKRINE 1160 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 1160 (1237)
. .....|+..|+|||++.+..++.++|||||||++||+++|+.||......... ....+........
T Consensus 158 ~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 229 (284)
T cd06620 158 I----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP---- 229 (284)
T ss_pred c----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc----
Confidence 1 12456899999999998888999999999999999999999999754322110 1111111111100
Q ss_pred ccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 000889 1161 ILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208 (1237)
Q Consensus 1161 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~ 1208 (1237)
.+.+. .......+.+++.+|++++|++|||+.+++++..-++
T Consensus 230 --~~~~~----~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 230 --PPRLP----SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred --CCCCC----chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 01111 1112345778889999999999999999998754443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=317.73 Aligned_cols=199 Identities=21% Similarity=0.293 Sum_probs=164.4
Q ss_pred CCceeccc--CCeEEEEEEEC-CCCEEEEEEeccccC--cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 932 ADSMIGSG--GFGEVYKAQLR-DGSVVAIKKLIHVTG--QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 932 ~~~~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
+.++||+| +|++||+++.+ +++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45689999 78899999876 688999998864322 22345778999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+.......
T Consensus 82 ~~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 82 AYGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 99999999975422 3588999999999999999999999 99999999999999999999999998754332111
Q ss_pred cce-----eeeccccCCCcCCccccCc--cccCcccchHHHHHHHHHHHcCCCCCCC
Q 000889 1087 THL-----SVSTLAGTPGYVPPEYYQS--FRCTTKGDVYSYGVILLELLSGKRPIDP 1136 (1237)
Q Consensus 1087 ~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~tg~~p~~~ 1136 (1237)
... ......++..|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 110 0122346778999999976 4588999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=315.82 Aligned_cols=246 Identities=25% Similarity=0.388 Sum_probs=195.9
Q ss_pred CCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCCC
Q 000889 932 ADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGS 1010 (1237)
Q Consensus 932 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 1010 (1237)
....||+|+||.||++... ++..||+|++........+.+.+|+.++++++||||+++++++..++..++||||+++++
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 3457999999999999875 588999998865444445668899999999999999999999999999999999999999
Q ss_pred HHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCccee
Q 000889 1011 LESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLS 1090 (1237)
Q Consensus 1011 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~ 1090 (1237)
|.+++.. ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||++........ .
T Consensus 106 L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~ 174 (292)
T cd06658 106 LTDIVTH------TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--K 174 (292)
T ss_pred HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--c
Confidence 9998753 3578899999999999999999999 999999999999999999999999999875432221 1
Q ss_pred eeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCC
Q 000889 1091 VSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQT 1170 (1237)
Q Consensus 1091 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1170 (1237)
.....|+..|+|||++.+..++.++||||+|+++|||++|+.||..... .... .. +.....+......
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----~~~~-~~------~~~~~~~~~~~~~ 242 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP-----LQAM-RR------IRDNLPPRVKDSH 242 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHH-HH------HHhcCCCcccccc
Confidence 2335688999999999888899999999999999999999999864321 1110 10 0011111111111
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1171 SDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1171 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.....+.+++.+|+..+|.+|||+.+++++
T Consensus 243 ---~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 243 ---KVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ---ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 112346678889999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=288.24 Aligned_cols=210 Identities=25% Similarity=0.352 Sum_probs=176.9
Q ss_pred HhCCCCCCceecccCCeEEEEEEECC-----CCEEEEEEeccccCc--CHHHHHHHHHHHHhcCCCCcccccceEEe-CC
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLRD-----GSVVAIKKLIHVTGQ--GDREFMAEMETIGKIKHRNLVPLLGYCKI-GE 997 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 997 (1237)
....|+....||+|.||.||+|..++ .+.+|+|+++..... -.....+|+..++.++||||+.+..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 34568999999999999999996543 336899998754322 12456789999999999999999998877 77
Q ss_pred eEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCC----CceEE
Q 000889 998 ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDEN----FEARV 1073 (1237)
Q Consensus 998 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~----~~vkl 1073 (1237)
..++++||.+ -+|..+++..+....+.++...++.|+.||+.|+.|||++ -|+|||+||.|||+..+ |.|||
T Consensus 102 ~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEe
Confidence 8899999998 6899999877666667899999999999999999999999 89999999999999876 99999
Q ss_pred eecccceeeccCCcce-eeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCC
Q 000889 1074 SDFGMARLVNALDTHL-SVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEF 1139 (1237)
Q Consensus 1074 ~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~ 1139 (1237)
+|||+|+.+...-... ....++-|..|+|||.+.|. .|+.+.|||++|||+.||++-++-|...+.
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~ 245 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE 245 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence 9999999876543322 34556789999999999875 589999999999999999999888876543
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=311.08 Aligned_cols=250 Identities=27% Similarity=0.398 Sum_probs=201.3
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
++|++.+.||+|+||.||+|... ++..||+|++........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888999999999999999865 57889999886444444567889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
++++|.+++.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 99 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 99999999864 2578889999999999999999999 99999999999999999999999999987654332
Q ss_pred cceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
. ......+++.|+|||++.+..++.++||||||+++|++++|+.||........ ... ....+ .+..
T Consensus 170 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--~~~----~~~~~------~~~~ 235 (293)
T cd06647 170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYL----IATNG------TPEL 235 (293)
T ss_pred c--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--eee----hhcCC------CCCC
Confidence 2 12345688899999999888899999999999999999999999975322110 000 00000 0001
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
. ........+.+++.+||..+|++||++.+++++
T Consensus 236 ~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 Q---NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred C---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 011122356788899999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=308.86 Aligned_cols=264 Identities=25% Similarity=0.347 Sum_probs=199.2
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
++|+..+.||+|+||.||+|+++ +++.||+|++.... ....+.+.+|++++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999987 58899999886432 2233567899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
|++++.+..+.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 81 YCDHTVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred ccCccHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 99998888776532 3589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcceeeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHh----------
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLH---------- 1153 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------- 1153 (1237)
... ......++..|+|||++.+ ..++.++||||+|+++|||++|+.||......+ ..........
T Consensus 153 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 153 PGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD--QLYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred Ccc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCChHHhhhc
Confidence 332 1223457889999999876 457889999999999999999999997533111 1111000000
Q ss_pred -hhcccccccCccccCCCC----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1154 -REKRINEILDPELTMQTS----DETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1154 -~~~~~~~~~~~~l~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
..........+....... .+.....+.+++.+|++.+|++||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000000000000000 00112457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=346.53 Aligned_cols=380 Identities=25% Similarity=0.335 Sum_probs=227.2
Q ss_pred CCEEEccCCCCCchhhhhcccCCCccEEEcccccccCccchhhhhccCCCccEEeCCCCcCCCCcccccccCCCCCceee
Q 000889 226 LNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVIT 305 (1237)
Q Consensus 226 L~~L~Ls~n~l~~~~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~ 305 (1237)
|+.||+++|++. ..|..+..+..|+.|+++.|.+. ..|.+ ...+.+|++|+|..|.+...+ ..+..+++|++|+
T Consensus 47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s--~~~~~~l~~lnL~~n~l~~lP--~~~~~lknl~~Ld 120 (1081)
T KOG0618|consen 47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSS--CSNMRNLQYLNLKNNRLQSLP--ASISELKNLQYLD 120 (1081)
T ss_pred eEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchh--hhhhhcchhheeccchhhcCc--hhHHhhhcccccc
Confidence 555555555442 23444444455555555555554 33322 233456666666666665322 2456677777777
Q ss_pred ccCccccCcccchhhcccccceEEEecCCccCCCCchhhhccCCCCcEEecCCCcCCCCCchhHhhhcCCCcEEEcccCc
Q 000889 306 LSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNR 385 (1237)
Q Consensus 306 L~~n~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~l~~L~~L~Ls~N~ 385 (1237)
++.|++. .+|..+..++.++.++.++|..... ++... ++.++|..|.+.+.++.++... .. .|||.+|.
T Consensus 121 lS~N~f~--~~Pl~i~~lt~~~~~~~s~N~~~~~-----lg~~~-ik~~~l~~n~l~~~~~~~i~~l-~~--~ldLr~N~ 189 (1081)
T KOG0618|consen 121 LSFNHFG--PIPLVIEVLTAEEELAASNNEKIQR-----LGQTS-IKKLDLRLNVLGGSFLIDIYNL-TH--QLDLRYNE 189 (1081)
T ss_pred cchhccC--CCchhHHhhhHHHHHhhhcchhhhh-----hcccc-chhhhhhhhhcccchhcchhhh-he--eeecccch
Confidence 7777774 3677788888888888888832212 12222 7788888888877777766542 22 58888888
Q ss_pred CCCCCCcCcccccccceeeccCccccCcccchhccccccceEEeccCCCCCCCCCccCCCCCCCcEEEccCCcCcccCCC
Q 000889 386 LTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPS 465 (1237)
Q Consensus 386 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~ 465 (1237)
+. ...+.++.+|+.|....|+++. ..-.-++|+.|+.++|.++...+.. .-.+|+++++++|+++ .+|+
T Consensus 190 ~~---~~dls~~~~l~~l~c~rn~ls~-----l~~~g~~l~~L~a~~n~l~~~~~~p--~p~nl~~~dis~n~l~-~lp~ 258 (1081)
T KOG0618|consen 190 ME---VLDLSNLANLEVLHCERNQLSE-----LEISGPSLTALYADHNPLTTLDVHP--VPLNLQYLDISHNNLS-NLPE 258 (1081)
T ss_pred hh---hhhhhhccchhhhhhhhcccce-----EEecCcchheeeeccCcceeecccc--ccccceeeecchhhhh-cchH
Confidence 76 2346677788888888887762 2234466777777777776333221 1246777777777776 3445
Q ss_pred CCCCCCCCcccceecccCceeeecccccccccccccEecccCCccccCCCccccCCcCcceeecccccccCccccccccc
Q 000889 466 GFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVN 545 (1237)
Q Consensus 466 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~ 545 (1237)
+++ .+.+|+.+...+|++. .+|..+...++|+.|++..|.++ .+|....+++.|+.|+|..|+|. .+|+.++.-
T Consensus 259 wi~---~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v 332 (1081)
T KOG0618|consen 259 WIG---ACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAV 332 (1081)
T ss_pred HHH---hcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhh
Confidence 553 4556667777777774 56666666677777777777776 56666666777777777777776 666655444
Q ss_pred CCC-ccEEEccccccccccc-cccccCCCccEEEeecccccccCCccccCccccceEEecCCccccCCCCCCCCCCCCCE
Q 000889 546 GGN-LETLILNNNHLTGAIP-KSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVW 623 (1237)
Q Consensus 546 l~~-L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 623 (1237)
+.. |..|+.+-|++. ..| ..=..+..|+.|+|.+|+++...-+.+-+.+.|++|+|++|+|.......+.++..|+.
T Consensus 333 ~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~Lee 411 (1081)
T KOG0618|consen 333 LNASLNTLNVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEE 411 (1081)
T ss_pred hhHHHHHHhhhhcccc-ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHH
Confidence 433 566666666665 233 11123345566666666666555555566666666666666665333334455666666
Q ss_pred EECCCCccccCCChhHHh
Q 000889 624 LDLNSNNLSGPLPSELAN 641 (1237)
Q Consensus 624 L~L~~N~l~g~ip~~~~~ 641 (1237)
|+||||+|+ .+|..+.+
T Consensus 412 L~LSGNkL~-~Lp~tva~ 428 (1081)
T KOG0618|consen 412 LNLSGNKLT-TLPDTVAN 428 (1081)
T ss_pred Hhcccchhh-hhhHHHHh
Confidence 666666665 55555443
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=317.50 Aligned_cols=197 Identities=28% Similarity=0.403 Sum_probs=170.9
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcC-C-----CCcccccceEEeCCeEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIK-H-----RNLVPLLGYCKIGEERLL 1001 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 1001 (1237)
+|.+.++||+|+||.|.+|.+. +++.||||.++... .-..+...|++++..++ | -|+|++++||...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7899999999999999999876 58999999987543 22345567999999997 4 389999999999999999
Q ss_pred EEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCC--CCceEEeecccc
Q 000889 1002 VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE--NFEARVSDFGMA 1079 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~--~~~vkl~DfGla 1079 (1237)
|+|.+. .+|.++++.... ..++...++.|+.||+.||.+||+. +|||+||||+|||+.+ ...|||+|||.|
T Consensus 266 VfELL~-~NLYellK~n~f---~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNKF---RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eehhhh-hhHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccc
Confidence 999986 899999987654 4689999999999999999999999 9999999999999964 347999999999
Q ss_pred eeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCC
Q 000889 1080 RLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSE 1138 (1237)
Q Consensus 1080 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~ 1138 (1237)
+..... ....+.+..|+|||++.|.+|+.+.||||||||++||++|.+-|.++.
T Consensus 339 c~~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 339 CFESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred cccCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 865421 125667889999999999999999999999999999999988887653
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=314.08 Aligned_cols=246 Identities=24% Similarity=0.368 Sum_probs=196.4
Q ss_pred CCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCCC
Q 000889 932 ADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGS 1010 (1237)
Q Consensus 932 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 1010 (1237)
....||+|+||.||+|... ++..||+|++........+.+.+|+.+++.++||||+++++++..++..++||||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999876 588999998865444455678899999999999999999999999999999999999999
Q ss_pred HHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCccee
Q 000889 1011 LESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLS 1090 (1237)
Q Consensus 1011 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~ 1090 (1237)
|.+++.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++........ .
T Consensus 105 L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~ 173 (297)
T cd06659 105 LTDIVSQ------TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K 173 (297)
T ss_pred HHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--c
Confidence 9987754 3578999999999999999999999 999999999999999999999999999875433221 1
Q ss_pred eeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCC
Q 000889 1091 VSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQT 1170 (1237)
Q Consensus 1091 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1170 (1237)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||..... ... ....... . .......
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~-~~~~~~~-~-----~~~~~~~- 240 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP-----VQA-MKRLRDS-P-----PPKLKNA- 240 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHH-HHHHhcc-C-----CCCcccc-
Confidence 2345688999999999988899999999999999999999999864321 111 1111100 0 0001000
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1171 SDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1171 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
......+.+++.+|++.+|++||++.+++++
T Consensus 241 --~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 241 --HKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred --CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0112346678889999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=313.16 Aligned_cols=262 Identities=22% Similarity=0.369 Sum_probs=203.3
Q ss_pred CCCCCCceecccCCeEEEEEEEC-----CCCEEEEEEeccccCc-CHHHHHHHHHHHHhcCCCCcccccceEEe--CCeE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-----DGSVVAIKKLIHVTGQ-GDREFMAEMETIGKIKHRNLVPLLGYCKI--GEER 999 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 999 (1237)
..|+..+.||+|+||.||+|++. .+..+|+|++...... ..+.+.+|++++++++||||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35777889999999999999864 3678999988754332 35678999999999999999999999877 5578
Q ss_pred EEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccc
Q 000889 1000 LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1079 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla 1079 (1237)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||.+
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 99999999999999997642 2589999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCccee-eeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCc---------hHHHHH
Q 000889 1080 RLVNALDTHLS-VSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDN---------NLVGWA 1149 (1237)
Q Consensus 1080 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~---------~~~~~~ 1149 (1237)
........... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......... ....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 87653222111 11234456799999998888999999999999999999999998643221100 011111
Q ss_pred HHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 000889 1150 KQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207 (1237)
Q Consensus 1150 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l 1207 (1237)
....... ..... .....++.+++.+|++.+|++|||+.+++++|+.+
T Consensus 237 ~~~~~~~--------~~~~~---~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 237 ELLKEGE--------RLPRP---PSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHcCC--------cCCCC---ccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111110 11111 11224677889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=307.48 Aligned_cols=252 Identities=28% Similarity=0.480 Sum_probs=196.1
Q ss_pred eecccCCeEEEEEEECC-------CCEEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 935 MIGSGGFGEVYKAQLRD-------GSVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 935 ~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
.||+|+||.||+|++.+ +..+|+|.+.... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 68999999999998753 2478888775432 234567889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcC--CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCC-----ceEEeecccc
Q 000889 1007 KWGSLESVLHDRAKG--GGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENF-----EARVSDFGMA 1079 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~-----~vkl~DfGla 1079 (1237)
++++|.+++...... ....+++..+..++.|++.|++|||+. +++|+||||+||+++.++ .+|++|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999764321 224578899999999999999999999 999999999999999877 8999999999
Q ss_pred eeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhccc
Q 000889 1080 RLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158 (1237)
Q Consensus 1080 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1158 (1237)
+...............++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..... .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~---~~~~~---~~~~~~~-- 230 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN---NQEVL---QHVTAGG-- 230 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC---HHHHH---HHHhcCC--
Confidence 76543322222223345678999999998899999999999999999998 999986332 11111 1111111
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 000889 1159 NEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206 (1237)
Q Consensus 1159 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 1206 (1237)
....... ....+.+++.+||..+|.+||++.++++.|++
T Consensus 231 ------~~~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 ------RLQKPEN---CPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ------ccCCccc---chHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111111 22456788899999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=307.29 Aligned_cols=238 Identities=24% Similarity=0.403 Sum_probs=187.4
Q ss_pred ceecccCCeEEEEEEECCCC-----------EEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEE
Q 000889 934 SMIGSGGFGEVYKAQLRDGS-----------VVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 1002 (1237)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36899999999999987433 4667765433222 6778999999999999999999999987 788999
Q ss_pred EEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCC-------ceEEee
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENF-------EARVSD 1075 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~-------~vkl~D 1075 (1237)
|||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+|++|
T Consensus 79 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 79 EEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence 99999999999997642 2688999999999999999999999 999999999999999887 799999
Q ss_pred cccceeeccCCcceeeeccccCCCcCCccccCcc--ccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHH
Q 000889 1076 FGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSF--RCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQL 1152 (1237)
Q Consensus 1076 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 1152 (1237)
||++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||...... ....+ .
T Consensus 152 fg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~---~~~~~---~ 219 (259)
T cd05037 152 PGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS---EKERF---Y 219 (259)
T ss_pred CCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch---hHHHH---H
Confidence 999986543 1234567789999999876 78899999999999999999 57776543211 11111 0
Q ss_pred hhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 000889 1153 HREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFK 1205 (1237)
Q Consensus 1153 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 1205 (1237)
... ...+... ...+.+++.+||..+|++|||+.++++.|+
T Consensus 220 ~~~--------~~~~~~~-----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 220 QDQ--------HRLPMPD-----CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred hcC--------CCCCCCC-----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 0011111 146778899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=333.81 Aligned_cols=263 Identities=21% Similarity=0.255 Sum_probs=191.9
Q ss_pred HHHhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCC------CCcccccceEEeC
Q 000889 924 LEATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKH------RNLVPLLGYCKIG 996 (1237)
Q Consensus 924 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~ 996 (1237)
....++|++.++||+|+||+||+|++. .++.||||++.... ...+.+..|+++++.++| ++++++++++...
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 345678999999999999999999876 47789999885422 223456678888777754 4588888888764
Q ss_pred -CeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeeeCCCC-----
Q 000889 997 -EERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH-SCIPHIIHRDMKSSNVLLDENF----- 1069 (1237)
Q Consensus 997 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDikp~NIll~~~~----- 1069 (1237)
...++|||++ +++|.+++... ..+++..+..|+.|++.||+|||+ . +||||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccccc
Confidence 5788999988 68888888653 468999999999999999999997 5 999999999999998765
Q ss_pred -----------ceEEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCC
Q 000889 1070 -----------EARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSE 1138 (1237)
Q Consensus 1070 -----------~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~ 1138 (1237)
.+||+|||.+..... .....+||+.|||||++.+..++.++|||||||++|||++|+.||+...
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 499999998864322 1235679999999999999999999999999999999999999997533
Q ss_pred CCCCchHHHHHHHHh--------------------hhcccccccCcccc------CCCCCHHHHHHHHHHHHhccccCCC
Q 000889 1139 FGDDNNLVGWAKQLH--------------------REKRINEILDPELT------MQTSDETELYQYLRISFECLDDRPF 1192 (1237)
Q Consensus 1139 ~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~l~------~~~~~~~~~~~l~~li~~cl~~dP~ 1192 (1237)
.. ..+........ .........++... ...........+.+++.+|++.||+
T Consensus 350 ~~--~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 427 (467)
T PTZ00284 350 NL--EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ 427 (467)
T ss_pred hH--HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence 11 00100000000 00000000000000 0000001124567899999999999
Q ss_pred CCCCHHHHHHH
Q 000889 1193 KRPTMIQVMAM 1203 (1237)
Q Consensus 1193 ~RPt~~ell~~ 1203 (1237)
+|||+.|++++
T Consensus 428 ~R~ta~e~L~H 438 (467)
T PTZ00284 428 KRLNARQMTTH 438 (467)
T ss_pred hCCCHHHHhcC
Confidence 99999999986
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=305.12 Aligned_cols=252 Identities=26% Similarity=0.425 Sum_probs=190.4
Q ss_pred ceecccCCeEEEEEEECC----CCEEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEE-eCCeEEEEEEecc
Q 000889 934 SMIGSGGFGEVYKAQLRD----GSVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCK-IGEERLLVYEYMK 1007 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~ 1007 (1237)
+.||+|+||.||+|.+.+ ...||+|++.... ....+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998642 3478999875322 223457888999999999999999999775 4556789999999
Q ss_pred CCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCc
Q 000889 1008 WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDT 1087 (1237)
Q Consensus 1008 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~ 1087 (1237)
+|+|.+++.... ....+..+..++.|+++|++|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 81 HGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 999999997542 3457778889999999999999999 999999999999999999999999999975532211
Q ss_pred c--eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcC-CCCCCCCCCCCCchHHHHHHHHhhhcccccccCc
Q 000889 1088 H--LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSG-KRPIDPSEFGDDNNLVGWAKQLHREKRINEILDP 1164 (1237)
Q Consensus 1088 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1164 (1237)
. .......++..|+|||++.+..++.++||||||+++|||++| .+||.... ............
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~~~~~~~~-------- 219 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD------SFDITVYLLQGR-------- 219 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHhcCC--------
Confidence 1 111233456789999999888899999999999999999995 45554221 111111111110
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 000889 1165 ELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQV 1209 (1237)
Q Consensus 1165 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~ 1209 (1237)
........ ...+.+++.+||+.+|++||++.++++.|+++..
T Consensus 220 ~~~~~~~~---~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 220 RLLQPEYC---PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCCCCcC---CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 01111111 2356788889999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=311.89 Aligned_cols=261 Identities=26% Similarity=0.414 Sum_probs=200.2
Q ss_pred cCHHHHHHHhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhc-CCCCcccccceEEe
Q 000889 918 LTFAHLLEATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKI-KHRNLVPLLGYCKI 995 (1237)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 995 (1237)
.+..++..+.+.|++.+.||+|+||.||+|++. +++.+|+|.+... .....++..|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 344455556778999999999999999999986 5788999877543 23345678899999998 69999999998853
Q ss_pred ------CCeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCC
Q 000889 996 ------GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENF 1069 (1237)
Q Consensus 996 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~ 1069 (1237)
....+++|||+++|+|.+++.... ...+++..+..++.|+++|++|||+. +++||||||+||++++++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~ 158 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA 158 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence 457899999999999999987543 24578888899999999999999999 999999999999999999
Q ss_pred ceEEeecccceeeccCCcceeeeccccCCCcCCccccC-----ccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCch
Q 000889 1070 EARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQ-----SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144 (1237)
Q Consensus 1070 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~ 1144 (1237)
.++|+|||++........ ......|++.|+|||++. ...++.++||||+||++|||++|+.||.....
T Consensus 159 ~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~----- 231 (282)
T cd06636 159 EVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP----- 231 (282)
T ss_pred CEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH-----
Confidence 999999999875532211 123456889999999985 34678899999999999999999999864321
Q ss_pred HHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1145 LVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1145 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
...... ......+... .......+.+++.+||+.+|.+|||+.+++++
T Consensus 232 ~~~~~~-------~~~~~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 232 MRALFL-------IPRNPPPKLK----SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred Hhhhhh-------HhhCCCCCCc----ccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 000000 0000011111 11122357788889999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=312.50 Aligned_cols=262 Identities=27% Similarity=0.392 Sum_probs=201.3
Q ss_pred HHHHHHHhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhc-CCCCcccccceEEeC-
Q 000889 920 FAHLLEATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKI-KHRNLVPLLGYCKIG- 996 (1237)
Q Consensus 920 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 996 (1237)
..++..+.++|++.+.||+|+||.||+|... +++.+|+|.+... ......+.+|+.+++++ +|||++++++++...
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 3444456788999999999999999999985 5788999987542 22345678899999999 799999999998653
Q ss_pred ----CeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceE
Q 000889 997 ----EERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEAR 1072 (1237)
Q Consensus 997 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vk 1072 (1237)
...++||||+++++|.++++.... ....+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEE
Confidence 358999999999999999875322 235689999999999999999999999 999999999999999999999
Q ss_pred EeecccceeeccCCcceeeeccccCCCcCCccccCcc-----ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHH
Q 000889 1073 VSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSF-----RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVG 1147 (1237)
Q Consensus 1073 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~ 1147 (1237)
|+|||++......... .....|+..|+|||++... .++.++||||+||++|||++|+.||..... ...
T Consensus 169 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-----~~~ 241 (291)
T cd06639 169 LVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-----VKT 241 (291)
T ss_pred Eeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-----HHH
Confidence 9999999765432211 2335688899999998643 367899999999999999999999864321 111
Q ss_pred HHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1148 WAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1148 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
. .... .... +.... .......+.+++.+|++.+|++||++.+++++
T Consensus 242 ~-~~~~-~~~~-----~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 242 L-FKIP-RNPP-----PTLLH---PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred H-HHHh-cCCC-----CCCCc---ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1 0100 0100 11111 11122357788999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=323.10 Aligned_cols=241 Identities=22% Similarity=0.283 Sum_probs=185.4
Q ss_pred ecccCCeEEEEEEEC-CCCEEEEEEeccccC---cCHHHHHHHHHHHHhc---CCCCcccccceEEeCCeEEEEEEeccC
Q 000889 936 IGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG---QGDREFMAEMETIGKI---KHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 936 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
||+|+||+||+|++. +++.||+|++..... .....+..|..++.+. +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999986 588999998854221 1223455677777665 699999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~- 151 (330)
T cd05586 81 GELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK- 151 (330)
T ss_pred ChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-
Confidence 9999988653 4688999999999999999999999 999999999999999999999999999975432221
Q ss_pred eeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcccc
Q 000889 1089 LSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELT 1167 (1237)
Q Consensus 1089 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1167 (1237)
.....+||+.|||||++.+. .++.++||||+||++|||++|+.||..... .......... . ..++
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~~~~~i~~~-~------~~~~ 217 (330)
T cd05586 152 -TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQMYRNIAFG-K------VRFP 217 (330)
T ss_pred -CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HHHHHHHHcC-C------CCCC
Confidence 12356799999999998764 478999999999999999999999975321 1111111110 0 1111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCC----CHHHHHHH
Q 000889 1168 MQTSDETELYQYLRISFECLDDRPFKRP----TMIQVMAM 1203 (1237)
Q Consensus 1168 ~~~~~~~~~~~l~~li~~cl~~dP~~RP----t~~ell~~ 1203 (1237)
... ....+.+++.+|++.+|.+|| ++.+++++
T Consensus 218 ~~~----~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 218 KNV----LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred Ccc----CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 111 112455788899999999998 56666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=304.12 Aligned_cols=250 Identities=25% Similarity=0.392 Sum_probs=198.7
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEe-CCeEEEEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKI-GEERLLVYE 1004 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 1004 (1237)
+|++.+.||+|++|.||+|+.+ +++.||+|++.... ....+.+.+|++++++++|||++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999976 47789999885432 2234568889999999999999999998764 446789999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
|+++++|.+++.... ...+++..+..++.+++.|++|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 999999999997642 24689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCc
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDP 1164 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1164 (1237)
... ......+++.|+|||++.+..++.++||||+|+++|||++|+.||.... .......... ... +
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~~~-~~~-----~ 220 (257)
T cd08223 155 QCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRIIE-GKL-----P 220 (257)
T ss_pred cCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHh-cCC-----C
Confidence 222 1234568899999999999889999999999999999999999986432 1111111111 111 0
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1165 ELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1165 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.. .......+.+++.+|++.+|++|||+.+++++
T Consensus 221 ~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 PM-----PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CC-----ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11 11122356788889999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=307.40 Aligned_cols=255 Identities=22% Similarity=0.380 Sum_probs=199.4
Q ss_pred CCCCCceecccCCeEEEEEEECC--CCEEEEEEecccc----------CcCHHHHHHHHHHHHh-cCCCCcccccceEEe
Q 000889 929 GFSADSMIGSGGFGEVYKAQLRD--GSVVAIKKLIHVT----------GQGDREFMAEMETIGK-IKHRNLVPLLGYCKI 995 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 995 (1237)
+|++.+.||+|+||.||+|+++. ++.+|+|.+.... .....++..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999999875 6789999875321 1122446778888765 799999999999999
Q ss_pred CCeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEee
Q 000889 996 GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSD 1075 (1237)
Q Consensus 996 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~D 1075 (1237)
++..++||||+++++|.+++..... ....+++..++.++.|++.|+.|||+.. +++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999999865322 2356899999999999999999999631 899999999999999999999999
Q ss_pred cccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhh
Q 000889 1076 FGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE 1155 (1237)
Q Consensus 1076 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1155 (1237)
||.+....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||..... .........
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~~~~~~~- 227 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSLATKIVE- 227 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHHHHHHhh-
Confidence 99998654432 23455688999999999988899999999999999999999999864321 111111111
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 000889 1156 KRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFK 1205 (1237)
Q Consensus 1156 ~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 1205 (1237)
.... + .. .......+.+++.+||+.+|++||++.|+.++++
T Consensus 228 ~~~~----~-~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 AVYE----P-LP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ccCC----c-CC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1000 0 00 0011235678888999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=309.70 Aligned_cols=239 Identities=21% Similarity=0.333 Sum_probs=185.0
Q ss_pred eecccCCeEEEEEEECC-------------------------CCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccc
Q 000889 935 MIGSGGFGEVYKAQLRD-------------------------GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPL 989 (1237)
Q Consensus 935 ~lG~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 989 (1237)
+||+|+||.||+|.... ...||+|.+..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 13578887754333334568889999999999999999
Q ss_pred cceEEeCCeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCC
Q 000889 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENF 1069 (1237)
Q Consensus 990 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~ 1069 (1237)
++++......++||||+++|+|..++... ...+++..+..++.|+++||+|||+. +|+||||||+||++++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE----KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence 99999999999999999999999988653 24678899999999999999999999 999999999999997643
Q ss_pred -------ceEEeecccceeeccCCcceeeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHH-cCCCCCCCCCCC
Q 000889 1070 -------EARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELL-SGKRPIDPSEFG 1140 (1237)
Q Consensus 1070 -------~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~-tg~~p~~~~~~~ 1140 (1237)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||......
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred cccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 4899999998644321 22357788999998865 56889999999999999985 799998643211
Q ss_pred CCchHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 000889 1141 DDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFK 1205 (1237)
Q Consensus 1141 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 1205 (1237)
. ...+. ... ...+.. ....+.+++.+||+.+|++|||+.++++.|+
T Consensus 229 ~---~~~~~---~~~--------~~~~~~-----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 E---KERFY---EKK--------HRLPEP-----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H---HHHHH---Hhc--------cCCCCC-----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 11110 000 011111 1125778889999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=316.97 Aligned_cols=244 Identities=24% Similarity=0.398 Sum_probs=191.5
Q ss_pred CceecccCCeEEEEEEEC-CCCEEEEEE--ecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCe--EEEEEEe
Q 000889 933 DSMIGSGGFGEVYKAQLR-DGSVVAIKK--LIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEE--RLLVYEY 1005 (1237)
Q Consensus 933 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~--~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e~ 1005 (1237)
..+||+|+|-+||+|.+. +|..||--. +.... +...+.|..|+.+++.++||||+++|+++.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 457999999999999986 355565322 22222 2334679999999999999999999999987655 6789999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCC-CCceEEeecccceeecc
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE-NFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~-~~~vkl~DfGla~~~~~ 1084 (1237)
+..|+|..|+.+. +.+.....+.|+.||++||.|||++ .|+|+|||||.+||+|+. .|.|||+|+|+|.....
T Consensus 125 ~TSGtLr~Y~kk~-----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 125 FTSGTLREYRKKH-----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ccCCcHHHHHHHh-----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999875 4678889999999999999999998 678999999999999974 68999999999987654
Q ss_pred CCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCc
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDP 1164 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1164 (1237)
.. .....|||.|||||+.. ..|...+||||||++|.||+|+..||.. -.+.++..++...+.....+
T Consensus 199 s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE-----C~n~AQIYKKV~SGiKP~sl--- 265 (632)
T KOG0584|consen 199 SH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE-----CTNPAQIYKKVTSGIKPAAL--- 265 (632)
T ss_pred cc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh-----hCCHHHHHHHHHcCCCHHHh---
Confidence 32 23478999999999998 5899999999999999999999999852 22333333333333211111
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1165 ELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1165 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
....+ .++.++|.+|+.. ..+|||+.|+++.
T Consensus 266 ---~kV~d----Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 266 ---SKVKD----PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ---hccCC----HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 11111 2456788899999 8999999999976
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=303.91 Aligned_cols=248 Identities=25% Similarity=0.438 Sum_probs=198.6
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC-----cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG-----QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 1002 (1237)
+|+..+.||+|+||.||+|... ++..|++|.+..... +..+.+.+|++++++++||||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777889999999999999987 688999998764321 2345688999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceee
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~ 1082 (1237)
|||+++++|.+++... ..+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.+||+|||++...
T Consensus 81 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 81 LELVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 9999999999998753 3578999999999999999999999 9999999999999999999999999999865
Q ss_pred ccCCcceeeeccccCCCcCCccccCccc-cCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccc
Q 000889 1083 NALDTHLSVSTLAGTPGYVPPEYYQSFR-CTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161 (1237)
Q Consensus 1083 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1161 (1237)
.... ......++..|+|||.+.... ++.++|+||+|+++|+|++|+.||.... ... ............
T Consensus 153 ~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-----~~~-~~~~~~~~~~~~-- 221 (258)
T cd06632 153 VEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-----GVA-AVFKIGRSKELP-- 221 (258)
T ss_pred cccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-----HHH-HHHHHHhcccCC--
Confidence 4332 223456889999999987766 8899999999999999999999986432 111 111111101110
Q ss_pred cCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1162 LDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1162 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.. + ......+.+++.+|++.+|.+||++.+++++
T Consensus 222 ---~~--~---~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 222 ---PI--P---DHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ---Cc--C---CCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 00 0 1112356678889999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=306.56 Aligned_cols=254 Identities=24% Similarity=0.391 Sum_probs=198.9
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCc------CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQ------GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLL 1001 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 1001 (1237)
+|+..+.||+|+||.||+|+.. +++.||+|++...... ..+.+.+|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4778899999999999999874 6889999988643311 23568889999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCC-ceEEeecccce
Q 000889 1002 VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENF-EARVSDFGMAR 1080 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~-~vkl~DfGla~ 1080 (1237)
||||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++ .+||+|||.+.
T Consensus 81 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEeccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 99999999999998753 3678899999999999999999999 999999999999998775 59999999997
Q ss_pred eeccCCcc--eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccc
Q 000889 1081 LVNALDTH--LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158 (1237)
Q Consensus 1081 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1158 (1237)
........ .......++..|+|||++.+..++.++||||+|+++|+|++|..||........ ...+... ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~-~~~--- 226 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH--LALIFKI-ASA--- 226 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch--HHHHHHH-hcc---
Confidence 66543211 111234678899999999888899999999999999999999999864332111 1111010 000
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1159 NEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1159 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
...+.. .......+.+++.+|++.+|.+|||+.+++++
T Consensus 227 --~~~~~~-----~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 227 --TTAPSI-----PEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred --CCCCCC-----chhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 001111 11223457788889999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=306.98 Aligned_cols=255 Identities=25% Similarity=0.432 Sum_probs=197.1
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC---c-------CHHHHHHHHHHHHhcCCCCcccccceEEeCC
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG---Q-------GDREFMAEMETIGKIKHRNLVPLLGYCKIGE 997 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 997 (1237)
+|...+.||+|+||.||+|... +++.||+|.+..... . ..+.+.+|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4777889999999999999875 588999998752111 0 1235778999999999999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecc
Q 000889 998 ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFG 1077 (1237)
Q Consensus 998 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfG 1077 (1237)
..++||||+++++|.++++.. ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+|++|||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecc
Confidence 999999999999999998764 3688889999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcceeeeccccCCCcCCccccCccc--cCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhh
Q 000889 1078 MARLVNALDTHLSVSTLAGTPGYVPPEYYQSFR--CTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE 1155 (1237)
Q Consensus 1078 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1155 (1237)
+++...............|+..|+|||++.... ++.++||||+|+++||+++|..||.... ....+... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~-~~~ 227 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE-----AIAAMFKL-GNK 227 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc-----hHHHHHHh-hcc
Confidence 997654322222223456888999999987654 7899999999999999999999986322 11111110 000
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1156 KRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1156 ~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.....+.... .......+.+++.+|++++|++|||+.+++++
T Consensus 228 -~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 228 -RSAPPIPPDV-----SMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -ccCCcCCccc-----cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0001111111 11123467788889999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=313.58 Aligned_cols=255 Identities=21% Similarity=0.282 Sum_probs=196.0
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC---cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG---QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
++|++.+.||+|+||.||+|+.. .++.||+|.+..... ...+.+.+|+++++.++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999987 467899998764321 22346778999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||++|++|.+++... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++...
T Consensus 81 e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 81 EYVEGGDCATLLKNI-----GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 999999999999653 3688999999999999999999999 99999999999999999999999999986421
Q ss_pred cCC-------------cceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHH
Q 000889 1084 ALD-------------THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAK 1150 (1237)
Q Consensus 1084 ~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~ 1150 (1237)
... .........++..|+|||.+.+..++.++|+||||+++|||++|..||.+... ..+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~------~~~~~ 226 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP------EELFG 226 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHH
Confidence 100 00011124578899999999888899999999999999999999999864321 11111
Q ss_pred HHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 000889 1151 QLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFK 1205 (1237)
Q Consensus 1151 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 1205 (1237)
...... ...+.. .......+.+++.+|++.+|++||++.++.+.++
T Consensus 227 ~~~~~~----~~~~~~-----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 227 QVISDD----IEWPEG-----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred HHHhcc----cCCCCc-----cccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 111110 001110 0112234678888999999999999655554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=305.24 Aligned_cols=259 Identities=25% Similarity=0.390 Sum_probs=203.3
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
++|++.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|++.++.++|+||+++++.+..++..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46889999999999999999875 57789999885422 23456789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
+++++|.++++.... ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 81 LSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred cCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999999999976432 24689999999999999999999999 9999999999999999999999999998766543
Q ss_pred Ccce--eeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccccccc
Q 000889 1086 DTHL--SVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162 (1237)
Q Consensus 1086 ~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1162 (1237)
.... ......|+..|+|||++... .++.++|||||||++|||++|+.||...... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----~~~~~~~~~~------- 223 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-----KVLMLTLQND------- 223 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-----hhHHHHhcCC-------
Confidence 3221 12344688999999998876 7899999999999999999999999643211 1111111110
Q ss_pred CccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1163 DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1163 ~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.+..............+.+++.+|++.+|++||++.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 01111110001123456788889999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=310.33 Aligned_cols=264 Identities=25% Similarity=0.342 Sum_probs=194.4
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
+|++.+.||+|+||.||+|++. +|+.||+|++.... ......+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999986 58899999886422 12234677899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
++ ++|.+++... ...+++..++.++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 81 CD-QDLKKYFDSC----NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred CC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 97 5888877643 24689999999999999999999999 9999999999999999999999999999765432
Q ss_pred CcceeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhh--c---ccc
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE--K---RIN 1159 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~---~~~ 1159 (1237)
.. ......++..|+|||++.+. .++.++||||+||++|||++|+.|+...... ...+.......... . .+.
T Consensus 153 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07839 153 VR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEESWPGVS 229 (284)
T ss_pred CC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-HHHHHHHHHHhCCCChHHhHHhh
Confidence 21 12334578899999998764 4788999999999999999999986432211 00010000000000 0 000
Q ss_pred cccC----ccccCCCC----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1160 EILD----PELTMQTS----DETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1160 ~~~~----~~l~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
...+ +....... .+....++.+++.+|++.+|.+|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000 00000000 01112456688889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=314.66 Aligned_cols=198 Identities=24% Similarity=0.369 Sum_probs=160.9
Q ss_pred ceecccCCeEEEEEEECC---CCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEe--CCeEEEEEEeccC
Q 000889 934 SMIGSGGFGEVYKAQLRD---GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI--GEERLLVYEYMKW 1008 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~ 1008 (1237)
.+||+|+||+||+|+.++ +..||+|++... .....+.+|++++++++||||+++++++.. +...++||||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 579999999999999753 468999987542 223467889999999999999999998854 457799999987
Q ss_pred CCHHHHHhhhhc----CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee----CCCCceEEeecccce
Q 000889 1009 GSLESVLHDRAK----GGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLL----DENFEARVSDFGMAR 1080 (1237)
Q Consensus 1009 gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll----~~~~~vkl~DfGla~ 1080 (1237)
++|.+++..... .....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 578888754321 1123578999999999999999999999 99999999999999 567899999999998
Q ss_pred eeccCCcc-eeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCC
Q 000889 1081 LVNALDTH-LSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPS 1137 (1237)
Q Consensus 1081 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~ 1137 (1237)
........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 66433221 122345689999999998764 5789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=305.36 Aligned_cols=251 Identities=22% Similarity=0.377 Sum_probs=192.9
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC-----cCHHHHHHHHHHHHhcCCCCcccccceEEe--CCeE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG-----QGDREFMAEMETIGKIKHRNLVPLLGYCKI--GEER 999 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 999 (1237)
.+|+..+.||+|+||.||+|... ++..||+|++..... .....+.+|+.++++++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46889999999999999999876 588999998754321 122457889999999999999999998865 3567
Q ss_pred EEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccc
Q 000889 1000 LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1079 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla 1079 (1237)
+++|||+++++|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-----GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 8999999999999998753 3578888999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCc-ceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccc
Q 000889 1080 RLVNALDT-HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158 (1237)
Q Consensus 1080 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1158 (1237)
+....... ........++..|+|||++.+..++.++||||+||++|||++|+.||.... ..... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~-----~~~~~-~~~~~~~-- 225 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE-----AMAAI-FKIATQP-- 225 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc-----hHHHH-HHHhcCC--
Confidence 76543211 111223458889999999998889999999999999999999999986421 11111 1110000
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1159 NEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1159 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
..+.++ ......+..++ +||..+|++||++.+++++
T Consensus 226 ---~~~~~~-----~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 226 ---TNPQLP-----SHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred ---CCCCCc-----hhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 111111 11112334454 6888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=309.30 Aligned_cols=258 Identities=23% Similarity=0.427 Sum_probs=200.0
Q ss_pred CCCCCCceecccCCeEEEEEEEC------CCCEEEEEEeccccCc-CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR------DGSVVAIKKLIHVTGQ-GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERL 1000 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 1000 (1237)
.+|+..+.||+|+||.||+|+.+ +...|++|.+...... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46888899999999999999865 2457888877543322 2457899999999999999999999999888999
Q ss_pred EEEEeccCCCHHHHHhhhhcCC----CCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeec
Q 000889 1001 LVYEYMKWGSLESVLHDRAKGG----GTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDF 1076 (1237)
Q Consensus 1001 lv~e~~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~Df 1076 (1237)
+||||+++|+|.+++....... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997643211 12589999999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhh
Q 000889 1077 GMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHRE 1155 (1237)
Q Consensus 1077 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1155 (1237)
|+++...... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.... ..... .... .
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~---~~~~~---~~~~-~ 233 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS---DEEVL---NRLQ-A 233 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc---hHHHH---HHHH-c
Confidence 9987543221 112233456778999999988888999999999999999998 788885322 11111 1111 1
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 000889 1156 KRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFK 1205 (1237)
Q Consensus 1156 ~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 1205 (1237)
..... ..... ....+.+++.+|++.+|++|||+.++++.|.
T Consensus 234 ~~~~~------~~~~~---~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLEL------PVPEG---CPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCC------CCCCC---CCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11110 00111 1235778888999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=304.33 Aligned_cols=250 Identities=22% Similarity=0.375 Sum_probs=200.6
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
+|++.+.||+|+||.||+++.. +++.||+|++.... ....+++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4888899999999999999876 57899999886422 22345788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
+++++|.+++.... ...+++..+.+++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++......
T Consensus 81 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 81 CEGGDLYKKINAQR---GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred CCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 99999999987532 23578899999999999999999999 9999999999999999999999999999866432
Q ss_pred CcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcc
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPE 1165 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1165 (1237)
... .....|++.|+|||+..+..++.++|||||||++|+|++|+.||.... ............ . +.
T Consensus 155 ~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~~~~-~-----~~ 220 (256)
T cd08218 155 VEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN------MKNLVLKIIRGS-Y-----PP 220 (256)
T ss_pred hhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC------HHHHHHHHhcCC-C-----CC
Confidence 221 123457889999999998889999999999999999999999986432 111111111110 0 00
Q ss_pred ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1166 LTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1166 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
. + ......+.+++.+|++.+|++||++.+++++
T Consensus 221 ~--~---~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 V--S---SHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred C--c---ccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1 1 1122356788889999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=305.86 Aligned_cols=249 Identities=26% Similarity=0.338 Sum_probs=200.8
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
.|+..+.||+|+||.||+|++. ++..||+|.+.... ......+.+|+++++++.||||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4677788999999999999986 47889999876432 233456888999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
++++|.+++.. ..+++..+..++.|++.|++|+|+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 85 ~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 85 GGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 99999998864 3578888999999999999999999 99999999999999999999999999997664322
Q ss_pred cceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
. ......++..|+|||++.+..++.++|||||||++|||++|..||....... .... +.....
T Consensus 156 ~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~------~~~~------~~~~~~--- 218 (277)
T cd06640 156 I--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR------VLFL------IPKNNP--- 218 (277)
T ss_pred c--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh------Hhhh------hhcCCC---
Confidence 1 1233467889999999988889999999999999999999999986432110 0000 000000
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFK 1205 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 1205 (1237)
+.........+.+++.+||+.+|++||++.+++++--
T Consensus 219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 219 --PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred --CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 1112234456778999999999999999999988743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=310.22 Aligned_cols=246 Identities=27% Similarity=0.386 Sum_probs=196.6
Q ss_pred CCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEecc
Q 000889 930 FSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMK 1007 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 1007 (1237)
|+..+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 555678999999999999876 47789999875332 2234568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCc
Q 000889 1008 WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDT 1087 (1237)
Q Consensus 1008 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~ 1087 (1237)
+++|.+++.. ..+++..+..++.|+++|+.|||+. +++|+||+|+||++++++.+|++|||++........
T Consensus 86 ~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 86 GGSALDLLKP------GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 9999998853 3678899999999999999999999 999999999999999999999999999976543221
Q ss_pred ceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcccc
Q 000889 1088 HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELT 1167 (1237)
Q Consensus 1088 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1167 (1237)
......++..|+|||++.+..++.++||||||+++|||++|+.||....... . ... +.....+..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~---~~~------~~~~~~~~~- 221 (277)
T cd06642 157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---V---LFL------IPKNSPPTL- 221 (277)
T ss_pred --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---H---Hhh------hhcCCCCCC-
Confidence 1223467889999999998889999999999999999999999986432110 0 000 000001111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1168 MQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1168 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.......+.+++.+|++.+|++||++.+++++
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 ----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ----CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11223457788899999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=313.41 Aligned_cols=254 Identities=23% Similarity=0.318 Sum_probs=200.4
Q ss_pred CCCCCCceecccCCeEEEEEEECC-CCEEEEEEeccccCc---CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQ---GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
++|+..+.||+|+||+||+|...+ ++.||+|.+...... ..+.+.+|++++++++||||+++++++..+...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 368888999999999999999874 889999988653322 3456888999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+.+++|.+++.... ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 9999999999987532 25689999999999999999999999 99999999999999999999999999987543
Q ss_pred cCCcce---------------------------eeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCC
Q 000889 1084 ALDTHL---------------------------SVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDP 1136 (1237)
Q Consensus 1084 ~~~~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~ 1136 (1237)
...... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 221100 11234678899999999988899999999999999999999999974
Q ss_pred CCCCCCchHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCC----HHHHHHH
Q 000889 1137 SEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPT----MIQVMAM 1203 (1237)
Q Consensus 1137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~ell~~ 1203 (1237)
.... ..+... .......... ......+.+++.+|+..+|++||+ +.+++++
T Consensus 235 ~~~~-----~~~~~~----------~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 235 SNRD-----ETFSNI----------LKKEVTFPGS-PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred CchH-----HHHHHH----------hcCCccCCCc-cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 3211 111111 1111111111 112346778888999999999999 7777764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=316.96 Aligned_cols=271 Identities=25% Similarity=0.383 Sum_probs=202.4
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeC------CeEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIG------EERL 1000 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 1000 (1237)
.|...+.||+|+||.||+|+.+ .|+.||||.+..... ...+...+|++++++++|||||++++.-.+. ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3455678999999999999965 699999999876443 2345678999999999999999999976543 3568
Q ss_pred EEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeC--CCC--ceEEeec
Q 000889 1001 LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLD--ENF--EARVSDF 1076 (1237)
Q Consensus 1001 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~--~~~--~vkl~Df 1076 (1237)
+|||||.||+|+.++++... ...+++.+.+.++.+++.||.|||++ +||||||||.||++- ++| ..||+||
T Consensus 94 lvmEyC~gGsL~~~L~~PEN--~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPEN--AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred EEEeecCCCcHHHHhcCccc--ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecc
Confidence 99999999999999987544 36799999999999999999999999 999999999999983 334 4799999
Q ss_pred ccceeeccCCcceeeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhh
Q 000889 1077 GMARLVNALDTHLSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE 1155 (1237)
Q Consensus 1077 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1155 (1237)
|.|+..+... .....+||..|.+||+... +.|+..+|.|||||++||++||..||.+........-..|.......
T Consensus 169 G~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp 245 (732)
T KOG4250|consen 169 GAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKP 245 (732)
T ss_pred cccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCC
Confidence 9999776433 5678899999999999985 78999999999999999999999999875433222222222111111
Q ss_pred cccccccC----------ccccCCCC-CHHHHHHHHHHHHhccccCCCCCC--CHHHHHHHHHhc
Q 000889 1156 KRINEILD----------PELTMQTS-DETELYQYLRISFECLDDRPFKRP--TMIQVMAMFKEL 1207 (1237)
Q Consensus 1156 ~~~~~~~~----------~~l~~~~~-~~~~~~~l~~li~~cl~~dP~~RP--t~~ell~~L~~l 1207 (1237)
..+.-... ..++.+.. .+.....+-+....++..+|++|. ...+....+..+
T Consensus 246 ~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 246 SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 11100000 11111111 133445666777778888999998 555555555444
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=306.20 Aligned_cols=258 Identities=24% Similarity=0.396 Sum_probs=197.9
Q ss_pred CCCCceecccCCeEEEEEEEC----CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeCC------
Q 000889 930 FSADSMIGSGGFGEVYKAQLR----DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGE------ 997 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 997 (1237)
|++.+.||+|+||.||+|.+. .+..||+|.+.... ....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999864 36789999886432 223456888999999999999999999886532
Q ss_pred eEEEEEEeccCCCHHHHHhhhhc-CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeec
Q 000889 998 ERLLVYEYMKWGSLESVLHDRAK-GGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDF 1076 (1237)
Q Consensus 998 ~~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~Df 1076 (1237)
..++++||+++|+|.+++..... .....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 24788999999999998754321 1223578899999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhh
Q 000889 1077 GMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHRE 1155 (1237)
Q Consensus 1077 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1155 (1237)
|+++...............+++.|++||.+....++.++||||||+++|||++ |+.||..... .....+ ....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~---~~~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNY---LIKG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHH---HHcC
Confidence 99986643332222233445678999999988889999999999999999999 8888764321 111111 1111
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 000889 1156 KRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207 (1237)
Q Consensus 1156 ~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l 1207 (1237)
.. .... ......+.+++.+|++.+|++||++.++++.|+.+
T Consensus 232 ~~--------~~~~---~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NR--------LKQP---PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred Cc--------CCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10 0000 11224677889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=302.16 Aligned_cols=251 Identities=29% Similarity=0.491 Sum_probs=199.2
Q ss_pred CCCCceecccCCeEEEEEEECC-----CCEEEEEEeccccCc-CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 930 FSADSMIGSGGFGEVYKAQLRD-----GSVVAIKKLIHVTGQ-GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
+++.+.||+|+||.||+|++.+ +..||+|++...... ..+.+..|++++++++||||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567889999999999999874 378999988654332 4567899999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||+++...
T Consensus 81 e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecc
Confidence 99999999999976432 1289999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhccccccc
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1162 (1237)
....... ....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||.... . ............
T Consensus 155 ~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~---~---~~~~~~~~~~~~----- 222 (258)
T smart00219 155 DDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS---N---EEVLEYLKKGYR----- 222 (258)
T ss_pred ccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---H---HHHHHHHhcCCC-----
Confidence 4422211 12336789999999988889999999999999999998 788876421 1 111111111111
Q ss_pred CccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1163 DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1163 ~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
...... ...++.+++.+|+..+|++|||+.++++.|
T Consensus 223 ---~~~~~~---~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 ---LPKPEN---CPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCCCCc---CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 000111 234577888899999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=310.47 Aligned_cols=261 Identities=23% Similarity=0.370 Sum_probs=197.9
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCc--CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQ--GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
++|++.++||+|+||.||+|.++ +++.||+|++...... ..+.+.+|+++++.++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888899999999999999987 4889999987643222 24567889999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
|++++++.++.... ..+++..+..++.|+++|++|||+. +++||||+|+||++++++.+|++|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 99999888876532 3589999999999999999999999 999999999999999999999999999986544
Q ss_pred CCcceeeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccc-----
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI----- 1158 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 1158 (1237)
... ......++..|+|||++.+ ..++.++||||||+++|||++|++||..... ...+..........
T Consensus 153 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07846 153 PGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-----IDQLYHIIKCLGNLIPRHQ 225 (286)
T ss_pred Ccc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch-----HHHHHHHHHHhCCCchhhH
Confidence 322 1233557889999999875 4578899999999999999999999864321 11111100000000
Q ss_pred ---------ccccCccccCCC----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1159 ---------NEILDPELTMQT----SDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1159 ---------~~~~~~~l~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.....+...... ..+.....+.+++.+||+.+|++||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000000000 001123457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=305.60 Aligned_cols=239 Identities=24% Similarity=0.408 Sum_probs=185.7
Q ss_pred eecccCCeEEEEEEECC--------CCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 935 MIGSGGFGEVYKAQLRD--------GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 935 ~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
.||+|+||.||+|.... ...+|+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 68999999999998752 2247777765433334457888999999999999999999999989999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCc--------eEEeeccc
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFE--------ARVSDFGM 1078 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~--------vkl~DfGl 1078 (1237)
++|+|.++++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++. ++++|||.
T Consensus 82 ~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 82 KFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999997642 3678999999999999999999999 9999999999999987665 69999999
Q ss_pred ceeeccCCcceeeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCC-CCCCCCCCCCCchHHHHHHHHhhhc
Q 000889 1079 ARLVNALDTHLSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGK-RPIDPSEFGDDNNLVGWAKQLHREK 1156 (1237)
Q Consensus 1079 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~ 1156 (1237)
+...... ....++..|+|||++.+ ..++.++||||||+++|||++|. .||..... ........ .
T Consensus 155 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~------~~~~~~~~--~ 220 (258)
T cd05078 155 SITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS------QKKLQFYE--D 220 (258)
T ss_pred ccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH------HHHHHHHH--c
Confidence 8654321 23467889999999986 45789999999999999999995 55442211 00001000 0
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 000889 1157 RINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFK 1205 (1237)
Q Consensus 1157 ~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 1205 (1237)
...++ .. ...++.+++.+||+.+|++|||+.++++.|+
T Consensus 221 ------~~~~~--~~---~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 ------RHQLP--AP---KWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------cccCC--CC---CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01111 11 1135678888999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=311.49 Aligned_cols=273 Identities=28% Similarity=0.406 Sum_probs=213.7
Q ss_pred CCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCc---CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 930 FSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQ---GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
|+..+.||+|+||.||+|+.. ++..||+|++...... ....+.+|++++++++|||++++++++..++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 666788999999999999976 5789999988643222 234688899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
++ |++.+++... ...+++..+..++.+++.|+.|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 107 CL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred CC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 97 5787776543 24689999999999999999999999 9999999999999999999999999998754321
Q ss_pred CcceeeeccccCCCcCCccccC---ccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccccccc
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQ---SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1162 (1237)
....|++.|+|||++. +..++.++|||||||++|||++|+.||.... ..... ........
T Consensus 179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-----~~~~~-~~~~~~~~----- 241 (317)
T cd06635 179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSAL-YHIAQNES----- 241 (317)
T ss_pred ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc-----HHHHH-HHHHhccC-----
Confidence 2346888999999973 4568899999999999999999999986421 11111 11111100
Q ss_pred CccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccccCCCCCCccCchhhHHHHHHHh
Q 000889 1163 DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGDSLDSFSLKDTVIEELRER 1232 (1237)
Q Consensus 1163 ~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 1232 (1237)
+.. ........+.+++.+|++.+|.+||++.+++++...+....+....+...+.+++.++++..
T Consensus 242 -~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (317)
T cd06635 242 -PTL----QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLIDLIQRTKDAVRELDNL 306 (317)
T ss_pred -CCC----CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcccchhhHHHHHHHHHHHHhhh
Confidence 000 01112235678888999999999999999999998888777776667777777777776654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=306.26 Aligned_cols=256 Identities=29% Similarity=0.433 Sum_probs=199.2
Q ss_pred HhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhc-CCCCcccccceEEeCC------
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGE------ 997 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------ 997 (1237)
++++|++.+.||+|+||.||+|+.+ +++.+++|.+.... ...+.+.+|+.+++++ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678999999999999999999986 56789999875433 3456788999999999 6999999999997644
Q ss_pred eEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecc
Q 000889 998 ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFG 1077 (1237)
Q Consensus 998 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfG 1077 (1237)
..++||||+++++|.++++.... ....+++..+..++.|+++|++|||+. +++|+||+|+||++++++.+|++|||
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 48999999999999999876431 135789999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcceeeeccccCCCcCCccccCc-----cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHH
Q 000889 1078 MARLVNALDTHLSVSTLAGTPGYVPPEYYQS-----FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQL 1152 (1237)
Q Consensus 1078 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 1152 (1237)
++........ ......|+..|+|||++.. ..++.++||||+|+++|+|++|+.||..... ...... .
T Consensus 159 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~-~ 230 (275)
T cd06608 159 VSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP-----MRALFK-I 230 (275)
T ss_pred cceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch-----HHHHHH-h
Confidence 9976543221 2234568899999998753 3467889999999999999999999863211 111111 0
Q ss_pred hhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1153 HREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1153 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
. ....+... ........+.+++.+|+..||++|||+.+++++
T Consensus 231 ~------~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 231 P------RNPPPTLK---SPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred h------ccCCCCCC---chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 00011111 111133467788999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=290.10 Aligned_cols=254 Identities=22% Similarity=0.347 Sum_probs=194.7
Q ss_pred CceecccCCeEEEEEEEC-CCCEEEEEEeccccC-cCHHHHHHHHHHHH-hcCCCCcccccceEEeCCeEEEEEEeccCC
Q 000889 933 DSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG-QGDREFMAEMETIG-KIKHRNLVPLLGYCKIGEERLLVYEYMKWG 1009 (1237)
Q Consensus 933 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 1009 (1237)
...||.|+||+|++..++ .|+..|||++..... .+.+++..|.+... .-++||||++||.+-.++..|+.||.|+ .
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence 346999999999999887 589999999975544 33456777887644 4479999999999988999999999997 6
Q ss_pred CHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcce
Q 000889 1010 SLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHL 1089 (1237)
Q Consensus 1010 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~ 1089 (1237)
+++.+......-....+++...-.|....+.||.||-... .|+||||||+|||++..|.||+||||.+..+.. ..
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~---Si 222 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD---SI 222 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH---HH
Confidence 7776654332222357888888899999999999999886 899999999999999999999999999875532 22
Q ss_pred eeeccccCCCcCCccccCc--cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcccc
Q 000889 1090 SVSTLAGTPGYVPPEYYQS--FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELT 1167 (1237)
Q Consensus 1090 ~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1167 (1237)
..+..+|...|||||.+.. ..|+-+|||||+|+++||+.||..||.. |.....+-..+..--.|.+.
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~-----------w~svfeql~~Vv~gdpp~l~ 291 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK-----------WDSVFEQLCQVVIGDPPILL 291 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch-----------HHHHHHHHHHHHcCCCCeec
Confidence 3355678999999999863 3589999999999999999999999862 33322222221111111222
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1168 MQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1168 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
....+......+.+++.-|+.+|-.+||.+.++.++
T Consensus 292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 222223344567888889999999999999999876
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=304.32 Aligned_cols=254 Identities=25% Similarity=0.415 Sum_probs=202.1
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
++|+..+.||+|+||.||+|.++ +++.+|+|++.... ....+++.+|++++++++||||+++++++......++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999987 57889999886543 23345688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH-SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
+++++|.+++.... ..+++....+++.|+++|++|+|+ . +++||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 81 MDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred cCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 99999999987642 468889999999999999999999 7 999999999999999999999999999875532
Q ss_pred CCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCc
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDP 1164 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1164 (1237)
... ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||....... .............. .+
T Consensus 154 ~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~------~~ 222 (265)
T cd06605 154 SLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEP------PP 222 (265)
T ss_pred HHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCC------CC
Confidence 211 12568889999999998899999999999999999999999986542111 11111111111110 01
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1165 ELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1165 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
... .......+.+++.+|+..+|++|||+.+++++
T Consensus 223 ~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 223 RLP----SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCC----hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 111 01123457788899999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=304.47 Aligned_cols=262 Identities=26% Similarity=0.356 Sum_probs=200.7
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeC--CeEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIG--EERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 1003 (1237)
++|+..+.||.|++|.||+|.+. +++.+|+|.+..... .....+.+|++++++++||||+++++++... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788899999999999999986 578889998764322 2345688999999999999999999988653 4689999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+++++|.+++..... ....+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999999998865432 235678899999999999999999999 99999999999999999999999999987543
Q ss_pred cCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccC
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
.... ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||........ ............. .... .
T Consensus 157 ~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~-~~~~-~ 229 (287)
T cd06621 157 NSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIELLSYIVNMP-NPEL-K 229 (287)
T ss_pred cccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHHHHHHHhcCC-chhh-c
Confidence 2211 234578899999999988999999999999999999999999986532111 1111111111111 0010 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.... ........+.+++.+|++.+|.+|||+.|++++
T Consensus 230 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 230 DEPG---NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred cCCC---CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0000 001123457789999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=342.96 Aligned_cols=253 Identities=28% Similarity=0.385 Sum_probs=198.0
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
+-+|+...+||.|.||.||-|... +|+..|+|-+.-.. ....+.+.+|+.++..++|||+|++||+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 346778889999999999999865 58888999775322 223346788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
|||++|+|.+.++.. +..++.....+..|++.|++|||+. |||||||||.||+++.+|.+|.+|||.|..+.
T Consensus 1314 EyC~~GsLa~ll~~g-----ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHG-----RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHhccCcHHHHHHhc-----chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEec
Confidence 999999999999763 3567777788899999999999999 99999999999999999999999999998876
Q ss_pred cCCc--ceeeeccccCCCcCCccccCcc---ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccc
Q 000889 1084 ALDT--HLSVSTLAGTPGYVPPEYYQSF---RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158 (1237)
Q Consensus 1084 ~~~~--~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1158 (1237)
.... ........||+.|||||++.+. ....++||||+|||+.||+||++||.... ..+.-+.. ...+..
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d----ne~aIMy~--V~~gh~ 1459 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD----NEWAIMYH--VAAGHK 1459 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc----chhHHHhH--HhccCC
Confidence 5321 1223467899999999999753 46678999999999999999999997432 12221111 111111
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1159 NEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1159 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
|.++.. -.. +=.+++.+|+..||+.|+++.|++++
T Consensus 1460 -----Pq~P~~--ls~---~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 -----PQIPER--LSS---EGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -----CCCchh--hhH---hHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 222111 122 23356679999999999999988865
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=309.45 Aligned_cols=261 Identities=26% Similarity=0.331 Sum_probs=199.7
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
+|++.+.||+|+||.||+|++. +++.||+|++.... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999986 68899999886433 23346788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
+ +++|.+++.... ..+++..++.++.|+++||+|||+. +++|+||||+||+++.++.++++|||++......
T Consensus 81 ~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 999999987542 4689999999999999999999999 9999999999999999999999999999866543
Q ss_pred CcceeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcc-------
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKR------- 1157 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 1157 (1237)
.. .......++..|+|||++.+. .++.++||||+|+++|||++|.+||..... ...+.........
T Consensus 153 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07832 153 EP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-----IEQLAIVFRTLGTPNEETWP 226 (286)
T ss_pred CC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-----HHHHHHHHHHcCCCChHHHh
Confidence 22 122345688999999998654 468899999999999999999887754321 1111111100000
Q ss_pred -------ccccc---CccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1158 -------INEIL---DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1158 -------~~~~~---~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
...+. ..........+.....+.+++.+|++.+|++|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 00000000001122567788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=299.55 Aligned_cols=249 Identities=23% Similarity=0.399 Sum_probs=198.7
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
+|+..+.||+|+||.||+|... +++.+|+|++.... ......+.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999875 57889999886432 23345788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCC-CceEEeecccceeecc
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDEN-FEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~-~~vkl~DfGla~~~~~ 1084 (1237)
+++++|.+++.... +..+++..+.+++.++++|++|||++ +++||||||+||+++.+ +.+|++|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 99999999997643 24689999999999999999999999 99999999999999854 4689999999986643
Q ss_pred CCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCc
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDP 1164 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1164 (1237)
... .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||...... ......... ....
T Consensus 155 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~~~-~~~~---- 220 (256)
T cd08220 155 KSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIMSG-TFAP---- 220 (256)
T ss_pred Ccc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHHhc-CCCC----
Confidence 221 12356888999999999888999999999999999999999998653211 111111111 0000
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1165 ELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1165 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.. . .....+.+++.+||+.+|++|||+.+++++
T Consensus 221 -~~--~---~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 221 -IS--D---RYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -CC--C---CcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 00 0 122356788889999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=302.25 Aligned_cols=201 Identities=29% Similarity=0.438 Sum_probs=177.6
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 1002 (1237)
.+.|+.-++||+|+||.||-++.+ +|+.+|.|++.+.. ...+.....|-.++++++.+.||.+-.+|++.+..|+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 456788889999999999999876 58899998875422 23445578899999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceee
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~ 1082 (1237)
|..|.||+|.-++.... ...+++..+..++.+|+.||++||.. +||+||+||+|||+|+.|+|+|+|.|+|..+
T Consensus 264 LtlMNGGDLkfHiyn~g---~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHG---NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEeecCCceeEEeeccC---CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence 99999999988876542 25789999999999999999999999 9999999999999999999999999999987
Q ss_pred ccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCC
Q 000889 1083 NALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDP 1136 (1237)
Q Consensus 1083 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~ 1136 (1237)
..... ....+||.+|||||++.++.|+...|+||+||++|||+.|+.||..
T Consensus 338 ~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 338 PEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred CCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 65443 3456899999999999999999999999999999999999999964
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=310.08 Aligned_cols=206 Identities=25% Similarity=0.371 Sum_probs=172.1
Q ss_pred CCCCCceecccCCeEEEEEEECC---CCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeC--CeEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLRD---GSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIG--EERL 1000 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 1000 (1237)
+|++.+.||+|+||.||+|+... +..||+|.+.... ....+.+.+|+.++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47888999999999999999864 7899999887532 33345678899999999999999999999888 7899
Q ss_pred EEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCC----CCceEEeec
Q 000889 1001 LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE----NFEARVSDF 1076 (1237)
Q Consensus 1001 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~----~~~vkl~Df 1076 (1237)
+||||++ +++.+++..........+++..++.++.|++.|++|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999997 5777777654443334789999999999999999999999 9999999999999999 999999999
Q ss_pred ccceeeccCCc-ceeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCC
Q 000889 1077 GMARLVNALDT-HLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSE 1138 (1237)
Q Consensus 1077 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~ 1138 (1237)
|+++....... ........++..|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 99986543222 1122345678899999988764 57899999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=306.80 Aligned_cols=248 Identities=24% Similarity=0.380 Sum_probs=197.7
Q ss_pred CCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccC
Q 000889 930 FSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
|...+.||+|++|.||+|... +++.+++|++........+.+.+|+.++++++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444568999999999999875 6788999988644444455688999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
++|.+++.. ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+........
T Consensus 101 ~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~- 170 (285)
T cd06648 101 GALTDIVTH------TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP- 170 (285)
T ss_pred CCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence 999999875 2578899999999999999999999 999999999999999999999999998865432211
Q ss_pred eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccC
Q 000889 1089 LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTM 1168 (1237)
Q Consensus 1089 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1168 (1237)
......|++.|+|||++.+..++.++||||+|+++|||++|+.||..... .......... . .+....
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~~~~-~-----~~~~~~ 237 (285)
T cd06648 171 -RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRIRDN-L-----PPKLKN 237 (285)
T ss_pred -ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHhc-C-----CCCCcc
Confidence 12335688999999999888899999999999999999999999864321 1111111111 0 011111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1169 QTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1169 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
. ......+.+++.+|++.+|++|||+.+++++
T Consensus 238 ~---~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 238 L---HKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred c---ccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 1 1122357788889999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-35 Score=323.35 Aligned_cols=373 Identities=29% Similarity=0.386 Sum_probs=214.4
Q ss_pred CCCCceeeccCccccCcccchhhcccccceEEEecCCccCCCCchhhhccCCCCcEEecCCCcCCCCCchhHhhhcCCCc
Q 000889 298 CGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLR 377 (1237)
Q Consensus 298 l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~l~~L~ 377 (1237)
++-.+-.++++|.+++..+|+.+..+++++.|.|...++. .+|.. ++.+.+|++|.+++|++. .+-.++.. ++.|+
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeE-L~~lqkLEHLs~~HN~L~-~vhGELs~-Lp~LR 81 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEE-LSRLQKLEHLSMAHNQLI-SVHGELSD-LPRLR 81 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHH-HHHHhhhhhhhhhhhhhH-hhhhhhcc-chhhH
Confidence 4445556777777776667777777777777777666665 44443 355555666666665555 33333332 24555
Q ss_pred EEEcccCcCCCC-CCcCcccccccceeeccCccccCcccchhccccccceEEeccCCCCCCCCCccCCCCCCCcEEEccC
Q 000889 378 ELDLSSNRLTGE-LPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSS 456 (1237)
Q Consensus 378 ~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~ 456 (1237)
.+++.+|++... +|..+..+..|..|||++|+++ ..|..+..-+++-+|+||+
T Consensus 82 sv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~--------------------------EvP~~LE~AKn~iVLNLS~ 135 (1255)
T KOG0444|consen 82 SVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR--------------------------EVPTNLEYAKNSIVLNLSY 135 (1255)
T ss_pred HHhhhccccccCCCCchhcccccceeeecchhhhh--------------------------hcchhhhhhcCcEEEEccc
Confidence 555555555321 3444444555555555555544 4566666666777777777
Q ss_pred CcCcccCCCCCCCCCCCcccceecccCceeeecccccccccccccEecccCCccccCCCccccCCcCcceeecccccccC
Q 000889 457 NGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTG 536 (1237)
Q Consensus 457 N~l~~~~p~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 536 (1237)
|+|. .||..++ .++..|-.|+|++|++. .+|..+..+..|++|+|++|.+....-..+-.+++|+.|.+++.+-+
T Consensus 136 N~Ie-tIPn~lf--inLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRT- 210 (1255)
T KOG0444|consen 136 NNIE-TIPNSLF--INLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRT- 210 (1255)
T ss_pred Cccc-cCCchHH--HhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccch-
Confidence 7776 4554443 34555555566666655 45555666666666666666655332223333444444444443322
Q ss_pred cccccccccCCCccEEEccccccccccccccccCCCccEEEeecccccccCCccccCccccceEEecCCccccCCCCCCC
Q 000889 537 EIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLG 616 (1237)
Q Consensus 537 ~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~l~ 616 (1237)
..-+|.++..+.+|..+|||.|.+. .+|+.+.++++|+.|+||+|+|+ .+--..+
T Consensus 211 -----------------------l~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~ 265 (1255)
T KOG0444|consen 211 -----------------------LDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEG 265 (1255)
T ss_pred -----------------------hhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHH
Confidence 1134555555555555555555555 55555555555555555555555 3444444
Q ss_pred CCCCCCEEECCCCccccCCChhHHhhcccccCccccCccceeeccCCCccccCCCCcccccCCCccccCCCccccCCCCc
Q 000889 617 KCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPST 696 (1237)
Q Consensus 617 ~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (1237)
...+|++|+||.|+|+ .+|..+..++
T Consensus 266 ~W~~lEtLNlSrNQLt-~LP~avcKL~----------------------------------------------------- 291 (1255)
T KOG0444|consen 266 EWENLETLNLSRNQLT-VLPDAVCKLT----------------------------------------------------- 291 (1255)
T ss_pred HHhhhhhhccccchhc-cchHHHhhhH-----------------------------------------------------
Confidence 4555555555555555 4555544432
Q ss_pred ceeccceeeeeccCCceeEEEccCCcCC-ccCCccccCCCCCcEEEecCcccccccccccccccCCcEEeCCCCccCCCC
Q 000889 697 RIYTGMTMYTFTTNGSLIYLDLSYNSLS-GTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSI 775 (1237)
Q Consensus 697 ~~~~~~~~~~f~~~~~L~~LdLs~N~l~-g~~p~~~~~L~~L~~L~Ls~N~l~~~~P~~~~~L~~L~~L~Ls~N~l~~~~ 775 (1237)
+|+.|.+.+|+++ .-||.-+|.|.+|+++.+++|+|. ..|+.++...+|+.|.|++|++- .+
T Consensus 292 ---------------kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TL 354 (1255)
T KOG0444|consen 292 ---------------KLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TL 354 (1255)
T ss_pred ---------------HHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-ec
Confidence 2334444445443 136777777777777777777777 77777777777777777777776 67
Q ss_pred CCcccCcccccceecccccccccCCC
Q 000889 776 PGSLGGLSFLSDLDVSNNNLSGIIPS 801 (1237)
Q Consensus 776 p~~~~~l~~L~~l~l~~N~l~g~~p~ 801 (1237)
|+.+.-|+.|..|||.+|+=---||.
T Consensus 355 PeaIHlL~~l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 355 PEAIHLLPDLKVLDLRENPNLVMPPK 380 (1255)
T ss_pred hhhhhhcCCcceeeccCCcCccCCCC
Confidence 77777777777777777754444443
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=308.99 Aligned_cols=263 Identities=25% Similarity=0.310 Sum_probs=197.6
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCc-----CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQ-----GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 1002 (1237)
+|+..+.||+|+||.||+|... +++.||+|++...... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999976 5889999998654322 234567899999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceee
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~ 1082 (1237)
|||+ +|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred Eccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 9999 899999987532 3689999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCcceeeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhh-------
Q 000889 1083 NALDTHLSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR------- 1154 (1237)
Q Consensus 1083 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------- 1154 (1237)
...... .....+++.|+|||.+.+ ..++.++|||||||++|||++|.+||...... ..+.........
T Consensus 153 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 153 GSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI--DQLGKIFEALGTPTEENWP 228 (298)
T ss_pred cCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH--HHHHHHHHHcCCCchhhhh
Confidence 543221 223456788999998864 45788999999999999999998777643211 111111000000
Q ss_pred -hcccccccCccccCCC----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1155 -EKRINEILDPELTMQT----SDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1155 -~~~~~~~~~~~l~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
................ ........+.+++.+|++++|++|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000000000 001123467789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=303.06 Aligned_cols=247 Identities=27% Similarity=0.436 Sum_probs=196.1
Q ss_pred CCCCCCceecccCCeEEEEEEECCCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEecc
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMK 1007 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 1007 (1237)
++|++.+.||+|+||.||++.. .++.||+|+.... ...+.+.+|+.++++++|||++++++++.. +..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCC
Confidence 3588899999999999999976 4788999987532 234678899999999999999999999865 45799999999
Q ss_pred CCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCc
Q 000889 1008 WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDT 1087 (1237)
Q Consensus 1008 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~ 1087 (1237)
+++|.+++.... ...+++..+..++.|+++|++|||+. +++||||||+||+++.++.+||+|||.+.......
T Consensus 82 ~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 82 KGNLVNFLRTRG---RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 999999997642 24678999999999999999999999 99999999999999999999999999997543211
Q ss_pred ceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccc
Q 000889 1088 HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1088 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
.....+..|+|||++.+..++.++||||+|+++|||++ |+.||..... ............ ...
T Consensus 155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~~~------~~~ 218 (254)
T cd05083 155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL------KEVKECVEKGYR------MEP 218 (254)
T ss_pred ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH------HHHHHHHhCCCC------CCC
Confidence 12234568999999988889999999999999999997 9999864321 111111111100 000
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 1206 (1237)
. ......+.+++.+||+.+|++||++.++++.|++
T Consensus 219 --~---~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 --P---EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --C---CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0 1122456788889999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=303.02 Aligned_cols=251 Identities=21% Similarity=0.332 Sum_probs=193.8
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC-----cCHHHHHHHHHHHHhcCCCCcccccceEEeC--CeE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG-----QGDREFMAEMETIGKIKHRNLVPLLGYCKIG--EER 999 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 999 (1237)
++|++.+.||+|+||.||+|+.. ++..||+|++..... ...+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999876 488999998753221 1134678899999999999999999988763 467
Q ss_pred EEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccc
Q 000889 1000 LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1079 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla 1079 (1237)
++||||+++++|.+++... ..+++....+++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccc
Confidence 8999999999999998753 3578888899999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcc-eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccc
Q 000889 1080 RLVNALDTH-LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158 (1237)
Q Consensus 1080 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1158 (1237)
+........ .......++..|+|||++.+..++.++||||||+++|||++|+.||.... ....... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-----~~~~~~~-~~~~~-- 225 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE-----AMAAIFK-IATQP-- 225 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc-----hHHHHHH-HhcCC--
Confidence 765432111 11233458889999999988889999999999999999999999986321 1111111 10000
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1159 NEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1159 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
..+. ........+..++.+|+. +|++||++.+++++
T Consensus 226 ---~~~~-----~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 ---TNPV-----LPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ---CCCC-----CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0111 112223456677788884 89999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=308.81 Aligned_cols=265 Identities=23% Similarity=0.344 Sum_probs=195.3
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
++|++.+.||+|+||.||+|+.+ +++.||+|.+..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999987 578999998864322 2234567899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
++ ++|.+++.... ..+++..++.++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~-~~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 85 LD-TDLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred CC-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 98 59999886532 3678999999999999999999999 9999999999999999999999999998754321
Q ss_pred CcceeeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhh--hcc-----
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR--EKR----- 1157 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~----- 1157 (1237)
.. ......++..|+|||++.+ ..++.++||||+|+++|||++|+.||...... ........+.... ...
T Consensus 157 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 157 SK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV-EDQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred Cc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH-HHHHHHHHHhcCCCChhhhhhhh
Confidence 11 1123346789999999875 45788999999999999999999999643210 0000000000000 000
Q ss_pred -cccccC--------ccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1158 -INEILD--------PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1158 -~~~~~~--------~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
...... ...............+.+++.+|++.+|++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000000 0000000000011456688899999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=309.92 Aligned_cols=265 Identities=25% Similarity=0.330 Sum_probs=199.3
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
++|++.+.||+|+||.||+|+++ +++.||+|++.... ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999987 47889999876432 2234678899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
|++++.+..+.... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 81 YVERTLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred cCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 99987776655432 3578999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcceeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHh----------
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLH---------- 1153 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------- 1153 (1237)
... .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||...... ...........
T Consensus 153 ~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07833 153 RPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI--DQLYLIQKCLGPLPPSHQELF 229 (288)
T ss_pred Ccc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHhhhc
Confidence 332 122345678899999999887 7899999999999999999999998743211 11110000000
Q ss_pred -hhcccc-----cccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1154 -REKRIN-----EILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1154 -~~~~~~-----~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
...... ...++.............++.+++.+||..+|++||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000000 00000000000001113567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-35 Score=342.69 Aligned_cols=462 Identities=28% Similarity=0.352 Sum_probs=375.5
Q ss_pred CCEEEccCCCCCchhhhhcccCCCccEEEcccccccCccchhhhhccCCCccEEeCCCCcCCCCcccccccCCCCCceee
Q 000889 226 LNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVIT 305 (1237)
Q Consensus 226 L~~L~Ls~n~l~~~~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~ 305 (1237)
++.|+++.|-+-...-+...++-+|+.||||+|++. ..|... ....+|+.|+++.|-|.... .....+.+|++|.
T Consensus 23 ~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~i--t~l~~L~~ln~s~n~i~~vp--~s~~~~~~l~~ln 97 (1081)
T KOG0618|consen 23 LQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQI--TLLSHLRQLNLSRNYIRSVP--SSCSNMRNLQYLN 97 (1081)
T ss_pred HHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchh--hhHHHHhhcccchhhHhhCc--hhhhhhhcchhhe
Confidence 778888888765443444556667999999999987 455443 34578999999999887433 4578899999999
Q ss_pred ccCccccCcccchhhcccccceEEEecCCccCCCCchhhhccCCCCcEEecCCCcCCCCCchhHhhhcCCCcEEEcccCc
Q 000889 306 LSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNR 385 (1237)
Q Consensus 306 L~~n~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~l~~L~~L~Ls~N~ 385 (1237)
|.+|++. ..|..+..+++|++|++|.|.+. .+|.. +..+..+..+..++|... ..+++ ..++.++|..|.
T Consensus 98 L~~n~l~--~lP~~~~~lknl~~LdlS~N~f~-~~Pl~-i~~lt~~~~~~~s~N~~~----~~lg~--~~ik~~~l~~n~ 167 (1081)
T KOG0618|consen 98 LKNNRLQ--SLPASISELKNLQYLDLSFNHFG-PIPLV-IEVLTAEEELAASNNEKI----QRLGQ--TSIKKLDLRLNV 167 (1081)
T ss_pred eccchhh--cCchhHHhhhcccccccchhccC-CCchh-HHhhhHHHHHhhhcchhh----hhhcc--ccchhhhhhhhh
Confidence 9999984 47899999999999999999998 56654 567888999999999322 12222 238889999999
Q ss_pred CCCCCCcCcccccccceeeccCccccCcccchhccccccceEEeccCCCCCCCCCccCCCCCCCcEEEccCCcCcccCCC
Q 000889 386 LTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPS 465 (1237)
Q Consensus 386 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~ 465 (1237)
+.+.++..+..++. .|+|.+|.+. ......+.+|+.|.+..|+++... -.-++|+.|+.++|.++...+.
T Consensus 168 l~~~~~~~i~~l~~--~ldLr~N~~~----~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~~ 237 (1081)
T KOG0618|consen 168 LGGSFLIDIYNLTH--QLDLRYNEME----VLDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDVH 237 (1081)
T ss_pred cccchhcchhhhhe--eeecccchhh----hhhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeeccc
Confidence 99888888888877 8999999986 245678899999999999988442 2357899999999999844332
Q ss_pred CCCCCCCCcccceecccCceeeecccccccccccccEecccCCccccCCCccccCCcCcceeecccccccCccccccccc
Q 000889 466 GFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVN 545 (1237)
Q Consensus 466 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~ 545 (1237)
..-.+|+.++++.|+++ .+|.+++.+.+|+.|+..+|+++ .+|..+..+.+|+.|.+.+|.+. .+|+.. ..
T Consensus 238 -----p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~l-e~ 308 (1081)
T KOG0618|consen 238 -----PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFL-EG 308 (1081)
T ss_pred -----cccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcc-cc
Confidence 23468999999999999 45699999999999999999997 89999999999999999999999 676644 45
Q ss_pred CCCccEEEcccccccccccccc-ccCC-CccEEEeecccccccCCcc-ccCccccceEEecCCccccCCCCCCCCCCCCC
Q 000889 546 GGNLETLILNNNHLTGAIPKSI-ASCT-NMLWVSLSSNQLTGEIPAG-IGNLVKLAILQLGNNSLTGQVPQGLGKCRSLV 622 (1237)
Q Consensus 546 l~~L~~L~Ls~N~l~~~~p~~~-~~l~-~L~~L~Ls~N~l~~~~p~~-~~~L~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 622 (1237)
++.|++|+|..|+|. ..|+.+ .-+. +|..|+.+.|++. ..|.. =..++.|+.|.+.+|.++...-+.+.+...|+
T Consensus 309 ~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLK 386 (1081)
T KOG0618|consen 309 LKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLK 386 (1081)
T ss_pred cceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHHHHhcCcccccchhhhcccccee
Confidence 789999999999999 555544 3333 3788999999998 55522 23467899999999999988888899999999
Q ss_pred EEECCCCccccCCChhHHhhcccccCccccCccceeeccCCCccccCCCCcccccCCCccccCCCccccCCCCcceeccc
Q 000889 623 WLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGM 702 (1237)
Q Consensus 623 ~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (1237)
.|+|++|+|. ++|...-
T Consensus 387 VLhLsyNrL~-~fpas~~-------------------------------------------------------------- 403 (1081)
T KOG0618|consen 387 VLHLSYNRLN-SFPASKL-------------------------------------------------------------- 403 (1081)
T ss_pred eeeecccccc-cCCHHHH--------------------------------------------------------------
Confidence 9999999997 6665421
Q ss_pred eeeeeccCCceeEEEccCCcCCccCCccccCCCCCcEEEecCcccccccccccccccCCcEEeCCCCccCCC-CCCcccC
Q 000889 703 TMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGS-IPGSLGG 781 (1237)
Q Consensus 703 ~~~~f~~~~~L~~LdLs~N~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~P~~~~~L~~L~~L~Ls~N~l~~~-~p~~~~~ 781 (1237)
..+..|++|+||+|+|+ .+|.++..+..|++|...+|++. ..| .+..+++|+++|+|.|+|+.. +|...-.
T Consensus 404 -----~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~ 475 (1081)
T KOG0618|consen 404 -----RKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS 475 (1081)
T ss_pred -----hchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCC
Confidence 12236899999999998 89999999999999999999999 788 899999999999999999853 4544433
Q ss_pred cccccceecccccc
Q 000889 782 LSFLSDLDVSNNNL 795 (1237)
Q Consensus 782 l~~L~~l~l~~N~l 795 (1237)
++|++|||++|.-
T Consensus 476 -p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 476 -PNLKYLDLSGNTR 488 (1081)
T ss_pred -cccceeeccCCcc
Confidence 8999999999974
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-35 Score=323.09 Aligned_cols=363 Identities=27% Similarity=0.399 Sum_probs=279.5
Q ss_pred CEEEccCCCCC-chhhhhcccCCCccEEEcccccccCccchhhhhccCCCccEEeCCCCcCCCCcccccccCCCCCceee
Q 000889 227 NLLNFSDNKLP-GKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVIT 305 (1237)
Q Consensus 227 ~~L~Ls~n~l~-~~~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~ 305 (1237)
+-.|+++|.++ +..|.....+++++.|.|....+. .+|..+. .+.+|++|.+++|+++... ..+..++.|+.+.
T Consensus 10 rGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~--~lqkLEHLs~~HN~L~~vh--GELs~Lp~LRsv~ 84 (1255)
T KOG0444|consen 10 RGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELS--RLQKLEHLSMAHNQLISVH--GELSDLPRLRSVI 84 (1255)
T ss_pred ecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHH--HHhhhhhhhhhhhhhHhhh--hhhccchhhHHHh
Confidence 33455555554 235555555566666666555554 4444442 2456677777777665322 2456788899999
Q ss_pred ccCccccCcccchhhcccccceEEEecCCccCCCCchhhhccCCCCcEEecCCCcCCCCCchhHhhhcCCCcEEEcccCc
Q 000889 306 LSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNR 385 (1237)
Q Consensus 306 L~~n~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~l~~L~~L~Ls~N~ 385 (1237)
+..|++...++|..+..+..|+.||||+|++. ..|.. +..-+++-.|+|++|+|. .||..++-.+..|-.||||+|+
T Consensus 85 ~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~-LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~Nr 161 (1255)
T KOG0444|consen 85 VRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTN-LEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNR 161 (1255)
T ss_pred hhccccccCCCCchhcccccceeeecchhhhh-hcchh-hhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccch
Confidence 99999988889999999999999999999998 66664 567789999999999998 9999999988999999999999
Q ss_pred CCCCCCcCcccccccceeeccCccccCcccchhccccccceEEeccCCCCC-CCCCccCCCCCCCcEEEccCCcCcccCC
Q 000889 386 LTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNIS-GPVPLSLTNCTQLRVLDLSSNGFTGTIP 464 (1237)
Q Consensus 386 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~l~~l~~L~~L~Ls~N~l~~~~p 464 (1237)
+. .+|..+..+..|++|+|++|.+. .+....+..+++|+.|.+++.+-+ ..+|.++..+.+|+.+|+|.|.+. .+|
T Consensus 162 Le-~LPPQ~RRL~~LqtL~Ls~NPL~-hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vP 238 (1255)
T KOG0444|consen 162 LE-MLPPQIRRLSMLQTLKLSNNPLN-HFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVP 238 (1255)
T ss_pred hh-hcCHHHHHHhhhhhhhcCCChhh-HHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cch
Confidence 98 67778899999999999999886 233344566778888888886544 467889999999999999999988 677
Q ss_pred CCCCCCCCCcccceecccCceeeecccccccccccccEecccCCccccCCCccccCCcCcceeeccccccc-Cccccccc
Q 000889 465 SGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLT-GEIPEGIC 543 (1237)
Q Consensus 465 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~ip~~~~ 543 (1237)
+.+ -++++|+.|+|++|+|+ .+....+.+.+|++|+||.|+++ .+|.++.+|++|+.|.+.+|++. .-||.++
T Consensus 239 ecl---y~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGI- 312 (1255)
T KOG0444|consen 239 ECL---YKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGI- 312 (1255)
T ss_pred HHH---hhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccch-
Confidence 766 36788899999999988 45556777888999999999998 88999999999999999888876 2466666
Q ss_pred ccCCCccEEEccccccccccccccccCCCccEEEeecccccccCCccccCccccceEEecCCccc
Q 000889 544 VNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLT 608 (1237)
Q Consensus 544 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~ 608 (1237)
..+.+|+.+..++|.+. .+|+.++.|..|+.|.|+.|++. .+|+.|.-|+.|+.|||.+|.-.
T Consensus 313 GKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 313 GKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred hhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence 45667777777777777 77777777777777777777777 67777777777777777777543
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=306.75 Aligned_cols=245 Identities=25% Similarity=0.338 Sum_probs=198.8
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++..+...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888999999999999999986 57899999886432 223456888999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+++++|.+++... ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 81 EYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 999999999998764 4688999999999999999999999 99999999999999999999999999998654
Q ss_pred cCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccC
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
.. .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ....+.. .. ..
T Consensus 153 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~-~~-~~------- 213 (290)
T cd05580 153 GR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-----PIQIYEK-IL-EG------- 213 (290)
T ss_pred CC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHH-Hh-cC-------
Confidence 32 234568899999999988888999999999999999999999986433 1111111 11 11
Q ss_pred ccccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRP-----TMIQVMAM 1203 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 1203 (1237)
....+... ...+.+++.+||..+|.+|| ++.+++++
T Consensus 214 -~~~~~~~~---~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 214 -KVRFPSFF---SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred -CccCCccC---CHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 11111111 23566788899999999999 77777755
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=304.03 Aligned_cols=248 Identities=23% Similarity=0.378 Sum_probs=198.0
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccc-cCcCHHHHHHHHHHHHhcC---CCCcccccceEEeCCeEEEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHV-TGQGDREFMAEMETIGKIK---HRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
.|+..+.||+|+||.||+|.+. ++..||+|.+... ......++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4777889999999999999975 6889999987543 2334456888999999997 999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+++++|.++++. ..+++..+..++.|+++|+.|||+. +++||||+|+||+++.++.++++|||++....
T Consensus 82 e~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 82 EYAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred ecCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 99999999998864 2688999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCcceeeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccccccc
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1162 (1237)
.... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ... ......
T Consensus 153 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~------~~~~~~ 218 (277)
T cd06917 153 QNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMM------LIPKSK 218 (277)
T ss_pred CCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhh------ccccCC
Confidence 4332 1234568899999998865 446889999999999999999999997543211 000 000001
Q ss_pred CccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1163 DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1163 ~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.+.+... ....++.+++.+|++.+|++||++.+++++
T Consensus 219 ~~~~~~~----~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 219 PPRLEDN----GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCCCcc----cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1111110 123457788889999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=307.95 Aligned_cols=264 Identities=23% Similarity=0.287 Sum_probs=195.3
Q ss_pred HhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
++++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|++++++++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3467999999999999999999875 588999998864332 22346788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+. +++.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 83 e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 83 EYMH-TDLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred eccc-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 9996 77777765431 3567888889999999999999999 99999999999999999999999999997543
Q ss_pred cCCcceeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHh---------
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLH--------- 1153 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------- 1153 (1237)
..... .....+++.|+|||++.+. .++.++||||+|+++|||++|+.||..... ..........
T Consensus 155 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~----~~~~~~~~~~~~~~~~~~~ 228 (291)
T cd07870 155 IPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD----VFEQLEKIWTVLGVPTEDT 228 (291)
T ss_pred CCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh----HHHHHHHHHHHcCCCChhh
Confidence 32211 2334578899999998754 578899999999999999999999974321 1111000000
Q ss_pred -----hh-cccccccC----ccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1154 -----RE-KRINEILD----PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1154 -----~~-~~~~~~~~----~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.. ........ ...............+.+++.+|+..||.+|||+.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 229 WPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00 00000000 0000000000112356678889999999999999998854
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=301.22 Aligned_cols=253 Identities=29% Similarity=0.445 Sum_probs=199.6
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCc--CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQ--GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
+|++.+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999876 6789999988654332 456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
+++++|.+++... ..+++..+..++.+++.|++|||+. +|+|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 9999999998753 3578889999999999999999999 9999999999999999999999999999876543
Q ss_pred Cccee--eeccccCCCcCCccccCccc---cCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccccc
Q 000889 1086 DTHLS--VSTLAGTPGYVPPEYYQSFR---CTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINE 1160 (1237)
Q Consensus 1086 ~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1160 (1237)
..... .....+++.|+|||++.+.. ++.++||||||+++||+++|+.||..... .. ........ .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~----~~-~~~~~~~~-~---- 222 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN----EF-QIMFHVGA-G---- 222 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc----hH-HHHHHHhc-C----
Confidence 32211 12356788999999998766 88999999999999999999999964321 11 11111010 0
Q ss_pred ccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1161 ILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1161 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
..+.++.. ......+.+++.+|++.+|++|||+.+++++
T Consensus 223 -~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 223 -HKPPIPDS---LQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred -CCCCCCcc---cccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11111111 1112345678889999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=330.32 Aligned_cols=273 Identities=18% Similarity=0.224 Sum_probs=188.2
Q ss_pred HhCCCCCCceecccCCeEEEEEEECC--CCEEEEEE--------------ec---cccCcCHHHHHHHHHHHHhcCCCCc
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLRD--GSVVAIKK--------------LI---HVTGQGDREFMAEMETIGKIKHRNL 986 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~--------------~~---~~~~~~~~~~~~E~~~l~~l~h~ni 986 (1237)
..++|++.+.||+|+||+||++..+. +..+++|. +. .........+.+|++++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45689999999999999999987642 22222220 11 1111123457889999999999999
Q ss_pred ccccceEEeCCeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeC
Q 000889 987 VPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLD 1066 (1237)
Q Consensus 987 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~ 1066 (1237)
+++++++...+..++|+|++. +++.+++...............+..++.|++.||+|||+. +||||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999985 6777777543222122334566778999999999999999 999999999999999
Q ss_pred CCCceEEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCC-CCCCCCCCCchH
Q 000889 1067 ENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRP-IDPSEFGDDNNL 1145 (1237)
Q Consensus 1067 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p-~~~~~~~~~~~~ 1145 (1237)
.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|..+ |..........+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999999876543222 12345799999999999998999999999999999999998764 332211111111
Q ss_pred HHHHHHHhh-hccc-------ccccC-ccccCCC-CCHH------HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1146 VGWAKQLHR-EKRI-------NEILD-PELTMQT-SDET------ELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1146 ~~~~~~~~~-~~~~-------~~~~~-~~l~~~~-~~~~------~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
......... ...+ ...++ ....... ..+. ....+.+++.+|++.||.+|||+.|++++
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 111110000 0000 00000 0000000 0000 11245667889999999999999999875
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=300.97 Aligned_cols=252 Identities=23% Similarity=0.386 Sum_probs=199.3
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEe--CCeEEEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKI--GEERLLVY 1003 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 1003 (1237)
+|++.+.||.|+||.||+|.+. ++..||+|.+.... ....+.+..|++++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999875 57889999875322 2234567889999999999999999998754 45679999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHH-----hcCCCCeeecCCCCCCeeeCCCCceEEeeccc
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLH-----HSCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1078 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-----~~~~~~ivHrDikp~NIll~~~~~vkl~DfGl 1078 (1237)
||+++++|.+++..... ....+++..++.++.|+++|++||| +. +++|+||||+||+++.++.+|++|||+
T Consensus 81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 81 EYCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred hhccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccc
Confidence 99999999999976432 2457899999999999999999999 66 999999999999999999999999999
Q ss_pred ceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccc
Q 000889 1079 ARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158 (1237)
Q Consensus 1079 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1158 (1237)
+......... .....+++.|+|||++.+..++.++||||||+++|+|++|+.||.... ...+..... ....
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~-~~~~ 227 (265)
T cd08217 157 AKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN------QLQLASKIK-EGKF 227 (265)
T ss_pred cccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC------HHHHHHHHh-cCCC
Confidence 9876543221 234568999999999998889999999999999999999999997533 111111111 1111
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1159 NEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1159 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
+.++ ......+.+++.+|++.+|++||++.+++++
T Consensus 228 -----~~~~-----~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 -----RRIP-----YRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -----CCCc-----cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1111 1122467788889999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=304.97 Aligned_cols=262 Identities=23% Similarity=0.314 Sum_probs=196.1
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
+|+..+.||+|+||.||+|+.. ++..||+|++.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999886 58899999886332 22335688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
+. ++|.+++.... ...+++..+..++.|+++|++|||+. +++||||+|+||+++.++.+|++|||+++.....
T Consensus 81 ~~-~~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 81 LH-QDLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred cc-cCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 96 68988886542 24689999999999999999999999 9999999999999999999999999998755432
Q ss_pred CcceeeeccccCCCcCCccccCccc-cCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhh---------
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQSFR-CTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE--------- 1155 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 1155 (1237)
.. ......++..|+|||++.+.. ++.++||||||+++|||++|+.||...... .............
T Consensus 154 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 154 VR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred cc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhhh
Confidence 21 123345688999999887644 588899999999999999999999643211 1111111100000
Q ss_pred ------cccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1156 ------KRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1156 ------~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
..+.......+... .+.....+.+++.+|++.||.+|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKV--VPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHHhhcccccccCHHHH--cccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000000000 00011345678899999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=299.50 Aligned_cols=253 Identities=28% Similarity=0.432 Sum_probs=204.4
Q ss_pred CCCCCCceecccCCeEEEEEEECC-CCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
++|++.+.||+|++|.||+|+... ++.|++|++..... ...+.+.+|++++++++|||++++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368888999999999999999874 88999998865433 3456789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH-SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
+++++|.+++... ..+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 81 MDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred cCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999764 468999999999999999999999 8 999999999999999999999999999986654
Q ss_pred CCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCc
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDP 1164 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1164 (1237)
.... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ............ ..+
T Consensus 153 ~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~~~------~~~ 221 (264)
T cd06623 153 TLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP---SFFELMQAICDG------PPP 221 (264)
T ss_pred CCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc---CHHHHHHHHhcC------CCC
Confidence 3322 12446788999999999888999999999999999999999998654321 111111111111 011
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1165 ELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1165 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.... ......+.+++.+|++.+|++||++.+++++
T Consensus 222 ~~~~----~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 SLPA----EEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCc----ccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1110 0023467788889999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=301.25 Aligned_cols=247 Identities=26% Similarity=0.306 Sum_probs=199.0
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC---cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG---QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
+|++.+.||+|+||.||+|++. ++..||+|.+..... ...+.+.+|++++++++||||+++++++..+...++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999987 588999998864322 235678899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
|+.+++|.+++... ..+++..+..++.|+++|++|||+. +++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 99999999998753 3688999999999999999999999 999999999999999999999999999976543
Q ss_pred CCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCc
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDP 1164 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1164 (1237)
.. ......|+..|+|||++.+..++.++|+||+|+++|+|++|+.||....... .......... .. +
T Consensus 153 ~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~--~~----~ 219 (258)
T cd05578 153 DT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET--AD----V 219 (258)
T ss_pred Cc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc--cc----c
Confidence 22 1234568889999999988889999999999999999999999997543221 1111111110 00 0
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCCCH--HHHH
Q 000889 1165 ELTMQTSDETELYQYLRISFECLDDRPFKRPTM--IQVM 1201 (1237)
Q Consensus 1165 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~--~ell 1201 (1237)
..+ ......+.+++.+||+.+|.+||++ .+++
T Consensus 220 ~~~-----~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 LYP-----ATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCc-----ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111 1112466788889999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-32 Score=307.53 Aligned_cols=268 Identities=22% Similarity=0.290 Sum_probs=196.0
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC--cCHHHHHHHHHHHHhcC-CCCcccccceEEeCCe-----
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG--QGDREFMAEMETIGKIK-HRNLVPLLGYCKIGEE----- 998 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 998 (1237)
++|++.+.||+|+||.||+|++. +++.||+|++..... .....+.+|+.+++++. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999986 588999998754322 22356888999999995 6999999999877665
Q ss_pred EEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCC-CCceEEeecc
Q 000889 999 RLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE-NFEARVSDFG 1077 (1237)
Q Consensus 999 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~-~~~vkl~DfG 1077 (1237)
.++||||+++ +|.+++..........+++..+..++.||++||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 899988765433245789999999999999999999999 9999999999999998 8999999999
Q ss_pred cceeeccCCcceeeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhh-
Q 000889 1078 MARLVNALDTHLSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE- 1155 (1237)
Q Consensus 1078 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~- 1155 (1237)
+++....... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||...... .............
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL--QQLLHIFKLLGTPT 232 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHhCCCC
Confidence 9986543221 1123356888999998865 45789999999999999999999998643210 0011000000000
Q ss_pred -cccccccC-------cccc---CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1156 -KRINEILD-------PELT---MQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1156 -~~~~~~~~-------~~l~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
........ +... .....+.....+.+++.+|++++|.+||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000000 0000 000001123457788999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=305.26 Aligned_cols=254 Identities=23% Similarity=0.386 Sum_probs=194.3
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC-cCHHHHHHHHHH-HHhcCCCCcccccceEEeCCeEEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG-QGDREFMAEMET-IGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
++|++.+.||+|+||.||+|++. +++.||+|++..... .....+..|+.. ++..+||||+++++++..+...++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999987 589999998864322 233455666665 666789999999999999999999999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
|++ |+|.++++..... ...+++..++.++.|++.|++|||++. +++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 7898888764322 357899999999999999999999853 899999999999999999999999999976532
Q ss_pred CCcceeeeccccCCCcCCccccCc----cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccccc
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQS----FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINE 1160 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1160 (1237)
.. ......++..|+|||++.+ ..++.++|+||+|+++|||++|+.||.... .......... ..
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~~-~~----- 223 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK----TPFQQLKQVV-EE----- 223 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc----cCHHHHHHHH-hc-----
Confidence 11 1123467889999998865 456889999999999999999999986321 1111111110 00
Q ss_pred ccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1161 ILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1161 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
..+..+. ......+.+++.+|+..+|++||++.+++++
T Consensus 224 -~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 224 -PSPQLPA----EKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred -CCCCCCc----cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111111 1112357788889999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=304.40 Aligned_cols=253 Identities=28% Similarity=0.427 Sum_probs=202.8
Q ss_pred HhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEE
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
..+.|+..+.||+|+||.||+|.+. ++..|++|++..... ..+.+.+|++++++++|+||+++++++...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4556888889999999999999987 688899998865333 45678899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
|+++++|.+++.... ..+++..+..++.+++.|++|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 96 ~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 96 YMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred ccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 999999999998742 3789999999999999999999998 999999999999999999999999999875543
Q ss_pred CCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCc
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDP 1164 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1164 (1237)
... ......++..|+|||++.+..++.++||||||+++|+|++|+.||..... ..... .... .....
T Consensus 169 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~-----~~~~~-~~~~-~~~~~---- 235 (286)
T cd06614 169 EKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP-----LRALF-LITT-KGIPP---- 235 (286)
T ss_pred chh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-----HHHHH-HHHh-cCCCC----
Confidence 221 12334578899999999888899999999999999999999999864221 11111 1000 00000
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1165 ELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1165 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.. ........+.+++.+|++.+|.+|||+.+++++
T Consensus 236 -~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 236 -LK---NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -Cc---chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00 011122457788899999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=330.80 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=187.0
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEeC---------
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIG--------- 996 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 996 (1237)
.+|+..++||+||||.||+++.+ ||..|||||+.... ......+.+|++.+.+++|||||+++..+.+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 45777789999999999999988 89999999997543 23345688999999999999999998643110
Q ss_pred --------------------------------------------------------------------------------
Q 000889 997 -------------------------------------------------------------------------------- 996 (1237)
Q Consensus 997 -------------------------------------------------------------------------------- 996 (1237)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred ------------------------------CeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHH
Q 000889 997 ------------------------------EERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLH 1046 (1237)
Q Consensus 997 ------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH 1046 (1237)
...||=||||+...+++++++.... -.....++++.+|++||+|+|
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHHHHHHHHHH
Confidence 0136778999988888888764321 146778999999999999999
Q ss_pred hcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec----c------------CCcceeeeccccCCCcCCccccCcc-
Q 000889 1047 HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN----A------------LDTHLSVSTLAGTPGYVPPEYYQSF- 1109 (1237)
Q Consensus 1047 ~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~~- 1109 (1237)
++ |||||||||.||++|++..|||+|||+|+... . .......+..+||.-|+|||++.+.
T Consensus 715 ~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 99 99999999999999999999999999998721 0 1111234568899999999999764
Q ss_pred --ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCC-CCCHHHHHHHHHHHHhc
Q 000889 1110 --RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQ-TSDETELYQYLRISFEC 1186 (1237)
Q Consensus 1110 --~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~l~~li~~c 1186 (1237)
.|+.|+|+||+|||++||+. ||.... . +...+..+-++.++.+ ....+....=.++|++|
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM-----E---------Ra~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~L 854 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSM-----E---------RASILTNLRKGSIPEPADFFDPEHPEEASLIRWL 854 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchH-----H---------HHHHHHhcccCCCCCCcccccccchHHHHHHHHH
Confidence 49999999999999999995 454221 0 1111111112222221 01122223335788899
Q ss_pred cccCCCCCCCHHHHHHH
Q 000889 1187 LDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1187 l~~dP~~RPt~~ell~~ 1203 (1237)
++.||.+||||.|+++.
T Consensus 855 l~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 855 LSHDPSKRPTATELLNS 871 (1351)
T ss_pred hcCCCccCCCHHHHhhc
Confidence 99999999999999863
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=302.18 Aligned_cols=259 Identities=20% Similarity=0.229 Sum_probs=182.5
Q ss_pred CCCCCCceecccCCeEEEEEEECCC----CEEEEEEeccccCcC--H---------HHHHHHHHHHHhcCCCCcccccce
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRDG----SVVAIKKLIHVTGQG--D---------REFMAEMETIGKIKHRNLVPLLGY 992 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~--~---------~~~~~E~~~l~~l~h~niv~l~~~ 992 (1237)
++|++.++||+|+||+||+|++.++ ..+|+|+........ . .....++..++.++|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5799999999999999999998654 345555432211111 0 112233445666789999999997
Q ss_pred EEeCC----eEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCC
Q 000889 993 CKIGE----ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDEN 1068 (1237)
Q Consensus 993 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~ 1068 (1237)
+.... ..++++|++. .++.+.+... ...++..+..++.|+++|++|||+. +|+||||||+||+++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN 162 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence 65543 3467888764 4666666542 2356778889999999999999999 99999999999999999
Q ss_pred CceEEeecccceeeccCCcc-----eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCc
Q 000889 1069 FEARVSDFGMARLVNALDTH-----LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDN 1143 (1237)
Q Consensus 1069 ~~vkl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~ 1143 (1237)
+.+||+|||+|+.+...... .......||+.|+|||+..+..++.++||||+||++|||++|+.||.......
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~-- 240 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG-- 240 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--
Confidence 99999999999876432211 11123469999999999999999999999999999999999999997542211
Q ss_pred hHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 000889 1144 NLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFK 1205 (1237)
Q Consensus 1144 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 1205 (1237)
....... .+.+..+......... ....+.+++..|+..+|++||++.++++.++
T Consensus 241 ~~~~~~~----~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 241 NLIHAAK----CDFIKRLHEGKIKIKN----ANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHhH----HHHHHHhhhhhhccCC----CCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1111100 0001111111111111 1245667888999999999999999998763
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=296.20 Aligned_cols=250 Identities=30% Similarity=0.443 Sum_probs=203.0
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEecc
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMK 1007 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 1007 (1237)
.|+..+.||+|++|.||+|... +++.+++|++........+.+.+|++++++++||+++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3778889999999999999987 688899998876444456778999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCc
Q 000889 1008 WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDT 1087 (1237)
Q Consensus 1008 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~ 1087 (1237)
+++|.+++.... ..+++..+..++.++++|++|||+. +++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 81 GGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 999999987642 4689999999999999999999998 999999999999999999999999999986654332
Q ss_pred ceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcccc
Q 000889 1088 HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELT 1167 (1237)
Q Consensus 1088 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1167 (1237)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ......... .... ...
T Consensus 154 ---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~-----~~~ 218 (253)
T cd05122 154 ---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP------MKALFKIAT-NGPP-----GLR 218 (253)
T ss_pred ---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch------HHHHHHHHh-cCCC-----CcC
Confidence 2345688899999999888899999999999999999999999864321 011111110 1011 111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1168 MQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1168 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
. .......+.+++.+|++.+|++|||+.+++++
T Consensus 219 ~---~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 219 N---PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred c---ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 11113457788889999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=305.37 Aligned_cols=257 Identities=23% Similarity=0.337 Sum_probs=193.2
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC-cCHHHHHHHHHHHHhcC-CCCcccccceEEeCCeEEEEEEe
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG-QGDREFMAEMETIGKIK-HRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
+|+..+.||+|+||.||++++. +++.||+|++..... .....+.+|+.++.++. ||||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3555678999999999999886 578999998864322 23456888999999996 99999999999988999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
+. +++.++...........+++..+..++.++++|++|||+.. +++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 86 56666543322112357899999999999999999999742 8999999999999999999999999999755432
Q ss_pred CcceeeeccccCCCcCCccccCcc---ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccccccc
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQSF---RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1162 (1237)
.. .....|+..|+|||++.+. .++.++||||+||++|||++|+.||.... ............ .
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~------~ 227 (288)
T cd06616 162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKG------D 227 (288)
T ss_pred Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCC------C
Confidence 21 1234678899999999776 68899999999999999999999986422 111111110000 0
Q ss_pred CccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1163 DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1163 ~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.+.+... ........+.+++.+|++.+|++|||+.+++++
T Consensus 228 ~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 PPILSNS-EEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCc-CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111 101123467788889999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=312.84 Aligned_cols=271 Identities=25% Similarity=0.357 Sum_probs=198.3
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEeC-----CeE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIG-----EER 999 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 999 (1237)
.++|++.++||+|+||.||+|++. +++.||+|++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999876 58899999886422 22345678899999999999999999987654 357
Q ss_pred EEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccc
Q 000889 1000 LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1079 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla 1079 (1237)
++||||++ +++.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 84 ~lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 84 YIVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence 99999997 588777753 3689999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcce-eeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhh--h
Q 000889 1080 RLVNALDTHL-SVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR--E 1155 (1237)
Q Consensus 1080 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~ 1155 (1237)
+......... ......|+..|+|||++.+ ..++.++||||+||++|+|++|+.||....... ....+...... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~--~~~~~~~~~~~~~~ 231 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH--QLNLILGVLGTPSQ 231 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCCH
Confidence 8654322211 1123568899999998754 468899999999999999999999996432100 00000000000 0
Q ss_pred cccccccCc-------cccCCCC------CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhccc
Q 000889 1156 KRINEILDP-------ELTMQTS------DETELYQYLRISFECLDDRPFKRPTMIQVMAM--FKELQV 1209 (1237)
Q Consensus 1156 ~~~~~~~~~-------~l~~~~~------~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~--L~~l~~ 1209 (1237)
+....+.+. ..+.... .+.....+.+++.+|++.+|++|||+.+++++ ++....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 000000000 0000000 01113457789999999999999999999998 555543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-33 Score=329.32 Aligned_cols=258 Identities=24% Similarity=0.273 Sum_probs=204.4
Q ss_pred HHHHhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecc---ccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCe
Q 000889 923 LLEATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIH---VTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEE 998 (1237)
Q Consensus 923 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 998 (1237)
+.-..++|.+.++||+|+||.|..++.+ +++.||.|++.+ .......-|..|-.+|..-+.+.|+.++.+|++..+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 3334568999999999999999999987 577899998876 233445678999999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeeccc
Q 000889 999 RLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1078 (1237)
Q Consensus 999 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGl 1078 (1237)
.|+|||||+||+|-.++.+. .++++..++.++..|+.||.-+|+. |+|||||||+|||+|..|++|++|||.
T Consensus 150 LYlVMdY~pGGDlltLlSk~-----~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKF-----DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred eEEEEecccCchHHHHHhhc-----CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchh
Confidence 99999999999999999865 2689999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCcceeeeccccCCCcCCccccC----c-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHh
Q 000889 1079 ARLVNALDTHLSVSTLAGTPGYVPPEYYQ----S-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLH 1153 (1237)
Q Consensus 1079 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 1153 (1237)
+-.+... ........+|||.|.+||++. + +.|+...|+||+||++|||+.|..||..... .-.|-....
T Consensus 222 Clkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl-----veTY~KIm~ 295 (1317)
T KOG0612|consen 222 CLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL-----VETYGKIMN 295 (1317)
T ss_pred HHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH-----HHHHHHHhc
Confidence 9877653 344557789999999999985 2 5688999999999999999999999974321 112222222
Q ss_pred hhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCC---HHHHHHHH
Q 000889 1154 REKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPT---MIQVMAMF 1204 (1237)
Q Consensus 1154 ~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~ell~~L 1204 (1237)
.... +..+ ...+-.....++|.+.+. +|+.|.. +.++..|-
T Consensus 296 hk~~--------l~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 296 HKES--------LSFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred hhhh--------cCCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 2211 1111 111122234455555444 7788888 88888874
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=305.16 Aligned_cols=248 Identities=29% Similarity=0.410 Sum_probs=195.4
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCc---CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQ---GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
..|+..+.||+|+||+||+|+.. +++.||+|++...... ..+++.+|+++++.++||||+++++++...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 35788889999999999999876 5889999988543222 2346889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||++ |++.+++.... ..+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.+||+|||++....
T Consensus 95 e~~~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 95 EYCL-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HhhC-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 9997 67777765432 3689999999999999999999999 99999999999999999999999999997654
Q ss_pred cCCcceeeeccccCCCcCCccccC---ccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccccc
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQ---SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINE 1160 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1160 (1237)
.. ....+++.|+|||++. ...++.++||||||+++|||++|+.||..... ... ........
T Consensus 167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~-----~~~-~~~~~~~~---- 230 (307)
T cd06607 167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSA-LYHIAQND---- 230 (307)
T ss_pred CC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH-----HHH-HHHHhcCC----
Confidence 32 2346788999999874 35688899999999999999999999864321 110 00000000
Q ss_pred ccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 000889 1161 ILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFK 1205 (1237)
Q Consensus 1161 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 1205 (1237)
.+.. ........+.+++.+||+.+|++||++.+++++..
T Consensus 231 --~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 231 --SPTL----SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred --CCCC----CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 0111 01123346788899999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=281.83 Aligned_cols=262 Identities=22% Similarity=0.323 Sum_probs=197.4
Q ss_pred ceecccCCeEEEEEE-ECCCCEEEEEEeccccCcCHHHHHHHHHHHHhcC-CCCcccccceEEeCCeEEEEEEeccCCCH
Q 000889 934 SMIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIK-HRNLVPLLGYCKIGEERLLVYEYMKWGSL 1011 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL 1011 (1237)
++||+|+||.|--++ ..+|..+|||++.+........+.+|++++.+++ |+||++++++|++++..|+|||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 579999999998875 4579999999998877777888999999999995 99999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCc---eEEeecccceeecc----
Q 000889 1012 ESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFE---ARVSDFGMARLVNA---- 1084 (1237)
Q Consensus 1012 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~---vkl~DfGla~~~~~---- 1084 (1237)
..+++++ ..+++.++.++..+|+.||.|||.+ ||.|||+||+|||.....+ ||||||.+..-...
T Consensus 164 LshI~~~-----~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 164 LSHIQKR-----KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred HHHHHHh-----hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 9999886 4689999999999999999999999 9999999999999975443 89999988743211
Q ss_pred -CCcceeeeccccCCCcCCccccC-----ccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccc
Q 000889 1085 -LDTHLSVSTLAGTPGYVPPEYYQ-----SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158 (1237)
Q Consensus 1085 -~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1158 (1237)
........+.+|+..|||||+.. ...|+.+.|.||+|||+|-|++|++||.+.-..+-.--....-..-+..-+
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 11112234578899999999873 346889999999999999999999999875432210000000000011112
Q ss_pred ccccCccccCCCCC-HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1159 NEILDPELTMQTSD-ETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1159 ~~~~~~~l~~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
..|.+..+..+..+ .....+-.+++...+..||.+|-++.+++++
T Consensus 316 esIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 316 ESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred HHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 22222222222111 1122344567777888999999999999884
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=303.64 Aligned_cols=264 Identities=25% Similarity=0.284 Sum_probs=196.4
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC--cCHHHHHHHHHHHHhcCCCCcccccceEEeC--CeEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG--QGDREFMAEMETIGKIKHRNLVPLLGYCKIG--EERLLV 1002 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 1002 (1237)
++|++.+.||+|+||.||+|+++ +++.+|+|++..... .....+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999987 578899998864322 2233567899999999999999999998877 889999
Q ss_pred EEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceee
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~ 1082 (1237)
|||++ ++|.+++.... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 85 ~e~~~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 85 MEYVE-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred ehhcC-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 99997 59999887542 3689999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCcceeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHh--------
Q 000889 1083 NALDTHLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLH-------- 1153 (1237)
Q Consensus 1083 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------- 1153 (1237)
..... ......+++.|+|||.+.+. .++.++|+||+|+++|||++|+.||....... ..........
T Consensus 157 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 157 GSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID--QLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred cCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCchHHHH
Confidence 54321 12334578899999998764 46889999999999999999999997432110 0100000000
Q ss_pred ------h-h-cccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1154 ------R-E-KRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1154 ------~-~-~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
. . ..........+............+.+++.+|++.+|++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 0 000000000000000000013456788889999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=297.48 Aligned_cols=246 Identities=26% Similarity=0.387 Sum_probs=197.5
Q ss_pred CCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc-CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEecc
Q 000889 930 FSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMK 1007 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 1007 (1237)
|+..+.||+|+||.||+|... ++..||+|...... ....+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 677889999999999999875 57889999875322 2234568889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCc
Q 000889 1008 WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDT 1087 (1237)
Q Consensus 1008 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~ 1087 (1237)
+++|.+++.. ..+++..+..++.+++.|+.|||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 86 ~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 86 GGSALDLLEP------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 9999999863 3578999999999999999999999 999999999999999999999999999976543221
Q ss_pred ceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcccc
Q 000889 1088 HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELT 1167 (1237)
Q Consensus 1088 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1167 (1237)
......++..|+|||.+.+..++.++||||+||++|+|++|..||..... ........ ... .+.+
T Consensus 157 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~-~~~-----~~~~- 221 (277)
T cd06641 157 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP------MKVLFLIP-KNN-----PPTL- 221 (277)
T ss_pred --hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch------HHHHHHHh-cCC-----CCCC-
Confidence 12335678899999999888889999999999999999999999864221 01111110 000 0111
Q ss_pred CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1168 MQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1168 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.......+.+++.+|++.+|.+||++.+++++
T Consensus 222 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 ----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ----CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11122356678889999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=293.12 Aligned_cols=252 Identities=26% Similarity=0.412 Sum_probs=203.1
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC--cCHHHHHHHHHHHHhcCCCCcccccceEEeC--CeEEEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG--QGDREFMAEMETIGKIKHRNLVPLLGYCKIG--EERLLVY 1003 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 1003 (1237)
+|+..+.||+|++|.||+|... ++..|++|++..... ...+.+.+|+.++++++||||+++++++... ...++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777889999999999999987 688999998864432 3456788999999999999999999999888 8899999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+++++|.+++... ..+++..+..++.++++|++|||+. +++|+||+|+||+++.++.+||+|||.+....
T Consensus 81 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 81 EYVSGGSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 999999999998764 2789999999999999999999998 99999999999999999999999999998776
Q ss_pred cCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccC
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
............++..|+|||.+.+..++.++||||+|+++|+|++|..||.... ................
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~---- 223 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEPP---- 223 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCCc----
Confidence 5432111234568889999999988889999999999999999999999997543 1111111111000000
Q ss_pred ccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.. + ......+.+++.+|+..+|++||++.+++++
T Consensus 224 -~~--~---~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 224 -EI--P---EHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred -CC--C---cccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 01 1 1113467788889999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=301.28 Aligned_cols=264 Identities=22% Similarity=0.343 Sum_probs=197.5
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC-cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
+|+..+.||+|++|.||+|++. ++..||+|++..... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999986 588899998864332 23456778999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
+ ++|.+++..... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||+++......
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 81 D-KDLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred C-ccHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 8 589888865432 24689999999999999999999999 99999999999999999999999999997553321
Q ss_pred cceeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhh--------cc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE--------KR 1157 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~ 1157 (1237)
. ......++..|+|||++.+. .++.++||||+|+++|||++|+.||...... ............. ..
T Consensus 155 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 155 N--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE--DQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred c--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCChhhHHHHhc
Confidence 1 12334578899999988654 5688999999999999999999999754321 1111110000000 00
Q ss_pred cccccCccccCCCC------CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1158 INEILDPELTMQTS------DETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1158 ~~~~~~~~l~~~~~------~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
... .....+.... .+.....+.+++.+|++.+|++||++.+++++
T Consensus 231 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 231 LPE-YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred Cch-hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 0000000000 01122456788899999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=306.81 Aligned_cols=265 Identities=28% Similarity=0.291 Sum_probs=195.1
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCc--CHHHHHHHHHHHHhcCCCCcccccceEEeC--CeEEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQ--GDREFMAEMETIGKIKHRNLVPLLGYCKIG--EERLL 1001 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 1001 (1237)
.++|++.+.||+|+||.||+|++. +++.||+|++...... ....+.+|++++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357889999999999999999986 5889999988643221 223467899999999999999999998654 56899
Q ss_pred EEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeeccccee
Q 000889 1002 VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~ 1081 (1237)
||||+. ++|.+++.... ..+++..+..++.|+++|++|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 86 v~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEecCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeee
Confidence 999997 58888887532 4689999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCcceeeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhh-ccc-
Q 000889 1082 VNALDTHLSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE-KRI- 1158 (1237)
Q Consensus 1082 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~- 1158 (1237)
....... .....+++.|+|||++.+ ..++.++||||+|+++|||++|+.||...... ..+.......... ...
T Consensus 158 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 158 YGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI--EQLDLIIQLLGTPNESIW 233 (309)
T ss_pred cCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCChhhc
Confidence 6543221 223345788999999865 45789999999999999999999999743211 1111111000000 000
Q ss_pred ccc------cCccccCC-C-CC----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1159 NEI------LDPELTMQ-T-SD----ETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1159 ~~~------~~~~l~~~-~-~~----~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
... ........ . .. ......+.+++.+|++.||++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 00000000 0 00 0012456688899999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=302.57 Aligned_cols=244 Identities=24% Similarity=0.381 Sum_probs=194.5
Q ss_pred ceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCCCHH
Q 000889 934 SMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLE 1012 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 1012 (1237)
.+||+|+||.||+|... +++.||+|++..........+.+|+.++++++|+||+++++++..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999885 68899999886444344556889999999999999999999999999999999999999999
Q ss_pred HHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcceeee
Q 000889 1013 SVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVS 1092 (1237)
Q Consensus 1013 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~~~ 1092 (1237)
+++.. ..+++.....++.|++.|++|||+. +++||||+|+||++++++.++|+|||++........ ...
T Consensus 106 ~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~ 174 (292)
T cd06657 106 DIVTH------TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRK 174 (292)
T ss_pred HHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc--ccc
Confidence 98753 3578899999999999999999999 999999999999999999999999999875543221 123
Q ss_pred ccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCCC
Q 000889 1093 TLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSD 1172 (1237)
Q Consensus 1093 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 1172 (1237)
...|++.|+|||++.+..++.++|+||+|+++|||++|..||..... ........ . ...+......
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~---~~~~~~~~---~------~~~~~~~~~~-- 240 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIR---D------NLPPKLKNLH-- 240 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH---h------hCCcccCCcc--
Confidence 45688999999999888889999999999999999999999864321 11111110 0 0111111111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1173 ETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1173 ~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.....+.+++.+|++.+|.+||++.+++++
T Consensus 241 -~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 241 -KVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred -cCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 112345678889999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=296.03 Aligned_cols=250 Identities=25% Similarity=0.386 Sum_probs=198.7
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
+|++.+.||+|+||.||+|..+ ++..+|+|.+.... ....+.+.+|++++++++|+||+++++++......++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999987 47889999875432 23345678999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCC-ceEEeecccceeecc
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENF-EARVSDFGMARLVNA 1084 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~-~vkl~DfGla~~~~~ 1084 (1237)
+++++|.+++.... ...+++..+..++.|+++|++|||+. +++|+||||+||++++++ .+|++|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 99999999987532 23579999999999999999999999 999999999999999875 469999999976643
Q ss_pred CCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCc
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDP 1164 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1164 (1237)
... ......|++.|+|||+..+..++.++||||+|+++|||++|+.||.... ...+....... . ..+
T Consensus 155 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~-~----~~~ 221 (257)
T cd08225 155 SME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQG-Y----FAP 221 (257)
T ss_pred Ccc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhcc-c----CCC
Confidence 221 1223468889999999988889999999999999999999999986432 11111111111 1 110
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1165 ELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1165 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
. .+.....+.+++.+|+..+|++|||+.+++++
T Consensus 222 ~------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 I------SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred C------CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0 01112357788889999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=298.70 Aligned_cols=259 Identities=22% Similarity=0.251 Sum_probs=192.2
Q ss_pred CCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc-CcCHHHHHHHHHHHHhcC-CCCcccccceEEeC--CeEEEEEE
Q 000889 930 FSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT-GQGDREFMAEMETIGKIK-HRNLVPLLGYCKIG--EERLLVYE 1004 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 1004 (1237)
|++.+.||+|+||.||+|+.. ++..||+|++.... ........+|+.+++++. |||++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999876 58899999886532 222334567899999885 99999999999887 88999999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
|++ |++.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++. +.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 997 58888876532 4689999999999999999999999 9999999999999999 9999999999986543
Q ss_pred CCcceeeeccccCCCcCCccccC-ccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhh--c-----
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQ-SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE--K----- 1156 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~----- 1156 (1237)
... .....++..|+|||++. +..++.++||||+||++|||++|..||...... ....+....... .
T Consensus 152 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07831 152 KPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL---DQIAKIHDVLGTPDAEVLKK 225 (282)
T ss_pred CCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH---HHHHHHHHHcCCCCHHHHHh
Confidence 222 12345788999999764 456788999999999999999999999653211 111111110000 0
Q ss_pred -ccccccCccccCCCC------CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1157 -RINEILDPELTMQTS------DETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1157 -~~~~~~~~~l~~~~~------~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
......+...+.... .......+.+++.+|++++|++||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000000000 01123577889999999999999999999874
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=305.39 Aligned_cols=266 Identities=23% Similarity=0.325 Sum_probs=193.1
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeCC------
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGE------ 997 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 997 (1237)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 346889999999999999999986 58899999886432 122345678999999999999999999886543
Q ss_pred --eEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEee
Q 000889 998 --ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSD 1075 (1237)
Q Consensus 998 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~D 1075 (1237)
..++||||+. +++.+++... ...+++..+..++.|++.|++|||+. +++|+||||+||+++.++.+||+|
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNK----NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECc
Confidence 4599999997 5888877643 23689999999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCcc--eeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHH
Q 000889 1076 FGMARLVNALDTH--LSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQL 1152 (1237)
Q Consensus 1076 fGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 1152 (1237)
||++......... .......++..|+|||.+.+. .++.++||||+|+++|||++|+.||...... .........
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~---~~~~~~~~~ 239 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ---HQLTLISQL 239 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHH
Confidence 9999765432221 112234578889999988664 4688999999999999999999998653211 111111110
Q ss_pred hhh---cccccc-----cC-ccccCC--------CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1153 HRE---KRINEI-----LD-PELTMQ--------TSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1153 ~~~---~~~~~~-----~~-~~l~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
... ...... .+ ...+.. .........+.+++.+|++.+|.+|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000 000000 00 000000 0000012345689999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=302.00 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=204.7
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcC--HHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQG--DREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
.+.|.+.+.||+|.|+.|.+|++. ++..||+|.+.+..... .+.+.+|+++|+.++|||||+++.+.......|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 457889999999999999999876 58899999886544332 345889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
||+.+|.+.+|+.... ...+..+..++.|++.|++|+|++ .|||||||++||+++.+..+||+|||++..+.
T Consensus 135 eya~~ge~~~yl~~~g-----r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHG-----RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EeccCchhHHHHHhcc-----cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence 9999999999998753 445578889999999999999999 99999999999999999999999999999876
Q ss_pred cCCcceeeeccccCCCcCCccccCcccc-CcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccccccc
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRC-TTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1162 (1237)
.. ....+.+|++.|.|||++.+..| +..+|+||+|+++|-|+.|..||++....+- +. ..+
T Consensus 207 ~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-----------r~----rvl 268 (596)
T KOG0586|consen 207 YG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-----------RP----RVL 268 (596)
T ss_pred cc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-----------cc----hhe
Confidence 32 23467899999999999998876 4679999999999999999999986432211 11 111
Q ss_pred CccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 000889 1163 DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFK 1205 (1237)
Q Consensus 1163 ~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 1205 (1237)
...+..+.+-..+ .-+++.+++-.+|.+|+++++++++-.
T Consensus 269 ~gk~rIp~~ms~d---ce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 269 RGKYRIPFYMSCD---CEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred eeeecccceeech---hHHHHHHhhccCccccCCHHHhhhhcc
Confidence 2222222222222 335666899999999999999998853
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=325.97 Aligned_cols=258 Identities=26% Similarity=0.413 Sum_probs=203.4
Q ss_pred CCCCceecccCCeEEEEEEEC----C----CCEEEEEEeccccC-cCHHHHHHHHHHHHhc-CCCCcccccceEEeCCeE
Q 000889 930 FSADSMIGSGGFGEVYKAQLR----D----GSVVAIKKLIHVTG-QGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEER 999 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~----~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 999 (1237)
..+.+.+|+|.||.||+|... . ...||||.+..... .+.+.+..|+++|+.+ +||||+.++|+|.+++..
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~ 377 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL 377 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence 345558999999999999754 1 44699998874433 3456789999999999 599999999999999999
Q ss_pred EEEEEeccCCCHHHHHhhhh---------cCCC--CccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCC
Q 000889 1000 LLVYEYMKWGSLESVLHDRA---------KGGG--TKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDEN 1068 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~---------~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~ 1068 (1237)
++|+||+..|+|.+|++..+ .... ..++......++.|||.|++||++. ++||||+.++|||++++
T Consensus 378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~ 454 (609)
T KOG0200|consen 378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKN 454 (609)
T ss_pred EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCC
Confidence 99999999999999998876 1111 2388999999999999999999999 99999999999999999
Q ss_pred CceEEeecccceeeccCCcceeeeccc--cCCCcCCccccCccccCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchH
Q 000889 1069 FEARVSDFGMARLVNALDTHLSVSTLA--GTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNL 1145 (1237)
Q Consensus 1069 ~~vkl~DfGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~ 1145 (1237)
..+||+|||+|+.....+.... .... -+..|||||.+....|+.++|||||||++||+++ |..||.+-. ....+
T Consensus 455 ~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~--~~~~l 531 (609)
T KOG0200|consen 455 KVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP--PTEEL 531 (609)
T ss_pred CEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC--cHHHH
Confidence 9999999999997665444332 2222 3557999999999999999999999999999999 888986411 11122
Q ss_pred HHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 000889 1146 VGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207 (1237)
Q Consensus 1146 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l 1207 (1237)
. .......+ +..+..+. .++.++++.||+.+|++||++.++++.++..
T Consensus 532 ~---~~l~~G~r--------~~~P~~c~---~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 532 L---EFLKEGNR--------MEQPEHCS---DEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred H---HHHhcCCC--------CCCCCCCC---HHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 1 11222211 12222333 3455788899999999999999999999884
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=297.05 Aligned_cols=261 Identities=23% Similarity=0.313 Sum_probs=195.5
Q ss_pred CCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 930 FSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
|++.+.||.|++|.||+|++. +|..||+|++.... ......+.+|++++++++|||++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 667889999999999999876 68899999886432 222356888999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
+ ++|.+++..... ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||+++......
T Consensus 81 ~-~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 81 D-LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred C-cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 5 689998875432 3689999999999999999999999 99999999999999999999999999997554322
Q ss_pred cceeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhc---------
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREK--------- 1156 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 1156 (1237)
. ......++..|+|||++.+. .++.++||||+|+++|||++|+.||..... ...............
T Consensus 154 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 154 R--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE--IDQLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred c--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCChHHhhhhhh
Confidence 1 11234568899999988654 568899999999999999999999864321 011111111000000
Q ss_pred --c----cccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1157 --R----INEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1157 --~----~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
. .......... ...+.....+.+++.+|++.+|++|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 230 LPDYKPTFPKWARQDLS--KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred chhhhhhcccccccchh--hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 0000000000 0001112456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=297.62 Aligned_cols=242 Identities=25% Similarity=0.332 Sum_probs=185.3
Q ss_pred eecccCCeEEEEEEEC-CCCEEEEEEeccccC---cCHHHHHHHHHHHHh---cCCCCcccccceEEeCCeEEEEEEecc
Q 000889 935 MIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG---QGDREFMAEMETIGK---IKHRNLVPLLGYCKIGEERLLVYEYMK 1007 (1237)
Q Consensus 935 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lv~e~~~ 1007 (1237)
+||+|+||.||+|... +++.+|+|.+..... .....+.+|..+++. .+||+|+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999986 578999998864321 112234455444433 479999999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCc
Q 000889 1008 WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDT 1087 (1237)
Q Consensus 1008 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~ 1087 (1237)
+|+|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.+|++|||++........
T Consensus 81 ~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~ 152 (279)
T cd05633 81 GGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (279)
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc
Confidence 99999988753 4689999999999999999999999 999999999999999999999999999975543221
Q ss_pred ceeeeccccCCCcCCccccC-ccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccc
Q 000889 1088 HLSVSTLAGTPGYVPPEYYQ-SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1088 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
....|+..|+|||++. +..++.++||||+||++|||++|+.||.......... ...... ..+..+
T Consensus 153 ----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~------~~~~~~ 218 (279)
T cd05633 153 ----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTL------TVNVEL 218 (279)
T ss_pred ----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHhh------cCCcCC
Confidence 2346899999999986 4568899999999999999999999997543211111 111000 011111
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRP-----TMIQVMAM 1203 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 1203 (1237)
+ .....++.+++.+|++.+|.+|| |+++++++
T Consensus 219 ~-----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 P-----DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred c-----cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1 11223567888899999999999 59988876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=309.79 Aligned_cols=268 Identities=23% Similarity=0.328 Sum_probs=200.1
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccc--cCcCHHHHHHHHHHHHhcCCCCcccccceEEeC-----Ce
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHV--TGQGDREFMAEMETIGKIKHRNLVPLLGYCKIG-----EE 998 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 998 (1237)
.++|++.+.||+|+||+||+|+.. ++..||+|++... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457899999999999999999876 5889999988642 223345677899999999999999999988654 34
Q ss_pred EEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeeccc
Q 000889 999 RLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1078 (1237)
Q Consensus 999 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGl 1078 (1237)
.++||||+. ++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcc
Confidence 799999996 7888887643 4689999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCcceeeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHh----
Q 000889 1079 ARLVNALDTHLSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLH---- 1153 (1237)
Q Consensus 1079 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~---- 1153 (1237)
++....... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||....... .........
T Consensus 155 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~ 229 (337)
T cd07858 155 ARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPS 229 (337)
T ss_pred ccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCC
Confidence 986643321 1234567889999998864 468899999999999999999999996542110 000000000
Q ss_pred -------hhcc-------cccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhcccc
Q 000889 1154 -------REKR-------INEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM--FKELQVD 1210 (1237)
Q Consensus 1154 -------~~~~-------~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~--L~~l~~~ 1210 (1237)
.... .....++... ...+.....+.+++.+|++.+|++|||+.+++++ +..+...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 230 EEDLGFIRNEKARRYIRSLPYTPRQSFA--RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred hHHhhhcCchhhhHHHHhcCcccccCHH--HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 0000 0000000000 0001123456789999999999999999999998 6665443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=306.24 Aligned_cols=274 Identities=24% Similarity=0.357 Sum_probs=199.9
Q ss_pred HhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccc--cCcCHHHHHHHHHHHHhc-CCCCcccccceEEeC--CeE
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHV--TGQGDREFMAEMETIGKI-KHRNLVPLLGYCKIG--EER 999 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 999 (1237)
..++|++.+.||+|+||.||+|.+. +++.+|+|++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888899999999999999986 5788999988542 122334577899999999 999999999988653 368
Q ss_pred EEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccc
Q 000889 1000 LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1079 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla 1079 (1237)
++||||++ ++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 85 ~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred EEEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccch
Confidence 99999997 5998887642 678888999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcc---eeeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHH---
Q 000889 1080 RLVNALDTH---LSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQL--- 1152 (1237)
Q Consensus 1080 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--- 1152 (1237)
+........ .......|+..|+|||++.+ ..++.++||||||+++|||++|+.||......+ .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~--~~~~~~~~~~~~ 232 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN--QLEKIIEVIGPP 232 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCC
Confidence 866443221 12234568889999998764 457889999999999999999999996432111 000000000
Q ss_pred -----------hhhcccccccCccccC-CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhccccc
Q 000889 1153 -----------HREKRINEILDPELTM-QTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM--FKELQVDT 1211 (1237)
Q Consensus 1153 -----------~~~~~~~~~~~~~l~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~--L~~l~~~~ 1211 (1237)
........+....... ....+.....+.+++.+|++.+|++|||+.+++++ +..+....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~ 305 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPS 305 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCC
Confidence 0000000000000000 00000123467788999999999999999999987 55664443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=293.25 Aligned_cols=249 Identities=23% Similarity=0.275 Sum_probs=189.2
Q ss_pred HHHHHhCCCCCCcee--cccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhc-CCCCcccccceEEeCC
Q 000889 922 HLLEATNGFSADSMI--GSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGE 997 (1237)
Q Consensus 922 ~~~~~~~~~~~~~~l--G~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 997 (1237)
+.....++|++.+.+ |+|+||.||+++.+ ++..+|+|.+....... .|+.....+ +||||+++++++...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 334445677777776 99999999999876 57778888775422111 122222222 6999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCC-ceEEeec
Q 000889 998 ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENF-EARVSDF 1076 (1237)
Q Consensus 998 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~-~vkl~Df 1076 (1237)
..++||||+++++|.+++... ..+++..+..++.|+++|++|||+. +++||||||+||+++.++ .++|+||
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKE-----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecC
Confidence 999999999999999999753 3789999999999999999999999 999999999999999988 9999999
Q ss_pred ccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhc
Q 000889 1077 GMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREK 1156 (1237)
Q Consensus 1077 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1156 (1237)
|+++..... ....++..|+|||++.+..++.++||||+|+++|||++|+.||...... ......+.... ..
T Consensus 155 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~--~~ 225 (267)
T PHA03390 155 GLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ--QK 225 (267)
T ss_pred ccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh--cc
Confidence 998765422 2346889999999999888999999999999999999999999743221 11112221111 00
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 000889 1157 RINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPT-MIQVMAM 1203 (1237)
Q Consensus 1157 ~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~ell~~ 1203 (1237)
..... ......+.+++.+|++.+|.+||+ +.+++++
T Consensus 226 --------~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 226 --------KLPFI---KNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred --------cCCcc---cccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 00000 112235677888999999999996 5888753
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=294.09 Aligned_cols=250 Identities=24% Similarity=0.398 Sum_probs=202.0
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
+|++.++||+|+||.||+++.. +++.+|+|++.... ......+.+|++++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999876 57889999886432 22344678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
+++++|.+++..... ....+++..++.++.|+++|++|||+. +++|+||+|+||+++.++.+|++|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 999999999876432 235789999999999999999999999 9999999999999999999999999999866543
Q ss_pred CcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcc
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPE 1165 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1165 (1237)
......+++.|+|||.+.+..++.++|+||+|+++|||++|+.||..... .... ... ...... .
T Consensus 157 ----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~---~~~-~~~~~~-----~ 220 (256)
T cd08530 157 ----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QDLR---YKV-QRGKYP-----P 220 (256)
T ss_pred ----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHH---HHH-hcCCCC-----C
Confidence 12234678899999999988899999999999999999999999974321 1111 111 011110 0
Q ss_pred ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1166 LTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1166 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
. ......++.+++.+|++.+|++||++.+++++
T Consensus 221 ~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 221 I-----PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred C-----chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1 11233567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=297.28 Aligned_cols=245 Identities=27% Similarity=0.363 Sum_probs=191.4
Q ss_pred ecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCCCH
Q 000889 936 IGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSL 1011 (1237)
Q Consensus 936 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 1011 (1237)
||+|+||+||+|... +++.||+|.+.... ....+.+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999876 58899999885422 22344567899999999999999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcceee
Q 000889 1012 ESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSV 1091 (1237)
Q Consensus 1012 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~~ 1091 (1237)
.+++..... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+||+|||.+...... ...
T Consensus 81 ~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~ 151 (277)
T cd05577 81 KYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKI 151 (277)
T ss_pred HHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccc
Confidence 999876432 4689999999999999999999999 9999999999999999999999999998765431 112
Q ss_pred eccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCC
Q 000889 1092 STLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTS 1171 (1237)
Q Consensus 1092 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 1171 (1237)
....++..|+|||++.+..++.++||||+|+++|+|++|+.||........ ... .... ...........
T Consensus 152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~----~~~~-----~~~~~~~~~~~ 220 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE--KEE----LKRR-----TLEMAVEYPDK 220 (277)
T ss_pred ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc--HHH----HHhc-----cccccccCCcc
Confidence 345678899999999888899999999999999999999999975432111 000 0000 00001111111
Q ss_pred CHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 000889 1172 DETELYQYLRISFECLDDRPFKRP-----TMIQVMAM 1203 (1237)
Q Consensus 1172 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 1203 (1237)
....+.+++.+|++.+|.+|| ++.+++++
T Consensus 221 ---~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 221 ---FSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred ---CCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 123566888899999999999 77777654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=292.56 Aligned_cols=252 Identities=24% Similarity=0.414 Sum_probs=204.3
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC--cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG--QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
+|++.+.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|++++++++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999986 588999998865432 3456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
+++++|.+++..... .+..+++..+..++.++++|++|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999999987532 235789999999999999999999999 9999999999999999999999999999866543
Q ss_pred CcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcc
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPE 1165 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1165 (1237)
. .......|++.|+|||...+..++.++||||+|+++|+|++|+.||.... ............ . +.
T Consensus 157 ~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~~~~-~-----~~ 222 (258)
T cd08215 157 V--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN------LLELALKILKGQ-Y-----PP 222 (258)
T ss_pred c--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc------HHHHHHHHhcCC-C-----CC
Confidence 2 12234568889999999988889999999999999999999999986432 111111111111 0 11
Q ss_pred ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1166 LTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1166 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
++ . .....+.+++.+|+..+|++|||+.+++++
T Consensus 223 ~~--~---~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 223 IP--S---QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CC--C---CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11 1 112356788889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=309.84 Aligned_cols=267 Identities=25% Similarity=0.337 Sum_probs=197.8
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEe----CCeE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKI----GEER 999 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 999 (1237)
.++|++.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367899999999999999999876 58899999886432 2334567789999999999999999998753 3467
Q ss_pred EEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccc
Q 000889 1000 LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1079 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla 1079 (1237)
++||||+. ++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred EEEEehhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccc
Confidence 99999996 6888887642 3589999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcc--eeeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHh---
Q 000889 1080 RLVNALDTH--LSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLH--- 1153 (1237)
Q Consensus 1080 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--- 1153 (1237)
+........ .......++..|+|||++.+ ..++.++||||+|+++|||++|+.||........ +........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~--~~~~~~~~g~~~ 232 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ--LKLILSVLGSPS 232 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH--HHHHHHHhCCCh
Confidence 765432211 11124568889999999865 4588999999999999999999999975432110 000000000
Q ss_pred -------hhccccccc---CccccCCC--CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1154 -------REKRINEIL---DPELTMQT--SDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1154 -------~~~~~~~~~---~~~l~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
....+.+.. ........ ..+.....+.+++.+|++.+|++|||+.+++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 000000000 00000000 0011235678899999999999999999999873
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=278.83 Aligned_cols=255 Identities=24% Similarity=0.273 Sum_probs=197.1
Q ss_pred HHhCCCCC-CceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhc-CCCCcccccceEEe----CC
Q 000889 925 EATNGFSA-DSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKI-KHRNLVPLLGYCKI----GE 997 (1237)
Q Consensus 925 ~~~~~~~~-~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~ 997 (1237)
..+++|++ .++||-|-.|.|-.+..+ +++.+|+|++.. .....+|++..-+. .|||||.+++++.. ..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 34666766 358999999999998876 688899998753 33456788876555 59999999998753 34
Q ss_pred eEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeC---CCCceEEe
Q 000889 998 ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLD---ENFEARVS 1074 (1237)
Q Consensus 998 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~---~~~~vkl~ 1074 (1237)
...+|||.|+||.|.+.++++. ...+++.++..|..||..|+.|||+. .|.||||||+|+|.+ .+..+|++
T Consensus 133 cLLiVmE~meGGeLfsriq~~g---~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRG---DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred eeEeeeecccchHHHHHHHHcc---cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEec
Confidence 6689999999999999998764 36799999999999999999999999 999999999999996 45679999
Q ss_pred ecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhh
Q 000889 1075 DFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR 1154 (1237)
Q Consensus 1075 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1154 (1237)
|||+|+.... .....+.+-||.|.|||++...+|+...|+||+||+||-|++|.+||........ ...+..
T Consensus 207 DfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai--spgMk~---- 277 (400)
T KOG0604|consen 207 DFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKR---- 277 (400)
T ss_pred ccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC--ChhHHh----
Confidence 9999986543 3445678899999999999999999999999999999999999999975322110 001111
Q ss_pred hcccccccCccccCCCC-CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1155 EKRINEILDPELTMQTS-DETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1155 ~~~~~~~~~~~l~~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
.|....+..+.. ...-.+...++|+.++..+|++|.|+.+++++=
T Consensus 278 -----rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 278 -----RIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred -----HhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence 111111111111 122234456788889999999999999999873
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=308.76 Aligned_cols=259 Identities=24% Similarity=0.319 Sum_probs=196.0
Q ss_pred HhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeC------
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIG------ 996 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 996 (1237)
..++|+..+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4568999999999999999999976 68899999875321 22334677899999999999999999987543
Q ss_pred CeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeec
Q 000889 997 EERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDF 1076 (1237)
Q Consensus 997 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~Df 1076 (1237)
...++||||+. ++|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccC
Confidence 35799999996 588887753 378888999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHh---
Q 000889 1077 GMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLH--- 1153 (1237)
Q Consensus 1077 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--- 1153 (1237)
|+++....... .....++..|+|||++.+..++.++||||+||++|+|++|+.||..... ...+.....
T Consensus 163 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~ 234 (353)
T cd07850 163 GLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH-----IDQWNKIIEQLG 234 (353)
T ss_pred ccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHHhcC
Confidence 99986543221 2334678899999999998999999999999999999999999964321 111111000
Q ss_pred -------------------hhc-----ccccccCccc-cCCCC--CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1154 -------------------REK-----RINEILDPEL-TMQTS--DETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1154 -------------------~~~-----~~~~~~~~~l-~~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
... .+.+...... +.... .......+.+++.+|++.||++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 235 TPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred CCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0000000000 00000 01123456788999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=302.30 Aligned_cols=252 Identities=23% Similarity=0.409 Sum_probs=192.0
Q ss_pred CCCCCCceecccCCeEEEEEEECC-CCEEEEEEeccccC-cCHHHHHHHHHHHHhcC-CCCcccccceEEeCCeEEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTG-QGDREFMAEMETIGKIK-HRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
++|++.+.||+|+||.||+|+++. +..||||.+..... .....+..|+.++.+.. ||||+++++++......++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 467888999999999999999875 88999998864322 23345667887777775 9999999999999999999999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
|+. +++.++..... ..+++..+..++.|+++|++|||+.. +|+||||+|+||++++++.+||+|||++.....
T Consensus 95 ~~~-~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 95 LMS-TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred ccC-cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 985 57777765532 37899999999999999999999732 899999999999999999999999999976543
Q ss_pred CCcceeeeccccCCCcCCccccCccc----cCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccccc
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQSFR----CTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINE 1160 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1160 (1237)
.... ....++..|+|||++.+.. ++.++||||||+++|||++|+.||..... .. ..........
T Consensus 168 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~-~~~~~~~~~~---- 235 (296)
T cd06618 168 SKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT----EF-EVLTKILQEE---- 235 (296)
T ss_pred CCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh----HH-HHHHHHhcCC----
Confidence 2221 2335788999999987553 78899999999999999999999864211 11 1111111010
Q ss_pred ccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1161 ILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1161 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.+...... ....++.+++.+|++.+|++||++.+++++
T Consensus 236 --~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 236 --PPSLPPNE---GFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred --CCCCCCCC---CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01111100 122357788889999999999999999977
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=294.50 Aligned_cols=242 Identities=24% Similarity=0.333 Sum_probs=192.8
Q ss_pred ecccCCeEEEEEEEC-CCCEEEEEEeccccC---cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCCCH
Q 000889 936 IGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG---QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSL 1011 (1237)
Q Consensus 936 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 1011 (1237)
||.|+||.||+|+.. +++.+|+|++..... ...+.+.+|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999987 488999998864322 2345688999999999999999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcceee
Q 000889 1012 ESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSV 1091 (1237)
Q Consensus 1012 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~~ 1091 (1237)
.+++... ..+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~ 149 (262)
T cd05572 81 WTILRDR-----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KT 149 (262)
T ss_pred HHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cc
Confidence 9999763 3578899999999999999999999 99999999999999999999999999998665432 12
Q ss_pred eccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCC
Q 000889 1092 STLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTS 1171 (1237)
Q Consensus 1092 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 1171 (1237)
....+++.|+|||++.+..++.++|+||+|+++|+|++|..||...... . ........... .....+..
T Consensus 150 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~-~~~~~~~~~~~-------~~~~~~~~ 218 (262)
T cd05572 150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED---P-MEIYNDILKGN-------GKLEFPNY 218 (262)
T ss_pred ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC---H-HHHHHHHhccC-------CCCCCCcc
Confidence 3346888999999998888999999999999999999999999754321 1 11111111000 01111111
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 000889 1172 DETELYQYLRISFECLDDRPFKRPT-----MIQVMA 1202 (1237)
Q Consensus 1172 ~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~ 1202 (1237)
. ...+.+++.+||+.+|++||+ +.|+++
T Consensus 219 ~---~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 I---DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred c---CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 1 346778888999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=298.74 Aligned_cols=262 Identities=27% Similarity=0.335 Sum_probs=198.3
Q ss_pred CCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCc--CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 930 FSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQ--GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
|++.+.||+|++|.||+|... +++.+++|++...... ....+.+|++++++++||||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999886 6888999988643322 3456888999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
+ +++.+++.... ..+++..+..++.|+++|++|||+. +|+|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~-~~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 81 D-TDLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred C-CCHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 7 48888887632 4789999999999999999999999 99999999999999999999999999998765433
Q ss_pred cceeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhh--cccccccC
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE--KRINEILD 1163 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 1163 (1237)
.......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||......+ ............ .......+
T Consensus 153 --~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 153 --RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID--QLFKIFRTLGTPDPEVWPKFTS 228 (283)
T ss_pred --ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCchHhcccchh
Confidence 112334578899999998876 78899999999999999999999986533111 000000000000 00000000
Q ss_pred ------ccc------cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1164 ------PEL------TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1164 ------~~l------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
... ......+....++.+++.+||+++|.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 0000011233567899999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=303.94 Aligned_cols=284 Identities=22% Similarity=0.307 Sum_probs=206.7
Q ss_pred HHHhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEe-CCeE
Q 000889 924 LEATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKI-GEER 999 (1237)
Q Consensus 924 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 999 (1237)
..++++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 456788999999999999999999876 68899999875322 2234678889999999999999999998865 5678
Q ss_pred EEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccc
Q 000889 1000 LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1079 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla 1079 (1237)
++||||+ +++|.+++.. ..+++.....++.|+++|++|||+. +|+||||+|+||++++++.+||+|||.+
T Consensus 86 ~lv~e~~-~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred EEEeehh-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence 9999998 5689888753 3578888889999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcceeeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHH-------
Q 000889 1080 RLVNALDTHLSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQ------- 1151 (1237)
Q Consensus 1080 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~------- 1151 (1237)
...... .....++..|+|||++.+ ..++.++||||+|+++|||++|+.||....... ....+.+.
T Consensus 156 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~--~~~~~~~~~~~~~~~ 228 (328)
T cd07856 156 RIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN--QFSIITDLLGTPPDD 228 (328)
T ss_pred cccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHH
Confidence 754321 123457889999998765 568899999999999999999999996432110 00000000
Q ss_pred ----HhhhcccccccCccccCCCCC----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhcccccCCCCC-CccC
Q 000889 1152 ----LHREKRINEILDPELTMQTSD----ETELYQYLRISFECLDDRPFKRPTMIQVMAM--FKELQVDTEGDSL-DSFS 1220 (1237)
Q Consensus 1152 ----~~~~~~~~~~~~~~l~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~ell~~--L~~l~~~~~~~~~-~~~~ 1220 (1237)
.........+........... +.....+.+++.+|++.+|++|||+.+++.+ ++..+...+.+.. +.|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~~~~~~ 308 (328)
T cd07856 229 VINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVAEEKFD 308 (328)
T ss_pred HHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccCchhhcC
Confidence 000000000000000000000 0112467788999999999999999999988 5555444333332 5666
Q ss_pred chhh
Q 000889 1221 LKDT 1224 (1237)
Q Consensus 1221 ~~~~ 1224 (1237)
|.++
T Consensus 309 ~~~~ 312 (328)
T cd07856 309 WSFN 312 (328)
T ss_pred Cchh
Confidence 6554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=301.40 Aligned_cols=265 Identities=22% Similarity=0.276 Sum_probs=193.5
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC--cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG--QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
++|++.+.||+|++|+||+|++. +++.||+|++..... ...+.+.+|++++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999986 588999998754322 223568889999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCC-CCceEEeecccceeec
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE-NFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~-~~~vkl~DfGla~~~~ 1083 (1237)
|++ +++.+++.... ....++..+..++.|++.||+|||+. +++||||+|+||+++. ++.+||+|||++....
T Consensus 82 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 996 58888775432 23467888889999999999999999 9999999999999985 5679999999997553
Q ss_pred cCCcceeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhh--cccc-
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE--KRIN- 1159 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~- 1159 (1237)
.... ......+++.|+|||++.+. .++.++||||+|+++|+|++|+.||...... ............. ....
T Consensus 155 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 155 IPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI--DELFKIFRILGTPNEETWPG 230 (294)
T ss_pred CCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChhhccc
Confidence 3211 12334578899999998664 5788999999999999999999999643211 1111100000000 0000
Q ss_pred -----ccc--CccccCCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1160 -----EIL--DPELTMQT---SDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1160 -----~~~--~~~l~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
... -+...... ..+....++.+++.+|++.+|++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00000000 001112346788889999999999999999974
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=294.88 Aligned_cols=246 Identities=24% Similarity=0.340 Sum_probs=193.6
Q ss_pred ecccCCeEEEEEEECC-CCEEEEEEeccccC---cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCCCH
Q 000889 936 IGSGGFGEVYKAQLRD-GSVVAIKKLIHVTG---QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSL 1011 (1237)
Q Consensus 936 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 1011 (1237)
||+|+||.||+|++.. ++.+++|.+..... ...+.+.+|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999874 88999998864332 2345688899999999999999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCc----
Q 000889 1012 ESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDT---- 1087 (1237)
Q Consensus 1012 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~---- 1087 (1237)
.+++... ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLENV-----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 9999753 3689999999999999999999999 999999999999999999999999999875443211
Q ss_pred --ceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcc
Q 000889 1088 --HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPE 1165 (1237)
Q Consensus 1088 --~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1165 (1237)
........++..|+|||+..+..++.++||||||+++||+++|+.||..... ......... ... .
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~-~~~------~ 219 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP------EEIFQNILN-GKI------E 219 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhc-CCc------C
Confidence 1122345678899999999888899999999999999999999999974321 111111111 000 0
Q ss_pred ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 000889 1166 LTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFK 1205 (1237)
Q Consensus 1166 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~ 1205 (1237)
.+.... ....+.+++.+|++.+|.+|||+.++.+.++
T Consensus 220 ~~~~~~---~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 WPEDVE---VSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCcccc---CCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 100000 1245678888999999999999955555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=288.44 Aligned_cols=248 Identities=26% Similarity=0.461 Sum_probs=200.7
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC--cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG--QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
+|++.+.||+|++|.||+|+.. +++.|++|.+..... ...+.+.+|++++++++|||++++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999876 578899998875433 2345788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
+++++|.+++... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 9999999998754 4689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCcc
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPE 1165 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1165 (1237)
... .....++..|+|||...+..++.++||||+|+++|+|++|+.||.... ......... . .. .+.
T Consensus 153 ~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-----~~~~~~~~~-~-~~-----~~~ 218 (254)
T cd06627 153 SKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN-----PMAALFRIV-Q-DD-----HPP 218 (254)
T ss_pred ccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHh-c-cC-----CCC
Confidence 322 234568889999999988888999999999999999999999986422 111111110 0 00 011
Q ss_pred ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1166 LTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1166 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.+ .. ....+.+++.+|+..+|++|||+.+++.+
T Consensus 219 ~~--~~---~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 219 LP--EG---ISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CC--CC---CCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 11 11 12356688889999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=302.46 Aligned_cols=294 Identities=23% Similarity=0.280 Sum_probs=204.2
Q ss_pred CCCCCceecccCCeEEEEEEECC---CCEEEEEEeccccC--cCHHHHHHHHHHHHhc-CCCCcccccceEEeC----Ce
Q 000889 929 GFSADSMIGSGGFGEVYKAQLRD---GSVVAIKKLIHVTG--QGDREFMAEMETIGKI-KHRNLVPLLGYCKIG----EE 998 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 998 (1237)
+|++.+.||+|+||.||+|+... +..||+|++..... ...+.+.+|+++++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 47788899999999999999863 67899998764221 2245678899999999 599999999875432 45
Q ss_pred EEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeeccc
Q 000889 999 RLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1078 (1237)
Q Consensus 999 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGl 1078 (1237)
.++++||+. ++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 688889886 6898888642 4688999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCcc--eeeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHH-----
Q 000889 1079 ARLVNALDTH--LSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAK----- 1150 (1237)
Q Consensus 1079 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~----- 1150 (1237)
++........ .......|+..|+|||++.+ ..++.++||||+||++|+|++|+.||....... .+.....
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~ 229 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD--QLNQILQVLGTP 229 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH--HHHHHHHHhCCC
Confidence 9865432211 11233568999999998765 468899999999999999999999987533110 0000000
Q ss_pred ------HHhhhc--cccccc--CccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhcccccCCCCC--
Q 000889 1151 ------QLHREK--RINEIL--DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM--FKELQVDTEGDSL-- 1216 (1237)
Q Consensus 1151 ------~~~~~~--~~~~~~--~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~--L~~l~~~~~~~~~-- 1216 (1237)
...... ...... .+........+.....+.+++.+|++.+|++|||+.+++++ +.+.....+.+-+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~ 309 (332)
T cd07857 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQK 309 (332)
T ss_pred CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccc
Confidence 000000 000000 00000000000112457788899999999999999999876 3333322222222
Q ss_pred --CccCchhhHHHHHHHhh
Q 000889 1217 --DSFSLKDTVIEELRERE 1233 (1237)
Q Consensus 1217 --~~~~~~~~~~~~~~~~~ 1233 (1237)
+....-|+.+|++|++-
T Consensus 310 ~~~~~~~~~~~~~~~~~~~ 328 (332)
T cd07857 310 PFDFSFESEDSMEELRDMI 328 (332)
T ss_pred cccCCccccccHHHHHHHH
Confidence 11234467778887753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=298.02 Aligned_cols=263 Identities=26% Similarity=0.334 Sum_probs=196.5
Q ss_pred CCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeC--CeEEEEEE
Q 000889 930 FSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIG--EERLLVYE 1004 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 1004 (1237)
|++.+.||+|+||.||+|+.. +++.+|+|++.... ....+.+.+|++++++++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999987 47899999987543 23345688999999999999999999999887 78999999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
|++ ++|.+++.... ..+++..+..++.|+++|++|||+. +++|+||||+||++++++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 81 YMD-HDLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred ccc-ccHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 997 58888876532 4689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcceeeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhh--cccccc
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE--KRINEI 1161 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 1161 (1237)
... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ............. ......
T Consensus 153 ~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 153 RNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL--EQLEKIFELCGSPTDENWPGV 229 (287)
T ss_pred CCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCchhhcccc
Confidence 332 11233456788999998765 45789999999999999999999998753311 1111100000000 000000
Q ss_pred --------cCccccCCCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1162 --------LDPELTMQTS-----DETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1162 --------~~~~l~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
..+....... .......+.+++.+|++.+|++||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000000000 00013467889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=306.20 Aligned_cols=271 Identities=26% Similarity=0.334 Sum_probs=203.4
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeCC-----eEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGE-----ERL 1000 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 1000 (1237)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888899999999999999986 48899999886533 334567889999999999999999999987765 789
Q ss_pred EEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccce
Q 000889 1001 LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1080 (1237)
Q Consensus 1001 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~ 1080 (1237)
+||||++ ++|.+++... ..+++..+..++.++++||+|||+. +|+||||||+||+++.++.++|+|||++.
T Consensus 81 lv~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 81 IVTELME-TDLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred EEecchh-hhHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 9999998 5888887643 3789999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCc-ceeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHh-----
Q 000889 1081 LVNALDT-HLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLH----- 1153 (1237)
Q Consensus 1081 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~----- 1153 (1237)
....... ........++..|+|||++.+. .++.++||||+|+++|+|++|+.||......+ ..........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~ 229 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID--QLNLIVEVLGTPSEE 229 (330)
T ss_pred eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHhcCCCChh
Confidence 7654321 0112345678899999999887 78999999999999999999999997543210 0000000000
Q ss_pred -----hhcccccccC---ccccCCC--CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhcccc
Q 000889 1154 -----REKRINEILD---PELTMQT--SDETELYQYLRISFECLDDRPFKRPTMIQVMAM--FKELQVD 1210 (1237)
Q Consensus 1154 -----~~~~~~~~~~---~~l~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~--L~~l~~~ 1210 (1237)
........+. ....... ..+.....+.+++.+||+.+|++||++.+++++ ++.+...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 0000000000 0000000 001123456788899999999999999999997 6666554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=300.21 Aligned_cols=268 Identities=26% Similarity=0.325 Sum_probs=196.4
Q ss_pred HHhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeCC----
Q 000889 925 EATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGE---- 997 (1237)
Q Consensus 925 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 997 (1237)
...++|++.+.||+|+||.||+|+++ +++.||+|++.... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34568999999999999999999987 57899999886432 223356778999999999999999999887654
Q ss_pred ------eEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCce
Q 000889 998 ------ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEA 1071 (1237)
Q Consensus 998 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~v 1071 (1237)
..++||||+++ ++.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcE
Confidence 78999999985 777776543 24689999999999999999999999 99999999999999999999
Q ss_pred EEeecccceeeccCCcceeeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHH
Q 000889 1072 RVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAK 1150 (1237)
Q Consensus 1072 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~ 1150 (1237)
||+|||.+......... ......++..|+|||++.+ ..++.++||||+||++|||++|+.||..... ...+.....
T Consensus 156 kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~--~~~~~~~~~ 232 (302)
T cd07864 156 KLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE--LAQLELISR 232 (302)
T ss_pred EeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHH
Confidence 99999999866543321 1123346778999998865 3578899999999999999999999974321 111111111
Q ss_pred HHhhh--ccccccc--------CccccCCC----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1151 QLHRE--KRINEIL--------DPELTMQT----SDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1151 ~~~~~--~~~~~~~--------~~~l~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
..... .....+. ++...... ........+.+++.+|++.+|.+||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 10000 0000000 00000000 000012457788899999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=298.90 Aligned_cols=257 Identities=20% Similarity=0.243 Sum_probs=188.5
Q ss_pred ceecccCCeEEEEEEECCCCEEEEEEeccc--cCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCCCH
Q 000889 934 SMIGSGGFGEVYKAQLRDGSVVAIKKLIHV--TGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSL 1011 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 1011 (1237)
+.+|.|+++.||++.. +++.||+|++... .....+.+.+|++++++++||||+++++++...+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3344444545555444 5889999998643 233446788999999999999999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc---
Q 000889 1012 ESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH--- 1088 (1237)
Q Consensus 1012 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~--- 1088 (1237)
.+++..... ..+++.....++.|+++||+|||+. +|+||||||+||+++.++.+|++|||.+.........
T Consensus 87 ~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 87 EDLLKTHFP---EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred HHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 999986432 3578889999999999999999999 9999999999999999999999999998755432211
Q ss_pred --eeeeccccCCCcCCccccCc--cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccccccc--
Q 000889 1089 --LSVSTLAGTPGYVPPEYYQS--FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL-- 1162 (1237)
Q Consensus 1089 --~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 1162 (1237)
.......++..|+|||++.+ ..++.++||||+||++|||++|+.||...... ... ..... ......+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~---~~~~~--~~~~~~~~~ 233 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QML---LEKVR--GTVPCLLDK 233 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHH---HHHHh--ccCcccccc
Confidence 11233456778999999876 35888999999999999999999999743211 000 01000 0000000
Q ss_pred ------------------CccccC---CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1163 ------------------DPELTM---QTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1163 ------------------~~~l~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
++.... .........++.+++.+||+.+|++|||+.+++++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 000000 000111224677899999999999999999999873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=294.31 Aligned_cols=264 Identities=25% Similarity=0.350 Sum_probs=196.1
Q ss_pred CCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC-cCHHHHHHHHHHHHhcC-CCCcccccceEEeCCeEEEEEEec
Q 000889 930 FSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG-QGDREFMAEMETIGKIK-HRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
|++.+.||+|+||+||+|+.. +++.|++|++..... .......+|+..+++++ ||||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999986 478899998864322 22334567999999999 999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
+|+|.+++.... +..+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 -~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 81 -EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred -CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 789999887643 24689999999999999999999999 99999999999999999999999999998654322
Q ss_pred cceeeeccccCCCcCCccccC-ccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCch----------HHHHHHHHhhh
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQ-SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN----------LVGWAKQLHRE 1155 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~----------~~~~~~~~~~~ 1155 (1237)
. .....++..|+|||++. +..++.++|+||||+++|||++|+.||......+... ...|.......
T Consensus 154 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 154 P---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred C---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence 2 23356788999999875 4457899999999999999999999986543211000 00011100000
Q ss_pred cccccccCccccCC--CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1156 KRINEILDPELTMQ--TSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1156 ~~~~~~~~~~l~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
......+....... ...+.....+.+++.+|++.+|++|||+.|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 11111100000000 0000112467889999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=299.73 Aligned_cols=249 Identities=29% Similarity=0.396 Sum_probs=193.8
Q ss_pred CCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC---cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 930 FSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG---QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
|+..+.||+|+||.||+|+.. ++..+|+|++..... ...+++.+|+++++.++|+|++++++++......++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 556678999999999999986 577899998753221 2234678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
+. |++.+++.... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+|++|||++......
T Consensus 97 ~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 97 CL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred cC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 97 68887775432 3578999999999999999999999 9999999999999999999999999999765432
Q ss_pred CcceeeeccccCCCcCCccccC---ccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccccccc
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQ---SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1162 (1237)
....+++.|+|||++. ...++.++|||||||++|||++|+.||..... . ....... ....
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~-~~~~~~~-~~~~---- 231 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----M-SALYHIA-QNES---- 231 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-----H-HHHHHHh-hcCC----
Confidence 2345788999999974 34678899999999999999999999854211 0 0000000 0000
Q ss_pred CccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 000889 1163 DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208 (1237)
Q Consensus 1163 ~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~ 1208 (1237)
+... .......+.+++.+||+.+|++||++.+++++-....
T Consensus 232 -~~~~----~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 232 -PALQ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred -CCcC----cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 1110 1112245678888999999999999999998855544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=291.01 Aligned_cols=251 Identities=22% Similarity=0.363 Sum_probs=193.8
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc-----CcCHHHHHHHHHHHHhcCCCCcccccceEEeC--CeE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT-----GQGDREFMAEMETIGKIKHRNLVPLLGYCKIG--EER 999 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 999 (1237)
.+|++.+.||+|+||.||+|++. ++..||+|.+.... ......+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46889999999999999999876 58899999874211 12234688899999999999999999998764 467
Q ss_pred EEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccc
Q 000889 1000 LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1079 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla 1079 (1237)
++||||+++++|.+++... ..+++..+.+++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccc
Confidence 8999999999999998753 3578888999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCc-ceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccc
Q 000889 1080 RLVNALDT-HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158 (1237)
Q Consensus 1080 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1158 (1237)
+....... ........++..|+|||++.+..++.++|||||||++|||++|+.||.... ....... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~-~~~~~-- 225 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE-----AMAAIFK-IATQP-- 225 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC-----HHHHHHH-HHcCC--
Confidence 86532111 111123568889999999998889999999999999999999999986421 1111111 00000
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1159 NEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1159 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
..+.+ .......+.+++.+|+. +|..||++.+++.+
T Consensus 226 ---~~~~~-----p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 226 ---TKPML-----PDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ---CCCCC-----CcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 01111 11122356778889999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=303.61 Aligned_cols=266 Identities=24% Similarity=0.356 Sum_probs=195.2
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeC------C
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIG------E 997 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 997 (1237)
.++|...+.||+|+||.||+|++. +++.||+|++.... ......+.+|++++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468999999999999999999975 58899999886422 22234678999999999999999999998654 3
Q ss_pred eEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecc
Q 000889 998 ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFG 1077 (1237)
Q Consensus 998 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfG 1077 (1237)
..++|+||+. .++.++.. ..+++..+..++.|+++|++|||+. +++||||||+||+++.++.+|++|||
T Consensus 94 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred eEEEEecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCC
Confidence 5699999996 46766542 3578899999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcceeeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHH----
Q 000889 1078 MARLVNALDTHLSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQL---- 1152 (1237)
Q Consensus 1078 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---- 1152 (1237)
+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .+.......
T Consensus 163 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~ 235 (342)
T cd07879 163 LARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPG 235 (342)
T ss_pred CCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCC
Confidence 99754321 123457888999999876 468889999999999999999999997532110 011000000
Q ss_pred ------hhhcccccccC--ccccCCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhcccc
Q 000889 1153 ------HREKRINEILD--PELTMQT---SDETELYQYLRISFECLDDRPFKRPTMIQVMAM--FKELQVD 1210 (1237)
Q Consensus 1153 ------~~~~~~~~~~~--~~l~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~--L~~l~~~ 1210 (1237)
........... +...... ..+.....+.+++.+|++.+|++||++.+++++ ++.+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 00000000000 0000000 000112356788999999999999999999976 7776543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=284.56 Aligned_cols=200 Identities=30% Similarity=0.402 Sum_probs=171.7
Q ss_pred CCCCCCceecccCCeEEEEEEECC-CCEEEEEEecccc---CcCHHHHHHHHHHHHhc-CCCCcccccceEEeCCeEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVT---GQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 1002 (1237)
.+|....+||+|+||.|-+|..+. .+.+|||++++.. ..+.+--+.|-+++.-- +-|.++++..+|+.-++.|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 368888999999999999998774 5679999887532 22223345677777766 468999999999999999999
Q ss_pred EEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceee
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~ 1082 (1237)
|||+.||+|--.+++. ..+.+..+..+|..||-||-+||++ +|++||+|.+|||+|.+|++||+|||+++.-
T Consensus 429 MEyvnGGDLMyhiQQ~-----GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQV-----GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEecCchhhhHHHHh-----cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999999988876 3566777888999999999999999 9999999999999999999999999999843
Q ss_pred ccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCC
Q 000889 1083 NALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPS 1137 (1237)
Q Consensus 1083 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~ 1137 (1237)
- -......+.+|||.|+|||.+..++|+.++|+||+||++|||+.|++||++.
T Consensus 501 i--~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe 553 (683)
T KOG0696|consen 501 I--FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 553 (683)
T ss_pred c--cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence 2 2233456899999999999999999999999999999999999999999864
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=299.71 Aligned_cols=257 Identities=21% Similarity=0.288 Sum_probs=189.4
Q ss_pred eeccc--CCeEEEEEEEC-CCCEEEEEEeccccC--cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCC
Q 000889 935 MIGSG--GFGEVYKAQLR-DGSVVAIKKLIHVTG--QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWG 1009 (1237)
Q Consensus 935 ~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 1009 (1237)
.||+| +||+||+|++. +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++..++..++||||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 99999999985 689999998764322 22356788999999999999999999999999999999999999
Q ss_pred CHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcce
Q 000889 1010 SLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHL 1089 (1237)
Q Consensus 1010 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~ 1089 (1237)
++.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++||+.+..........
T Consensus 85 ~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 85 SANSLLKTYFP---EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999876432 3588899999999999999999999 99999999999999999999999998654332111110
Q ss_pred e-----eeccccCCCcCCccccCcc--ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcc-----
Q 000889 1090 S-----VSTLAGTPGYVPPEYYQSF--RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKR----- 1157 (1237)
Q Consensus 1090 ~-----~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 1157 (1237)
. .....++..|||||++.+. .++.++||||+||++|||++|+.||...... ............
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~ 233 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT-----QMLLQKLKGPPYSPLDI 233 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH-----HHHHHHhcCCCCCCccc
Confidence 0 0112345679999999763 4788999999999999999999999643211 000000000000
Q ss_pred --------------------cc----------cccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1158 --------------------IN----------EILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1158 --------------------~~----------~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
+. ...+.... ..........+.+++.+|++.||++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR-TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred cccchhhhhhccchhhhhcccccchhcccccccccccccc-chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00 00000000 00112234568899999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=291.34 Aligned_cols=242 Identities=26% Similarity=0.302 Sum_probs=184.7
Q ss_pred ceecccCCeEEEEEEEC-CCCEEEEEEeccccCc---CHHHHHHHHHHH-HhcCCCCcccccceEEeCCeEEEEEEeccC
Q 000889 934 SMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQ---GDREFMAEMETI-GKIKHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
+.||+|+||.||+|+.. +++.||+|.+...... ....+..|..++ ...+|||++++++++..++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999886 5789999988543211 122344455443 445899999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
++|.+++... ..+++..+..++.|+++||.|||+. +++||||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 82 GDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 9999998753 3678899999999999999999999 999999999999999999999999999875432
Q ss_pred eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccC
Q 000889 1089 LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTM 1168 (1237)
Q Consensus 1089 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1168 (1237)
.....+++.|+|||.+.+..++.++||||+|+++|||++|..||..... . ....... ..... .....
T Consensus 150 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~---~~~~~~~-~~~~~--~~~~~-- 216 (260)
T cd05611 150 --NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---D---AVFDNIL-SRRIN--WPEEV-- 216 (260)
T ss_pred --cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---H---HHHHHHH-hcccC--CCCcc--
Confidence 1234688899999999888889999999999999999999999964321 1 1111111 11100 00000
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1169 QTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1169 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.......+.+++.+|++.+|++||++.++.+.
T Consensus 217 ---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 217 ---KEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred ---cccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 00122456788889999999999977544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=293.43 Aligned_cols=252 Identities=23% Similarity=0.312 Sum_probs=193.6
Q ss_pred CCCCCceecccCCeEEEEEEEC----CCCEEEEEEecccc----CcCHHHHHHHHHHHHhc-CCCCcccccceEEeCCeE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR----DGSVVAIKKLIHVT----GQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEER 999 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 999 (1237)
+|++.+.||+|+||.||+|+.. +|..||+|++.... ....+.+.+|+++++++ +|++|+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4778899999999999999873 68899999886422 12235678899999999 599999999999999999
Q ss_pred EEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccc
Q 000889 1000 LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1079 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla 1079 (1237)
++||||+++++|.+++... ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.+||+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccc
Confidence 9999999999999998753 3578888999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcceeeeccccCCCcCCccccCcc--ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcc
Q 000889 1080 RLVNALDTHLSVSTLAGTPGYVPPEYYQSF--RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKR 1157 (1237)
Q Consensus 1080 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1157 (1237)
+........ ......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||...... .....+.......
T Consensus 153 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~-- 227 (290)
T cd05613 153 KEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKS-- 227 (290)
T ss_pred eeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhcc--
Confidence 865432211 12235688899999998753 4678999999999999999999998643211 1111111111111
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 000889 1158 INEILDPELTMQTSDETELYQYLRISFECLDDRPFKRP-----TMIQVMAM 1203 (1237)
Q Consensus 1158 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 1203 (1237)
.+.. +. .....+.+++.+|++.+|++|| ++.+++++
T Consensus 228 -----~~~~--~~---~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 -----EPPY--PQ---EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -----CCCC--Cc---cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0111 11 1123566788899999999997 56666544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=294.04 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=200.0
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcC-CCCcccccceEEeCCeEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIK-HRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 1002 (1237)
++|.+.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|++++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999986 68899999876422 223456788999999998 99999999999999999999
Q ss_pred EEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceee
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~ 1082 (1237)
|||+++++|.+++... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++...
T Consensus 81 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 81 LEYAPNGELLQYIRKY-----GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 9999999999999763 3689999999999999999999999 9999999999999999999999999999865
Q ss_pred ccCCcc------------------eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCch
Q 000889 1083 NALDTH------------------LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144 (1237)
Q Consensus 1083 ~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~ 1144 (1237)
...... .......++..|+|||+..+..++.++||||+|+++|++++|+.||.... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~ 227 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-----E 227 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-----H
Confidence 432211 22234567889999999988889999999999999999999999987432 1
Q ss_pred HHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCH----HHHHHH
Q 000889 1145 LVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTM----IQVMAM 1203 (1237)
Q Consensus 1145 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~ell~~ 1203 (1237)
....... . +.....+.. ....+.+++.+|++.+|.+||++ .+++++
T Consensus 228 ~~~~~~~-~---------~~~~~~~~~---~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 228 YLTFQKI-L---------KLEYSFPPN---FPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHHHHH-H---------hcCCCCCCc---cCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 1111110 0 000001111 12356788889999999999999 777654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=292.27 Aligned_cols=262 Identities=24% Similarity=0.316 Sum_probs=194.6
Q ss_pred CCCCceecccCCeEEEEEEECC-CCEEEEEEeccccCc--CHHHHHHHHHHHHhc---CCCCcccccceEEeCCe-----
Q 000889 930 FSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQ--GDREFMAEMETIGKI---KHRNLVPLLGYCKIGEE----- 998 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 998 (1237)
|++.+.||+|+||.||+|+++. +..||+|++...... ....+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5677899999999999999874 889999988643222 233566788777666 59999999999988776
Q ss_pred EEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeeccc
Q 000889 999 RLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1078 (1237)
Q Consensus 999 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGl 1078 (1237)
.+++|||++ ++|.+++..... ..+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCc
Confidence 899999997 589988865322 3589999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccc
Q 000889 1079 ARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158 (1237)
Q Consensus 1079 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1158 (1237)
+........ .....++..|+|||++.+..++.++||||||+++|||++|+.||...... .....+..........
T Consensus 154 ~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 228 (287)
T cd07838 154 ARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA--DQLDKIFDVIGLPSEE 228 (287)
T ss_pred ceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH--HHHHHHHHHcCCCChH
Confidence 987643322 12345788999999999888999999999999999999999998753211 1111111111000000
Q ss_pred c---c------ccCccccC--CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1159 N---E------ILDPELTM--QTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1159 ~---~------~~~~~l~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
. . ........ ....+.....+.+++.+||+.||.+||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0 0 00000000 00011223566789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=291.36 Aligned_cols=242 Identities=25% Similarity=0.320 Sum_probs=185.3
Q ss_pred eecccCCeEEEEEEEC-CCCEEEEEEeccccCc---CHHHHHHHHH---HHHhcCCCCcccccceEEeCCeEEEEEEecc
Q 000889 935 MIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQ---GDREFMAEME---TIGKIKHRNLVPLLGYCKIGEERLLVYEYMK 1007 (1237)
Q Consensus 935 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 1007 (1237)
+||+|+||.||+|+.. +++.||+|.+...... ....+..|.. .++...||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 5789999988643211 1222344443 3444579999999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCc
Q 000889 1008 WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDT 1087 (1237)
Q Consensus 1008 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~ 1087 (1237)
||+|.+++... ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~ 152 (278)
T cd05606 81 GGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (278)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC
Confidence 99999888642 4689999999999999999999999 999999999999999999999999999975543221
Q ss_pred ceeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccc
Q 000889 1088 HLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1088 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
....|+..|+|||++.++ .++.++||||+|+++|||++|+.||........... ... .. ..+...
T Consensus 153 ----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~---~~~-~~------~~~~~~ 218 (278)
T cd05606 153 ----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRM-TL------TMAVEL 218 (278)
T ss_pred ----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH---HHH-hh------ccCCCC
Confidence 234689999999998754 688999999999999999999999975432211111 000 00 011111
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRP-----TMIQVMAM 1203 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ell~~ 1203 (1237)
+. . ....+.+++.+|+..+|.+|| ++.+++++
T Consensus 219 ~~--~---~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 219 PD--S---FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CC--c---CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 11 1 123566788899999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=302.20 Aligned_cols=263 Identities=22% Similarity=0.289 Sum_probs=193.6
Q ss_pred CCCC-CCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcC--------------HHHHHHHHHHHHhcCCCCcccccc
Q 000889 928 NGFS-ADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQG--------------DREFMAEMETIGKIKHRNLVPLLG 991 (1237)
Q Consensus 928 ~~~~-~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~ 991 (1237)
++|. +.+.||+|+||+||+|++. +++.||+|++....... ...+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4555 3567999999999999976 58899999886432221 124678999999999999999999
Q ss_pred eEEeCCeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCce
Q 000889 992 YCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEA 1071 (1237)
Q Consensus 992 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~v 1071 (1237)
++..++..++||||+. |+|.+++... ..+++.....++.|++.|++|||+. +++||||+|+||+++.++.+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCE
Confidence 9999999999999997 6899988643 4588999999999999999999999 99999999999999999999
Q ss_pred EEeecccceeeccCC------------cceeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCC
Q 000889 1072 RVSDFGMARLVNALD------------THLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSE 1138 (1237)
Q Consensus 1072 kl~DfGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~ 1138 (1237)
|++|||+++...... .........++..|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999998654111 01111234567889999998764 46889999999999999999999987442
Q ss_pred CCCCchHHHHHHHHhhh--ccccccc------------CccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1139 FGDDNNLVGWAKQLHRE--KRINEIL------------DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1139 ~~~~~~~~~~~~~~~~~--~~~~~~~------------~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.. ..+.......... ....... .+.... ........+.+++.+|++.+|++|||+.+++.+
T Consensus 239 ~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 239 EI--DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT--IFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HH--HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH--hCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 11 1111100000000 0000000 000000 000112456788899999999999999999975
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=302.78 Aligned_cols=265 Identities=23% Similarity=0.311 Sum_probs=193.1
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeC---------
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIG--------- 996 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 996 (1237)
..+|++.+.||+|+||.||+|+.. ++..||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367899999999999999999886 5889999988765555567788999999999999999999876543
Q ss_pred -----CeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeC-CCCc
Q 000889 997 -----EERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLD-ENFE 1070 (1237)
Q Consensus 997 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~-~~~~ 1070 (1237)
...++||||++ ++|.+++.. ..+++..++.++.|+++|++|||+. +|+||||||+||+++ +++.
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~ 153 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLV 153 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCce
Confidence 35789999997 588887753 3588999999999999999999999 999999999999997 4567
Q ss_pred eEEeecccceeeccCCcce-eeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHH
Q 000889 1071 ARVSDFGMARLVNALDTHL-SVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGW 1148 (1237)
Q Consensus 1071 vkl~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~ 1148 (1237)
+|++|||.++......... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .....
T Consensus 154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~~~~~ 231 (342)
T cd07854 154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE--QMQLI 231 (342)
T ss_pred EEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH
Confidence 8999999998654322111 1123457889999998754 567889999999999999999999996432100 00000
Q ss_pred HHHHh------hh---cccccccCccccCCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1149 AKQLH------RE---KRINEILDPELTMQTSD-----ETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1149 ~~~~~------~~---~~~~~~~~~~l~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
..... .. ................. +....++.+++.+|++.+|++|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00000 00 00000000000000000 0112356788899999999999999999965
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=292.76 Aligned_cols=255 Identities=22% Similarity=0.301 Sum_probs=196.1
Q ss_pred CCCCCceecccCCeEEEEEEEC----CCCEEEEEEecccc----CcCHHHHHHHHHHHHhc-CCCCcccccceEEeCCeE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR----DGSVVAIKKLIHVT----GQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEER 999 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 999 (1237)
+|++.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+++++++ +||||+++++++..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3777889999999999999753 46789999886422 12235678899999999 599999999999999999
Q ss_pred EEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccc
Q 000889 1000 LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1079 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla 1079 (1237)
++||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.++++|||++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccc
Confidence 9999999999999998653 3578889999999999999999999 9999999999999999999999999998
Q ss_pred eeeccCCcceeeeccccCCCcCCccccCccc--cCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcc
Q 000889 1080 RLVNALDTHLSVSTLAGTPGYVPPEYYQSFR--CTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKR 1157 (1237)
Q Consensus 1080 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1157 (1237)
+........ ......|+..|+|||.+.+.. ++.++||||+|+++|||++|..||...... .............
T Consensus 153 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~-- 227 (288)
T cd05583 153 KEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRILKS-- 227 (288)
T ss_pred ccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHHcc--
Confidence 765432221 112346888999999987655 788999999999999999999998632211 1111111111110
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 000889 1158 INEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206 (1237)
Q Consensus 1158 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 1206 (1237)
.+.. +.. ....+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 228 -----~~~~--~~~---~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 -----KPPF--PKT---MSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -----CCCC--Ccc---cCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0111 111 11345678889999999999998888776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=300.34 Aligned_cols=266 Identities=25% Similarity=0.342 Sum_probs=196.7
Q ss_pred HhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC--cCHHHHHHHHHHHHhcCCCCcccccceEEeCC-----
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG--QGDREFMAEMETIGKIKHRNLVPLLGYCKIGE----- 997 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 997 (1237)
..++|++.+.||+|+||.||+|... ++..||+|++..... .....+.+|++++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999865 688999998853221 12345788999999999999999999886543
Q ss_pred -eEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeec
Q 000889 998 -ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDF 1076 (1237)
Q Consensus 998 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~Df 1076 (1237)
..++||||+ +++|.+++.. ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+|++||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 458999999 6899888753 3688999999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcceeeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHH-----
Q 000889 1077 GMARLVNALDTHLSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAK----- 1150 (1237)
Q Consensus 1077 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~----- 1150 (1237)
|++....... ....+++.|+|||++.+ ..++.++|+||+|+++|++++|+.||...... ........
T Consensus 163 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~ 235 (343)
T cd07880 163 GLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL--DQLMEIMKVTGTP 235 (343)
T ss_pred ccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCC
Confidence 9997654321 23457889999999876 45888999999999999999999999743210 00000000
Q ss_pred ------HHhhh------cccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhcccc
Q 000889 1151 ------QLHRE------KRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM--FKELQVD 1210 (1237)
Q Consensus 1151 ------~~~~~------~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~--L~~l~~~ 1210 (1237)
..... ..........+.. ........+.+++.+|++.+|++|||+.+++++ ++.....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRS--LLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccCcchHHH--hccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 00000 0000000000000 000112346788899999999999999999955 5555433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=323.63 Aligned_cols=145 Identities=27% Similarity=0.384 Sum_probs=129.9
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcC---HHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQG---DREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
++|++.++||+|+||.||+|++. +++.||+|++....... ...+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999987 58899999886432222 356788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccce
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1080 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~ 1080 (1237)
||+.+++|.+++... ..+++..++.++.||+.||+|||+. +||||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998753 3578888999999999999999999 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=294.57 Aligned_cols=244 Identities=28% Similarity=0.420 Sum_probs=190.9
Q ss_pred CCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCc---CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 930 FSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQ---GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
|...+.||+|+||+||+|+.. ++..|++|++...... ..+.+.+|++++++++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 556678999999999999875 5788999988643222 224678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
+. |++.+++... ...+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~- 173 (313)
T cd06633 103 CL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP- 173 (313)
T ss_pred CC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence 96 6787777543 24689999999999999999999999 999999999999999999999999999864322
Q ss_pred CcceeeeccccCCCcCCccccC---ccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccccccc
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQ---SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1162 (1237)
.....|+..|+|||++. ...++.++|||||||++|||++|+.||..... ... ........ .
T Consensus 174 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-----~~~-~~~~~~~~-~---- 237 (313)
T cd06633 174 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSA-LYHIAQND-S---- 237 (313)
T ss_pred -----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHH-HHHHHhcC-C----
Confidence 12456888999999984 45688899999999999999999999864321 111 11111110 0
Q ss_pred CccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1163 DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1163 ~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
+... .......+.+++.+|++++|++||++.+++++
T Consensus 238 -~~~~----~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 -PTLQ----SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -CCCC----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1110 01112346778889999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=302.76 Aligned_cols=269 Identities=25% Similarity=0.300 Sum_probs=197.6
Q ss_pred CHHHHHHHhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEe
Q 000889 919 TFAHLLEATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKI 995 (1237)
Q Consensus 919 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 995 (1237)
...++....++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 44556677899999999999999999999865 68899999886422 1224567789999999999999999998854
Q ss_pred C------CeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCC
Q 000889 996 G------EERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENF 1069 (1237)
Q Consensus 996 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~ 1069 (1237)
. ...+++++++ +++|.+++.. ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence 3 3467888876 7899887753 3588999999999999999999999 999999999999999999
Q ss_pred ceEEeecccceeeccCCcceeeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHH
Q 000889 1070 EARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGW 1148 (1237)
Q Consensus 1070 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~ 1148 (1237)
.+||+|||+++..... .....++..|+|||++.+ ..++.++||||+||++|||++|+.||...... ......
T Consensus 158 ~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~--~~~~~~ 230 (345)
T cd07877 158 ELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLI 230 (345)
T ss_pred CEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH
Confidence 9999999999754321 123467889999999866 46788999999999999999999998643211 111110
Q ss_pred HHHHhhh--cccccc-----------cCccccCCCC--CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1149 AKQLHRE--KRINEI-----------LDPELTMQTS--DETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1149 ~~~~~~~--~~~~~~-----------~~~~l~~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
....... .....+ .+........ .......+.+++.+|++.+|++||++.+++++=
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 0000000 000000 0000000000 000123567888999999999999999999873
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=296.16 Aligned_cols=267 Identities=25% Similarity=0.343 Sum_probs=192.7
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCc--CHHHHHHHHHHHHhcCCCCcccccceEEeCC------
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQ--GDREFMAEMETIGKIKHRNLVPLLGYCKIGE------ 997 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 997 (1237)
.++|++.++||+|+||.||+|++. +++.+|+|++...... ....+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467999999999999999999976 5789999988643222 2345778999999999999999999875433
Q ss_pred --eEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEee
Q 000889 998 --ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSD 1075 (1237)
Q Consensus 998 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~D 1075 (1237)
..++||||+. +++...+... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENP----SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECc
Confidence 4699999997 4677766542 24689999999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCcce---------eeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchH
Q 000889 1076 FGMARLVNALDTHL---------SVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNL 1145 (1237)
Q Consensus 1076 fGla~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~ 1145 (1237)
||+++......... ......+++.|+|||++.+. .++.++||||+|+++|||++|+.||...... ...
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~--~~~ 236 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI--DQL 236 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH--HHH
Confidence 99997654322111 11234567889999987653 5788999999999999999999998643211 001
Q ss_pred HHHHHHHhhh--------ccccccc----CccccCCC--CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1146 VGWAKQLHRE--------KRINEIL----DPELTMQT--SDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1146 ~~~~~~~~~~--------~~~~~~~----~~~l~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.......... ..+.... ....+... ........+.+++.+|++.+|++|||+.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 1100000000 0000000 00000000 000112457789999999999999999998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=287.10 Aligned_cols=251 Identities=23% Similarity=0.353 Sum_probs=193.6
Q ss_pred CCCCCceecccCCeEEEEEEECC-CCEEEEEEeccc-----cCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHV-----TGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 1002 (1237)
+|.+.+.||+|+||.||+|++.. +..+++|.+... ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57888999999999999998764 344555544321 112234567799999999999999999999989999999
Q ss_pred EEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceee
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~ 1082 (1237)
|||+++++|.+++..... ....+++..++.++.|+++|+.|||+. +++|+||||+||+++. +.+|++|||.++..
T Consensus 81 ~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeec
Confidence 999999999999876432 235789999999999999999999999 9999999999999975 56999999999765
Q ss_pred ccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccccccc
Q 000889 1083 NALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162 (1237)
Q Consensus 1083 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1162 (1237)
..... ......|++.|+|||...+..++.++|+||+|+++|+|++|..||.... .......... ..
T Consensus 156 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~-~~----- 221 (260)
T cd08222 156 MGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVE-GP----- 221 (260)
T ss_pred CCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHc-CC-----
Confidence 43221 1234567889999999988888999999999999999999999986322 1111111110 00
Q ss_pred CccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1163 DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1163 ~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.+.. .......+.+++.+|++.+|++||++.+++++
T Consensus 222 ~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 222 TPSL-----PETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCCC-----cchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1111 11223466788889999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=289.52 Aligned_cols=262 Identities=25% Similarity=0.342 Sum_probs=197.4
Q ss_pred CCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 930 FSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|+.++++++|+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999987 48899999887542 233456788999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
+ ++|.+++.... ..+++..+.+++.+++.|++|||+. +|+||||+|+||++++++.+||+|||.++......
T Consensus 81 ~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 81 D-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred C-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 8 58999997642 3689999999999999999999999 99999999999999999999999999998654322
Q ss_pred cceeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhh--cc---ccc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE--KR---INE 1160 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~---~~~ 1160 (1237)
. ......++..|+|||++.+. .++.++||||+|+++||+++|+.||......+ .+.......... .. +..
T Consensus 153 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07829 153 R--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID--QLFKIFQILGTPTEESWPGVTK 228 (282)
T ss_pred c--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--HHHHHHHHhCCCcHHHHHhhcc
Confidence 2 22334567789999998766 78899999999999999999999986533110 000000000000 00 000
Q ss_pred c--cCccccCCCC------CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1161 I--LDPELTMQTS------DETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1161 ~--~~~~l~~~~~------~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
. .+...+.... .+.....+.+++.+|+..+|++||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0 0000000000 00113467889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=299.59 Aligned_cols=261 Identities=26% Similarity=0.339 Sum_probs=194.8
Q ss_pred HhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCe----
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEE---- 998 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 998 (1237)
..++|++.+.||+|+||.||+|++. ++..||+|++.... ....+.+.+|+.++++++|||++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4567999999999999999999986 57889999875422 2233557789999999999999999998866554
Q ss_pred --EEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeec
Q 000889 999 --RLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDF 1076 (1237)
Q Consensus 999 --~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~Df 1076 (1237)
.++|+||+ +++|.+++.. ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccc
Confidence 89999998 5799998864 3689999999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCcceeeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhh-
Q 000889 1077 GMARLVNALDTHLSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR- 1154 (1237)
Q Consensus 1077 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~- 1154 (1237)
|++...... .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...... ..+.........
T Consensus 163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~--~~~~~i~~~~~~~ 235 (343)
T cd07851 163 GLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI--DQLKRIMNLVGTP 235 (343)
T ss_pred ccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCC
Confidence 999765432 233467889999999865 36788999999999999999999999643211 001000000000
Q ss_pred ---------hcccccccCccccCCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1155 ---------EKRINEILDPELTMQTSD-----ETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1155 ---------~~~~~~~~~~~l~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.......+.......... ......+.+++.+|++.+|++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000000000000000 0113467789999999999999999999886
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=301.00 Aligned_cols=255 Identities=26% Similarity=0.391 Sum_probs=205.5
Q ss_pred HHhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhc-CCCCcccccceEEe-----CC
Q 000889 925 EATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKI-KHRNLVPLLGYCKI-----GE 997 (1237)
Q Consensus 925 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----~~ 997 (1237)
..++.|++.++||+|.+|.||+++.. +++.+|+|...... ...++...|.++++.. +|||++.+||++.. ++
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 34566888899999999999999876 57778888765433 4455677899999888 59999999998854 57
Q ss_pred eEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecc
Q 000889 998 ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFG 1077 (1237)
Q Consensus 998 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfG 1077 (1237)
+.|+|||||.+|+..|.++... +..+.|.....|++.++.|+.+||.+ .++|||||-.|||++.++.||++|||
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeee
Confidence 8999999999999999998654 57899999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcceeeeccccCCCcCCccccCcc-----ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHH
Q 000889 1078 MARLVNALDTHLSVSTLAGTPGYVPPEYYQSF-----RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQL 1152 (1237)
Q Consensus 1078 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 1152 (1237)
.+...+. +.....+..|||.|||||++... .|+..+|+||+|++..||..|.+|+-...
T Consensus 169 vSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH-------------- 232 (953)
T KOG0587|consen 169 VSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH-------------- 232 (953)
T ss_pred eeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc--------------
Confidence 9987663 33445778999999999999643 46778999999999999999999975321
Q ss_pred hhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1153 HREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1153 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
+...+..+..-..+..........+|.++|..|+.+|.++||++.+++++
T Consensus 233 -PmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 233 -PMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -hhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11111111111111111234566788899999999999999999999876
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=246.58 Aligned_cols=263 Identities=24% Similarity=0.341 Sum_probs=193.1
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC--cCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG--QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
+|...++||+|.||+||+|+.+ .++.||+|++.-... .......+|+.+++.++|+|||++++....+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 3555678999999999999876 478899998864322 2245678999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
|+ .+|..|..... ..++...++.++.|+++|+.++|++ .+.|||+||+|.++..+|+.|++|||+|+-++-.
T Consensus 83 cd-qdlkkyfdsln----g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLN----GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred hh-HHHHHHHHhcC----CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 96 78888877643 5788899999999999999999999 9999999999999999999999999999866532
Q ss_pred CcceeeeccccCCCcCCccccCccc-cCcccchHHHHHHHHHHHcCCCC-CCCCCCCCCchHHHHHHHHh--hhcc---c
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQSFR-CTTKGDVYSYGVILLELLSGKRP-IDPSEFGDDNNLVGWAKQLH--REKR---I 1158 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~tg~~p-~~~~~~~~~~~~~~~~~~~~--~~~~---~ 1158 (1237)
- .-.+..+-|..|.+|.++.+.. |++..|+||-||++.|+.....| |.+.... +.+....+... .++. +
T Consensus 155 v--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd--dqlkrif~~lg~p~ed~wps~ 230 (292)
T KOG0662|consen 155 V--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEDQWPSM 230 (292)
T ss_pred e--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH--HHHHHHHHHhCCCccccCCcc
Confidence 2 1234456789999999998765 88999999999999999985444 5543321 22222222211 1111 1
Q ss_pred ccccCccc----cCCCCCHHHH----HHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1159 NEILDPEL----TMQTSDETEL----YQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1159 ~~~~~~~l----~~~~~~~~~~----~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.+.-|... +........+ ..=.++.++.+.-+|..|.++.+.+++
T Consensus 231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 11111111 1111111111 112355667777899999999998875
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=279.23 Aligned_cols=236 Identities=26% Similarity=0.336 Sum_probs=189.9
Q ss_pred ecccCCeEEEEEEEC-CCCEEEEEEeccccCc---CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCCCH
Q 000889 936 IGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQ---GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSL 1011 (1237)
Q Consensus 936 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 1011 (1237)
||+|+||.||++... +++.+|+|.+...... ....+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999986 4889999987643322 345688899999999999999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcceee
Q 000889 1012 ESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSV 1091 (1237)
Q Consensus 1012 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~~ 1091 (1237)
.+++... ..+++..+..++.|+++|+.|+|+. +++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~ 150 (250)
T cd05123 81 FSHLSKE-----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRT 150 (250)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC--Ccc
Confidence 9998753 3688999999999999999999998 99999999999999999999999999998664322 122
Q ss_pred eccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCC
Q 000889 1092 STLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTS 1171 (1237)
Q Consensus 1092 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 1171 (1237)
....++..|+|||...+..++.++|+||||+++||+++|+.||..... ......... .....+..
T Consensus 151 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~---------~~~~~~~~ 215 (250)
T cd05123 151 NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILK---------DPLRFPEF 215 (250)
T ss_pred cCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhc---------CCCCCCCC
Confidence 345688899999999888889999999999999999999999964321 111111111 11111111
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHH
Q 000889 1172 DETELYQYLRISFECLDDRPFKRPTMIQ 1199 (1237)
Q Consensus 1172 ~~~~~~~l~~li~~cl~~dP~~RPt~~e 1199 (1237)
. ...+.+++.+|+..+|++||++.+
T Consensus 216 ~---~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 L---SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred C---CHHHHHHHHHHhcCCHhhCCCccc
Confidence 1 235667888999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-31 Score=286.43 Aligned_cols=245 Identities=25% Similarity=0.371 Sum_probs=194.6
Q ss_pred CceecccCCeEEEEEEEC-CCCEEEEEEeccc--cCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCC
Q 000889 933 DSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHV--TGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWG 1009 (1237)
Q Consensus 933 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 1009 (1237)
.++||.|.||+||-|+++ +|+.||||++.+. ....+.++.+|+.+++.++||.||.+-.-|+..+..+.|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 578999999999999876 6999999998643 3455678999999999999999999999999999999999999754
Q ss_pred CHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCC---CCceEEeecccceeeccCC
Q 000889 1010 SLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE---NFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1010 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~---~~~vkl~DfGla~~~~~~~ 1086 (1237)
-|+-.+... ...+++...+.++.||+.||.|||.+ +|||+|+||+|||+.. -.++||||||+|+..++..
T Consensus 649 MLEMILSsE----kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 649 MLEMILSSE----KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred HHHHHHHhh----cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 455555432 25789999999999999999999999 9999999999999964 3579999999999887543
Q ss_pred cceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccc
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
- ....+|||.|.|||++..+.|...-|+||.||++|--++|..||...+. +.. +.. ....++.+..
T Consensus 722 F---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----Ind---QIQ---NAaFMyPp~P 787 (888)
T KOG4236|consen 722 F---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----IND---QIQ---NAAFMYPPNP 787 (888)
T ss_pred h---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hhH---Hhh---ccccccCCCc
Confidence 3 2567899999999999999999999999999999999999999975431 110 000 0111111111
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
..+.....+++|...+++.-++|-+++..+.+
T Consensus 788 -----W~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 788 -----WSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred -----hhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 12222345677788899999999998887655
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=278.87 Aligned_cols=258 Identities=25% Similarity=0.357 Sum_probs=194.6
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcC----HHHHHHHHHHHHhcCCCCcccccceEEe-CCe
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQG----DREFMAEMETIGKIKHRNLVPLLGYCKI-GEE 998 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 998 (1237)
++|-...+||+|+|+.||+|.+- ..+.||||.-.... .+. .+...+|.++.+.++||.||++|+|+.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 35666778999999999999865 46678887543211 111 1346789999999999999999999864 567
Q ss_pred EEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeC---CCCceEEee
Q 000889 999 RLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLD---ENFEARVSD 1075 (1237)
Q Consensus 999 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~---~~~~vkl~D 1075 (1237)
+|-|+|||+|-+|+-|++.. +.+++.+++.|+.||+.||.||.+. .++|||-|+||.|||+- .-|.+||+|
T Consensus 543 FCTVLEYceGNDLDFYLKQh-----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQH-----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ceeeeeecCCCchhHHHHhh-----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 89999999999999999875 4689999999999999999999988 56899999999999995 458899999
Q ss_pred cccceeeccCCcc-----eeeeccccCCCcCCccccCcc----ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHH
Q 000889 1076 FGMARLVNALDTH-----LSVSTLAGTPGYVPPEYYQSF----RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLV 1146 (1237)
Q Consensus 1076 fGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~ 1146 (1237)
||+++.++..... ......+||..|.+||.+.-+ ..+.|+||||+|||+|.++.|+.||......
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ------ 690 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ------ 690 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH------
Confidence 9999988754432 123567899999999987432 4678999999999999999999999754321
Q ss_pred HHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1147 GWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1147 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.....+..+...-.-.++.......+ ...+|++|+++.-++|.++.++...
T Consensus 691 ---QdILqeNTIlkAtEVqFP~KPvVsse---AkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 691 ---QDILQENTILKATEVQFPPKPVVSSE---AKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred ---HHHHhhhchhcceeccCCCCCccCHH---HHHHHHHHHHhhhhhhhhHHHHccC
Confidence 11112222222222223222222233 3456779999999999998887653
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-31 Score=267.44 Aligned_cols=201 Identities=27% Similarity=0.465 Sum_probs=164.9
Q ss_pred CCCCCceecccCCeEEEEEEECC-CCEEEEEEecccc--CcCHHHHHHHHHHHHhcCCCCcccccceEEe--------CC
Q 000889 929 GFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKI--------GE 997 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~~ 997 (1237)
.|+...+||+|.||+||+|+.++ ++.||+|++.... ..-.....+|+++++.++|+|++.+++.|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 34555689999999999998874 6678988775321 1223456889999999999999999998754 23
Q ss_pred eEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecc
Q 000889 998 ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFG 1077 (1237)
Q Consensus 998 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfG 1077 (1237)
..|+||++|+ -+|..++.... ..++..++.+++.++..||.|+|.. .|+|||+||.||||+.+|.+||+|||
T Consensus 98 t~ylVf~~ce-hDLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 98 TFYLVFDFCE-HDLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred eeeeeHHHhh-hhHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence 4799999997 58888886542 4688899999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCcc--eeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCC
Q 000889 1078 MARLVNALDTH--LSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPS 1137 (1237)
Q Consensus 1078 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~ 1137 (1237)
+|+.+...+.. ..++..+-|..|.+||.+.+. .|+++.|||+-||++.||++|.+-+.+.
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgn 232 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGN 232 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCC
Confidence 99866543322 223456679999999998764 6899999999999999999999888653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-30 Score=290.85 Aligned_cols=243 Identities=22% Similarity=0.248 Sum_probs=191.6
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhc-CCCCcccccceEEeCCeEEEEEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
++.|.....+|.|+|+.|-.+.+. +++..+||.+.+.. .+-.+|+.++... +||||+++.+.+.++.+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 556788888999999999988876 57789999886542 2334577666665 69999999999999999999999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee-CCCCceEEeecccceeec
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLL-DENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll-~~~~~vkl~DfGla~~~~ 1083 (1237)
++.|+-+.+.+... +.....+..|+.+++.|+.|||++ ||||||+||+|||+ +..++++|+|||.++...
T Consensus 397 ~l~g~ell~ri~~~------~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 397 LLDGGELLRRIRSK------PEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hccccHHHHHHHhc------chhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 99999887777653 222267778999999999999999 99999999999999 699999999999998765
Q ss_pred cCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccC
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
.. ..+.+-|..|.|||++....|+.++|+||+|+++|+|++|+.||.....+ ..+ +.+. ..
T Consensus 468 ~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei------~~~i------~~ 528 (612)
T KOG0603|consen 468 RS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI------HTRI------QM 528 (612)
T ss_pred hh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH------HHhh------cC
Confidence 43 34557788999999999999999999999999999999999999755422 011 1111 11
Q ss_pred ccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 1206 (1237)
+... .... ....+++.+|++.||.+||+|.++..+=..
T Consensus 529 ~~~s--~~vS---~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 529 PKFS--ECVS---DEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred Cccc--cccC---HHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 1111 1112 234567779999999999999999987544
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=278.12 Aligned_cols=262 Identities=24% Similarity=0.328 Sum_probs=200.2
Q ss_pred hCCCCCCceecccCCeEEEEEEECC-CCEEEEEEeccccCcCHHHHHHHHHHHHhcC-C-C----CcccccceEEeCCeE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKIK-H-R----NLVPLLGYCKIGEER 999 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~~ 999 (1237)
+++|.+...+|+|.||.|-.+.+.. +..||+|+++.+... .+..+-|+++++++. + | -+|.+.+||...++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 6789999999999999999998764 688999988765433 234466999999994 2 3 278889999999999
Q ss_pred EEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCC------------
Q 000889 1000 LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE------------ 1067 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~------------ 1067 (1237)
|+|+|.+ |-++.+++.... -.+++...++.|+.|++++++|||+. +++|-|+||+||++..
T Consensus 167 Civfell-G~S~~dFlk~N~---y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENN---YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred EEEEecc-ChhHHHHhccCC---ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCc
Confidence 9999988 469999998643 35789999999999999999999999 9999999999999931
Q ss_pred --------CCceEEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCC
Q 000889 1068 --------NFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEF 1139 (1237)
Q Consensus 1068 --------~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~ 1139 (1237)
...||++|||.|....... ...+.|..|+|||++.+-.++.++||||+|||++|+++|..-|...+.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 2458999999998654322 456789999999999999999999999999999999999999976541
Q ss_pred CCCchHHHHHHHH----------------hhhccc--------------ccccCccccCCCCCHHHHHHHHHHHHhcccc
Q 000889 1140 GDDNNLVGWAKQL----------------HREKRI--------------NEILDPELTMQTSDETELYQYLRISFECLDD 1189 (1237)
Q Consensus 1140 ~~~~~~~~~~~~~----------------~~~~~~--------------~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~ 1189 (1237)
...+..+.... ...+++ .+...+.-........+...+.+++.+|+..
T Consensus 315 --~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 315 --LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred --HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 11111111000 000000 0001111111112344667899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 000889 1190 RPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1190 dP~~RPt~~ell~~ 1203 (1237)
||.+|+|+.|++.+
T Consensus 393 DP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 393 DPARRITLREALSH 406 (415)
T ss_pred CccccccHHHHhcC
Confidence 99999999999876
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=252.15 Aligned_cols=199 Identities=24% Similarity=0.405 Sum_probs=166.6
Q ss_pred CCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc-CcCHHHHHHHHHHHHhc-CCCCcccccceEEeCCeEEEEEEec
Q 000889 930 FSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT-GQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
......||+|++|.|-+.++. +|...|+|++...- .+..++...|+.+..+. .+|.+|.+||........|+.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 334567999999999888876 68999999987433 33345677888875554 7999999999988899999999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCC
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~ 1086 (1237)
+ .+|+.+.++..+ .+..+++...-+|+..+++||.|||++. .|+|||+||+|||++.+|+||+||||.+..+...
T Consensus 128 ~-tSldkfy~~v~~-~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS- 202 (282)
T KOG0984|consen 128 D-TSLDKFYRKVLK-KGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS- 202 (282)
T ss_pred h-hhHHHHHHHHHh-cCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh-
Confidence 7 788887766543 3578999999999999999999999996 8999999999999999999999999999876532
Q ss_pred cceeeeccccCCCcCCccccCc----cccCcccchHHHHHHHHHHHcCCCCCC
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQS----FRCTTKGDVYSYGVILLELLSGKRPID 1135 (1237)
Q Consensus 1087 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGv~l~el~tg~~p~~ 1135 (1237)
...+...|.-.|||||.+.. ..|+-++||||+|+.+.||.+++.||+
T Consensus 203 --iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 203 --IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred --hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 22234578889999998853 378999999999999999999999986
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-30 Score=264.61 Aligned_cols=200 Identities=26% Similarity=0.377 Sum_probs=173.6
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccC---cCHHHHHHHHHHHHhc-CCCCcccccceEEeCCeEEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG---QGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEERLL 1001 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 1001 (1237)
.++|++.++||+|+|+.|..++++ +.+.+|+|++++..- ++.+-...|-.+..+. +||.+|.+..+|+.+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 357899999999999999999987 467789888865332 2333355677777666 69999999999999999999
Q ss_pred EEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeeccccee
Q 000889 1002 VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~ 1081 (1237)
|.||++||+|--+++.. +.++++.++.+...|.-||.|||+. ||++||+|.+||++|..|++|++|||+++.
T Consensus 329 vieyv~ggdlmfhmqrq-----rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEecCcceeeehhhh-----hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhc
Confidence 99999999998888765 4689999999999999999999999 999999999999999999999999999975
Q ss_pred eccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCC
Q 000889 1082 VNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDP 1136 (1237)
Q Consensus 1082 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~ 1136 (1237)
--. .....++++|||.|.|||.+.+..|...+|+|++||+|+||+.|+.||+-
T Consensus 401 ~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 401 GLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred CCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 322 22334689999999999999999999999999999999999999999974
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=283.62 Aligned_cols=249 Identities=22% Similarity=0.313 Sum_probs=199.3
Q ss_pred CCCCCceecccCCeEEEEEEECCCC-EEEEEEecc---ccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLRDGS-VVAIKKLIH---VTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~~~~-~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
+++.+..||-|+||+|-+++.+... .+|.|.+++ +...+.+++..|-++|..++.|.||++|..|.+....||.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 3455667999999999999887544 377776653 233445568889999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
-|-||.+...++++ +.++...++.++..+++|++|||++ +||+||+||+|.++|.+|-+|+.|||+|+....
T Consensus 501 aClGGElWTiLrdR-----g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 501 ACLGGELWTILRDR-----GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhcCchhhhhhhhc-----CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999886 5688888899999999999999999 999999999999999999999999999998765
Q ss_pred CCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCc
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDP 1164 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1164 (1237)
.. +..++||||.|.|||++....++.++|.||+|+++||+++|.+||.+.. .+..|...+..-+.+.. |
T Consensus 573 g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d-----pmktYn~ILkGid~i~~---P 641 (732)
T KOG0614|consen 573 GR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD-----PMKTYNLILKGIDKIEF---P 641 (732)
T ss_pred CC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc-----hHHHHHHHHhhhhhhhc---c
Confidence 43 3467999999999999999999999999999999999999999997543 23333322222211111 1
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHHH
Q 000889 1165 ELTMQTSDETELYQYLRISFECLDDRPFKRPT-----MIQVMAMF 1204 (1237)
Q Consensus 1165 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ell~~L 1204 (1237)
+. ....-.+++.+..+..|.+|.- +.++.+|-
T Consensus 642 r~--------I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 642 RR--------ITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred cc--------cchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 11 1123346666788889999875 66777664
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=295.04 Aligned_cols=248 Identities=23% Similarity=0.333 Sum_probs=188.5
Q ss_pred CCCCceecccCCeE-EEEEEECCCCEEEEEEeccccCcCHHHHHHHHHHHHhc-CCCCcccccceEEeCCeEEEEEEecc
Q 000889 930 FSADSMIGSGGFGE-VYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEERLLVYEYMK 1007 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 1007 (1237)
|...+++|.|+.|+ ||+|... ++.||||++.. +-..-..+|+..++.- +|||||++|+.-.+....|++.|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 45566789999875 5999986 88999998854 2233457899999988 59999999999888999999999996
Q ss_pred CCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCC---C--CceEEeecccceee
Q 000889 1008 WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE---N--FEARVSDFGMARLV 1082 (1237)
Q Consensus 1008 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~---~--~~vkl~DfGla~~~ 1082 (1237)
.+|++++..... ..........+.+..|+++|+++||+. +|||||+||.||||+. + ..++|+|||+++..
T Consensus 587 -~sL~dlie~~~~-d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 587 -CSLQDLIESSGL-DVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhHHHHHhcccc-chhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 899999987311 001111145577889999999999998 9999999999999975 3 57999999999988
Q ss_pred ccCCccee-eeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcC-CCCCCCCCCCCCchHHHHHHHHhhhccccc
Q 000889 1083 NALDTHLS-VSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSG-KRPIDPSEFGDDNNLVGWAKQLHREKRINE 1160 (1237)
Q Consensus 1083 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1160 (1237)
.......+ .....||.+|+|||++....-+.++||+|+||++|+.++| ..||.... ..-+...........
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~-------~R~~NIl~~~~~L~~ 734 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL-------ERQANILTGNYTLVH 734 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH-------HhhhhhhcCccceee
Confidence 76554332 3567799999999999998888899999999999999985 89987432 111111111111111
Q ss_pred ccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1161 ILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1161 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
+. ...++ +..++|.+|++++|..||++.+|+.|
T Consensus 735 L~--------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 735 LE--------PLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ec--------cCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 11 11111 45578889999999999999999865
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=272.36 Aligned_cols=220 Identities=24% Similarity=0.186 Sum_probs=174.8
Q ss_pred cCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCCCHHHHHhh
Q 000889 939 GGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHD 1017 (1237)
Q Consensus 939 G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 1017 (1237)
|.||.||++++. +++.||+|++.... .+.+|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999986 57899999886432 233455556666799999999999999999999999999999999875
Q ss_pred hhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcceeeeccccC
Q 000889 1018 RAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGT 1097 (1237)
Q Consensus 1018 ~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt 1097 (1237)
. ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.++++|||.+...... .....++
T Consensus 79 ~-----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~ 145 (237)
T cd05576 79 F-----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVE 145 (237)
T ss_pred h-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcC
Confidence 4 3588999999999999999999999 9999999999999999999999999988655432 1234457
Q ss_pred CCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCCCHHHHH
Q 000889 1098 PGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELY 1177 (1237)
Q Consensus 1098 ~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 1177 (1237)
..|+|||...+..++.++||||+|+++|||++|+.|+...... +........ +.. ...
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----------------~~~~~~~~~--~~~---~~~ 203 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----------------INTHTTLNI--PEW---VSE 203 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----------------cccccccCC--ccc---CCH
Confidence 7899999998888999999999999999999999887532110 000000011 111 123
Q ss_pred HHHHHHHhccccCCCCCCCHH
Q 000889 1178 QYLRISFECLDDRPFKRPTMI 1198 (1237)
Q Consensus 1178 ~l~~li~~cl~~dP~~RPt~~ 1198 (1237)
.+.+++.+|++.||.+||++.
T Consensus 204 ~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 204 EARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHHHccCCHHHhcCCC
Confidence 466788899999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=279.38 Aligned_cols=206 Identities=26% Similarity=0.367 Sum_probs=173.9
Q ss_pred CCCCCCceecccCCeEEEEEEEC-CCCEEEEEEecccc---CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
.-|..++.||-|+||+|.+++-. +...+|.|.+.+.. .....++++|-.|+...+.+.||++|..|++++..|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 34777889999999999999754 35578888776422 234456889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccce---
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR--- 1080 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~--- 1080 (1237)
||++||++-.+|-+. ..+++..++.++.+++.|+++.|.. |+|||||||+|||||.+|++||+|||++.
T Consensus 709 dYIPGGDmMSLLIrm-----gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRM-----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred eccCCccHHHHHHHh-----ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccce
Confidence 999999999988764 4688888999999999999999999 99999999999999999999999999985
Q ss_pred ------eeccCCcce-------------------------------eeeccccCCCcCCccccCccccCcccchHHHHHH
Q 000889 1081 ------LVNALDTHL-------------------------------SVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVI 1123 (1237)
Q Consensus 1081 ------~~~~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~ 1123 (1237)
++...+... ..-..+||+.|+|||++....|+...|+||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 222111110 0124679999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCCCC
Q 000889 1124 LLELLSGKRPIDPSEFGD 1141 (1237)
Q Consensus 1124 l~el~tg~~p~~~~~~~~ 1141 (1237)
+|||+.|+.||-.....+
T Consensus 861 l~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHHHhhCCCCccCCCCCc
Confidence 999999999997665544
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=299.98 Aligned_cols=263 Identities=21% Similarity=0.262 Sum_probs=170.0
Q ss_pred HhCCCCCCceecccCCeEEEEEEECC-----CCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccce------EE
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLRD-----GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGY------CK 994 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 994 (1237)
..++|++.+.||+|+||.||+|++.+ +..||+|++..... .+.+..| .++...+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 35679999999999999999999864 58899998753221 1111111 1222223333333222 23
Q ss_pred eCCeEEEEEEeccCCCHHHHHhhhhcC---------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 000889 995 IGEERLLVYEYMKWGSLESVLHDRAKG---------------GGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMK 1059 (1237)
Q Consensus 995 ~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDik 1059 (1237)
.+.+.++||||+++++|.+++...... .+.......+..++.|++.||+|||+. +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 567889999999999999998753210 001112344567999999999999999 99999999
Q ss_pred CCCeeeCC-CCceEEeecccceeeccCCcceeeeccccCCCcCCccccCcc----------------------ccCcccc
Q 000889 1060 SSNVLLDE-NFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSF----------------------RCTTKGD 1116 (1237)
Q Consensus 1060 p~NIll~~-~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sD 1116 (1237)
|+|||++. ++.+||+|||+|+........ ......+++.|||||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 689999999999865432222 22456789999999965322 2344679
Q ss_pred hHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhc----ccccccCccccCC----CC-CHHHHHHHHHHHHhcc
Q 000889 1117 VYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREK----RINEILDPELTMQ----TS-DETELYQYLRISFECL 1187 (1237)
Q Consensus 1117 vwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~~----~~-~~~~~~~l~~li~~cl 1187 (1237)
|||+||++|||+++..|++.. ...+.......+ .......+..... .. .........+++.+|+
T Consensus 362 VwSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 999999999999977664321 111111111100 0000011110000 00 0001123447888999
Q ss_pred ccCCCCCCCHHHHHHH
Q 000889 1188 DDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1188 ~~dP~~RPt~~ell~~ 1203 (1237)
+.||++|||+.+++++
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999997
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-28 Score=286.53 Aligned_cols=263 Identities=21% Similarity=0.285 Sum_probs=179.1
Q ss_pred HhCCCCCCceecccCCeEEEEEEE-----------------CCCCEEEEEEeccccCcCHHH--------------HHHH
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQL-----------------RDGSVVAIKKLIHVTGQGDRE--------------FMAE 974 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 974 (1237)
..++|++.++||+|+||+||+|.+ ..++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 356899999999999999999964 235679999986433222222 3347
Q ss_pred HHHHHhcCCCCc-----ccccceEEe--------CCeEEEEEEeccCCCHHHHHhhhhcC-------------------C
Q 000889 975 METIGKIKHRNL-----VPLLGYCKI--------GEERLLVYEYMKWGSLESVLHDRAKG-------------------G 1022 (1237)
Q Consensus 975 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~ 1022 (1237)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++..... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776554 677777653 35689999999999999998753210 1
Q ss_pred CCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcceeeeccccCCCcCC
Q 000889 1023 GTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP 1102 (1237)
Q Consensus 1023 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 1102 (1237)
...+++..++.++.|+++|++|+|+. +|+||||||+||+++.++.+||+|||+++....... .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 12356778899999999999999999 999999999999999999999999999976543211 11122345789999
Q ss_pred ccccCccc--------------------c--CcccchHHHHHHHHHHHcCCC-CCCCCCCCC------CchHHHHHHHHh
Q 000889 1103 PEYYQSFR--------------------C--TTKGDVYSYGVILLELLSGKR-PIDPSEFGD------DNNLVGWAKQLH 1153 (1237)
Q Consensus 1103 PE~~~~~~--------------------~--~~~sDvwSlGv~l~el~tg~~-p~~~~~~~~------~~~~~~~~~~~~ 1153 (1237)
||.+.... + ..+.||||+||++|+|++|.. ||....... ......|...
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~-- 456 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY-- 456 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--
Confidence 99875322 1 124799999999999999875 664321110 0011111110
Q ss_pred hhcccccccCccccCCCCCHHHHHHHHHHHHhccccCC---CCCCCHHHHHHH
Q 000889 1154 REKRINEILDPELTMQTSDETELYQYLRISFECLDDRP---FKRPTMIQVMAM 1203 (1237)
Q Consensus 1154 ~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~ell~~ 1203 (1237)
... ...+..... ......+++.+++..+| .+|+|+.|+++|
T Consensus 457 ~~~------~~~~~~~d~---~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 457 KGQ------KYDFSLLDR---NKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ccc------CCCcccccc---cChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000 011111111 12344567778888765 789999999976
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-28 Score=264.83 Aligned_cols=238 Identities=31% Similarity=0.444 Sum_probs=191.7
Q ss_pred CCeEEEEEEECC-CCEEEEEEeccccCcC-HHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCCCHHHHHhh
Q 000889 940 GFGEVYKAQLRD-GSVVAIKKLIHVTGQG-DREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHD 1017 (1237)
Q Consensus 940 ~fg~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 1017 (1237)
+||.||+|+... ++.+|+|++....... .+.+.+|++.+++++|+||+++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999874 8899999987554444 67899999999999999999999999999999999999999999999875
Q ss_pred hhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcceeeeccccC
Q 000889 1018 RAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGT 1097 (1237)
Q Consensus 1018 ~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt 1097 (1237)
. ..+++..+..++.++++++.|||+. +++|+||+|+||+++.++.++++|||.+....... ......++
T Consensus 81 ~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~ 149 (244)
T smart00220 81 R-----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGT 149 (244)
T ss_pred c-----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCC
Confidence 3 2378899999999999999999999 99999999999999999999999999998765432 22445688
Q ss_pred CCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCCCHHHHH
Q 000889 1098 PGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELY 1177 (1237)
Q Consensus 1098 ~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 1177 (1237)
..|+|||...+..++.++||||+|+++|++++|..||.... ............. ............
T Consensus 150 ~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-----~~~~~~~~~~~~~---------~~~~~~~~~~~~ 215 (244)
T smart00220 150 PEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-----QLLELFKKIGKPK---------PPFPPPEWKISP 215 (244)
T ss_pred cCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----cHHHHHHHHhccC---------CCCccccccCCH
Confidence 89999999988888999999999999999999999986421 1111111111110 000000000224
Q ss_pred HHHHHHHhccccCCCCCCCHHHHHH
Q 000889 1178 QYLRISFECLDDRPFKRPTMIQVMA 1202 (1237)
Q Consensus 1178 ~l~~li~~cl~~dP~~RPt~~ell~ 1202 (1237)
++.+++.+|+..+|++||++.++++
T Consensus 216 ~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 216 EAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHccCCchhccCHHHHhh
Confidence 6778889999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-29 Score=256.20 Aligned_cols=262 Identities=26% Similarity=0.348 Sum_probs=190.3
Q ss_pred CCceecccCCeEEEEEEEC-CCCEEEEEEeccccC--cCHHHHHHHHHHHHhcCCCCcccccceEEeC-----CeEEEEE
Q 000889 932 ADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG--QGDREFMAEMETIGKIKHRNLVPLLGYCKIG-----EERLLVY 1003 (1237)
Q Consensus 932 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~ 1003 (1237)
..+.||-|+||.||.+++. +|+.||.||+..... ...+.+.+|++++..++|.||...++..+-. ++.|.++
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 3567999999999999876 799999999865432 2346788999999999999999998876533 2457777
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
|.|. .+|.+.+-. .+.++...++-+++||++||.|||+. +|.||||||.|.++..+..+||||||+|+..+
T Consensus 137 ELmQ-SDLHKIIVS-----PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 137 ELMQ-SDLHKIIVS-----PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHH-hhhhheecc-----CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence 8775 566666543 36788888999999999999999999 99999999999999999999999999998654
Q ss_pred cCCcceeeeccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHH---------HHHHHh
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVG---------WAKQLH 1153 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~---------~~~~~~ 1153 (1237)
. +....++..+-|..|+|||.+.|. .|+.++||||.||++.|++..+..|.....-....+.. .++..-
T Consensus 208 ~-d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 208 Q-RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred h-hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 4 334445666778899999999875 58999999999999999999888886543211111100 000000
Q ss_pred hhcccccccCccccCCC--------CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1154 REKRINEILDPELTMQT--------SDETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1154 ~~~~~~~~~~~~l~~~~--------~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
++.-..++......+. +......+-+.+..+++..||++|.+..+.+.+.
T Consensus 287 -EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 287 -EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred -hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 0000111111111100 1111223345666789999999999999998875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-27 Score=256.44 Aligned_cols=265 Identities=23% Similarity=0.333 Sum_probs=195.4
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcC-----C---CCcccccceEEe--
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIK-----H---RNLVPLLGYCKI-- 995 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~-- 995 (1237)
.++|-+.++||.|.|++||+|.+. ..+.||+|+.+.. ..-.+..+.|++++++++ | .+||+++++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 367889999999999999999876 4667888877543 233455678999999984 3 469999999976
Q ss_pred --CCeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCC-----
Q 000889 996 --GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDEN----- 1068 (1237)
Q Consensus 996 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~----- 1068 (1237)
+.+.|||+|++ |.+|..++..... +.++...+++|++||+.||.|||..| +|||-||||+|||+..+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~Y---rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~ 229 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNY---RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPA 229 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCC---CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchh
Confidence 45889999998 6789998876543 56889999999999999999999998 99999999999999210
Q ss_pred --------------------------------------------------------------------------------
Q 000889 1069 -------------------------------------------------------------------------------- 1068 (1237)
Q Consensus 1069 -------------------------------------------------------------------------------- 1068 (1237)
T Consensus 230 ~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~ 309 (590)
T KOG1290|consen 230 KDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRI 309 (590)
T ss_pred hhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCC
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 000889 1069 -------------------------------------------------------------------------------- 1068 (1237)
Q Consensus 1069 -------------------------------------------------------------------------------- 1068 (1237)
T Consensus 310 n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~ 389 (590)
T KOG1290|consen 310 NGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPEC 389 (590)
T ss_pred CccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcc
Confidence
Q ss_pred -CceEEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCC----Cc
Q 000889 1069 -FEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGD----DN 1143 (1237)
Q Consensus 1069 -~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~----~~ 1143 (1237)
-.|||+|||-|+.+. ..++....|..|+||||+.+..|++.+||||++|++|||+||...|++.+..+ .+
T Consensus 390 di~vKIaDlGNACW~~-----khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDED 464 (590)
T KOG1290|consen 390 DIRVKIADLGNACWVH-----KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDED 464 (590)
T ss_pred ceeEEEeeccchhhhh-----hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHH
Confidence 013455555544322 12234456889999999999999999999999999999999999998754322 22
Q ss_pred hHHHHHHHH------------------hhhcccccccCcc-------c-cCCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 000889 1144 NLVGWAKQL------------------HREKRINEILDPE-------L-TMQTSDETELYQYLRISFECLDDRPFKRPTM 1197 (1237)
Q Consensus 1144 ~~~~~~~~~------------------~~~~~~~~~~~~~-------l-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 1197 (1237)
.++.+++-+ .+.+.+..|-.-. + .......++..+|.+++.-|++.+|++||||
T Consensus 465 HiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA 544 (590)
T KOG1290|consen 465 HIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTA 544 (590)
T ss_pred HHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccH
Confidence 233222222 1111122221100 0 0111234567789999999999999999999
Q ss_pred HHHHHH
Q 000889 1198 IQVMAM 1203 (1237)
Q Consensus 1198 ~ell~~ 1203 (1237)
.+++++
T Consensus 545 ~~cl~h 550 (590)
T KOG1290|consen 545 AQCLKH 550 (590)
T ss_pred HHHhcC
Confidence 999987
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=241.59 Aligned_cols=251 Identities=22% Similarity=0.366 Sum_probs=187.3
Q ss_pred CCCCCceecccCCeEEEEEEECC-CCEEEEEEeccccCcCHHHHHHHHHHHHhc-CCCCcccccc-eEEeCCeEEEEEEe
Q 000889 929 GFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKI-KHRNLVPLLG-YCKIGEERLLVYEY 1005 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~-~~~~~~~~~lv~e~ 1005 (1237)
.|.+.+.+|+|.||.+-+++++. ...+++|.+ +......++|.+|+..--.+ .|.||+.-|+ .|+..+.+++++||
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKav-p~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAV-PRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeecc-CcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 58888999999999999999985 456666655 44445677899998876666 4899998887 46777888999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeC--CCCceEEeecccceeec
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLD--ENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~--~~~~vkl~DfGla~~~~ 1083 (1237)
++.|+|.+-+.. ..+.+...++++.|++.|++|+|++ .+||||||.+||||- +...||+||||..+..+
T Consensus 104 aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 104 APRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred CccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999887754 3577888899999999999999999 999999999999993 34579999999998654
Q ss_pred cCCcceeeeccccCCCcCCccccCcc-----ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccc
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSF-----RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158 (1237)
Q Consensus 1084 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1158 (1237)
.. ......+..|.|||+.... ...+.+|||.||+++|.++||..||... ...+..++.|.....+...
T Consensus 175 ~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y~~~~~w~~rk~~- 247 (378)
T KOG1345|consen 175 TT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPYWEWEQWLKRKNP- 247 (378)
T ss_pred ce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCchHHHHHHHhcccCc-
Confidence 32 2234456789999987432 3467799999999999999999999843 3445566666554443321
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHHhccccCCCCC---CCHHHHHHHH
Q 000889 1159 NEILDPELTMQTSDETELYQYLRISFECLDDRPFKR---PTMIQVMAMF 1204 (1237)
Q Consensus 1159 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~ell~~L 1204 (1237)
.+...+ ..-..+.+++..+-+..+|++| .++....+.+
T Consensus 248 --~~P~~F------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 248 --ALPKKF------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred --cCchhh------cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 111111 1112345566678899999999 5555555544
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=236.66 Aligned_cols=259 Identities=20% Similarity=0.269 Sum_probs=193.7
Q ss_pred hCCCCCCceecccCCeEEEEEEE-CCCCEEEEEEeccccCcCHHHHHHHHHHHHhcC-CCCcccccceEEeC--CeEEEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQL-RDGSVVAIKKLIHVTGQGDREFMAEMETIGKIK-HRNLVPLLGYCKIG--EERLLV 1002 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv 1002 (1237)
.++|++.+++|+|.|++||.|.. .+.+.++||.+++. ..+.+.+|+++++.+. ||||+++++...+. ....+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 45788899999999999999974 45788999988654 3567889999999997 99999999998764 456899
Q ss_pred EEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCC-CCceEEeeccccee
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE-NFEARVSDFGMARL 1081 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~-~~~vkl~DfGla~~ 1081 (1237)
+||+.+.+...+.. .++...++.++.++++||.|+|+. ||.|||+||.||++|. .-.++++|+|+|.+
T Consensus 114 FE~v~n~Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP--------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred hhhhccccHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhh
Confidence 99999888766543 466777888999999999999999 9999999999999994 56799999999988
Q ss_pred eccCCcceeeeccccCCCcCCccccCc-cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcc---
Q 000889 1082 VNALDTHLSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKR--- 1157 (1237)
Q Consensus 1082 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 1157 (1237)
+.+.... +..+.+..|.-||.+.. ..|+.+-|+|||||++..|+..+.||..... ..+.++..+..+...+-
T Consensus 183 YHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIakVLGt~el~~Y 258 (338)
T KOG0668|consen 183 YHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAKVLGTDELYAY 258 (338)
T ss_pred cCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHHHhChHHHHHH
Confidence 7654432 34456778899999865 4588899999999999999999999864321 22334433333222111
Q ss_pred ---cccccCccccC---------------CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1158 ---INEILDPELTM---------------QTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1158 ---~~~~~~~~l~~---------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
..-.+|+++.. .....-...+.++++.+.++.|-.+|+|+.|++.+
T Consensus 259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 00111221110 00001112455677778999999999999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-28 Score=271.54 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=201.7
Q ss_pred hCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
.++|+....+|.|.||.||||++. .++..|+|.++-....+.+-...|+-+++.++|||||.++|.+...+..|++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 457888999999999999999987 5888999999877777777788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccC
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~ 1085 (1237)
|.||+|++..+-. .++++.+...+.+...+|++|||+. +-+|||||-.||++++.|.+|++|||.+..+..
T Consensus 94 cgggslQdiy~~T-----gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita- 164 (829)
T KOG0576|consen 94 CGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA- 164 (829)
T ss_pred cCCCcccceeeec-----ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh-
Confidence 9999999987653 5788999999999999999999999 999999999999999999999999999876653
Q ss_pred CcceeeeccccCCCcCCcccc---CccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccccccc
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYY---QSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162 (1237)
Q Consensus 1086 ~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1162 (1237)
+-.+...+.||+.|||||+. ..+.|...+|||+.|+...|+-.-++|...... +.. -.+.. +... -
T Consensus 165 -ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-----mr~--l~LmT-kS~~--q 233 (829)
T KOG0576|consen 165 -TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-----MRA--LFLMT-KSGF--Q 233 (829)
T ss_pred -hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-----HHH--HHHhh-ccCC--C
Confidence 23334678999999999986 355788999999999999999988888432110 000 00000 0000 1
Q ss_pred CccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1163 DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1163 ~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
.+.+.-.....+ .|-++++.|+.+.|++||++..++++
T Consensus 234 pp~lkDk~kws~---~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 234 PPTLKDKTKWSE---FFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred CCcccCCccchH---HHHHHHHHHhcCCCccCCChhhheec
Confidence 122222222233 34456668999999999999887653
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-27 Score=261.48 Aligned_cols=197 Identities=22% Similarity=0.341 Sum_probs=166.8
Q ss_pred hCCCCCCceecccCCeEEEEEEECC-CCEEEEEEeccccCcC--------HHHHHHHHHHHHhcC---CCCcccccceEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQG--------DREFMAEMETIGKIK---HRNLVPLLGYCK 994 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~---h~niv~l~~~~~ 994 (1237)
...|+..+.+|+|+||.|+.|.++. ...|++|.+.+.+--. .-.+-.|+++|.+++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3468899999999999999999884 5567788775432110 011345999999997 999999999999
Q ss_pred eCCeEEEEEEec-cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEE
Q 000889 995 IGEERLLVYEYM-KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARV 1073 (1237)
Q Consensus 995 ~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl 1073 (1237)
+.+.+|++||-. +|-+|.+++... ..+++.++..|+.||+.|+++||++ +|||||||-+||.++.+|.+|+
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~k-----p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFK-----PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhcc-----CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEE
Confidence 999999999964 455899999764 4689999999999999999999999 9999999999999999999999
Q ss_pred eecccceeeccCCcceeeeccccCCCcCCccccCcccc-CcccchHHHHHHHHHHHcCCCCCC
Q 000889 1074 SDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRC-TTKGDVYSYGVILLELLSGKRPID 1135 (1237)
Q Consensus 1074 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGv~l~el~tg~~p~~ 1135 (1237)
+|||.|...... ....++||.+|.|||++.|..| +..-|||++|+++|-++....||.
T Consensus 712 idfgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 712 IDFGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eeccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999765432 3456789999999999999887 456899999999999998888874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=241.98 Aligned_cols=286 Identities=24% Similarity=0.310 Sum_probs=205.5
Q ss_pred CCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccc--cCcCHHHHHHHHHHHHhcCCCCcccccceEEeC------CeE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHV--TGQGDREFMAEMETIGKIKHRNLVPLLGYCKIG------EER 999 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 999 (1237)
+|.-.+.+|.|.- .|..|.+. .+++||+|+.... .....+...+|...+..++|+||++++.++.-. .+.
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4555677888888 56666544 5889999988642 123345677899999999999999999988533 367
Q ss_pred EEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccc
Q 000889 1000 LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1079 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla 1079 (1237)
|+|||||. .+|..++.. .++-..+..+..|++.|+.|||+. +|+|||+||+||++..++.+||.|||+|
T Consensus 97 y~v~e~m~-~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 97 YLVMELMD-ANLCQVILM-------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHhhh-hHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 99999997 799998873 466678889999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcc--
Q 000889 1080 RLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKR-- 1157 (1237)
Q Consensus 1080 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 1157 (1237)
+.-+. ....+..+.|..|.|||++.+..+...+||||+||++.||++|+.-|.+. +.+.+|.+.....+.
T Consensus 166 r~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~-----d~idQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 166 RTEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK-----DHIDQWNKIIEQLGTPD 237 (369)
T ss_pred cccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc-----hHHHHHHHHHHHhcCCC
Confidence 85432 24456677889999999999988999999999999999999999988743 122222211111000
Q ss_pred -------------------------cccc-cCccccCCCCC-HHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HH---
Q 000889 1158 -------------------------INEI-LDPELTMQTSD-ETELYQYLRISFECLDDRPFKRPTMIQVMAM--FK--- 1205 (1237)
Q Consensus 1158 -------------------------~~~~-~~~~l~~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~ell~~--L~--- 1205 (1237)
+.+. -|..++..... .-......+++.+|+-.+|++|-++.+++++ ++
T Consensus 238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~ 317 (369)
T KOG0665|consen 238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWY 317 (369)
T ss_pred HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeec
Confidence 0111 11111111111 1122344567789999999999999999998 22
Q ss_pred ---hcccc--------cCCCCCCccCchhhHHHHHHHhhc
Q 000889 1206 ---ELQVD--------TEGDSLDSFSLKDTVIEELRERES 1234 (1237)
Q Consensus 1206 ---~l~~~--------~~~~~~~~~~~~~~~~~~~~~~~~ 1234 (1237)
+++.. .+.+......|+|.+.+|+++-++
T Consensus 318 ~~~ev~ap~pe~~d~~~d~~~~t~~e~ke~If~ev~~f~~ 357 (369)
T KOG0665|consen 318 DPDEVEAPPPEIYDKQLDEREHTIEEWKELIFKEVQRFEE 357 (369)
T ss_pred ccccccCCCCchhhhhcccccCCHHHHHHHHHHHHHhhcc
Confidence 11111 111112233688888888877665
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=238.10 Aligned_cols=211 Identities=35% Similarity=0.566 Sum_probs=182.6
Q ss_pred ecccCCeEEEEEEECC-CCEEEEEEeccccCc-CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCCCHHH
Q 000889 936 IGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQ-GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLES 1013 (1237)
Q Consensus 936 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 1013 (1237)
||+|++|.||+++..+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999875 889999988654322 24678999999999999999999999999899999999999999999
Q ss_pred HHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCC-CCceEEeecccceeeccCCcceeee
Q 000889 1014 VLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE-NFEARVSDFGMARLVNALDTHLSVS 1092 (1237)
Q Consensus 1014 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~-~~~vkl~DfGla~~~~~~~~~~~~~ 1092 (1237)
++.... ..+++..+..++.+++++++|||+. +++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~ 151 (215)
T cd00180 81 LLKENE----GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLK 151 (215)
T ss_pred HHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhh
Confidence 987542 3678999999999999999999999 9999999999999999 89999999999986654321 123
Q ss_pred ccccCCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCC
Q 000889 1093 TLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTS 1171 (1237)
Q Consensus 1093 ~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 1171 (1237)
...+...|++||..... .++.++|+|++|++++++
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence 35578899999999887 788999999999999999
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 000889 1172 DETELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204 (1237)
Q Consensus 1172 ~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L 1204 (1237)
..+.+++.+|++.+|++||++.++++++
T Consensus 188 -----~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3566888899999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=253.26 Aligned_cols=273 Identities=22% Similarity=0.246 Sum_probs=204.0
Q ss_pred cCHHHHHHHhCCCCCCceecccCCeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcC------CCCccccc
Q 000889 918 LTFAHLLEATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIK------HRNLVPLL 990 (1237)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~ 990 (1237)
+.+.-.+..-.+|.+....|+|-|++|.+|.+. .|..||||.+.... ...+.=.+|+++++++. --|+++++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 333334445678999999999999999999876 47799999986422 11233357999999995 34899999
Q ss_pred ceEEeCCeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCC-C
Q 000889 991 GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDEN-F 1069 (1237)
Q Consensus 991 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~-~ 1069 (1237)
..|....+.|||+|-+. .+|.+++.+.... ..+...++..++.|+.-||..|-.. +|+|.||||+|||+.+. .
T Consensus 501 r~F~hknHLClVFE~Ls-lNLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPLS-LNLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHhhhcceeEEEehhhh-chHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcc
Confidence 99999999999999885 7999999887553 4577788899999999999999998 99999999999999864 5
Q ss_pred ceEEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHH
Q 000889 1070 EARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWA 1149 (1237)
Q Consensus 1070 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~ 1149 (1237)
.+||||||.|......+ .+.+.-+..|.|||++.|..|+...|+||.||++||+.||+..|.+..-.. .+..++
T Consensus 575 iLKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~--MLrl~m 648 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ--MLRLFM 648 (752)
T ss_pred eeeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH--HHHHHH
Confidence 68999999997664322 233344567999999999999999999999999999999999998653211 111100
Q ss_pred H-------HHhhhcc---------------------------cccccCc------cc----cCCCCCHHHHHHHHHHHHh
Q 000889 1150 K-------QLHREKR---------------------------INEILDP------EL----TMQTSDETELYQYLRISFE 1185 (1237)
Q Consensus 1150 ~-------~~~~~~~---------------------------~~~~~~~------~l----~~~~~~~~~~~~l~~li~~ 1185 (1237)
+ .+.+.+. +...+.| .+ ..+..+...+..|.+++.+
T Consensus 649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk 728 (752)
T KOG0670|consen 649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK 728 (752)
T ss_pred HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence 0 0000000 0000111 11 1122234456778889999
Q ss_pred ccccCCCCCCCHHHHHHH
Q 000889 1186 CLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1186 cl~~dP~~RPt~~ell~~ 1203 (1237)
|+..||++|.|..+++++
T Consensus 729 ml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 729 MLILDPEKRITVNQALKH 746 (752)
T ss_pred HhccChhhcCCHHHHhcC
Confidence 999999999999999876
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-27 Score=251.86 Aligned_cols=405 Identities=25% Similarity=0.281 Sum_probs=241.9
Q ss_pred CCcEEecCCCcCCCCCchhHhhhcCCCcEEEcccCcCCCCCCcCcccccccceeeccC-ccccCcccchhccccccceEE
Q 000889 350 NLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGS-NMLSGNFLNTVVSKISSLIYL 428 (1237)
Q Consensus 350 ~L~~L~L~~n~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~~l~~L~~L 428 (1237)
.-..++|..|+|+ .||+..|+.+++|+.||||+|+|+.+.|++|..+.+|.+|-+.+ |+|+ ......|.++.+|+.|
T Consensus 68 ~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrL 145 (498)
T KOG4237|consen 68 ETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRL 145 (498)
T ss_pred cceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHH
Confidence 3445555555555 55555555555555555555555555555555555555554444 5554 3445555555555555
Q ss_pred eccCCCCCCCCCccCCCCCCCcEEEccCCcCcccCCC-CCCCCCCCcccceecccCcee------------eeccccccc
Q 000889 429 YVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPS-GFCSPPNFPALEKIVLPNNYL------------SGTVPLELG 495 (1237)
Q Consensus 429 ~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~~~~l~~L~~L~L~~N~l------------~~~~~~~l~ 495 (1237)
.+.-|++.-+....|..+++|..|.+.+|.+. .++. .| ..+..++.+.+..|.+ ....|..++
T Consensus 146 llNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf---~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~iets 221 (498)
T KOG4237|consen 146 LLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTF---QGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETS 221 (498)
T ss_pred hcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccc---cchhccchHhhhcCccccccccchhhhHHhhchhhcc
Confidence 55555555555555555666666666666555 2232 22 3445555555555542 112344455
Q ss_pred ccccccEecccCCccccCCCccccC-CcCcceeecccccccCcccccccccCCCccEEEccccccccccccccccCCCcc
Q 000889 496 SCKNLKTIDLSFNSLAGPVPSEIWS-LPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNML 574 (1237)
Q Consensus 496 ~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 574 (1237)
...-..-..+.++++..+.+..|.. +..+..-..+.+...+.-|..-|..+++|+.|+|++|+|+++-+.+|.++..++
T Consensus 222 garc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~ 301 (498)
T KOG4237|consen 222 GARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQ 301 (498)
T ss_pred cceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhh
Confidence 5555555566666666554544432 223322233445455577888899999999999999999999999999999999
Q ss_pred EEEeecccccccCCccccCccccceEEecCCccccCCCCCCCCCCCCCEEECCCCccccCC-----ChhHHhhc-----c
Q 000889 575 WVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPL-----PSELANQA-----G 644 (1237)
Q Consensus 575 ~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~i-----p~~~~~~~-----~ 644 (1237)
+|.|..|+|...-...|.++..|+.|+|.+|+|+...|..|..+.+|.+|+|-.|++.-.- -+|+..-. .
T Consensus 302 eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~ 381 (498)
T KOG4237|consen 302 ELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPR 381 (498)
T ss_pred hhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCC
Confidence 9999999999666677899999999999999999889999999999999999999885321 12221111 0
Q ss_pred cccCccccCccceeeccCCCccccCCCCcccccCCCccccCCCccccCCCCcceeccceeeeeccCCcee-EEEccCCcC
Q 000889 645 VVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLI-YLDLSYNSL 723 (1237)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~L~-~LdLs~N~l 723 (1237)
..-|+.+. ++.+.....+ .|.-..++... ......||..- +-+. ...-|++.+
T Consensus 382 Cq~p~~~~--~~~~~dv~~~----------~~~c~~~ee~~-~~~s~~cP~~c-------------~c~~tVvRcSnk~l 435 (498)
T KOG4237|consen 382 CQSPGFVR--QIPISDVAFG----------DFRCGGPEELG-CLTSSPCPPPC-------------TCLDTVVRCSNKLL 435 (498)
T ss_pred CCCCchhc--cccchhcccc----------ccccCCccccC-CCCCCCCCCCc-------------chhhhhHhhcccch
Confidence 00011111 0111000000 00000111100 00001111110 0011 112333344
Q ss_pred CccCCccccCCCCCcEEEecCcccccccccccccccCCcEEeCCCCccCCCCCCcccCcccccceecccc
Q 000889 724 SGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNN 793 (1237)
Q Consensus 724 ~g~~p~~~~~L~~L~~L~Ls~N~l~~~~P~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N 793 (1237)
+ .+|.-+- ..-++|++.+|.++ .+|++ .+..| .+|||+|+++-.--..|.++++|..|-||+|
T Consensus 436 k-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 436 K-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred h-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 3 5554332 24568899999999 88887 77888 8999999998666678889999999988887
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=234.93 Aligned_cols=199 Identities=33% Similarity=0.505 Sum_probs=172.5
Q ss_pred CCCCceecccCCeEEEEEEECC-CCEEEEEEeccccCc-CHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEecc
Q 000889 930 FSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQ-GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMK 1007 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 1007 (1237)
|++.+.||+|++|.||+|+..+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667889999999999999875 789999988754443 56678899999999999999999999998899999999999
Q ss_pred CCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCc
Q 000889 1008 WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDT 1087 (1237)
Q Consensus 1008 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~ 1087 (1237)
+++|.+++..... .+++.....++.+++.++.|||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 81 GGDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 9999999876421 178899999999999999999999 999999999999999999999999999987654321
Q ss_pred ceeeeccccCCCcCCcccc-CccccCcccchHHHHHHHHHHHcCCCCCCC
Q 000889 1088 HLSVSTLAGTPGYVPPEYY-QSFRCTTKGDVYSYGVILLELLSGKRPIDP 1136 (1237)
Q Consensus 1088 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGv~l~el~tg~~p~~~ 1136 (1237)
. ......++..|++||.. ....++.++|||++|++++||++|+.||..
T Consensus 154 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 A-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred c-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 1 22345678899999998 666788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-25 Score=238.70 Aligned_cols=201 Identities=29% Similarity=0.435 Sum_probs=167.3
Q ss_pred HHHhCCCCCCceecccCCeEEEEEEECC----CCEEEEEEeccccCcCHHHHHHHHHHHHhcC-CCCcccccceEEeCCe
Q 000889 924 LEATNGFSADSMIGSGGFGEVYKAQLRD----GSVVAIKKLIHVTGQGDREFMAEMETIGKIK-HRNLVPLLGYCKIGEE 998 (1237)
Q Consensus 924 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 998 (1237)
....+.|..+.+||+|.|++||+|++.. ...||+|.+... +....+.+|++++..+. +.||+++.+++..++.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 3445678899999999999999997653 568999998754 34556889999999995 8999999999999999
Q ss_pred EEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCC-CCceEEeecc
Q 000889 999 RLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE-NFEARVSDFG 1077 (1237)
Q Consensus 999 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~-~~~vkl~DfG 1077 (1237)
..+|+||++..+..++... ++...+..+++.+..||+++|.+ |||||||||+|++.+. .+.-.|+|||
T Consensus 110 v~ivlp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eEEEecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence 9999999999998888763 66788899999999999999999 9999999999999984 5678899999
Q ss_pred cceeeccCC------------------c---------------c---------eeeeccccCCCcCCccccCc-cccCcc
Q 000889 1078 MARLVNALD------------------T---------------H---------LSVSTLAGTPGYVPPEYYQS-FRCTTK 1114 (1237)
Q Consensus 1078 la~~~~~~~------------------~---------------~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~ 1114 (1237)
+|...+... . . .......||++|.|||++.. ...+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 997221100 0 0 00124669999999999865 457889
Q ss_pred cchHHHHHHHHHHHcCCCCCCCC
Q 000889 1115 GDVYSYGVILLELLSGKRPIDPS 1137 (1237)
Q Consensus 1115 sDvwSlGv~l~el~tg~~p~~~~ 1137 (1237)
+||||.|||+.-+++++.||...
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred cceeeccceeehhhccccccccC
Confidence 99999999999999999999754
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.7e-23 Score=270.46 Aligned_cols=285 Identities=21% Similarity=0.221 Sum_probs=168.9
Q ss_pred ccceEEeccCCCCCCCCCccCCCCCCCcEEEccCCcCcccCCCCCCCCCCCcccceecccCceeeecccccccccccccE
Q 000889 423 SSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKT 502 (1237)
Q Consensus 423 ~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~ 502 (1237)
.+|++|++.+|.+. .++..+..+++|+.|+|++|.....+|. + ..+++|+.|+|++|.....+|..+.++++|+.
T Consensus 611 ~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-l---s~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~ 685 (1153)
T PLN03210 611 ENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-L---SMATNLETLKLSDCSSLVELPSSIQYLNKLED 685 (1153)
T ss_pred cCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-c---ccCCcccEEEecCCCCccccchhhhccCCCCE
Confidence 44444444444444 3344555666666666666544334443 2 34566666666666544456666666777777
Q ss_pred ecccCCccccCCCccccCCcCcceeecccccccCcccccccccCCCccEEEccccccccccccccccCCCccEEEeeccc
Q 000889 503 IDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQ 582 (1237)
Q Consensus 503 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 582 (1237)
|++++|..-+.+|..+ ++++|+.|++++|...+.+|.. .++|++|+|++|.+. .+|..+ .+++|++|++.++.
T Consensus 686 L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~----~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~ 758 (1153)
T PLN03210 686 LDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI----STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMK 758 (1153)
T ss_pred EeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc----cCCcCeeecCCCccc-cccccc-cccccccccccccc
Confidence 7777654434556544 5667777777766555455532 346677777777765 455544 46666666666533
Q ss_pred cc-------ccCCccccCccccceEEecCCccccCCCCCCCCCCCCCEEECCCCccccCCChhHHhhcccccCccccCcc
Q 000889 583 LT-------GEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQ 655 (1237)
Q Consensus 583 l~-------~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~~~~ 655 (1237)
.. ...|..+...++|+.|+|++|...+.+|..++++++|+.|+|++|+..+.+|..+
T Consensus 759 ~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~---------------- 822 (1153)
T PLN03210 759 SEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI---------------- 822 (1153)
T ss_pred hhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC----------------
Confidence 21 1112222334567777777776666677777777777777777765443444321
Q ss_pred ceeeccCCCccccCCCCcccccCCCccccCCCccccCCCCcceeccceeeeeccCCceeEEEccCCcCCccCCccccCCC
Q 000889 656 FAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLN 735 (1237)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~L~~LdLs~N~l~g~~p~~~~~L~ 735 (1237)
.+.+|++|+|++|..-..+|.. .+
T Consensus 823 -----------------------------------------------------~L~sL~~L~Ls~c~~L~~~p~~---~~ 846 (1153)
T PLN03210 823 -----------------------------------------------------NLESLESLDLSGCSRLRTFPDI---ST 846 (1153)
T ss_pred -----------------------------------------------------CccccCEEECCCCCcccccccc---cc
Confidence 0125667777776544455542 24
Q ss_pred CCcEEEecCcccccccccccccccCCcEEeCCC-CccCCCCCCcccCcccccceecccc
Q 000889 736 YLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSH-NNFQGSIPGSLGGLSFLSDLDVSNN 793 (1237)
Q Consensus 736 ~L~~L~Ls~N~l~~~~P~~~~~L~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~l~l~~N 793 (1237)
+|+.|+|++|.++ .+|.++..+++|+.|+|++ |+|. .+|..+..++.|+.++++++
T Consensus 847 nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 847 NISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred ccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence 6667777777776 5677777777777777776 4444 56666677777777777665
|
syringae 6; Provisional |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-25 Score=237.00 Aligned_cols=272 Identities=21% Similarity=0.235 Sum_probs=209.8
Q ss_pred ceEEccCCccCCCccccCCcccEEEcCCCCCCCchhhhccccCCCCCCEEEccCCCCCchhhhhcccCCCccEEEccc-c
Q 000889 180 SYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSY-N 258 (1237)
Q Consensus 180 ~~L~ls~n~l~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~LdLs~-N 258 (1237)
..+++++-.++.+|-..++..++|+|..|+|+. +.+.+|+.+++|+.||||+|.|+.+.+++|.++++|.+|-+-+ |
T Consensus 49 ~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~--iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~N 126 (498)
T KOG4237|consen 49 GIVDCRGKGLTEVPANLPPETVEIRLDQNQISS--IPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNN 126 (498)
T ss_pred ceEEccCCCcccCcccCCCcceEEEeccCCccc--CChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCC
Confidence 357888889999999999999999999999987 4467789999999999999999999999999999987775555 8
Q ss_pred cccCccchhhhhccCCCccEEeCCCCcCCCCcccccccCCCCCceeeccCccccCcccch-hhcccccceEEEecCCccC
Q 000889 259 LLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPA-SLKNCQLLETLNMSHNALQ 337 (1237)
Q Consensus 259 ~l~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-~l~~l~~L~~L~Ls~N~l~ 337 (1237)
+|+ .+|... ...+.+|+.|.+.-|++. -+....|..+++|..|.+.+|.+.. ++. .+..+..++.+.+..|.+-
T Consensus 127 kI~-~l~k~~-F~gL~slqrLllNan~i~-Cir~~al~dL~~l~lLslyDn~~q~--i~~~tf~~l~~i~tlhlA~np~i 201 (498)
T KOG4237|consen 127 KIT-DLPKGA-FGGLSSLQRLLLNANHIN-CIRQDALRDLPSLSLLSLYDNKIQS--ICKGTFQGLAAIKTLHLAQNPFI 201 (498)
T ss_pred chh-hhhhhH-hhhHHHHHHHhcChhhhc-chhHHHHHHhhhcchhcccchhhhh--hccccccchhccchHhhhcCccc
Confidence 887 444433 245778999999999887 4455678889999999999998844 343 7888888888888888722
Q ss_pred CC------------CchhhhccCCC----------------------CcEE---ecCCCcCCCCCchhHhhhcCCCcEEE
Q 000889 338 GG------------IPGFLLGSFRN----------------------LKQL---SLAHNQFAGEIPPELGQACGTLRELD 380 (1237)
Q Consensus 338 ~~------------~~~~~~~~l~~----------------------L~~L---~L~~n~l~~~ip~~~~~~l~~L~~L~ 380 (1237)
.. .|. .++.++- ++.+ ..+.+...+..|..-|+.+++|+.|+
T Consensus 202 cdCnL~wla~~~a~~~i-etsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~ln 280 (498)
T KOG4237|consen 202 CDCNLPWLADDLAMNPI-ETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLN 280 (498)
T ss_pred cccccchhhhHHhhchh-hcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEec
Confidence 11 000 0111111 1222 22334444567777788888888888
Q ss_pred cccCcCCCCCCcCcccccccceeeccCccccCcccchhccccccceEEeccCCCCCCCCCccCCCCCCCcEEEccCCcCc
Q 000889 381 LSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFT 460 (1237)
Q Consensus 381 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~ 460 (1237)
|++|+|+.+-+.+|..+..++.|.|..|+|. .+....|.++..|+.|+|.+|+|+...|.+|..+..|..|+|-.|.+.
T Consensus 281 lsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~-~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 281 LSNNKITRIEDGAFEGAAELQELYLTRNKLE-FVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred cCCCccchhhhhhhcchhhhhhhhcCcchHH-HHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence 8888888888888888888888888888886 456677888888888888888888888888888888888888888765
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=212.04 Aligned_cols=274 Identities=19% Similarity=0.253 Sum_probs=212.6
Q ss_pred CCCCCceecccCCeEEEEEEE-CCCCEEEEEEeccccCcCHHHHHHHHHHHHhcC-CCCcccccceEEeCCeEEEEEEec
Q 000889 929 GFSADSMIGSGGFGEVYKAQL-RDGSVVAIKKLIHVTGQGDREFMAEMETIGKIK-HRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
.|++.++||+|+||+++.|+. -++++||||.-.. .....++..|.+.++.+. .+.|..+|.+..++-+..+|||.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 588999999999999999974 3799999995432 234457888999999985 799999999988888999999988
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCC-----CceEEeeccccee
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDEN-----FEARVSDFGMARL 1081 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~-----~~vkl~DfGla~~ 1081 (1237)
|-+|+|+..-. ++.++...+..+|.|++.-++|+|++ ..|+|||||+|+||... ..+.|+|||+|+.
T Consensus 107 -GPSLEDLFD~C----gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 107 -GPSLEDLFDLC----GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred -CcCHHHHHHHh----cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 68999988765 35799999999999999999999999 99999999999999743 3589999999998
Q ss_pred eccCCccee-----eeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhc
Q 000889 1082 VNALDTHLS-----VSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREK 1156 (1237)
Q Consensus 1082 ~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1156 (1237)
+....+... ....-||.+||+--...+..-+...|+=|+|-++.+.+-|..||.+........-.+.+....+.-
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 876655433 245669999999999999999999999999999999999999998765443322222222222222
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccccCCCCCCccCch
Q 000889 1157 RINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGDSLDSFSLK 1222 (1237)
Q Consensus 1157 ~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~~~~~~~~~~~~~ 1222 (1237)
.+.+.+. ..++++...++.++ ..+-.+-|+.+-+...+.++......-.--.++|.
T Consensus 259 ~i~~Lc~-------g~P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~ 314 (449)
T KOG1165|consen 259 PIEVLCE-------GFPEEFATYLRYVR---RLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWM 314 (449)
T ss_pred CHHHHHh-------cCHHHHHHHHHHHH---hcCcccCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence 2222221 23455556666544 46788899999999888887666655555556664
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=266.88 Aligned_cols=346 Identities=24% Similarity=0.244 Sum_probs=258.7
Q ss_pred CCcCcccccccceeeccCccccC-----cccchhcccc-ccceEEeccCCCCCCCCCccCCCCCCCcEEEccCCcCcccC
Q 000889 390 LPSTFASCSSLHSLNLGSNMLSG-----NFLNTVVSKI-SSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTI 463 (1237)
Q Consensus 390 ~~~~~~~l~~L~~L~L~~N~l~~-----~~~~~~~~~l-~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 463 (1237)
.+.+|.++++|+.|.+..+.... ...+..+..+ .+|+.|++.++.+. .+|..| ...+|+.|+|++|++. .+
T Consensus 550 ~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L 626 (1153)
T PLN03210 550 HENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KL 626 (1153)
T ss_pred cHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cc
Confidence 44567788888888886654321 0112223333 46888888888876 556666 4688999999999887 45
Q ss_pred CCCCCCCCCCcccceecccCceeeecccccccccccccEecccCCccccCCCccccCCcCcceeecccccccCccccccc
Q 000889 464 PSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGIC 543 (1237)
Q Consensus 464 p~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~ 543 (1237)
+..+ ..+++|+.|+|++|.....+| .++.+++|++|+|++|.....+|..+..+++|+.|++++|...+.+|..+
T Consensus 627 ~~~~---~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i- 701 (1153)
T PLN03210 627 WDGV---HSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI- 701 (1153)
T ss_pred cccc---ccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-
Confidence 6555 467889999998876544555 47888899999999887666888889999999999999876556888765
Q ss_pred ccCCCccEEEccccccccccccccccCCCccEEEeecccccccCCccccCccccceEEecCCcc-------ccCCCCCCC
Q 000889 544 VNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSL-------TGQVPQGLG 616 (1237)
Q Consensus 544 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l-------~~~~p~~l~ 616 (1237)
++++|+.|+|++|...+.+|.. .++|++|+|++|.++ .+|..+ .+++|+.|++.++.. ....|..+.
T Consensus 702 -~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~ 775 (1153)
T PLN03210 702 -NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTM 775 (1153)
T ss_pred -CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhh
Confidence 6788999999988766566653 467888999999987 677765 578888888877432 212222233
Q ss_pred CCCCCCEEECCCCccccCCChhHHhhcccccCccccCccceeeccCCCccccCCCCcccccCCCccccCCCccccCCCCc
Q 000889 617 KCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPST 696 (1237)
Q Consensus 617 ~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 696 (1237)
..++|+.|+|++|+..+.+|.+++++
T Consensus 776 ~~~sL~~L~Ls~n~~l~~lP~si~~L------------------------------------------------------ 801 (1153)
T PLN03210 776 LSPSLTRLFLSDIPSLVELPSSIQNL------------------------------------------------------ 801 (1153)
T ss_pred ccccchheeCCCCCCccccChhhhCC------------------------------------------------------
Confidence 45688899999988877788766543
Q ss_pred ceeccceeeeeccCCceeEEEccCCcCCccCCccccCCCCCcEEEecCcccccccccccccccCCcEEeCCCCccCCCCC
Q 000889 697 RIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIP 776 (1237)
Q Consensus 697 ~~~~~~~~~~f~~~~~L~~LdLs~N~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~P~~~~~L~~L~~L~Ls~N~l~~~~p 776 (1237)
.+|+.|+|++|..-+.+|..+ ++++|+.|+|++|..-..+|.. ..+|+.|+|++|.++ .+|
T Consensus 802 --------------~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP 862 (1153)
T PLN03210 802 --------------HKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVP 862 (1153)
T ss_pred --------------CCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cCh
Confidence 268999999986556888776 7899999999998766567754 468999999999998 789
Q ss_pred CcccCcccccceeccc-ccccccCCCCCCCCccCCCcccCCCCCCCC
Q 000889 777 GSLGGLSFLSDLDVSN-NNLSGIIPSGGQLTTFPASRYENNSGLCGL 822 (1237)
Q Consensus 777 ~~~~~l~~L~~l~l~~-N~l~g~~p~~~~~~~~~~~~~~~n~~~~~~ 822 (1237)
.++..+++|+.|+|++ |+|.+.++....+..+....+.++..+-..
T Consensus 863 ~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~~L~~~ 909 (1153)
T PLN03210 863 WWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCGALTEA 909 (1153)
T ss_pred HHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCcccccc
Confidence 9999999999999998 788887777777777777777776655433
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.6e-23 Score=249.43 Aligned_cols=241 Identities=26% Similarity=0.318 Sum_probs=153.6
Q ss_pred CCcEEEccCCcCcccCCCCCCCCCCCcccceecccCceeeecccccccccccccEecccCCccccCCCccccCCcCccee
Q 000889 448 QLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDL 527 (1237)
Q Consensus 448 ~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 527 (1237)
+|+.|++++|+++. +|.. .++|++|++++|+|+. +|.. .++|+.|++++|.++ .+|..+ ++|+.|
T Consensus 223 ~L~~L~L~~N~Lt~-LP~l------p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L 287 (788)
T PRK15387 223 HITTLVIPDNNLTS-LPAL------PPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSNPLT-HLPALP---SGLCKL 287 (788)
T ss_pred CCCEEEccCCcCCC-CCCC------CCCCcEEEecCCccCc-ccCc---ccccceeeccCCchh-hhhhch---hhcCEE
Confidence 45555555555552 3321 2455555555555553 2321 245666666666665 344322 345566
Q ss_pred ecccccccCcccccccccCCCccEEEccccccccccccccccCCCccEEEeecccccccCCccccCccccceEEecCCcc
Q 000889 528 VMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSL 607 (1237)
Q Consensus 528 ~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l 607 (1237)
++++|+++ .+|.. +++|+.|+|++|++++ +|... .+|+.|++++|+|+ .+|.. ..+|+.|+|++|+|
T Consensus 288 ~Ls~N~Lt-~LP~~----p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~-~LP~l---p~~Lq~LdLS~N~L 354 (788)
T PRK15387 288 WIFGNQLT-SLPVL----PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLT-SLPTL---PSGLQELSVSDNQL 354 (788)
T ss_pred ECcCCccc-ccccc----ccccceeECCCCcccc-CCCCc---ccccccccccCccc-ccccc---ccccceEecCCCcc
Confidence 66666666 45542 3567777777777773 44322 34667777777777 45542 13677888888888
Q ss_pred ccCCCCCCCCCCCCCEEECCCCccccCCChhHHhhcccccCccccCccceeeccCCCccccCCCCcccccCCCccccCCC
Q 000889 608 TGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGF 687 (1237)
Q Consensus 608 ~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (1237)
+ .+|... ++|+.|++++|+|+ .+|...
T Consensus 355 s-~LP~lp---~~L~~L~Ls~N~L~-~LP~l~------------------------------------------------ 381 (788)
T PRK15387 355 A-SLPTLP---SELYKLWAYNNRLT-SLPALP------------------------------------------------ 381 (788)
T ss_pred C-CCCCCC---cccceehhhccccc-cCcccc------------------------------------------------
Confidence 7 455432 45677778887776 244210
Q ss_pred ccccCCCCcceeccceeeeeccCCceeEEEccCCcCCccCCccccCCCCCcEEEecCcccccccccccccccCCcEEeCC
Q 000889 688 PMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLS 767 (1237)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~f~~~~~L~~LdLs~N~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~P~~~~~L~~L~~L~Ls 767 (1237)
.+|+.|+|++|+|+ .+|... ++|+.|++++|+|+ .+|..+ .+|+.|+|+
T Consensus 382 -----------------------~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls 430 (788)
T PRK15387 382 -----------------------SGLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLT-SLPMLP---SGLLSLSVY 430 (788)
T ss_pred -----------------------cccceEEecCCccc-CCCCcc---cCCCEEEccCCcCC-CCCcch---hhhhhhhhc
Confidence 14778888888887 466543 56788888888888 477543 467788889
Q ss_pred CCccCCCCCCcccCcccccceecccccccccCCC
Q 000889 768 HNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPS 801 (1237)
Q Consensus 768 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~ 801 (1237)
+|+|+ .+|.++..++.|+.|+|++|+|+|.+|.
T Consensus 431 ~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 431 RNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred cCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 99887 7888888888889999999998887774
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-23 Score=268.05 Aligned_cols=197 Identities=18% Similarity=0.212 Sum_probs=138.8
Q ss_pred hcCC-CCcccccceEE-------eCCeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCC
Q 000889 980 KIKH-RNLVPLLGYCK-------IGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIP 1051 (1237)
Q Consensus 980 ~l~h-~niv~l~~~~~-------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 1051 (1237)
.++| +||++++++|. +.+..+.+|||+ +++|.++++.. ...+++..++.++.||++||+|||++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~--- 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHSQ--- 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHhC---
Confidence 3445 57888888772 234567788987 57999999743 24689999999999999999999999
Q ss_pred CeeecCCCCCCeeeCC-------------------CCceEEeecccceeeccCCc--------------ceeeeccccCC
Q 000889 1052 HIIHRDMKSSNVLLDE-------------------NFEARVSDFGMARLVNALDT--------------HLSVSTLAGTP 1098 (1237)
Q Consensus 1052 ~ivHrDikp~NIll~~-------------------~~~vkl~DfGla~~~~~~~~--------------~~~~~~~~gt~ 1098 (1237)
+||||||||+|||++. ++.+|++|||+++....... ........||+
T Consensus 100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 9999999999999954 44566666666653221000 00011245788
Q ss_pred CcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCCCHHHHHH
Q 000889 1099 GYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQ 1178 (1237)
Q Consensus 1099 ~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 1178 (1237)
.|||||++.+..++.++|||||||++|||++|..|+.... ........ ....+.. ......
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------~~~~~~~~-----~~~~~~~------~~~~~~ 240 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--------RTMSSLRH-----RVLPPQI------LLNWPK 240 (793)
T ss_pred ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------HHHHHHHH-----hhcChhh------hhcCHH
Confidence 9999999999999999999999999999999988864211 00111100 0111111 011223
Q ss_pred HHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1179 YLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1179 l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
...++.+|++++|.+||++.+++++
T Consensus 241 ~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 241 EASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHHhCCCChhhCcChHHHhhc
Confidence 4567779999999999999999876
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=245.16 Aligned_cols=267 Identities=28% Similarity=0.356 Sum_probs=182.1
Q ss_pred ceEEEecCCccCCCCchhhhccCCCCcEEecCCCcCCCCCchhHhhhcCCCcEEEcccCcCCCCCCcCcccccccceeec
Q 000889 326 LETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNL 405 (1237)
Q Consensus 326 L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 405 (1237)
-..|+|++|.++ .+|..+. ++|+.|++.+|+++ .+|.. .++|++|+|++|+|+. +|.. .++|+.|++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~---~~L~~L~L~~N~Lt-~LP~l----p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~L 269 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLT-SLPAL----PPELRTLEVSGNQLTS-LPVL---PPGLLELSI 269 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh---cCCCEEEccCCcCC-CCCCC----CCCCcEEEecCCccCc-ccCc---ccccceeec
Confidence 345566666555 3443321 35666666666665 45531 2556666666666663 3322 245666666
Q ss_pred cCccccCcccchhccccccceEEeccCCCCCCCCCccCCCCCCCcEEEccCCcCcccCCCCCCCCCCCcccceecccCce
Q 000889 406 GSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNY 485 (1237)
Q Consensus 406 ~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~L~~N~ 485 (1237)
++|.++. .+ ..+.+|+.|++++|+++. +|. ..++|+.|+|++|+|++ +|.. .+.|+.|++++|+
T Consensus 270 s~N~L~~--Lp---~lp~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~-Lp~l------p~~L~~L~Ls~N~ 333 (788)
T PRK15387 270 FSNPLTH--LP---ALPSGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLAS-LPAL------PSELCKLWAYNNQ 333 (788)
T ss_pred cCCchhh--hh---hchhhcCEEECcCCcccc-ccc---cccccceeECCCCcccc-CCCC------cccccccccccCc
Confidence 6666552 11 122456666677776663 333 23568888888888874 3432 2357777888888
Q ss_pred eeecccccccccccccEecccCCccccCCCccccCCcCcceeecccccccCcccccccccCCCccEEEcccccccccccc
Q 000889 486 LSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPK 565 (1237)
Q Consensus 486 l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~ 565 (1237)
+++ +|.. ..+|+.|+|++|+|+ .+|.. ..+|+.|++++|+++ .+|.. ..+|+.|+|++|+|+ .+|.
T Consensus 334 L~~-LP~l---p~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~-~LP~l----~~~L~~LdLs~N~Lt-~LP~ 399 (788)
T PRK15387 334 LTS-LPTL---PSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLT-SLPAL----PSGLKELIVSGNRLT-SLPV 399 (788)
T ss_pred ccc-cccc---ccccceEecCCCccC-CCCCC---Ccccceehhhccccc-cCccc----ccccceEEecCCccc-CCCC
Confidence 874 4431 247888999999988 45543 346778889999988 57753 357999999999998 4665
Q ss_pred ccccCCCccEEEeecccccccCCccccCccccceEEecCCccccCCCCCCCCCCCCCEEECCCCccccCCChhHHhhc
Q 000889 566 SIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQA 643 (1237)
Q Consensus 566 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~ 643 (1237)
. .++|+.|++++|+|+ .+|... .+|+.|+|++|+|+ .+|..++++++|+.|+|++|+|+|.+|..+.++.
T Consensus 400 l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l~ 469 (788)
T PRK15387 400 L---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 469 (788)
T ss_pred c---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHHh
Confidence 4 367999999999999 578643 46889999999999 7999999999999999999999999998886654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=210.08 Aligned_cols=167 Identities=24% Similarity=0.275 Sum_probs=126.4
Q ss_pred CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcc
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~ 1088 (1237)
|+|.++++.+ +..+++..++.++.|+++||+|||+. + ||+||+++.++.+|+ ||.++.....
T Consensus 1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~--- 62 (176)
T smart00750 1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE--- 62 (176)
T ss_pred CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc---
Confidence 7899999764 24699999999999999999999999 5 999999999999999 9999866432
Q ss_pred eeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccC
Q 000889 1089 LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTM 1168 (1237)
Q Consensus 1089 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1168 (1237)
...|++.|||||++.+..++.++|||||||++|||++|+.||..... ............. .. ++.
T Consensus 63 ----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-----~~~~~~~~~~~~~--~~-~~~--- 127 (176)
T smart00750 63 ----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-----LSAILEILLNGMP--AD-DPR--- 127 (176)
T ss_pred ----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-----hcHHHHHHHHHhc--cC-Ccc---
Confidence 22588999999999999999999999999999999999999864321 1111111111100 00 000
Q ss_pred CCCCHHHH---HHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 000889 1169 QTSDETEL---YQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208 (1237)
Q Consensus 1169 ~~~~~~~~---~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~ 1208 (1237)
........ ..+.+++.+|+..+|++||++.++++++..+.
T Consensus 128 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 128 DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 00011111 25788999999999999999999999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-21 Score=223.35 Aligned_cols=275 Identities=21% Similarity=0.239 Sum_probs=202.4
Q ss_pred CCCCCceecccCCeEEEEEEECCC--CEEEEEEeccccCcCHHHHHHHHHHHHhcCC----CCcccccceE-EeCCeEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLRDG--SVVAIKKLIHVTGQGDREFMAEMETIGKIKH----RNLVPLLGYC-KIGEERLL 1001 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 1001 (1237)
+|.+.++||+|+||.||.|..... ..+|+|............+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999998754 3677776655433333367789999988873 6899999988 47778899
Q ss_pred EEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCC-----CceEEeec
Q 000889 1002 VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDEN-----FEARVSDF 1076 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~-----~~vkl~Df 1076 (1237)
||+.+ |.+|.++..... ...++...+.+|+.|++.+|+++|+. |++||||||.|++++.. ..+.+.||
T Consensus 99 VM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 99987 689999876543 36899999999999999999999999 99999999999999864 46999999
Q ss_pred ccceeec--cCCcc----e-e-eeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHH
Q 000889 1077 GMARLVN--ALDTH----L-S-VSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGW 1148 (1237)
Q Consensus 1077 Gla~~~~--~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~ 1148 (1237)
|+|+.+. ..... . . .....||..|+++.+..+...+.+.|+||++.++.|+..|..||...+.... ....
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--~~~~ 249 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--KSKF 249 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--HHHH
Confidence 9998332 22211 1 1 1235699999999999999999999999999999999999999965432211 1111
Q ss_pred HHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccccCCCCCCccCchh
Q 000889 1149 AKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGDSLDSFSLKD 1223 (1237)
Q Consensus 1149 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~~~~~~~~~~~~~~ 1223 (1237)
.. ....... .. .....+.+...+. ..+-..+..++|....+.+.++...........+.++|..
T Consensus 250 ~~-~~~~~~~----~~---~~~~~~~~~~~~~---~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~ 313 (322)
T KOG1164|consen 250 EK-DPRKLLT----DR---FGDLKPEEFAKIL---EYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEV 313 (322)
T ss_pred HH-Hhhhhcc----cc---ccCCChHHHHHHH---HHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCcccc
Confidence 11 1111111 10 1122233444433 3445589999999999999998876665555556666654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=196.58 Aligned_cols=280 Identities=17% Similarity=0.195 Sum_probs=211.9
Q ss_pred HhCCCCCCceecccCCeEEEEEEE-CCCCEEEEEEeccccCcCHHHHHHHHHHHHhcCC-CCcccccceEEeCCeEEEEE
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQL-RDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKH-RNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 1003 (1237)
..++|.++++||.|+||.+|.|.. .+|+.||+|.-.... .-.++..|.++.+.+++ ..|..+..|..++....+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 356899999999999999999975 479999999765432 23467789999999975 67888888998899999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCC---CCceEEeecccce
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE---NFEARVSDFGMAR 1080 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~---~~~vkl~DfGla~ 1080 (1237)
+.. |-+|+++..-.. ..++..++.-++-|++.-++|+|.+ ++|||||||+|+|..- ...+.++|||+|+
T Consensus 91 dLL-GPsLEdLfnfC~----R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCS----RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred ecc-CccHHHHHHHHh----hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence 988 689999887654 3688889999999999999999999 9999999999999974 3468999999999
Q ss_pred eeccCCccee-----eeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhh
Q 000889 1081 LVNALDTHLS-----VSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE 1155 (1237)
Q Consensus 1081 ~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1155 (1237)
.+....+... .....||.+|.+--...+..-+...|+=|+|.++.++-.|..||.+............+......
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s 242 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS 242 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence 8766554332 23466999999988888777888999999999999999999999875432211111111111111
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccccCCCCCCccCchhhH
Q 000889 1156 KRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGDSLDSFSLKDTV 1225 (1237)
Q Consensus 1156 ~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~~~~~~~~~~~~~~~~~~ 1225 (1237)
..+... +...+.+|...+.-|-...-++-|+..-+.+.+.-+......+.---++|.--.
T Consensus 243 ~~ie~L----------C~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lk 302 (341)
T KOG1163|consen 243 TPIEVL----------CKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLK 302 (341)
T ss_pred CCHHHH----------hCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHH
Confidence 111111 111123445555678888999999999999998888777777776677776443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.1e-22 Score=224.83 Aligned_cols=175 Identities=17% Similarity=0.197 Sum_probs=133.3
Q ss_pred HhCCCCCCceecccCCeEEEEEEEC--CCCEEEEEEecccc-----CcCHHHHHHHHHHHHhcCCCCcccccceEEeCCe
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLR--DGSVVAIKKLIHVT-----GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEE 998 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 998 (1237)
..++|++.+.||+|+||+||+|+++ ++..||||++.... ....+.+.+|++++++++|+|+++.+.. .+.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~ 92 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK 92 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence 4567999999999999999999875 46778999875321 1124468899999999999999853322 246
Q ss_pred EEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCCeeeCCCCceEEeecc
Q 000889 999 RLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDM-KSSNVLLDENFEARVSDFG 1077 (1237)
Q Consensus 999 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDi-kp~NIll~~~~~vkl~DfG 1077 (1237)
.++||||++|++|... .. .. ...++.++++||+|||+. +|+|||| ||+||+++.++.+||+|||
T Consensus 93 ~~LVmE~~~G~~L~~~-~~--------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-RP--------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred cEEEEEccCCCCHHHh-Cc--------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 7999999999999632 10 01 145788999999999999 9999999 9999999999999999999
Q ss_pred cceeeccCCccee------eeccccCCCcCCccccCccc------cCcccchH
Q 000889 1078 MARLVNALDTHLS------VSTLAGTPGYVPPEYYQSFR------CTTKGDVY 1118 (1237)
Q Consensus 1078 la~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~~~~sDvw 1118 (1237)
+|+.+........ .....+++.|+|||++...+ .+..+|-|
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9997755332221 23567888999999986432 23346666
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.1e-22 Score=200.84 Aligned_cols=247 Identities=24% Similarity=0.411 Sum_probs=183.7
Q ss_pred CCceecccCCeEEEEEEECCCCEEEEEEec--cccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCC
Q 000889 932 ADSMIGSGGFGEVYKAQLRDGSVVAIKKLI--HVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWG 1009 (1237)
Q Consensus 932 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 1009 (1237)
...+|.+...|+.|+|+++ |..+++|.+. .......++|..|.-.++-+.||||.++++.|.......++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 3457889999999999998 5555666554 233334568999999999999999999999999999999999999999
Q ss_pred CHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEe--ecccceeeccCCc
Q 000889 1010 SLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVS--DFGMARLVNALDT 1087 (1237)
Q Consensus 1010 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~--DfGla~~~~~~~~ 1087 (1237)
+|+.++++.. ...++..++.+++.++|+|++|||+.. +-|..--+.+..|++|++.+++|. |--++.
T Consensus 273 slynvlhe~t---~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf------- 341 (448)
T KOG0195|consen 273 SLYNVLHEQT---SVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF------- 341 (448)
T ss_pred HHHHHHhcCc---cEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee-------
Confidence 9999998753 346788899999999999999999984 223334578899999999888874 221111
Q ss_pred ceeeeccccCCCcCCccccCccccC---cccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCc
Q 000889 1088 HLSVSTLAGTPGYVPPEYYQSFRCT---TKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDP 1164 (1237)
Q Consensus 1088 ~~~~~~~~gt~~y~aPE~~~~~~~~---~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1164 (1237)
......-.|.||+||.+...+-+ .++|+|||++++||+.|...||..-...+-..... .+. +..
T Consensus 342 --qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia-------leg----lrv 408 (448)
T KOG0195|consen 342 --QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA-------LEG----LRV 408 (448)
T ss_pred --eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-------hcc----ccc
Confidence 11233457899999999876543 47999999999999999999997544332111110 011 111
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 000889 1165 ELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208 (1237)
Q Consensus 1165 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~ 1208 (1237)
.+ +.. ....+.+++.-|+..||.+||.++.++-.|++++
T Consensus 409 ~i--ppg---is~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 409 HI--PPG---ISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cC--CCC---ccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 11 111 2234556667799999999999999999998764
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.4e-21 Score=237.01 Aligned_cols=79 Identities=29% Similarity=0.528 Sum_probs=40.4
Q ss_pred ccEEEccccccccccccccccCCCccEEEeecccccccCCccccCccccceEEecCCccccCCCCCCCCCCCCCEEECCC
Q 000889 549 LETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNS 628 (1237)
Q Consensus 549 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 628 (1237)
|+.|++++|+++ .+|..+. ++|+.|++++|.++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++
T Consensus 306 L~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~ 376 (754)
T PRK15370 306 ITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALT-SLPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSR 376 (754)
T ss_pred HHHHHhcCCccc-cCCcccc--ccceeccccCCccc-cCChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCC
Confidence 444444444444 2333221 34555555555555 3454443 45666666666665 4454442 4566666666
Q ss_pred CccccCCCh
Q 000889 629 NNLSGPLPS 637 (1237)
Q Consensus 629 N~l~g~ip~ 637 (1237)
|+|+ .+|.
T Consensus 377 N~Lt-~LP~ 384 (754)
T PRK15370 377 NALT-NLPE 384 (754)
T ss_pred CcCC-CCCH
Confidence 6665 3444
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.4e-21 Score=232.97 Aligned_cols=254 Identities=23% Similarity=0.282 Sum_probs=187.0
Q ss_pred CCceecccCCeEEEEEEEC-CCCEEEEEEeccc--cCcCHHH----HHHHHHHHHhcCCCCcccccceEEeCCeEEEEEE
Q 000889 932 ADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHV--TGQGDRE----FMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 932 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~----~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
...++|.|++|.|+.+... ..+.++.|..... .....+. +..|+.+-..++|||++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3568999999988887654 3444444433210 2222222 5568888888999999988888777766666699
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
||++ +|..++... ..+...++..++.|+..|+.|+|+. ||.|||+|++|++++.+|.+||+|||.+..+..
T Consensus 402 ~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred cccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 9998 999998763 3577888899999999999999999 999999999999999999999999999987665
Q ss_pred CCcc--eeeeccccCCCcCCccccCccccCc-ccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccc
Q 000889 1085 LDTH--LSVSTLAGTPGYVPPEYYQSFRCTT-KGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161 (1237)
Q Consensus 1085 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1161 (1237)
.... ......+|+..|+|||++.+..|+. .+||||.|+++..|.+|+.||......++... ...........
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-----~~~~~~~~~~~ 547 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-----TNNYSDQRNIF 547 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh-----hhccccccccc
Confidence 4443 4446788999999999999988875 58999999999999999999986554333210 00000111110
Q ss_pred cCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1162 LDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1162 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
..+... ......+-..++.+|++.+|.+|.|+.++++.
T Consensus 548 ~~~~~~----~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 548 EGPNRL----LSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cChHHH----HHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 000000 01223445678889999999999999999863
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-20 Score=233.11 Aligned_cols=246 Identities=26% Similarity=0.462 Sum_probs=129.5
Q ss_pred cceEEeccCCCCCCCCCccCCCCCCCcEEEccCCcCcccCCCCCCCCCCCcccceecccCceeeecccccccccccccEe
Q 000889 424 SLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTI 503 (1237)
Q Consensus 424 ~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L 503 (1237)
+...|+++++.++. +|..+. +.|+.|+|++|+|+ .+|..+ .++|+.|++++|+++. +|..+. .+|+.|
T Consensus 179 ~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l-----~~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L 246 (754)
T PRK15370 179 NKTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENL-----QGNIKTLYANSNQLTS-IPATLP--DTIQEM 246 (754)
T ss_pred CceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhh-----ccCCCEEECCCCcccc-CChhhh--ccccEE
Confidence 45667777777763 444442 46777777777776 344433 1245555555555542 333222 244555
Q ss_pred cccCCccccCCCccccCCcCcceeecccccccCcccccccccCCCccEEEccccccccccccccccCCCccEEEeecccc
Q 000889 504 DLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQL 583 (1237)
Q Consensus 504 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 583 (1237)
+|++|++. .+|..+. .+|+.|+|++|+++ .+|..+. ++|+.|+|++|+|
T Consensus 247 ~Ls~N~L~-------------------------~LP~~l~---s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~L 295 (754)
T PRK15370 247 ELSINRIT-------------------------ELPERLP---SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSI 295 (754)
T ss_pred ECcCCccC-------------------------cCChhHh---CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcc
Confidence 55555544 4444332 24555555555555 3444432 3555666666665
Q ss_pred cccCCccccCccccceEEecCCccccCCCCCCCCCCCCCEEECCCCccccCCChhHHhhcccccCccccCccceeeccCC
Q 000889 584 TGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEG 663 (1237)
Q Consensus 584 ~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (1237)
+ .+|..+. ++|+.|+|++|+++ .+|..+. ++|+.|++++|.+++ +|..+.
T Consensus 296 t-~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~----------------------- 345 (754)
T PRK15370 296 R-TLPAHLP--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALTS-LPASLP----------------------- 345 (754)
T ss_pred c-cCcccch--hhHHHHHhcCCccc-cCCcccc--ccceeccccCCcccc-CChhhc-----------------------
Confidence 5 3444332 24566666666665 3444332 456666666666652 332210
Q ss_pred CccccCCCCcccccCCCccccCCCccccCCCCcceeccceeeeeccCCceeEEEccCCcCCccCCccccCCCCCcEEEec
Q 000889 664 GTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLG 743 (1237)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~L~~LdLs~N~l~g~~p~~~~~L~~L~~L~Ls 743 (1237)
.+|+.|+|++|+|+ .+|..+. ++|+.|+|+
T Consensus 346 -----------------------------------------------~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs 375 (754)
T PRK15370 346 -----------------------------------------------PELQVLDVSKNQIT-VLPETLP--PTITTLDVS 375 (754)
T ss_pred -----------------------------------------------CcccEEECCCCCCC-cCChhhc--CCcCEEECC
Confidence 13566666666665 4555442 456666666
Q ss_pred CcccccccccccccccCCcEEeCCCCccCCCCCCcc----cCcccccceeccccccc
Q 000889 744 HNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSL----GGLSFLSDLDVSNNNLS 796 (1237)
Q Consensus 744 ~N~l~~~~P~~~~~L~~L~~L~Ls~N~l~~~~p~~~----~~l~~L~~l~l~~N~l~ 796 (1237)
+|+|+ .+|+.+. ..|+.||+++|+|. .+|..+ +.++.+..|+|.+|+|+
T Consensus 376 ~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 376 RNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 66666 4555443 24666666666665 444433 23355666666666665
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5e-19 Score=205.43 Aligned_cols=260 Identities=28% Similarity=0.400 Sum_probs=196.4
Q ss_pred CCCCceecccCCeEEEEEEECCCCEEEEEEeccccCc---CHHHHHHHHHHHHhcCCC-CcccccceEEeCCeEEEEEEe
Q 000889 930 FSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQ---GDREFMAEMETIGKIKHR-NLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
|.+.+.||.|+||.||++.+. ..+++|.+...... ....+.+|+.+++.+.|+ +++++++++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667788999999999999987 77888988654333 356789999999999988 799999999777778999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCC-ceEEeecccceeecc
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENF-EARVSDFGMARLVNA 1084 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~-~vkl~DfGla~~~~~ 1084 (1237)
+.++++.+++...... ..+.......+..|++.+++|+|+. +++|||+||+||+++..+ .++++|||.++....
T Consensus 80 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 80 VDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred CCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 9999999776653211 2688889999999999999999999 999999999999999988 799999999986654
Q ss_pred CCcce----eeeccccCCCcCCccccCc---cccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhc-
Q 000889 1085 LDTHL----SVSTLAGTPGYVPPEYYQS---FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREK- 1156 (1237)
Q Consensus 1085 ~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~- 1156 (1237)
..... ......|+..|+|||.+.+ ..+....|+||+|++++++++|..||...... ..............
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~ 232 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--SATSQTLKIILELPT 232 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--ccHHHHHHHHHhcCC
Confidence 33221 2356789999999999987 57888999999999999999999997643311 00011111111110
Q ss_pred c-cccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1157 R-INEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1157 ~-~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
. .......... ......+.+++..|+..+|..|.++.+....
T Consensus 233 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 PSLASPLSPSNP-----ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccccCcccc-----chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 0000000000 1122456678889999999999999988775
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.8e-19 Score=190.25 Aligned_cols=171 Identities=12% Similarity=0.141 Sum_probs=133.6
Q ss_pred HhCCCCCCceecccCCeEEEEEEECCCCEEEEEEeccccCcCHHH---------HHHHHHHHHhcCCCCcccccceEEeC
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDRE---------FMAEMETIGKIKHRNLVPLLGYCKIG 996 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~ 996 (1237)
..++|+..+++|.|+||.||++.. ++..+|+|.+........+. +.+|++.+.++.||+|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 478899999999999999999766 57789999887544333332 57899999999999999999986543
Q ss_pred --------CeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCC
Q 000889 997 --------EERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDEN 1068 (1237)
Q Consensus 997 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~ 1068 (1237)
...++||||++|.+|.++.. ++. ....++++++..+|+. +++|||+||+||+++.+
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence 35789999999999988632 222 2455899999999999 99999999999999998
Q ss_pred CceEEeecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHH
Q 000889 1069 FEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELL 1128 (1237)
Q Consensus 1069 ~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~ 1128 (1237)
| ++++|||........... ..+.....+..++|+|+||+.+....
T Consensus 172 g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 8 999999988654321110 01333445667899999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.9e-19 Score=184.68 Aligned_cols=140 Identities=15% Similarity=0.155 Sum_probs=109.0
Q ss_pred CceecccCCeEEEEEEECCCCEEEEEEeccccCc--C-------HH-----------------HHHHHHHHHHhcCCCCc
Q 000889 933 DSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQ--G-------DR-----------------EFMAEMETIGKIKHRNL 986 (1237)
Q Consensus 933 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~-----------------~~~~E~~~l~~l~h~ni 986 (1237)
...||+|+||.||+|+..+|+.||+|++...... . .. ....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4579999999999999888999999998643211 1 01 12349999999988877
Q ss_pred ccccceEEeCCeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHH-HhcCCCCeeecCCCCCCeee
Q 000889 987 VPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFL-HHSCIPHIIHRDMKSSNVLL 1065 (1237)
Q Consensus 987 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivHrDikp~NIll 1065 (1237)
.....+.. ...++||||++|+++...... ...++...+..++.|++.+|+|+ |+. +|+||||||+||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEE
Confidence 54443322 234899999998877654322 13678889999999999999999 688 99999999999999
Q ss_pred CCCCceEEeecccceeec
Q 000889 1066 DENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1066 ~~~~~vkl~DfGla~~~~ 1083 (1237)
+ ++.++++|||+|...+
T Consensus 152 ~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 152 H-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred E-CCcEEEEEccccccCC
Confidence 8 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-20 Score=179.54 Aligned_cols=166 Identities=37% Similarity=0.595 Sum_probs=110.7
Q ss_pred cCCCccEEEccccccccccccccccCCCccEEEeecccccccCCccccCccccceEEecCCccccCCCCCCCCCCCCCEE
Q 000889 545 NGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWL 624 (1237)
Q Consensus 545 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 624 (1237)
++.+++.|.||+|+++ .+|..++.+.+|+.|++++|+|+ .+|.+++.|++|+.|+++-|++. .+|..|+.++.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 3455666777777777 66777777777777777777777 67777777777777777777777 677777777777777
Q ss_pred ECCCCccccCCChhHHhhcccccCccccCccceeeccCCCccccCCCCcccccCCCccccCCCccccCCCCcceecccee
Q 000889 625 DLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTM 704 (1237)
Q Consensus 625 ~L~~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (1237)
||..|+++.
T Consensus 108 dltynnl~e----------------------------------------------------------------------- 116 (264)
T KOG0617|consen 108 DLTYNNLNE----------------------------------------------------------------------- 116 (264)
T ss_pred hcccccccc-----------------------------------------------------------------------
Confidence 777777652
Q ss_pred eeeccCCceeEEEccCCcCCccCCccccCCCCCcEEEecCcccccccccccccccCCcEEeCCCCccCCCCCCcccCccc
Q 000889 705 YTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSF 784 (1237)
Q Consensus 705 ~~f~~~~~L~~LdLs~N~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~P~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~ 784 (1237)
..+|..|..++.|+-|+|++|.|. .+|+.++.|++|+.|.+.+|.+- .+|.+++.++.
T Consensus 117 --------------------~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~ 174 (264)
T KOG0617|consen 117 --------------------NSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTR 174 (264)
T ss_pred --------------------ccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHH
Confidence 134555555555666666666665 55666666666666666666665 56666666666
Q ss_pred ccceecccccccccCCCCCCCC
Q 000889 785 LSDLDVSNNNLSGIIPSGGQLT 806 (1237)
Q Consensus 785 L~~l~l~~N~l~g~~p~~~~~~ 806 (1237)
|+.|.+.+|+|+-.+|+.+++.
T Consensus 175 lrelhiqgnrl~vlppel~~l~ 196 (264)
T KOG0617|consen 175 LRELHIQGNRLTVLPPELANLD 196 (264)
T ss_pred HHHHhcccceeeecChhhhhhh
Confidence 6666666666666666554443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.3e-18 Score=174.15 Aligned_cols=186 Identities=16% Similarity=0.102 Sum_probs=138.9
Q ss_pred CCCceecccCCeEEEEEEECCCCEEEEEEeccccCcC----HHHHHHHHHHHHhcC-CCCcccccceEEeCCeEEEEEEe
Q 000889 931 SADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQG----DREFMAEMETIGKIK-HRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 931 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
.+...|++|+||+||.+.. .+..++.+.+....... .+.+.+|++++++++ |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999998876 57777777665433211 124788999999995 5889999886 456999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCCeeeCCCCceEEeecccceeecc
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDM-KSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDi-kp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
+.|.+|...... ....++.|++++++|+|+. ||+|||| ||+||+++.++.++|+|||+|.....
T Consensus 80 I~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 80 LAGAAMYQRPPR------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred ecCccHHhhhhh------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 999998654311 0134678899999999999 9999999 79999999999999999999986543
Q ss_pred CCcc----e-------eeeccccCCCcCCccccCcc-ccC-cccchHHHHHHHHHHHcCCCCCCC
Q 000889 1085 LDTH----L-------SVSTLAGTPGYVPPEYYQSF-RCT-TKGDVYSYGVILLELLSGKRPIDP 1136 (1237)
Q Consensus 1085 ~~~~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwSlGv~l~el~tg~~p~~~ 1136 (1237)
.... . .......++.|++|+...-. ..+ ...+.++-|.-+|.++|++.++-.
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 2210 0 01123468888999865432 223 457999999999999999988643
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-17 Score=176.69 Aligned_cols=139 Identities=17% Similarity=0.180 Sum_probs=110.3
Q ss_pred CceecccCCeEEEEEEECCCCEEEEEEeccccCc---------------------C-----HHHHHHHHHHHHhcCCCCc
Q 000889 933 DSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQ---------------------G-----DREFMAEMETIGKIKHRNL 986 (1237)
Q Consensus 933 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~h~ni 986 (1237)
...||+|+||.||+|++.+|+.||||++...... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999888999999988753211 0 1123578999999999987
Q ss_pred ccccceEEeCCeEEEEEEeccCCCHHHH-HhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCee
Q 000889 987 VPLLGYCKIGEERLLVYEYMKWGSLESV-LHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH-SCIPHIIHRDMKSSNVL 1064 (1237)
Q Consensus 987 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDikp~NIl 1064 (1237)
.....+... ..++||||++|+++... +.. ..++.....+++.+++.++.|+|+ . +|+||||||+||+
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIl 150 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNIL 150 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEE
Confidence 555444332 34899999998865433 322 356778889999999999999999 8 9999999999999
Q ss_pred eCCCCceEEeecccceeec
Q 000889 1065 LDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1065 l~~~~~vkl~DfGla~~~~ 1083 (1237)
++ ++.++|+|||+|....
T Consensus 151 l~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred EE-CCCEEEEEcccceecC
Confidence 99 7899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.1e-18 Score=183.51 Aligned_cols=232 Identities=21% Similarity=0.281 Sum_probs=146.5
Q ss_pred CCceecccCCeEEEEEEECC-CCEEEEEEeccccC---cCHHHHHHHHHHHHhcCC----------CCcccccce-----
Q 000889 932 ADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTG---QGDREFMAEMETIGKIKH----------RNLVPLLGY----- 992 (1237)
Q Consensus 932 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h----------~niv~l~~~----- 992 (1237)
..+.||.|+++.||.+++.. ++.+|+|.+..... ...+++.+|.-....+.+ -.++..++.
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 45689999999999999984 88999998864332 223456666554444322 122222222
Q ss_pred ----EEeCC--------eEEEEEEeccCCCHHHHHhhhhcCC--CCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 000889 993 ----CKIGE--------ERLLVYEYMKWGSLESVLHDRAKGG--GTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDM 1058 (1237)
Q Consensus 993 ----~~~~~--------~~~lv~e~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDi 1058 (1237)
+.... ..+++|+-+. ++|.+++..-.... ........+..+..|+++.+++||+. |+||+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred CCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence 11111 2367888775 78888865321111 22345556677889999999999999 9999999
Q ss_pred CCCCeeeCCCCceEEeecccceeeccCCcceeeeccccCCCcCCccccCc--------cccCcccchHHHHHHHHHHHcC
Q 000889 1059 KSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQS--------FRCTTKGDVYSYGVILLELLSG 1130 (1237)
Q Consensus 1059 kp~NIll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlGv~l~el~tg 1130 (1237)
||+|++++++|.++++||+.....+. .. .....+..|.+||.... ..++.+.|.|++|+++|.+++|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~---~~--~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGT---RY--RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTE---EE--EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCc---ee--eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999998875542 11 11345678999998744 2578899999999999999999
Q ss_pred CCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCC
Q 000889 1131 KRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKR 1194 (1237)
Q Consensus 1131 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~R 1194 (1237)
..||+.......... .+ .. +....+.+..+|..+++.+|++|
T Consensus 247 ~lPf~~~~~~~~~~~-------------------~f--~~-C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW-------------------DF--SR-CRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG-------------------GG--TT-SS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc-------------------cc--hh-cCCcCHHHHHHHHHHccCCcccC
Confidence 999985432221111 11 11 11444567788889999999988
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=193.31 Aligned_cols=219 Identities=26% Similarity=0.455 Sum_probs=165.8
Q ss_pred HHhcCCCCcccccceEEeCCeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCe-eec
Q 000889 978 IGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHI-IHR 1056 (1237)
Q Consensus 978 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i-vHr 1056 (1237)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+... ...+++.....+..++++|++|+|+. +| .|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~----~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE----DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc----ccCccHHHHHHHHHHHHHHHHHHhcC---cceeee
Confidence 46788999999999999999999999999999999999763 35789999999999999999999998 55 999
Q ss_pred CCCCCCeeeCCCCceEEeecccceeeccCCcceeeeccccCCCcCCccccCcc---c----cCcccchHHHHHHHHHHHc
Q 000889 1057 DMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSF---R----CTTKGDVYSYGVILLELLS 1129 (1237)
Q Consensus 1057 Dikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~----~~~~sDvwSlGv~l~el~t 1129 (1237)
.++++|.++|....+|++|||+.................-..-|.|||.+.+. . .+.+.||||||++++|+++
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 99999999999999999999998766431111111222345579999999763 1 4667999999999999999
Q ss_pred CCCCCCCCCCCCCc-hHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 000889 1130 GKRPIDPSEFGDDN-NLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208 (1237)
Q Consensus 1130 g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~l~ 1208 (1237)
.+.||+........ ....+.. . .-.....|...... +....+..++.+||..+|.+||++.++-..++.+.
T Consensus 154 r~~~~~~~~~~~~~~eii~~~~---~--~~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 154 RSGPFDLRNLVEDPDEIILRVK---K--GGSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccCccccccccCChHHHHHHHH---h--cCCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 99999864333221 1222211 1 11112222222111 22235778888999999999999999999998876
Q ss_pred ccc
Q 000889 1209 VDT 1211 (1237)
Q Consensus 1209 ~~~ 1211 (1237)
...
T Consensus 226 ~~~ 228 (484)
T KOG1023|consen 226 KGG 228 (484)
T ss_pred ccc
Confidence 654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.5e-17 Score=176.76 Aligned_cols=198 Identities=21% Similarity=0.263 Sum_probs=136.3
Q ss_pred CCCCcccccceEEeC---------------------------CeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHH
Q 000889 982 KHRNLVPLLGYCKIG---------------------------EERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKI 1034 (1237)
Q Consensus 982 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 1034 (1237)
+|||||++.++|.+. ...|+||..++ .+|..|+..+ ..+.....-|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~------~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR------HRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC------CCchHHHHHH
Confidence 599999999977441 24589998876 7899998764 4455667778
Q ss_pred HHHHHHHHHHHHhcCCCCeeecCCCCCCeeeC--CC--CceEEeecccceeeccCCcc----eeeeccccCCCcCCcccc
Q 000889 1035 AIGSARGLAFLHHSCIPHIIHRDMKSSNVLLD--EN--FEARVSDFGMARLVNALDTH----LSVSTLAGTPGYVPPEYY 1106 (1237)
Q Consensus 1035 ~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~--~~--~~vkl~DfGla~~~~~~~~~----~~~~~~~gt~~y~aPE~~ 1106 (1237)
+.|+++|+.|||.+ +|.|||+|++|||+. +| ..+.|+|||++--.+...-. ...-...|...-||||+.
T Consensus 347 laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 99999999999999 999999999999994 33 35789999998533321111 111234577789999998
Q ss_pred Ccccc------CcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHH
Q 000889 1107 QSFRC------TTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYL 1180 (1237)
Q Consensus 1107 ~~~~~------~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~ 1180 (1237)
....- -.|+|.|+.|.+.||++....||...-. ..-+... .++.. -|.+ +...+ ..+.
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~r~-----Yqe~q-----LPal--p~~vp---p~~r 487 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDTRT-----YQESQ-----LPAL--PSRVP---PVAR 487 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch-heechhh-----hhhhh-----CCCC--cccCC---hHHH
Confidence 64321 2479999999999999999999974210 0001111 11111 1112 11222 2345
Q ss_pred HHHHhccccCCCCCCCHHHHHHHHH
Q 000889 1181 RISFECLDDRPFKRPTMIQVMAMFK 1205 (1237)
Q Consensus 1181 ~li~~cl~~dP~~RPt~~ell~~L~ 1205 (1237)
+++...++.+|.+|++..-....+.
T Consensus 488 qlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 488 QLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHHhcCCccccCCccHHHhHHH
Confidence 6777899999999999877666653
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1e-19 Score=173.36 Aligned_cols=188 Identities=27% Similarity=0.424 Sum_probs=152.1
Q ss_pred CCCCCCCcEEEccCCcCcccCCCCCCCCCCCcccceecccCceeeecccccccccccccEecccCCccccCCCccccCCc
Q 000889 443 LTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLP 522 (1237)
Q Consensus 443 l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 522 (1237)
+.++...+.|.||+|+++ .+|..+ ..+.+|+.|++.+|+|. ..|..++.+++|+.|+++-|++. ..|..|+.+|
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppni---a~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p 102 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNI---AELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFP 102 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcH---HHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCc
Confidence 445667777777777777 444444 45677777788888877 67778889999999999999998 8899999999
Q ss_pred CcceeecccccccCcccccccccCCCccEEEccccccccccccccccCCCccEEEeecccccccCCccccCccccceEEe
Q 000889 523 NLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQL 602 (1237)
Q Consensus 523 ~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L 602 (1237)
.|+.|||.+|++....-++-|..++.|+.|+|++|.+. .+|..++.+++|+.|.+..|.+- .+|..++.|++|+.|++
T Consensus 103 ~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhi 180 (264)
T KOG0617|consen 103 ALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHI 180 (264)
T ss_pred hhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhc
Confidence 99999999999875433344456788999999999998 89999999999999999999998 79999999999999999
Q ss_pred cCCccccCCCCCCCCCCC---CCEEECCCCccccCCChhH
Q 000889 603 GNNSLTGQVPQGLGKCRS---LVWLDLNSNNLSGPLPSEL 639 (1237)
Q Consensus 603 ~~N~l~~~~p~~l~~l~~---L~~L~L~~N~l~g~ip~~~ 639 (1237)
.+|+++ .+|++++++.- =+.+.+.+|++...|.+.+
T Consensus 181 qgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv~pIaeQf 219 (264)
T KOG0617|consen 181 QGNRLT-VLPPELANLDLVGNKQVMRMEENPWVNPIAEQF 219 (264)
T ss_pred ccceee-ecChhhhhhhhhhhHHHHhhhhCCCCChHHHHH
Confidence 999999 78888887653 3567788888876665544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.3e-17 Score=200.71 Aligned_cols=197 Identities=22% Similarity=0.265 Sum_probs=164.3
Q ss_pred HHhCCCCCCceecccCCeEEEEEEECCCCEEEEEEeccccCcCHHHHHHHHHHHHhcC---CCCcccccceEEeCCeEEE
Q 000889 925 EATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIK---HRNLVPLLGYCKIGEERLL 1001 (1237)
Q Consensus 925 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l 1001 (1237)
.....|.+.+.||+|+||.||+|...+|+.||+|+-+.... .+|.-=.+++.|++ -+.|..+..++...+.-++
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 34557888999999999999999998999999998764332 23333334444444 3456777777777888899
Q ss_pred EEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeC-------CCCceEEe
Q 000889 1002 VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLD-------ENFEARVS 1074 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~-------~~~~vkl~ 1074 (1237)
|+||.+.|+|.+++.. .+.++|..+..++.|++..++.||.. +|||+||||+|.++. ....++|+
T Consensus 772 v~ey~~~Gtlld~~N~-----~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINT-----NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeccccccHHHhhcc-----CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEE
Confidence 9999999999999983 35789999999999999999999999 999999999999995 23469999
Q ss_pred ecccceeeccCCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCC
Q 000889 1075 DFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKR 1132 (1237)
Q Consensus 1075 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~ 1132 (1237)
|||.+-.+.-.....+....++|-.+-.+|+..|..|++.+|-|.++.+++-|+.|+.
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9999987766555566778899999999999999999999999999999999999864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.7e-19 Score=201.04 Aligned_cols=186 Identities=25% Similarity=0.332 Sum_probs=153.6
Q ss_pred eecccCCeEEEEEE----ECCCCEEEEEEeccccCc--CHHHHHHHHHHHHhcC-CCCcccccceEEeCCeEEEEEEecc
Q 000889 935 MIGSGGFGEVYKAQ----LRDGSVVAIKKLIHVTGQ--GDREFMAEMETIGKIK-HRNLVPLLGYCKIGEERLLVYEYMK 1007 (1237)
Q Consensus 935 ~lG~G~fg~Vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 1007 (1237)
++|+|+||.|++++ ...+..+|.|...+.... .......|..++...+ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 36999999999864 223666777766533221 1124556888888887 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCc
Q 000889 1008 WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDT 1087 (1237)
Q Consensus 1008 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~ 1087 (1237)
||++...+... ..+.+.....+...++-+++++|+. +|+|||+|++||+++.+|++|+.|||+++..-...
T Consensus 81 gg~lft~l~~~-----~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~- 151 (612)
T KOG0603|consen 81 GGDLFTRLSKE-----VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK- 151 (612)
T ss_pred cchhhhccccC-----CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhh-
Confidence 99998877653 4567777788888999999999999 99999999999999999999999999998654322
Q ss_pred ceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCC
Q 000889 1088 HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDP 1136 (1237)
Q Consensus 1088 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~ 1136 (1237)
..|||..|||||++. .+..++|.||||++++||++|..||..
T Consensus 152 -----~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 152 -----IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -----hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 228999999999998 577889999999999999999999974
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.2e-17 Score=170.63 Aligned_cols=136 Identities=16% Similarity=0.194 Sum_probs=105.9
Q ss_pred CCCceecccCCeEEEEEEECCCCEEEEEEeccccCcCHHHHHHHHHHHHhc-----CCCCcccccceEEeCC---e-EEE
Q 000889 931 SADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKI-----KHRNLVPLLGYCKIGE---E-RLL 1001 (1237)
Q Consensus 931 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~l 1001 (1237)
.-.+.||+|+||.||. +.+....+||++........+.+.+|+++++++ .||||++++|++.++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3456899999999995 444444578888654444567799999999999 5799999999998864 3 347
Q ss_pred EEEe--ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHH-HHHHhcCCCCeeecCCCCCCeeeCC----CCceEEe
Q 000889 1002 VYEY--MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGL-AFLHHSCIPHIIHRDMKSSNVLLDE----NFEARVS 1074 (1237)
Q Consensus 1002 v~e~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~ivHrDikp~NIll~~----~~~vkl~ 1074 (1237)
|+|| +++|+|.+++... .+++. ..++.+++.++ +|||++ +||||||||+||+++. ++.++|+
T Consensus 83 I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 8999 5679999999652 24444 35577777777 999999 9999999999999974 3479999
Q ss_pred ecccc
Q 000889 1075 DFGMA 1079 (1237)
Q Consensus 1075 DfGla 1079 (1237)
||+.+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95544
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.71 E-value=1e-18 Score=201.82 Aligned_cols=208 Identities=27% Similarity=0.362 Sum_probs=98.9
Q ss_pred eeccCccccCcccchhccccccceEEeccCCCCCCC----CCccCCCCCCCcEEEccCCcCcccCCCCCCCCCCCcccce
Q 000889 403 LNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGP----VPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEK 478 (1237)
Q Consensus 403 L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~ 478 (1237)
|+|..+.+++......+..+..|++|+++++.++.. ++..+...++|+.|+++++.+.+ .+..+
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~-~~~~~----------- 70 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGR-IPRGL----------- 70 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCC-cchHH-----------
Confidence 445555554444444444555555555555555321 33345555667777777665542 11111
Q ss_pred ecccCceeeecccccccccccccEecccCCccccCCCccccCCcC---cceeecccccccCc----ccccccccC-CCcc
Q 000889 479 IVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPN---LSDLVMWANNLTGE----IPEGICVNG-GNLE 550 (1237)
Q Consensus 479 L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~~----ip~~~~~~l-~~L~ 550 (1237)
..++..+..+++|+.|++++|.+.+..+..+..+.+ |++|++++|++++. +...+ ..+ ++|+
T Consensus 71 ---------~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l-~~~~~~L~ 140 (319)
T cd00116 71 ---------QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGL-KDLPPALE 140 (319)
T ss_pred ---------HHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHH-HhCCCCce
Confidence 123344555666677777766666444444443333 55555555554421 11111 122 4555
Q ss_pred EEEccccccccc----cccccccCCCccEEEeeccccccc----CCccccCccccceEEecCCccccC----CCCCCCCC
Q 000889 551 TLILNNNHLTGA----IPKSIASCTNMLWVSLSSNQLTGE----IPAGIGNLVKLAILQLGNNSLTGQ----VPQGLGKC 618 (1237)
Q Consensus 551 ~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~L~~L~~L~L~~N~l~~~----~p~~l~~l 618 (1237)
.|+|++|.+++. ++..+..+++|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++. ++..+..+
T Consensus 141 ~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~ 220 (319)
T cd00116 141 KLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASL 220 (319)
T ss_pred EEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhccc
Confidence 555555555421 223344445555555555555521 222233334555555555555422 22334445
Q ss_pred CCCCEEECCCCccc
Q 000889 619 RSLVWLDLNSNNLS 632 (1237)
Q Consensus 619 ~~L~~L~L~~N~l~ 632 (1237)
++|+.|++++|+++
T Consensus 221 ~~L~~L~ls~n~l~ 234 (319)
T cd00116 221 KSLEVLNLGDNNLT 234 (319)
T ss_pred CCCCEEecCCCcCc
Confidence 55555555555554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.3e-18 Score=203.68 Aligned_cols=245 Identities=23% Similarity=0.286 Sum_probs=174.9
Q ss_pred CCCCCceecccCCeEEEEEEECCCCEEEEEEecccc-CcCHHHHHH---HHHHHHhcCCCCcccccceEEeCCeEEEEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVT-GQGDREFMA---EMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
.|..++.+|.+.|=.|.+|++++|. |+||++.+.. .-..+.|.+ |++ ...++|||++++..+.......|||=+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4666788999999999999998776 8889887544 233444444 444 555689999999888666666678878
Q ss_pred eccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec-
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN- 1083 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~- 1083 (1237)
|+. -+|+|.+..+ .-+...+.+.|+.|++.|+.-+|.. +|+|||||.+|||++.=.-+.|+||..-+..-
T Consensus 102 yvk-hnLyDRlSTR-----PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 102 YVK-HNLYDRLSTR-----PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHh-hhhhhhhccc-----hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccC
Confidence 875 5888877654 3467778888999999999999999 99999999999999988889999997654221
Q ss_pred cCCcc----eeeeccccCCCcCCccccCcc----------c-cCcccchHHHHHHHHHHHc-CCCCCCCCCCCCCchHHH
Q 000889 1084 ALDTH----LSVSTLAGTPGYVPPEYYQSF----------R-CTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVG 1147 (1237)
Q Consensus 1084 ~~~~~----~~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDvwSlGv~l~el~t-g~~p~~~~~~~~~~~~~~ 1147 (1237)
+.+.. .-..+...-..|.|||.+... . .+++-||||+||+++|+++ |++||.-+. +..
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~a 246 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLA 246 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHh
Confidence 11111 112233334479999987431 1 4567899999999999998 788886321 111
Q ss_pred HHHH--HhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1148 WAKQ--LHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1148 ~~~~--~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
|... ...+..++++-|. .+..++..|++.||.+|.++.+.++.
T Consensus 247 Yr~~~~~~~e~~Le~Ied~-------------~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 247 YRSGNADDPEQLLEKIEDV-------------SLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HhccCccCHHHHHHhCcCc-------------cHHHHHHHHHccCchhccCHHHHHHh
Confidence 1100 0011112222221 45678889999999999999999987
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.7e-17 Score=191.56 Aligned_cols=138 Identities=25% Similarity=0.308 Sum_probs=64.7
Q ss_pred CCCCCceeeccCccccCccc---chhhcccccceEEEecCCccCCCCchh---hhccCCCCcEEecCCCcCCCCCchhHh
Q 000889 297 RCGNLSVITLSQNGLSGTEF---PASLKNCQLLETLNMSHNALQGGIPGF---LLGSFRNLKQLSLAHNQFAGEIPPELG 370 (1237)
Q Consensus 297 ~l~~L~~L~L~~n~l~~~~~---~~~l~~l~~L~~L~Ls~N~l~~~~~~~---~~~~l~~L~~L~L~~n~l~~~ip~~~~ 370 (1237)
.+++|++|++++|.+++..+ +..+..+++|++|+|++|.+++..... .+..+++|++|++++|.+++.....+.
T Consensus 163 ~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~ 242 (319)
T cd00116 163 ANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALA 242 (319)
T ss_pred hCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHH
Confidence 34445555555554443221 122333345555555555554322111 123445566666666655543333333
Q ss_pred hhc----CCCcEEEcccCcCCCC----CCcCcccccccceeeccCccccCcccc---hhcccc-ccceEEeccCCC
Q 000889 371 QAC----GTLRELDLSSNRLTGE----LPSTFASCSSLHSLNLGSNMLSGNFLN---TVVSKI-SSLIYLYVPFNN 434 (1237)
Q Consensus 371 ~~l----~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~---~~~~~l-~~L~~L~L~~N~ 434 (1237)
..+ +.|++|++++|.+++. +...+..+++|+.+++++|.++..... ...... +.|++|++.+|.
T Consensus 243 ~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (319)
T cd00116 243 SALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDS 318 (319)
T ss_pred HHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCC
Confidence 322 4566666666665421 223344445666666666666533111 122223 566666666654
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.4e-17 Score=196.38 Aligned_cols=215 Identities=21% Similarity=0.320 Sum_probs=142.8
Q ss_pred CCCCCCceecccCCeEEEEEEECC-CCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
.+|..++.|..|+||.||.++++. .+++|. ++.+.. .+.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~-----lilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQN-----LILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhh-cccccc-----hhhhc--cccccCCccee-------------------
Confidence 468889999999999999999874 556777 443211 11111 33333444444
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc--
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA-- 1084 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~-- 1084 (1237)
|+=...+... .+++... +.+++|+|+. +|||||+||+|.+|+.-|++|+.|||+++..-.
T Consensus 136 --gDc~tllk~~-----g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 --GDCATLLKNI-----GPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred --chhhhhcccC-----CCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 3333333221 2333322 6789999999 999999999999999999999999999874211
Q ss_pred -----------CCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHh
Q 000889 1085 -----------LDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLH 1153 (1237)
Q Consensus 1085 -----------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 1153 (1237)
..........+||+.|.|||++..+.|...+|+|++|+|+||.+.|..||.+...++ + .....
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee---l---fg~vi 271 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---L---FGQVI 271 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH---H---Hhhhh
Confidence 001112345789999999999999999999999999999999999999998653221 1 11111
Q ss_pred hhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 000889 1154 REKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMA 1202 (1237)
Q Consensus 1154 ~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~ 1202 (1237)
.+ .......+.+...+..+++.+.++..|.+|--....++
T Consensus 272 sd---------~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~e 311 (1205)
T KOG0606|consen 272 SD---------DIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALE 311 (1205)
T ss_pred hh---------hccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhh
Confidence 11 11111112222335567777899999999974444443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.9e-16 Score=167.62 Aligned_cols=142 Identities=14% Similarity=0.127 Sum_probs=110.0
Q ss_pred CCCCCceecccCCeEEEEEE--ECCCCEEEEEEeccccCc-------------------C-----HHHHHHHHHHHHhcC
Q 000889 929 GFSADSMIGSGGFGEVYKAQ--LRDGSVVAIKKLIHVTGQ-------------------G-----DREFMAEMETIGKIK 982 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~-------------------~-----~~~~~~E~~~l~~l~ 982 (1237)
-|++.+.||+|+||.||+|+ ..+|+.||+|++...... . ...+..|++.++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48889999999999999998 457999999988643210 0 122567999999997
Q ss_pred CC--CcccccceEEeCCeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCC-eeecCCC
Q 000889 983 HR--NLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPH-IIHRDMK 1059 (1237)
Q Consensus 983 h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-ivHrDik 1059 (1237)
+. .+++++++ ...++||||++|+++....... .......+..++.|++.+++|||+. + |+|||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dik 176 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLS 176 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCC
Confidence 53 33444432 2358999999998886654221 2345556788999999999999999 9 9999999
Q ss_pred CCCeeeCCCCceEEeecccceeec
Q 000889 1060 SSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1060 p~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
|+||+++ ++.++++|||.|....
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999 8899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.6e-15 Score=162.01 Aligned_cols=134 Identities=22% Similarity=0.293 Sum_probs=112.9
Q ss_pred ceecccCCeEEEEEEECCCCEEEEEEeccccCcC--------HHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 934 SMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQG--------DREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
+.||+|++|.||+|.+ .+..+++|+........ ...+.+|++++..+.|++++....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999988 57788999765322111 13467899999999999998888887778888999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeeccccee
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~ 1081 (1237)
++|++|.+++... .+ .+..++.+++.++.++|+. +++|||++|.||+++ ++.++++|||.++.
T Consensus 81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988642 11 7788999999999999999 999999999999999 78999999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.2e-15 Score=161.00 Aligned_cols=131 Identities=18% Similarity=0.309 Sum_probs=107.0
Q ss_pred eecccCCeEEEEEEECCCCEEEEEEeccccCcC--------HHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEec
Q 000889 935 MIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQG--------DREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 935 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
.||+|+||.||+|.+ ++..|++|+........ ...+.+|+++++.++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999996 47789999865322111 244678999999999887766666666677789999999
Q ss_pred cCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceee
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~ 1082 (1237)
+|++|.+++.... . .++.+++++++++|+. +++|||++|.||+++ ++.++++|||+++..
T Consensus 80 ~g~~l~~~~~~~~-----~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH-----H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998875421 1 7889999999999999 999999999999999 789999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.1e-16 Score=180.35 Aligned_cols=124 Identities=26% Similarity=0.392 Sum_probs=109.2
Q ss_pred eEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecc
Q 000889 998 ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFG 1077 (1237)
Q Consensus 998 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfG 1077 (1237)
..|+.|++|.-.+|.+++..+.. +...++.....++.|++.|++| + +.+|||+||.||+...+.++||.|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhh
Confidence 57899999999999999976543 3567888899999999999999 6 89999999999999999999999999
Q ss_pred cceeeccCC----cceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHc
Q 000889 1078 MARLVNALD----THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS 1129 (1237)
Q Consensus 1078 la~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t 1129 (1237)
+........ .....+...||..||+||.+.+..|+.++||||+|++++|++.
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 987665544 2334567789999999999999999999999999999999997
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.5e-15 Score=160.14 Aligned_cols=143 Identities=18% Similarity=0.137 Sum_probs=110.9
Q ss_pred HHHhCCCCCCceecccCCeEEEEEEECCCCEEEEEEeccccCc----------------------CHHHHHHHHHHHHhc
Q 000889 924 LEATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQ----------------------GDREFMAEMETIGKI 981 (1237)
Q Consensus 924 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l 981 (1237)
......|.+.+.||+|+||.||+|..++|+.||||++...... ....+..|+.++..+
T Consensus 11 ~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 90 (198)
T cd05144 11 VKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL 90 (198)
T ss_pred HHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH
Confidence 3334448888999999999999999888999999986532100 011356789999999
Q ss_pred CCCC--cccccceEEeCCeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 000889 982 KHRN--LVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMK 1059 (1237)
Q Consensus 982 ~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDik 1059 (1237)
.|++ +++.++ ....++||||++|++|.+.... .....++.++++++.++|+. +|+|||||
T Consensus 91 ~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~ 152 (198)
T cd05144 91 YEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKH---GIIHGDLS 152 (198)
T ss_pred HHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence 8874 444443 2456899999999998765321 23457889999999999998 99999999
Q ss_pred CCCeeeCCCCceEEeecccceeecc
Q 000889 1060 SSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1060 p~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
|+||++++++.++|+|||.+.....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.3e-15 Score=183.53 Aligned_cols=137 Identities=21% Similarity=0.300 Sum_probs=111.0
Q ss_pred CCCCCCceecccCCeEEEEEEECCCCEEEEEEecccc-Cc-------CHHHHHHHHHHHHhcCCCCcccccceEEeCCeE
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVT-GQ-------GDREFMAEMETIGKIKHRNLVPLLGYCKIGEER 999 (1237)
Q Consensus 928 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 999 (1237)
..|...+.||+|+||+||+|.+.... +++|+..... .. ..+.+.+|++++++++|++++....++......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 34566789999999999999886443 4444332111 11 124578899999999999999888888777788
Q ss_pred EEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccc
Q 000889 1000 LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1079 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla 1079 (1237)
++||||++|++|.+++. ....++.++++++.|||+. +++||||||+||++ .++.++|+|||++
T Consensus 412 ~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred EEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 99999999999999875 2356899999999999999 99999999999999 5779999999999
Q ss_pred eee
Q 000889 1080 RLV 1082 (1237)
Q Consensus 1080 ~~~ 1082 (1237)
+..
T Consensus 475 ~~~ 477 (535)
T PRK09605 475 KYS 477 (535)
T ss_pred ccC
Confidence 753
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.1e-15 Score=185.26 Aligned_cols=117 Identities=40% Similarity=0.700 Sum_probs=106.1
Q ss_pred ceeEEEccCCcCCccCCccccCCCCCcEEEecCcccccccccccccccCCcEEeCCCCccCCCCCCcccCcccccceecc
Q 000889 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVS 791 (1237)
Q Consensus 712 ~L~~LdLs~N~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~P~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~ 791 (1237)
.++.|+|++|.++|.+|..++.|++|+.|+|++|+|+|.+|..++.+++|+.|||++|+|+|.+|..++.+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCC--CCCCccCCCcccCCCCCCCCCC-CCCC
Q 000889 792 NNNLSGIIPSG--GQLTTFPASRYENNSGLCGLPL-LPCS 828 (1237)
Q Consensus 792 ~N~l~g~~p~~--~~~~~~~~~~~~~n~~~~~~p~-~~c~ 828 (1237)
+|+|+|.+|.. ..+.......+.+|+++|+.|. .+|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCCCCCCc
Confidence 99999999964 1223345667899999999875 5774
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.51 E-value=4.7e-16 Score=174.62 Aligned_cols=177 Identities=29% Similarity=0.428 Sum_probs=140.5
Q ss_pred CCccEEEccccccccccccccccCCCccEEEeecccccccCCccccCccccceEEecCCccccCCCCCCCCCCCCCEEEC
Q 000889 547 GNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDL 626 (1237)
Q Consensus 547 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 626 (1237)
..-...||+.|++. .+|..+..+..|+.+.|.+|.+. .+|..+++|..|++|||+.|+++ .+|..++.|+ |+.|-+
T Consensus 75 tdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~ 150 (722)
T KOG0532|consen 75 TDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIV 150 (722)
T ss_pred cchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEE
Confidence 34456778888887 78888888888888888888888 78888888888888888888888 7888888876 888888
Q ss_pred CCCccccCCChhHHhhcccccCccccCccceeeccCCCccccCCCCcccccCCCccccCCCccccCCCCcceeccceeee
Q 000889 627 NSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYT 706 (1237)
Q Consensus 627 ~~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (1237)
++|+++ .+|.+++-+
T Consensus 151 sNNkl~-~lp~~ig~~---------------------------------------------------------------- 165 (722)
T KOG0532|consen 151 SNNKLT-SLPEEIGLL---------------------------------------------------------------- 165 (722)
T ss_pred ecCccc-cCCcccccc----------------------------------------------------------------
Confidence 888887 677766521
Q ss_pred eccCCceeEEEccCCcCCccCCccccCCCCCcEEEecCcccccccccccccccCCcEEeCCCCccCCCCCCcccCccccc
Q 000889 707 FTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLS 786 (1237)
Q Consensus 707 f~~~~~L~~LdLs~N~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~P~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 786 (1237)
..|..||.|.|.+. .+|..+++|.+|+.|+++.|++. .+|.+++.| .|..||+|.|+++ .||-.|..|+.|+
T Consensus 166 ----~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq 237 (722)
T KOG0532|consen 166 ----PTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQ 237 (722)
T ss_pred ----hhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhhe
Confidence 14667788888887 77888888888888888888888 677777755 4778888888887 8888888888888
Q ss_pred ceecccccccccCC
Q 000889 787 DLDVSNNNLSGIIP 800 (1237)
Q Consensus 787 ~l~l~~N~l~g~~p 800 (1237)
+|-|.+|+|...+-
T Consensus 238 ~l~LenNPLqSPPA 251 (722)
T KOG0532|consen 238 VLQLENNPLQSPPA 251 (722)
T ss_pred eeeeccCCCCCChH
Confidence 88888888876444
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=9.7e-14 Score=146.65 Aligned_cols=136 Identities=19% Similarity=0.252 Sum_probs=97.9
Q ss_pred CceecccCCeEEEEEEECCCCEEEEEEeccccCc--CHHHH----------------------HHHHHHHHhcCCCC--c
Q 000889 933 DSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQ--GDREF----------------------MAEMETIGKIKHRN--L 986 (1237)
Q Consensus 933 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~E~~~l~~l~h~n--i 986 (1237)
.+.||+|+||+||+|.+.+++.||||++...... ....+ ..|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999987643211 11111 34566666664432 4
Q ss_pred ccccceEEeCCeEEEEEEeccCCCHHH-HHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCee
Q 000889 987 VPLLGYCKIGEERLLVYEYMKWGSLES-VLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH-SCIPHIIHRDMKSSNVL 1064 (1237)
Q Consensus 987 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDikp~NIl 1064 (1237)
.+.+++ ...++||||++++.+.. .+.... .. ..+..++.+++.++.++|. . +|+||||||+||+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nil 147 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNIL 147 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEE
Confidence 444433 34689999999854321 111110 01 5567899999999999999 7 9999999999999
Q ss_pred eCCCCceEEeecccceeec
Q 000889 1065 LDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1065 l~~~~~vkl~DfGla~~~~ 1083 (1237)
++ ++.++++|||.+....
T Consensus 148 i~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred EE-CCcEEEEECccccccc
Confidence 99 8899999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.5e-13 Score=139.64 Aligned_cols=135 Identities=19% Similarity=0.182 Sum_probs=112.7
Q ss_pred CCceecccCCeEEEEEEECCCCEEEEEEeccccCcCHHHHHHHHHHHHhcCC--CCcccccceEEeCCeEEEEEEeccCC
Q 000889 932 ADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKH--RNLVPLLGYCKIGEERLLVYEYMKWG 1009 (1237)
Q Consensus 932 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 1009 (1237)
+.+.||+|.++.||+++..+ ..+++|....... ...+.+|+.+++.++| +++++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35679999999999999864 7889998754322 4578899999999976 58999998888778899999999987
Q ss_pred CHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeeccccee
Q 000889 1010 SLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081 (1237)
Q Consensus 1010 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~ 1081 (1237)
.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.++.
T Consensus 79 ~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 76543 4455677889999999999987444799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=5.3e-15 Score=180.15 Aligned_cols=256 Identities=24% Similarity=0.305 Sum_probs=185.8
Q ss_pred CCCCCceecccCCeEEEEEEECC--CCEEEEEEecccc--CcCHHHHHHHHHHHHhcC-CCCcccccceEEeCCeEEEEE
Q 000889 929 GFSADSMIGSGGFGEVYKAQLRD--GSVVAIKKLIHVT--GQGDREFMAEMETIGKIK-HRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 929 ~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
.|...+.||+|+|+.|-.+.... ...+|+|.+.... .........|..+-+.+. |+|++.+++...+.+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 46666779999999998887642 4456666554332 112233445777777776 999999999999999999999
Q ss_pred EeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHH-hcCCCCeeecCCCCCCeeeCCCC-ceEEeeccccee
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLH-HSCIPHIIHRDMKSSNVLLDENF-EARVSDFGMARL 1081 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivHrDikp~NIll~~~~-~vkl~DfGla~~ 1081 (1237)
+|.+|+++.+.+... .....+...+..++.|+..++.|+| .. +++||||||+|.+++..+ ..|++|||+|..
T Consensus 101 ~~s~g~~~f~~i~~~---~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHP---DSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred CcccccccccccccC---CccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999998877311 1124555667788999999999999 77 999999999999999999 999999999988
Q ss_pred ecc-CCcceeeecccc-CCCcCCccccCcc-ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhccc
Q 000889 1082 VNA-LDTHLSVSTLAG-TPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158 (1237)
Q Consensus 1082 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1158 (1237)
+.. ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..|++...... ..+..|...... .
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~~~---~ 250 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNKGR---F 250 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccccc---c
Confidence 776 455555567788 9999999999884 45678999999999999999999987544322 222222221100 0
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1159 NEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1159 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
... .+ ..-.....++..+++..+|..|.+..++...
T Consensus 251 ----~~~---~~--~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 251 ----TQL---PW--NSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ----ccC---cc--ccCChhhhhcccccccCCchhcccccccccc
Confidence 000 00 0011133455567888999999998877643
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.6e-15 Score=167.56 Aligned_cols=189 Identities=34% Similarity=0.501 Sum_probs=108.4
Q ss_pred EecccCCccccCCCccccCCcCcceeecccccccCcccccccccCCCccEEEccccccccccccccccCCCccEEEeecc
Q 000889 502 TIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSN 581 (1237)
Q Consensus 502 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 581 (1237)
..||+.|++. .+|..+..+-.|+.+.|++|-+. .||..++ ++..|++|||+.|+++ .+|..++.|+ |+.|-+++|
T Consensus 79 ~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~-~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNN 153 (722)
T KOG0532|consen 79 FADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAIC-NLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNN 153 (722)
T ss_pred hhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhh-hhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecC
Confidence 3444444444 44444444444444444444444 3333331 2334444444444444 4444444443 556666666
Q ss_pred cccccCCccccCccccceEEecCCccccCCCCCCCCCCCCCEEECCCCccccCCChhHHhhcccccCccccCccceeecc
Q 000889 582 QLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRN 661 (1237)
Q Consensus 582 ~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (1237)
+++ .+|..++.+..|..||.+.|.+. .+|..++.+.+|+.|.+..|++. .+|++++.+
T Consensus 154 kl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L------------------- 211 (722)
T KOG0532|consen 154 KLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL------------------- 211 (722)
T ss_pred ccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-------------------
Confidence 666 56666666666666666666666 56666666666766666666665 555555422
Q ss_pred CCCccccCCCCcccccCCCccccCCCccccCCCCcceeccceeeeeccCCceeEEEccCCcCCccCCccccCCCCCcEEE
Q 000889 662 EGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLN 741 (1237)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~L~~LdLs~N~l~g~~p~~~~~L~~L~~L~ 741 (1237)
.|..||+|.|+++ .||-+|.+|+.|++|-
T Consensus 212 --------------------------------------------------pLi~lDfScNkis-~iPv~fr~m~~Lq~l~ 240 (722)
T KOG0532|consen 212 --------------------------------------------------PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQ 240 (722)
T ss_pred --------------------------------------------------ceeeeecccCcee-ecchhhhhhhhheeee
Confidence 3667777777776 6777777777777777
Q ss_pred ecCcccccccccccccccCC---cEEeCCCC
Q 000889 742 LGHNKLTGHIPDSFGGLKAI---GVLDLSHN 769 (1237)
Q Consensus 742 Ls~N~l~~~~P~~~~~L~~L---~~L~Ls~N 769 (1237)
|.+|.|+ ..|..+....++ ++|+..-+
T Consensus 241 LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 241 LENNPLQ-SPPAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred eccCCCC-CChHHHHhccceeeeeeecchhc
Confidence 7777777 666666544433 33444444
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.7e-13 Score=145.86 Aligned_cols=134 Identities=18% Similarity=0.237 Sum_probs=103.6
Q ss_pred ceec-ccCCeEEEEEEECCCCEEEEEEecccc-------------CcCHHHHHHHHHHHHhcCCCCc--ccccceEEeCC
Q 000889 934 SMIG-SGGFGEVYKAQLRDGSVVAIKKLIHVT-------------GQGDREFMAEMETIGKIKHRNL--VPLLGYCKIGE 997 (1237)
Q Consensus 934 ~~lG-~G~fg~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~ 997 (1237)
..|| .|+.|+||++... +..+++|.+.... ......+.+|++++.++.|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8999999999886 7788888774210 1223457889999999998774 67777644322
Q ss_pred ----eEEEEEEeccC-CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceE
Q 000889 998 ----ERLLVYEYMKW-GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEAR 1072 (1237)
Q Consensus 998 ----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vk 1072 (1237)
..++||||++| .+|.+++... .++.. .+.++++++.+||+. ||+||||||.|||++.++.++
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 23599999997 6898887542 34433 356889999999999 999999999999999988999
Q ss_pred Eeeccccee
Q 000889 1073 VSDFGMARL 1081 (1237)
Q Consensus 1073 l~DfGla~~ 1081 (1237)
|+|||.++.
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999999864
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=6.5e-14 Score=149.72 Aligned_cols=211 Identities=19% Similarity=0.197 Sum_probs=137.4
Q ss_pred ceeEEecCCCCCCCc---cccccccCCCCCCeEEccCCCCC---ccc------chhhhhcCcccceecccCCcc--cCCc
Q 000889 102 HVTSLNLNNSGLSGS---LNLTTLTALPYLEHLNLQGNSFS---AGD------LSTSKTSSCSLVTMDLSSNNI--TGSL 167 (1237)
Q Consensus 102 ~v~~L~L~~~~l~~~---~~~~~l~~l~~L~~L~Ls~n~l~---~~~------~~~~~~~~~~L~~L~Ls~n~l--~g~~ 167 (1237)
.++.|+|++|.++-. ..+..+.+.+.|+.-++|+---+ +.- +...+..+++|++||||+|.+ .|..
T Consensus 31 s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~~ 110 (382)
T KOG1909|consen 31 SLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGIR 110 (382)
T ss_pred ceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccchH
Confidence 578888888877532 23456677777888777764221 111 122244445788888888877 5666
Q ss_pred ccccccccCCccceEEccCCccCCCc----------------cccCCcccEEEcCCCCCCCchh--hhccccCCCCCCEE
Q 000889 168 PGRSFLLSCDRLSYVNLSHNSISGGS----------------LHIGPSLLQLDLSGNQISDSAL--LTYSLSNCQNLNLL 229 (1237)
Q Consensus 168 ~~~~~l~~~~~L~~L~ls~n~l~~~~----------------~~~~~~L~~L~Ls~N~i~~~~~--~~~~l~~l~~L~~L 229 (1237)
+....+.+|..|++|+|.+|.+.... ....+.|++++.++|.+.+.+. .+..|..++.|+.+
T Consensus 111 ~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leev 190 (382)
T KOG1909|consen 111 GLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEV 190 (382)
T ss_pred HHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccceE
Confidence 67777778888888888888776411 3345689999999999888774 34557778899999
Q ss_pred EccCCCCCc----hhhhhcccCCCccEEEcccccccCcc--chhhhhccCCCccEEeCCCCcCCCCccccc----ccCCC
Q 000889 230 NFSDNKLPG----KLNATSVNCKSISTIDLSYNLLSGEI--PASFVADSSGSLKYLDLSHNNFTGKFSNLD----FGRCG 299 (1237)
Q Consensus 230 ~Ls~n~l~~----~~~~~~~~~~~L~~LdLs~N~l~~~~--~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~----~~~l~ 299 (1237)
.++.|.|.. .+...+..|++|+.|||.+|.++... ..+-.....++|++|++++|.+........ -...+
T Consensus 191 r~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p 270 (382)
T KOG1909|consen 191 RLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAP 270 (382)
T ss_pred EEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCC
Confidence 999998842 25667788999999999999987322 222223344567777777777764332211 11244
Q ss_pred CCceeeccCcccc
Q 000889 300 NLSVITLSQNGLS 312 (1237)
Q Consensus 300 ~L~~L~L~~n~l~ 312 (1237)
+|++|.|.+|.|+
T Consensus 271 ~L~vl~l~gNeIt 283 (382)
T KOG1909|consen 271 SLEVLELAGNEIT 283 (382)
T ss_pred CCceeccCcchhH
Confidence 5555555555543
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1e-12 Score=156.34 Aligned_cols=180 Identities=39% Similarity=0.548 Sum_probs=134.1
Q ss_pred CCccEEEccccccccccccccccCC-CccEEEeecccccccCCccccCccccceEEecCCccccCCCCCCCCCCCCCEEE
Q 000889 547 GNLETLILNNNHLTGAIPKSIASCT-NMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLD 625 (1237)
Q Consensus 547 ~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 625 (1237)
+.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..++.+++|+.|++++|+++ .+|...+.+++|+.|+
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 45677777777777 5666666664 7888888888887 67777788888888888888887 6666666778888888
Q ss_pred CCCCccccCCChhHHhhcccccCccccCccceeeccCCCccccCCCCcccccCCCccccCCCccccCCCCcceeccceee
Q 000889 626 LNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMY 705 (1237)
Q Consensus 626 L~~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (1237)
+++|+++ .+|..+...
T Consensus 193 ls~N~i~-~l~~~~~~~--------------------------------------------------------------- 208 (394)
T COG4886 193 LSGNKIS-DLPPEIELL--------------------------------------------------------------- 208 (394)
T ss_pred ccCCccc-cCchhhhhh---------------------------------------------------------------
Confidence 8888887 566543211
Q ss_pred eeccCCceeEEEccCCcCCccCCccccCCCCCcEEEecCcccccccccccccccCCcEEeCCCCccCCCCCCcccCcccc
Q 000889 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFL 785 (1237)
Q Consensus 706 ~f~~~~~L~~LdLs~N~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~P~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L 785 (1237)
..|++|++++|.+. .++..+..+.++..|.+++|++. .+|..++.+.+++.|++++|+++ .++. ++.+.+|
T Consensus 209 -----~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l 279 (394)
T COG4886 209 -----SALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNL 279 (394)
T ss_pred -----hhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccc-cccc-ccccCcc
Confidence 13677788888543 46777888888888888888887 55778888888888888888887 5555 7888888
Q ss_pred cceecccccccccCCCC
Q 000889 786 SDLDVSNNNLSGIIPSG 802 (1237)
Q Consensus 786 ~~l~l~~N~l~g~~p~~ 802 (1237)
+.|++++|.++..+|..
T Consensus 280 ~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 280 RELDLSGNSLSNALPLI 296 (394)
T ss_pred CEEeccCccccccchhh
Confidence 88888888888877754
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.3e-13 Score=147.58 Aligned_cols=263 Identities=24% Similarity=0.312 Sum_probs=152.4
Q ss_pred cccccCCCCCCeEEccCCCCCcccchhh---hhcCcccceecccCC---cccCCcccccccccCCccceEEccCCccCCC
Q 000889 119 LTTLTALPYLEHLNLQGNSFSAGDLSTS---KTSSCSLVTMDLSSN---NITGSLPGRSFLLSCDRLSYVNLSHNSISGG 192 (1237)
Q Consensus 119 ~~~l~~l~~L~~L~Ls~n~l~~~~~~~~---~~~~~~L~~L~Ls~n---~l~g~~~~~~~l~~~~~L~~L~ls~n~l~~~ 192 (1237)
...+.....+++|+||||.|+......+ +.+.++|+..++|+= .....+|. .|..| ..
T Consensus 23 ~~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e--------~L~~l--------~~ 86 (382)
T KOG1909|consen 23 EEELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPE--------ALKML--------SK 86 (382)
T ss_pred HHHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHH--------HHHHH--------HH
Confidence 3456678889999999999976654333 555556666666652 11222221 11110 11
Q ss_pred ccccCCcccEEEcCCCCCCCchhhh--ccccCCCCCCEEEccCCCCCchhhhhcccCCCccEEEcccccccCccchhhhh
Q 000889 193 SLHIGPSLLQLDLSGNQISDSALLT--YSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVA 270 (1237)
Q Consensus 193 ~~~~~~~L~~L~Ls~N~i~~~~~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~~ 270 (1237)
.+..++.|++||||+|-++..++.. .-++.|..|++|.|++|.+.-.....++. .|..| ..|...
T Consensus 87 aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l--~~~kk~--------- 153 (382)
T KOG1909|consen 87 ALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFEL--AVNKKA--------- 153 (382)
T ss_pred HHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHH--HHHhcc---------
Confidence 2334456777777777777666432 23567888888888888885332222211 01111 111111
Q ss_pred ccCCCccEEeCCCCcCCCCcc---cccccCCCCCceeeccCccccCccc---chhhcccccceEEEecCCccCCCC---c
Q 000889 271 DSSGSLKYLDLSHNNFTGKFS---NLDFGRCGNLSVITLSQNGLSGTEF---PASLKNCQLLETLNMSHNALQGGI---P 341 (1237)
Q Consensus 271 ~~~~~L~~L~Ls~N~l~~~~~---~~~~~~l~~L~~L~L~~n~l~~~~~---~~~l~~l~~L~~L~Ls~N~l~~~~---~ 341 (1237)
...+.|+.+..+.|++..... ...|..++.|+.+.+..|.|...++ ...+..|++|++|||.+|-++... -
T Consensus 154 ~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~L 233 (382)
T KOG1909|consen 154 ASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVAL 233 (382)
T ss_pred CCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHH
Confidence 112356666666665543221 1235566777777777776643322 346677888888888888776332 1
Q ss_pred hhhhccCCCCcEEecCCCcCCCCCchhHhhhc----CCCcEEEcccCcCCCC----CCcCcccccccceeeccCccc
Q 000889 342 GFLLGSFRNLKQLSLAHNQFAGEIPPELGQAC----GTLRELDLSSNRLTGE----LPSTFASCSSLHSLNLGSNML 410 (1237)
Q Consensus 342 ~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~l----~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l 410 (1237)
...+..+++|++|++++|.+.......++..+ |+|+.|.|.+|.|+.. +...+...+.|+.|+|++|++
T Consensus 234 akaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 234 AKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 22355667788888888888766555554433 5777888888877632 223344567777777777777
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.2e-13 Score=148.05 Aligned_cols=187 Identities=21% Similarity=0.194 Sum_probs=112.9
Q ss_pred hhcCcccceecccCCcccCCcccccccccCCccceEEccCCccCC-----CccccCCcccEEEcCCCCCCCchhhhcccc
Q 000889 147 KTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISG-----GSLHIGPSLLQLDLSGNQISDSALLTYSLS 221 (1237)
Q Consensus 147 ~~~~~~L~~L~Ls~n~l~g~~~~~~~l~~~~~L~~L~ls~n~l~~-----~~~~~~~~L~~L~Ls~N~i~~~~~~~~~l~ 221 (1237)
.....+|+...|.++.+... +.......|++++.||||+|-++. ...+-.|+|+.|+|+.|.+....-. ..-.
T Consensus 117 Qsn~kkL~~IsLdn~~V~~~-~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s-~~~~ 194 (505)
T KOG3207|consen 117 QSNLKKLREISLDNYRVEDA-GIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISS-NTTL 194 (505)
T ss_pred hhhHHhhhheeecCcccccc-chhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccc-cchh
Confidence 34444555556666554321 111334456666666666665543 1133345666666666654321100 0012
Q ss_pred CCCCCCEEEccCCCCCch-hhhhcccCCCccEEEcccccccCccchhhhhccCCCccEEeCCCCcCCCCcccccccCCCC
Q 000889 222 NCQNLNLLNFSDNKLPGK-LNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGN 300 (1237)
Q Consensus 222 ~l~~L~~L~Ls~n~l~~~-~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~l~~ 300 (1237)
.++.|+.|.|+.|.++.. +......+++|+.|+|++|...+ -.......+..|++|||++|++.+.......+.++.
T Consensus 195 ~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~--~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~ 272 (505)
T KOG3207|consen 195 LLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIIL--IKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPG 272 (505)
T ss_pred hhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccc--eecchhhhhhHHhhccccCCcccccccccccccccc
Confidence 457788888999988744 45566788899999999985221 122223445688899999998875443445667888
Q ss_pred CceeeccCccccCcccchh-----hcccccceEEEecCCccC
Q 000889 301 LSVITLSQNGLSGTEFPAS-----LKNCQLLETLNMSHNALQ 337 (1237)
Q Consensus 301 L~~L~L~~n~l~~~~~~~~-----l~~l~~L~~L~Ls~N~l~ 337 (1237)
|+.|+++.|.++...+|.. ....++|++|+++.|++.
T Consensus 273 L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 273 LNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred hhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 8888888888877666654 345566677777766664
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.2e-13 Score=147.18 Aligned_cols=216 Identities=23% Similarity=0.225 Sum_probs=127.0
Q ss_pred cCCCCCCEEEccCCCCCchhh-hhcccCCCccEEEcccccccCccchhhhhccCCCccEEeCCCCcCCCCcccccccCCC
Q 000889 221 SNCQNLNLLNFSDNKLPGKLN-ATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCG 299 (1237)
Q Consensus 221 ~~l~~L~~L~Ls~n~l~~~~~-~~~~~~~~L~~LdLs~N~l~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~l~ 299 (1237)
+++.+|+...|.++.+..... .....|++++.||||.|.+....+..-++..+++|+.|+|+.|++.-......-.-++
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 566777777777777643322 4566788888888888888877777777788888888888888886433333333466
Q ss_pred CCceeeccCccccCcccchhhcccccceEEEecCCccCCCCchhhhccCCCCcEEecCCCcCCCCCchhHhhhcCCCcEE
Q 000889 300 NLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLREL 379 (1237)
Q Consensus 300 ~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~l~~L~~L 379 (1237)
.|+.|.|+.|.++..++...+..+++|+.|+|+.|... .+.......+..|++|+|++|++- ..+.
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~-~~~~~~~~i~~~L~~LdLs~N~li-~~~~------------ 263 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEII-LIKATSTKILQTLQELDLSNNNLI-DFDQ------------ 263 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhccccc-ceecchhhhhhHHhhccccCCccc-cccc------------
Confidence 67777777777766555566666666666666666411 111111223344555555555443 2220
Q ss_pred EcccCcCCCCCCcCcccccccceeeccCccccCcccchh-----ccccccceEEeccCCCCCCC-CCccCCCCCCCcEEE
Q 000889 380 DLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTV-----VSKISSLIYLYVPFNNISGP-VPLSLTNCTQLRVLD 453 (1237)
Q Consensus 380 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~~l~~L~~L~L~~N~i~~~-~~~~l~~l~~L~~L~ 453 (1237)
-...+.++.|+.|+++.+.+.....++. ...+++|++|+++.|+|... .-..+..+.+|+.|.
T Consensus 264 -----------~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~ 332 (505)
T KOG3207|consen 264 -----------GYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLR 332 (505)
T ss_pred -----------ccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhh
Confidence 1223344444444444444443222222 23455666666666666432 123455567778888
Q ss_pred ccCCcCcc
Q 000889 454 LSSNGFTG 461 (1237)
Q Consensus 454 Ls~N~l~~ 461 (1237)
+..|.++.
T Consensus 333 ~~~n~ln~ 340 (505)
T KOG3207|consen 333 ITLNYLNK 340 (505)
T ss_pred cccccccc
Confidence 88888874
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.5e-11 Score=145.68 Aligned_cols=140 Identities=20% Similarity=0.244 Sum_probs=99.1
Q ss_pred CceecccCCeEEEEEEECCCCEEEEEEeccccCcC--------------------------H--------------HHHH
Q 000889 933 DSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQG--------------------------D--------------REFM 972 (1237)
Q Consensus 933 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~--------------~~~~ 972 (1237)
.+.||.|++|.||+|+.++|+.||||+..+..... . -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999999999999999875321000 0 0244
Q ss_pred HHHHHHHhcC-----CCCcccccceE-EeCCeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHH-HHHHH
Q 000889 973 AEMETIGKIK-----HRNLVPLLGYC-KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSAR-GLAFL 1045 (1237)
Q Consensus 973 ~E~~~l~~l~-----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-~L~yL 1045 (1237)
+|.+.+.++. +++| .+-..+ ...+..++||||++|++|.++...... .. .+.+++..++. .+..+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 202 REAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQV 273 (437)
T ss_pred HHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHH
Confidence 4555555552 3332 222222 224567999999999999887654211 11 23456666665 46788
Q ss_pred HhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeec
Q 000889 1046 HHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1046 H~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
|.. |++|+|++|.||+++.++.++++|||++..+.
T Consensus 274 ~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 274 LRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 988 99999999999999999999999999998664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG4341 consensus F-box protein containing LRR [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.7e-13 Score=149.43 Aligned_cols=309 Identities=22% Similarity=0.256 Sum_probs=164.4
Q ss_pred ccccCCCCCCceeeeee-------------cC----CCCceeEEecCCCC-CCCccccccccCCCCCCeEEccCC-CCCc
Q 000889 80 ANWTADALTPCSWQGVS-------------CS----LNSHVTSLNLNNSG-LSGSLNLTTLTALPYLEHLNLQGN-SFSA 140 (1237)
Q Consensus 80 ~sW~~~~~~~c~W~gv~-------------c~----~~~~v~~L~L~~~~-l~~~~~~~~l~~l~~L~~L~Ls~n-~l~~ 140 (1237)
..|+..+.|.-.|+.|. |+ ..+++.+|+|.++. ..++-.-....+++++++|++.+| ++++
T Consensus 100 ~~~n~~AlD~~~~q~idL~t~~rDv~g~VV~~~~~Rcgg~lk~LSlrG~r~v~~sslrt~~~~CpnIehL~l~gc~~iTd 179 (483)
T KOG4341|consen 100 TMWNKLALDGSCWQHIDLFTFQRDVDGGVVENMISRCGGFLKELSLRGCRAVGDSSLRTFASNCPNIEHLALYGCKKITD 179 (483)
T ss_pred HHhhhhhhccccceeeehhcchhcCCCcceehHhhhhccccccccccccccCCcchhhHHhhhCCchhhhhhhcceeccH
Confidence 35766666777776554 22 12566677776652 333333445566777777777777 5666
Q ss_pred ccchhhhhcCcccceecccCCcccCCcccccccccCCccceEEccCCccCCCccccCCcccEEEcCCCCCCCchhhhccc
Q 000889 141 GDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYSL 220 (1237)
Q Consensus 141 ~~~~~~~~~~~~L~~L~Ls~n~l~g~~~~~~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~l 220 (1237)
..+..+...+++|++|+|..|..-..........+|++|+++++|||. +|+..++.+. +
T Consensus 180 ~s~~sla~~C~~l~~l~L~~c~~iT~~~Lk~la~gC~kL~~lNlSwc~--------------------qi~~~gv~~~-~ 238 (483)
T KOG4341|consen 180 SSLLSLARYCRKLRHLNLHSCSSITDVSLKYLAEGCRKLKYLNLSWCP--------------------QISGNGVQAL-Q 238 (483)
T ss_pred HHHHHHHHhcchhhhhhhcccchhHHHHHHHHHHhhhhHHHhhhccCc--------------------hhhcCcchHH-h
Confidence 666777777777777777775432233333344567777777777762 2333333322 2
Q ss_pred cCCCCCCEEEccCCCCCch--hhhhcccCCCccEEEcccccccCccchhhhhccCCCccEEeCCCCcCCCCcc-cccccC
Q 000889 221 SNCQNLNLLNFSDNKLPGK--LNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFS-NLDFGR 297 (1237)
Q Consensus 221 ~~l~~L~~L~Ls~n~l~~~--~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~~~ 297 (1237)
.++..++.+.+.+|.-.+. +...-+.+.-+..+|+..|...++.....+...+..|+.|+.+++.-.+... ...-.+
T Consensus 239 rG~~~l~~~~~kGC~e~~le~l~~~~~~~~~i~~lnl~~c~~lTD~~~~~i~~~c~~lq~l~~s~~t~~~d~~l~aLg~~ 318 (483)
T KOG4341|consen 239 RGCKELEKLSLKGCLELELEALLKAAAYCLEILKLNLQHCNQLTDEDLWLIACGCHALQVLCYSSCTDITDEVLWALGQH 318 (483)
T ss_pred ccchhhhhhhhcccccccHHHHHHHhccChHhhccchhhhccccchHHHHHhhhhhHhhhhcccCCCCCchHHHHHHhcC
Confidence 5555566665555532111 2222334455566666565544444444445556667777776663322222 122245
Q ss_pred CCCCceeeccCc-cccCcccchhhcccccceEEEecCCccC-CCCchhhhccCCCCcEEecCCCcC-CCCCchhH---hh
Q 000889 298 CGNLSVITLSQN-GLSGTEFPASLKNCQLLETLNMSHNALQ-GGIPGFLLGSFRNLKQLSLAHNQF-AGEIPPEL---GQ 371 (1237)
Q Consensus 298 l~~L~~L~L~~n-~l~~~~~~~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~~l~~L~~L~L~~n~l-~~~ip~~~---~~ 371 (1237)
+++|++|-++.| ++++..+...-.+++.|+.+++..+... +.--.....+++.|+.|.|++|.. +++....+ ..
T Consensus 319 ~~~L~~l~l~~c~~fsd~~ft~l~rn~~~Le~l~~e~~~~~~d~tL~sls~~C~~lr~lslshce~itD~gi~~l~~~~c 398 (483)
T KOG4341|consen 319 CHNLQVLELSGCQQFSDRGFTMLGRNCPHLERLDLEECGLITDGTLASLSRNCPRLRVLSLSHCELITDEGIRHLSSSSC 398 (483)
T ss_pred CCceEEEeccccchhhhhhhhhhhcCChhhhhhcccccceehhhhHhhhccCCchhccCChhhhhhhhhhhhhhhhhccc
Confidence 677777777777 3555554444556677777777776532 111112234556677777776643 21110111 11
Q ss_pred hcCCCcEEEcccCcCC-CCCCcCcccccccceeeccCcc
Q 000889 372 ACGTLRELDLSSNRLT-GELPSTFASCSSLHSLNLGSNM 409 (1237)
Q Consensus 372 ~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~ 409 (1237)
....|+.+.|+++... ...-..+..+++|+.++|-.++
T Consensus 399 ~~~~l~~lEL~n~p~i~d~~Le~l~~c~~Leri~l~~~q 437 (483)
T KOG4341|consen 399 SLEGLEVLELDNCPLITDATLEHLSICRNLERIELIDCQ 437 (483)
T ss_pred cccccceeeecCCCCchHHHHHHHhhCcccceeeeechh
Confidence 2245666666666543 2223344555666666665553
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.9e-12 Score=152.40 Aligned_cols=193 Identities=33% Similarity=0.490 Sum_probs=80.3
Q ss_pred EEeccCCCCCCCCCccCCCCCCCcEEEccCCcCcccCCCCCCCCCCC-cccceecccCceeeecccccccccccccEecc
Q 000889 427 YLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNF-PALEKIVLPNNYLSGTVPLELGSCKNLKTIDL 505 (1237)
Q Consensus 427 ~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L 505 (1237)
.+.+..|.+... ...+..++.++.|++.+|.++.. |... ..+ ++|+.|++++|.+. .+|..+..+++|+.|++
T Consensus 97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~~i-~~~~---~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l 170 (394)
T COG4886 97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNITDI-PPLI---GLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDL 170 (394)
T ss_pred eeeccccccccC-chhhhcccceeEEecCCcccccC-cccc---ccchhhcccccccccchh-hhhhhhhcccccccccc
Confidence 455555554311 22333445566666666665522 2221 112 14455555555544 23333444445555555
Q ss_pred cCCccccCCCccccCCcCcceeecccccccCcccccccccCCCccEEEccccccccccccccccCCCccEEEeecccccc
Q 000889 506 SFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTG 585 (1237)
Q Consensus 506 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 585 (1237)
++|+++ .+|...+.+++|+.|++++|+++ .+|..+ .....|++|.+++|.+. ..+..+..+.++..|.+.+|++.
T Consensus 171 ~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~-~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~- 245 (394)
T COG4886 171 SFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEI-ELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE- 245 (394)
T ss_pred CCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhh-hhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-
Confidence 555544 33333334444444444444444 333322 11122444444444322 23333444444444444444444
Q ss_pred cCCccccCccccceEEecCCccccCCCCCCCCCCCCCEEECCCCccc
Q 000889 586 EIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLS 632 (1237)
Q Consensus 586 ~~p~~~~~L~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 632 (1237)
.++..++.+++|+.|++++|.++ .++. ++.+.+|+.|++++|.++
T Consensus 246 ~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~ 290 (394)
T COG4886 246 DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLS 290 (394)
T ss_pred eccchhccccccceecccccccc-cccc-ccccCccCEEeccCcccc
Confidence 22334444444444444444444 2222 344444444444444443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=7.6e-12 Score=132.31 Aligned_cols=214 Identities=22% Similarity=0.273 Sum_probs=145.3
Q ss_pred HHHHHHhcCCCCcccccceEEeC-----CeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhc
Q 000889 974 EMETIGKIKHRNLVPLLGYCKIG-----EERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHS 1048 (1237)
Q Consensus 974 E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~ 1048 (1237)
-+.-+-++.|-|+|+++.|+.+. .+..++.|||.-|++..++++..+. ...+....-.+|+-||..||.|||+.
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~-~~a~~~~~wkkw~tqIlsal~yLhs~ 195 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN-QKALFQKAWKKWCTQILSALSYLHSC 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh-hhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence 34445666799999999988653 4568999999999999999876543 35667777789999999999999996
Q ss_pred CCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCc--ceeeeccccCCCcCCccccCccccCcccchHHHHHHHHH
Q 000889 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDT--HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLE 1126 (1237)
Q Consensus 1049 ~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~e 1126 (1237)
.|+|+|+++..+-|++..+|-+|+.---.......... ........+-++|.|||.-.....+.++|||+||+...|
T Consensus 196 -~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 196 -DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred -CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 67899999999999999999888752111110000000 000122346789999999887778889999999999999
Q ss_pred HHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 000889 1127 LLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206 (1237)
Q Consensus 1127 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 1206 (1237)
|..+..--..++.. .... ..-...+...-++ + =...+.+|+...|..||+|.+++.+.-.
T Consensus 275 mailEiq~tnseS~---~~~e----e~ia~~i~~len~-l------------qr~~i~kcl~~eP~~rp~ar~llfHpll 334 (458)
T KOG1266|consen 275 MAILEIQSTNSESK---VEVE----ENIANVIIGLENG-L------------QRGSITKCLEGEPNGRPDARLLLFHPLL 334 (458)
T ss_pred HHHheeccCCCcce---eehh----hhhhhheeeccCc-c------------ccCcCcccccCCCCCCcchhhhhcCcee
Confidence 99876542211100 0000 0000000000000 0 0135568999999999999999888655
Q ss_pred ccc
Q 000889 1207 LQV 1209 (1237)
Q Consensus 1207 l~~ 1209 (1237)
+.+
T Consensus 335 feV 337 (458)
T KOG1266|consen 335 FEV 337 (458)
T ss_pred eec
Confidence 544
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=6.8e-12 Score=145.32 Aligned_cols=249 Identities=21% Similarity=0.220 Sum_probs=179.2
Q ss_pred CCCCCceecc--cCCeEEEEEEE--C-CCCEEEEEEecc--ccCcCHHHHHHHHHHHHhcC-CCCcccccceEEeCCeEE
Q 000889 929 GFSADSMIGS--GGFGEVYKAQL--R-DGSVVAIKKLIH--VTGQGDREFMAEMETIGKIK-HRNLVPLLGYCKIGEERL 1000 (1237)
Q Consensus 929 ~~~~~~~lG~--G~fg~Vy~~~~--~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 1000 (1237)
.|.+.+.+|. |.+|.||.+.. . ++..+|+|+-.. ..+.....-.+|+...+.++ |++.++.+..+..++..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566778999 99999999987 3 577889987432 22233334456777777774 999999999999999999
Q ss_pred EEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHH----HHHHHHhcCCCCeeecCCCCCCeeeCCC-CceEEee
Q 000889 1001 LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSAR----GLAFLHHSCIPHIIHRDMKSSNVLLDEN-FEARVSD 1075 (1237)
Q Consensus 1001 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~ivHrDikp~NIll~~~-~~vkl~D 1075 (1237)
+-+|++. .++.++.+.... .++....+.+..+..+ |+.++|+. .++|-|+||.||+...+ ...+++|
T Consensus 195 iqtE~~~-~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeecccc-chhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence 9999985 788888766432 3566667777777777 99999999 99999999999999999 8899999
Q ss_pred cccceeeccCCccee---eeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHH
Q 000889 1076 FGMARLVNALDTHLS---VSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQL 1152 (1237)
Q Consensus 1076 fGla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 1152 (1237)
||+...+....-... .....|...|++||+..+ .++.++|+|++|.++.+..++..+...... ..|...
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~~~- 338 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN------SSWSQL- 338 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC------CCcccc-
Confidence 999987765442211 123367888999999876 678899999999999999998777543211 111111
Q ss_pred hhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 000889 1153 HREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1153 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~ 1203 (1237)
+... .....+..-..++...+.+|++.+|..|++...+..+
T Consensus 339 ------r~~~----ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 339 ------RQGY----IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ------cccc----CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 0100 0001111111223336678999999999998777654
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.4e-11 Score=150.78 Aligned_cols=79 Identities=30% Similarity=0.539 Sum_probs=57.3
Q ss_pred CCCchhHHHHHHhhccccCCCCCCCcccccCCCCCCc----eeeeeecCC---C--CceeEEecCCCCCCCccccccccC
Q 000889 54 SGGNEELTILMAFKQSSIGSDPNGYLANWTADALTPC----SWQGVSCSL---N--SHVTSLNLNNSGLSGSLNLTTLTA 124 (1237)
Q Consensus 54 ~~~~~~~~aLl~~k~~~~~~~~~~~l~sW~~~~~~~c----~W~gv~c~~---~--~~v~~L~L~~~~l~~~~~~~~l~~ 124 (1237)
.+.++|..||++||+++ .++.. .+|+.. .|| .|.||+|+. . .+|+.|+|+++++.|.++ ..+..
T Consensus 368 ~t~~~~~~aL~~~k~~~--~~~~~--~~W~g~--~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip-~~i~~ 440 (623)
T PLN03150 368 KTLLEEVSALQTLKSSL--GLPLR--FGWNGD--PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIP-NDISK 440 (623)
T ss_pred ccCchHHHHHHHHHHhc--CCccc--CCCCCC--CCCCcccccccceeeccCCCCceEEEEEECCCCCccccCC-HHHhC
Confidence 45678999999999975 34432 589752 332 799999952 1 258999999999988776 45777
Q ss_pred CCCCCeEEccCCCCC
Q 000889 125 LPYLEHLNLQGNSFS 139 (1237)
Q Consensus 125 l~~L~~L~Ls~n~l~ 139 (1237)
+++|+.|+|++|.+.
T Consensus 441 L~~L~~L~Ls~N~l~ 455 (623)
T PLN03150 441 LRHLQSINLSGNSIR 455 (623)
T ss_pred CCCCCEEECCCCccc
Confidence 777777777777663
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=8e-10 Score=129.03 Aligned_cols=233 Identities=17% Similarity=0.253 Sum_probs=155.0
Q ss_pred CCCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEeccCCCHHHHHhhhhcCCCCccCHH
Q 000889 950 RDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWA 1029 (1237)
Q Consensus 950 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~ 1029 (1237)
.++.+|.|...............+-++.++.++||+|+++++.+...+..|+|+|.+. .|..++... ...
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l--------~~~ 104 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL--------GKE 104 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh--------HHH
Confidence 3577888887765444334556778899999999999999999999999999999984 688888653 245
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeeccCCcceeeeccccCCCcCCccccCcc
Q 000889 1030 ARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSF 1109 (1237)
Q Consensus 1030 ~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 1109 (1237)
.....+.||+.||.|||+.+ +++|++|..+.|++++.|..||++|.++........ ......--..|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 56667899999999999776 899999999999999999999999998875543332 11112222356777765432
Q ss_pred ccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhcccc
Q 000889 1110 RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDD 1189 (1237)
Q Consensus 1110 ~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~ 1189 (1237)
. -..|.|-||+++||++.|..+-.... ...+........ .. ..+....... .+ ...+++..|...
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~~~~~~~~-~~~~~ipk~~~~-~~---~k~~~~~~~~----r~----n~~~~~~~~~~~ 245 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGSLLTKTDL-SNTGKIPKALIE-LY---CKKLGATELK----RP----NKLRFILECRLL 245 (690)
T ss_pred c--cchhhhhHHHHHHHHhCcccCcchhh-hccCccchhHHH-HH---HHHhcccccc----cc----chhhHHHHHHhc
Confidence 2 34699999999999999933311100 000000000000 00 0000000000 00 134566677777
Q ss_pred CCCCCCCHHHHHHHHHhccccc
Q 000889 1190 RPFKRPTMIQVMAMFKELQVDT 1211 (1237)
Q Consensus 1190 dP~~RPt~~ell~~L~~l~~~~ 1211 (1237)
..--|=..-+++..|+++....
T Consensus 246 ~gff~n~fvd~~~fLeel~lks 267 (690)
T KOG1243|consen 246 GGFFRNDFVDTLLFLEELRLKS 267 (690)
T ss_pred cccccchHHHHHHHHHhcccCc
Confidence 7777778888888888776543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.16 E-value=5.2e-11 Score=142.31 Aligned_cols=147 Identities=20% Similarity=0.219 Sum_probs=93.7
Q ss_pred hCCCCCCceecccCCeEEEEEEECC-CCEEEEEEeccccCc--------------------------C--------HH--
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQ--------------------------G--------DR-- 969 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--------------------------~--------~~-- 969 (1237)
...|+. +.||.|++|.||+|++++ |+.||||+..+.... . .+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345666 789999999999999987 999999988642100 0 01
Q ss_pred ----HHHHHHHHHHhcC----CCCcccccceEEe-CCeEEEEEEeccCCCHHHHHhhhhcC-CCCccCHHHHHHHHHHHH
Q 000889 970 ----EFMAEMETIGKIK----HRNLVPLLGYCKI-GEERLLVYEYMKWGSLESVLHDRAKG-GGTKLDWAARKKIAIGSA 1039 (1237)
Q Consensus 970 ----~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia 1039 (1237)
++.+|+..+.+++ +...+.+-.++.+ ....++||||++|+.+.++-.-...+ ....+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 1333444444442 3332333222222 45678999999999998753221111 00122222233333333
Q ss_pred HHHHHHHhcCCCCeeecCCCCCCeeeCCCC----ceEEeecccceeecc
Q 000889 1040 RGLAFLHHSCIPHIIHRDMKSSNVLLDENF----EARVSDFGMARLVNA 1084 (1237)
Q Consensus 1040 ~~L~yLH~~~~~~ivHrDikp~NIll~~~~----~vkl~DfGla~~~~~ 1084 (1237)
+.. |++|+|+||.||+++.++ .++++|||++..+..
T Consensus 277 ------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 345 999999999999999888 999999999987754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.12 E-value=2e-10 Score=119.22 Aligned_cols=129 Identities=19% Similarity=0.102 Sum_probs=95.2
Q ss_pred ceecccCCeEEEEEEECCCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcc-cccceEEeCCeEEEEEEeccCCCHH
Q 000889 934 SMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLV-PLLGYCKIGEERLLVYEYMKWGSLE 1012 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL~ 1012 (1237)
+.++.|.++.||+++.. ++.+++|....... ....+..|+++++.+.+.+++ +++++. .+..++||||++|.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 56899999999999976 77899997654321 223467899999998655544 454443 33458999999998875
Q ss_pred HHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCeeeCCCCceEEeecccce
Q 000889 1013 SVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC--IPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1080 (1237)
Q Consensus 1013 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDikp~NIll~~~~~vkl~DfGla~ 1080 (1237)
+. . .....++.+++++++.||+.. ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 80 ~~--~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 80 TE--D-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cc--c-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 42 0 011245678999999999982 11259999999999999 6689999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.9e-11 Score=124.99 Aligned_cols=65 Identities=28% Similarity=0.488 Sum_probs=42.5
Q ss_pred CCCCCcEEEecCcccccccccccccccCCcEEeCCCCccCCCCC--CcccCcccccceecccccccccCC
Q 000889 733 SLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIP--GSLGGLSFLSDLDVSNNNLSGIIP 800 (1237)
Q Consensus 733 ~L~~L~~L~Ls~N~l~~~~P~~~~~L~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~l~l~~N~l~g~~p 800 (1237)
.|-+.+.|+|++|.+.. + ..++.|-+|..||+++|+|. .+. ..+++|+-|+.+.|.+|++.+.+-
T Consensus 350 KLGNIKtL~La~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie-~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 350 KLGNIKTLKLAQNKIET-L-SGLRKLYSLVNLDLSSNQIE-ELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred hhcCEeeeehhhhhHhh-h-hhhHhhhhheeccccccchh-hHHHhcccccccHHHHHhhcCCCccccch
Confidence 33444555555555541 1 23455666777777777776 332 467888889999999999988665
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.05 E-value=5.3e-11 Score=123.98 Aligned_cols=132 Identities=23% Similarity=0.304 Sum_probs=97.5
Q ss_pred ccccccccEecccCCccccCCCccccCCcCcceeecccccccCcccccccccCCCccEEEccccccccccccccccCCCc
Q 000889 494 LGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNM 573 (1237)
Q Consensus 494 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 573 (1237)
+..+..|+++|||+|.|+ .+.+++.-+|.++.|++++|.+. .+.. ...+++|+.||||+|.++ .+..+-..+.+.
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n--La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNI 354 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN--LAELPQLQLLDLSGNLLA-ECVGWHLKLGNI 354 (490)
T ss_pred cchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh--hhhcccceEeecccchhH-hhhhhHhhhcCE
Confidence 344566777777777777 56667777777777888877776 4443 345678888888888887 555566677888
Q ss_pred cEEEeecccccccCCccccCccccceEEecCCccccCC--CCCCCCCCCCCEEECCCCcccc
Q 000889 574 LWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQV--PQGLGKCRSLVWLDLNSNNLSG 633 (1237)
Q Consensus 574 ~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~--p~~l~~l~~L~~L~L~~N~l~g 633 (1237)
+.|.|++|.|. .-..++.|-+|..||+++|+|. .+ -..+++++-|+.+.|.+|++.+
T Consensus 355 KtL~La~N~iE--~LSGL~KLYSLvnLDl~~N~Ie-~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 355 KTLKLAQNKIE--TLSGLRKLYSLVNLDLSSNQIE-ELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred eeeehhhhhHh--hhhhhHhhhhheeccccccchh-hHHHhcccccccHHHHHhhcCCCccc
Confidence 88888888887 2245677788888888888887 33 2468888889999999998874
|
|
| >KOG4341 consensus F-box protein containing LRR [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.2e-11 Score=135.18 Aligned_cols=276 Identities=21% Similarity=0.231 Sum_probs=149.4
Q ss_pred CCc-eeeeeecCCCCceeEEecCCCC--CCCccccccccCCC-CCCeEEccCCC-CCcccchhhhhcCcccceecccCCc
Q 000889 88 TPC-SWQGVSCSLNSHVTSLNLNNSG--LSGSLNLTTLTALP-YLEHLNLQGNS-FSAGDLSTSKTSSCSLVTMDLSSNN 162 (1237)
Q Consensus 88 ~~c-~W~gv~c~~~~~v~~L~L~~~~--l~~~~~~~~l~~l~-~L~~L~Ls~n~-l~~~~~~~~~~~~~~L~~L~Ls~n~ 162 (1237)
.|| .|.+-.-+. +.=+.+||.... ..|......+..+- +|+.|.|+|+. ..+.++..+...++++++|++.+|.
T Consensus 97 ~~c~~~n~~AlD~-~~~q~idL~t~~rDv~g~VV~~~~~Rcgg~lk~LSlrG~r~v~~sslrt~~~~CpnIehL~l~gc~ 175 (483)
T KOG4341|consen 97 QCCTMWNKLALDG-SCWQHIDLFTFQRDVDGGVVENMISRCGGFLKELSLRGCRAVGDSSLRTFASNCPNIEHLALYGCK 175 (483)
T ss_pred HHHHHhhhhhhcc-ccceeeehhcchhcCCCcceehHhhhhccccccccccccccCCcchhhHHhhhCCchhhhhhhcce
Confidence 455 487655441 223345554432 23333333333333 56777777663 3444444444444444444444443
Q ss_pred ccCCcccccccccCCccceEEccCCccCCCccccCCcccEEEcCCC-CCCCchhhhccccCCCCCCEEEccCCC-CCch-
Q 000889 163 ITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGN-QISDSALLTYSLSNCQNLNLLNFSDNK-LPGK- 239 (1237)
Q Consensus 163 l~g~~~~~~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~Ls~N-~i~~~~~~~~~l~~l~~L~~L~Ls~n~-l~~~- 239 (1237)
...+.....+. ..++.|+.|+|..| .|++..++.. -..|++|++|++|+|. |++.
T Consensus 176 ~iTd~s~~sla---------------------~~C~~l~~l~L~~c~~iT~~~Lk~l-a~gC~kL~~lNlSwc~qi~~~g 233 (483)
T KOG4341|consen 176 KITDSSLLSLA---------------------RYCRKLRHLNLHSCSSITDVSLKYL-AEGCRKLKYLNLSWCPQISGNG 233 (483)
T ss_pred eccHHHHHHHH---------------------HhcchhhhhhhcccchhHHHHHHHH-HHhhhhHHHhhhccCchhhcCc
Confidence 22222222222 23445556666664 4666555433 2689999999999995 4432
Q ss_pred hhhhcccCCCccEEEcccccccCccchhhhhccCCCccEEeCCCC-cCCCCcccccccCCCCCceeeccCc-cccCcccc
Q 000889 240 LNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHN-NFTGKFSNLDFGRCGNLSVITLSQN-GLSGTEFP 317 (1237)
Q Consensus 240 ~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~~~~~~~L~~L~Ls~N-~l~~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~ 317 (1237)
+...+.+++.++.+-+.+|.=.+.-........+.-+..+++.+| .+++......-..+..|++|..+++ .+++..+-
T Consensus 234 v~~~~rG~~~l~~~~~kGC~e~~le~l~~~~~~~~~i~~lnl~~c~~lTD~~~~~i~~~c~~lq~l~~s~~t~~~d~~l~ 313 (483)
T KOG4341|consen 234 VQALQRGCKELEKLSLKGCLELELEALLKAAAYCLEILKLNLQHCNQLTDEDLWLIACGCHALQVLCYSSCTDITDEVLW 313 (483)
T ss_pred chHHhccchhhhhhhhcccccccHHHHHHHhccChHhhccchhhhccccchHHHHHhhhhhHhhhhcccCCCCCchHHHH
Confidence 334566788888887777664433222333444556777777777 4443322223345777888888777 45544444
Q ss_pred hhhcccccceEEEecCCc-cCCCCchhhhccCCCCcEEecCCCcCCCCC-chhHhhhcCCCcEEEcccCcC
Q 000889 318 ASLKNCQLLETLNMSHNA-LQGGIPGFLLGSFRNLKQLSLAHNQFAGEI-PPELGQACGTLRELDLSSNRL 386 (1237)
Q Consensus 318 ~~l~~l~~L~~L~Ls~N~-l~~~~~~~~~~~l~~L~~L~L~~n~l~~~i-p~~~~~~l~~L~~L~Ls~N~l 386 (1237)
..-+++.+|+.|-++.++ +++..-...-.+.+.|+.+++..+...... -..+...++.|+.|.|+++.+
T Consensus 314 aLg~~~~~L~~l~l~~c~~fsd~~ft~l~rn~~~Le~l~~e~~~~~~d~tL~sls~~C~~lr~lslshce~ 384 (483)
T KOG4341|consen 314 ALGQHCHNLQVLELSGCQQFSDRGFTMLGRNCPHLERLDLEECGLITDGTLASLSRNCPRLRVLSLSHCEL 384 (483)
T ss_pred HHhcCCCceEEEeccccchhhhhhhhhhhcCChhhhhhcccccceehhhhHhhhccCCchhccCChhhhhh
Confidence 444667778888888776 443333333345566777777766433111 233444556677777766644
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.7e-10 Score=115.80 Aligned_cols=110 Identities=28% Similarity=0.376 Sum_probs=38.4
Q ss_pred cCCCCCceeeccCccccCcccchhhc-ccccceEEEecCCccCCCCchhhhccCCCCcEEecCCCcCCCCCchhHhhhcC
Q 000889 296 GRCGNLSVITLSQNGLSGTEFPASLK-NCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACG 374 (1237)
Q Consensus 296 ~~l~~L~~L~L~~n~l~~~~~~~~l~-~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~l~ 374 (1237)
.++.++++|+|++|+|+.++ .+. .+.+|+.|+|++|.|+ .++. +..+++|++|++++|+|+ .+.+.+...++
T Consensus 16 ~n~~~~~~L~L~~n~I~~Ie---~L~~~l~~L~~L~Ls~N~I~-~l~~--l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp 88 (175)
T PF14580_consen 16 NNPVKLRELNLRGNQISTIE---NLGATLDKLEVLDLSNNQIT-KLEG--LPGLPRLKTLDLSNNRIS-SISEGLDKNLP 88 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---TT------TT--EEE--SS----S-CHHHHHH-T
T ss_pred cccccccccccccccccccc---chhhhhcCCCEEECCCCCCc-cccC--ccChhhhhhcccCCCCCC-ccccchHHhCC
Confidence 34455667777777765432 243 4677788888888877 3443 456788888888888887 66655555568
Q ss_pred CCcEEEcccCcCCCCC-CcCcccccccceeeccCccccC
Q 000889 375 TLRELDLSSNRLTGEL-PSTFASCSSLHSLNLGSNMLSG 412 (1237)
Q Consensus 375 ~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~ 412 (1237)
+|++|+|++|+|.... -..++.+++|+.|+|.+|.++.
T Consensus 89 ~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~ 127 (175)
T PF14580_consen 89 NLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE 127 (175)
T ss_dssp T--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred cCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence 8888888888886432 2456667788888888887763
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.5e-09 Score=111.01 Aligned_cols=136 Identities=16% Similarity=0.167 Sum_probs=98.1
Q ss_pred ceecccCCeEEEEEEECC-------CCEEEEEEecccc------------C---------cC-HHHH----HHHHHHHHh
Q 000889 934 SMIGSGGFGEVYKAQLRD-------GSVVAIKKLIHVT------------G---------QG-DREF----MAEMETIGK 980 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~------------~---------~~-~~~~----~~E~~~l~~ 980 (1237)
..||.|--+.||.|...+ +..+|||..+... . .. .+.+ .+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 4789999664110 0 01 1122 279999999
Q ss_pred cCC--CCcccccceEEeCCeEEEEEEeccCCCHHH-HHhhhhcCCCCccCHHHHHHHHHHHHHHHHHH-HhcCCCCeeec
Q 000889 981 IKH--RNLVPLLGYCKIGEERLLVYEYMKWGSLES-VLHDRAKGGGTKLDWAARKKIAIGSARGLAFL-HHSCIPHIIHR 1056 (1237)
Q Consensus 981 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivHr 1056 (1237)
+.. -++++++++ ...++||||+.++.+.. .+++ ..++......+..+++.++.++ |.. ++||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA 149 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 953 466777754 56789999997654322 1221 1334455667889999999999 788 99999
Q ss_pred CCCCCCeeeCCCCceEEeecccceeec
Q 000889 1057 DMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1057 Dikp~NIll~~~~~vkl~DfGla~~~~ 1083 (1237)
|+++.||++++ +.++++|||.|...+
T Consensus 150 DLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 99999999974 689999999987554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=4e-09 Score=104.87 Aligned_cols=131 Identities=21% Similarity=0.311 Sum_probs=99.5
Q ss_pred ceecccCCeEEEEEEECCCCEEEEEEeccccCcCH--------HHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEEEe
Q 000889 934 SMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGD--------REFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~--------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
..+++|+-+.+|.+.+. |..+++|.-.+...... ....+|++++.+++--.|...+=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999876 44566665443322211 2356799999998765665555566677888999999
Q ss_pred ccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeeccccee
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~ 1081 (1237)
++|..|.+++... ...++..+-.-+.-||.. +|||+|+.++||.+..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888753 134555666667889999 999999999999998775 99999999974
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.2e-10 Score=114.47 Aligned_cols=125 Identities=26% Similarity=0.285 Sum_probs=34.3
Q ss_pred cccEEEcCCCCCCCchhhhcccc-CCCCCCEEEccCCCCCchhhhhcccCCCccEEEcccccccCccchhhhhccCCCcc
Q 000889 199 SLLQLDLSGNQISDSALLTYSLS-NCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLK 277 (1237)
Q Consensus 199 ~L~~L~Ls~N~i~~~~~~~~~l~-~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~~~~~~~L~ 277 (1237)
.+++|+|++|+|+.+. .++ .+.+|+.|+|++|+|+.+. .+..++.|++|++++|.++...+ .+ ...+++|+
T Consensus 20 ~~~~L~L~~n~I~~Ie----~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~~i~~-~l-~~~lp~L~ 91 (175)
T PF14580_consen 20 KLRELNLRGNQISTIE----NLGATLDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRISSISE-GL-DKNLPNLQ 91 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S--T--T----TT--EEE--SS---S-CH-HH-HHH-TT--
T ss_pred cccccccccccccccc----chhhhhcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCCcccc-ch-HHhCCcCC
Confidence 4555666666655422 222 3455666666666665332 34445555555555555543211 11 11234444
Q ss_pred EEeCCCCcCCCCcccccccCCCCCceeeccCccccCcccchhhcccccceEEEecCCccCCCC--chhhhccCCCCcEEe
Q 000889 278 YLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGI--PGFLLGSFRNLKQLS 355 (1237)
Q Consensus 278 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~--~~~~~~~l~~L~~L~ 355 (1237)
+|+|++|+|. +..--..+..+++|++|+|.+|.++... ...++..+|+|+.||
T Consensus 92 ~L~L~~N~I~-------------------------~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 92 ELYLSNNKIS-------------------------DLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp EEE-TTS----------------------------SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred EEECcCCcCC-------------------------ChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 4444444444 3322234555666666666666655321 123455667777766
Q ss_pred c
Q 000889 356 L 356 (1237)
Q Consensus 356 L 356 (1237)
-
T Consensus 147 ~ 147 (175)
T PF14580_consen 147 G 147 (175)
T ss_dssp T
T ss_pred C
Confidence 4
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.97 E-value=7.5e-10 Score=128.60 Aligned_cols=247 Identities=18% Similarity=0.202 Sum_probs=173.2
Q ss_pred HhCCCCCCceecccCCeEEEEEEEC--CCCEEEEEEeccccCcCHHH--HHHHHHHHHhc-CCCCcccccceEEeCCeEE
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLR--DGSVVAIKKLIHVTGQGDRE--FMAEMETIGKI-KHRNLVPLLGYCKIGEERL 1000 (1237)
Q Consensus 926 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 1000 (1237)
-..+|..+..||.|.|+.|+....+ ++..+++|...........+ -..|+.+...+ .|.++++++..+..-+..|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3557888999999999999998644 57788888775433222222 23466665555 4888999888887778888
Q ss_pred EEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCC-CceEEeecccc
Q 000889 1001 LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDEN-FEARVSDFGMA 1079 (1237)
Q Consensus 1001 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~-~~vkl~DfGla 1079 (1237)
+=-|||.+++....... ...++...++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||++
T Consensus 343 ip~e~~~~~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred CchhhhcCcchhhhhHH-----HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence 88999999988776632 14567788899999999999999999 99999999999999886 88899999998
Q ss_pred eeeccCCcceeeeccccCCCcC--CccccCccccCcccchHHHHHHHHHHHcCCCCCCCCCCCCCchHHHHHHHHhhhcc
Q 000889 1080 RLVNALDTHLSVSTLAGTPGYV--PPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKR 1157 (1237)
Q Consensus 1080 ~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1157 (1237)
..+.... ....++.+++ +|+......+-.++|++|||.-+.|..+|..--. .. ..|
T Consensus 415 t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~-~~-------~~~--------- 472 (524)
T KOG0601|consen 415 TRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE-SG-------VQS--------- 472 (524)
T ss_pred cccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCc-cc-------ccc---------
Confidence 6432211 1223344455 5555566677889999999999999999865421 10 001
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 000889 1158 INEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKE 1206 (1237)
Q Consensus 1158 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ell~~L~~ 1206 (1237)
..+.....+...... ..+..+...+..+++..||.+.++..+.+.
T Consensus 473 -~~i~~~~~p~~~~~~---~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 473 -LTIRSGDTPNLPGLK---LQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred -eeeecccccCCCchH---HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 111111111111111 345566667899999999999888766543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1e-08 Score=101.04 Aligned_cols=143 Identities=16% Similarity=0.194 Sum_probs=106.6
Q ss_pred CCceecccCCeEEEEEEECCCCEEEEEEeccccCcC--------HHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEEE
Q 000889 932 ADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQG--------DREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 932 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
....+-+|+-+.|+++.+. |+...||.-....... .+...+|++.+.+++--.|.-..=++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4568899999999999986 7777777554322111 235678999999987555555555666777788999
Q ss_pred EeccC-CCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCC---ceEEeecccc
Q 000889 1004 EYMKW-GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENF---EARVSDFGMA 1079 (1237)
Q Consensus 1004 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~---~vkl~DfGla 1079 (1237)
||++| .++.+++...... .........++..|-+.+.-||.. +++|+|+..+||++..++ .+.++|||++
T Consensus 90 E~~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EeccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecch
Confidence 99986 3788988775432 222223366788888889999999 999999999999996544 3589999998
Q ss_pred ee
Q 000889 1080 RL 1081 (1237)
Q Consensus 1080 ~~ 1081 (1237)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 63
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.2e-10 Score=137.46 Aligned_cols=249 Identities=21% Similarity=0.277 Sum_probs=166.9
Q ss_pred hCCCCCCceecccCCeEEEEEEECC-CCEEEEEEecc---ccCcCHHHHHHHHHHHHhcCCCCcccccceEEeCCeEEEE
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIH---VTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 927 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 1002 (1237)
.+.+.+.+-+-.|.++.++.++-.. |...+.|.... ....+.+....+-.+.-.-++|.+++....+......+++
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 3456667788899999999876442 33333332221 1111222222333333334467777666666667888999
Q ss_pred EEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceee
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~ 1082 (1237)
++|..+++|..-++... ..+...++.....+.++.+|||.. .++|||++|.|.+...+++.+++|||.....
T Consensus 883 ~~~~~~~~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG-----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hHHhccCCchhhhhcCC-----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence 99999999999887642 344445556667788899999998 7999999999999999999999999843322
Q ss_pred ccC---------------------Cc--------ceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCC
Q 000889 1083 NAL---------------------DT--------HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRP 1133 (1237)
Q Consensus 1083 ~~~---------------------~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p 1133 (1237)
.-. .. ........||+.|.|||...+.....++|+|+.|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 110 00 0112345689999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchHHHHHHHHhhhcccccccCccccCCCCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 000889 1134 IDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMI 1198 (1237)
Q Consensus 1134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1198 (1237)
|.....+ ..+..+.....+.+...........+++...+..+|.+|-.+.
T Consensus 1035 ~na~tpq---------------~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQ---------------QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchh---------------hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9754321 1122233333333333333334445666677778888888766
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.2e-10 Score=136.41 Aligned_cols=267 Identities=25% Similarity=0.251 Sum_probs=140.9
Q ss_pred cceEEEecCCccCCCCchhhhccCCCCcEEecCCCcCCCCCchhHhhhcCCCcEEEcccCcCCCCCCcCcccccccceee
Q 000889 325 LLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLN 404 (1237)
Q Consensus 325 ~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 404 (1237)
.++.++..++.+.. .... ...+..++.+++..|.+. .+-..+. .+.+|+.|++.+|+|..+ ...+..+++|++|+
T Consensus 50 ~~~~~~~~~~~~~~-~~~~-~~~l~~l~~l~l~~n~i~-~~~~~l~-~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ 124 (414)
T KOG0531|consen 50 DLEEIDLIFNLDGS-DEDL-VESLTSLKELNLRQNLIA-KILNHLS-KLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLD 124 (414)
T ss_pred hhhhhcchhccccc-hhhh-HHHhHhHHhhccchhhhh-hhhcccc-cccceeeeeccccchhhc-ccchhhhhcchhee
Confidence 45555665554431 1111 134556666666666665 3222222 235666666766666632 22255566666666
Q ss_pred ccCccccCcccchhccccccceEEeccCCCCCCCCCccCCCCCCCcEEEccCCcCcccCCCCCCCCCCCcccceecccCc
Q 000889 405 LGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNN 484 (1237)
Q Consensus 405 L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~L~~N 484 (1237)
|++|.|+.. ..+..++.|+.|++++|.|+.. ..+..++.|+.++ +++|
T Consensus 125 ls~N~I~~i---~~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~---------------------------l~~n 172 (414)
T KOG0531|consen 125 LSFNKITKL---EGLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLD---------------------------LSYN 172 (414)
T ss_pred ccccccccc---cchhhccchhhheeccCcchhc--cCCccchhhhccc---------------------------CCcc
Confidence 666666532 1223333344444444444422 1223344444444 4444
Q ss_pred eeeeccc-ccccccccccEecccCCccccCCCccccCCcCcceeecccccccCcccccccccCC--CccEEEcccccccc
Q 000889 485 YLSGTVP-LELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGG--NLETLILNNNHLTG 561 (1237)
Q Consensus 485 ~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~--~L~~L~Ls~N~l~~ 561 (1237)
.+....+ . ...+.+++.+++.+|.+. ....+..+..+..+++..|.++..-+.. .+. .|+.+++++|++.
T Consensus 173 ~i~~ie~~~-~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~~~~~l~---~~~~~~L~~l~l~~n~i~- 245 (414)
T KOG0531|consen 173 RIVDIENDE-LSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKISKLEGLN---ELVMLHLRELYLSGNRIS- 245 (414)
T ss_pred hhhhhhhhh-hhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccceeccCcc---cchhHHHHHHhcccCccc-
Confidence 4443222 1 344455555555555554 1222333334444455555554211111 111 2677777777776
Q ss_pred ccccccccCCCccEEEeecccccccCCccccCccccceEEecCCcccc---CCCCC-CCCCCCCCEEECCCCccccCCCh
Q 000889 562 AIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTG---QVPQG-LGKCRSLVWLDLNSNNLSGPLPS 637 (1237)
Q Consensus 562 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~---~~p~~-l~~l~~L~~L~L~~N~l~g~ip~ 637 (1237)
..+..+..+..+..|++.+|++... ..+...+.+..+.+..|.+.. ..... .+..+.++.+.+..|+.....+.
T Consensus 246 ~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (414)
T KOG0531|consen 246 RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISSL 323 (414)
T ss_pred cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCcccccccc
Confidence 4446667777888888888887732 234556667777778887652 12222 56677888888888888765553
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.90 E-value=7.9e-09 Score=112.39 Aligned_cols=141 Identities=19% Similarity=0.217 Sum_probs=104.9
Q ss_pred ceecccCCeEEEEEEECCCCEEEEEEeccccC-cCHHHHHHHHHHHHhcCC--CCcccccceEEeC---CeEEEEEEecc
Q 000889 934 SMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTG-QGDREFMAEMETIGKIKH--RNLVPLLGYCKIG---EERLLVYEYMK 1007 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~e~~~ 1007 (1237)
+.++.|.++.||+++..+|+.+++|....... .....+..|+++++.+.+ ..+.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999987768899998754322 134568899999999975 3457777776543 25689999999
Q ss_pred CCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 000889 1008 WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC-------------------------------------- 1049 (1237)
Q Consensus 1008 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------------------------------------- 1049 (1237)
|.++.+.+.. ..++......++.++++++.+||+..
T Consensus 84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9887665421 13555666667777777777777421
Q ss_pred ---------------CCCeeecCCCCCCeeeCC--CCceEEeecccce
Q 000889 1050 ---------------IPHIIHRDMKSSNVLLDE--NFEARVSDFGMAR 1080 (1237)
Q Consensus 1050 ---------------~~~ivHrDikp~NIll~~--~~~vkl~DfGla~ 1080 (1237)
...++|+|+.|.||+++. ++.+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 235899999999999998 6778999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.2e-10 Score=134.95 Aligned_cols=265 Identities=28% Similarity=0.306 Sum_probs=115.3
Q ss_pred CCcccEEEcCCCCCCCchhhhccccCCCCCCEEEccCCCCCchhhhhcccCCCccEEEcccccccCccchhhhhccCCCc
Q 000889 197 GPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSL 276 (1237)
Q Consensus 197 ~~~L~~L~Ls~N~i~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~~~~~~~L 276 (1237)
.+.++.++...+.+...... ...+..++.+++..|.+.. +...+..+++|+.|++.+|.+......
T Consensus 48 ~~~~~~~~~~~~~~~~~~~~---~~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~~---------- 113 (414)
T KOG0531|consen 48 PSDLEEIDLIFNLDGSDEDL---VESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIENL---------- 113 (414)
T ss_pred cchhhhhcchhccccchhhh---HHHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhcccc----------
Confidence 34555566555544432111 1344555555566665543 122234444555555555554422110
Q ss_pred cEEeCCCCcCCCCcccccccCCCCCceeeccCccccCcccchhhcccccceEEEecCCccCCCCchhhhccCCCCcEEec
Q 000889 277 KYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSL 356 (1237)
Q Consensus 277 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L 356 (1237)
+..+++|++|+|++|.|+... .+..++.|+.|++++|.|+ .+.. +..+.+|+.+++
T Consensus 114 ------------------l~~~~~L~~L~ls~N~I~~i~---~l~~l~~L~~L~l~~N~i~-~~~~--~~~l~~L~~l~l 169 (414)
T KOG0531|consen 114 ------------------LSSLVNLQVLDLSFNKITKLE---GLSTLTLLKELNLSGNLIS-DISG--LESLKSLKLLDL 169 (414)
T ss_pred ------------------hhhhhcchheecccccccccc---chhhccchhhheeccCcch-hccC--CccchhhhcccC
Confidence 233444444444444443322 2333444555555555554 2222 233455555555
Q ss_pred CCCcCCCCCchhHhhhcCCCcEEEcccCcCCCCCCcCcccccccceeeccCccccCcccchhccccc--cceEEeccCCC
Q 000889 357 AHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKIS--SLIYLYVPFNN 434 (1237)
Q Consensus 357 ~~n~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~--~L~~L~L~~N~ 434 (1237)
++|++. .+.......+.+++.+++..|.+... ..+..+..+..+++..|.++... ....+. .|+.+++++|.
T Consensus 170 ~~n~i~-~ie~~~~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~---~l~~~~~~~L~~l~l~~n~ 243 (414)
T KOG0531|consen 170 SYNRIV-DIENDELSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKISKLE---GLNELVMLHLRELYLSGNR 243 (414)
T ss_pred Ccchhh-hhhhhhhhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccceecc---CcccchhHHHHHHhcccCc
Confidence 555554 33321012234555555555555421 22333334444455555544210 111111 24555555555
Q ss_pred CCCCCCccCCCCCCCcEEEccCCcCcccCCCCCCCCCCCcccceecccCceeeec---cccc-ccccccccEecccCCcc
Q 000889 435 ISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGT---VPLE-LGSCKNLKTIDLSFNSL 510 (1237)
Q Consensus 435 i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~-l~~l~~L~~L~Ls~N~l 510 (1237)
+... +..+..+.++..|++.+|++...- .....+.+..+....|.+... .... ......++.+.+..|.+
T Consensus 244 i~~~-~~~~~~~~~l~~l~~~~n~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (414)
T KOG0531|consen 244 ISRS-PEGLENLKNLPVLDLSSNRISNLE-----GLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPI 317 (414)
T ss_pred cccc-cccccccccccccchhhccccccc-----cccccchHHHhccCcchhcchhhhhccccccccccccccccccCcc
Confidence 5422 244555666666677666665221 123344455555555544311 1111 33344455555555554
Q ss_pred c
Q 000889 511 A 511 (1237)
Q Consensus 511 ~ 511 (1237)
.
T Consensus 318 ~ 318 (414)
T KOG0531|consen 318 R 318 (414)
T ss_pred c
Confidence 4
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.2e-09 Score=83.50 Aligned_cols=41 Identities=44% Similarity=1.023 Sum_probs=30.3
Q ss_pred chhHHHHHHhhccccCCCCCCCcccccCCC-CCCceeeeeecC
Q 000889 57 NEELTILMAFKQSSIGSDPNGYLANWTADA-LTPCSWQGVSCS 98 (1237)
Q Consensus 57 ~~~~~aLl~~k~~~~~~~~~~~l~sW~~~~-~~~c~W~gv~c~ 98 (1237)
++|++||++||+++ ..||.+.+++|+... .+||.|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l-~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSL-NNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCT-T-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhc-ccccCcccccCCCcCCCCCeeeccEEeC
Confidence 57999999999974 446789999999864 799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.7e-10 Score=118.04 Aligned_cols=181 Identities=24% Similarity=0.239 Sum_probs=82.4
Q ss_pred ccEEEcCCCCCCCchhhhccccCCCCCCEEEccCCCCCchhhhhcccCCCccEEEcccccccCccchhhhhccCCCccEE
Q 000889 200 LLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYL 279 (1237)
Q Consensus 200 L~~L~Ls~N~i~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~LdLs~N~l~~~~~~~~~~~~~~~L~~L 279 (1237)
|++||||+-.|+-..+. ..++.|.+|+.|.|.++++.+.+...++...+|+.|||+.+.=-+......+...++.|.+|
T Consensus 187 lq~lDLS~s~it~stl~-~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~L 265 (419)
T KOG2120|consen 187 LQHLDLSNSVITVSTLH-GILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDEL 265 (419)
T ss_pred hHHhhcchhheeHHHHH-HHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhc
Confidence 44555555444432221 22445555555555555555555555555555555555554422233333344445555555
Q ss_pred eCCCCcCCCCcccccccC-CCCCceeeccCcc--ccCcccchhhcccccceEEEecCCc-cCCCCchhhhccCCCCcEEe
Q 000889 280 DLSHNNFTGKFSNLDFGR-CGNLSVITLSQNG--LSGTEFPASLKNCQLLETLNMSHNA-LQGGIPGFLLGSFRNLKQLS 355 (1237)
Q Consensus 280 ~Ls~N~l~~~~~~~~~~~-l~~L~~L~L~~n~--l~~~~~~~~l~~l~~L~~L~Ls~N~-l~~~~~~~~~~~l~~L~~L~ 355 (1237)
+|++|.++.......... -++|+.|+|++++ +....+......+++|.+||||+|. ++... ...+-.++.|++|.
T Consensus 266 NlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~-~~~~~kf~~L~~lS 344 (419)
T KOG2120|consen 266 NLSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDC-FQEFFKFNYLQHLS 344 (419)
T ss_pred CchHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccccccCchH-HHHHHhcchheeee
Confidence 555554443221111111 2345555555542 2212223334556666666666654 33221 12234556666666
Q ss_pred cCCCcCCCCCchhHh--hhcCCCcEEEcccC
Q 000889 356 LAHNQFAGEIPPELG--QACGTLRELDLSSN 384 (1237)
Q Consensus 356 L~~n~l~~~ip~~~~--~~l~~L~~L~Ls~N 384 (1237)
|+.|.. .+|..+. ...|.|.+||..++
T Consensus 345 lsRCY~--i~p~~~~~l~s~psl~yLdv~g~ 373 (419)
T KOG2120|consen 345 LSRCYD--IIPETLLELNSKPSLVYLDVFGC 373 (419)
T ss_pred hhhhcC--CChHHeeeeccCcceEEEEeccc
Confidence 666542 2333321 12255666665544
|
|
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.9e-10 Score=118.90 Aligned_cols=206 Identities=17% Similarity=0.132 Sum_probs=132.0
Q ss_pred ceeEEecCCCCCCCccccccccCC-CCCCeEEccCCCCCcccchhhhhcCcccceecccCCcccCCcccccccccCCccc
Q 000889 102 HVTSLNLNNSGLSGSLNLTTLTAL-PYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLS 180 (1237)
Q Consensus 102 ~v~~L~L~~~~l~~~~~~~~l~~l-~~L~~L~Ls~n~l~~~~~~~~~~~~~~L~~L~Ls~n~l~g~~~~~~~l~~~~~L~ 180 (1237)
.|..+.|...-...+-.+..+..+ +.||+||||.-.|+...+..++..|++|+.|.|.++++.+.+. ..++...+|+
T Consensus 160 gV~v~Rlar~~~~~prlae~~~~frsRlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~--~~iAkN~~L~ 237 (419)
T KOG2120|consen 160 GVIVFRLARSFMDQPRLAEHFSPFRSRLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIV--NTIAKNSNLV 237 (419)
T ss_pred CeEEEEcchhhhcCchhhhhhhhhhhhhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHH--HHHhccccce
Confidence 366666654433333222223322 2588888888888777777778888888888888888766544 4455677888
Q ss_pred eEEccCC-ccCCCc----cccCCcccEEEcCCCCCCCchhhhccccCCCCCCEEEccCCCC---CchhhhhcccCCCccE
Q 000889 181 YVNLSHN-SISGGS----LHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKL---PGKLNATSVNCKSIST 252 (1237)
Q Consensus 181 ~L~ls~n-~l~~~~----~~~~~~L~~L~Ls~N~i~~~~~~~~~l~~l~~L~~L~Ls~n~l---~~~~~~~~~~~~~L~~ 252 (1237)
.|+++.| .+|..+ +..+..|.+|+|++|.+....+....-.--.+|+.|+|++++= ...+......|++|.+
T Consensus 238 ~lnlsm~sG~t~n~~~ll~~scs~L~~LNlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~ 317 (419)
T KOG2120|consen 238 RLNLSMCSGFTENALQLLLSSCSRLDELNLSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVH 317 (419)
T ss_pred eeccccccccchhHHHHHHHhhhhHhhcCchHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceee
Confidence 8888876 666533 5566778888888887665443222223346788888887742 1234445568888888
Q ss_pred EEcccccccCccchhhhhccCCCccEEeCCCCcCCCCcccccccCCCCCceeeccCcc
Q 000889 253 IDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNG 310 (1237)
Q Consensus 253 LdLs~N~l~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~n~ 310 (1237)
||||+|..... .........+.|++|.|+.|..-..-.-..|...|.|.+|+..++-
T Consensus 318 LDLSD~v~l~~-~~~~~~~kf~~L~~lSlsRCY~i~p~~~~~l~s~psl~yLdv~g~v 374 (419)
T KOG2120|consen 318 LDLSDSVMLKN-DCFQEFFKFNYLQHLSLSRCYDIIPETLLELNSKPSLVYLDVFGCV 374 (419)
T ss_pred eccccccccCc-hHHHHHHhcchheeeehhhhcCCChHHeeeeccCcceEEEEecccc
Confidence 88888764322 1112223467888888888854322223457888999999988773
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.72 E-value=7.6e-09 Score=108.40 Aligned_cols=208 Identities=22% Similarity=0.206 Sum_probs=124.9
Q ss_pred cCCCccEEEcccccccCccchhhhhccCCCccEEeCCCCcCCCCcccccccCCCCCceeeccCccccCcccchhhccccc
Q 000889 246 NCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQL 325 (1237)
Q Consensus 246 ~~~~L~~LdLs~N~l~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~ 325 (1237)
.++.++.|||.+|.++.......+...++.|+.|+|++|.+...+.... ....+|++|.|.+..+........+..++.
T Consensus 69 ~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp-~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~ 147 (418)
T KOG2982|consen 69 SVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLP-LPLKNLRVLVLNGTGLSWTQSTSSLDDLPK 147 (418)
T ss_pred HhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCc-ccccceEEEEEcCCCCChhhhhhhhhcchh
Confidence 4556666777777776543344445667777777777777765444322 456788888888888876666677888999
Q ss_pred ceEEEecCCccCCC-Cchhhh-ccCCCCcEEecCCCcCCCC-CchhHhhhcCCCcEEEcccCcCCCC-CCcCcccccccc
Q 000889 326 LETLNMSHNALQGG-IPGFLL-GSFRNLKQLSLAHNQFAGE-IPPELGQACGTLRELDLSSNRLTGE-LPSTFASCSSLH 401 (1237)
Q Consensus 326 L~~L~Ls~N~l~~~-~~~~~~-~~l~~L~~L~L~~n~l~~~-ip~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~ 401 (1237)
+++|.+|.|.+.-. +..... ..-+.+++|++..|...-- --..+.+.++++..+-+..|.+... ....+..++.+-
T Consensus 148 vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~ 227 (418)
T KOG2982|consen 148 VTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSVFVCEGPLKTESSEKGSEPFPSLS 227 (418)
T ss_pred hhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchheeeecCcccchhhcccCCCCCcch
Confidence 99999998843210 000000 1122455555555432200 0012334457778888888877543 234555666777
Q ss_pred eeeccCccccCcccchhccccccceEEeccCCCCCCCCCc------cCCCCCCCcEEEc
Q 000889 402 SLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPL------SLTNCTQLRVLDL 454 (1237)
Q Consensus 402 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~------~l~~l~~L~~L~L 454 (1237)
-|+|+.|+|......+.+.++++|..|.+++|.+...+.. -++.++++++|+=
T Consensus 228 ~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~~~err~llIaRL~~v~vLNG 286 (418)
T KOG2982|consen 228 CLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLRGGERRFLLIARLTKVQVLNG 286 (418)
T ss_pred hhhhcccccccHHHHHHHcCCchhheeeccCCcccccccCCcceEEEEeeccceEEecC
Confidence 7888888876655556666777777777777777644322 1345555555543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.5e-08 Score=84.69 Aligned_cols=60 Identities=43% Similarity=0.643 Sum_probs=36.0
Q ss_pred ceeEEEccCCcCCccCCccccCCCCCcEEEecCcccccccccccccccCCcEEeCCCCcc
Q 000889 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771 (1237)
Q Consensus 712 ~L~~LdLs~N~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~P~~~~~L~~L~~L~Ls~N~l 771 (1237)
+|++|+|++|+++...+..|.++++|++|++++|+++...|..|.++++|+.|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 456666666666644445566666666666666666655555666666666666666654
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.4e-08 Score=84.93 Aligned_cols=61 Identities=46% Similarity=0.619 Sum_probs=56.6
Q ss_pred CCCcEEEecCcccccccccccccccCCcEEeCCCCccCCCCCCcccCcccccceecccccc
Q 000889 735 NYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNL 795 (1237)
Q Consensus 735 ~~L~~L~Ls~N~l~~~~P~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l 795 (1237)
++|++|++++|+++...+..|.++++|++||+++|+++...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4789999999999966668999999999999999999988888999999999999999986
|
... |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.65 E-value=5.4e-07 Score=102.18 Aligned_cols=171 Identities=21% Similarity=0.265 Sum_probs=128.0
Q ss_pred CeEEEEEEEC-CCCEEEEEEeccccCcCHHHHHHHHHHHHhcCCCCcccccceEEe----CCeEEEEEEeccCC-CHHHH
Q 000889 941 FGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI----GEERLLVYEYMKWG-SLESV 1014 (1237)
Q Consensus 941 fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~g-sL~~~ 1014 (1237)
-.+.|++... +|..|++|++..........-..-+++.+++.|+|||++.+++.. +...++||+|.++. +|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3678999765 789999999843333333233456788999999999999998863 34678999999864 67765
Q ss_pred Hhhhhc----------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeecccceeecc
Q 000889 1015 LHDRAK----------GGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1015 l~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~~~~ 1084 (1237)
-..... ..+...++...|.++.|++.||.++|+. |..-+-+.+.+|+++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 533221 1234568889999999999999999999 999999999999999999999988777765543
Q ss_pred CCcceeeeccccCCCcCCccccCccccCcccchHHHHHHHHHHHcCCCC
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRP 1133 (1237)
Q Consensus 1085 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~tg~~p 1133 (1237)
... |-+.+ -.+-|.=.+|.++..+.+|..-
T Consensus 446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 220 11211 2346888999999999999543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.65 E-value=4.6e-07 Score=99.87 Aligned_cols=141 Identities=16% Similarity=0.095 Sum_probs=101.2
Q ss_pred ceecccCCeEEEEEEECCCCEEEEEEeccccC-----------cCHHHHHHHHHHHHhcCCC--CcccccceEEe-----
Q 000889 934 SMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTG-----------QGDREFMAEMETIGKIKHR--NLVPLLGYCKI----- 995 (1237)
Q Consensus 934 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~----- 995 (1237)
+.+-+.....|++++. +|+.+.||+...... .....+.+|++.+.++... .+++++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444455777766 477899997643210 1112477899999888533 34455556543
Q ss_pred CCeEEEEEEeccCC-CHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCC-------
Q 000889 996 GEERLLVYEYMKWG-SLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE------- 1067 (1237)
Q Consensus 996 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~------- 1067 (1237)
....++|||++++. +|.+++..... .+.+......++.++++.+.-||.. ||+|+|++++|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCC
Confidence 23578999999976 89999864321 2445667778999999999999999 9999999999999975
Q ss_pred CCceEEeeccccee
Q 000889 1068 NFEARVSDFGMARL 1081 (1237)
Q Consensus 1068 ~~~vkl~DfGla~~ 1081 (1237)
++.+.++||+.++.
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 46899999998853
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.9e-08 Score=125.83 Aligned_cols=291 Identities=25% Similarity=0.279 Sum_probs=136.3
Q ss_pred ccceEEEecCCccCCCCchhhhccCCCCcEEecCCCc--CCCCCchhHhhhcCCCcEEEcccCcCCCCCCcCcccccccc
Q 000889 324 QLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQ--FAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLH 401 (1237)
Q Consensus 324 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~n~--l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 401 (1237)
...+...+-+|.+. .++.. ...++|++|-+..|. +. .++..+|..++.|+.|||++|.=-+.+|..++.+-+|+
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~--~~~~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lr 598 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGS--SENPKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLR 598 (889)
T ss_pred hheeEEEEeccchh-hccCC--CCCCccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhh
Confidence 34455555555443 22221 123345555555554 33 45555555555566666655544445555555555666
Q ss_pred eeeccCccccCcccchhccccccceEEeccCCCCCCCCCccCCCCCCCcEEEccCCcCcccCCCCCCCCCCCcccceecc
Q 000889 402 SLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVL 481 (1237)
Q Consensus 402 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~L 481 (1237)
.|+|++..++ ..+..+..+..|.+|++.++.-...+|.....|++|++|.+..-... .....+..+.++.+|+.+..
T Consensus 599 yL~L~~t~I~--~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~-~~~~~l~el~~Le~L~~ls~ 675 (889)
T KOG4658|consen 599 YLDLSDTGIS--HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALS-NDKLLLKELENLEHLENLSI 675 (889)
T ss_pred cccccCCCcc--ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccc-cchhhHHhhhcccchhhhee
Confidence 6666555554 23444555555555555555544444555555666666666554311 00111111223334444433
Q ss_pred cCceeeeccccccccccccc----EecccCCccccCCCccccCCcCcceeecccccccCccccccccc------CCCccE
Q 000889 482 PNNYLSGTVPLELGSCKNLK----TIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVN------GGNLET 551 (1237)
Q Consensus 482 ~~N~l~~~~~~~l~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~------l~~L~~ 551 (1237)
..... .+-..+..+..|. .+.+.++... ..+..++.+.+|+.|.+.++.+. ++....+.. ++++..
T Consensus 676 ~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~-e~~~~~~~~~~~~~~f~~l~~ 751 (889)
T KOG4658|consen 676 TISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGIS-EIVIEWEESLIVLLCFPNLSK 751 (889)
T ss_pred ecchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCc-hhhcccccccchhhhHHHHHH
Confidence 22222 0111122222222 2333333333 45556677777777777777765 221111110 111222
Q ss_pred EEccccccccccccccccCCCccEEEeecccccccCCccccCccccceEEecCCccccC-CCCCCCCCCCCCEEEC
Q 000889 552 LILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQ-VPQGLGKCRSLVWLDL 626 (1237)
Q Consensus 552 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~L 626 (1237)
+...++..- ..+.+.--.++|+.|.+..+.....+.+....+..+..+.+..+.+.+. .-...+.++++..+.+
T Consensus 752 ~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l 826 (889)
T KOG4658|consen 752 VSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPL 826 (889)
T ss_pred HHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEeccc
Confidence 212221111 1222223346777777777776655666666666666666666666654 2333444444444433
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.5e-07 Score=99.44 Aligned_cols=134 Identities=21% Similarity=0.198 Sum_probs=96.9
Q ss_pred CCCCceecccCCeEEEEEEECCCCEEEEEEecc----------ccCc------------CHHHHHHHHHHHHhcCCC--C
Q 000889 930 FSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIH----------VTGQ------------GDREFMAEMETIGKIKHR--N 985 (1237)
Q Consensus 930 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~----------~~~~------------~~~~~~~E~~~l~~l~h~--n 985 (1237)
+.+...||.|--+.||.|....|.++|+|.=.. .... ......+|+++|+++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456688999999999999999999999993210 0000 012356799999999755 7
Q ss_pred cccccceEEeCCeEEEEEEeccCCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 000889 986 LVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLL 1065 (1237)
Q Consensus 986 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll 1065 (1237)
|++.+++ +...+||||++|-.|...- ++......++..|++-+.-+-.. ||||+|+.+-||++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV 235 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILV 235 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEE
Confidence 8888765 5678999999987765432 12222333444444444444466 99999999999999
Q ss_pred CCCCceEEeecccce
Q 000889 1066 DENFEARVSDFGMAR 1080 (1237)
Q Consensus 1066 ~~~~~vkl~DfGla~ 1080 (1237)
+++|.+.++||--+.
T Consensus 236 ~~dg~~~vIDwPQ~v 250 (304)
T COG0478 236 TEDGDIVVIDWPQAV 250 (304)
T ss_pred ecCCCEEEEeCcccc
Confidence 999999999997664
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=2e-06 Score=95.05 Aligned_cols=265 Identities=14% Similarity=0.148 Sum_probs=153.0
Q ss_pred CCceecccCCeEEEEEEECCCCEEEEEEeccccCcCHHHHHHHHHHHHhc-CCCCcccccce------EEeC-CeEEEEE
Q 000889 932 ADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKI-KHRNLVPLLGY------CKIG-EERLLVY 1003 (1237)
Q Consensus 932 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~~~~-~~~~lv~ 1003 (1237)
..+.||+|+-+.+|-.--- +. .+.|+..........+ .+..|... .||-+-.-+.+ ...+ ....+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh-hc-hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 3457999999999965321 22 2344443222221222 12222222 45543321111 1112 2356788
Q ss_pred EeccCCC-HHHHHhhh-hcCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeeCCCCceEEeeccccee
Q 000889 1004 EYMKWGS-LESVLHDR-AKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081 (1237)
Q Consensus 1004 e~~~~gs-L~~~l~~~-~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDikp~NIll~~~~~vkl~DfGla~~ 1081 (1237)
..+.|.. ...+..-. ++..-....|....+++..+|.+.+.||.. |.+-+|+.++|+|+++++.|.+.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceee
Confidence 8877652 23333211 111224568999999999999999999999 999999999999999999999998654433
Q ss_pred eccCCcceeeeccccCCCcCCccccC-----ccccCcccchHHHHHHHHHHHcC-CCCCCCCCCCCCc--hHH-HHHHHH
Q 000889 1082 VNALDTHLSVSTLAGTPGYVPPEYYQ-----SFRCTTKGDVYSYGVILLELLSG-KRPIDPSEFGDDN--NLV-GWAKQL 1152 (1237)
Q Consensus 1082 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGv~l~el~tg-~~p~~~~~~~~~~--~~~-~~~~~~ 1152 (1237)
.. ........+|...|.+||... +...+...|.|.+||++++++.| +.||.+-....+. .+. ......
T Consensus 167 ~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 167 NA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred cc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 32 222334567899999999764 34456779999999999999886 9999864322211 111 000000
Q ss_pred hhh--cccccccCccccCCCCCHHHHHHHHHHHHhcccc--CCCCCCCHHHHHHHHHhccc
Q 000889 1153 HRE--KRINEILDPELTMQTSDETELYQYLRISFECLDD--RPFKRPTMIQVMAMFKELQV 1209 (1237)
Q Consensus 1153 ~~~--~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~--dP~~RPt~~ell~~L~~l~~ 1209 (1237)
... +.-.....+ +.......-...+.-+..+|+.. .+.-|||++..+..|..+..
T Consensus 244 f~ya~~~~~g~~p~--P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 244 FAYASDQRRGLKPP--PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred eeechhccCCCCCC--CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 000 000000011 11111111122344455578854 36789999988887766543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.61 E-value=2e-07 Score=96.66 Aligned_cols=126 Identities=22% Similarity=0.268 Sum_probs=82.2
Q ss_pred EEEEEEECCCCEEEEEEecccc-------------Cc--------C-----HHHHHHHHHHHHhcCCC--CcccccceEE
Q 000889 943 EVYKAQLRDGSVVAIKKLIHVT-------------GQ--------G-----DREFMAEMETIGKIKHR--NLVPLLGYCK 994 (1237)
Q Consensus 943 ~Vy~~~~~~~~~vavK~~~~~~-------------~~--------~-----~~~~~~E~~~l~~l~h~--niv~l~~~~~ 994 (1237)
.||.|...+|..+|+|...... .. . .....+|++.|.++..- ++++++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899999889999999764210 00 0 01256799999999755 567776542
Q ss_pred eCCeEEEEEEecc--CCCHHHHHhhhhcCCCCccCHHHHHHHHHHHHHHHHH-HHhcCCCCeeecCCCCCCeeeCCCCce
Q 000889 995 IGEERLLVYEYMK--WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAF-LHHSCIPHIIHRDMKSSNVLLDENFEA 1071 (1237)
Q Consensus 995 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~y-LH~~~~~~ivHrDikp~NIll~~~~~v 1071 (1237)
..++||||++ |..+..+.... ++......++.+++..+.. +|.. |+||+|+.+.||+++++ .+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eE
Confidence 4579999999 66665543321 1123345667777775555 4677 99999999999999988 89
Q ss_pred EEeecccceeec
Q 000889 1072 RVSDFGMARLVN 1083 (1237)
Q Consensus 1072 kl~DfGla~~~~ 1083 (1237)
.++|||.+....
T Consensus 146 ~iIDf~qav~~~ 157 (188)
T PF01163_consen 146 YIIDFGQAVDSS 157 (188)
T ss_dssp EE--GTTEEETT
T ss_pred EEEecCcceecC
Confidence 999999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.56 E-value=3e-08 Score=104.09 Aligned_cols=244 Identities=19% Similarity=0.178 Sum_probs=127.7
Q ss_pred CCceeeeeecCCCCceeEEecCCCCCCCccc-cccccCCCCCCeEEccCCCCCccc-chhhhhcCcccceecccCCcccC
Q 000889 88 TPCSWQGVSCSLNSHVTSLNLNNSGLSGSLN-LTTLTALPYLEHLNLQGNSFSAGD-LSTSKTSSCSLVTMDLSSNNITG 165 (1237)
Q Consensus 88 ~~c~W~gv~c~~~~~v~~L~L~~~~l~~~~~-~~~l~~l~~L~~L~Ls~n~l~~~~-~~~~~~~~~~L~~L~Ls~n~l~g 165 (1237)
..|...||.-- +...-|.|+++.+-.... ...-..+++++.|||.+|.|++.. +..++..++.|+.|+|+.|.+..
T Consensus 34 ~g~s~~~v~s~--ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s 111 (418)
T KOG2982|consen 34 AGLSYLGVSSL--RALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSS 111 (418)
T ss_pred cccceeeeccc--cchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCC
Confidence 34566666432 223344455555533322 223345667788888888887643 45567777777777777777753
Q ss_pred CcccccccccCCccceEEccCCccCCCccccCCcccEEEcCCCCCCCchhhhccccCCCCCCEEEccCCCCCch--hhhh
Q 000889 166 SLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGK--LNAT 243 (1237)
Q Consensus 166 ~~~~~~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~Ls~N~i~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~--~~~~ 243 (1237)
.|--. -....+|+.|-|.+.++.... ....+..++.++.|.+|.|.+.-. ....
T Consensus 112 ~I~~l--p~p~~nl~~lVLNgT~L~w~~----------------------~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c 167 (418)
T KOG2982|consen 112 DIKSL--PLPLKNLRVLVLNGTGLSWTQ----------------------STSSLDDLPKVTELHMSDNSLRQLNLDDNC 167 (418)
T ss_pred ccccC--cccccceEEEEEcCCCCChhh----------------------hhhhhhcchhhhhhhhccchhhhhcccccc
Confidence 32210 023446666666665554311 111233444444444444422100 0000
Q ss_pred cccC-CCccEEEcccccccCccchhhhhccCCCccEEeCCCCcCCCCcccccccCCCCCceeeccCccccCcccchhhcc
Q 000889 244 SVNC-KSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKN 322 (1237)
Q Consensus 244 ~~~~-~~L~~LdLs~N~l~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~ 322 (1237)
.... +.+++|++..|...--....-.....+++..+.+..|.+.+......+..++.+..|+|+.|+|....--..+.+
T Consensus 168 ~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~ 247 (418)
T KOG2982|consen 168 IEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNG 247 (418)
T ss_pred ccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcC
Confidence 0101 123333333333221111111123345677777777777655555566677777788888888755444456777
Q ss_pred cccceEEEecCCccCCCCch-----hhhccCCCCcEEecC
Q 000889 323 CQLLETLNMSHNALQGGIPG-----FLLGSFRNLKQLSLA 357 (1237)
Q Consensus 323 l~~L~~L~Ls~N~l~~~~~~-----~~~~~l~~L~~L~L~ 357 (1237)
+++|..|.+++|.+.+.+.. .+++.+++++.|+=+
T Consensus 248 f~~l~dlRv~~~Pl~d~l~~~err~llIaRL~~v~vLNGs 287 (418)
T KOG2982|consen 248 FPQLVDLRVSENPLSDPLRGGERRFLLIARLTKVQVLNGS 287 (418)
T ss_pred CchhheeeccCCcccccccCCcceEEEEeeccceEEecCc
Confidence 78888888888877654322 134566666666543
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=1e-07 Score=121.05 Aligned_cols=271 Identities=23% Similarity=0.254 Sum_probs=130.2
Q ss_pred cceEEEecCCc--cCCCCchhhhccCCCCcEEecCCCcCCCCCchhHhhhcCCCcEEEcccCcCCCCCCcCcccccccce
Q 000889 325 LLETLNMSHNA--LQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHS 402 (1237)
Q Consensus 325 ~L~~L~Ls~N~--l~~~~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 402 (1237)
+|+.|-+..|. +. .++..+|..++.|+.|||++|.=-+.+|..++.. -+|++|+|++..+. .+|..+.++..|.+
T Consensus 546 ~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~L-i~LryL~L~~t~I~-~LP~~l~~Lk~L~~ 622 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGEL-VHLRYLDLSDTGIS-HLPSGLGNLKKLIY 622 (889)
T ss_pred ccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhh-hhhhcccccCCCcc-ccchHHHHHHhhhe
Confidence 45555555554 22 3444445555555555555554333555555543 45555555555555 45555555555555
Q ss_pred eeccCccccCcccchhccccccceEEeccCCC--CCCCCCccCCCCCCCcEEEccCCcCcccCCCCCCCCCCCc-cccee
Q 000889 403 LNLGSNMLSGNFLNTVVSKISSLIYLYVPFNN--ISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFP-ALEKI 479 (1237)
Q Consensus 403 L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~--i~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~-~L~~L 479 (1237)
|++..+.-... .+.....+++|++|.+..-. .+...-..+.++.+|+.+........ +-..+.....+. ..+.+
T Consensus 623 Lnl~~~~~l~~-~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~~--~~e~l~~~~~L~~~~~~l 699 (889)
T KOG4658|consen 623 LNLEVTGRLES-IPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSVL--LLEDLLGMTRLRSLLQSL 699 (889)
T ss_pred ecccccccccc-ccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchhH--hHhhhhhhHHHHHHhHhh
Confidence 55555432211 13344445555555554432 11122233344455555544333220 000110001111 11222
Q ss_pred cccCceeeecccccccccccccEecccCCccccCCCccccC------CcCcceeecccccccCcccccccccCCCccEEE
Q 000889 480 VLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWS------LPNLSDLVMWANNLTGEIPEGICVNGGNLETLI 553 (1237)
Q Consensus 480 ~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~ 553 (1237)
.+.++... ..+..+..+.+|+.|.+.++.+.......... ++++..+...++.....+... .-.++|+.|+
T Consensus 700 ~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~r~l~~~--~f~~~L~~l~ 776 (889)
T KOG4658|consen 700 SIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHMLRDLTWL--LFAPHLTSLS 776 (889)
T ss_pred hhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccccccchh--hccCcccEEE
Confidence 22222222 34556667777788877777765332222221 222222222222211111111 2346899999
Q ss_pred ccccccccccccccccCCCccEEEeeccccccc-CCccccCccccceEEecC
Q 000889 554 LNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGE-IPAGIGNLVKLAILQLGN 604 (1237)
Q Consensus 554 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~L~~L~~L~L~~ 604 (1237)
+..+.....+......+..+..+-+..+.+.+. .-.+.+.++++..+.+..
T Consensus 777 l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l~~ 828 (889)
T KOG4658|consen 777 LVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPLSF 828 (889)
T ss_pred EecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEecccCc
Confidence 998887766666666777777777777777755 334455555555554443
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.9e-09 Score=123.52 Aligned_cols=178 Identities=24% Similarity=0.247 Sum_probs=90.3
Q ss_pred ccccCCCCCCeEEccCCCCCc-ccchhhhhcCcccceecccCCc--c----c---CCcccccccccCCccceEEccCCcc
Q 000889 120 TTLTALPYLEHLNLQGNSFSA-GDLSTSKTSSCSLVTMDLSSNN--I----T---GSLPGRSFLLSCDRLSYVNLSHNSI 189 (1237)
Q Consensus 120 ~~l~~l~~L~~L~Ls~n~l~~-~~~~~~~~~~~~L~~L~Ls~n~--l----~---g~~~~~~~l~~~~~L~~L~ls~n~l 189 (1237)
-.+..++.|+.|.|.+|.++. .++..+. .+|++|..++-- + + |++.- .-.-..|...+++.|.+
T Consensus 103 i~ifpF~sLr~LElrg~~L~~~~GL~~lr---~qLe~LIC~~Sl~Al~~v~ascggd~~n---s~~Wn~L~~a~fsyN~L 176 (1096)
T KOG1859|consen 103 ISIFPFRSLRVLELRGCDLSTAKGLQELR---HQLEKLICHNSLDALRHVFASCGGDISN---SPVWNKLATASFSYNRL 176 (1096)
T ss_pred ceeccccceeeEEecCcchhhhhhhHHHH---HhhhhhhhhccHHHHHHHHHHhcccccc---chhhhhHhhhhcchhhH
Confidence 346677888999999988854 2222222 344555444320 0 0 11110 00122566666666666
Q ss_pred CC--CccccCCcccEEEcCCCCCCCchhhhccccCCCCCCEEEccCCCCCchhhhhcccCCCccEEEcccccccCccchh
Q 000889 190 SG--GSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPAS 267 (1237)
Q Consensus 190 ~~--~~~~~~~~L~~L~Ls~N~i~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~LdLs~N~l~~~~~~~ 267 (1237)
+. ..+...+.|+.|||++|++++.. .+..|+.|++|||++|++..+..-...+|+ |..|.|++|.++...
T Consensus 177 ~~mD~SLqll~ale~LnLshNk~~~v~----~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL~--- 248 (1096)
T KOG1859|consen 177 VLMDESLQLLPALESLNLSHNKFTKVD----NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTLR--- 248 (1096)
T ss_pred HhHHHHHHHHHHhhhhccchhhhhhhH----HHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhhh---
Confidence 53 44555566666666666665532 345556666666666655444333333343 444444444444211
Q ss_pred hhhccCCCccEEeCCCCcCCCCcccccccCCCCCceeeccCccccCcccchhhcccccceEEEecCCccC
Q 000889 268 FVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQ 337 (1237)
Q Consensus 268 ~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~Ls~N~l~ 337 (1237)
.+.++.+|+.|||++|-|.+..--..+..+..|+.|.|.+|.+-
T Consensus 249 --------------------------gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 249 --------------------------GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred --------------------------hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 23445555555555555544332334455556666666666554
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1237 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-125 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-124 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-65 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-64 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-45 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-44 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-37 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-36 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-36 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-35 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-29 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-28 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-22 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-22 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-22 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-22 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-22 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-22 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-21 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-21 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-21 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-19 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-16 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 5e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-15 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-15 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-15 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-15 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-15 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-14 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-08 | ||
| 3j0a_A | 844 | Homology Model Of Human Toll-Like Receptor 5 Fitted | 2e-08 | ||
| 3j0a_A | 844 | Homology Model Of Human Toll-Like Receptor 5 Fitted | 1e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 7e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-07 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 1e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-06 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 1e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-06 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-06 | ||
| 2z63_A | 570 | Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A | 8e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-05 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 1e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-05 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 2e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-05 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 8e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-05 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 9e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into An Electron Microscopy Single Particle Reconstruction Length = 844 | Back alignment and structure |
|
| >pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into An Electron Microscopy Single Particle Reconstruction Length = 844 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 690 bits (1784), Expect = 0.0
Identities = 315/802 (39%), Positives = 457/802 (56%), Gaps = 51/802 (6%)
Query: 48 SSSSRQSGGNEELTILMAFKQSSIGSDPNGYLANWTADALTPCSWQGVSCSLNSHVTSLN 107
+S E+ L++FK L +W+++ PC++ GV+C + VTS++
Sbjct: 2 FQASPSQSLYREIHQLISFKDVL---PDKNLLPDWSSNK-NPCTFDGVTCR-DDKVTSID 56
Query: 108 LNNSGLSGSLNL--TTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNITG 165
L++ L+ + ++L +L LE L L + + G +S S SL ++DLS N+++G
Sbjct: 57 LSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHIN-GSVS-GFKCSASLTSLDLSRNSLSG 114
Query: 166 SLPGRSFLLSCDRLSYVNLSHNSISG-GSLHIG---PSLLQLDLSGNQISDSALLTYSLS 221
+ + L SC L ++N+S N++ G + G SL LDLS N IS + ++ + LS
Sbjct: 115 PVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLS 174
Query: 222 NCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDL 281
+ C + + +S N +SG++ S +L++LD+
Sbjct: 175 D-----------------------GCGELKHLAISGNKISGDVDVS----RCVNLEFLDV 207
Query: 282 SHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIP 341
S NNF+ G C L + +S N LSG +F ++ C L+ LN+S N G IP
Sbjct: 208 SSNNFSTGIP--FLGDCSALQHLDISGNKLSG-DFSRAISTCTELKLLNISSNQFVGPIP 264
Query: 342 GFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLH 401
L ++L+ LSLA N+F GEIP L AC TL LDLS N G +P F SCS L
Sbjct: 265 PLPL---KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLE 321
Query: 402 SLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCT-QLRVLDLSSNGFT 460
SL L SN SG + K+ L L + FN SG +P SLTN + L LDLSSN F+
Sbjct: 322 SLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFS 381
Query: 461 GTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWS 520
G I C P L+++ L NN +G +P L +C L ++ LSFN L+G +PS + S
Sbjct: 382 GPILPNLCQNP-KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGS 440
Query: 521 LPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSS 580
L L DL +W N L GEIP+ + LETLIL+ N LTG IP +++CTN+ W+SLS+
Sbjct: 441 LSKLRDLKLWLNMLEGEIPQELM-YVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSN 499
Query: 581 NQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELA 640
N+LTGEIP IG L LAIL+L NNS +G +P LG CRSL+WLDLN+N +G +P+ +
Sbjct: 500 NRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMF 559
Query: 641 NQAGVVMPGIVSGKQFAFVRNEG-GTACRGAGGLVEFEGIRPERLEGFPMVHSCP-STRI 698
Q+G + ++GK++ +++N+G C GAG L+EF+GIR E+L + C ++R+
Sbjct: 560 KQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRV 619
Query: 699 YTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGL 758
Y G T TF NGS+++LD+SYN LSG +P+ GS+ YL +LNLGHN ++G IPD G L
Sbjct: 620 YGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDL 679
Query: 759 KAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSG 818
+ + +LDLS N G IP ++ L+ L+++D+SNNNLSG IP GQ TFP +++ NN G
Sbjct: 680 RGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPG 739
Query: 819 LCGLPLLPCSSGNHAATVHPHE 840
LCG PL C N H
Sbjct: 740 LCGYPLPRCDPSNADGYAHHQR 761
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 413 bits (1063), Expect = e-135
Identities = 130/306 (42%), Positives = 193/306 (63%), Gaps = 15/306 (4%)
Query: 915 LRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQG-DREFMA 973
L++ + L A++ FS +++G GGFG+VYK +L DG++VA+K+L QG + +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 974 EMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKK 1033
E+E I HRNL+ L G+C ERLLVY YM GS+ S L +R + LDW R++
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP-LDWPKRQR 135
Query: 1034 IAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVST 1093
IA+GSARGLA+LH C P IIHRD+K++N+LLDE FEA V DFG+A+L++ DTH V+T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTT 193
Query: 1094 -LAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEF--GDDNNLVGWAK 1150
+ GT G++ PEY + + + K DV+ YGV+LLEL++G+R D + DD L+ W K
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 1151 QLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVD 1210
L +EK++ ++D +L + E+ Q ++++ C P +RP M +V+ M
Sbjct: 254 GLLKEKKLEALVDVDLQGN-YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML------ 306
Query: 1211 TEGDSL 1216
EGD L
Sbjct: 307 -EGDGL 311
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 386 bits (995), Expect = e-125
Identities = 117/318 (36%), Positives = 176/318 (55%), Gaps = 9/318 (2%)
Query: 891 GSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQLR 950
GS K ++ + ++ L EATN F +IG G FG+VYK LR
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 951 DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGS 1010
DG+ VA+K+ + QG EF E+ET+ +H +LV L+G+C E +L+Y+YM+ G+
Sbjct: 62 DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121
Query: 1011 LESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFE 1070
L+ L+ + + W R +I IG+ARGL +LH IIHRD+KS N+LLDENF
Sbjct: 122 LKRHLYGSDLPTMS-MSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFV 177
Query: 1071 ARVSDFGMARLVNALD-THLSVST-LAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELL 1128
+++DFG+++ LD TH +ST + GT GY+ PEY+ R T K DVYS+GV+L E+L
Sbjct: 178 PKITDFGISKKGTELDQTH--LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235
Query: 1129 SGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLD 1188
+ I S + NL WA + H ++ +I+DP L + E L ++ + +CL
Sbjct: 236 CARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPE-SLRKFGDTAVKCLA 294
Query: 1189 DRPFKRPTMIQVMAMFKE 1206
RP+M V+ +
Sbjct: 295 LSSEDRPSMGDVLWKLEY 312
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 363 bits (935), Expect = e-116
Identities = 101/308 (32%), Positives = 164/308 (53%), Gaps = 26/308 (8%)
Query: 915 LRKLTFAHLLEATNGFS------ADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVT---- 964
+F L TN F + +G GGFG VYK + + + VA+KKL +
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 70
Query: 965 GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGT 1024
+ ++F E++ + K +H NLV LLG+ G++ LVY YM GSL L G
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL--DGTP 128
Query: 1025 KLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084
L W R KIA G+A G+ FLH + IHRD+KS+N+LLDE F A++SDFG+AR
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 1085 LD-THLSVST-LAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDD 1142
T +++ + GT Y+ PE + T K D+YS+GV+LLE+++G +D +
Sbjct: 186 FAQTV--MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR--EP 240
Query: 1143 NNLVGWAKQLHREKR-INEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVM 1201
L+ +++ E++ I + +D ++ +D T + ++ +CL ++ KRP + +V
Sbjct: 241 QLLLDIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 298
Query: 1202 AMFKELQV 1209
+ +E+
Sbjct: 299 QLLQEMTA 306
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 322 bits (827), Expect = 3e-96
Identities = 136/690 (19%), Positives = 230/690 (33%), Gaps = 89/690 (12%)
Query: 150 SCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISG---GSLHIGPSLLQLDLS 206
+ S D S +T +P ++ +NL+HN + + L LD+
Sbjct: 3 TVSHEVADCSHLKLT-QVPDDLP----TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVG 57
Query: 207 GNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPA 266
N IS L L +LN N+L + T C +++ + L N +
Sbjct: 58 FNTISK--LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNN 115
Query: 267 SFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPA-SLKNCQL 325
F +L LDLSHN + + NL + LS N + + +
Sbjct: 116 PF--VKQKNLITLDLSHNGLSS-TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSS 172
Query: 326 LETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGT--LRELDLSS 383
L+ L +S N ++ PG + L L L + Q + +L +R L LS+
Sbjct: 173 LKKLELSSNQIKEFSPG-CFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSN 231
Query: 384 NRLTGELPSTFASC--SSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPL 441
++L+ +TF ++L L+L N L+ N + + L Y ++ +NNI
Sbjct: 232 SQLSTTSNTTFLGLKWTNLTMLDLSYNNLNV-VGNDSFAWLPQLEYFFLEYNNIQHLFSH 290
Query: 442 SLTNCTQLRVLDLSSNGFTGTIPSGFCSPP------NFPALEKIVLPNNYLSGTVPLELG 495
SL +R L+L + +I LE + + +N + G
Sbjct: 291 SLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFT 350
Query: 496 SCKNLKTIDLSFNSL-AGPVPSEIWS---LPNLSDLVMWANNLTGEIPEGICVNGGNLET 551
NLK + LS + + +E + L L + N ++ + G+LE
Sbjct: 351 GLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFS-WLGHLEV 409
Query: 552 LILNNNHLTGAIPKS-IASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTG- 609
L L N + + N+ + LS N+ + L L L +L
Sbjct: 410 LDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNV 469
Query: 610 -QVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACR 668
P R+L LDL++NN++
Sbjct: 470 DSSPSPFQPLRNLTILDLSNNNIA------------------------------------ 493
Query: 669 GAGGLVEFEGIRPERLEGFPMVH---------SCPSTRIYTGMTMYTFTTNGSLIYLDLS 719
I + LEG + + G +Y L L+L
Sbjct: 494 ---------NINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLE 544
Query: 720 YNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSL 779
N E F L L++++LG N L F ++ L+L N
Sbjct: 545 SNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVF 604
Query: 780 G-GLSFLSDLDVSNNNLSGIIPSGGQLTTF 808
G L++LD+ N S +
Sbjct: 605 GPAFRNLTELDMRFNPFDCTCESIAWFVNW 634
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 292 bits (750), Expect = 1e-85
Identities = 125/569 (21%), Positives = 208/569 (36%), Gaps = 39/569 (6%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSC-SLVTMDLS 159
S +TSL++ + +S L LP L+ LNLQ N S LS + C +L + L
Sbjct: 49 SQLTSLDVGFNTISK-LEPELCQKLPMLKVLNLQHNELS--QLSDKTFAFCTNLTELHLM 105
Query: 160 SNNITGSLPGRSFLLSCDRLSYVNLSHNSISG---GSLHIGPSLLQLDLSGNQISDSALL 216
SN+I + L ++LSHN +S G+ +L +L LS N+I
Sbjct: 106 SNSIQKIKNN--PFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163
Query: 217 TYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSG-S 275
+ +L L S N++ + + L+ L + + + S
Sbjct: 164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTS 223
Query: 276 LKYLDLSHNNFTGKFSNLDFGRCG--NLSVITLSQNGLSGTEFPASLKNCQLLETLNMSH 333
++ L LS++ + SN F NL+++ LS N L+ S LE + +
Sbjct: 224 IRNLSLSNSQLST-TSNTTFLGLKWTNLTMLDLSYNNLNVVG-NDSFAWLPQLEYFFLEY 281
Query: 334 NALQGGIPGFLLGSFRNLKQLSLAHNQFAG--------EIPPELGQACGTLRELDLSSNR 385
N +Q L N++ L+L + +I Q L L++ N
Sbjct: 282 NNIQHLFSHS-LHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDND 340
Query: 386 LTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVV---SKISSLIYLYVPFNNISGPVPLS 442
+ G + F +L L+L ++ S L S L L + N IS +
Sbjct: 341 IPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDA 400
Query: 443 LTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKT 502
+ L VLDL N + + +I L N +L+
Sbjct: 401 FSWLGHLEVLDLGLNEIGQELTGQ--EWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQR 458
Query: 503 IDLSFNSLAG--PVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLT 560
+ L +L PS L NL+ L + NN+ I + + LE L L +N+L
Sbjct: 459 LMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN-INDDMLEGLEKLEILDLQHNNLA 517
Query: 561 --------GAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVP 612
G + +++ ++L SN +L +L I+ LG N+L
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577
Query: 613 QGLGKCRSLVWLDLNSNNLSGPLPSELAN 641
SL L+L N ++
Sbjct: 578 SVFNNQVSLKSLNLQKNLITSVEKKVFGP 606
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 7e-81
Identities = 120/557 (21%), Positives = 204/557 (36%), Gaps = 46/557 (8%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSS 160
+++T L+L ++ + N L L+L N S+ L T +L + LS+
Sbjct: 97 TNLTELHLMSNSIQKIKN-NPFVKQKNLITLDLSHNGLSSTKLGTQVQLE-NLQELLLSN 154
Query: 161 NNITGSLPGRSFLLSCDRLSYVNLSHNSISG---GSLHIGPSLLQLDLSGNQISDSAL-L 216
N I + + L + LS N I G H L L L+ Q+ S
Sbjct: 155 NKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEK 214
Query: 217 TYSLSNCQNLNLLNFSDNKLPGKLNATSVNCK--SISTIDLSYNLLSGEIPASFVADSSG 274
++ L+ S+++L N T + K +++ +DLSYN L+ SF
Sbjct: 215 LCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF--AWLP 272
Query: 275 SLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEF--------PASLKNCQLL 326
L+Y L +NN FS+ N+ + L ++ + S + + L
Sbjct: 273 QLEYFFLEYNNIQHLFSH-SLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331
Query: 327 ETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPE---LGQACGTLRELDLSS 383
E LNM N + G I + NLK LSL+++ + + A L L+L+
Sbjct: 332 EHLNMEDNDIPG-IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTK 390
Query: 384 NRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSL 443
N+++ F+ L L+LG N + + ++ +Y+ +N S
Sbjct: 391 NKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSF 450
Query: 444 TNCTQLRVLDLSSNGFTG--TIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLK 501
L+ L L + PS F L + L NN ++ L + L+
Sbjct: 451 ALVPSLQRLMLRRVALKNVDSSPSPFQ---PLRNLTILDLSNNNIANINDDMLEGLEKLE 507
Query: 502 TIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTG 561
+DL N+L + +W N + + L+ +L L L +N
Sbjct: 508 ILDLQHNNL-----ARLWKHANPGGPIYFLKGLS------------HLHILNLESNGFDE 550
Query: 562 AIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKC-RS 620
+ + + L N L + N V L L L N +T + G R+
Sbjct: 551 IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610
Query: 621 LVWLDLNSNNLSGPLPS 637
L LD+ N S
Sbjct: 611 LTELDMRFNPFDCTCES 627
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 8e-81
Identities = 115/570 (20%), Positives = 190/570 (33%), Gaps = 59/570 (10%)
Query: 98 SLNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMD 157
L +++T LNL ++ L L T L L D
Sbjct: 22 DLPTNITVLNLTHNQLRR-LPAANFTRYSQLTSL-------------------------D 55
Query: 158 LSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISG---GSLHIGPSLLQLDLSGNQISDSA 214
+ N I+ P L +NL HN +S + +L +L L N I
Sbjct: 56 VGFNTISKLEPE--LCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK-- 111
Query: 215 LLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSG 274
+ +NL L+ S N L T V +++ + LS N + ++
Sbjct: 112 IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANS 171
Query: 275 SLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQL--LETLNMS 332
SLK L+LS N FS F G L + L+ L + + L++S
Sbjct: 172 SLKKLELSSNQIKE-FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLS 230
Query: 333 HNALQGGIPGFLLG-SFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELP 391
++ L LG + NL L L++N L L N +
Sbjct: 231 NSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAW-LPQLEYFFLEYNNIQHLFS 289
Query: 392 STFASCSSLHSLNLGSNMLSGNFLNTVVSKI--------SSLIYLYVPFNNISGPVPLSL 443
+ ++ LNL + + + KI L +L + N+I G
Sbjct: 290 HSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMF 349
Query: 444 TNCTQLRVLDLSSNGFT-GTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKT 502
T L+ L LS++ + T+ + L + L N +S +L+
Sbjct: 350 TGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEV 409
Query: 503 IDLSFNSLAGPVP-SEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTG 561
+DL N + + E L N+ ++ + N + +L+ L+L L
Sbjct: 410 LDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ-LTRNSFALVPSLQRLMLRRVALKN 468
Query: 562 --AIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLT--------GQV 611
+ P N+ + LS+N + + L KL IL L +N+L G
Sbjct: 469 VDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGP 528
Query: 612 PQGLGKCRSLVWLDLNSNNLSGPLPSELAN 641
L L L+L SN +
Sbjct: 529 IYFLKGLSHLHILNLESNGFDEIPVEVFKD 558
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 3e-74
Identities = 105/501 (20%), Positives = 176/501 (35%), Gaps = 43/501 (8%)
Query: 326 LETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNR 385
E + SH L +P L N+ L+L HNQ + L LD+ N
Sbjct: 6 HEVADCSHLKLTQ-VPDDL---PTNITVLNLTHNQLRRLPAANFTR-YSQLTSLDVGFNT 60
Query: 386 LTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTN 445
++ P L LNL N LS + + ++L L++ N+I
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQ-LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 446 CTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKN--LKTI 503
L LDLS NG + T L++++L NN + EL N LK +
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQV---QLENLQELLLSNNKIQALKSEELDIFANSSLKKL 176
Query: 504 DLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGN--LETLILNNNHLTG 561
+LS N + P ++ L L + L + E +C+ N + L L+N+ L+
Sbjct: 177 ELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST 236
Query: 562 AIPKSIASC--TNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCR 619
+ TN+ + LS N L L +L L N++ L
Sbjct: 237 TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLF 296
Query: 620 SLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSG----KQFAFVRNEGGTACRGAGGLVE 675
++ +L+L + + + + N+
Sbjct: 297 NVRYLNLKRSFTKQSISL---ASLPKIDDFSFQWLKCLEHLNMEDND------------- 340
Query: 676 FEGIRPERLEGFP------MVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPE 729
GI+ G + +S S R T T + L L+L+ N +S +
Sbjct: 341 IPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETF-VSLAHSPLHILNLTKNKISKIESD 399
Query: 730 NFGSLNYLQVLNLGHNKLTGHIP-DSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDL 788
F L +L+VL+LG N++ + + GL+ I + LS+N + S + L L
Sbjct: 400 AFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRL 459
Query: 789 DVSNNNLSGIIPSGGQLTTFP 809
+ L + S
Sbjct: 460 MLRRVALKNVDSSPSPFQPLR 480
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 6e-47
Identities = 75/396 (18%), Positives = 123/396 (31%), Gaps = 44/396 (11%)
Query: 446 CT-QLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTID 504
CT V D S T +P + + L +N L L ++D
Sbjct: 2 CTVSHEVADCSHLKLT-QVPDDL-----PTNITVLNLTHNQLRRLPAANFTRYSQLTSLD 55
Query: 505 LSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIP 564
+ FN+++ P LP L L + N L+ + + NL L L +N +
Sbjct: 56 VGFNTISKLEPELCQKLPMLKVLNLQHNELSQ-LSDKTFAFCTNLTELHLMSNSIQKIKN 114
Query: 565 KSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLG--KCRSLV 622
N++ + LS N L+ L L L L NN + + L SL
Sbjct: 115 NPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLK 174
Query: 623 WLDLNSNNLSGPLPSELANQAGVVMPGI----VSGKQFAFVRNEGGTACRGAGGLVE--- 675
L+L+SN + P + + ++ Q E +
Sbjct: 175 KLELSSNQIKEFSPGCFHA-----IGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSL 229
Query: 676 ----FEGIRPERLEGFPMVHSCPSTRIY------TGMTMYTFTTNGSLIYLDLSYNSLSG 725
G + T + + +F L Y L YN++
Sbjct: 230 SNSQLSTTSNTTFLGLKWTN---LTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH 286
Query: 726 TLPENFGSLNYLQVLNLGHN---------KLTGHIPDSFGGLKAIGVLDLSHNNFQGSIP 776
+ L ++ LNL + L SF LK + L++ N+ G
Sbjct: 287 LFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS 346
Query: 777 GSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASR 812
GL L L +SN+ S + + S
Sbjct: 347 NMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSP 382
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 3e-85
Identities = 92/592 (15%), Positives = 178/592 (30%), Gaps = 94/592 (15%)
Query: 79 LANWTADALTPCSW---QGVSCSLNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQG 135
ANW + W GVS + N VT L+L G SG + + L LE L L
Sbjct: 57 GANWNFNK-ELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVP-DAIGQLTELEVLALGS 114
Query: 136 NSFSAGDLST---SKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGG 192
+ + +++ S + + L ++ +
Sbjct: 115 HGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKS 174
Query: 193 ---SLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKS 249
S I Q+ N I+ ++ ++ L ++ + + ++
Sbjct: 175 IKKSSRITLKDTQIGQLSNNITF---VSKAVMRLTKLRQFYMGNSPFVAENICEAWENEN 231
Query: 250 ISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQN 309
Y + D+ L +++ + K + +I ++ N
Sbjct: 232 -----SEYAQQYKTEDLKW--DNLKDLTDVEVYNCPNLTKLPT-FLKALPEMQLINVACN 283
Query: 310 GLSGTE-------FPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFA 362
E A + ++ + + +N L+ L + L L +NQ
Sbjct: 284 RGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLE 343
Query: 363 GEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKI 422
G P G L L+L+ N++T + + +L+ N L
Sbjct: 344 G-KLPAFGS-EIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYI--------- 392
Query: 423 SSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLP 482
P + + + +D S N F
Sbjct: 393 ---------------PNIFDAKSVSVMSAIDFSYNEIGSVDGKNF--------------- 422
Query: 483 NNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTG------ 536
+ N+ +I+LS N ++ + LS + + N LT
Sbjct: 423 -----DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSL 477
Query: 537 -EIPEGICVNGGNLETLILNNNHLTGAIPKSIA--SCTNMLWVSLSSNQLTGEIPAGIGN 593
+ E N L ++ L N LT + + ++ + LS N + P N
Sbjct: 478 KDENENFK-NTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLN 534
Query: 594 LVKLAILQLGN------NSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSEL 639
L + N N + P+G+ C SL L + SN++ + ++
Sbjct: 535 SSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI 585
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 1e-83
Identities = 75/560 (13%), Positives = 165/560 (29%), Gaps = 82/560 (14%)
Query: 271 DSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSG---TEFPASLKNCQLLE 327
+S+G + L L +G+ + G+ L V+ L +G P + E
Sbjct: 78 NSNGRVTGLSLEGFGASGRVPD-AIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 328 TLNMSHNALQGGIPGFL-LGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRL 386
Q + F +L + + + I ++ SN +
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI-TLKDTQIGQLSNNI 195
Query: 387 TGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNC 446
T + + L +G++ + + + L N
Sbjct: 196 TF-VSKAVMRLTKLRQFYMGNSPFVAENI------CEAWENENSEYAQQYKTEDLKWDNL 248
Query: 447 TQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYL--------SGTVPLELGSCK 498
L +++ + +P+ P ++ I + N + +
Sbjct: 249 KDLTDVEVYNCPNLTKLPTFLK---ALPEMQLINVACNRGISGEQLKDDWQALADAPVGE 305
Query: 499 NLKTIDLSFNSLA-GPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNN 557
++ I + +N+L PV + + + L L N L G++P + L +L L N
Sbjct: 306 KIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FG-SEIKLASLNLAYN 363
Query: 558 HLTGAIPKSIASCTNMLWVSLSSNQLTGEIPA--GIGNLVKLAILQLGNNSLTG------ 609
+T + +S + N+L IP ++ ++ + N +
Sbjct: 364 QITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNF 422
Query: 610 -QVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACR 668
+ K ++ ++L++N +S + + + + N
Sbjct: 423 DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPL--------SSINLMGNM------ 468
Query: 669 GAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLP 728
I L+ F L +DL +N L+
Sbjct: 469 -------LTEIPKNSLKDENE----------------NFKNTYLLTSIDLRFNKLTKLSD 505
Query: 729 E-NFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVL------DLSHNNFQGSIPGSLGG 781
+ +L YL ++L +N + P + D N P +
Sbjct: 506 DFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITL 564
Query: 782 LSFLSDLDVSNNNLSGIIPS 801
L+ L + +N++ +
Sbjct: 565 CPSLTQLQIGSNDIRKVNEK 584
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 1e-66
Identities = 89/576 (15%), Positives = 175/576 (30%), Gaps = 86/576 (14%)
Query: 55 GGNEELTILMAFKQSSIGSDPNGYLANWTADALTPCSWQGVSCSLNSHVTSLNLNNSGLS 114
G + E F I ++ + S + +N+
Sbjct: 113 GSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQ 172
Query: 115 GSLNLTTLTALPYLEHLNLQGNSFSA-----GDLSTSKTSSCSLVTMDLSSNNITGSLPG 169
S+ ++ + N+ + L+ L + ++
Sbjct: 173 KSIKKSSRI-TLKDTQIGQLSNNITFVSKAVMRLT-------KLRQFYMGNSPFVAENIC 224
Query: 170 RSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLL 229
++ + + +L L +++ L L + L+
Sbjct: 225 EAWENENSEYAQ-QYKTEDLKWDNL---KDLTDVEVYNCPNLTK--LPTFLKALPEMQLI 278
Query: 230 NFSDNKL------PGKLN--ATSVNCKSISTIDLSYN-LLSGEIPASFVADSSGSLKYLD 280
N + N+ A + + I I + YN L + + S L L+
Sbjct: 279 NVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQ--KMKKLGMLE 336
Query: 281 LSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASL-KNCQLLETLNMSHNALQGG 339
+N GK FG L+ + L+ N + TE PA+ + +E L+ +HN L+
Sbjct: 337 CLYNQLEGKLP--AFGSEIKLASLNLAYNQI--TEIPANFCGFTEQVENLSFAHNKLKYI 392
Query: 340 IPGFLLGSFRNLKQLSLAHNQFAG-------EIPPELGQACGTLRELDLSSNRLTGELPS 392
F S + + ++N+ + P + + ++LS+N+++
Sbjct: 393 PNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFK-GINVSSINLSNNQISKFPKE 451
Query: 393 TFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVL 452
F++ S L S+NL NML+ +P N + N L +
Sbjct: 452 LFSTGSPLSSINLMGNMLTE-----------------IP-KNSLKDENENFKNTYLLTSI 493
Query: 453 DLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAG 512
DL N T + P L I L N S P + + LK +
Sbjct: 494 DLRFNKLTKLSDDFRAT--TLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ---- 546
Query: 513 PVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTN 572
N E PEGI +L L + +N + + + I N
Sbjct: 547 --------------RDAQGNRTLREWPEGIT-LCPSLTQLQIGSNDIRK-VNEKI--TPN 588
Query: 573 MLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLT 608
+ + + N + + ++ + L +
Sbjct: 589 ISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-33
Identities = 36/268 (13%), Positives = 74/268 (27%), Gaps = 43/268 (16%)
Query: 410 LSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTG----TIPS 465
+ G ++ + L + SG VP ++ T+L VL L S+G P
Sbjct: 68 MWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPK 127
Query: 466 GFCS--------------PPNFPA---------LEKIVLPNNYLSGTVPLELGSCKNLKT 502
G + F L K + ++ ++
Sbjct: 128 GISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQ 187
Query: 503 IDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGA 562
I N++ V + L L M + E E
Sbjct: 188 IGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEA------WENENSEYAQQYKT 240
Query: 563 IPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLT--------GQVPQG 614
+ ++ V + + ++P + L ++ ++ + N Q
Sbjct: 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALAD 300
Query: 615 LGKCRSLVWLDLNSNNL-SGPLPSELAN 641
+ + + NNL + P+ + L
Sbjct: 301 APVGEKIQIIYIGYNNLKTFPVETSLQK 328
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-29
Identities = 46/303 (15%), Positives = 88/303 (29%), Gaps = 45/303 (14%)
Query: 533 NLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTG----EIP 588
++ G P + G + L L +G +P +I T + ++L S+ P
Sbjct: 67 DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126
Query: 589 AGIGNLVKLAILQLGNNSLTGQVPQGLGKCR--SLVWLDLNSNNLSGPLPSELANQAGVV 646
GI + Q + L+ +NS+ +
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT---- 182
Query: 647 MPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIY-TGMTMY 705
+ Q + N + L +L F M +S
Sbjct: 183 ----LKDTQIGQLSNNITFVSKAVMRLT--------KLRQFYMGNSPFVAENICEAWENE 230
Query: 706 TFTTNGSLIYLDLSYNSLS-------------GTLPENFGSLNYLQVLNLGHNKLT---- 748
DL +++L LP +L +Q++N+ N+
Sbjct: 231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQ 290
Query: 749 ----GHIPDSFGGLKAIGVLDLSHNNFQ-GSIPGSLGGLSFLSDLDVSNNNLSGIIPSGG 803
+ I ++ + +NN + + SL + L L+ N L G +P+ G
Sbjct: 291 LKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFG 350
Query: 804 QLT 806
Sbjct: 351 SEI 353
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 6e-17
Identities = 19/93 (20%), Positives = 40/93 (43%), Gaps = 2/93 (2%)
Query: 712 SLIYLDLSYNSL-SGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNN 770
+ + + YN+L + + + + L +L +N+L G +P +FG + L+L++N
Sbjct: 306 KIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQ 364
Query: 771 FQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGG 803
G + +L ++N L I
Sbjct: 365 ITEIPANFCGFTEQVENLSFAHNKLKYIPNIFD 397
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-16
Identities = 20/124 (16%), Positives = 42/124 (33%), Gaps = 6/124 (4%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTG----HIPDSFGGLKAI 761
+ +NG + L L SG +P+ G L L+VL LG + P +
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 762 GVLDLSHNNFQGSIPGSLGGLSF--LSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGL 819
++Q + F L ++++ I ++T + ++ +
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195
Query: 820 CGLP 823
+
Sbjct: 196 TFVS 199
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-15
Identities = 16/103 (15%), Positives = 40/103 (38%), Gaps = 10/103 (9%)
Query: 712 SLIYLDLSYNSLSGTLPENF--GSLNYLQVLNLGHNKLTG-------HIPDSFGGLKAIG 762
+ L ++N L +P F S++ + ++ +N++ + + +
Sbjct: 378 QVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS 436
Query: 763 VLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQL 805
++LS+N S LS +++ N L+ I + +
Sbjct: 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKD 479
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-12
Identities = 14/84 (16%), Positives = 22/84 (26%), Gaps = 3/84 (3%)
Query: 715 YLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGS 774
D N PE L L +G N + + + I VLD+ N
Sbjct: 546 QRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISI 602
Query: 775 IPGSLGGLSFLSDLDVSNNNLSGI 798
+ + + I
Sbjct: 603 DLSYVCPYIEAGMYMLFYDKTQDI 626
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 9e-12
Identities = 15/119 (12%), Positives = 31/119 (26%), Gaps = 4/119 (3%)
Query: 717 DLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQG--- 773
+ + + S + L+L +G +PD+ G L + VL L + +
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122
Query: 774 -SIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPLLPCSSGN 831
P + + F + + + SS
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI 181
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-07
Identities = 11/61 (18%), Positives = 20/61 (32%), Gaps = 3/61 (4%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
SL L + N + + E + VL++ N G+ L ++
Sbjct: 567 SLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
Query: 772 Q 772
Q
Sbjct: 624 Q 624
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 8e-81
Identities = 93/610 (15%), Positives = 183/610 (30%), Gaps = 79/610 (12%)
Query: 67 KQSSIGSDPNGYLANWTADALTPCSWQ---GVSCSLNSHVTSLNLNNSGLSGSLNLTTLT 123
+ S + + NW + W GV N VT L+L G G + +
Sbjct: 287 RYYSGTINNTIHSLNWNFNK-ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVP-DAIG 344
Query: 124 ALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVN 183
L L+ L+ +S + + + + I + FL RL+ +
Sbjct: 345 QLTELKVLSFGTHSET-VSGRLFGDEELTPDMSEERKHRIRMHYK-KMFLDYDQRLNLSD 402
Query: 184 LSHNSISGGSLHIG-PSLLQLDLSGNQISDS----ALLTYSLSNCQNLNLLNFSDNKLPG 238
L ++I+ ++ L QI + ++ ++ L ++ F+++
Sbjct: 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTY 462
Query: 239 KLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRC 298
+ Y S+ + L ++L + + +
Sbjct: 463 -----DNIAVDWEDANSDYAKQYENEELSW--SNLKDLTDVELYNCPNMTQLPD-FLYDL 514
Query: 299 GNLSVITLSQNGLSG--------TEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRN 350
L + ++ N T ++ M +N L+ L
Sbjct: 515 PELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVK 574
Query: 351 LKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELP-STFASCSSLHSLNLGSNM 409
L L HN+ G L +L L N++ E+P A + L N
Sbjct: 575 LGLLDCVHNKV--RHLEAFGT-NVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHN- 629
Query: 410 LSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCS 469
K+ + P + + + +D S N + CS
Sbjct: 630 -----------KLKYI------------PNIFNAKSVYVMGSVDFSYNKIGSEGRNISCS 666
Query: 470 PPNFPA--LEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSL-------AGPVPSEIWS 520
++ + L N + + + TI LS N + P +
Sbjct: 667 MDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKN 726
Query: 521 LPNLSDLVMWANNLTGEIPEGICVNG-GNLETLILNNNHLTGAIPKSIASCTNMLWVSL- 578
L+ + + N LT + + L + ++ N + P + + + +
Sbjct: 727 TYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIR 784
Query: 579 -----SSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNL-S 632
N++ + P GI L LQ+G+N + V + L L LD+ N S
Sbjct: 785 HQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNIS 841
Query: 633 GPLPSELANQ 642
+ S
Sbjct: 842 IDVTSVCPYI 851
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 255 bits (652), Expect = 5e-71
Identities = 80/664 (12%), Positives = 175/664 (26%), Gaps = 138/664 (20%)
Query: 156 MDLSSNNITGSLP-GRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSA 214
+D + L+ + +++ + G L + L L+G
Sbjct: 281 LDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQP-GVDLDNNGRVTGLSLAGFGAKGR- 338
Query: 215 LLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSG 274
+ ++ L +L+F + + + + + F+ D
Sbjct: 339 -VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFL-DYDQ 396
Query: 275 SLKYLDLSHNNFTG--KFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMS 332
L DL + + + +L + T +++ L+ + +
Sbjct: 397 RLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFA 456
Query: 333 HNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPS 392
++ + + + + + L +++L + +LP
Sbjct: 457 NSPFTYDNIAV------DWEDANSDYAKQYENEELSWSN-LKDLTDVELYNCPNMTQLPD 509
Query: 393 TFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVL 452
L SLN+ N + S L + + ++++
Sbjct: 510 FLYDLPELQSLNIACN------------RGISAAQLKADWTRL----ADDEDTGPKIQIF 553
Query: 453 DLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAG 512
+ N P+ L L +D N +
Sbjct: 554 YMGYNNLEE-FPA-------------------------SASLQKMVKLGLLDCVHNKVR- 586
Query: 513 PVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPK--SIASC 570
+ L+DL + N + EIPE C +E L ++N L IP + S
Sbjct: 587 -HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSV 643
Query: 571 TNMLWVSLSSNQLTGEIP-----AGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLD 625
M V S N++ E + + + L N + + + +
Sbjct: 644 YVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTI- 702
Query: 626 LNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLE 685
LS N I L+
Sbjct: 703 ----ILSN-------NL---------------------------------MTSIPENSLK 718
Query: 686 GFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPEN--FGSLNYLQVLNLG 743
+ L +DL +N L+ +L ++ +L YL +++
Sbjct: 719 PKD----------------GNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVS 761
Query: 744 HNKLTGHIPDSFGGLKAIGVLDLSH------NNFQGSIPGSLGGLSFLSDLDVSNNNLSG 797
+N + P + + H N P + L L + +N++
Sbjct: 762 YNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK 820
Query: 798 IIPS 801
+
Sbjct: 821 VDEK 824
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 2e-47
Identities = 84/424 (19%), Positives = 143/424 (33%), Gaps = 70/424 (16%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSA--------GDLSTSKTSSCS 152
+T + L N L L LP L+ LN+ N + L+ + +
Sbjct: 491 KDLTDVELYNCPNMTQLP-DFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPK 549
Query: 153 LVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISG----GSLHIGPSLLQLDLSGN 208
+ + NN+ P + L +L ++ HN + G+ L L L N
Sbjct: 550 IQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVRHLEAFGTN---VKLTDLKLDYN 605
Query: 209 QISDSALLTYSLSNCQNLNLLNFSDNKL---PGKLNATSVNCKSISTIDLSYNLLSG--- 262
QI + + + + L FS NKL P NA + + ++D SYN +
Sbjct: 606 QIEE--IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAK--SVYVMGSVDFSYNKIGSEGR 661
Query: 263 EIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLS------GTEF 316
I S + + LS+N + L F +S I LS N ++
Sbjct: 662 NISCSMDDYKGINASTVTLSYNEIQKFPTEL-FATGSPISTIILSNNLMTSIPENSLKPK 720
Query: 317 PASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTL 376
+ KN LL T+++ N L F + L + +++N F+ P + L
Sbjct: 721 DGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLN-SSQL 778
Query: 377 RELDL------SSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYV 430
+ + NR+ + P+ +C SL L +GSN +
Sbjct: 779 KAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK------------------ 820
Query: 431 PFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTV 490
V L QL +LD++ N + C + + G
Sbjct: 821 --------VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCD 870
Query: 491 PLEL 494
L +
Sbjct: 871 ALGI 874
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-29
Identities = 50/375 (13%), Positives = 107/375 (28%), Gaps = 45/375 (12%)
Query: 449 LRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFN 508
L+ + + +G SG + + ++L + + + L+
Sbjct: 274 LKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGF 333
Query: 509 SLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIA 568
G VP I L L L ++ T + + +
Sbjct: 334 GAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLD 393
Query: 569 SCTNMLWVSLSSNQLTGE---IPAGIGNLVKLAILQLGN--NSLTGQVPQGLGKCRSLVW 623
+ L + + P + + L Q+GN N +T + + + + L
Sbjct: 394 YDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQI 452
Query: 624 LDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPER 683
+ ++ + + A ++ ++ L + +
Sbjct: 453 IYFANSPFTYDNIAVDWEDANSDYAKQYENEELSW------------SNLKDLTDVE--- 497
Query: 684 LEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSG---------TLPENFGSL 734
L P + P L L+++ N L ++ +
Sbjct: 498 LYNCPNMTQLPDF----------LYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTG 547
Query: 735 NYLQVLNLGHNKLTGHIPDS--FGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSN 792
+Q+ +G+N L P S + +G+LD HN + G L+DL +
Sbjct: 548 PKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDY 604
Query: 793 NNLSGIIPSGGQLTT 807
N + I T
Sbjct: 605 NQIEEIPEDFCAFTD 619
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-27
Identities = 38/266 (14%), Positives = 77/266 (28%), Gaps = 16/266 (6%)
Query: 377 RELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNIS 436
LD + R + + + N +M G+ + + L +
Sbjct: 279 EALDGKNWRYYSGTINNTIHSLNW-NFNKELDM-WGDQPGVDLDNNGRVTGLSLAGFGAK 336
Query: 437 GPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGS 496
G VP ++ T+L+VL ++ T + + + L
Sbjct: 337 GRVPDAIGQLTELKVLSFGTHSETVSGRLFGDE--ELTPDMSEERKHRIRMHYKKMFLDY 394
Query: 497 CKNLKTIDLSFNSL-----AGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLET 551
+ L DL +++ P+ + + + N +T I + I L+
Sbjct: 395 DQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQ-RLTKLQI 452
Query: 552 LILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQV 611
+ N+ T + + + NL L ++L N Q+
Sbjct: 453 IYFANSPFTYDNI-----AVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQL 507
Query: 612 PQGLGKCRSLVWLDLNSNNLSGPLPS 637
P L L L++ N
Sbjct: 508 PDFLYDLPELQSLNIACNRGISAAQL 533
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 3e-23
Identities = 31/276 (11%), Positives = 76/276 (27%), Gaps = 37/276 (13%)
Query: 556 NNHLTGAIPKSIASCTNMLW-VSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQG 614
N + N W + + + + N ++ L L G+VP
Sbjct: 285 NWRYYSGTINNTIHSLN--WNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDA 342
Query: 615 LGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLV 674
+G+ L L +++ + + + +S ++ +R +
Sbjct: 343 IGQLTELKVLSFGTHSETVSGRLFGDEE----LTPDMSEERKHRIRMHYKKMFLDYDQRL 398
Query: 675 EFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSL 734
+ + + P + + + N ++ + + L
Sbjct: 399 NLSDLLQDAINRNPEMKPIKKDSR----------ISLKDTQIGNLTNRITF-ISKAIQRL 447
Query: 735 NYLQVLNLGHNKLTG-------------------HIPDSFGGLKAIGVLDLSHNNFQGSI 775
LQ++ ++ T + S+ LK + ++L + +
Sbjct: 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQL 507
Query: 776 PGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPAS 811
P L L L L+++ N T
Sbjct: 508 PDFLYDLPELQSLNIACNRGISAAQLKADWTRLADD 543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 6e-14
Identities = 22/101 (21%), Positives = 37/101 (36%), Gaps = 7/101 (6%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPEN--FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGV 763
T + + YN+L P + + L +L+ HNK+ ++FG +
Sbjct: 543 DEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTD 599
Query: 764 LDLSHNNFQGSIPGSLG-GLSFLSDLDVSNNNLSGIIPSGG 803
L L +N + IP + L S+N L I
Sbjct: 600 LKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFN 639
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 9e-81
Identities = 113/638 (17%), Positives = 200/638 (31%), Gaps = 106/638 (16%)
Query: 182 VNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLN 241
+ ++ S LDLS N + L +YS + L +L
Sbjct: 12 YQCMELNFYKIPDNLPFSTKNLDLSFNPLRH--LGSYSFFSFPELQVL------------ 57
Query: 242 ATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNL 301
DLS + ++ S L L L+ N + F +L
Sbjct: 58 ------------DLSRCEIQTIEDGAY--QSLSHLSTLILTGNPIQS-LALGAFSGLSSL 102
Query: 302 SVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQF 361
+ + L+ E + + + L+ LN++HN +Q + NL+ L L+ N+
Sbjct: 103 QKLVAVETNLASLE-NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161
Query: 362 AGEIPPELGQACG---TLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTV 418
+L LDLS N + P F LH L L +N S N + T
Sbjct: 162 QSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTC 220
Query: 419 VSKISSLIYL------YVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPN 472
+ ++ L + N+ +L L + + +
Sbjct: 221 IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNC 280
Query: 473 FPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWAN 532
+ L + + + ++L ++ SL L+
Sbjct: 281 LTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG 338
Query: 533 NLTGEIPEGICVNGGNLETLILNNNHLT--GAIPKSIASCTNMLWVSLSSNQLTGEIPAG 590
N E+ + +LE L L+ N L+ G +S T++ ++ LS N + + +
Sbjct: 339 NAFSEV------DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSN 391
Query: 591 IGNLVKLAILQLGNNSLTGQVPQG-LGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPG 649
L +L L +++L R+L++LD++ +
Sbjct: 392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH------------------- 432
Query: 650 IVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPM-----VHSCPSTRIYTGMTM 704
G +
Sbjct: 433 --------------------------TRVAFNGIFNGLSSLEVLKMAGN---SFQENFLP 463
Query: 705 YTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVL 764
FT +L +LDLS L P F SL+ LQVLN+ HN + L ++ VL
Sbjct: 464 DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 523
Query: 765 DLSHNNFQGSIPGSLGGL-SFLSDLDVSNNNLSGIIPS 801
D S N+ S L S L+ L+++ N+ +
Sbjct: 524 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 561
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 2e-79
Identities = 107/559 (19%), Positives = 182/559 (32%), Gaps = 39/559 (6%)
Query: 98 SLNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMD 157
+L +L+L+ + L L + + P L+ L+L + ++ S L T+
Sbjct: 25 NLPFSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLS-HLSTLI 82
Query: 158 LSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISG---GSLHIGPSLLQLDLSGNQISDSA 214
L+ N I G L + +++ + +L +L+++ N I S
Sbjct: 83 LTGNPIQSLALG--AFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SF 139
Query: 215 LLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSIS----TIDLSYNLLSGEIPASFVA 270
L SN NL L+ S NK+ + ++DLS N ++ P +F
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-- 197
Query: 271 DSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTE-----FPASLKNCQL 325
L L L +N + L V L ++L+
Sbjct: 198 -KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 326 L--ETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSS 383
L E +++ L N+ SL + L+L +
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD---FSYNFGWQHLELVN 313
Query: 384 NRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNIS--GPVPL 441
+ S L + + SL +L + N +S G
Sbjct: 314 CKFGQFPTLKLKSLKRLTFTSNKGGNAFSE------VDLPSLEFLDLSRNGLSFKGCCSQ 367
Query: 442 SLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLE-LGSCKNL 500
S T L+ LDLS NG T+ S F LE + ++ L S +NL
Sbjct: 368 SDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQ---LEHLDFQHSNLKQMSEFSVFLSLRNL 423
Query: 501 KTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLT 560
+D+S L +L L M N+ I NL L L+ L
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
Query: 561 GAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKC-R 619
P + S +++ +++S N L L +L N + Q L
Sbjct: 484 QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPS 543
Query: 620 SLVWLDLNSNNLSGPLPSE 638
SL +L+L N+ + +
Sbjct: 544 SLAFLNLTQNDFACTCEHQ 562
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 1e-71
Identities = 102/509 (20%), Positives = 176/509 (34%), Gaps = 40/509 (7%)
Query: 152 SLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISG---GSLHIGPSLLQLDLSGN 208
S +DLS N + S L ++LS I G+ L L L+GN
Sbjct: 29 STKNLDLSFNPLRHLGS--YSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 209 QISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLL-SGEIPAS 267
I L + S +L L + L N + K++ +++++NL+ S ++P
Sbjct: 87 PIQS--LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 268 FVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVIT----LSQNGLSGTEFPASLKNC 323
F + +L++LDLS N D + ++ LS N ++ + P + K
Sbjct: 145 F--SNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQ-PGAFKEI 200
Query: 324 QLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGE--IPPELGQACGTLRELDL 381
+L L + +N + + L+ L +F E + A L L +
Sbjct: 201 RL-HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 382 SSNRLT------GELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNI 435
RL ++ F +++ S +L S + S +L +
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF---SYNFGWQHLELVNCKF 316
Query: 436 SGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLS--GTVPLE 493
L L + +L S + P+LE + L N LS G
Sbjct: 317 GQFPTLKLKSLKRLTFTSNKGGNAF--------SEVDLPSLEFLDLSRNGLSFKGCCSQS 368
Query: 494 LGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLI 553
+LK +DLSFN + + S L L L +NL + ++ NL L
Sbjct: 369 DFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 427
Query: 554 LNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNNSLTGQVP 612
+++ H A +++ + ++ N I L L L L L P
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487
Query: 613 QGLGKCRSLVWLDLNSNNLSGPLPSELAN 641
SL L+++ NN
Sbjct: 488 TAFNSLSSLQVLNMSHNNFFSLDTFPYKC 516
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 7e-64
Identities = 87/476 (18%), Positives = 161/476 (33%), Gaps = 48/476 (10%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFS---AGDLSTSKTSSCSLVTMD 157
+ LN+ ++ + + L LEHL+L N DL +++D
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183
Query: 158 LSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIG----PSLLQLDLSGNQISDS 213
LS N + PG RL + L +N S + L L + +
Sbjct: 184 LSLNPMNFIQPG---AFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240
Query: 214 ALLT----YSLSNCQNLNLLNFSDNKLPGKLN---ATSVNCKSISTIDLSYNLLSGEIPA 266
L +L NL + F L L+ ++S+ L +
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF 300
Query: 267 SFVADSSGSLKYLDLSHNNFTG-------KFSNLD-----------FGRCGNLSVITLSQ 308
S+ + ++L+L + F L +L + LS+
Sbjct: 301 SY----NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSR 356
Query: 309 NGLSGTEF-PASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPP 367
NGLS S L+ L++S N + FL L+ L H+
Sbjct: 357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFL--GLEQLEHLDFQHSNLKQMSEF 414
Query: 368 ELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIY 427
+ + L LD+S F SSL L + N NFL + +++ +L +
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474
Query: 428 LYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLS 487
L + + P + + + L+VL++S N F + +L+ + N++
Sbjct: 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPY---KCLNSLQVLDYSLNHIM 531
Query: 488 GTVPLELGSC-KNLKTIDLSFNSLAGPVPSE--IWSLPNLSDLVMWANNLTGEIPE 540
+ EL +L ++L+ N A + + + + L++ + P
Sbjct: 532 TSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS 587
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 3e-48
Identities = 80/449 (17%), Positives = 141/449 (31%), Gaps = 64/449 (14%)
Query: 364 EIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKIS 423
+IP L + + LDLS N L +F S L L+L
Sbjct: 21 KIPDNLPF---STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC--------------- 62
Query: 424 SLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPN 483
I + + + L L L+ N F + L+K+V
Sbjct: 63 ----------EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSS---LQKLVAVE 109
Query: 484 NYLSGTVPLELGSCKNLKTIDLSFNSLAG-PVPSEIWSLPNLSDLVMWANNLTGEIPEGI 542
L+ +G K LK ++++ N + +P +L NL L + +N + +
Sbjct: 110 TNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169
Query: 543 CVNGG---NLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAG-IGNLVKLA 598
V +L L+ N + P + + ++L +N + + I L L
Sbjct: 170 RVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLE 228
Query: 599 ILQLGNNSLTGQVPQG---LGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQ 655
+ +L + L L + L+ + + + +
Sbjct: 229 VHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA--YLDYYLDDIIDLFNCLTNVSS 286
Query: 656 FAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIY 715
F+ V ER++ F + F T
Sbjct: 287 FSLVSV------------------TIERVKDFSYNFGWQHLELV-NCKFGQFPTLKLKSL 327
Query: 716 LDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLT--GHIPDSFGGLKAIGVLDLSHNNFQG 773
L++ S G + L L+ L+L N L+ G S G ++ LDLS N
Sbjct: 328 KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387
Query: 774 SIPGSLGGLSFLSDLDVSNNNLSGIIPSG 802
+ + GL L LD ++NL +
Sbjct: 388 -MSSNFLGLEQLEHLDFQHSNLKQMSEFS 415
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-44
Identities = 75/424 (17%), Positives = 129/424 (30%), Gaps = 68/424 (16%)
Query: 410 LSGNFLNTVVSKI-SSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFC 468
+ + S L + FN + S + +L+VLDLS +
Sbjct: 14 CMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ 73
Query: 469 SPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLV 528
+ L ++L N + +L+ + +LA I L L +L
Sbjct: 74 ---SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130
Query: 529 MWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNM----LWVSLSSNQLT 584
+ N + N NLE L L++N + + M L + LS N +
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
Query: 585 GEIPAGIGNLVKLAILQLGNNSLTGQVPQG-LGKCRSLVWLDLNSNNLSGPLPSELANQA 643
I G ++L L L NN + V + + L L E +++
Sbjct: 191 F-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249
Query: 644 GVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMT 703
EG+ +E F + + Y
Sbjct: 250 A-------------------------------LEGLCNLTIEEFRLAYL----DYYLDDI 274
Query: 704 MYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLT--------------- 748
+ F ++ L ++ ++F Q L L + K
Sbjct: 275 IDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTF 332
Query: 749 ----GHIPDSFGGLKAIGVLDLSHN--NFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSG 802
G S L ++ LDLS N +F+G S G + L LD+S N + + +
Sbjct: 333 TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNF 392
Query: 803 GQLT 806
L
Sbjct: 393 LGLE 396
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-27
Identities = 44/315 (13%), Positives = 90/315 (28%), Gaps = 49/315 (15%)
Query: 496 SCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILN 555
N+ T + +P + + +L + N L + L+ L L+
Sbjct: 6 VVPNI-TYQCMELNFYK-IPDNL--PFSTKNLDLSFNPLRHLGSYSFF-SFPELQVLDLS 60
Query: 556 NNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGL 615
+ + S +++ + L+ N + L L L +L +
Sbjct: 61 RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120
Query: 616 GKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVE 675
G ++L L++ N + E + + + N+
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEY-------FSNLTNLEHLDLSSNK------------- 160
Query: 676 FEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLN 735
+ I L + + LDLS N ++ P F +
Sbjct: 161 IQSIYCTDLRVLHQMPL-------------------LNLSLDLSLNPMNFIQPGAFKEIR 201
Query: 736 YLQVLNLGHNKLTGHIP-DSFGGLKAIGVLDLSHNNFQGSI---PGSLGGLSFLSDLDVS 791
L L L +N + ++ GL + V L F+ L L +L +
Sbjct: 202 -LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 792 NNNLSGIIPSGGQLT 806
L+ + +
Sbjct: 261 EFRLAYLDYYLDDII 275
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 6e-11
Identities = 20/119 (16%), Positives = 41/119 (34%), Gaps = 28/119 (23%)
Query: 700 TGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGL- 758
++ F + SL L++S+N+ + LN LQVL+ N +
Sbjct: 483 EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP 542
Query: 759 KAIGVLDLSHNNFQGSI--------------------------PGSLGGLSFLSDLDVS 791
++ L+L+ N+F + P G+ + L+++
Sbjct: 543 SSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLSLNIT 600
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 2e-77
Identities = 77/309 (24%), Positives = 115/309 (37%), Gaps = 33/309 (10%)
Query: 923 LLEATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEME--TIGK 980
L + + G FG V+KAQL VA+K Q + + E E ++
Sbjct: 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIF---PIQDKQSWQNEYEVYSLPG 74
Query: 981 IKHRNLVPLLGYCKIGE----ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAI 1036
+KH N++ +G K G + L+ + + GSL L + W IA
Sbjct: 75 MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWNELCHIAE 128
Query: 1037 GSARGLAFLHHSCI-------PHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHL 1089
ARGLA+LH P I HRD+KS NVLL N A ++DFG+A A +
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 1090 SVSTLAGTPGYVPPEYYQ-----SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144
GT Y+ PE + + D+Y+ G++L EL S D
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248
Query: 1145 LVGWAKQLH-----REKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQ 1199
Q +E +++ P L + EC D R +
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308
Query: 1200 VMAMFKELQ 1208
V ++Q
Sbjct: 309 VGERITQMQ 317
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 9e-70
Identities = 116/570 (20%), Positives = 185/570 (32%), Gaps = 41/570 (7%)
Query: 88 TPCSWQGVSCSLNSHVTSLNLNNSGLSGSLNLTTLTA--LPYLEHLNLQGNSFS---AGD 142
T S Q + + N N L L + E L N
Sbjct: 1 TTSSDQKCIEKEVN--KTYNCEN------LGLNEIPGTLPNSTECLEFSFNVLPTIQNTT 52
Query: 143 LSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISG---GSLHIGPS 199
S +L +DL+ I + +F S RL + L+ N + +L +
Sbjct: 53 FSRLI----NLTFLDLTRCQIY-WIHEDTFQ-SQHRLDTLVLTANPLIFMAETALSGPKA 106
Query: 200 LLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNL 259
L L IS + L N + L L N + + + +D N
Sbjct: 107 LKHLFFIQTGISS--IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA 164
Query: 260 LSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPAS 319
+ + + L+L+ N+ G + F
Sbjct: 165 IHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGA--FDSAVFQSLNFGGTQNLLVIFKG- 221
Query: 320 LKNCQL--LETLNMSHNALQGGIPGFLLGSFR-NLKQLSLAHNQFAGEIPPELGQACGTL 376
LKN + L + P G +++ ++L + F I L
Sbjct: 222 LKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFN-ISSNTFHCFSGL 280
Query: 377 RELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNIS 436
+ELDL++ L+ ELPS S+L L L +N S SL +L + N
Sbjct: 281 QELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFEN-LCQISASNFPSLTHLSIKGNTKR 338
Query: 437 GPV-PLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELG 495
+ L N LR LDLS + T N L+ + L N
Sbjct: 339 LELGTGCLENLENLRELDLSHDDIE-TSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFK 397
Query: 496 SCKNLKTIDLSFNSLAG-PVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLIL 554
C L+ +DL+F L S +L L L + + L E + L+ L L
Sbjct: 398 ECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI-SSEQLFDGLPALQHLNL 456
Query: 555 NNNHLTGAI---PKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQV 611
NH S+ + + + LS L+ +L + + L +N LT
Sbjct: 457 QGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSS 516
Query: 612 PQGLGKCRSLVWLDLNSNNLSGPLPSELAN 641
+ L + + L+L SN++S LPS L
Sbjct: 517 IEALSHLKGIY-LNLASNHISIILPSLLPI 545
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 1e-69
Identities = 105/604 (17%), Positives = 193/604 (31%), Gaps = 69/604 (11%)
Query: 182 VNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLN 241
N + ++ + S L+ S N + + + S NL L
Sbjct: 17 YNCENLGLNEIPGTLPNSTECLEFSFNVLPT--IQNTTFSRLINLTFL------------ 62
Query: 242 ATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNL 301
DL+ + +F S L L L+ N + L
Sbjct: 63 ------------DLTRCQIYWIHEDTF--QSQHRLDTLVLTANPLIF-MAETALSGPKAL 107
Query: 302 SVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQF 361
+ Q G+S + L N + LE+L + N + LK L +N
Sbjct: 108 KHLFFIQTGISSID-FIPLHNQKTLESLYLGSNHISSIKLP-KGFPTEKLKVLDFQNNAI 165
Query: 362 AGEIPPELGQACG-TLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVV- 419
++ T L+L+ N + + + SLN G +
Sbjct: 166 HYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKN 224
Query: 420 SKISSLIYLYVPFNNISGPVPLSLTNC--TQLRVLDLSSNGFTGTIPSGFCSPPNFPALE 477
S I SL + P + ++L + F + F F L+
Sbjct: 225 STIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFH---CFSGLQ 281
Query: 478 KIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGE 537
++ L +LS +P L LK + LS N + P+L+ L + N E
Sbjct: 282 ELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLE 340
Query: 538 IPEGICVNGGNLETLILNNNHLT--GAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLV 595
+ G N NL L L+++ + + + +++ ++LS N+
Sbjct: 341 LGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECP 400
Query: 596 KLAILQLGNNSLTGQVPQG-LGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIV--- 651
+L +L L L + Q L L+L+ + L +P +
Sbjct: 401 QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDG-----LPALQHLN 455
Query: 652 -SGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTN 710
G F + + + G L + C + + + + FT+
Sbjct: 456 LQGNHFPKGNIQKTNSLQTLGRLEILV------------LSFC---DL-SSIDQHAFTSL 499
Query: 711 GSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNN 770
+ ++DLS+N L+ + E L + LNL N ++ +P L ++L N
Sbjct: 500 KMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNP 558
Query: 771 FQGS 774
+
Sbjct: 559 LDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 1e-67
Identities = 98/550 (17%), Positives = 197/550 (35%), Gaps = 40/550 (7%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSC-SLVTMDLS 159
++T L+L + ++ T + L+ L L N ++ + S +L +
Sbjct: 57 INLTFLDLTRCQIY-WIHEDTFQSQHRLDTLVLTANPLI--FMAETALSGPKALKHLFFI 113
Query: 160 SNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIG---PSLLQLDLSGNQISDSALL 216
I+ S+ + L + L N IS L G L LD N I L
Sbjct: 114 QTGIS-SIDFIPLH-NQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY--LS 169
Query: 217 TYSLSNCQNLNL--LNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSG 274
+S+ Q LN + N + + + + +++ I +
Sbjct: 170 KEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQ 228
Query: 275 SLKYLDLSHNNFTGKFSNLDFGRCGNLSVITL--SQNGLSGTEFPASLKNCQLLETLNMS 332
SL + S F +SV ++ ++ + L+ L+++
Sbjct: 229 SLWLGTFEDMDDE-DISPAVFEGLCEMSVESINLQKHYFFNIS-SNTFHCFSGLQELDLT 286
Query: 333 HNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPS 392
L +P L+G LK+L L+ N+F + +L L + N EL +
Sbjct: 287 ATHLSE-LPSGLVG-LSTLKKLVLSANKF-ENLCQISASNFPSLTHLSIKGNTKRLELGT 343
Query: 393 -TFASCSSLHSLNLGSNMLSG-NFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLR 450
+ +L L+L + + + N + +S L L + +N + C QL
Sbjct: 344 GCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLE 403
Query: 451 VLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSL 510
+LDL+ N L+ + L ++ L + L+ ++L N
Sbjct: 404 LLDLAFTRLKVKDAQSPFQ--NLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHF 461
Query: 511 AG---PVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSI 567
+ + +L L LV+ +L+ I + + + + L++N LT + +++
Sbjct: 462 PKGNIQKTNSLQTLGRLEILVLSFCDLS-SIDQHAFTSLKMMNHVDLSHNRLTSSSIEAL 520
Query: 568 ASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRS---LVWL 624
+ ++++L+SN ++ +P+ + L + + L N L C + L W
Sbjct: 521 SHLKG-IYLNLASNHISIILPSLLPILSQQRTINLRQNPLD-------CTCSNIYFLEWY 572
Query: 625 DLNSNNLSGP 634
N L
Sbjct: 573 KENMQKLEDT 582
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 2e-65
Identities = 104/519 (20%), Positives = 171/519 (32%), Gaps = 30/519 (5%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSS 160
+ L +G+S S++ L LE L L N S+ L + L +D +
Sbjct: 105 KALKHLFFIQTGIS-SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTE-KLKVLDFQN 162
Query: 161 NNITGSLPGRSFLLSCDRLSYVNLSHNSISG--GSLHIGPSLLQLDLSGNQISDSALLTY 218
N I L +NL+ N I+G L+ G Q
Sbjct: 163 NAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGL 222
Query: 219 SLSNCQNLNLLNFSDNKLPGKLNATSVNCK--SISTIDLSYNLLSGEIPASFVADSSGSL 276
S Q+L L F D A S+ +I+L + +F L
Sbjct: 223 KNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTF--HCFSGL 280
Query: 277 KYLDLSHNNFTG---KFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSH 333
+ LDL+ + + L L + LS N S N L L++
Sbjct: 281 QELDLTATHLSELPSGLVGLS-----TLKKLVLSANKFENLC-QISASNFPSLTHLSIKG 334
Query: 334 NALQGGIPGFLLGSFRNLKQLSLAHNQFAG-EIPPELGQACGTLRELDLSSNRLTGELPS 392
N + + L + NL++L L+H+ + + L+ L+LS N
Sbjct: 335 NTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTE 394
Query: 393 TFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVL 452
F C L L+L L + + L L + + + L+ L
Sbjct: 395 AFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHL 454
Query: 453 DLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAG 512
+L N F S LE +VL LS S K + +DLS N L
Sbjct: 455 NLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS 514
Query: 513 PVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTN 572
+ L + L + +N+++ I + T+ L N L +C+N
Sbjct: 515 SSIEALSHLKGIY-LNLASNHISI-ILPSLLPILSQQRTINLRQNPLDC-------TCSN 565
Query: 573 ---MLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLT 608
+ W + +L N L ++L + +L+
Sbjct: 566 IYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 2e-53
Identities = 91/492 (18%), Positives = 158/492 (32%), Gaps = 74/492 (15%)
Query: 324 QLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSS 383
++ +T N + L IPG L + + L + N I L LDL+
Sbjct: 12 EVNKTYNCENLGLNE-IPGTL---PNSTECLEFSFNVLP-TIQNTTFSRLINLTFLDLTR 66
Query: 384 NRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSL 443
++ TF S L +L L +N L T +S +L +L+ IS + L
Sbjct: 67 CQIYWIHEDTFQSQHRLDTLVLTANPLIF-MAETALSGPKALKHLFFIQTGISSIDFIPL 125
Query: 444 TNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLK-- 501
N L L L SN + L+ + NN + ++ S +
Sbjct: 126 HNQKTLESLYLGSNHISSIKLPKG---FPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNL 182
Query: 502 TIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNG-GNLETLILNNNHLT 560
+++L+ N +AG + + L I +G+ + +L +
Sbjct: 183 SLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE 241
Query: 561 GAIPKSIASCTNM--LWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKC 618
P M ++L + L L L L+ ++P GL
Sbjct: 242 DISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGL 300
Query: 619 RSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEG 678
+L L LS N+ FE
Sbjct: 301 STLKKL-----VLSA-------NK---------------------------------FEN 315
Query: 679 IRPERLEGFP------MVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSL--SGTLPEN 730
+ FP + + + TG +L LDLS++ + S
Sbjct: 316 LCQISASNFPSLTHLSIKGNTKRLELGTG----CLENLENLRELDLSHDDIETSDCCNLQ 371
Query: 731 FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGS-LGGLSFLSDLD 789
+L++LQ LNL +N+ ++F + +LDL+ + S L L L+
Sbjct: 372 LRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLN 431
Query: 790 VSNNNLSGIIPS 801
+S++ L
Sbjct: 432 LSHSLLDISSEQ 443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 4e-48
Identities = 71/403 (17%), Positives = 124/403 (30%), Gaps = 54/403 (13%)
Query: 410 LSGNFLNTVVSKI-SSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFC 468
LN + + +S L FN + + + L LDL+ F
Sbjct: 19 CENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQ 78
Query: 469 SPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLV 528
+ L+ +VL N L L K LK + ++ + + L L
Sbjct: 79 ---SQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLY 135
Query: 529 MWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTN--MLWVSLSSNQLTGE 586
+ +N+++ I L+ L NN + + ++S L ++L+ N +
Sbjct: 136 LGSNHISS-IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-G 193
Query: 587 IPAGIGNLVKLAILQLGNNSLTGQVPQGLGKC--RSLVWLDLNSNNLSGPLPSELANQAG 644
I G + L G + +GL +SL + P+
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG--- 250
Query: 645 VVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTM 704
+S + ++ F I F
Sbjct: 251 ---LCEMSVESINLQKHY-------------FFNISSNTFHCFS---------------- 278
Query: 705 YTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVL 764
L LDL+ LS LP L+ L+ L L NK S ++ L
Sbjct: 279 -------GLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHL 330
Query: 765 DLSHNNFQGSI-PGSLGGLSFLSDLDVSNNNLSGIIPSGGQLT 806
+ N + + G L L L +LD+S++++ QL
Sbjct: 331 SIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR 373
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-41
Identities = 58/355 (16%), Positives = 110/355 (30%), Gaps = 27/355 (7%)
Query: 450 RVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNS 509
+ + + G IP + E + N L NL +DL+
Sbjct: 15 KTYNCENLGLN-EIPGTL-----PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQ 68
Query: 510 LAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIAS 569
+ S L LV+ AN L + E L+ L ++ + +
Sbjct: 69 IYWIHEDTFQSQHRLDTLVLTANPLIF-MAETALSGPKALKHLFFIQTGISSIDFIPLHN 127
Query: 570 CTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSL--VWLDLN 627
+ + L SN ++ KL +L NN++ + + + + L+LN
Sbjct: 128 QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLN 187
Query: 628 SNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGF 687
N+++G + + A + F + + + E
Sbjct: 188 GNDIAG-IEPGAFDSAVF--------QSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
Query: 688 PMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKL 747
P+ + S+ ++L + F + LQ L+L L
Sbjct: 239 DDEDISPAV--------FEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL 290
Query: 748 TGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSG 802
+ +P GL + L LS N F+ S L+ L + N + +G
Sbjct: 291 S-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTG 344
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-17
Identities = 32/106 (30%), Positives = 46/106 (43%), Gaps = 4/106 (3%)
Query: 700 TGMTMYTFTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGL 758
+ F L LDL++ L ++ F +L+ L+VLNL H+ L F GL
Sbjct: 389 LSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGL 448
Query: 759 KAIGVLDLSHNNFQGSI---PGSLGGLSFLSDLDVSNNNLSGIIPS 801
A+ L+L N+F SL L L L +S +LS I
Sbjct: 449 PALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQH 494
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-16
Identities = 19/101 (18%), Positives = 35/101 (34%), Gaps = 3/101 (2%)
Query: 705 YTFTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLT--GHIPDSFGGLKAI 761
+ + SL +L + N+ L +L L+ L+L H+ + L +
Sbjct: 319 ISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHL 378
Query: 762 GVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSG 802
L+LS+N + L LD++ L
Sbjct: 379 QSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQS 419
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-16
Identities = 19/105 (18%), Positives = 38/105 (36%), Gaps = 2/105 (1%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
+ +L +L +S + L+ L LG N ++ + + VLD
Sbjct: 100 ALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLD 159
Query: 766 LSHNNFQGSIPGSLGGLSFLS--DLDVSNNNLSGIIPSGGQLTTF 808
+N + L + L+++ N+++GI P F
Sbjct: 160 FQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVF 204
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-15
Identities = 28/92 (30%), Positives = 43/92 (46%), Gaps = 1/92 (1%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
+ T G L L LS+ LS F SL + ++L HN+LT ++ LK I L+
Sbjct: 471 SLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLN 529
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSG 797
L+ N+ +P L LS +++ N L
Sbjct: 530 LASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-12
Identities = 18/105 (17%), Positives = 33/105 (31%), Gaps = 1/105 (0%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
+L L L N +S L+VL+ +N + + L+ L
Sbjct: 124 PLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLS 183
Query: 766 LS-HNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFP 809
L+ + N I + L+ +I G + +T
Sbjct: 184 LNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQ 228
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 2e-68
Identities = 98/556 (17%), Positives = 175/556 (31%), Gaps = 47/556 (8%)
Query: 98 SLNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFS---AGDLSTSKTSSCSLV 154
+ S +++L+ + L L + + L+ L+L L
Sbjct: 29 DIPSSTKNIDLSFNPLK-ILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLH----HLS 83
Query: 155 TMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISG---GSLHIGPSLLQLDLSGNQIS 211
+ L+ N I PG L + ++ + +L +L+++ N I
Sbjct: 84 NLILTGNPIQSFSPG--SFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIH 141
Query: 212 DSALLTYSLSNCQNLNLLNFSDNKL----PGKLNATSVNCKSISTIDLSYNLLSGEIPAS 267
L SN NL ++ S N + L N + ++D+S N + +
Sbjct: 142 SCKLPA-YFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQA 200
Query: 268 FVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSG--------TEFPAS 319
F L L L N + L V L
Sbjct: 201 F---QGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEG 257
Query: 320 LKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLREL 379
L + + E +++ N+ +SLA + + L
Sbjct: 258 LCDVTIDE-FRLTYTNDFSDDIV-KFHCLANVSAMSLAGVSIK-YLED--VPKHFKWQSL 312
Query: 380 DLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNIS--G 437
+ +L L SL L N S +F + SL YL + N +S G
Sbjct: 313 SIIRCQLKQ---FPTLDLPFLKSLTLTMNKGSISFKKV---ALPSLSYLDLSRNALSFSG 366
Query: 438 PVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLE-LGS 496
S LR LDLS NG + + F L+ + ++ L S
Sbjct: 367 CCSYSDLGTNSLRHLDLSFNGAI-IMSANFM---GLEELQHLDFQHSTLKRVTEFSAFLS 422
Query: 497 CKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNN 556
+ L +D+S+ + L +L+ L M N+ + N NL L L+
Sbjct: 423 LEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSK 482
Query: 557 NHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLG 616
L + + +++S N L + L L+ L N +
Sbjct: 483 CQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQH 542
Query: 617 KCRSLVWLDLNSNNLS 632
+SL + +L +N+++
Sbjct: 543 FPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 5e-65
Identities = 100/569 (17%), Positives = 176/569 (30%), Gaps = 54/569 (9%)
Query: 96 SCSLNSHVTSLNLNNSGLSGSLNLTTL-TALP-YLEHLNLQGNSFS---AGDLSTSKTSS 150
C + + L+ + +P ++++L N + S
Sbjct: 6 PCIEVVPNITYQCMD------QKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFS--- 56
Query: 151 CSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISG---GSLHIGPSLLQLDLSG 207
L +DLS I LS + L+ N I GS SL L
Sbjct: 57 -ELQWLDLSRCEIETIEDK--AWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVE 113
Query: 208 NQISDSALLTYSLSNCQNLNLLNFSDNKLPG-KLNATSVNCKSISTIDLSYNLLSGEIPA 266
+++ L ++ + L LN + N + KL A N ++ +DLSYN +
Sbjct: 114 TKLAS--LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN 171
Query: 267 SF--VADSSGSLKYLDLSHNNFT----GKFSNLDFGRCGNLSVITLSQNGLSGTEFPASL 320
+ ++ LD+S N F + L +TL N S L
Sbjct: 172 DLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI------KLHELTLRGNFNSSNIMKTCL 225
Query: 321 KNCQLLETLNMSHNALQGG--IPGFLLGSFRNLKQLSLAHNQFAG----EIPPELGQACG 374
+N L + + + F L +++ +
Sbjct: 226 QNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLA 285
Query: 375 TLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNN 434
+ + L+ + SL++ L + L L + N
Sbjct: 286 NVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLD----LPFLKSLTLTMNK 339
Query: 435 ISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLEL 494
S + L LDLS N + S +L + L N +
Sbjct: 340 GS--ISFKKVALPSLSYLDLSRNALS-FSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANF 395
Query: 495 GSCKNLKTIDLSFNSLAG-PVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLI 553
+ L+ +D ++L S SL L L + N +GI + +L TL
Sbjct: 396 MGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKI-DFDGIFLGLTSLNTLK 454
Query: 554 LNNNHLTGAIPKSI-ASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVP 612
+ N ++ A+ TN+ ++ LS QL L +L +L + +N+L
Sbjct: 455 MAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDS 514
Query: 613 QGLGKCRSLVWLDLNSNNLSGPLPSELAN 641
+ SL LD + N +
Sbjct: 515 SHYNQLYSLSTLDCSFNRIETSKGILQHF 543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-44
Identities = 70/466 (15%), Positives = 138/466 (29%), Gaps = 80/466 (17%)
Query: 354 LSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGN 413
+ + ++P ++ + + +DLS N L +F++ S L L+L +
Sbjct: 16 YQCMDQKLS-KVPDDIPS---STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET- 70
Query: 414 FLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNF 473
+ + L L + N I P S + T L L
Sbjct: 71 IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIG---QL 127
Query: 474 PALEKIVLPNNYLSG-TVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWAN 532
L+K+ + +N++ +P + NL +DLS+N + +++ L +
Sbjct: 128 ITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQV----- 182
Query: 533 NLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAG-I 591
+L ++ N + I + ++L N + I +
Sbjct: 183 ----------------NLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCL 225
Query: 592 GNLVKLAILQLGNNSLTG---------QVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQ 642
NL L + +L + +GL L N +
Sbjct: 226 QNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDE-FRLTYTNDFSDDIVKFHC- 283
Query: 643 AGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRI---- 698
+ + + ++ V +
Sbjct: 284 -------LANVSAMSLAGV---------------------SIKYLEDVPKHFKWQSLSII 315
Query: 699 YTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSF--G 756
+ + L L L+ N S + +L L L+L N L+ S+
Sbjct: 316 RCQLKQFPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDL 373
Query: 757 GLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSG 802
G ++ LDLS N + + GL L LD ++ L +
Sbjct: 374 GTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFS 418
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-38
Identities = 72/407 (17%), Positives = 119/407 (29%), Gaps = 35/407 (8%)
Query: 410 LSGNFLNTVVSKI-SSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFC 468
L+ V I SS + + FN + S +N ++L+ LDLS +
Sbjct: 18 CMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWH 77
Query: 469 SPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLV 528
L ++L N + P +L+ + LA I L L L
Sbjct: 78 ---GLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLN 134
Query: 529 MWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWV----SLSSNQLT 584
+ N + N NL + L+ N++ + V +S N +
Sbjct: 135 VAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID 194
Query: 585 GEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGK-CRSLVWLDLNSNNLSGPLPSELANQA 643
I +KL L L N + + + + L L E+ +
Sbjct: 195 -FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPS 253
Query: 644 GVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVH--SCPSTRIYTG 701
+ V+ +F + V S I
Sbjct: 254 IMEGLCDVTIDEFRLTYTN-------------DFSDDIVKFHCLANVSAMSLAGVSI--- 297
Query: 702 MTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAI 761
+ + L + L L +L+ L L NK + I L ++
Sbjct: 298 KYLEDVPKHFKWQSLSIIRCQLKQF---PTLDLPFLKSLTLTMNKGS--ISFKKVALPSL 352
Query: 762 GVLDLSHNNFQGSIPGSL--GGLSFLSDLDVSNNNLSGIIPSGGQLT 806
LDLS N S S G + L LD+S N + + L
Sbjct: 353 SYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLE 399
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-22
Identities = 49/330 (14%), Positives = 94/330 (28%), Gaps = 68/330 (20%)
Query: 488 GTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGG 547
G++ + N+ T L+ VP +I + ++ + N L + N
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLSK-VPDDI--PSSTKNIDLSFNPLK-ILKSYSFSNFS 56
Query: 548 NLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSL 607
L+ L L+ + K+ ++ + L+ N + P L L L L
Sbjct: 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116
Query: 608 TGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTAC 667
+G+ +L L++ N + F+ + N
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHS----------------CKLPAYFSNLTN------ 154
Query: 668 RGAGGLVE-------FEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSY 720
LV + I L+ + LD+S
Sbjct: 155 -----LVHVDLSYNYIQTITVNDLQFLRENPQ-------------------VNLSLDMSL 190
Query: 721 NSLSGTLPENFGSLNYLQVLNLGHNKLTGHIP-DSFGGLKAIGVLDLSHNNFQGSI---- 775
N + + F + L L L N + +I L + V L F+
Sbjct: 191 NPIDFIQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI 249
Query: 776 --PGSLGGLSFLS--DLDVSNNNLSGIIPS 801
P + GL ++ + ++ N
Sbjct: 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIV 279
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-18
Identities = 26/98 (26%), Positives = 36/98 (36%), Gaps = 1/98 (1%)
Query: 705 YTFTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGV 763
F SL L ++ NS N F + L L+L +L F L + +
Sbjct: 442 GIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQL 501
Query: 764 LDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPS 801
L++SHNN L LS LD S N +
Sbjct: 502 LNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGI 539
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 6e-17
Identities = 22/98 (22%), Positives = 40/98 (40%), Gaps = 2/98 (2%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVL 764
F L +LD +++L + F SL L L++ + F GL ++ L
Sbjct: 394 NFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTL 453
Query: 765 DLSHNNFQGSIP-GSLGGLSFLSDLDVSNNNLSGIIPS 801
++ N+F+ + + L+ LD+S L I
Sbjct: 454 KMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWG 491
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-16
Identities = 25/92 (27%), Positives = 42/92 (45%)
Query: 705 YTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVL 764
F +L +LDLS L F +L+ LQ+LN+ HN L + L ++ L
Sbjct: 467 NVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTL 526
Query: 765 DLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLS 796
D S N + S L+ +++NN+++
Sbjct: 527 DCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-15
Identities = 28/108 (25%), Positives = 40/108 (37%), Gaps = 5/108 (4%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTG-HIPDSFGGLKAIGVL 764
+F+ SL L L+ G L L+ LN+ HN + +P F L + +
Sbjct: 99 SFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHV 158
Query: 765 DLSHNNFQGSIPGSLGGLSFLSD----LDVSNNNLSGIIPSGGQLTTF 808
DLS+N Q L L LD+S N + I Q
Sbjct: 159 DLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKL 206
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 6e-14
Identities = 27/100 (27%), Positives = 42/100 (42%), Gaps = 4/100 (4%)
Query: 705 YTFTTNGSLIYLDLSYNSLSGTLPENFGSLNY--LQVLNLGHNKLTGHIPDSFGGLKAIG 762
+ SL YLDLS N+LS + ++ L L+ L+L N + +F GL+ +
Sbjct: 344 FKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQ 402
Query: 763 VLDLSHNNFQGSIP-GSLGGLSFLSDLDVSNNNLSGIIPS 801
LD H+ + + L L LD+S N
Sbjct: 403 HLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDG 442
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 1e-66
Identities = 73/263 (27%), Positives = 117/263 (44%), Gaps = 9/263 (3%)
Query: 379 LDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNF-LNTVVSKISSLIYLYVP-FNNIS 436
D + G L T +++L+L L + + + ++ + L +LY+ NN+
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90
Query: 437 GPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGS 496
GP+P ++ TQL L ++ +G IP L + N LSGT+P + S
Sbjct: 91 GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS---QIKTLVTLDFSYNALSGTLPPSISS 147
Query: 497 CKNLKTIDLSFNSLAGPVPSEIWSLPNLS-DLVMWANNLTGEIPEGICVNGGNLETLILN 555
NL I N ++G +P S L + + N LTG+IP NL + L+
Sbjct: 148 LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA--NLNLAFVDLS 205
Query: 556 NNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGL 615
N L G S N + L+ N L ++ +G L L L NN + G +PQGL
Sbjct: 206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGL 264
Query: 616 GKCRSLVWLDLNSNNLSGPLPSE 638
+ + L L+++ NNL G +P
Sbjct: 265 TQLKFLHSLNVSFNNLCGEIPQG 287
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 8e-58
Identities = 80/333 (24%), Positives = 128/333 (38%), Gaps = 45/333 (13%)
Query: 219 SLSNCQNL----NLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGE--IPASFVADS 272
L N L + + G L T ++ +DLS L IP+S +A+
Sbjct: 17 DLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSS-LANL 75
Query: 273 SGSLKYLDLSH-NNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNM 331
L +L + NN G + L + ++ +SG P L + L TL+
Sbjct: 76 P-YLNFLYIGGINNLVGPIPP-AIAKLTQLHYLYITHTNVSG-AIPDFLSQIKTLVTLDF 132
Query: 332 SHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELP 391
S+NAL G +P + S NL ++ N+ +G IP G + +S NRLTG++P
Sbjct: 133 SYNALSGTLPPSI-SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191
Query: 392 STFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRV 451
TFA+ +L ++L NML G + + +
Sbjct: 192 PTFANL-NLAFVDLSRNML-------------------------EGDASVLFGSDKNTQK 225
Query: 452 LDLSSNGFTGTIPS-GFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSL 510
+ L+ N + G L + L NN + GT+P L K L ++++SFN+L
Sbjct: 226 IHLAKNSLAFDLGKVGLSK-----NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280
Query: 511 AGPVPSEIWSLPNLSDLVMWANNLTGEIPEGIC 543
G +P +L N P C
Sbjct: 281 CGEIPQG-GNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-57
Identities = 78/306 (25%), Positives = 116/306 (37%), Gaps = 40/306 (13%)
Query: 183 NLSHNSISG---GSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGK 239
+ + + G + + LDLSG + + SL+N LN L
Sbjct: 32 DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGG------ 85
Query: 240 LNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCG 299
N L G IP + L YL ++H N +G + +
Sbjct: 86 -----------------INNLVGPIPPAI--AKLTQLHYLYITHTNVSGAIPD-FLSQIK 125
Query: 300 NLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQ-LSLAH 358
L + S N LSGT P S+ + L + N + G IP GSF L ++++
Sbjct: 126 TLVTLDFSYNALSGT-LPPSISSLPNLVGITFDGNRISGAIPDS-YGSFSKLFTSMTISR 183
Query: 359 NQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTV 418
N+ G+IPP L +DLS N L G+ F S + ++L N L+ +
Sbjct: 184 NRLTGKIPPTFANL--NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL--GK 239
Query: 419 VSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEK 478
V +L L + N I G +P LT L L++S N G IP G N +
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG----NLQRFDV 295
Query: 479 IVLPNN 484
NN
Sbjct: 296 SAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 171 bits (437), Expect = 1e-47
Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 13/208 (6%)
Query: 442 SLTNCTQLR----VLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGT--VPLELG 495
L N T L D + + G + + + L L +P L
Sbjct: 17 DLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYR---VNNLDLSGLNLPKPYPIPSSLA 73
Query: 496 SCKNLKTIDLS-FNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLIL 554
+ L + + N+L GP+P I L L L + N++G IP+ + L TL
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS-QIKTLVTLDF 132
Query: 555 NNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLA-ILQLGNNSLTGQVPQ 613
+ N L+G +P SI+S N++ ++ N+++G IP G+ KL + + N LTG++P
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192
Query: 614 GLGKCRSLVWLDLNSNNLSGPLPSELAN 641
+L ++DL+ N L G +
Sbjct: 193 TFANL-NLAFVDLSRNMLEGDASVLFGS 219
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-46
Identities = 74/389 (19%), Positives = 137/389 (35%), Gaps = 118/389 (30%)
Query: 57 NEELTILMAFKQSSIGSDPNGYLANWTADA-LTPCSWQGVSCSLNSH---VTSLNLNNSG 112
++ L+ K +G+ L++W +W GV C ++ V +L+L+
Sbjct: 5 PQDKQALLQIK-KDLGNPTT--LSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLN 61
Query: 113 LSGSL-------NLTTLTAL-------------------PYLEHLNLQGNSFSAGDLSTS 146
L NL L L L +L + + S G +
Sbjct: 62 LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS-GAIPDF 120
Query: 147 KTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLS 206
+ +LVT+D S N ++G+LP
Sbjct: 121 LSQIKTLVTLDFSYNALSGTLPP------------------------------------- 143
Query: 207 GNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSIST-IDLSYNLLSGEIP 265
S+S+ NL + F N++ G + + + + T + +S N L+G+IP
Sbjct: 144 ------------SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191
Query: 266 ASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQL 325
+F ++ +L ++DLS N G + + +
Sbjct: 192 PTF---ANLNLAFVDLSRNMLEG--------------------------DASVLFGSDKN 222
Query: 326 LETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNR 385
+ ++++ N+L + +G +NL L L +N+ G +P L Q L L++S N
Sbjct: 223 TQKIHLAKNSLAFDLGK--VGLSKNLNGLDLRNNRIYGTLPQGLTQ-LKFLHSLNVSFNN 279
Query: 386 LTGELPSTFASCSSLHSLNLGSN-MLSGN 413
L GE+P + +N L G+
Sbjct: 280 LCGEIPQGG-NLQRFDVSAYANNKCLCGS 307
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-40
Identities = 50/119 (42%), Positives = 62/119 (52%), Gaps = 1/119 (0%)
Query: 710 NGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHN 769
N +L ++DLS N L G FGS Q ++L N L + G K + LDL +N
Sbjct: 196 NLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNN 254
Query: 770 NFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPLLPCS 828
G++P L L FL L+VS NNL G IP GG L F S Y NN LCG PL C+
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 3e-26
Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 2/91 (2%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIG-VLDLSHNN 770
+L+ LD SYN+LSGTLP + SL L + N+++G IPDS+G + + +S N
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR 185
Query: 771 FQGSIPGSLGGLSFLSDLDVSNNNLSGIIPS 801
G IP + L+ L+ +D+S N L G
Sbjct: 186 LTGKIPPTFANLN-LAFVDLSRNMLEGDASV 215
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 3e-26
Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 1/91 (1%)
Query: 712 SLIYLDLS-YNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNN 770
L +L + N+L G +P L L L + H ++G IPD +K + LD S+N
Sbjct: 77 YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA 136
Query: 771 FQGSIPGSLGGLSFLSDLDVSNNNLSGIIPS 801
G++P S+ L L + N +SG IP
Sbjct: 137 LSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 1/91 (1%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
L YL +++ ++SG +P+ + L L+ +N L+G +P S L + + N
Sbjct: 102 QLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161
Query: 772 QGSIPGSLGGLSFLS-DLDVSNNNLSGIIPS 801
G+IP S G S L + +S N L+G IP
Sbjct: 162 SGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (258), Expect = 6e-24
Identities = 36/105 (34%), Positives = 49/105 (46%), Gaps = 4/105 (3%)
Query: 706 TFTTNGSLIYLDLSYNSLSGT--LPENFGSLNYLQVLNL-GHNKLTGHIPDSFGGLKAIG 762
T T + LDLS +L +P + +L YL L + G N L G IP + L +
Sbjct: 45 TDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLH 104
Query: 763 VLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSG-GQLT 806
L ++H N G+IP L + L LD S N LSG +P L
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLP 149
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 4e-17
Identities = 25/95 (26%), Positives = 39/95 (41%), Gaps = 4/95 (4%)
Query: 716 LDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTG--HIPDSFGGLKAIGVLDLSH-NNFQ 772
D + G L + + L+L L IP S L + L + NN
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90
Query: 773 GSIPGSLGGLSFLSDLDVSNNNLSGIIPSG-GQLT 806
G IP ++ L+ L L +++ N+SG IP Q+
Sbjct: 91 GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 1e-63
Identities = 92/328 (28%), Positives = 156/328 (47%), Gaps = 46/328 (14%)
Query: 888 PTSGSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKA 947
P S ++ +++ + P L IG+G FG V++A
Sbjct: 9 PMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKE------------KIGAGSFGTVHRA 56
Query: 948 QLRDGSVVAIKKLI--HVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005
+ GS VA+K L+ + EF+ E+ + +++H N+V +G +V EY
Sbjct: 57 EWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115
Query: 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLL 1065
+ GSL +LH G +LD R +A A+G+ +LH + P I+HR++KS N+L+
Sbjct: 116 LSRGSLYRLLHK--SGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLV 172
Query: 1066 DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILL 1125
D+ + +V DFG++RL T LS + AGTP ++ PE + K DVYS+GVIL
Sbjct: 173 DKKYTVKVCDFGLSRLKA--STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILW 230
Query: 1126 ELLSGKRP---IDPSEFGDDNNLVGWAKQLHREKR--INEILDPELTMQTSDETELYQYL 1180
EL + ++P ++P++ V A + KR I L+P++ + +
Sbjct: 231 ELATLQQPWGNLNPAQ-------VVAAV-GFKCKRLEIPRNLNPQV-------AAIIE-- 273
Query: 1181 RISFECLDDRPFKRPTMIQVMAMFKELQ 1208
C + P+KRP+ +M + + L
Sbjct: 274 ----GCWTNEPWKRPSFATIMDLLRPLI 297
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-62
Identities = 76/281 (27%), Positives = 125/281 (44%), Gaps = 32/281 (11%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI 995
+G G FG V KA+ R VAIK++ + F+ E+ + ++ H N+V L G C
Sbjct: 16 VGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL- 71
Query: 996 GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIH 1055
LV EY + GSL +VLH A + ++G+A+LH +IH
Sbjct: 72 -NPVCLVMEYAEGGSLYNVLHG--AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 1056 RDMKSSNVLLDENFE-ARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTK 1114
RD+K N+LL ++ DFG A + T G+ ++ PE ++ + K
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT-----NNKGSAAWMAPEVFEGSNYSEK 183
Query: 1115 GDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKR--INEILDPELTMQTSD 1172
DV+S+G+IL E+++ ++P D E G + WA +H R + + L +
Sbjct: 184 CDVFSWGIILWEVITRRKPFD--EIGGPAFRIMWA--VHNGTRPPLIKNLPKPI------ 233
Query: 1173 ETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEG 1213
L C P +RP+M +++ + L G
Sbjct: 234 -ESLMT------RCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 2e-61
Identities = 71/292 (24%), Positives = 126/292 (43%), Gaps = 35/292 (11%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCK 994
+G G FG+ K R+ G V+ +K+LI + R F+ E++ + ++H N++ +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 995 IGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHII 1054
+ + EY+K G+L ++ ++ W+ R A A G+A+LH +II
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSM----DSQYPWSQRVSFAKDIASGMAYLHSM---NII 130
Query: 1055 HRDMKSSNVLLDENFEARVSDFGMARLVNALDTH------------LSVSTLAGTPGYVP 1102
HRD+ S N L+ EN V+DFG+ARL+ T T+ G P ++
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 1103 PEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162
PE K DV+S+G++L E++ ++ G + ++
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNA--DPDYLPRTMDFGLNVRGFLDRYCPPNC 248
Query: 1163 DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGD 1214
P I+ C D P KRP+ +++ + L++ G
Sbjct: 249 PPSF-------------FPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 5e-61
Identities = 81/292 (27%), Positives = 131/292 (44%), Gaps = 49/292 (16%)
Query: 935 MIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGD-------REFMAEMETIGKIKHRNL 986
IG GGFG V+K +L D SVVAIK LI +G+ +EF E+ + + H N+
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 987 VPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLH 1046
V L G +V E++ G L L D+A + W+ + ++ + A G+ ++
Sbjct: 86 VKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAH----PIKWSVKLRLMLDIALGIEYMQ 139
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFE-----ARVSDFGMARLVNALDTHLSVSTLAGTPGYV 1101
+ P I+HRD++S N+ L E A+V+DFG+++ + SVS L G ++
Sbjct: 140 -NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWM 193
Query: 1102 PPE--YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNL-VGWAKQLHREKR- 1157
PE + T K D YS+ +IL +L+G+ P F + + + + + E
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGP-----FDEYSYGKIKFINMIREEGLR 248
Query: 1158 --INEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207
I E P L + + C P KRP ++ EL
Sbjct: 249 PTIPEDCPPRL-------RNVIE------LCWSGDPKKRPHFSYIVKELSEL 287
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 1e-60
Identities = 115/579 (19%), Positives = 208/579 (35%), Gaps = 64/579 (11%)
Query: 96 SCSLNSHVTSLNLNNSGLSGSLNLTTL-TALPYLEHLNLQGNSFS---AGDLSTSKTSSC 151
SCS NLT + L E L L N A +
Sbjct: 1 SCS----FDGRIAFYRFC----NLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLE---- 48
Query: 152 SLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISG---GSLHIGPSLLQLDLSGN 208
L ++L S ++ +F + L ++L + I + L +L L
Sbjct: 49 QLQLLELGSQYTPLTIDKEAFR-NLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFC 107
Query: 209 QISDSALLTYSLSNCQNLNLLNFSDNKLPG-KLNATSVNCKSISTIDLSYNLLSGEIPAS 267
+SD+ L N + L L+ S N++ L+ + S+ +ID S N +
Sbjct: 108 GLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHE 167
Query: 268 FVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGN------LSVITLSQNGLSGTEF----- 316
+L + L+ N+ ++D+G+C N L ++ +S NG +
Sbjct: 168 LEPLQGKTLSFFSLAANSLY-SRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSN 226
Query: 317 ------PASLKNCQLLETLNMSHNALQGGIPGFLLGSFR-NLKQLSLAHNQFAGEIPPEL 369
SL + + ++ G R +++ L L+H + +
Sbjct: 227 AISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRV 285
Query: 370 GQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLY 429
+ L+ L+L+ N++ F +L LNL N+L ++ + + Y+
Sbjct: 286 FETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPKVAYID 344
Query: 430 VPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGT 489
+ N+I+ + +L+ LDL N T + P++ I L N L
Sbjct: 345 LQKNHIAIIQDQTFKFLEKLQTLDLRDNALT--------TIHFIPSIPDIFLSGNKLVTL 396
Query: 490 VPLELGSCKNLKTIDLSFNSLAG-PVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGN 548
+ L I LS N L + + +P+L L++ N + + +
Sbjct: 397 PKINL----TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPS 452
Query: 549 LETLILNNNHLTGAIPKSI-----ASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQL 602
LE L L N L A + +++ + L+ N L +P G+ +L L L L
Sbjct: 453 LEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSL 511
Query: 603 GNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELAN 641
+N LT + +L LD++ N L P P +
Sbjct: 512 NSNRLT-VLSHNDLP-ANLEILDISRNQLLAPNPDVFVS 548
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 1e-55
Identities = 121/670 (18%), Positives = 200/670 (29%), Gaps = 121/670 (18%)
Query: 175 SCD-RLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSD 233
SC +++ + + +L LS N I + S + L LL
Sbjct: 1 SCSFDGRIAFYRFCNLTQVPQVL-NTTERLLLSFNYIRT--VTASSFPFLEQLQLLELGS 57
Query: 234 NKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNL 293
P ++ +F + +L+ LDL +
Sbjct: 58 QYTPLTID-----------------------KEAF--RNLPNLRILDLGSSKIY-FLHPD 91
Query: 294 DFGRCGNLSVITLSQNGLSGTEFPAS-LKNCQLLETLNMSHNALQGGIPGFLLGSFRNLK 352
F +L + L GLS +N + L L++S N ++ G +LK
Sbjct: 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLK 151
Query: 353 QLSLAHNQFAGEIPPEL--GQACGTLRELDLSSNRLTGELPSTFASC-SSLHSLNLGSNM 409
+ + NQ + TL L++N L + + C + ++ L
Sbjct: 152 SIDFSSNQIF-LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILD 210
Query: 410 LSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCS 469
+SGN ++ N IS SL + +
Sbjct: 211 VSGNGWTVDITGNF--------SNAISKSQAFSLILAHHIMGAGFGFHNIK--------- 253
Query: 470 PPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVM 529
N +G +++ +DLS + +L +L L +
Sbjct: 254 ----------DPDQNTFAGLARS------SVRHLDLSHGFVFSLNSRVFETLKDLKVLNL 297
Query: 530 WANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPA 589
N + +I + NL+ L L+ N L + + ++ L N +
Sbjct: 298 AYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQ 356
Query: 590 GIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPG 649
L KL L L +N+LT + S+ + L+ N L L
Sbjct: 357 TFKFLEKLQTLDLRDNALTT-----IHFIPSIPDIFLSGNKLVTLPKINLTAN------- 404
Query: 650 IVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPS--------TRIYTG 701
L+ R E L+ + P R +
Sbjct: 405 -----------------------LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSC 441
Query: 702 MTMYTFTTNGSLIYLDLSYNSLSGT-----LPENFGSLNYLQVLNLGHNKLTGHIPDSFG 756
T + N SL L L N L + F L++LQVL L HN L P F
Sbjct: 442 SGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFS 501
Query: 757 GLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENN 816
L A+ L L+ N L + L LD+S N L P + +N
Sbjct: 502 HLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPD--VFVSLSVLDITHN 557
Query: 817 SGLCGLPLLP 826
+C L
Sbjct: 558 KFICECELST 567
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 7e-44
Identities = 93/510 (18%), Positives = 176/510 (34%), Gaps = 60/510 (11%)
Query: 87 LTPCSWQGVSCSLNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSA-GDLST 145
L+ + +T L+L+ + + + L L+ ++ N +
Sbjct: 109 LSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHEL 168
Query: 146 SKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDL 205
+L L++N++ S + + + L LD+
Sbjct: 169 EPLQGKTLSFFSLAANSLY-SRVSVDWGKCMNPFRNMVLEI----------------LDV 211
Query: 206 SGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIP 265
SGN + +++ N + + + I ++ +
Sbjct: 212 SGNGWT--------------VDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQ 257
Query: 266 ASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQL 325
+F + S+++LDLSH ++ F +L V+ L+ N ++ +
Sbjct: 258 NTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIA-DEAFYGLDN 315
Query: 326 LETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNR 385
L+ LN+S+N L + + + L N A I + + L+ LDL N
Sbjct: 316 LQVLNLSYNLLG-ELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNA 373
Query: 386 LTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISG-PVPLSLT 444
LT T S+ + LSGN L T+ + +++ N + + L
Sbjct: 374 LT-----TIHFIPSIPDIF-----LSGNKLVTLPKINLTANLIHLSENRLENLDILYFLL 423
Query: 445 NCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLEL-----GSCKN 499
L++L L+ N F+ S P+LE++ L N L EL +
Sbjct: 424 RVPHLQILILNQNRFSSCSGDQTPSEN--PSLEQLFLGENMLQLAWETELCWDVFEGLSH 481
Query: 500 LKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHL 559
L+ + L+ N L P L L L + +N LT + NLE L ++ N L
Sbjct: 482 LQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHND--LPANLEILDISRNQL 538
Query: 560 TGAIPKSIASCTNMLWVSLSSNQLTGEIPA 589
P S + + ++ N+ E
Sbjct: 539 LAPNPDVFVSLSVLD---ITHNKFICECEL 565
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-35
Identities = 74/383 (19%), Positives = 137/383 (35%), Gaps = 30/383 (7%)
Query: 97 CSLNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLST-SKTSSCSLVT 155
S N + N S +L ++ ++ D +T + + S+
Sbjct: 211 VSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRH 270
Query: 156 MDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSIS---GGSLHIGPSLLQLDLSGNQISD 212
+DLS + SL R F + L +NL++N I+ + + +L L+LS N + +
Sbjct: 271 LDLSHGFVF-SLNSRVFE-TLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGE 328
Query: 213 SALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLS----------- 261
L + + + ++ N + + T + + T+DL N L+
Sbjct: 329 --LYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDI 386
Query: 262 --GEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPAS 319
+ + + + LS N R +L ++ L+QN S +
Sbjct: 387 FLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQT 446
Query: 320 LKNCQLLETLNMSHNALQG----GIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGT 375
LE L + N LQ + + +L+ L L HN +PP +
Sbjct: 447 PSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTA 505
Query: 376 LRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNI 435
LR L L+SNRLT + ++L L++ N L V +S L + F
Sbjct: 506 LRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLL-APNPDVFVSLSVLDITHNKFICE 562
Query: 436 SGPVPL-SLTNCTQLRVLDLSSN 457
+ N T + + ++
Sbjct: 563 CELSTFINWLNHTNVTIAGPPAD 585
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 1e-60
Identities = 66/324 (20%), Positives = 114/324 (35%), Gaps = 46/324 (14%)
Query: 926 ATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEME--TIGKIKH 983
+ +IG G +G VYK L VA+K + + F+ E + ++H
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVF---SFANRQNFINEKNIYRVPLMEH 66
Query: 984 RNLVPLLGYCKIGE-----ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGS 1038
N+ + + E LLV EY GSL L DW + ++A
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSV 120
Query: 1039 ARGLAFLH------HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA------LD 1086
RGLA+LH P I HRD+ S NVL+ + +SDFG++ + +
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180
Query: 1087 THLSVSTLAGTPGYVPPEYYQS-------FRCTTKGDVYSYGVILLELLSGKRPIDPSEF 1139
+ + GT Y+ PE + + D+Y+ G+I E+ + P E
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240
Query: 1140 GDDNNLVGWAKQLHREKRINEILDPELTMQ---------TSDETELYQYLRISFECLDDR 1190
+ + + ++ ++ + + + +C D
Sbjct: 241 VPEYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299
Query: 1191 PFKRPTMIQVMAMFKELQVDTEGD 1214
R T EL + E +
Sbjct: 300 AEARLTAQXAEERMAELMMIWERN 323
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 1e-60
Identities = 68/281 (24%), Positives = 124/281 (44%), Gaps = 37/281 (13%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLI--HVTGQGDREFMAEMETIGKIKHRNLVPLLGYC 993
+ GE++K + + G+ + +K L + + R+F E + H N++P+LG C
Sbjct: 18 LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 994 KIGEERLL--VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIP 1051
+ + +M +GSL +VLH +G +D + K A+ ARG+AFLH + P
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLH---EGTNFVVDQSQAVKFALDMARGMAFLH-TLEP 132
Query: 1052 HIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQ---S 1108
I + S +V++DE+ AR+S + P +V PE Q
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFS-------FQSPGRMYAPAWVAPEALQKKPE 185
Query: 1109 FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNL-VGWAKQLHREKRINEILDPELT 1167
D++S+ V+L EL++ + P F D +N+ +G E L P +
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVP-----FADLSNMEIGMKV-------ALEGLRPTIP 233
Query: 1168 MQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208
S ++ C+++ P KRP ++ + +++Q
Sbjct: 234 PGISPH-----VSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 1e-58
Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 41/286 (14%)
Query: 935 MIGSGGFGEVYKAQLRDGSVVAIKKL----IHVTGQGDREFMAEMETIGKIKHRNLVPLL 990
+IG GGFG+VY+A G VA+K Q E + +KH N++ L
Sbjct: 14 IIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 991 GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCI 1050
G C LV E+ + G L VL + ++ A+ ARG+ +LH I
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLSGK------RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 1051 PHIIHRDMKSSNVLLDENFEAR--------VSDFGMARLVNALDTHLSVSTLAGTPGYVP 1102
IIHRD+KSSN+L+ + E ++DFG+AR + + AG ++
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW----HRTTKMSAAGAYAWMA 182
Query: 1103 PEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNL-VGWAKQLHREKRINEI 1161
PE ++ + DV+SYGV+L ELL+G+ P F + L V + +
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVP-----FRGIDGLAVAYGV-AMNKLA---- 232
Query: 1162 LDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207
L + ++ + + +C + P RP+ ++ +
Sbjct: 233 ----LPIPSTCPEPFAKLME---DCWNPDPHSRPSFTNILDQLTTI 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 2e-57
Identities = 76/279 (27%), Positives = 135/279 (48%), Gaps = 29/279 (10%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLI--HVTGQGDREFMAEMETIGKIKHRNLVPLLGYC 993
IGSG FG VYK + VA+K L T Q + F E+ + K +H N++ +GY
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 994 KIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPH 1052
+L +V ++ + SL LH TK + IA +ARG+ +LH
Sbjct: 90 T--APQLAIVTQWCEGSSLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLHA---KS 140
Query: 1053 IIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE---YYQSF 1109
IIHRD+KS+N+ L E+ ++ DFG+A + L+G+ ++ PE S
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 1110 RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQ 1169
+ + DVY++G++L EL++G+ P + + NN + + R ++ ++
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLP-----YSNINNRDQIIEMVGRGSLSPDLSK----VR 251
Query: 1170 TSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208
++ + + + ECL + +RP+ +++A +EL
Sbjct: 252 SNCPKRMKRLMA---ECLKKKRDERPSFPRILAEIEELA 287
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-55
Identities = 80/353 (22%), Positives = 131/353 (37%), Gaps = 55/353 (15%)
Query: 883 YIESLPTSGSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFG 942
IE +SGS S + + +++ IG G +G
Sbjct: 14 LIEQSQSSGSGS----------GLPLLVQRTIAKQIQMVK------------QIGKGRYG 51
Query: 943 EVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEME--TIGKIKHRNLVPLLGYCKIGEER- 999
EV+ + R G VA+K + + E E ++H N++ + G
Sbjct: 52 EVWMGKWR-GEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107
Query: 1000 ---LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLH-----HSCIP 1051
L+ +Y + GSL L LD + K+A S GL LH P
Sbjct: 108 TQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKP 161
Query: 1052 HIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH--LSVSTLAGTPGYVPPE----- 1104
I HRD+KS N+L+ +N ++D G+A + + +T GT Y+PPE
Sbjct: 162 AIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES 221
Query: 1105 -YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDD--NNLVGWAKQLHREKRI--N 1159
F+ D+YS+G+IL E+ E ++LV + I
Sbjct: 222 LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCI 281
Query: 1160 EILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTE 1212
+ L P + S + L Q ++ EC P R T ++V ++ +
Sbjct: 282 KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 1e-55
Identities = 62/302 (20%), Positives = 119/302 (39%), Gaps = 45/302 (14%)
Query: 935 MIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEME--TIGKIKHRNLVPLLGY 992
+G G +GEV++ + G VA+K + + ++ + E E ++H N++ +
Sbjct: 15 CVGKGRYGEVWRGSWQ-GENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 993 CKIGE----ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLH-- 1046
+ L+ Y + GSL L LD + +I + A GLA LH
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIE 124
Query: 1047 ---HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH--LSVSTLAGTPGYV 1101
P I HRD+KS N+L+ +N + ++D G+A + + + + GT Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 1102 PPE------YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSE-----FGDDNNLVGWAK 1150
PE F + D++++G++L E+ E F D +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 1151 QL-----HREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFK 1205
+ ++R P + + + L ++ EC P R T +++
Sbjct: 245 DMRKVVCVDQQR------PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
Query: 1206 EL 1207
++
Sbjct: 299 KI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-53
Identities = 76/358 (21%), Positives = 133/358 (37%), Gaps = 61/358 (17%)
Query: 877 DEQREKYIESLPTSGSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMI 936
+ I + TSGS S + + R + I
Sbjct: 13 GTTLKDLIYDMTTSGSGS----------GLPLLVQRTIARTIVLQE------------SI 50
Query: 937 GSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEME--TIGKIKHRNLVPLLGYCK 994
G G FGEV++ + R G VA+K + + +R + E E ++H N++ +
Sbjct: 51 GKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAADN 106
Query: 995 IGE----ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLH---- 1046
+ LV +Y + GSL L+ + K+A+ +A GLA LH
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 1047 -HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH--LSVSTLAGTPGYVPP 1103
P I HRD+KS N+L+ +N ++D G+A ++ ++ + GT Y+ P
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 1104 E------YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSE-----FGDDNNLVGWAKQL 1152
E + F + D+Y+ G++ E+ E + D LV +
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD---LVPSDPSV 277
Query: 1153 H--REKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208
R+ + L P + + L +I EC R T +++ +L
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-53
Identities = 70/338 (20%), Positives = 121/338 (35%), Gaps = 55/338 (16%)
Query: 888 PTSGSSSWKLSSVPEPLSINVATFEK---PLRKLTFAHLLEATNGFSADSMIGSGGFGEV 944
P S S P S ++ P +L +IG G FG+V
Sbjct: 2 PEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGE------------LIGKGRFGQV 49
Query: 945 YKAQLRDGSVVAIKKLI--HVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLV 1002
Y + VAI+ + + F E+ + +H N+V +G C ++
Sbjct: 50 YHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107
Query: 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSN 1062
K +L SV+ D LD ++IA +G+ +LH I+H+D+KS N
Sbjct: 108 TSLCKGRTLYSVVRDA----KIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKN 160
Query: 1063 VLLDENFEARVSDFGMARL---VNALDTHLSVSTLAGTPGYVPPEYYQSFR--------- 1110
V D + ++DFG+ + + A + G ++ PE +
Sbjct: 161 VFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLP 219
Query: 1111 CTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQT 1170
+ DV++ G I EL + + P Q+ + P L+
Sbjct: 220 FSKHSDVFALGTIWYELHAREWPF------KTQPAEAIIWQMGTGMK------PNLSQIG 267
Query: 1171 SDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208
+ E+ L C +RPT ++M M ++L
Sbjct: 268 MGK-EISDILL---FCWAFEQEERPTFTKLMDMLEKLP 301
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-50
Identities = 106/557 (19%), Positives = 183/557 (32%), Gaps = 72/557 (12%)
Query: 98 SLNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMD 157
+L +L+L+ + L L + + P L+ L+L
Sbjct: 25 NLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ------------------ 65
Query: 158 LSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISG---GSLHIGPSLLQLDLSGNQISDSA 214
++ ++ S LS + L+ N I G+ SL +L ++
Sbjct: 66 --------TIEDGAY-QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS-- 114
Query: 215 LLTYSLSNCQNLNLLNFSDNKLP-GKLNATSVNCKSISTIDLSYNLLSGEIPASF--VAD 271
L + + + + L LN + N + KL N ++ +DLS N + +
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
Query: 272 SSGSLKYLDLSHNNFT----GKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLE 327
LDLS N G F + L +TL N S ++ LE
Sbjct: 175 MPLLNLSLDLSLNPMNFIQPGAFKEI------RLHKLTLRNNFDSLNVMKTCIQGLAGLE 228
Query: 328 TLNMSHNALQGG--IPGFLLGSFRNLKQLS-----LAHNQFAGEIPPELGQACGTLRELD 380
+ + + F + L L+ LA+ + + +L +
Sbjct: 229 VHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFS 288
Query: 381 LSSNRLTGELPSTF-ASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPV 439
L S + ++ L +N L SL L N
Sbjct: 289 LVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLK-------SLKRLTFTSNKGGN-- 339
Query: 440 PLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKN 499
S + L LDLS NG + S +L+ + L N + T+ +
Sbjct: 340 AFSEVDLPSLEFLDLSRNGLS-FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQ 397
Query: 500 LKTIDLSFNSLAG-PVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNH 558
L+ +D ++L S SL NL L + + GI +LE L + N
Sbjct: 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNS 456
Query: 559 LTGAIPKSI-ASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNNSLTGQVPQG-L 615
I N+ ++ LS QL ++ +L L +L + +N L VP G
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLK-SVPDGIF 514
Query: 616 GKCRSLVWLDLNSNNLS 632
+ SL + L++N
Sbjct: 515 DRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-45
Identities = 84/473 (17%), Positives = 152/473 (32%), Gaps = 34/473 (7%)
Query: 182 VNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLN 241
+ ++ S LDLS N + L +YS + L +L+ S ++ +
Sbjct: 12 YQCMELNFYKIPDNLPFSTKNLDLSFNPLRH--LGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 242 ATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNL 301
+ +ST+ L+ N + +F SL+ L N N G L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAF--SGLSSLQKLVAVETNLA-SLENFPIGHLKTL 126
Query: 302 SVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLK----QLSLA 357
+ ++ N + + P N LE L++S N +Q I L + L L+
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLS 185
Query: 358 HNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTF---ASCSSLHSLNLGSNMLSGNF 414
N I P + L +L L +N + + T + +H L LG GN
Sbjct: 186 LNPMN-FIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243
Query: 415 LNTVVSKISSLIYLYVPFNNISG------PVPLSLTNCTQLRVLDLSSNGFTGTIPSGFC 468
S + L L + ++ + T + L S +
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDF-- 300
Query: 469 SPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLV 528
+ + L N K+LK + + N G SE+ LP+L L
Sbjct: 301 --SYNFGWQHLELVNCKFGQ---FPTLKLKSLKRLTFTSNKG-GNAFSEV-DLPSLEFLD 353
Query: 529 MWANNLTG-EIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEI 587
+ N L+ +L+ L L+ N + + + + + + L
Sbjct: 354 LSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMS 412
Query: 588 PAGI-GNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSEL 639
+ +L L L + + SL L + N+ ++
Sbjct: 413 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-43
Identities = 100/523 (19%), Positives = 169/523 (32%), Gaps = 87/523 (16%)
Query: 300 NLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHN 359
N++ + + P +L + L++S N L+ + + SF L+ L L+
Sbjct: 9 NITY-QCMELNF--YKIPDNLPF--STKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRC 62
Query: 360 QFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVV 419
+ I Q+ L L L+ N + F+ SSL L L+ + N +
Sbjct: 63 EIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPI 120
Query: 420 SKISSLIYLYVPFNNI-SGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEK 478
+ +L L V N I S +P +N T L LDLSSN + P L
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL-- 178
Query: 479 IVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEI 538
++DLS N + + + L L + N + +
Sbjct: 179 ---------------------NLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNV 216
Query: 539 PEGICVNGGNLETLIL------NNNHLTGAIPKSIASCTNMLWVSLSSNQLTG---EIPA 589
+ LE L N +L ++ N+ L +I
Sbjct: 217 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIID 276
Query: 590 GIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPG 649
L ++ L + ++ +V L+L + +L + +
Sbjct: 277 LFNCLTNVSSFSLVSVTIE-RVKDFSY-NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTS 334
Query: 650 IVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRI---------YT 700
G F+ V PS +
Sbjct: 335 NKGGNAFSEV--------------------------------DLPSLEFLDLSRNGLSFK 362
Query: 701 GMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDS-FGGLK 759
G + SL YLDLS+N + T+ NF L L+ L+ H+ L S F L+
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421
Query: 760 AIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSG 802
+ LD+SH + + + G GLS L L ++ N+
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 7e-41
Identities = 93/504 (18%), Positives = 158/504 (31%), Gaps = 96/504 (19%)
Query: 100 NSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLS 159
S + L + L+ SL + L L+ LN+ N + L ++ +L +DLS
Sbjct: 99 LSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157
Query: 160 SNNITGSLPGRSFLLSCD---RLSYVNLSHNSISGGSLHI--GPSLLQLDLSGNQISDS- 213
SN I S+ + ++LS N ++ L +L L N S +
Sbjct: 158 SNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNV 216
Query: 214 ----------------------------ALLTYSLSNCQNLNLLNFSDNKLPGKLN---A 242
+L NL + F L L+
Sbjct: 217 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIID 276
Query: 243 TSVNCKSISTIDLSYNLLSGEIPASFV-----------------ADSSGSLKYLDLSHNN 285
++S+ L + S+ SLK L + N
Sbjct: 277 LFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNK 336
Query: 286 FTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPA-SLKNCQLLETLNMSHNALQGGIPGFL 344
FS +L + LS+NGLS + S L+ L++S N + FL
Sbjct: 337 GGNAFS---EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFL 393
Query: 345 LGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLN 404
L+ L H+ + + L LD+S F SSL L
Sbjct: 394 --GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451
Query: 405 LGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIP 464
+ N NFL + +++ +L +L + + P + + + L+VL+++SN ++P
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVP 510
Query: 465 SGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNL 524
G +L+ I L N S P +
Sbjct: 511 DGI--------------------------FDRLTSLQKIWLHTNPWDC-------SCPRI 537
Query: 525 SDLVMWANNLTGEIPEGICVNGGN 548
L W N + + +G
Sbjct: 538 DYLSRWLNKNSQKEQGSAKCSGSG 561
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 3e-14
Identities = 28/98 (28%), Positives = 45/98 (45%), Gaps = 1/98 (1%)
Query: 705 YTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHI-PDSFGGLKAIGV 763
F + +LIYLD+S+ F L+ L+VL + N + PD F L+ +
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474
Query: 764 LDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPS 801
LDLS + P + LS L L++++N L +
Sbjct: 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDG 512
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 6e-14
Identities = 24/105 (22%), Positives = 41/105 (39%), Gaps = 1/105 (0%)
Query: 705 YTFTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGV 763
F SL L ++ NS + F L L L+L +L P +F L ++ V
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498
Query: 764 LDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTF 808
L+++ N + G L+ L + + N P L+ +
Sbjct: 499 LNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRW 543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 4e-49
Identities = 102/487 (20%), Positives = 179/487 (36%), Gaps = 79/487 (16%)
Query: 152 SLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISG----GSLHIGPSLLQLDLSG 207
+ L N+T ++ D+++ + I L +L Q++ S
Sbjct: 25 EKMKTVLGKTNVTDTVS----QTDLDQVTTLQADRLGIKSIDGVEYL---NNLTQINFSN 77
Query: 208 NQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPAS 267
NQ++D L N L + ++N++ + + N +++ + L N ++ P
Sbjct: 78 NQLTDIT----PLKNLTKLVDILMNNNQIAD-ITPLA-NLTNLTGLTLFNNQITDIDPLK 131
Query: 268 FVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLE 327
+ +L L+LS N + S L +L ++ L N LE
Sbjct: 132 ----NLTNLNRLELSSNTISD-ISAL--SGLTSLQQLSFGNQVTD----LKPLANLTTLE 180
Query: 328 TLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLT 387
L++S N + I L NL+ L +NQ + P LG L EL L+ N+L
Sbjct: 181 RLDISSNKVSD-ISV--LAKLTNLESLIATNNQISDITP--LGI-LTNLDELSLNGNQLK 234
Query: 388 GELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCT 447
T AS ++L L+L +N +S +S ++ L L + N IS PL+ T
Sbjct: 235 D--IGTLASLTNLTDLDLANNQISNL---APLSGLTKLTELKLGANQISNISPLA--GLT 287
Query: 448 QLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSF 507
L L+L+ N P N L + L N +S P+ S L+ +
Sbjct: 288 ALTNLELNENQLEDISPIS-----NLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFYN 340
Query: 508 NSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSI 567
N + S++ SL NL+ N+ L +N ++ P +
Sbjct: 341 NKV-----SDVSSLANLT----------------------NINWLSAGHNQISDLTP--L 371
Query: 568 ASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLN 627
A+ T + + L+ T N+ ++ +L P + S D+
Sbjct: 372 ANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDIT 429
Query: 628 SNNLSGP 634
N S
Sbjct: 430 WNLPSYT 436
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 1e-47
Identities = 85/391 (21%), Positives = 150/391 (38%), Gaps = 42/391 (10%)
Query: 246 NCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVIT 305
L ++ + + + + L + NL+ I
Sbjct: 22 ALAEKMKTVLGKTNVTDTVSQTDLD----QVTTLQADRLGIK-SIDGV--EYLNNLTQIN 74
Query: 306 LSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEI 365
S N L+ +L L + M++N + P L + NL L+L +NQ
Sbjct: 75 FSNNQLTDITPLKNLTK---LVDILMNNNQIADITP---LANLTNLTGLTLFNNQITDID 128
Query: 366 PPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSL 425
P L L L+LSSN ++ S + +SL L+ G+ + ++ +++L
Sbjct: 129 P--LKN-LTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD----LKPLANLTTL 179
Query: 426 IYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNY 485
L + N +S L+ T L L ++N + P G L+++ L N
Sbjct: 180 ERLDISSNKVSDISVLA--KLTNLESLIATNNQISDITPLG-----ILTNLDELSLNGNQ 232
Query: 486 LSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVN 545
L L S NL +DL+ N ++ + + L L++L + AN ++ P
Sbjct: 233 LKDIGTL--ASLTNLTDLDLANNQISNL--APLSGLTKLTELKLGANQISNISPLAGLTA 288
Query: 546 GGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNN 605
L L LN N L P I++ N+ +++L N ++ P + +L KL L NN
Sbjct: 289 ---LTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNN 341
Query: 606 SLTGQVPQGLGKCRSLVWLDLNSNNLSGPLP 636
++ L ++ WL N +S P
Sbjct: 342 KVSD--VSSLANLTNINWLSAGHNQISDLTP 370
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 1e-46
Identities = 88/445 (19%), Positives = 164/445 (36%), Gaps = 48/445 (10%)
Query: 197 GPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLS 256
GP I+ + + + ++ T + ++T+
Sbjct: 1 GPLGSATITQDTPINQIF----TDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQAD 54
Query: 257 YNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEF 316
+ ++ +L ++ S+N T L I ++ N ++
Sbjct: 55 RLGIKSIDGVEYLN----NLTQINFSNNQLTDI---TPLKNLTKLVDILMNNNQIADIT- 106
Query: 317 PASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTL 376
L N L L + +N + P L + NL +L L+ N + L +L
Sbjct: 107 --PLANLTNLTGLTLFNNQITDIDP---LKNLTNLNRLELSSNTISD--ISALSG-LTSL 158
Query: 377 RELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNIS 436
++L N++T P A+ ++L L++ SN +S +V++K+++L L N IS
Sbjct: 159 QQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSDI---SVLAKLTNLESLIATNNQIS 212
Query: 437 GPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGS 496
PL T L L L+ N + L + L NN +S PL
Sbjct: 213 DITPLG--ILTNLDELSLNGNQLKD--IGTLA---SLTNLTDLDLANNQISNLAPL--SG 263
Query: 497 CKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNN 556
L + L N ++ S + L L++L + N L P N L L L
Sbjct: 264 LTKLTELKLGANQISNI--SPLAGLTALTNLELNENQLEDISPISNLKN---LTYLTLYF 318
Query: 557 NHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLG 616
N+++ P ++S T + + +N+++ + + NL + L G+N ++ P L
Sbjct: 319 NNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LA 372
Query: 617 KCRSLVWLDLNSNNLSGPLPSELAN 641
+ L LN + + AN
Sbjct: 373 NLTRITQLGLNDQAWTNAPVNYKAN 397
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-44
Identities = 103/492 (20%), Positives = 191/492 (38%), Gaps = 80/492 (16%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSS 160
VT+L + G+ ++ + L L + + S+
Sbjct: 46 DQVTTLQADRLGIK---SIDGVEYLNNLTQI-------------------------NFSN 77
Query: 161 NNITGSLPGRSFLLSCDRLSYVNLSHNSISG----GSLHIGPSLLQLDLSGNQISDSALL 216
N +T + L + +L + +++N I+ +L +L L L NQI+D
Sbjct: 78 NQLTDI----TPLKNLTKLVDILMNNNQIADITPLANL---TNLTGLTLFNNQITDID-- 128
Query: 217 TYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSL 276
L N NLN L S N + ++A S S+ + + + A+ +L
Sbjct: 129 --PLKNLTNLNRLELSSNTI-SDISALS-GLTSLQQLSFGNQVTDLKPLANLT-----TL 179
Query: 277 KYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNAL 336
+ LD+S N + S L + NL + + N +S L N L+ L+++ N L
Sbjct: 180 ERLDISSNKVSD-ISVL--AKLTNLESLIATNNQISDITPLGILTN---LDELSLNGNQL 233
Query: 337 QGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFAS 396
+ I S NL L LA+NQ + P L L EL L +N+++ S A
Sbjct: 234 K-DIGTL--ASLTNLTDLDLANNQISNLAP--LSG-LTKLTELKLGANQISN--ISPLAG 285
Query: 397 CSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSS 456
++L +L L N L + +S + +L YL + FNNIS P+S + T+L+ L +
Sbjct: 286 LTALTNLELNENQLED---ISPISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFYN 340
Query: 457 NGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPS 516
N + S + N + + +N +S P L + + + L+ + P
Sbjct: 341 NKVSD--VSSLANLTN---INWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNA-PV 392
Query: 517 EIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWV 576
+ ++ + V P I +GG+ + N + + + + + +
Sbjct: 393 NYKANVSIPNTVKNVTGAL-IAPATIS-DGGSYTEPDITWNLPSY-TNEVSYTFSQPVTI 449
Query: 577 SLSSNQLTGEIP 588
+ +G +
Sbjct: 450 GKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-12
Identities = 25/108 (23%), Positives = 42/108 (38%), Gaps = 6/108 (5%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
+L YL L +N++S SL LQ L +NK++ S L I L HN
Sbjct: 310 NLTYLTLYFNNISDI--SPVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQI 365
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGL 819
P L L+ ++ L +++ + + + P + L
Sbjct: 366 SDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL 411
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 6e-11
Identities = 27/89 (30%), Positives = 45/89 (50%), Gaps = 6/89 (6%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
+L LD+S N +S L L+ L +N+++ P G L + L L+ N
Sbjct: 178 TLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQL 233
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIP 800
+ G+L L+ L+DLD++NN +S + P
Sbjct: 234 KD--IGTLASLTNLTDLDLANNQISNLAP 260
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 9e-11
Identities = 28/95 (29%), Positives = 43/95 (45%), Gaps = 6/95 (6%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
T + +L LDL+ N +S L L L LG N+++ GL A+ L+
Sbjct: 238 TLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISN--ISPLAGLTALTNLE 293
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIP 800
L+ N + P + L L+ L + NN+S I P
Sbjct: 294 LNENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-10
Identities = 20/92 (21%), Positives = 36/92 (39%), Gaps = 6/92 (6%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
+ L + + LN L +N +N+LT P L + + +++N
Sbjct: 47 QVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 102
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGG 803
P L L+ L+ L + NN ++ I P
Sbjct: 103 ADITP--LANLTNLTGLTLFNNQITDIDPLKN 132
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-09
Identities = 23/89 (25%), Positives = 37/89 (41%), Gaps = 7/89 (7%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
+L L L N ++ + +L L L L N ++ + GL ++ L N
Sbjct: 113 NLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQV 167
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIP 800
P L L+ L LD+S+N +S I
Sbjct: 168 TDLKP--LANLTTLERLDISSNKVSDISV 194
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 6e-09
Identities = 20/89 (22%), Positives = 34/89 (38%), Gaps = 7/89 (7%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
SL L + +L L+ L++ NK++ L + L ++N
Sbjct: 157 SLQQLSFGNQVTD---LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQI 211
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIP 800
P LG L+ L +L ++ N L I
Sbjct: 212 SDITP--LGILTNLDELSLNGNQLKDIGT 238
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-07
Identities = 20/97 (20%), Positives = 34/97 (35%), Gaps = 6/97 (6%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
L L N +S + +L + L+ GHN+++ P L I L L+ +
Sbjct: 332 KLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW 387
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGI--IPSGGQLT 806
+ +S + + L I GG T
Sbjct: 388 TNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYT 424
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-06
Identities = 13/93 (13%), Positives = 30/93 (32%), Gaps = 6/93 (6%)
Query: 707 FTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDL 766
++ +L +N +S +L + L L T + + + +
Sbjct: 349 LANLTNINWLSAGHNQISD--LTPLANLTRITQLGLNDQAWTNAPVNYKANVS---IPNT 403
Query: 767 SHNNFQGSI-PGSLGGLSFLSDLDVSNNNLSGI 798
N I P ++ ++ D++ N S
Sbjct: 404 VKNVTGALIAPATISDGGSYTEPDITWNLPSYT 436
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-05
Identities = 19/90 (21%), Positives = 35/90 (38%), Gaps = 5/90 (5%)
Query: 711 GSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNN 770
G L ++ ++ + +L LG +T + L + L
Sbjct: 1 GPLGSATITQDTPINQI-FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLG 57
Query: 771 FQGSIPGSLGGLSFLSDLDVSNNNLSGIIP 800
+ SI G + L+ L+ ++ SNN L+ I P
Sbjct: 58 IK-SIDG-VEYLNNLTQINFSNNQLTDITP 85
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 3e-48
Identities = 80/518 (15%), Positives = 177/518 (34%), Gaps = 51/518 (9%)
Query: 150 SC-SLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISG---GSLHIGPSLLQLDL 205
SC + D S + T S+P + ++LS N I+ G L +L L L
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGLT----AAMKSLDLSFNKITYIGHGDLRACANLQVLIL 57
Query: 206 SGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIP 265
++I+ + + + +L L+ SDN L ++ S+ ++L N +
Sbjct: 58 KSSRINT--IEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLG 114
Query: 266 ASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQL 325
+ + + +L+ L + + + +DF +L+ + + L + SLK+ +
Sbjct: 115 VTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQ-SQSLKSIRD 173
Query: 326 LETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNR 385
+ L + + + +++ L L A + + R
Sbjct: 174 IHHLTLHLSESAF-LLEIFADILSSVRYLELRDTNLA-RFQFSPLPVDEVSSPMKKLAFR 231
Query: 386 LTGELPSTFASCSSLHSLNLGSNMLS-----------------GNFLNTVVSKISSLIYL 428
+ +F L L + + + ++ L
Sbjct: 232 GSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRL 291
Query: 429 YVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSG 488
++P + + + +++ + + ++ +P F + +LE + L N +
Sbjct: 292 HIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQ--HLKSLEFLDLSENLMVE 348
Query: 489 TV---PLELGSCKNLKTIDLSFNSLA--GPVPSEIWSLPNLSDLVMWANNLTGEIPEGIC 543
G+ +L+T+ LS N L + +L NL+ L + N +P+ C
Sbjct: 349 EYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDS-C 406
Query: 544 VNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLG 603
+ L L++ + + I + + +S+N L L +L L +
Sbjct: 407 QWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSL---FLPRLQELYIS 459
Query: 604 NNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELAN 641
N L +P L+ + ++ N L
Sbjct: 460 RNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDR 495
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 5e-46
Identities = 97/553 (17%), Positives = 185/553 (33%), Gaps = 67/553 (12%)
Query: 244 SVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSV 303
S++C + D + IP + + ++K LDLS N T + D C NL V
Sbjct: 1 SLSCDASGVCDGRSRSFT-SIP----SGLTAAMKSLDLSFNKIT-YIGHGDLRACANLQV 54
Query: 304 ITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAG 363
+ L + ++ E + + LE L++S N L + G +LK L+L N +
Sbjct: 55 LILKSSRINTIE-GDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQT 112
Query: 364 EIPPELGQACGTLRELDLSSNRLTGELP-STFASCSSLHSLNLGSNMLSGNFLNTVVSKI 422
L L+ L + + E+ FA +SL+ L + + L N+ + + I
Sbjct: 113 LGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSI 171
Query: 423 SSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLP 482
+ +L + + + + + + +R L+L S ++K+
Sbjct: 172 RDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFR 231
Query: 483 NNYLSG-------TVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWA---- 531
+ L+ + + ++ D + N L PSE + L +
Sbjct: 232 GSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRL 291
Query: 532 ---NNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEI- 587
+ ++ + + N+ + ++ ++ LS N + E
Sbjct: 292 HIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYL 351
Query: 588 --PAGIGNLVKLAILQLGNNSLT--GQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQA 643
A G L L L N L + + L ++L LD++ N P+P
Sbjct: 352 KNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQW-- 408
Query: 644 GVVMPGIV----SGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIY 699
+ S V+ P+ LE + +
Sbjct: 409 ---PEKMRFLNLSSTGIRVVKTCI-----------------PQTLEVLDV-SNNNLDSFS 447
Query: 700 TGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLK 759
+ L L +S N L TLP+ L V+ + N+L F L
Sbjct: 448 LFLP--------RLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLT 497
Query: 760 AIGVLDLSHNNFQ 772
++ + L N +
Sbjct: 498 SLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-44
Identities = 93/554 (16%), Positives = 194/554 (35%), Gaps = 63/554 (11%)
Query: 96 SCSLNSHVTSLNLNNSGLSGSLNLTTLTA--LPYLEHLNLQGNSFSAGDLSTSKTSSCS- 152
S S ++ + + + T++ + ++ L+L N + + +C+
Sbjct: 1 SLSCDAS-GVCDGRS------RSFTSIPSGLTAAMKSLDLSFNKIT--YIGHGDLRACAN 51
Query: 153 LVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHN---SISGGSLHIGPSLLQLDLSGNQ 209
L + L S+ I ++ G +F S L +++LS N S+S SL L+L GN
Sbjct: 52 LQVLILKSSRIN-TIEGDAF-YSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNP 109
Query: 210 ISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATS-VNCKSISTIDLSYNLLSGEIPASF 268
+ +T N NL L + + ++ S++ +++ L S
Sbjct: 110 YQ-TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSL 168
Query: 269 VADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPA--SLKNCQLL 326
S + +L L + + ++ + L L+ +F + +
Sbjct: 169 --KSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPM 225
Query: 327 ETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRL 386
+ L + L LL R + +LS + D + N L
Sbjct: 226 KKLAFRGSVLTDESFNELLKLLRYILELS-------------------EVEFDDCTLNGL 266
Query: 387 T---GELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKI----SSLIYLYVPFNNISGPV 439
+ + ++ + + +L +S + + + V + +
Sbjct: 267 GDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVP 326
Query: 440 PLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLS--GTVPLELGSC 497
+ L LDLS N +P+L+ +VL N+L L +
Sbjct: 327 CSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL 386
Query: 498 KNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNN 557
KNL ++D+S N+ P+P + L + + + + I LE L ++NN
Sbjct: 387 KNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP---QTLEVLDVSNN 441
Query: 558 HLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGK 617
+L + + + + +S N+L +P L ++++ N L +
Sbjct: 442 NLD-SFSLFL---PRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDR 495
Query: 618 CRSLVWLDLNSNNL 631
SL + L++N
Sbjct: 496 LTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 5e-44
Identities = 95/512 (18%), Positives = 192/512 (37%), Gaps = 54/512 (10%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSC-SLVTMDLS 159
+++ L L +S ++ ++ +L LEHL+L N S LS+S SL ++L
Sbjct: 50 ANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLS--SLSSSWFGPLSSLKYLNLM 106
Query: 160 SNNITGSLPGRSFLLSCDRLSYVNLSHN----SISGGSLHIGPSLLQLDLSGNQISDSAL 215
N +L S + L + + + I SL +L++ + +
Sbjct: 107 GNPYQ-TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN--Y 163
Query: 216 LTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASF-VADSSG 274
+ SL + ++++ L ++ L + S+ ++L L+ + V + S
Sbjct: 164 QSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSS 223
Query: 275 SLKYLDLSHNNFTG--------------KFSNLDFGRCGNLSVITLSQNGLSGTEFPASL 320
+K L + T + S ++F C + + + +
Sbjct: 224 PMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKV 283
Query: 321 KNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELD 380
+ + L++ L + +K++++ +++ +P Q +L LD
Sbjct: 284 ETVTIRR-LHIPQFYLF-YDLSTVYSLLEKVKRITVENSKV-FLVPCSFSQHLKSLEFLD 340
Query: 381 LSSNRLTGELPST---FASCSSLHSLNLGSNMLSG-NFLNTVVSKISSLIYLYVPFNNIS 436
LS N + E + SL +L L N L ++ + +L L + N
Sbjct: 341 LSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH 400
Query: 437 GPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGS 496
P+P S ++R L+LSS G + + LE + + NN L + L L
Sbjct: 401 -PMPDSCQWPEKMRFLNLSSTGIR-VVKTC-----IPQTLEVLDVSNNNLD-SFSLFL-- 450
Query: 497 CKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNN 556
L+ + +S N L + P L + + N L +P+GI +L+ + L+
Sbjct: 451 -PRLQELYISRNKLK--TLPDASLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHT 506
Query: 557 NHLTGAIPKSIASCTNMLWVSLSSNQLTGEIP 588
N SC + ++S N+ + +
Sbjct: 507 NPWDC-------SCPRIDYLSRWLNKNSQKEQ 531
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-41
Identities = 76/465 (16%), Positives = 148/465 (31%), Gaps = 49/465 (10%)
Query: 174 LSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSD 233
LSCD + S + + ++ LDLS N+I+ + L C NL +L
Sbjct: 2 LSCDASGVCDGRSRSFTSIPSGLTAAMKSLDLSFNKITY--IGHGDLRACANLQVLILKS 59
Query: 234 NKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNL 293
++ I+TI+ +F S GSL++LDLS N+ + S+
Sbjct: 60 SR--------------INTIE----------GDAF--YSLGSLEHLDLSDNHLS-SLSSS 92
Query: 294 DFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQ 353
FG +L + L N + N L+TL + + I +L +
Sbjct: 93 WFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNE 152
Query: 354 LSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGN 413
L + + ++ + L L + L SS+ L L L+
Sbjct: 153 LEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARF 211
Query: 414 FLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNF 473
+ + + S S +L L + +
Sbjct: 212 QFSPL-PVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFD---------DC 261
Query: 474 PALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANN 533
+ L ++ + + L + + L + + + +
Sbjct: 262 TLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSK 321
Query: 534 LTGEIPEGICVNGGNLETLILNNNHLTGAIPKS---IASCTNMLWVSLSSNQLTGEIPAG 590
+ +P + +LE L L+ N + K+ + ++ + LS N L +
Sbjct: 322 VF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKT 379
Query: 591 IG---NLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLS 632
L L L + N+ +P + +L+L+S +
Sbjct: 380 GEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-39
Identities = 76/419 (18%), Positives = 139/419 (33%), Gaps = 39/419 (9%)
Query: 396 SCSSLHSLNLGSNMLSGNFLNTVVSKI-SSLIYLYVPFNNISGPVPLSLTNCTQLRVLDL 454
SC + + ++ S + +++ L + FN I+ L C L+VL L
Sbjct: 3 SCDASGVCDG-----RSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLIL 57
Query: 455 SSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAG-P 513
S+ TI + +LE + L +N+LS G +LK ++L N
Sbjct: 58 KSSRIN-TIEGDAFY--SLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLG 114
Query: 514 VPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNM 573
V S +L NL L + EI +L L + L +S+ S ++
Sbjct: 115 VTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDI 174
Query: 574 LWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSG 633
++L ++ + L + L+L + +L L + + S
Sbjct: 175 HHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSV 234
Query: 634 PLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSC 693
L E N+ ++ I+ + F L G +
Sbjct: 235 -LTDESFNELLKLLRYILELSEVEFDDC---------------------TLNGLGDFNPS 272
Query: 694 PSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPD 753
S + ++ L + L L + L ++ + + ++K+
Sbjct: 273 ESDVVSEL----GKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCS 328
Query: 754 SFGGLKAIGVLDLSHNNFQGSI---PGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFP 809
LK++ LDLS N G L L +S N+L + +G L T
Sbjct: 329 FSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-39
Identities = 82/506 (16%), Positives = 155/506 (30%), Gaps = 89/506 (17%)
Query: 298 CGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLA 357
C V T P+ L +++L++S N + I L + NL+ L L
Sbjct: 4 CDASGVCDGRSRSF--TSIPSGL--TAAMKSLDLSFNKITY-IGHGDLRACANLQVLILK 58
Query: 358 HNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNT 417
++ I + + G+L LDLS N L+ S F SSL LNL GN T
Sbjct: 59 SSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL-----MGNPYQT 112
Query: 418 VVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALE 477
+ V N T L+ L + + I + +L
Sbjct: 113 L-------------------GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFA--GLTSLN 151
Query: 478 KIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGE 537
++ + L L S +++ + L + A + L ++ L + NL
Sbjct: 152 ELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLA-R 210
Query: 538 IPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKL 597
+ + +S +L L +++ +
Sbjct: 211 FQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE------FDDCTLN 264
Query: 598 AILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFA 657
+ + + + + + + ++ + + S
Sbjct: 265 GLGDFNPSESDV-----VSELGKVETVTIRRLHIPQ-------FYLFYDLSTVYSL---- 308
Query: 658 FVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLD 717
E ++ +E +++ + SL +LD
Sbjct: 309 ------------------LEKVKRITVEN---------SKV-FLVPCSFSQHLKSLEFLD 340
Query: 718 LSYNSLSGTLPEN---FGSLNYLQVLNLGHNKLT--GHIPDSFGGLKAIGVLDLSHNNFQ 772
LS N + +N G+ LQ L L N L + LK + LD+S N F
Sbjct: 341 LSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH 400
Query: 773 GSIPGSLGGLSFLSDLDVSNNNLSGI 798
+P S + L++S+ + +
Sbjct: 401 -PMPDSCQWPEKMRFLNLSSTGIRVV 425
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-10
Identities = 24/101 (23%), Positives = 41/101 (40%), Gaps = 9/101 (8%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
T +L LD+S N+ +P++ ++ LNL + + + + VLD
Sbjct: 382 ILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLD 437
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLT 806
+S+NN S L L +L +S N L +P
Sbjct: 438 VSNNNLD-SFSL---FLPRLQELYISRNKLK-TLPDASLFP 473
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-10
Identities = 28/103 (27%), Positives = 38/103 (36%), Gaps = 6/103 (5%)
Query: 707 FTTNGSLIYLDLSYNSLS--GTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVL 764
SL L LS N L E +L L L++ N +PDS + + L
Sbjct: 357 KGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFL 415
Query: 765 DLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTT 807
+LS + + L LDVSNNNL +L
Sbjct: 416 NLSSTGIR-VVK--TCIPQTLEVLDVSNNNLDSFSLFLPRLQE 455
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 2e-10
Identities = 25/133 (18%), Positives = 40/133 (30%), Gaps = 3/133 (2%)
Query: 697 RIYTGMTMYTFTTNGSLIYLDLS-YNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSF 755
T F +L L + + S +F L L L + L + S
Sbjct: 109 PYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSL 168
Query: 756 GGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYEN 815
++ I L L + + LS + L++ + NL+ S L S
Sbjct: 169 KSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFS--PLPVDEVSSPMK 226
Query: 816 NSGLCGLPLLPCS 828
G L S
Sbjct: 227 KLAFRGSVLTDES 239
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-07
Identities = 22/84 (26%), Positives = 36/84 (42%), Gaps = 6/84 (7%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
+L LD+S N+L + L LQ L + NKL +PD+ + V+ +S N
Sbjct: 432 TLEVLDVSNNNLD-SFSLF---LPRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQL 485
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNL 795
+ G L+ L + + N
Sbjct: 486 KSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 6e-06
Identities = 15/121 (12%), Positives = 33/121 (27%)
Query: 705 YTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVL 764
+ + + +L L + + L L+ ++ L L L + +
Sbjct: 166 QSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPM 225
Query: 765 DLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPL 824
S L L + + + + L F S + S L +
Sbjct: 226 KKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVET 285
Query: 825 L 825
+
Sbjct: 286 V 286
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-47
Identities = 69/358 (19%), Positives = 139/358 (38%), Gaps = 34/358 (9%)
Query: 275 SLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHN 334
L + T + +++ + ++ ++ + L N LE LN++ N
Sbjct: 23 EGIRAVLQKASVTDV---VTQEELESITKLVVAGEKVASIQGIEYLTN---LEYLNLNGN 76
Query: 335 ALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTF 394
+ P L + L L + N+ L LREL L+ + ++ S
Sbjct: 77 QITDISP---LSNLVKLTNLYIGTNKI--TDISALQN-LTNLRELYLNEDNISD--ISPL 128
Query: 395 ASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDL 454
A+ + ++SLNLG+N + + +S ++ L YL V + + P++ N T L L L
Sbjct: 129 ANLTKMYSLNLGANHNLSDL--SPLSNMTGLNYLTVTESKVKDVTPIA--NLTDLYSLSL 184
Query: 455 SSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPV 514
+ N P + +L N ++ P+ + L ++ + N +
Sbjct: 185 NYNQIEDISPLA-----SLTSLHYFTAYVNQITDITPV--ANMTRLNSLKIGNNKITDL- 236
Query: 515 PSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNML 574
S + +L L+ L + N ++ + L+ L + +N ++ + + + +
Sbjct: 237 -SPLANLSQLTWLEIGTNQISD--INAVKDLT-KLKMLNVGSNQISD--ISVLNNLSQLN 290
Query: 575 WVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLS 632
+ L++NQL E IG L L L L N +T + L + D + +
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD--IRPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-45
Identities = 72/409 (17%), Positives = 150/409 (36%), Gaps = 64/409 (15%)
Query: 200 LLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNL 259
L I+ + ++ + + +SI+ + ++
Sbjct: 2 AATLATLPAPINQ----IFPDADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEK 55
Query: 260 LSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPAS 319
++ ++ +L+YL+L+ N T L+ + + N ++ ++
Sbjct: 56 VASIQGIEYLT----NLEYLNLNGNQITDISP---LSNLVKLTNLYIGTNKITD---ISA 105
Query: 320 LKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLREL 379
L+N L L ++ + + P L + + L+L N ++ P L L L
Sbjct: 106 LQNLTNLRELYLNEDNISDISP---LANLTKMYSLNLGANHNLSDLSP-LSN-MTGLNYL 160
Query: 380 DLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPV 439
++ +++ + A+ + L+SL+L N + + ++ ++SL Y N I+
Sbjct: 161 TVTESKVKD--VTPIANLTDLYSLSLNYNQIEDI---SPLASLTSLHYFTAYVNQITDIT 215
Query: 440 PLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKN 499
P++ N T+L L + +N T P N L + + N +S +
Sbjct: 216 PVA--NMTRLNSLKIGNNKITDLSPLA-----NLSQLTWLEIGTNQISD--INAVKDLTK 266
Query: 500 LKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHL 559
LK +++ N +I + L++L L +L LNNN L
Sbjct: 267 LKMLNVGSN--------QISDISVLNNLS-------------------QLNSLFLNNNQL 299
Query: 560 TGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLT 608
+ I TN+ + LS N +T P + +L K+ N +
Sbjct: 300 GNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-41
Identities = 65/341 (19%), Positives = 140/341 (41%), Gaps = 33/341 (9%)
Query: 301 LSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQ 360
+ + ++ A L + ++ + ++ +L +A +
Sbjct: 2 AATLATLPAPINQIFPDADLAE---GIRAVLQKASVTDVVT---QEELESITKLVVAGEK 55
Query: 361 FAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVS 420
A + L L+L+ N++T S ++ L +L +G+N ++ + +
Sbjct: 56 VAS--IQGIEY-LTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKITDI---SALQ 107
Query: 421 KISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIV 480
+++L LY+ +NIS PL+ N T++ L+L +N + S N L +
Sbjct: 108 NLTNLRELYLNEDNISDISPLA--NLTKMYSLNLGANHNL-SDLSPLS---NMTGLNYLT 161
Query: 481 LPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPE 540
+ + + P+ + +L ++ L++N + S + SL +L + N +T P
Sbjct: 162 VTESKVKDVTPI--ANLTDLYSLSLNYNQIEDI--SPLASLTSLHYFTAYVNQITDITPV 217
Query: 541 GICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAIL 600
L +L + NN +T P +A+ + + W+ + +NQ++ + +L KL +L
Sbjct: 218 ANMTR---LNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKML 270
Query: 601 QLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELAN 641
+G+N ++ L L L LN+N L +
Sbjct: 271 NVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGG 309
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-37
Identities = 70/365 (19%), Positives = 147/365 (40%), Gaps = 51/365 (13%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSA----GDLSTSKTSSCSLVTM 156
+ L + ++ + T L + L + G ++ L+ +L +
Sbjct: 22 AEGIRAVLQKASVTD---VVTQEELESITKLVVAGEKVASIQGIEYLT-------NLEYL 71
Query: 157 DLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISG----GSLHIGPSLLQLDLSGNQISD 212
+L+ N IT P L + +L+ + + N I+ +L +L +L L+ + ISD
Sbjct: 72 NLNGNQITDISP----LSNLVKLTNLYIGTNKITDISALQNL---TNLRELYLNEDNISD 124
Query: 213 SALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADS 272
+ L+N + LN N L+ S N ++ + ++ + + P + +
Sbjct: 125 IS----PLANLTKMYSLNLGANHNLSDLSPLS-NMTGLNYLTVTESKVKDVTPIA----N 175
Query: 273 SGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMS 332
L L L++N S L +L T N ++ + N L +L +
Sbjct: 176 LTDLYSLSLNYNQIED-ISPL--ASLTSLHYFTAYVNQITDIT---PVANMTRLNSLKIG 229
Query: 333 HNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPS 392
+N + P L + L L + NQ + + L+ L++ SN+++ S
Sbjct: 230 NNKITDLSP---LANLSQLTWLEIGTNQISD--INAVKD-LTKLKMLNVGSNQISD--IS 281
Query: 393 TFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVL 452
+ S L+SL L +N L + + +++L L++ N+I+ PL+ + +++
Sbjct: 282 VLNNLSQLNSLFLNNNQLGNEDMEV-IGGLTNLTTLFLSQNHITDIRPLA--SLSKMDSA 338
Query: 453 DLSSN 457
D ++
Sbjct: 339 DFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 2e-13
Identities = 23/89 (25%), Positives = 43/89 (48%), Gaps = 4/89 (4%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
L +L++ N +S L L++LN+G N+++ L + L L++N
Sbjct: 244 QLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQL 299
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIP 800
+GGL+ L+ L +S N+++ I P
Sbjct: 300 GNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 7e-13
Identities = 23/90 (25%), Positives = 36/90 (40%), Gaps = 4/90 (4%)
Query: 707 FTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDL 766
L L++ N +S +L+ L L L +N+L + GGL + L L
Sbjct: 261 VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFL 318
Query: 767 SHNNFQGSIPGSLGGLSFLSDLDVSNNNLS 796
S N+ P L LS + D +N +
Sbjct: 319 SQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 7e-12
Identities = 16/89 (17%), Positives = 35/89 (39%), Gaps = 5/89 (5%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
L L + N ++ +L L+ L L + ++ L + L+L N+
Sbjct: 89 KLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHN 144
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIP 800
+ L ++ L+ L V+ + + + P
Sbjct: 145 LSDLS-PLSNMTGLNYLTVTESKVKDVTP 172
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 4e-11
Identities = 22/87 (25%), Positives = 34/87 (39%), Gaps = 6/87 (6%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
L L L+YN + SL L N++T P + + L + +N
Sbjct: 178 DLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKI 233
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGI 798
P L LS L+ L++ N +S I
Sbjct: 234 TDLSP--LANLSQLTWLEIGTNQISDI 258
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 5e-11
Identities = 17/89 (19%), Positives = 36/89 (40%), Gaps = 6/89 (6%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
L YL ++ + + +L L L+L +N++ P L ++ N
Sbjct: 156 GLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQI 211
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIP 800
P + ++ L+ L + NN ++ + P
Sbjct: 212 TDITP--VANMTRLNSLKIGNNKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 2e-10
Identities = 21/89 (23%), Positives = 40/89 (44%), Gaps = 6/89 (6%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
S+ L ++ ++ + L L+ LNL N++T P L + L + N
Sbjct: 45 SITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI 100
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIP 800
+ +L L+ L +L ++ +N+S I P
Sbjct: 101 --TDISALQNLTNLRELYLNEDNISDISP 127
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 4e-09
Identities = 20/96 (20%), Positives = 34/96 (35%), Gaps = 7/96 (7%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
I L S++ L + L + K+ I L + L+L+ N
Sbjct: 23 EGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQI 78
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTT 807
P L L L++L + N ++ I + LT
Sbjct: 79 TDISP--LSNLVKLTNLYIGTNKIT-DISALQNLTN 111
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 4e-09
Identities = 30/136 (22%), Positives = 62/136 (45%), Gaps = 17/136 (12%)
Query: 104 TSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNI 163
SL + N+ ++ +L+ L L L L + N S D++ K + L +++ SN I
Sbjct: 224 NSLKIGNNKIT---DLSPLANLSQLTWLEIGTNQIS--DINAVKDLT-KLKMLNVGSNQI 277
Query: 164 TGSLPGRSFLLSCDRLSYVNLSHNSISG---GSLHIGPSLLQLDLSGNQISDSALLTYSL 220
+ S L + +L+ + L++N + + +L L LS N I+D L
Sbjct: 278 SDI----SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIR----PL 329
Query: 221 SNCQNLNLLNFSDNKL 236
++ ++ +F++ +
Sbjct: 330 ASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 9e-07
Identities = 17/85 (20%), Positives = 32/85 (37%), Gaps = 6/85 (7%)
Query: 716 LDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSI 775
L ++ P L L +T + L++I L ++ SI
Sbjct: 5 LATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SI 59
Query: 776 PGSLGGLSFLSDLDVSNNNLSGIIP 800
G + L+ L L+++ N ++ I P
Sbjct: 60 QG-IEYLTNLEYLNLNGNQITDISP 83
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 7e-06
Identities = 24/112 (21%), Positives = 44/112 (39%), Gaps = 15/112 (13%)
Query: 104 TSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNI 163
T L + + +S ++ + L L+ LN+ N S D+S S L ++ L++N +
Sbjct: 246 TWLEIGTNQIS---DINAVKDLTKLKMLNVGSNQIS--DISVLNNLS-QLNSLFLNNNQL 299
Query: 164 TGSLPGRSFLLSCDRLSYVNLSHNSISG----GSLHIGPSLLQLDLSGNQIS 211
+ L+ + LS N I+ SL + D + I
Sbjct: 300 GNEDM--EVIGGLTNLTTLFLSQNHITDIRPLASL---SKMDSADFANQVIK 346
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 3e-47
Identities = 94/517 (18%), Positives = 176/517 (34%), Gaps = 88/517 (17%)
Query: 125 LPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNL 184
+L+ ++ + ++ + S + + + P
Sbjct: 10 NTFLQEPLRHSSNLT--EMPVEAENVKSKTEYYNAWSEWERNAP----------PGNGEQ 57
Query: 185 SHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATS 244
++S + +L+L+ +S L + ++L S N L +L
Sbjct: 58 REMAVSRLRDCLDRQAHELELNNLGLSS---LPELPPHLESLVA---SCNSL-TELPELP 110
Query: 245 VNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVI 304
+ KS+ + + LS P L+YL +S+N + L +I
Sbjct: 111 QSLKSLLVDNNNLKALSDLPP---------LLEYLGVSNNQLE---KLPELQNSSFLKII 158
Query: 305 TLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGE 364
+ N L + P + LE + +N L+ +P + L + +N +
Sbjct: 159 DVDNNSL--KKLPDLPPS---LEFIAAGNNQLEE-LPEL--QNLPFLTAIYADNNSLK-K 209
Query: 365 IPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISS 424
+P L + +N L ELP + L ++ N L T+ S
Sbjct: 210 LPDLPLS----LESIVAGNNILE-ELPE-LQNLPFLTTIYA-----DNNLLKTLPDLPPS 258
Query: 425 LIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNN 484
L L V N ++ +P + T L V + +G + P+ L + +N
Sbjct: 259 LEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPPN----------LYYLNASSN 307
Query: 485 YLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICV 544
+ ++ +L+ +++S N L +P+ P L L+ N+L E+PE
Sbjct: 308 EIR-SLCDLP---PSLEELNVSNNKLIE-LPALP---PRLERLIASFNHLA-EVPELP-- 356
Query: 545 NGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGN 604
NL+ L + N L P S + L N E+P NL +L +
Sbjct: 357 --QNLKQLHVEYNPLR-EFPDIPESVED-----LRMNSHLAEVPELPQNLKQL---HVET 405
Query: 605 NSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELAN 641
N L + P S+ L +NS + P
Sbjct: 406 NPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHET 438
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-42
Identities = 100/512 (19%), Positives = 172/512 (33%), Gaps = 129/512 (25%)
Query: 99 LNSHVTSLNLNNSGLSGSLNLTTL-TALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMD 157
L+ L LNN L L++L P+LE L
Sbjct: 69 LDRQAHELELNN------LGLSSLPELPPHLESL-------------------------V 97
Query: 158 LSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLT 217
S N++T LP S L N + ++S + P L L +S NQ+
Sbjct: 98 ASCNSLT-ELP--ELPQSLKSLLVDNNNLKALSD----LPPLLEYLGVSNNQLEKLP--- 147
Query: 218 YSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLK 277
L N L +++ +N L ++P SL+
Sbjct: 148 -ELQNSSFLKIIDVDNNSLK-------------------------KLPDLP-----PSLE 176
Query: 278 YLDLSHNNFTGKFSNL-DFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNAL 336
++ +N L + L+ I N L + P + LE++ +N L
Sbjct: 177 FIAAGNNQLE----ELPELQNLPFLTAIYADNNSL--KKLPDLPLS---LESIVAGNNIL 227
Query: 337 QGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFAS 396
+ +P L + L + +N +P L L++ N LT +LP S
Sbjct: 228 E-ELPE--LQNLPFLTTIYADNNLLK-TLPDLPPS----LEALNVRDNYLT-DLPELPQS 278
Query: 397 CSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSS 456
+ L +S N + + +L YL N I + + L L++S+
Sbjct: 279 LTFLD--------VSENIFSGLSELPPNLYYLNASSNEIRS-LCDLPPS---LEELNVSN 326
Query: 457 NGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPS 516
N +P+ LE+++ N+L+ VP NLK + + +N L P
Sbjct: 327 NKLI-ELPALPPR------LERLIASFNHLA-EVPELPQ---NLKQLHVEYNPLRE-FPD 374
Query: 517 EIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWV 576
S+ +L N+ E+PE NL+ L + N L P S + +
Sbjct: 375 IPESVEDLR-----MNSHLAEVPELP----QNLKQLHVETNPLR-EFPDIPESVED---L 421
Query: 577 SLSSNQLTGEIPAGIGNLVKLAILQLGNNSLT 608
++S ++ KL ++
Sbjct: 422 RMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-41
Identities = 101/539 (18%), Positives = 165/539 (30%), Gaps = 136/539 (25%)
Query: 300 NLSVITLSQNGLSG---TEFPASLKNCQLLETLNMSHNALQGGIPGFLL----------- 345
N+S L + TE P +N + + + + P
Sbjct: 7 NVSNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLR 66
Query: 346 -GSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLN 404
R +L L + +P L L S N LT ELP S SL N
Sbjct: 67 DCLDRQAHELELNNLGL-SSLPELPPH----LESLVASCNSLT-ELPELPQSLKSLLVDN 120
Query: 405 LGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIP 464
LS L YL V N + +P L N + L+++D+ +N
Sbjct: 121 NNLKALSDL--------PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKL-- 168
Query: 465 SGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNL 524
P P+LE I NN L +P EL + L I NSL
Sbjct: 169 -----PDLPPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK------------- 208
Query: 525 SDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLT 584
++P+ +LE+++ NN L + + + + +N L
Sbjct: 209 ------------KLPDLP----LSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK 250
Query: 585 GEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAG 644
+P +L L + +N LT +P+ L + + LS LP L
Sbjct: 251 -TLPDLPPSLEAL---NVRDNYLT-DLPELPQSLTFLDVSENIFSGLS-ELPPNL----- 299
Query: 645 VVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTM 704
NE + C L E + +L P
Sbjct: 300 ---------YYLNASSNEIRSLCDLPPSLEELN-VSNNKLIELP---------------- 333
Query: 705 YTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGV- 763
L L S+N L+ +PE +L + L++ +N L PD ++ + +
Sbjct: 334 ---ALPPRLERLIASFNHLA-EVPELPQNL---KQLHVEYNPLR-EFPDIPESVEDLRMN 385
Query: 764 ---------------LDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTT 807
L + N + P + DL +++ + + T
Sbjct: 386 SHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVE---DLRMNSERVVDPYEFAHETTD 440
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-32
Identities = 71/373 (19%), Positives = 128/373 (34%), Gaps = 63/373 (16%)
Query: 98 SLNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMD 157
L + L ++N+ L L L +L+ +++ NS L SL +
Sbjct: 128 DLPPLLEYLGVSNNQLE---KLPELQNSSFLKIIDVDNNS-----LKKLPDLPPSLEFIA 179
Query: 158 LSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLT 217
+N + LP L + L+ + +NS+ SL + N + +
Sbjct: 180 AGNNQLE-ELP---ELQNLPFLTAIYADNNSLKKLPDLPL-SLESIVAGNNILEELP--- 231
Query: 218 YSLSNCQNLNLLNFSDNKLPGKLNATSV--NCKSISTIDLSYNLLSGEIPASFVADSSGS 275
L N L + +N L ++ S+ +++ N L+ ++P S
Sbjct: 232 -ELQNLPFLTTIYADNNLL------KTLPDLPPSLEALNVRDNYLT-DLPELP-----QS 278
Query: 276 LKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNA 335
L +LD+S N F+G NL + S N + + LE LN+S+N
Sbjct: 279 LTFLDVSENIFSGLSELP-----PNLYYLNASSNEI--RSLCDLPPS---LEELNVSNNK 328
Query: 336 LQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFA 395
L +P L++L + N A E+P L++L + N L E P
Sbjct: 329 LIE-LPA----LPPRLERLIASFNHLA-EVPELPQN----LKQLHVEYNPLR-EFPDIPE 377
Query: 396 SCSSLHSLNLGSNM-----------LSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLT 444
S L + + + + N L S+ L + + P +
Sbjct: 378 SVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPESVEDLRMNSERVVDPYEFAHE 437
Query: 445 NCTQLRVLDLSSN 457
+L +
Sbjct: 438 TTDKLEDDVFEHH 450
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-27
Identities = 59/329 (17%), Positives = 109/329 (33%), Gaps = 60/329 (18%)
Query: 98 SLNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMD 157
L + + N+ L L L LP+L + NS L SL ++
Sbjct: 170 DLPPSLEFIAAGNNQLE---ELPELQNLPFLTAIYADNNS-----LKKLPDLPLSLESIV 221
Query: 158 LSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLT 217
+N + LP L + L+ + +N + SL L++ N ++D L
Sbjct: 222 AGNNILE-ELPE---LQNLPFLTTIYADNNLLKTLPDLPP-SLEALNVRDNYLTD---LP 273
Query: 218 YSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLK 277
+ L++ + L ++ ++ S N + + D SL+
Sbjct: 274 ELPQSLTFLDVSENIFSGLSELP-------PNLYYLNASSNEIR-SLC-----DLPPSLE 320
Query: 278 YLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQ 337
L++S+N + L + S N L E P +N L+ L++ +N L+
Sbjct: 321 ELNVSNNKLIELPALP-----PRLERLIASFNHL--AEVPELPQN---LKQLHVEYNPLR 370
Query: 338 GGIP---------------GFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLS 382
P + +NLKQL + N E P + +L ++
Sbjct: 371 E-FPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPES----VEDLRMN 424
Query: 383 SNRLTGELPSTFASCSSLHSLNLGSNMLS 411
S R+ + L +
Sbjct: 425 SERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-15
Identities = 37/190 (19%), Positives = 76/190 (40%), Gaps = 32/190 (16%)
Query: 467 FCSPPNF--PALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSL--- 521
F +P N L++ + ++ L+ +P+E + K+ +++ P
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 522 ----------PNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCT 571
+L + L+ +PE +LE+L+ + N LT +P+ S
Sbjct: 61 AVSRLRDCLDRQAHELELNNLGLS-SLPELP----PHLESLVASCNSLT-ELPELPQSLK 114
Query: 572 NMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNL 631
++L + + L+ P L L + NN L ++P+ L L +D+++N+L
Sbjct: 115 SLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSL 165
Query: 632 SGPLPSELAN 641
LP +
Sbjct: 166 KK-LPDLPPS 174
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 6e-12
Identities = 30/118 (25%), Positives = 44/118 (37%), Gaps = 12/118 (10%)
Query: 711 GSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNN 770
SL ++ N L LPE +L +L + +N L +PD L+ + +N
Sbjct: 173 PSLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLSLE---SIVAGNNI 226
Query: 771 FQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPLLPCS 828
L L FL+ + NN L + L +N L LP LP S
Sbjct: 227 L--EELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVR---DNY-LTDLPELPQS 278
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 27/117 (23%), Positives = 43/117 (36%), Gaps = 14/117 (11%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
L + NSL LP+ SL + + G+N L L + + +N
Sbjct: 196 FLTAIYADNNSLK-KLPDLPLSL---ESIVAGNNILE--ELPELQNLPFLTTIYADNNLL 249
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPLLPCS 828
+ ++P L L+V +N L+ + LT S N GL LP +
Sbjct: 250 K-TLPDLPPSLE---ALNVRDNYLTDLPELPQSLTFLDVS---ENI-FSGLSELPPN 298
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 4e-05
Identities = 16/93 (17%), Positives = 32/93 (34%), Gaps = 15/93 (16%)
Query: 728 PENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSF--- 784
P N S +LQ + LT +P +K+ + + ++ + P G
Sbjct: 5 PRNV-SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 785 ----------LSDLDVSNNNLSGIIPSGGQLTT 807
+L+++N LS + L +
Sbjct: 63 SRLRDCLDRQAHELELNNLGLSSLPELPPHLES 95
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-44
Identities = 71/379 (18%), Positives = 134/379 (35%), Gaps = 51/379 (13%)
Query: 254 DLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSG 313
D+ ++ + ++ F + + K + ++ K + ++ L+ +
Sbjct: 25 DVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE 83
Query: 314 TEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQAC 373
+ + ++ L M NA++ +P + + L L L N + +P +
Sbjct: 84 ID-TYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNT 140
Query: 374 GTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFN 433
L L +S+N L TF + +SL +L L SN L+ L+ I SL + V +N
Sbjct: 141 PKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSL----IPSLFHANVSYN 196
Query: 434 NISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLE 493
+S +L + LD S N +
Sbjct: 197 LLS-----TLAIPIAVEELDASHNSIN-VVRGPVNV------------------------ 226
Query: 494 LGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLI 553
L + L N+L + + + P L ++ + N L +I V LE L
Sbjct: 227 -----ELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLY 278
Query: 554 LNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQ 613
++NN L A+ + + LS N L + +L L L +NS+ +
Sbjct: 279 ISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL 335
Query: 614 GLGKCRSLVWLDLNSNNLS 632
+L L L+ N+
Sbjct: 336 ST--HHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-39
Identities = 77/362 (21%), Positives = 134/362 (37%), Gaps = 35/362 (9%)
Query: 153 LVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSIS---GGSLHIGPSLLQLDLSGNQ 209
V D+ + T + ++ + V ++++ L + L+L+ Q
Sbjct: 21 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 80
Query: 210 ISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFV 269
I + + TY+ + + L N + N ++ + L N LS +P
Sbjct: 81 IEE--IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIF 137
Query: 270 ADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPAS-LKNCQLLET 328
++ L L +S+NN + + F +L + LS N L T S + + L
Sbjct: 138 HNTP-KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL--THVDLSLIPS---LFH 190
Query: 329 LNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTG 388
N+S+N L L +++L +HN + L L L N LT
Sbjct: 191 ANVSYNLLS------TLAIPIAVEELDASHNSIN-VVRGP---VNVELTILKLQHNNLTD 240
Query: 389 ELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQ 448
+ + L ++L N L + K+ L LY+ N + + L
Sbjct: 241 --TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPT 296
Query: 449 LRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFN 508
L+VLDLS N + P F LE + L +N + L+L + LK + LS N
Sbjct: 297 LKVLDLSHNHLL-HVERNQ---PQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHN 349
Query: 509 SL 510
Sbjct: 350 DW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-36
Identities = 78/360 (21%), Positives = 139/360 (38%), Gaps = 39/360 (10%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSC-SLVTMDLS 159
++ + NS + L L + +E LNL ++ T + ++ + +
Sbjct: 45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE--EIDTYAFAYAHTIQKLYMG 101
Query: 160 SNNITGSLPGRSFLLSCDRLSYVNLSHNSIS---GGSLHIGPSLLQLDLSGNQISDSALL 216
N I LP F + L+ + L N +S G H P L L +S N + +
Sbjct: 102 FNAIR-YLPPHVF-QNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER--IE 157
Query: 217 TYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSL 276
+ +L L S N+L + S+ ++SYNLLS + ++
Sbjct: 158 DDTFQATTSLQNLQLSSNRL---THVDLSLIPSLFHANVSYNLLS-TLAIPI------AV 207
Query: 277 KYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNAL 336
+ LD SHN+ + L+++ L N L T+ L N L +++S+N L
Sbjct: 208 EELDASHNSIN----VVRGPVNVELTILKLQHNNL--TDTAW-LLNYPGLVEVDLSYNEL 260
Query: 337 QGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFAS 396
+ I + L++L +++N+ + TL+ LDLS N L +
Sbjct: 261 E-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQP-IPTLKVLDLSHNHLL-HVERNQPQ 316
Query: 397 CSSLHSLNLGSNMLSGNFLNTV-VSKISSLIYLYVPFNNISGPVPLSL-TNCTQLRVLDL 454
L +L L N + T+ +S +L L + N+ +L N + V D
Sbjct: 317 FDRLENLY-----LDHNSIVTLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDA 371
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-32
Identities = 72/337 (21%), Positives = 122/337 (36%), Gaps = 35/337 (10%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSS 160
V LNLN+ + ++ ++ L + N+ + L + L
Sbjct: 69 RQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVP-LLTVLVLER 126
Query: 161 NNITGSLPGRSFLLSCDRLSYVNLSHN---SISGGSLHIGPSLLQLDLSGNQISDSALLT 217
N+++ SLP F + +L+ +++S+N I + SL L LS N+++
Sbjct: 127 NDLS-SLPRGIFH-NTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-----H 179
Query: 218 YSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLK 277
LS +L N S N L +T ++ +D S+N ++ + L
Sbjct: 180 VDLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPVNV----ELT 229
Query: 278 YLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPA-SLKNCQLLETLNMSHNAL 336
L L HNN T L + LS N L + Q LE L +S+N L
Sbjct: 230 ILKLQHNNLT---DTAWLLNYPGLVEVDLSYNEL--EKIMYHPFVKMQRLERLYISNNRL 284
Query: 337 QGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFAS 396
+ + LK L L+HN + Q L L L N + L ++
Sbjct: 285 VA-LNLYG-QPIPTLKVLDLSHNHLL-HVERNQPQ-FDRLENLYLDHNSIV-TLK--LST 337
Query: 397 CSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFN 433
+L +L L N N L + ++ +
Sbjct: 338 HHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQH 374
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-14
Identities = 22/93 (23%), Positives = 42/93 (45%), Gaps = 2/93 (2%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
L+ +DLSYN L + F + L+ L + +N+L + + + VLD
Sbjct: 243 WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLD 301
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGI 798
LSHN+ + + L +L + +N++ +
Sbjct: 302 LSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL 333
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 24/91 (26%), Positives = 38/91 (41%), Gaps = 5/91 (5%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
F L L +S N L L + L+VL+L HN L H+ + + L
Sbjct: 267 PFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 324
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNLS 796
L HN+ ++ L L +L +S+N+
Sbjct: 325 LDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-12
Identities = 21/93 (22%), Positives = 41/93 (44%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
F ++ L + +N++ P F ++ L VL L N L+ F + L
Sbjct: 88 AFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 147
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGI 798
+S+NN + + + L +L +S+N L+ +
Sbjct: 148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 180
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 6e-12
Identities = 22/93 (23%), Positives = 36/93 (38%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
+ + L+L+ + F + +Q L +G N + P F + + VL
Sbjct: 64 LLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGI 798
L N+ G L+ L +SNNNL I
Sbjct: 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERI 156
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 7e-11
Identities = 14/87 (16%), Positives = 32/87 (36%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
+ + +++ S +++LNL ++ +F I L + N
Sbjct: 46 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI 105
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGI 798
+ P + L+ L + N+LS +
Sbjct: 106 RYLPPHVFQNVPLLTVLVLERNDLSSL 132
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 9e-11
Identities = 29/108 (26%), Positives = 42/108 (38%), Gaps = 6/108 (5%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVL 764
F L L L N LS +LP F + L L++ +N L D+F ++ L
Sbjct: 112 VFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNL 170
Query: 765 DLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASR 812
LS N + L + L +VS N LS + + AS
Sbjct: 171 QLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-TLAIPIAVEELDASH 214
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 9e-11
Identities = 24/101 (23%), Positives = 40/101 (39%), Gaps = 5/101 (4%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
T ++ LD S+NS++ + L +L L HN LT + +D
Sbjct: 200 TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVD 254
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLT 806
LS+N + + + L L +SNN L + G +
Sbjct: 255 LSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIP 295
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 8/88 (9%), Positives = 32/88 (36%), Gaps = 2/88 (2%)
Query: 713 LIYLDLSYNSLSGTLPENF--GSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNN 770
++ D+ + + + F +LN +++ ++ + + + +L+L+
Sbjct: 21 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 80
Query: 771 FQGSIPGSLGGLSFLSDLDVSNNNLSGI 798
+ + + L + N + +
Sbjct: 81 IEEIDTYAFAYAHTIQKLYMGFNAIRYL 108
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 25/93 (26%), Positives = 40/93 (43%), Gaps = 11/93 (11%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
TF SL L LS N L+ + + L N+ +N L+ + A+ LD
Sbjct: 160 TFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELD 211
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGI 798
SHN+ + G + L+ L + +NNL+
Sbjct: 212 ASHNSIN-VVRGPV--NVELTILKLQHNNLTDT 241
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-07
Identities = 31/146 (21%), Positives = 50/146 (34%), Gaps = 24/146 (16%)
Query: 98 SLNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGN---SFSAGDLSTSKTSSCSLV 154
+N +T L L ++ L+ + L P L ++L N + L
Sbjct: 223 PVNVELTILKLQHNNLT---DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ----RLE 275
Query: 155 TMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIG----PSLLQLDLSGNQI 210
+ +S+N + +L + L ++LSHN + + L L L N I
Sbjct: 276 RLYISNNRLV-ALNLYGQPIP--TLKVLDLSHNHLL--HVERNQPQFDRLENLYLDHNSI 330
Query: 211 SDSALLTYSLSNCQNLNLLNFSDNKL 236
T LS L L S N
Sbjct: 331 V-----TLKLSTHHTLKNLTLSHNDW 351
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-43
Identities = 71/467 (15%), Positives = 132/467 (28%), Gaps = 67/467 (14%)
Query: 350 NLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNM 409
K + + + L Q+ ++ELDLS N L+ + A + L LNL SN+
Sbjct: 11 RYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 410 LSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCS 469
L + +S+L L + N + L + L ++N + +
Sbjct: 70 LYE---TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVS----- 115
Query: 470 PPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAG-PVPSEIWSLPNLSDLV 528
+ I L NN ++ L+ G ++ +DL N + S L L
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 529 MWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIP 588
+ N + ++ + L+TL L++N L + S + W+SL +N+L I
Sbjct: 176 LQYNFIY-DVKGQVVFA--KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIE 230
Query: 589 AGIGNLVKLAILQLGNNSL-TGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVM 647
+ L L N G + K + + + + E +
Sbjct: 231 KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLG- 289
Query: 648 PGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTF 707
+ G C + +RL
Sbjct: 290 -------------HYGAYCCE------DLPAPFADRL---------------------IA 309
Query: 708 TTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLS 767
L + L + + ++ + I +A L+
Sbjct: 310 LKRKEHALLSGQGSETER-LECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQK 368
Query: 768 HNNFQGSIPGSLGGLSFLS---DLDVSNNNLSGIIPSGGQLTTFPAS 811
+ + L V L L A
Sbjct: 369 KKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAI 415
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-41
Identities = 72/481 (14%), Positives = 140/481 (29%), Gaps = 60/481 (12%)
Query: 170 RSFLLSCDRLSYVNLSHNSISG---GSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNL 226
+ +R ++ +S+ ++ +LDLSGN +S + L+ L
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQ--ISAADLAPFTKL 60
Query: 227 NLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNF 286
LLN S N L + ++ T+DL+ N + E+ S++ L ++NN
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELLVG------PSIETLHAANNNI 111
Query: 287 TGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLG 346
+ + R I L+ N ++ ++ L++ N + L
Sbjct: 112 S----RVSCSRGQGKKNIYLANNKITMLR-DLDEGCRSRVQYLDLKLNEIDTVNFAELAA 166
Query: 347 SFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLG 406
S L+ L+L +N ++ ++ L+ LDLSSN+L + F S + + ++L
Sbjct: 167 SSDTLEHLNLQYNFIY-DVKGQVV--FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLR 222
Query: 407 SNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSG 466
+N L + +L L DL NGF
Sbjct: 223 NNKLVL--------------------------IEKALRFSQNLEHFDLRGNGFHCG---- 252
Query: 467 FCSPPNFPALEKI-VLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLS 525
F +++ + + C L L
Sbjct: 253 -TLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALK 311
Query: 526 DLVMWANNLTGEIPEGI---CVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQ 582
+ G E + N + I + + +
Sbjct: 312 RKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKA 371
Query: 583 LTGEIPAGIGNLVKLAILQLGNNSLTG--QVPQGLGKCRSLVWLDLNSNNLSGPLPSELA 640
L ++ G +L + + L + + S
Sbjct: 372 LDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQN 431
Query: 641 N 641
N
Sbjct: 432 N 432
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 9e-40
Identities = 73/536 (13%), Positives = 153/536 (28%), Gaps = 100/536 (18%)
Query: 99 LNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDL 158
+ + +S L + + ++ L DL
Sbjct: 8 NGNRYKIEKVTDSSLK-QALASLRQSAWNVKEL-------------------------DL 41
Query: 159 SSNNITGSLPGRSFLLSCDRLSYVNLSHNSISG-GSLHIGPSLLQLDLSGNQISDSALLT 217
S N ++ + +L +NLS N + L +L LDL+ N +
Sbjct: 42 SGNPLS-QISAADL-APFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ------ 93
Query: 218 YSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLK 277
L ++ L+ ++N IS + + K
Sbjct: 94 -ELLVGPSIETLHAANNN--------------ISRVS----------CSRGQ-----GKK 123
Query: 278 YLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQ 337
+ L++N T +LD G + + L N + F + LE LN+ +N +
Sbjct: 124 NIYLANNKIT-MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
Query: 338 GGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASC 397
+ G ++ F LK L L+ N+ A + PE + + L +N+L +
Sbjct: 183 -DVKGQVV--FAKLKTLDLSSNKLA-FMGPEFQS-AAGVTWISLRNNKLV-LIEKALRFS 236
Query: 398 SSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSN 457
+L +L N L SK + V + + CT + +
Sbjct: 237 QNLEHFDLRGNGFHCGTLRDFFSKNQRV--QTVAKQTVKKLTGQNEEECTVPTLGHYGAY 294
Query: 458 GFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSE 517
C P ++++ K + + + E
Sbjct: 295 ---------CCEDLPAPFADRLIALKR-------------KEHALLSGQGSETER-LECE 331
Query: 518 IWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVS 577
+ ++ + + + + TL L + + +
Sbjct: 332 RENQARQREIDALKEQYR-TVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTL 390
Query: 578 LSSNQLTGEIPAGIGNLVKLAILQ-LGNNSLTGQVPQGLGKCRSLVWLDLNSNNLS 632
+ E+ L +L+ + V Q + ++ D+ + +
Sbjct: 391 QQAVGQI-ELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 2e-13
Identities = 21/130 (16%), Positives = 37/130 (28%), Gaps = 5/130 (3%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
+L +L+L YN + + L+ L+L NKL + F + + L +N
Sbjct: 170 TLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPLLPCSSGN 831
I +L L D+ N + + + L
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECT 284
Query: 832 HAATVHPHEN 841
H
Sbjct: 285 VPTLGHYGAY 294
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 1e-11
Identities = 23/112 (20%), Positives = 37/112 (33%), Gaps = 3/112 (2%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
L LDLS N L+ + F S + ++L +NKL I + + + DL N F
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLP 823
V+ + + + T P + LP
Sbjct: 250 HCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLP 300
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 1e-11
Identities = 14/74 (18%), Positives = 27/74 (36%)
Query: 727 LPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLS 786
+ E + N ++ + + L + + LDLS N L + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 787 DLDVSNNNLSGIIP 800
L++S+N L +
Sbjct: 62 LLNLSSNVLYETLD 75
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 9e-05
Identities = 15/75 (20%), Positives = 27/75 (36%)
Query: 562 AIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSL 621
AI + + ++ + L + + + + L L N L+ L L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 622 VWLDLNSNNLSGPLP 636
L+L+SN L L
Sbjct: 61 ELLNLSSNVLYETLD 75
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-42
Identities = 73/380 (19%), Positives = 135/380 (35%), Gaps = 53/380 (13%)
Query: 254 DLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSG 313
D+ ++ + ++ F + + K + ++ K + ++ L+ +
Sbjct: 31 DVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQI-- 87
Query: 314 TEFPA-SLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQA 372
E + ++ L M NA++ +P + + L L L N + +P +
Sbjct: 88 EEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHN 145
Query: 373 CGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPF 432
L L +S+N L TF + +SL +L L SN L+ L+ I SL + V +
Sbjct: 146 TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSL----IPSLFHANVSY 201
Query: 433 NNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPL 492
N +S +L + LD S N +
Sbjct: 202 NLLS-----TLAIPIAVEELDASHNSINV------------------------------V 226
Query: 493 ELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETL 552
L + L N+L + + + P L ++ + N L +I V LE L
Sbjct: 227 RGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERL 283
Query: 553 ILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVP 612
++NN L A+ + + LS N L + +L L L +NS+ +
Sbjct: 284 YISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK 340
Query: 613 QGLGKCRSLVWLDLNSNNLS 632
L +L L L+ N+
Sbjct: 341 --LSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 8e-38
Identities = 91/474 (19%), Positives = 166/474 (35%), Gaps = 46/474 (9%)
Query: 153 LVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSIS---GGSLHIGPSLLQLDLSGNQ 209
V D+ + T + ++ + V ++++ L + L+L+ Q
Sbjct: 27 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 86
Query: 210 ISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFV 269
I + + TY+ + + L N + N ++ + L N LS +P
Sbjct: 87 IEE--IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIF 143
Query: 270 ADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPAS-LKNCQLLET 328
++ L L +S+NN + + F +L + LS N L T S + + L
Sbjct: 144 HNTP-KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL--THVDLSLIPS---LFH 196
Query: 329 LNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTG 388
N+S+N L L +++L +HN + L L L N LT
Sbjct: 197 ANVSYNLLS------TLAIPIAVEELDASHNSIN-VVRGP---VNVELTILKLQHNNLTD 246
Query: 389 ELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQ 448
+ + L ++L N L + K+ L LY+ N + + L
Sbjct: 247 --TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPT 302
Query: 449 LRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFN 508
L+VLDLS N + P F LE + L +N + L+L + LK + LS N
Sbjct: 303 LKVLDLSHNHLL-HVERNQ---PQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHN 355
Query: 509 SLAGPVPSEIWSLPNLSDLVMWANNLTGEIP----EGICVNGGNLETLILNNNHLTGA-- 562
S N++ + + +I G+C + L ++
Sbjct: 356 DWDC--NSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSV 413
Query: 563 ---IPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQ 613
+ ++ C+ ++ + G L L+ N L +V Q
Sbjct: 414 VEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQ 467
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-34
Identities = 88/458 (19%), Positives = 157/458 (34%), Gaps = 61/458 (13%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGN---SFSAGDLSTSKTSSCSLVTMD 157
++ + NS + L L + +E LNL + + ++ +
Sbjct: 51 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAH----TIQKLY 105
Query: 158 LSSNNITGSLPGRSFLLSCDRLSYVNLSHN---SISGGSLHIGPSLLQLDLSGNQISDSA 214
+ N I LP F + L+ + L N S+ G H P L L +S N +
Sbjct: 106 MGFNAIR-YLPPHVF-QNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER-- 161
Query: 215 LLTYSLSNCQNLNLLNFSDNKL----PGKLNATSVNCKSISTIDLSYNLLSGEIPASFVA 270
+ + +L L S N+L + S+ ++SYNLLS +
Sbjct: 162 IEDDTFQATTSLQNLQLSSNRLTHVDLSLI-------PSLFHANVSYNLLS-TLAIPI-- 211
Query: 271 DSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLN 330
+++ LD SHN+ + L+++ L N L T+ L N L ++
Sbjct: 212 ----AVEELDASHNSIN----VVRGPVNVELTILKLQHNNL--TDTAW-LLNYPGLVEVD 260
Query: 331 MSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGEL 390
+S+N L+ I + L++L +++N+ + TL+ LDLS N L +
Sbjct: 261 LSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQP-IPTLKVLDLSHNHLL-HV 316
Query: 391 PSTFASCSSLHSLNLGSNMLS----GNFLNTVVSKISSLIYLYVPFNNISGPVPLSL-TN 445
L +L L N + +L L + N+ +L N
Sbjct: 317 ERNQPQFDRLENLYLDHNSIVTLKLSTH--------HTLKNLTLSHNDWDCNSLRALFRN 368
Query: 446 CTQLRVLDLSSNGFTGTIPSGF--CSPPNFPALEKIV--LPNNYLSGTVPLELGSCKNLK 501
+ V D + C + P L++++ + + V G C
Sbjct: 369 VARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATD 428
Query: 502 TIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIP 539
TI+ + L L N L E+
Sbjct: 429 TINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQ 466
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 2e-21
Identities = 59/262 (22%), Positives = 102/262 (38%), Gaps = 50/262 (19%)
Query: 100 NSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLS 159
+T+L+++N+ L + T A L++L L N + DLS SL ++S
Sbjct: 146 TPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIP----SLFHANVS 200
Query: 160 SNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYS 219
N ++ +L + ++ SHNSI+ + L L L N ++D+A
Sbjct: 201 YNLLS-TLAIPIAV------EELDASHNSINVVRGPVNVELTILKLQHNNLTDTA----W 249
Query: 220 LSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYL 279
L N L ++ S N+L + V + + + +S N L + +LK L
Sbjct: 250 LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYG--QPIPTLKVL 306
Query: 280 DLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGG 339
DLSHN+ + LE L + HN++
Sbjct: 307 DLSHNHL---------------------------LHVERNQPQFDRLENLYLDHNSIV-T 338
Query: 340 IPGFLLGSFRNLKQLSLAHNQF 361
+ L + LK L+L+HN +
Sbjct: 339 LK---LSTHHTLKNLTLSHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 5e-12
Identities = 22/94 (23%), Positives = 43/94 (45%), Gaps = 2/94 (2%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVL 764
F ++ L + +N++ LP + F ++ L VL L N L+ F + L
Sbjct: 94 AFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTL 152
Query: 765 DLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGI 798
+S+NN + + + L +L +S+N L+ +
Sbjct: 153 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 186
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 1e-11
Identities = 24/91 (26%), Positives = 38/91 (41%), Gaps = 5/91 (5%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
F L L +S N L L + L+VL+L HN L H+ + + L
Sbjct: 273 PFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 330
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNLS 796
L HN+ ++ L L +L +S+N+
Sbjct: 331 LDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 66.9 bits (163), Expect = 3e-11
Identities = 22/93 (23%), Positives = 36/93 (38%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
+ + L+L+ + F + +Q L +G N + P F + + VL
Sbjct: 70 LLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGI 798
L N+ G L+ L +SNNNL I
Sbjct: 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERI 162
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 1e-10
Identities = 14/87 (16%), Positives = 32/87 (36%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
+ + +++ S +++LNL ++ +F I L + N
Sbjct: 52 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI 111
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGI 798
+ P + L+ L + N+LS +
Sbjct: 112 RYLPPHVFQNVPLLTVLVLERNDLSSL 138
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 2e-10
Identities = 22/93 (23%), Positives = 42/93 (45%), Gaps = 8/93 (8%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
F L L +S N+L + F + LQ L L N+LT H+ + ++ +
Sbjct: 142 IFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHAN 198
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGI 798
+S+N +L + +LD S+N+++ +
Sbjct: 199 VSYNLLS-----TLAIPIAVEELDASHNSINVV 226
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 3e-10
Identities = 24/101 (23%), Positives = 40/101 (39%), Gaps = 5/101 (4%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
T ++ LD S+NS++ + L +L L HN LT + +D
Sbjct: 206 TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLTD--TAWLLNYPGLVEVD 260
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLT 806
LS+N + + + L L +SNN L + G +
Sbjct: 261 LSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIP 301
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 5e-08
Identities = 8/88 (9%), Positives = 32/88 (36%), Gaps = 2/88 (2%)
Query: 713 LIYLDLSYNSLSGTLPENF--GSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNN 770
++ D+ + + + F +LN +++ ++ + + + +L+L+
Sbjct: 27 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 86
Query: 771 FQGSIPGSLGGLSFLSDLDVSNNNLSGI 798
+ + + L + N + +
Sbjct: 87 IEEIDTYAFAYAHTIQKLYMGFNAIRYL 114
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-42
Identities = 68/282 (24%), Positives = 118/282 (41%), Gaps = 39/282 (13%)
Query: 936 IGSGGFGEVYKAQLRDGSV-VAIKKL-IHVTGQGDREFMAEMETIGKIKHRNLVPLLGYC 993
IG G FGEV+ +LR + VA+K + +F+ E + + H N+V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHI 1053
+ +V E ++ G + L G +L ++ +A G+ +L
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTE----GARLRVKTLLQMVGDAAAGMEYLESK---CC 234
Query: 1054 IHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP-----PEYYQS 1108
IHRD+ + N L+ E ++SDFGM+R V +G VP PE
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEAD-----GVYAASGGLRQVPVKWTAPEALNY 289
Query: 1109 FRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD-PEL 1166
R +++ DV+S+G++L E S G P N + + + R L PEL
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYP----NLSNQQT--REFVEKGGR----LPCPEL 339
Query: 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208
+++ + +C P +RP+ + + ++
Sbjct: 340 C-----PDAVFR---LMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 3e-41
Identities = 58/303 (19%), Positives = 106/303 (34%), Gaps = 22/303 (7%)
Query: 349 RNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSN 408
K + + + L Q+ ++ELDLS N L+ + A + L LNL SN
Sbjct: 10 NRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 409 MLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFC 468
+L + +S+L L + N + L + L ++N + +
Sbjct: 69 VLYE---TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVS---- 115
Query: 469 SPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAG-PVPSEIWSLPNLSDL 527
+ I L NN ++ L+ G ++ +DL N + S L L
Sbjct: 116 -CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174
Query: 528 VMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEI 587
+ N + ++ + L+TL L++N L + S + W+SL +N+L I
Sbjct: 175 NLQYNFIY-DVKGQVVFA--KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LI 229
Query: 588 PAGIGNLVKLAILQLGNNSLT-GQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVV 646
+ L L N G + K + + + + E +
Sbjct: 230 EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLG 289
Query: 647 MPG 649
G
Sbjct: 290 HYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 4e-36
Identities = 56/277 (20%), Positives = 102/277 (36%), Gaps = 21/277 (7%)
Query: 367 PELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLI 426
E+ Q + ++ + L L S S ++ L+L N LS ++ + L
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLE 61
Query: 427 YLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYL 486
L + N + + L + + LR LDL++N + G P++E + NN +
Sbjct: 62 LLNLSSNVLYETLDLE--SLSTLRTLDLNNNYVQ-ELLVG-------PSIETLHAANNNI 111
Query: 487 SGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNG 546
S V G + K I L+ N + + + L + N + +
Sbjct: 112 S-RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAAS 167
Query: 547 -GNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNN 605
LE L L N + + + + + LSSN+L + + + + L NN
Sbjct: 168 SDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNN 224
Query: 606 SLTGQVPQGLGKCRSLVWLDLNSNNLS-GPLPSELAN 641
L + + L ++L DL N G L +
Sbjct: 225 KLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-36
Identities = 59/331 (17%), Positives = 123/331 (37%), Gaps = 29/331 (8%)
Query: 170 RSFLLSCDRLSYVNLSHNSISG---GSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNL 226
+ +R ++ +S+ ++ +LDLSGN +S + L+ L
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQ--ISAADLAPFTKL 60
Query: 227 NLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNF 286
LLN S N L + + ++ T+DL+ N + E+ S++ L ++NN
Sbjct: 61 ELLNLSSNVL-YETLDLE-SLSTLRTLDLNNNYVQ-ELL------VGPSIETLHAANNNI 111
Query: 287 TGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLG 346
+ + R I L+ N ++ ++ L++ N + L
Sbjct: 112 S----RVSCSRGQGKKNIYLANNKITMLR-DLDEGCRSRVQYLDLKLNEIDTVNFAELAA 166
Query: 347 SFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLG 406
S L+ L+L +N ++ ++ L+ LDLSSN+L + F S + + ++L
Sbjct: 167 SSDTLEHLNLQYNFIY-DVKGQVV--FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLR 222
Query: 407 SNMLSGNFLNTVVSKISSLIYLYVPFNNIS-GPVPLSLTNCTQLRVLDLSSNGFTGTIPS 465
+N L + + +L + + N G + + +++ + +
Sbjct: 223 NNKLV--LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE 280
Query: 466 GFCSPPNFPALEKIV---LPNNYLSGTVPLE 493
C+ P LP + + L
Sbjct: 281 EECTVPTLGHYGAYCCEDLPAPFADRLIALG 311
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 66/348 (18%), Positives = 111/348 (31%), Gaps = 54/348 (15%)
Query: 222 NCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDL 281
N + +D+ L L + + ++ +DLS N LS A L+ L+L
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADL--APFTKLELLNL 65
Query: 282 SHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIP 341
S N LD L + L+ N + L +ETL+ ++N + +
Sbjct: 66 SSNVLY---ETLDLESLSTLRTLDLNNNYVQ------ELLVGPSIETLHAANNNIS-RVS 115
Query: 342 GFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTG-ELPSTFASCSSL 400
+ K + LA+N+ + ++ LDL N + AS +L
Sbjct: 116 ---CSRGQGKKNIYLANNKIT-MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 401 HSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFT 460
LNL N + + + +L+ LDLSSN
Sbjct: 172 EHLNLQYNFI---------YDVKGQVVF------------------AKLKTLDLSSNKLA 204
Query: 461 GTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLA-GPVPSEIW 519
+ F + + I L NN L + L +NL+ DL N G +
Sbjct: 205 -FMGPEFQ---SAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259
Query: 520 SLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSI 567
+ + E C + TL + +P
Sbjct: 260 KNQRVQTVAKQTVKKLTGQNEEEC----TVPTLGHYGAYCCEDLPAPF 303
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-32
Identities = 52/331 (15%), Positives = 108/331 (32%), Gaps = 28/331 (8%)
Query: 198 PSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSY 257
++ + + L + N+ L+ S N L A + ++LS
Sbjct: 10 NRYKIEKVTDSSLKQ--ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 258 NLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFP 317
N+L E +S +L+ LDL++N + ++ + + N + +
Sbjct: 68 NVLY-ETLDL---ESLSTLRTLDLNNNYVQ------ELLVGPSIETLHAANNNI--SRVS 115
Query: 318 ASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLR 377
S Q + + +++N + + G ++ L L N+ EL + TL
Sbjct: 116 CS--RGQGKKNIYLANNKITM-LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE 172
Query: 378 ELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISG 437
L+L N + ++ + L +L+L SN L+ F+ + + ++ + N +
Sbjct: 173 HLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLA--FMGPEFQSAAGVTWISLRNNKLVL 228
Query: 438 PVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKI-VLPNNYLSGTVPLELGS 496
+ +L L DL NGF F +++ + +
Sbjct: 229 -IEKALRFSQNLEHFDLRGNGFHCG-----TLRDFFSKNQRVQTVAKQTVKKLTGQNEEE 282
Query: 497 CKNLKTIDLSFNSLAGPVPSEIWSLPNLSDL 527
C L L
Sbjct: 283 CTVPTLGHYGAYCCEDLPAPFADRLIALGHH 313
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 64/389 (16%), Positives = 121/389 (31%), Gaps = 84/389 (21%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSS 160
+ + +S L + + ++ L DLS
Sbjct: 10 NRYKIEKVTDSSLK-QALASLRQSAWNVKEL-------------------------DLSG 43
Query: 161 NNITGSLPGRSFLLSCDRLSYVNLSHNSISG-GSLHIGPSLLQLDLSGNQISDSALLTYS 219
N ++ + +L +NLS N + L +L LDL+ N +
Sbjct: 44 NPLS-QISAADL-APFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-------E 94
Query: 220 LSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYL 279
L ++ L+ ++N IS + S K +
Sbjct: 95 LLVGPSIETLHAANNN--------------ISRVSCSRGQ---------------GKKNI 125
Query: 280 DLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGG 339
L++N T +LD G + + L N + F + LE LN+ +N +
Sbjct: 126 YLANNKIT-MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-D 183
Query: 340 IPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSS 399
+ G + F LK L L+ N+ A + PE + + L +N+L + +
Sbjct: 184 VKGQV--VFAKLKTLDLSSNKLA-FMGPEFQS-AAGVTWISLRNNKLV-LIEKALRFSQN 238
Query: 400 LHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGF 459
L +L N L SK + V + + CT + +
Sbjct: 239 LEHFDLRGNGFHCGTLRDFFSKNQRV--QTVAKQTVKKLTGQNEEECTVPTLGHYGAY-- 294
Query: 460 TGTIPSGFCSPPNFPALEKIV-LPNNYLS 487
C P ++++ L +++
Sbjct: 295 -------CCEDLPAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 22/120 (18%), Positives = 38/120 (31%), Gaps = 6/120 (5%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
+L +L+L YN + + L+ L+L NKL + F + + L +N
Sbjct: 170 TLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIPSG--GQLTTFPASRYENNSGLCGLPLLPCSS 829
I +L L D+ N + + L G C+
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 22/96 (22%), Positives = 37/96 (38%), Gaps = 3/96 (3%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
++ +SL L S ++ L+L N L+ + +L+LS N
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTT 807
L LS L LD++NN + + G + T
Sbjct: 71 Y-ETL-DLESLSTLRTLDLNNNYVQE-LLVGPSIET 103
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 29/99 (29%), Positives = 42/99 (42%), Gaps = 7/99 (7%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
+ ++ LDLS N LS + L++LNL N L D L + LD
Sbjct: 29 LRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLD-LESLSTLRTLD 86
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQ 804
L++N Q L + L +NNN+S + S GQ
Sbjct: 87 LNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQ 120
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 21/105 (20%), Positives = 35/105 (33%), Gaps = 3/105 (2%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
L LDLS N L+ + F S + ++L +NKL I + + + DL N F
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENN 816
V+ + + + T P +
Sbjct: 250 H-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGA 293
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 7e-12
Identities = 17/96 (17%), Positives = 33/96 (34%), Gaps = 5/96 (5%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
S+ L + N++S + + G + + L +NK+T G + LDL N
Sbjct: 100 SIETLHAANNNIS-RVSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI 156
Query: 772 QG-SIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLT 806
+ L L++ N + +
Sbjct: 157 DTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFA 191
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 14/77 (18%), Positives = 27/77 (35%)
Query: 727 LPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLS 786
+ E + N ++ + + L + + LDLS N L + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 787 DLDVSNNNLSGIIPSGG 803
L++S+N L +
Sbjct: 62 LLNLSSNVLYETLDLES 78
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 9e-10
Identities = 16/93 (17%), Positives = 33/93 (35%), Gaps = 8/93 (8%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
+ +L LDL+ N + ++ L+ +N ++ G K +
Sbjct: 75 DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQGKK---NIY 126
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGI 798
L++N G S + LD+ N + +
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV 159
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 8e-05
Identities = 15/75 (20%), Positives = 27/75 (36%)
Query: 562 AIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSL 621
AI + + ++ + L + + + + L L N L+ L L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 622 VWLDLNSNNLSGPLP 636
L+L+SN L L
Sbjct: 61 ELLNLSSNVLYETLD 75
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 9e-05
Identities = 13/97 (13%), Positives = 31/97 (31%), Gaps = 5/97 (5%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLT-GHIPDSFGGLKAIGVL 764
F + + ++ L N L + + L+ +L N G + D F + +
Sbjct: 209 EFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV--Q 265
Query: 765 DLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPS 801
++ + + G + L +P+
Sbjct: 266 TVAKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLPA 301
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-39
Identities = 53/366 (14%), Positives = 104/366 (28%), Gaps = 59/366 (16%)
Query: 275 SLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHN 334
+ L + + + + N + +
Sbjct: 13 GRENLYFQGSTALRPYHD----VLSQWQ--RHYNADRNRWHSAWRQANSNNPQIETRTGR 66
Query: 335 ALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTF 394
AL+ + L L + P + + L+ + + + L ELP T
Sbjct: 67 ALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFR-LSHLQHMTIDAAGLM-ELPDTM 123
Query: 395 ASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDL 454
+ L +L L N L +P S+ + +LR L +
Sbjct: 124 QQFAGLETLTLARNPLRA--------------------------LPASIASLNRLRELSI 157
Query: 455 SSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPV 514
+ +P S E NL+++ L + + +
Sbjct: 158 RACPELTELPEPLAST------------------DASGEHQGLVNLQSLRLEWTGIRS-L 198
Query: 515 PSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNML 574
P+ I +L NL L + + L+ + I + LE L L P +
Sbjct: 199 PASIANLQNLKSLKIRNSPLS-ALGPAIH-HLPKLEELDLRGCTALRNYPPIFGGRAPLK 256
Query: 575 WVSLSS-NQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSG 633
+ L + L +P I L +L L L ++P + + + + + +L
Sbjct: 257 RLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILV-PPHLQA 314
Query: 634 PLPSEL 639
L
Sbjct: 315 QLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-35
Identities = 63/340 (18%), Positives = 109/340 (32%), Gaps = 31/340 (9%)
Query: 193 SLHIGPSLLQLDLSGNQISDSALLTY--SLSNCQNLNLLNFSDNKLPGKLNATSVNCKSI 250
H L G+ +AL Y LS Q + + + N +
Sbjct: 7 HHHHSSGRENLYFQGS----TALRPYHDVLSQWQRHYNADRNRWHSAWRQ----ANSNNP 58
Query: 251 STIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNG 310
+ L + L+L +F + R +L +T+ G
Sbjct: 59 QIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPD-QAFRLSHLQHMTIDAAG 115
Query: 311 LSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELG 370
L E P +++ LETL ++ N L+ +P + S L++LS+ E+P L
Sbjct: 116 L--MELPDTMQQFAGLETLTLARNPLRA-LPASI-ASLNRLRELSIRACPELTELPEPLA 171
Query: 371 Q--------ACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKI 422
L+ L L + LP++ A+ +L SL + ++ LS L + +
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA--LGPAIHHL 228
Query: 423 SSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLP 482
L L + P L+ L L T+P LEK+ L
Sbjct: 229 PKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIH---RLTQLEKLDLR 285
Query: 483 NNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLP 522
+P + I + + A + P
Sbjct: 286 GCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-33
Identities = 50/277 (18%), Positives = 93/277 (33%), Gaps = 24/277 (8%)
Query: 375 TLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNN 434
L + + ++ + + N ++
Sbjct: 13 GRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN-----SNNPQIETRTGRA 67
Query: 435 ISGPVPLSLTNCTQ--LRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPL 492
+ L + TQ L+L S P L+ + + L +P
Sbjct: 68 LKA-TADLLEDATQPGRVALELRSVPLP-QFPDQAF---RLSHLQHMTIDAAGLM-ELPD 121
Query: 493 ELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGG----- 547
+ L+T+ L+ N L +P+ I SL L +L + A E+PE +
Sbjct: 122 TMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ 180
Query: 548 ---NLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGN 604
NL++L L + ++P SIA+ N+ + + ++ L+ + I +L KL L L
Sbjct: 181 GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRG 238
Query: 605 NSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELAN 641
+ P G L L L + LP ++
Sbjct: 239 CTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHR 275
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 42/327 (12%), Positives = 95/327 (29%), Gaps = 52/327 (15%)
Query: 98 SLNSHVTSL-NLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTM 156
+ ++ N+ + + + G + A + V +
Sbjct: 27 PYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVAL 86
Query: 157 DLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALL 216
+L S + P ++F LS L + + + + L
Sbjct: 87 ELRSVPLP-QFPDQAFRLS-----------------------HLQHMTIDAAGLME---L 119
Query: 217 TYSLSNCQNLNLLNFSDNKLPGKLNATSV-----NCKSISTIDLSYNLLSGEIPASFVAD 271
++ L L + N L ++ + + + + E+P +
Sbjct: 120 PDTMQQFAGLETLTLARNPL------RALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 272 SSG-------SLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQ 324
+ +L+ L L NL + + + L + ++ +
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPA-SIANLQNLKSLKIRNSPL--SALGPAIHHLP 229
Query: 325 LLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSN 384
LE L++ P G LK+L L +P ++ + L +LDL
Sbjct: 230 KLEELDLRGCTALRNYPPI-FGGRAPLKRLILKDCSNLLTLPLDIHR-LTQLEKLDLRGC 287
Query: 385 RLTGELPSTFASCSSLHSLNLGSNMLS 411
LPS A + + + ++ +
Sbjct: 288 VNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 22/169 (13%), Positives = 47/169 (27%), Gaps = 23/169 (13%)
Query: 493 ELGSCKNLKTIDLSFNSLAGPVPSEI-----------------WSLPNLSDLVMWANNLT 535
+ + ++ P + W N ++ +
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGR 66
Query: 536 G--EIPEGICV-NGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIG 592
+ + L L + L P +++ +++ + L E+P +
Sbjct: 67 ALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQ 124
Query: 593 NLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELAN 641
L L L N L +P + L L + + LP LA+
Sbjct: 125 QFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS 172
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 22/103 (21%), Positives = 41/103 (39%), Gaps = 12/103 (11%)
Query: 709 TNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSH 768
T + L+L L P+ L++LQ + + L +PD+ + L L+
Sbjct: 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLAR 136
Query: 769 NNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPAS 811
N + ++P S+ L+ L +L + +LT P
Sbjct: 137 NPLR-ALPASIASLNRLRELSIRACP---------ELTELPEP 169
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 4e-15
Identities = 21/100 (21%), Positives = 40/100 (40%), Gaps = 11/100 (11%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
+L L L + + +LP + +L L+ L + ++ L+ + + L + LDL
Sbjct: 184 NLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTA 241
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPAS 811
+ P GG + L L + + + L T P
Sbjct: 242 LRNYPPIFGGRAPLKRLILKDCS---------NLLTLPLD 272
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 7e-15
Identities = 25/118 (21%), Positives = 41/118 (34%), Gaps = 2/118 (1%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
+L L + + LS L L L+ L+L + P FGG + L L +
Sbjct: 207 NLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSN 265
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIPSG-GQLTTFPASRYENNSGLCGLPLLPCS 828
++P + L+ L LD+ +PS QL + P +
Sbjct: 266 LLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVA 323
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-14
Identities = 19/104 (18%), Positives = 31/104 (29%), Gaps = 11/104 (10%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
L ++ + L LP+ L+ L L N L +P S L + L +
Sbjct: 105 HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPE 162
Query: 772 QGSIPGSLGGLSF---------LSDLDVSNNNLSGIIPSGGQLT 806
+P L L L + + + S L
Sbjct: 163 LTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQ 206
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 21/100 (21%), Positives = 33/100 (33%), Gaps = 4/100 (4%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNL-GHNKLTGHIPDSFGGLKAIGVLDLSHNN 770
L LDL + P FG L+ L L + L +P L + LDL
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCV 288
Query: 771 FQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPA 810
+P + L + V + + + + PA
Sbjct: 289 NLSRLPSLIAQLPANCIILVPPHLQAQLDQH--RPVARPA 326
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 1e-05
Identities = 14/117 (11%), Positives = 23/117 (19%), Gaps = 24/117 (20%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSL--------------------NYLQVLNLGHNKLTGHI 751
L ++ + N Q+ L
Sbjct: 13 GRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALK-AT 71
Query: 752 PDSFGGLKAIG--VLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLT 806
D G L+L P LS L + + L + + Q
Sbjct: 72 ADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFA 127
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 3e-38
Identities = 84/487 (17%), Positives = 162/487 (33%), Gaps = 83/487 (17%)
Query: 75 PNGYLANWTADALTPCSWQGVSCSLNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQ 134
P+ A+ A A + +S + +TSL+ +NS ++ ++T + L L L
Sbjct: 16 PDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT---DMTGIEKLTGLTKLICT 72
Query: 135 GNSFSAGDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSL 194
N+ + DLS + +L + SN +T +L + +L+Y+N N ++ +
Sbjct: 73 SNNITTLDLSQNT----NLTYLACDSNKLT-NLD----VTPLTKLTYLNCDTNKLTKLDV 123
Query: 195 HIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTID 254
P L L+ + N ++ +S+ L L+ NK I+ +D
Sbjct: 124 SQNPLLTYLNCARNTLT-----EIDVSHNTQLTELDCHLNKK-------------ITKLD 165
Query: 255 LSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGT 314
++ L LD S N T LD + L+ + N ++
Sbjct: 166 VTPQT---------------QLTTLDCSFNKIT----ELDVSQNKLLNRLNCDTNNITKL 206
Query: 315 EFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACG 374
+ L L+ S N L I + L + N E+
Sbjct: 207 DL----NQNIQLTFLDCSSNKLT-EID---VTPLTQLTYFDCSVNPLT-ELDVS---TLS 254
Query: 375 TLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTV-VSKISSLIYLYVPFN 433
L L L E+ + L + + V+ + L L
Sbjct: 255 KLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGC----RKIKELDVTHNTQLYLLDCQAA 307
Query: 434 NISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLE 493
I+ L L+ +L L L++ T + + L+ + N ++
Sbjct: 308 GIT---ELDLSQNPKLVYLYLNNTELT-ELDVS-----HNTKLKSLSCVNAHIQ-DFS-S 356
Query: 494 LGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLI 553
+G L + +P E + +L+ V + +L + + + G+
Sbjct: 357 VGKIPALNNNFEAEGQTIT-MPKETLTNNSLTIAV--SPDLLDQFGNPMNIEPGDGGVYD 413
Query: 554 LNNNHLT 560
N +T
Sbjct: 414 QATNTIT 420
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-34
Identities = 79/421 (18%), Positives = 135/421 (32%), Gaps = 55/421 (13%)
Query: 221 SNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLD 280
N + F + +++++D + ++ ++ + L L
Sbjct: 18 DNFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSIT-DMTGI---EKLTGLTKLI 70
Query: 281 LSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGI 340
+ NN T LD + NL+ + N L T + L LN N L +
Sbjct: 71 CTSNNIT----TLDLSQNTNLTYLACDSNKL--TNLD--VTPLTKLTYLNCDTNKLTK-L 121
Query: 341 PGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSL 400
+ L L+ A N EI L ELD N+ +L + L
Sbjct: 122 D---VSQNPLLTYLNCARNTLT-EIDVSH---NTQLTELDCHLNKKITKLD--VTPQTQL 172
Query: 401 HSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFT 460
+L+ N ++ L+ VS+ L L NNI+ L L QL LD SSN T
Sbjct: 173 TTLDCSFNKITE--LD--VSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT 225
Query: 461 GTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWS 520
I L N L+ L++ + L T+ L + ++
Sbjct: 226 -EIDVT-----PLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDL---LEIDLTH 273
Query: 521 LPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSS 580
L E+ L L +T ++ ++++ L++
Sbjct: 274 NTQLIYFQAEGCRKIKELDVTHNTQ---LYLLDCQAAGIT---ELDLSQNPKLVYLYLNN 327
Query: 581 NQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELA 640
+LT E+ + + KL L N + +GK +L L
Sbjct: 328 TELT-ELD--VSHNTKLKSLSCVNAHIQDFSS--VGKIPALNNNFEAEGQTITMPKETLT 382
Query: 641 N 641
N
Sbjct: 383 N 383
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-12
Identities = 51/287 (17%), Positives = 92/287 (32%), Gaps = 36/287 (12%)
Query: 548 NLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSL 607
L +L +N+ +T I T + + +SN +T + + L L +N L
Sbjct: 43 TLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKL 97
Query: 608 TGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTAC 667
T + + L +L+ ++N L+ S+ + + + T
Sbjct: 98 T-NLD--VTPLTKLTYLNCDTNKLTKLDVSQNPLLTYL----NCARNTLTEIDVSHNTQ- 149
Query: 668 RGAGGLVEFEGIRPERLEGFPMVHSCPSTRI----YTGMTMYTFTTNGSLIYLDLSYNSL 723
L E + + V + +T + N L L+ N++
Sbjct: 150 -----LTELD-CHLNKKITKLDVTPQTQLTTLDCSFNKITELDVSQNKLLNRLNCDTNNI 203
Query: 724 SGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLS 783
+ L L L+ NKLT I L + D S N + + LS
Sbjct: 204 T-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLS 254
Query: 784 FLSDLDVSNNNLSGI-IPSGGQLTTFPASRYENNSGLCGLPLLPCSS 829
L+ L +L I + QL F A + L + +
Sbjct: 255 KLTTLHCIQTDLLEIDLTHNTQLIYFQAE---GCRKIKELDVTHNTQ 298
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-08
Identities = 18/126 (14%), Positives = 36/126 (28%), Gaps = 8/126 (6%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
T N L LD ++ L L L L + +LT + + L
Sbjct: 292 DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLS 345
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPLL 825
+ + Q S+G + L++ + + + + + G P+
Sbjct: 346 CVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN 403
Query: 826 PCSSGN 831
Sbjct: 404 IEPGDG 409
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-06
Identities = 17/97 (17%), Positives = 34/97 (35%), Gaps = 8/97 (8%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
+ +L LD +S++ + L L L N +T + + L
Sbjct: 37 SEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLA 91
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSG 802
N ++ + L+ L+ L+ N L+ + S
Sbjct: 92 CDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKLDVSQ 125
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-06
Identities = 21/123 (17%), Positives = 34/123 (27%), Gaps = 20/123 (16%)
Query: 707 FTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDL 766
T N LIY L + L +L+ +T + L L
Sbjct: 271 LTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYL 325
Query: 767 SHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIP------------SGGQLTTFPASRYE 814
++ + + + L L N ++ + GQ T P
Sbjct: 326 NNTELT-ELD--VSHNTKLKSLSCVNAHIQDFSSVGKIPALNNNFEAEGQTITMPKETLT 382
Query: 815 NNS 817
NNS
Sbjct: 383 NNS 385
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 16/92 (17%), Positives = 27/92 (29%), Gaps = 8/92 (8%)
Query: 707 FTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDL 766
T L Y D S N L+ L +L+ L L+ L I +
Sbjct: 229 VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQA 282
Query: 767 SHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGI 798
+ + + L LD ++ +
Sbjct: 283 EGCRKIKELD--VTHNTQLYLLDCQAAGITEL 312
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 5e-04
Identities = 14/83 (16%), Positives = 30/83 (36%), Gaps = 5/83 (6%)
Query: 716 LDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSI 775
+ + T + L L L+ ++ +T L + L + NN ++
Sbjct: 23 EVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNIT-TL 79
Query: 776 PGSLGGLSFLSDLDVSNNNLSGI 798
L + L+ L +N L+ +
Sbjct: 80 D--LSQNTNLTYLACDSNKLTNL 100
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-38
Identities = 64/300 (21%), Positives = 125/300 (41%), Gaps = 31/300 (10%)
Query: 936 IGSGGFGEVYKAQLR-----DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLL 990
+G G FG V + G++VA+K+L H R+F E++ + + +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 991 GYCKIGEER--LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHS 1048
G + LV EY+ G L L +LD + + +G+ +L
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRH----RARLDASRLLLYSSQICKGMEYLGSR 146
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV---PPE- 1104
+HRD+ + N+L++ +++DFG+A+L+ + V +P + PE
Sbjct: 147 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP--IFWYAPES 201
Query: 1105 -YYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162
F + + DV+S+GV+L EL + + PS + ++G + + R+ E+L
Sbjct: 202 LSDNIF--SRQSDVWSFGVVLYELFTYCDKSCSPSA--EFLRMMGCERDVPALSRLLELL 257
Query: 1163 DPELTMQTSDE--TELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGDSLDSFS 1220
+ + E+++ ++ C P RP+ + L + G +F+
Sbjct: 258 EEGQRLPAPPACPAEVHELMK---LCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFT 314
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-37
Identities = 72/388 (18%), Positives = 135/388 (34%), Gaps = 56/388 (14%)
Query: 152 SLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQIS 211
+++ + +T +LP ++ + + N+++ L L++SGNQ++
Sbjct: 41 GNAVLNVGESGLT-TLPDCLP----AHITTLVIPDNNLTSLPALPP-ELRTLEVSGNQLT 94
Query: 212 DSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVAD 271
L L++ + LP + + + N L+ +P
Sbjct: 95 S---LPVLPPGLLELSIFSNPLTHLPALP-------SGLCKLWIFGNQLT-SLPVLP--- 140
Query: 272 SSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNM 331
L+ L +S N + L + N L T P L+ L++
Sbjct: 141 --PGLQELSVSDNQLASLPALP-----SELCKLWAYNNQL--TSLPMLPSG---LQELSV 188
Query: 332 SHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELP 391
S N L +P L +L +N+ +P L+EL +S NRLT LP
Sbjct: 189 SDNQLAS-LPT----LPSELYKLWAYNNRLT-SLPALPSG----LKELIVSGNRLT-SLP 237
Query: 392 STFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRV 451
S L L + SGN L ++ S L+ L V N ++ +P SL + +
Sbjct: 238 ---VLPSELKELMV-----SGNRLTSLPMLPSGLLSLSVYRNQLTR-LPESLIHLSSETT 288
Query: 452 LDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLA 511
++L N + + P ++ + + P E + L
Sbjct: 289 VNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREG 348
Query: 512 GPVPSEIW----SLPNLSDLVMWANNLT 535
P P++ W N ++ + L+
Sbjct: 349 EPAPADRWHMFGQEDNADAFSLFLDRLS 376
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-37
Identities = 64/333 (19%), Positives = 120/333 (36%), Gaps = 60/333 (18%)
Query: 315 EFPASLKNCQL--LETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQA 372
++ C LN+ + L +P L ++ L + N +P +
Sbjct: 29 AVVQKMRACLNNGNAVLNVGESGLTT-LPDCL---PAHITTLVIPDNNLT-SLPALPPE- 82
Query: 373 CGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPF 432
LR L++S N+LT LP L + L S L L++
Sbjct: 83 ---LRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPAL--------PSGLCKLWIFG 130
Query: 433 NNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCS--------------PPNFPALEK 478
N ++ +P+ L+ L +S N ++P+ P L++
Sbjct: 131 NQLTS-LPVLPPG---LQELSVSDNQLA-SLPALPSELCKLWAYNNQLTSLPMLPSGLQE 185
Query: 479 IVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEI 538
+ + +N L+ ++P L + SL P+ L +L++ N LT +
Sbjct: 186 LSVSDNQLA-SLPTLPSELYKLWAYNNRLTSL----PALP---SGLKELIVSGNRLT-SL 236
Query: 539 PEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLA 598
P L+ L+++ N LT ++P + +S+ NQLT +P + +L
Sbjct: 237 PVLP----SELKELMVSGNRLT-SLPMLPSGLL---SLSVYRNQLT-RLPESLIHLSSET 287
Query: 599 ILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNL 631
+ L N L+ + Q R + S +
Sbjct: 288 TVNLEGNPLSERTLQ---ALREITSAPGYSGPI 317
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-36
Identities = 77/370 (20%), Positives = 131/370 (35%), Gaps = 56/370 (15%)
Query: 275 SLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHN 334
L++ + T L +++ + + N L T PA L TL +S N
Sbjct: 41 GNAVLNVGESGLT----TLPDCLPAHITTLVIPDNNL--TSLPALPPE---LRTLEVSGN 91
Query: 335 ALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTF 394
L +P L L S +P L +L + N+LT LP
Sbjct: 92 QLTS-LPV-LPPGLLELSIFSNPLTH----LPALPSG----LCKLWIFGNQLT-SLPVLP 140
Query: 395 ASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDL 454
L +S N L ++ + S L L+ N ++ +P+ + L+ L +
Sbjct: 141 PGLQELS--------VSDNQLASLPALPSELCKLWAYNNQLTS-LPMLPSG---LQELSV 188
Query: 455 SSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPV 514
S N ++P+ L K+ NN L+ ++P LK + +S N L +
Sbjct: 189 SDNQLA-SLPTLPSE------LYKLWAYNNRLT-SLPALPS---GLKELIVSGNRLTS-L 236
Query: 515 PSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNML 574
P L +L++ N LT +P L +L + N LT +P+S+ ++
Sbjct: 237 PVLP---SELKELMVSGNRLT-SLPMLP----SGLLSLSVYRNQLT-RLPESLIHLSSET 287
Query: 575 WVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGP 634
V+L N L+ E + A + + G R L L + + P
Sbjct: 288 TVNLEGNPLS-ERTLQALREITSAPGY--SGPIIRFDMAGASAPRETRALHLAAADWLVP 344
Query: 635 LPSELANQAG 644
A
Sbjct: 345 AREGEPAPAD 354
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-27
Identities = 65/315 (20%), Positives = 104/315 (33%), Gaps = 76/315 (24%)
Query: 98 SLNSHVTSLNLNNSGLSGSLNLTTL-TALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTM 156
L +H+T+L + ++ NLT+L P L L + GN + L L
Sbjct: 58 CLPAHITTLVIPDN------NLTSLPALPPELRTLEVSGNQLT--SLPVLPPGLLELSIF 109
Query: 157 DLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALL 216
++ G L + + N ++ + L +L +S NQ++ L
Sbjct: 110 SNPLTHLPALPSG---------LCKLWIFGNQLTSLPVLPP-GLQELSVSDNQLAS---L 156
Query: 217 TYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSL 276
S L N N+L +P L
Sbjct: 157 PALPSELCKLWAYN---NQLT-------------------------SLPMLP-----SGL 183
Query: 277 KYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNAL 336
+ L +S N + L + N L T PA L+ L +S N L
Sbjct: 184 QELSVSDNQLASLPTLP-----SELYKLWAYNNRL--TSLPALPSG---LKELIVSGNRL 233
Query: 337 QGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFAS 396
+P LK+L ++ N+ +P L L + N+LT LP +
Sbjct: 234 T-SLPVLP----SELKELMVSGNRLT-SLPMLPSG----LLSLSVYRNQLT-RLPESLIH 282
Query: 397 CSSLHSLNLGSNMLS 411
SS ++NL N LS
Sbjct: 283 LSSETTVNLEGNPLS 297
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-26
Identities = 51/263 (19%), Positives = 94/263 (35%), Gaps = 53/263 (20%)
Query: 395 ASCSSLHSLNLGSNML----------------SGNFLNTVVSKISSLIYLYVPFNNISGP 438
+ LN+G + L N L ++ + L L V N ++
Sbjct: 37 CLNNGNAVLNVGESGLTTLPDCLPAHITTLVIPDNNLTSLPALPPELRTLEVSGNQLTS- 95
Query: 439 VPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCK 498
+P+ +L + L K+ + N L+ ++P+
Sbjct: 96 LPVLPPGLLELSIFSNPLTHLPALPSG----------LCKLWIFGNQLT-SLPVLPP--- 141
Query: 499 NLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNH 558
L+ + +S N LA +P+ L L + N LT +P L+ L +++N
Sbjct: 142 GLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLT-SLPMLP----SGLQELSVSDNQ 192
Query: 559 LTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKC 618
L ++P + + +N+LT +PA L + L + N LT +P
Sbjct: 193 LA-SLPTLPSELYKL---WAYNNRLT-SLPALPSGLKE---LIVSGNRLT-SLPVLPS-- 241
Query: 619 RSLVWLDLNSNNLSGPLPSELAN 641
L L ++ N L+ LP +
Sbjct: 242 -ELKELMVSGNRLTS-LPMLPSG 262
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 6e-16
Identities = 30/166 (18%), Positives = 55/166 (33%), Gaps = 33/166 (19%)
Query: 492 LELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLET 551
+ +++ + L +P + +++ LV+ NNLT +P L T
Sbjct: 34 MRACLNNGNAVLNVGESGLTT-LPDCL--PAHITTLVIPDNNLT-SLPALP----PELRT 85
Query: 552 LILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTG----------------EIPAGIGNLV 595
L ++ N LT ++P + S L +P L
Sbjct: 86 LEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQ 144
Query: 596 KLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELAN 641
+ L + +N L +P L L +N L+ LP +
Sbjct: 145 E---LSVSDNQLA-SLPALPS---ELCKLWAYNNQLTS-LPMLPSG 182
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 9e-13
Identities = 26/107 (24%), Positives = 42/107 (39%), Gaps = 15/107 (14%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
L++ + L+ TLP+ + + L + N LT +P L+ L++S N
Sbjct: 41 GNAVLNVGESGLT-TLPDCLPAH--ITTLVIPDNNLT-SLPALPPELR---TLEVSGNQL 93
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIP-------SGGQLTTFPAS 811
S+P GL LS +L + G QLT+ P
Sbjct: 94 T-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVL 139
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 4e-11
Identities = 31/134 (23%), Positives = 44/134 (32%), Gaps = 28/134 (20%)
Query: 711 GSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTG----------------HIPDS 754
L L++S N L+ +LP L L + + L +P
Sbjct: 81 PELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVL 139
Query: 755 FGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYE 814
GL+ L +S N S+P L L NN L+ + L S
Sbjct: 140 PPGLQ---ELSVSDNQLA-SLPALPSE---LCKLWAYNNQLTSLPMLPSGLQELSVS--- 189
Query: 815 NNSGLCGLPLLPCS 828
+N L LP LP
Sbjct: 190 DNQ-LASLPTLPSE 202
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 3e-10
Identities = 31/118 (26%), Positives = 47/118 (39%), Gaps = 16/118 (13%)
Query: 711 GSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNN 770
L L + N L+ +LP L Q L++ N+L +P L L +N
Sbjct: 121 SGLCKLWIFGNQLT-SLPVLPPGL---QELSVSDNQLA-SLPALPSELC---KLWAYNNQ 172
Query: 771 FQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPLLPCS 828
S+P GL +L VS+N L+ + +L + N+ L LP LP
Sbjct: 173 LT-SLPMLPSGLQ---ELSVSDNQLASLPTLPSELYKL----WAYNNRLTSLPALPSG 222
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 1e-09
Identities = 29/113 (25%), Positives = 41/113 (36%), Gaps = 26/113 (23%)
Query: 711 GSLIYLDLSYNSLSGTLPENFGSLNYL-----------------QVLNLGHNKLTGHIPD 753
L L +S N L+ +LP L L + L + N+LT +P
Sbjct: 181 SGLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLT-SLPV 238
Query: 754 SFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLT 806
LK L +S N S+P GL L V N L+ + S L+
Sbjct: 239 LPSELK---ELMVSGNRLT-SLPMLPSGLLS---LSVYRNQLTRLPESLIHLS 284
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 1e-06
Identities = 17/107 (15%), Positives = 35/107 (32%), Gaps = 2/107 (1%)
Query: 711 GSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNN 770
L+ L + N L+ LPE+ L+ +NL N L+ + + +
Sbjct: 261 SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIR 319
Query: 771 FQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNS 817
F + S + L ++ + + E+N+
Sbjct: 320 FDMA-GASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNA 365
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 27/152 (17%), Positives = 48/152 (31%), Gaps = 16/152 (10%)
Query: 104 TSLNLNNSGLSGSLNLTTLTALP-YLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNN 162
L ++ LT+L LP L+ L + GN L++ L+++ + N
Sbjct: 224 KELIVSG------NRLTSLPVLPSELKELMVSGNR-----LTSLPMLPSGLLSLSVYRNQ 272
Query: 163 ITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYSLSN 222
+T LP L+ + VNL N +S +L + I + S
Sbjct: 273 LT-RLP--ESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASA-P 328
Query: 223 CQNLNLLNFSDNKLPGKLNATSVNCKSISTID 254
+ L + + L
Sbjct: 329 RETRALHLAAADWLVPAREGEPAPADRWHMFG 360
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-37
Identities = 92/502 (18%), Positives = 173/502 (34%), Gaps = 50/502 (9%)
Query: 155 TMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISG---GSLHIGPSLLQLDLSGNQIS 211
+D S N + +P + + +N+S N IS + L L +S N+I
Sbjct: 4 LVDRSKNGLI-HVPKDLS----QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ 58
Query: 212 DSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNC---KSISTIDLSYNLLSGEIPASF 268
L Q L L+ S NKL ++C ++ +DLS+N +P
Sbjct: 59 --YLDISVFKFNQELEYLDLSHNKL------VKISCHPTVNLKHLDLSFNAFD-ALPICK 109
Query: 269 VADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLET 328
+ LK+L LS +L++ + + Q T
Sbjct: 110 EFGNMSQLKFLGLSTT----HLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNT 165
Query: 329 LNMSHNALQGGIPGFLLG---------SFRNLKQLSLAHNQFAGEIPPELGQACGTLREL 379
++ F+L N+K + + Q L L
Sbjct: 166 ESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL 225
Query: 380 DLSSNRLTGELPST---FASCSSLHSLNLGSNMLSGN----FLNTVVSKISSLIYLYVPF 432
L++ T +++ ++ + L G + + + +L V
Sbjct: 226 TLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVS 285
Query: 433 NNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPL 492
+ P + + + + + +G + S + NN L+ TV
Sbjct: 286 DVFGFPQSYIYEIFSNMNIKNFTVSGTR-MVHMLCPS--KISPFLHLDFSNNLLTDTVFE 342
Query: 493 ELGSCKNLKTIDLSFNSLA--GPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLE 550
G L+T+ L N L + + +L L + N+++ + +G C +L
Sbjct: 343 NCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402
Query: 551 TLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQ 610
+L +++N LT I + + +L L SN++ IP + L L L + +N L
Sbjct: 403 SLNMSSNILTDTIFRCLPPRIKVLD--LHSNKIK-SIPKQVVKLEALQELNVASNQLK-S 458
Query: 611 VPQG-LGKCRSLVWLDLNSNNL 631
VP G + SL + L++N
Sbjct: 459 VPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-31
Identities = 79/468 (16%), Positives = 166/468 (35%), Gaps = 51/468 (10%)
Query: 104 TSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNI 163
L ++++ + L+++ LE+L+L N +S T +L +DLS N
Sbjct: 48 RILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKLVK--ISCHPTV--NLKHLDLSFNAF 102
Query: 164 TGSLPGRSFLLSCDRLSYVNLSHNSISGGSL----HIGPSLLQLDLSGNQISDSALLTYS 219
+LP + +L ++ LS + S+ H+ S + L L
Sbjct: 103 D-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQ 161
Query: 220 LSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSG----- 274
N ++L+++ ++ + L+ + ++ ++ L + +
Sbjct: 162 DFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPK 221
Query: 275 ----SLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTE-FPASLKNCQLLETL 329
+L ++ + N+F + S+ + G F S + + L
Sbjct: 222 LSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIH 281
Query: 330 NMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGE 389
+ + ++ F N+ + + + LD S+N LT
Sbjct: 282 QVVSDVFG-FPQSYIYEIFSNMNIKNFTVSG-TRMVHMLCPSKISPFLHLDFSNNLLTDT 339
Query: 390 LPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQL 449
+ + L +L L N ++ L + T L
Sbjct: 340 VFENCGHLTELETLILQMN------------QLKEL-----------SKIAEMTTQMKSL 376
Query: 450 RVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNS 509
+ LD+S N + G CS +L + + +N L+ T+ L +K +DL N
Sbjct: 377 QQLDISQNSVSYDEKKGDCSWT--KSLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSNK 432
Query: 510 LAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNN 557
+ +P ++ L L +L + +N L +P+GI +L+ + L+ N
Sbjct: 433 IKS-IPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-29
Identities = 85/457 (18%), Positives = 154/457 (33%), Gaps = 33/457 (7%)
Query: 182 VNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLN 241
V+ S N + + L++S N IS+ L T + + L +L S N++
Sbjct: 5 VDRSKNGLIHVPKDLSQKTTILNISQNYISE--LWTSDILSLSKLRILIISHNRIQYLDI 62
Query: 242 ATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNL 301
+ + + +DLS+N L +I + +LK+LDLS N F +FG L
Sbjct: 63 SVFKFNQELEYLDLSHNKLV-KISC----HPTVNLKHLDLSFNAFDALPICKEFGNMSQL 117
Query: 302 SVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQF 361
+ LS L + L + + ++ SL
Sbjct: 118 KFLGLSTTHLEKSSV----LPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173
Query: 362 -AGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVS 420
E L + T+ L+LS + + L++ + + + L
Sbjct: 174 TNKEFHFILDVSVKTVANLELS------NIKCVLEDNKCSYFLSILAKLQTNPKL----- 222
Query: 421 KISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGF--CSPPNFPALEK 478
S+L + S L L T + +S+ G + S + AL
Sbjct: 223 --SNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSI 280
Query: 479 IVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEI 538
+ ++ N+ + + + + L N LT +
Sbjct: 281 HQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT-DT 339
Query: 539 PEGICVNGGNLETLILNNNHLT--GAIPKSIASCTNMLWVSLSSNQLTGEIPAGI-GNLV 595
C + LETLIL N L I + ++ + +S N ++ + G
Sbjct: 340 VFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTK 399
Query: 596 KLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLS 632
L L + +N LT + + L + LDL+SN +
Sbjct: 400 SLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK 434
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-26
Identities = 76/401 (18%), Positives = 135/401 (33%), Gaps = 25/401 (6%)
Query: 252 TIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGL 311
+D S N L +P D S L++S N + + D L ++ +S N +
Sbjct: 4 LVDRSKNGLI-HVPK----DLSQKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRI 57
Query: 312 SGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQ 371
+ + K Q LE L++SHN L I NLK L L+ N F +
Sbjct: 58 QYLD-ISVFKFNQELEYLDLSHNKLVK-IS---CHPTVNLKHLDLSFNAFDALPICKEFG 112
Query: 372 ACGTLRELDLSSNRLTGELPSTFASCSSLH-SLNLGSNMLS----GNFLNTVVSKISSLI 426
L+ L LS+ L A + L LG + + +
Sbjct: 113 NMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVF 172
Query: 427 YLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYL 486
F+ I ++ N + + + S P L + L N
Sbjct: 173 PTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIET 232
Query: 487 SGTVPLELGSCKNLKTI---DLSFNSLAGPVPSEI--WSLPNLSDLVMW--ANNLTGEIP 539
+ + + T+ +S L G + +S +L L + +++ G
Sbjct: 233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQ 292
Query: 540 EGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAI 599
I N+ + + + L + S+N LT + G+L +L
Sbjct: 293 SYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELET 352
Query: 600 LQLGNNSLT--GQVPQGLGKCRSLVWLDLNSNNLSGPLPSE 638
L L N L ++ + + +SL LD++ N++S
Sbjct: 353 LILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKG 393
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 8e-24
Identities = 83/469 (17%), Positives = 145/469 (30%), Gaps = 85/469 (18%)
Query: 375 TLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNN 434
L++S N ++ S S S L L + N + +V L YL + N
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNK 80
Query: 435 ISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLEL 494
+ +S L+ LDLS N F +P E
Sbjct: 81 LVK---ISCHPTVNLKHLDLSFNAFD-ALPIC-------------------------KEF 111
Query: 495 GSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLIL 554
G+ LK + LS L I L L++ + + T L
Sbjct: 112 GNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPE---GLQDFNTESL 168
Query: 555 NNNHLTGAIPKSIASCTNMLWVSLSSNQLTG-----------EIPAGIGNLVKLAILQLG 603
+ T I + +L + + I A + KL+ L L
Sbjct: 169 HIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLN 228
Query: 604 NNSLTGQVPQGLGKC---RSLVWLDLNSNNLSGPLPSELANQAGVVMPGI----VSGKQF 656
N T + + ++ + +++ L G L + +G + + V F
Sbjct: 229 NIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF 288
Query: 657 AFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYL 716
F ++ + + M+ + ++L
Sbjct: 289 GFPQSYIYEIFS----NMNIKNFTVSGTRMVHML---------------CPSKISPFLHL 329
Query: 717 DLSYNSLSGTLPENFGSLNYLQVLNLGHNKLT--GHIPDSFGGLKAIGVLDLSHNNFQGS 774
D S N L+ T+ EN G L L+ L L N+L I + +K++ LD+S N+
Sbjct: 330 DFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYD 389
Query: 775 IP-GSLGGLSFLSDLDVSNNNLSGIIP------------SGGQLTTFPA 810
G L L++S+N L+ I ++ + P
Sbjct: 390 EKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKSIPK 438
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 3e-19
Identities = 64/398 (16%), Positives = 124/398 (31%), Gaps = 40/398 (10%)
Query: 410 LSGNFLNTVVSKI-SSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFC 468
S N L V + L + N IS + + ++LR+L +S N S F
Sbjct: 7 RSKNGLIHVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFK 66
Query: 469 SPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLV 528
LE + L +N L + NLK +DLSFN+ +LP +
Sbjct: 67 FNQE---LEYLDLSHNKLVK---ISCHPTVNLKHLDLSFNAFD--------ALPICKEF- 111
Query: 529 MWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNM-LWVSLSSNQLTGEI 587
N++ L+ L L+ HL + IA + + L E
Sbjct: 112 ---GNMS------------QLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED 156
Query: 588 PAGIGNLV--KLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGV 645
P G+ + L I+ N + + +L ++ L+ A +
Sbjct: 157 PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKL 216
Query: 646 VMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMY 705
+S + + + + + F + + ++ Y
Sbjct: 217 QTNPKLSNLTLNNIE------TTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDY 270
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
+ T+ +L + + + + + + N + + LD
Sbjct: 271 SGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLD 330
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGG 803
S+N ++ + G L+ L L + N L +
Sbjct: 331 FSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAE 368
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 7e-18
Identities = 60/326 (18%), Positives = 102/326 (31%), Gaps = 66/326 (20%)
Query: 89 PCSWQGVSCSLNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKT 148
Q N + ++ + L L T + Y
Sbjct: 213 LAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFS------------------- 253
Query: 149 SSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGN 208
+S+ + G L R F S L +++ S + S
Sbjct: 254 ---------ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSD--VFGFPQSYIYEIFS-- 300
Query: 209 QISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASF 268
N+N+ NF+ + +D S NLL+ + +
Sbjct: 301 ----------------NMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENC 344
Query: 269 VADSSGSLKYLDLSHNNFT------GKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKN 322
L+ L L N + + +L + +SQN +S E
Sbjct: 345 --GHLTELETLILQMNQLKELSKIAEMTTQMK-----SLQQLDISQNSVSYDEKKGDCSW 397
Query: 323 CQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLS 382
+ L +LNMS N L I L +K L L N+ IP ++ + L+EL+++
Sbjct: 398 TKSLLSLNMSSNILTDTIFRCLP---PRIKVLDLHSNKIK-SIPKQVVKL-EALQELNVA 452
Query: 383 SNRLTGELPSTFASCSSLHSLNLGSN 408
SN+L F +SL + L +N
Sbjct: 453 SNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 6e-10
Identities = 31/93 (33%), Positives = 42/93 (45%), Gaps = 4/93 (4%)
Query: 707 FTTNGSLIYLDLSYNSLSGTLP-ENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
T SL LD+S NS+S + L LN+ N LT I I VLD
Sbjct: 370 TTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLD 427
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGI 798
L N + SIP + L L +L+V++N L +
Sbjct: 428 LHSNKIK-SIPKQVVKLEALQELNVASNQLKSV 459
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 5e-09
Identities = 31/164 (18%), Positives = 47/164 (28%), Gaps = 6/164 (3%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDS--FGGLKAIGV 763
F N L YLDLS+N L + L+ L+L N +P FG + +
Sbjct: 64 VFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKF 119
Query: 764 LDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLP 823
L LS + + S + L+ L V G S +
Sbjct: 120 LGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFH 179
Query: 824 LLPCSSGNHAATVHPHENKQNVETGVVIGIAFFLLIILGLTLAL 867
+ S A + K +E L +
Sbjct: 180 FILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLS 223
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 6e-07
Identities = 24/91 (26%), Positives = 44/91 (48%), Gaps = 5/91 (5%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
+ SL+ L++S N L+ T+ ++VL+L NK+ IP L+A+ L+
Sbjct: 394 DCSWTKSLLSLNMSSNILTDTIFRCLPPR--IKVLDLHSNKIK-SIPKQVVKLEALQELN 450
Query: 766 LSHNNFQGSIP-GSLGGLSFLSDLDVSNNNL 795
++ N + S+P G L+ L + + N
Sbjct: 451 VASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 18/62 (29%), Positives = 30/62 (48%), Gaps = 3/62 (4%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPD-SFGGLKAIGVLDLSHNN 770
+ LDL N + ++P+ L LQ LN+ N+L +PD F L ++ + L N
Sbjct: 422 RIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNP 479
Query: 771 FQ 772
+
Sbjct: 480 WD 481
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-37
Identities = 73/305 (23%), Positives = 137/305 (44%), Gaps = 41/305 (13%)
Query: 936 IGSGGFGEVYKAQLRDGSV-VAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCK 994
+G G +GEVY+ + S+ VA+K L T + + EF+ E + +IKH NLV LLG C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 995 IGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHII 1054
++ E+M +G+L L + ++ +A + + +L + I
Sbjct: 287 REPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKK---NFI 340
Query: 1055 HRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP-GYVPPEYYQSFRCTT 1113
HR++ + N L+ EN +V+DFG++RL+ + A P + PE + +
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 1114 KGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSD 1172
K DV+++GV+L E+ + G P G D + V + L ++ R+ E +
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYP----GIDLSQV--YELLEKDYRM------ERPEGCPE 446
Query: 1173 ETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGDSLDSFSLKDTVIEELRER 1232
++Y+ + C P RP+ F E+ + ++ + ++ +E+ +
Sbjct: 447 --KVYE---LMRACWQWNPSDRPS-------FAEIH-----QAFETMFQESSISDEVEKE 489
Query: 1233 ESSSG 1237
G
Sbjct: 490 LGKRG 494
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 78/312 (25%), Positives = 138/312 (44%), Gaps = 55/312 (17%)
Query: 936 IGSGGFGEVYKAQLRDGSV-VAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCK 994
+G G +GEVY+ + S+ VA+K L EF+ E + +IKH NLV LLG C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 995 IGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHII 1054
++ E+M +G+L L + ++ +A + + +L + I
Sbjct: 80 REPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 1055 HRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP-----PE--YYQ 1107
HRD+ + N L+ EN +V+DFG++RL+ DT+ A P PE Y
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTG-DTY-----TAHAGAKFPIKWTAPESLAYN 187
Query: 1108 SFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD-PE 1165
F + K DV+++GV+L E+ + G P G D + V + L ++ R ++ PE
Sbjct: 188 KF--SIKSDVWAFGVLLWEIATYGMSPYP----GIDLSQV--YELLEKDYR----MERPE 235
Query: 1166 LTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGDSLDSFSLKDTV 1225
+ ++Y+ + C P RP+ F E+ + ++ + ++
Sbjct: 236 GCPE-----KVYE---LMRACWQWNPSDRPS-------FAEIH-----QAFETMFQESSI 275
Query: 1226 IEELRERESSSG 1237
+E+ + G
Sbjct: 276 SDEVEKELGKRG 287
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 78/297 (26%), Positives = 120/297 (40%), Gaps = 49/297 (16%)
Query: 935 MIGSGGFGEVYKAQLRDGS----VVAIKKLIHVTGQGDR-EFMAEMETIGKIKHRNLVPL 989
+IG G FG VY + D + AIK L +T F+ E + + H N++ L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 990 LGYCKIGEERLL-VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHS 1048
+G E + YM G L + + ARG+ +L
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQFIRSP----QRNPTVKDLISFGLQVARGMEYLAEQ 143
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP-----P 1103
+HRD+ + N +LDE+F +V+DFG+AR + + + S +P
Sbjct: 144 ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY---SVQQHRHARLPVKWTAL 197
Query: 1104 E--YYQSFRCTTKGDVYSYGVILLELLS-GKRP---IDPSEFGDDNNLVGWAKQLHREKR 1157
E F TTK DV+S+GV+L ELL+ G P IDP + L + Q R +
Sbjct: 198 ESLQTYRF--TTKSDVWSFGVLLWELLTRGAPPYRHIDPFD------LTHFLAQGRRLPQ 249
Query: 1158 INEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGD 1214
PE LYQ + +C + P RPT ++ +++ GD
Sbjct: 250 ------PEYC-----PDSLYQ---VMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-37
Identities = 75/297 (25%), Positives = 126/297 (42%), Gaps = 49/297 (16%)
Query: 935 MIGSGGFGEVYKAQLRDGS----VVAIKKLIHVTGQGDR-EFMAEMETIGKIKHRNLVPL 989
+IG G FG VY L D A+K L +T G+ +F+ E + H N++ L
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 990 LGYCKIGEE-RLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHS 1048
LG C E L+V YMK G L + + + + A+G+ +L
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP-----P 1103
+HRD+ + N +LDE F +V+DFG+AR + + + + T +P
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK---TGAKLPVKWMAL 201
Query: 1104 E--YYQSFRCTTKGDVYSYGVILLELLS-GKRP---IDPSEFGDDNNLVGWAKQLHREKR 1157
E Q F TTK DV+S+GV+L EL++ G P ++ + + + Q R +
Sbjct: 202 ESLQTQKF--TTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVYLLQGRRLLQ 253
Query: 1158 INEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGD 1214
PE LY+ + +C + RP+ ++++ + G+
Sbjct: 254 ------PEYC-----PDPLYEVML---KCWHPKAEMRPSFSELVSRISAIFSTFIGE 296
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 8e-37
Identities = 75/384 (19%), Positives = 139/384 (36%), Gaps = 34/384 (8%)
Query: 275 SLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHN 334
+ Y+DLS N+ + + F R +L + + Q + + L L + +N
Sbjct: 31 HVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 335 ALQGGIPGFLLGSFRNLKQLSLAHNQF-AGEIPPELGQACGTLRELDLSSNRLTGELPST 393
+ NL+ L+L + + +L L L N + P++
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 394 -FASCSSLHSLNLGSNMLS----GNFLNTVVSKISSL-----IYLYVPFNNISGPVPLSL 443
F + H L+L N + + LN + L + + +
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208
Query: 444 TNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTV-------PLELGS 496
T + LDLS NGF ++ F ++ ++L N+Y G+ + +
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFT 268
Query: 497 CK-----NLKTIDLSFNSLAGPVPSEIWS-LPNLSDLVMWANNLTGEIPEGICVNGGNLE 550
K +KT DLS + + + ++S +L L + N + +I + +L
Sbjct: 269 FKGLEASGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLL 326
Query: 551 TLILNNNHLTGAIPKSI-ASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNNSLT 608
L L+ N L +I + + + + LS N + + L L L L N L
Sbjct: 327 KLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK 384
Query: 609 GQVPQG-LGKCRSLVWLDLNSNNL 631
VP G + SL + L++N
Sbjct: 385 S-VPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-32
Identities = 60/334 (17%), Positives = 115/334 (34%), Gaps = 32/334 (9%)
Query: 326 LETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNR 385
+ +++S N++ + ++L+ L + I + +L L L N+
Sbjct: 32 VNYVDLSLNSIAE-LNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 386 LTGELPSTFASCSSLHSLNLGSNMLSGNFL-NTVVSKISSLIYLYVPFNNISGPVPLSL- 443
F ++L L L L G L ++SL L + NNI P S
Sbjct: 91 FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150
Query: 444 TNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGS------- 496
N + VLDL+ N +I + L + L LG
Sbjct: 151 LNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPF 209
Query: 497 -CKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVN---------- 545
++ T+DLS N + + + + + + +
Sbjct: 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269
Query: 546 ----GGNLETLILNNNHLTGAIPKSI-ASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAI 599
++T L+ + + A+ KS+ + T++ ++L+ N++ +I L L
Sbjct: 270 KGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLK 327
Query: 600 LQLGNNSLTGQVPQGL-GKCRSLVWLDLNSNNLS 632
L L N L + + L LDL+ N++
Sbjct: 328 LNLSQNFLGS-IDSRMFENLDKLEVLDLSYNHIR 360
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-30
Identities = 68/401 (16%), Positives = 136/401 (33%), Gaps = 46/401 (11%)
Query: 116 SLNLTTLTALP-YLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLL 174
+ L + LP ++ +++L NS + + TS + L + + + +F
Sbjct: 19 NRGLHQVPELPAHVNYVDLSLNSIAELN-ETSFSRLQDLQFLKVEQQTPGLVIRNNTF-R 76
Query: 175 SCDRLSYVNLSHNSISGGSLHIG-----PSLLQLDLSGNQISDSALLTYSLSNCQNLNLL 229
L + L +N L G +L L L+ + + L +L +L
Sbjct: 77 GLSSLIILKLDYNQFL--QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEML 134
Query: 230 NFSDNKLPG-KLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHN---- 284
DN + + + +N + +DL++N + + L LS
Sbjct: 135 VLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQD 194
Query: 285 ---NFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIP 341
+ G + + +++ + LS NG + + ++ +
Sbjct: 195 MNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGS 254
Query: 342 GFLLGSFR-------------NLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTG 388
F +F+ +K L+ ++ + + L +L L+ N +
Sbjct: 255 SFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN- 312
Query: 389 ELPS-TFASCSSLHSLNLGSNML----SGNFLNTVVSKISSLIYLYVPFNNISGPVPLSL 443
++ F + L LNL N L S F + L L + +N+I S
Sbjct: 313 KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMF-----ENLDKLEVLDLSYNHIRALGDQSF 367
Query: 444 TNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNN 484
L+ L L +N ++P G +L+KI L N
Sbjct: 368 LGLPNLKELALDTNQLK-SVPDGIFD--RLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-28
Identities = 83/475 (17%), Positives = 142/475 (29%), Gaps = 93/475 (19%)
Query: 150 SCSLVTMDLSSNNITG--SLPGRSFLLSCDRLSYVNLSHNSIS---GGSLHIGPSLLQLD 204
S + + LP ++YV+LS NSI+ S L L
Sbjct: 9 SVIGYNAICINRGLHQVPELP--------AHVNYVDLSLNSIAELNETSFSRLQDLQFLK 60
Query: 205 LSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEI 264
+ + + +L +L N+ ++ + L+ L G +
Sbjct: 61 VEQQTPGLV-IRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAV 119
Query: 265 PASFVADSSGSLKYLDLSHNNFT-----GKFSNLDFGRCGNLSVITLSQNGLSGTEFPAS 319
+ SL+ L L NN F N+ V+ L+ N +
Sbjct: 120 LSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNM-----RRFHVLDLTFNKVKSIC-EED 173
Query: 320 LKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLREL 379
L N Q + +++ L ++ L
Sbjct: 174 LLNFQGKHFTLLRLSSIT-------LQDMNEYWLGWEKCGNPFK---------NTSITTL 217
Query: 380 DLSSNRLTGELPSTF---ASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNIS 436
DLS N + F + + + SL L ++ G+ N
Sbjct: 218 DLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF---------------GHTNFK 262
Query: 437 GPVPLSLTN--CTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLEL 494
P + + ++ DLS + + +F LE++ L N
Sbjct: 263 DPDNFTFKGLEASGVKTCDLSKSKIF-ALLKS--VFSHFTDLEQLTLAQN---------- 309
Query: 495 GSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLIL 554
+ ID + W L +L L + N L I + N LE L L
Sbjct: 310 ----EINKID----------DNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDL 354
Query: 555 NNNHLTGAIPKSI-ASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNNSL 607
+ NH+ A+ N+ ++L +NQL +P GI L L + L N
Sbjct: 355 SYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-28
Identities = 63/366 (17%), Positives = 120/366 (32%), Gaps = 24/366 (6%)
Query: 445 NCTQLRVLDLSSNGFTGTIPSGFCSPPNFPA-LEKIVLPNNYLSGTVPLELGSCKNLKTI 503
+ + G P PA + + L N ++ ++L+ +
Sbjct: 9 SVIGYNA-ICINRGLH--------QVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFL 59
Query: 504 DLSFNSLAGPVPSEI-WSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGA 562
+ + + + L +L L + N ++ G NLE L L +L GA
Sbjct: 60 KVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGA 118
Query: 563 -IPKSI-ASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNNSLTGQVPQGL---G 616
+ + T++ + L N + PA N+ + +L L N + + +
Sbjct: 119 VLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNF 177
Query: 617 KCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGA-GGLVE 675
+ + L L+S L L + S N + +
Sbjct: 178 QGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIA 237
Query: 676 FEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFT--TNGSLIYLDLSYNSLSGTLPEN-FG 732
I+ L + S + +TF + DLS + + L ++ F
Sbjct: 238 GTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFS 296
Query: 733 SLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSN 792
L+ L L N++ ++F GL + L+LS N L L LD+S
Sbjct: 297 HFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSY 356
Query: 793 NNLSGI 798
N++ +
Sbjct: 357 NHIRAL 362
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-27
Identities = 68/380 (17%), Positives = 130/380 (34%), Gaps = 27/380 (7%)
Query: 423 SSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLP 482
+ + Y+ + N+I+ S + L+ L + I + +L + L
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFR--GLSSLIILKLD 87
Query: 483 NNYLSGTVPLELGSCKNLKTIDLSFNSL-AGPVPSEIWS-LPNLSDLVMWANNLTGEIPE 540
N NL+ + L+ +L + + L +L LV+ NN+ P
Sbjct: 88 YNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPA 147
Query: 541 GICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAIL 600
+N L L N + +I + ++ T + L + +
Sbjct: 148 SFFLNMRRFHVLDLTFNKVK-SICEED-------LLNFQGKHFT------LLRLSSITLQ 193
Query: 601 QLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVR 660
+ L + K S+ LDL+ N + + + +
Sbjct: 194 DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG 253
Query: 661 NEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSY 720
+ G F+G+ ++ ++I + F+ L L L+
Sbjct: 254 SSFGHTNFKDPDNFTFKGLEASGVKTC----DLSKSKI-FALLKSVFSHFTDLEQLTLAQ 308
Query: 721 NSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIP-GS 778
N ++ + +N F L +L LNL N L F L + VLDLS+N+ + ++ S
Sbjct: 309 NEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQS 366
Query: 779 LGGLSFLSDLDVSNNNLSGI 798
GL L +L + N L +
Sbjct: 367 FLGLPNLKELALDTNQLKSV 386
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 71/368 (19%), Positives = 127/368 (34%), Gaps = 64/368 (17%)
Query: 98 SLNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMD 157
L +HV ++L+ + ++ LN T+ + L L+ L ++ + + + SL+ +
Sbjct: 27 ELPAHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85
Query: 158 LSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIG-----PSLLQLDLSGNQISD 212
L N L +F L + L+ ++ G L SL L L N I
Sbjct: 86 LDYNQFL-QLETGAFN-GLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK- 142
Query: 213 SALLTYSLSNCQNLNLLNFSDNKLP----------GKLNATSVNCKSISTIDLSYNLLSG 262
N + ++L+ + NK+ + T + SI+ D++ L
Sbjct: 143 KIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW 202
Query: 263 EIPASFVADSSGSLKYLDLSHNNFT---------------------------------GK 289
E + + S+ LDLS N F
Sbjct: 203 EKCGNP--FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTN 260
Query: 290 FSNLDFGRCG-----NLSVITLSQNGLSGTEFPASL-KNCQLLETLNMSHNALQGGIPGF 343
F + D + LS++ + S+ + LE L ++ N + I
Sbjct: 261 FKDPDNFTFKGLEASGVKTCDLSKSKI--FALLKSVFSHFTDLEQLTLAQNEINK-IDDN 317
Query: 344 LLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSL 403
+L +L+L+ N G I + + L LDLS N + +F +L L
Sbjct: 318 AFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKEL 376
Query: 404 NLGSNMLS 411
L +N L
Sbjct: 377 ALDTNQLK 384
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 6e-11
Identities = 26/91 (28%), Positives = 44/91 (48%), Gaps = 4/91 (4%)
Query: 715 YLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIP-DSFGGLKAIGVLDLSHNNFQG 773
Y+DLS NS++ +F L LQ L + I ++F GL ++ +L L +N F
Sbjct: 34 YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL- 92
Query: 774 SIP-GSLGGLSFLSDLDVSNNNL-SGIIPSG 802
+ G+ GL+ L L ++ NL ++
Sbjct: 93 QLETGAFNGLANLEVLTLTQCNLDGAVLSGN 123
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 6e-08
Identities = 27/92 (29%), Positives = 43/92 (46%), Gaps = 4/92 (4%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVL 764
F L+ L+LS N L ++ F +L+ L+VL+L +N + SF GL + L
Sbjct: 318 AFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKEL 376
Query: 765 DLSHNNFQGSIP-GSLGGLSFLSDLDVSNNNL 795
L N + S+P G L+ L + + N
Sbjct: 377 ALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 1e-06
Identities = 29/124 (23%), Positives = 46/124 (37%), Gaps = 7/124 (5%)
Query: 706 TFTTNGSLIYLDLSYNSL-SGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDS-FGGLKAIG 762
F +L L L+ +L L N F L L++L L N + P S F ++
Sbjct: 98 AFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFH 157
Query: 763 VLDLSHNNFQGSIPGSLGGL--SFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLC 820
VLDL+ N + L + L +S+ L + + L N+ +
Sbjct: 158 VLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDM--NEYWLGWEKCGNPFKNTSIT 215
Query: 821 GLPL 824
L L
Sbjct: 216 TLDL 219
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 21/63 (33%), Positives = 30/63 (47%), Gaps = 4/63 (6%)
Query: 712 SLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDS-FGGLKAIGVLDLSHN 769
L LDLSYN + L + F L L+ L L N+L +PD F L ++ + L N
Sbjct: 348 KLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
Query: 770 NFQ 772
+
Sbjct: 406 PWD 408
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-37
Identities = 75/346 (21%), Positives = 138/346 (39%), Gaps = 65/346 (18%)
Query: 890 SGSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQL 949
SS + E L + L +L G G FG V + L
Sbjct: 8 HHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKIL------------GEGEFGSVMEGNL 55
Query: 950 RDGS----VVAIK--KLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYC-----KIGEE 998
+ VA+K KL + + + EF++E + H N++ LLG C + +
Sbjct: 56 KQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPK 115
Query: 999 RLLVYEYMKWGSLESVL-HDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRD 1057
+++ +MK+G L + L + R + G + K + A G+ +L + + +HRD
Sbjct: 116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRD 172
Query: 1058 MKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP-----PE--YYQSFR 1110
+ + N +L ++ V+DFG+++ + + D + G +P E + +
Sbjct: 173 LAARNCMLRDDMTVCVADFGLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVY- 226
Query: 1111 CTTKGDVYSYGVILLELLS-GKRP---IDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166
T+K DV+++GV + E+ + G P + E + + HR K+ PE
Sbjct: 227 -TSKSDVWAFGVTMWEIATRGMTPYPGVQNHE------MYDYLLHGHRLKQ------PED 273
Query: 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTE 1212
+ ELY+ I + C P RPT + ++L
Sbjct: 274 CLD-----ELYE---IMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 35/223 (15%)
Query: 936 IGSGGFGEVYKAQLRDGS------VVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPL 989
+G G FG+V+ A+ + S +VA+K L T ++F E E + ++H ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKK-----------IAIGS 1038
G C G+ ++V+EYMK G L L +D R+ IA
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 1039 ARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP 1098
A G+ +L H +HRD+ + N L+ N ++ DFGM+R V + D + G
Sbjct: 143 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY-----RVGGH 194
Query: 1099 GYVP-----PE--YYQSFRCTTKGDVYSYGVILLELLS-GKRP 1133
+P PE Y+ F TT+ DV+S+GVIL E+ + GK+P
Sbjct: 195 TMLPIRWMPPESIMYRKF--TTESDVWSFGVILWEIFTYGKQP 235
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 72/296 (24%), Positives = 124/296 (41%), Gaps = 36/296 (12%)
Query: 936 IGSGGFGEVYKAQLR-----DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLL 990
+G G FG V + G VVA+KKL H T + R+F E+E + ++H N+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 991 GYCKIGEER--LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHS 1048
G C R L+ EY+ +GSL L ++D + +G+ +L
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP-----P 1103
IHRD+ + N+L++ ++ DFG+ +++ V PG P P
Sbjct: 134 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK----EPGESPIFWYAP 186
Query: 1104 E--YYQSFRCTTKGDVYSYGVILLELLS--GKRPIDPSEFGDDNNLVGWAKQLHREKRIN 1159
E F + DV+S+GV+L EL + K P+EF + + +
Sbjct: 187 ESLTESKF--SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH--LI 242
Query: 1160 EILDPELTMQTSDE--TELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEG 1213
E+L + D E+Y + EC ++ +RP+ + +++ + G
Sbjct: 243 ELLKNNGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRVDQIRDNMAG 295
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 82/285 (28%), Positives = 134/285 (47%), Gaps = 37/285 (12%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI 995
+G+G FGEV+ + VA+K L + D F+AE + +++H+ LV L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVV-T 78
Query: 996 GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIH 1055
E ++ EYM+ GSL L G KL +A A G+AF+ + IH
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 1056 RDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV---PPE--YYQSFR 1110
RD++++N+L+ + +++DFG+ARL+ D + A P + PE Y +F
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFP--IKWTAPEAINYGTF- 187
Query: 1111 CTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQ 1169
T K DV+S+G++L E+++ G+ P G N V + L R R+
Sbjct: 188 -TIKSDVWSFGILLTEIVTHGRIPYP----GMTNPEV--IQNLERGYRM------VRPDN 234
Query: 1170 TSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGD 1214
+ ELYQ + C +RP RPT + ++ ++ TEG
Sbjct: 235 CPE--ELYQ---LMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 29/212 (13%)
Query: 936 IGSGGFGEVYKAQLRDGS-----VVAIKKLIHVTGQGDR-EFMAEMETIGKIKHRNLVPL 989
+GSG FG VYK VAIK+L T E + E + + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC 1049
LG C + L+ + M +G L + + + + A+G+ +L
Sbjct: 83 LGIC-LTSTVQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDR- 136
Query: 1050 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP-----PE 1104
++HRD+ + NVL+ +++DFG+A+L+ A + G VP E
Sbjct: 137 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALE 189
Query: 1105 --YYQSFRCTTKGDVYSYGVILLELLS-GKRP 1133
++ + T + DV+SYGV + EL++ G +P
Sbjct: 190 SILHRIY--THQSDVWSYGVTVWELMTFGSKP 219
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-36
Identities = 74/301 (24%), Positives = 116/301 (38%), Gaps = 44/301 (14%)
Query: 936 IGSGGFGEVYKAQLRD-----GSVVAIKKLIHVTGQGDR-EFMAEMETIGKIKHRNLVPL 989
+G G FG+V G +VA+K L G R + E++ + + H +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 990 LGYC--KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH 1047
G C LV EY+ GSL L + G L +A G+A+LH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQ------QICEGMAYLHA 152
Query: 1048 SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP----- 1102
H IHRD+ + NVLLD + ++ DFG+A+ V + V G P
Sbjct: 153 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR----EDGDSPVFWYA 205
Query: 1103 PE--YYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGW----AKQLHRE 1155
PE F DV+S+GV L ELL+ P + + +L
Sbjct: 206 PECLKEYKF--YYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263
Query: 1156 KRINEILD-PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGD 1214
E L P+ E+Y ++ C + RPT ++ + K + +G
Sbjct: 264 LERGERLPRPDKCPA-----EVYHLMK---NCWETEASFRPTFENLIPILKTVHEKYQGQ 315
Query: 1215 S 1215
+
Sbjct: 316 A 316
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 63/204 (30%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI 995
+GSG FG V + + VA+K + + EF E +T+ K+ H LV G C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 996 GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIH 1055
+V EY+ G L + L G L+ + ++ G+AFL IH
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSH----GKGLEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 1056 RDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV---PPE--YYQSFR 1110
RD+ + N L+D + +VSDFGM R V LD S P V PE +Y +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYV--LDDQYVSSVGTKFP--VKWSAPEVFHYFKY- 182
Query: 1111 CTTKGDVYSYGVILLELLS-GKRP 1133
++K DV+++G+++ E+ S GK P
Sbjct: 183 -SSKSDVWAFGILMWEVFSLGKMP 205
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-36
Identities = 91/409 (22%), Positives = 149/409 (36%), Gaps = 65/409 (15%)
Query: 824 LLPCSSGNHAATVHPHENKQNVETGVVIGIAFFLLIILGLTLALYRVKKDQKKDEQREKY 883
+ P H H G+++ L + L + E
Sbjct: 1 MSPIDPMGHHHHHHGRRRASVA-AGILVPRGSPGLDGICSIEELSTSLYKKAGSENL--- 56
Query: 884 IESLPTSGSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGE 943
+ + LS++ L V L H E +IG G FG
Sbjct: 57 --YFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIV-HFNE---------VIGRGHFGC 104
Query: 944 VYKAQLRDGS----VVAIKKLIHVTGQGDR-EFMAEMETIGKIKHRNLVPLLGYCKIGEE 998
VY L D A+K L +T G+ +F+ E + H N++ LLG C E
Sbjct: 105 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 164
Query: 999 -RLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRD 1057
L+V YMK G L + + + + A+G+ FL +HRD
Sbjct: 165 SPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRD 217
Query: 1058 MKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP-----PE--YYQSFR 1110
+ + N +LDE F +V+DFG+AR + + S T +P E Q F
Sbjct: 218 LAARNCMLDEKFTVKVADFGLARDMYDKEFD---SVHNKTGAKLPVKWMALESLQTQKF- 273
Query: 1111 CTTKGDVYSYGVILLELLS-GKRP---IDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166
TTK DV+S+GV+L EL++ G P ++ + + + Q R + PE
Sbjct: 274 -TTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVYLLQGRRLLQ------PEY 320
Query: 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGDS 1215
LY+ + +C + RP+ ++++ + G+
Sbjct: 321 CPD-----PLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-36
Identities = 72/296 (24%), Positives = 124/296 (41%), Gaps = 36/296 (12%)
Query: 936 IGSGGFGEVYKAQL-----RDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLL 990
+G G FG V + G VVA+KKL H T + R+F E+E + ++H N+V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 991 GYCKIGEER--LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHS 1048
G C R L+ EY+ +GSL L ++D + +G+ +L
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGTK 164
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP-----P 1103
IHRD+ + N+L++ ++ DFG+ +++ + V PG P P
Sbjct: 165 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK----EPGESPIFWYAP 217
Query: 1104 E--YYQSFRCTTKGDVYSYGVILLELLS--GKRPIDPSEFGDDNNLVGWAKQLHREKRIN 1159
E F + DV+S+GV+L EL + K P+EF + + +
Sbjct: 218 ESLTESKF--SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH--LI 273
Query: 1160 EILDPELTMQTSDE--TELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEG 1213
E+L + D E+Y + EC ++ +RP+ + +++ G
Sbjct: 274 ELLKNNGRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRVDQIRDQMAG 326
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 65/204 (31%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI 995
IGSG FG V+ + VAIK + + +F+ E E + K+ H LV L G C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 996 GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIH 1055
LV E+M+ G L L + + + G+A+L + +IH
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEA---CVIH 127
Query: 1056 RDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV---PPE--YYQSFR 1110
RD+ + N L+ EN +VSDFGM R V D + ST P V PE + +
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVL--DDQYTSSTGTKFP--VKWASPEVFSFSRY- 182
Query: 1111 CTTKGDVYSYGVILLELLS-GKRP 1133
++K DV+S+GV++ E+ S GK P
Sbjct: 183 -SSKSDVWSFGVLMWEVFSEGKIP 205
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-36
Identities = 98/400 (24%), Positives = 157/400 (39%), Gaps = 95/400 (23%)
Query: 869 RVKKDQKKDEQREKYIESLPTSGSSSWKLSSVPEPLSINVATFEKPL--------RKLTF 920
++ E + P ++ S+ P+ V+ +E P KLT
Sbjct: 26 LRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTL 85
Query: 921 AHLLEATNGFSADSMIGSGGFGEVYKAQLRD--------GSVVAIKKLIHVTGQGDR-EF 971
L G G FG+V A+ VA+K L + D +
Sbjct: 86 GKPL------------GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 133
Query: 972 MAEMETIGKI-KHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVL-----------HDRA 1019
++EME + I KH+N++ LLG C ++ EY G+L L +D
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 193
Query: 1020 KGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1079
+ ++ + ARG+ +L + IHRD+ + NVL+ EN +++DFG+A
Sbjct: 194 RVPEEQMTFKDLVSCTYQLARGMEYL--ASQ-KCIHRDLAARNVLVTENNVMKIADFGLA 250
Query: 1080 RLVNALDTHLSVSTLAGTPGYVP-----PE--YYQSFRCTTKGDVYSYGVILLELLS-GK 1131
R +N +D + T G +P PE + + + T + DV+S+GV++ E+ + G
Sbjct: 251 RDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFTLGG 303
Query: 1132 RP---IDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLD 1188
P I E L K+ HR + P ELY +R +C
Sbjct: 304 SPYPGIPVEE------LFKLLKEGHRMDK------PANCTN-----ELYMMMR---DCWH 343
Query: 1189 DRPFKRPTMIQVMAMFKELQVDTEGDSLDSFSLKDTVIEE 1228
P +RPT FK+L + LD L T EE
Sbjct: 344 AVPSQRPT-------FKQLV-----EDLDRI-LTLTTNEE 370
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-35
Identities = 75/291 (25%), Positives = 125/291 (42%), Gaps = 53/291 (18%)
Query: 868 YRVKKDQKKDEQREKYIESLPTSGSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEAT 927
Y+ K+ + K + R K IES + + + +P +E P L F L
Sbjct: 4 YKYKQ-KPKYQVRWKIIESYEGNSYTFIDPTQLPYNEK-----WEFPRNNLQFGKTL--- 54
Query: 928 NGFSADSMIGSGGFGEVYKAQLRD------GSVVAIKKLIHVTGQGDR-EFMAEMETIGK 980
G+G FG+V +A VA+K L ++ M+E++ +
Sbjct: 55 ---------GAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 981 I-KHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARK------- 1032
+ +H N+V LLG C G L++ EY +G L + L +++ T +A
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 1033 --KIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLS 1090
+ A+G+AFL + IHRD+ + NVLL A++ DFG+AR + +
Sbjct: 166 LLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY-- 220
Query: 1091 VSTLAGTPGYVP-----PE--YYQSFRCTTKGDVYSYGVILLELLS-GKRP 1133
+ +P PE + + T + DV+SYG++L E+ S G P
Sbjct: 221 ---IVKGNARLPVKWMAPESIFDCVY--TVQSDVWSYGILLWEIFSLGLNP 266
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-35
Identities = 66/304 (21%), Positives = 124/304 (40%), Gaps = 54/304 (17%)
Query: 936 IGSGGFGEVYKAQLRDGS----VVAIKKL-IHVTGQGDRE-FMAEMETIGKIKHRNLVPL 989
+G G FG V +AQL+ VA+K L + D E F+ E + + H ++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 990 LGYCKIGEER------LLVYEYMKWGSLESVL-HDRAKGGGTKLDWAARKKIAIGSARGL 1042
+G + +++ +MK G L + L R L + + A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 1043 AFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP 1102
+L + IHRD+ + N +L E+ V+DFG++R + + D + G +P
Sbjct: 151 EYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY-----RQGCASKLP 202
Query: 1103 -----PE--YYQSFRCTTKGDVYSYGVILLELLS-GKRP---IDPSEFGDDNNLVGWAKQ 1151
E + T DV+++GV + E+++ G+ P I+ +E + +
Sbjct: 203 VKWLALESLADNLY--TVHSDVWAFGVTMWEIMTRGQTPYAGIENAE------IYNYLIG 254
Query: 1152 LHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDT 1211
+R K+ P M+ E+Y + ++C P +RP+ + + +
Sbjct: 255 GNRLKQ------PPECME-----EVYD---LMYQCWSADPKQRPSFTCLRMELENILGHL 300
Query: 1212 EGDS 1215
S
Sbjct: 301 SVLS 304
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-35
Identities = 81/281 (28%), Positives = 125/281 (44%), Gaps = 29/281 (10%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI 995
+G G FGEV+ + VAIK L T + F+ E + + K++H LV L
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV-S 249
Query: 996 GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIH 1055
E +V EYM GSL L G L +A A G+A++ + +H
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERM---NYVH 303
Query: 1056 RDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP-GYVPPEYYQSFRCTTK 1114
RD++++N+L+ EN +V+DFG+ARL+ D + A P + PE R T K
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 1115 GDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDE 1173
DV+S+G++L EL + G+ P G N V Q+ R R+ P +
Sbjct: 362 SDVWSFGILLTELTTKGRVPYP----GMVNREV--LDQVERGYRMPC---PPECPE---- 408
Query: 1174 TELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGD 1214
L+ + +C P +RPT + A ++ TE
Sbjct: 409 -SLHD---LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 73/304 (24%), Positives = 124/304 (40%), Gaps = 57/304 (18%)
Query: 936 IGSGGFGEVYKAQLRDGS------VVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPL 989
+G G FG+V+ A+ + +VA+K L + ++F E E + ++H+++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKK----------IAIGSA 1039
G C G L+V+EYM+ G L L +A A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 1040 RGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPG 1099
G+ +L H +HRD+ + N L+ + ++ DFGM+R + + D G
Sbjct: 169 AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY-----YRVGGRT 220
Query: 1100 YVP-----PE--YYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNN--LVGWA 1149
+P PE Y+ F TT+ DV+S+GV+L E+ + GK+P + +N +
Sbjct: 221 MLPIRWMPPESILYRKF--TTESDVWSFGVVLWEIFTYGKQP-----WYQLSNTEAIDCI 273
Query: 1150 KQLHREKRINEILD-PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208
Q L+ P E+Y +R C P +R ++ V A + L
Sbjct: 274 TQGRE-------LERPRACPP-----EVYAIMR---GCWQREPQQRHSIKDVHARLQALA 318
Query: 1209 VDTE 1212
Sbjct: 319 QAPP 322
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-35
Identities = 75/288 (26%), Positives = 126/288 (43%), Gaps = 37/288 (12%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI 995
+G+G FGEV+ A + VA+K + F+AE + ++H LV L
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-T 253
Query: 996 GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIH 1055
E ++ E+M GSL L G+K + A G+AF+ + IH
Sbjct: 254 KEPIYIITEFMAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIH 307
Query: 1056 RDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV---PPEYYQSFRCT 1112
RD++++N+L+ + +++DFG+AR++ D + A P + PE T
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIE--DNEYTAREGAKFP--IKWTAPEAINFGSFT 363
Query: 1113 TKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTS 1171
K DV+S+G++L+E+++ G+ P G N V + L R R M
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPYP----GMSNPEV--IRALERGYR----------MPRP 407
Query: 1172 DE--TELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGDSLD 1217
+ ELY I C +RP +RPT + ++ + TE +
Sbjct: 408 ENCPEELYN---IMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEE 452
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 2e-35
Identities = 64/362 (17%), Positives = 117/362 (32%), Gaps = 40/362 (11%)
Query: 273 SGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMS 332
S + + F + ++ L +N + + LE L ++
Sbjct: 10 SAQDRAVLCHRKRFVAVPEGIP----TETRLLDLGKNRIKTLN-QDEFASFPHLEELELN 64
Query: 333 HNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPS 392
N + + + NL+ L L N+ IP + L +LD+S N++ L
Sbjct: 65 ENIVSA-VEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDY 122
Query: 393 TFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVL 452
F +L SL +G N + + + + L L
Sbjct: 123 MFQDLYNLKSLEVGDN------------DLVYI-------------SHRAFSGLNSLEQL 157
Query: 453 DLSSNGFTGTIPSG-FCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLA 511
L T +IP+ + L + L + ++ LK +++S
Sbjct: 158 TLEKCNLT-SIPTEALS---HLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYL 213
Query: 512 GPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCT 571
+ NL+ L + NLT +P + L L L+ N ++ +
Sbjct: 214 DTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELL 272
Query: 572 NMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNN 630
+ + L QL + L L +L + N LT +L L L+SN
Sbjct: 273 RLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNP 331
Query: 631 LS 632
L+
Sbjct: 332 LA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-35
Identities = 78/345 (22%), Positives = 138/345 (40%), Gaps = 43/345 (12%)
Query: 90 CSWQG--VSCS----------LNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNS 137
CS Q V C + + L+L + + +LN + P+LE L L N
Sbjct: 9 CSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENI 67
Query: 138 FSA------GDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSIS- 190
SA +L +L T+ L SN + +P F L+ +++S N I
Sbjct: 68 VSAVEPGAFNNLF-------NLRTLGLRSNRLK-LIPLGVF-TGLSNLTKLDISENKIVI 118
Query: 191 --GGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATS-VNC 247
+L L++ N + + + S +L L L + + +
Sbjct: 119 LLDYMFQDLYNLKSLEVGDNDLVY--ISHRAFSGLNSLEQLTLEKCNL-TSIPTEALSHL 175
Query: 248 KSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLS 307
+ + L + ++ SF LK L++SH + + NL+ ++++
Sbjct: 176 HGLIVLRLRHLNINAIRDYSF--KRLYRLKVLEISHWPYLDTMTPNCL-YGLNLTSLSIT 232
Query: 308 QNGLSGTEFPA-SLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIP 366
L T P ++++ L LN+S+N + I G +L L+++ L Q A +
Sbjct: 233 HCNL--TAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVE 288
Query: 367 PELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLS 411
P + LR L++S N+LT S F S +L +L L SN L+
Sbjct: 289 PYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-35
Identities = 68/346 (19%), Positives = 129/346 (37%), Gaps = 30/346 (8%)
Query: 150 SCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSIS---GGSLHIGPSLLQLDLS 206
S + ++P + + ++L N I P L +L+L+
Sbjct: 10 SAQDRAVLCHRKRFV-AVPEG---IPTE-TRLLDLGKNRIKTLNQDEFASFPHLEELELN 64
Query: 207 GNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPA 266
N +S + + +N NL L N+L +++ +D+S N + +
Sbjct: 65 ENIVSA--VEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDY 122
Query: 267 SFVADSSGSLKYLDLSHNNFT----GKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKN 322
F +LK L++ N+ FS L+ +L +TL + L+ +L +
Sbjct: 123 MF--QDLYNLKSLEVGDNDLVYISHRAFSGLN-----SLEQLTLEKCNLTSIP-TEALSH 174
Query: 323 CQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLS 382
L L + H + I + LK L ++H + + P L L ++
Sbjct: 175 LHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNC-LYGLNLTSLSIT 232
Query: 383 SNRLTGELPS-TFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPL 441
LT +P L LNL N +S +++ ++ L + + ++ P
Sbjct: 233 HCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPY 290
Query: 442 SLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLS 487
+ LRVL++S N T T+ LE ++L +N L+
Sbjct: 291 AFRGLNYLRVLNVSGNQLT-TLEESVFHS--VGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 8e-30
Identities = 71/352 (20%), Positives = 127/352 (36%), Gaps = 52/352 (14%)
Query: 447 TQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLS 506
T+ R+LDL N F +FP LE++ L N +S P + NL+T+ L
Sbjct: 32 TETRLLDLGKNRIKTLNQDEF---ASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLR 88
Query: 507 FNSLAGPVPSEI-WSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPK 565
N L +P + L NL+ L + N + + + + + NL++L + +N L +
Sbjct: 89 SNRLKL-IPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHR 146
Query: 566 SIASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWL 624
+ + ++ ++L LT IP +L L +L+L + ++ + L L
Sbjct: 147 AFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVL 205
Query: 625 DLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERL 684
+++ + G+ L
Sbjct: 206 EISHWPYLDTMTPNC------------------------------------LYGLNLTSL 229
Query: 685 EGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGH 744
+ C T + L +L+LSYN +S L LQ + L
Sbjct: 230 S----ITHCNLTAVPYL----AVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVG 281
Query: 745 NKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLS 796
+L P +F GL + VL++S N + L L + +N L+
Sbjct: 282 GQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 5e-13
Identities = 24/93 (25%), Positives = 42/93 (45%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
F+ SL L L +L+ E L+ L VL L H + SF L + VL+
Sbjct: 147 AFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLE 206
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGI 798
+SH + ++ + L+ L +++ NL+ +
Sbjct: 207 ISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAV 239
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-12
Identities = 26/99 (26%), Positives = 37/99 (37%), Gaps = 4/99 (4%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPD-SFGGLKAIGV 763
F +L L++ N L + F LN L+ L L LT IP + L + V
Sbjct: 123 MFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIV 180
Query: 764 LDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSG 802
L L H N S L L L++S+ +
Sbjct: 181 LRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPN 219
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 8e-12
Identities = 28/93 (30%), Positives = 41/93 (44%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
F + L L+L+ N +S P F +L L+ L L N+L F GL + LD
Sbjct: 51 EFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLD 110
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGI 798
+S N + L L L+V +N+L I
Sbjct: 111 ISENKIVILLDYMFQDLYNLKSLEVGDNDLVYI 143
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-11
Identities = 24/94 (25%), Positives = 38/94 (40%), Gaps = 2/94 (2%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
F +L L L N L F L+ L L++ NK+ + F L + L+
Sbjct: 75 AFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE 134
Query: 766 LSHNNFQGSIP-GSLGGLSFLSDLDVSNNNLSGI 798
+ N+ I + GL+ L L + NL+ I
Sbjct: 135 VGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSI 167
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-11
Identities = 25/87 (28%), Positives = 38/87 (43%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
LDL N + + F S +L+ L L N ++ P +F L + L L N
Sbjct: 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL 92
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGI 798
+ G GLS L+ LD+S N + +
Sbjct: 93 KLIPLGVFTGLSNLTKLDISENKIVIL 119
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 1e-10
Identities = 21/95 (22%), Positives = 42/95 (44%), Gaps = 2/95 (2%)
Query: 705 YTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVL 764
+ LI L L + +++ +F L L+VL + H + + + L
Sbjct: 170 EALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSL 229
Query: 765 DLSHNNFQGSIP-GSLGGLSFLSDLDVSNNNLSGI 798
++H N ++P ++ L +L L++S N +S I
Sbjct: 230 SITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTI 263
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI 995
+G+G FG V + R VAIK + + D EF+ E + + + H LV L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 996 GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIH 1055
++ EYM G L + L + + ++ + +L +H
Sbjct: 91 QRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLH 143
Query: 1056 RDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV---PPE--YYQSFR 1110
RD+ + N L+++ +VSDFG++R V LD + S + P V PPE Y F
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFP--VRWSPPEVLMYSKF- 198
Query: 1111 CTTKGDVYSYGVILLELLS-GKRP 1133
++K D++++GV++ E+ S GK P
Sbjct: 199 -SSKSDIWAFGVLMWEIYSLGKMP 221
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 78/320 (24%), Positives = 129/320 (40%), Gaps = 53/320 (16%)
Query: 936 IGSGGFGEVYKAQLRDGS------VVAIKKLIHVTGQGDR-EFMAEMETIGKIKHRNLVP 988
+G G FG VY+ + VAIK + +R EF+ E + + ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARK-----KIAIGSARGLA 1043
LLG G+ L++ E M G L+S L A ++A A G+A
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 1044 FLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP- 1102
+L+ + +HRD+ + N ++ E+F ++ DFGM R + D G G +P
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY-----YRKGGKGLLPV 204
Query: 1103 ----PE--YYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHRE 1155
PE F TT DV+S+GV+L E+ + ++P G N V + +
Sbjct: 205 RWMSPESLKDGVF--TTYSDVWSFGVVLWEIATLAEQPY----QGLSNEQV--LRFVMEG 256
Query: 1156 KRINEILD-PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGD 1214
LD P+ L++ +R C P RP+ +++++ KE
Sbjct: 257 GL----LDKPDNCPD-----MLFELMR---MCWQYNPKMRPSFLEIISSIKEEM----EP 300
Query: 1215 SLDSFSLKDTVIEELRERES 1234
S + +L E E
Sbjct: 301 GFREVSFYYSEENKLPEPEE 320
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-35
Identities = 75/295 (25%), Positives = 116/295 (39%), Gaps = 43/295 (14%)
Query: 936 IGSGGFGEVYKAQLRDGS------VVAIKKLIHVTGQGDR-EFMAEMETIGKIKHRNLVP 988
+G G FGEVY+ Q+ VA+K L V + D +F+ E I K H+N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVL--HDRAKGGGTKLDWAARKKIAIGSARGLAFLH 1046
+G R ++ E M G L+S L + L +A A G +L
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 1047 HSCIPHIIHRDMKSSNVLLD---ENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP- 1102
+ H IHRD+ + N LL A++ DFGMAR + G +P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY-----YRKGGCAMLPV 209
Query: 1103 ----PEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKR 1157
PE + T+K D +S+GV+L E+ S G P N V + + R
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY----PSKSNQEV--LEFVTSGGR 263
Query: 1158 INEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTE 1212
+DP +Y+ + +C +P RP ++ + D +
Sbjct: 264 ----MDP--PKNCPG--PVYRIMT---QCWQHQPEDRPNFAIILERIEYCTQDPD 307
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 59/224 (26%), Positives = 91/224 (40%), Gaps = 36/224 (16%)
Query: 936 IGSGGFGEVYKAQLRDGS------VVAIKKLIHVTGQGDR-EFMAEMETIGKIKHRNLVP 988
+G FG+VYK L + VAIK L R EF E +++H N+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARK-----------KIAIG 1037
LLG + +++ Y G L L R+ R +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 1038 SARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGT 1097
A G+ +L H++H+D+ + NVL+ + ++SD G+ R V A D
Sbjct: 137 IAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY-----YKLLG 188
Query: 1098 PGYVP-----PE--YYQSFRCTTKGDVYSYGVILLELLS-GKRP 1133
+P PE Y F + D++SYGV+L E+ S G +P
Sbjct: 189 NSLLPIRWMAPEAIMYGKF--SIDSDIWSYGVVLWEVFSYGLQP 230
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 6e-35
Identities = 82/389 (21%), Positives = 150/389 (38%), Gaps = 85/389 (21%)
Query: 868 YRVKKDQKKDEQREKYIESLPTSGSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEAT 927
++ KK Q + E + + ++ +S + + + + +E P L F +L
Sbjct: 1 HKYKK-QFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLK---WEFPRENLEFGKVL--- 53
Query: 928 NGFSADSMIGSGGFGEVYKAQLRDGS------VVAIKKLIHVTGQGDR-EFMAEMETIGK 980
GSG FG+V A S VA+K L +R M+E++ + +
Sbjct: 54 ---------GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 981 I-KHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHD-RAKGGGTKLDWAARKKIAIGS 1038
+ H N+V LLG C + L++EY +G L + L R K ++++ +K++
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 1039 -----------------ARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081
A+G+ FL +HRD+ + NVL+ ++ DFG+AR
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL--EFK-SCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 1082 VNALDTHLSVSTLAGTPGYVP-----PE--YYQSFRCTTKGDVYSYGVILLELLS-GKRP 1133
+ + + + +P PE + + T K DV+SYG++L E+ S G P
Sbjct: 222 IMSDSNY-----VVRGNARLPVKWMAPESLFEGIY--TIKSDVWSYGILLWEIFSLGVNP 274
Query: 1134 ---IDPSEFGDDNNLVGWAKQLHR-EKRINEILDPELTMQTSDETELYQYLRISFECLDD 1189
I N + + ++ P + E+Y ++ C
Sbjct: 275 YPGIPVDA-----NFYKLIQNGFKMDQ-------PFYATE-----EIYIIMQ---SCWAF 314
Query: 1190 RPFKRPTMIQVMAMFKE-LQVDTEGDSLD 1217
KRP+ + + L E +
Sbjct: 315 DSRKRPSFPNLTSFLGCQLADAEEAMYQN 343
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 8e-35
Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 30/207 (14%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI 995
IG G FG+V R G+ VA+K + + F+AE + +++H NLV LLG
Sbjct: 29 IGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 996 GEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHII 1054
+ L +V EYM GSL L R G + L K ++ + +L + + +
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFV 139
Query: 1055 HRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP-----PE--YYQ 1107
HRD+ + NVL+ E+ A+VSDFG+ + + + T G +P PE +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDT-----GKLPVKWTAPEALREK 189
Query: 1108 SFRCTTKGDVYSYGVILLELLS-GKRP 1133
F +TK DV+S+G++L E+ S G+ P
Sbjct: 190 KF--STKSDVWSFGILLWEIYSFGRVP 214
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-35
Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 936 IGSGGFGEVYKAQL-----RDGSVVAIKKLIHVTGQGDR-EFMAEMETIGKIKHRNLVPL 989
+G G FG+V + G VA+K L +G + E+E + + H N+V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 990 LGYC--KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH 1047
G C G L+ E++ GSL+ L K++ + K A+ +G+ +L
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKN----KNKINLKQQLKYAVQICKGMDYLGS 144
Query: 1048 SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV---PPE 1104
+HRD+ + NVL++ + ++ DFG+ + + + +V +P V PE
Sbjct: 145 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP--VFWYAPE 199
Query: 1105 --YYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSE 1138
F DV+S+GV L ELL+ P
Sbjct: 200 CLMQSKF--YIASDVWSFGVTLHELLTYCDSDSSPMA 234
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-35
Identities = 81/305 (26%), Positives = 132/305 (43%), Gaps = 62/305 (20%)
Query: 936 IGSGGFGEVYKAQLRDGSV---VAIKKLIHVTGQGDR-EFMAEMETIGKI-KHRNLVPLL 990
IG G FG+V KA+++ + AIK++ + D +F E+E + K+ H N++ LL
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 991 GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARK-----------KIAIGSA 1039
G C+ L EY G+L L A A A
Sbjct: 93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 1040 RGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPG 1099
RG+ +L S IHRD+ + N+L+ EN+ A+++DFG++R + T G
Sbjct: 153 RGMDYL--SQK-QFIHRDLAARNILVGENYVAKIADFGLSRGQEV--------YVKKTMG 201
Query: 1100 YVP-----PE--YYQSFRCTTKGDVYSYGVILLELLS-GKRP---IDPSEFGDDNNLVGW 1148
+P E Y + TT DV+SYGV+L E++S G P + +E L
Sbjct: 202 RLPVRWMAIESLNYSVY--TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEK 253
Query: 1149 AKQLHR-EKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207
Q +R EK P E+Y +R +C ++P++RP+ Q++ +
Sbjct: 254 LPQGYRLEK-------PLNCDD-----EVYDLMR---QCWREKPYERPSFAQILVSLNRM 298
Query: 1208 QVDTE 1212
+ +
Sbjct: 299 LEERK 303
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 58/274 (21%), Positives = 110/274 (40%), Gaps = 44/274 (16%)
Query: 936 IGSGGFGEVYKA-QLRDGSVVAIK--KLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGY 992
IG G F VYK VA + +T + F E E + ++H N+V
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 993 CKI---GEERLLVY-EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHS 1048
+ G++ +++ E M G+L++ L + + + +GL FLH +
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYLK---RFK--VMKIKVLRSWCRQILKGLQFLH-T 147
Query: 1049 CIPHIIHRDMKSSNVLLD-ENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQ 1107
P IIHRD+K N+ + ++ D G+A L A + GTP ++ PE Y+
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMAPEMYE 203
Query: 1108 SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKR---INEILDP 1164
+ DVY++G+ +LE+ + + P + + N +++ + +++ P
Sbjct: 204 E-KYDESVDVYAFGMCMLEMATSEYP-----YSECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 1165 ELTMQTSDETELYQYLRISF--ECLDDRPFKRPT 1196
E+ C+ +R +
Sbjct: 258 EVK---------------EIIEGCIRQNKDERYS 276
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-34
Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 29/212 (13%)
Query: 936 IGSGGFGEVYKAQLRDGS-----VVAIKKLIHVTGQGDR-EFMAEMETIGKIKHRNLVPL 989
+GSG FG V+K V IK + +G+ M IG + H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTK--LDWAARKKIAIGSARGLAFLHH 1047
LG C G LV +Y+ GSL + G + L+W A+G+ +L
Sbjct: 81 LGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV------QIAKGMYYLEE 133
Query: 1048 SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP----- 1102
++HR++ + NVLL + +V+DFG+A L+ D L + P
Sbjct: 134 H---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD-----KQLLYSEAKTPIKWMA 185
Query: 1103 PEYYQSFRCTTKGDVYSYGVILLELLS-GKRP 1133
E + T + DV+SYGV + EL++ G P
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-34
Identities = 76/296 (25%), Positives = 119/296 (40%), Gaps = 45/296 (15%)
Query: 936 IGSGGFGEVYKAQLRDGS------VVAIKKLIHVTGQGDR-EFMAEMETIGKIKHRNLVP 988
+G G FGEVY+ Q+ VA+K L V + D +F+ E I K H+N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARK--KIAIGSARGLAFLH 1046
+G R ++ E M G L+S L + A +A A G +L
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 1047 HSCIPHIIHRDMKSSNVLLD---ENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP- 1102
+ H IHRD+ + N LL A++ DFGMAR D + + G +P
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAMLPV 250
Query: 1103 ----PEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKR 1157
PE + T+K D +S+GV+L E+ S G P N V + + R
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY----PSKSNQEV--LEFVTSGGR 304
Query: 1158 INEILD-PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTE 1212
+D P+ +Y+ + +C +P RP ++ + D +
Sbjct: 305 ----MDPPKNCPG-----PVYRIMT---QCWQHQPEDRPNFAIILERIEYCTQDPD 348
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 61/301 (20%), Positives = 110/301 (36%), Gaps = 66/301 (21%)
Query: 936 IGSGGFGEVYKAQLRDGSV--------VAIKKLIHVTGQGDREFMAEMETIGKIKHRNLV 987
+G G F +++K R+ V +K L F + K+ H++LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 988 PLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH 1047
G C G+E +LV E++K+GSL++ L K ++ + ++A A + FL
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYL----KKNKNCINILWKLEVAKQLAAAMHFLEE 131
Query: 1048 SCIPHIIHRDMKSSNVLLD--------ENFEARVSDFGMARLVNALDTHLSVSTLAGTPG 1099
+ +IH ++ + N+LL ++SD G++ V D
Sbjct: 132 N---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------------I 176
Query: 1100 Y------VPPE---YYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWA 1149
VPPE ++ D +S+G L E+ S G +P+ D+
Sbjct: 177 LQERIPWVPPECIENPKNL--NLATDKWSFGTTLWEICSGGDKPL----SALDSQRK--L 228
Query: 1150 KQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQV 1209
+ + + EL + C+D P RP+ ++ L
Sbjct: 229 QFYEDRHQ----------LPAPKAAELAN---LINNCMDYEPDHRPSFRAIIRDLNSLFT 275
Query: 1210 D 1210
Sbjct: 276 P 276
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-34
Identities = 72/283 (25%), Positives = 117/283 (41%), Gaps = 34/283 (12%)
Query: 935 MIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGD----REFMAEMETIGKIKHRNLVPL 989
IG G F EVY+A L DG VA+KK + + D + + E++ + ++ H N++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKK-VQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGT---KLDWAARKKIAIGSARGLAFLH 1046
E +V E G L ++ K + W K + L +H
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW----KYFVQLCSALEHMH 153
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYY 1106
++HRD+K +NV + ++ D G+ R ++ T +L GTP Y+ PE
Sbjct: 154 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERI 208
Query: 1107 QSFRCTTKGDVYSYGVILLELLSGKRPIDPSEF-GDDNNLVGWAKQLHREKRINEILDPE 1165
K D++S G +L E+ + + P F GD NL K K P
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSP-----FYGDKMNLYSLCK-----KIEQCDYPPL 258
Query: 1166 LTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208
+ S+ EL Q + C++ P KRP + V + K +
Sbjct: 259 PSDHYSE--ELRQLVN---MCINPDPEKRPDVTYVYDVAKRMH 296
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 29/213 (13%)
Query: 935 MIGSGGFGEVYKAQLRDGS-----VVAIKKLIHVTGQGDR-EFMAEMETIGKIKHRNLVP 988
++GSG FG VYK VAIK+L T E + E + + + ++
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHS 1048
LLG C + L+ + M +G L + + + + A+G+ +L
Sbjct: 82 LLGIC-LTSTVQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP-----P 1103
++HRD+ + NVL+ +++DFG+A+L+ A + G VP
Sbjct: 137 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-----KEYHAEGGKVPIKWMAL 188
Query: 1104 E--YYQSFRCTTKGDVYSYGVILLELLS-GKRP 1133
E ++ + T + DV+SYGV + EL++ G +P
Sbjct: 189 ESILHRIY--THQSDVWSYGVTVWELMTFGSKP 219
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-34
Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 26/205 (12%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI 995
IG G FG+V R G+ VA+K + + F+AE + +++H NLV LLG
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 996 GEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHII 1054
+ L +V EYM GSL L R G + L K ++ + +L + + +
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFV 311
Query: 1055 HRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP-----PEYYQSF 1109
HRD+ + NVL+ E+ A+VSDFG+ + ++ G +P PE +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----------GKLPVKWTAPEALREK 361
Query: 1110 RCTTKGDVYSYGVILLELLS-GKRP 1133
+ +TK DV+S+G++L E+ S G+ P
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-34
Identities = 79/292 (27%), Positives = 132/292 (45%), Gaps = 47/292 (16%)
Query: 936 IGSGGFGEVYKAQLRDGS----VVAIKKLIHVTGQGDR-EFMAEMETIGKIKHRNLVPLL 990
IGSG GEV +LR VAIK L + R +F++E +G+ H N++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 991 GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCI 1050
G G ++V EYM+ GSL++ L + + + G G+ +L
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL----RTHDGQFTIMQLVGMLRGVGAGMRYLSDL-- 170
Query: 1051 PHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP-----PE- 1104
+HRD+ + NVL+D N +VSDFG++R++ D + T G G +P PE
Sbjct: 171 -GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL--EDDPDAAYTTTG--GKIPIRWTAPEA 225
Query: 1105 -YYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGD-DNNLVGWAKQLHREKRINEI 1161
+++F ++ DV+S+GV++ E+L+ G+RP + + N V + R
Sbjct: 226 IAFRTF--SSASDVWSFGVVMWEVLAYGERP-----YWNMTNRDV--ISSVEEGYR---- 272
Query: 1162 LD-PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTE 1212
L P L+Q + +C +RP Q++++ L E
Sbjct: 273 LPAPMGCPH-----ALHQ---LMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-34
Identities = 81/331 (24%), Positives = 136/331 (41%), Gaps = 62/331 (18%)
Query: 936 IGSGGFGEVYKAQLRD--------GSVVAIKKLIHVTGQGDR-EFMAEMETIGKI-KHRN 985
+G G FG+V A+ + VA+K L + D + ++EME + I KH+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 986 LVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARK-----------KI 1034
++ LLG C ++ EY G+L L R G +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 1035 AIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTL 1094
A ARG+ +L IHRD+ + NVL+ E+ +++DFG+AR ++ +D +
Sbjct: 197 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY-----K 248
Query: 1095 AGTPGYVP-----PE--YYQSFRCTTKGDVYSYGVILLELLS-GKRP---IDPSEFGDDN 1143
T G +P PE + + + T + DV+S+GV+L E+ + G P + E
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----- 301
Query: 1144 NLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203
L K+ HR + P ELY +R +C P +RPT Q++
Sbjct: 302 -LFKLLKEGHRMDK------PSNCTN-----ELYMMMR---DCWHAVPSQRPTFKQLVED 346
Query: 1204 FKELQVDTEGDSLDSFSLKDTVIEELRERES 1234
+ T + + ++ E+
Sbjct: 347 LDRIVALTSNQEMGYYHHHHHHDYDIPTTEN 377
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-34
Identities = 80/312 (25%), Positives = 132/312 (42%), Gaps = 62/312 (19%)
Query: 936 IGSGGFGEVYKAQLRD--------GSVVAIKKLIHVTGQGDR-EFMAEMETIGKI-KHRN 985
+G G FG+V A+ VA+K L + D + ++EME + I KH+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 986 LVPLLGYCKIGEERLLVYEYMKWGSLESVL-----------HDRAKGGGTKLDWAARKKI 1034
++ LLG C ++ EY G+L L +D + ++ +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 1035 AIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTL 1094
ARG+ +L IHRD+ + NVL+ EN +++DFG+AR +N +D +
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY-----K 214
Query: 1095 AGTPGYVP-----PE--YYQSFRCTTKGDVYSYGVILLELLS-GKRP---IDPSEFGDDN 1143
T G +P PE + + + T + DV+S+GV++ E+ + G P I E
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----- 267
Query: 1144 NLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203
L K+ HR + P ELY +R +C P +RPT Q++
Sbjct: 268 -LFKLLKEGHRMDK------PANCTN-----ELYMMMR---DCWHAVPSQRPTFKQLVED 312
Query: 1204 FKELQVDTEGDS 1215
+ T +
Sbjct: 313 LDRILTLTTNEE 324
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 4e-34
Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 936 IGSGGFGEVYKAQLRDGSV---VAIKKLIHVTGQGDR-EFMAEMETIGKIKHRNLVPLLG 991
+G G FG V + R VAIK L T + D E M E + + ++ + +V L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 992 YCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIP 1051
C+ E +LV E G L L G ++ + ++ + G+ +L
Sbjct: 78 VCQ-AEALMLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVSMGMKYLEEK--- 129
Query: 1052 HIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV---PPE--YY 1106
+ +HRD+ + NVLL A++SDFG+++ + A D++ + + P + PE +
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP--LKWYAPECINF 187
Query: 1107 QSFRCTTKGDVYSYGVILLELLS-GKRP 1133
+ F +++ DV+SYGV + E LS G++P
Sbjct: 188 RKF--SSRSDVWSYGVTMWEALSYGQKP 213
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 4e-34
Identities = 81/281 (28%), Positives = 124/281 (44%), Gaps = 29/281 (10%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI 995
+G G FGEV+ + VAIK L T + F+ E + + K++H LV L
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV-S 332
Query: 996 GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIH 1055
E +V EYM GSL L G L +A A G+A++ + +H
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERM---NYVH 386
Query: 1056 RDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP-GYVPPEYYQSFRCTTK 1114
RD++++N+L+ EN +V+DFG+ARL+ D + A P + PE R T K
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 1115 GDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDE 1173
DV+S+G++L EL + G+ P G N V Q+ R R+ P
Sbjct: 445 SDVWSFGILLTELTTKGRVPYP----GMVNREV--LDQVERGYRMPC---PPEC-----P 490
Query: 1174 TELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGD 1214
L+ + +C P +RPT + A ++ TE
Sbjct: 491 ESLHD---LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 528
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 73/309 (23%), Positives = 133/309 (43%), Gaps = 67/309 (21%)
Query: 936 IGSGGFGEVYKAQLRDG------SVVAIKKLIHVTGQGDR-EFMAEMETIGKIKHRNLVP 988
+G G FG+V KA + VA+K L + + ++E + ++ H +++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARK---------------- 1032
L G C LL+ EY K+GSL L + K G L +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 1033 ---KIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHL 1089
A ++G+ +L + + ++HRD+ + N+L+ E + ++SDFG++R V D++
Sbjct: 151 DLISFAWQISQGMQYL--AEM-KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY- 206
Query: 1090 SVSTLAGTPGYVP-----PE--YYQSFRCTTKGDVYSYGVILLELLS-GKRP---IDPSE 1138
+ + G +P E + + TT+ DV+S+GV+L E+++ G P I P
Sbjct: 207 ----VKRSQGRIPVKWMAIESLFDHIY--TTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260
Query: 1139 FGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMI 1198
L K HR +R P+ + E+Y+ + +C P KRP
Sbjct: 261 ------LFNLLKTGHRMER------PDNCSE-----EMYRLML---QCWKQEPDKRPVFA 300
Query: 1199 QVMAMFKEL 1207
+ +++
Sbjct: 301 DISKDLEKM 309
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 134 bits (337), Expect = 6e-34
Identities = 33/312 (10%), Positives = 72/312 (23%), Gaps = 58/312 (18%)
Query: 935 MIGSGGFGEVYKAQLRD-GSVVAIKKLI---HVTGQGDREFMAEMETIGKIKHRNLVPLL 990
+ G V+ + + A+K + ++ +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 991 GYCKIG--------------------------EERLLVYEYMKWGSLESVLH--DRAKGG 1022
++ LL+ LE + D
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVF 187
Query: 1023 GTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082
A + R A L ++H N+ + + + D V
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 1083 NALDTHLSVSTLAGTPGYVPPEYYQSFRC--TTKGDVYSYGVILLELLSGKRPIDPSEFG 1140
+ Y P E+ + T + + G+ + + P
Sbjct: 245 GT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG----L 295
Query: 1141 DDNNLVGWAKQLHREKRINEILDPELTMQTSDETE--LYQYLRISFECLDDRPFKRPTMI 1198
+ G K+ + L D + + + L+ +R +
Sbjct: 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGR-------FLNFDRRRRLLPL 348
Query: 1199 QVMAM--FKELQ 1208
+ M F +LQ
Sbjct: 349 EAMETPEFLQLQ 360
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-34
Identities = 75/310 (24%), Positives = 124/310 (40%), Gaps = 63/310 (20%)
Query: 936 IGSGGFGEVYKAQLRD------GSVVAIKKLIHVTGQGDR-EFMAEMETIGKI-KHRNLV 987
+G+G FG+V +A VA+K L +R M+E++ + + H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 988 PLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKK-------------I 1034
LLG C IG L++ EY +G L + L + A +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 1035 AIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTL 1094
+ A+G+AFL + IHRD+ + N+LL ++ DFG+AR + + +
Sbjct: 151 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY-----V 202
Query: 1095 AGTPGYVP-----PE--YYQSFRCTTKGDVYSYGVILLELLS-GKRP---IDPSEFGDDN 1143
+P PE + + T + DV+SYG+ L EL S G P +
Sbjct: 203 VKGNARLPVKWMAPESIFNCVY--TFESDVWSYGIFLWELFSLGSSPYPGMPVDS----- 255
Query: 1144 NLVGWAKQLHR-EKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMA 1202
K+ R PE E+Y ++ C D P KRPT Q++
Sbjct: 256 KFYKMIKEGFRMLS-------PE---HAPA--EMYDIMK---TCWDADPLKRPTFKQIVQ 300
Query: 1203 MFKELQVDTE 1212
+ ++ ++
Sbjct: 301 LIEKQISEST 310
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 76/291 (26%), Positives = 137/291 (47%), Gaps = 44/291 (15%)
Query: 936 IGSGGFGEVYKAQLRDGSV-----VAIKKLIHVTGQGDR-EFMAEMETIGKIKHRNLVPL 989
IG+G FGEVYK L+ S VAIK L + R +F+ E +G+ H N++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC 1049
G + +++ EYM+ G+L+ L + + + G A G+ +L +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFL----REKDGEFSVLQLVGMLRGIAAGMKYLANM- 166
Query: 1050 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP-----PE 1104
+ +HRD+ + N+L++ N +VSDFG++R++ D + T +G G +P PE
Sbjct: 167 --NYVHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEATYTTSG--GKIPIRWTAPE 220
Query: 1105 --YYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161
Y+ F T+ DV+S+G+++ E+++ G+RP N+ V K ++ R
Sbjct: 221 AISYRKF--TSASDVWSFGIVMWEVMTYGERPYW----ELSNHEV--MKAINDGFR---- 268
Query: 1162 LDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTE 1212
L M +YQ + +C +RP ++++ +L +
Sbjct: 269 LPT--PMDCPS--AIYQ---LMMQCWQQERARRPKFADIVSILDKLIRAPD 312
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 69/289 (23%), Positives = 116/289 (40%), Gaps = 36/289 (12%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLVPLLGYC 993
+G GGF V + L DG A+K+ I Q DRE E + H N++ L+ YC
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKR-ILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 994 KI----GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC 1049
E L+ + K G+L + + +R K G L + +G RGL +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEI-ERLKDKGNFLTEDQILWLLLGICRGLEAIHA-- 152
Query: 1050 IPHIIHRDMKSSNVLLDENFEARVSDFGMAR-LVNALDTHLSVSTLA------GTPGYVP 1102
HRD+K +N+LL + + + D G ++ TL T Y
Sbjct: 153 -KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 1103 PE---YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRIN 1159
PE + DV+S G +L ++ G+ P + D G + L N
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP-----Y-DMVFQKGDSVAL---AVQN 262
Query: 1160 EILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208
++ P+ +S +L ++ + P +RP + +++ + LQ
Sbjct: 263 QLSIPQSPRHSSALWQL-----LNS-MMTVDPHQRPHIPLLLSQLEALQ 305
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 79/352 (22%), Positives = 140/352 (39%), Gaps = 79/352 (22%)
Query: 899 SVPEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQLRDG------ 952
+P L+ + + E P + + + G G FG V++A+
Sbjct: 30 RMPLLLNPKLLSLEYPRNNIEYVRDI------------GEGAFGRVFQARAPGLLPYEPF 77
Query: 953 SVVAIKKL-IHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSL 1011
++VA+K L + +F E + + + N+V LLG C +G+ L++EYM +G L
Sbjct: 78 TMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDL 137
Query: 1012 ESVLHDRAKGGGTKLDWAARK-------------------KIAIGSARGLAFLHHSCIPH 1052
L + L + IA A G+A+L
Sbjct: 138 NEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---K 194
Query: 1053 IIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP-----PE--Y 1105
+HRD+ + N L+ EN +++DFG++R + + D + A +P PE +
Sbjct: 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY-----KADGNDAIPIRWMPPESIF 249
Query: 1106 YQSFRCTTKGDVYSYGVILLELLS-GKRP---IDPSEFGDDNNLVGWAKQLHREKRINEI 1161
Y + TT+ DV++YGV+L E+ S G +P + E ++ + + +
Sbjct: 250 YNRY--TTESDVWAYGVVLWEIFSYGLQPYYGMAHEE------VIYYVRDGNILAC---- 297
Query: 1162 LDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEG 1213
PE ELY +R C P RP+ + + + + EG
Sbjct: 298 --PENCPL-----ELYNLMR---LCWSKLPADRPSFCSIHRILQRMCERAEG 339
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 21/209 (10%)
Query: 933 DSMIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMA----EMETIGKIKHRNLV 987
+G GG VY A+ VAIK I + + E + E+ ++ H+N+V
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 988 PLLGYCKIGEERLLVY---EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAF 1044
++ EE Y EY++ +L + L G+
Sbjct: 75 SMIDV---DEEDDCYYLVMEYIEGPTLSEYIESHGP-----LSVDTAINFTNQILDGIKH 126
Query: 1045 LHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE 1104
H I+HRD+K N+L+D N ++ DFG+A+ ++ + + + GT Y PE
Sbjct: 127 AHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE-TSLTQTNHVLGTVQYFSPE 182
Query: 1105 YYQSFRCTTKGDVYSYGVILLELLSGKRP 1133
+ D+YS G++L E+L G+ P
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 82/358 (22%), Positives = 137/358 (38%), Gaps = 85/358 (23%)
Query: 902 EPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQLRD------GSVV 955
E L + + +E P +L L G G FG+V +A V
Sbjct: 13 ERLPYDASKWEFPRDRLKLGKPL------------GRGAFGQVIEADAFGIDKTATCRTV 60
Query: 956 AIKKLIHVTGQGDR-EFMAEMETIGKI-KHRNLVPLLGYC-KIGEERLLVYEYMKWGSLE 1012
A+K L + M+E++ + I H N+V LLG C K G +++ E+ K+G+L
Sbjct: 61 AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 120
Query: 1013 SVLHDRAKGGGTKLDWAARK-----------KIAIGSARGLAFLHHSCIPHIIHRDMKSS 1061
+ L + + A+G+ FL IHRD+ +
Sbjct: 121 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR 177
Query: 1062 NVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP-----PE--YYQSFRCTTK 1114
N+LL E ++ DFG+AR + + + +P PE + + + T +
Sbjct: 178 NILLSEKNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVY--TIQ 230
Query: 1115 GDVYSYGVILLELLS-GKRP---IDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQT 1170
DV+S+GV+L E+ S G P + E K+ R + P+ T
Sbjct: 231 SDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRLKEGTRMRA------PDYTTP- 278
Query: 1171 SDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGDSLDSFSLKDTVIEE 1228
E+YQ + +C P +RPT F EL + L + L+ ++
Sbjct: 279 ----EMYQTML---DCWHGEPSQRPT-------FSELV-----EHLGNL-LQANAQQD 316
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 28/214 (13%)
Query: 933 DSMIGSGGFGEVYKAQLRDGSV---VAIKKLIHVTGQGDR--EFMAEMETIGKIKHRNLV 987
D +GSG FG V K + V VA+K L + E +AE + ++ + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 988 PLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH 1047
++G C+ E +LV E + G L L + ++ + G+ +L
Sbjct: 82 RMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLEE 135
Query: 1048 SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP----- 1102
S + +HRD+ + NVLL A++SDFG+++ + A + + A T G P
Sbjct: 136 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY----YKAQTHGKWPVKWYA 188
Query: 1103 PE--YYQSFRCTTKGDVYSYGVILLELLS-GKRP 1133
PE Y F ++K DV+S+GV++ E S G++P
Sbjct: 189 PECINYYKF--SSKSDVWSFGVLMWEAFSYGQKP 220
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-33
Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 23/210 (10%)
Query: 933 DSMIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMA----EMETIGKIKHRNLV 987
++G GG G+VY+A+ +VA+K L+ T D F E T G+++ ++V
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 988 PLLGYCKIGEERLLVY---EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAF 1044
P+ + GE +Y + L ++L + L I L
Sbjct: 98 PIHDF---GEIDGQLYVDMRLINGVDLAAMLRRQGP-----LAPPRAVAIVRQIGSALDA 149
Query: 1045 LHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHL-SVSTLAGTPGYVPP 1103
H + HRD+K N+L+ + A + DFG+A D L + GT Y+ P
Sbjct: 150 AHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAP 204
Query: 1104 EYYQSFRCTTKGDVYSYGVILLELLSGKRP 1133
E + T + D+Y+ +L E L+G P
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 66/280 (23%), Positives = 113/280 (40%), Gaps = 35/280 (12%)
Query: 935 MIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDRE---FMAEMETIGKIKHRNLVPLL 990
IG+G +G K + DG ++ K+ + + E ++E+ + ++KH N+V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKE-LDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 991 G--YCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLH-- 1046
+ +V EY + G L SV+ + LD ++ L H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVI-TKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSV-STLAGTPGYVPPEY 1105
++HRD+K +NV LD ++ DFG+AR+ L+ S T GTP Y+ PE
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI---LNHDTSFAKTFVGTPYYMSPEQ 187
Query: 1106 YQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREK--RINEILD 1163
K D++S G +L EL + P F + A ++ K RI
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPP-----F-TAFSQKELAGKIREGKFRRIPYRYS 241
Query: 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203
EL I L+ + + RP++ +++
Sbjct: 242 DELNE-------------IITRMLNLKDYHRPSVEEILEN 268
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-33
Identities = 56/275 (20%), Positives = 109/275 (39%), Gaps = 34/275 (12%)
Query: 935 MIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDRE---FMAEMETIGKIKHRNLVPLL 990
IG G FG+ + DG IK+ I+++ +E E+ + +KH N+V
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKE-INISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 991 GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCI 1050
+ +V +Y + G L ++ + G + L +H
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQ---KGVLFQEDQILDWFVQICLALKHVHDR-- 144
Query: 1051 PHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFR 1110
I+HRD+KS N+ L ++ ++ DFG+AR++N+ T GTP Y+ PE ++
Sbjct: 145 -KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICENKP 201
Query: 1111 CTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREK--RINEILDPELTM 1168
K D+++ G +L EL + K F + ++ ++ ++ +L
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHA-----F-EAGSMKNLVLKIISGSFPPVSLHYSYDLR- 254
Query: 1169 QTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203
+ + P RP++ ++
Sbjct: 255 ------------SLVSQLFKRNPRDRPSVNSILEK 277
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 25/211 (11%)
Query: 936 IGSGGFGEVYKAQLRDGSV----VAIKKL---IHVTGQGDREFMAEMETIGKIKHRNLVP 988
+G G FG V + + S VA+K L + + +F+ E+ + + HRNL+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHS 1048
L G + +V E GSL DR + + A+ A G+ +L
Sbjct: 86 LYGVV-LTPPMKMVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP-----P 1103
IHRD+ + N+LL ++ DFG+ R + D H + VP P
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH----YVMQEHRKVPFAWCAP 193
Query: 1104 EYYQSFRCTTKGDVYSYGVILLELLS-GKRP 1133
E ++ + D + +GV L E+ + G+ P
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 933 DSMIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMA----EMETIGKIKHRNLV 987
++G GG EV+ A+ LRD VA+K L D F E + + H +V
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 988 PLLGYCKIGEERL-------LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSAR 1040
+ GE +V EY+ +L ++H + ++ + +
Sbjct: 76 AVYDT---GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKRAIEVIADACQ 127
Query: 1041 GLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHL-SVSTLAGTPG 1099
L F H + IIHRD+K +N+++ +V DFG+AR + + + + GT
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 1100 YVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRP 1133
Y+ PE + + DVYS G +L E+L+G+ P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 64/340 (18%), Positives = 115/340 (33%), Gaps = 46/340 (13%)
Query: 175 SCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDN 234
C L V S + + P LDL N+I+ + N +NL+ L +N
Sbjct: 30 QCH-LRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT--EIKDGDFKNLKNLHTLILINN 86
Query: 235 KLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLD 294
K+ + + LS N L E+P +L+ L + N T K
Sbjct: 87 KISKISPGAFAPLVKLERLYLSKNQLK-ELPE----KMPKTLQELRVHENEIT-KVRKSV 140
Query: 295 FGRCGNLSVITLSQNGLSGTEFPA-SLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQ 353
F + V+ L N L + + + + L + ++ + IP G +L +
Sbjct: 141 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQ---GLPPSLTE 196
Query: 354 LSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGN 413
L L N+ ++ + L +L LS N ++ + A+ L L+L +N L
Sbjct: 197 LHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK- 254
Query: 414 FLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNF 473
VP L + ++V+ L +N + + FC P
Sbjct: 255 -------------------------VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYN 289
Query: 474 ---PALEKIVLPNNYLSGT-VPLELGSC-KNLKTIDLSFN 508
+ + L +N + + C + L
Sbjct: 290 TKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-32
Identities = 76/365 (20%), Positives = 134/365 (36%), Gaps = 75/365 (20%)
Query: 249 SISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQ 308
+ + S L ++P LDL +N T +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDL----PPDTALLDLQNNKIT-----------------EIKD 69
Query: 309 NGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPE 368
LKN L TL + +N + I L++L L+ NQ E+P +
Sbjct: 70 GDFKN------LKN---LHTLILINNKISK-ISPGAFAPLVKLERLYLSKNQLK-ELPEK 118
Query: 369 LGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYL 428
+ + TL+EL + N +T S F + + + LG+N L + +
Sbjct: 119 MPK---TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE------------ 163
Query: 429 YVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSG 488
+ +L + ++ T TIP G P+L ++ L N ++
Sbjct: 164 -----------NGAFQGMKKLSYIRIADTNIT-TIPQGL-----PPSLTELHLDGNKITK 206
Query: 489 TVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGN 548
L NL + LSFNS++ + + P+L +L + N L ++P G+ +
Sbjct: 207 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL-ADHKY 264
Query: 549 LETLILNNNHLTG------AIPKSIASCTNMLWVSLSSNQLT-GEIPAGI-GNLVKLAIL 600
++ + L+NN+++ P + VSL SN + EI + A +
Sbjct: 265 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 324
Query: 601 QLGNN 605
QLGN
Sbjct: 325 QLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 67/342 (19%), Positives = 114/342 (33%), Gaps = 66/342 (19%)
Query: 90 CSWQGVSCS----------LNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFS 139
C + V CS L L+L N+ ++ + L L L L N S
Sbjct: 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKIS 89
Query: 140 ---AGDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSIS---GGS 193
G + L + LS N + LP + L + + N I+
Sbjct: 90 KISPGAFAPLV----KLERLYLSKNQLK-ELPEKMP----KTLQELRVHENEITKVRKSV 140
Query: 194 LHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTI 253
+ ++ ++L N + S + + + L+ + +D + +I
Sbjct: 141 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-----------TTIPQ- 188
Query: 254 DLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSG 313
L SL L L N T K NL+ + LS N +S
Sbjct: 189 ----GLPP-------------SLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISA 230
Query: 314 TEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQF-----AGEIPPE 368
+ SL N L L++++N L +PG L + ++ + L +N PP
Sbjct: 231 VD-NGSLANTPHLRELHLNNNKLV-KVPGGLAD-HKYIQVVYLHNNNISAIGSNDFCPPG 287
Query: 369 LGQACGTLRELDLSSNRLTGEL--PSTFASCSSLHSLNLGSN 408
+ + L SN + PSTF ++ LG+
Sbjct: 288 YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 65/314 (20%), Positives = 122/314 (38%), Gaps = 47/314 (14%)
Query: 326 LETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNR 385
L + S L+ +P L + L L +N+ EI + L L L +N+
Sbjct: 33 LRVVQCSDLGLEK-VPKDL---PPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNK 87
Query: 386 LTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKI-SSLIYLYVPFNNISGPVPLSLT 444
++ P FA L L L N L + K+ +L L V N I+
Sbjct: 88 ISKISPGAFAPLVKLERLYLSKNQLK-----ELPEKMPKTLQELRVHENEITKVRKSVFN 142
Query: 445 NCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTID 504
Q+ V++L +N L+ + N G K L I
Sbjct: 143 GLNQMIVVELGTN-----------------PLKSSGIENGAFQG--------MKKLSYIR 177
Query: 505 LSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIP 564
++ ++ +P + P+L++L + N +T ++ NL L L+ N ++
Sbjct: 178 IADTNITT-IPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDN 233
Query: 565 KSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTG------QVPQGLGKC 618
S+A+ ++ + L++N+L ++P G+ + + ++ L NN+++ P K
Sbjct: 234 GSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKK 292
Query: 619 RSLVWLDLNSNNLS 632
S + L SN +
Sbjct: 293 ASYSGVSLFSNPVQ 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 54/236 (22%), Positives = 88/236 (37%), Gaps = 16/236 (6%)
Query: 410 LSGNFLNTVVSKI-SSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFC 468
S L V + L + N I+ N L L L +N + I G
Sbjct: 38 CSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPG-- 94
Query: 469 SPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWS-LPNLSDL 527
+ LE++ L N L L K L+ + + N + V +++ L + +
Sbjct: 95 AFAPLVKLERLYLSKNQLKE---LPEKMPKTLQELRVHENEITK-VRKSVFNGLNQMIVV 150
Query: 528 VMWANNLT-GEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGE 586
+ N L I G L + + + ++T IP+ + L L N++T +
Sbjct: 151 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELH--LDGNKIT-K 206
Query: 587 IPAGI-GNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELAN 641
+ A L LA L L NS++ L L L LN+N L +P LA+
Sbjct: 207 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLAD 261
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 23/87 (26%), Positives = 37/87 (42%), Gaps = 1/87 (1%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
SL L L N ++ + LN L L L N ++ S + L L++N
Sbjct: 193 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 252
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGI 798
+PG L ++ + + NNN+S I
Sbjct: 253 V-KVPGGLADHKYIQVVYLHNNNISAI 278
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 25/105 (23%), Positives = 43/105 (40%), Gaps = 8/105 (7%)
Query: 705 YTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVL 764
+ +L L LS+NS+S + + +L+ L+L +NKL +P K I V+
Sbjct: 210 ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVV 268
Query: 765 DLSHNNFQG------SIPGSLGGLSFLSDLDVSNNNLSGI-IPSG 802
L +NN PG + S + + +N + I
Sbjct: 269 YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 9e-11
Identities = 28/122 (22%), Positives = 42/122 (34%), Gaps = 26/122 (21%)
Query: 705 YTFTTNGSLIYLDLSYNSL-SGTLPEN-FGSLNYLQVLNLGHNKLTGHIP---------- 752
F +I ++L N L S + F + L + + +T IP
Sbjct: 139 SVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTEL 197
Query: 753 ------------DSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIP 800
S GL + L LS N+ GSL L +L ++NN L +P
Sbjct: 198 HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVP 256
Query: 801 SG 802
G
Sbjct: 257 GG 258
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 17/96 (17%), Positives = 32/96 (33%), Gaps = 9/96 (9%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTG------HIPDSFGGLK 759
+ L L L+ N L +P Y+QV+ L +N ++ P
Sbjct: 235 SLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKA 293
Query: 760 AIGVLDLSHNNFQGSI--PGSLGGLSFLSDLDVSNN 793
+ + L N Q P + + + + + N
Sbjct: 294 SYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 22/89 (24%), Positives = 42/89 (47%), Gaps = 5/89 (5%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLT-GHIPD-SFGGLKAIGVLDLSHN 769
+L L + N ++ F LN + V+ LG N L I + +F G+K + + ++
Sbjct: 122 TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181
Query: 770 NFQGSIPGSLGGLSFLSDLDVSNNNLSGI 798
N +IP L L++L + N ++ +
Sbjct: 182 NIT-TIPQGL--PPSLTELHLDGNKITKV 207
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 23/87 (26%), Positives = 39/87 (44%), Gaps = 3/87 (3%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
LDL N ++ +F +L L L L +NK++ P +F L + L LS N
Sbjct: 53 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGI 798
+ +P + L +L V N ++ +
Sbjct: 113 K-ELPEKM--PKTLQELRVHENEITKV 136
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 24/98 (24%), Positives = 36/98 (36%), Gaps = 4/98 (4%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
F +L L L N +S P F L L+ L L N+L L+ L
Sbjct: 71 DFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQ---ELR 127
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNL-SGIIPSG 802
+ N GL+ + +++ N L S I +G
Sbjct: 128 VHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG 165
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 28/144 (19%), Positives = 53/144 (36%), Gaps = 14/144 (9%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSS 160
+T L+L+ + ++ ++ +L L L L L NS SA D + + L + L++
Sbjct: 192 PSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP-HLRELHLNN 249
Query: 161 NNITGSLPGRSFLLSCDRLSYVNLSHNSIS---------GGSLHIGPSLLQLDLSGNQIS 211
N + +PG + V L +N+IS G S + L N +
Sbjct: 250 NKLV-KVPGGLADHK--YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306
Query: 212 DSALLTYSLSNCQNLNLLNFSDNK 235
+ + + + K
Sbjct: 307 YWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 27/93 (29%), Positives = 42/93 (45%), Gaps = 6/93 (6%)
Query: 548 NLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNNS 606
+L + ++ L +PK + T +L L +N++T EI G NL L L L NN
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPPDTALL--DLQNNKIT-EIKDGDFKNLKNLHTLILINNK 87
Query: 607 LTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSEL 639
++ P L L L+ N L LP ++
Sbjct: 88 ISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM 119
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 64/284 (22%), Positives = 112/284 (39%), Gaps = 44/284 (15%)
Query: 935 MIGSGGFGEVYKAQLRDGSVVAIK--KLIHVTGQGDREFMAEMETIGKIKHRNL--VPLL 990
IGSGG +V++ + AIK L Q + E+ + K++ + + L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 991 GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCI 1050
Y + +V E L S L + +D RK + +H
Sbjct: 95 DYEITDQYIYMVMECGN-IDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQH-- 146
Query: 1051 PHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE------ 1104
I+H D+K +N L+ + ++ DFG+A + T + + GT Y+PPE
Sbjct: 147 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 1105 -----YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRIN 1159
+ + K DV+S G IL + GK P F N + +++
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-----FQQIINQI---------SKLH 250
Query: 1160 EILDPELTMQTSD--ETELYQYLRISFECLDDRPFKRPTMIQVM 1201
I+DP ++ D E +L L+ CL P +R ++ +++
Sbjct: 251 AIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPELL 291
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-32
Identities = 67/252 (26%), Positives = 117/252 (46%), Gaps = 14/252 (5%)
Query: 888 PTSGSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKA 947
P +S K +P S+ + F P L+ N AD +G G FG V +
Sbjct: 296 PARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQG 355
Query: 948 QLRDGSV---VAIKKLIHVTGQGDR-EFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003
R VAIK L T + D E M E + + ++ + +V L+G C+ E +LV
Sbjct: 356 VYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVM 414
Query: 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNV 1063
E G L L + ++ + ++ + G+ +L + +HR++ + NV
Sbjct: 415 EMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNV 467
Query: 1064 LLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP-GYVPPEYYQSFRCTTKGDVYSYGV 1122
LL A++SDFG+++ + A D++ + + P + PE + +++ DV+SYGV
Sbjct: 468 LLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGV 527
Query: 1123 ILLELLS-GKRP 1133
+ E LS G++P
Sbjct: 528 TMWEALSYGQKP 539
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 25/209 (11%)
Query: 936 IGSGGFGEVYKAQLRDGS----VVAIKKL-IHVTGQGDREFMAEMETIGKIKHRNLVPLL 990
IG G FG+V++ VAIK + +F+ E T+ + H ++V L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 991 GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCI 1050
G ++ E G L S L + LD A+ A + LA+L
Sbjct: 83 GVI-TENPVWIIMELCTLGELRSFL----QVRKYSLDLASLILYAYQLSTALAYLESK-- 135
Query: 1051 PHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP-----PEY 1105
+HRD+ + NVL+ N ++ DFG++R + + + G +P PE
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY------KASKGKLPIKWMAPES 188
Query: 1106 YQSFRCTTKGDVYSYGVILLELLS-GKRP 1133
R T+ DV+ +GV + E+L G +P
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-32
Identities = 95/495 (19%), Positives = 176/495 (35%), Gaps = 52/495 (10%)
Query: 174 LSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSD 233
S + S V+ S+ +++ + P L LS N IS+ L +S L +L S
Sbjct: 28 FSNELESMVDYSNRNLTHVPKDLPPRTKALSLSQNSISE--LRMPDISFLSELRVLRLSH 85
Query: 234 NKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNL 293
N++ + + + +D+S+N L I SL++LDLS N+F
Sbjct: 86 NRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISC----CPMASLRHLDLSFNDFDVLPVCK 140
Query: 294 DFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFL--------- 344
+FG L+ + LS + L++ ++GG L
Sbjct: 141 EFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLH 200
Query: 345 -------------LGSFRNLKQLSLAHNQFAGE------IPPELGQACGTLRELDLSSNR 385
S L L L++ + E TL + L
Sbjct: 201 LVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIE 260
Query: 386 LTGELPS---TFASCSSLHSLNLGSNMLSGN----FLNTVVSKISSLIYLYVPFNNISGP 438
T + F + LN+ + ++ + + SL+ +V
Sbjct: 261 TTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFS 320
Query: 439 VPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCK 498
+ ++ + LS + SP + + N + +V + K
Sbjct: 321 KEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSS---FTFLNFTQNVFTDSVFQGCSTLK 377
Query: 499 NLKTIDLSFNSLA--GPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNN 556
L+T+ L N L V ++ +L L + N+L + C ++ L L++
Sbjct: 378 RLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSS 437
Query: 557 NHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQG-L 615
N LTG++ + + +L L +N++ IP + +L L L + +N L VP G
Sbjct: 438 NMLTGSVFRCLPPKVKVLD--LHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVF 493
Query: 616 GKCRSLVWLDLNSNN 630
+ SL ++ L+ N
Sbjct: 494 DRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-27
Identities = 85/475 (17%), Positives = 172/475 (36%), Gaps = 37/475 (7%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSS 160
+L+L+ + +S L + ++ L L L L N + D + L +D+S
Sbjct: 52 PRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRSLDFHVFL-FNQDLEYLDVSH 109
Query: 161 NNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIG------PSLLQLDLSGNQISDSA 214
N + ++ L +++LS N L + L L LS +
Sbjct: 110 NRLQ-NISCCPM----ASLRHLDLSFNDFD--VLPVCKEFGNLTKLTFLGLSAAKFRQLD 162
Query: 215 LLTYSLSNCQNLNLLNFSDNKLPG--KLNATSVNCKSISTIDLSYNLLSGEIPASFVADS 272
LL + + + LL+ + G + N + + +L S ++ S A
Sbjct: 163 LLPVAHLH-LSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALG 221
Query: 273 SGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPA----SLKNCQLLET 328
L + L+ N + +++ ++ + T + + +E
Sbjct: 222 HLQLSNIKLNDENCQ-RLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEY 280
Query: 329 LNMSHNALQG----GIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSN 384
LN+ + + + + ++L + + F L + LS +
Sbjct: 281 LNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFL-FSKEALYSVFAEMNIKMLSIS 339
Query: 385 RLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNIS--GPVPLS 442
S SS LN N+ + + + S + L L + N + V L
Sbjct: 340 DTPFIHMVCPPSPSSFTFLNFTQNVFT-DSVFQGCSTLKRLQTLILQRNGLKNFFKVALM 398
Query: 443 LTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKT 502
N + L LD+S N C+ ++ + L +N L+G+V L +K
Sbjct: 399 TKNMSSLETLDVSLNSLNSHAYDRTCAWA--ESILVLNLSSNMLTGSVFRCLPP--KVKV 454
Query: 503 IDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNN 557
+DL N + +P ++ L L +L + +N L +P+G+ +L+ + L++N
Sbjct: 455 LDLHNNRIMS-IPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-24
Identities = 91/557 (16%), Positives = 170/557 (30%), Gaps = 87/557 (15%)
Query: 247 CKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITL 306
+ S +D S L+ +P K L LS N+ + + D L V+ L
Sbjct: 30 NELESMVDYSNRNLT-HVPKDL----PPRTKALSLSQNSIS-ELRMPDISFLSELRVLRL 83
Query: 307 SQNGLSGTEFPASL-KNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEI 365
S N + + Q LE L++SHN LQ I +L+ L L+ N F +
Sbjct: 84 SHNRI--RSLDFHVFLFNQDLEYLDVSHNRLQN-IS---CCPMASLRHLDLSFNDFD-VL 136
Query: 366 PPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSL 425
P F + + L L L + L V S
Sbjct: 137 PV-----------------------CKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSC 173
Query: 426 IYLYVPFNNISGPVPLSLTN-CTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNN 484
I L + +I G SL T + L N + + L I L +
Sbjct: 174 ILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDE 233
Query: 485 YLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICV 544
+ + ++++ + +
Sbjct: 234 NCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF-------------------- 273
Query: 545 NGGNLETLILNNNHLTGAIPKSIASCTN-----MLWVSLSSNQLTGEIPAGIGNLVKLAI 599
+E L + N +T I + + + ++ + + A ++ I
Sbjct: 274 WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNI 333
Query: 600 LQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFV 659
L + S +L+ N + + + +
Sbjct: 334 KMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQ--------GCSTLKRLQTLILQ 385
Query: 660 RNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLS 719
RN + A + + + T S++ L+LS
Sbjct: 386 RNGLKNFFKVALMTKNMSSLE---------TLDVSLNSLNSHAYDRTCAWAESILVLNLS 436
Query: 720 YNSLSGTLPENFGSLNY-LQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIP-G 777
N L+G++ F L ++VL+L +N++ IP L+A+ L+++ N + S+P G
Sbjct: 437 SNMLTGSV---FRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDG 491
Query: 778 SLGGLSFLSDLDVSNNN 794
L+ L + + +N
Sbjct: 492 VFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 2e-19
Identities = 72/432 (16%), Positives = 128/432 (29%), Gaps = 59/432 (13%)
Query: 396 SCSSLHSLNLGSNMLSGNFLNTVVSKI-SSLIYLYVPFNNISGPVPLSLTNCTQLRVLDL 454
S ++ S L V + L + N+IS ++ ++LRVL L
Sbjct: 29 SNELESMVDY-----SNRNLTHVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRL 83
Query: 455 SSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAG-P 513
S N ++ LE + + +N L + +L+ +DLSFN P
Sbjct: 84 SHNRIR-SLDFHVFL--FNQDLEYLDVSHNRLQN---ISCCPMASLRHLDLSFNDFDVLP 137
Query: 514 VPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIAS-CTN 572
V E +L L+ L + A + + L L + H+ G +S+ T
Sbjct: 138 VCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTT 197
Query: 573 MLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQ-------VPQGLGKCRSLVWLD 625
+L + N L N L LQL N L + L + +L+ +
Sbjct: 198 VLHLVFHPNSLFSVQVNMSVN--ALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT 255
Query: 626 LNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLE 685
L + +L F+ P +E
Sbjct: 256 LQHIETTWKCSVKL------------------------------------FQFFWPRPVE 279
Query: 686 GFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHN 745
+ + + RI Y+ T SL+ + + + + + L +
Sbjct: 280 YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSIS 339
Query: 746 KLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQL 805
+ L+ + N F S+ L L L + N L
Sbjct: 340 DTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMT 399
Query: 806 TTFPASRYENNS 817
+ + S
Sbjct: 400 KNMSSLETLDVS 411
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 5e-17
Identities = 80/449 (17%), Positives = 142/449 (31%), Gaps = 54/449 (12%)
Query: 375 TLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVV-SKISSLIYLYVPFN 433
+ L LS N ++ + S L L L N + L+ V L YL V N
Sbjct: 53 RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR--SLDFHVFLFNQDLEYLDVSHN 110
Query: 434 NISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSG--FCSPPNFPALEKIVLPNNYLSGTVP 491
+ +S LR LDLS N F +P F N L + L +
Sbjct: 111 RLQN---ISCCPMASLRHLDLSFNDFD-VLPVCKEF---GNLTKLTFLGLSAAKFR-QLD 162
Query: 492 LELGSCKNLKTIDLSFNSLAGP-VPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLE 550
L + +L I L S +E +PN + L + + + + ++ L
Sbjct: 163 LLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNS-LFSVQVNMSVNALG 221
Query: 551 TLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQ 610
L L+N L + + + + L + +T + + + Q
Sbjct: 222 HLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQ-HIETTWKCSVKLFQFFWPR---- 276
Query: 611 VPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGI----VSGKQFAFVRNEGGTA 666
+ +L++ + ++ + E + + + V + F F + +
Sbjct: 277 ---------PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSV 327
Query: 667 CRGAGGLVEFEGIRPERLEGFPMV--HSCPSTRI-------YTGMTMYTFTTNGSLIYLD 717
+ + + MV S S +T +T L L
Sbjct: 328 F----AEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLI 383
Query: 718 LSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSF----GGLKAIGVLDLSHNNFQG 773
L N L + + L L ++ ++I VL+LS N G
Sbjct: 384 LQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTG 442
Query: 774 SIPGSLGGLSFLSDLDVSNNNLSGIIPSG 802
S+ L + LD+ NN + IP
Sbjct: 443 SVFRCLPPK--VKVLDLHNNRIM-SIPKD 468
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 4e-05
Identities = 18/62 (29%), Positives = 31/62 (50%), Gaps = 3/62 (4%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPD-SFGGLKAIGVLDLSHNN 770
+ LDL N + ++P++ L LQ LN+ N+L +PD F L ++ + L N
Sbjct: 451 KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508
Query: 771 FQ 772
+
Sbjct: 509 WD 510
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 4e-32
Identities = 76/319 (23%), Positives = 122/319 (38%), Gaps = 39/319 (12%)
Query: 933 DSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLVPLL 990
+G+GGFG V + +D G VAIK+ +RE + E++ + K+ H N+V
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 991 ------GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAF 1044
+ LL EY + G L L+ G K I SA L +
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA--LRY 136
Query: 1045 LHHSCIPHIIHRDMKSSNVLLDENFEAR---VSDFGMARLVNALDTHLSVSTLAGTPGYV 1101
LH + IIHRD+K N++L + + D G A+ ++ L + GT Y+
Sbjct: 137 LHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGEL-CTEFVGTLQYL 190
Query: 1102 PPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161
PE + + T D +S+G + E ++G RP P + V W ++ REK I
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP-----NWQPVQWHGKV-REKSNEHI 244
Query: 1162 LDP-------ELTMQTSDETELYQYLRISFEC-----LDDRPFKRPTMIQVMAM--FKEL 1207
+ + + L L E L +R T Q + F+ L
Sbjct: 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304
Query: 1208 QVDTEGDSLDSFSLKDTVI 1226
L ++ +
Sbjct: 305 DSILSLKLLSVMNMVSGRV 323
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-32
Identities = 81/261 (31%), Positives = 130/261 (49%), Gaps = 26/261 (9%)
Query: 885 ESLPTSGSSSWKLSSVPEPLSINVATFEKPLRKL-TFAHLLEATNGFSADSMIGSGGFGE 943
E G+ KL + ++ TFE P + + FA L+ATN S D ++G+G FGE
Sbjct: 4 EKRLHFGNGHLKLPGLRTF--VDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGE 60
Query: 944 VYKAQLRDGS----VVAIKKLIHVTGQGDR-EFMAEMETIGKIKHRNLVPLLGYCKIGEE 998
V +L+ S VAIK L + R +F+ E +G+ H N++ L G +
Sbjct: 61 VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120
Query: 999 RLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDM 1058
++V EYM+ GSL+S L + + + G A G+ +L +HRD+
Sbjct: 121 VMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDL 173
Query: 1059 KSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP-----PEYYQSFRCTT 1113
+ N+L++ N +VSDFG+ R++ D + T G G +P PE + T+
Sbjct: 174 AARNILINSNLVCKVSDFGLGRVLE--DDPEAAYTTRG--GKIPIRWTSPEAIAYRKFTS 229
Query: 1114 KGDVYSYGVILLELLS-GKRP 1133
DV+SYG++L E++S G+RP
Sbjct: 230 ASDVWSYGIVLWEVMSYGERP 250
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 29/211 (13%)
Query: 936 IGSGGFGEVYKAQLRDGSV----VAIKKL-IHVTGQGDREFMAEMETIGKIKHRNLVPLL 990
+G G FGEVY+ + VA+K T +FM+E + + H ++V L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 991 GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCI 1050
G + E ++ E +G L L + L ++ + +A+L
Sbjct: 80 GIIE-EEPTWIIMELYPYGELGHYL----ERNKNSLKVLTLVLYSLQICKAMAYLESI-- 132
Query: 1051 PHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP-----PE- 1104
+ +HRD+ N+L+ ++ DFG++R + D + + +P PE
Sbjct: 133 -NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY------KASVTRLPIKWMSPES 185
Query: 1105 -YYQSFRCTTKGDVYSYGVILLELLS-GKRP 1133
++ F TT DV+ + V + E+LS GK+P
Sbjct: 186 INFRRF--TTASDVWMFAVCMWEILSFGKQP 214
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-31
Identities = 87/517 (16%), Positives = 173/517 (33%), Gaps = 114/517 (22%)
Query: 99 LNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFS---AGDLSTSKTSSCSLVT 155
++ + SL++ LS + L L + + L + D+S++ + +L
Sbjct: 1 MSLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 60
Query: 156 MDLSSNNITGSLPGRSFLLSC-----DRLSYVNLSHNSISG-GSLHIG------PSLLQL 203
++L SN + G +L ++ ++L + ++G G + P+L +L
Sbjct: 61 LNLRSNELGDV--GVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQEL 118
Query: 204 DLSGNQISDS---ALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLL 260
LS N + D+ L L L L L ++ +C+ +++ +L
Sbjct: 119 HLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSL------SAASCEPLAS------VL 166
Query: 261 SGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASL 320
+ K L +S+N+ V L Q L
Sbjct: 167 R----------AKPDFKELTVSNNDI------------NEAGVRVLCQ----------GL 194
Query: 321 KNCQL-LETLNMSHNAL-QGGIPGF--LLGSFRNLKQLSLAHNQF----AGEIPPELGQA 372
K+ LE L + + ++ S +L++L+L N+ E+ P L
Sbjct: 195 KDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHP 254
Query: 373 CGTLRELDLSSNRLTGE----LPSTFASCSSLHSLNLGSNMLSG----NFLNTVVSKISS 424
LR L + +T + L + SL L+L N L T++
Sbjct: 255 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQ 314
Query: 425 LIYLYVPFNNIS--GPVPLS--LTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIV 480
L L+V + + S L L L +S+N C L +
Sbjct: 315 LESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ-----GLGQ-- 367
Query: 481 LPNNYLSGTVPLELGSCKNLKTIDLSFNSL----AGPVPSEIWSLPNLSDLVMWANNLTG 536
L+ + L+ + + + + + +L +L + N L
Sbjct: 368 ---------------PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 412
Query: 537 E----IPEGICVNGGNLETLILNNNHLTGAIPKSIAS 569
+ E + G LE L+L + + + + + +
Sbjct: 413 AGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQA 449
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 6e-26
Identities = 79/477 (16%), Positives = 149/477 (31%), Gaps = 112/477 (23%)
Query: 199 SLLQLDLSGNQISDSAL--LTYSLSNCQNLNLLNFSDNKLPGKLNATSV-----NCKSIS 251
+ LD+ ++SD+ L L CQ + L D L + + +++
Sbjct: 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRL---DDCGL-TEARCKDISSALRVNPALA 59
Query: 252 TIDLSYNLLSGE---IPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQ 308
++L N L + S ++ L L + TG
Sbjct: 60 ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA------------------- 100
Query: 309 NGLSGTEFPASLKNCQLLETLNMSHNALQGG----IPGFLLGSFRNLKQLSLAHNQFAGE 364
++L+ L+ L++S N L + LL L++L L + +
Sbjct: 101 ---GCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAA 157
Query: 365 IPPELGQA---CGTLRELDLSSNRLTGE----LPSTFASC-SSLHSLNLGSNMLSGNFLN 416
L +EL +S+N + L L +L L S ++ +
Sbjct: 158 SCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVT----S 213
Query: 417 TVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPAL 476
+ + + + LR L L SN G
Sbjct: 214 DNCRDLCGI-----------------VASKASLRELALGSNKLGD---VGM--------- 244
Query: 477 EKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSL----AGPVPSEIWSLPNLSDLVMWAN 532
L + L L+T+ + + G + + + +L +L + N
Sbjct: 245 -------AELCPGL---LHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGN 294
Query: 533 NLTGE----IPEGICVNGGNLETLILNNNHLTG----AIPKSIASCTNMLWVSLSSNQLT 584
L E + E + G LE+L + + T +A +L + +S+N+L
Sbjct: 295 ELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLE 354
Query: 585 GEIPAGIG-----NLVKLAILQLGNNSLTGQ----VPQGLGKCRSLVWLDLNSNNLS 632
+ L +L L + ++ + L SL LDL++N L
Sbjct: 355 DAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-23
Identities = 70/401 (17%), Positives = 127/401 (31%), Gaps = 80/401 (19%)
Query: 98 SLNSHVTSLNLNNSGLS--GSLNL-TTLTALPYLEHLNLQGNSFSAGDL----STSKTSS 150
+ + + L+L N L+ G L +TL LP L+ L+L N L
Sbjct: 82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ 141
Query: 151 CSLVTMDLSSNNIT--GSLPGRSFLLSCDRLSYVNLSHNSISG-GSLHIGP-------SL 200
C L + L +++ P S L + + +S+N I+ G + L
Sbjct: 142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQL 201
Query: 201 LQLDLSGNQISDSAL--LTYSLSNCQNLNLLNFSDNKLPGK-----LNATSVNCKSISTI 253
L L ++ L +++ +L L NKL + T+
Sbjct: 202 EALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTL 261
Query: 254 DLSYNLLSGEIPASFVAD---SSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNG 310
+ + + + SLK L L+ N G+ L +
Sbjct: 262 WIWECGI-TAKGCGDLCRVLRAKESLKELSLAGNEL------------GDEGARLLCE-- 306
Query: 311 LSGTEFPASLKNCQLLETLNMSHNAL--QGGIP-GFLLGSFRNLKQLSLAHNQFAGEIPP 367
L+ LE+L + + +L R L +L +++N+
Sbjct: 307 -------TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR 359
Query: 368 ELGQA----CGTLRELDLSSNRLTGE----LPSTFASCSSLHSLNLGSNMLSGNFLNTVV 419
EL Q LR L L+ ++ L +T + SL L+L +N L + +
Sbjct: 360 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG----DAGI 415
Query: 420 SKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFT 460
++ + L L L ++
Sbjct: 416 LQLVESV----------------RQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-21
Identities = 70/396 (17%), Positives = 131/396 (33%), Gaps = 79/396 (19%)
Query: 273 SGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPA---SLKNCQLLETL 329
S ++ LD+ + V+ L GL+ +L+ L L
Sbjct: 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61
Query: 330 NMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGE 389
N+ N L + + L +++L L + LTG
Sbjct: 62 NLRSNELGD----------VGVHCVLQG-----------LQTPSCKIQKLSLQNCCLTGA 100
Query: 390 ----LPSTFASCSSLHSLNLGSNMLSG----NFLNTVVSKISSLIYLYVPFNNIS--GPV 439
L ST + +L L+L N+L ++ L L + + ++S
Sbjct: 101 GCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE 160
Query: 440 PLS--LTNCTQLRVLDLSSNGFTGT----IPSGFCSPPNFPALEKIVLPNNYLS--GTVP 491
PL+ L + L +S+N + G P LE + L + ++
Sbjct: 161 PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSP--CQLEALKLESCGVTSDNCRD 218
Query: 492 L--ELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNL 549
L + S +L+ + L N L D+ M + G+ L
Sbjct: 219 LCGIVASKASLRELALGSN--------------KLGDVGMAE------LCPGLLHPSSRL 258
Query: 550 ETLILNNNHLT----GAIPKSIASCTNMLWVSLSSNQLTGE-----IPAGIGNLVKLAIL 600
TL + +T G + + + + ++ +SL+ N+L E + +L L
Sbjct: 259 RTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESL 318
Query: 601 QLGNNSLTGQ----VPQGLGKCRSLVWLDLNSNNLS 632
+ + S T L + R L+ L +++N L
Sbjct: 319 WVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLE 354
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-31
Identities = 42/320 (13%), Positives = 88/320 (27%), Gaps = 78/320 (24%)
Query: 935 MIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDRE----------------------- 970
++G +A G +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 971 -----FMAEMETIGKIKHRNLVPLLGYCKIGE--ERLLVYEYMKW--GSLESVLHDRAKG 1021
F+ + + + + ++ + + R +Y M+ + VL +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 1022 GGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081
L AR ++ + R LA LHH ++H ++ +++LD+ ++ F
Sbjct: 200 HK-SLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 1082 VNALDTHLSVSTLAGTPGYVPPEYYQSFRC-----------TTKGDVYSYGVILLELLSG 1130
A + + G+ PPE T D ++ G+++ +
Sbjct: 256 DGAR------VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 1131 KRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDR 1190
P D L G K I + + L L
Sbjct: 310 DLP-----ITKDAALGGSEWIFRSCKNIPQ--------------PVRALLE---GFLRYP 347
Query: 1191 PFKRPTMIQVMAM--FKELQ 1208
R +Q M +++L+
Sbjct: 348 KEDRLLPLQAMETPEYEQLR 367
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 63/284 (22%), Positives = 111/284 (39%), Gaps = 44/284 (15%)
Query: 935 MIGSGGFGEVYKAQLRDGSVVAIK--KLIHVTGQGDREFMAEMETIGKIKHRNL--VPLL 990
IGSGG +V++ + AIK L Q + E+ + K++ + + L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 991 GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCI 1050
Y + +V E L S L + +D RK + +H
Sbjct: 76 DYEITDQYIYMVMECGN-IDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQH-- 127
Query: 1051 PHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE------ 1104
I+H D+K +N L+ + ++ DFG+A + T + + GT Y+PPE
Sbjct: 128 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 1105 -----YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRIN 1159
+ + K DV+S G IL + GK P F N + +++
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-----FQQIINQI---------SKLH 231
Query: 1160 EILDPELTMQTSDE--TELYQYLRISFECLDDRPFKRPTMIQVM 1201
I+DP ++ D +L L+ CL P +R ++ +++
Sbjct: 232 AIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPELL 272
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-31
Identities = 70/349 (20%), Positives = 128/349 (36%), Gaps = 63/349 (18%)
Query: 870 VKKDQKKDEQREKYIESLPTSGSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNG 929
+K+ +R+ + SS E +S+ + +L+
Sbjct: 17 MKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIY----------SILK---- 62
Query: 930 FSADSMIGSGGFGEVYKAQLRDGSVVAIK--KLIHVTGQGDREFMAEMETIGKIKHRNL- 986
IGSGG +V++ + AIK L Q + E+ + K++ +
Sbjct: 63 -----QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 987 -VPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFL 1045
+ L Y + +V E L S L + +D RK + +
Sbjct: 118 IIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTI 171
Query: 1046 HHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE- 1104
H I+H D+K +N L+ + ++ DFG+A + T + + G Y+PPE
Sbjct: 172 HQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 1105 ----------YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR 1154
+ + K DV+S G IL + GK P F N +
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-----FQQIINQI-------- 274
Query: 1155 EKRINEILDPELTMQTSD--ETELYQYLRISFECLDDRPFKRPTMIQVM 1201
+++ I+DP ++ D E +L L+ CL P +R ++ +++
Sbjct: 275 -SKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPELL 319
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 63/305 (20%), Positives = 120/305 (39%), Gaps = 52/305 (17%)
Query: 935 MIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGD--REFMAEMETIGKIKHRNLV---- 987
+G GGFG V++A+ D AIK+ I + + + M E++ + K++H +V
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKR-IRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 988 -----PLLGYCKIGEERLLVY---EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSA 1039
+ ++ +Y + + +L+ ++ R + + + I + A
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR--CTIEERERSVCLHIFLQIA 128
Query: 1040 RGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN----------ALDTHL 1089
+ FLH ++HRD+K SN+ + +V DFG+ ++ + +
Sbjct: 129 EAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 1090 SVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWA 1149
+ GT Y+ PE + K D++S G+IL ELL P F V
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YP-----FSTQMERVRTL 237
Query: 1150 KQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM--FKEL 1207
+ K P T + E + + + L P +RP I ++ F++L
Sbjct: 238 TDVRNLK-----FPPLFTQKYPCEYVM-----VQ-DMLSPSPMERPEAINIIENAVFEDL 286
Query: 1208 QVDTE 1212
+
Sbjct: 287 DFPGK 291
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 67/274 (24%), Positives = 103/274 (37%), Gaps = 37/274 (13%)
Query: 935 MIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDRE---FMAEMETIGKI-KHRNLVPL 989
+G G +GEV+K + DG + A+K+ +G ++ +AE+ + K+ +H V L
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC 1049
+ G L E SL + G L A + LA LH
Sbjct: 123 EQAWEEGGILYLQTELC-GPSL----QQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ- 176
Query: 1050 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSF 1109
++H D+K +N+ L ++ DFG+ L T + G P Y+ PE Q
Sbjct: 177 --GLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELLQG- 230
Query: 1110 RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQ 1169
T DV+S G+ +LE+ P L L PE T
Sbjct: 231 SYGTAADVFSLGLTILEVACNMEL--PHGGEGWQQL------------RQGYLPPEFTAG 276
Query: 1170 TSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203
S EL L L+ P R T ++A+
Sbjct: 277 LSS--ELRSVLV---MMLEPDPKLRATAEALLAL 305
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-31
Identities = 46/316 (14%), Positives = 94/316 (29%), Gaps = 71/316 (22%)
Query: 935 MIGSGGFGEVYKA-QLRDGSVVAIKKLIHVTGQGDREFMAEME-------TIGKIKH--- 983
++G +A G + + + T + + +M+ + IK+
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVH-VPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 984 ----------RNLVPLLGYCKIGE-----------ERLLVYEYMKWGSLESV---LHDRA 1019
+LV K+ R +Y M+ +L++ L +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHS 202
Query: 1020 KGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1079
+ L AR ++ + R LA LHH ++H ++ +++LD+ ++ F
Sbjct: 203 STHKS-LVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHL 258
Query: 1080 RLVNALDTHLSVSTLAGTPGYVPPE-----YYQSFRCTTKGDVYSYGVILLELLSGKRPI 1134
A + P + T D ++ G+ + + P
Sbjct: 259 VRDGA-SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP- 316
Query: 1135 DPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKR 1194
DD L G K I + + L L R
Sbjct: 317 ----NTDDAALGGSEWIFRSCKNIPQPVRA-LLEG----------------FLRYPKEDR 355
Query: 1195 PTMIQVM--AMFKELQ 1208
+Q M +++L+
Sbjct: 356 LLPLQAMETPEYEQLR 371
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 63/300 (21%), Positives = 116/300 (38%), Gaps = 63/300 (21%)
Query: 935 MIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLG-- 991
++G G FG+V KA+ D AIKK I T + ++E+ + + H+ +V
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKK-IRHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 992 --------YCKIGEERLLVY---EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSAR 1040
+++ ++ EY + G+L ++H ++
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE----NLNQQRDEYWRLFRQILE 127
Query: 1041 GLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSV--------- 1091
L+++H IIHRD+K N+ +DE+ ++ DFG+A+ V+ L +
Sbjct: 128 ALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 1092 ---STLAGTPGYVPPE------YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDD 1142
++ GT YV E +Y K D+YS G+I E++ F
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHY-----NEKIDMYSLGIIFFEMIYP--------FSTG 231
Query: 1143 NNLVGWAKQLHREKRINEILDPELTMQTSDE-TELYQYLRISFECLDDRPFKRPTMIQVM 1201
V K+L + ++ P+ ++ I +D P KRP ++
Sbjct: 232 MERVNILKKL---RSVSIEFPPDFDDNKMKVEKKI-----IR-LLIDHDPNKRPGARTLL 282
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-31
Identities = 64/284 (22%), Positives = 119/284 (41%), Gaps = 52/284 (18%)
Query: 935 MIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLV------ 987
+IGSGGFG+V+KA+ DG IK++ + + + E++ + K+ H N+V
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKY----NNEKAEREVKALAKLDHVNIVHYNGCW 73
Query: 988 -------PLLGYCKIGEERLLVY---EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIG 1037
+ ++ E+ G+LE + R G KLD ++
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR---RGEKLDKVLALELFEQ 130
Query: 1038 SARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGT 1097
+G+ ++H +I+RD+K SN+ L + + ++ DFG+ +L + GT
Sbjct: 131 ITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDGKRTRSKGT 184
Query: 1098 PGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKR 1157
Y+ PE S + D+Y+ G+IL ELL + + R+
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKFF----TDLRDGI 235
Query: 1158 INEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVM 1201
I++I D + + L + + L +P RP +++
Sbjct: 236 ISDIFDKKE-----------KTL-LQ-KLLSKKPEDRPNTSEIL 266
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 58/299 (19%), Positives = 113/299 (37%), Gaps = 37/299 (12%)
Query: 930 FSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLV 987
+ ++G G V++ + + G + AIK +++ + M E E + K+ H+N+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 988 PLLGYCKIGEERL--LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFL 1045
L + R L+ E+ GSL +VL + + G + + L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG--MNHL 128
Query: 1046 HHSCIPHIIHRDMKSSNVLL----DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV 1101
+ I+HR++K N++ D +++DFG AR + D +L GT Y+
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFV--SLYGTEEYL 182
Query: 1102 PPEYYQSFRCTTKG--------DVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLH 1153
P+ Y+ D++S GV +G P P E N K++
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN------KEVM 236
Query: 1154 REKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPT--MIQVMAMFKELQVD 1210
+ + +Q ++ + + C R + ++ + L+ D
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI-----LEAD 290
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 45/312 (14%), Positives = 88/312 (28%), Gaps = 30/312 (9%)
Query: 897 LSSVPEPLSI--NVATFEKPLRKLTFAHLLEATNG-FSADSMIGSGGFGEVYKAQLRD-- 951
LS + +P+S N ++ L + + + ++G G F +VY+A D
Sbjct: 31 LSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLN 90
Query: 952 ----GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMK 1007
+K ME + + +LV E
Sbjct: 91 DAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYS 150
Query: 1008 WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLL-- 1065
+G+L + ++ + A+ + +H IIH D+K N +L
Sbjct: 151 YGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGN 207
Query: 1066 ---------DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGD 1116
D + + D G + + + T G+ E + + D
Sbjct: 208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQID 267
Query: 1117 VYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKR---INEILDPELTMQTSDE 1173
+ + +L G + ++ R NE L +
Sbjct: 268 YFGVAATVYCMLFGT----YMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHH 323
Query: 1174 TELYQYLRISFE 1185
LR +
Sbjct: 324 LPSLDLLRQKLK 335
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-30
Identities = 75/382 (19%), Positives = 131/382 (34%), Gaps = 44/382 (11%)
Query: 843 QNVETGVVIGIAFFLLIILGLTLALYRVKKDQKKDEQREKYIESLPTSGSSSWKLSSVPE 902
E + + L+ + R +K+ ++ + + G S +S
Sbjct: 305 TIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSET 364
Query: 903 PLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQLRDGS----VVAIK 958
+ E + IG G FG+V++ VAIK
Sbjct: 365 DDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIK 424
Query: 959 KL-IHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHD 1017
+ +F+ E T+ + H ++V L+G ++ E G L S L
Sbjct: 425 TCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV 483
Query: 1018 RAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFG 1077
R LD A+ A + LA+L +HRD+ + NVL+ N ++ DFG
Sbjct: 484 R----KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG 536
Query: 1078 MARLVNALDTHLSVSTLAGTPGYVP-----PEYYQSFRCTTKGDVYSYGVILLELLS-GK 1131
++R + + + G +P PE R T+ DV+ +GV + E+L G
Sbjct: 537 LSRYMEDSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV 590
Query: 1132 RPIDPSEFGDDNNLVGWAKQLHREKRINEILD-PELTMQTSDETELYQYLRISFECLDDR 1190
+P F N + E L P LY + +C
Sbjct: 591 KP-----FQGVKN-----NDVIGRIENGERLPMPPNC-----PPTLYS---LMTKCWAYD 632
Query: 1191 PFKRPTMIQVMAMFKELQVDTE 1212
P +RP ++ A + + +
Sbjct: 633 PSRRPRFTELKAQLSTILEEEK 654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 63/263 (23%), Positives = 118/263 (44%), Gaps = 17/263 (6%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGD--REFMAEMETIGKIKHRNLVPLLGYC 993
+G+G G V+K + +V +KLIH+ + + + E++ + + +V G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHI 1053
E + E+M GSL+ VL K G K++I +GL +L I
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILG--KVSIAVIKGLTYLREKH--KI 153
Query: 1054 IHRDMKSSNVLLDENFEARVSDFGMA-RLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCT 1112
+HRD+K SN+L++ E ++ DFG++ +L++++ ++ GT Y+ PE Q +
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRSYMSPERLQGTHYS 208
Query: 1113 TKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSD 1172
+ D++S G+ L+E+ G+ PI P + + + G + + P +
Sbjct: 209 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268
Query: 1173 ETELYQYLRISFECLDDRPFKRP 1195
+ FE LD + P
Sbjct: 269 MDS--RPPMAIFELLDYIVNEPP 289
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-30
Identities = 49/212 (23%), Positives = 84/212 (39%), Gaps = 32/212 (15%)
Query: 933 DSMIGSGGFGEVYKAQ-LR-DGSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLVPL 989
I GG G +Y A +G V +K L+H + MAE + + ++ H ++V +
Sbjct: 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 990 LGYCKIGEERL--------LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARG 1041
+ E +V EY+ SL+ + L A +
Sbjct: 145 FNF---VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-------LPVAEAIAYLLEILPA 194
Query: 1042 LAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV 1101
L++LH +++ D+K N++L E + ++ D G +N S L GTPG+
Sbjct: 195 LSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN------SFGYLYGTPGFQ 244
Query: 1102 PPEYYQSFRCTTKGDVYSYGVILLELLSGKRP 1133
PE ++ T D+Y+ G L L
Sbjct: 245 APEIVRT-GPTVATDIYTVGRTLAALTLDLPT 275
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 60/266 (22%), Positives = 109/266 (40%), Gaps = 14/266 (5%)
Query: 150 SCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHN---SISGGSLHIGPSLLQLDLS 206
SCS + +S +T S+P + + L N S+ G L +L LS
Sbjct: 6 SCSGTEIRCNSKGLT-SVPTGIP----SSATRLELESNKLQSLPHGVFDKLTQLTKLSLS 60
Query: 207 GNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPA 266
N +S + S +L L+ S N + +++ + + + +D ++ L ++
Sbjct: 61 SNGLSFKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLK-QMSE 118
Query: 267 SFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLL 326
V S +L YLD+SH + F+ + F +L V+ ++ N P + L
Sbjct: 119 FSVFLSLRNLIYLDISHTHTRVAFNGI-FNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 177
Query: 327 ETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRL 386
L++S L+ + S +L+ L+++HN F + + +L+ LD S N +
Sbjct: 178 TFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHI 235
Query: 387 TGELPSTFAS-CSSLHSLNLGSNMLS 411
SSL LNL N +
Sbjct: 236 MTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 55/266 (20%), Positives = 103/266 (38%), Gaps = 15/266 (5%)
Query: 249 SISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQ 308
S + I + L+ +P S L+L N + F + L+ ++LS
Sbjct: 8 SGTEIRCNSKGLT-SVPTGI----PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSS 61
Query: 309 NGLSGTEFPA-SLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPP 367
NGLS + S L+ L++S N + FL L+ L H+
Sbjct: 62 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFL--GLEQLEHLDFQHSNLKQMSEF 119
Query: 368 ELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIY 427
+ + L LD+S F SSL L + N NFL + +++ +L +
Sbjct: 120 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 179
Query: 428 LYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLS 487
L + + P + + + L+VL++S N F ++ + +L+ + N++
Sbjct: 180 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYK--CLNSLQVLDYSLNHIM 236
Query: 488 GTVPLEL--GSCKNLKTIDLSFNSLA 511
T + +L ++L+ N A
Sbjct: 237 -TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 44/262 (16%), Positives = 89/262 (33%), Gaps = 13/262 (4%)
Query: 350 NLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNM 409
+ ++ +P + + L+L SN+L F + L L+L SN
Sbjct: 8 SGTEIRCNSKGLT-SVPTGIPS---SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNG 63
Query: 410 LSGNFL-NTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFC 468
LS + +SL YL + FN + + + QL LD +
Sbjct: 64 LSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 122
Query: 469 SPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWS-LPNLSDL 527
+ L + + + + +L+ + ++ NS +I++ L NL+ L
Sbjct: 123 L--SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 180
Query: 528 VMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEI 587
+ L ++ + +L+ L +++N+ ++ + S N +
Sbjct: 181 DLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TS 238
Query: 588 PAGI--GNLVKLAILQLGNNSL 607
LA L L N
Sbjct: 239 KKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 7e-19
Identities = 48/226 (21%), Positives = 76/226 (33%), Gaps = 30/226 (13%)
Query: 410 LSGNFLNTVVSKI-SSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFC 468
+ L +V + I SS L + N + TQL L LSSNG + C
Sbjct: 14 CNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNG----LSFKGC 69
Query: 469 SPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLV 528
+ +LK +DLSFN + + S L L L
Sbjct: 70 CSQSDFGT---------------------TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLD 107
Query: 529 MWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIP 588
+NL + ++ NL L +++ H A +++ + ++ N
Sbjct: 108 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 167
Query: 589 AGI-GNLVKLAILQLGNNSLTGQVPQGLGKC-RSLVWLDLNSNNLS 632
I L L L L L Q+ SL L+++ NN
Sbjct: 168 PDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF 212
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 3/95 (3%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHI-PDSFGGLKAIGVL 764
F + +LIYLD+S+ F L+ L+VL + N + PD F L+ + L
Sbjct: 121 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 180
Query: 765 DLSHNNFQGSIP-GSLGGLSFLSDLDVSNNNLSGI 798
DLS + + + LS L L++S+NN +
Sbjct: 181 DLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSL 214
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 26/93 (27%), Positives = 37/93 (39%), Gaps = 3/93 (3%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGH--IPDSFGGLKAIGVLDLSHN 769
S L+L N L F L L L+L N L+ S G ++ LDLS N
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88
Query: 770 NFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSG 802
++ + GL L LD ++NL +
Sbjct: 89 GVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFS 120
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 30/98 (30%), Positives = 46/98 (46%), Gaps = 2/98 (2%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDS-FGGLKAIGVL 764
+ SL YLDLS+N + T+ NF L L+ L+ H+ L S F L+ + L
Sbjct: 73 SDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 131
Query: 765 DLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSG 802
D+SH + + + G GLS L L ++ N+
Sbjct: 132 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 169
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 28/94 (29%), Positives = 41/94 (43%), Gaps = 1/94 (1%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVL 764
F SL L ++ NS + F L L L+L +L P +F L ++ VL
Sbjct: 145 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 204
Query: 765 DLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGI 798
++SHNNF L+ L LD S N++
Sbjct: 205 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS 238
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 25/97 (25%), Positives = 40/97 (41%), Gaps = 6/97 (6%)
Query: 706 TFTTNGSLIYLDLSYNSLS--GTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGV 763
F L L LS N LS G ++ L+ L+L N + + +F GL+ +
Sbjct: 47 VFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEH 105
Query: 764 LDLSHNNFQGSIP--GSLGGLSFLSDLDVSNNNLSGI 798
LD H+N + + L L LD+S+ +
Sbjct: 106 LDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVA 141
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 31/190 (16%), Positives = 65/190 (34%), Gaps = 40/190 (21%)
Query: 104 TSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSC----SLVTMDLS 159
L+ +S L + +L L +L++ + SL + ++
Sbjct: 104 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH-----TRVAFNGIFNGLSSLEVLKMA 158
Query: 160 SNNITGSLPGRSFLLSCDRLSYVNLSHN---SISGGSLHIGPSLLQLDLSGNQISDSALL 216
N+ + F L++++LS +S + + SL L++S N +L
Sbjct: 159 GNSFQENFLPDIF-TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF--FSLD 215
Query: 217 TYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSL 276
T+ +L +L++S N + + SL
Sbjct: 216 TFPYKCLNSLQVLDYSLNHIM-------------------------TSKKQELQHFPSSL 250
Query: 277 KYLDLSHNNF 286
+L+L+ N+F
Sbjct: 251 AFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 31/93 (33%), Positives = 45/93 (48%), Gaps = 3/93 (3%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVL 764
FT +L +LDLS L L F SL+ LQVLN+ HN + L ++ VL
Sbjct: 170 IFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 228
Query: 765 DLSHNNFQGSIPGSLGGL-SFLSDLDVSNNNLS 796
D S N+ S L S L+ L+++ N+ +
Sbjct: 229 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 28/168 (16%), Positives = 60/168 (35%), Gaps = 24/168 (14%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSS 160
S + L + + + T L L L+L + + S SL +++S
Sbjct: 150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS-SLQVLNMSH 208
Query: 161 NNITGSLPGRSFLLSCDRLSYVNLSHN---SISGGSL-HIGPSLLQLDLSGNQISDSALL 216
NN SL + + L ++ S N + L H SL L+L+ N +
Sbjct: 209 NNFF-SLDTFPY-KCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA----- 261
Query: 217 TYSLSNCQNLNLLNFSDNKLPGKLNATSVNC--------KSISTIDLS 256
C++ + L + ++ + + C + +++++
Sbjct: 262 ----CTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSLNIT 305
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-30
Identities = 64/342 (18%), Positives = 117/342 (34%), Gaps = 52/342 (15%)
Query: 249 SISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQ 308
+ + S L +P S LDL +N+ + L +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEI----SPDTTLLDLQNNDIS-----------------ELRK 71
Query: 309 NGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPE 368
+ G L++ L L + +N + I R L++L ++ N EIPP
Sbjct: 72 DDFKG------LQH---LYALVLVNNKISK-IHEKAFSPLRKLQKLYISKNHLV-EIPPN 120
Query: 369 LGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYL 428
L +L EL + NR+ F+ +++ + +G N L + L YL
Sbjct: 121 LPS---SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYL 177
Query: 429 YVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSG 488
+ ++G L L L N I + L ++ L +N +
Sbjct: 178 RISEAKLTGIPKDLPET---LNELHLDHNKIQ-AIELE--DLLRYSKLYRLGLGHNQIRM 231
Query: 489 TVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEG------I 542
L L+ + L N L+ VP+ + L L + + NN+T ++
Sbjct: 232 IENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGF 289
Query: 543 CVNGGNLETLILNNNHLT-GAIPKSIASC-TNMLWVSLSSNQ 582
V + L NN + + + C T+ L + + +
Sbjct: 290 GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 75/368 (20%), Positives = 112/368 (30%), Gaps = 78/368 (21%)
Query: 150 SCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISG---GSLHIGPSLLQLDLS 206
C L + S + ++P + ++L +N IS L L L
Sbjct: 32 HCHLRVVQCSDLGLK-AVPKEIS----PDTTLLDLQNNDISELRKDDFKGLQHLYALVLV 86
Query: 207 GNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPA 266
N+IS + + S + L L S N L ++ NL S
Sbjct: 87 NNKISK--IHEKAFSPLRKLQKLYISKNHLV----------------EIPPNLPS----- 123
Query: 267 SFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLL 326
SL L + N K F N++ I + N L + F + L
Sbjct: 124 --------SLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKL 174
Query: 327 ETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRL 386
L +S L GIP L +L L HN+ I E L L L N++
Sbjct: 175 NYLRISEAKLT-GIPK---DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQI 229
Query: 387 TGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNC 446
+ + +L L+L +N LS VP L +
Sbjct: 230 RMIENGSLSFLPTLRELHLDNNKLSR--------------------------VPAGLPDL 263
Query: 447 TQLRVLDLSSNGFTGTIPSG-FCS---PPNFPALEKIVLPNNYLS-GTVPLELGSC-KNL 500
L+V+ L +N T + FC I L NN + V C +
Sbjct: 264 KLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDR 322
Query: 501 KTIDLSFN 508
I
Sbjct: 323 LAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 65/343 (18%), Positives = 109/343 (31%), Gaps = 69/343 (20%)
Query: 90 CSWQGVSCS----------LNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFS 139
C + V CS ++ T L+L N+ +S L L +L L L N S
Sbjct: 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS 91
Query: 140 ---AGDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSIS---GGS 193
S + L + +S N++ +P L + + N I G
Sbjct: 92 KIHEKAFSPLR----KLQKLYISKNHLV-EIPPNLP----SSLVELRIHDNRIRKVPKGV 142
Query: 194 LHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTI 253
++ +++ GN + +S + LN L S+ KL
Sbjct: 143 FSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKL----------------- 184
Query: 254 DLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSG 313
IP +L L L HN D R L + L N +
Sbjct: 185 --------TGIPKDLPE----TLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRM 231
Query: 314 TEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPE----- 368
E SL L L++ +N L +P L + L+ + L N ++
Sbjct: 232 IE-NGSLSFLPTLRELHLDNNKLS-RVPAGLPD-LKLLQVVYLHTNNIT-KVGVNDFCPV 287
Query: 369 -LGQACGTLRELDLSSNRLTGEL--PSTFASCSSLHSLNLGSN 408
G + L +N + P+TF + ++ G+
Sbjct: 288 GFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-26
Identities = 56/315 (17%), Positives = 111/315 (35%), Gaps = 50/315 (15%)
Query: 326 LETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNR 385
L + S L+ +P + + L L +N + E+ + + L L L +N+
Sbjct: 35 LRVVQCSDLGLKA-VPKEI---SPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNK 89
Query: 386 LTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKI-SSLIYLYVPFNNISGPVPLSLT 444
++ F+ L L + N L + + SSL+ L + N I +
Sbjct: 90 ISKIHEKAFSPLRKLQKLYISKNHLV-----EIPPNLPSSLVELRIHDNRIRKVPKGVFS 144
Query: 445 NCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTID 504
+ +++ N LE G L +
Sbjct: 145 GLRNMNCIEMGGN-----------------PLENSGFEPGAFDGL---------KLNYLR 178
Query: 505 LSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIP 564
+S L G +P ++ L++L + N + I + L L L +N +
Sbjct: 179 ISEAKLTG-IPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIEN 234
Query: 565 KSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQG-------LGK 617
S++ + + L +N+L+ +PAG+ +L L ++ L N++T +V K
Sbjct: 235 GSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVK 292
Query: 618 CRSLVWLDLNSNNLS 632
+ L +N +
Sbjct: 293 RAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 9e-18
Identities = 59/272 (21%), Positives = 100/272 (36%), Gaps = 47/272 (17%)
Query: 548 NLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAG-IGNLVKLAILQLGNNS 606
+L + ++ L A+PK I+ T +L L +N ++ E+ L L L L NN
Sbjct: 34 HLRVVQCSDLGLK-AVPKEISPDTTLL--DLQNNDIS-ELRKDDFKGLQHLYALVLVNNK 89
Query: 607 LTGQVPQGLGKCRSLVWLDLNSNN---LSGPLPSEL------ANQAGVVMPGIVSGK--- 654
++ + R L L ++ N+ + LPS L N+ V G+ SG
Sbjct: 90 ISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNM 149
Query: 655 --------QFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYT 706
E G F+G++ L ++ TG+
Sbjct: 150 NCIEMGGNPLENSGFEPGA----------FDGLKLNYL-------RISEAKL-TGIPKDL 191
Query: 707 FTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDL 766
+L L L +N + E+ + L L LGHN++ S L + L L
Sbjct: 192 PE---TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHL 248
Query: 767 SHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGI 798
+N +P L L L + + NN++ +
Sbjct: 249 DNNKLS-RVPAGLPDLKLLQVVYLHTNNITKV 279
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 21/100 (21%), Positives = 38/100 (38%), Gaps = 11/100 (11%)
Query: 705 YTFTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGV 763
L L L +N + + L L+ L+L +NKL+ +P LK + V
Sbjct: 211 EDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQV 268
Query: 764 LDLSHNNFQGSIP-------GSLGGLSFLSDLDVSNNNLS 796
+ L NN + G ++ + + + NN +
Sbjct: 269 VYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 28/121 (23%), Positives = 42/121 (34%), Gaps = 25/121 (20%)
Query: 705 YTFTTNGSLIYLDLSYNSL-SGTLPEN-FGSLNYLQVLNLGHNKLTG------------- 749
F+ ++ +++ N L + F L L L + KLTG
Sbjct: 141 GVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRISEAKLTGIPKDLPETLNELH 199
Query: 750 -------HIPD-SFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPS 801
I + L L HN + GSL L L +L + NN LS +P+
Sbjct: 200 LDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPA 258
Query: 802 G 802
G
Sbjct: 259 G 259
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 5e-30
Identities = 60/306 (19%), Positives = 111/306 (36%), Gaps = 35/306 (11%)
Query: 930 FSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLV 987
+ ++G G V++ + + G + AIK +++ + M E E + K+ H+N+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 988 PLLGYCKIGEERL--LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFL 1045
L + R L+ E+ GSL +VL + + G + + L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG--MNHL 128
Query: 1046 HHSCIPHIIHRDMKSSNVLL----DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV 1101
+ I+HR++K N++ D +++DFG AR + D +L GT Y+
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFV--SLYGTEEYL 182
Query: 1102 PPEYYQSFRCTTKG--------DVYSYGVILLELLSGKRPIDPSEFGDDNN------LVG 1147
P+ Y+ D++S GV +G P P E N + G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 1148 WAKQLHREKRINEILDPELTMQTSDETELYQYLRISFE-----CLDDRPFKRPTMIQVMA 1202
+ E + + L + L++ L+ K Q A
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302
Query: 1203 MFKELQ 1208
++
Sbjct: 303 ETSDIL 308
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 60/250 (24%), Positives = 100/250 (40%), Gaps = 18/250 (7%)
Query: 889 TSGSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQ 948
T S S KL + N K E + + +G G FGEV++ +
Sbjct: 19 TWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMK 78
Query: 949 -LRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMK 1007
+ G A+KK + + E + + +VPL G + G + E ++
Sbjct: 79 DKQTGFQCAVKK-VRLEVFRVEE----LVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133
Query: 1008 WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE 1067
GSL ++ + G L + GL +LH I+H D+K+ NVLL
Sbjct: 134 GGSLGQLIK---QMG--CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSS 185
Query: 1068 N-FEARVSDFGMARLVNAL---DTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVI 1123
+ A + DFG A + + L+ + GT ++ PE C K D++S +
Sbjct: 186 DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCM 245
Query: 1124 LLELLSGKRP 1133
+L +L+G P
Sbjct: 246 MLHMLNGCHP 255
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-29
Identities = 71/285 (24%), Positives = 114/285 (40%), Gaps = 61/285 (21%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIK----KLIHVTGQGDREFMAEMETIGKIKHRNLVPLL 990
+G G F VY+A+ + G VAIK K ++ G R E++ ++KH +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILELY 77
Query: 991 GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLD-WAARKKIA-IGSARGLAFLHHS 1048
Y + LV E G + L +R K AR + I G+ +LH
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVK----PFSENEARHFMHQI--ITGMLYLHSH 131
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE---- 1104
I+HRD+ SN+LL N +++DFG+A + TL GTP Y+ PE
Sbjct: 132 ---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH--YTLCGTPNYISPEIATR 186
Query: 1105 -YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163
+ + DV+S G + LL G+ P F D + + K ++
Sbjct: 187 SAH-----GLESDVWSLGCMFYTLLIGRPP-----F-DTDTV----KNTLN--KVVLA-- 227
Query: 1164 PELTMQTSDETELYQYLRISFEC-------LDDRPFKRPTMIQVM 1201
+ M + +S E L P R ++ V+
Sbjct: 228 -DYEMPSF----------LSIEAKDLIHQLLRRNPADRLSLSSVL 261
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 11/203 (5%)
Query: 935 MIGSGGFGEVYKA-QLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYC 993
++G G +G VY L + +AIK++ + + E+ +KH+N+V LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHI 1053
+ E + GSL ++L R+K G K + GL +LH + I
Sbjct: 89 SENGFIKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QI 143
Query: 1054 IHRDMKSSNVLLD-ENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFR-- 1110
+HRD+K NVL++ + ++SDFG ++ + ++ T GT Y+ PE
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT--ETFTGTLQYMAPEIIDKGPRG 201
Query: 1111 CTTKGDVYSYGVILLELLSGKRP 1133
D++S G ++E+ +GK P
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPP 224
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKL----IHVTGQGDREFMAEMETIGKIKHRNLVPLL 990
+G G FG VY A+ + ++A+K L + G + E+E ++H N++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLRHPNILRMY 80
Query: 991 GYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLD-WAARKKIA-IGSARGLAFLHH 1047
Y +R+ L+ E+ G L L K G + D + + + A L + H
Sbjct: 81 NYFH-DRKRIYLMLEFAPRGELYKEL---QKHG--RFDEQRSATFMEELADA--LHYCHE 132
Query: 1048 SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQ 1107
+IHRD+K N+L+ E +++DFG + +L T+ GT Y+PPE +
Sbjct: 133 R---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR----TMCGTLDYLPPEMIE 185
Query: 1108 SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDN 1143
K D++ GV+ E L G P F +
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPP-----FDSPS 216
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-28
Identities = 59/348 (16%), Positives = 114/348 (32%), Gaps = 60/348 (17%)
Query: 298 CGNLSVIT--LSQNGLSGT--EFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQ 353
N ++ N +SGT ++ ++ + + N + L+ +
Sbjct: 7 INNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLI---NQFSE 63
Query: 354 LSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGN 413
L L + +P L + L+++ N L LP +SL L+ N
Sbjct: 64 LQLNRLNLS-SLPDNLPPQ---ITVLEITQNALI-SLPELP---ASLEYLDA-----CDN 110
Query: 414 FLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNF 473
L+T+ +SL +L V N ++ +P L ++ +N T +P S
Sbjct: 111 RLSTLPELPASLKHLDVDNNQLTM-LPELPAL---LEYINADNNQLT-MLPELPTS---- 161
Query: 474 PALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANN 533
LE + + NN L+ +P +L+ +D+S N L +P+ + + ++
Sbjct: 162 --LEVLSVRNNQLT-FLPELPE---SLEALDVSTNLLES-LPAVPVRNHHSEETEIF--- 211
Query: 534 LTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGN 593
N +T IP++I S + L N L+ I +
Sbjct: 212 ------------------FRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQ 252
Query: 594 LVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELAN 641
+ Q R L S+++
Sbjct: 253 QTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAW--FPENKQSDVSQ 298
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 8e-28
Identities = 63/274 (22%), Positives = 103/274 (37%), Gaps = 43/274 (15%)
Query: 378 ELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVS-----KISSLIYLYVPF 432
+ N ++G F++ L G N VS I+ L +
Sbjct: 14 SQNSFYNTISGTYADYFSAWDKWEKQAL-----PGENRNEAVSLLKECLINQFSELQLNR 68
Query: 433 NNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPL 492
N+S +P +L Q+ VL+++ N ++P S LE + +N LS T+P
Sbjct: 69 LNLSS-LPDNL--PPQITVLEITQNALI-SLPELPAS------LEYLDACDNRLS-TLPE 117
Query: 493 ELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETL 552
S K+L D+ N L +P L + N LT +PE +LE L
Sbjct: 118 LPASLKHL---DVDNNQLTM-LPELP---ALLEYINADNNQLT-MLPELP----TSLEVL 165
Query: 553 ILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKL----AILQLGNNSLT 608
+ NN LT +P+ S + +S+N L +PA + N +T
Sbjct: 166 SVRNNQLT-FLPELPESLE---ALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT 220
Query: 609 GQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQ 642
+P+ + + L N LS + L+ Q
Sbjct: 221 -HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-24
Identities = 75/464 (16%), Positives = 142/464 (30%), Gaps = 83/464 (17%)
Query: 109 NNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNITGSLP 168
NN LS + T++ D ++ + N SL
Sbjct: 9 NNFSLSQNSFYNTISGTY--------------ADYFSAWDKWEKQALPGENRNEAV-SLL 53
Query: 169 GRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNL 228
+ ++ S + L+ ++S ++ P + L+++ N + L ++ + L
Sbjct: 54 KECLI---NQFSELQLNRLNLSSLPDNLPPQITVLEITQNALIS---LPELPASLEYL-- 105
Query: 229 LNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTG 288
D N LS +P SLK+LD+ +N T
Sbjct: 106 -------------------------DACDNRLS-TLPELP-----ASLKHLDVDNNQLT- 133
Query: 289 KFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSF 348
L L I N L T P + LE L++ +N L +P
Sbjct: 134 MLPEL----PALLEYINADNNQL--TMLPELPTS---LEVLSVRNNQLT-FLPELP---- 179
Query: 349 RNLKQLSLAHNQFAGEIPPELGQACG---TLRELDLSSNRLTGELPSTFASCSSLHSLNL 405
+L+ L ++ N +P + T NR+T +P S ++ L
Sbjct: 180 ESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIIL 237
Query: 406 GSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPS 465
N LS + + +S+ ++ + P I + N + D + F S
Sbjct: 238 EDNPLS-SRIRESLSQQTAQPDYHGP--RIYFSMSDGQQNTLHRPLADAVTAWFPENKQS 294
Query: 466 GFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLS 525
+ A E N + + L + + +A ++ + L
Sbjct: 295 D--VSQIWHAFEHEEHANTFSA--FLDRLSDTVSARNTSGFREQVAA-WLEKLSASAELR 349
Query: 526 DLVM-WANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIA 568
A + T + + + NL +L + G
Sbjct: 350 QQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTG 393
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 1e-12
Identities = 34/117 (29%), Positives = 47/117 (40%), Gaps = 15/117 (12%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
L L+ +LS +LP+N + VL + N L +P+ L+ LD N
Sbjct: 60 QFSELQLNRLNLS-SLPDNLPPQ--ITVLEITQNALI-SLPELPASLE---YLDACDNRL 112
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPLLPCS 828
++P L LDV NN L+ + L A NN L LP LP S
Sbjct: 113 S-TLPELPASLK---HLDVDNNQLTMLPELPALLEYINAD---NNQ-LTMLPELPTS 161
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 3e-11
Identities = 23/96 (23%), Positives = 43/96 (44%), Gaps = 12/96 (12%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
+ L+++ N+L +LPE SL + L+ N+L+ +P+ LK LD+ +N
Sbjct: 81 QITVLEITQNALI-SLPELPASL---EYLDACDNRLS-TLPELPASLK---HLDVDNNQL 132
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTT 807
+P L ++ + NN L+ + L
Sbjct: 133 T-MLPELPALLEYI---NADNNQLTMLPELPTSLEV 164
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 4e-11
Identities = 23/118 (19%), Positives = 36/118 (30%), Gaps = 10/118 (8%)
Query: 711 GSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGL----KAIGVLDL 766
SL L + N L+ LPE SL + L++ N L +P +
Sbjct: 160 TSLEVLSVRNNQLT-FLPELPESL---EALDVSTNLLE-SLPAVPVRNHHSEETEIFFRC 214
Query: 767 SHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPL 824
N IP ++ L + + +N LS I T +
Sbjct: 215 RENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDG 271
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 1e-10
Identities = 35/121 (28%), Positives = 52/121 (42%), Gaps = 16/121 (13%)
Query: 711 GSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNN 770
SL YLD N LS TLPE SL + L++ +N+LT +P+ L+ ++ +N
Sbjct: 100 ASLEYLDACDNRLS-TLPELPASL---KHLDVDNNQLT-MLPELPALLE---YINADNNQ 151
Query: 771 FQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPLLPCSSG 830
+P L L V NN L+ + L S N L LP +P +
Sbjct: 152 LT-MLPELPTSLE---VLSVRNNQLTFLPELPESLEALDVS---TN-LLESLPAVPVRNH 203
Query: 831 N 831
+
Sbjct: 204 H 204
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 60.8 bits (147), Expect = 2e-09
Identities = 25/100 (25%), Positives = 43/100 (43%), Gaps = 13/100 (13%)
Query: 711 GSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNN 770
L Y++ N L+ LPE SL +VL++ +N+LT +P+ L+ LD+S N
Sbjct: 140 ALLEYINADNNQLT-MLPELPTSL---EVLSVRNNQLT-FLPELPESLE---ALDVSTNL 191
Query: 771 FQGSIPGSLGGLSFLSD----LDVSNNNLSGIIPSGGQLT 806
+ S+P + N ++ I + L
Sbjct: 192 LE-SLPAVPVRNHHSEETEIFFRCRENRITHIPENILSLD 230
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 4e-09
Identities = 22/98 (22%), Positives = 33/98 (33%), Gaps = 6/98 (6%)
Query: 711 GSLIYLDLSYNSLSGTLPENFGSLNYLQ----VLNLGHNKLTGHIPDSFGGLKAIGVLDL 766
SL LD+S N L +LP ++ + N++T HIP++ L + L
Sbjct: 180 ESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIIL 237
Query: 767 SHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQ 804
N I SL + D S
Sbjct: 238 EDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNT 275
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 7e-07
Identities = 20/107 (18%), Positives = 39/107 (36%), Gaps = 9/107 (8%)
Query: 704 MYTFTTNGSLIYLDLSYNSLSGTLPE---NFGSLNYLQVLNLGHNKLTGHIPDSFGGLKA 760
M N SL + YN++SGT + + + N+ + + +
Sbjct: 4 MLPINNNFSLS-QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQ 60
Query: 761 IGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTT 807
L L+ N S+P +L ++ L+++ N L + L
Sbjct: 61 FSELQLNRLNLS-SLPDNLP--PQITVLEITQNALISLPELPASLEY 104
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 20/203 (9%)
Query: 936 IGSGGFGEVYKA-QLRDGSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLVPLLGYC 993
IG G G VY A + G VAI++ +++ Q +E + E+ + + K+ N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQ-MNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAI---GSARGLAFLHHSCI 1050
+G+E +V EY+ GSL V+ + T +D +IA + L FLH +
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTE------TCMD---EGQIAAVCRECLQALEFLHSN-- 135
Query: 1051 PHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFR 1110
+IHRD+KS N+LL + +++DFG + ST+ GTP ++ PE
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 1111 CTTKGDVYSYGVILLELLSGKRP 1133
K D++S G++ +E++ G+ P
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 29/216 (13%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKL----IHVTGQGDREFMAEMETIGKIKHRNLVPLL 990
+G G FG VY A+ + ++A+K L + G + E+E ++H N++ L
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILRLY 75
Query: 991 GYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLD-WAARKKIA-IGSARGLAFLHH 1047
GY R+ L+ EY G++ L K K D I + +A L++ H
Sbjct: 76 GYFH-DATRVYLILEYAPLGTVYREL---QKLS--KFDEQRTATYITELANA--LSYCHS 127
Query: 1048 SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQ 1107
+IHRD+K N+LL E +++DFG + + L GT Y+PPE +
Sbjct: 128 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----DLCGTLDYLPPEMIE 180
Query: 1108 SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDN 1143
K D++S GV+ E L GK P F +
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPP-----FEANT 211
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-28
Identities = 73/296 (24%), Positives = 117/296 (39%), Gaps = 45/296 (15%)
Query: 935 MIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIK-HRNLVPLLGY 992
++ GGF VY+AQ + G A+K+L+ + +R + E+ + K+ H N+V
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 993 CKIGEER-------LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFL 1045
IG+E L+ + G L L G L KI + R + +
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG--PLSCDTVLKIFYQTCRAVQHM 152
Query: 1046 HHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR-LVNALDTHLSVSTLA--------- 1095
H P IIHRD+K N+LL ++ DFG A + + D S A
Sbjct: 153 H-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 1096 GTPGYVPPE---YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQL 1152
TP Y PE Y +F K D+++ G IL L + P F D L + +
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP-----FEDGAKL----RIV 262
Query: 1153 HREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208
+ + I P Q + L + L P +R ++ +V+ +E+
Sbjct: 263 NGKYSI-----PPHDTQYTVFHSLIRA------MLQVNPEERLSIAEVVHQLQEIA 307
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-28
Identities = 53/200 (26%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLVPLLGYC 993
IG G G V A+ G VA+K + + Q RE E+ + +H N+V +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKM-MDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHI 1053
+GEE ++ E+++ G+L ++ +L+ + + LA+LH +
Sbjct: 112 LVGEELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHAQ---GV 162
Query: 1054 IHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTT 1113
IHRD+KS ++LL + ++SDFG ++ +L GTP ++ PE T
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQIS--KDVPKRKSLVGTPYWMAPEVISRSLYAT 220
Query: 1114 KGDVYSYGVILLELLSGKRP 1133
+ D++S G++++E++ G+ P
Sbjct: 221 EVDIWSLGIMVIEMVDGEPP 240
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 50/292 (17%), Positives = 103/292 (35%), Gaps = 58/292 (19%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDRE---FMAEMETIGKI-KHRNLVPLL 990
IGSG FG V+K DG + AIK+ G + + E+ + +H ++V
Sbjct: 19 IGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 991 GYCKIGEERLLVY-EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC 1049
++ +L+ EY GSL + + + A K + + RGL ++H
Sbjct: 78 S-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSY-FKEAELKDLLLQVGRGLRYIHSM- 134
Query: 1050 IPHIIHRDMKSSNVLLDEN-------------------FEARVSDFGMARLVNALDTHLS 1090
++H D+K SN+ + ++ D G ++ S
Sbjct: 135 --SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS------S 186
Query: 1091 VSTLAGTPGYVPPEYYQ-SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWA 1149
G ++ E Q ++ K D+++ + ++ + + +
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL-----PRNGDQW---- 237
Query: 1150 KQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVM 1201
I + P + S E + L+ + P +RP+ + ++
Sbjct: 238 ------HEIRQGRLPRIPQVLSQ--EFTELLK---VMIHPDPERRPSAMALV 278
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-27
Identities = 55/289 (19%), Positives = 100/289 (34%), Gaps = 47/289 (16%)
Query: 930 FSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFM--AEMETIGKI-----K 982
F ++G G G + + D VA+K++ E A+ E ++ +
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI-------LPECFSFADREV--QLLRESDE 76
Query: 983 HRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGL 1042
H N++ K + + + E + L + + + + GL
Sbjct: 77 HPNVIRYFCTEKDRQFQYIAIELCA-AT----LQEYVEQKDFAHLGLEPITLLQQTTSGL 131
Query: 1043 AFLHHSCIPHIIHRDMKSSNVLLDENFE-----ARVSDFGMARLVNALDTHLSV-STLAG 1096
A LH +I+HRD+K N+L+ A +SDFG+ + + S S + G
Sbjct: 132 AHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188
Query: 1097 TPGYVPPEYYQSF---RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLH 1153
T G++ PE T D++S G + ++S P FG +Q +
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH--P--FGKSLQ-----RQAN 239
Query: 1154 REKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMA 1202
+ I + + P KRP+ V+
Sbjct: 240 ILLGACSLDCLHPEKHEDVIAREL----IE-KMIAMDPQKRPSAKHVLK 283
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 56/307 (18%), Positives = 105/307 (34%), Gaps = 65/307 (21%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIK--------KLIHVTGQGDREFMA---------EMETI 978
+ G F ++ + +D A+K K T + + E++ I
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 979 GKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAK----GGGTKLDWAARKKI 1034
IK+ + G +E ++YEYM+ S+ + I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 1035 A-IGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVST 1093
+ +++H+ +I HRD+K SN+L+D+N ++SDFG + + D +
Sbjct: 158 KSV--LNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DKKI--KG 209
Query: 1094 LAGTPGYVPPE------YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVG 1147
GT ++PPE Y + D++S G+ L + P F +L
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGAKV----DIWSLGICLYVMFYNVVP-----FSLKISL-- 258
Query: 1148 WAKQLHREKRINE------ILDPELTMQTSDETELYQYLRISFEC-------LDDRPFKR 1194
+L I + +++ +S E L P +R
Sbjct: 259 --VELF--NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAER 314
Query: 1195 PTMIQVM 1201
T +
Sbjct: 315 ITSEDAL 321
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 69/237 (29%), Positives = 113/237 (47%), Gaps = 28/237 (11%)
Query: 913 KPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREF 971
+ L ++ + L + F ++G+G +G+VYK + ++ G + AIK + VTG + E
Sbjct: 9 RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKV-MDVTGDEEEEI 67
Query: 972 MAEMETIGKI-KHRNLVPLLG-YCKIGEERL-----LVYEYMKWGSLESVLHDRAKGGGT 1024
E+ + K HRN+ G + K + LV E+ GS+ ++ + KG
Sbjct: 68 KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTL 126
Query: 1025 KLDWAARKKIAI---GSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081
K +W IA RGL+ LH +IHRD+K NVLL EN E ++ DFG++
Sbjct: 127 KEEW-----IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178
Query: 1082 VNALDTHLSVSTLAGTPGYVPPEYYQSFRCT-----TKGDVYSYGVILLELLSGKRP 1133
++ T +T GTP ++ PE K D++S G+ +E+ G P
Sbjct: 179 LD--RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 66/279 (23%), Positives = 112/279 (40%), Gaps = 48/279 (17%)
Query: 935 MIGSGGFGEVYKAQ-LRDGSVVAIK----KLIHVTGQGDREFMAEMETIGKIKHRNLVPL 989
+G GGF + ++ V A K L+ Q ++ E+ + H+++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 80
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC 1049
G+ + + +V E + SL + K + AR + G +LH +
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYL-RQIVLGCQYLHRN- 134
Query: 1050 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSF 1109
+IHRD+K N+ L+E+ E ++ DFG+A V L GTP Y+ PE
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KVLCGTPNYIAPEVLSKK 190
Query: 1110 RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQ 1169
+ + DV+S G I+ LL GK P F + + L K+ + + NE P+
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPP-----F-ETSCL----KETYLRIKKNEYSIPK---- 236
Query: 1170 TSDETELYQYLRISFEC-------LDDRPFKRPTMIQVM 1201
I+ L P RPT+ +++
Sbjct: 237 -----------HINPVAASLIQKMLQTDPTARPTINELL 264
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-27
Identities = 68/284 (23%), Positives = 112/284 (39%), Gaps = 58/284 (20%)
Query: 935 MIGSGGFGEVYKAQ-LRDGSVVAIK----KLIHVTGQGDREFMAEMETIGKIKHRNLVPL 989
+G GGF + ++ V A K L+ Q ++ E+ + H+++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 106
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC 1049
G+ + + +V E + SL + K + AR + G +LH +
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLR-QIVLGCQYLHRN- 160
Query: 1050 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSF 1109
+IHRD+K N+ L+E+ E ++ DFG+A V L GTP Y+ PE
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KVLCGTPNYIAPEVLSK- 215
Query: 1110 RCTTKG-----DVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDP 1164
KG DV+S G I+ LL GK P F + + L K+ + + NE P
Sbjct: 216 ----KGHSFEVDVWSIGCIMYTLLVGKPP-----F-ETSCL----KETYLRIKKNEYSIP 261
Query: 1165 ELTMQTSDETELYQYLRISFEC-------LDDRPFKRPTMIQVM 1201
+ I+ L P RPT+ +++
Sbjct: 262 K---------------HINPVAASLIQKMLQTDPTARPTINELL 290
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 54/214 (25%), Positives = 99/214 (46%), Gaps = 23/214 (10%)
Query: 930 FSADSMIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLV 987
+ +G G FG+VYKA+ G++ A K I + + E ++ E+E + H +V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKV-IETKSEEELEDYIVEIEILATCDHPYIV 79
Query: 988 PLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAI---GSARGLAF 1044
LLG + ++ E+ G++++++ + + L +I + L F
Sbjct: 80 KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR----GLT---EPQIQVVCRQMLEALNF 132
Query: 1045 LHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE 1104
LH IIHRD+K+ NVL+ + R++DFG++ T + GTP ++ PE
Sbjct: 133 LHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL--KTLQKRDSFIGTPYWMAPE 187
Query: 1105 -----YYQSFRCTTKGDVYSYGVILLELLSGKRP 1133
+ K D++S G+ L+E+ + P
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 50/210 (23%), Positives = 89/210 (42%), Gaps = 17/210 (8%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGD--REFMAEMETIGK-IKHRNLVPLLG 991
IG G +G V K G ++A+K+ I T ++ + +++ + + +V G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKR-IRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 992 YCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIP 1051
+ + E M S + + KI + + + L L +
Sbjct: 89 ALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL-- 145
Query: 1052 HIIHRDMKSSNVLLDENFEARVSDFGM-ARLVNALDTHLSVSTLAGTPGYVPPEYYQSFR 1110
IIHRD+K SN+LLD + ++ DFG+ +LV+++ + AG Y+ PE
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK----TRDAGCRPYMAPERIDPSA 201
Query: 1111 C----TTKGDVYSYGVILLELLSGKRPIDP 1136
+ DV+S G+ L EL +G+ P
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGRFPYPK 231
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 64/272 (23%), Positives = 88/272 (32%), Gaps = 40/272 (14%)
Query: 275 SLKYLDLSHNNFTGK--FSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQL-LETLNM 331
SLK L + + F L L +TL ++GT P L+ L LN+
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 332 SHNALQGG---IPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTG 388
+ + + LK LS+A E + L LDLS N G
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS-LNFSCEQVRVFPALSTLDLSDNPELG 187
Query: 389 ELPSTFASC----SSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLT 444
E A C +L L L + + SG
Sbjct: 188 ERGLISALCPLKFPTLQVLALRNAGM----------------------ETPSGVCSALAA 225
Query: 445 NCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTID 504
QL+ LDLS N + C P L + L L VP L + L +D
Sbjct: 226 ARVQLQGLDLSHNSLRDAAGAPSCDWP--SQLNSLNLSFTGLK-QVPKGLPA--KLSVLD 280
Query: 505 LSFNSLAGPVPSEIWSLPNLSDLVMWANNLTG 536
LS+N L PS LP + +L + N
Sbjct: 281 LSYNRLDR-NPS-PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-23
Identities = 51/293 (17%), Positives = 88/293 (30%), Gaps = 41/293 (13%)
Query: 179 LSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTY-SLSNCQNLNLLNFSDNKLP 237
L V+ + + SL +L + +I L + L L + ++
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 238 GKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSG----SLKYLDLSHNNFTGKFSNL 293
G + L+ +S +++A+ LK L ++ + FS
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLN-FSCE 167
Query: 294 DFGRCGNLSVITLSQNGLSG-TEFPASLKNCQL--LETLNMSHNALQ--GGIPGFLLGSF 348
LS + LS N G ++L + L+ L + + ++ G+ L +
Sbjct: 168 QVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAAR 227
Query: 349 RNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSN 408
L+ L L+HN L L+LS L + L L+L N
Sbjct: 228 VQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP---AKLSVLDLSYN 284
Query: 409 MLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTG 461
L P P L + L L N F
Sbjct: 285 RLD------------------------RNPSPDELPQ---VGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 2e-20
Identities = 53/242 (21%), Positives = 80/242 (33%), Gaps = 30/242 (12%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTL-TALPYLEHLNLQGNSFSAGDLSTSKTSSC---SLVTM 156
S + L L N ++G+ L P L LNL+ S++ D ++ L +
Sbjct: 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVL 154
Query: 157 DLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALL 216
++ + + + LS ++LS N G I SAL
Sbjct: 155 SIAQAHSLNFSCEQVRVFP--ALSTLDLSDNPELGERGLI----------------SALC 196
Query: 217 TYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSL 276
Q L L N G +A + + +DLS+N L A S L
Sbjct: 197 PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS-QL 255
Query: 277 KYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNAL 336
L+LS L LSV+ LS N L P L + L++ N
Sbjct: 256 NSLNLSFTGLKQVPKGLP----AKLSVLDLSYNRLDRNPSPDELPQ---VGNLSLKGNPF 308
Query: 337 QG 338
Sbjct: 309 LD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 6e-18
Identities = 60/322 (18%), Positives = 100/322 (31%), Gaps = 53/322 (16%)
Query: 487 SGTVPLEL-GSCKNLKTIDLSFNSLAGPVP-SEIWSLPNLSDLVMWANNLTGEIPEGI-- 542
G +EL G ++L+ + ++ A ++I +L L + A + I G
Sbjct: 31 LGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALR 90
Query: 543 CVNGGNLETLILNNNHLTGAIPKSIASCT--NMLWVSLSSNQLTGE--IPAGIGNLVKLA 598
+ L+ L L N +TG P + T ++ ++L + A + +K
Sbjct: 91 VLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPG 150
Query: 599 I--LQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQF 656
+ L + + + +L LDL+ N G
Sbjct: 151 LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS----------------- 193
Query: 657 AFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYL 716
C ++ +R +E V S L L
Sbjct: 194 --------ALCPLKFPTLQVLALRNAGMETPSGVCSA------------LAAARVQLQGL 233
Query: 717 DLSYNSLSGTLPE-NFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSI 775
DLS+NSL + + L LNL L L VLDLS+N
Sbjct: 234 DLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLS---VLDLSYNRLD-RN 289
Query: 776 PGSLGGLSFLSDLDVSNNNLSG 797
P S L + +L + N
Sbjct: 290 P-SPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 4e-17
Identities = 65/283 (22%), Positives = 94/283 (33%), Gaps = 19/283 (6%)
Query: 374 GTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFN 433
+ + N L + SL L + + T + K SL L V
Sbjct: 19 DPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAA 78
Query: 434 NISGPVP---LSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTV 490
I + L + + L+ L L + TGT P P L + L N +
Sbjct: 79 RIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL-LEATGPDLNILNLRNVSWATRD 137
Query: 491 P----LELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIP--EGICV 544
L+ LK + ++ ++ P LS L + N GE +C
Sbjct: 138 AWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP 197
Query: 545 NG-GNLETLILNNNHLT---GAIPKSIASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAI 599
L+ L L N + G A+ + + LS N L A +L
Sbjct: 198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNS 257
Query: 600 LQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSG-PLPSELAN 641
L L L QVP+GL L LDL+ N L P P EL
Sbjct: 258 LNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRNPSPDELPQ 297
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 55/285 (19%), Positives = 94/285 (32%), Gaps = 54/285 (18%)
Query: 531 ANNLTGEIPEGICVNGGNLETLILN-NNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPA 589
A N G + G +LE L+ + I ++ +++ + ++ I
Sbjct: 27 AFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILF 86
Query: 590 G---IGNLVKLAILQLGNNSLTGQVPQGLGKC--RSLVWLDLNSNNLSGPLPSELANQAG 644
G + + L L L N +TG P L + L L+L + + + + LA
Sbjct: 87 GALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQ 145
Query: 645 VVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTM 704
+ PG+ K + + F C R++
Sbjct: 146 WLKPGL---KVLSIAQA---------------------HSLNFS----CEQVRVFP---- 173
Query: 705 YTFTTNGSLIYLDLSYNSLSGTL-------PENFGSLNYLQVLNLGHNKLTGHIPDSFGG 757
+L LDLS N G P F +L L + N G +G
Sbjct: 174 -------ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAA 226
Query: 758 LKAIGVLDLSHNNFQGSIP-GSLGGLSFLSDLDVSNNNLSGIIPS 801
+ LDLSHN+ + + S S L+ L++S L +
Sbjct: 227 RVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKG 271
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 38/198 (19%), Positives = 63/198 (31%), Gaps = 42/198 (21%)
Query: 99 LNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAG---DLSTSKTSSCSLVT 155
L + L++ + + + + P L L+L N + +L
Sbjct: 147 LKPGLKVLSIAQAHSL-NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQV 205
Query: 156 MDLSSNNITG-SLPGRSFLLSCDRLSYVNLSHNSISG----GSLHIGPSLLQLDLSGNQI 210
+ L + + S + + +L ++LSHNS+ S L L+LS +
Sbjct: 206 LALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL 265
Query: 211 SDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVA 270
+ LP KL S +DLSYN L P+
Sbjct: 266 K-------QVPKG------------LPAKL----------SVLDLSYNRLD-RNPSP--- 292
Query: 271 DSSGSLKYLDLSHNNFTG 288
D + L L N F
Sbjct: 293 DELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 8e-09
Identities = 27/116 (23%), Positives = 45/116 (38%), Gaps = 8/116 (6%)
Query: 101 SHVTSLNLNNSGLS--GSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDL 158
+ L L N+G+ + A L+ L+L NS + S L +++L
Sbjct: 201 PTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNL 260
Query: 159 SSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIG-PSLLQLDLSGNQISDS 213
S + +P +LS ++LS+N + P + L L GN DS
Sbjct: 261 SFTGLK-QVPKGLP----AKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 18/101 (17%), Positives = 28/101 (27%), Gaps = 7/101 (6%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIP----DSFGGLKAIGVLDLS 767
L L ++ E L L+L N G + VL L
Sbjct: 150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALR 209
Query: 768 HNNFQ---GSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQL 805
+ + G L LD+S+N+L +
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 4e-07
Identities = 19/107 (17%), Positives = 29/107 (27%), Gaps = 8/107 (7%)
Query: 709 TNGSLIYLDLSYNSLSGTLPENFGSLNY----LQVLNLGHNKLTGHIPDSFGGLKAIGVL 764
T L L+L S + + L+VL++ + A+ L
Sbjct: 119 TGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTL 178
Query: 765 DLSHNNFQGSIP----GSLGGLSFLSDLDVSNNNLSGIIPSGGQLTT 807
DLS N G L L + N + L
Sbjct: 179 DLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAA 225
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLVPLLGYC 993
IG G FGEV+K R VVAIK + + + E E+ + + + G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAI---GSARGLAFLHHSCI 1050
+ ++ EY+ GS +L LD +IA +GL +LH
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLLEPG------PLD---ETQIATILREILKGLDYLHSE-- 138
Query: 1051 PHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFR 1110
IHRD+K++NVLL E+ E +++DFG+A + DT + +T GTP ++ PE +
Sbjct: 139 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSA 195
Query: 1111 CTTKGDVYSYGVILLELLSGKRP 1133
+K D++S G+ +EL G+ P
Sbjct: 196 YDSKADIWSLGITAIELARGEPP 218
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 52/211 (24%), Positives = 90/211 (42%), Gaps = 20/211 (9%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGD--REFMAEMETIGK-IKHRNLVPLLG 991
+G G +G V K + G ++A+K+ I T + + +++ + + V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKR-IRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 992 YCKIGEERLLVYEYMKWGSLESVLHD-RAKGGGTKLDWAARKKIAIGSARGLAFLHHSCI 1050
+ + E M SL+ KG D KIA+ + L LH
Sbjct: 74 ALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILG--KIAVSIVKALEHLHSKL- 129
Query: 1051 PHIIHRDMKSSNVLLDENFEARVSDFGM-ARLVNALDTHLSVSTLAGTPGYVPPE----Y 1105
+IHRD+K SNVL++ + ++ DFG+ LV+ ++ AG Y+ PE
Sbjct: 130 -SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD----VAKDIDAGCKPYMAPERINPE 184
Query: 1106 YQSFRCTTKGDVYSYGVILLELLSGKRPIDP 1136
+ K D++S G+ ++EL + P D
Sbjct: 185 LNQKGYSVKSDIWSLGITMIELAILRFPYDS 215
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 7e-26
Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCK 994
+G G +G VYKA G +VAIK+ + V E + E+ + + ++V G
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQ-VPVESDLQ-EIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 995 IGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAI---GSARGLAFLHHSCIP 1051
+ +V EY GS+ ++ R K L +IA + +GL +LH
Sbjct: 95 KNTDLWIVMEYCGAGSVSDIIRLRNK----TLT---EDEIATILQSTLKGLEYLHFM--- 144
Query: 1052 HIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRC 1111
IHRD+K+ N+LL+ A+++DFG+A + DT +T+ GTP ++ PE Q
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT--DTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 1112 TTKGDVYSYGVILLELLSGKRP 1133
D++S G+ +E+ GK P
Sbjct: 203 NCVADIWSLGITAIEMAEGKPP 224
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 20/210 (9%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGD--REFMAEMETIGK-IKHRNLVPLLGY 992
+GSG G+V+K + R V K + +G + + + +++ + K +V G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 993 CKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPH 1052
+ + E M + + G K+ + + L +L
Sbjct: 93 FITNTDVFIAMELMGTCAE---KLKKRMQGPIPERILG--KMTVAIVKALYYLKEK--HG 145
Query: 1053 IIHRDMKSSNVLLDENFEARVSDFGM-ARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRC 1111
+IHRD+K SN+LLDE + ++ DFG+ RLV+ + AG Y+ PE
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD----KAKDRSAGCAAYMAPERIDPPDP 201
Query: 1112 -----TTKGDVYSYGVILLELLSGKRPIDP 1136
+ DV+S G+ L+EL +G+ P
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKN 231
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 63/310 (20%), Positives = 112/310 (36%), Gaps = 68/310 (21%)
Query: 930 FSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMA----EMETIGKIK-HR 984
++ ++G G G V G VA+K++ +F E++ + + H
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRM-------LIDFCDIALMEIKLLTESDDHP 69
Query: 985 NLVPLLGYCKIGEERLLVYEYMKWGSLESVL--HDRAKGGGTKLDWAARKKIAIGSARGL 1042
N++ + E +L+ ++ + + + A G+
Sbjct: 70 NVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 1043 AFLHHSCIPHIIHRDMKSSNVLLD-------------ENFEARVSDFGMARLVNALDTHL 1089
A LH IIHRD+K N+L+ EN +SDFG+ + +++ +
Sbjct: 129 AHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 1090 S--VSTLAGTPGYVPPE-------YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFG 1140
++ +GT G+ PE R T D++S G + +LS + P FG
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH--P--FG 241
Query: 1141 DDNNLVGWAKQLHREKRI-NEILDPELTMQTSDETELYQYLRISFE-------CLDDRPF 1192
D + RE I I DE + + E +D P
Sbjct: 242 DKYS---------RESNIIRGIFS-------LDEMKCLHDRSLIAEATDLISQMIDHDPL 285
Query: 1193 KRPTMIQVMA 1202
KRPT ++V+
Sbjct: 286 KRPTAMKVLR 295
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-25
Identities = 64/341 (18%), Positives = 107/341 (31%), Gaps = 59/341 (17%)
Query: 174 LSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSD 233
LSCDR S S++ + ++ LDLS N+I+ + L C NL L +
Sbjct: 28 LSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITY--ISNSDLQRCVNLQALVLTS 85
Query: 234 NKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFT----GK 289
N I+TI+ SF S GSL++LDLS+N +
Sbjct: 86 NG--------------INTIE----------EDSF--SSLGSLEHLDLSYNYLSNLSSSW 119
Query: 290 FSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFR 349
F L +L+ + L N + + L+ L + + I
Sbjct: 120 FKPL-----SSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLT 174
Query: 350 NLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNM 409
L++L + + P+ ++ + L L + L SS+ L L
Sbjct: 175 FLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTD 233
Query: 410 LSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCS 469
L F+ +S SL R + ++ +
Sbjct: 234 LDTF-----------------HFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLL-- 273
Query: 470 PPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSL 510
L ++ N L +L+ I L N
Sbjct: 274 -NQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 60/332 (18%), Positives = 115/332 (34%), Gaps = 47/332 (14%)
Query: 238 GKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGR 297
N S++C S L+ IP+ + ++K LDLS+N T
Sbjct: 21 ESSNQASLSCDRNGICKGSSGSLN-SIPSGL----TEAVKSLDLSNNRIT---------- 65
Query: 298 CGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLA 357
+S + L+ C L+ L ++ N + I S +L+ L L+
Sbjct: 66 -------YIS---------NSDLQRCVNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLS 108
Query: 358 HNQFAGEIPPELGQACGTLRELDLSSNRLTGELP-STFASCSSLHSLNLGSNMLSGNFLN 416
+N + + + +L L+L N S F+ + L L +G+
Sbjct: 109 YNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQR 167
Query: 417 TVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPAL 476
+ ++ L L + +++ P SL + + L L + F ++
Sbjct: 168 KDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIF--VDVTSSV 224
Query: 477 EKIVLPNNYLSGT--------VPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLV 528
E + L + L L + + ++ SL V + + L +L
Sbjct: 225 ECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELE 283
Query: 529 MWANNLTGEIPEGICVNGGNLETLILNNNHLT 560
N L +P+GI +L+ + L+ N
Sbjct: 284 FSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 52/267 (19%), Positives = 101/267 (37%), Gaps = 16/267 (5%)
Query: 375 TLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNN 434
++ LDLS+NR+T S C +L +L L SN ++ S + SL +L + +N
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY 111
Query: 435 ISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLE- 493
+S + L L+L N + + + L+ + + N + +
Sbjct: 112 LSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSL--FSHLTKLQILRVGNMDTFTKIQRKD 169
Query: 494 LGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLI 553
L+ +++ + L P + S+ N+S L++ + E ++E L
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLE 228
Query: 554 LNNNHLTGAIPKSI-----ASCTNMLW---VSLSSNQLTGEIPAGIGNLVKLAILQLGNN 605
L + L + S V ++ L ++ + + L L+ N
Sbjct: 229 LRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRN 287
Query: 606 SLTGQVPQG-LGKCRSLVWLDLNSNNL 631
L VP G + SL + L++N
Sbjct: 288 QLKS-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 55/340 (16%), Positives = 113/340 (33%), Gaps = 48/340 (14%)
Query: 436 SGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELG 495
+ +C + + SS +IPSG A++ + L NN ++ +L
Sbjct: 20 EESSNQASLSCDRNGICKGSSGSLN-SIPSGL-----TEAVKSLDLSNNRITYISNSDLQ 73
Query: 496 SCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILN 555
C NL+ + L+ N + SL +L L + N L+ + +L L L
Sbjct: 74 RCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLL 132
Query: 556 NNHLTGAIPKSI-ASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNNSLTGQVPQ 613
N S+ + T + + + + +I L L L++ + L P+
Sbjct: 133 GNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPK 192
Query: 614 GLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGL 673
L +++ L L+ L + + S + +
Sbjct: 193 SLKSIQNVSHLILHMKQHIL-LLE-------IFVDVTSSVECLELRDTD----------- 233
Query: 674 VEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGS 733
+ + + + TG T + + + ++ SL + +
Sbjct: 234 ----------------LDTFHFSELSTGET-NSLIKKFTFRNVKITDESLF-QVMKLLNQ 275
Query: 734 LNYLQVLNLGHNKLTGHIPDS-FGGLKAIGVLDLSHNNFQ 772
++ L L N+L +PD F L ++ + L N +
Sbjct: 276 ISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 7e-21
Identities = 47/270 (17%), Positives = 85/270 (31%), Gaps = 20/270 (7%)
Query: 152 SLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHN---SISGGSLHIGPSLLQLDLSGN 208
++ ++DLS+N IT + C L + L+ N +I S SL LDLS N
Sbjct: 53 AVKSLDLSNNRIT-YISNSDLQ-RCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYN 110
Query: 209 QISDSALLTYSLSNCQNLNLLNFSDNKLPG-KLNATSVNCKSISTIDLSYNLLSGEIPAS 267
+ S L + +L LN N + + + + + +I
Sbjct: 111 YL--SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168
Query: 268 FVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLE 327
L+ L++ ++ + N+S + L + +E
Sbjct: 169 -DFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLL-EIFVDVTSSVE 225
Query: 328 TLNMSHNALQG-------GIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELD 380
L + L L + + + +L L EL+
Sbjct: 226 CLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ--VMKLLNQISGLLELE 283
Query: 381 LSSNRLTGELPSTFASCSSLHSLNLGSNML 410
S N+L F +SL + L +N
Sbjct: 284 FSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 52/248 (20%), Positives = 88/248 (35%), Gaps = 20/248 (8%)
Query: 396 SCSSLHSLNLGSNMLSGNFLNTVVSKI-SSLIYLYVPFNNISGPVPLSLTNCTQLRVLDL 454
SC S LN++ S + ++ L + N I+ L C L+ L L
Sbjct: 29 SCDRNGICKG-----SSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVL 83
Query: 455 SSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPV 514
+SNG TI S + +LE + L NYLS +L ++L N
Sbjct: 84 TSNGIN-TIEED--SFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLG 140
Query: 515 PSEIWS-LPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNM 573
+ ++S L L L + + +I LE L ++ + L PKS+ S N+
Sbjct: 141 ETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNV 200
Query: 574 LWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNN--------SLTGQVPQGLGKCRSLVWL 624
+ L Q + + L+L + L+ L K + +
Sbjct: 201 SHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNV 259
Query: 625 DLNSNNLS 632
+ +L
Sbjct: 260 KITDESLF 267
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 6e-18
Identities = 48/277 (17%), Positives = 92/277 (33%), Gaps = 31/277 (11%)
Query: 99 LNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGN---SFSAGDLSTSKTSSCSLVT 155
L V SL+L+N+ ++ ++ + L L+ L L N + S+ SL
Sbjct: 50 LTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLG----SLEH 104
Query: 156 MDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSIS----GGSLHIGPSLLQLDLSGNQ-- 209
+DLS N ++ +L F L+++NL N L L +
Sbjct: 105 LDLSYNYLS-NLSSSWF-KPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTF 162
Query: 210 --ISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPAS 267
I + L L + L + + +++S + L +
Sbjct: 163 TKIQRKD-----FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEI 216
Query: 268 FVADSSGSLKYLDLSHNNFTG----KFSNLDFGRCGNLSVIT-LSQNGLSGTEFPASLKN 322
D + S++ L+L + + S + + S + L
Sbjct: 217 -FVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQ 275
Query: 323 CQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHN 359
L L S N L+ +P + +L+++ L N
Sbjct: 276 ISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 45/282 (15%), Positives = 88/282 (31%), Gaps = 45/282 (15%)
Query: 532 NNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGI 591
+L IP G+ +++L L+NN +T + C N+ + L+SN + I
Sbjct: 41 GSLN-SIPSGLTEA---VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDS 95
Query: 592 -GNLVKLAILQLGNNSLTGQVPQGL-GKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPG 649
+L L L L N L+ + SL +L+L N
Sbjct: 96 FSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKT---------------- 138
Query: 650 IVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPM-----VHSCPSTRIYTGMTM 704
+ F+ + G + F I+ + G + +
Sbjct: 139 LGETSLFSHLTK---LQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPK--- 192
Query: 705 YTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGH--------IPDSFG 756
+ + ++ +L L L + ++ L L L +S
Sbjct: 193 -SLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLI 251
Query: 757 GLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGI 798
+ ++ + + L +S L +L+ S N L +
Sbjct: 252 KKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSV 292
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 24/92 (26%), Positives = 40/92 (43%), Gaps = 2/92 (2%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
++ LDLS N ++ + LQ L L N + DSF L ++ LDLS+N
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112
Query: 772 QGSIP-GSLGGLSFLSDLDVSNNNLSGIIPSG 802
++ LS L+ L++ N + +
Sbjct: 113 S-NLSSSWFKPLSSLTFLNLLGNPYKTLGETS 143
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 8e-10
Identities = 15/122 (12%), Positives = 36/122 (29%), Gaps = 8/122 (6%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVL 764
F+ L L + + F L +L+ L + + L + P S ++ + L
Sbjct: 144 LFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHL 203
Query: 765 DLSHNNFQGSIP-GSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLP 823
L + + S + L++ + +L + +
Sbjct: 204 ILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTF-----HFSELSTGETNSLIKKFTFR 257
Query: 824 LL 825
+
Sbjct: 258 NV 259
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 25/100 (25%), Positives = 44/100 (44%), Gaps = 5/100 (5%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVL 764
+L L L+ N ++ T+ E+ F SL L+ L+L +N L+ F L ++ L
Sbjct: 71 DLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFL 129
Query: 765 DLSHNNFQGSIP--GSLGGLSFLSDLDVSNNNLSGIIPSG 802
+L N ++ ++ L+ L L V N + I
Sbjct: 130 NLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-25
Identities = 68/326 (20%), Positives = 113/326 (34%), Gaps = 59/326 (18%)
Query: 179 LSYVNLSHNSIS-------GGSLHIGPSLLQLDLSGNQISDSA--LLTYSLSNCQNLNLL 229
+ +L ++I+ L S+ ++ LSGN I A L+ ++++ ++L +
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 230 NFSDNKLPGKLNATSV-----------NCKSISTIDLSYNLLSGEIPASFVAD---SSGS 275
FSD G++ C + T+ LS N G + D
Sbjct: 66 EFSDIFT-GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAF-GPTAQEPLIDFLSKHTP 123
Query: 276 LKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNA 335
L++L L +N G + +++ L KN L ++ N
Sbjct: 124 LEHLYLHNNGL------------GPQAGAKIAR-ALQELAVNKKAKNAPPLRSIICGRNR 170
Query: 336 LQ-GGIPGF--LLGSFRNLKQLSLAHNQFAGE-IPPELGQA---CGTLRELDLSSNRLTG 388
L+ G + + S R L + + N E I L + C L+ LDL N T
Sbjct: 171 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTH 230
Query: 389 E----LPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKI-----SSLIYLYVPFNNISGPV 439
L S +L L L +LS VV L L + +N I
Sbjct: 231 LGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDA 290
Query: 440 PLSL-----TNCTQLRVLDLSSNGFT 460
+L L L+L+ N F+
Sbjct: 291 VRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-18
Identities = 61/356 (17%), Positives = 101/356 (28%), Gaps = 64/356 (17%)
Query: 105 SLNLNNSGLSGSLNL-TTLTALPYLEHLNLQGNSFS---AGDLSTSKTSSCSLVTMDLSS 160
SL L+ ++ L ++ + L GN+ A LS + S L + S
Sbjct: 10 SLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 69
Query: 161 NNI-----TGSLPGRSF---LLSCDRLSYVNLSHNSIS-------GGSLHIGPSLLQLDL 205
R LL C +L V LS N+ L L L L
Sbjct: 70 IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 129
Query: 206 SGNQISDSA--LLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGE 263
N + A + +L N + +I N L
Sbjct: 130 HNNGLGPQAGAKIARALQELAVNKKAK---------------NAPPLRSIICGRNRL-EN 173
Query: 264 IPASFVAD---SSGSLKYLDLSHNNFTGK-----FSNLDFGRCGNLSVITLSQNGLS--- 312
A S L + + N + C L V+ L N +
Sbjct: 174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEG-LAYCQELKVLDLQDNTFTHLG 232
Query: 313 GTEFPASLKNCQLLETLNMSHNAL--QGGIP---GFLLGSFRNLKQLSLAHNQF----AG 363
+ +LK+ L L ++ L +G F L+ L L +N+
Sbjct: 233 SSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVR 292
Query: 364 EIPPELGQACGTLRELDLSSNRLT------GELPSTFASCSSLHSLNLGSNMLSGN 413
+ + + L L+L+ NR + E+ F++ L +
Sbjct: 293 TLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEELTD 348
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 7e-17
Identities = 63/329 (19%), Positives = 106/329 (32%), Gaps = 61/329 (18%)
Query: 349 RNLKQLSLAHNQFAGEIPPELGQA---CGTLRELDLSSNRLTGE----LPSTFASCSSLH 401
+++ SL + E + +++E+ LS N + E L AS L
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 402 SLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTG 461
G + + + L+ +L C +L + LS N F
Sbjct: 64 IAEFSDIFT-GRVKDEIPEALRLLLQ--------------ALLKCPKLHTVRLSDNAFGP 108
Query: 462 TIPSGFCSP-PNFPALEKIVLPNNYLS-------------GTVPLELGSCKNLKTIDLSF 507
T LE + L NN L V + + L++I
Sbjct: 109 TAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGR 168
Query: 508 NSL----AGPVPSEIWSLPNLSDLVMWANNLTGE-----IPEGICVNGGNLETLILNNNH 558
N L S L + M N + E + EG+ L+ L L +N
Sbjct: 169 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQ-ELKVLDLQDNT 227
Query: 559 LTG----AIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVK------LAILQLGNNSLT 608
T A+ ++ S N+ + L+ L+ A + + L L+L N +
Sbjct: 228 FTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287
Query: 609 GQVPQGLG-----KCRSLVWLDLNSNNLS 632
+ L K L++L+LN N S
Sbjct: 288 LDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 30/162 (18%), Positives = 62/162 (38%), Gaps = 27/162 (16%)
Query: 100 NSHVTSLNLNNSGLS--GSLNL--TTLTALPYLEHLNLQGNSFS---AGDLSTSKTSSCS 152
+ + ++ + +G+ G +L L L+ L+LQ N+F+ + L+ + S +
Sbjct: 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 245
Query: 153 LVTMDLSSNNITGSLPGRSFLLSC------DRLSYVNLSHNSISG-GSLHIG-------P 198
L + L+ ++ G + ++ L + L +N I + P
Sbjct: 246 LRELGLNDCLLSAR--GAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 303
Query: 199 SLLQLDLSGNQISDS----ALLTYSLSNCQNLNLLNFSDNKL 236
LL L+L+GN+ S+ + S L D +
Sbjct: 304 DLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEE 345
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-05
Identities = 48/316 (15%), Positives = 97/316 (30%), Gaps = 77/316 (24%)
Query: 524 LSDLVMWANNLTGEIPEGIC---VNGGNLETLILNNNHLTG----AIPKSIASCTNMLWV 576
+ + + +T E + + + +++ ++L+ N + + ++IAS ++
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 577 SLSSNQ---LTGEIPAGIGNLVK-------LAILQLGNNSLTGQVPQGLG----KCRSLV 622
S + EIP + L++ L ++L +N+ + L K L
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 623 WLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFA--FVRNEGGTACRGAGGLVEFEGIR 680
L L++N L G +G + A + A L
Sbjct: 126 HLYLHNNGL-----------------GPQAGAKIARALQELAVNKKAKNAPPLRSII-CG 167
Query: 681 PERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSL-----SGTLPENFGSLN 735
RLE M + F ++ L + + N + L E
Sbjct: 168 RNRLENGSMKEWAKT-----------FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQ 216
Query: 736 YLQVLNLGHNKLTG----HIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSF------- 784
L+VL+L N T + + + L L+ + G +
Sbjct: 217 ELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL-----SARGAAAVVDAFSKL 271
Query: 785 ----LSDLDVSNNNLS 796
L L + N +
Sbjct: 272 ENIGLQTLRLQYNEIE 287
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-25
Identities = 57/263 (21%), Positives = 89/263 (33%), Gaps = 19/263 (7%)
Query: 152 SLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHN---SISGGSLHIGPSLLQLDLSGN 208
+ + ++ +P Y+NL N I + L L L N
Sbjct: 55 QFSKVVCTRRGLS-EVPQGIP----SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN 109
Query: 209 QISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPA-S 267
I + + + +LN L DN L + + + L N + IP+ +
Sbjct: 110 SI--RQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYA 166
Query: 268 FVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLE 327
F + SL LDL S F NL + L + + P L LE
Sbjct: 167 F--NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI--KDMPN-LTPLVGLE 221
Query: 328 TLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLT 387
L MS N I +LK+L + ++Q + I +L EL+L+ N L+
Sbjct: 222 ELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS 279
Query: 388 GELPSTFASCSSLHSLNLGSNML 410
F L L+L N
Sbjct: 280 SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-23
Identities = 50/242 (20%), Positives = 85/242 (35%), Gaps = 19/242 (7%)
Query: 348 FRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGS 407
N + L+L N I + + L L L N + F +SL++L L
Sbjct: 74 PSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132
Query: 408 NMLS----GNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTI 463
N L+ G F S L L++ N I + L LDL I
Sbjct: 133 NWLTVIPSGAFEYL-----SKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYI 187
Query: 464 PSG-FCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLP 522
G F L+ + L + +P L L+ +++S N P L
Sbjct: 188 SEGAF---EGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLS 242
Query: 523 NLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSI-ASCTNMLWVSLSSN 581
+L L + + ++ I +L L L +N+L+ ++P + ++ + L N
Sbjct: 243 SLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
Query: 582 QL 583
Sbjct: 301 PW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-14
Identities = 46/262 (17%), Positives = 90/262 (34%), Gaps = 59/262 (22%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSS 160
H+ L L + + + + L L L +L
Sbjct: 99 HHLEVLQLGRNSIR-QIEVGAFNGLASLNTL-------------------------ELFD 132
Query: 161 NNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYSL 220
N +T +P +F L L +L L N I ++ +Y+
Sbjct: 133 NWLT-VIPSGAF---------EYL-------------SKLRELWLRNNPI--ESIPSYAF 167
Query: 221 SNCQNLNLLNFSDNKLPGKLNATS-VNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYL 279
+ +L L+ + K ++ + ++ ++L + ++P L+ L
Sbjct: 168 NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-L--TPLVGLEEL 223
Query: 280 DLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGG 339
++S N+F + F +L + + + +S E + L LN++HN L
Sbjct: 224 EMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIE-RNAFDGLASLVELNLAHNNLS-S 280
Query: 340 IPGFLLGSFRNLKQLSLAHNQF 361
+P L R L +L L HN +
Sbjct: 281 LPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 7e-12
Identities = 24/93 (25%), Positives = 44/93 (47%), Gaps = 2/93 (2%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
F +L YL+L ++ +P L L+ L + N P SF GL ++ L
Sbjct: 191 AFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLW 248
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGI 798
+ ++ + GL+ L +L++++NNLS +
Sbjct: 249 VMNSQVSLIERNAFDGLASLVELNLAHNNLSSL 281
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 1e-11
Identities = 26/95 (27%), Positives = 41/95 (43%), Gaps = 3/95 (3%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIP-DSFGGLKAIGVL 764
F SL L+L N L+ F L+ L+ L L +N + IP +F + ++ L
Sbjct: 118 AFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRL 176
Query: 765 DLSHNNFQGSIP-GSLGGLSFLSDLDVSNNNLSGI 798
DL I G+ GL L L++ N+ +
Sbjct: 177 DLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM 211
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 3e-11
Identities = 27/96 (28%), Positives = 40/96 (41%), Gaps = 3/96 (3%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGH-NKLTGHIPDSFGGLKAIGVL 764
F L L L N + F + L L+LG KL +F GL + L
Sbjct: 142 AFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYL 201
Query: 765 DLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIP 800
+L N + +P +L L L +L++S N+ I P
Sbjct: 202 NLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRP 235
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-11
Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
+ YL+L N++ + F L++L+VL LG N + +F GL ++ L+L N
Sbjct: 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135
Query: 772 QGSIP-GSLGGLSFLSDLDVSNNNLSGIIPSG 802
IP G+ LS L +L + NN + IPS
Sbjct: 136 T-VIPSGAFEYLSKLRELWLRNNPIE-SIPSY 165
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-10
Identities = 25/98 (25%), Positives = 34/98 (34%), Gaps = 2/98 (2%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVL 764
TF L L L NS+ + F L L L L N LT +F L + L
Sbjct: 94 TFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLREL 152
Query: 765 DLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSG 802
L +N + + + L LD+ I G
Sbjct: 153 WLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEG 190
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 5e-10
Identities = 22/90 (24%), Positives = 43/90 (47%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
T L L++S N P +F L+ L+ L + +++++ ++F GL ++ L+
Sbjct: 213 NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELN 272
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNL 795
L+HNN L +L +L + +N
Sbjct: 273 LAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 6e-07
Identities = 21/67 (31%), Positives = 29/67 (43%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
+F SL L + + +S F L L LNL HN L+ D F L+ + L
Sbjct: 237 SFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELH 296
Query: 766 LSHNNFQ 772
L HN +
Sbjct: 297 LHHNPWN 303
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 51/228 (22%), Positives = 90/228 (39%), Gaps = 43/228 (18%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIK----KLIHVTGQGDREFMAEMETIGKIKHRNLVPLL 990
+G G +G+V + A+K K + G+ E++ + +++H+N++ L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL- 71
Query: 991 GYCKIGEER----LLVYEYMKWGSLESVLHDRAKGGGTKL-DWAARKKIAIGSAR----- 1040
+ E +V EY G ++ D K+ + A
Sbjct: 72 -VDVLYNEEKQKMYMVMEY-------------CVCGMQEMLDSVPEKRFPVCQAHGYFCQ 117
Query: 1041 ---GLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGT 1097
GL +LH I+H+D+K N+LL ++S G+A ++ + T G+
Sbjct: 118 LIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGS 174
Query: 1098 PGYVPPEYYQSFRC--TTKGDVYSYGVILLELLSGKRPIDPSEFGDDN 1143
P + PPE K D++S GV L + +G P F DN
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP-----FEGDN 217
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 12/207 (5%)
Query: 936 IGSGGFGEVYKA-QLRDGSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLVPLLGYC 993
IGSG V A VAIK++ Q + + E++ + + H N+V
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAI---GSARGLAFLHHSCI 1050
+ +E LV + + GS+ ++ G K IA GL +LH +
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-- 140
Query: 1051 PHIIHRDMKSSNVLLDENFEARVSDFGM-ARLVNALDTHLSVS--TLAGTPGYVPPEYYQ 1107
IHRD+K+ N+LL E+ +++DFG+ A L D + T GTP ++ PE +
Sbjct: 141 -GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 1108 SFRC-TTKGDVYSYGVILLELLSGKRP 1133
R K D++S+G+ +EL +G P
Sbjct: 200 QVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-25
Identities = 44/214 (20%), Positives = 80/214 (37%), Gaps = 26/214 (12%)
Query: 936 IGSG--GFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREF---MAEMETIGKIKHRNLVPL 989
IG G V A+ G V +++ I++ + E+ H N+VP
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRR-INLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAI---GSARGLAFLH 1046
E +V +M +GS + ++ G + IA G + L ++H
Sbjct: 92 RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE------LAIAYILQGVLKALDYIH 145
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARVSDFG-MARLVNALD----THLSVSTLAGTPGYV 1101
H +HR +K+S++L+ + + +S +++ H ++
Sbjct: 146 HM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202
Query: 1102 PPEYYQSFRC--TTKGDVYSYGVILLELLSGKRP 1133
PE Q K D+YS G+ EL +G P
Sbjct: 203 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-25
Identities = 59/255 (23%), Positives = 90/255 (35%), Gaps = 55/255 (21%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIK-----KLIHVTGQGDREFMAEMETIGKIKHRNLVPL 989
IG G +G V A ++ AIK K+ + + E+ + K+ H N+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSAR--------- 1040
+ + LV E G L L+ K K
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 1041 --------------------------GLAFLHHSCIPHIIHRDMKSSNVLL--DENFEAR 1072
L +LH+ I HRD+K N L +++FE +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 1073 VSDFGMARLVNALDTH--LSVSTLAGTPGYVPPE--YYQSFRCTTKGDVYSYGVILLELL 1128
+ DFG+++ L+ ++T AGTP +V PE + K D +S GV+L LL
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 1129 SGKRPIDPSEFGDDN 1143
G P F N
Sbjct: 271 MGAVP-----FPGVN 280
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-24
Identities = 70/273 (25%), Positives = 114/273 (41%), Gaps = 36/273 (13%)
Query: 867 LYRVKKDQKKDEQREKYIESLPTSGSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEA 926
L R +++++SL WK +P+ + F
Sbjct: 146 LLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLE-AQPMGED-----------WFLDF--- 190
Query: 927 TNGFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKL--IHVTGQGDREF-MAEMETIGKIK 982
++G GGFGEV+ Q++ G + A KKL + + + M E + + K+
Sbjct: 191 -------RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 983 HRNLVPLLGYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIA-IGSAR 1040
R +V L Y + L LV M G + +++ + + A A I S
Sbjct: 244 SRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG- 301
Query: 1041 GLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGY 1100
L LH +II+RD+K NVLLD++ R+SD G+A + A T AGTPG+
Sbjct: 302 -LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGF 355
Query: 1101 VPPEYYQSFRCTTKGDVYSYGVILLELLSGKRP 1133
+ PE D ++ GV L E+++ + P
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 50/218 (22%), Positives = 90/218 (41%), Gaps = 30/218 (13%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLVPLLGYC 993
+GSG FG V++ + G V K I+ D+ E+ + ++ H L+ L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAK-FINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 994 KIGEERLLVYEYMKWGSLESVLHDR--AKGGG-TKLDWAAR--KKIAIGSARGLAFLHHS 1048
+ E +L+ E++ G E L DR A+ ++ + ++ GL +H
Sbjct: 118 EDKYEMVLILEFLSGG--E--LFDRIAAEDYKMSEAE-VINYMRQAC----EGLKHMHEH 168
Query: 1049 CIPHIIHRDMKSSNVLL--DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYY 1106
I+H D+K N++ + ++ DFG+A L+ V T + PE
Sbjct: 169 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATK---LNPDEIVKVTTATAEFAAPEIV 222
Query: 1107 QSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144
D+++ GV+ LLSG P F +++
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSGLSP-----FAGEDD 255
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIK-----KLIHVTGQGDRE-FMAEMETIGKIKHRNLVP 988
+GSG F V K + + G A K +L RE E+ + +I+H N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDR--AKGGGTKLDWAAR--KKIAIGSARGLAF 1044
L + + +L+ E + G E L D K T+ + A + K+I G+ +
Sbjct: 73 LHDIFENKTDVVLILELVSGG--E--LFDFLAEKESLTEDE-ATQFLKQIL----DGVHY 123
Query: 1045 LHHSCIPHIIHRDMKSSNVLL----DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGY 1100
LH I H D+K N++L N ++ DFG+A + A + + GTP +
Sbjct: 124 LHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEF 177
Query: 1101 VPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144
V PE + D++S GVI LLSG P F +
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP-----FLGETK 216
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 70/288 (24%), Positives = 119/288 (41%), Gaps = 41/288 (14%)
Query: 871 KKDQKKDEQREKYIESLPTSGSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGF 930
+ + ++ + S + S++ + A F+ + +
Sbjct: 33 RSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYT-V 91
Query: 931 SADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLVP 988
S ++G G FG+V+K + G +A K +I G D+E E+ + ++ H NL+
Sbjct: 92 SKTEILGGGRFGQVHKCEETATGLKLAAK-IIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDR--AKGGG-TKLDWAAR--KKIAIGSARGLA 1043
L + + +LV EY+ G E L DR + T+LD K+I G+
Sbjct: 151 LYDAFESKNDIVLVMEYVDGG--E--LFDRIIDESYNLTELD-TILFMKQIC----EGIR 201
Query: 1044 FLHHSCIPHIIHRDMKSSNVLLDENFEARV--SDFGMARLVNALDTHLSVSTLAGTPGYV 1101
+H +I+H D+K N+L ++ DFG+AR + + GTP ++
Sbjct: 202 HMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNFGTPEFL 255
Query: 1102 PPE-----YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144
PE + SF D++S GVI LLSG P F DN+
Sbjct: 256 APEVVNYDFV-SFPT----DMWSVGVIAYMLLSGLSP-----FLGDND 293
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 47/217 (21%), Positives = 87/217 (40%), Gaps = 29/217 (13%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCK 994
+G G FG V++ K + V G E+ + +HRN++ L +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 995 IGEERLLVYEYMKWGSLESVLHDR--AKGGG-TKLDWAAR--KKIAIGSARGLAFLHHSC 1049
EE ++++E++ + + +R + + ++ L FLH
Sbjct: 72 SMEELVMIFEFISGL--D--IFERINTSAFELNERE-IVSYVHQV----CEALQFLHSH- 121
Query: 1050 IPHIIHRDMKSSNVLL--DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQ 1107
+I H D++ N++ + ++ +FG AR L + L P Y PE +Q
Sbjct: 122 --NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ---LKPGDNFRLLFTAPEYYAPEVHQ 176
Query: 1108 SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144
+T D++S G ++ LLSG P F + N
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINP-----FLAETN 208
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-24
Identities = 73/315 (23%), Positives = 127/315 (40%), Gaps = 58/315 (18%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKLI--HVTGQGDRE-FMAEMETIGKIKHRNLVPLLG 991
+G G FGEV + + G A+K + V + D+E + E++ + ++ H N++ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 992 YCKIGEERLLVYEYMKWGSLESVLHDR--AKGGGTKLDWAAR--KKIAIGSARGLAFLHH 1047
+ + LV E G L D ++ +++D AAR +++ G+ ++H
Sbjct: 94 FFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVD-AARIIRQVL----SGITYMHK 144
Query: 1048 SCIPHIIHRDMKSSNVLL---DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE 1104
+ I+HRD+K N+LL ++ R+ DFG++ A + GT Y+ PE
Sbjct: 145 N---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIAPE 198
Query: 1105 YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI-NEILD 1163
K DV+S GVIL LLSG P F N E I ++
Sbjct: 199 VLHG-TYDEKCDVWSTGVILYILLSGCPP-----FNGAN-----------EYDILKKVEK 241
Query: 1164 PELTMQTSDETELYQYLRISFE-------CLDDRPFKRPTMIQVMAMFKELQVDTEGDSL 1216
+ T + + ++S L P R + + + +Q T+
Sbjct: 242 GKYTFELPQ------WKKVSESAKDLIRKMLTYVPSMRISARDALDH-EWIQTYTKEQIS 294
Query: 1217 DSFSLKDTVIEELRE 1231
D I +R+
Sbjct: 295 VDVPSLDNAILNIRQ 309
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-24
Identities = 64/283 (22%), Positives = 116/283 (40%), Gaps = 56/283 (19%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKLI--HVTGQGDREFMAEMETIGKIKHRNLVPLLGY 992
+GSG +GEV + + AIK + V+ + + + E+ + + H N++ L +
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 993 CKIGEERLLVYEYMKWGSLESVLHDR--AKGGGTKLDWAAR--KKIAIGSARGLAFLHHS 1048
+ LV E K G L D + ++D AA K++ G+ +LH
Sbjct: 105 FEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVD-AAVIIKQVL----SGVTYLHKH 155
Query: 1049 CIPHIIHRDMKSSNVLL---DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEY 1105
+I+HRD+K N+LL +++ ++ DFG++ + + GT Y+ PE
Sbjct: 156 ---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYIAPEV 209
Query: 1106 YQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI-NEILDP 1164
+ + K DV+S GVIL LL+G P FG ++ I ++
Sbjct: 210 LRK-KYDEKCDVWSIGVILFILLAGYPP-----FGGQT-----------DQEILRKVEKG 252
Query: 1165 ELTMQTSDETELYQYLRISFE-------CLDDRPFKRPTMIQV 1200
+ T + + + +S L +R + Q
Sbjct: 253 KYTFDSPE------WKNVSEGAKDLIKQMLQFDSQRRISAQQA 289
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-24
Identities = 69/318 (21%), Positives = 121/318 (38%), Gaps = 64/318 (20%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKLI--HVTGQGDREFMAEMETIGKIKHRNLVPLLGY 992
+G G FGEV K + R A+K + + + E+E + K+ H N++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 993 CKIGEERLLVY---EYMKWGSLESVLHDR--AKGGGTKLDWAAR--KKIAIGSARGLAFL 1045
E+ Y E G L D + ++ D AAR K++ G+ ++
Sbjct: 90 L---EDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHD-AARIIKQVF----SGITYM 137
Query: 1046 HHSCIPHIIHRDMKSSNVLL---DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP 1102
H +I+HRD+K N+LL +++ + ++ DFG++ + GT Y+
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIA 191
Query: 1103 PEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162
PE + K DV+S GVIL LLSG P F N + +
Sbjct: 192 PEVLRG-TYDEKCDVWSAGVILYILLSGTPP-----FYGKNE----------YDILKRVE 235
Query: 1163 DPELTMQTSDETELYQYLRISFE-------CLDDRPFKRPTMIQVMAM--FKELQVDTEG 1213
+ + IS + L P R T Q + + + +E
Sbjct: 236 TGKYAFDLPQ------WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ--KYSSET 287
Query: 1214 DSLDSFSLKDTVIEELRE 1231
++ ++ + +R+
Sbjct: 288 PTISDLPSLESAMTNIRQ 305
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-24
Identities = 73/278 (26%), Positives = 118/278 (42%), Gaps = 39/278 (14%)
Query: 862 GLTLALYRVKKDQKKDEQREKYIESLPTSGSSSWKLSSVPEPLSINVATFEKPLRKLTFA 921
L L R+ + Y++S+ + WK +P+ K TF
Sbjct: 140 DLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLE------------RQPVTKNTFR 187
Query: 922 HLLEATNGFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKL--IHVTGQGDREF-MAEMET 977
++G GGFGEV Q+R G + A KKL + + + E +
Sbjct: 188 QY----------RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI 237
Query: 978 IGKIKHRNLVPLLGYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIA- 1035
+ K+ R +V L Y ++ L LV M G L+ ++ + G + A A
Sbjct: 238 LEKVNSRFVVS-LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR--AVFYAAE 294
Query: 1036 IGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLA 1095
I L LH I++RD+K N+LLD++ R+SD G+A V T +
Sbjct: 295 ICCG--LEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRV 346
Query: 1096 GTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRP 1133
GT GY+ PE ++ R T D ++ G +L E+++G+ P
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 72/315 (22%), Positives = 112/315 (35%), Gaps = 93/315 (29%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIK-----KLIHVTGQGDREFMAEMETIG---------- 979
IG G +G V A D + A+K KLI G R
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 980 -----------KIKHRNLVPLLGYCKIG---EERL-LVYEYMKWGSLESVLHDRAKGGGT 1024
K+ H N+V L + E+ L +V+E + G
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVN--------------QGP 124
Query: 1025 KLDWAARKKIAIGSAR--------GLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDF 1076
++ K ++ AR G+ +LH+ IIHRD+K SN+L+ E+ +++DF
Sbjct: 125 VMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 1077 GMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKG---DVYSYGVILLELLSGKRP 1133
G++ D L S GTP ++ PE R G DV++ GV L + G+ P
Sbjct: 182 GVSNEFKGSDALL--SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
Query: 1134 IDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFEC------- 1186
F D ++ LH +I S E I+ +
Sbjct: 240 -----F-MDERIM----CLH--SKI-----------KSQALEFPDQPDIAEDLKDLITRM 276
Query: 1187 LDDRPFKRPTMIQVM 1201
LD P R + ++
Sbjct: 277 LDKNPESRIVVPEIK 291
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-23
Identities = 57/280 (20%), Positives = 113/280 (40%), Gaps = 30/280 (10%)
Query: 874 QKKDEQREKYIESLPTSGSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSAD 933
+ +R + + K + + +++ + + +
Sbjct: 103 PGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIH 162
Query: 934 SMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMA-EMETIGKIKHRNLVPLLG 991
+G+G FG V++ R G+ A K + + D+E + E++T+ ++H LV L
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAK-FVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD 221
Query: 992 YCKIGEERLLVYEYMKWGSLESVLHDR---AKGGGTKLDWAAR--KKIAIGSARGLAFLH 1046
+ E +++YE+M G E L ++ ++ + A +++ +GL +H
Sbjct: 222 AFEDDNEMVMIYEFMSGG--E--LFEKVADEHNKMSEDE-AVEYMRQV----CKGLCHMH 272
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARV--SDFGMARLVNALDTHLSVSTLAGTPGYVPPE 1104
+ + +H D+K N++ + DFG+ LD SV GT + PE
Sbjct: 273 EN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPE 326
Query: 1105 YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144
+ D++S GV+ LLSG P FG +N+
Sbjct: 327 VAEGKPVGYYTDMWSVGVLSYILLSGLSP-----FGGEND 361
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 59/224 (26%), Positives = 92/224 (41%), Gaps = 35/224 (15%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIK-----KLIHVTGQGDREFMA-EMETIGKIKHRNLVP 988
+GSG F V K + + G A K + RE + E+ + +I+H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDR--AKGGGTKLDWAAR--KKIAIGSARGLAF 1044
L + + +L+ E + G E L D K T+ + A K+I G+ +
Sbjct: 79 LHEVYENKTDVILILELVAGG--E--LFDFLAEKESLTEEE-ATEFLKQIL----NGVYY 129
Query: 1045 LHHSCIPHIIHRDMKSSNVLL----DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGY 1100
LH I H D+K N++L ++ DFG+A +D + GTP +
Sbjct: 130 LHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEF 183
Query: 1101 VPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144
V PE + D++S GVI LLSG P F D
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP-----FLGDTK 222
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-23
Identities = 56/224 (25%), Positives = 91/224 (40%), Gaps = 35/224 (15%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIK-----KLIHVTGQGDRE-FMAEMETIGKIKHRNLVP 988
+GSG F V K + + G A K + RE E+ + ++ H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDR--AKGGGTKLDWAAR--KKIAIGSARGLAF 1044
L + + +L+ E + G E L D K ++ + A K+I G+ +
Sbjct: 80 LHDVYENRTDVVLILELVSGG--E--LFDFLAQKESLSEEE-ATSFIKQIL----DGVNY 130
Query: 1045 LHHSCIPHIIHRDMKSSNVLL----DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGY 1100
LH I H D+K N++L ++ DFG+A ++ + + GTP +
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPEF 184
Query: 1101 VPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144
V PE + D++S GVI LLSG P F D
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP-----FLGDTK 223
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 54/265 (20%), Positives = 96/265 (36%), Gaps = 41/265 (15%)
Query: 348 FRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGS 407
N + L+L NQ I + L L LS N + F ++L++L L
Sbjct: 63 STNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121
Query: 408 NMLS----GNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTI 463
N L+ G F+ S L L++ N I + LR LDL I
Sbjct: 122 NRLTTIPNGAFVYL-----SKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYI 176
Query: 464 PSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPN 523
G NL+ ++L+ +L +P+ + L
Sbjct: 177 SEGA--------------------------FEGLSNLRYLNLAMCNLRE-IPN-LTPLIK 208
Query: 524 LSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQL 583
L +L + N+L+ I G +L+ L + + + + + +++ ++L+ N L
Sbjct: 209 LDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNL 267
Query: 584 TGEIPAGI-GNLVKLAILQLGNNSL 607
T +P + L L + L +N
Sbjct: 268 T-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 60/340 (17%), Positives = 106/340 (31%), Gaps = 86/340 (25%)
Query: 82 WTADALTPCSWQGVSCSLNSHVTSLNLNNSGLSGSLNLTTLTALP-----YLEHLNLQGN 136
+ C CS ++ + + L +P LNL N
Sbjct: 27 AETGSAQTCP---SVCSCSNQFSKVICVRKNL---------REVPDGISTNTRLLNLHEN 74
Query: 137 SFS---AGDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHN---SIS 190
+ L + LS N+I ++ +F L+ + L N +I
Sbjct: 75 QIQIIKVNSFKHLR----HLEILQLSRNHIR-TIEIGAFN-GLANLNTLELFDNRLTTIP 128
Query: 191 GGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSI 250
G+ L +L L N I ++ +Y+ + +L L+ + K +
Sbjct: 129 NGAFVYLSKLKELWLRNNPI--ESIPSYAFNRIPSLRRLDLGEL-------------KRL 173
Query: 251 STIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNG 310
S I +F + +L+YL+L+ N
Sbjct: 174 SYIS----------EGAF--EGLSNLRYLNLAMCNL------------------------ 197
Query: 311 LSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELG 370
E P L L+ L++S N L I +L++L + +Q I
Sbjct: 198 ---REIPN-LTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAF 251
Query: 371 QACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNML 410
+L E++L+ N LT F L ++L N
Sbjct: 252 DNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 6e-12
Identities = 28/95 (29%), Positives = 43/95 (45%), Gaps = 3/95 (3%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIP-DSFGGLKAIGVL 764
F +L L+L N L+ F L+ L+ L L +N + IP +F + ++ L
Sbjct: 107 AFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRL 165
Query: 765 DLSHNNFQGSIP-GSLGGLSFLSDLDVSNNNLSGI 798
DL I G+ GLS L L+++ NL I
Sbjct: 166 DLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI 200
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 1e-11
Identities = 34/133 (25%), Positives = 48/133 (36%), Gaps = 6/133 (4%)
Query: 499 NLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNH 558
+ +L VP I N L + N + I + +LE L L+ NH
Sbjct: 44 QFSKVICVRKNLRE-VPDGI--STNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNH 99
Query: 559 LTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNNSLTGQVPQGLGK 617
+ + N+ + L N+LT IP G L KL L L NN + +
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNR 158
Query: 618 CRSLVWLDLNSNN 630
SL LDL
Sbjct: 159 IPSLRRLDLGELK 171
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 4e-11
Identities = 27/92 (29%), Positives = 43/92 (46%), Gaps = 3/92 (3%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
+ L+L N + +F L +L++L L N + +F GL + L+L N
Sbjct: 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124
Query: 772 QGSIP-GSLGGLSFLSDLDVSNNNLSGIIPSG 802
+IP G+ LS L +L + NN + IPS
Sbjct: 125 T-TIPNGAFVYLSKLKELWLRNNPIE-SIPSY 154
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 4e-11
Identities = 25/93 (26%), Positives = 44/93 (47%), Gaps = 2/93 (2%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
F +L YL+L+ +L +P L L L+L N L+ P SF GL + L
Sbjct: 180 AFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLW 237
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGI 798
+ + Q + L L ++++++NNL+ +
Sbjct: 238 MIQSQIQVIERNAFDNLQSLVEINLAHNNLTLL 270
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 9e-11
Identities = 24/97 (24%), Positives = 34/97 (35%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
+F L L LS N + F L L L L N+LT +F L + L
Sbjct: 83 SFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELW 142
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSG 802
L +N + + + L LD+ I G
Sbjct: 143 LRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEG 179
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-10
Identities = 24/90 (26%), Positives = 41/90 (45%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
T L LDLS N LS P +F L +LQ L + +++ ++F L+++ ++
Sbjct: 202 NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEIN 261
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNL 795
L+HNN L L + + +N
Sbjct: 262 LAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 23/91 (25%), Positives = 35/91 (38%), Gaps = 5/91 (5%)
Query: 543 CVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQ 601
C +I +L +P I++ T +L L NQ+ I +L L ILQ
Sbjct: 39 CSCSNQFSKVICVRKNLR-EVPDGISTNTRLLN--LHENQIQ-IIKVNSFKHLRHLEILQ 94
Query: 602 LGNNSLTGQVPQGLGKCRSLVWLDLNSNNLS 632
L N + +L L+L N L+
Sbjct: 95 LSRNHIRTIEIGAFNGLANLNTLELFDNRLT 125
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 2e-06
Identities = 18/67 (26%), Positives = 27/67 (40%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
+F L L + + + F +L L +NL HN LT D F L + +
Sbjct: 226 SFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIH 285
Query: 766 LSHNNFQ 772
L HN +
Sbjct: 286 LHHNPWN 292
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 7e-23
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 27/217 (12%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLI--HVTGQGDREFMAEMETIGKIKHRNLVPLLGY 992
+G G FGEV K + R A+K + + + E+E + K+ H N++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 993 CKIGEERLLVYEYMKWGSLESVLHDR--AKGGGTKLDWAARKKIAIGSARGLAFLHHSCI 1050
+ +V E G E L D + ++ D AAR + S + ++H
Sbjct: 90 LEDSSSFYIVGELYTGG--E--LFDEIIKRKRFSEHD-AARIIKQVFSG--ITYMHKH-- 140
Query: 1051 PHIIHRDMKSSNVLL---DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQ 1107
+I+HRD+K N+LL +++ + ++ DFG++ GT Y+ PE +
Sbjct: 141 -NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPEVLR 196
Query: 1108 SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144
K DV+S GVIL LLSG P F N
Sbjct: 197 G-TYDEKCDVWSAGVILYILLSGTPP-----FYGKNE 227
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-23
Identities = 56/224 (25%), Positives = 89/224 (39%), Gaps = 35/224 (15%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIK-----KLIHVTGQGDRE-FMAEMETIGKIKHRNLVP 988
+GSG F V K + + G A K + RE E+ + ++ H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDR--AKGGGTKLDWAAR--KKIAIGSARGLAF 1044
L + + +L+ E + G E L D K ++ + A K+I G+ +
Sbjct: 80 LHDVYENRTDVVLILELVSGG--E--LFDFLAQKESLSEEE-ATSFIKQIL----DGVNY 130
Query: 1045 LHHSCIPHIIHRDMKSSNVLL----DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGY 1100
LH I H D+K N++L ++ DFG+A + + GTP +
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEF 184
Query: 1101 VPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144
V PE + D++S GVI LLSG P F D
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP-----FLGDTK 223
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 59/218 (27%), Positives = 88/218 (40%), Gaps = 22/218 (10%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIK-----KLIHVTGQGDREFMAEMETIGKIKHRNLVPL 989
IG G F V + R+ G A+K K G + E +KH ++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKI-AIGSARGLAFLHHS 1048
L +V+E+M L + RA G + A + I A L + H +
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA--LRYCHDN 149
Query: 1049 CIPHIIHRDMKSSNVLL---DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEY 1105
+IIHRD+K VLL + + ++ FG+A + ++ L GTP ++ PE
Sbjct: 150 ---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGLVAGGRVGTPHFMAPEV 204
Query: 1106 YQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDN 1143
+ DV+ GVIL LLSG P F
Sbjct: 205 VKREPYGKPVDVWGCGVILFILLSGCLP-----FYGTK 237
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-22
Identities = 69/279 (24%), Positives = 113/279 (40%), Gaps = 59/279 (21%)
Query: 872 KDQKKDEQREKYIESLPTSGSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFS 931
+ + +K+IES + WK + L++N F+
Sbjct: 154 CQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMN-----------DFSVH-------- 194
Query: 932 ADSMIGSGGFGEVYKAQLRD-GSVVAIKKL----IHVTGQGDREFMAE---METIGKIKH 983
+IG GGFGEVY + D G + A+K L I QG+ + E + +
Sbjct: 195 --RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSLVSTGDC 251
Query: 984 RNLVPLLGYCKIGEERL-LVYEYMKWGSLESVLH-------DRAKGGGTKLDWAARKKIA 1035
+V + Y ++L + + M G L L + +AA +I
Sbjct: 252 PFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF------YAA--EII 302
Query: 1036 IGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLA 1095
+G L +H+ +++RD+K +N+LLDE+ R+SD G+A + H
Sbjct: 303 LG----LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASV 351
Query: 1096 GTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRP 1133
GT GY+ PE Q + D +S G +L +LL G P
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 64/289 (22%), Positives = 111/289 (38%), Gaps = 66/289 (22%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIK-----KLIHVTGQGDREFMAEMETIGKIKHRNLVPL 989
+G G +GEV A VA+K + + +E + + H N+V
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKF 70
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDR-AKGGGTKLDWAARKK----IAIGSARGLAF 1044
G+ + G + L EY G E L DR G A++ +A G+ +
Sbjct: 71 YGHRREGNIQYLFLEYCSGG--E--LFDRIEPDIGMPEP-DAQRFFHQLMA-----GVVY 120
Query: 1045 LHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE 1104
LH I HRD+K N+LLDE ++SDFG+A + + ++ + GT YV PE
Sbjct: 121 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 1105 -----YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRIN 1159
+ + DV+S G++L +L+G+ P + ++ Q + + +
Sbjct: 178 LLKRREFHA----EPVDVWSCGIVLTAMLAGELP-----WDQPSDSC----QEYSDWKEK 224
Query: 1160 EILDPELTMQTSDETELYQYLRISFEC-------LDDRPFKRPTMIQVM 1201
+ + +I L + P R T+ +
Sbjct: 225 KTYLNP-------------WKKIDSAPLALLHKILVENPSARITIPDIK 260
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 56/240 (23%), Positives = 85/240 (35%), Gaps = 25/240 (10%)
Query: 222 NCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDL 281
+C L +P + I L N +S ASF + +L L L
Sbjct: 17 SCPQQGLQAVPVG-IP----------AASQRIFLHGNRISHVPAASF--RACRNLTILWL 63
Query: 282 SHNNFT----GKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQ 337
N F+ L L + LS N + PA+ L TL++ LQ
Sbjct: 64 HSNVLARIDAAAFTGL-----ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ 118
Query: 338 GGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASC 397
+ L L+ L L N +P + + G L L L NR++ F
Sbjct: 119 E-LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGL 176
Query: 398 SSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSN 457
SL L L N ++ + + L+ LY+ NN+S +L L+ L L+ N
Sbjct: 177 HSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 51/226 (22%), Positives = 88/226 (38%), Gaps = 12/226 (5%)
Query: 411 SGNFLNTVVSKIS-SLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCS 469
L V I + +++ N IS S C L +L L SN I + +
Sbjct: 19 PQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFT 77
Query: 470 PPNFPALEKIVLPNNYLSGTVPLE-LGSCKNLKTIDLSFNSLAGPVPSEIWS-LPNLSDL 527
LE++ L +N +V L T+ L L + ++ L L L
Sbjct: 78 --GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYL 134
Query: 528 VMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEI 587
+ N L +P+ + GNL L L+ N ++ ++ ++ + L N++ +
Sbjct: 135 YLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HV 192
Query: 588 PAGI-GNLVKLAILQLGNNSLTGQVPQG-LGKCRSLVWLDLNSNNL 631
+L +L L L N+L+ +P L R+L +L LN N
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 53/262 (20%), Positives = 84/262 (32%), Gaps = 49/262 (18%)
Query: 155 TMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSIS---GGSLHIGPSLLQLDLSGNQIS 211
T + ++P + + L N IS S +L L L N ++
Sbjct: 15 TTSCPQQGLQ-AVPVG---IPAA-SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA 69
Query: 212 DSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVAD 271
+ + + L L+ SDN + ++D PA+F
Sbjct: 70 R--IDAAAFTGLALLEQLDLSDNAQ-------------LRSVD----------PATF--H 102
Query: 272 SSGSLKYLDLSHNNFT----GKFSNLDFGRCGNLSVITLSQNGLSGTEFPA-SLKNCQLL 326
G L L L G F L L + L N L P + ++ L
Sbjct: 103 GLGRLHTLHLDRCGLQELGPGLFRGL-----AALQYLYLQDNAL--QALPDDTFRDLGNL 155
Query: 327 ETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRL 386
L + N + +P +L +L L N+ A + P + G L L L +N L
Sbjct: 156 THLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNL 213
Query: 387 TGELPSTFASCSSLHSLNLGSN 408
+ A +L L L N
Sbjct: 214 SALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 50/226 (22%), Positives = 82/226 (36%), Gaps = 33/226 (14%)
Query: 150 SCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHN---SISGGSLHIGPSLLQLDLS 206
+ + L N I+ +P SF +C L+ + L N I + L QLDLS
Sbjct: 31 PAASQRIFLHGNRIS-HVPAASFR-ACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88
Query: 207 GN-QISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSV------NCKSISTIDLSYNL 259
N Q+ + + L+ L+ L + ++ + L N
Sbjct: 89 DNAQLRS--VDPATFHGLGRLHTLHLDRCGL------QELGPGLFRGLAALQYLYLQDNA 140
Query: 260 LSGEIPASFVADSSGSLKYLDLSHNNFT----GKFSNLDFGRCGNLSVITLSQNGLSGTE 315
L +P D +L +L L N + F L +L + L QN ++
Sbjct: 141 LQ-ALPDDTFRDLG-NLTHLFLHGNRISSVPERAFRGL-----HSLDRLLLHQNRVAHVH 193
Query: 316 FPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQF 361
P + ++ L TL + N L +P L R L+ L L N +
Sbjct: 194 -PHAFRDLGRLMTLYLFANNLSA-LPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 54/272 (19%), Positives = 76/272 (27%), Gaps = 64/272 (23%)
Query: 569 SCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNS 628
+ S L +P GI + L N ++ CR+L L L+S
Sbjct: 9 YNEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHS 65
Query: 629 NNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFP 688
N L + + A F G+ LE
Sbjct: 66 NVL-----ARIDAAA--------------------------------FTGLA--LLEQLD 86
Query: 689 MVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKL 747
+ + + TF G L L L L L F L LQ L L N L
Sbjct: 87 LSDNAQLRSVDPA----TFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141
Query: 748 TGHIPD-SFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIP------ 800
+PD +F L + L L N + GL L L + N ++ + P
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200
Query: 801 --------SGGQLTTFPASRYENNSGLCGLPL 824
L+ P L L L
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRL 232
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 44/221 (19%), Positives = 75/221 (33%), Gaps = 25/221 (11%)
Query: 99 LNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFS---AGDLSTSKTSSCSLVT 155
+ + + L+ + +S + + A L L L N + A + L
Sbjct: 30 IPAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLA----LLEQ 84
Query: 156 MDLSSNNITGSLPGRSFLLSCDRLSYVNLSHN---SISGGSLHIGPSLLQLDLSGNQISD 212
+DLS N S+ +F RL ++L + G +L L L N +
Sbjct: 85 LDLSDNAQLRSVDPATF-HGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL-- 141
Query: 213 SALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADS 272
AL + + NL L N++ S+ + L N ++ P +F
Sbjct: 142 QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAF--RD 199
Query: 273 SGSLKYLDLSHNNFT----GKFSNLDFGRCGNLSVITLSQN 309
G L L L NN + + L L + L+ N
Sbjct: 200 LGRLMTLYLFANNLSALPTEALAPLR-----ALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 27/91 (29%), Positives = 41/91 (45%), Gaps = 2/91 (2%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
TF G+L +L L N +S F L+ L L L N++ P +F L + L
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207
Query: 766 LSHNNFQGSIP-GSLGGLSFLSDLDVSNNNL 795
L NN ++P +L L L L +++N
Sbjct: 208 LFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 25/103 (24%), Positives = 37/103 (35%), Gaps = 7/103 (6%)
Query: 532 NNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGI 591
L +P GI + + L+ N ++ S +C N+ + L SN L I A
Sbjct: 21 QGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAA 75
Query: 592 -GNLVKLAILQLGNNSLTGQVPQG-LGKCRSLVWLDLNSNNLS 632
L L L L +N+ V L L L+ L
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ 118
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 22/97 (22%), Positives = 35/97 (36%), Gaps = 6/97 (6%)
Query: 543 CVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQ 601
C N + T L A+P I + + ++ L N+++ +PA L IL
Sbjct: 8 CYNEPKV-TTSCPQQGLQ-AVPVGIPAASQRIF--LHGNRIS-HVPAASFRACRNLTILW 62
Query: 602 LGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSE 638
L +N L L LDL+ N +
Sbjct: 63 LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPA 99
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 29/209 (13%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDRE----FMAEMETIGKIKHRNLVPLL 990
IG G FG VY A+ +R+ VVAIKK + +G+ E + E+ + K++H N +
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKK-MSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 991 GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAI---GSARGLAFLHH 1047
G LV EY GS +L K L +IA G+ +GLA+LH
Sbjct: 121 GCYLREHTAWLVMEYCL-GSASDLLEVHKK----PLQ---EVEIAAVTHGALQGLAYLHS 172
Query: 1048 SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE--- 1104
++IHRD+K+ N+LL E ++ DFG A ++ ++ GTP ++ PE
Sbjct: 173 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANSFVGTPYWMAPEVIL 223
Query: 1105 YYQSFRCTTKGDVYSYGVILLELLSGKRP 1133
+ K DV+S G+ +EL K P
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 62/290 (21%), Positives = 106/290 (36%), Gaps = 68/290 (23%)
Query: 935 MIGSGGFGEVYKAQ-LRDGSVVAIKKL----IHVTGQGDREFMAEMETI-------GKIK 982
++G GGFG V+ L D VAIK + + +E +
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLE-VALLWKVGAGGG 96
Query: 983 HRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDW-AARKKIAIGSAR- 1040
H ++ LL + + E +LV E D+ + + G +R
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLER-------------PLPAQDLFDYITEKGPLGEGPSRC 143
Query: 1041 -------GLAFLHHSCIPHIIHRDMKSSNVLLD-ENFEARVSDFGMARLVNALDTHLSVS 1092
+ H ++HRD+K N+L+D A++ DFG L++ D +
Sbjct: 144 FFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPY--T 196
Query: 1093 TLAGTPGYVPPEYYQSFR-CTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQ 1151
GT Y PPE+ + V+S G++L +++ G P F D
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP-----FERD--------- 242
Query: 1152 LHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVM 1201
EIL+ EL + +R CL +P RP++ +++
Sbjct: 243 -------QEILEAELHFPAHVSPDCCALIR---RCLAPKPSSRPSLEEIL 282
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 4e-22
Identities = 69/237 (29%), Positives = 109/237 (45%), Gaps = 48/237 (20%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDRE----FMA--EMETIGKIKHRNLVP 988
+G G F VYKA+ +VAIKK I + + + + A E++ + ++ H N++
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKK-IKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 989 LLGYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH 1047
LL + + LV+++M+ LE ++ D L + K + + +GL +LH
Sbjct: 77 LLD-AFGHKSNISLVFDFMET-DLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQ 130
Query: 1048 SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL----VNALDTHLSVSTLAGTPGYVPP 1103
I+HRD+K +N+LLDEN +++DFG+A+ A TH V T Y P
Sbjct: 131 H---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQ-VVTR----WYRAP 181
Query: 1104 E------YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR 1154
E Y D+++ G IL ELL P P GD + QL R
Sbjct: 182 ELLFGARMY-----GVGVDMWAVGCILAELLLRV-PFLP---GDSD-----LDQLTR 224
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 52/230 (22%), Positives = 94/230 (40%), Gaps = 41/230 (17%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIK--------KLIHVTGQGDRE-FMAEMETIGKIK-HR 984
+G G V + + A+K Q RE + E++ + K+ H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 985 NLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDR--AKGGGTKLDWAAR--KKIAIGSAR 1040
N++ L + LV++ MK G E L D K ++ + + + +
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKG--E--LFDYLTEKVTLSEKE-TRKIMRALL----E 135
Query: 1041 GLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGY 1100
+ LH +I+HRD+K N+LLD++ +++DFG + ++ + + + GTP Y
Sbjct: 136 VICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSY 189
Query: 1101 VPPE------YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144
+ PE + D++S GVI+ LL+G P F
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-----FWHRKQ 234
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 4e-22
Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 39/223 (17%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKL--------IHVTGQGDREFMAEMETIGKIKHRNL 986
IG G +G V+KA+ +VA+K++ + + + E+ + ++KH+N+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA------LREICLLKELKHKNI 63
Query: 987 VPLLGYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFL 1045
V L +++L LV+E+ L+ LD K +GL F
Sbjct: 64 VRLHDVL-HSDKKLTLVFEFCDQ-DLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFC 117
Query: 1046 HHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL----VNALDTHLSVSTLAGTPGYV 1101
H +++HRD+K N+L++ N E ++++FG+AR V + V TL Y
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAE-VVTL----WYR 168
Query: 1102 PPEY-YQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDN 1143
PP+ + + +T D++S G I EL + RP+ P G+D
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP---GNDV 208
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 32/221 (14%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLVPLLGYC 993
+GSG FG+V+ + R G IK + Q E AE+E + + H N++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 994 KIGEERLLVYEYMKWGSL-ESVLHDRAKGGGTKLDWAAR--KKIAIGSARGLAFLHHSCI 1050
+ +V E + G L E ++ +A+G + A K++ LA+ H
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM----NALAYFHSQ-- 143
Query: 1051 PHIIHRDMKSSNVLL---DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE--- 1104
H++H+D+K N+L + ++ DFG+A L + + + AGT Y+ PE
Sbjct: 144 -HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYMAPEVFK 199
Query: 1105 -YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144
T K D++S GV++ LL+G P F +
Sbjct: 200 RDV-----TFKCDIWSAGVVMYFLLTGCLP-----FTGTSL 230
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 4e-22
Identities = 59/248 (23%), Positives = 104/248 (41%), Gaps = 49/248 (19%)
Query: 936 IGSGGFGEVYKAQLRD---GSVVAIKKL----IHVTGQGDREFMAEMETIGKIKHRNLVP 988
+G G +G VYKA+ +D A+K++ I ++ E+ + ++KH N++
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNVIS 82
Query: 989 LLGYCKI-GEERL-LVYEYMK---WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLA 1043
L + ++ L+++Y + W ++ +A +L K + G+
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 1044 FLHHSCIPHIIHRDMKSSNVLLDENFEAR----VSDFGMARLVNALD---THLS--VSTL 1094
+LH + ++HRD+K +N+L+ R ++D G ARL N+ L V T
Sbjct: 143 YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199
Query: 1095 AGTPGYVPPE------YYQSFRCTTKGDVYSYGVILLELLSGKRPIDP--SEFGDDNNLV 1146
Y PE +Y T D+++ G I ELL+ PI E +N
Sbjct: 200 ----WYRAPELLLGARHY-----TKAIDIWAIGCIFAELLT-SEPIFHCRQEDIKTSN-P 248
Query: 1147 GWAKQLHR 1154
QL R
Sbjct: 249 YHHDQLDR 256
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-22
Identities = 68/297 (22%), Positives = 116/297 (39%), Gaps = 71/297 (23%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKL------------IHVTGQGDRE-FMAEMETIGKI 981
+GSG +GEV + + S AIK + + + E E+ + +
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 982 KHRNLVPLLGYCKIGEERL---LVYEYMKWGSLESVLHDR--AKGGGTKLDWAAR--KKI 1034
H N++ L E++ LV E+ + G L ++ + + D AA K+I
Sbjct: 104 DHPNIIKLFDVF---EDKKYFYLVTEFYEGGEL----FEQIINRHKFDECD-AANIMKQI 155
Query: 1035 AIGSARGLAFLHHSCIPHIIHRDMKSSNVLL---DENFEARVSDFGMARLVNALDTHLSV 1091
G+ +LH +I+HRD+K N+LL + ++ DFG++ + +
Sbjct: 156 L----SGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---L 205
Query: 1092 STLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQ 1151
GT Y+ PE + + K DV+S GVI+ LL G P FG N+
Sbjct: 206 RDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPP-----FGGQND------- 252
Query: 1152 LHREKRINEILDPELTMQTSDETELYQYLRISFEC-------LDDRPFKRPTMIQVM 1201
+ I ++ + +D + IS E L KR T + +
Sbjct: 253 ---QDIIKKVEKGKYYFDFND------WKNISDEAKELIKLMLTYDYNKRCTAEEAL 300
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 6e-22
Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 55/229 (24%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDRE---FMA--EMETIGKIKHRNLVPL 989
IG G FGEV+KA+ + G VA+KK++ + ++E A E++ + +KH N+V L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKEGFPITALREIKILQLLKHENVVNL 81
Query: 990 LGYCKIGEERL--------LVYEYMKWGSLESVLHDRAK---GGGTKLDWAARKKIAIGS 1038
+ C+ LV+++ + HD A K + K++
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFDFCE--------HDLAGLLSNVLVKFTLSEIKRVMQML 133
Query: 1039 ARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD-------THLSV 1091
GL ++H + I+HRDMK++NVL+ + +++DFG+AR + T+ V
Sbjct: 134 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR-V 189
Query: 1092 STLAGTPGYVPPE------YYQSFRCTTKGDVYSYGVILLELLSGKRPI 1134
TL Y PPE Y D++ G I+ E+ + PI
Sbjct: 190 VTL----WYRPPELLLGERDY-----GPPIDLWGAGCIMAEMWTRS-PI 228
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 7e-22
Identities = 59/247 (23%), Positives = 101/247 (40%), Gaps = 33/247 (13%)
Query: 935 MIGSGGFGEVYKA-QLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIK-HRNLVPLLGY 992
++G G V L A+K + G E+E + + + HRN++ L+ +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 993 CKIGEERLLVYEYMKWGSLESVLHDR--AKGGGTKLDWAARKKIAIGSARGLAFLHHSCI 1050
+ + LV+E M+ GS+ + +L+ A+ + SA L FLH+
Sbjct: 80 FEEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELE-ASVVVQDVASA--LDFLHN--- 129
Query: 1051 PHIIHRDMKSSNVLL---DENFEARVSDFGMARLVNALDTHLSVS-----TLAGTPGYVP 1102
I HRD+K N+L ++ ++ DF + + +S T G+ Y+
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 1103 PEYYQSFRCTTKG-----DVYSYGVILLELLSGKRPIDPSEF-GDDNNLVGWAKQLHREK 1156
PE ++F D++S GVIL LLSG P F G + GW +
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP-----FVGRCGSDCGWDRGEACPA 244
Query: 1157 RINEILD 1163
N + +
Sbjct: 245 CQNMLFE 251
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 7e-22
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 45/215 (20%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKL--------IHVTGQGDREFMAEMETIGKIKHRNLV 987
+G G +G VYKA+ G +VA+K++ I T + E+ + ++ H N+V
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA------IREISLLKELHHPNIV 82
Query: 988 PLLGYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLH 1046
L+ E L LV+E+M+ L+ VL + T L + K RG+A H
Sbjct: 83 SLIDVI-HSERCLTLVFEFMEK-DLKKVLDEN----KTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL----VNALDTHLSVSTLAGTPGYVP 1102
I+HRD+K N+L++ + +++DFG+AR V + TH V TL Y
Sbjct: 137 QH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-THE-VVTL----WYRA 187
Query: 1103 PE------YYQSFRCTTKGDVYSYGVILLELLSGK 1131
P+ Y +T D++S G I E+++GK
Sbjct: 188 PDVLMGSKKY-----STSVDIWSIGCIFAEMITGK 217
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 8e-22
Identities = 70/287 (24%), Positives = 107/287 (37%), Gaps = 62/287 (21%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLVPLLGYC 993
IG G +GEV A + A K I D + F E+E + + H N++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAK-KIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 994 KIGEERLLVYEYMKWGSLESVLHDR--AKGGGTKLDWAARKKIAIGSARGLAFLHHSCIP 1051
+ + LV E G E L +R K + D AAR + SA +A+ H
Sbjct: 76 EDNTDIYLVMELCTGG--E--LFERVVHKRVFRESD-AARIMKDVLSA--VAYCHKL--- 125
Query: 1052 HIIHRDMKSSNVLL---DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE---- 1104
++ HRD+K N L + ++ DFG+A T GTP YV P+
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVSPQVLEG 182
Query: 1105 -YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI-NEIL 1162
Y + D +S GV++ LL G P F + + +I
Sbjct: 183 LY------GPECDEWSAGVMMYVLLCGYPP-----FSAPT-----------DSEVMLKIR 220
Query: 1163 DPELTMQTSDETELYQYLRISFE-------CLDDRPFKRPTMIQVMA 1202
+ T D +L +S + L P +R T +Q +
Sbjct: 221 EGTFTFPEKD------WLNVSPQAESLIRRLLTKSPKQRITSLQALE 261
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 8e-22
Identities = 64/218 (29%), Positives = 102/218 (46%), Gaps = 31/218 (14%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLVPLLGYC 993
+GSG F EV+ + R G + A+K I + E+ + KIKH N+V L
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKC-IKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 994 KIGEERLLVYEYMKWGSLESVLHDR--AKGGGTKLDWAAR--KKIAIGSARGLAFLHHSC 1049
+ LV + + G E L DR +G T+ D A+ +++ + +LH +
Sbjct: 76 ESTTHYYLVMQLVSGG--E--LFDRILERGVYTEKD-ASLVIQQVL----SAVKYLHEN- 125
Query: 1050 IPHIIHRDMKSSNVLL---DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYY 1106
I+HRD+K N+L +EN + ++DFG++++ + +S T GTPGYV PE
Sbjct: 126 --GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ--NGIMS--TACGTPGYVAPEVL 179
Query: 1107 QSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144
+ D +S GVI LL G P F ++
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYPP-----FYEETE 212
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-21
Identities = 65/234 (27%), Positives = 97/234 (41%), Gaps = 38/234 (16%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIK-----KLIHVTGQGDRE---FMAEMETIGKIKHRNL 986
+GSG GEV A R VAI+ K + + E+E + K+ H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 987 VPLLGYCKIGEERL-LVYEYMKWGSLESVLHDR--AKGGGTKLDWAARKKIAIGSARGLA 1043
+ + + E +V E M+ G E L D+ +L A K +
Sbjct: 203 IKIKNFFD--AEDYYIVLELMEGG--E--LFDKVVGNK---RLKEATCKLYFYQMLLAVQ 253
Query: 1044 FLHHSCIPHIIHRDMKSSNVLL---DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGY 1100
+LH + IIHRD+K NVLL +E+ +++DFG ++++ + TL GTP Y
Sbjct: 254 YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTPTY 307
Query: 1101 VPPEYYQSFRC---TTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQ 1151
+ PE S D +S GVIL LSG P F + V Q
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP-----FSEHRTQVSLKDQ 356
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-21
Identities = 59/237 (24%), Positives = 99/237 (41%), Gaps = 39/237 (16%)
Query: 925 EATNGFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKIKH 983
+ + F + M G G FG V + + G VAIKK+I +RE M+ + + H
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHH 78
Query: 984 RNLVPLLGYCKIGEER-------LLVYEYMKWGSLESVLHDRAK---GGGTKLDWAARKK 1033
N+V L Y ER +V EY+ LH + K
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLHRCCRNYYRRQVAPPPILIKV 133
Query: 1034 IAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLD-ENFEARVSDFGMARLVNALDTHLSVS 1092
R + LH + ++ HRD+K NVL++ + ++ DFG A+ ++ + +++
Sbjct: 134 FLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA-- 190
Query: 1093 TLAGTPGYVPPEYYQ-------SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDD 1142
Y+ YY+ + TT D++S G I E++ G+ PI GD+
Sbjct: 191 -------YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PIFR---GDN 236
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-21
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 28/207 (13%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDRE---FMA--EMETIGKIKHRNLVPL 989
+G G +G V K + +D G +VAIKK + D + +A E++ + +++H NLV L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKK-FLESD--DDKMVKKIAMREIKLLKQLRHENLVNL 89
Query: 990 LGYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHS 1048
L CK ++R LV+E++ ++ L G LD+ +K G+ F H
Sbjct: 90 LEVCK-KKKRWYLVFEFVDH-TILDDLELFPNG----LDYQVVQKYLFQIINGIGFCHSH 143
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD---THLSVSTLAGTPGYVPPEY 1105
+IIHRD+K N+L+ ++ ++ DFG AR + A V+T Y PE
Sbjct: 144 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE-VATRW----YRAPEL 195
Query: 1106 -YQSFRCTTKGDVYSYGVILLELLSGK 1131
+ DV++ G ++ E+ G+
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 65/286 (22%), Positives = 111/286 (38%), Gaps = 64/286 (22%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIK-----KLIHVTGQGDREFMA-EMETIGKIKHR--NL 986
+GSGGFG VY + D VAIK ++ + + E+ + K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 987 VPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDW-AARKKIAIGSAR----- 1040
+ LL + + + +L+ E + D+ R + AR
Sbjct: 111 IRLLDWFERPDSFVLILER-------------PEPVQDLFDFITERGALQEELARSFFWQ 157
Query: 1041 ---GLAFLHHSCIPHIIHRDMKSSNVLLDEN-FEARVSDFGMARLVNALDTHLSVSTLAG 1096
+ H+ ++HRD+K N+L+D N E ++ DFG L+ DT + G
Sbjct: 158 VLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVY--TDFDG 210
Query: 1097 TPGYVPPEYYQSFRCT-TKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE 1155
T Y PPE+ + R V+S G++L +++ G P F D
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHD------------- 252
Query: 1156 KRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVM 1201
EI+ ++ + +E +R CL RP RPT ++
Sbjct: 253 ---EEIIRGQVFFRQRVSSECQHLIR---WCLALRPSDRPTFEEIQ 292
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 2e-21
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 43/214 (20%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGD-------REFMAEMETIGKIKHRNLVP 988
IG G +G VYKAQ G A+KK I + + + RE E +KH N+V
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKK-IRLEKEDEGIPSTTIREISILKE----LKHSNIVK 64
Query: 989 LLGYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH 1047
L ++RL LV+E++ L+ +L G L+ K + G+A+ H
Sbjct: 65 LYDVI-HTKKRLVLVFEHLDQ-DLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCHD 118
Query: 1048 SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL----VNALDTHLSVSTLAGTPGYVPP 1103
++HRD+K N+L++ E +++DFG+AR V TH + TL Y P
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THE-IVTL----WYRAP 169
Query: 1104 E------YYQSFRCTTKGDVYSYGVILLELLSGK 1131
+ Y +T D++S G I E+++G
Sbjct: 170 DVLMGSKKY-----STTIDIWSVGCIFAEMVNGT 198
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 64/289 (22%), Positives = 111/289 (38%), Gaps = 66/289 (22%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIK-----KLIHVTGQGDREFMAEMETIGKIKHRNLVPL 989
+G G +GEV A VA+K + + +E + + H N+V
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKF 70
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDR-AKGGGTKLDWAARKK----IAIGSARGLAF 1044
G+ + G + L EY G E L DR G A++ +A G+ +
Sbjct: 71 YGHRREGNIQYLFLEYCSGG--E--LFDRIEPDIGMPEP-DAQRFFHQLMA-----GVVY 120
Query: 1045 LHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE 1104
LH I HRD+K N+LLDE ++SDFG+A + + ++ + GT YV PE
Sbjct: 121 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 1105 -----YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRIN 1159
+ + DV+S G++L +L+G+ P + ++ Q + + +
Sbjct: 178 LLKRREFHA----EPVDVWSCGIVLTAMLAGELP-----WDQPSDSC----QEYSDWKEK 224
Query: 1160 EILDPELTMQTSDETELYQYLRISFEC-------LDDRPFKRPTMIQVM 1201
+ + +I L + P R T+ +
Sbjct: 225 KTYLNP-------------WKKIDSAPLALLHKILVENPSARITIPDIK 260
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 34/208 (16%), Positives = 57/208 (27%), Gaps = 49/208 (23%)
Query: 933 DSMIGSGGFGEVYKAQLRD---GSVVAIKKLIHVTGQGD----REFMAEMETIGKIKHRN 985
G + ++A D VA+ + G +E ++ + +I
Sbjct: 36 LIFHGGVPPLQFWQA--LDTALDRQVALT-FVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 986 LVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFL 1045
+ +L L+V E+++ GSL+ V A R A
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVAD-----TSPSPVGAIR--AMQSLAAAADAA 145
Query: 1046 HHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEY 1105
H + + S V VS G L P +P
Sbjct: 146 HRA---GVALSIDHPSRVR--------VSIDGDVVL--------------AYPATMPDA- 179
Query: 1106 YQSFRCTTKGDVYSYGVILLELLSGKRP 1133
+ D+ G L LL + P
Sbjct: 180 ------NPQDDIRGIGASLYALLVNRWP 201
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 61/236 (25%), Positives = 102/236 (43%), Gaps = 21/236 (8%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKL--IHVTGQGDREF-MAEMETIGKIKHRNLVPLLG 991
+G G F V A+ AIK L H+ + + E + + ++ H V L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 992 YCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIA-IGSARGLAFLHHSC 1049
+ +E+L Y K G L + + G+ + R A I SA L +LH
Sbjct: 98 TFQ-DDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSA--LEYLHGK- 149
Query: 1050 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSF 1109
IIHRD+K N+LL+E+ +++DFG A++++ ++ GT YV PE
Sbjct: 150 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207
Query: 1110 RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPE 1165
D+++ G I+ +L++G P F N + + K + E E P+
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPP-----FRAGNEYLIFQKIIKLEYDFPEKFFPK 258
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-21
Identities = 58/229 (25%), Positives = 98/229 (42%), Gaps = 40/229 (17%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIK-------KLIHVTGQGDRE-FMAEMETIGKIK-HRN 985
IG G V + R G A+K +L + RE E + ++ H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 986 LVPLLGYCKIGEERLLVYEYMKWGSLESVLHDR--AKGGGTKLDWAAR--KKIAIGSARG 1041
++ L+ + LV++ M+ G E L D K ++ + + +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKG--E--LFDYLTEKVALSEKE-TRSIMRSLL----EA 212
Query: 1042 LAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV 1101
++FLH + +I+HRD+K N+LLD+N + R+SDFG + + + + L GTPGY+
Sbjct: 213 VSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYL 266
Query: 1102 PPE------YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144
PE + D+++ GVIL LL+G P F
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP-----FWHRRQ 310
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 4e-21
Identities = 56/331 (16%), Positives = 102/331 (30%), Gaps = 83/331 (25%)
Query: 935 MIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLVPLLGY 992
+G GGFG V++A+ D AIK++ + RE M E++ + K++H +V
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72
Query: 993 CKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKI------------------ 1034
E + + + + +
Sbjct: 73 WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132
Query: 1035 ------------------AIGSARGLAFLHHSCIPHI----------IH------RDMKS 1060
+ L H HI +H RD+K
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKP 192
Query: 1061 SNVLLDENFEARVSDFGMARLVNALDTHLSVSTLA----------GTPGYVPPEYYQSFR 1110
SN+ + +V DFG+ ++ + +V T GT Y+ PE
Sbjct: 193 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN 252
Query: 1111 CTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQT 1170
+ K D++S G+IL ELL F V + R + + +
Sbjct: 253 YSHKVDIFSLGLILFELLYS--------FSTQMERVRIITDV-RNLKFPLLFTQKY---- 299
Query: 1171 SDETELYQYLRISFECLDDRPFKRPTMIQVM 1201
+ + ++ + L P +RP ++
Sbjct: 300 ---PQEHMMVQ---DMLSPSPTERPEATDII 324
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 5e-21
Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 935 MIGSGGFGEVYKAQLRD-GSVVAIKKL--IHVTGQGDREF-MAEMETIGKIKHRNLVPLL 990
IG G FG+V Q D + A+K + + + E++ + ++H LV L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 991 GYCKIGEERL-LVYEYMKWGSLESVLH-------DRAKGGGTKLDWAARKKIAIGSARGL 1042
Y EE + +V + + G L L + K + + A L
Sbjct: 82 -YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL------FICE----LVMA--L 128
Query: 1043 AFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP 1102
+L + IIHRDMK N+LLDE+ ++DF +A ++ +T+AGT Y+
Sbjct: 129 DYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMA 182
Query: 1103 PEYYQSFRCTTKG---DVYSYGVILLELLSGKRP 1133
PE + S + D +S GV ELL G+RP
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 5e-21
Identities = 53/222 (23%), Positives = 91/222 (40%), Gaps = 33/222 (14%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIK--KLIHVTGQGDREFMAEMETIGKIKHR-NLVPLLG 991
+G G F V + + G A K K E + E+ + K ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 992 YCKIGEERLLVYEYMKWGSLESVLHDR--AKGGG--TKLDWAAR--KKIAIGSARGLAFL 1045
+ E +L+ EY G E + + ++ D R K+I G+ +L
Sbjct: 97 VYENTSEIILILEYAAGG--E--IFSLCLPELAEMVSEND-VIRLIKQIL----EGVYYL 147
Query: 1046 HHSCIPHIIHRDMKSSNVLL---DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP 1102
H + +I+H D+K N+LL + ++ DFGM+R + + + GTP Y+
Sbjct: 148 HQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK---IGHACELREIMGTPEYLA 201
Query: 1103 PEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144
PE TT D+++ G+I LL+ P F ++N
Sbjct: 202 PEILNYDPITTATDMWNIGIIAYMLLTHTSP-----FVGEDN 238
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 7e-21
Identities = 61/302 (20%), Positives = 105/302 (34%), Gaps = 58/302 (19%)
Query: 920 FAHLLEATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIG 979
A L + ++ I SG +G V +G VAIK++ + G + +
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 980 K-----------IKHRNLVPLL-----GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGG 1023
K H N++ L + LV E M + L
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQR 128
Query: 1024 TKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083
+ + GL LH ++HRD+ N+LL +N + + DF +AR
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLH-EA--GVVHRDLHPGNILLADNNDITICDFNLAREDT 185
Query: 1084 ALDTHLSVSTLAGTPGYV------PPEYYQSFRCTTKG-DVYSYGVILLELLSGKRPIDP 1136
A D + + YV PE F+ TK D++S G ++ E+ + K +
Sbjct: 186 A-DANKT--------HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK-ALFR 235
Query: 1137 SEFGDDNNLVGWAKQLHREKRINEIL----DPELTMQTSDETELYQYLRISFECLDDRPF 1192
G ++ +I E++ ++ M +S YLR S + R +
Sbjct: 236 ---GST--------FYNQLNKIVEVVGTPKIEDVVMFSSPSA--RDYLRNSLSNVPARAW 282
Query: 1193 KR 1194
Sbjct: 283 TA 284
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 8e-21
Identities = 65/236 (27%), Positives = 99/236 (41%), Gaps = 42/236 (17%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIK-----KLIHVTGQGDRE---FMAEMETIGKIKHRNL 986
+GSG GEV A R VAIK K + + E+E + K+ H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 987 VPLLGYCKIGEERL-LVYEYMKWGSLESVLHDR--AKGGGTKLDWAAR--KKIAIGSARG 1041
+ + + E +V E M+ G E L D+ + ++
Sbjct: 78 IKIKNF--FDAEDYYIVLELMEGG--E--LFDKVVGNKRLKEAT-CKLYFYQML----LA 126
Query: 1042 LAFLHHSCIPHIIHRDMKSSNVLL---DENFEARVSDFGMARLVNALDTHLSVSTLAGTP 1098
+ +LH + IIHRD+K NVLL +E+ +++DFG ++++ +T L + TL GTP
Sbjct: 127 VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSL-MRTLCGTP 180
Query: 1099 GYVPPEYYQSFRCTTKG---DVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQ 1151
Y+ PE S D +S GVIL LSG P F + V Q
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP-----FSEHRTQVSLKDQ 231
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 8e-21
Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 30/219 (13%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLI--HVTGQGDREFMAEMETIGKIKHRNLVPLLGY 992
+G G F V + + G A K + ++ + ++ E K++H N+V L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 993 CKIGEERLLVYEYMKWGSLESVLHDR--AKGGGTKLDWAAR--KKIAIGSARGLAFLHHS 1048
+ LV++ + G E L + A+ ++ D A+ ++I +A+ H +
Sbjct: 74 IQEESFHYLVFDLVTGG--E--LFEDIVAREFYSEAD-ASHCIQQIL----ESIAYCHSN 124
Query: 1049 CIPHIIHRDMKSSNVLL---DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEY 1105
I+HR++K N+LL + +++DFG+A VN + AGTPGY+ PE
Sbjct: 125 ---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEV 178
Query: 1106 YQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144
+ + D+++ GVIL LL G P F D++
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVGYPP-----FWDEDQ 212
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-20
Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 28/207 (13%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDRE---FMA--EMETIGKIKHRNLVPL 989
IG G +G V+K + RD G +VAIKK D +A E+ + ++KH NLV L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKK---FLESEDDPVIKKIALREIRMLKQLKHPNLVNL 67
Query: 990 LGYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHS 1048
L + + RL LV+EY ++ L +G + K I + + + F H
Sbjct: 68 LEVFR-RKRRLHLVFEYCDH-TVLHELDRYQRG----VPEHLVKSITWQTLQAVNFCHKH 121
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD---THLSVSTLAGTPGYVPPEY 1105
+ IHRD+K N+L+ ++ ++ DFG ARL+ V+T Y PE
Sbjct: 122 ---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE-VATR----WYRSPEL 173
Query: 1106 -YQSFRCTTKGDVYSYGVILLELLSGK 1131
+ DV++ G + ELLSG
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-20
Identities = 70/267 (26%), Positives = 115/267 (43%), Gaps = 42/267 (15%)
Query: 897 LSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSADS------MIGSGGFGEVYKAQLR 950
+ PL+ K+ + G + +IG+G FG V++A+L
Sbjct: 3 FTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLV 62
Query: 951 DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGY-----CKIGEERL-LVYE 1004
+ VAIKK++ Q R E++ + +KH N+V L + K E L LV E
Sbjct: 63 ESDEVAIKKVL----QDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118
Query: 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVL 1064
Y+ ++ AK T + K R LA++H I HRD+K N+L
Sbjct: 119 YVP-ETVYRASRHYAKLKQT-MPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLL 173
Query: 1065 LDEN-FEARVSDFGMARLVNALDTHLS-VSTLAGTPGYVPPE------YYQSFRCTTKGD 1116
LD ++ DFG A+++ A + ++S + + Y PE Y TT D
Sbjct: 174 LDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY----YRAPELIFGATNY-----TTNID 224
Query: 1117 VYSYGVILLELLSGKRPIDPSEFGDDN 1143
++S G ++ EL+ G+ P+ P G+
Sbjct: 225 IWSTGCVMAELMQGQ-PLFP---GESG 247
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 2e-20
Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 42/216 (19%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKL-------IHVTGQGDREFMAEMETIGKIKHRNLV 987
+G+G + VYK G VA+K++ T + E+ + ++KH N+V
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA------IREISLMKELKHENIV 66
Query: 988 PLLGYCKIGEERL-LVYEYMKWGSLESVLHDR-AKGGGTKLDWAARKKIAIGSARGLAFL 1045
L E +L LV+E+M L+ + R L+ K +GLAF
Sbjct: 67 RLYDVI-HTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 1046 HHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL----VNALDTHLSVSTLAGTPGYV 1101
H + I+HRD+K N+L+++ + ++ DFG+AR VN + V TL Y
Sbjct: 125 HEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF-SSE-VVTL----WYR 175
Query: 1102 PPE------YYQSFRCTTKGDVYSYGVILLELLSGK 1131
P+ Y +T D++S G IL E+++GK
Sbjct: 176 APDVLMGSRTY-----STSIDIWSCGCILAEMITGK 206
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 48/293 (16%), Positives = 97/293 (33%), Gaps = 48/293 (16%)
Query: 343 FLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHS 402
F + N +++ + + + L +T ++L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVTQA---DLDGITTLSAFGTGVTT--IEGVQYLNNLIG 67
Query: 403 LNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGT 462
L L N ++ + ++ + L + N + ++ ++ LDL+S T
Sbjct: 68 LELKDNQITDL---APLKNLTKITELELSGNPLKNVSAIA--GLQSIKTLDLTSTQITDV 122
Query: 463 IPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLP 522
P L+ + L N ++ PL NL+ + + ++ L
Sbjct: 123 TPLA-----GLSNLQVLYLDLNQITNISPLA--GLTNLQYLSIGNAQVS--------DLT 167
Query: 523 NLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQ 582
L++L L TL ++N ++ P +AS N++ V L +NQ
Sbjct: 168 PLANLS-------------------KLTTLKADDNKISDISP--LASLPNLIEVHLKNNQ 206
Query: 583 LTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPL 635
++ P + N L I+ L N ++T Q + S P
Sbjct: 207 ISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPA 257
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 40/267 (14%), Positives = 99/267 (37%), Gaps = 30/267 (11%)
Query: 198 PSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSY 257
+ +++ + ++D+ + ++ + L+ + + ++ ++L
Sbjct: 19 ANAIKIAAGKSNVTDTV----TQADLDGITTLSAFGTGV-TTIEGVQ-YLNNLIGLELKD 72
Query: 258 NLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFP 317
N ++ P + + L+LS N S + ++ + L+ ++
Sbjct: 73 NQITDLAPLKNLT----KITELELSGNPLK-NVSAIA--GLQSIKTLDLTSTQITDVT-- 123
Query: 318 ASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLR 377
L L+ L + N + I L NL+ LS+ + Q + ++ P L L
Sbjct: 124 -PLAGLSNLQVLYLDLNQIT-NISP--LAGLTNLQYLSIGNAQVS-DLTP-LAN-LSKLT 176
Query: 378 ELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISG 437
L N+++ ++ AS +L ++L +N +S + ++ S+L + + I+
Sbjct: 177 TLKADDNKIS-DISP-LASLPNLIEVHLKNNQISD---VSPLANTSNLFIVTLTNQTITN 231
Query: 438 PVPLSLTNCTQLRVLDLSSNGFTGTIP 464
N L V ++ I
Sbjct: 232 QPVFYNNN---LVVPNVVKGPSGAPIA 255
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 51/294 (17%), Positives = 103/294 (35%), Gaps = 56/294 (19%)
Query: 152 SLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISG-GSLHIGPSLLQLDLSGNQI 210
+ + + +N+T + D ++ ++ ++ + +L+ L+L NQI
Sbjct: 20 NAIKIAAGKSNVTDT----VTQADLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQI 75
Query: 211 SDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVA 270
+D A L N + L S N + + L
Sbjct: 76 TDLA----PLKNLTKITELELSGNP--------------LKNVSAIAGL----------- 106
Query: 271 DSSGSLKYLDLSHNNFTG--KFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLET 328
S+K LDL+ T + L NL V+ L N ++ L L+
Sbjct: 107 ---QSIKTLDLTSTQITDVTPLAGLS-----NLQVLYLDLNQITNIS---PLAGLTNLQY 155
Query: 329 LNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTG 388
L++ + + + L + L L N+ + +I P + L E+ L +N+++
Sbjct: 156 LSIGNAQVS-DLTP--LANLSKLTTLKADDNKIS-DISPL--ASLPNLIEVHLKNNQISD 209
Query: 389 ELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLS 442
P A+ S+L + L + ++ N + + + P P +S
Sbjct: 210 VSP--LANTSNLFIVTLTNQTIT-NQPVFYNNNLVVPNVVKGPSGAPIAPATIS 260
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 26/89 (29%), Positives = 39/89 (43%), Gaps = 6/89 (6%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
+LI L+L N ++ +L + L L N L + GL++I LDL+
Sbjct: 64 NLIGLELKDNQITD--LAPLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQI 119
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIP 800
P L GLS L L + N ++ I P
Sbjct: 120 TDVTP--LAGLSNLQVLYLDLNQITNISP 146
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 20/89 (22%), Positives = 36/89 (40%), Gaps = 6/89 (6%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
+L L L N ++ L LQ L++G+ +++ + L + L N
Sbjct: 130 NLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS-DL-TPLANLSKLTTLKADDNKI 185
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIP 800
I L L L ++ + NN +S + P
Sbjct: 186 S-DISP-LASLPNLIEVHLKNNQISDVSP 212
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 37/180 (20%), Positives = 66/180 (36%), Gaps = 22/180 (12%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSS 160
S++ L L+ + ++ N++ L L L++L++ S DL+ S L T+
Sbjct: 129 SNLQVLYLDLNQIT---NISPLAGLTNLQYLSIGNAQVS--DLTPLANLS-KLTTLKADD 182
Query: 161 NNITGSLPGRSFLLSCDRLSYVNLSHNSISGGS-LHIGPSLLQLDLSGNQISD------- 212
N I+ + L S L V+L +N IS S L +L + L+ I++
Sbjct: 183 NKIS-DISP---LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTITNQPVFYNN 238
Query: 213 --SALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLL--SGEIPASF 268
+ + SDN N T I+ + ++N F
Sbjct: 239 NLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQSVTFKNTTVPF 298
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 20/89 (22%), Positives = 38/89 (42%), Gaps = 6/89 (6%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
+ L ++ E LN L L L N++T + L I L+LS N
Sbjct: 42 GITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPL 97
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIP 800
+ ++ + GL + LD+++ ++ + P
Sbjct: 98 K-NVSA-IAGLQSIKTLDLTSTQITDVTP 124
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 15/89 (16%), Positives = 35/89 (39%), Gaps = 6/89 (6%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
+ I + ++++ L+ + L+ +T I L + L+L N
Sbjct: 20 NAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQI 75
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIP 800
+ L L+ +++L++S N L +
Sbjct: 76 T-DLAP-LKNLTKITELELSGNPLKNVSA 102
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 64/286 (22%), Positives = 109/286 (38%), Gaps = 53/286 (18%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKIK-HRNLVPLLGYC 993
+G G F K + A+K +I + + + E+ + + H N+V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVK-IISKRMEANTQ--KEITALKLCEGHPNIVKLHEVF 75
Query: 994 KIGEERLLVYEYMKWGSLESVLHDR--AKGGGTKLDWAARKKIAIGSARGLAFLHHSCIP 1051
LV E + G L +R K ++ + A+ + SA ++ +H
Sbjct: 76 HDQLHTFLVMELLNGGEL----FERIKKKKHFSETE-ASYIMRKLVSA--VSHMHDV--- 125
Query: 1052 HIIHRDMKSSNVLL---DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE---- 1104
++HRD+K N+L ++N E ++ DFG ARL + L T T Y PE
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK--TPCFTLHYAAPELLNQ 183
Query: 1105 -YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163
Y C D++S GVIL +LSG+ P F + + + + +I
Sbjct: 184 NGY-DESC----DLWSLGVILYTMLSGQVP-----FQSHDRSLTCTSA---VEIMKKIKK 230
Query: 1164 PELTMQTSDETELYQYLRISFE-------CLDDRPFKRPTMIQVMA 1202
+ + + + +S E L P KR M +
Sbjct: 231 GDFSF-EGEA-----WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 2e-20
Identities = 68/452 (15%), Positives = 148/452 (32%), Gaps = 40/452 (8%)
Query: 95 VSCSLNSHVTSLNLNNSGLSGSLN---LTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSC 151
V H NL G G + ++ +LE + L+ + L S
Sbjct: 71 VELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFK 130
Query: 152 SLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHI-------GPSLLQLD 204
+ + LSS + + +C L ++L + + S H SL+ L+
Sbjct: 131 NFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLN 190
Query: 205 LSG--NQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSY--NLL 260
+S +++S SAL ++ C NL L + KL + + +
Sbjct: 191 ISCLASEVSFSALERL-VTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEV 249
Query: 261 SGEIPASFVADSSGSLKYLDLSH-NNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPAS 319
++ + SG + LS + + + C L+ + LS + +
Sbjct: 250 RPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKL 309
Query: 320 LKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPP---------ELG 370
L C L+ L + G+ L + ++L++L + ++ P +
Sbjct: 310 LCQCPKLQRLWVLDYIEDAGL-EVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVS 368
Query: 371 QACGTLRELDLSSNRLTGE-LPSTFASCSSLHSLNL------GSNMLSGNFLNTVVSKI- 422
C L + ++T L + + ++ L + L+ L+ I
Sbjct: 369 MGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIV 428
Query: 423 ---SSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKI 479
L L + T ++ +L ++ G + S +L K+
Sbjct: 429 EHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLS--GCDSLRKL 486
Query: 480 VLPNNYLSG-TVPLELGSCKNLKTIDLSFNSL 510
+ + + + ++++ +S S+
Sbjct: 487 EIRDCPFGDKALLANASKLETMRSLWMSSCSV 518
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 4e-20
Identities = 77/485 (15%), Positives = 153/485 (31%), Gaps = 63/485 (12%)
Query: 173 LLSCDRLSYVNLSHNSISGGSLHI-------GPSLLQLDLSGNQISDSAL--LTYSLSNC 223
L + NL + G L ++ L ++D L + S N
Sbjct: 73 LKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNF 132
Query: 224 QNLNLLN---FSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASF--VADSSGSLKY 278
+ L L + FS + L A + C+++ +DL + + D+ SL
Sbjct: 133 KVLVLSSCEGFSTDGL----AAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVS 188
Query: 279 LDLS--HNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSH--N 334
L++S + + RC NL + L++ + + L+ LE L
Sbjct: 189 LNISCLASEVSFSALERLVTRCPNLKSLKLNRA-VPLEKLATLLQRAPQLEELGTGGYTA 247
Query: 335 ALQGGIPGFLLGSFRNLKQL-SLAHNQFAGEIP-PELGQACGTLRELDLSSNRLTGE-LP 391
++ + L + K+L L+ A P + C L L+LS + L
Sbjct: 248 EVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLV 307
Query: 392 STFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRV 451
C L L + + + L + S L L V V T+ +
Sbjct: 308 KLLCQCPKLQRLWV-LDYIEDAGLEVLASTCKDLRELRV--FPSEPFVMEPNVALTEQGL 364
Query: 452 LDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELG-SCKNLKTIDLSFNSL 510
+ +S P LE ++ ++ + + + N+ L
Sbjct: 365 VSVSMG---------------CPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEP 409
Query: 511 AGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIAS- 569
P I + +L L L+ LT + + I +
Sbjct: 410 KAPDY--------------LTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTY 454
Query: 570 CTNMLWVSLSSNQLTGE-IPAGIGNLVKLAILQLGNNSLTGQ-VPQGLGKCRSLVWLDLN 627
M +S++ + + + L L++ + + + K ++ L ++
Sbjct: 455 AKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMS 514
Query: 628 SNNLS 632
S ++S
Sbjct: 515 SCSVS 519
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-20
Identities = 51/219 (23%), Positives = 90/219 (41%), Gaps = 29/219 (13%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLI--HVTGQGDREFMAEMETIGKIKHRNLVPLLGY 992
+G G F V + G A + ++ + ++ E +KH N+V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 993 CKIGEERLLVYEYMKWGSLESVLHDR--AKGGGTKLDWAAR--KKIAIGSARGLAFLHHS 1048
L+++ + G E L + A+ ++ D A+ ++I + H
Sbjct: 79 ISEEGHHYLIFDLVTGG--E--LFEDIVAREYYSEAD-ASHCIQQIL----EAVLHCHQM 129
Query: 1049 CIPHIIHRDMKSSNVLL---DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEY 1105
++HR++K N+LL + +++DFG+A V AGTPGY+ PE
Sbjct: 130 ---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF--GFAGTPGYLSPEV 184
Query: 1106 YQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144
+ D+++ GVIL LL G P F D++
Sbjct: 185 LRKDPYGKPVDLWACGVILYILLVGYPP-----FWDEDQ 218
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 3e-20
Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKL-IHVTGQGDREF-------MAEMETIGKIKHRNL 986
IG G +G VYKA+ G VA+K + + G G +A + + +H N+
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 987 VPLL----GYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARG 1041
V L+ E ++ LV+E++ L + L L K + RG
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKA---PPPGLPAETIKDLMRQFLRG 132
Query: 1042 LAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL--VNALDTHLSVSTLAGTPG 1099
L FLH + I+HRD+K N+L+ +++DFG+AR+ T + V TL
Sbjct: 133 LDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV-VVTL----W 184
Query: 1100 YVPPEYYQSFRCTTKGDVYSYGVILLELLSGK 1131
Y PE T D++S G I E+ K
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 5e-20
Identities = 63/236 (26%), Positives = 106/236 (44%), Gaps = 26/236 (11%)
Query: 935 MIGSGGFGEVYKAQLRD-GSVVAIKKL--IHVTGQGDRE-FMAEMETIGKIKHRNLVPLL 990
+IG G FGEV +L++ V A+K L + + + F E + + + + L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 991 GYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIA-IGSARGLAFLHHS 1048
Y + L LV +Y G L ++L +K + AR +A + A + +H
Sbjct: 141 -YAFQDDNNLYLVMDYYVGGDLLTLL---SKFEDRLPEEMARFYLAEMVIA--IDSVHQL 194
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQS 1108
H +HRD+K N+L+D N R++DFG + T S S GTP Y+ PE Q+
Sbjct: 195 ---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS-SVAVGTPDYISPEILQA 250
Query: 1109 FRCTTKG-----DVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRIN 1159
D +S GV + E+L G+ P F ++ + + K ++ ++R
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETP-----FYAESLVETYGKIMNHKERFQ 301
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 8e-20
Identities = 64/244 (26%), Positives = 100/244 (40%), Gaps = 28/244 (11%)
Query: 935 MIGSGGFGEVYKAQLRD-GSVVAIKKL--IHVTGQGDRE-FMAEMETIGKIKHRNLVPLL 990
+IG G F EV +++ G V A+K + + +G+ F E + + R + L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 991 GYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIA-IGSARGLAFLHHS 1048
+ E L LV EY G L + G + A R +A I A + +H
Sbjct: 128 -FAFQDENYLYLVMEYYVGGDL--LTLLSKFGERIPAEMA-RFYLAEIVMA--IDSVHRL 181
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQS 1108
+HRD+K N+LLD R++DFG + A T S GTP Y+ PE Q+
Sbjct: 182 ---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS-LVAVGTPDYLSPEILQA 237
Query: 1109 FRCTTKGDVY-------SYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161
Y + GV E+ G+ P F D+ + K +H ++ ++
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTP-----FYADSTAETYGKIVHYKEHLSLP 292
Query: 1162 LDPE 1165
L E
Sbjct: 293 LVDE 296
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-19
Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 30/217 (13%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCK 994
+G G VY+ + + A+K L + E+ + ++ H N++ L +
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 995 IGEERLLVYEYMKWGSLESVLHDR--AKGGGTKLDWAAR--KKIAIGSARGLAFLHHSCI 1050
E LV E + G L DR KG ++ D AA K+I +A+LH +
Sbjct: 119 TPTEISLVLELVTGGEL----FDRIVEKGYYSERD-AADAVKQIL----EAVAYLHEN-- 167
Query: 1051 PHIIHRDMKSSNVLL---DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQ 1107
I+HRD+K N+L + +++DFG++++V + T+ GTPGY PE +
Sbjct: 168 -GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILR 223
Query: 1108 SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144
+ D++S G+I LL G P F D+
Sbjct: 224 GCAYGPEVDMWSVGIITYILLCGFEP-----FYDERG 255
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 1e-19
Identities = 64/233 (27%), Positives = 105/233 (45%), Gaps = 44/233 (18%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKL-------IHVTGQGDREFMAEMETIGKIKHRNLV 987
+G G + VYK + + ++VA+K++ T + E+ + +KH N+V
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA------IREVSLLKDLKHANIV 63
Query: 988 PLLGYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLH 1046
L E+ L LV+EY+ L+ L D G ++ K RGLA+ H
Sbjct: 64 TLHDII-HTEKSLTLVFEYLDK-DLKQYLDDC----GNIINMHNVKLFLFQLLRGLAYCH 117
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL----VNALDTHLSVSTLAGTPGYVP 1102
++HRD+K N+L++E E +++DFG+AR + V TL Y P
Sbjct: 118 R---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-DNE-VVTL----WYRP 168
Query: 1103 PEY-YQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR 1154
P+ S +T+ D++ G I E+ +G RP+ P G +QLH
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATG-RPLFP---GSTV-----EEQLHF 212
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-19
Identities = 68/223 (30%), Positives = 106/223 (47%), Gaps = 39/223 (17%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMA-EMETIGKIKHRNLVPLLGYC 993
IG+G FG VY+A+L D G +VAIKK++ D+ F E++ + K+ H N+V L +
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 994 KIGEERL------LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH 1047
E+ LV +Y+ ++ V ++ L K R LA++H
Sbjct: 117 YSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAK-QTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 1048 SCIPHIIHRDMKSSNVLLDEN-FEARVSDFGMARLVNALDTHLS-VSTLAGTPGYVPPE- 1104
I HRD+K N+LLD + ++ DFG A+ + + ++S + + Y PE
Sbjct: 175 F---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY----YRAPEL 227
Query: 1105 -----YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDD 1142
Y T+ DV+S G +L ELL G +PI P GD
Sbjct: 228 IFGATDY-----TSSIDVWSAGCVLAELLLG-QPIFP---GDS 261
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-19
Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 30/219 (13%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLI--HVTGQGDREFMAEMETIGKIKHRNLVPLLGY 992
+G G F V + + G A K + ++ + ++ E K++H N+V L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 993 CKIGEERLLVYEYMKWGSLESVLHDR--AKGGGTKLDWAAR--KKIAIGSARGLAFLHHS 1048
+ LV++ + G E L + A+ ++ D A+ ++I +A+ H +
Sbjct: 97 IQEESFHYLVFDLVTGG--E--LFEDIVAREFYSEAD-ASHCIQQIL----ESIAYCHSN 147
Query: 1049 CIPHIIHRDMKSSNVLL---DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEY 1105
I+HR++K N+LL + +++DFG+A VN + AGTPGY+ PE
Sbjct: 148 ---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEV 201
Query: 1106 YQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144
+ + D+++ GVIL LL G P F D++
Sbjct: 202 LKKDPYSKPVDIWACGVILYILLVGYPP-----FWDEDQ 235
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 93.2 bits (231), Expect = 2e-19
Identities = 50/327 (15%), Positives = 101/327 (30%), Gaps = 54/327 (16%)
Query: 200 LLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNL 259
+ + I + N + T + L
Sbjct: 1 MGETITVSTPIKQ----IFPDDAFAETIKDNLKKKSV-----------TDAVTQN---EL 42
Query: 260 LSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPAS 319
S+ + ++++ + + N++ + L+ N L+ + +
Sbjct: 43 N--------------SIDQIIANNSDIK-SVQGIQY--LPNVTKLFLNGNKLTDIKPLTN 85
Query: 320 LKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLREL 379
LKN L L + N ++ + L + LK LSL HN + +I L L L
Sbjct: 86 LKN---LGWLFLDENKIK-DLSS--LKDLKKLKSLSLEHNGIS-DING-LVH-LPQLESL 136
Query: 380 DLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPV 439
L +N++T + + + L +L+L N +S ++ ++ L LY+ N+IS
Sbjct: 137 YLGNNKITD--ITVLSRLTKLDTLSLEDNQISD---IVPLAGLTKLQNLYLSKNHISDLR 191
Query: 440 PLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKN 499
L+ L VL+L S + N + + L +
Sbjct: 192 ALA--GLKNLDVLELFSQECLNKPINHQS---NLVVPNTVKNTDGSLVTPEIISDDGDYE 246
Query: 500 LKTIDLSFNSLAGPVPSEIWSLPNLSD 526
+ V + +
Sbjct: 247 KPNVKWHLPEFTNEVSFIFYQPVTIGK 273
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 92.5 bits (229), Expect = 3e-19
Identities = 48/286 (16%), Positives = 102/286 (35%), Gaps = 31/286 (10%)
Query: 300 NLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHN 359
L + ++ L + ++ + +++ ++ + G + N+ +L L N
Sbjct: 22 ETIKDNLKKKSVTDAVTQNELNS---IDQIIANNSDIKS-VQG--IQYLPNVTKLFLNGN 75
Query: 360 QFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVV 419
+ +I P L L L L N++ +L S+ L SL+L N +S +
Sbjct: 76 KLT-DIKP-LTN-LKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS---DINGL 127
Query: 420 SKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKI 479
+ L LY+ N I+ LS T+L L L N + I L+ +
Sbjct: 128 VHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS-DIVPL----AGLTKLQNL 180
Query: 480 VLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIP 539
L N++S L KNL ++L + +L + + N G +
Sbjct: 181 YLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINHQSNLVVPNTV----KNTDGSLV 234
Query: 540 EGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTG 585
++ + ++ +P+ + + + ++ +
Sbjct: 235 TPEIIS----DDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKA 276
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 90.9 bits (225), Expect = 9e-19
Identities = 51/323 (15%), Positives = 108/323 (33%), Gaps = 53/323 (16%)
Query: 153 LVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISG-GSLHIGPSLLQLDLSGNQIS 211
+ +L ++T + + + + +++ I + P++ +L L+GN+++
Sbjct: 23 TIKDNLKKKSVTDA----VTQNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLT 78
Query: 212 DSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVAD 271
D L+N +NL L +NK+ K +S++ +L
Sbjct: 79 D----IKPLTNLKNLGWLFLDENKI-----------KDLSSLK---DL------------ 108
Query: 272 SSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNM 331
LK L L HN + + L L + L N ++ L L+TL++
Sbjct: 109 --KKLKSLSLEHNGIS-DINGLVH--LPQLESLYLGNNKITDIT---VLSRLTKLDTLSL 160
Query: 332 SHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELP 391
N + I L L+ L L+ N + ++ L L+L S +
Sbjct: 161 EDNQIS-DIVP--LAGLTKLQNLYLSKNHIS-DLRAL--AGLKNLDVLELFSQECLNKPI 214
Query: 392 STFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRV 451
+ ++ +++ L ++S V ++ +S Q
Sbjct: 215 NHQSNLVVPNTVKNTDGSLVTPE---IISDDGDYEKPNVKWHLPEFTNEVSFI-FYQPVT 270
Query: 452 LDLSSNGFTGTIPSGFCSPPNFP 474
+ + F G +
Sbjct: 271 IGKAKARFHGRVTQPLKEVYTVS 293
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 83.2 bits (205), Expect = 2e-16
Identities = 54/315 (17%), Positives = 95/315 (30%), Gaps = 58/315 (18%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSS 160
+ NL ++ + T L ++ + + + + ++ + L+
Sbjct: 21 AETIKDNLKKKSVT---DAVTQNELNSIDQIIANNSDIK--SVQGIQYLP-NVTKLFLNG 74
Query: 161 NNITGSLPGRSFLLSCDRLSYVNLSHNSISG-GSLHIGPSLLQLDLSGNQISDSALLTYS 219
N +T + L + L ++ L N I SL L L L N ISD +
Sbjct: 75 NKLT-DIKP---LTNLKNLGWLFLDENKIKDLSSLKDLKKLKSLSLEHNGISD---IN-G 126
Query: 220 LSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYL 279
L + L L +NK+ I+ + L L L
Sbjct: 127 LVHLPQLESLYLGNNKI-----------TDITVLS---RLT--------------KLDTL 158
Query: 280 DLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGG 339
L N + L L + LS+N +S A LKN L+ L +
Sbjct: 159 SLEDNQIS-DIVPLA--GLTKLQNLYLSKNHISDLRALAGLKN---LDVLELFSQE---- 208
Query: 340 IPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSS 399
+ NL + N + PE+ G + ++ + LP S
Sbjct: 209 CLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWH-----LPEFTNEVSF 263
Query: 400 LHSLNLGSNMLSGNF 414
+ + F
Sbjct: 264 IFYQPVTIGKAKARF 278
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 81.7 bits (201), Expect = 6e-16
Identities = 42/230 (18%), Positives = 85/230 (36%), Gaps = 44/230 (19%)
Query: 405 LGSNMLSGNFLNTV--VSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGT 462
+G + + + + I + +++ V + + + +++ +
Sbjct: 1 MGETITVSTPIKQIFPDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-S 57
Query: 463 IPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLP 522
+ G P + K+ L N L+ PL + KNL + L N +I L
Sbjct: 58 V-QGI---QYLPNVTKLFLNGNKLTDIKPLT--NLKNLGWLFLDEN--------KIKDLS 103
Query: 523 NLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQ 582
+L DL L++L L +N ++ I + + + L +N+
Sbjct: 104 SLKDLK-------------------KLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNK 142
Query: 583 LTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLS 632
+T +I + L KL L L +N ++ L L L L+ N++S
Sbjct: 143 IT-DIT-VLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHIS 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 26/89 (29%), Positives = 38/89 (42%), Gaps = 6/89 (6%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
L L L +N +S L L+ L LG+NK+T L + L L N
Sbjct: 110 KLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQI 165
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIP 800
I L GL+ L +L +S N++S +
Sbjct: 166 S-DIVP-LAGLTKLQNLYLSKNHISDLRA 192
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 2e-06
Identities = 15/88 (17%), Positives = 29/88 (32%), Gaps = 6/88 (6%)
Query: 713 LIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQ 772
I +L S++ LN + + ++ + + L + L L+ N
Sbjct: 23 TIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT 78
Query: 773 GSIPGSLGGLSFLSDLDVSNNNLSGIIP 800
I L L L L + N + +
Sbjct: 79 -DIKP-LTNLKNLGWLFLDENKIKDLSS 104
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 7e-06
Identities = 21/95 (22%), Positives = 34/95 (35%), Gaps = 6/95 (6%)
Query: 707 FTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDL 766
L L L N ++ L L L+L N+++ I GL + L L
Sbjct: 127 LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYL 182
Query: 767 SHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPS 801
S N+ + L GL L L++ + +
Sbjct: 183 SKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPIN 215
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 8e-06
Identities = 22/89 (24%), Positives = 35/89 (39%), Gaps = 6/89 (6%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
S+ + + + + + L + L L NKLT I LK +G L L N
Sbjct: 44 SIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKI 99
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIP 800
+ + L L L L + +N +S I
Sbjct: 100 K-DLSS-LKDLKKLKSLSLEHNGISDING 126
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 9e-06
Identities = 34/213 (15%), Positives = 68/213 (31%), Gaps = 44/213 (20%)
Query: 104 TSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNI 163
SL L N+ ++ ++T L+ L L+ L+ L N I
Sbjct: 134 ESLYLGNNKIT---DITVLSRLTKLDTLS-------------------------LEDNQI 165
Query: 164 TGSLPGRSFLLSCDRLSYVNLSHNSISG-GSLHIGPSLLQLDLSGNQISDSALLTYSLSN 222
+ + L +L + LS N IS +L +L L+L + + + SN
Sbjct: 166 S-DI---VPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNKPI--NHQSN 219
Query: 223 CQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLS 282
N + +D L + + ++ ++L SF + Y ++
Sbjct: 220 LVVPNTVKNTDGSLVTPEIIS--DDGDYEKPNVKWHLPEFTNEVSF-------IFYQPVT 270
Query: 283 HNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTE 315
+F + ++ +G
Sbjct: 271 IGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKT 303
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 19/87 (21%), Positives = 30/87 (34%), Gaps = 4/87 (4%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
L L L N +S L LQ L L N ++ + GLK + VL+L
Sbjct: 154 KLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQEC 209
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGI 798
L + + ++ +L
Sbjct: 210 LNKPINHQSNLVVPNTVKNTDGSLVTP 236
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 9e-04
Identities = 13/72 (18%), Positives = 30/72 (41%), Gaps = 4/72 (5%)
Query: 729 ENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDL 788
+ NL +T + L +I + ++++ + S+ G + L ++ L
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 70
Query: 789 DVSNNNLSGIIP 800
++ N L+ I P
Sbjct: 71 FLNGNKLTDIKP 82
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 38/216 (17%)
Query: 936 IGSGGFGEVYKAQLRD----GSVVAIKKLIHVTGQGD-------RE--FMAEMETIGKIK 982
IG G +G+V+KA RD G VA+K+ + V + RE + +ET +
Sbjct: 19 IGEGAYGKVFKA--RDLKNGGRFVALKR-VRVQTGEEGMPLSTIREVAVLRHLETF---E 72
Query: 983 HRNLVPLL----GYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIG 1037
H N+V L E +L LV+E++ L + L + G + K +
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG---VPTETIKDMMFQ 128
Query: 1038 SARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL--VNALDTHLSVSTLA 1095
RGL FLH ++HRD+K N+L+ + + +++DFG+AR+ T + V TL
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-VVTL- 183
Query: 1096 GTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGK 1131
Y PE T D++S G I E+ K
Sbjct: 184 ---WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 2e-19
Identities = 65/279 (23%), Positives = 102/279 (36%), Gaps = 67/279 (24%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHV-TGQGD-----RE--FMAEMETIGKIKHRNL 986
IGSG G V A VAIKKL Q RE M + H+N+
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV------NHKNI 123
Query: 987 VPLL------GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSAR 1040
+ LL + ++ LV E M ++ L + +LD +
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQ---MELDHERMSYLLYQMLC 175
Query: 1041 GLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGY 1100
G+ LH + IIHRD+K SN+++ + ++ DFG+AR + T Y
Sbjct: 176 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTSFMMTPY 223
Query: 1101 V------PPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR 1154
V PE D++S G I+ E++ K + P G D + +
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK-ILFP---GRD--------YIDQ 271
Query: 1155 EKRINEIL---DPELTMQTSDETELY-----QYLRISFE 1185
++ E L PE + Y +Y ++F
Sbjct: 272 WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFP 310
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 65/229 (28%), Positives = 103/229 (44%), Gaps = 53/229 (23%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIK----------HR 984
+G G FG+V + G VA+K L +R+ + ++ +GKIK H
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKIL-------NRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 985 NLVPLLGYCKIGEER--LLVYEYMKWGSL--ESVLHDRAKGGGTKLDWAARKKIA-IGSA 1039
+++ L Y I +V EY+ G L H R + + AR+ I SA
Sbjct: 72 HIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHGRVE------EMEARRLFQQILSA 123
Query: 1040 RGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPG 1099
+ + H ++HRD+K NVLLD + A+++DFG++ +++ L T G+P
Sbjct: 124 --VDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFL--RTSCGSPN 175
Query: 1100 YVPPE-----YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDN 1143
Y PE Y + D++S GVIL LL G P F D++
Sbjct: 176 YAAPEVISGRLYAG----PEVDIWSCGVILYALLCGTLP-----FDDEH 215
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-19
Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 935 MIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYC 993
++G G G+V + R G A+K L++ + + +E + G ++V +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASG---GPHIVCILDVY 91
Query: 994 ----KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC 1049
L++ E M+ G L S + +R T+ + AA IG+A + FLH
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE-AAEIMRDIGTA--IQFLHSH- 147
Query: 1050 IPHIIHRDMKSSNVLL---DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYY 1106
+I HRD+K N+L +++ +++DFG A+ T ++ T TP YV PE
Sbjct: 148 --NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET----TQNALQTPCYTPYYVAPEVL 201
Query: 1107 QSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNN 1144
+ D++S GVI+ LL G P F +
Sbjct: 202 GPEKYDKSCDMWSLGVIMYILLCGFPP-----FYSNTG 234
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-19
Identities = 67/279 (24%), Positives = 102/279 (36%), Gaps = 67/279 (24%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHV-TGQGD-----RE--FMAEMETIGKIKHRNL 986
IGSG G V A VAIKKL Q RE M + H+N+
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV------NHKNI 86
Query: 987 VPLL------GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSAR 1040
+ LL + ++ +V E M +L V+ +LD +
Sbjct: 87 IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLC 138
Query: 1041 GLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGY 1100
G+ LH + IIHRD+K SN+++ + ++ DFG+AR + T Y
Sbjct: 139 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTSFMMTPY 186
Query: 1101 V------PPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR 1154
V PE D++S G I+ E++ G + P G D + +
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG-VLFP---GTD--------HIDQ 234
Query: 1155 EKRINEIL---DPELTMQTSDETELY-----QYLRISFE 1185
++ E L PE + Y +Y SFE
Sbjct: 235 WNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFE 273
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 7e-19
Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGK-IKHRNLVPLLGYC 993
IG G + + + A+K +I + + E E+E + + +H N++ L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVK-IIDKSKRDPTE---EIEILLRYGQHPNIITLKDVY 85
Query: 994 KIGEERLLVYEYMKWGSLESVLHDR--AKGGGTKLDWAARKKIAIGSARGLAFLHHSCIP 1051
G+ +V E MK G L D+ + ++ + A+ I + +LH
Sbjct: 86 DDGKYVYVVTELMKGGEL----LDKILRQKFFSERE-ASAVLFTITKT--VEYLHAQ--- 135
Query: 1052 HIIHRDMKSSNVLL---DENFEA-RVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQ 1107
++HRD+K SN+L N E+ R+ DFG A+ + A + L T T +V PE +
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM--TPCYTANFVAPEVLE 193
Query: 1108 SFRCTTKGDVYSYGVILLELLSGKRP 1133
D++S GV+L +L+G P
Sbjct: 194 RQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 9e-19
Identities = 64/336 (19%), Positives = 114/336 (33%), Gaps = 47/336 (13%)
Query: 98 SLNSHVTSLNLNNSGLS--GSLNL-TTLTALP-YLEHLNLQGNSFS---AGDLSTS-KTS 149
S+ VTSL+L+ + L ++ L P + LNL GNS + +L
Sbjct: 19 SIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAI 78
Query: 150 SCSLVTMDLSSNNIT---GSLPGRSFLLSCDRLSYVNLSHNSIS-GGSLHIGP------- 198
++ +++LS N ++ ++ ++ ++L N S S
Sbjct: 79 PANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPA 138
Query: 199 SLLQLDLSGNQISDS--ALLTYSLSNCQ-NLNLLNFSDNKLPGK-----LNATSVNCKSI 250
S+ L+L GN + L L+ N+N LN N L K + S+
Sbjct: 139 SITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASV 198
Query: 251 STIDLSYNLLSGE---IPASFVADSSGSLKYLDLSHNNFTGK-FSNLD--FGRCGNLSVI 304
+++DLS NLL + A + + L+L N G NL +L +
Sbjct: 199 TSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTV 258
Query: 305 TLSQNGLSG------TEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFR----NLKQL 354
L + + A+ N Q + ++ + + + R
Sbjct: 259 YLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVP 318
Query: 355 SLAHNQF----AGEIPPELGQACGTLRELDLSSNRL 386
SL + + E LRE + L
Sbjct: 319 SLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 7e-18
Identities = 64/360 (17%), Positives = 119/360 (33%), Gaps = 66/360 (18%)
Query: 194 LHIGPSLLQLDLSGNQISDS---ALLTYSLSNCQNLNLLNFSDNKLPGK-----LNATSV 245
I + LDLS N + L+ + ++ LN S N L K + +
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 246 NCKSISTIDLSYNLLS---GEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLS 302
++++++LS N LS + +A ++ LDL N+F + S
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDF------------SSKS 125
Query: 303 VITLSQNGLSGTEFPASLKNCQL-LETLNMSHNALQG----GIPGFLLGSFRNLKQLSLA 357
Q + N + +LN+ N L + L N+ L+L
Sbjct: 126 SSEFKQ----------AFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLR 175
Query: 358 HNQF----AGEIPPELGQACGTLRELDLSSNRLTGE----LPSTFASC-SSLHSLNLGSN 408
N E+ L ++ LDLS+N L + L F+S + + SLNL N
Sbjct: 176 GNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLN 235
Query: 409 MLSG---NFLNTVVSKISSLIYLYVPFNNISGPVP-------LSLTNCTQLRVLDLSSNG 458
L G L + + L +Y+ ++ + + N ++ ++D +
Sbjct: 236 CLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKE 295
Query: 459 FTGTIPSGFCS---PPNFPALEKIVLPNNYLSGTVPLELGSCKN-----LKTIDLSFNSL 510
+ + + + L N L + L+ + L
Sbjct: 296 IHPSHSIPISNLIRELSG-KADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 61/389 (15%), Positives = 122/389 (31%), Gaps = 74/389 (19%)
Query: 106 LNLNNSGLSGSLNL-TTLTALPYLEHLNLQGNSFS---AGDLSTS-KTSSCSLVTMDLSS 160
+N + GS + + + L+L N+ +L + + S+ +++LS
Sbjct: 1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSG 60
Query: 161 NNIT---GSLPGRSFLLSCDRLSYVNLSHNSISGGSL--------HIGPSLLQLDLSGNQ 209
N++ + ++ +NLS N +S S I ++ LDL N
Sbjct: 61 NSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWND 120
Query: 210 ISDS---ALLTYSLSNCQNLNLLNFSDNKLPGK-----LNATSVNCKSISTIDLSYNLLS 261
S + ++ LN N L K + + ++++++L N L+
Sbjct: 121 FSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180
Query: 262 ---GEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPA 318
A F+A S+ LDLS N G S L+
Sbjct: 181 SKNCAELAKFLASIPASVTSLDLSANLL------------GLKSYAELAY---------I 219
Query: 319 SLKNCQLLETLNMSHNALQG-GIPGF--LLGSFRNLKQLSLAHNQFAGEIPPELGQA--- 372
+ +LN+ N L G + L S ++L+ + L ++ + E +A
Sbjct: 220 FSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIV-KNMSKEQCKALGA 278
Query: 373 ----CGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYL 428
+ +D + + ++ S L L +++
Sbjct: 279 AFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNI--- 335
Query: 429 YVPFNNISGPVPLSLTNCTQLRVLDLSSN 457
L +LR +
Sbjct: 336 ------------EDLNIPDELRESIQTCK 352
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 7e-12
Identities = 51/350 (14%), Positives = 104/350 (29%), Gaps = 85/350 (24%)
Query: 318 ASLKNCQLLETLNMSHNALQG----GIPGFLLGSFRNLKQLSLAHNQF----AGEIPPEL 369
+ +L++S N L + + ++ L+L+ N + E+ L
Sbjct: 16 EFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQIL 75
Query: 370 GQACGTLRELDLSSNRLTGE----LPSTFASC-SSLHSLNLGSNMLSGNFLNTVVSKISS 424
+ L+LS N L+ + L T A+ ++ L+LG N S + S+
Sbjct: 76 AAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS----SKSSSEFKQ 131
Query: 425 LIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNN 484
S + + L+L N L I
Sbjct: 132 A---------------FSNLPAS-ITSLNLRGNDLGIKSSDELIQ-----ILAAI----- 165
Query: 485 YLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSL-----PNLSDLVMWANNLTGE-- 537
N+ +++L N+LA +E+ +++ L + AN L +
Sbjct: 166 ------------PANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSY 213
Query: 538 --IPEGICVNGGNLETLILNNNHLTG----AIPKSIASCTNMLWVSLSSNQLTGEIPAGI 591
+ ++ +L L N L G + S ++ V L + +
Sbjct: 214 AELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQC 273
Query: 592 GNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELAN 641
L + ++ +D N + ++N
Sbjct: 274 KALGA-----------------AFPNIQKIILVDKNGKEIHPSHSIPISN 306
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 27/163 (16%), Positives = 49/163 (30%), Gaps = 23/163 (14%)
Query: 97 CSLNSHVTSLNL--NNSGLSGSLNLTTLTALP--YLEHLNLQGNSFS---AGDLSTSKTS 149
S+ + VTSL+L N GL L + + ++ LNL N +L K S
Sbjct: 192 ASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDS 251
Query: 150 SCSLVTMDLSSNNITGSLPG-----RSFLLSCDRLSYVNLSHNSI--SGGSL------HI 196
L T+ L + + + + ++ V+ + I S +
Sbjct: 252 LKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIREL 311
Query: 197 GPSLLQLDLSGNQISDSA---LLTYSLSNCQNLNLLNFSDNKL 236
L + + L+ L + L
Sbjct: 312 SGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 9e-19
Identities = 57/220 (25%), Positives = 88/220 (40%), Gaps = 50/220 (22%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGD-------REFMAEMETIGKIKHRNLV 987
+G G +GEVYKA VAIK+ I + + + RE E ++HRN++
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKR-IRLEHEEEGVPGTAIREVSLLKE----LQHRNII 96
Query: 988 PLLGYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLH 1046
L RL L++EY + L+ + + K G+ F H
Sbjct: 97 ELKSVI-HHNHRLHLIFEYAEN-DLKKYMDK-----NPDVSMRVIKSFLYQLINGVNFCH 149
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEAR-----VSDFGMARL----VNALDTHLSVSTLAGT 1097
+HRD+K N+LL + + + DFG+AR + TH + TL
Sbjct: 150 S---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-THE-IITL--- 201
Query: 1098 PGYVPPE------YYQSFRCTTKGDVYSYGVILLELLSGK 1131
Y PPE +Y +T D++S I E+L
Sbjct: 202 -WYRPPEILLGSRHY-----STSVDIWSIACIWAEMLMKT 235
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-18
Identities = 65/253 (25%), Positives = 106/253 (41%), Gaps = 37/253 (14%)
Query: 935 MIGSGGFGEVYKAQLRD-GSVVAIKKL--IHVTGQGDRE-FMAEMETIGKIKHRNLVPLL 990
+IG G FGEV + + V A+K L + + D F E + + +V L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 991 GYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIA-IGSARGLAFLHHS 1048
Y + L +V EYM G L +++ WA R A + A L +H
Sbjct: 136 -YAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKWA-RFYTAEVVLA--LDAIHSM 187
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQS 1108
IHRD+K N+LLD++ +++DFG +N T GTP Y+ PE +S
Sbjct: 188 ---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC-DTAVGTPDYISPEVLKS 243
Query: 1109 FRCTTKGDVYSY---------GVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRIN 1159
+G Y GV L E+L G P F D+ + ++K ++ + +
Sbjct: 244 -----QGGDGYYGRECDWWSVGVFLYEMLVGDTP-----FYADSLVGTYSKIMNHKNSLT 293
Query: 1160 EILDPELTMQTSD 1172
D +++ + +
Sbjct: 294 FPDDNDISKEAKN 306
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-18
Identities = 77/284 (27%), Positives = 113/284 (39%), Gaps = 61/284 (21%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIK-----KLIHVTGQGDREFMAEMETIGKIKHRNLVPL 989
IG G F +V A+ + G VAIK +L + Q + E+ + + H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ---KLFREVRIMKILNHPNIVKL 79
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC 1049
+ + L+ EY G + L G K A K I SA + + H
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYL---VAHGRMKEKEARSKFRQIVSA--VQYCHQK- 133
Query: 1050 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE----- 1104
I+HRD+K+ N+LLD + +++DFG + L G P Y PE
Sbjct: 134 --RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKL--DAFCGAPPYAAPELFQGK 188
Query: 1105 YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDP 1164
Y + DV+S GVIL L+SG P F D NL K+L +L
Sbjct: 189 KYDG----PEVDVWSLGVILYTLVSGSLP-----F-DGQNL----KELRE-----RVLRG 229
Query: 1165 ELTMQTSDETELYQYLRISFEC-------LDDRPFKRPTMIQVM 1201
+ + +S +C L P KR T+ Q+M
Sbjct: 230 KYRIPFY----------MSTDCENLLKRFLVLNPIKRGTLEQIM 263
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-18
Identities = 55/218 (25%), Positives = 90/218 (41%), Gaps = 50/218 (22%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHV-TGQGD-----RE--FMAEMETIGKIKHRNL 986
+GSG +G V A R G VAIKKL + RE + M +H N+
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM------QHENV 85
Query: 987 VPLL------GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSAR 1040
+ LL + + LV +M ++ L K + + +
Sbjct: 86 IGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMG---LKFSEEKIQYLVYQMLK 137
Query: 1041 GLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGY 1100
GL ++H + ++HRD+K N+ ++E+ E ++ DFG+AR +A T GY
Sbjct: 138 GLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-----------GY 183
Query: 1101 VPPEYY-------QSFRCTTKGDVYSYGVILLELLSGK 1131
V +Y D++S G I+ E+L+GK
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-18
Identities = 52/233 (22%), Positives = 95/233 (40%), Gaps = 62/233 (26%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIK----------HR 984
+G G FG+V A + VA+K + R+ + + + +++ H
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFI-------SRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 985 NLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDW-AARKKIAIGSAR--- 1040
+++ L + ++V EY GG D+ +K++ R
Sbjct: 70 HIIKLYDVITTPTDIVMVIEYA---------------GGELFDYIVEKKRMTEDEGRRFF 114
Query: 1041 -----GLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLA 1095
+ + H I+HRD+K N+LLD+N +++DFG++ ++ L T
Sbjct: 115 QQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFL--KTSC 168
Query: 1096 GTPGYVPPE-----YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDN 1143
G+P Y PE Y + DV+S G++L +L G+ P F D+
Sbjct: 169 GSPNYAAPEVINGKLYAG----PEVDVWSCGIVLYVMLVGRLP-----FDDEF 212
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 3e-18
Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 49/227 (21%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIK----------HR 984
+G G FG+V + G VA+K L +R+ + ++ +GKI+ H
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKIL-------NRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 985 NLVPLLGYCKIGEERLLVYEYMKWGSL--ESVLHDRAKGGGTKLDWAARKKIA-IGSARG 1041
+++ L + +V EY+ G L + R + +R+ I S
Sbjct: 77 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLD------EKESRRLFQQILSG-- 128
Query: 1042 LAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV 1101
+ + H ++HRD+K NVLLD + A+++DFG++ +++ L T G+P Y
Sbjct: 129 VDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFL--RTSCGSPNYA 182
Query: 1102 PPE-----YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDN 1143
PE Y + D++S GVIL LL G P F DD+
Sbjct: 183 APEVISGRLYAG----PEVDIWSSGVILYALLCGTLP-----FDDDH 220
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 6e-18
Identities = 77/360 (21%), Positives = 133/360 (36%), Gaps = 92/360 (25%)
Query: 925 EATNGFSADSMIGSGGFGEVYKAQ-LRDGSVVAIKKLIHV-TGQGD-----RE--FMAEM 975
E + +GSG +G V A R G+ VAIKKL + RE + M
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 81
Query: 976 ETIGKIKHRNLVPLL------GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWA 1029
+H N++ LL + LV +M + L K KL
Sbjct: 82 ------RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHE--KLGED 128
Query: 1030 ARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHL 1089
+ + +GL ++H + IIHRD+K N+ ++E+ E ++ DFG+AR ++ T
Sbjct: 129 RIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT-- 183
Query: 1090 SVSTLAGTPGYVPPEYY-------QSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDD 1142
GYV +Y R T D++S G I+ E+++GK + G D
Sbjct: 184 ---------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK-TLFK---GSD 230
Query: 1143 NNLVGWAKQLHREKRINEIL----DPELTMQTSDETELY-----QYLRISF--------- 1184
L + K I ++ + SDE + Y + + F
Sbjct: 231 --------HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP 282
Query: 1185 ECLD--DR-----PFKRPTMIQV-----MAMFKELQVDTEGDSLD-SFSLKDTVIEELRE 1231
++ ++ +R T + + + + + D SF D ++E +
Sbjct: 283 LAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKR 342
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 88.1 bits (218), Expect = 7e-18
Identities = 74/550 (13%), Positives = 157/550 (28%), Gaps = 98/550 (17%)
Query: 95 VSCSLNSHVTSLNLNNSGLSGSLNLTTLTA-LPYLEHLNLQGNSFSAGDLSTSKTSSC-S 152
+ + + +L N G + +T ++ L L+ ++ + S DL +
Sbjct: 80 LKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADD 139
Query: 153 LVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISD 212
L T+ L C + L I + L + + S+
Sbjct: 140 LETLKLDK---------------CSGFTTDGLLS--IVTHC----RKIKTLLMEESSFSE 178
Query: 213 --SALLTYSLSNCQNLNLLNFSDNKLPG----KLNATSVNCKSISTIDLSYNLLSGEIPA 266
L + +L +LNF + L + NC+S+ ++ + + +
Sbjct: 179 KDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVG- 237
Query: 267 SFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLL 326
++ +L+ N + L + + E P +
Sbjct: 238 --FFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQI 295
Query: 327 ETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRL 386
L++ + L+ L+ NL+ L + + L Q C L+ L +
Sbjct: 296 RKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGL-EVLAQYCKQLKRLRIE---- 350
Query: 387 TGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNIS----GPVPLS 442
+ + ++S L + L Y+ V ++I+ +
Sbjct: 351 ---------RGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTY 401
Query: 443 LTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKT 502
L N R++ L P + + L CK L+
Sbjct: 402 LKNLCDFRLVLLDR-------EERITDLPLDNGVRSL--------------LIGCKKLRR 440
Query: 503 IDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGA 562
L+DL + I N+ ++L +
Sbjct: 441 FAFYLRQ------------GGLTDLGLSY----------IGQYSPNVRWMLLGYVGESDE 478
Query: 563 IPKSIA-SCTNMLWVSLSSNQLTGE-IPAGIGNLVKLAILQLGNN--SLTGQVPQGLGK- 617
+ C N+ + + + I A + L L L + S+TGQ + +
Sbjct: 479 GLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARP 538
Query: 618 CRSLVWLDLN 627
++ +
Sbjct: 539 YWNIELIPSR 548
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 4e-17
Identities = 65/464 (14%), Positives = 124/464 (26%), Gaps = 103/464 (22%)
Query: 198 PSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKL--PGKLNATSVNCKSISTIDL 255
L + +SD L + + +L L L + +C+ I T+ +
Sbjct: 112 RQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLM 171
Query: 256 SYNLLSGEIPASF--VADSSGSLKYLDLSHNNFTGKFSNLD----FGRCGNLSVITLSQ- 308
+ S + +A + SL+ L+ F K S D C +L + +
Sbjct: 172 EESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFA-KISPKDLETIARNCRSLVSVKVGDF 230
Query: 309 NGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPE 368
L F + N + +++ + G+P + K L + P
Sbjct: 231 EILELVGFFKAAANLEEFCGGSLNEDI---GMPEKYMNLVFPRKLCRLGLSYMGPNEMPI 287
Query: 369 LGQACGTLRELDLSSNRL-TGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIY 427
L +R+LDL L T + + C +L L N++ L + L
Sbjct: 288 LFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLET-RNVIGDRGLEVLAQYCKQLKR 346
Query: 428 LYVPFNNISGPVPLSLT------------NCTQLRVLDLSSNGFTGTIPSGFCS-PPNFP 474
L + + C +L + + + T + N
Sbjct: 347 LRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLC 406
Query: 475 ALEKIVLPNNYLSGTVPLELG------SCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLV 528
++L +PL+ G CK L+ L+DL
Sbjct: 407 DFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQ------------GGLTDLG 454
Query: 529 MWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIP 588
+ I N+ ++L +
Sbjct: 455 LSY----------IGQYSPNVRWMLLGYVGESDE-------------------------- 478
Query: 589 AGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLS 632
G+ + C +L L++ S
Sbjct: 479 -GLMEFSR--------------------GCPNLQKLEMRGCCFS 501
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 8e-18
Identities = 59/285 (20%), Positives = 106/285 (37%), Gaps = 60/285 (21%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIK----KLIHVTGQGDREFMA----EMETIGKIKHRNL 986
+GSG FG V+ A V +K + + + + E+ + +++H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 987 VPLLGYCKIGEERLLVYEYMKWGSLESVLHDR--AKGGGTKLD-WAARKKIA-IGSARGL 1042
+ +L + LV E G L+ L +LD A + SA +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG-LD--LFAFIDRHP---RLDEPLASYIFRQLVSA--V 143
Query: 1043 AFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP 1102
+L IIHRD+K N+++ E+F ++ DFG A + T GT Y
Sbjct: 144 GYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER-GKLF--YTFCGTIEYCA 197
Query: 1103 PE-----YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKR 1157
PE Y+ + +++S GV L L+ + P F +
Sbjct: 198 PEVLMGNPYRG----PELEMWSLGVTLYTLVFEENP-----FCE---------------- 232
Query: 1158 INEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMA 1202
+ E ++ + EL + L P +R T+ +++
Sbjct: 233 LEETVEAAIHPPYLVSKELMSLVS---GLLQPVPERRTTLEKLVT 274
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-17
Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 30/220 (13%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDRE-FMAEMETIGKI-KHRNLVPLLGY 992
+G G G+V + + A+K L D E+E + + ++V ++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKML------QDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 993 C---KIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHS 1048
G + L +V E + G L S + DR T+ + A+ +IG A + +LH
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE-ASEIMKSIGEA--IQYLHSI 180
Query: 1049 CIPHIIHRDMKSSNVLL---DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEY 1105
+I HRD+K N+L N +++DFG A+ +H S++T TP YV PE
Sbjct: 181 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET---TSHNSLTTPCYTPYYVAPEV 234
Query: 1106 YQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNL 1145
+ D++S GVI+ LL G P F ++ L
Sbjct: 235 LGPEKYDKSCDMWSLGVIMYILLCGYPP-----FYSNHGL 269
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-17
Identities = 56/232 (24%), Positives = 94/232 (40%), Gaps = 41/232 (17%)
Query: 920 FAHLLEATNGFSADSMIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGD-----RE--F 971
+ + ++ S IG G +G V A + VAIKK+ Q RE
Sbjct: 19 RGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKI 78
Query: 972 MAEMETIGKIKHRNLVPLLGYCKIGEERL-----LVYEYMKWGSLESVLHDRAKGGGTKL 1026
+ +H N++ + + +V + M E+ L+ K L
Sbjct: 79 LLRF------RHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQ--HL 125
Query: 1027 DWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086
RGL ++H + +++HRD+K SN+LL+ + ++ DFG+AR+ +
Sbjct: 126 SNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
Query: 1087 THLSVSTLAGTPGYV------PPEYYQSFRCTTKG-DVYSYGVILLELLSGK 1131
H T YV PE + + TK D++S G IL E+LS +
Sbjct: 183 DHTGFLT-----EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 50/237 (21%), Positives = 87/237 (36%), Gaps = 37/237 (15%)
Query: 375 TLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNN 434
+ + LDLS N L +F S L L+L +
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ----------------------T 66
Query: 435 ISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLEL 494
I SL++ L L L+ N ++ G + +L+K+V L+ +
Sbjct: 67 IEDGAYQSLSH---LSTLILTGNPIQ-SLALG--AFSGLSSLQKLVAVETNLASLENFPI 120
Query: 495 GSCKNLKTIDLSFNSL-AGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLE--- 550
G K LK ++++ N + + +P +L NL L + +N + I +
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLN 179
Query: 551 -TLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNN 605
+L L+ N + I + ++L +NQL +P GI L L + L N
Sbjct: 180 LSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 51/213 (23%), Positives = 81/213 (38%), Gaps = 12/213 (5%)
Query: 423 SSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLP 482
S L + FN + S + +L+VLDLS TI G + L ++L
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQ--SLSHLSTLILT 84
Query: 483 NNYLSGTVPLEL-GSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEG 541
N + ++ L +L+ + +LA I L L +L + N +
Sbjct: 85 GNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 143
Query: 542 ICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWV----SLSSNQLTGEIPAGIGNLVKL 597
N NLE L L++N + + M + LS N + I G ++L
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRL 202
Query: 598 AILQLGNNSLTGQVPQG-LGKCRSLVWLDLNSN 629
L L N L VP G + SL + L++N
Sbjct: 203 KELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 58/234 (24%), Positives = 93/234 (39%), Gaps = 31/234 (13%)
Query: 326 LETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNR 385
+ L++S N L+ + + SF L+ L L+ + I Q+ L L L+ N
Sbjct: 30 TKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 386 LTGELPS-TFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNI-SGPVPLSL 443
+ L F+ SSL L L+ + N + + +L L V N I S +P
Sbjct: 88 IQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145
Query: 444 TNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTI 503
+N T L LDLSSN +I + L ++ L N L
Sbjct: 146 SNLTNLEHLDLSSNKIQ-SIYCT-----DLRVLHQMPLLNLSL----------------- 182
Query: 504 DLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNN 557
DLS N + + + L +L + N L +P+GI +L+ + L+ N
Sbjct: 183 DLSLNPMNF-IQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 51/221 (23%), Positives = 82/221 (37%), Gaps = 20/221 (9%)
Query: 196 IGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKL----PGKLNATSVNCKSIS 251
+ S LDLS N + L +YS + L +L+ S ++ G + +S
Sbjct: 26 LPFSTKNLDLSFNPLR--HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ----SLSHLS 79
Query: 252 TIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGL 311
T+ L+ N + + SL+ L N N G L + ++ N +
Sbjct: 80 TLILTGNPIQ-SLALG-AFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLI 136
Query: 312 SGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLK----QLSLAHNQFAGEIPP 367
+ P N LE L++S N +Q I L + L L+ N I P
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQP 194
Query: 368 ELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSN 408
L+EL L +N+L F +SL + L +N
Sbjct: 195 GA-FKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 53/242 (21%), Positives = 81/242 (33%), Gaps = 36/242 (14%)
Query: 90 CSWQGVSCSLNSH----------VTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFS 139
C + +L+L+ + L L + + P L+ L+L
Sbjct: 7 VPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ 65
Query: 140 AGDLSTSK-TSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHN---SISGGSLH 195
+ S L T+ L+ N I SL +F L + S+ +
Sbjct: 66 T--IEDGAYQSLSHLSTLILTGNPIQ-SLALGAFS-GLSSLQKLVAVETNLASLENFPIG 121
Query: 196 IGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKL----PGKLNATSVNCKSIS 251
+L +L+++ N I L Y SN NL L+ S NK+ L
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEY-FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180
Query: 252 TIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFT----GKFSNLDFGRCGNLSVITLS 307
++DLS N ++ I A LK L L N G F L +L I L
Sbjct: 181 SLDLSLNPMN-FIQPG--AFKEIRLKELALDTNQLKSVPDGIFDRL-----TSLQKIWLH 232
Query: 308 QN 309
N
Sbjct: 233 TN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 25/99 (25%), Positives = 44/99 (44%), Gaps = 4/99 (4%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVL 764
+F + L LDLS + T+ + + SL++L L L N + +F GL ++ L
Sbjct: 47 SFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKL 105
Query: 765 DLSHNNFQGSIP-GSLGGLSFLSDLDVSNNNLSGIIPSG 802
N S+ +G L L +L+V++N +
Sbjct: 106 VAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPE 143
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 26/100 (26%), Positives = 40/100 (40%), Gaps = 6/100 (6%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVL 764
+ + L L L+ N + +L F L+ LQ L L G LK + L
Sbjct: 71 AYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 765 DLSHNNFQGSIP--GSLGGLSFLSDLDVSNNNLSGIIPSG 802
+++HN Q S L+ L LD+S+N + I
Sbjct: 130 NVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCT 167
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 31/99 (31%), Positives = 45/99 (45%), Gaps = 5/99 (5%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
S LDLS+N L +F S LQVL+L ++ ++ L + L L+ N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 772 QGSIP-GSLGGLSFLSDLDVSNNNLSGIIPSG--GQLTT 807
Q S+ G+ GLS L L NL+ + + G L T
Sbjct: 89 Q-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKT 125
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 6e-05
Identities = 20/93 (21%), Positives = 39/93 (41%), Gaps = 7/93 (7%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQV----LNLGHNKLTGHIPDSFGGLKA 760
F+ +L +LDLS N + ++ L+ + + L+L N + P +F ++
Sbjct: 144 YFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR- 201
Query: 761 IGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNN 793
+ L L N + G L+ L + + N
Sbjct: 202 LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 60/215 (27%), Positives = 91/215 (42%), Gaps = 26/215 (12%)
Query: 935 MIGSGGFGEVYKAQLRD-GSVVAIKKL--IHVTGQGDRE-FMAEMETIGKIKHRNLVPLL 990
+G+G FG V + ++ G+ A+K L V E + E + + LV L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 991 GYCKIGEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIA-IGSARGLAFLHHS 1048
K L +V EY+ G + S L G + AR A I +LH
Sbjct: 108 FSFK-DNSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLT--FEYLHSL 160
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQS 1108
+I+RD+K N+L+D+ +V+DFG A+ V T TL GTP + PE S
Sbjct: 161 ---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-TW----TLCGTPEALAPEIILS 212
Query: 1109 FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDN 1143
D ++ GV++ E+ +G P F D
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPP-----FFADQ 242
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-17
Identities = 68/289 (23%), Positives = 105/289 (36%), Gaps = 66/289 (22%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIK---KLIHVTGQGDREFMAEMETIGKIKHRNLVPLLG 991
IGSG FG + +VA+K + + RE + ++H N+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE----IINHRSLRHPNIVRFKE 83
Query: 992 YCKIGEERLLVYEYMKWGSLESVLHDR-AKGGGTKLDWAARKK----IAIGSARGLAFLH 1046
++ EY G L ++R G D AR ++ G+++ H
Sbjct: 84 VILTPTHLAIIMEYASGGEL----YERICNAGRFSED-EARFFFQQLLS-----GVSYCH 133
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEAR--VSDFGMARLVNALDTHLSVSTLAGTPGYVPPE 1104
I HRD+K N LLD + R + DFG + + H + GTP Y+ PE
Sbjct: 134 SM---QICHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIAPE 187
Query: 1105 -----YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRIN 1159
Y DV+S GV L +L G P F D + K + R
Sbjct: 188 VLLRQEYDG----KIADVWSCGVTLYVMLVGAYP-----FEDPEEPRDYRKTIQR----- 233
Query: 1160 EILDPELTMQTSDETELYQYLRISFEC-------LDDRPFKRPTMIQVM 1201
IL + ++ +RIS EC P R ++ ++
Sbjct: 234 -ILSVKYSIP--------DDIRISPECCHLISRIFVADPATRISIPEIK 273
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 57/259 (22%), Positives = 100/259 (38%), Gaps = 69/259 (26%)
Query: 905 SINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQ-LRDGSVVAIKKLI-- 961
S+N+ F+ R + +G GG G V+ A VAIKK++
Sbjct: 1 SMNIHGFDLGSR-------------YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT 47
Query: 962 HVTGQGD-----RE--FMAEMETIGKIKHRNLVPLLGYCKIGEERL-------------- 1000
RE + + H N+V + +L
Sbjct: 48 DPQ---SVKHALREIKIIRRL------DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVY 98
Query: 1001 LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKS 1060
+V EYM E+ L + + G L + RGL ++H S +++HRD+K
Sbjct: 99 IVQEYM-----ETDLANVLEQG--PLLEEHARLFMYQLLRGLKYIH-SA--NVLHRDLKP 148
Query: 1061 SNVLLD-ENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV------PPEYYQSFRCTT 1113
+N+ ++ E+ ++ DFG+AR+++ +H + + P S T
Sbjct: 149 ANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS-----EGLVTKWYRSPRLLLSPNNYT 203
Query: 1114 KG-DVYSYGVILLELLSGK 1131
K D+++ G I E+L+GK
Sbjct: 204 KAIDMWAAGCIFAEMLTGK 222
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-17
Identities = 81/349 (23%), Positives = 132/349 (37%), Gaps = 92/349 (26%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHV-TGQGD-----RE--FMAEMETIGKIKHRNL 986
+GSG +G V A + G VA+KKL RE + M KH N+
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM------KHENV 90
Query: 987 VPLL------GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSAR 1040
+ LL + + LV M + L++ K KL + + R
Sbjct: 91 IGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQ--KLTDDHVQFLIYQILR 143
Query: 1041 GLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGY 1100
GL ++H + IIHRD+K SN+ ++E+ E ++ DFG+AR T GY
Sbjct: 144 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT-----------GY 189
Query: 1101 VPPEYY-------QSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLH 1153
V +Y D++S G I+ ELL+G+ + P G D +
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR-TLFP---GTD--------HID 237
Query: 1154 REKRINEIL----DPELTMQTSDETELY-----QYLRISF---------ECLD--DR--- 1190
+ K I ++ L +S+ Y Q +++F +D ++
Sbjct: 238 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 297
Query: 1191 --PFKRPTMIQV-----MAMFKELQVDTEGDSLD-SFSLKDTVIEELRE 1231
KR T Q A + + + D D S +D +I+E +
Sbjct: 298 LDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSLESRDLLIDEWKS 346
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 5e-17
Identities = 48/258 (18%), Positives = 84/258 (32%), Gaps = 35/258 (13%)
Query: 375 TLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVP-FN 433
EL +L F+ L + + N + V S + L + + N
Sbjct: 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90
Query: 434 NISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLE 493
N+ P + N L+ L +S+ G + P + KI L L+
Sbjct: 91 NLLYINPEAFQNLPNLQYLLISNTGIK-----------HLPDVHKIHSLQKVL-----LD 134
Query: 494 LGSCKNLKTI-DLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETL 552
+ N+ TI SF L+ L + N + EI E
Sbjct: 135 IQDNINIHTIERNSFVGLS----------FESVILWLNKNGIQ-EIHNSAFNGTQLDELN 183
Query: 553 ILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNNSLTGQV 611
+ +NN+L + + + +S ++ +P+ NL KL N ++
Sbjct: 184 LSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KL 239
Query: 612 PQGLGKCRSLVWLDLNSN 629
P L K +L+ L
Sbjct: 240 PT-LEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 41/264 (15%), Positives = 83/264 (31%), Gaps = 20/264 (7%)
Query: 150 SCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHN---SISGGSLHIGPSLLQLDLS 206
CS + +T +P + L I G+ L ++++S
Sbjct: 8 HCSNRVFLCQESKVT-EIP-SDLPRNAIEL---RFVLTKLRVIQKGAFSGFGDLEKIEIS 62
Query: 207 GNQISDSALLTYSLSNCQNLNLLNFSD-NKLPGKLNATSVNCKSISTIDLSYNLLSGEIP 265
N + + SN L+ + N L N ++ + +S + +P
Sbjct: 63 QNDVL-EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLP 120
Query: 266 ASFVADSSGSLKYLDLSHNNFTGKFSNLDF-GRCGNLSVITLSQNGLSGTEFPASLKNCQ 324
S LD+ N F G ++ L++NG+ ++ Q
Sbjct: 121 -DVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIH-NSAFNGTQ 178
Query: 325 LLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSN 384
L E +N L+ +P + L ++ + +P + LR +
Sbjct: 179 LDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNL 236
Query: 385 RLTGELPSTFASCSSLHSLNLGSN 408
+ +LP+ +L +L
Sbjct: 237 K---KLPT-LEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 5e-16
Identities = 40/242 (16%), Positives = 69/242 (28%), Gaps = 18/242 (7%)
Query: 248 KSISTIDLSYNLLSGEIPA-SFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITL 306
++ + L I +F G L+ +++S N+ F L I +
Sbjct: 30 RNAIELRFVLTKLR-VIQKGAF--SGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86
Query: 307 SQ-NGLSGTEFPAS-LKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGE 364
+ N L +N L+ L +S+ ++ +P L + N
Sbjct: 87 EKANNL--LYINPEAFQNLPNLQYLLISNTGIKH-LPDVHKIHSLQKVLLDIQDNINIHT 143
Query: 365 IPPELGQACGT-LRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKIS 423
I L L+ N + S F +N L N V S
Sbjct: 144 IERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGAS 202
Query: 424 SLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPN 483
+ L + I L N +LR + +P+ AL + L
Sbjct: 203 GPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT----LEKLVALMEASLTY 255
Query: 484 NY 485
Sbjct: 256 PS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 41/232 (17%), Positives = 72/232 (31%), Gaps = 11/232 (4%)
Query: 410 LSGNFLNTVVSKI-SSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSG-F 467
+ + + S + + I L + + + L +++S N I + F
Sbjct: 16 CQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF 75
Query: 468 CSPPNFPALEKIVLPN-NYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSD 526
N P L +I + N L P + NL+ + +S +
Sbjct: 76 ---SNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVL 132
Query: 527 LVMWANNLTGEIPEGICVN-GGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSS-NQLT 584
L + N I V L LN N + I S + T + ++LS N L
Sbjct: 133 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE 191
Query: 585 GEIPAGI-GNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPL 635
E+P + IL + + GL + L + L
Sbjct: 192 -ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPTL 242
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 3e-14
Identities = 34/239 (14%), Positives = 74/239 (30%), Gaps = 17/239 (7%)
Query: 152 SLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHN----SISGGSLHIGPSLLQLDLS- 206
+ + + + + +F L + +S N I P L ++ +
Sbjct: 31 NAIELRFVLTKLR-VIQKGAFS-GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88
Query: 207 GNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPA 266
N + + + N NL L S+ + + ++ +D+ N+ I
Sbjct: 89 ANNLLY--INPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER 146
Query: 267 SFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLL 326
+ S L L+ N + N F + N L
Sbjct: 147 NSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELP-NDVFHGASGP 204
Query: 327 ETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNR 385
L++S + +P + L + + L+ S + + ++P + L E L+
Sbjct: 205 VILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPTL--EKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 5e-13
Identities = 47/310 (15%), Positives = 85/310 (27%), Gaps = 64/310 (20%)
Query: 249 SISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQ 308
S + ++ EIP+ + L L VI
Sbjct: 10 SNRVFLCQESKVT-EIPSDL----PRNAIELRFVLTK---------------LRVIQ--- 46
Query: 309 NGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPE 368
+ LE + +S N + I + + L ++ + I PE
Sbjct: 47 --------KGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPE 98
Query: 369 LGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYL 428
Q L+ L +S+ + L++ N+ I ++
Sbjct: 99 AFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNI-----------NIHTI--- 144
Query: 429 YVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSG 488
N+ G L+ + +L L+ NG I + + E + NN L
Sbjct: 145 --ERNSFVG-----LSF--ESVILWLNKNGIQ-EIHNSAFNGTQ--LDELNLSDNNNLEE 192
Query: 489 TVPLELGSCKNLKTIDLSFNSLAGPVPSEI-WSLPNLSDLVMWANNLTGEIPEGICVNGG 547
+D+S + +PS +L L NL ++P
Sbjct: 193 LPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRAR--STYNLK-KLP--TLEKLV 246
Query: 548 NLETLILNNN 557
L L
Sbjct: 247 ALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 8e-13
Identities = 33/191 (17%), Positives = 65/191 (34%), Gaps = 12/191 (6%)
Query: 446 CTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDL 505
C+ RV + T IPS ++ L +L+ I++
Sbjct: 9 CSN-RVFLCQESKVT-EIPSDL-----PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEI 61
Query: 506 SFNSLAGPVPSEIWS-LPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIP 564
S N + + ++++S LP L ++ + N I N NL+ L+++N +
Sbjct: 62 SQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD 121
Query: 565 KSIASCTNMLWVSLSSNQLTGEIPAGI--GNLVKLAILQLGNNSLTGQVPQG-LGKCRSL 621
+ + + N I G + IL L N + ++ +
Sbjct: 122 VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLD 180
Query: 622 VWLDLNSNNLS 632
++NNL
Sbjct: 181 ELNLSDNNNLE 191
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 28/123 (22%), Positives = 43/123 (34%), Gaps = 4/123 (3%)
Query: 705 YTFTTNGSLIYLDLSYNSLSGTLPEN-FGSL-NYLQVLNLGHNKLTGHIPDSFGGLKAIG 762
+ + LD+ N T+ N F L +L L N + +F G +
Sbjct: 122 VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDE 181
Query: 763 VLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGL 822
+ +NN + G S LD+S + +PS G L R + L L
Sbjct: 182 LNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYG-LENLKKLRARSTYNLKKL 239
Query: 823 PLL 825
P L
Sbjct: 240 PTL 242
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 18/94 (19%), Positives = 32/94 (34%), Gaps = 5/94 (5%)
Query: 712 SLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIP-DSFGGLKAIGVLDLSHN 769
+ I L L + + F L+ + + N + I D F L + + +
Sbjct: 31 NAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89
Query: 770 NFQGSIP-GSLGGLSFLSDLDVSNNNLSGIIPSG 802
N I + L L L +SN + +P
Sbjct: 90 NNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDV 122
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 20/100 (20%), Positives = 39/100 (39%), Gaps = 4/100 (4%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGH-NKLTGHIPDSFGGLKAIGV 763
F+ G L +++S N + + + F +L L + + N L P++F L +
Sbjct: 49 AFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQY 108
Query: 764 LDLSHNNFQGSIP-GSLGGLSFLSDLDVSNNNLSGIIPSG 802
L +S+ + +P LD+ +N I
Sbjct: 109 LLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERN 147
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 21/95 (22%), Positives = 32/95 (33%), Gaps = 2/95 (2%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPD-SFGGLKA-IGV 763
F +L YL +S + + +L++ N I SF GL +
Sbjct: 99 AFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVI 158
Query: 764 LDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGI 798
L L+ N Q + G NNNL +
Sbjct: 159 LWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEEL 193
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 5e-07
Identities = 33/189 (17%), Positives = 60/189 (31%), Gaps = 22/189 (11%)
Query: 104 TSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNI 163
+ + + +N LP L++L + K S V +D+ N
Sbjct: 82 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH-LPDVHKIHSLQKVLLDIQDNIN 140
Query: 164 TGSLPGRSFLLSCDRLSYVNLSHN---SISGGSLHIGPSLLQLDLSG-NQISDSALLTYS 219
++ SF+ + L+ N I + + G L +L+LS N + L
Sbjct: 141 IHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFN-GTQLDELNLSDNNNL--EELPNDV 197
Query: 220 LSNCQNLNLLNFSDNKL----PGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGS 275
+L+ S ++ L N K + YNL V +
Sbjct: 198 FHGASGPVILDISRTRIHSLPSYGLE----NLKKLRARST-YNLKKLPTLEKLV-----A 247
Query: 276 LKYLDLSHN 284
L L++
Sbjct: 248 LMEASLTYP 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 46/266 (17%), Positives = 97/266 (36%), Gaps = 46/266 (17%)
Query: 343 FLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHS 402
F +F + +L + ++ ++ +++ + + ++
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVTQN---ELNSIDQIIANNSDIK-SV-QGIQYLPNVTK 72
Query: 403 LNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGT 462
L L N L+ ++ + +L +L++ N + L + +L+ L L NG +
Sbjct: 73 LFLNGNKLTDI---KPLANLKNLGWLFLDENKVKDLSSLK--DLKKLKSLSLEHNGIS-D 126
Query: 463 IPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLP 522
I +G + P LE + L NN ++ L L T+ L N +I +
Sbjct: 127 I-NGL---VHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDN--------QISDIV 172
Query: 523 NLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQ 582
L+ L L+ L L+ NH++ +++A N+ + L S +
Sbjct: 173 PLAGLT-------------------KLQNLYLSKNHISDL--RALAGLKNLDVLELFSQE 211
Query: 583 LTGEIPAGIGNLVKLAILQLGNNSLT 608
+ NLV ++ + SL
Sbjct: 212 CLNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 47/245 (19%), Positives = 94/245 (38%), Gaps = 25/245 (10%)
Query: 198 PSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSY 257
++ +L ++D + + +++ + +++ + + +++ + L+
Sbjct: 24 AETIKDNLKKKSVTD----AVTQNELNSIDQIIANNSDI-KSVQGIQ-YLPNVTKLFLNG 77
Query: 258 NLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFP 317
N L+ P + + +L +L L N S+L L ++L NG+S
Sbjct: 78 NKLTDIKPLANLK----NLGWLFLDENKVK-DLSSLK--DLKKLKSLSLEHNGISDIN-- 128
Query: 318 ASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLR 377
L + LE+L + +N + I L L LSL NQ + +I P L+
Sbjct: 129 -GLVHLPQLESLYLGNNKIT-DITV--LSRLTKLDTLSLEDNQIS-DIVP--LAGLTKLQ 181
Query: 378 ELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISG 437
L LS N ++ +L A +L L L S N S + + ++
Sbjct: 182 NLYLSKNHIS-DL-RALAGLKNLDVLELFSQECL-NKPINHQSNLVVPNTVKNTDGSLVT 238
Query: 438 PVPLS 442
P +S
Sbjct: 239 PEIIS 243
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 48/222 (21%), Positives = 92/222 (41%), Gaps = 20/222 (9%)
Query: 420 SKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKI 479
+ I + +++ V + + + +++ ++ G PN + K+
Sbjct: 21 DAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SV-QGIQYLPN---VTKL 73
Query: 480 VLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIP 539
L N L+ PL + KNL + L N + + L L L + N ++ +I
Sbjct: 74 FLNGNKLTDIKPLA--NLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS-DI- 127
Query: 540 EGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAI 599
G+ V+ LE+L L NN +T ++ T + +SL NQ++ +I + L KL
Sbjct: 128 NGL-VHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQN 182
Query: 600 LQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELAN 641
L L N ++ + L ++L L+L S + +N
Sbjct: 183 LYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSN 222
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 51/261 (19%), Positives = 94/261 (36%), Gaps = 51/261 (19%)
Query: 197 GPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLS 256
GP + I +S N + T +
Sbjct: 1 GPLGSETITVPTPIKQ----IFSDDAFAETIKDNLKKKSV-----------TDAVTQN-- 43
Query: 257 YNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEF 316
L S+ + ++++ + + N++ + L+ N L+ +
Sbjct: 44 -ELN--------------SIDQIIANNSDIK-SVQGIQY--LPNVTKLFLNGNKLTDIKP 85
Query: 317 PASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTL 376
A+LKN L L + N ++ + L + LK LSL HN + +I L L
Sbjct: 86 LANLKN---LGWLFLDENKVK-DLSS--LKDLKKLKSLSLEHNGIS-DING-LVH-LPQL 136
Query: 377 RELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNIS 436
L L +N++T + + + L +L+L N +S ++ ++ L LY+ N+IS
Sbjct: 137 ESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD---IVPLAGLTKLQNLYLSKNHIS 191
Query: 437 GPVPLSLTNCTQLRVLDLSSN 457
L+ L VL+L S
Sbjct: 192 DLRALA--GLKNLDVLELFSQ 210
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 50/314 (15%), Positives = 104/314 (33%), Gaps = 57/314 (18%)
Query: 153 LVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISG-GSLHIGPSLLQLDLSGNQIS 211
+ +L ++T + + + + +++ I + P++ +L L+GN+++
Sbjct: 26 TIKDNLKKKSVTDA----VTQNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLT 81
Query: 212 DSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVAD 271
D L+N +NL L +NK + + +L
Sbjct: 82 D----IKPLANLKNLGWLFLDENK--------------VKDLSSLKDL------------ 111
Query: 272 SSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNM 331
LK L L HN + + L L + L N ++ + L L+TL++
Sbjct: 112 --KKLKSLSLEHNGIS-DINGLV--HLPQLESLYLGNNKITDITVLSRLTK---LDTLSL 163
Query: 332 SHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELP 391
N + I L L+ L L+ N + ++ L L L+L S +
Sbjct: 164 EDNQIS-DIVP--LAGLTKLQNLYLSKNHIS-DLRA-L-AGLKNLDVLELFSQECLNKPI 217
Query: 392 STFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRV 451
+ ++ +++ L IS P P + + +
Sbjct: 218 NHQSNLVVPNTVKNTDGSL------VTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQP 271
Query: 452 LDLSSNG--FTGTI 463
+ + F G +
Sbjct: 272 VTIGKAKARFHGRV 285
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 34/205 (16%), Positives = 68/205 (33%), Gaps = 42/205 (20%)
Query: 428 LYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLS 487
I + +L T + ++++I+ N+ +
Sbjct: 7 TITVPTPIKQIFSDD--AFAETIKDNLKKKSVTDAVTQN-----ELNSIDQIIANNSDIK 59
Query: 488 GTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGG 547
++ N+ + L+ N ++ + L++L
Sbjct: 60 SVQGIQ--YLPNVTKLFLNGN--------KLTDIKPLANLK------------------- 90
Query: 548 NLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSL 607
NL L L+ N + + + +SL N ++ +I G+ +L +L L LGNN +
Sbjct: 91 NLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKI 146
Query: 608 TGQVPQGLGKCRSLVWLDLNSNNLS 632
T L + L L L N +S
Sbjct: 147 TD--ITVLSRLTKLDTLSLEDNQIS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 32/159 (20%), Positives = 65/159 (40%), Gaps = 13/159 (8%)
Query: 474 PALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANN 533
P + + + + + +L S+ V L ++ ++ ++
Sbjct: 2 PLGSETITVPTPIKQIFSDD--AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSD 57
Query: 534 LTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGN 593
+ + +GI N+ L LN N LT P +A+ N+ W+ L N++ ++ + +
Sbjct: 58 IK-SV-QGIQ-YLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DLS-SLKD 110
Query: 594 LVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLS 632
L KL L L +N ++ GL L L L +N ++
Sbjct: 111 LKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKIT 147
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 41/186 (22%), Positives = 74/186 (39%), Gaps = 19/186 (10%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSS 160
++ L L+ + + +L++L L L+ L+L+ N S D++ L ++ L +
Sbjct: 90 KNLGWLFLDENKVK---DLSSLKDLKKLKSLSLEHNGIS--DINGLVHLP-QLESLYLGN 143
Query: 161 NNITGSLPGRSFLLSCDRLSYVNLSHNSISG-GSLHIGPSLLQLDLSGNQISDSALLTYS 219
N IT + L +L ++L N IS L L L LS N ISD +
Sbjct: 144 NKIT----DITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD----LRA 195
Query: 220 LSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYL 279
L+ +NL++L + K N +T+ + L S G +
Sbjct: 196 LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISD----DGDYEKP 251
Query: 280 DLSHNN 285
++ +
Sbjct: 252 NVKWHL 257
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 44/158 (27%), Positives = 66/158 (41%), Gaps = 17/158 (10%)
Query: 102 HVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSN 161
+VT L LN + L+ ++ L L L L L N DLS+ K L ++ L N
Sbjct: 69 NVTKLFLNGNKLT---DIKPLANLKNLGWLFLDENKVK--DLSSLKDLK-KLKSLSLEHN 122
Query: 162 NITGSLPGRSFLLSCDRLSYVNLSHNSISG-GSLHIGPSLLQLDLSGNQISDSALLTYSL 220
I+ + G L+ +L + L +N I+ L L L L NQISD L
Sbjct: 123 GIS-DING---LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV----PL 174
Query: 221 SNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYN 258
+ L L S N + L A + K++ ++L
Sbjct: 175 AGLTKLQNLYLSKNHIS-DLRALA-GLKNLDVLELFSQ 210
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 26/89 (29%), Positives = 38/89 (42%), Gaps = 6/89 (6%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
L L L +N +S L L+ L LG+NK+T L + L L N
Sbjct: 113 KLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQI 168
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIP 800
I L GL+ L +L +S N++S +
Sbjct: 169 S-DIVP-LAGLTKLQNLYLSKNHISDLRA 195
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 21/95 (22%), Positives = 34/95 (35%), Gaps = 6/95 (6%)
Query: 707 FTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDL 766
L L L N ++ L L L+L N+++ I GL + L L
Sbjct: 130 LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYL 185
Query: 767 SHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPS 801
S N+ + L GL L L++ + +
Sbjct: 186 SKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPIN 218
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 15/88 (17%), Positives = 29/88 (32%), Gaps = 6/88 (6%)
Query: 713 LIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQ 772
I +L S++ LN + + ++ + + L + L L+ N
Sbjct: 26 TIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT 81
Query: 773 GSIPGSLGGLSFLSDLDVSNNNLSGIIP 800
I L L L L + N + +
Sbjct: 82 -DIKP-LANLKNLGWLFLDENKVKDLSS 107
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 22/89 (24%), Positives = 37/89 (41%), Gaps = 6/89 (6%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
S+ + + + + ++ + L + L L NKLT I LK +G L L N
Sbjct: 47 SIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKV 102
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIP 800
+ + L L L L + +N +S I
Sbjct: 103 K-DLSS-LKDLKKLKSLSLEHNGISDING 129
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 28/138 (20%), Positives = 49/138 (35%), Gaps = 35/138 (25%)
Query: 100 NSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLS 159
+ SL L N+ ++ ++T L+ L L+ L+ L
Sbjct: 133 LPQLESLYLGNNKIT---DITVLSRLTKLDTLS-------------------------LE 164
Query: 160 SNNITGSLPGRSFLLSCDRLSYVNLSHNSISG-GSLHIGPSLLQLDLSGNQISDSALLTY 218
N I+ + L +L + LS N IS +L +L L+L + + +
Sbjct: 165 DNQIS-DI---VPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNKPI--N 218
Query: 219 SLSNCQNLNLLNFSDNKL 236
SN N + +D L
Sbjct: 219 HQSNLVVPNTVKNTDGSL 236
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 1e-16
Identities = 62/221 (28%), Positives = 104/221 (47%), Gaps = 38/221 (17%)
Query: 935 MIGSGGFGEVYKAQLRD-GSVVAIKKL--IHVTGQGDRE-FMAEMETIGKIKHRNLVPLL 990
+G+G FG V+ + R G A+K L V E E + + H ++ +
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 991 GYCKIGEERL-LVYEYMKWGSLESVLH-------DRAKGGGTKLDWAARKKIAIGSARGL 1042
G + +++ ++ +Y++ G L S+L AK +AA + A L
Sbjct: 73 GTFQ-DAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF------YAAE----VCLA--L 119
Query: 1043 AFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP 1102
+LH II+RD+K N+LLD+N +++DFG A+ V + T+ TL GTP Y+
Sbjct: 120 EYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-TY----TLCGTPDYIA 171
Query: 1103 PEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDN 1143
PE + D +S+G+++ E+L+G P F D N
Sbjct: 172 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTP-----FYDSN 207
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 49/211 (23%), Positives = 76/211 (36%), Gaps = 11/211 (5%)
Query: 397 CSSLHSLNLGSNMLSGNFLNTVVSKI-SSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLS 455
C + L + + L++ N + +L T+L L+L
Sbjct: 4 CEVSKVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 456 SNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVP 515
T + P L + L +N L ++PL + L +D+SFN L
Sbjct: 64 RAELT-KLQVD----GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPL 117
Query: 516 SEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSI-ASCTNML 574
+ L L +L + N L +P G+ LE L L NN+LT +P + N+
Sbjct: 118 GALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLD 175
Query: 575 WVSLSSNQLTGEIPAGIGNLVKLAILQLGNN 605
+ L N L IP G L L N
Sbjct: 176 TLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 43/194 (22%), Positives = 68/194 (35%), Gaps = 16/194 (8%)
Query: 442 SLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLK 501
++ ++ T +P + L N L L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDL-----PKDTTILHLSENLLYTFSLATLMPYTRLT 58
Query: 502 TIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTG 561
++L L +LP L L + N L +P L L ++ N LT
Sbjct: 59 QLNLDRAELT--KLQVDGTLPVLGTLDLSHNQLQ-SLPLLG-QTLPALTVLDVSFNRLT- 113
Query: 562 AIPKSI-ASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNNSLTGQVPQGL-GKC 618
++P + + L N+L +P G+ KL L L NN+LT ++P GL
Sbjct: 114 SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGL 171
Query: 619 RSLVWLDLNSNNLS 632
+L L L N+L
Sbjct: 172 ENLDTLLLQENSLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 55/212 (25%), Positives = 76/212 (35%), Gaps = 15/212 (7%)
Query: 273 SGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMS 332
S ++ N T +L + +++ LS+N L A+L L LN+
Sbjct: 9 VASHLEVNCDKRNLTALPPDLP----KDTTILHLSENLLYTFS-LATLMPYTRLTQLNLD 63
Query: 333 HNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPS 392
L + G+ L L L+HNQ +P LGQ L LD+S NRLT
Sbjct: 64 RAELTK-LQVD--GTLPVLGTLDLSHNQLQ-SLPL-LGQTLPALTVLDVSFNRLTSLPLG 118
Query: 393 TFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVL 452
L L L N L +++ L L + NN++ L L L
Sbjct: 119 ALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 453 DLSSNGFTGTIPSGFCSPPNFPALEKIVLPNN 484
L N TIP GF L L N
Sbjct: 178 LLQENSLY-TIPKGFFGSHL---LPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 35/108 (32%), Positives = 51/108 (47%), Gaps = 9/108 (8%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
T L LDLS+N L +LP +L L VL++ N+LT + GL + L
Sbjct: 72 VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130
Query: 766 LSHNNFQGSIP-GSLGGLSFLSDLDVSNNNLSGIIPSG-----GQLTT 807
L N + ++P G L L L ++NNNL+ +P+G L T
Sbjct: 131 LKGNELK-TLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDT 176
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 33/88 (37%), Positives = 40/88 (45%), Gaps = 4/88 (4%)
Query: 715 YLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGS 774
L LS N L L LNL +LT + G L +G LDLSHN Q S
Sbjct: 35 ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-S 91
Query: 775 IPGSLGGLSFLSDLDVSNNNLSGIIPSG 802
+P L L+ LDVS N L+ +P G
Sbjct: 92 LPLLGQTLPALTVLDVSFNRLTS-LPLG 118
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 33/99 (33%), Positives = 45/99 (45%), Gaps = 5/99 (5%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVL 764
T +L LD+S+N L+ +LP L LQ L L N+L P + L
Sbjct: 95 LGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153
Query: 765 DLSHNNFQGSIP-GSLGGLSFLSDLDVSNNNLSGIIPSG 802
L++NN +P G L GL L L + N+L IP G
Sbjct: 154 SLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKG 190
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 50/221 (22%), Positives = 81/221 (36%), Gaps = 35/221 (15%)
Query: 125 LPYLEHLNLQGNSFSA--GDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYV 182
+ +N + +A DL T + LS N + + + + RL+ +
Sbjct: 9 VASHLEVNCDKRNLTALPPDLPKDTTI------LHLSENLLY-TFSLATLM-PYTRLTQL 60
Query: 183 NLSHNSISGGSLHIG-PSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKL----P 237
NL ++ + P L LDLS NQ+ LL +L L++ S N+L
Sbjct: 61 NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDV---SFNRLTSLPL 117
Query: 238 GKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFT----GKFSNL 293
G L + + L N L +P + + L+ L L++NN T G + L
Sbjct: 118 GALRGLG----ELQELYLKGNELK-TLPPG-LLTPTPKLEKLSLANNNLTELPAGLLNGL 171
Query: 294 DFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHN 334
NL + L +N L P LL + N
Sbjct: 172 -----ENLDTLLLQENSL--YTIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 24/83 (28%), Positives = 32/83 (38%), Gaps = 3/83 (3%)
Query: 712 SLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNN 770
L L L N L TLP L+ L+L +N LT GL+ + L L N+
Sbjct: 125 ELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
Query: 771 FQGSIPGSLGGLSFLSDLDVSNN 793
+IP G L + N
Sbjct: 184 LY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 20/102 (19%), Positives = 36/102 (35%), Gaps = 5/102 (4%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
+ S + ++ +L+ LP + +L+L N L + + L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTT 807
L + G L L LD+S+N L + G L
Sbjct: 62 LDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQSLPLLGQTLPA 101
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-16
Identities = 72/309 (23%), Positives = 112/309 (36%), Gaps = 76/309 (24%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGD-----RE--FMAEMETIGKIKHRNLV 987
+G G +G V A G +VAIKK+ RE + KH N++
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF------KHENII 72
Query: 988 PLL-----GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGL 1042
+ + E ++ E M ++ LH L + + R +
Sbjct: 73 TIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQ--MLSDDHIQYFIYQTLRAV 125
Query: 1043 AFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP--GY 1100
LH ++IHRD+K SN+L++ N + +V DFG+AR+++ S T + +
Sbjct: 126 KVLH-GS--NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 1101 V------PPEYYQSFRCTTKG-DVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLH 1153
V PE + ++ DV+S G IL EL + PI P G D H
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PIFP---GRDY--------RH 230
Query: 1154 REKRINEIL-----DPELTMQTSDETELY-----QYLRISF---------ECLD--DR-- 1190
+ I I+ D +L S Y Y + +D R
Sbjct: 231 QLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRML 290
Query: 1191 ---PFKRPT 1196
P KR T
Sbjct: 291 VFDPAKRIT 299
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 4e-16
Identities = 26/162 (16%), Positives = 60/162 (37%), Gaps = 11/162 (6%)
Query: 300 NLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHN 359
+L+ ITL+ ++ N ++ L +++ P + NL++L +
Sbjct: 45 SLTYITLANINVTDLTGIEYAHN---IKDLTINNIHATNYNP---ISGLSNLERLRIMGK 98
Query: 360 QFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVV 419
+ P L +L LD+S + + + + ++S++L N + +
Sbjct: 99 DVTSDKIPNLSG-LTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI--MPL 155
Query: 420 SKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTG 461
+ L L + F+ + + + +L L S G
Sbjct: 156 KTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 29/165 (17%), Positives = 62/165 (37%), Gaps = 8/165 (4%)
Query: 469 SPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLV 528
+ +L I L N ++ +E N+K + ++ + I L NL L
Sbjct: 39 TEAQMNSLTYITLANINVTDLTGIE--YAHNIKDLTINNIHATNY--NPISGLSNLERLR 94
Query: 529 MWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIP 588
+ ++T + + +L L ++++ +I I + + + LS N +I
Sbjct: 95 IMGKDVTSDKIPNLS-GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM 153
Query: 589 AGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSG 633
+ L +L L + + + +G+ L L S + G
Sbjct: 154 -PLKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 5e-14
Identities = 23/167 (13%), Positives = 66/167 (39%), Gaps = 11/167 (6%)
Query: 420 SKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKI 479
++++SL Y+ + N++ + ++ L +++ T P LE++
Sbjct: 41 AQMNSLTYITLANINVTDLTGIE--YAHNIKDLTINNIHATNYNPIS-----GLSNLERL 93
Query: 480 VLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIP 539
+ ++ L +L +D+S ++ + ++I +LP ++ + + N +I
Sbjct: 94 RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI- 152
Query: 540 EGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGE 586
+ L++L + + + I + + S + G+
Sbjct: 153 MPLK-TLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 32/191 (16%), Positives = 76/191 (39%), Gaps = 15/191 (7%)
Query: 347 SFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLG 406
+F+ L + A ++ L + L++ +T +L + ++ L +
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNS----LTYITLANINVT-DL-TGIEYAHNIKDLTIN 74
Query: 407 SNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSG 466
+ + +S +S+L L + +++ +L+ T L +LD+S + +I +
Sbjct: 75 NIHATNY---NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
Query: 467 FCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSD 526
P + I L N + L + LK++++ F+ + I P L+
Sbjct: 132 IN---TLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQ 185
Query: 527 LVMWANNLTGE 537
L ++ + G+
Sbjct: 186 LYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 24/162 (14%), Positives = 52/162 (32%), Gaps = 31/162 (19%)
Query: 472 NFP--ALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVM 529
N P + + S T + +L I L+ + L +
Sbjct: 16 NIPDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANI--------NVTDLTGIEYAH- 66
Query: 530 WANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPA 589
N++ L +NN H T P I+ +N+ + + +T +
Sbjct: 67 ------------------NIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIP 106
Query: 590 GIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNL 631
+ L L +L + +++ + + + +DL+ N
Sbjct: 107 NLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 5e-13
Identities = 18/89 (20%), Positives = 33/89 (37%), Gaps = 1/89 (1%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
+L L + ++ N L L +L++ H+ I L + +DLS+N
Sbjct: 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIP 800
I L L L L++ + +
Sbjct: 149 ITDIMP-LKTLPELKSLNIQFDGVHDYRG 176
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 31/167 (18%), Positives = 58/167 (34%), Gaps = 14/167 (8%)
Query: 198 PSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSY 257
SL + L+ ++D LT + N+ L ++ N S ++ + +
Sbjct: 44 NSLTYITLANINVTD---LT-GIEYAHNIKDLTINNIHA-TNYNPIS-GLSNLERLRIMG 97
Query: 258 NLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFP 317
++ + + SL LD+SH+ ++ I LS NG
Sbjct: 98 KDVTSDKIPNL--SGLTSLTLLDISHSAHDDS-ILTKINTLPKVNSIDLSYNGAITD--I 152
Query: 318 ASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGE 364
LK L++LN+ + + + F L QL G+
Sbjct: 153 MPLKTLPELKSLNIQFDGVHDYRG---IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 21/163 (12%), Positives = 53/163 (32%), Gaps = 20/163 (12%)
Query: 177 DRLSYVNLSHNSISGGSLHIGP-----SLLQLDLSGNQISDSALLTYSLSNCQNLNLLNF 231
+ L+Y+ L++ +++ + ++ L ++ ++ +S NL L
Sbjct: 44 NSLTYITLANINVT----DLTGIEYAHNIKDLTINNIHATNYN----PISGLSNLERLRI 95
Query: 232 SDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFS 291
+ S++ +D+S++ I ++ + +DLS+N
Sbjct: 96 MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI--NTLPKVNSIDLSYNGAITDIM 153
Query: 292 NLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHN 334
L L + + +G+ L L
Sbjct: 154 PL--KTLPELKSLNIQFDGVHDYRGIEDFPK---LNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 19/95 (20%), Positives = 39/95 (41%), Gaps = 2/95 (2%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
++ L ++ + L+ L+ L + +T + GL ++ +LD+SH+
Sbjct: 67 NIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAH 124
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLT 806
SI + L ++ +D+S N I L
Sbjct: 125 DDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLP 159
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 35/233 (15%), Positives = 76/233 (32%), Gaps = 38/233 (16%)
Query: 56 GNEELTILMAFKQSSIGSDPNGYLANWTADALTPCSWQGVSCSLNSHVTSLNLNNSGLSG 115
G E T L A + + D + L S ++ + + +T + L N ++
Sbjct: 1 GAAEQTGLKASQDNVNIPDST--FKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT- 57
Query: 116 SLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLS 175
+LT + ++ L + + + + S +L + + ++T
Sbjct: 58 --DLTGIEYAHNIKDLTINNIHAT--NYNPISGLS-NLERLRIMGKDVTSDKIP------ 106
Query: 176 CDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNK 235
NLS SL LD+S + DS L ++ +N ++ S N
Sbjct: 107 -------NLSGL----------TSLTLLDISHSAHDDSILT--KINTLPKVNSIDLSYNG 147
Query: 236 LPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTG 288
+ + ++++ ++ + + D L L G
Sbjct: 148 AITDIMPLK-TLPELKSLNIQFDGVHD---YRGIEDFP-KLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 9e-09
Identities = 17/94 (18%), Positives = 37/94 (39%), Gaps = 4/94 (4%)
Query: 548 NLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSL 607
+L + L N ++T I N+ +++++ T I L L L++ +
Sbjct: 45 SLTYITLANINVTDL--TGIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDV 100
Query: 608 TGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELAN 641
T L SL LD++ + + +++
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 17/91 (18%), Positives = 38/91 (41%), Gaps = 4/91 (4%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
SL Y+ L+ +++ + ++ L + + T + GL + L + +
Sbjct: 45 SLTYITLANINVTDL--TGIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDV 100
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIPSG 802
+L GL+ L+ LD+S++ I +
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 4e-16
Identities = 69/309 (22%), Positives = 124/309 (40%), Gaps = 50/309 (16%)
Query: 877 DEQREKYIESLPT-----SGSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFS 931
E+RE++ ++ T ++ ++ S N E + H + F
Sbjct: 93 PEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE-FE 151
Query: 932 ADSMIGSGGFGEVYKAQLRD-GSVVAIKKL--IHVTGQGDREF-MAEMETIGKIKHRNLV 987
++G G FG+V + + G A+K L + + + + E + +H L
Sbjct: 152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 988 PLLGYCKIGEERL-LVYEYMKWGSLESVLH-------DRAKGGGTKLDWAARKKIAIGSA 1039
L Y +RL V EY G L L DRA+ + A I SA
Sbjct: 212 ALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR------FYGAE----IVSA 260
Query: 1040 RGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPG 1099
L +LH ++++RD+K N++LD++ +++DFG+ + + ++ T GTP
Sbjct: 261 --LDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTPE 314
Query: 1100 YVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRIN 1159
Y+ PE + D + GV++ E++ G+ P F + + EK
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-----FYNQD----------HEKLFE 359
Query: 1160 EILDPELTM 1168
IL E+
Sbjct: 360 LILMEEIRF 368
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 50/240 (20%), Positives = 95/240 (39%), Gaps = 48/240 (20%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIK-------HRNLV 987
+G G + EV++A + + V +K L + + + +IK N++
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKIL--------KPVKKK-KIKREIKILENLRGGPNII 94
Query: 988 PLLGYCKIGEER--LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFL 1045
L K R LV+E++ + + L + + L +
Sbjct: 95 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYC 146
Query: 1046 HHSCIPHIIHRDMKSSNVLLD-ENFEARVSDFGMARLVNALDTH-LSVSTLAGTPGYVPP 1103
H I+HRD+K NV++D E+ + R+ D+G+A + + + V++ + P
Sbjct: 147 HSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY----FKGP 199
Query: 1104 EYYQSFRCTTKG-DVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162
E ++ D++S G +L ++ K P G DN QL RI ++L
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH---GHDNY-----DQL---VRIAKVL 248
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 1e-15
Identities = 57/304 (18%), Positives = 108/304 (35%), Gaps = 59/304 (19%)
Query: 875 KKDEQREKYIESLPTSGSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSADS 934
+ +++ + S S + + + T P + + + +
Sbjct: 4 HEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDW----QIPDRYEIRH 59
Query: 935 MIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTG-QGD-----RE--FMAEMETIGKIKHRN 985
+IG+G +G V +A + VVAIKK++ V D RE + + H +
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL------NHDH 113
Query: 986 LVPLLGYCKIGEERL-----LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSAR 1040
+V +L + +V E + + L K +
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFR-----TPVYLTELHIKTLLYNLLV 167
Query: 1041 GLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP-- 1098
G+ ++H + I+HRD+K +N L++++ +V DFG+AR V+ + S ++
Sbjct: 168 GVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 1099 -----------------GYV------PPEYYQSFRCTTKG-DVYSYGVILLELLSGKRPI 1134
G+V PE T+ DV+S G I ELL+ +
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284
Query: 1135 DPSE 1138
Sbjct: 285 VAYH 288
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-15
Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 46/227 (20%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHV-TGQGD-----RE--FMAEMETIGKIKHRNL 986
+G G +G V+K+ R G VVA+KK+ D RE + E+ H N+
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS-----GHENI 71
Query: 987 VPLLGYCKI--GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAF 1044
V LL + + LV++YM E+ LH + L+ ++ + + + +
Sbjct: 72 VNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKY 124
Query: 1045 LHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP------ 1098
LH ++HRDMK SN+LL+ +V+DFG++R + + L+
Sbjct: 125 LHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 1099 -------GYV------PPEYYQSFRCTTKG-DVYSYGVILLELLSGK 1131
YV PE TKG D++S G IL E+L GK
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-15
Identities = 55/256 (21%), Positives = 83/256 (32%), Gaps = 82/256 (32%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHV-TGQGD-----RE--FMAEMETIGKIKHRNL 986
IG G +G VY A VAIKK+ + D RE + + K +
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL------KSDYI 87
Query: 987 VPLLGYCKIGEERL-----LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSA-- 1039
+ L + +V E +S L K+ +
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIA-----DSDLK----------------KL-FKTPIF 125
Query: 1040 --------------RGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085
G F+H IIHRD+K +N LL+++ +V DFG+AR +N+
Sbjct: 126 LTEEHIKTILYNLLLGENFIH-ES--GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182
Query: 1086 DTHLSVSTLAGTP--------------GYV------PPEYYQSFRCTTKG-DVYSYGVIL 1124
V+ L +V PE TK D++S G I
Sbjct: 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIF 242
Query: 1125 LELLSGKRPIDPSEFG 1140
ELL+ +
Sbjct: 243 AELLNMLQSHINDPTN 258
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 51/189 (26%), Positives = 78/189 (41%), Gaps = 16/189 (8%)
Query: 447 TQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLS---GTVPLELGSCKNLKTI 503
+ LDL SN + F L + L +N L + EL KNL+T+
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAF---HRLTKLRLLYLNDNKLQTLPAGIFKEL---KNLETL 90
Query: 504 DLSFNSLAGPVPSEI-WSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGA 562
++ N L +P + L NL++L + N L +P + + L L L N L +
Sbjct: 91 WVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-S 147
Query: 563 IPKSI-ASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNNSLTGQVPQGLGKCRS 620
+PK + T++ + L +NQL +P G L +L L+L NN L
Sbjct: 148 LPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEK 206
Query: 621 LVWLDLNSN 629
L L L N
Sbjct: 207 LKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 55/235 (23%), Positives = 84/235 (35%), Gaps = 61/235 (25%)
Query: 375 TLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNN 434
++LDL SN+L+ F + L L L N L
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ----------------------T 75
Query: 435 ISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSG-FCSPPNFPALEKIVLPNNYLSGTVPLE 493
+ + L N L L ++ N +P G F
Sbjct: 76 LPAGIFKELKN---LETLWVTDNKLQ-ALPIGVFDQLV---------------------- 109
Query: 494 LGSCKNLKTIDLSFNSLAGPVPSEIW-SLPNLSDLVMWANNLTGEIPEGICVNGGNLETL 552
NL + L N L +P ++ SL L+ L + N L +P+G+ +L+ L
Sbjct: 110 -----NLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKEL 162
Query: 553 ILNNNHLTGAIPKSI-ASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNN 605
L NN L +P+ T + + L +NQL +P G +L KL +LQL N
Sbjct: 163 RLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 45/137 (32%), Positives = 63/137 (45%), Gaps = 7/137 (5%)
Query: 499 NLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNH 558
+ K +DL N L+ L L L + N L +P GI NLETL + +N
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNK 96
Query: 559 LTGAIPKSI-ASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNNSLTGQVPQGL- 615
L A+P + N+ + L NQL +P + +L KL L LG N L +P+G+
Sbjct: 97 LQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVF 153
Query: 616 GKCRSLVWLDLNSNNLS 632
K SL L L +N L
Sbjct: 154 DKLTSLKELRLYNNQLK 170
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 46/179 (25%), Positives = 74/179 (41%), Gaps = 7/179 (3%)
Query: 306 LSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEI 365
L N LS + L L ++ N LQ +P + +NL+ L + N+ +
Sbjct: 44 LQSNKLSSLP-SKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKLQ-AL 100
Query: 366 PPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSL 425
P + L EL L N+L P F S + L L+LG N L + V K++SL
Sbjct: 101 PIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSL 159
Query: 426 IYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNN 484
L + N + + T+L+ L L +N +P G + + L+ + L N
Sbjct: 160 KELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEG--AFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 38/136 (27%), Positives = 52/136 (38%), Gaps = 20/136 (14%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVL 764
F +L L ++ N L LP F L L L L N+L P F L + L
Sbjct: 80 IFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYL 138
Query: 765 DLSHNNFQGSIP-GSLGGLSFLSDLDVSNNNLSGIIPSG---------------GQLTTF 808
L +N Q S+P G L+ L +L + NN L +P G QL
Sbjct: 139 SLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQLKRV 196
Query: 809 PASRYENNSGLCGLPL 824
P +++ L L L
Sbjct: 197 PEGAFDSLEKLKMLQL 212
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 28/89 (31%), Positives = 40/89 (44%), Gaps = 3/89 (3%)
Query: 715 YLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGS 774
LDL N LS + F L L++L L NKL F LK + L ++ N Q +
Sbjct: 41 KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-A 99
Query: 775 IP-GSLGGLSFLSDLDVSNNNLSGIIPSG 802
+P G L L++L + N L +P
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLKS-LPPR 127
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 30/99 (30%), Positives = 40/99 (40%), Gaps = 5/99 (5%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVL 764
F L L L+ N L TLP F L L+ L + NKL F L + L
Sbjct: 56 AFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAEL 114
Query: 765 DLSHNNFQGSIP-GSLGGLSFLSDLDVSNNNLSGIIPSG 802
L N + S+P L+ L+ L + N L +P G
Sbjct: 115 RLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKG 151
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 52/248 (20%), Positives = 86/248 (34%), Gaps = 56/248 (22%)
Query: 148 TSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHN---SISGGSLHIGPSLLQLD 204
+ + + ++D SS +T ++P ++L N S+ + H L L
Sbjct: 13 SCNNNKNSVDCSSKKLT-AIPSNIP----ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLY 67
Query: 205 LSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEI 264
L+ N++ L +NL L +DNKL + +
Sbjct: 68 LNDNKL--QTLPAGIFKELKNLETLWVTDNKL------QA-------------------L 100
Query: 265 PASFVADSSGSLKYLDLSHNNFT----GKFSNLDFGRCGNLSVITLSQNGLSGTEFPA-- 318
P V D +L L L N F +L L+ ++L N L P
Sbjct: 101 PIG-VFDQLVNLAELRLDRNQLKSLPPRVFDSL-----TKLTYLSLGYNEL--QSLPKGV 152
Query: 319 --SLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTL 376
L + L+ L + +N L+ +P LK L L +NQ +P + L
Sbjct: 153 FDKLTS---LKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKL 207
Query: 377 RELDLSSN 384
+ L L N
Sbjct: 208 KMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 30/103 (29%), Positives = 50/103 (48%), Gaps = 7/103 (6%)
Query: 532 NNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGI 591
N + G+C N ++ ++ LT AIP +I + T L L SN+L+ +P+
Sbjct: 1 NEALCKKDGGVCSCNNNKNSVDCSSKKLT-AIPSNIPADTKKLD--LQSNKLS-SLPSKA 56
Query: 592 -GNLVKLAILQLGNNSLTGQVPQGL-GKCRSLVWLDLNSNNLS 632
L KL +L L +N L +P G+ + ++L L + N L
Sbjct: 57 FHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ 98
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 27/88 (30%), Positives = 39/88 (44%), Gaps = 2/88 (2%)
Query: 707 FTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
F + L YL L YN L +LP+ F L L+ L L +N+L +F L + L
Sbjct: 129 FDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLK 187
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNN 793
L +N + G+ L L L + N
Sbjct: 188 LDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 47/196 (23%), Positives = 72/196 (36%), Gaps = 35/196 (17%)
Query: 104 TSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGN---SFSAG---DLSTSKTSSCSLVTMD 157
L+L ++ LS SL L L L L N + AG +L +L T+
Sbjct: 40 KKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELK-------NLETLW 91
Query: 158 LSSNNITGSLPGRSFLLSCDRLS---YVNLSHNSISGGSLHIG-----PSLLQLDLSGNQ 209
++ N + +LP F D+L + L N + SL L L L N+
Sbjct: 92 VTDNKLQ-ALPIGVF----DQLVNLAELRLDRNQLK--SLPPRVFDSLTKLTYLSLGYNE 144
Query: 210 ISD-SALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASF 268
+ + L++ + L L +N+L + T+ L N L +F
Sbjct: 145 LQSLPKGVFDKLTSLKELRL---YNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAF 201
Query: 269 VADSSGSLKYLDLSHN 284
DS LK L L N
Sbjct: 202 --DSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 27/98 (27%), Positives = 44/98 (44%), Gaps = 8/98 (8%)
Query: 707 FTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
+ N + +D S L+ +P N + L+L NKL+ +F L + +L
Sbjct: 12 CSCNNNKNSVDCSSKKLT-AIPSNIPADT---KKLDLQSNKLSSLPSKAFHRLTKLRLLY 67
Query: 766 LSHNNFQGSIP-GSLGGLSFLSDLDVSNNNLSGIIPSG 802
L+ N Q ++P G L L L V++N L +P G
Sbjct: 68 LNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA-LPIG 103
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 6e-15
Identities = 47/262 (17%), Positives = 94/262 (35%), Gaps = 85/262 (32%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCK 994
+G+G FG V + + G A+KK++ +RE ++ + + H N++ L+ Y
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVNIIKLVDYFY 70
Query: 995 IGEERL--------------------------------------LVYEYMKWGSLESVLH 1016
+ ++ EY+ LH
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-----PDTLH 125
Query: 1017 DRAKGGGTKLDWAARKKIAIGS--------ARGLAFLHHSCIPHIIHRDMKSSNVLLD-E 1067
K + + I + R + F+H I HRD+K N+L++ +
Sbjct: 126 KVLKSF-----IRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSK 177
Query: 1068 NFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQS----FRC---TTKGDVYSY 1120
+ ++ DFG A+ + + ++ Y+ +Y++ T D++S
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPSVA---------YICSRFYRAPELMLGATEYTPSIDLWSI 228
Query: 1121 GVILLELLSGKRPIDPSEFGDD 1142
G + EL+ GK P+ G+
Sbjct: 229 GCVFGELILGK-PLFS---GET 246
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 8e-15
Identities = 56/246 (22%), Positives = 102/246 (41%), Gaps = 45/246 (18%)
Query: 935 MIGSGGFGEVYKAQLRD-GSVVAIKKL--IHVTGQGDREF-MAEMETIGKIKHRNLVPLL 990
++G G FG+V + + G A+K L + + + + E + +H L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 991 GYCKIGEERL-LVYEYMKWGSLESVLH-------DRAKGGGTKLDWAARKKIAIGSARGL 1042
Y +RL V EY G L L +RA+ + A +I L
Sbjct: 72 -YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR------FYGA--EIVS----AL 118
Query: 1043 AFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP 1102
+LH +++RD+K N++LD++ +++DFG+ + + ++ T GTP Y+
Sbjct: 119 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLA 173
Query: 1103 PEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162
PE + D + GV++ E++ G+ P F + + E+ IL
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-----FYNQD----------HERLFELIL 218
Query: 1163 DPELTM 1168
E+
Sbjct: 219 MEEIRF 224
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 37/214 (17%), Positives = 81/214 (37%), Gaps = 43/214 (20%)
Query: 419 VSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEK 478
+++ + + +++ V + ++ + ++ ++ +G N L++
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQ-SL-AGMQFFTN---LKE 67
Query: 479 IVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEI 538
+ L +N +S PL+ L+ + ++ N + +L +
Sbjct: 68 LHLSHNQISDLSPLK--DLTKLEELSVNRN--------RLKNLNGIPSA----------- 106
Query: 539 PEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLA 598
L L L+NN L S+ N+ +S+ +N+L I +G L KL
Sbjct: 107 ---------CLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLE 153
Query: 599 ILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLS 632
+L L N +T GL + + + W+DL
Sbjct: 154 VLDLHGNEIT--NTGGLTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 46/266 (17%), Positives = 93/266 (34%), Gaps = 27/266 (10%)
Query: 198 PSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSY 257
+ ++ +L ++D S + N ++ + L ++ + LS+
Sbjct: 19 ANAVKQNLGKQSVTDLV----SQKELSGVQNFNGDNSNI-QSLAGMQ-FFTNLKELHLSH 72
Query: 258 NLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFP 317
N +S ++ L+ L ++ N + NL+ LS + L N L T+
Sbjct: 73 NQIS-DLSP---LKDLTKLEELSVNRN----RLKNLNGIPSACLSRLFLDNNELRDTD-- 122
Query: 318 ASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLR 377
SL + + LE L++ +N L+ I LG L+ L L N+ +
Sbjct: 123 -SLIHLKNLEILSIRNNKLK-SIVM--LGFLSKLEVLDLHGNEIT-NTGGL--TRLKKVN 175
Query: 378 ELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISG 437
+DL+ + E L+ N + +S S + V +
Sbjct: 176 WIDLTGQKCVNEPVKYQ---PELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVY 232
Query: 438 PVPLSLTNCTQLRVLDLSSNGFTGTI 463
+S ++ + + F GT+
Sbjct: 233 TDEVSYKF-SEYINVGETEAIFDGTV 257
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 34/187 (18%), Positives = 76/187 (40%), Gaps = 20/187 (10%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSS 160
++ NL ++ +L + L +++ N ++ L+ + + +L + LS
Sbjct: 19 ANAVKQNLGKQSVT---DLVSQKELSGVQNFNGDNSNIQ--SLAGMQFFT-NLKELHLSH 72
Query: 161 NNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYSL 220
N I+ L L +L ++++ N + + L +L L N++ D T SL
Sbjct: 73 NQIS-DLSP---LKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNNELRD----TDSL 124
Query: 221 SNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLD 280
+ +NL +L+ +NKL + + +DL N ++ + + ++D
Sbjct: 125 IHLKNLEILSIRNNKL-KSIVMLG-FLSKLEVLDLHGNEITNTGGLT----RLKKVNWID 178
Query: 281 LSHNNFT 287
L+
Sbjct: 179 LTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 39/233 (16%), Positives = 77/233 (33%), Gaps = 44/233 (18%)
Query: 376 LRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNI 435
+ +L +T + S + + N ++ + + + ++L L++ N I
Sbjct: 21 AVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNIQ-SLAG--MQFFTNLKELHLSHNQI 75
Query: 436 SGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELG 495
S PL + T+L L ++ N + L ++ L NN L T L
Sbjct: 76 SDLSPLK--DLTKLEELSVNRNRLKNL------NGIPSACLSRLFLDNNELRDTDSLI-- 125
Query: 496 SCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILN 555
KNL+ + + N ++ S+ L L LE L L+
Sbjct: 126 HLKNLEILSIRNN--------KLKSIVMLGFLS-------------------KLEVLDLH 158
Query: 556 NNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLT 608
N +T + + W+ L+ + E L ++ +
Sbjct: 159 GNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWI 209
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 39/238 (16%), Positives = 72/238 (30%), Gaps = 26/238 (10%)
Query: 205 LSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEI 264
I+ + N N + L + + + + + +
Sbjct: 4 QRPTPINQ----VFPDPGLANAVKQNLGKQSV-TDLVSQK-ELSGVQNFNGDNSNIQ-SL 56
Query: 265 PASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQ 324
+LK L LSHN + S L L +++++N L S
Sbjct: 57 AG---MQFFTNLKELHLSHNQIS-DLSPLK--DLTKLEELSVNRNRLKNLNGIPSAC--- 107
Query: 325 LLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSN 384
L L + +N L+ L +NL+ LS+ +N+ I L LDL N
Sbjct: 108 -LSRLFLDNNELRDTDS---LIHLKNLEILSIRNNKLK-SIVM--LGFLSKLEVLDLHGN 160
Query: 385 RLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLS 442
+T ++ ++L N ++ + P P +S
Sbjct: 161 EITN--TGGLTRLKKVNWIDLTGQKCV-NEPVKYQPELYITNTVKDPDGRWISPYYIS 215
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 32/189 (16%), Positives = 73/189 (38%), Gaps = 20/189 (10%)
Query: 102 HVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSN 161
++ L+L+++ +S +L+ L L LE L++ N + + S L + L +N
Sbjct: 64 NLKELHLSHNQIS---DLSPLKDLTKLEELSVNRNRLK----NLNGIPSACLSRLFLDNN 116
Query: 162 NITGSLPGRSFLLSCDRLSYVNLSHNSISG-GSLHIGPSLLQLDLSGNQISDSALLTYSL 220
+ L+ L +++ +N + L L LDL GN+I+++ L
Sbjct: 117 ELR-DTDS---LIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEITNTG----GL 168
Query: 221 SNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLD 280
+ + +N ++ + K +N + + + I ++++ GS
Sbjct: 169 TRLKKVNWIDLTGQKC---VNEPVKYQPELYITNTVKDPDGRWISPYYISN-GGSYVDGC 224
Query: 281 LSHNNFTGK 289
+
Sbjct: 225 VLWELPVYT 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 17/87 (19%), Positives = 35/87 (40%), Gaps = 6/87 (6%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
+ + +L S++ + L+ +Q N ++ + + + L LSHN
Sbjct: 20 NAVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQI 75
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGI 798
+ L L+ L +L V+ N L +
Sbjct: 76 S-DLSP-LKDLTKLEELSVNRNRLKNL 100
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 23/89 (25%), Positives = 34/89 (38%), Gaps = 7/89 (7%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
+L L LS+N +S L L+ L++ N+L L L L +N
Sbjct: 64 NLKELHLSHNQISDL--SPLKDLTKLEELSVNRNRLKNLNGIPSACLS---RLFLDNNEL 118
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIP 800
+ L L L L + NN L I+
Sbjct: 119 R-DTDS-LIHLKNLEILSIRNNKLKSIVM 145
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 15/89 (16%), Positives = 34/89 (38%), Gaps = 7/89 (7%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
+ + +++ L+ L+L HN+++ + L + L ++ N
Sbjct: 42 GVQNFNGDNSNIQSL--AGMQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRL 97
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIP 800
+ ++ G + LS L + NN L
Sbjct: 98 K-NLNG-IPSAC-LSRLFLDNNELRDTDS 123
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 23/138 (16%), Positives = 48/138 (34%), Gaps = 35/138 (25%)
Query: 100 NSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLS 159
++ ++ L L+N+ L + +L L LE L+ +
Sbjct: 105 SACLSRLFLDNNELR---DTDSLIHLKNLEILS-------------------------IR 136
Query: 160 SNNITGSLPGRSFLLSCDRLSYVNLSHNSISG-GSLHIGPSLLQLDLSGNQISDSALLTY 218
+N + S+ L +L ++L N I+ G L + +DL+G + + +
Sbjct: 137 NNKLK-SIVM---LGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQKCVNEPV--K 190
Query: 219 SLSNCQNLNLLNFSDNKL 236
N + D +
Sbjct: 191 YQPELYITNTVKDPDGRW 208
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 77.8 bits (191), Expect = 1e-14
Identities = 65/250 (26%), Positives = 104/250 (41%), Gaps = 50/250 (20%)
Query: 934 SMIGSGGFGEVYKAQLRD-GSVVAIKKL--IHVTGQGDREF-MAE---METIGKIKHRNL 986
++G G FG+V ++ + + A+K L V D E M E + GK L
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK--PPFL 404
Query: 987 VPLLGYCKIGEERL-LVYEYMKWGSLESVLH-------DRAKGGGTKLDWAARKKIAIGS 1038
L C +RL V EY+ G L + A +AA +IAIG
Sbjct: 405 TQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAV------FYAA--EIAIG- 454
Query: 1039 ARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP 1098
L FL II+RD+K NV+LD +++DFGM + + ++ T GTP
Sbjct: 455 ---LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKTFCGTP 506
Query: 1099 GYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158
Y+ PE D +++GV+L E+L+G+ P F ++ ++
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP-----FEGED----------EDELF 551
Query: 1159 NEILDPELTM 1168
I++ +
Sbjct: 552 QSIMEHNVAY 561
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-14
Identities = 64/224 (28%), Positives = 98/224 (43%), Gaps = 40/224 (17%)
Query: 935 MIGSGGFGEVYKAQLRD-GSVVAIKKL--IHVTGQGDRE-FMAE---METIGKIKHRNLV 987
M+G G FG+V+ A+ + AIK L V D E M E + +H L
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA--WEHPFLT 81
Query: 988 PLLGYCKIGEERL-LVYEYMKWGSLESVLH-------DRAKGGGTKLDWAARKKIAIGSA 1039
+ +E L V EY+ G L + RA +AA +I +G
Sbjct: 82 HMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRAT------FYAA--EIILG-- 130
Query: 1040 RGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPG 1099
L FLH I++RD+K N+LLD++ +++DFGM + + +T GTP
Sbjct: 131 --LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE--NMLGDAKTNTFCGTPD 183
Query: 1100 YVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDN 1143
Y+ PE + D +S+GV+L E+L G+ P F +
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP-----FHGQD 222
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 38/243 (15%), Positives = 77/243 (31%), Gaps = 39/243 (16%)
Query: 396 SCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLS 455
C + + + + S S L + ++ + +N + + +S
Sbjct: 9 ECHQEEDFRV-----TCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVS 63
Query: 456 SNGFTGTIPSG-FCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPV 514
+ + S F N + I + N +NL ID
Sbjct: 64 IDVTLQQLESHSFY---NLSKVTHIEIRNT-------------RNLTYID---------- 97
Query: 515 PSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETL--ILNNNHLTGAIPKSIASCTN 572
P + LP L L ++ L P+ V ++ + I +N ++T + N
Sbjct: 98 PDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCN 156
Query: 573 ML-WVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGL--GKCRSLVWLDLNSN 629
+ L +N T + N KL + L N + + G LD++
Sbjct: 157 ETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQT 215
Query: 630 NLS 632
+++
Sbjct: 216 SVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 39/237 (16%), Positives = 79/237 (33%), Gaps = 15/237 (6%)
Query: 175 SCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDN 234
C + ++ I + PS L L + + +++ SN N++ + S +
Sbjct: 9 ECHQEEDFRVTCKDIQRIP-SLPPSTQTLKLIETHL--RTIPSHAFSNLPNISRIYVSID 65
Query: 235 KLPGKLNATS-VNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNL 293
+L + S N ++ I++ I LK+L + +
Sbjct: 66 VTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPD-ALKELPLLKFLGIFNTGLKMFPDLT 124
Query: 294 DFGRCGNLSVITLSQNGLSGTEFPASLKN-CQLLETLNMSHNALQGGIPGFLLGSFR--N 350
++ ++ N + + + C TL + +N + G +F
Sbjct: 125 KVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQG---YAFNGTK 180
Query: 351 LKQLSLAHNQFAGEIPPE-LGQACGTLRELDLSSNRLTGELPS-TFASCSSLHSLNL 405
L + L N++ I + G LD+S +T LPS L + N
Sbjct: 181 LDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 35/217 (16%), Positives = 72/217 (33%), Gaps = 37/217 (17%)
Query: 300 NLSVITLSQNGLSGTEFPA-SLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAH 358
+ + L + L P+ + N + + +S + + + + + + +
Sbjct: 32 STQTLKLIETHL--RTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 359 NQFAGEIPPELGQACGTLRELDLSSNRLTGELP--STFASCSSLHSLNLGSNMLSGNFLN 416
+ I P+ + L+ L + + L P + S L + N
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDN-------- 140
Query: 417 TVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSG-FCSPPNFPA 475
++S+ P N G L N + L L +NGFT ++ F N
Sbjct: 141 ---PYMTSI-----PVNAFQG-----LCN--ETLTLKLYNNGFT-SVQGYAF----NGTK 180
Query: 476 LEKIVLPNNYLSGTVPLEL--GSCKNLKTIDLSFNSL 510
L+ + L N + + G +D+S S+
Sbjct: 181 LDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSV 217
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 27/215 (12%), Positives = 65/215 (30%), Gaps = 33/215 (15%)
Query: 98 SLNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGN----SFSAG---DLSTSKTSS 150
SL +L L + L ++ + LP + + + + + +LS
Sbjct: 28 SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLS------ 80
Query: 151 CSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSIS----GGSLHIGPSLLQLDLS 206
+ +++ + + + L ++ + + + ++ L+++
Sbjct: 81 -KVTHIEIRNTRNLTYIDPDAL-KELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEIT 138
Query: 207 GNQ----ISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSG 262
N I +A L N L +N + + N + + L+ N
Sbjct: 139 DNPYMTSIPVNAFQ--GLCN--ETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLT 193
Query: 263 EIPASFVADSSGSLKYLDLSHNNFT----GKFSNL 293
I LD+S + T +L
Sbjct: 194 VIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHL 228
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 14/101 (13%), Positives = 39/101 (38%), Gaps = 5/101 (4%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIP-DSFGGLKAIGV 763
F+ ++ + +S + L + F +L+ + + + + + +I D+ L +
Sbjct: 50 AFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF 109
Query: 764 LDLSHNNFQGSIPG--SLGGLSFLSDLDVSNNNLSGIIPSG 802
L + + + P + L++++N IP
Sbjct: 110 LGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 18/90 (20%), Positives = 33/90 (36%), Gaps = 4/90 (4%)
Query: 712 SLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIP-DSFGGLKAIGVLDLSHN 769
S L L L T+P + F +L + + + + + SF L + +++ +
Sbjct: 32 STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 770 NFQGSIP-GSLGGLSFLSDLDVSNNNLSGI 798
I +L L L L + N L
Sbjct: 91 RNLTYIDPDALKELPLLKFLGIFNTGLKMF 120
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 5e-08
Identities = 28/102 (27%), Positives = 46/102 (45%), Gaps = 8/102 (7%)
Query: 707 FTTNGSLIYLDLSYNSLSGTLPEN-FGSL-NYLQVLNLGHNKLTGHIPDS-FGGLKAIGV 763
+ L+++ N ++P N F L N L L +N T + F G K +
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTK-LDA 183
Query: 764 LDLSHNNFQGSIP-GSLGGL-SFLSDLDVSNNNLSGIIPSGG 803
+ L+ N + I + GG+ S S LDVS +++ +PS G
Sbjct: 184 VYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSKG 224
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 21/101 (20%), Positives = 36/101 (35%), Gaps = 6/101 (5%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPEN--FGSLNYLQVLNLGHNKLTGHIP-DSFGGL-KAI 761
L +L + L P+ S + +L + N IP ++F GL
Sbjct: 100 ALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNET 158
Query: 762 GVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSG 802
L L +N F S+ G + L + ++ N +I
Sbjct: 159 LTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKD 198
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 13/67 (19%), Positives = 23/67 (34%), Gaps = 1/67 (1%)
Query: 737 LQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIP-GSLGGLSFLSDLDVSNNNL 795
Q L L L +F L I + +S + + S LS ++ +++ N
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92
Query: 796 SGIIPSG 802
I
Sbjct: 93 LTYIDPD 99
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 2e-14
Identities = 43/187 (22%), Positives = 72/187 (38%), Gaps = 12/187 (6%)
Query: 251 STIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNG 310
+ + S L +P S LDLSHNN + + R NL + LS N
Sbjct: 21 NILSCSKQQLP-NVPQSL----PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNH 75
Query: 311 LSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELG 370
L+ + L L++S N L + FL + L+ L L +N +
Sbjct: 76 LNFIS-SEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAF 132
Query: 371 QACGTLRELDLSSNRLTGELPSTFASCSSLHSL---NLGSNMLSGNFLNTVVSKISSLIY 427
+ L++L LS N+++ + L L +L SN L T + K+ + +
Sbjct: 133 EDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVK 191
Query: 428 LYVPFNN 434
+ +N
Sbjct: 192 NGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 9e-14
Identities = 49/215 (22%), Positives = 70/215 (32%), Gaps = 35/215 (16%)
Query: 297 RCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSL 356
C + + S+ L P SL + L++SHN L + NL L L
Sbjct: 17 LCASNILS-CSKQQL--PNVPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLL 71
Query: 357 AHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPS-TFASCSSLHSLNLGSNMLSGNFL 415
+HN I E LR LDLSSN L L F+ +L L L +N
Sbjct: 72 SHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNN------- 122
Query: 416 NTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSG-FCSPPNFP 474
I + + + QL+ L LS N + P P
Sbjct: 123 -----HIVVV-------------DRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLP 163
Query: 475 ALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNS 509
L + L +N L +L L ++
Sbjct: 164 KLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 35/141 (24%), Positives = 61/141 (43%), Gaps = 11/141 (7%)
Query: 499 NLKTIDLSFNSLAGPVPSEIWS-LPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNN 557
+DLS N+L+ + L NL L++ N+L I V NL L L++N
Sbjct: 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98
Query: 558 HLTGAIPKSI-ASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNNSLTGQVPQG- 614
HL + + + + + + L +N + + ++ +L L L N ++ + P
Sbjct: 99 HLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVEL 155
Query: 615 ---LGKCRSLVWLDLNSNNLS 632
K L+ LDL+SN L
Sbjct: 156 IKDGNKLPKLMLLDLSSNKLK 176
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 5e-11
Identities = 35/128 (27%), Positives = 53/128 (41%), Gaps = 19/128 (14%)
Query: 715 YLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIP-DSFGGLKAIGVLDLSHNNFQ 772
LDLS+N+LS E L L L L HN L I ++F + + LDLS N+
Sbjct: 43 LLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH 101
Query: 773 GSIP-GSLGGLSFLSDLDVSNNNLSGIIP--------------SGGQLTTFPASRYENNS 817
++ L L L + NN++ + S Q++ FP ++ +
Sbjct: 102 -TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGN 160
Query: 818 GLCGLPLL 825
L L LL
Sbjct: 161 KLPKLMLL 168
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 6e-11
Identities = 35/139 (25%), Positives = 57/139 (41%), Gaps = 8/139 (5%)
Query: 496 SCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILN 555
C + S L VP + + L + NNL+ E NL +L+L+
Sbjct: 17 LC-ASNILSCSKQQLPN-VPQSL--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLS 72
Query: 556 NNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNNSLTGQVPQG 614
+NHL ++ N+ ++ LSSN L + + +L L +L L NN + V +
Sbjct: 73 HNHLNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRN 130
Query: 615 -LGKCRSLVWLDLNSNNLS 632
L L L+ N +S
Sbjct: 131 AFEDMAQLQKLYLSQNQIS 149
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 38/179 (21%), Positives = 65/179 (36%), Gaps = 19/179 (10%)
Query: 122 LTALP-----YLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSC 176
L +P Y L+L N+ S + T +L ++ LS N++ + +F+
Sbjct: 30 LPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFV-PV 87
Query: 177 DRLSYVNLSHNSISGGSLHIG-----PSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNF 231
L Y++LS N + +L +L L L N I + + + L L
Sbjct: 88 PNLRYLDLSSNHLH--TLDEFLFSDLQALEVLLLYNNHIV--VVDRNAFEDMAQLQKLYL 143
Query: 232 SDNKL---PGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFT 287
S N++ P +L + +DLS N L + L L +N
Sbjct: 144 SQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 7e-11
Identities = 38/169 (22%), Positives = 70/169 (41%), Gaps = 12/169 (7%)
Query: 447 TQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLS 506
+ +LDLS N + + + + +P L ++L +N+L+ NL+ +DLS
Sbjct: 39 SYTALLDLSHNNLS-RLRAEW-TPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96
Query: 507 FNSLAGPVPSEI-WSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIP- 564
N L + + L L L+++ N++ + + L+ L L+ N ++ P
Sbjct: 97 SNHLHT-LDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPV 153
Query: 565 ---KSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKL--AILQLGNNSLT 608
K ++ + LSSN+L + L L L NN L
Sbjct: 154 ELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 9e-11
Identities = 31/93 (33%), Positives = 43/93 (46%), Gaps = 9/93 (9%)
Query: 712 SLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIP-DSFGGLKAIGVLDLSHN 769
+L YLDLS N L TL E F L L+VL L +N + + ++F + + L LS N
Sbjct: 89 NLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQN 146
Query: 770 NFQGSIP----GSLGGLSFLSDLDVSNNNLSGI 798
P L L LD+S+N L +
Sbjct: 147 QIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKL 178
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 39/158 (24%), Positives = 59/158 (37%), Gaps = 14/158 (8%)
Query: 157 DLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIG-----PSLLQLDLSGNQIS 211
DLS NN++ L L + LSHN ++ + P+L LDLS N +
Sbjct: 45 DLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN--FISSEAFVPVPNLRYLDLSSNHL- 100
Query: 212 DSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVAD 271
L + S+ Q L +L +N + + + + LS N +S P + D
Sbjct: 101 -HTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKD 158
Query: 272 SSG--SLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLS 307
+ L LDLS N K D + L
Sbjct: 159 GNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 40/214 (18%), Positives = 69/214 (32%), Gaps = 38/214 (17%)
Query: 377 RELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNIS 436
L S +L +P + S L+L N LS +++++L L + N+++
Sbjct: 21 NILSCSKQQLP-NVPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN 77
Query: 437 GPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGS 496
+ LR LDLSSN L S
Sbjct: 78 FISSEAFVPVPNLRYLDLSSNHLH-------------------TLDEFLFSDLQ------ 112
Query: 497 CKNLKTIDLSFNSLAGPVPSEIWS-LPNLSDLVMWANNLTGEIPEGICVNGGN---LETL 552
L+ + L N + V + + L L + N ++ P + +G L L
Sbjct: 113 --ALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLL 168
Query: 553 ILNNNHLTGAIPKSIASCTNM--LWVSLSSNQLT 584
L++N L + + L +N L
Sbjct: 169 DLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 21/93 (22%), Positives = 34/93 (36%), Gaps = 4/93 (4%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGG---LKAIG 762
F+ +L L L N + F + LQ L L N+++ + L +
Sbjct: 107 LFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLM 166
Query: 763 VLDLSHNNFQGSIPGSLGGLSFLSDLDVS-NNN 794
+LDLS N + L L + +NN
Sbjct: 167 LLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 24/89 (26%), Positives = 40/89 (44%), Gaps = 7/89 (7%)
Query: 716 LDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPD-SFGGLKAIGVLDLSHNNFQGS 774
L S L +P++ S Y +L+L HN L+ + + L + L LSHN+
Sbjct: 23 LSCSKQQLP-NVPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-F 78
Query: 775 IP-GSLGGLSFLSDLDVSNNNLSGIIPSG 802
I + + L LD+S+N+L +
Sbjct: 79 ISSEAFVPVPNLRYLDLSSNHLH-TLDEF 106
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 76.3 bits (187), Expect = 3e-14
Identities = 55/315 (17%), Positives = 103/315 (32%), Gaps = 15/315 (4%)
Query: 321 KNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELD 380
C + + + ++ P + L + P+ + D
Sbjct: 244 VLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCD 303
Query: 381 LSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPF--NNISGP 438
L + L +LP S + +L + ++ L+ S
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTV 363
Query: 439 VPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCK 498
+ L +C +L+ L+ + TI AL+ ++ L L+
Sbjct: 364 LQSELESCKELQELEPENKWCLLTIIL------LMRALDPLLYEKETLQYFSTLKAVDPM 417
Query: 499 NLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNH 558
+D + ++ L + +LT + + L L++N
Sbjct: 418 RAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLEQLLL---VTHLDLSHNR 474
Query: 559 LTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTG-QVPQGLGK 617
L A+P ++A+ + + S N L + G+ NL +L L L NN L Q L
Sbjct: 475 LR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVS 531
Query: 618 CRSLVWLDLNSNNLS 632
C LV L+L N+L
Sbjct: 532 CPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 74.4 bits (182), Expect = 1e-13
Identities = 45/338 (13%), Positives = 92/338 (27%), Gaps = 60/338 (17%)
Query: 468 CSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDL 527
P + + LS L + T+ L + V N
Sbjct: 239 AEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSH 298
Query: 528 VMWANNLTGEIPEGICVNGGNLETLILNN-------NHLTGAIPKSIASCTNMLWVSLSS 580
V + + + + + + ++ + A+ + LS
Sbjct: 299 VWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSV 358
Query: 581 NQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELA 640
+ T + + + + +L L+ N + + L++ S
Sbjct: 359 EKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFS-------- 409
Query: 641 NQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYT 700
+ + P R + S
Sbjct: 410 ----------------------------------TLKAVDPMRAAYLDDLRSKFLLENSV 435
Query: 701 GMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKA 760
Y L L++ L T+ + L + L+L HN+L +P + L+
Sbjct: 436 LKMEYADVR-----VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRC 487
Query: 761 IGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGI 798
+ VL S N + ++ G + L L +L + NN L
Sbjct: 488 LEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQS 523
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.2 bits (171), Expect = 2e-12
Identities = 60/384 (15%), Positives = 109/384 (28%), Gaps = 64/384 (16%)
Query: 148 TSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSG 207
C V+ + + ++ S P L V+ + S+ + + L
Sbjct: 244 VLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCD 303
Query: 208 NQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPAS 267
+ + + + K S + L LS E
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTV 363
Query: 268 FVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLE 327
++ + +L N + + R L + + L ++ +
Sbjct: 364 LQSELESCKELQELEPENKWCLLTIILLMR--ALDPLLYEKETLQYFSTLKAVDPMRAAY 421
Query: 328 TLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLT 387
++ L L + +++ L LAH + L Q + LDLS NRL
Sbjct: 422 LDDLRSKFLLE--NSVLKMEYADVRVLHLAHKDL--TVLCHLEQ-LLLVTHLDLSHNRLR 476
Query: 388 GELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCT 447
LP A+ L L N L N+ G + N
Sbjct: 477 -ALPPALAALRCLEVLQASDNALE----------------------NVDG-----VANLP 508
Query: 448 QLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSF 507
+L+ L L +N A++ L SC L ++L
Sbjct: 509 RLQELLLCNNRLQ-----------QSAAIQ---------------PLVSCPRLVLLNLQG 542
Query: 508 NSLAGPVPSE---IWSLPNLSDLV 528
NSL + LP++S ++
Sbjct: 543 NSLCQEEGIQERLAEMLPSVSSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 7e-11
Identities = 55/353 (15%), Positives = 103/353 (29%), Gaps = 46/353 (13%)
Query: 33 LLCHLLIMPSYARELSSSSRQSGGNEELTILMAFKQS-SIGSDPNGYLANWTADALTPCS 91
+ + A EE + + F + ++GS L L+
Sbjct: 228 AWFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEW 287
Query: 92 WQGVSCSLNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSC 151
+ SHV +L + L+ L T + + + S+
Sbjct: 288 RTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSAT 347
Query: 152 --SLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQ 209
L +LS T +S L SC L + + + + +L L
Sbjct: 348 DEQLFRCELSVEKST---VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKET 404
Query: 210 ISDSALLT----------------------YSLSNCQNLNLLNFSDNKLPGKLNATSV-- 245
+ + L ++ +L+ + L T +
Sbjct: 405 LQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL------TVLCH 458
Query: 246 --NCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSV 303
++ +DLS+N L +P + + L+ L S N + L
Sbjct: 459 LEQLLLVTHLDLSHNRLR-ALPPAL--AALRCLEVLQASDNALE-NVDGV--ANLPRLQE 512
Query: 304 ITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQG--GIPGFLLGSFRNLKQL 354
+ L N L + L +C L LN+ N+L GI L ++ +
Sbjct: 513 LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 4e-14
Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 47/248 (18%)
Query: 935 MIGSGGFGEVY---KAQLRD-GSVVAIKKL--IHVTGQGDREFMAEMETIGKIKHRNLVP 988
++G G FG+V+ K D + A+K L + + E + + ++ H +V
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 989 LLGYCKIGEERL-LVYEYMKWGSLESVLH-------DRAKGGGTKLDWAARKKIAIGSAR 1040
L Y E +L L+ ++++ G L + L + K + A ++A+
Sbjct: 91 LH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF------YLA--ELALA--- 138
Query: 1041 GLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGY 1100
L LH II+RD+K N+LLDE +++DFG+++ ++D + GT Y
Sbjct: 139 -LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVEY 192
Query: 1101 VPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINE 1160
+ PE T D +S+GV++ E+L+G P F + R++ +
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP-----FQGKD----------RKETMTM 237
Query: 1161 ILDPELTM 1168
IL +L M
Sbjct: 238 ILKAKLGM 245
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 45/178 (25%), Positives = 73/178 (41%), Gaps = 36/178 (20%)
Query: 1039 ARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP 1098
A+G+ FL IHRD+ + N+LL E ++ DFG+AR + + +
Sbjct: 203 AKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-----VRKGD 254
Query: 1099 GYVP-----PEYYQSFRCTTKGDVYSYGVILLELLS-GKRP---IDPSEFGDDNNLVGWA 1149
+P PE T + DV+S+GV+L E+ S G P + E
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRL 309
Query: 1150 KQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207
K+ R + P+ T E+YQ + +C P +RPT +++ L
Sbjct: 310 KEGTRMRA------PDYTTP-----EMYQTML---DCWHGEPSQRPTFSELVEHLGNL 353
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 2e-12
Identities = 40/196 (20%), Positives = 73/196 (37%), Gaps = 33/196 (16%)
Query: 902 EPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQL------RDGSVV 955
E L + + +E P +L +G G FG+V +A V
Sbjct: 8 ERLPYDASKWEFPRDRLKL------------GKPLGRGAFGQVIEADAFGIDKTATCRTV 55
Query: 956 AIKKLIHVTGQGDR-EFMAEMETIGKI-KHRNLVPLLGYC-KIGEERLLVYEYMKWGSLE 1012
A+K L + M+E++ + I H N+V LLG C K G +++ E+ K+G+L
Sbjct: 56 AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 115
Query: 1013 SVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEAR 1072
+ L + R + +G F I D+K + + +
Sbjct: 116 TYLRSK------------RNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSA 163
Query: 1073 VSDFGMARLVNALDTH 1088
S F + ++ ++
Sbjct: 164 SSGFVEEKSLSDVEEE 179
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-13
Identities = 67/249 (26%), Positives = 104/249 (41%), Gaps = 50/249 (20%)
Query: 935 MIGSGGFGEVYKAQLRD-GSVVAIKKL--IHVTGQGDREF-MAE---METIGKIKHRNLV 987
++G G FG+V ++ + + A+K L V D E M E + G K L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--KPPFLT 84
Query: 988 PLLGYCKIGEERL-LVYEYMKWGSLESVLH-------DRAKGGGTKLDWAARKKIAIGSA 1039
L C +RL V EY+ G L + A +AA +IAI
Sbjct: 85 QLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAV------FYAA--EIAI--- 132
Query: 1040 RGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPG 1099
GL FL II+RD+K NV+LD +++DFGM + N D + T GTP
Sbjct: 133 -GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTT-KTFCGTPD 186
Query: 1100 YVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRIN 1159
Y+ PE D +++GV+L E+L+G+ P F ++ ++
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP-----FEGED----------EDELFQ 231
Query: 1160 EILDPELTM 1168
I++ +
Sbjct: 232 SIMEHNVAY 240
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 63/250 (25%), Positives = 109/250 (43%), Gaps = 43/250 (17%)
Query: 935 MIGSGGFGEVYKAQLRD-GSVVAIKKL--IHVTGQGDREF-MAEMETIGKI-KHRNLVPL 989
+IG G + +V +L+ + A+K + V D ++ E + H LV L
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 990 LGYCKIGEERL-LVYEYMKWGSL------ESVLH-DRAKGGGTKLDWAARKKIAIGSARG 1041
C E RL V EY+ G L + L + A+ ++A +I++
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHAR------FYSA--EISL----A 122
Query: 1042 LAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV 1101
L +LH II+RD+K NVLLD +++D+GM + L + ST GTP Y+
Sbjct: 123 LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYI 177
Query: 1102 PPEYYQSFRCTTKGDVYSYGVILLELLSGKRP---IDPSEFGDDNNLVGWAKQLHREKRI 1158
PE + D ++ GV++ E+++G+ P + S+ D N +
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT---------EDYLF 228
Query: 1159 NEILDPELTM 1168
IL+ ++ +
Sbjct: 229 QVILEKQIRI 238
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-13
Identities = 68/247 (27%), Positives = 104/247 (42%), Gaps = 46/247 (18%)
Query: 935 MIGSGGFGEVYKAQLRD-GSVVAIKKL--IHVTGQGDREF-MAEMETIGKI-KHRNLVPL 989
++G G FG+V A++++ G + A+K L + D E M E + H L L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 990 LGYCKIGEERL-LVYEYMKWGSLESVLH-------DRAKGGGTKLDWAARKKIAIGSARG 1041
C +RL V E++ G L + RA+ +AA I
Sbjct: 90 F-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARAR------FYAAE--IIS----A 136
Query: 1042 LAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV 1101
L FLH II+RD+K NVLLD +++DFGM + + ++ +T GTP Y+
Sbjct: 137 LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE--GICNGVTTATFCGTPDYI 191
Query: 1102 PPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161
PE Q D ++ GV+L E+L G P F +N + I
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGHAP-----FEAEN----------EDDLFEAI 236
Query: 1162 LDPELTM 1168
L+ E+
Sbjct: 237 LNDEVVY 243
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-13
Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 36/222 (16%)
Query: 935 MIGSGGFGEVYKAQLRD-GSVVAIKKL--IHVTGQGDREF-MAEMETIGK-IKHRNLVPL 989
+IG G FG+V A+ + A+K L + + + + M+E + K +KH LV L
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 990 LGYCKIGEERL-LVYEYMKWGSLESVLH-------DRAKGGGTKLDWAARKKIAIGSARG 1041
+ ++L V +Y+ G L L RA+ +AA +IA
Sbjct: 105 H-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF------YAA--EIASA---- 151
Query: 1042 LAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV 1101
L +LH +I++RD+K N+LLD ++DFG+ + ++ + + ST GTP Y+
Sbjct: 152 LGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNSTTSTFCGTPEYL 206
Query: 1102 PPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDN 1143
PE D + G +L E+L G P F N
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP-----FYSRN 243
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 5e-13
Identities = 63/250 (25%), Positives = 109/250 (43%), Gaps = 49/250 (19%)
Query: 935 MIGSGGFGEVY---KAQLRD-GSVVAIK---KLIHVTGQGDREF-MAEMETIGKIKHRNL 986
++G GG+G+V+ K + G + A+K K + V D AE + ++KH +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 987 VPLLGYCKIGEERL-LVYEYMKWGSLESVLH-------DRAKGGGTKLDWAARKKIAIGS 1038
V L+ Y +L L+ EY+ G L L D A + A +I++
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF------YLA--EISMA- 133
Query: 1039 ARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP 1098
L LH II+RD+K N++L+ +++DFG+ + ++ T GT
Sbjct: 134 ---LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE--SIHDGTVTHTFCGTI 185
Query: 1099 GYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158
Y+ PE D +S G ++ ++L+G P F +N R+K I
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP-----FTGEN----------RKKTI 230
Query: 1159 NEILDPELTM 1168
++IL +L +
Sbjct: 231 DKILKCKLNL 240
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 8e-13
Identities = 62/250 (24%), Positives = 109/250 (43%), Gaps = 43/250 (17%)
Query: 935 MIGSGGFGEVYKAQLRD-GSVVAIKKL--IHVTGQGDREF-MAEMETIGKI-KHRNLVPL 989
+IG G + +V +L+ + A++ + V D ++ E + H LV L
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 990 LGYCKIGEERL-LVYEYMKWGSL------ESVLH-DRAKGGGTKLDWAARKKIAIGSARG 1041
C E RL V EY+ G L + L + A+ ++A +I++
Sbjct: 119 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHAR------FYSA--EISL----A 165
Query: 1042 LAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV 1101
L +LH II+RD+K NVLLD +++D+GM + L + ST GTP Y+
Sbjct: 166 LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYI 220
Query: 1102 PPEYYQSFRCTTKGDVYSYGVILLELLSGKRP---IDPSEFGDDNNLVGWAKQLHREKRI 1158
PE + D ++ GV++ E+++G+ P + S+ D N +
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT---------EDYLF 271
Query: 1159 NEILDPELTM 1168
IL+ ++ +
Sbjct: 272 QVILEKQIRI 281
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-12
Identities = 54/327 (16%), Positives = 89/327 (27%), Gaps = 75/327 (22%)
Query: 98 SLNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFS---AGDLSTS-KTSSCSL 153
S + +NL + L + T L L LQ NS DL C +
Sbjct: 98 SGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQI 157
Query: 154 VTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDS 213
T+ LS+N +T + L L+ N+ S+ L L + D
Sbjct: 158 TTLRLSNNPLTAA--------GVAVLMEG-LAGNT----------SVTHLSLLHTGLGDE 198
Query: 214 --ALLTYSLSNCQNLNLLNFSDNKLPGK----LNATSVNCKSISTIDLSYNLLSGE---- 263
LL L + L LN + N L + S+ + L +N LS E
Sbjct: 199 GLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQV 258
Query: 264 IPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNC 323
+ A G+ + L+ ++ ++ +N
Sbjct: 259 LRDLGGAAEGGARVVVSLTEGTAVSEYWSVILS---------------------EVQRNL 297
Query: 324 QLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQAC---GTLRELD 380
+ + + L L ++ A P Q G +R L
Sbjct: 298 NSWDRARVQRHL--------------ELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALL 343
Query: 381 LSSNRLTGE----LPSTFASCSSLHSL 403
F + H
Sbjct: 344 EQLGSSGSPSGSWSHPQFEKGAGHHHH 370
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-11
Identities = 53/332 (15%), Positives = 93/332 (28%), Gaps = 70/332 (21%)
Query: 124 ALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFL-----LSCDR 178
LP E L+ + + S SL ++L+ +T + +
Sbjct: 45 VLPPSELLDHLFFHYEFQNQRFSAEVLSSLRQLNLAGVRMTPV--KCTVVAAVLGSGRHA 102
Query: 179 LSYVNLSHNSISG-GSLHIGPSLLQ---LDLSGNQISDS---ALLTYSLSNCQNLNLLNF 231
L VNL+ + G + P L+ L L N + L L + + L
Sbjct: 103 LDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRL 162
Query: 232 SDNKLPGKLNATSVNCKSIS----------TIDLSYNLLSGEIPASFVAD---SSGSLKY 278
S+N L T+ + + L + L G+ +A + L+
Sbjct: 163 SNNPL------TAAGVAVLMEGLAGNTSVTHLSLLHTGL-GDEGLELLAAQLDRNRQLQE 215
Query: 279 LDLSHNNFTGKFSNLDFG---------RCGNLSVITLSQNGLSGT------EFPASLKNC 323
L++++N D +L ++ L N LS + + +
Sbjct: 216 LNVAYNGAG------DTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGG 269
Query: 324 QLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSS 383
+ A+ L RNL A Q L DL
Sbjct: 270 ARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARV-----------QRHLELLLRDLED 318
Query: 384 NRLTGELPSTFASC----SSLHSLNLGSNMLS 411
+R P A + +L
Sbjct: 319 SRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 47/308 (15%), Positives = 92/308 (29%), Gaps = 76/308 (24%)
Query: 199 SLLQLDLSGNQISD---SALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSIS---- 251
SL QL+L+G +++ + + S L+ +N + +L +++
Sbjct: 73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQL------DPAGLRTLLPVFL 126
Query: 252 ---TIDLSYNLLS---GEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVIT 305
+ L N L + + + L LS+N T V
Sbjct: 127 RARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAA------------GVAV 174
Query: 306 LSQNGLSGTEFPASLKNCQLLETLNMSHNAL--QGGIPGFL---LGSFRNLKQLSLAHNQ 360
L L + L++ H L +G L L R L++L++A+N
Sbjct: 175 LM----------EGLAGNTSVTHLSLLHTGLGDEGLE--LLAAQLDRNRQLQELNVAYNG 222
Query: 361 FAGEIPPELGQA---CGTLRELDLSSNRLT-------GELPSTFASCSSLHSLNLGSNML 410
L +A +L L L N L+ +L + + +
Sbjct: 223 AGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAV 282
Query: 411 S--------------GNFLNTVVSKISSLIYLYVPFNNIS--GPVPLS--LTNCTQLRVL 452
S ++ V + L+ + + + P + L ++R L
Sbjct: 283 SEYWSVILSEVQRNLNSWDRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRAL 342
Query: 453 DLSSNGFT 460
Sbjct: 343 LEQLGSSG 350
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 5e-08
Identities = 58/445 (13%), Positives = 120/445 (26%), Gaps = 109/445 (24%)
Query: 200 LLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNL 259
L+ L + N+ + L + N L KL + + + Y
Sbjct: 3 LVGLLSAHNRAVLAQLGC-PIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEF 61
Query: 260 LSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPAS 319
+ F A+ SL+ L+L+ + ++
Sbjct: 62 QN----QRFSAEVLSSLRQLNLAGVRM------------TPVKCTVVAA---------VL 96
Query: 320 LKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQF----AGEIPPELGQACGT 375
L+ +N++ L LL F ++L L N ++ L
Sbjct: 97 GSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQ 156
Query: 376 LRELDLSSNRLTGE----LPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVP 431
+ L LS+N LT L A +S+ L+L L + + +++
Sbjct: 157 ITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLG----DEGLELLAA------- 205
Query: 432 FNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVP 491
L QL+ L+++ NG + + L+
Sbjct: 206 ----------QLDRNRQLQELNVAYNGAG---DTAALA----------------LARA-- 234
Query: 492 LELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLET 551
+L+ + L FN L ++ L DL A +
Sbjct: 235 --AREHPSLELLHLYFNEL-SSEGRQV-----LRDLGGAAEGGA------------RVVV 274
Query: 552 LILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQV 611
+ ++ ++ + A + ++L + L ++
Sbjct: 275 SLTEGTAVSEYWSVILSE-------VQRNLNSWDR--ARVQRHLELLLRDLEDSRGATLN 325
Query: 612 PQGLGKC----RSLVWLDLNSNNLS 632
P + + L +
Sbjct: 326 PWRKAQLLRVEGEVRALLEQLGSSG 350
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 39/171 (22%), Positives = 67/171 (39%), Gaps = 22/171 (12%)
Query: 241 NATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGN 300
T+V+C S L+ +IP L L++N FT + F +
Sbjct: 12 EGTTVDC--------SNQKLN-KIPEHIPQY----TAELRLNNNEFTVLEATGIFKKLPQ 58
Query: 301 LSVITLSQNGLSGTE---FPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLA 357
L I S N ++ E F + + ++ N L+ + + +LK L L
Sbjct: 59 LRKINFSNNKITDIEEGAF-EGASG---VNEILLTSNRLE-NVQHKMFKGLESLKTLMLR 113
Query: 358 HNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSN 408
N+ + + ++R L L N++T P F + SL +LNL +N
Sbjct: 114 SNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 8e-11
Identities = 31/139 (22%), Positives = 52/139 (37%), Gaps = 8/139 (5%)
Query: 496 SCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILN 555
C T+D S L +P I ++L + N T GI L + +
Sbjct: 10 RC-EGTTVDCSNQKLNK-IPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFS 65
Query: 556 NNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNNSLTGQVPQG 614
NN +T + + + + L+SN+L + + L L L L +N +T V
Sbjct: 66 NNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGND 123
Query: 615 L-GKCRSLVWLDLNSNNLS 632
S+ L L N ++
Sbjct: 124 SFIGLSSVRLLSLYDNQIT 142
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 21/95 (22%), Positives = 40/95 (42%), Gaps = 4/95 (4%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVL 764
F L ++ S N ++ + E F + + + L N+L F GL+++ L
Sbjct: 52 IFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTL 110
Query: 765 DLSHNNFQGSIP-GSLGGLSFLSDLDVSNNNLSGI 798
L N + S GLS + L + +N ++ +
Sbjct: 111 MLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTV 144
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 32/135 (23%), Positives = 57/135 (42%), Gaps = 4/135 (2%)
Query: 350 NLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNM 409
+L L +N+F + + LR+++ S+N++T F S ++ + L SN
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNR 92
Query: 410 LSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCS 469
L N + + + SL L + N I+ S + +R+L L N T T+ G
Sbjct: 93 LE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFD 150
Query: 470 PPNFPALEKIVLPNN 484
+L + L N
Sbjct: 151 --TLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 4/90 (4%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVL 764
F + + L+ N L + F L L+ L L N++T DSF GL ++ +L
Sbjct: 76 AFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLL 134
Query: 765 DLSHNNFQGSIP-GSLGGLSFLSDLDVSNN 793
L N ++ G+ L LS L++ N
Sbjct: 135 SLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 37/165 (22%), Positives = 56/165 (33%), Gaps = 37/165 (22%)
Query: 90 CSWQGVSCS---LNS-------HVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGN--- 136
C V CS LN + L LNN+ + LP L +N N
Sbjct: 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT 70
Query: 137 SFSAG---DLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGS 193
G S + + L+SN + ++ + F + L + L N I+
Sbjct: 71 DIEEGAFEGAS-------GVNEILLTSNRLE-NVQHKMF-KGLESLKTLMLRSNRIT--C 119
Query: 194 LHIG-----PSLLQLDLSGNQIS---DSALLTYSLSNCQNLNLLN 230
+ S+ L L NQI+ A +L + LNLL
Sbjct: 120 VGNDSFIGLSSVRLLSLYDNQITTVAPGAF--DTLHSLSTLNLLA 162
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 31/133 (23%), Positives = 54/133 (40%), Gaps = 9/133 (6%)
Query: 428 LYVPFNNISG-PVPLSLTNCTQLRVLDLSSNGFTGTIPSG-FCSPPNFPALEKIVLPNNY 485
L + N + QLR ++ S+N T I G F + +I+L +N
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASG---VNEILLTSNR 92
Query: 486 LSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWS-LPNLSDLVMWANNLTGEIPEGICV 544
L ++LKT+ L N + V ++ + L ++ L ++ N +T + G
Sbjct: 93 LENVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFD 150
Query: 545 NGGNLETLILNNN 557
+L TL L N
Sbjct: 151 TLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 13/66 (19%), Positives = 28/66 (42%), Gaps = 2/66 (3%)
Query: 738 QVLNLGHNKLTGHIPD-SFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLS 796
L L +N+ T F L + ++ S+N G+ G S ++++ +++N L
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94
Query: 797 GIIPSG 802
+
Sbjct: 95 N-VQHK 99
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 6e-12
Identities = 61/280 (21%), Positives = 105/280 (37%), Gaps = 49/280 (17%)
Query: 876 KDEQREKYIESLPTSGSSSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSADSM 935
++E + ++ + + A K+ + F +
Sbjct: 9 EEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIEN-------FELLKV 61
Query: 936 IGSGGFGEVY---KAQLRD-GSVVAIK---KLIHVTGQGDREF-MAEMETIGKIKHRN-L 986
+G+G +G+V+ K D G + A+K K V E E + + I+ L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 987 VPLLGYCKIGEERL-LVYEYMKWGSLESVLH-------DRAKGGGTKLDWAARKKIAIGS 1038
V L Y E +L L+ +Y+ G L + L + + +I +
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI------YVG--EIVLA- 171
Query: 1039 ARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP 1098
L LH II+RD+K N+LLD N ++DFG+++ D GT
Sbjct: 172 ---LEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTI 224
Query: 1099 GYVPPEYYQSFRCTTKG-----DVYSYGVILLELLSGKRP 1133
Y+ P+ + G D +S GV++ ELL+G P
Sbjct: 225 EYMAPDIVRGGD---SGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 40/134 (29%), Positives = 61/134 (45%), Gaps = 7/134 (5%)
Query: 501 KTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLT 560
+ +DL LA + L L+ L + N L + G+ + L TL L NN L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96
Query: 561 GAIPKSI-ASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNNSLTGQVPQGL-GK 617
++P + T + + L NQL +P+G+ L KL L+L N L +P G K
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDK 153
Query: 618 CRSLVWLDLNSNNL 631
+L L L++N L
Sbjct: 154 LTNLQTLSLSTNQL 167
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 45/165 (27%), Positives = 69/165 (41%), Gaps = 10/165 (6%)
Query: 470 PPNFPA-LEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIW-SLPNLSDL 527
P PA EK+ L + L+ L ++L +N L + + ++ L L L
Sbjct: 30 PSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTL 88
Query: 528 VMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSI-ASCTNMLWVSLSSNQLTGE 586
+ N L +P G+ + L+ L L N L ++P + T + + L++NQL
Sbjct: 89 GLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-S 145
Query: 587 IPAGI-GNLVKLAILQLGNNSLTGQVPQG-LGKCRSLVWLDLNSN 629
IPAG L L L L N L VP G + L + L N
Sbjct: 146 IPAGAFDKLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 45/181 (24%), Positives = 68/181 (37%), Gaps = 34/181 (18%)
Query: 428 LYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLS 487
L + ++ + T+L L+L N T+ +G
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDL---------------- 82
Query: 488 GTVPLELGSCKNLKTIDLSFNSLAGPVPSEIW-SLPNLSDLVMWANNLTGEIPEGICVNG 546
L T+ L+ N LA +P ++ L L L + N L +P G+
Sbjct: 83 ----------TELGTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRL 130
Query: 547 GNLETLILNNNHLTGAIPKSI-ASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGN 604
L+ L LN N L +IP TN+ +SLS+NQL +P G L KL + L
Sbjct: 131 TKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFG 188
Query: 605 N 605
N
Sbjct: 189 N 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 29/96 (30%), Positives = 42/96 (43%), Gaps = 7/96 (7%)
Query: 538 IPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGI-GNLVK 596
+P GI + E L L + L + T + W++L NQL + AG+ +L +
Sbjct: 29 VPSGIPAD---TEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTE 84
Query: 597 LAILQLGNNSLTGQVPQGL-GKCRSLVWLDLNSNNL 631
L L L NN L +P G+ L L L N L
Sbjct: 85 LGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQL 119
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 9e-07
Identities = 27/87 (31%), Positives = 36/87 (41%), Gaps = 1/87 (1%)
Query: 716 LDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSI 775
LDL L+ F L L LNL +N+L F L +G L L++N
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLP 99
Query: 776 PGSLGGLSFLSDLDVSNNNLSGIIPSG 802
G L+ L L + N L +PSG
Sbjct: 100 LGVFDHLTQLDKLYLGGNQLKS-LPSG 125
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 32/98 (32%), Positives = 44/98 (44%), Gaps = 5/98 (5%)
Query: 707 FTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
F L +L+L YN L TL F L L L L +N+L F L + L
Sbjct: 55 FRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLY 113
Query: 766 LSHNNFQGSIP-GSLGGLSFLSDLDVSNNNLSGIIPSG 802
L N + S+P G L+ L +L ++ N L IP+G
Sbjct: 114 LGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAG 149
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 45/182 (24%), Positives = 68/182 (37%), Gaps = 31/182 (17%)
Query: 377 RELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNIS 436
+LDL S L +TF + L LNL N L V ++ L L + N ++
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 437 GPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGS 496
+ TQL L L N ++PSG +++
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSG--------VFDRLT---------------- 131
Query: 497 CKNLKTIDLSFNSLAGPVPSEIW-SLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILN 555
LK + L+ N L +P+ + L NL L + N L +P G G L+T+ L
Sbjct: 132 --KLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLF 187
Query: 556 NN 557
N
Sbjct: 188 GN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 9e-05
Identities = 39/163 (23%), Positives = 62/163 (38%), Gaps = 16/163 (9%)
Query: 327 ETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRL 386
E L++ L + L L+L +NQ + + L L L++N+L
Sbjct: 38 EKLDLQSTGLAT-LSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQL 95
Query: 387 TGELPSTFASCSSLHSLNLGSNML----SGNFLNTVVSKISSLIYLYVPFNNISGPVPLS 442
F + L L LG N L SG F +++ L L + N + +P
Sbjct: 96 ASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVF-----DRLTKLKELRLNTNQLQS-IPAG 149
Query: 443 L-TNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNN 484
T L+ L LS+N ++P G + L+ I L N
Sbjct: 150 AFDKLTNLQTLSLSTNQLQ-SVPHG--AFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 30/90 (33%), Positives = 38/90 (42%), Gaps = 6/90 (6%)
Query: 707 FTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDS-FGGLKAIGVL 764
F L L L N L +LP F L L+ L L N+L IP F L + L
Sbjct: 103 FDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTL 160
Query: 765 DLSHNNFQGSIP-GSLGGLSFLSDLDVSNN 793
LS N Q S+P G+ L L + + N
Sbjct: 161 SLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-11
Identities = 51/252 (20%), Positives = 101/252 (40%), Gaps = 38/252 (15%)
Query: 934 SMIGSGGFGEVYKAQ-LRDGSVVAIKKLI---HVTGQGDRE-----FMAEMETIGKIK-- 982
+G G F V+ A+ + + + VA+K + T + E + + + +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 983 HRNLVPLLGY----CKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGS 1038
+++ LL + G ++V+E + +L +++ + + G L + K+I+
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIK-KYEHRGIPLIYV--KQISKQL 140
Query: 1039 ARGLAFLHHSCIPHIIHRDMKSSNVLLDE------NFEARVSDFGMARLVNALDTHLSVS 1092
GL ++H C IIH D+K NVL++ + +++D G NA +
Sbjct: 141 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLG-----NACWYDEHYT 193
Query: 1093 TLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQL 1152
T Y PE D++S ++ EL++G +P E + K
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH------SYTKDD 247
Query: 1153 HREKRINEILDP 1164
+I E+L
Sbjct: 248 DHIAQIIELLGE 259
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 58/282 (20%), Positives = 99/282 (35%), Gaps = 68/282 (24%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCK 994
+G G G+V + + A+K + + RE ++V ++ +
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKM-LQDCPKARREVELHWRASQ---CPHIVRIVDVYE 81
Query: 995 IGEER----LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCI 1050
L+V E + G L S + DR T+ + A+ +IG A + +LH
Sbjct: 82 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE-ASEIMKSIGEA--IQYLHSI-- 136
Query: 1051 PHIIHRDMKSSNVLL---DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQ 1107
+I HRD+K N+L N +++DFG A+ Y
Sbjct: 137 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-----------TGE--KYDKS---- 178
Query: 1108 SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI-NEILDPEL 1166
C D++S GVI+ LL G P F ++ L + I +
Sbjct: 179 ---C----DMWSLGVIMYILLCGYPP-----FYSNHGLAI-------SPGMKTRIRMGQY 219
Query: 1167 TMQTSDETELYQYLRISFE-------CLDDRPFKRPTMIQVM 1201
+ E + +S E L P +R T+ + M
Sbjct: 220 EF-PNPE-----WSEVSEEVKMLIRNLLKTEPTQRMTITEFM 255
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 27/134 (20%), Positives = 57/134 (42%), Gaps = 7/134 (5%)
Query: 499 NLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNH 558
+ I L N++ P L + + N ++ E+ +L +L+L N
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNK 91
Query: 559 LTGAIPKSI-ASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNNSLTGQVPQG-L 615
+T +PKS+ ++ + L++N++ + +L L +L L +N L + +G
Sbjct: 92 IT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTF 148
Query: 616 GKCRSLVWLDLNSN 629
R++ + L N
Sbjct: 149 SPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 35/172 (20%), Positives = 61/172 (35%), Gaps = 25/172 (14%)
Query: 241 NATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGN 300
+ V+C L+ EIP + + + L N F
Sbjct: 12 SNNIVDC--------RGKGLT-EIPTNLPET----ITEIRLEQNTIK-VIPPGAFSPYKK 57
Query: 301 LSVITLSQNGLSGTEFPA----SLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSL 356
L I LS N + +E L++ L +L + N + +P L +L+ L L
Sbjct: 58 LRRIDLSNNQI--SELAPDAFQGLRS---LNSLVLYGNKITE-LPKSLFEGLFSLQLLLL 111
Query: 357 AHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSN 408
N+ + + Q L L L N+L TF+ ++ +++L N
Sbjct: 112 NANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 7e-10
Identities = 27/89 (30%), Positives = 40/89 (44%), Gaps = 4/89 (4%)
Query: 712 SLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNN 770
L +DLS N +S L + F L L L L NK+T F GL ++ +L L+ N
Sbjct: 57 KLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANK 115
Query: 771 FQGSIP-GSLGGLSFLSDLDVSNNNLSGI 798
+ + L L+ L + +N L I
Sbjct: 116 IN-CLRVDAFQDLHNLNLLSLYDNKLQTI 143
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 21/88 (23%), Positives = 41/88 (46%), Gaps = 3/88 (3%)
Query: 716 LDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSI 775
+ L N++ P F L+ ++L +N+++ PD+F GL+++ L L N +
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-EL 95
Query: 776 P-GSLGGLSFLSDLDVSNNNLSGIIPSG 802
P GL L L ++ N ++ +
Sbjct: 96 PKSLFEGLFSLQLLLLNANKINC-LRVD 122
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 28/140 (20%), Positives = 55/140 (39%), Gaps = 11/140 (7%)
Query: 496 SCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILN 555
+C N +D L +P+ + ++++ + N + IP G L + L+
Sbjct: 10 TCSN-NIVDCRGKGLTE-IPTNL--PETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLS 64
Query: 556 NNHLTGAIPKSI-ASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNNSLTGQVPQ 613
NN ++ + ++ + L N++T E+P + L L +L L N + +
Sbjct: 65 NNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRV 121
Query: 614 GL-GKCRSLVWLDLNSNNLS 632
+L L L N L
Sbjct: 122 DAFQDLHNLNLLSLYDNKLQ 141
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 25/83 (30%), Positives = 39/83 (46%), Gaps = 2/83 (2%)
Query: 712 SLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNN 770
SL L L N ++ LP++ F L LQ+L L NK+ D+F L + +L L N
Sbjct: 81 SLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNK 139
Query: 771 FQGSIPGSLGGLSFLSDLDVSNN 793
Q G+ L + + ++ N
Sbjct: 140 LQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 27/138 (19%), Positives = 52/138 (37%), Gaps = 12/138 (8%)
Query: 375 TLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLS----GNFLNTVVSKISSLIYLYV 430
T+ E+ L N + P F+ L ++L +N +S F + SL L +
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAF-----QGLRSLNSLVL 87
Query: 431 PFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTV 490
N I+ L++L L++N + + + L + L +N L
Sbjct: 88 YGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVD--AFQDLHNLNLLSLYDNKLQTIA 144
Query: 491 PLELGSCKNLKTIDLSFN 508
+ ++T+ L+ N
Sbjct: 145 KGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 16/65 (24%), Positives = 28/65 (43%), Gaps = 1/65 (1%)
Query: 738 QVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSG 797
+ L N + P +F K + +DLS+N P + GL L+ L + N ++
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITE 94
Query: 798 IIPSG 802
+P
Sbjct: 95 -LPKS 98
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 47/259 (18%), Positives = 89/259 (34%), Gaps = 15/259 (5%)
Query: 275 SLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHN 334
S + + + + LS + + + L C L+ L++
Sbjct: 69 SQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 128
Query: 335 ALQGGIPGFLLGSFRNLKQLSLAH-NQFAGEIPPELGQACGTLRELDLSS-NRLT--GEL 390
L I L NL +L+L+ + F+ L +C L EL+LS T
Sbjct: 129 RLSDPI-VNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQ 187
Query: 391 PSTFASCSSLHSLNLG--SNMLSGNFLNTVVSKISSLIYLYVPF-NNISGPVPLSLTNCT 447
+ ++ LNL L + L+T+V + +L++L + +
Sbjct: 188 VAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 247
Query: 448 QLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKT----- 502
L+ L LS IP P L+ + + GT+ L + +L+
Sbjct: 248 YLQHLSLS--RCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQINCSHF 305
Query: 503 IDLSFNSLAGPVPSEIWSL 521
++ ++ EIW +
Sbjct: 306 TTIARPTIGNKKNQEIWGI 324
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 44/283 (15%), Positives = 85/283 (30%), Gaps = 44/283 (15%)
Query: 82 WTADALTPCSWQGVSCSLNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAG 141
W LT + + L + ++H++L +
Sbjct: 49 WQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 108
Query: 142 DLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSH-NSISGGSL-HIG-- 197
L + L + L ++ + L L +NLS + S +L +
Sbjct: 109 TLHGILSQCSKLQNLSLEGLRLSDP--IVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 166
Query: 198 -PSLLQLDLSG-NQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSV-----NCKSI 250
L +L+LS ++ + + + LN S L + + C ++
Sbjct: 167 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG--YRKNLQKSDLSTLVRRCPNL 224
Query: 251 STIDLSY-NLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQN 309
+DLS +L + F L++L LS C ++ TL
Sbjct: 225 VHLDLSDSVMLKNDCFQEFF--QLNYLQHLSLSR--------------CYDIIPETL--- 265
Query: 310 GLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLK 352
L L+TL + G + L + +L+
Sbjct: 266 --------LELGEIPTLKTLQVFGIVPDGTLQ-LLKEALPHLQ 299
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 51/265 (19%), Positives = 89/265 (33%), Gaps = 16/265 (6%)
Query: 317 PASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTL 376
P + P S ++ + L+++ + C L
Sbjct: 61 PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 120
Query: 377 RELDLSSNRLTGELPSTFASCSSLHSLNL-GSNMLSGNFLNTVVSKISSLIYLYVPF-NN 434
+ L L RL+ + +T A S+L LNL G + S L T++S S L L + + +
Sbjct: 121 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 180
Query: 435 IS--GPVPLSLTNCTQLRVLDLS--SNGFTGTIPSGFCSPPNFPALEKIVLPN-NYLSGT 489
+ + L+LS + S P L + L + L
Sbjct: 181 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVR--RCPNLVHLDLSDSVMLKND 238
Query: 490 VPLELGSCKNLKTIDLSFNSLAGPV-PSEIWSLPNLSDLVMWANNLTGEIPE-GICVNGG 547
E L+ + LS P E+ +P L L + G +P+ + +
Sbjct: 239 CFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTL-----QVFGIVPDGTLQLLKE 293
Query: 548 NLETLILNNNHLTGAIPKSIASCTN 572
L L +N +H T +I + N
Sbjct: 294 ALPHLQINCSHFTTIARPTIGNKKN 318
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 41/251 (16%), Positives = 87/251 (34%), Gaps = 56/251 (22%)
Query: 383 SNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLS 442
+ + S + ++L ++++ + L+ ++S+ S L L + +S P+ +
Sbjct: 78 PRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNT 137
Query: 443 LTNCTQLRVLDLSS-NGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLK 501
L + L L+LS +GF+ AL+ ++ SC L
Sbjct: 138 LAKNSNLVRLNLSGCSGFSEF------------ALQTLL--------------SSCSRLD 171
Query: 502 TIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGE-IPEGICVNGGNLETLILN--NNH 558
++LS W + T + + + + L L+ +
Sbjct: 172 ELNLS-----------------------WCFDFTEKHVQVAVAHVSETITQLNLSGYRKN 208
Query: 559 LTGAIPKSIA-SCTNMLWVSLSS-NQLTGEIPAGIGNLVKLAILQL-GNNSLTGQVPQGL 615
L + ++ C N++ + LS L + L L L L + + L
Sbjct: 209 LQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLEL 268
Query: 616 GKCRSLVWLDL 626
G+ +L L +
Sbjct: 269 GEIPTLKTLQV 279
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 64.1 bits (155), Expect = 9e-11
Identities = 54/333 (16%), Positives = 95/333 (28%), Gaps = 73/333 (21%)
Query: 916 RKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGD------- 968
+ F+H L T IG G FGEV++ D + VAIK I + G
Sbjct: 9 GPVPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKI-IAIEGPDLVNGSHQK 65
Query: 969 --REFMAE---------METIGKIKHRNLVPLLGYC----KIGEERLLVYEYMKW--GSL 1011
E + E + + + L L +++ GS
Sbjct: 66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125
Query: 1012 ESVLHDRAKG----------GGTKL--------DWAARKKIAIGSARGLAFLHHSCIPHI 1053
GG L A K I LA S
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RF 183
Query: 1054 IHRDMKSSNVLLDENFEARVSDFGMARL---------VNALDTHLSVSTLAGTPGYV--- 1101
HRD+ NVLL + ++ + V+ +D LS G +
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVS 243
Query: 1102 -PPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGW----AKQLHREK 1156
+ + + D+Y L+ + E+ +N++ W ++ ++
Sbjct: 244 MDEDLFTG-DGDYQFDIYR-------LMKKENNNRWGEYHPYSNVL-WLHYLTDKMLKQM 294
Query: 1157 RINEILDPELTMQTSDETELYQYLRISFECLDD 1189
+ Q + + + ++F D
Sbjct: 295 TFKTKCNTPAMKQIKRKIQEFHRTMLNFSSATD 327
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-10
Identities = 28/136 (20%), Positives = 52/136 (38%), Gaps = 9/136 (6%)
Query: 297 RCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSL 356
++ + L + + + + LE L+ + L I L LK+L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN--LPKLNKLKKLEL 71
Query: 357 AHNQFAGEIPPELGQACGTLRELDLSSNRLT--GELPSTFASCSSLHSLNLGSN--MLSG 412
+ N+ +G L + C L L+LS N++ + +L SL+L +
Sbjct: 72 SDNRVSG-GLEVLAEKCPNLTHLNLSGNKIKDLSTI-EPLKKLENLKSLDLFNCEVTNLN 129
Query: 413 NFLNTVVSKISSLIYL 428
++ V + L YL
Sbjct: 130 DYRENVFKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 32/137 (23%), Positives = 51/137 (37%), Gaps = 33/137 (24%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSS 160
S V L L+NS + LE L+ +
Sbjct: 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLS-------------------------TIN 51
Query: 161 NNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIG---PSLLQLDLSGNQISDSALLT 217
+T S+ L ++L + LS N +SGG + P+L L+LSGN+I D + +
Sbjct: 52 VGLT-SIAN---LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIE 107
Query: 218 YSLSNCQNLNLLNFSDN 234
L +NL L+ +
Sbjct: 108 P-LKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 29/138 (21%), Positives = 51/138 (36%), Gaps = 29/138 (21%)
Query: 321 KNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAG-EIPPELGQACGTLREL 379
+ ++ L + ++ G L F L+ LS + P+L + L++L
Sbjct: 14 RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPKLNK----LKKL 69
Query: 380 DLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPV 439
+LS NR++G L C +L LNL N + +S++
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI---------KDLSTIEP------------ 108
Query: 440 PLSLTNCTQLRVLDLSSN 457
L L+ LDL +
Sbjct: 109 ---LKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 4e-07
Identities = 22/86 (25%), Positives = 43/86 (50%), Gaps = 3/86 (3%)
Query: 548 NLETLILNNNHLT-GAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNS 606
+++ L+L+N+ G + + ++S + LT I A + L KL L+L +N
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNR 75
Query: 607 LTGQVPQGLGKCRSLVWLDLNSNNLS 632
++G + KC +L L+L+ N +
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 22/83 (26%), Positives = 35/83 (42%), Gaps = 3/83 (3%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
L +L L+ ++ N LN L+ L L N+++G + + L+LS N
Sbjct: 43 ELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI 100
Query: 772 QG-SIPGSLGGLSFLSDLDVSNN 793
+ S L L L LD+ N
Sbjct: 101 KDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 34/168 (20%), Positives = 57/168 (33%), Gaps = 45/168 (26%)
Query: 370 GQACGTLRELDLSSNRLT-GELPSTFASCSSLHSLNLGSNMLS--GNFLNTVVSKISSLI 426
+ ++EL L ++R G+L L L+ + L+ N K++ L
Sbjct: 13 NRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANL-----PKLNKLK 67
Query: 427 YLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYL 486
L + N +SG + + C L L+LS N + +E
Sbjct: 68 KLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK-----------DLSTIEP-------- 108
Query: 487 SGTVPLELGSCKNLKTIDLSFNSLAGPVPSE-------IWSLPNLSDL 527
L +NLK++DL V + LP L+ L
Sbjct: 109 -------LKKLENLKSLDLFNC----EVTNLNDYRENVFKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 26/136 (19%), Positives = 49/136 (36%), Gaps = 30/136 (22%)
Query: 199 SLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYN 258
+ +L L ++ ++ L + L L+ + L SI+ +
Sbjct: 18 DVKELVLDNSRSNEGKLEG-LTDEFEELEFLSTINVGL-----------TSIANLPKLNK 65
Query: 259 LLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPA 318
L K L+LS N +G L +C NL+ + LS N +
Sbjct: 66 L-----------------KKLELSDNRVSGGLEVL-AEKCPNLTHLNLSGNKIKDLSTIE 107
Query: 319 SLKNCQLLETLNMSHN 334
LK + L++L++ +
Sbjct: 108 PLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 6e-06
Identities = 25/96 (26%), Positives = 41/96 (42%), Gaps = 10/96 (10%)
Query: 443 LTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKT 502
+L L + G T +I + P L+K+ L +N +SG + + C NL
Sbjct: 38 TDEFEELEFLSTINVGLT-SI-ANL---PKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92
Query: 503 IDLSFNSLAGPVPSEIWSL---PNLSDLVMWANNLT 535
++LS N + S I L NL L ++ +T
Sbjct: 93 LNLSGNKIKD--LSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 20/85 (23%), Positives = 35/85 (41%), Gaps = 3/85 (3%)
Query: 714 IYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQG 773
+ LD S ++ G L L+ L+ + LT I + L + L+LS N G
Sbjct: 22 LVLDNSRSNE-GKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSG 78
Query: 774 SIPGSLGGLSFLSDLDVSNNNLSGI 798
+ L+ L++S N + +
Sbjct: 79 GLEVLAEKCPNLTHLNLSGNKIKDL 103
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 9e-05
Identities = 20/87 (22%), Positives = 35/87 (40%), Gaps = 5/87 (5%)
Query: 198 PSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSY 257
L L ++ A +L L L SDN++ G L + C +++ ++LS
Sbjct: 42 EELEFLSTINVGLTSIA----NLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSG 97
Query: 258 NLLSGEIPASFVADSSGSLKYLDLSHN 284
N + + +LK LDL +
Sbjct: 98 NKIKDLSTIEPLKKLE-NLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 20/115 (17%), Positives = 45/115 (39%), Gaps = 5/115 (4%)
Query: 472 NFPALEKIVLPNNYLSGTVPLELG-SCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMW 530
++++VL N+ + L + L+ + L + + L L L +
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT--SIANLPKLNKLKKLELS 72
Query: 531 ANNLTGEIPEGICVNGGNLETLILNNNHLTG-AIPKSIASCTNMLWVSLSSNQLT 584
N ++G E + NL L L+ N + + + + N+ + L + ++T
Sbjct: 73 DNRVSG-GLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 33/164 (20%), Positives = 66/164 (40%), Gaps = 20/164 (12%)
Query: 200 LLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNL 259
++L I + +LS + L S N + K+++ S +++ + L NL
Sbjct: 27 KVELHGMIPPIEK---MDATLSTLKACKHLALSTNNIE-KISSLS-GMENLRILSLGRNL 81
Query: 260 LSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPAS 319
+ +I + + +L+ L +S+N S ++ + NL V+ +S N ++
Sbjct: 82 IK-KI--ENLDAVADTLEELWISYNQIA-SLSGIE--KLVNLRVLYMSNNKITNWGEIDK 135
Query: 320 LKNCQLLETLNMSHNALQGGIPG---------FLLGSFRNLKQL 354
L LE L ++ N L ++ NLK+L
Sbjct: 136 LAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 36/182 (19%), Positives = 57/182 (31%), Gaps = 31/182 (17%)
Query: 289 KFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSF 348
F + L + A+L + + L +S N ++ I L
Sbjct: 13 IFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISS--LSGM 69
Query: 349 RNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSN 408
NL+ LSL N +I L TL EL +S N++ L S +L L + +N
Sbjct: 70 ENLRILSLGRNLIK-KIEN-LDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNN 125
Query: 409 MLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFC 468
KI++ I L +L L L+ N
Sbjct: 126 ------------KITNW-------GEID-----KLAALDKLEDLLLAGNPLYNDYKENNA 161
Query: 469 SP 470
+
Sbjct: 162 TS 163
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 29/138 (21%), Positives = 53/138 (38%), Gaps = 10/138 (7%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSA-GDLSTSKTSSCSLVTMDLS 159
+ + L+ TL+ L +HL L N+ LS + +L + L
Sbjct: 23 TEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKISSLSGME----NLRILSLG 78
Query: 160 SNNITGSLPGRSFLLSCDRLSYVNLSHNSISG-GSLHIGPSLLQLDLSGNQISDSALLTY 218
N I + + D L + +S+N I+ + +L L +S N+I++ +
Sbjct: 79 RNLIK-KIENLDAV--ADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNKITNWGEIDK 135
Query: 219 SLSNCQNLNLLNFSDNKL 236
L+ L L + N L
Sbjct: 136 -LAALDKLEDLLLAGNPL 152
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 32/172 (18%), Positives = 58/172 (33%), Gaps = 39/172 (22%)
Query: 378 ELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISG 437
EL + ++ +T ++ + L L +N + IS
Sbjct: 29 ELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE----------------------KISS 65
Query: 438 PVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSC 497
L+ LR+L L N I + LE++ + N ++ +E
Sbjct: 66 -----LSGMENLRILSLGRNLIK-KIENLDA---VADTLEELWISYNQIASLSGIE--KL 114
Query: 498 KNLKTIDLSFNSLAGPVPSEIWSL---PNLSDLVMWANNLTGEIPEGICVNG 546
NL+ + +S N + EI L L DL++ N L + E +
Sbjct: 115 VNLRVLYMSNNKITN--WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 21/85 (24%), Positives = 40/85 (47%), Gaps = 5/85 (5%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
+ +L LS N++ + + L++L+LG N + I + + L +S+N
Sbjct: 49 ACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQI 105
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLS 796
S+ G + L L L +SNN ++
Sbjct: 106 A-SLSG-IEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 25/126 (19%), Positives = 48/126 (38%), Gaps = 13/126 (10%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSS 160
L L+ + + +++L+ + L L+L N + + +L + +S
Sbjct: 48 KACKHLALSTNNIE---KISSLSGMENLRILSLGRNLIK--KIENLDAVADTLEELWISY 102
Query: 161 NNITGSLPGRSFLLSCDRLSYVNLSHNSISG----GSLHIGPSLLQLDLSGNQISDSALL 216
N I SL G + L + +S+N I+ L L L L+GN + +
Sbjct: 103 NQIA-SLSG---IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158
Query: 217 TYSLSN 222
+ S
Sbjct: 159 NNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 17/90 (18%), Positives = 33/90 (36%), Gaps = 4/90 (4%)
Query: 709 TNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSH 768
T + L + + +L + L L N + I S G++ + +L L
Sbjct: 23 TEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGR 79
Query: 769 NNFQGSIPGSLGGLSFLSDLDVSNNNLSGI 798
N + I L +L +S N ++ +
Sbjct: 80 NLIK-KIENLDAVADTLEELWISYNQIASL 108
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 18/85 (21%), Positives = 37/85 (43%), Gaps = 5/85 (5%)
Query: 548 NLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSL 607
+ L L+ N++ I S++ N+ +SL N + +I L L + N +
Sbjct: 49 ACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQI 105
Query: 608 TGQVPQGLGKCRSLVWLDLNSNNLS 632
G+ K +L L +++N ++
Sbjct: 106 A--SLSGIEKLVNLRVLYMSNNKIT 128
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 27/133 (20%), Positives = 47/133 (35%), Gaps = 15/133 (11%)
Query: 106 LNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSA-GDLSTSKTSSCSLVTMDLSSNNIT 164
+ L + + T L+L+G +L + +D S N I
Sbjct: 2 VKLTAELIEQAAQYTNAVRD---RELDLRGYKIPVIENLGATLD---QFDAIDFSDNEIR 55
Query: 165 GSLPGRSFLLSCDRLSYVNLSHN---SISGGSLHIGPSLLQLDLSGNQISDSALLTYSLS 221
L G RL + +++N I G P L +L L+ N + + L L+
Sbjct: 56 -KLDG---FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP-LA 110
Query: 222 NCQNLNLLNFSDN 234
+ ++L L N
Sbjct: 111 SLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 22/144 (15%), Positives = 41/144 (28%), Gaps = 31/144 (21%)
Query: 318 ASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPP-ELGQACGTL 376
A N L++ + I L + + + N EI + L
Sbjct: 13 AQYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDN----EIRKLDGFPLLRRL 66
Query: 377 RELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNIS 436
+ L +++NR+ + L L L +N + L ++
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNN------------SLVEL-------GDLD 107
Query: 437 GPVPLSLTNCTQLRVLDLSSNGFT 460
L + L L + N T
Sbjct: 108 -----PLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 9e-08
Identities = 23/134 (17%), Positives = 43/134 (32%), Gaps = 11/134 (8%)
Query: 156 MDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSIS--GGSLHIGPSLLQLDLSGNQISDS 213
+ L++ I + + R ++L I +D S N+I
Sbjct: 2 VKLTAELIEQAAQ----YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRK- 56
Query: 214 ALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSS 273
L + L L ++N++ ++ + L+ N L +A
Sbjct: 57 --LDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLK 113
Query: 274 GSLKYLDLSHNNFT 287
SL YL + N T
Sbjct: 114 -SLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 24/141 (17%), Positives = 48/141 (34%), Gaps = 14/141 (9%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSA-GDLSTSKTSSCSLVTMDLS 159
L+L + NL L + ++ N + L T+ ++
Sbjct: 19 VRDRELDLRGYKIPVIENLGA--TLDQFDAIDFSDNEIRKLDGFPLLR----RLKTLLVN 72
Query: 160 SNNITGSLPGRSFLLSCDRLSYVNLSHNSISG----GSLHIGPSLLQLDLSGNQISDSAL 215
+N I G + L+ + L++NS+ L SL L + N +++
Sbjct: 73 NNRICRIGEG--LDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 130
Query: 216 L-TYSLSNCQNLNLLNFSDNK 235
Y + + +L+F K
Sbjct: 131 YRLYVIYKVPQVRVLDFQKVK 151
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 27/158 (17%), Positives = 53/158 (33%), Gaps = 34/158 (21%)
Query: 379 LDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGP 438
+ L++ + E + + + L+L + I +L
Sbjct: 2 VKLTAELI--EQAAQYTNAVRDRELDLRGYKIP---------VIENL------------- 37
Query: 439 VPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCK 498
Q +D S N + GF P L+ +++ NN + +
Sbjct: 38 ----GATLDQFDAIDFSDNEIR-KL-DGF---PLLRRLKTLLVNNNRICRIGEGLDQALP 88
Query: 499 NLKTIDLSFNSLAGPVP-SEIWSLPNLSDLVMWANNLT 535
+L + L+ NSL + SL +L+ L + N +T
Sbjct: 89 DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 27/162 (16%), Positives = 48/162 (29%), Gaps = 39/162 (24%)
Query: 203 LDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSG 262
+ L+ I +A +N L+ K I I+ NL +
Sbjct: 2 VKLTAELIEQAA----QYTNAVRDRELDLRGYK--------------IPVIE---NLGA- 39
Query: 263 EIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKN 322
+ +D S N K L + ++ N + +
Sbjct: 40 ---------TLDQFDAIDFSDNEIR-KLDGFP--LLRRLKTLLVNNNRICRIG-EGLDQA 86
Query: 323 CQLLETLNMSHNALQGGIPGFL--LGSFRNLKQLSLAHNQFA 362
L L +++N+L G L L S ++L L + N
Sbjct: 87 LPDLTELILTNNSLVE--LGDLDPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 18/84 (21%), Positives = 33/84 (39%), Gaps = 5/84 (5%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
+D S N + + F L L+ L + +N++ L + L L++N+
Sbjct: 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL 100
Query: 772 Q--GSIPGSLGGLSFLSDLDVSNN 793
G + L L L+ L + N
Sbjct: 101 VELGDL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 20/86 (23%), Positives = 38/86 (44%), Gaps = 5/86 (5%)
Query: 712 SLIYLDLSYNSLSGTLPENFGS-LNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNN 770
LDL + + EN G+ L+ ++ N++ D F L+ + L +++N
Sbjct: 20 RDRELDLRGYKI--PVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNR 75
Query: 771 FQGSIPGSLGGLSFLSDLDVSNNNLS 796
G L L++L ++NN+L
Sbjct: 76 ICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 18/88 (20%), Positives = 30/88 (34%), Gaps = 3/88 (3%)
Query: 545 NGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGN 604
N L L + I A+ + S N++ ++ G L +L L + N
Sbjct: 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNN 73
Query: 605 NSLTGQVPQGLGKCRSLVWLDLNSNNLS 632
N + L L L +N+L
Sbjct: 74 NRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 21/89 (23%), Positives = 31/89 (34%), Gaps = 4/89 (4%)
Query: 472 NFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWA 531
N ++ L + L + ID S N + L L L++
Sbjct: 17 NAVRDRELDLRGYKIPVIENLG-ATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNN 73
Query: 532 NNLTGEIPEGICVNGGNLETLILNNNHLT 560
N + I EG+ +L LIL NN L
Sbjct: 74 NRIC-RIGEGLDQALPDLTELILTNNSLV 101
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 9e-10
Identities = 38/131 (29%), Positives = 58/131 (44%), Gaps = 6/131 (4%)
Query: 501 KTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLT 560
+ + L N + P SL NL +L + +N L +P G+ + L L L N LT
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 561 GAIPKSI-ASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQG-LGKC 618
+P ++ ++ + + N+LT E+P GI L L L L N L +P G +
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRL 158
Query: 619 RSLVWLDLNSN 629
SL L N
Sbjct: 159 SSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 43/138 (31%), Positives = 69/138 (50%), Gaps = 10/138 (7%)
Query: 496 SCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILN 555
SC + T+D A VP+ I + N L + N +T ++ G+ + NL+ L L
Sbjct: 18 SC-SGTTVDCRSKRHAS-VPAGIPT--NAQILYLHDNQIT-KLEPGVFDSLINLKELYLG 72
Query: 556 NNHLTGAIPKSI-ASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNNSLTGQVPQ 613
+N L A+P + S T + + L +NQLT +P+ + LV L L + N LT +P+
Sbjct: 73 SNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPR 129
Query: 614 GLGKCRSLVWLDLNSNNL 631
G+ + L L L+ N L
Sbjct: 130 GIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 27/88 (30%), Positives = 36/88 (40%), Gaps = 1/88 (1%)
Query: 715 YLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGS 774
L L N ++ P F SL L+ L LG N+L F L + VLDL N
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVL 103
Query: 775 IPGSLGGLSFLSDLDVSNNNLSGIIPSG 802
L L +L + N L+ +P G
Sbjct: 104 PSAVFDRLVHLKELFMCCNKLTE-LPRG 130
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 59.8 bits (144), Expect = 2e-09
Identities = 22/114 (19%), Positives = 38/114 (33%), Gaps = 4/114 (3%)
Query: 297 RCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSL 356
S + +++G + L + L L + + + L L+ L++
Sbjct: 6 CPHGSSGLRCTRDGA--LDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTI 63
Query: 357 AHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNML 410
+ + P+ L L+LS N L T SL L L N L
Sbjct: 64 VKSGLR-FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQG-LSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 22/91 (24%), Positives = 35/91 (38%), Gaps = 2/91 (2%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVL 764
+L L + L L L+ L + + L PD+F + L
Sbjct: 26 HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85
Query: 765 DLSHNNFQGSIPGSLGGLSFLSDLDVSNNNL 795
+LS N + ++ GLS L +L +S N L
Sbjct: 86 NLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.7 bits (131), Expect = 8e-08
Identities = 16/101 (15%), Positives = 31/101 (30%), Gaps = 1/101 (0%)
Query: 721 NSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPD-SFGGLKAIGVLDLSHNNFQGSIPGSL 779
+ + L L + + + H+ GL + L + + + P +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 780 GGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLC 820
LS L++S N L + Q + N C
Sbjct: 77 HFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 18/114 (15%), Positives = 33/114 (28%), Gaps = 4/114 (3%)
Query: 496 SCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILN 555
+ + + + NL++L + + G L L +
Sbjct: 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 556 NNHLTGAIPKSIASCTNML-WVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLT 608
+ L + T L ++LS N L + + L L L N L
Sbjct: 65 KSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 2e-06
Identities = 22/115 (19%), Positives = 42/115 (36%), Gaps = 6/115 (5%)
Query: 247 CKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITL 306
S + + + + + +L L + + D G L +T+
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHL--PGAENLTELYIENQQHLQHLELRDLRGLGELRNLTI 63
Query: 307 SQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQF 361
++GL P + L LN+S NAL+ + G +L++L L+ N
Sbjct: 64 VKSGLRFVA-PDAFHFTPRLSRLNLSFNALESLSWKTVQGL--SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.4 bits (117), Expect = 5e-06
Identities = 17/63 (26%), Positives = 24/63 (38%)
Query: 349 RNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSN 408
NL +L + + Q + + G LR L + + L P F L LNL N
Sbjct: 31 ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90
Query: 409 MLS 411
L
Sbjct: 91 ALE 93
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 16/115 (13%), Positives = 37/115 (32%), Gaps = 5/115 (4%)
Query: 372 ACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVP 431
L + + + +L L + + + + + L L +
Sbjct: 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 432 FNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYL 486
+ + P + +L L+LS N ++ + L+++VL N L
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLS---LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 5e-05
Identities = 15/91 (16%), Positives = 29/91 (31%), Gaps = 3/91 (3%)
Query: 543 CVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAG-IGNLVKLAILQ 601
C G+ + L + N+ + + + Q + + L +L L
Sbjct: 5 CCPHGSSGLRCTRDGALD--SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62
Query: 602 LGNNSLTGQVPQGLGKCRSLVWLDLNSNNLS 632
+ + L P L L+L+ N L
Sbjct: 63 IVKSGLRFVAPDAFHFTPRLSRLNLSFNALE 93
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 4e-04
Identities = 23/116 (19%), Positives = 39/116 (33%), Gaps = 7/116 (6%)
Query: 446 CTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLE-LGSCKNLKTID 504
L + +G P L ++ + N + L L L+ +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHL---PGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62
Query: 505 LSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLT 560
+ + L P P LS L + N L + V G +L+ L+L+ N L
Sbjct: 63 IVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKT-VQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 6e-04
Identities = 8/56 (14%), Positives = 17/56 (30%), Gaps = 1/56 (1%)
Query: 744 HNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIP-GSLGGLSFLSDLDVSNNNLSGI 798
G + + L + + + L GL L +L + + L +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 65/250 (26%), Positives = 95/250 (38%), Gaps = 52/250 (20%)
Query: 933 DSMIGSGGFGEVYKAQ-LRDGSVVAIK-----KLIHVTGQGDREFMAEMETIGKIKHRNL 986
+IG G FG+V KA + VA+K K H + + + K N+
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 987 VPLLGY-------CKIGEERLL---VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAI 1036
+ +L C E LL +YE +K K +K A
Sbjct: 162 IHMLENFTFRNHICMTFE--LLSMNLYELIK------------KNKFQGFSLPLVRKFAH 207
Query: 1037 GSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEA--RVSDFGMARLVNALDTHLSVSTL 1094
+ L LH + IIH D+K N+LL + + +V DFG ++ H V T
Sbjct: 208 SILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG-----SSCYEHQRVYTY 259
Query: 1095 AGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR 1154
+ Y PE R D++S G IL ELL+G P+ P G+D QL
Sbjct: 260 IQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY-PLLP---GEDEG-----DQL-- 308
Query: 1155 EKRINEILDP 1164
+ E+L
Sbjct: 309 -ACMIELLGM 317
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-09
Identities = 57/246 (23%), Positives = 92/246 (37%), Gaps = 44/246 (17%)
Query: 934 SMIGSGGFGEVYKAQ-LRDGSVVAIK-----KLIHVTGQGDREFMAEMETIGKIKHRNLV 987
S+IG G FG+V KA + VAIK K Q + + M +V
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119
Query: 988 PLLGY-------CKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSAR 1040
L + C LV+E + +L +L + G + +K A
Sbjct: 120 HLKRHFMFRNHLC-------LVFEML-SYNLYDLLRNTNFRG---VSLNLTRKFAQQMCT 168
Query: 1041 GLAFLHHSCIPHIIHRDMKSSNVLL--DENFEARVSDFGMARLVNALDTHLSVSTLAGTP 1098
L FL + IIH D+K N+LL + ++ DFG + + + +
Sbjct: 169 ALLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ-----RIYQYIQSR 222
Query: 1099 GYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158
Y PE D++S G IL+E+ +G+ P+ G + Q+ +I
Sbjct: 223 FYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE-PLFS---GANEV-----DQM---NKI 270
Query: 1159 NEILDP 1164
E+L
Sbjct: 271 VEVLGI 276
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 45/189 (23%), Positives = 80/189 (42%), Gaps = 18/189 (9%)
Query: 447 TQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLS 506
+ +L T + ++++I+ N+ + ++ N++ + L
Sbjct: 19 AETIKANLKKKSVT-DAVTQN----ELNSIDQIIANNSDIKSVQGIQ--YLPNVRYLALG 71
Query: 507 FNSLAG-PVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPK 565
N L L NL+ L++ N L +P G+ NL+ L+L N L ++P
Sbjct: 72 GNKLHDISALK---ELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPD 126
Query: 566 SI-ASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNNSLTGQVPQGL-GKCRSLV 622
+ TN+ +++L+ NQL +P G+ L L L L N L +P+G+ K L
Sbjct: 127 GVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLK 184
Query: 623 WLDLNSNNL 631
L L N L
Sbjct: 185 DLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 44/213 (20%), Positives = 84/213 (39%), Gaps = 26/213 (12%)
Query: 352 KQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLS 411
+ +L + ++ ++ +++ + + ++ L LG N L
Sbjct: 22 IKANLKKKSVT-DAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKLH 76
Query: 412 --GNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSG-FC 468
++++L YL + N + T L+ L L N ++P G F
Sbjct: 77 DISAL-----KELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFD 130
Query: 469 SPPNFPALEKIVLPNNYLSGTVPLELG---SCKNLKTIDLSFNSLAGPVPSEIW-SLPNL 524
N L + L +N L L G NL +DLS+N L +P ++ L L
Sbjct: 131 KLTN---LTYLNLAHNQLQS---LPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQL 183
Query: 525 SDLVMWANNLTGEIPEGICVNGGNLETLILNNN 557
DL ++ N L +P+G+ +L+ + L++N
Sbjct: 184 KDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 51/254 (20%), Positives = 87/254 (34%), Gaps = 53/254 (20%)
Query: 244 SVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSV 303
++ + F D+ +L + T + ++
Sbjct: 2 TITVSTPIK-------------QIFPDDAFAETIKANLKKKSVT---DAVTQNELNSIDQ 45
Query: 304 ITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFR---NLKQLSLAHNQ 360
I + + + + L N + L + N L + + + NL L L NQ
Sbjct: 46 IIANNSDIKSVQGIQYLPN---VRYLALGGNKLHD------ISALKELTNLTYLILTGNQ 96
Query: 361 FAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNML----SGNFLN 416
+P + L+EL L N+L F ++L LNL N L G F
Sbjct: 97 LQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVF-- 153
Query: 417 TVVSKISSLIYLYVPFNNISGPVPLSLTN-----CTQLRVLDLSSNGFTGTIPSG-FCSP 470
K+++L L + +N + SL TQL+ L L N ++P G F
Sbjct: 154 ---DKLTNLTELDLSYNQLQ-----SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVF--- 201
Query: 471 PNFPALEKIVLPNN 484
+L+ I L +N
Sbjct: 202 DRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 34/102 (33%), Positives = 47/102 (46%), Gaps = 8/102 (7%)
Query: 712 SLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNN 770
+L YL L+ N L +LP F L L+ L L N+L F L + L+L+HN
Sbjct: 86 NLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQ 144
Query: 771 FQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSG-----GQLTT 807
Q G L+ L++LD+S N L +P G QL
Sbjct: 145 LQSLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKD 185
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 25/96 (26%), Positives = 37/96 (38%), Gaps = 3/96 (3%)
Query: 707 FTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDL 766
++ YL L N L + L L L L N+L F L + L L
Sbjct: 59 IQYLPNVRYLALGGNKLH-DISA-LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVL 116
Query: 767 SHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSG 802
N Q G L+ L+ L++++N L +P G
Sbjct: 117 VENQLQSLPDGVFDKLTNLTYLNLAHNQLQS-LPKG 151
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 6e-09
Identities = 30/141 (21%), Positives = 48/141 (34%), Gaps = 12/141 (8%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSF-SAGDLSTSKTSSCSLVTMDLS 159
+ V L L+N + LE L+L S +L L ++LS
Sbjct: 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPKLP----KLKKLELS 79
Query: 160 SNNITGSLPGRSFLLSCDRLSYVNLSHNSISG----GSLHIGPSLLQLDLSGNQISD-SA 214
N I G L L+++NLS N + L L LDL ++++ +
Sbjct: 80 ENRIFGGLDM--LAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLND 137
Query: 215 LLTYSLSNCQNLNLLNFSDNK 235
L L+ D +
Sbjct: 138 YRESVFKLLPQLTYLDGYDRE 158
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 33/138 (23%), Positives = 49/138 (35%), Gaps = 29/138 (21%)
Query: 321 KNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAG-EIPPELGQACGTLREL 379
+ + L + + G L F NL+ LSL + P+L + L++L
Sbjct: 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPKLPK----LKKL 76
Query: 380 DLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPV 439
+LS NR+ G L +L LNL N L IS+L
Sbjct: 77 ELSENRIFGGLDMLAEKLPNLTHLNLSGNKL---------KDISTLEP------------ 115
Query: 440 PLSLTNCTQLRVLDLSSN 457
L L+ LDL +
Sbjct: 116 ---LKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 23/86 (26%), Positives = 39/86 (45%), Gaps = 3/86 (3%)
Query: 548 NLETLILNNNHLT-GAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNS 606
+ L+L+N G I A N+ ++SL + L + + + L KL L+L N
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENR 82
Query: 607 LTGQVPQGLGKCRSLVWLDLNSNNLS 632
+ G + K +L L+L+ N L
Sbjct: 83 IFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 23/83 (27%), Positives = 33/83 (39%), Gaps = 3/83 (3%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
+L +L L L N L L+ L L N++ G + L + L+LS N
Sbjct: 50 NLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL 107
Query: 772 QG-SIPGSLGGLSFLSDLDVSNN 793
+ S L L L LD+ N
Sbjct: 108 KDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 9e-06
Identities = 27/159 (16%), Positives = 51/159 (32%), Gaps = 32/159 (20%)
Query: 198 PSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSY 257
++ +L L + +D + + NL L+ + L S+S +
Sbjct: 24 AAVRELVLDNCKSNDGKIEG-LTAEFVNLEFLSLINVGL-----------ISVSNLPKLP 71
Query: 258 NLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFP 317
L K L+LS N ++ + NL+ + LS N L
Sbjct: 72 KL-----------------KKLELSENRIF-GGLDMLAEKLPNLTHLNLSGNKLKDISTL 113
Query: 318 ASLKNCQLLETLNMSHN--ALQGGIPGFLLGSFRNLKQL 354
LK + L++L++ + + L L
Sbjct: 114 EPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 23/96 (23%), Positives = 37/96 (38%), Gaps = 10/96 (10%)
Query: 443 LTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKT 502
L L L + G ++ S P P L+K+ L N + G + + NL
Sbjct: 45 TAEFVNLEFLSLINVGLI-SV-SNL---PKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99
Query: 503 IDLSFNSLAGPVPSEIW---SLPNLSDLVMWANNLT 535
++LS N L S + L L L ++ +T
Sbjct: 100 LNLSGNKLKD--ISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 20/85 (23%), Positives = 35/85 (41%), Gaps = 3/85 (3%)
Query: 714 IYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQG 773
+ LD ++ G + L+ L+L + L + + L + L+LS N G
Sbjct: 29 LVLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFG 85
Query: 774 SIPGSLGGLSFLSDLDVSNNNLSGI 798
+ L L+ L++S N L I
Sbjct: 86 GLDMLAEKLPNLTHLNLSGNKLKDI 110
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 7e-05
Identities = 24/115 (20%), Positives = 45/115 (39%), Gaps = 5/115 (4%)
Query: 472 NFPALEKIVLPNNYLSGTVPLELGS-CKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMW 530
A+ ++VL N + L + NL+ + L L S + LP L L +
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELS 79
Query: 531 ANNLTGEIPEGICVNGGNLETLILNNNHLTG-AIPKSIASCTNMLWVSLSSNQLT 584
N + G + + NL L L+ N L + + + + + L + ++T
Sbjct: 80 ENRIFG-GLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 46/238 (19%), Positives = 81/238 (34%), Gaps = 60/238 (25%)
Query: 936 IGSGGFGEVYKAQ------LRDGSVVAIKKLIHVTGQGDREF-----MAEMETIGKIKHR 984
IG GGFG +Y A + + +K G E A+ E I K
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 985 NLVPLLGYCKI----------GEERLLVYEYMKWG-SLESVLHDRAKGGGTKLDWAARK- 1032
+ LG K R ++ + G L+ + + A++
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKI-----------YEANAKRF 149
Query: 1033 ------KIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARV--SDFGMARLVNA 1084
++++ L ++H +H D+K+SN+LL+ +V D+G+A
Sbjct: 150 SRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206
Query: 1085 LDTHL-----SVSTLAGTPGYVPPE----YYQSFRCTTKGDVYSYGVILLELLSGKRP 1133
H GT + + S R GD+ G +++ L+G P
Sbjct: 207 EGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRR----GDLEILGYCMIQWLTGHLP 260
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 23/88 (26%), Positives = 44/88 (50%), Gaps = 4/88 (4%)
Query: 716 LDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSI 775
L L N + +P+ + +L +++L +N+++ SF + + L LS+N + I
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CI 93
Query: 776 P-GSLGGLSFLSDLDVSNNNLSGIIPSG 802
P + GL L L + N++S +P G
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDISV-VPEG 120
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 25/98 (25%), Positives = 48/98 (48%), Gaps = 8/98 (8%)
Query: 537 EIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGI-GNLV 595
+P+GI + L L+ N T +PK +++ ++ + LS+N+++ + N+
Sbjct: 24 VLPKGIPRDVTELY---LDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMT 78
Query: 596 KLAILQLGNNSLTGQVPQGL-GKCRSLVWLDLNSNNLS 632
+L L L N L +P +SL L L+ N++S
Sbjct: 79 QLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS 115
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 27/104 (25%), Positives = 46/104 (44%), Gaps = 6/104 (5%)
Query: 504 DLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAI 563
L N VP E+ + +L+ + + N ++ + N L TLIL+ N L I
Sbjct: 37 YLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-CI 93
Query: 564 PKSI-ASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNN 605
P ++ +SL N ++ +P G +L L+ L +G N
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 8e-06
Identities = 30/89 (33%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 707 FTTNGSLIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
+ L +DLS N +S TL F ++ L L L +N+L P +F GLK++ +L
Sbjct: 50 LSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLS 108
Query: 766 LSHNNFQGSIP-GSLGGLSFLSDLDVSNN 793
L N+ +P G+ LS LS L + N
Sbjct: 109 LHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 6e-08
Identities = 65/364 (17%), Positives = 110/364 (30%), Gaps = 112/364 (30%)
Query: 934 SMIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREF-MAEMETIGKIK--------H 983
+G G F V+ + ++ VA+K + + + E + E+ + ++
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMK--VVKSAEHYTETALDEIRLLKSVRNSDPNDPNR 100
Query: 984 RNLVPLLGYCKI----GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSA 1039
+V LL KI G +V+E + L + ++ G L KKI
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWII-KSNYQGLPLPCV--KKIIQQVL 156
Query: 1040 RGLAFLHHSCIPHIIHRDMKSSNVLL---------------------------------- 1065
+GL +LH C IIH D+K N+LL
Sbjct: 157 QGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 1066 ---------------DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFR 1110
E + +++D G A V+ T T Y E
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQYRSLEVLIGSG 269
Query: 1111 CTTKGDVYSYGVILLELLSGKR---PIDPSEFGDDN-------NLVG------WAK---- 1150
T D++S + EL +G P E+ D L+G
Sbjct: 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS 329
Query: 1151 --------QLHREKRIN-----EILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTM 1197
L ++ E+L + + +L L+ P KR T
Sbjct: 330 KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLL---PMLELIPEKRATA 386
Query: 1198 IQVM 1201
+ +
Sbjct: 387 AECL 390
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 8e-08
Identities = 46/239 (19%), Positives = 78/239 (32%), Gaps = 62/239 (25%)
Query: 936 IGSGGFGEVYKAQ---------LRDGSVVAIKKLIHVTGQGDREF-----MAEMETIGKI 981
G +Y+A ++ KL G+ E A+ + K
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSL-KLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 982 KHRNLVPLLGYCKI-------GEERLLVYEYMKWG-SLESVLHDRAKGGGTKLDWAARKK 1033
K PLL + R LV + G SL+S LD + +
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSA-----------LDVSPKHV 155
Query: 1034 --------IAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARV--SDFGMARLVN 1083
+A L FLH + +H ++ + N+ +D +++V + +G A
Sbjct: 156 LSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212
Query: 1084 ALDTHL-----SVSTLAGTPGYVPPE----YYQSFRCTTKGDVYSYGVILLELLSGKRP 1133
H+ S S G ++ + S R D+ S G +L+ L G P
Sbjct: 213 PSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRR----SDLQSLGYCMLKWLYGFLP 267
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 9e-08
Identities = 48/229 (20%), Positives = 76/229 (33%), Gaps = 45/229 (19%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKL---IHVTGQGDREF-----MAEMETIGKIKHRNL 986
IGSGGFG +Y A A + G E +A+ + I K R
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 987 VPLLGYCKI----------GEERLLVYEYMKWG-SLESVLHDRAKGGGTKLDWAARKKIA 1035
+ LG R +V E + G L+ + + ++
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNG-----TFKKSTVLQLG 157
Query: 1036 IGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARV--SDFGMARLVNALDTHL---- 1089
I L ++H + +H D+K++N+LL +V +D+G++ H
Sbjct: 158 IRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214
Query: 1090 -SVSTLAGTPGYVP----PEYYQSFRCTTKGDVYSYGVILLELLSGKRP 1133
GT + S R DV G +L L GK P
Sbjct: 215 NPRKGHNGTIEFTSLDAHKGVALSRR----SDVEILGYCMLRWLCGKLP 259
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 52.6 bits (125), Expect = 4e-07
Identities = 27/165 (16%), Positives = 55/165 (33%), Gaps = 20/165 (12%)
Query: 494 LGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICV-NGGNLETL 552
L + L + + + + PNL L + + L + E I + NLE L
Sbjct: 168 LDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKL 224
Query: 553 IL---NNNHLTGAIPKSIA------SCTNMLWVSLSSNQLTGEIPAGIGN---LVKLAIL 600
+L ++ N+ W+ + + + L +L +
Sbjct: 225 VLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETM 284
Query: 601 QLGNNSLTG----QVPQGLGKCRSLVWLDLNSNNLSGPLPSELAN 641
+ LT + + K + L ++++ N LS + EL
Sbjct: 285 DISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.5 bits (122), Expect = 9e-07
Identities = 34/230 (14%), Positives = 71/230 (30%), Gaps = 22/230 (9%)
Query: 373 CGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGS-----NMLSGNFLNTVVSKISSLIY 427
G + + + + L G +S + + ++
Sbjct: 114 IGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPL 173
Query: 428 LYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVL---PNN 484
L + + + L+ L++ S G ++ + P LEK+VL +
Sbjct: 174 LNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILG-SDLPNLEKLVLYVGVED 232
Query: 485 YLSGTVP------LELGSCKNLKTIDLSFNSLAGPVPSEIWS---LPNLSDLVMWANNLT 535
Y NLK + + V LP L + + A LT
Sbjct: 233 YGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLT 292
Query: 536 GEIPEGICVNGG---NLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQ 582
E + + +L+ + + N+L+ + K + M + +S +Q
Sbjct: 293 DEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMK-IDVSDSQ 341
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 47.6 bits (112), Expect = 2e-05
Identities = 31/192 (16%), Positives = 64/192 (33%), Gaps = 27/192 (14%)
Query: 202 QLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLS 261
Q+DLS + L + NL++ L ++++ L
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNL--------------KSLEIISGGLP 206
Query: 262 GEIPASFVADSSGSLKYLDLSHNNFTGKFSN--------LDFGRCGNLSVITLSQNGLSG 313
+ + +L+ L L F R NL + +
Sbjct: 207 DSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQN 266
Query: 314 TEFPASLKNCQL--LETLNMSHNALQG-GIPGFL--LGSFRNLKQLSLAHNQFAGEIPPE 368
L++ L LET+++S L G L + ++LK +++ +N + E+ E
Sbjct: 267 VVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKE 326
Query: 369 LGQACGTLRELD 380
L ++ ++
Sbjct: 327 LQKSLPMKIDVS 338
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.7 bits (107), Expect = 6e-05
Identities = 21/183 (11%), Positives = 48/183 (26%), Gaps = 23/183 (12%)
Query: 297 RCGNLSVITLSQNGLSG---TEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQ 353
I + +S + L LL L + NLK
Sbjct: 142 EGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIK----GTNNLSIGKKPRPNLKS 197
Query: 354 LSLAHNQFAGEIPPELGQA-CGTLRELDL---SSNRLTGELPSTFA------SCSSLHSL 403
L + + ++ + L +L L + + F +L L
Sbjct: 198 LEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWL 257
Query: 404 NLGSNMLSGNFLNTVVS--KISSLIYLYVPFNNIS--GPVPL--SLTNCTQLRVLDLSSN 457
+ + + + L + + ++ G L + L+ +++ N
Sbjct: 258 GIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYN 317
Query: 458 GFT 460
+
Sbjct: 318 YLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.9 bits (105), Expect = 1e-04
Identities = 25/160 (15%), Positives = 48/160 (30%), Gaps = 33/160 (20%)
Query: 88 TPCSWQGVSCSLNSHVTSLNLN--------NSGLSGSLNLTTLTALPYLEHLNLQGNSFS 139
+ + S ++ L L + ++ L + P L+ L +
Sbjct: 206 PDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQ 265
Query: 140 ---AGDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHI 196
S L TMD+S+ +T R L D++
Sbjct: 266 NVVVEMFLESDILP-QLETMDISAGVLTDE-GARLLLDHVDKIK---------------- 307
Query: 197 GPSLLQLDLSGNQISDSAL--LTYSLSNCQNLNLLNFSDN 234
L +++ N +SD L SL +++ D+
Sbjct: 308 --HLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQEYDD 345
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 38/139 (27%), Positives = 61/139 (43%), Gaps = 11/139 (7%)
Query: 496 SCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILN 555
SC + T++ VP+ I P + + N +P G+ +L L L
Sbjct: 6 SC-SGTTVECYSQGRTS-VPTGI---PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLG 60
Query: 556 NNHLTGAIPKSI-ASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNNSLTGQVPQ 613
N L ++P + T++ +++LS+NQL +P G+ L +L L L N L +P
Sbjct: 61 GNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPD 117
Query: 614 GL-GKCRSLVWLDLNSNNL 631
G+ K L L L N L
Sbjct: 118 GVFDKLTQLKDLRLYQNQL 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 33/98 (33%), Positives = 41/98 (41%), Gaps = 6/98 (6%)
Query: 715 YLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGS 774
YLDL NSL F L L L LG NKL F L ++ L+LS N Q
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSL 91
Query: 775 IPGSLGGLSFLSDLDVSNNNLSGIIPSG-----GQLTT 807
G L+ L +L ++ N L +P G QL
Sbjct: 92 PNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKD 128
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 37/140 (26%), Positives = 62/140 (44%), Gaps = 16/140 (11%)
Query: 496 SCKNLKTIDLSFNSLAGPVPSEIWSLP-NLSDLVMWANNLTGEIPEGICVNGGNLETLIL 554
C T+D + L +P +I P + ++L++ N L +G+ +L L L
Sbjct: 7 HC-EGTTVDCTGRGLKE-IPRDI---PLHTTELLLNDNELGRISSDGLFGRLPHLVKLEL 61
Query: 555 NNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNNSLTGQVPQ 613
N LTG P + +++ + L N++ EI + L +L L L +N ++ V
Sbjct: 62 KRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISC-VMP 119
Query: 614 G----LGKCRSLVWLDLNSN 629
G L SL L+L SN
Sbjct: 120 GSFEHLN---SLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 29/90 (32%), Positives = 41/90 (45%), Gaps = 4/90 (4%)
Query: 715 YLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQG 773
L L+ N L + FG L +L L L N+LTG P++F G I L L N +
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK- 91
Query: 774 SIP-GSLGGLSFLSDLDVSNNNLSGIIPSG 802
I GL L L++ +N +S + G
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQISC-VMPG 120
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 7e-05
Identities = 28/103 (27%), Positives = 45/103 (43%), Gaps = 2/103 (1%)
Query: 306 LSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEI 365
L+ N L L L + N L G I ++++L L N+ EI
Sbjct: 36 LNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKIK-EI 93
Query: 366 PPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSN 408
++ L+ L+L N+++ +P +F +SL SLNL SN
Sbjct: 94 SNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 9e-05
Identities = 25/83 (30%), Positives = 42/83 (50%), Gaps = 4/83 (4%)
Query: 713 LIYLDLSYNSLSGTLPEN-FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
L+ L+L N L+ + N F +++Q L LG NK+ F GL + L+L N
Sbjct: 56 LVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQI 114
Query: 772 QGSIP-GSLGGLSFLSDLDVSNN 793
+ GS L+ L+ L++++N
Sbjct: 115 S-CVMPGSFEHLNSLTSLNLASN 136
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 7e-07
Identities = 66/298 (22%), Positives = 104/298 (34%), Gaps = 62/298 (20%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIK--KLIHVTGQGDREFMAEMETIGKIKHRNLVP-LLG 991
IGSG FG++Y + G VAIK + Q E + + +P +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIES-KIYKMMQGGVG---IPTIRW 72
Query: 992 YCKIGEERLLVYEYMKWG-SLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCI 1050
G+ ++V E + G SLE + + ++ K +A + ++H
Sbjct: 73 CGAEGDYNVMVMELL--GPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSK-- 124
Query: 1051 PHIIHRDMKSSNVLL---DENFEARVSDFGMARLVNALDTHLSVST-----LAGTPGYVP 1102
+ IHRD+K N L+ + + DFG+A+ TH + L GT Y
Sbjct: 125 -NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
Query: 1103 P----EYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGW--AKQLHREK 1156
QS R D+ S G +L+ G P W K + +
Sbjct: 184 INTHLGIEQSRR----DDLESLGYVLMYFNLGSLP--------------WQGLKAATKRQ 225
Query: 1157 RINEILDPELTMQTSDET-------ELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207
+ I E M T E E YL C R +P + +F+ L
Sbjct: 226 KYERIS--EKKMSTPIEVLCKGYPSEFATYLNF---CRSLRFDDKPDYSYLRQLFRNL 278
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 31/96 (32%), Positives = 43/96 (44%), Gaps = 7/96 (7%)
Query: 538 IPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGI-GNLVK 596
+P GI + L L +N L T + +SLS NQ+ +P G+ L K
Sbjct: 22 VPTGIPSS---ATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK 77
Query: 597 LAILQLGNNSLTGQVPQGL-GKCRSLVWLDLNSNNL 631
L IL L N L +P G+ K L L L++N L
Sbjct: 78 LTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQL 112
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 26/89 (29%), Positives = 37/89 (41%), Gaps = 3/89 (3%)
Query: 715 YLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGS 774
L+L N L F L L L+L N++ F L + +L L N Q S
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-S 90
Query: 775 IP-GSLGGLSFLSDLDVSNNNLSGIIPSG 802
+P G L+ L +L + N L +P G
Sbjct: 91 LPNGVFDKLTQLKELALDTNQLKS-VPDG 118
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-05
Identities = 63/345 (18%), Positives = 104/345 (30%), Gaps = 114/345 (33%)
Query: 934 SMIGSGGFGEVYKA--QLRDGSVVAIKKLIHV---TGQGDRE-----FMAEMETIGKIK- 982
+G G FG+V + R S VA+K + +V E + E + K
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 983 --------HRN---LV-PLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAA 1030
+ LLG +E++K +
Sbjct: 85 VLMSDWFNFHGHMCIAFELLGKN--------TFEFLK------------ENNFQPYPLPH 124
Query: 1031 RKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEA------------------- 1071
+ +A L FLH + + H D+K N+L +
Sbjct: 125 VRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181
Query: 1072 RVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE-----YYQSFRCTTKGDVYSYGVILLE 1126
RV+DFG +A H +T+ T Y PPE + + C DV+S G IL E
Sbjct: 182 RVADFG-----SATFDHEHHTTIVATRHYRPPEVILELGW-AQPC----DVWSIGCILFE 231
Query: 1127 LLSGKRPIDPSEFGDDNN--------LVG----------------------WAKQLHREK 1156
G + +N ++G W + +
Sbjct: 232 YYRGF-TLFQ---THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGR 287
Query: 1157 RINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVM 1201
+ E P + D E Q + L+ P +R T+ + +
Sbjct: 288 YVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEAL 332
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 49/222 (22%), Positives = 83/222 (37%), Gaps = 46/222 (20%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVP-LLGYC 993
IG G FGE+ + L VAIK + + E ++ + +P + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK--LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 994 KIGEERLLVYEYMKWG-SLESVLHDRAKGGGTKLDWAARK-------KIAIGSARGLAFL 1045
G+ +V E + G SLE + D R IAI + ++
Sbjct: 75 PCGKYNAMVLELL--GPSLEDLF-----------DLCDRTFSLKTVLMIAIQLISRMEYV 121
Query: 1046 HHSCIPHIIHRDMKSSNVLL--DENFEAR---VSDFGMARLVNALDTHLSVS-----TLA 1095
H ++I+RD+K N L+ N + + DF +A+ +T + +L
Sbjct: 122 HSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLT 178
Query: 1096 GTPGYVPP----EYYQSFRCTTKGDVYSYGVILLELLSGKRP 1133
GT Y+ QS R D+ + G + + L G P
Sbjct: 179 GTARYMSINTHLGKEQSRR----DDLEALGHMFMYFLRGSLP 216
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Length = 176 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 16/104 (15%), Positives = 38/104 (36%), Gaps = 15/104 (14%)
Query: 142 DLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNS---------ISGG 192
L T + +D + + I G + + + L +S
Sbjct: 52 HLPTGPLDKYKIQAIDATDSCIMSI--GFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQL 109
Query: 193 SLHIGPSLLQLDLSGN-QISDSALLTYSLSNCQNLNLLNFSDNK 235
++ S+L++++ ++D ++ +L + +NL L SD
Sbjct: 110 E-NLQKSMLEMEIISCGNVTDKGII--ALHHFRNLKYLFLSDLP 150
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 27/117 (23%), Positives = 42/117 (35%), Gaps = 8/117 (6%)
Query: 198 PSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSY 257
S LDL G + + + LN + + L N + +++LS
Sbjct: 127 GSQQALDLKGLRSDP---DLVAQNIDVVLNRRSC----MAATLRIIEENIPELLSLNLSN 179
Query: 258 NLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGT 314
N L S + + +LK L+LS N LD + L + L N L T
Sbjct: 180 NRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLCDT 235
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 5e-05
Identities = 67/306 (21%), Positives = 111/306 (36%), Gaps = 72/306 (23%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVP-LLGYC 993
IGSG FGE+Y ++ VAIK + + E + ++ +P + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLEN--VKTKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 994 KIGEERLLVYEYMKWG-SLESVLHDRAKGGGTKLDWAARK-------KIAIGSARGLAFL 1045
G+ +LV + + G SLE + ++ +RK +A + F+
Sbjct: 73 VEGDYNVLVMDLL--GPSLEDL-----------FNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 1046 HHSCIPHIIHRDMKSSNVLLDENFEAR---VSDFGMARLVNALDTHLSVS-----TLAGT 1097
H +HRD+K N L+ A + DFG+A+ TH + L GT
Sbjct: 120 HSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176
Query: 1098 PGYVPP----EYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGW--AKQ 1151
Y QS R D+ S G +L+ L G P W K
Sbjct: 177 ARYASVNTHLGIEQSRR----DDLESLGYVLMYFLRGSLP--------------WQGLKA 218
Query: 1152 LHREKRINEILDPELTMQTSDET-------ELYQYLRISFECLDDRPFKRPTMIQVMAMF 1204
++++ +I E + TS E E Y C R +P + +F
Sbjct: 219 GTKKQKYEKIS--EKKVATSIEALCRGYPTEFASYFHY---CRSLRFDDKPDYSYLKRLF 273
Query: 1205 KELQVD 1210
++L +
Sbjct: 274 RDLFIR 279
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 5e-05
Identities = 46/287 (16%), Positives = 85/287 (29%), Gaps = 106/287 (36%)
Query: 934 SMIGSGGFGEVYKAQ-LRDGSVVAIKKLIHV---TGQGDREFMAEMETIGKIK------- 982
+G G FG V Q + + A+K + ++ T E + + KI+
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNN 96
Query: 983 ----------HRN---LV-PLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDW 1028
+ + L+ LG +YE + +
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPLGPS--------LYEIIT------------RNNYNGFHI 136
Query: 1029 AARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEA----------------- 1071
K I + L +L + H D+K N+LLD+ +
Sbjct: 137 EDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193
Query: 1072 --------RVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE------YYQSFRCTTKGDV 1117
++ DFG A ++ T Y PE + D+
Sbjct: 194 YRTKSTGIKLIDFG-----CATFKSDYHGSIINTRQYRAPEVILNLGW--DVSS----DM 242
Query: 1118 YSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDP 1164
+S+G +L EL +G + ++ + L + I+ P
Sbjct: 243 WSFGCVLAELYTGS-LLFR---THEHM-----EHL---AMMESIIQP 277
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 28/150 (18%), Positives = 55/150 (36%), Gaps = 24/150 (16%)
Query: 100 NSHVTSLNLNNS---GLSGSLNL-TTLTALPYLEHLNLQGNSFS---AGDLSTSKTSSCS 152
+ + +NLNN + L Y++ ++ G + A L+ + +
Sbjct: 35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNT 94
Query: 153 LVTMDLSSNNITGSLPG----RSFLLSCDRLSYVNLSHNSISGG---------SLHIGPS 199
L ++++ SN I+GS G L S L + + + S G L +
Sbjct: 95 LKSLNVESNFISGS--GILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTT 152
Query: 200 LLQLDLSGNQISDSALLTYSLSNCQNLNLL 229
LL+ Q + ++ N N +L+
Sbjct: 153 LLKFGYHFTQQGPRLRASNAMMN--NNDLV 180
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 30/164 (18%), Positives = 56/164 (34%), Gaps = 39/164 (23%)
Query: 320 LKNCQLLETLNMSHNALQGGIPGF-----LLGSFRNLKQLSLAHNQFAGEIPPELGQAC- 373
N LE +N++ N + +P L + +K+ S+ + + L +
Sbjct: 32 QNNDPDLEEVNLN-NIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLK 90
Query: 374 --GTLRELDLSSNRLTGE----LPSTFASCSSLHSLNLGSN--------------MLSGN 413
TL+ L++ SN ++G L S +SL L + + ML N
Sbjct: 91 VNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKN 150
Query: 414 FLNTVVSKISSLIYLYVPFNNISGPVPLS---LTNCTQLRVLDL 454
++L+ F + S + N +R L
Sbjct: 151 ---------TTLLKFGYHFTQQGPRLRASNAMMNNNDLVRKRRL 185
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 34/112 (30%), Positives = 52/112 (46%), Gaps = 9/112 (8%)
Query: 496 SCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILN 555
SC + ++ LA VP+ I + L + N +T ++ G+ + NL+ L N
Sbjct: 11 SC-DQTLVNCQNIRLAS-VPAGI--PTDKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFN 65
Query: 556 NNHLTGAIPKSI-ASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNN 605
+N LT AIP + T + + L+ N L IP G NL L + L NN
Sbjct: 66 SNKLT-AIPTGVFDKLTQLTQLDLNDNHLKS-IPRGAFDNLKSLTHIYLYNN 115
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 38/112 (33%), Positives = 54/112 (48%), Gaps = 9/112 (8%)
Query: 496 SCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILN 555
SC + T+D S SLA VP+ I L ++ N +T ++ G+ L L L+
Sbjct: 8 SC-SGTTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLD 62
Query: 556 NNHLTGAIPKSI-ASCTNMLWVSLSSNQLTGEIPAGI-GNLVKLAILQLGNN 605
NN LT +P + T + +SL+ NQL IP G NL L + L NN
Sbjct: 63 NNQLT-VLPAGVFDKLTQLTQLSLNDNQLKS-IPRGAFDNLKSLTHIWLLNN 112
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 49/224 (21%), Positives = 78/224 (34%), Gaps = 50/224 (22%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIK--KLIHVTGQGDREFMAEMETIGKIKHRNLVP-LLG 991
IG G FG +++ L + VAIK Q E+ + + +P +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEY-RTYKLLAGCTG---IPNVYY 73
Query: 992 YCKIGEERLLVYEYMKWG-SLESVLHDRAKGGGTKLDWAARK-------KIAIGSARGLA 1043
+ + G +LV + + G SLE + LD RK A +
Sbjct: 74 FGQEGLHNVLVIDLL--GPSLEDL-----------LDLCGRKFSVKTVAMAAKQMLARVQ 120
Query: 1044 FLHHSCIPHIIHRDMKSSNVLLDENFEAR-----VSDFGMARLVNALDTHL-----SVST 1093
+H +++RD+K N L+ V DFGM + T
Sbjct: 121 SIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 177
Query: 1094 LAGTPGYVPPE----YYQSFRCTTKGDVYSYGVILLELLSGKRP 1133
L+GT Y+ QS R D+ + G + + L G P
Sbjct: 178 LSGTARYMSINTHLGREQSRR----DDLEALGHVFMYFLRGSLP 217
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 63/345 (18%), Positives = 108/345 (31%), Gaps = 114/345 (33%)
Query: 934 SMIGSGGFGEVYKAQ--LRDGSVVAIKKLIHV---TGQGDRE-----FMAEMETIGKIK- 982
+G G FG+V + G VA+K + +V E + + +
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 983 --------HRN---LV-PLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAA 1030
H +V LLG Y+++K + G
Sbjct: 80 VQMLEWFEHHGHICIVFELLGLS--------TYDFIK------------ENGFLPFRLDH 119
Query: 1031 RKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEA------------------- 1071
+K+A + + FLH + + H D+K N+L ++
Sbjct: 120 IRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 1072 RVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE-----YYQSFRCTTKGDVYSYGVILLE 1126
+V DFG +A STL T Y PE + S C DV+S G IL+E
Sbjct: 177 KVVDFG-----SATYDDEHHSTLVSTRHYRAPEVILALGW-SQPC----DVWSIGCILIE 226
Query: 1127 LLSGKRPIDPSEFGDDNN--------LVG----------------------WAKQLHREK 1156
G + P D+ ++G W + +
Sbjct: 227 YYLGF-TVFP---THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGR 282
Query: 1157 RINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVM 1201
++ P S + E + + + L+ P KR T+ + +
Sbjct: 283 YVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREAL 327
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 2e-04
Identities = 73/466 (15%), Positives = 132/466 (28%), Gaps = 152/466 (32%)
Query: 10 LSQDQQQQGKGIMGIFGF----------------------VLWL----------LL---- 33
L + + + I G+ G + WL +L
Sbjct: 144 LLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQ 203
Query: 34 -LCHLLIMPSYARELSSSS----RQSGGNEELTILMAFKQSSIGSDPNGYL------ANW 82
L + I P++ SS R EL L+ K N L
Sbjct: 204 KLLY-QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY-----ENCLLVLLNVQNAK 257
Query: 83 TADALTPCSWQGVSC-SLNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAG 141
+A +SC L +T+ ++ L+ T T + L+H ++ + +
Sbjct: 258 AWNAF------NLSCKIL---LTT---RFKQVTDFLSAATTTHIS-LDHHSM---TLTPD 301
Query: 142 DLST--SKTSSCSLVTMDLSSNNITG-----SLPG---RSFLLSCDRLSYVNLS-HNSIS 190
++ + K C DL +T S+ R L + D +VN +I
Sbjct: 302 EVKSLLLKYLDCR--PQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTII 359
Query: 191 GGSL-HIGPSLLQ---LDLS----GNQISDSALLTY-----------SLSNCQNLNLLNF 231
SL + P+ + LS I L ++ +L+
Sbjct: 360 ESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVE- 418
Query: 232 SDNK-----LPG---KLNATSVNCKSI--STIDLSYNLLSGEIPASFVADSSGS------ 275
K +P +L N ++ S +D YN+ +
Sbjct: 419 KQPKESTISIPSIYLELKVKLENEYALHRSIVD-HYNIPKTFDSDDLIPPYLDQYFYSHI 477
Query: 276 ---LKYLDLSH--NNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLN 330
LK ++ F F + F + + + N S+ N L+ L
Sbjct: 478 GHHLKNIEHPERMTLFRMVFLDFRFLE-QKIRHDSTAWNA------SGSILN--TLQQLK 528
Query: 331 M----------SHNALQGGIPGFLL--------GSFRNLKQLSLAH 358
+ L I FL + +L +++L
Sbjct: 529 FYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMA 574
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1237 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-70 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-66 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-59 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-57 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-56 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-51 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-49 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-48 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-37 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-31 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-22 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-20 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-06 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-22 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-15 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-12 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-11 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-08 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-07 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-08 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 3e-07 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 7e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.001 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 9e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 8e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (599), Expect = 2e-70
Identities = 75/276 (27%), Positives = 131/276 (47%), Gaps = 23/276 (8%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI 995
IGSG FG VYK + V + + T Q + F E+ + K +H N++ +GY
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 74
Query: 996 GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIH 1055
+ +V ++ + SL LH TK + IA +A+G+ +LH IIH
Sbjct: 75 APQLAIVTQWCEGSSLYHHLHII----ETKFEMIKLIDIARQTAQGMDYLHA---KSIIH 127
Query: 1056 RDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRC---T 1112
RD+KS+N+ L E+ ++ DFG+A + + L+G+ ++ PE + +
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 1113 TKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSD 1172
+ DVY++G++L EL++G+ P + + NN + R L P+L+ S+
Sbjct: 188 FQSDVYAFGIVLYELMTGQLP-----YSNINNRDQIIFMVGR-----GYLSPDLSKVRSN 237
Query: 1173 ETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208
+ R+ ECL + +RP Q++A + L
Sbjct: 238 CPK--AMKRLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 8e-66
Identities = 71/277 (25%), Positives = 128/277 (46%), Gaps = 25/277 (9%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI 995
+G+G FGEV+ + VA+K + F+AE + +++H+ LV L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-T 78
Query: 996 GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIH 1055
E ++ EYM+ GSL L G KL +A A G+AF+ + IH
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIH 132
Query: 1056 RDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKG 1115
RD++++N+L+ + +++DFG+ARL+ + + + + PE T K
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 1116 DVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETE 1175
DV+S+G++L E+++ R P + ++ ++ +R R + + E
Sbjct: 192 DVWSFGILLTEIVTHGRI--PYPGMTNPEVIQNLERGYRMVRPDNCPE-----------E 238
Query: 1176 LYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTE 1212
LYQ +R C +RP RPT + ++ ++ TE
Sbjct: 239 LYQLMR---LCWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 4e-64
Identities = 66/294 (22%), Positives = 116/294 (39%), Gaps = 29/294 (9%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYC-- 993
IG G FGEV++ + R G VA+K + AE+ ++H N++ +
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 994 --KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCI- 1050
+ LV +Y + GSL L+ + K+A+ +A GLA LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 1051 ----PHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSV--STLAGTPGYVPPE 1104
P I HRD+KS N+L+ +N ++D G+A ++ + + + GT Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 1105 YYQS------FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGD----DNNLVGWAKQLHR 1154
F + D+Y+ G++ E+ E D + + R
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 1155 EKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208
+ + L P + + L +I EC R T +++ +L
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 1e-63
Identities = 73/273 (26%), Positives = 114/273 (41%), Gaps = 25/273 (9%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI 995
IGSG FG V+ + VAIK I + +F+ E E + K+ H LV L G C
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 996 GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIH 1055
LV+E+M+ G L L + + + G + + +IH
Sbjct: 72 QAPICLVFEFMEHGCLSDYLRTQRG----LFAAETLLGMCLDVCEG---MAYLEEACVIH 124
Query: 1056 RDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKG 1115
RD+ + N L+ EN +VSDFGM R V S T + PE + R ++K
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEVFSFSRYSSKS 183
Query: 1116 DVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETE 1175
DV+S+GV++ E+ S + P E ++ +V R + P L
Sbjct: 184 DVWSFGVLMWEVFSEGKI--PYENRSNSEVVEDISTGFR------LYKPRLAST-----H 230
Query: 1176 LYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208
+YQ + C +RP RP +++ E+
Sbjct: 231 VYQIMN---HCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 7e-61
Identities = 60/272 (22%), Positives = 115/272 (42%), Gaps = 25/272 (9%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI 995
+G+G FG V + R VAIK I + EF+ E + + + H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKM-IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 996 GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIH 1055
++ EYM G L + L + + ++ + +L +H
Sbjct: 71 QRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLES---KQFLH 123
Query: 1056 RDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKG 1115
RD+ + N L+++ +VSDFG++R V + SV + + PPE + ++K
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS-KFPVRWSPPEVLMYSKFSSKS 182
Query: 1116 DVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETE 1175
D++++GV++ E+ S + P E ++ + I + L S++
Sbjct: 183 DIWAFGVLMWEIYSLGKM--PYERFTNSETA---------EHIAQGLRLYRPHLASEK-- 229
Query: 1176 LYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207
I + C ++ +RPT +++ ++
Sbjct: 230 ---VYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 2e-60
Identities = 69/274 (25%), Positives = 122/274 (44%), Gaps = 31/274 (11%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKI 995
IG G FG+V R G+ VA+K + + + F+AE + +++H NLV LLG
Sbjct: 15 IGKGEFGDVMLGDYR-GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 996 GEERL-LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHII 1054
+ L +V EYM GSL L R G + L K ++ + +L + +
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFV 125
Query: 1055 HRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTK 1114
HRD+ + NVL+ E+ A+VSDFG+ + ++ T + PE + + +TK
Sbjct: 126 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTK 180
Query: 1115 GDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDET 1174
DV+S+G++L E+ S R P ++V R+ + +
Sbjct: 181 SDVWSFGILLWEIYSFGRV--PYPRIPLKDVV---------PRVEKGYKMDAPDGCPP-- 227
Query: 1175 ELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208
+Y+ ++ C RP+ +Q+ + ++
Sbjct: 228 AVYEVMK---NCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 206 bits (526), Expect = 3e-60
Identities = 72/306 (23%), Positives = 131/306 (42%), Gaps = 40/306 (13%)
Query: 919 TFAHLLEATNGFSA---------DSMIGSGGFGEVYKAQLR----DGSVVAIKKL-IHVT 964
TF EA F+ + +IG+G FGEV L+ VAIK L T
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 965 GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGT 1024
+ R+F++E +G+ H N++ L G +++ E+M+ GSL+S L
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG---- 123
Query: 1025 KLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN- 1083
+ + G A G+ +L + +HRD+ + N+L++ N +VSDFG++R +
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 1084 --ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGD 1141
+ T+ S + PE Q + T+ DV+SYG+++ E++S P
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER--PYWDMT 238
Query: 1142 DNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVM 1201
+ +++ +Q +R + L+Q + +C RP Q++
Sbjct: 239 NQDVINAIEQDYRLPPPMDCPS-----------ALHQLML---DCWQKDRNHRPKFGQIV 284
Query: 1202 AMFKEL 1207
++
Sbjct: 285 NTLDKM 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 206 bits (525), Expect = 4e-60
Identities = 74/299 (24%), Positives = 126/299 (42%), Gaps = 47/299 (15%)
Query: 936 IGSGGFGEVYKAQLR------DGSVVAIKKL-IHVTGQGDREFMAEMETIGKIKHRNLVP 988
IG G FG V++A+ ++VA+K L + +F E + + + N+V
Sbjct: 21 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 80
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDR-------------------AKGGGTKLDWA 1029
LLG C +G+ L++EYM +G L L + G L A
Sbjct: 81 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 140
Query: 1030 ARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHL 1089
+ IA A G+A+L +HRD+ + N L+ EN +++DFG++R + + D +
Sbjct: 141 EQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 197
Query: 1090 SVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWA 1149
+ A ++PPE R TT+ DV++YGV+L E+ S
Sbjct: 198 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG------------ 245
Query: 1150 KQLHREKRINEILDPELTMQTSDET-ELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207
+ E+ I + D + + ELY +R C P RP+ + + + +
Sbjct: 246 --MAHEEVIYYVRDGNILACPENCPLELYNLMR---LCWSKLPADRPSFCSIHRILQRM 299
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 6e-60
Identities = 72/283 (25%), Positives = 119/283 (42%), Gaps = 25/283 (8%)
Query: 930 FSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPL 989
+ +G G FGEV+ + VAIK + F+ E + + K++H LV L
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKT-LKPGTMSPEAFLQEAQVMKKLRHEKLVQL 77
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC 1049
E +V EYM GSL L G L +A A G+A++
Sbjct: 78 YAVVSE-EPIYIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVER-- 131
Query: 1050 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSF 1109
+ +HRD++++N+L+ EN +V+DFG+ARL+ + + + + PE
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYG 189
Query: 1110 RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQ 1169
R T K DV+S+G++L EL + R P G N V ++ +
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYP---GMVNREV--------LDQVERGYRMPCPPE 238
Query: 1170 TSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTE 1212
+ L+ + +C P +RPT + A ++ TE
Sbjct: 239 CPE--SLHDLMC---QCWRKEPEERPTFEYLQAFLEDYFTSTE 276
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 1e-59
Identities = 74/288 (25%), Positives = 124/288 (43%), Gaps = 31/288 (10%)
Query: 935 MIGSGGFGEVYKAQLRDGS----VVAIKKLIHVTGQGD-REFMAEMETIGKIKHRNLVPL 989
+IG G FG VY L D A+K L +T G+ +F+ E + H N++ L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 990 LGYCKIGEER-LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHS 1048
LG C E L+V YMK G L + + + + A+G+
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGM---KFL 146
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV--NALDTHLSVSTLAGTPGYVPPEYY 1106
+HRD+ + N +LDE F +V+DFG+AR + D+ + + ++ E
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 1107 QSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166
Q+ + TTK DV+S+GV+L EL++ P D N L + +R +L PE
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPEY 258
Query: 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGD 1214
LY+ + +C + RP+ ++++ + G+
Sbjct: 259 CPD-----PLYEVML---KCWHPKAEMRPSFSELVSRISAIFSTFIGE 298
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 4e-59
Identities = 63/305 (20%), Positives = 116/305 (38%), Gaps = 39/305 (12%)
Query: 926 ATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKH 983
+ F S +G+G G V+K + G V+A K + R + E++ + +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 984 RNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLA 1043
+V G E + E+M GSL+ VL ++ K++I +GL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLT 118
Query: 1044 FLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPP 1103
+L I+HRD+K SN+L++ E ++ DFG++ + + + GT Y+ P
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSP 172
Query: 1104 EYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163
E Q + + D++S G+ L+E+ G+ PI P + + + G + +
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 1164 PELTMQTSDETELYQYLRISFE--------------------------CLDDRPFKRPTM 1197
P + + CL P +R +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 1198 IQVMA 1202
Q+M
Sbjct: 293 KQLMV 297
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 1e-58
Identities = 67/283 (23%), Positives = 121/283 (42%), Gaps = 29/283 (10%)
Query: 933 DSMIGSGGFGEVYKAQLR---DGSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLVP 988
D +G G FG V + R VAIK L T + D E M E + + ++ + +V
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHS 1048
L+G C+ E +LV E G L L + + ++ + ++ + G+ +L
Sbjct: 74 LIGVCQ-AEALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEE- 127
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSV-STLAGTPGYVPPEYYQ 1107
+ +HRD+ + NVLL A++SDFG+++ + A D++ + S + PE
Sbjct: 128 --KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 185
Query: 1108 SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELT 1167
+ +++ DV+SYGV + E LS + P + ++ + +Q R + E
Sbjct: 186 FRKFSSRSDVWSYGVTMWEALSYGQK--PYKKMKGPEVMAFIEQGKRMECPPECPP---- 239
Query: 1168 MQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVD 1210
ELY + +C + RP + V +
Sbjct: 240 -------ELYALMS---DCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 199 bits (507), Expect = 7e-58
Identities = 76/331 (22%), Positives = 142/331 (42%), Gaps = 49/331 (14%)
Query: 902 EPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKL 960
+P S N +E +T H +G G +GEVY+ + VA+K
Sbjct: 3 DPSSPNYDKWEMERTDITMKHK------------LGGGQYGEVYEGVWKKYSLTVAVKT- 49
Query: 961 IHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAK 1020
+ EF+ E + +IKH NLV LLG C ++ E+M +G+L L + +
Sbjct: 50 LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 109
Query: 1021 GGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1080
++ +A + + +L + IHRD+ + N L+ EN +V+DFG++R
Sbjct: 110 Q---EVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSR 163
Query: 1081 LVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFG 1140
L+ DT+ + + + PE + + K DV+++GV+L E+ + P
Sbjct: 164 LMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-- 220
Query: 1141 DDNNLVGWAKQLHREKRINEILDPELTMQTSDET--ELYQYLRISFECLDDRPFKRPTMI 1198
++ E+L+ + M+ + ++Y+ +R C P RP+
Sbjct: 221 -------------DLSQVYELLEKDYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFA 264
Query: 1199 QVMAMFKELQVDTEGDSLDSFSLKDTVIEEL 1229
++ F+ + ++ S+ D V +EL
Sbjct: 265 EIHQAFETMFQES--------SISDEVEKEL 287
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 1e-57
Identities = 72/295 (24%), Positives = 125/295 (42%), Gaps = 43/295 (14%)
Query: 936 IGSGGFGEVYKAQLR------DGSVVAIKKLIHVTGQGDRE-FMAEMETIGKIK-HRNLV 987
+G+G FG+V +A VA+K L +RE M+E++ + + H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 988 PLLGYCKIGEERLLVYEYMKWGSLESVLHDR-------------AKGGGTKLDWAARKKI 1034
LLG C IG L++ EY +G L + L + + LD
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 1035 AIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTL 1094
+ A+G+AFL + IHRD+ + N+LL ++ DFG+AR + ++
Sbjct: 151 SYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 1095 AGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR 1154
++ PE + T + DV+SYG+ L EL S P +
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG--------------MPV 253
Query: 1155 EKRINEILDPELTMQTSDE--TELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207
+ + +++ M + + E+Y ++ C D P KRPT Q++ + ++
Sbjct: 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 3e-57
Identities = 77/326 (23%), Positives = 136/326 (41%), Gaps = 48/326 (14%)
Query: 928 NGFSADSMIGSGGFGEVYKAQLRDGS---VVAIKKL-IHVTGQGDREFMAEMETIGKI-K 982
N +IG G FG+V KA+++ AIK++ + + R+F E+E + K+
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 983 HRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDR-----------AKGGGTKLDWAAR 1031
H N++ LLG C+ L EY G+L L A + L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 1032 KKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSV 1091
A ARG+ + IHRD+ + N+L+ EN+ A+++DFG++R + ++
Sbjct: 130 LHFAADVARGM---DYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183
Query: 1092 STLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQ 1151
+ ++ E TT DV+SYGV+L E++S ++
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELYEK 238
Query: 1152 LHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDT 1211
L + R E + D E+Y +R +C ++P++RP+ Q++ + +
Sbjct: 239 LPQGYR------LEKPLNCDD--EVYDLMR---QCWREKPYERPSFAQILVSLNRMLEE- 286
Query: 1212 EGDSLDSFSLKDTVIEELRERESSSG 1237
K V L E+ + +G
Sbjct: 287 ---------RKTYVNTTLYEKFTYAG 303
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 8e-57
Identities = 58/273 (21%), Positives = 119/273 (43%), Gaps = 30/273 (10%)
Query: 936 IGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCK 994
+G G FG+VYKAQ ++ + A K + + + ++M E++ + H N+V LL
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 995 IGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHII 1054
++ E+ G++++V+ + + L + + + + L +LH + II
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELER----PLTESQIQVVCKQTLDALNYLHDN---KII 132
Query: 1055 HRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRC--- 1111
HRD+K+ N+L + + +++DFG++ + GTP ++ PE
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKDR 190
Query: 1112 --TTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQ 1169
K DV+S G+ L+E+ + P + N + ++ + +E +
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPP-----HHELNPM-----RVLLKIAKSEPPTLAQPSR 240
Query: 1170 TSDETELYQYLRISFECLDDRPFKRPTMIQVMA 1202
S +L+ +CL+ R T Q++
Sbjct: 241 WSS--NFKDFLK---KCLEKNVDARWTTSQLLQ 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-56
Identities = 65/273 (23%), Positives = 115/273 (42%), Gaps = 27/273 (9%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKL--IHVTGQGDREFMAEMETIGKIKHRNLVPLLGY 992
IG+G +G K + + DG ++ K+L +T + ++E+ + ++KH N+V
Sbjct: 12 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 71
Query: 993 CKIGEERLL--VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLH--HS 1048
L V EY + G L SV+ K LD ++ L H
Sbjct: 72 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY-LDEEFVLRVMTQLTLALKECHRRSD 130
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQS 1108
++HRD+K +NV LD ++ DFG+AR++N + GTP Y+ PE
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGTPYYMSPEQMNR 188
Query: 1109 FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTM 1168
K D++S G +L EL + P + A ++ K +
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPPF------TAFSQKELAGKIREGKF------RRIPY 236
Query: 1169 QTSDETELYQYLRISFECLDDRPFKRPTMIQVM 1201
+ SD EL + + L+ + + RP++ +++
Sbjct: 237 RYSD--ELNEIIT---RMLNLKDYHRPSVEEIL 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 1e-56
Identities = 65/295 (22%), Positives = 117/295 (39%), Gaps = 44/295 (14%)
Query: 935 MIGSGGFGEVYKAQLRDGS------VVAIKKLIHVTGQGDRE-FMAEMETIGKI-KHRNL 986
++GSG FG+V A S VA+K L +RE M+E++ + ++ H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 987 VPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAK------------------GGGTKLDW 1028
V LLG C + L++EY +G L + L + + L +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 1029 AARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088
A A+G+ FL +HRD+ + NVL+ ++ DFG+AR + + +
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 1089 LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGW 1148
+ ++ PE T K DV+SYG++L E+ S + +
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP----YPGIPVDANF 276
Query: 1149 AKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203
K + + + ++ E+Y ++ C KRP+ + +
Sbjct: 277 YKLIQNGFK------MDQPFYATE--EIYIIMQ---SCWAFDSRKRPSFPNLTSF 320
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 2e-56
Identities = 61/286 (21%), Positives = 113/286 (39%), Gaps = 33/286 (11%)
Query: 933 DSMIGSGGFGEVYKAQLRD---GSVVAIKKLIHVTGQGD--REFMAEMETIGKIKHRNLV 987
D +GSG FG V K + VA+K L + E +AE + ++ + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 988 PLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH 1047
++G C+ E +LV E + G L L + ++ + G+ +L
Sbjct: 72 RMIGICEA-ESWMLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEE 125
Query: 1048 SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVST-LAGTPGYVPPEYY 1106
S + +HRD+ + NVLL A++SDFG+++ + A + + T + PE
Sbjct: 126 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 1107 QSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPE 1165
++ ++K DV+S+GV++ E S G++P + ++ + +
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKP-----YRGMKG-----SEVT--AMLEKGERMG 230
Query: 1166 LTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDT 1211
E+Y + C RP V + D
Sbjct: 231 CPAGCPR--EMYDLMN---LCWTYDVENRPGFAAVELRLRNYYYDV 271
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 9e-56
Identities = 64/277 (23%), Positives = 111/277 (40%), Gaps = 34/277 (12%)
Query: 933 DSMIGSGGFGEVYKAQLRD-GSVVAIKKLI--HVTGQGDREFMAEMETIGKIKHRNLVPL 989
D IG G F VYK + VA +L +T + F E E + ++H N+V
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 990 LGYC----KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFL 1045
K + +LV E M G+L++ L + + +GL FL
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFL 128
Query: 1046 HHSCIPHIIHRDMKSSNVLL-DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE 1104
H P IIHRD+K N+ + ++ D G+A L A + GTP ++ PE
Sbjct: 129 HTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMAPE 183
Query: 1105 YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDP 1164
Y+ + DVY++G+ +LE+ + + P SE + + + +++ P
Sbjct: 184 MYEE-KYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRVTSGVKPASFDKVAIP 240
Query: 1165 ELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVM 1201
E+ I C+ +R ++ ++
Sbjct: 241 EV-------------KEIIEGCIRQNKDERYSIKDLL 264
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 1e-55
Identities = 64/298 (21%), Positives = 126/298 (42%), Gaps = 32/298 (10%)
Query: 930 FSADSMIGSGGFGEVYKAQLRDGS-----VVAIKKLIHVTGQGDR-EFMAEMETIGKIKH 983
+ +IG+G FGEVYK L+ S VAIK L + R +F+ E +G+ H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 984 RNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLA 1043
N++ L G + +++ EYM+ G+L+ L ++ + + G A G+
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGM- 123
Query: 1044 FLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVST-LAGTPGYVP 1102
+ + +HRD+ + N+L++ N +VSDFG++R++ ++ +
Sbjct: 124 --KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 1103 PEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162
PE + T+ DV+S+G+++ E+++ + K IN+
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-----------MKAINDGF 230
Query: 1163 DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGDSLDSFS 1220
M ++ +C +RP ++++ +L DSL + +
Sbjct: 231 RLPTPMDCPSA-----IYQLMMQCWQQERARRPKFADIVSILDKLIRAP--DSLKTLA 281
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (488), Expect = 5e-55
Identities = 68/273 (24%), Positives = 116/273 (42%), Gaps = 37/273 (13%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGD---REFMAEMETIGKIKHRNLVPLLG 991
IG G FG VY A+ +R+ VVAIKK+ + Q + ++ + E+ + K++H N + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 992 YCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIP 1051
LV EY + + + + L + G+ +GLA+LH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSH--- 134
Query: 1052 HIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSF-- 1109
++IHRD+K+ N+LL E ++ DFG A ++ ++ GTP ++ PE +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANSFVGTPYWMAPEVILAMDE 188
Query: 1110 -RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTM 1168
+ K DV+S G+ +EL K P + N + E +
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPP-----LFNMNAMSALYHIAQNESP------ALQSG 237
Query: 1169 QTSDETELYQYLRISFECLDDRPFKRPTMIQVM 1201
S+ ++ CL P RPT ++
Sbjct: 238 HWSE--YFRNFVD---SCLQKIPQDRPTSEVLL 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 3e-54
Identities = 64/270 (23%), Positives = 106/270 (39%), Gaps = 34/270 (12%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGD---REFMAEMETIGKIKHRNLVPLLG 991
+G G FG VY A+ + ++A+K L + + E+E ++H N++ L G
Sbjct: 14 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 73
Query: 992 YCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIP 1051
Y L+ EY G++ L +K D A L++ H
Sbjct: 74 YFHDATRVYLILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSK--- 125
Query: 1052 HIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRC 1111
+IHRD+K N+LL E +++DFG + + TL GT Y+PPE +
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMH 181
Query: 1112 TTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTS 1171
K D++S GV+ E L GK P F + + + E + +
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPP-----FEANTYQETYKRISRVEFTFPDFVTEGA----- 231
Query: 1172 DETELYQYLRISFECLDDRPFKRPTMIQVM 1201
+ L P +RP + +V+
Sbjct: 232 --------RDLISRLLKHNPSQRPMLREVL 253
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 3e-54
Identities = 69/267 (25%), Positives = 119/267 (44%), Gaps = 27/267 (10%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCK 994
IG G G VY A + G VAI+++ + E+ + + K+ N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 995 IGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHII 1054
+G+E +V EY+ GSL V+ + +D + + L FLH + +I
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 1055 HRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTK 1114
HRD+KS N+LL + +++DFG + + ST+ GTP ++ PE K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPK 196
Query: 1115 GDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSDET 1174
D++S G++ +E++ G+ P + ++N L + L+ I PEL
Sbjct: 197 VDIWSLGIMAIEMIEGEPP-----YLNENPL----RALY---LIATNGTPELQNPEKLSA 244
Query: 1175 ELYQYLRISFECLDDRPFKRPTMIQVM 1201
+L CLD KR + +++
Sbjct: 245 IFRDFLN---RCLDMDVEKRGSAKELL 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 9e-54
Identities = 61/271 (22%), Positives = 108/271 (39%), Gaps = 30/271 (11%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKL-IHVTGQGDREFMAEMETIGKIKHRNLVPLLGYC 993
+G G +GEV A R VA+K + + E+ + H N+V G+
Sbjct: 13 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHI 1053
+ G + L EY G L + + ++ G+ +LH I
Sbjct: 73 REGNIQYLFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHG---IGI 124
Query: 1054 IHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFR-CT 1112
HRD+K N+LLDE ++SDFG+A + + ++ + GT YV PE +
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 1113 TKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEI--LDPELTMQT 1170
DV+S G++L +L+G+ P D ++ ++ ++ +N +D
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWD----QPSDSCQEYSDWKEKKTYLNPWKKIDSAP---- 236
Query: 1171 SDETELYQYLRISFECLDDRPFKRPTMIQVM 1201
L + + L + P R T+ +
Sbjct: 237 ---------LALLHKILVENPSARITIPDIK 258
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 1e-53
Identities = 64/284 (22%), Positives = 121/284 (42%), Gaps = 31/284 (10%)
Query: 936 IGSGGFGEVYKAQLR------DGSVVAIKKLIHVTGQGDR-EFMAEMETIGKIKHRNLVP 988
+G G FG VY+ + + VAIK + +R EF+ E + + ++V
Sbjct: 28 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 87
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGG-----TKLDWAARKKIAIGSARGLA 1043
LLG G+ L++ E M G L+S L + ++A A G+A
Sbjct: 88 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 147
Query: 1044 FLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPP 1103
+L+ + +HRD+ + N ++ E+F ++ DFGM R + D + ++ P
Sbjct: 148 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 204
Query: 1104 EYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163
E + TT DV+S+GV+L E+ + P + + ++ + + + + D
Sbjct: 205 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLSNEQVLRFVMEGGLLDKPDNCPD 262
Query: 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207
L++ +R C P RP+ +++++ KE
Sbjct: 263 -----------MLFELMR---MCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 6e-53
Identities = 66/278 (23%), Positives = 111/278 (39%), Gaps = 30/278 (10%)
Query: 935 MIGSGGFGEVYKAQLRD----GSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLVPL 989
IG G FG+V++ VAIK + T RE F+ E T+ + H ++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC 1049
+G ++ E G L S L R LD A+ A + LA+L
Sbjct: 74 IGVI-TENPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLES-- 126
Query: 1050 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSF 1109
+HRD+ + NVL+ N ++ DFG++R + + + S ++ PE
Sbjct: 127 -KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFR 184
Query: 1110 RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQ 1169
R T+ DV+ +GV + E+L P + +N+++G + R
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVK--PFQGVKNNDVIGRIENGERLPMPPNCPP------ 236
Query: 1170 TSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207
LY + +C P +RP ++ A +
Sbjct: 237 -----TLYSLMT---KCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 1e-52
Identities = 58/281 (20%), Positives = 100/281 (35%), Gaps = 31/281 (11%)
Query: 936 IGSGGFGEVYKAQLR----DGSVVAIKKL---IHVTGQGDREFMAEMETIGKIKHRNLVP 988
+G G FG V + + VA+K L + + +F+ E+ + + HRNL+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHS 1048
L G ++ V E GSL L + A+ A G+ +L
Sbjct: 76 LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLES- 129
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVST-LAGTPGYVPPEYYQ 1107
IHRD+ + N+LL ++ DFG+ R + D H + + PE +
Sbjct: 130 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 1108 SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELT 1167
+ + D + +GV L E+ + + G K E
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----------ILHKIDKEGERLPRP 237
Query: 1168 MQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208
++Y + +C +P RPT + + E Q
Sbjct: 238 EDCPQ--DIYNVMV---QCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-52
Identities = 57/289 (19%), Positives = 115/289 (39%), Gaps = 30/289 (10%)
Query: 930 FSADSMIGSGGFGEVYKAQLRD-----GSVVAIKKLIHVT-GQGDREFMAEMETIGKIKH 983
F ++GSG FG VYK VAIK+L T + ++E + E + + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 984 RNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLA 1043
++ LLG C + L+ + M +G L + + + + A+G+
Sbjct: 71 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMN 125
Query: 1044 FLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPP 1103
+L ++HRD+ + NVL+ +++DFG+A+L+ A + ++
Sbjct: 126 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 1104 EYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163
E T + DV+SYGV + EL++ P + + + + +
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEIS---------SILEKGER 231
Query: 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTE 1212
+ ++Y + +C RP +++ F ++ D +
Sbjct: 232 LPQPPICTI--DVYMIMV---KCWMIDADSRPKFRELIIEFSKMARDPQ 275
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 186 bits (474), Expect = 1e-52
Identities = 64/270 (23%), Positives = 112/270 (41%), Gaps = 27/270 (10%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCK 994
+G+G FG V++ R G+ A K ++ E++T+ ++H LV L +
Sbjct: 34 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 93
Query: 995 IGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHII 1054
E +++YE+M G L + D K+ + +GL +H + +
Sbjct: 94 DDNEMVMIYEFMSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHE---NNYV 146
Query: 1055 HRDMKSSNVLL--DENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCT 1112
H D+K N++ + E ++ DFG+ LD SV GT + PE +
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVAEGKPVG 203
Query: 1113 TKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSD 1172
D++S GV+ LLSG P FG +N+ + L K + +D S+
Sbjct: 204 YYTDMWSVGVLSYILLSGLSP-----FGGEND----DETLRNVKSCDWNMDDSAFSGISE 254
Query: 1173 ETELYQYLRISFECLDDRPFKRPTMIQVMA 1202
+ ++R + L P R T+ Q +
Sbjct: 255 --DGKDFIR---KLLLADPNTRMTIHQALE 279
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 1e-51
Identities = 59/278 (21%), Positives = 101/278 (36%), Gaps = 30/278 (10%)
Query: 935 MIGSGGFGEVYKAQ-LRDGSVVAIKKL--IHVTGQGDRE-FMAEMETIGKIKHRNLVPLL 990
++G G F V A+ L AIK L H+ + E + + ++ H V L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 991 GYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCI 1050
+ E+ Y K G L + D + L +LH
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALEYLHG--- 126
Query: 1051 PHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFR 1110
IIHRD+K N+LL+E+ +++DFG A++++ ++ GT YV PE
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186
Query: 1111 CTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQT 1170
D+++ G I+ +L++G P F N + + K + E E P
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPP-----FRAGNEYLIFQKIIKLEYDFPEKFFP------ 235
Query: 1171 SDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208
+ + + L KR ++
Sbjct: 236 ----KARDLVE---KLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-51
Identities = 74/293 (25%), Positives = 124/293 (42%), Gaps = 40/293 (13%)
Query: 936 IGSGGFGEVYKAQLR--------DGSVVAIKKL-IHVTGQGDREFMAEMETIGKI-KHRN 985
+G G FG+V A+ + VA+K L T + + ++EME + I KH+N
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 986 LVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGG-----------GTKLDWAARKKI 1034
++ LLG C ++ EY G+L L R G +L
Sbjct: 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 140
Query: 1035 AIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTL 1094
A ARG+ +L IHRD+ + NVL+ E+ +++DFG+AR ++ +D + +
Sbjct: 141 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 1095 AGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR 1154
++ PE T + DV+S+GV+L E+ + P L K+ HR
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVPVEELFKLLKEGHR 255
Query: 1155 EKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207
+ + + ELY +R +C P +RPT Q++ +
Sbjct: 256 MDKPSNCTN-----------ELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 181 bits (460), Expect = 8e-51
Identities = 58/270 (21%), Positives = 102/270 (37%), Gaps = 27/270 (10%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCK 994
+GSG FG V++ G V K + E+ + ++ H L+ L +
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 995 IGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHII 1054
E +L+ E++ G L + K+ A + GL +H I+
Sbjct: 97 DKYEMVLILEFLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEH---SIV 149
Query: 1055 HRDMKSSNVLLDENFEARV--SDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCT 1112
H D+K N++ + + V DFG+A +N + + T + PE
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVG 206
Query: 1113 TKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSD 1172
D+++ GV+ LLSG P F +++L + L KR + D + S
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSP-----FAGEDDL----ETLQNVKRCDWEFDEDAFSSVSP 257
Query: 1173 ETELYQYLRISFECLDDRPFKRPTMIQVMA 1202
E +++ L P KR T+ +
Sbjct: 258 --EAKDFIK---NLLQKEPRKRLTVHDALE 282
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 177 bits (451), Expect = 4e-50
Identities = 71/306 (23%), Positives = 125/306 (40%), Gaps = 33/306 (10%)
Query: 935 MIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDRE-FMAEMETIGKIKHRNLVPLLGY 992
++G+G F EV A+ R +VAIK + +G E+ + KIKH N+V L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 993 CKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPH 1052
+ G L+ + + G L + ++ ++ + +LH I H
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLHDLGIVH 130
Query: 1053 IIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCT 1112
+ LDE+ + +SDFG++++ D +ST GTPGYV PE +
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQKPYS 187
Query: 1113 TKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSD 1172
D +S GVI LL G P F D+N+ + + L E + +++
Sbjct: 188 KAVDCWSIGVIAYILLCGYPP-----FYDENDAKLFEQILKAEYEFDSPYWDDIS----- 237
Query: 1173 ETELYQYLRISFECLDDRPFKRPTMIQVMAM--FKELQVDTEGDSLDSFSLKDTVIEELR 1230
++R ++ P KR T Q + GD+ ++ +V E+++
Sbjct: 238 -DSAKDFIR---HLMEKDPEKRFTCEQALQHPWIA-------GDTALDKNIHQSVSEQIK 286
Query: 1231 ERESSS 1236
+ + S
Sbjct: 287 KNFAKS 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 1e-49
Identities = 71/292 (24%), Positives = 119/292 (40%), Gaps = 38/292 (13%)
Query: 936 IGSGGFGEVYKAQLR------DGSVVAIKKLIHVTGQGD-REFMAEMETIGKIKHR-NLV 987
+G G FG+V +A VA+K L + R M+E++ + I H N+V
Sbjct: 21 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 80
Query: 988 PLLGYC-KIGEERLLVYEYMKWGSLESVLHDRAKG-----------GGTKLDWAARKKIA 1035
LLG C K G +++ E+ K+G+L + L + L +
Sbjct: 81 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 140
Query: 1036 IGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLA 1095
A+G+ FL IHRD+ + N+LL E ++ DFG+AR + ++
Sbjct: 141 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 197
Query: 1096 GTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE 1155
++ PE T + DV+S+GV+L E+ S P D+
Sbjct: 198 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----------EFC 247
Query: 1156 KRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207
+R+ E T+ E+YQ + +C P +RPT +++ L
Sbjct: 248 RRLKEGTRMRAPDYTTP--EMYQTML---DCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 1e-48
Identities = 55/276 (19%), Positives = 102/276 (36%), Gaps = 30/276 (10%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCK 994
+G G FG V++ K + V G E+ + +HRN++ L +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKF-VKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 995 IGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHII 1054
EE ++++E++ + ++ +L+ L FLH +I
Sbjct: 72 SMEELVMIFEFISGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLHS---HNIG 124
Query: 1055 HRDMKSSNVLLDENFEARV--SDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCT 1112
H D++ N++ + + +FG AR + D L P Y PE +Q +
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVS 181
Query: 1113 TKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSD 1172
T D++S G ++ LLSG P F + N ++ E +E E++
Sbjct: 182 TATDMWSLGTLVYVLLSGINP-----FLAETNQQIIENIMNAEYTFDEEAFKEIS----- 231
Query: 1173 ETELYQYLRISFECLDDRPFKRPTMIQVMAM--FKE 1206
E ++ L R T + + K+
Sbjct: 232 -IEAMDFVD---RLLVKERKSRMTASEALQHPWLKQ 263
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-47
Identities = 68/333 (20%), Positives = 134/333 (40%), Gaps = 29/333 (8%)
Query: 923 LLEATNGFSADSMIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDRE-FMAEMETIGK 980
+ + ++ S IG G +G V A + VAIKK+ Q + + E++ + +
Sbjct: 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 62
Query: 981 IKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSAR 1040
+H N++ + + + Y+ + + L+ K L R
Sbjct: 63 FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILR 120
Query: 1041 GLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN-ALDTHLSVSTLAGTPG 1099
GL ++H + +++HRD+K SN+LL+ + ++ DFG+AR+ + D ++ T
Sbjct: 121 GLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 1100 YVPPEY-YQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158
Y PE S T D++S G IL E+LS + + D N + ++ +
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237
Query: 1159 NEILDP-----ELTMQTSDETELYQYL-RISFE-------CLDDRPFKRPTMIQVMAM-- 1203
N I++ L++ ++ + + L P KR + Q +A
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297
Query: 1204 FKELQVDTEGDSLD-----SFSLKDTVIEELRE 1231
++ ++ + L D E+L+E
Sbjct: 298 LEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKE 330
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 165 bits (419), Expect = 3e-46
Identities = 61/285 (21%), Positives = 114/285 (40%), Gaps = 31/285 (10%)
Query: 927 TNGFSADSMIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGD---REFMAEMETIGKIK 982
++ + ++G GG EV+ A+ LR VA+K L + F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 983 HRNLVPLLGYC----KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGS 1038
H +V + G +V EY+ +L ++H + ++ +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADA 120
Query: 1039 ARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR-LVNALDTHLSVSTLAGT 1097
+ L F H IIHRD+K +N+++ +V DFG+AR + ++ ++ + + GT
Sbjct: 121 CQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
Query: 1098 PGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKR 1157
Y+ PE + + DVYS G +L E+L+G+ P F D+ + + + +
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP-----FTGDSPVSVAYQHVREDPI 232
Query: 1158 INEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMA 1202
L+ +L + + L P R M
Sbjct: 233 PPSARHEGLS------ADLDAVVL---KALAKNPENRYQTAAEMR 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 166 bits (420), Expect = 7e-46
Identities = 66/266 (24%), Positives = 120/266 (45%), Gaps = 27/266 (10%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKL---IHVTGQGDREFMAEMETIGKIKHRNLVPLLG 991
+G+G FG V+ + R +G A+K L I V + E + + H ++ + G
Sbjct: 12 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 71
Query: 992 YCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIP 1051
+ ++ ++ +Y++ G L S+L + K A A L +
Sbjct: 72 TFQDAQQIFMIMDYIEGGELFSLLRKS-----QRFPNPVAKFYA---AEVCLALEYLHSK 123
Query: 1052 HIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRC 1111
II+RD+K N+LLD+N +++DFG A+ V + TL GTP Y+ PE +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEVVSTKPY 178
Query: 1112 TTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELT---- 1167
D +S+G+++ E+L+G P F D N + + K L+ E R + ++
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTP-----FYDSNTMKTYEKILNAELRFPPFFNEDVKDLLS 233
Query: 1168 -MQTSDETELYQYLRISFECLDDRPF 1192
+ T D ++ L+ E + + P+
Sbjct: 234 RLITRDLSQRLGNLQNGTEDVKNHPW 259
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (413), Expect = 3e-45
Identities = 56/283 (19%), Positives = 94/283 (33%), Gaps = 30/283 (10%)
Query: 935 MIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYC 993
IGSG FG++Y + G VAIK + E + ++ +P + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLEC--VKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 994 KI-GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPH 1052
G+ ++V E + L D K +A + ++H +
Sbjct: 72 GAEGDYNVMVMELLGPS-----LEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---N 123
Query: 1053 IIHRDMKSSNVL---LDENFEARVSDFGMARLVNALDTHLSV-----STLAGTPGYVPPE 1104
IHRD+K N L + + DFG+A+ TH + L GT Y
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 1105 YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDP 1164
+ + + D+ S G +L+ G P + K ++
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-----RQKYERISEKKMSTPIE 238
Query: 1165 ELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207
L E YL C R +P + +F+ L
Sbjct: 239 VLCKGYPS--EFATYLN---FCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 161 bits (409), Expect = 6e-45
Identities = 62/296 (20%), Positives = 114/296 (38%), Gaps = 44/296 (14%)
Query: 930 FSADSMIGSGGFGEVYKAQ-LRDGSVVAIKKL--------IHVTGQGDRE-FMAEMETIG 979
+ ++G G V + A+K + Q RE + E++ +
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 980 KIK-HRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGS 1038
K+ H N++ L + LV++ MK G L L ++ L +KI
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRAL 119
Query: 1039 ARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTP 1098
+ LH +I+HRD+K N+LLD++ +++DFG + LD + + GTP
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTP 173
Query: 1099 GYVPPEYYQSFRC------TTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQL 1152
Y+ PE + + D++S GVI+ LL+G P F ++ +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-----FWHRKQMLMLRMIM 228
Query: 1153 HREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM--FKE 1206
+ + + + + L +P KR T + +A F++
Sbjct: 229 SGNYQFGSPEWDDYS------DTVKDLVS---RFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 163 bits (413), Expect = 2e-44
Identities = 73/283 (25%), Positives = 110/283 (38%), Gaps = 35/283 (12%)
Query: 928 NGFSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIH---VTGQGDREFMAE---METIGK 980
N FS +IG GGFGEVY + D G + A+K L QG+ + E + +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 981 IKHRNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSAR 1040
+V + ++ + + M G L L A + A
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIIL 118
Query: 1041 GLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGY 1100
GL +H+ +++RD+K +N+LLDE+ R+SD G+A + H SV GT GY
Sbjct: 119 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGY 171
Query: 1101 VPPEYYQSFR-CTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRIN 1159
+ PE Q + D +S G +L +LL G P + K H R+
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK----------TKDKHEIDRMT 221
Query: 1160 EILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMA 1202
+ EL S EL L L +R + A
Sbjct: 222 LTMAVELPDSFSP--ELRSLLE---GLLQRDVNRRLGCLGRGA 259
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-44
Identities = 69/307 (22%), Positives = 116/307 (37%), Gaps = 41/307 (13%)
Query: 935 MIGSGGFGEVYKAQLR-DGSVVAIKKL-----IHVTGQGDREFMAEMETIGKIKHRNLVP 988
+G G F VYKA+ + +VAIKK+ +R + E++ + ++ H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHS 1048
LL LV+++M+ + + L + K + + +GL +LH
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQ- 118
Query: 1049 CIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQS 1108
I+HRD+K +N+LLDEN +++DFG+A+ + + + T Y PE
Sbjct: 119 --HWILHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRWYRAPELLFG 174
Query: 1109 FRC-TTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELT 1167
R D+++ G IL ELL D++L + E P++
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPF-----LPGDSDLDQLTRIFETLGTPTEEQWPDMC 229
Query: 1168 MQTSDETELYQYLRISFE----------------CLDDRPFKRPTMIQVMAM--FKELQV 1209
D + I P R T Q + M F
Sbjct: 230 -SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288
Query: 1210 DTEGDSL 1216
T G L
Sbjct: 289 PTPGCQL 295
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 2e-44
Identities = 65/294 (22%), Positives = 118/294 (40%), Gaps = 36/294 (12%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKL--IHVTGQGDREFMAEMETIGKIKHRNLVPLLGY 992
IG G +G VYKA+ + G VVA+KK+ T + E+ + ++ H N+V LL
Sbjct: 10 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 993 CKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPH 1052
+ LV+E++ + + G + K +GLAF H
Sbjct: 70 IHTENKLYLVFEFLHQDLKKFMDASALTG----IPLPLIKSYLFQLLQGLAFCHS---HR 122
Query: 1053 IIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFR-C 1111
++HRD+K N+L++ +++DFG+AR + T Y PE +
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYY 180
Query: 1112 TTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTS 1171
+T D++S G I E+++ + F D+ + + +E++ P +T
Sbjct: 181 STAVDIWSLGCIFAEMVTRRAL-----FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 1172 DETELYQYLRISFE----------------CLDDRPFKRPTMIQVMAM--FKEL 1207
+ ++ R F L P KR + +A F+++
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 160 bits (405), Expect = 3e-44
Identities = 50/285 (17%), Positives = 93/285 (32%), Gaps = 34/285 (11%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCK 994
IG G FG +++ L + VAIK + E T + +P + Y
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 995 IGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHII 1054
++ + SLE +L G K A + +H ++
Sbjct: 71 QEGLHNVLVIDLLGPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHEK---SLV 123
Query: 1055 HRDMKSSNVLLDENFE-----ARVSDFGMARLVNALDTHLSV-----STLAGTPGYVPPE 1104
+RD+K N L+ V DFGM + T + L+GT Y+
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 1105 YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD- 1163
+ + + D+ + G + + L G P + + + + + E+
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 243
Query: 1164 -PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207
PE E Y+Y+ + P + +F ++
Sbjct: 244 FPE---------EFYKYMH---YARNLAFDATPDYDYLQGLFSKV 276
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 160 bits (404), Expect = 3e-44
Identities = 63/292 (21%), Positives = 110/292 (37%), Gaps = 36/292 (12%)
Query: 936 IGSGGFGEVYKAQLRDGSVVAIKKL--IHVTGQGDREFMAEMETIGKIKHRNLVPLLGYC 993
IG G +G VYKAQ G A+KK+ + E+ + ++KH N+V L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 994 KIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHI 1053
+ +LV+E++ + + L+ K + G+A+ H +
Sbjct: 70 HTKKRLVLVFEHLDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHD---RRV 121
Query: 1054 IHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSF-RCT 1112
+HRD+K N+L++ E +++DFG+AR + T Y P+ + +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFG--IPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 1113 TKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTSD 1172
T D++S G I E+++G F + + N P +T
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPL-----FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 1173 ETELYQYLRISFE----------------CLDDRPFKRPTMIQVMAM--FKE 1206
+ Y + +E L P +R T Q + FKE
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 3e-44
Identities = 62/292 (21%), Positives = 117/292 (40%), Gaps = 25/292 (8%)
Query: 936 IGSGGFGEVYKAQLR--DGSVVAIKKLIHVTGQGDRE-----FMAEMETIGKIKHRNLVP 988
IG G +G+V+KA+ G VA+K++ TG+ +A + + +H N+V
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 989 LLGYCKIGEERLLVYEYMKWGSLE-SVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH 1047
L C + + + ++ + K + K + RGL FLH
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134
Query: 1048 SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQ 1107
++HRD+K N+L+ + + +++DFG+AR+ + +++ T Y PE
Sbjct: 135 H---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYRAPEVLL 188
Query: 1108 SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI-NEILDPEL 1166
T D++S G I E+ K S D + L E+ ++ P
Sbjct: 189 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 248
Query: 1167 TMQTSDETELYQYLR-ISFE-------CLDDRPFKRPTMIQVMAM--FKELQ 1208
+ + +++ I CL P KR + ++ F++L+
Sbjct: 249 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-43
Identities = 66/318 (20%), Positives = 119/318 (37%), Gaps = 41/318 (12%)
Query: 935 MIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMAEMETIGKI-KHRNLVPLLGY 992
++G G G+V + R A+K L Q + E+E + + ++V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73
Query: 993 CK----IGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHS 1048
+ + L+V E + G L S + DR G +I + +LH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 1049 CIPHIIHRDMKSSNVLLDENFE---ARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEY 1105
+I HRD+K N+L +++DFG A+ + ++ +T TP YV PE
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEV 184
Query: 1106 YQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPE 1165
+ D++S GVI+ LL G P F ++ L R +
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPP-----FYSNHGLAISPGMKTRIRMGQYEFPNP 239
Query: 1166 LTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM--FKE------LQVDTEGDSLD 1217
+ S+ E+ +R L P +R T+ + M + + T +
Sbjct: 240 EWSEVSE--EVKMLIR---NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKE 294
Query: 1218 SFSLKDTVIEELRERESS 1235
+ V EE+ ++
Sbjct: 295 DKERWEDVKEEMTSALAT 312
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-43
Identities = 66/270 (24%), Positives = 102/270 (37%), Gaps = 33/270 (12%)
Query: 935 MIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDRE---FMAEMETIGK-IKHRNLVPL 989
M+G G FG+V+ A+ + AIK L D + M E + +H L +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 990 LGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC 1049
+ E V EY+ G L + K D + A GL FLH
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHS-- 121
Query: 1050 IPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSF 1109
I++RD+K N+LLD++ +++DFGM + D +T GTP Y+ PE
Sbjct: 122 -KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQ 178
Query: 1110 RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQ 1169
+ D +S+GV+L E+L G+ P F + + L+
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSP-----FHGQDEEELFHSIRMDNPFYPRWLEK----- 228
Query: 1170 TSDETELYQYLRISFECLDDRPFKRPTMIQ 1199
E L + P KR +
Sbjct: 229 -----EAKDLLV---KLFVREPEKRLGVRG 250
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-42
Identities = 78/330 (23%), Positives = 130/330 (39%), Gaps = 34/330 (10%)
Query: 930 FSADSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVP 988
++ +IG+G FG VY+A+L D G +VAIKK++ Q R E++ + K+ H N+V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 989 LLGYCKIGEER------LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGL 1042
L + E+ LV +Y+ H L K R L
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ--TLPVIYVKLYMYQLFRSL 135
Query: 1043 AFLHHSCIPHIIHRDMKSSNVLLD-ENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYV 1101
A++H I HRD+K N+LLD + ++ DFG A+ + +VS +
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRA 190
Query: 1102 PPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161
P + + T+ DV+S G +L ELL G+ D + ++I E+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 1162 ----LDPELTMQTSDETELYQYLRISFE-------CLDDRPFKRPTMIQVMAM--FKELQ 1208
+ + + R E L+ P R T ++ A F EL+
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310
Query: 1209 VDTE--GDSLDSFSLKDTVIEELRERESSS 1236
+ D+ +L + +EL +
Sbjct: 311 DPNVKLPNGRDTPALFNFTTQELSSNPPLA 340
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-40
Identities = 61/278 (21%), Positives = 104/278 (37%), Gaps = 36/278 (12%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKL------IHVTGQGDREFMAEMETIGKIKHRNLVP 988
+GSG F V K + G A K + G + E+ + +I+H N++
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 989 LLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHS 1048
L + + +L+ E + G L L ++ L + G+ ++
Sbjct: 78 LHEVYENKTDVILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGV---YYL 129
Query: 1049 CIPHIIHRDMKSSNVLLDENFEAR----VSDFGMARLVNALDTHLSVSTLAGTPGYVPPE 1104
I H D+K N++L + + + DFG+A ++ + + GTP +V PE
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPE 186
Query: 1105 YYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDP 1164
+ D++S GVI LLSG P F D + L +N +
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASP-----FLGDTK----QETLANVSAVNYEFED 237
Query: 1165 ELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMA 1202
E TS ++R L P KR T+ +
Sbjct: 238 EYFSNTSA--LAKDFIR---RLLVKDPKKRMTIQDSLQ 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-40
Identities = 64/291 (21%), Positives = 112/291 (38%), Gaps = 48/291 (16%)
Query: 935 MIGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDRE------FMAEMETIGKIK--HRN 985
++GSGGFG VY + D VAIK + E E+ + K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 986 LVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFL 1045
++ LL + + + +L+ E + L + +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHC 126
Query: 1046 HHSCIPHIIHRDMKSSNVLLDEN-FEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPE 1104
H+ ++HRD+K N+L+D N E ++ DFG L+ DT + GT Y PPE
Sbjct: 127 HNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVY--TDFDGTRVYSPPE 179
Query: 1105 YYQSFR-CTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163
+ + R V+S G++L +++ G P F D ++ Q+ +R++
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHDEEII--RGQVFFRQRVSS--- 229
Query: 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM--FKELQVDTE 1212
E +R CL RP RPT ++ +++ + E
Sbjct: 230 -----------ECQHLIR---WCLALRPSDRPTFEEIQNHPWMQDVLLPQE 266
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 9e-40
Identities = 68/324 (20%), Positives = 123/324 (37%), Gaps = 42/324 (12%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLI--HVTGQGDREFMAEMETIGKIKHRNLVPLLGY 992
+GSG +G V A R G+ VAIKKL + + E+ + ++H N++ LL
Sbjct: 26 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 85
Query: 993 CKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPH 1052
E ++ + KL + + +GL ++H
Sbjct: 86 FTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIHA---AG 141
Query: 1053 IIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSF-RC 1111
IIHRD+K N+ ++E+ E ++ DFG+AR ++ ++ T Y PE ++ R
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRY 196
Query: 1112 TTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQTS 1171
T D++S G I+ E+++GK F ++L + + L +
Sbjct: 197 TQTVDIWSVGCIMAEMITGKTL-----FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 1172 DE--TELYQYLRISFE----------------CLDDRPFKRPTMIQVMAM--FKELQVDT 1211
L + + F L +R T + +A F+ L
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311
Query: 1212 EGDSL----DSFSLKDTVIEELRE 1231
+ + DSF D ++E +
Sbjct: 312 DEPQVQKYDDSFDDVDRTLDEWKR 335
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-39
Identities = 59/295 (20%), Positives = 113/295 (38%), Gaps = 36/295 (12%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKLI--HVTGQGDREFMAEMETIGKIKHRNLVPLLGY 992
IG G FGEV+KA+ R G VA+KK++ + + E++ + +KH N+V L+
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 993 CKIGEER--------LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAF 1044
C+ LV+++ + + + K + K++ GL +
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYY 132
Query: 1045 LHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDT--HLSVSTLAGTPGYVP 1102
+H I+HRDMK++NVL+ + +++DFG+AR + + T Y P
Sbjct: 133 IHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 1103 PEYYQSFR-CTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161
PE R D++ G I+ E+ + + + L+ + +
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 1162 LDPELTMQTSDETELYQYLRISFE--------------CLDDRPFKRPTMIQVMA 1202
+ EL + + ++ + L P +R +
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 7e-39
Identities = 62/290 (21%), Positives = 114/290 (39%), Gaps = 28/290 (9%)
Query: 936 IGSGGFGEVYKAQLR-DGSVVAIKKL--IHVTGQGDREFMAEMETIGKIKHRNLVPLLGY 992
IG G +G V+KA+ R +VA+K++ + E+ + ++KH+N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 993 CKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPH 1052
++ LV+E+ + D K +GL F H +
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDL-----DPEIVKSFLFQLLKGLGFCHS---RN 121
Query: 1053 IIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRC- 1111
++HRD+K N+L++ N E ++++FG+AR S T Y PP+ +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLY 179
Query: 1112 TTKGDVYSYGVILLELLSGKRPIDPSEFGDDN-----NLVGWAKQLHREKRINEILDPEL 1166
+T D++S G I EL + RP+ P DD L+G +
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 1167 TMQTSDETELYQYLRISFE-------CLDDRPFKRPTMIQVMAM--FKEL 1207
M + + + +++ L P +R + + + F +
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-38
Identities = 58/279 (20%), Positives = 100/279 (35%), Gaps = 32/279 (11%)
Query: 928 NGFSADSMIGSGGFGEVYKAQ-LRDGSVVAIKKL---IHVTGQGDREFMAEMETIGKIKH 983
N F ++G G FG+V + G A+K L + + + E + +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 984 RNLVPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLA 1043
L L + + V EY G L L + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALE 119
Query: 1044 FLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPP 1103
+LH +++RD+K N++LD++ +++DFG+ + + + T GTP Y+ P
Sbjct: 120 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAP 174
Query: 1104 EYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163
E + D + GV++ E++ G+ P F + ++ + L E R L
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-----FYNQDHERLFELILMEEIRFPRTLS 229
Query: 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMA 1202
P E L L P +R A
Sbjct: 230 P----------EAKSLLA---GLLKKDPKQRLGGGPSDA 255
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (357), Expect = 3e-37
Identities = 57/266 (21%), Positives = 101/266 (37%), Gaps = 27/266 (10%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDRE---FMAEMETIGKIKHRNLVPLLG 991
+G+G FG V + G+ A+K L ++ + E + + LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 992 YCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIP 1051
K +V EY+ G + S L + + A +LH
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSL--- 160
Query: 1052 HIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRC 1111
+I+RD+K N+L+D+ +V+DFG A+ TL GTP + PE S
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGY 215
Query: 1112 TTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELT---- 1167
D ++ GV++ E+ +G P F D + + K + + R +L
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP-----FFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 1168 -MQTSDETELYQYLRISFECLDDRPF 1192
+ D T+ + L+ + + +
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKW 296
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 6e-35
Identities = 72/329 (21%), Positives = 131/329 (39%), Gaps = 52/329 (15%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKL--IHVTGQGDREFMAEMETIGKIKHRNLVPLLGY 992
+GSG +G V A + G VA+KKL + + E+ + +KH N++ LL
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 993 CKIGE-----ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH 1047
+ + ++ L +++ + KL + + RGL ++H
Sbjct: 86 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHS 139
Query: 1048 SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQ 1107
IIHRD+K SN+ ++E+ E ++ DFG+AR T ++ T Y PE
Sbjct: 140 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIML 191
Query: 1108 SFR-CTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166
++ D++S G I+ ELL+G+ F +++ L L ++
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTL-----FPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 1167 TMQTSDET--ELYQYLRISFE----------------CLDDRPFKRPTMIQVMAM--FKE 1206
+ +++ L Q +++F L KR T Q +A F +
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 1207 LQVDTEGDSLD----SFSLKDTVIEELRE 1231
+ D SF +D +I+E +
Sbjct: 307 YHDPDDEPVADPYDQSFESRDLLIDEWKS 335
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 134 bits (337), Expect = 7e-35
Identities = 57/304 (18%), Positives = 111/304 (36%), Gaps = 47/304 (15%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIK-HRNLVPLLGYC 993
+G G + EV++A + + V +K L V ++ E++ + ++ N++ L
Sbjct: 43 LGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIV 99
Query: 994 KIGEERL--LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIP 1051
K R LV+E++ + + L + + L + H I
Sbjct: 100 KDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMGIM 151
Query: 1052 HIIHRDMKSSNVLLD-ENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFR 1110
H RD+K NV++D E+ + R+ D+G+A + + + + + PE ++
Sbjct: 152 H---RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQ 205
Query: 1111 -CTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELTMQ 1169
D++S G +L ++ K P + + LV AK L E + I + +
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGH-DNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 1170 TSDETELYQYLRISFE---------------------CLDDRPFKRPTMIQVMAM--FKE 1206
L ++ R +E L R T + M F
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324
Query: 1207 LQVD 1210
+ D
Sbjct: 325 VVKD 328
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 3e-34
Identities = 66/343 (19%), Positives = 112/343 (32%), Gaps = 65/343 (18%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKL--IHVTGQGDREFMAEMETIGKIKHRNLVPLLGY 992
IGSG G V A VAIKKL + E+ + + H+N++ LL
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 993 CK------IGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLH 1046
++ LV E M + + + D + G+ LH
Sbjct: 85 FTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--------DHERMSYLLYQMLCGIKHLH 136
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYY 1106
IIHRD+K SN+++ + ++ DFG+AR T ++ T Y PE
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVI 190
Query: 1107 QSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166
D++S G I+ E++ K F + + W K + + +L
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKIL-----FPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 1167 TMQTSDETE-LYQYLRISFE----------------------------CLDDRPFKRPTM 1197
+ E +Y ++F L P KR ++
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 1198 IQVMAM--FKELQVDTEGDSL------DSFSLKDTVIEELRER 1232
+ E ++ ++ IEE +E
Sbjct: 306 DDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKEL 348
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 2e-33
Identities = 60/278 (21%), Positives = 104/278 (37%), Gaps = 34/278 (12%)
Query: 936 IGSGGFGEVYKAQL----RDGSVVAIKKL----IHVTGQGDREFMAEMETIGKIKHR-NL 986
+G+G +G+V+ + G + A+K L I + E + + I+ L
Sbjct: 32 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 91
Query: 987 VPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLH 1046
V L + + L+ +Y+ G L + L R + + + L
Sbjct: 92 VTLHYAFQTETKLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYV---GEIVLALE 143
Query: 1047 HSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYY 1106
H II+RD+K N+LLD N ++DFG+++ A +T + GT Y+ P+
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF-CGTIEYMAPDIV 202
Query: 1107 QSFR--CTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDP 1164
+ D +S GV++ ELL+G P F D A+ R +
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASP-----FTVDGEKNSQAEISRRILKSEPPYPQ 257
Query: 1165 ELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMA 1202
E++ ++ L P KR A
Sbjct: 258 EMS------ALAKDLIQ---RLLMKDPKKRLGCGPRDA 286
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 123 bits (310), Expect = 5e-31
Identities = 44/232 (18%), Positives = 84/232 (36%), Gaps = 16/232 (6%)
Query: 936 IGSGGFGEVYKAQ-LRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNL-------- 986
+G G F V+ A+ + + + VA+K + E++ + ++ +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKI-VRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 987 ---VPLLGYCKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLA 1043
+ LL + + + E++L K + K+I+ GL
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 1044 FLHHSCIPHIIHRDMKSSNVLLD-ENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVP 1102
++H C IIH D+K NVL++ + + +A L NA + T Y
Sbjct: 140 YMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 1103 PEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR 1154
PE D++S ++ EL++G +P E Q+
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 98.3 bits (243), Expect = 1e-22
Identities = 70/287 (24%), Positives = 110/287 (38%), Gaps = 24/287 (8%)
Query: 545 NGGNLETLILNNNHLTGA--IPKSIASCTNMLWVSLSSN-QLTGEIPAGIGNLVKLAILQ 601
+ L L+ +L IP S+A+ + ++ + L G IP I L +L L
Sbjct: 48 QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107
Query: 602 LGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRN 661
+ + +++G +P L + ++LV LD + N LSG LP +++ +V + + +
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
Query: 662 EGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYN 721
G+ + L I RL G + ++ +
Sbjct: 168 SYGSFSK----LFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGD----------- 212
Query: 722 SLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGG 781
+ G K + LDL +N G++P L
Sbjct: 213 ------ASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQ 266
Query: 782 LSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPLLPCS 828
L FL L+VS NNL G IP GG L F S Y NN LCG PL C+
Sbjct: 267 LKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 90.2 bits (222), Expect = 6e-20
Identities = 70/317 (22%), Positives = 132/317 (41%), Gaps = 22/317 (6%)
Query: 58 EELTILMAFKQSSIGSDPNGYLANWTADA-LTPCSWQGVSCSLNS---HVTSLNLNNSGL 113
++ L+ K+ +P L++W +W GV C ++ V +L+L+ L
Sbjct: 6 QDKQALLQIKKDL--GNPTT-LSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 114 SGSLNL-TTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNITGSLPGRSF 172
+ ++L LPYL L + G + G + + L + ++ N++G++P
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 173 LLSCDRLSYVNLSHNSISG---GSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLL 229
L ++ S+N++SG S+ P+L+ + GN+IS + + S + L
Sbjct: 123 --QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA--IPDSYGSFSKLFTS 178
Query: 230 NFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGK 289
+ +++ +DLS N+L G+ F +D + + +
Sbjct: 179 MTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIH----LAKNSLA 234
Query: 290 FSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFR 349
F G NL+ + L N + GT P L + L +LN+S N L G IP G+ +
Sbjct: 235 FDLGKVGLSKNLNGLDLRNNRIYGT-LPQGLTQLKFLHSLNVSFNNLCGEIP--QGGNLQ 291
Query: 350 NLKQLSLAHNQFAGEIP 366
+ A+N+ P
Sbjct: 292 RFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 84.4 bits (207), Expect = 4e-18
Identities = 61/287 (21%), Positives = 108/287 (37%), Gaps = 30/287 (10%)
Query: 495 GSCKNLKTIDLSFNSLAG--PVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETL 552
+ +DLS +L P+PS + +LP L+ L +
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIG---------------------- 84
Query: 553 ILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVP 612
N+L G IP +IA T + ++ ++ ++G IP + + L L N+L+G +P
Sbjct: 85 --GINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP 142
Query: 613 QGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGG 672
+ +LV + + N +SG +P + + + +S + A
Sbjct: 143 PSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFV 202
Query: 673 LVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNG---SLIYLDLSYNSLSGTLPE 729
+ + + F + + + G +L LDL N + GTLP+
Sbjct: 203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQ 262
Query: 730 NFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIP 776
L +L LN+ N L G IP G L+ V ++N P
Sbjct: 263 GLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 72.1 bits (175), Expect = 6e-14
Identities = 57/268 (21%), Positives = 94/268 (35%), Gaps = 22/268 (8%)
Query: 296 GRCGNLSVITLSQNGLSGT-EFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQL 354
+ ++ + LS L P+SL N L L + G + L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 355 SLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNF 414
+ H +G IP TL LD S N L+G LP + +S +L + N +SG
Sbjct: 107 YITHTNVSGAIPDF-LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165
Query: 415 LNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDL-------------------S 455
++ S + + N ++G +P + N V
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQK 225
Query: 456 SNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVP 515
+ ++ L + L NN + GT+P L K L ++++SFN+L G +P
Sbjct: 226 IHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
Query: 516 SEIWSLPNLSDLVMWANNLTGEIPEGIC 543
+ +L N P C
Sbjct: 286 -QGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 63.6 bits (153), Expect = 3e-11
Identities = 69/309 (22%), Positives = 107/309 (34%), Gaps = 37/309 (11%)
Query: 213 SALLTY--SLSNCQNLNLLNFSDNKLPGKLNATSVNCKS------ISTIDLSYNLLSGEI 264
ALL L N L+ + + V C + ++ +DLS L
Sbjct: 9 QALLQIKKDLGNPTTLSSWLPTTD--CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPY 66
Query: 265 PASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQ 324
P + L +L + N + L + ++ +SG +
Sbjct: 67 PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL-SQIK 125
Query: 325 LLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSN 384
L TL+ S+NAL G +P + S NL ++ N+ +G IP G + +S N
Sbjct: 126 TLVTLDFSYNALSGTLPPSI-SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
Query: 385 RLTGELPSTFASCSSLHSLNLGSNMLSG---------------------NFLNTVVSKIS 423
RLTG++P TFA+ + + + F V
Sbjct: 185 RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSK 244
Query: 424 SLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPN 483
+L L + N I G +P LT L L++S N G IP G N + N
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG----GNLQRFDVSAYAN 300
Query: 484 NYLSGTVPL 492
N PL
Sbjct: 301 NKCLCGSPL 309
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 40.5 bits (93), Expect = 8e-04
Identities = 37/131 (28%), Positives = 55/131 (41%), Gaps = 3/131 (2%)
Query: 694 PSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSG--TLPENFGSLNYLQVLNLGHN-KLTGH 750
R + G+ T T + LDLS +L +P + +L YL L +G L G
Sbjct: 33 CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP 92
Query: 751 IPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPA 810
IP + L + L ++H N G+IP L + L LD S N LSG +P
Sbjct: 93 IPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV 152
Query: 811 SRYENNSGLCG 821
+ + + G
Sbjct: 153 GITFDGNRISG 163
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 99.3 bits (246), Expect = 1e-22
Identities = 75/427 (17%), Positives = 130/427 (30%), Gaps = 82/427 (19%)
Query: 379 LDLSSNRLTGELPSTFASCSSLHSLNLGSNM---LSGNFLNTVVSKISSLIYLYVPFNNI 435
L +T + + + +L + G V +++L + N +
Sbjct: 27 TVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSIDG------VEYLNNLTQINFSNNQL 78
Query: 436 SGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELG 495
+ PL N T+L + +++N P + L + + +
Sbjct: 79 TDITPLK--NLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 136
Query: 496 SCKNLKTIDLSFNSLAGPVPSEIWS---------LPNLSDLVMWANNLTGEIPEGICVNG 546
+ TI ++ L NL+ L + +
Sbjct: 137 LELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKL 196
Query: 547 GNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNS 606
NLE+LI NN ++ P I TN+ +SL+ NQL + +L L L L NN
Sbjct: 197 TNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQ 252
Query: 607 LTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTA 666
++ P L L L L +N +S P
Sbjct: 253 ISNLAP--LSGLTKLTELKLGANQISNISPLA---------------------------- 282
Query: 667 CRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGT 726
+ + + +L YL L +N++S
Sbjct: 283 --------------------GLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDI 322
Query: 727 LPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLS 786
P SL LQ L +NK++ S L I L HN P L L+ ++
Sbjct: 323 SP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRIT 376
Query: 787 DLDVSNN 793
L +++
Sbjct: 377 QLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 95.8 bits (237), Expect = 2e-21
Identities = 56/366 (15%), Positives = 114/366 (31%), Gaps = 35/366 (9%)
Query: 101 SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSA----GDLSTSKTSSCSLVTM 156
VT+L + G+ ++ + L L +N N + +L+ + +
Sbjct: 44 DQVTTLQADRLGIK---SIDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQI 100
Query: 157 DLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALL 216
+ + L + L + + ++ + S L
Sbjct: 101 ADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLS 160
Query: 217 TYSLSNCQNLNLLNFSDNKLPGKLNATSV-----NCKSISTIDLSYNLLSGEIPASFVAD 271
+ + +L N S ++ ++ + N +S P +
Sbjct: 161 FGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT- 219
Query: 272 SSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNM 331
+L L L+ N + NL+ + L+ N +S A L L L +
Sbjct: 220 ---NLDELSLNGNQLKDIGT---LASLTNLTDLDLANNQISN---LAPLSGLTKLTELKL 270
Query: 332 SHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELP 391
N + P L L+ L L L N ++ P
Sbjct: 271 GANQISNISP------LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP 324
Query: 392 STFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRV 451
+S + L L +N +S + ++ ++++ +L N IS PL+ N T++
Sbjct: 325 --VSSLTKLQRLFFANNKVSD---VSSLANLTNINWLSAGHNQISDLTPLA--NLTRITQ 377
Query: 452 LDLSSN 457
L L+
Sbjct: 378 LGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 95.5 bits (236), Expect = 2e-21
Identities = 71/367 (19%), Positives = 121/367 (32%), Gaps = 38/367 (10%)
Query: 274 GSLKYLDLSHNNFTGKFSNLD-FGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMS 332
+ L ++D NL+ I S N L+ LKN L + M+
Sbjct: 44 DQVTTLQADRLGIK----SIDGVEYLNNLTQINFSNNQLTDIT---PLKNLTKLVDILMN 96
Query: 333 HNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQAC----------GTLRELDLS 382
+N + P L + L + L L
Sbjct: 97 NNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSL 156
Query: 383 SNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLS 442
G + ++L +L + +V++K+++L L N IS P
Sbjct: 157 QQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP-- 214
Query: 443 LTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKT 502
L T L L L+ N + + L + L NN +S P L L
Sbjct: 215 LGILTNLDELSLNGNQLK-----DIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTE 267
Query: 503 IDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGA 562
+ L N ++ P L L+ L N N NL L L N+++
Sbjct: 268 LKLGANQISNISP-----LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDI 322
Query: 563 IPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLV 622
P ++S T + + ++N+++ + + NL + L G+N ++ P L +
Sbjct: 323 SP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRIT 376
Query: 623 WLDLNSN 629
L LN
Sbjct: 377 QLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 92.0 bits (227), Expect = 3e-20
Identities = 63/390 (16%), Positives = 132/390 (33%), Gaps = 40/390 (10%)
Query: 153 LVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISG-GSLHIGPSLLQLDLSGNQIS 211
+ L N+T ++ D+++ + I + +L Q++ S NQ++
Sbjct: 24 KMKTVLGKTNVTDTVS----QTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLT 79
Query: 212 DSALLTYSLSNCQNLNLLNFSDNKLPG----KLNATSVNCKSISTIDLSYNLLSGEIPAS 267
D L N L + ++N++ + + L +
Sbjct: 80 DIT----PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135
Query: 268 FVADSSGSLKYLDLSHNNFTGKFSNLDFGRC-----GNLSVITLSQNGLSGTEFPASLKN 322
+ SS ++ + + + + NL+ + + + L
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195
Query: 323 CQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLS 382
LE+L ++N + P + NL +LSL NQ L L +LDL+
Sbjct: 196 LTNLESLIATNNQISDITPLGI---LTNLDELSLNGNQLKD--IGTLAS-LTNLTDLDLA 249
Query: 383 SNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLS 442
+N+++ P + + L L LG+N +S + + N
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISN-----ISPLAGLTALTNLELNENQLEDISP 302
Query: 443 LTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKT 502
++N L L L N + P + L+++ NN +S L + N+
Sbjct: 303 ISNLKNLTYLTLYFNNISDISPVS-----SLTKLQRLFFANNKVSD--VSSLANLTNINW 355
Query: 503 IDLSFNSLAGPVPSEIWSLPNLSDLVMWAN 532
+ N ++ P + +L ++ L +
Sbjct: 356 LSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 90.1 bits (222), Expect = 2e-19
Identities = 65/361 (18%), Positives = 121/361 (33%), Gaps = 49/361 (13%)
Query: 305 TLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGE 364
L + ++ T L + TL ++ I G + NL Q++ ++NQ
Sbjct: 28 VLGKTNVTDTVSQTDLDQ---VTTLQADRLGIKS-IDG--VEYLNNLTQINFSNNQLTDI 81
Query: 365 IPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKI-- 422
P + L ++ +++N++ P + + +L N
Sbjct: 82 TP---LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLE 138
Query: 423 ---SSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGT----IPSGFCSPPNFPA 475
+++ + S T L+ L + S
Sbjct: 139 LSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTN 198
Query: 476 LEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLT 535
LE ++ NN +S PL + NL + L+ N L + SL NL+DL + N ++
Sbjct: 199 LESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQIS 254
Query: 536 GEIPEGICVNGGNLETLILNNNHLTGAIP--------------------KSIASCTNMLW 575
P L L L N ++ P I++ N+ +
Sbjct: 255 NLAPLSGLT---KLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTY 311
Query: 576 VSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPL 635
++L N ++ P + +L KL L NN ++ L ++ WL N +S
Sbjct: 312 LTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLT 367
Query: 636 P 636
P
Sbjct: 368 P 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 73.9 bits (180), Expect = 3e-14
Identities = 41/202 (20%), Positives = 76/202 (37%), Gaps = 39/202 (19%)
Query: 155 TMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISG-GSLHIGPSLLQLDLSGNQISDS 213
++ ++N I+ P L ++L+ N + G+L +L LDL+ NQIS+
Sbjct: 201 SLIATNNQISDITPLGI----LTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNL 256
Query: 214 ALLTYSLSNCQNLNLLNFSDNKLPG--------------------KLNATSVNCKSISTI 253
A LS L L N++ + + N K+++ +
Sbjct: 257 A----PLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYL 312
Query: 254 DLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSG 313
L +N +S P S S L+ L ++N + S N++ ++ N +S
Sbjct: 313 TLYFNNISDISPVS----SLTKLQRLFFANNKVSDVSS---LANLTNINWLSAGHNQISD 365
Query: 314 TEFPASLKNCQLLETLNMSHNA 335
L N + L ++ A
Sbjct: 366 LT---PLANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 65.4 bits (158), Expect = 1e-11
Identities = 65/433 (15%), Positives = 128/433 (29%), Gaps = 95/433 (21%)
Query: 343 FLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHS 402
F + + L + + L + + ++L
Sbjct: 16 FTDTALAEKMKTVLGKTNVTDTVSQT---DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQ 70
Query: 403 LNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGT 462
+N +N L+ T + ++ L+ + + N I+ PL+ L +
Sbjct: 71 INFSNNQLTD---ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP 127
Query: 463 IPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIW--- 519
+ + + I + T +L + + N
Sbjct: 128 LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKV 187
Query: 520 -------SLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTN 572
L NL L+ N ++ P GI NL+ L LN N L ++AS TN
Sbjct: 188 SDISVLAKLTNLESLIATNNQISDITPLGILT---NLDELSLNGNQLKD--IGTLASLTN 242
Query: 573 MLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVP-------------------- 612
+ + L++NQ++ P + L KL L+LG N ++ P
Sbjct: 243 LTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDI 300
Query: 613 QGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGG 672
+ ++L +L L NN+S P + + ++ F N
Sbjct: 301 SPISNLKNLTYLTLYFNNISDISP----------VSSLTKLQRLFFANN----------- 339
Query: 673 LVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFG 732
++ + + ++ +L +N +S P
Sbjct: 340 ----------KVSDVSSLANLT-----------------NINWLSAGHNQISDLTP--LA 370
Query: 733 SLNYLQVLNLGHN 745
+L + L L
Sbjct: 371 NLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 65.4 bits (158), Expect = 2e-11
Identities = 51/316 (16%), Positives = 100/316 (31%), Gaps = 24/316 (7%)
Query: 505 LSFNSLAGPVP-SEIWSLPNLSDLV---MWANNLTGEIPEGICVNGGNLETLILNNNHLT 560
L ++ P ++I++ L++ + + N+T + + + + TL + +
Sbjct: 1 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQT---DLDQVTTLQADRLGIK 57
Query: 561 GAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRS 620
+ N+ ++ S+NQLT P + NL KL + Q
Sbjct: 58 SI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKL-------VDILMNNNQIADITPL 106
Query: 621 LVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIR 680
+L L +++ + + + L +
Sbjct: 107 ANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVT 166
Query: 681 PERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVL 740
+ + +L L + N +S P + L L
Sbjct: 167 DLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDEL 224
Query: 741 NLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIP 800
+L N+L + L + LDL++N P L GL+ L++L + N +S I P
Sbjct: 225 SLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP 280
Query: 801 SGGQLTTFPASRYENN 816
G EN
Sbjct: 281 LAGLTALTNLELNENQ 296
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 58.9 bits (141), Expect = 2e-09
Identities = 38/181 (20%), Positives = 68/181 (37%), Gaps = 31/181 (17%)
Query: 97 CSLNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTM 156
+ +++ L+LN + L + TL +L L L+L N S + L +
Sbjct: 215 LGILTNLDELSLNGNQLKD---IGTLASLTNLTDLDLANNQISN---LAPLSGLTKLTEL 268
Query: 157 DLSSNNITGSLPGRSFLLS------------------CDRLSYVNLSHNSISG-GSLHIG 197
L +N I+ P L+Y+ L N+IS +
Sbjct: 269 KLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSL 328
Query: 198 PSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSY 257
L +L + N++SD + SL+N N+N L+ N++ N I+ + L+
Sbjct: 329 TKLQRLFFANNKVSDVS----SLANLTNINWLSAGHNQISDLTPLA--NLTRITQLGLND 382
Query: 258 N 258
Sbjct: 383 Q 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 50.0 bits (118), Expect = 1e-06
Identities = 54/353 (15%), Positives = 98/353 (27%), Gaps = 64/353 (18%)
Query: 471 PNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMW 530
K VL ++ TV + T+ I S+ + L
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLG--------IKSIDGVEYLN-- 66
Query: 531 ANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAG 590
NL + +NN LT P + + T ++ + +++NQ+ P
Sbjct: 67 -----------------NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLA 107
Query: 591 IGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGI 650
+ K + + S+N + + + +
Sbjct: 108 NLTNL-----TGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFG 162
Query: 651 VSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTN 710
+ N + +L + + + + +T TN
Sbjct: 163 NQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQ--ISDITPLGILTN 220
Query: 711 GSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNN 770
L L L+ N L SL L L+L +N+++ P GL + L L N
Sbjct: 221 --LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 274
Query: 771 FQGSIP--------------------GSLGGLSFLSDLDVSNNNLSGIIPSGG 803
P + L L+ L + NN+S I P
Sbjct: 275 ISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSS 327
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 48.8 bits (115), Expect = 2e-06
Identities = 29/134 (21%), Positives = 51/134 (38%), Gaps = 11/134 (8%)
Query: 55 GGNEELTILMAFKQSSIGSDPNGYLANWTADALTPCSWQGVSCSLN-SHVTSLNLNNSGL 113
G +LT L P L T L + +S N ++T L L + +
Sbjct: 260 SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNI 319
Query: 114 SGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFL 173
S +++LT L+ L N S D+S S + ++ + N I+ P L
Sbjct: 320 SDISPVSSLTK---LQRLFFANNKVS--DVS-SLANLTNINWLSAGHNQISDLTP----L 369
Query: 174 LSCDRLSYVNLSHN 187
+ R++ + L+
Sbjct: 370 ANLTRITQLGLNDQ 383
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 93.7 bits (232), Expect = 3e-22
Identities = 31/207 (14%), Positives = 62/207 (29%), Gaps = 35/207 (16%)
Query: 934 SMIGSGGFGEVYKAQLRDGSVVAIK----------KLIHVTGQGDREFMAEMETIGKIKH 983
++G G V+ +K K+ GD F + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 984 RNLVPLLGYCKIG----EERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSA 1039
R L L G E ++ E + ++ ++
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKE------------LYRVRVENPDEVLDMIL 113
Query: 1040 RGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPG 1099
+A +H I+H D+ NVL+ E + DF + + L
Sbjct: 114 EEVAKFYH---RGIVHGDLSQYNVLVSE-EGIWIIDFPQSV---EVGEEGWREILERDVR 166
Query: 1100 YVPPEYYQSFRCTTKGDVYSYGVILLE 1126
+ + +++R T+ D+ S +L+
Sbjct: 167 NIITYFSRTYR--TEKDINSAIDRILQ 191
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.6 bits (223), Expect = 2e-20
Identities = 47/270 (17%), Positives = 89/270 (32%), Gaps = 11/270 (4%)
Query: 364 EIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKIS 423
+P + + + L NR++ ++F +C +L L L SN+L+
Sbjct: 25 AVPVGIPA---ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81
Query: 424 SLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPN 483
+ P + +L L L G P F L+ + L +
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA---LQYLYLQD 138
Query: 484 NYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGIC 543
N L NL + L N ++ L +L L++ N + P
Sbjct: 139 NALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR 198
Query: 544 VNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLG 603
G + + NN +++A + ++ L+ N + A L +
Sbjct: 199 DLGRLMTLYLFANNLSA-LPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGS 256
Query: 604 NNSLTGQVPQGLGKCRSLVWLDLNSNNLSG 633
++ + +PQ L L +N+L G
Sbjct: 257 SSEVPCSLPQRL---AGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.6 bits (202), Expect = 1e-17
Identities = 53/323 (16%), Positives = 89/323 (27%), Gaps = 54/323 (16%)
Query: 451 VLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSL 510
G +P G P ++I L N +S +C+NL + L N L
Sbjct: 15 TTSCPQQGLQ-AVPVGI--PAA---SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL 68
Query: 511 AGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASC 570
A + L L L + N + G L TL L+ L P
Sbjct: 69 ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGL 128
Query: 571 TNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNN 630
+ ++ L N L +L L L L N ++ + SL L L+ N
Sbjct: 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR 188
Query: 631 LSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMV 690
++ P + ++
Sbjct: 189 VAHVHPHAFRDL--------------------------------------------GRLM 204
Query: 691 HSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGH 750
+ + +L YL L+ N +LQ +++
Sbjct: 205 TLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD-CRARPLWAWLQKFRGSSSEVPCS 263
Query: 751 IPDSFGGLKAIGVLDLSHNNFQG 773
+P G + L+ N+ QG
Sbjct: 264 LPQRLAGRD---LKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.4 bits (173), Expect = 6e-14
Identities = 54/287 (18%), Positives = 92/287 (32%), Gaps = 12/287 (4%)
Query: 175 SCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDN 234
+ + + + I + ++ L GN+IS + S C+NL +L N
Sbjct: 9 YNEPKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISH--VPAASFRACRNLTILWLHSN 66
Query: 235 KLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLD 294
L A + +DLS N + + G L L L
Sbjct: 67 VLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATF-HGLGRLHTLHLDRCGLQELGPG-L 124
Query: 295 FGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQL 354
F L + L N L + ++ L L + N + +P +L +L
Sbjct: 125 FRGLAALQYLYLQDNALQALP-DDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRL 182
Query: 355 SLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNF 414
L N+ A + P + G L L L +N L+ A +L L L N +
Sbjct: 183 LLHQNRVAH-VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241
Query: 415 LNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTG 461
+ L + + +P L + L++N G
Sbjct: 242 --RARPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.4 bits (160), Expect = 3e-12
Identities = 51/309 (16%), Positives = 83/309 (26%), Gaps = 50/309 (16%)
Query: 489 TVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGN 548
VP+ + + + I L N ++ + + NL+ L + +N L
Sbjct: 25 AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 549 LETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLT 608
+ + +N L P + + + L L P L L L L +N+L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 609 GQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACR 668
+L L L+ N +S
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRG--------------------------- 175
Query: 669 GAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLP 728
+ L + H P G M L N+LS
Sbjct: 176 -------LHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL----------YLFANNLSALPT 218
Query: 729 ENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDL 788
E L LQ L L N + + S + S+P L G
Sbjct: 219 EALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQRLAGRDL---K 274
Query: 789 DVSNNNLSG 797
++ N+L G
Sbjct: 275 RLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.1 bits (149), Expect = 7e-11
Identities = 45/261 (17%), Positives = 87/261 (33%), Gaps = 10/261 (3%)
Query: 152 SLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQIS 211
+ + L N I+ + +++ + + + G +LL+ +
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 212 DSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVAD 271
++ + L+ L+ L ++ + L N L +F
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTF--R 150
Query: 272 SSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNM 331
G+L +L L N + F +L + L QN ++ P + ++ L TL +
Sbjct: 151 DLGNLTHLFLHGNRISSVPERA-FRGLHSLDRLLLHQNRVAHV-HPHAFRDLGRLMTLYL 208
Query: 332 SHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELP 391
N +P L R L+ L L N + + L++ SS+ + LP
Sbjct: 209 FANN-LSALPTEALAPLRALQYLRLNDNPWVCDCR--ARPLWAWLQKFRGSSSEVPCSLP 265
Query: 392 STFASCSSLHSLNLGSNMLSG 412
A L +N L G
Sbjct: 266 QRLA---GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.5 bits (137), Expect = 3e-09
Identities = 54/306 (17%), Positives = 93/306 (30%), Gaps = 29/306 (9%)
Query: 89 PCSWQGVSCSLNSHVTSLNLNNSGLSGSLNLTTLTALP-----YLEHLNLQGNSFSA-GD 142
PC C N + + GL A+P + + L GN S
Sbjct: 1 PCP-GACVCY-NEPKVTTSCPQQGL---------QAVPVGIPAASQRIFLHGNRISHVPA 49
Query: 143 LSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQ 202
S + +++ + + + L N S+ + H L
Sbjct: 50 ASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHT 109
Query: 203 LDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSG 262
L L + + L L L DN L + T + +++ + L N +S
Sbjct: 110 LHLDRCGLQE--LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS 167
Query: 263 EIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKN 322
+F SL L L N + F G L + L N LS A
Sbjct: 168 VPERAF--RGLHSLDRLLLHQNRVAHVHPHA-FRDLGRLMTLYLFANNLSALPTEAL-AP 223
Query: 323 CQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLS 382
+ L+ L ++ N + L++ + ++ +P L L+
Sbjct: 224 LRALQYLRLNDNPWVCDCR--ARPLWAWLQKFRGSSSEVPCSLPQRLAG----RDLKRLA 277
Query: 383 SNRLTG 388
+N L G
Sbjct: 278 ANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.8 bits (130), Expect = 2e-08
Identities = 44/255 (17%), Positives = 74/255 (29%), Gaps = 33/255 (12%)
Query: 576 VSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPL 635
S L +P GI + + L N ++ CR+L L L+SN L+
Sbjct: 16 TSCPQQGLQ-AVPVGIPAASQ--RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72
Query: 636 PSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPS 695
+ A + + Q V L E G +
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132
Query: 696 TRIYTGMTMY-----TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGH 750
+ TF G+L +L L N +S F L+ L L L N++
Sbjct: 133 YLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192
Query: 751 IPDSFGGLKAIG------------------------VLDLSHNNFQGSIPGSLGGLSFLS 786
P +F L + L L+ N + + ++L
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQ 251
Query: 787 DLDVSNNNLSGIIPS 801
S++ + +P
Sbjct: 252 KFRGSSSEVPCSLPQ 266
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.3 bits (126), Expect = 7e-08
Identities = 41/238 (17%), Positives = 65/238 (27%), Gaps = 22/238 (9%)
Query: 604 NNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEG 663
L VP G+ + + L+ N +S + + + + S
Sbjct: 20 QQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF 76
Query: 664 GTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSL 723
+ TF G L L L L
Sbjct: 77 TGLA-------------------LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL 117
Query: 724 SGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLS 783
P F L LQ L L N L D+F L + L L N + GL
Sbjct: 118 QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH 177
Query: 784 FLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPLLPCSSGNHAATVHPHEN 841
L L + N ++ + P + + Y + L LP + + ++N
Sbjct: 178 SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 90.1 bits (222), Expect = 5e-20
Identities = 57/338 (16%), Positives = 110/338 (32%), Gaps = 41/338 (12%)
Query: 437 GPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGS 496
GPV C LRV+ S G +P PP+ + L NN ++ + +
Sbjct: 1 GPVCPFRCQC-HLRVVQCSDLGLE-KVPKDL--PPD---TALLDLQNNKITEIKDGDFKN 53
Query: 497 CKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNN 556
KNL T+ L N ++ P L L L + N L E+PE + L
Sbjct: 54 LKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEI 112
Query: 557 NHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLG 616
+ ++ + + ++ + + + +G + KL+ +++ + ++T +PQGL
Sbjct: 113 TKVRKSVFNGL-NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL- 169
Query: 617 KCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEF 676
SL L L+ N ++ + L + G+
Sbjct: 170 -PPSLTELHLDGNKITKVDAASLKGLNNLAKLGL---------------------SFNSI 207
Query: 677 EGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSG------TLPEN 730
+ L P + + + + L N++S P
Sbjct: 208 SAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGY 267
Query: 731 FGSLNYLQVLNLGHNKLTGH--IPDSFGGLKAIGVLDL 766
++L N + P +F + + L
Sbjct: 268 NTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 87.0 bits (214), Expect = 5e-19
Identities = 58/275 (21%), Positives = 112/275 (40%), Gaps = 19/275 (6%)
Query: 364 EIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKIS 423
++P +L LDL +N++T F + +LH+L L +N +S + +
Sbjct: 24 KVPKDLPP---DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK-ISPGAFAPLV 79
Query: 424 SLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPN 483
L LY+ N + L L+ L + N T S F +E +
Sbjct: 80 KLERLYLSKNQLKE---LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNP 135
Query: 484 NYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGIC 543
SG K L I ++ ++ +P + P+L++L + N +T +
Sbjct: 136 LKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGL--PPSLTELHLDGNKITKVDAASLK 192
Query: 544 VNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLG 603
NL L L+ N ++ S+A+ ++ + L++N+L ++P G+ + + ++ L
Sbjct: 193 -GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLH 250
Query: 604 NNSLTG------QVPQGLGKCRSLVWLDLNSNNLS 632
NN+++ P K S + L SN +
Sbjct: 251 NNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 78.5 bits (192), Expect = 4e-16
Identities = 68/325 (20%), Positives = 114/325 (35%), Gaps = 38/325 (11%)
Query: 90 CSWQGVSCSLNSHVTSLNLNNSGLSGSLNLTTLTA--LPYLEHLNLQGNSFSAGDLSTSK 147
C + V CS L L + P L+LQ N +
Sbjct: 10 CHLRVVQCS-----------------DLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDF 51
Query: 148 TSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSG 207
+ +L T+ L +N I+ PG +L + LS N + + +L +L +
Sbjct: 52 KNLKNLHTLILINNKISKISPG--AFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHE 109
Query: 208 NQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPAS 267
N+I+ ++ N + L + K G N K +S I ++ ++ IP
Sbjct: 110 NEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQG 168
Query: 268 FVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLE 327
SL L L N T + NL+ + LS N +S SL N L
Sbjct: 169 L----PPSLTELHLDGNKITKVDAA-SLKGLNNLAKLGLSFNSISAV-DNGSLANTPHLR 222
Query: 328 TLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAG-----EIPPELGQACGTLRELDLS 382
L++++N L G + ++ + L +N + PP + + L
Sbjct: 223 ELHLNNNKLVKVPGGL--ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLF 280
Query: 383 SNRLTGE--LPSTFASCSSLHSLNL 405
SN + PSTF ++ L
Sbjct: 281 SNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 78.5 bits (192), Expect = 4e-16
Identities = 56/289 (19%), Positives = 97/289 (33%), Gaps = 21/289 (7%)
Query: 175 SCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDN 234
C L V S + + P LDL N+I++ + N +NL+ L +N
Sbjct: 9 QCH-LRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITE--IKDGDFKNLKNLHTLILINN 65
Query: 235 KLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLD 294
K+ + + LS N L E+P + L + N T ++
Sbjct: 66 KISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTL----QELRVHENEITKVRKSVF 120
Query: 295 FGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQL 354
G + V + S + + + L + ++ + G +L +L
Sbjct: 121 NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL----PPSLTEL 176
Query: 355 SLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNF 414
L N+ L L +L LS N ++ + A+ L L+L +N L
Sbjct: 177 HLDGNKITKVDAASLKG-LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP 235
Query: 415 LNTVVSKISSLIYLYVPFNNISG------PVPLSLTNCTQLRVLDLSSN 457
+ + +Y+ NNIS P T + L SN
Sbjct: 236 GGL--ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 282
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 76.6 bits (187), Expect = 2e-15
Identities = 50/270 (18%), Positives = 90/270 (33%), Gaps = 29/270 (10%)
Query: 532 NNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGI 591
L ++P+ + + L L NN +T + N+ + L +N+++ P
Sbjct: 20 LGLE-KVPKDL---PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 75
Query: 592 GNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIV 651
LVKL L L N L + + L + + + + L V +
Sbjct: 76 APLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN- 134
Query: 652 SGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNG 711
++ GI +G + T +T
Sbjct: 135 ---------------------PLKSSGIENGAFQGMKKLSYIRIA--DTNITTIPQGLPP 171
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
SL L L N ++ + LN L L L N ++ S + L L++N
Sbjct: 172 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 231
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIPS 801
+PG L ++ + + NNN+S I +
Sbjct: 232 V-KVPGGLADHKYIQVVYLHNNNISAIGSN 260
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 73.5 bits (179), Expect = 2e-14
Identities = 56/270 (20%), Positives = 93/270 (34%), Gaps = 27/270 (10%)
Query: 548 NLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSL 607
+L + ++ L +PK + T +L L +N++T NL L L L NN +
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLPPDTALLD--LQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 608 TGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTAC 667
+ P L L L+ N L LP ++ ++ NE
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKE-LPEKMPKT----------LQELRVHENEITKVR 116
Query: 668 RGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTL 727
+ L +V + +G+ F L Y+ ++ +++
Sbjct: 117 KSVFN----------GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIP 166
Query: 728 PENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSD 787
SL L+L NK+T S GL + L LS N+ GSL L +
Sbjct: 167 QGLPPSL---TELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRE 223
Query: 788 LDVSNNNLSGIIPSGGQLTTFPASRYENNS 817
L ++NN L + NN+
Sbjct: 224 LHLNNNKLVKVPGGLADHKYIQVVYLHNNN 253
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 72.4 bits (176), Expect = 4e-14
Identities = 52/247 (21%), Positives = 86/247 (34%), Gaps = 32/247 (12%)
Query: 411 SGNFLNTVVSKIS-SLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCS 469
S L V + L + N I+ N L L L +N + P F
Sbjct: 18 SDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFA- 76
Query: 470 PPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLA------------------ 511
LE++ L N L + + L+ + +
Sbjct: 77 --PLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN 134
Query: 512 -----GPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKS 566
G + LS + + N+T IP+G+ +L L L+ N +T S
Sbjct: 135 PLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP---PSLTELHLDGNKITKVDAAS 190
Query: 567 IASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDL 626
+ N+ + LS N ++ + N L L L NN L +VP GL + + + L
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 249
Query: 627 NSNNLSG 633
++NN+S
Sbjct: 250 HNNNISA 256
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 56.2 bits (134), Expect = 9e-09
Identities = 25/120 (20%), Positives = 44/120 (36%), Gaps = 3/120 (2%)
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNF 771
LDL N ++ +F +L L L L +NK++ P +F L + L LS N
Sbjct: 32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91
Query: 772 QGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPLLPCSSGN 831
+ +P + L +L V N ++ + S + L + +
Sbjct: 92 K-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 148
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.0 bits (180), Expect = 7e-15
Identities = 34/208 (16%), Positives = 54/208 (25%), Gaps = 5/208 (2%)
Query: 566 SIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLD 625
++ + L V+ LT +P + IL L N L L L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKDTT--ILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 626 LNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLE 685
L+ L+ G + + + + L
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 686 GFPMVHSCPSTRIYTGMTMYTFTTNGSLIYL-DLSYNSLSGTLPENFGSLNYLQVLNLGH 744
G + T + L+ N+L+ L L L L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 745 NKLTGHIPDSFGGLKAIGVLDLSHNNFQ 772
N L IP F G + L N +
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.1 bits (131), Expect = 1e-08
Identities = 39/213 (18%), Positives = 60/213 (28%), Gaps = 11/213 (5%)
Query: 396 SCSSLHSLNLGSNMLSGNFLNTVVSKIS-SLIYLYVPFNNISGPVPLSLTNCTQLRVLDL 454
S + S + L + + L++ N + +L T+L L+L
Sbjct: 5 EVSKVASHLEVN--CDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 455 SSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPV 514
T P L + L +N L L + +
Sbjct: 63 DRAELTK-----LQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS--L 115
Query: 515 PSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNML 574
P + N +P G+ LE L L NN+LT + N+
Sbjct: 116 PLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD 175
Query: 575 WVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSL 607
+ L N L IP G L L N
Sbjct: 176 TLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.8 bits (125), Expect = 9e-08
Identities = 36/194 (18%), Positives = 65/194 (33%), Gaps = 12/194 (6%)
Query: 364 EIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKIS 423
+PP+L + L LS N L +T + L LNL L+ ++ + +
Sbjct: 24 ALPPDLPK---DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLG 80
Query: 424 SLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPN 483
+L + ++ + ++ G + +
Sbjct: 81 TLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL-------KG 133
Query: 484 NYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGIC 543
N L P L L+ + L+ N+L + L NL L++ N+L IP+G
Sbjct: 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF 192
Query: 544 VNGGNLETLILNNN 557
L L+ N
Sbjct: 193 -GSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 2e-07
Identities = 38/189 (20%), Positives = 61/189 (32%), Gaps = 10/189 (5%)
Query: 442 SLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLK 501
++ ++ T +P P + + L N L L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDL--PKD---TTILHLSENLLYTFSLATLMPYTRLT 58
Query: 502 TIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTG 561
++L +LP L L + N L G + L L ++ N LT
Sbjct: 59 QLNLDRAE--LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLP--ALTVLDVSFNRLTS 114
Query: 562 AIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSL 621
++ + + L N+L P + KL L L NN+LT L +L
Sbjct: 115 LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENL 174
Query: 622 VWLDLNSNN 630
L L N+
Sbjct: 175 DTLLLQENS 183
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.4 bits (111), Expect = 5e-06
Identities = 34/218 (15%), Positives = 55/218 (25%), Gaps = 16/218 (7%)
Query: 294 DFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQ 353
+ + + + + L T P L + L++S N L L + L Q
Sbjct: 5 EVSKVASHLEVNCDKRNL--TALPPDL--PKDTTILHLSENLLYTFSLATL-MPYTRLTQ 59
Query: 354 LSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGN 413
L+L + GTL L + L +
Sbjct: 60 LNLDRAELTKLQV------DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT 113
Query: 414 FLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSS-NGFTGTIPSGFCSPPN 472
L + + N +P L T + N T
Sbjct: 114 SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLN---G 170
Query: 473 FPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSL 510
L+ ++L N L T+P L L N
Sbjct: 171 LENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 7e-06
Identities = 36/214 (16%), Positives = 66/214 (30%), Gaps = 14/214 (6%)
Query: 246 NCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVIT 305
S ++ L+ +P L LS N FS L+ +
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDL----PKDTTILHLSENLLYT-FSLATLMPYTRLTQLN 61
Query: 306 LSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEI 365
L + L+ + +L L+ + +L + +
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQ------TLPALTVLDVSFNRLTSL 115
Query: 366 PPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSL 425
P + G L+EL L N L P L L+L +N L+ +++ + +L
Sbjct: 116 PLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENL 174
Query: 426 IYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGF 459
L + N++ +P L L N +
Sbjct: 175 DTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (107), Expect = 1e-05
Identities = 37/215 (17%), Positives = 55/215 (25%), Gaps = 15/215 (6%)
Query: 175 SCDRLS---YVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNF 231
+++ VN +++ + L LS N + +L L LN
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYT--FSLATLMPYTRLTQLNL 62
Query: 232 SDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFS 291
+ + + L LS S L +
Sbjct: 63 DRAE-------LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSL 115
Query: 292 NLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNL 351
L R + T P L LE L++++N L G L NL
Sbjct: 116 PLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGL-LNGLENL 174
Query: 352 KQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRL 386
L L N IP L L N
Sbjct: 175 DTLLLQENSLY-TIPKGFFG-SHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.5 bits (106), Expect = 2e-05
Identities = 35/216 (16%), Positives = 58/216 (26%), Gaps = 28/216 (12%)
Query: 532 NNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGI 591
NLT +P + + L L+ N L ++ T + ++L +LT
Sbjct: 20 RNLT-ALPPDL---PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT------- 68
Query: 592 GNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIV 651
QV L +L +L + A V +
Sbjct: 69 ----------------KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRL 112
Query: 652 SGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNG 711
+ +R G G + + T +
Sbjct: 113 TSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLE 172
Query: 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKL 747
+L L L NSL T+P+ F + L L N
Sbjct: 173 NLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.4 bits (98), Expect = 2e-04
Identities = 38/210 (18%), Positives = 67/210 (31%), Gaps = 15/210 (7%)
Query: 199 SLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYN 258
S L+++ ++ L L ++ +L+ S+N L AT + ++ ++L
Sbjct: 11 SHLEVNCDKRNLTA---LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 259 LLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPA 318
L+ L L + S G+ + +
Sbjct: 66 ELTKLQVDGT-------LPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 319 SLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRE 378
+L+ L+ L + N L+ PG L + + N E+P L L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPG--LLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176
Query: 379 LDLSSNRLTGELPSTFASCSSLHSLNLGSN 408
L L N L +P F L L N
Sbjct: 177 LLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (92), Expect = 0.001
Identities = 12/64 (18%), Positives = 21/64 (32%), Gaps = 3/64 (4%)
Query: 731 FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDV 790
+ +N LT +P K +L LS N +L + L+ L++
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 791 SNNN 794
Sbjct: 63 DRAE 66
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 66.8 bits (161), Expect = 4e-12
Identities = 55/340 (16%), Positives = 103/340 (30%), Gaps = 27/340 (7%)
Query: 446 CTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDL 505
Q L+L++ G + ++P PP+ LE +V N L+ +P +LK++ +
Sbjct: 37 DRQAHELELNNLGLS-SLPE---LPPH---LESLVASCNSLT-ELPELPQ---SLKSLLV 85
Query: 506 SFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPK 565
N+L + LP L + + +NN ++PE + L+ + ++NN L
Sbjct: 86 DNNNLKA-----LSDLPPLLEYLGVSNNQLEKLPELQNSS--FLKIIDVDNNSLKKLPDL 138
Query: 566 SIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLD 625
+ + + + + L + + L L
Sbjct: 139 PPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELP 198
Query: 626 LNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLE 685
N N + S + N L +
Sbjct: 199 ELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSG 258
Query: 686 GFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHN 745
+ + + SL L++S N L LP L+ L N
Sbjct: 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFN 314
Query: 746 KLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFL 785
L +P+ LK L + +N + P + L
Sbjct: 315 HLA-EVPELPQNLK---QLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.1 bits (136), Expect = 5e-09
Identities = 22/116 (18%), Positives = 37/116 (31%), Gaps = 8/116 (6%)
Query: 691 HSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGH 750
P + + ++ F+ L N+ S + L+ LN+ +NKL
Sbjct: 240 PELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-E 298
Query: 751 IPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLT 806
+P L+ L S N+ +P L L V N L +
Sbjct: 299 LPALPPRLE---RLIASFNHLA-EVPELPQNLKQ---LHVEYNPLREFPDIPESVE 347
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.8 bits (130), Expect = 3e-08
Identities = 52/341 (15%), Positives = 98/341 (28%), Gaps = 34/341 (9%)
Query: 99 LNSHVTSLNLNNSGLSGSLNLTTLTA-LPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMD 157
L+ L LNN L L++L P+LE L NS L+ SL ++
Sbjct: 36 LDRQAHELELNN------LGLSSLPELPPHLESLVASCNS-----LTELPELPQSLKSLL 84
Query: 158 LSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLT 217
+ +NN+ L + + S + L +L
Sbjct: 85 VDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEF 144
Query: 218 YSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLK 277
+ N Q L + + A + + K + + LS + +L
Sbjct: 145 IAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLP 204
Query: 278 YLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQ 337
+L + + + D + + + +
Sbjct: 205 FLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPP 264
Query: 338 --------GGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGE 389
L +L++L++++N+ E+P + L L S N L E
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR----LERLIASFNHLA-E 318
Query: 390 LPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYV 430
+P + LH + N L S+ L +
Sbjct: 319 VPELPQNLKQLH--------VEYNPLREFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.1 bits (128), Expect = 6e-08
Identities = 51/330 (15%), Positives = 94/330 (28%), Gaps = 20/330 (6%)
Query: 247 CKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFT---GKFSNLDFGRCGNLSV 303
+ ++L+ LS +P + L+ L S N+ T +L N ++
Sbjct: 37 DRQAHELELNNLGLS-SLP-----ELPPHLESLVASCNSLTELPELPQSLKSLLVDNNNL 90
Query: 304 ITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAG 363
LS S + L L S + L +L
Sbjct: 91 KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNN 150
Query: 364 EIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKIS 423
++ + N +LP S S+ + N L ++ I
Sbjct: 151 QLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIY 210
Query: 424 SLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPN 483
+ L ++ + + L +
Sbjct: 211 ADNNLLKTLPDLPPSLEALNVRDNY-LTDLPELPQSLTFLDVSENIFSGLSELPPNLYYL 269
Query: 484 NYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGIC 543
N S + +L+ +++S N L +P+ P L L+ N+L E+PE
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLA-EVPELP- 323
Query: 544 VNGGNLETLILNNNHLTGAIPKSIASCTNM 573
NL+ L + N L P S ++
Sbjct: 324 ---QNLKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.3 bits (126), Expect = 9e-08
Identities = 49/328 (14%), Positives = 89/328 (27%), Gaps = 22/328 (6%)
Query: 275 SLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHN 334
L+L++ + +L + S N L TE P ++ + L N +
Sbjct: 39 QAHELELNNLGLSSLPELP-----PHLESLVASCNSL--TELPELPQSLKSLLVDNNNLK 91
Query: 335 ALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTF 394
AL P N + L Q + + + DL + +
Sbjct: 92 ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQ 151
Query: 395 ASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDL 454
+ + + L + N L N L +
Sbjct: 152 LEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYA 211
Query: 455 SSNGFTGTIPSGFCSPPNFPALEKI-----VLPNNYLSGTVPLELGSCKNLKTIDLSFNS 509
+N + + + L N+
Sbjct: 212 DNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNA 271
Query: 510 LAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIAS 569
+ + S P+L +L + N L E+P LE LI + NHL +P+
Sbjct: 272 SSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP----PRLERLIASFNHLA-EVPELP-- 323
Query: 570 CTNMLWVSLSSNQLTGEIPAGIGNLVKL 597
N+ + + N L E P ++ L
Sbjct: 324 -QNLKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.3 bits (126), Expect = 1e-07
Identities = 45/335 (13%), Positives = 100/335 (29%), Gaps = 31/335 (9%)
Query: 320 LKNCQL--LETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLR 377
L++C L +++ L +P +L+ L + N E+P L+
Sbjct: 32 LRDCLDRQAHELELNNLGLSS-LPELP----PHLESLVASCNSLT-ELPELPQS----LK 81
Query: 378 ELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISG 437
L + +N L S N + + + L +
Sbjct: 82 SLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPS 141
Query: 438 PVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSC 497
++ N + +L + F I + S P L + + +
Sbjct: 142 LEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQ 201
Query: 498 KNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETL----- 552
+ ++ ++ ++ E+P+ + +
Sbjct: 202 NLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSE 261
Query: 553 ----ILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLT 608
+ N + I ++ +++S+N+L E+PA L +L N L
Sbjct: 262 LPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA 317
Query: 609 GQVPQGLGKCRSLVWLDLNSNNLSG--PLPSELAN 641
+VP+ +L L + N L +P + +
Sbjct: 318 -EVPELPQ---NLKQLHVEYNPLREFPDIPESVED 348
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.5 bits (124), Expect = 2e-07
Identities = 52/340 (15%), Positives = 97/340 (28%), Gaps = 30/340 (8%)
Query: 297 RCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSL 356
+ L+ GL + P + LE+L S N+L +P ++LK L +
Sbjct: 36 LDRQAHELELNNLGL--SSLPELPPH---LESLVASCNSLT-ELPELP----QSLKSLLV 85
Query: 357 AHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLN 416
+N + L +SL ++
Sbjct: 86 DNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFI 145
Query: 417 TVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPAL 476
+ + ++ + + + + G
Sbjct: 146 AAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPF 205
Query: 477 EKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWA----- 531
+ +N L T+P S + L D L S + + + +
Sbjct: 206 LTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPN 265
Query: 532 ---NNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIP 588
N + +C +LE L ++NN L +P + + S N L E+P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVP 320
Query: 589 AGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNS 628
NL + L + N L + P S+ L +NS
Sbjct: 321 ELPQNLKQ---LHVEYNPLR-EFPDIPE---SVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.0 bits (120), Expect = 5e-07
Identities = 48/332 (14%), Positives = 96/332 (28%), Gaps = 27/332 (8%)
Query: 199 SLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKL------PGKLNATSVNCKSIST 252
+L+L+ +S L + ++L S N L P L + V+ ++
Sbjct: 39 QAHELELNNLGLSS---LPELPPHLESLVA---SCNSLTELPELPQSLKSLLVDNNNLKA 92
Query: 253 IDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLS 312
+ LL ++ + L+ N + +L +
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNS---SFLKIIDVDNNSLKKLPDLPPSLEFIAAGN 149
Query: 313 GTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQA 372
T + N +P L + ++ + P L
Sbjct: 150 NQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTI 209
Query: 373 CGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPF 432
L + L ++ + + S +S L
Sbjct: 210 YADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYL 269
Query: 433 NNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPL 492
N S + L L++S+N +P+ LE+++ N+L+ VP
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR------LERLIASFNHLA-EVP- 320
Query: 493 ELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNL 524
+NLK + + +N L P S+ +L
Sbjct: 321 --ELPQNLKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.6 bits (119), Expect = 6e-07
Identities = 50/338 (14%), Positives = 97/338 (28%), Gaps = 29/338 (8%)
Query: 497 CKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNN 556
+ ++L+ L+ +P P+L LV N+LT E+PE +L++L+++N
Sbjct: 37 DRQAHELELNNLGLSS-LPELP---PHLESLVASCNSLT-ELPELPQ----SLKSLLVDN 87
Query: 557 NHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLG 616
N+L + L L ++ + L + L++ +
Sbjct: 88 NNLK---------ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDL 138
Query: 617 KCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEF 676
N+ P L + K +
Sbjct: 139 PPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELP 198
Query: 677 EGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNY 736
E L ++ T ++ + + L + +
Sbjct: 199 ELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSG 258
Query: 737 LQVL---NLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNN 793
L L N + I ++ L++S+N +P L L S N
Sbjct: 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFN 314
Query: 794 NLSGIIPSGGQLTTFPASRYENNSGLCGLPLLPCSSGN 831
+L+ + L E N L P +P S +
Sbjct: 315 HLAEVPELPQNLKQL---HVEYNP-LREFPDIPESVED 348
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 3e-06
Identities = 53/328 (16%), Positives = 95/328 (28%), Gaps = 20/328 (6%)
Query: 128 LEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHN 187
L L LS+ L ++ S N++T LP L + NL
Sbjct: 40 AHELELNNL-----GLSSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93
Query: 188 SISGGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNC 247
S L ++ +S+ L + +L L L +
Sbjct: 94 SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLE 153
Query: 248 KSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLS 307
+ +L + S L + N + ++ +
Sbjct: 154 ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADN 213
Query: 308 QNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQF----AG 363
+ + P SL+ + + L + + L N + +
Sbjct: 214 NLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 273
Query: 364 EIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKIS 423
L +L EL++S+N+L ELP+ L L S N L V
Sbjct: 274 NEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIA-----SFNHLAEVPELPQ 324
Query: 424 SLIYLYVPFNNISGPVPLSLTNCTQLRV 451
+L L+V +N + P + LR+
Sbjct: 325 NLKQLHVEYNPLRE-FPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 4e-06
Identities = 52/324 (16%), Positives = 91/324 (28%), Gaps = 23/324 (7%)
Query: 152 SLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQIS 211
++L++ ++ SLP L + S NS++ SL L + N +
Sbjct: 39 QAHELELNNLGLS-SLPE-----LPPHLESLVASCNSLTELPELPQ-SLKSLLVDNNNLK 91
Query: 212 DSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVAD 271
+ L L N +L ++ + S L S E A+
Sbjct: 92 ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQ 151
Query: 272 SSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPA------SLKNCQL 325
+ +L +N + G + E L
Sbjct: 152 LEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYA 211
Query: 326 LETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNR 385
L + L + + L + ++ + L N
Sbjct: 212 DNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNA 271
Query: 386 LTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTN 445
+ E+ S SL LN +S N L + + L L FN+++ VP N
Sbjct: 272 SSNEIRSLCDLPPSLEELN-----VSNNKLIELPALPPRLERLIASFNHLAE-VPELPQN 325
Query: 446 CTQLRVLDLSSNGFTGTIPSGFCS 469
L+ L + N P S
Sbjct: 326 ---LKQLHVEYNPLR-EFPDIPES 345
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 5e-05
Identities = 15/80 (18%), Positives = 32/80 (40%), Gaps = 10/80 (12%)
Query: 151 CSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQI 210
SL +++S+N + LP RL + S N ++ +L QL + N +
Sbjct: 284 PSLEELNVSNNKLI-ELPA-----LPPRLERLIASFNHLAEVPELPQ-NLKQLHVEYNPL 336
Query: 211 SDSALLTYSLSNCQNLNLLN 230
+ + ++L + +
Sbjct: 337 RE---FPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.5 bits (98), Expect = 2e-04
Identities = 50/328 (15%), Positives = 93/328 (28%), Gaps = 16/328 (4%)
Query: 176 CDRLSYVNLSHNSISGGSL-HIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDN 234
+ + L++ +S SL + P L L S N +++ L SL + N + +
Sbjct: 37 DRQAHELELNNLGLS--SLPELPPHLESLVASCNSLTELPELPQSLKSLLVDNNNLKALS 94
Query: 235 KLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLD 294
LP L V+ + + N +I G +
Sbjct: 95 DLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEE 154
Query: 295 FGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGF-LLGSFRNLKQ 353
NL +T + + L + + L +
Sbjct: 155 LPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNN 214
Query: 354 LSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGN 413
L + + +L + ++ S S NL S N
Sbjct: 215 LLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSN 274
Query: 414 FLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNF 473
+ ++ SL L V N + +P L L S N +P +
Sbjct: 275 EIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-EVPELPQN---- 325
Query: 474 PALEKIVLPNNYLSGTVPLELGSCKNLK 501
L+++ + N L P S ++L+
Sbjct: 326 --LKQLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.7 bits (96), Expect = 4e-04
Identities = 18/98 (18%), Positives = 28/98 (28%), Gaps = 8/98 (8%)
Query: 735 NYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNN 794
L L + L+ +P+ L+ L S N+ +P L L V NNN
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPELPQSLKS---LLVDNNN 89
Query: 795 LSGIIPSGGQLTTFPASRYENNSGLCGLPLLPCSSGNH 832
L + L S + +
Sbjct: 90 LKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDV 127
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.002
Identities = 17/88 (19%), Positives = 36/88 (40%), Gaps = 16/88 (18%)
Query: 195 HIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTID 254
+ PSL +L++S N++ + L + L ++P +++ +
Sbjct: 281 DLPPSLEELNVSNNKLIE---LPALPPRLERLIASFNHLAEVPELP-------QNLKQLH 330
Query: 255 LSYNLLSGEIPASFVADSSGSLKYLDLS 282
+ YN L E P D S++ L ++
Sbjct: 331 VEYNPLR-EFP-----DIPESVEDLRMN 352
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.4 bits (150), Expect = 6e-11
Identities = 46/282 (16%), Positives = 90/282 (31%), Gaps = 20/282 (7%)
Query: 252 TIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGL 311
T+DL+ L ++ + S + + + + + LS + +
Sbjct: 4 TLDLTGKNLHPDVTGRLL---SQGVIAFRCPRSFMDQ--PLAEHFSPFRVQHMDLSNSVI 58
Query: 312 SGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQ-FAGEIPPELG 370
+ L C L+ L++ L I L NL +L+L+ F+ L
Sbjct: 59 EVSTLHGILSQCSKLQNLSLEGLRLSDPIV-NTLAKNSNLVRLNLSGCSGFSEFALQTLL 117
Query: 371 QACGTLRELDL------SSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISS 424
+C L EL+L + + + + + L+ N+ + V +
Sbjct: 118 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL 177
Query: 425 LIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNN 484
+ + L+ L LS IP P L+ + +
Sbjct: 178 VHLDLSDSVMLKNDCFQEFFQLNYLQHLSLS--RCYDIIPETLLELGEIPTLKTLQVFGI 235
Query: 485 YLSGTVPLELGSCKNLKTIDLSFNSLAGPV-----PSEIWSL 521
GT+ L + +L+ F ++A P EIW +
Sbjct: 236 VPDGTLQLLKEALPHLQINCSHFTTIARPTIGNKKNQEIWGI 277
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.9 bits (146), Expect = 2e-10
Identities = 37/245 (15%), Positives = 75/245 (30%), Gaps = 14/245 (5%)
Query: 401 HSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFT 460
+L+L L + ++S+ +I P + + P+ + +++ +DLS++
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ--GVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIE 59
Query: 461 GTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSF--NSLAGPVPSEI 518
+ G S L+ + L LS + L NL ++LS + + +
Sbjct: 60 VSTLHGILS--QCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL 117
Query: 519 WSLPNLSDLVMWANNLTG------EIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTN 572
S L +L + + + N +
Sbjct: 118 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL 177
Query: 573 MLWVSLSSNQLTGEIPAGIGNLVKLAILQLGN-NSLTGQVPQGLGKCRSLVWLDLNSNNL 631
+ S L + L L L L + + LG+ +L L +
Sbjct: 178 VHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVP 237
Query: 632 SGPLP 636
G L
Sbjct: 238 DGTLQ 242
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.9 bits (133), Expect = 1e-08
Identities = 46/279 (16%), Positives = 98/279 (35%), Gaps = 18/279 (6%)
Query: 229 LNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTG 288
L+ + L + ++ + + + + + F S ++++DLS++
Sbjct: 5 LDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHF---SPFRVQHMDLSNSVIEV 60
Query: 289 KFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNA-LQGGIPGFLLGS 347
+ +C L ++L LS +L L LN+S + LL S
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSD-PIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119
Query: 348 FRNLKQLSLAHNQFAGEIPPELGQACGTLRE-----LDLSSNRLTGELPSTFASCSSLHS 402
L +L+L+ E ++ A + N +L + C +L
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179
Query: 403 LNLGSNMLSGNFLNTVVSKISSLIYLYVPF-NNISGPVPLSLTNCTQLRVLDLSSNGFTG 461
L+L +++ N +++ L +L + +I L L L+ L + G
Sbjct: 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239
Query: 462 TIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNL 500
T+ AL + + ++ + +G+ KN
Sbjct: 240 TLQLL------KEALPHLQINCSHFTTIARPTIGNKKNQ 272
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.5 bits (119), Expect = 5e-07
Identities = 52/275 (18%), Positives = 90/275 (32%), Gaps = 16/275 (5%)
Query: 104 TSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNI 163
+L+L L L + + S + MDLS++ I
Sbjct: 3 QTLDLTGKNLHPD----VTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVI 58
Query: 164 TGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHI---GPSLLQLDLSGNQISDSALLTYSL 220
S L C +L ++L +S ++ +L++L+LSG L L
Sbjct: 59 EVSTL-HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL 117
Query: 221 SNCQNLNLLNFSDNKLPG----KLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSL 276
S+C L+ LN S ++ V+ Y + S + +L
Sbjct: 118 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL 177
Query: 277 KYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNAL 336
+LDLS + +F + L ++LS+ E L L+TL +
Sbjct: 178 VHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVP 237
Query: 337 QGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQ 371
G + L L + + F P +G
Sbjct: 238 DGTLQLLK----EALPHLQINCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (107), Expect = 2e-05
Identities = 23/130 (17%), Positives = 45/130 (34%), Gaps = 5/130 (3%)
Query: 716 LDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQG-S 774
LDL+ +L + S + + + + + F + + +DLS++ + +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVST 62
Query: 775 IPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPLLPCSSGNHAA 834
+ G L S L +L + LS I + L N SG G + +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVN--TLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 835 TVHPHENKQN 844
+ N
Sbjct: 121 SRLDELNLSW 130
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 57.7 bits (138), Expect = 1e-09
Identities = 29/222 (13%), Positives = 68/222 (30%), Gaps = 14/222 (6%)
Query: 571 TNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNN 630
N + ++ + +T + +L + L +T +G+ +L+ L+L N
Sbjct: 19 ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQ 74
Query: 631 LSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMV 690
++ P + + + K + + + + + +
Sbjct: 75 ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTL------DLTSTQITDVTPLAGL 128
Query: 691 HSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGH 750
+ + G LS + + +L+ L L NK++
Sbjct: 129 SNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI 188
Query: 751 IPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSN 792
P L + + L +N P L S L + ++N
Sbjct: 189 SP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 3e-06
Identities = 34/264 (12%), Positives = 77/264 (29%), Gaps = 43/264 (16%)
Query: 509 SLAGPVP-SEIWSLPNLSDLVMWA---NNLTGEIPEGICVNGGNLETLILNNNHLTGAIP 564
S+ P + I+ P L++ + A +N+T + + + + TL +T
Sbjct: 2 SITQPTAINVIFPDPALANAIKIAAGKSNVTDTVTQA---DLDGITTLSAFGTGVT---- 54
Query: 565 KSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWL 624
++ G+ L L L+L +N +T P + + L
Sbjct: 55 ------------TIE----------GVQYLNNLIGLELKDNQITDLAPLKNLTKITELEL 92
Query: 625 DLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERL 684
N + + + + ++ + + +
Sbjct: 93 SGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLA---- 148
Query: 685 EGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGH 744
S + L L N +S P SL L ++L +
Sbjct: 149 --GLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKN 204
Query: 745 NKLTGHIPDSFGGLKAIGVLDLSH 768
N+++ P + ++ L++
Sbjct: 205 NQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.9 bits (102), Expect = 5e-05
Identities = 32/217 (14%), Positives = 68/217 (31%), Gaps = 20/217 (9%)
Query: 152 SLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISG-GSLHIGPSLLQLDLSGNQI 210
+ + + +N+T ++ D ++ ++ ++ + +L+ L+L NQI
Sbjct: 20 NAIKIAAGKSNVTDTVT----QADLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQI 75
Query: 211 SDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVA 270
+D A L + N N + ST L+G +
Sbjct: 76 TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLY 135
Query: 271 DSSGSLKYLD---------LSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLK 321
+ + L+ + N +S ASL
Sbjct: 136 LDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLASLP 195
Query: 322 NCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAH 358
N L +++ +N + P L + NL ++L +
Sbjct: 196 N---LIEVHLKNNQISDVSP---LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.9 bits (102), Expect = 5e-05
Identities = 40/207 (19%), Positives = 70/207 (33%), Gaps = 18/207 (8%)
Query: 410 LSGNFLNTVVSK--ISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSG- 466
+ + V++ + + L ++ + L L+L N T P
Sbjct: 26 AGKSNVTDTVTQADLDGITTLSAFGTGVTTIEGVQ--YLNNLIGLELKDNQITDLAPLKN 83
Query: 467 ---FCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPN 523
K V L L+L S + L+ S + ++ + N
Sbjct: 84 LTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITN 143
Query: 524 LSDLVMWANNLTGEIPEGICV------NGGNLETLILNNNHLTGAIPKSIASCTNMLWVS 577
+S L N I N L TL ++N ++ P +AS N++ V
Sbjct: 144 ISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVH 201
Query: 578 LSSNQLTGEIPAGIGNLVKLAILQLGN 604
L +NQ++ P + N L I+ L N
Sbjct: 202 LKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 9e-05
Identities = 25/211 (11%), Positives = 62/211 (29%), Gaps = 17/211 (8%)
Query: 253 IDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLS 312
I + ++ + + + + L T + NL + L N ++
Sbjct: 24 IAAGKSNVTDTVTQADLD----GITTLSAFGTGVT---TIEGVQYLNNLIGLELKDNQIT 76
Query: 313 GTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQF-AGEIPPELGQ 371
+L LE + + + L
Sbjct: 77 DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYL 136
Query: 372 ACGTLRELDLSSNRLTGELPSTFASCSSLHSL-----NLGSNMLSGNFLNTV--VSKISS 424
+ + + + S + S + L + N ++ + ++ + +
Sbjct: 137 DLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLASLPN 196
Query: 425 LIYLYVPFNNISGPVPLSLTNCTQLRVLDLS 455
LI +++ N IS PL+ N + L ++ L+
Sbjct: 197 LIEVHLKNNQISDVSPLA--NTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 9e-05
Identities = 33/216 (15%), Positives = 62/216 (28%), Gaps = 24/216 (11%)
Query: 279 LDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQG 338
+ +N T + D ++ ++ G++ E ++ L L + N +
Sbjct: 24 IAAGKSNVTDTVTQADLD---GITTLSAFGTGVTTIE---GVQYLNNLIGLELKDNQITD 77
Query: 339 GIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASC- 397
P L L+ + + + L G
Sbjct: 78 LAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLD 137
Query: 398 ----------SSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCT 447
+ L +L S + T ++ +S L L N IS PL+ +
Sbjct: 138 LNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA--SLP 195
Query: 448 QLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPN 483
L + L +N + P N L + L N
Sbjct: 196 NLIEVHLKNNQISDVSPLA-----NTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 9e-05
Identities = 40/219 (18%), Positives = 67/219 (30%), Gaps = 25/219 (11%)
Query: 300 NLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHN 359
N I ++ ++ T A L + TL+ + I G + NL L L N
Sbjct: 20 NAIKIAAGKSNVTDTVTQADLDG---ITTLSAFGTGVTT-IEG--VQYLNNLIGLELKDN 73
Query: 360 QFAGEIPPE-LGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTV 418
Q P + L + + N + + + L+G V
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 419 VSKISSLIYLYVPFNN-----------ISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGF 467
+ + I P L N ++L L N + P
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA- 192
Query: 468 CSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLS 506
+ P L ++ L NN +S P L + NL + L+
Sbjct: 193 ----SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 1e-04
Identities = 30/211 (14%), Positives = 59/211 (27%), Gaps = 21/211 (9%)
Query: 183 NLSHNSISG-GSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKL----- 236
++++ + + L G ++ + NL L DN++
Sbjct: 25 AAGKSNVTDTVTQADLDGITTLSAFGTGVTTIE----GVQYLNNLIGLELKDNQITDLAP 80
Query: 237 PGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFG 296
L + S + + + + + S+ L+ +
Sbjct: 81 LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQ 140
Query: 297 RCGNLSVIT-----LSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNL 351
+ G + L N L TL N + P L S NL
Sbjct: 141 ITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP---LASLPNL 197
Query: 352 KQLSLAHNQFAGEIPPELGQACGTLRELDLS 382
++ L +NQ + P L L + L+
Sbjct: 198 IEVHLKNNQISDVSP--LAN-TSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 2e-04
Identities = 27/218 (12%), Positives = 67/218 (30%), Gaps = 24/218 (11%)
Query: 423 SSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLP 482
++ I + +N++ V + + + L G T G L + L
Sbjct: 19 ANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQ---YLNNLIGLELK 71
Query: 483 NNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGI 542
+N ++ PL+ + + + + + +
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 543 CVNGGNLETL-------------ILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPA 589
V +L + L+ + + +A+ + + + N+++ P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 590 GIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLN 627
+ +L L + L NN ++ P L +L + L
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 3e-04
Identities = 32/224 (14%), Positives = 63/224 (28%), Gaps = 20/224 (8%)
Query: 343 FLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHS 402
F + N +++ + + + L +T ++L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVTQA---DLDGITTLSAFGTGVTTI--EGVQYLNNLIG 67
Query: 403 LNLGSNML------SGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSS 456
L L N + T + + + + L LT+ V L+
Sbjct: 68 LELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAG 127
Query: 457 NGFTGTIPSGFCSPPNFPALEKIVLPNNY----LSGTVPLELGSCKNLKTIDLSFNSLAG 512
+ N L + + L + L T+ N ++
Sbjct: 128 LSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD 187
Query: 513 PVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNN 556
P + SLPNL ++ + N ++ P NL + L N
Sbjct: 188 ISP--LASLPNLIEVHLKNNQISDVSPLANTS---NLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 0.001
Identities = 28/220 (12%), Positives = 63/220 (28%), Gaps = 26/220 (11%)
Query: 434 NISGPVPLS----LTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGT 489
+I+ P ++ + + T T+ + + + ++
Sbjct: 2 SITQPTAINVIFPDPALANAIKIAAGKSNVTDTVTQA-----DLDGITTLSAFGTGVTTI 56
Query: 490 VPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNL 549
++ NL ++L N + P + + +L I + +L
Sbjct: 57 EGVQ--YLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDL 114
Query: 550 ETLILNN-------------NHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVK 596
+ + + I LS + NL K
Sbjct: 115 TSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSK 174
Query: 597 LAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLP 636
L L+ +N ++ P L +L+ + L +N +S P
Sbjct: 175 LTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.002
Identities = 33/222 (14%), Positives = 67/222 (30%), Gaps = 22/222 (9%)
Query: 75 PNGYLANWTADALTPCSWQGVSCSLN-SHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNL 133
P+ LAN A + + +T+L+ +G++ + + L L L L
Sbjct: 14 PDPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT---TIEGVQYLNNLIGLEL 70
Query: 134 QGNSF----SAGDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSI 189
+ N +L+ S + S L S L+ S
Sbjct: 71 KDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130
Query: 190 SGGSLHIGPSLLQLDL--------SGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLN 241
+ + + + L+N L L DNK+
Sbjct: 131 LQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP 190
Query: 242 ATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSH 283
+ ++ + L N +S P + ++ +L + L++
Sbjct: 191 LA--SLPNLIEVHLKNNQISDVSPLA----NTSNLFIVTLTN 226
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.2 bits (141), Expect = 2e-09
Identities = 15/92 (16%), Positives = 27/92 (29%), Gaps = 3/92 (3%)
Query: 326 LETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQA---CGTLRELDLS 382
+++L++ L LL + + + L ++ A L EL+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 383 SNRLTGELPSTFASCSSLHSLNLGSNMLSGNF 414
SN L S + L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.0 bits (130), Expect = 4e-08
Identities = 17/114 (14%), Positives = 36/114 (31%), Gaps = 24/114 (21%)
Query: 350 NLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGE----LPSTFASCSSLHSLNL 405
+++ L + + + EL + + L LT + S +L LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 406 GSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGF 459
SN L ++ V+ + + +++ L L +
Sbjct: 63 RSNELGDVGVHCVLQGLQT--------------------PSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.2 bits (128), Expect = 6e-08
Identities = 14/95 (14%), Positives = 33/95 (34%), Gaps = 8/95 (8%)
Query: 199 SLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGK----LNATSVNCKSISTID 254
+ LD+ ++SD+ L Q ++ D L +++ +++ ++
Sbjct: 3 DIQSLDIQCEELSDARW-AELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 255 LSYNLLSGEIP---ASFVADSSGSLKYLDLSHNNF 286
L N L + S ++ L L +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 1e-07
Identities = 17/96 (17%), Positives = 33/96 (34%), Gaps = 7/96 (7%)
Query: 273 SGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSG---TEFPASLKNCQLLETL 329
S ++ LD+ + V+ L GL+ + ++L+ L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 330 NMSHNALQG----GIPGFLLGSFRNLKQLSLAHNQF 361
N+ N L + L +++LSL +
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.1 bits (125), Expect = 1e-07
Identities = 17/91 (18%), Positives = 26/91 (28%), Gaps = 5/91 (5%)
Query: 712 SLIYLDLSYNSLSGT-LPENFGSLNYLQVLNLGHNKLTG----HIPDSFGGLKAIGVLDL 766
+ LD+ LS E L QV+ L LT I + A+ L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 767 SHNNFQGSIPGSLGGLSFLSDLDVSNNNLSG 797
N + + +L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (123), Expect = 2e-07
Identities = 13/92 (14%), Positives = 30/92 (32%), Gaps = 7/92 (7%)
Query: 300 NLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFL---LGSFRNLKQLSL 356
++ + + LS + L Q + + + L + L L +L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 357 AHNQFAGEIPPELGQA----CGTLRELDLSSN 384
N+ + Q +++L L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (122), Expect = 3e-07
Identities = 18/97 (18%), Positives = 32/97 (32%), Gaps = 7/97 (7%)
Query: 176 CDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSAL--LTYSLSNCQNLNLLNFSD 233
+ + G G L L L+ +SDS+ L +L +L L+ S+
Sbjct: 347 ISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSN 406
Query: 234 NKLPGK-----LNATSVNCKSISTIDLSYNLLSGEIP 265
N L + + + + L S E+
Sbjct: 407 NCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 7e-07
Identities = 15/96 (15%), Positives = 37/96 (38%), Gaps = 9/96 (9%)
Query: 529 MWANNLTGEIPEGICVNGGNLETLILNNNHLTG----AIPKSIASCTNMLWVSLSSNQLT 584
+ E+ +G+ G L L L + ++ ++ ++ + ++ + LS+N L
Sbjct: 351 RLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 410
Query: 585 GEIPAGIGNLVK-----LAILQLGNNSLTGQVPQGL 615
+ V+ L L L + + ++ L
Sbjct: 411 DAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 4e-06
Identities = 16/96 (16%), Positives = 38/96 (39%), Gaps = 8/96 (8%)
Query: 98 SLNSHVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFS---AGDLSTSKTSSCSLV 154
SL+ + SL++ LS + L L + + L + D+S++ + +L
Sbjct: 1 SLD--IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALA 58
Query: 155 TMDLSSNNITGSLP---GRSFLLSCDRLSYVNLSHN 187
++L SN + + ++ ++L +
Sbjct: 59 ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 4e-06
Identities = 22/108 (20%), Positives = 38/108 (35%), Gaps = 7/108 (6%)
Query: 283 HNNFTGKFSNLDFGRCGNLSVITLSQNGLSGT---EFPASLKNCQLLETLNMSHNALQGG 339
+ + L V+ L+ +S + A+L L L++S+N L
Sbjct: 353 EDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412
Query: 340 IPGFLLGSFRN----LKQLSLAHNQFAGEIPPELGQACGTLRELDLSS 383
L+ S R L+QL L ++ E+ L L + S
Sbjct: 413 GILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 5e-06
Identities = 21/94 (22%), Positives = 34/94 (36%), Gaps = 12/94 (12%)
Query: 371 QACGTLRELDLSSNRLTGE----LPSTFASCSSLHSLNLGSNMLSGN----FLNTVVSKI 422
Q LR L L+ ++ L +T + SL L+L +N L + +V
Sbjct: 366 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425
Query: 423 SSLIYLYVPFNNISGPVPLSLT----NCTQLRVL 452
L L + S + L + LRV+
Sbjct: 426 CLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 5e-06
Identities = 16/93 (17%), Positives = 31/93 (33%), Gaps = 10/93 (10%)
Query: 548 NLETLILNNNHLTGA-IPKSIASCTNMLWVSLSSNQLTGE----IPAGIGNLVKLAILQL 602
++++L + L+ A + + V L LT I + + LA L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 603 GNNSLTGQVPQGLGK-----CRSLVWLDLNSNN 630
+N L + + + L L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 5e-06
Identities = 12/92 (13%), Positives = 32/92 (34%), Gaps = 4/92 (4%)
Query: 523 NLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTG----AIPKSIASCTNMLWVSL 578
++ L + L+ + + + L++ LT I ++ + ++L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 579 SSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQ 610
SN+L + ++ ++ SL
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 7e-06
Identities = 12/95 (12%), Positives = 21/95 (22%), Gaps = 22/95 (23%)
Query: 376 LRELDLSSNRLTGE-LPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNN 434
++ LD+ L+ + L L+ + S
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISS-------------- 49
Query: 435 ISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCS 469
+L L L+L SN
Sbjct: 50 -------ALRVNPALAELNLRSNELGDVGVHCVLQ 77
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 8e-06
Identities = 14/74 (18%), Positives = 30/74 (40%), Gaps = 6/74 (8%)
Query: 733 SLNYLQVLNLGHNKLT-GHIPDSFGGLKAIGVLDLSHNNFQG----SIPGSLGGLSFLSD 787
SL+ +Q L++ +L+ + L+ V+ L I +L L++
Sbjct: 1 SLD-IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59
Query: 788 LDVSNNNLSGIIPS 801
L++ +N L +
Sbjct: 60 LNLRSNELGDVGVH 73
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 9e-06
Identities = 18/78 (23%), Positives = 23/78 (29%), Gaps = 8/78 (10%)
Query: 347 SFRNLKQLSLAHNQFAGEIPPELGQA---CGTLRELDLSSNRLTGELPSTFAS-----CS 398
L+ L LA + L +LRELDLS+N L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 399 SLHSLNLGSNMLSGNFLN 416
L L L S +
Sbjct: 427 LLEQLVLYDIYWSEEMED 444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 12/82 (14%), Positives = 32/82 (39%), Gaps = 8/82 (9%)
Query: 496 SCKNLKTIDLSFNSL----AGPVPSEIWSLPNLSDLVMWANNLTGE----IPEGICVNGG 547
L+ + L+ + + + + + +L +L + N L + E + G
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 548 NLETLILNNNHLTGAIPKSIAS 569
LE L+L + + + + + +
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQA 448
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 2e-05
Identities = 17/110 (15%), Positives = 36/110 (32%), Gaps = 22/110 (20%)
Query: 128 LEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHN 187
++ L++Q S + + L +T + C +S L N
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEA--------RCKDISSA-LRVN 54
Query: 188 SISGGSLHIGPSLLQLDLSGNQISDS---ALLTYSLSNCQNLNLLNFSDN 234
P+L +L+L N++ D +L + + L+ +
Sbjct: 55 ----------PALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 2e-05
Identities = 13/83 (15%), Positives = 26/83 (31%), Gaps = 9/83 (10%)
Query: 728 PENFGSLNYLQVLNLGHNKLTG----HIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGG-- 781
+ L+VL L ++ + + ++ LDLS+N + L
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 782 ---LSFLSDLDVSNNNLSGIIPS 801
L L + + S +
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMED 444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 4e-05
Identities = 15/119 (12%), Positives = 34/119 (28%), Gaps = 15/119 (12%)
Query: 687 FPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGT----LPENFGSLNYLQVLNL 742
+ ++ + L L L+ +S + L + + L+ L+L
Sbjct: 345 LQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDL 404
Query: 743 GHNKLTGHIPDSFG-GLK----AIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLS 796
+N L ++ + L L + + L L+ +L
Sbjct: 405 SNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME------DRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 4e-05
Identities = 12/75 (16%), Positives = 28/75 (37%), Gaps = 5/75 (6%)
Query: 572 NMLWVSLSSNQLTGE-IPAGIGNLVKLAILQLGNNSLTGQ----VPQGLGKCRSLVWLDL 626
++ + + +L+ + L + +++L + LT + L +L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 627 NSNNLSGPLPSELAN 641
SN L +
Sbjct: 63 RSNELGDVGVHCVLQ 77
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 9e-05
Identities = 16/81 (19%), Positives = 27/81 (33%), Gaps = 10/81 (12%)
Query: 170 RSFLLSCDRLSYVNLSHNSIS-------GGSLHIGPSLLQLDLSGNQISDS---ALLTYS 219
+ L + L+ +S +L SL +LDLS N + D+ L+
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 220 LSNCQNLNLLNFSDNKLPGKL 240
L L D ++
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEM 442
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 1e-04
Identities = 20/121 (16%), Positives = 38/121 (31%), Gaps = 35/121 (28%)
Query: 445 NCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTID 504
+ LRVL L+ + + S + L + +L+ +D
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAAT-----------------------LLANHSLRELD 403
Query: 505 LSFNSLAGPVPSEI-----WSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHL 559
LS N L ++ L LV++ + E+ + L+ L + L
Sbjct: 404 LSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDR-------LQALEKDKPSL 456
Query: 560 T 560
Sbjct: 457 R 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 1e-04
Identities = 21/91 (23%), Positives = 34/91 (37%), Gaps = 10/91 (10%)
Query: 423 SSLIYLYVPFNNISG----PVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCS--PPNFPAL 476
S L L++ ++S + +L LR LDLS+N L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 477 EKIVLPNNYLSGTVPLELG----SCKNLKTI 503
E++VL + Y S + L +L+ I
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 2e-04
Identities = 10/74 (13%), Positives = 24/74 (32%), Gaps = 6/74 (8%)
Query: 449 LRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGS----CKNLKTID 504
++ LD+ + + P + + L + L+ ++ S L ++
Sbjct: 4 IQSLDIQCEELSDARWAELL--PLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 505 LSFNSLAGPVPSEI 518
L N L +
Sbjct: 62 LRSNELGDVGVHCV 75
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 0.001
Identities = 17/103 (16%), Positives = 31/103 (30%), Gaps = 13/103 (12%)
Query: 241 NATSVNCKSISTIDLSYNLLSGEIPASFVAD--SSGSLKYLDLSHNNFTGK----FSNLD 294
+ + L+ +S +S A ++ SL+ LDLS+N
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 295 FGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQ 337
L + L S + L+ L +L+
Sbjct: 422 RQPGCLLEQLVLYDIYWSE-------EMEDRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 0.001
Identities = 15/72 (20%), Positives = 24/72 (33%), Gaps = 6/72 (8%)
Query: 126 PYLEHLNLQGNSFS---AGDLSTSKTSSCSLVTMDLSSNNITGSLP---GRSFLLSCDRL 179
L L L S L+ + ++ SL +DLS+N + + S L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 180 SYVNLSHNSISG 191
+ L S
Sbjct: 429 EQLVLYDIYWSE 440
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.003
Identities = 17/87 (19%), Positives = 26/87 (29%), Gaps = 7/87 (8%)
Query: 89 PCSWQGVSCSLNSHVTSLNLNNSGLS--GSLNL-TTLTALPYLEHLNLQGNSFS---AGD 142
S + L L + +S +L TL A L L+L N
Sbjct: 357 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQ 416
Query: 143 LSTS-KTSSCSLVTMDLSSNNITGSLP 168
L S + C L + L + +
Sbjct: 417 LVESVRQPGCLLEQLVLYDIYWSEEME 443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.0 bits (124), Expect = 2e-08
Identities = 23/114 (20%), Positives = 37/114 (32%), Gaps = 24/114 (21%)
Query: 715 YLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIP---------------------D 753
L L++ L T+ + L + L+L HN+L P D
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 754 SFGGLKAIGVLDLSHNNFQG-SIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLT 806
L + L L +N Q + L L L++ N+L +L
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLA 113
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 51.6 bits (123), Expect = 2e-08
Identities = 28/130 (21%), Positives = 47/130 (36%), Gaps = 8/130 (6%)
Query: 352 KQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLS 411
+ L LAH + L Q + LDLS NRL P+ ++L L + +
Sbjct: 1 RVLHLAHKDL--TVLCHLEQ-LLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDN 53
Query: 412 GNFLNTVVSKISSLIYLYVPFNNI-SGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSP 470
V+ + L L + N + L +C +L +L+L N
Sbjct: 54 ALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLA 113
Query: 471 PNFPALEKIV 480
P++ I+
Sbjct: 114 EMLPSVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.1 bits (119), Expect = 8e-08
Identities = 30/130 (23%), Positives = 50/130 (38%), Gaps = 11/130 (8%)
Query: 277 KYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNAL 336
+ L L+H + T + ++ + LS N L P +L + LE L S NAL
Sbjct: 1 RVLHLAHKDLT---VLCHLEQLLLVTHLDLSHNRLRA--LPPALAALRCLEVLQASDNAL 55
Query: 337 QGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGE---LPST 393
+ + L++L L +N+ + +C L L+L N L E
Sbjct: 56 ENVDGVA---NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERL 112
Query: 394 FASCSSLHSL 403
S+ S+
Sbjct: 113 AEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.6 bits (110), Expect = 1e-06
Identities = 29/156 (18%), Positives = 50/156 (32%), Gaps = 37/156 (23%)
Query: 377 RELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNIS 436
R L L+ LT + L+L S N L + +++L L V + +
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDL-----SHNRLRALPPALAALRCLEVLQASDN 53
Query: 437 GPVPL-SLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELG 495
+ + N +L+ L L +N + L
Sbjct: 54 ALENVDGVANLPRLQELLLCNNRLQQSAA--------------------------IQPLV 87
Query: 496 SCKNLKTIDLSFNSLAGP---VPSEIWSLPNLSDLV 528
SC L ++L NSL LP++S ++
Sbjct: 88 SCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.2 bits (109), Expect = 1e-06
Identities = 28/118 (23%), Positives = 45/118 (38%), Gaps = 8/118 (6%)
Query: 481 LPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPE 540
L + L TV L + +DLS N L P+ L L L + +
Sbjct: 5 LAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDNALENV 58
Query: 541 GICVNGGNLETLILNNNHLTG-AIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKL 597
N L+ L+L NN L A + + SC ++ ++L N L + L ++
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.2 bits (109), Expect = 2e-06
Identities = 24/128 (18%), Positives = 46/128 (35%), Gaps = 10/128 (7%)
Query: 229 LNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTG 288
L+ + L + ++ +DLS+N L P + +L+ L++ +
Sbjct: 3 LHLAHKDLTVLCHLE--QLLLVTHLDLSHNRLRALPP------ALAALRCLEVLQASDNA 54
Query: 289 KFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQG--GIPGFLLG 346
+ L + L N L + L +C L LN+ N+L GI L
Sbjct: 55 LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114
Query: 347 SFRNLKQL 354
++ +
Sbjct: 115 MLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.9 bits (95), Expect = 1e-04
Identities = 22/88 (25%), Positives = 38/88 (43%), Gaps = 3/88 (3%)
Query: 152 SLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQIS 211
+ +DLS N + P + L + L + + ++ + P L +L L N++
Sbjct: 21 LVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD--GVANLPRLQELLLCNNRLQ 78
Query: 212 DSALLTYSLSNCQNLNLLNFSDNKLPGK 239
SA + L +C L LLN N L +
Sbjct: 79 QSAAIQ-PLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.3 bits (91), Expect = 4e-04
Identities = 25/106 (23%), Positives = 35/106 (33%), Gaps = 26/106 (24%)
Query: 551 TLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAI----------- 599
L L + LT + + + + LS N+L P + L L +
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 600 -----------LQLGNNSLTG-QVPQGLGKCRSLVWLDLNSNNLSG 633
L L NN L Q L C LV L+L N+L
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.5 bits (89), Expect = 9e-04
Identities = 20/135 (14%), Positives = 38/135 (28%), Gaps = 31/135 (22%)
Query: 155 TMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSA 214
+ L+ ++T L L + LDLS N++
Sbjct: 2 VLHLAHKDLT-VLCHLEQL------------------------LLVTHLDLSHNRLRALP 36
Query: 215 LLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSG 274
+L + L + + + G N + + L N L +
Sbjct: 37 PALAALRCLEVLQASDNALENVDGV-----ANLPRLQELLLCNNRLQQSAAIQPLVSCP- 90
Query: 275 SLKYLDLSHNNFTGK 289
L L+L N+ +
Sbjct: 91 RLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.4 bits (86), Expect = 0.002
Identities = 24/124 (19%), Positives = 41/124 (33%), Gaps = 30/124 (24%)
Query: 106 LNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLSTSKTSSCSLV----------- 154
L+L + L+ L L L + HL+L N A + + ++
Sbjct: 3 LHLAHKDLT---VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 155 ---------TMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIG------PS 199
+ L +N + L+SC RL +NL NS+ PS
Sbjct: 60 GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118
Query: 200 LLQL 203
+ +
Sbjct: 119 VSSI 122
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.5 bits (129), Expect = 2e-08
Identities = 32/243 (13%), Positives = 68/243 (27%), Gaps = 14/243 (5%)
Query: 564 PKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVW 623
I C+N +++T EIP+ + L+ L L
Sbjct: 2 HHRICHCSN-RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 57
Query: 624 LDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGG--------LVE 675
++++ N++ + +++ + + + N +
Sbjct: 58 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117
Query: 676 FEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLN 735
+ ++ + I+T + + L L+ N + F
Sbjct: 118 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ 177
Query: 736 YLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNL 795
++ +N L D F G +LD+S L L L S NL
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR--STYNL 235
Query: 796 SGI 798
+
Sbjct: 236 KKL 238
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.3 bits (118), Expect = 4e-07
Identities = 30/228 (13%), Positives = 57/228 (25%), Gaps = 4/228 (1%)
Query: 411 SGNFLNTVVSKI-SSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCS 469
+ + + S + + I L + + + L +++S N I + S
Sbjct: 16 QESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFS 75
Query: 470 PPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVM 529
+I NN L + + P +I SL + +
Sbjct: 76 NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQ 135
Query: 530 WANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPA 589
N+ L LN N + + +N L
Sbjct: 136 DNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPND 195
Query: 590 GIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPS 637
IL + + GL + L + LP+
Sbjct: 196 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 2e-06
Identities = 29/223 (13%), Positives = 59/223 (26%), Gaps = 12/223 (5%)
Query: 532 NNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGI 591
+ +T EIP + N L L + + ++ + +S N + I A +
Sbjct: 18 SKVT-EIPSDLPRN---AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADV 73
Query: 592 GNLVKLAILQLG---NNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMP 648
+ + NN L L N+ P ++ + V++
Sbjct: 74 FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLD 133
Query: 649 GIVSGKQFAFVRNEGGTACRGAGGL-----VEFEGIRPERLEGFPMVHSCPSTRIYTGMT 703
+ RN + L E + +
Sbjct: 134 IQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELP 193
Query: 704 MYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNK 746
F + LD+S + +L L+ + + K
Sbjct: 194 NDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.4 bits (108), Expect = 8e-06
Identities = 26/231 (11%), Positives = 68/231 (29%), Gaps = 5/231 (2%)
Query: 175 SCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDN 234
C + ++ + + ++L ++ + + S +L + S N
Sbjct: 7 HCSNRV-FLCQESKVTEIPSDLPRNAIELRFVLTKLRV--IQKGAFSGFGDLEKIEISQN 63
Query: 235 KLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLD 294
+ + A + + + +L+YL +S+
Sbjct: 64 DVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHK 123
Query: 295 FGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQL 354
+ + + E + + L ++ N +Q + L +L
Sbjct: 124 IHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCA--FNGTQLDEL 181
Query: 355 SLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNL 405
+L+ N E+P ++ LD+S R+ + L + +
Sbjct: 182 NLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.8 bits (96), Expect = 2e-04
Identities = 34/244 (13%), Positives = 67/244 (27%), Gaps = 17/244 (6%)
Query: 222 NCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDL 281
CQ + ++P L ++ + L +F G L+ +++
Sbjct: 14 LCQESKV-----TEIPSDL------PRNAIELRFVLTKLRVIQKGAF--SGFGDLEKIEI 60
Query: 282 SHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIP 341
S N+ F L I + + P + +N L+ L +S+ ++
Sbjct: 61 SQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD 120
Query: 342 GFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLH 401
+ S + + + L L+ N + F
Sbjct: 121 VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDE 180
Query: 402 SLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTG 461
N N V S + L + I L N +LR +
Sbjct: 181 LNL-SDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---K 236
Query: 462 TIPS 465
+P+
Sbjct: 237 KLPT 240
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 53.7 bits (127), Expect = 6e-08
Identities = 50/314 (15%), Positives = 97/314 (30%), Gaps = 26/314 (8%)
Query: 172 FLLSCDRLSYVNLSHNSISG--GSLHIGPSLLQLDLSGNQISDSAL--LTYSLSNCQNLN 227
F + L ++ L S+ ++ LSGN I A L+ ++++ ++L
Sbjct: 3 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 62
Query: 228 LLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFT 287
+ FSD + + + L L + + +D +
Sbjct: 63 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 122
Query: 288 GKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGS 347
+ L G + +++ KN L ++ N L+ G +
Sbjct: 123 LEHLYLHNNGLGPQAGAKIARALQE-LAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 181
Query: 348 FRNLKQLSLAHNQFAGEIPPELGQACGTL-----------RELDLSSNRLTGELPSTFAS 396
F++ + L G P + + + ++ + L S
Sbjct: 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 241
Query: 397 CSSLHSLNLGSNMLSGNFLNTVVSKIS-----SLIYLYVPFNNISGPVPLSL-----TNC 446
+L L L +LS VV S L L + +N I +L
Sbjct: 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301
Query: 447 TQLRVLDLSSNGFT 460
L L+L+ N F+
Sbjct: 302 PDLLFLELNGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 52.6 bits (124), Expect = 1e-07
Identities = 44/322 (13%), Positives = 94/322 (29%), Gaps = 32/322 (9%)
Query: 349 RNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGE----LPSTFASCSSLHSLN 404
++LK ++ + L + +++E+ LS N + E L AS L
Sbjct: 8 KSLKLDAITTED-EKSVFAVLLE-DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAE 65
Query: 405 LGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIP 464
+ + + L+ + + + + +
Sbjct: 66 FSDIFTG-RVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 465 SGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSL----AGPVPSEIWS 520
+ + V + + L++I N L S
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184
Query: 521 LPNLSDLVMWANNLTGEIPEGICVNG--------GNLETLILNNNHLTGAIPKSIASCTN 572
L + M N + E E + + G + + A+ ++ S N
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 573 MLWVSLSSNQLTGEIPAGIGN------LVKLAILQLGNNSLTGQVPQGL-----GKCRSL 621
+ + L+ L+ A + + + L L+L N + + L K L
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304
Query: 622 VWLDLNSNNLS--GPLPSELAN 641
++L+LN N S + E+
Sbjct: 305 LFLELNGNRFSEEDDVVDEIRE 326
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 49.1 bits (115), Expect = 2e-06
Identities = 35/323 (10%), Positives = 94/323 (29%), Gaps = 29/323 (8%)
Query: 300 NLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFL---LGSFRNLKQLSL 356
+L + ++ A L ++ + +S N + +L + S ++L+
Sbjct: 9 SLKLDAITTEDEK--SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 357 AHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLN 416
+ G + E+ +A L + L +L S A + + +
Sbjct: 67 SDIFT-GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEH 125
Query: 417 TVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPAL 476
+ + ++ + + S F +
Sbjct: 126 LYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSH 185
Query: 477 EKIVLPNNYLSGTVPLELGS------------CKNLKTIDLSFNSLAGPVPSEIWSLPNL 524
+ +G P + + + + + + S PNL
Sbjct: 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL 245
Query: 525 SDLVMWANNLTGEIPEGIC-----VNGGNLETLILNNNHLTGAIPKSIAS-----CTNML 574
+L + L+ + + L+TL L N + +++ + ++L
Sbjct: 246 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLL 305
Query: 575 WVSLSSNQLTGEIPAGIGNLVKL 597
++ L+ N+ E + + ++
Sbjct: 306 FLELNGNRF-SEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.9 bits (104), Expect = 4e-05
Identities = 46/300 (15%), Positives = 82/300 (27%), Gaps = 26/300 (8%)
Query: 490 VPLELGSCKNLKTIDLSFNSL----AGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVN 545
V L ++K I LS N++ A + I S +L +++ TG + + I
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA-EFSDIFTGRVKDEIPEA 81
Query: 546 GGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQ---LTGEIPAGIGNLVKLAILQL 602
L +L L A + + L A ++
Sbjct: 82 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141
Query: 603 GNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNE 662
V + L + N L E A +R E
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201
Query: 663 GGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNS 722
G EG+ + + T + + + +L L L+
Sbjct: 202 GIEHLL-------LEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCL 254
Query: 723 LSGTLPE------NFGSLNYLQVLNLGHNKLTGHIPDS-----FGGLKAIGVLDLSHNNF 771
LS + LQ L L +N++ + + + L+L+ N F
Sbjct: 255 LSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 314
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.1 bits (102), Expect = 8e-05
Identities = 34/331 (10%), Positives = 70/331 (21%), Gaps = 32/331 (9%)
Query: 438 PVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSC 497
V L ++ + LS N + S
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSE-----------------------NIASK 58
Query: 498 KNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNL--TGEIPEGICVNGGNLETLILN 555
K+L+ + S +L L ++ L L+
Sbjct: 59 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 118
Query: 556 NNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGL 615
+ + ++ + N L + G N L
Sbjct: 119 KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE-NGSMKE 177
Query: 616 GKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVE 675
L++ + + ++ + + G+ L
Sbjct: 178 WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 237
Query: 676 FEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPEN----- 730
P E + + ++ N L L L YN +
Sbjct: 238 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI 297
Query: 731 FGSLNYLQVLNLGHNKLTGHIPDSFGGLKAI 761
+ L L L N+ D ++ +
Sbjct: 298 DEKMPDLLFLELNGNRF-SEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.3 bits (100), Expect = 1e-04
Identities = 43/316 (13%), Positives = 86/316 (27%), Gaps = 27/316 (8%)
Query: 218 YSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVAD---SSG 274
+S+ ++L L + S+ I LS N + E A ++++ S
Sbjct: 3 FSIEG-KSLKLDAITTEDEKSVFAVLL-EDDSVKEIVLSGNTIGTE-AARWLSENIASKK 59
Query: 275 SLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHN 334
L+ + S + FTG+ + L L L + E L +
Sbjct: 60 DLEIAEFS-DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 118
Query: 335 ALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPS-- 392
+L + + + + + LR + NRL
Sbjct: 119 KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW 178
Query: 393 ----------TFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLS 442
G L L + + S + ++
Sbjct: 179 AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 238
Query: 443 LTNCTQLRVLDLSSNGFTGTIPSGFCSPPNF---PALEKIVLPNNYLSGTVPLELGS--- 496
L + LR L L+ + + + L+ + L N + L +
Sbjct: 239 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID 298
Query: 497 --CKNLKTIDLSFNSL 510
+L ++L+ N
Sbjct: 299 EKMPDLLFLELNGNRF 314
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.6 bits (98), Expect = 2e-04
Identities = 52/314 (16%), Positives = 92/314 (29%), Gaps = 25/314 (7%)
Query: 249 SISTIDLSYNLLSGEIPASFVAD--SSGSLKYLDLSHNNFTGKFSNL---DFGRCGNLSV 303
SI L + ++ E S A S+K + LS N + + + +L +
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 304 ITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAG 363
S + LL+ L + G +
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123
Query: 364 EIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKIS 423
E G ++ + + L S+ G N L +
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183
Query: 424 SLIYLYVP--------FNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPP-NFP 474
S L+ I + L C +L+VLDL N FT S ++P
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243
Query: 475 ALEKIVLPNNYLSGTVPLELGSC------KNLKTIDLSFNSLAGPVPSEIWS-----LPN 523
L ++ L + LS + L+T+ L +N + + + +P+
Sbjct: 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303
Query: 524 LSDLVMWANNLTGE 537
L L + N + E
Sbjct: 304 LLFLELNGNRFSEE 317
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.5 bits (90), Expect = 0.002
Identities = 49/339 (14%), Positives = 95/339 (28%), Gaps = 36/339 (10%)
Query: 105 SLNLNNSGLSGSLNL-TTLTALPYLEHLNLQGNSFS---AGDLSTSKTSSCSLVTMDLSS 160
SL L+ ++ L ++ + L GN+ A LS + S L + S
Sbjct: 9 SLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 161 N---NITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLT 217
+ +P LL L L +S + +D L
Sbjct: 69 IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128
Query: 218 YSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLK 277
++ + + +N + N + +I N L +
Sbjct: 129 HN-NGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 278 YLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQ 337
+ + ++ L+ + ++L+ + + L
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLA----------------YCQELKVLDLQDNTFTHLG 231
Query: 338 GGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACG-----TLRELDLSSNRLTGELPS 392
L S+ NL++L L + + A L+ L L N + +
Sbjct: 232 SSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVR 291
Query: 393 TFAS-----CSSLHSLNLGSNMLSGNFLNTVVSKISSLI 426
T + L L L N S + VV +I +
Sbjct: 292 TLKTVIDEKMPDLLFLELNGNRFSE--EDDVVDEIREVF 328
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 50.4 bits (119), Expect = 3e-07
Identities = 31/197 (15%), Positives = 58/197 (29%), Gaps = 12/197 (6%)
Query: 571 TNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNN 630
+ +L +T + L + + N+ + QG+ ++ L LN N
Sbjct: 24 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNGNK 79
Query: 631 LSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMV 690
L+ P G + K + +++ E + G +
Sbjct: 80 LTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSL------SLEHNGISDINGLVHL 133
Query: 691 HSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGH 750
S + + LS + L LQ L L N ++
Sbjct: 134 PQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD- 192
Query: 751 IPDSFGGLKAIGVLDLS 767
+ GLK + VL+L
Sbjct: 193 -LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 5e-04
Identities = 28/189 (14%), Positives = 52/189 (27%), Gaps = 19/189 (10%)
Query: 183 NLSHNSISGG-SLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPG--- 238
NL S++ + + S+ Q+ + + I + N+ L + NKL
Sbjct: 30 NLKKKSVTDAVTQNELNSIDQIIANNSDIKS----VQGIQYLPNVTKLFLNGNKLTDIKP 85
Query: 239 -------KLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFS 291
N + L L +L + + G
Sbjct: 86 LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNK 145
Query: 292 NLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNL 351
D L+ + + L L+ L +S N + + +NL
Sbjct: 146 ITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLRAL--AGLKNL 202
Query: 352 KQLSLAHNQ 360
L L +Q
Sbjct: 203 DVLEL-FSQ 210
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 37/239 (15%), Positives = 70/239 (29%), Gaps = 41/239 (17%)
Query: 508 NSLAGPVP-SEIWSLPNLSDLVMWA---NNLTGEIPEGICVNGGNLETLILNNNHLTGAI 563
++ P P +I+S ++ + ++T + + +++ +I NN+ +
Sbjct: 6 ETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN---ELNSIDQIIANNSDIKSVQ 62
Query: 564 PKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVW 623
I N+ + L+ N+LT P + NL L L L N + K +
Sbjct: 63 G--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLS 118
Query: 624 LDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPER 683
L+ N + L ++ + ++
Sbjct: 119 LEHNGISDINGLVHLPQLESLYLGNNKITDITVLS------------------------- 153
Query: 684 LEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNL 742
S + L L LS N +S L L VL L
Sbjct: 154 ---RLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLEL 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 34/206 (16%), Positives = 60/206 (29%), Gaps = 30/206 (14%)
Query: 218 YSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLK 277
+S N + + T SI I + + + ++ ++
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQGIQYLP----NVT 71
Query: 278 YLDLSHNNFTGK--FSNLDFGRCGNLSVITLSQNGLSGTEF--------------PASLK 321
L L+ N T +NL L + L
Sbjct: 72 KLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLV 131
Query: 322 NCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDL 381
+ LE+L + +N + L L + +I P G L+ L L
Sbjct: 132 HLPQLESLYLGNNKITDITVLSRLTKLDTLSL----EDNQISDIVPLAG--LTKLQNLYL 185
Query: 382 SSNRLTGELPSTFASCSSLHSLNLGS 407
S N ++ +L + A +L L L S
Sbjct: 186 SKNHIS-DLRA-LAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 0.002
Identities = 32/203 (15%), Positives = 61/203 (30%), Gaps = 23/203 (11%)
Query: 254 DLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSG 313
+L ++ + + + S+ + ++++ N++ + L+ N L+
Sbjct: 30 NLKKKSVTDAVTQNELN----SIDQIIANNSDIKSVQG---IQYLPNVTKLFLNGNKLTD 82
Query: 314 TEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQAC 373
+ A+LKN L L L S N E
Sbjct: 83 IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLG 142
Query: 374 GTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFN 433
+RLT + + L + ++ L LY+ N
Sbjct: 143 NNKITDITVLSRLTKLDTLSLEDNQISDIVPL--------------AGLTKLQNLYLSKN 188
Query: 434 NISGPVPLSLTNCTQLRVLDLSS 456
+IS L+ L VL+L S
Sbjct: 189 HISDLRALA--GLKNLDVLELFS 209
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.0 bits (115), Expect = 3e-07
Identities = 19/147 (12%), Positives = 40/147 (27%), Gaps = 1/147 (0%)
Query: 496 SCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILN 555
+ + + + NL++L + + G L L +
Sbjct: 6 CPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 556 NNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGL 615
+ L P + + ++LS N L + L ++ GN + L
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWL 124
Query: 616 GKCRSLVWLDLNSNNLSGPLPSELANQ 642
+ + L LA+
Sbjct: 125 QRWEEEGLGGVPEQKLQCHGQGPLAHM 151
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (95), Expect = 1e-04
Identities = 20/128 (15%), Positives = 36/128 (28%), Gaps = 2/128 (1%)
Query: 716 LDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIP-DSFGGLKAIGVLDLSHNNFQGS 774
L + + + L L + + + H+ GL + L + + +
Sbjct: 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71
Query: 775 IPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYENNSGLCGLPLLPCSSGNHAA 834
P + LS L++S N L + Q + N C L
Sbjct: 72 APDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEG 131
Query: 835 TVHPHENK 842
E K
Sbjct: 132 LGGVPEQK 139
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (88), Expect = 0.001
Identities = 27/148 (18%), Positives = 46/148 (31%), Gaps = 6/148 (4%)
Query: 297 RCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSL 356
S + +++G + L + L L + + + L L+ L++
Sbjct: 6 CPHGSSGLRCTRDGA--LDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTI 63
Query: 357 AHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLN 416
+ P L L+LS N L L SL L L N L +
Sbjct: 64 VKSGLRFVAPDA-FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCAL 121
Query: 417 TVVSKISSLIYLYVPFNNI--SGPVPLS 442
+ + VP + G PL+
Sbjct: 122 RWLQRWEEEGLGGVPEQKLQCHGQGPLA 149
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (110), Expect = 2e-06
Identities = 19/132 (14%), Positives = 38/132 (28%), Gaps = 5/132 (3%)
Query: 376 LRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNI 435
RELDL ++ + + A+ +++ N + + L L V N I
Sbjct: 20 DRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI---RKLDGFPLLRRLKTLLVNNNRI 75
Query: 436 SGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSP-PNFPALEKIVLPNNYLSGTVPLEL 494
L L L++N + + L + P +
Sbjct: 76 CRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVI 135
Query: 495 GSCKNLKTIDLS 506
++ +D
Sbjct: 136 YKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (93), Expect = 4e-04
Identities = 18/93 (19%), Positives = 38/93 (40%), Gaps = 3/93 (3%)
Query: 706 TFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLD 765
+T LDL + + +L+ ++ N++ D F L+ + L
Sbjct: 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLL 69
Query: 766 LSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGI 798
+++N G L L++L ++NN+L +
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSLVEL 102
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (91), Expect = 7e-04
Identities = 20/152 (13%), Positives = 45/152 (29%), Gaps = 6/152 (3%)
Query: 182 VNLSHNSISGGSLHIGPSLLQ-LDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKL 240
V L+ I + + + LDL G +I + + + ++FSDN++
Sbjct: 1 VKLTAELIEQAAQYTNAVRDRELDLRGYKIPV---IENLGATLDQFDAIDFSDNEIRKLD 57
Query: 241 NATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGN 300
+ + T+ ++ N + A + L + G L +
Sbjct: 58 GFP--LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 115
Query: 301 LSVITLSQNGLSGTEFPASLKNCQLLETLNMS 332
I + + + L+
Sbjct: 116 YLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (89), Expect = 0.001
Identities = 19/95 (20%), Positives = 36/95 (37%), Gaps = 6/95 (6%)
Query: 441 LSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNL 500
TN + R LDL I + + I +N + + L
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGA---TLDQFDAIDFSDNEIRKLDGFP--LLRRL 65
Query: 501 KTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLT 535
KT+ ++ N + +LP+L++L++ N+L
Sbjct: 66 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 44.4 bits (103), Expect = 2e-05
Identities = 36/198 (18%), Positives = 65/198 (32%), Gaps = 18/198 (9%)
Query: 275 SLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHN 334
+D + ++ + + + L+ N L L L + N
Sbjct: 9 EGTTVDCTGRGLKEIPRDIP----LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRN 64
Query: 335 ALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTF 394
L G P + Q EI ++ L+ L+L N+++ +P +F
Sbjct: 65 QLTGIEPNA--FEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSF 122
Query: 395 ASCSSLHSLNLGSNMLSGNFLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDL 454
+SL SLNL SN + N ++ L P + + +++ DL
Sbjct: 123 EHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNG--GAARCGAPSKVRD---VQIKDL 177
Query: 455 SSNGFTGTIPSGFCSPPN 472
+ F CS N
Sbjct: 178 PHSEFK-------CSSEN 188
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.4 bits (90), Expect = 0.001
Identities = 32/188 (17%), Positives = 61/188 (32%), Gaps = 11/188 (5%)
Query: 175 SCDRLSYVNLSHNSISGGSLHIGPSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDN 234
C+ + V+ + + I +L L+ N++ +L L N
Sbjct: 7 HCEGTT-VDCTGRGLKEIPRDIPLHTTELLLNDNELGRI-SSDGLFGRLPHLVKLELKRN 64
Query: 235 KLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLD 294
+L G I + L N + F LK L+L N +
Sbjct: 65 QLTGIEPNAFEGASHIQELQLGENKIKEISNKMF--LGLHQLKTLNLYDNQISCVMPGS- 121
Query: 295 FGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQL 354
F +L+ + L+ N + A +++ A + G P R+++
Sbjct: 122 FEHLNSLTSLNLASNPFNCNCHLAWFAEWLR--KKSLNGGAARCGAP----SKVRDVQIK 175
Query: 355 SLAHNQFA 362
L H++F
Sbjct: 176 DLPHSEFK 183
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 38.2 bits (87), Expect = 0.003
Identities = 18/80 (22%), Positives = 30/80 (37%)
Query: 744 HNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGG 803
NK+ F GL + L+L N +PGS L+ L+ L++++N +
Sbjct: 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW 146
Query: 804 QLTTFPASRYENNSGLCGLP 823
+ CG P
Sbjct: 147 FAEWLRKKSLNGGAARCGAP 166
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (100), Expect = 5e-05
Identities = 26/123 (21%), Positives = 44/123 (35%), Gaps = 5/123 (4%)
Query: 344 LLGSFRNLKQLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPSTFASCSSLHSL 403
++ + Q +L P+L A L+ S+ L + L SL
Sbjct: 15 IMSKRYDGSQQALDLKGL--RSDPDL-VAQNIDVVLNRRSSMAA-TLRIIEENIPELLSL 70
Query: 404 NLGSNMLSGN-FLNTVVSKISSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGT 462
NL +N L ++++V K +L L + N + L +L L L N + T
Sbjct: 71 NLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDT 130
Query: 463 IPS 465
Sbjct: 131 FRD 133
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (100), Expect = 5e-05
Identities = 30/140 (21%), Positives = 53/140 (37%), Gaps = 9/140 (6%)
Query: 146 SKTSSCSLVTMDLSSNNITGSLPGRSFLLSCDRLSYVNLSHNSISGGSLHIGPSLLQLDL 205
SK S +DL L ++ + L+ + ++ +I P LL L+L
Sbjct: 17 SKRYDGSQQALDLKGLRSDPDLVAQNIDVV---LNRRSSMAATLRIIEENI-PELLSLNL 72
Query: 206 SGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIP 265
S N++ ++ + NL +LN S N+L + + + + L N LS
Sbjct: 73 SNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132
Query: 266 A-----SFVADSSGSLKYLD 280
S + + L LD
Sbjct: 133 DQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (98), Expect = 9e-05
Identities = 30/168 (17%), Positives = 51/168 (30%), Gaps = 10/168 (5%)
Query: 254 DLSYNLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSG 313
+L + ++ GS + LDL + N
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSSMA------- 54
Query: 314 TEFPASLKNCQLLETLNMSHNALQGGIP-GFLLGSFRNLKQLSLAHNQFAGEIPPELGQA 372
+N L +LN+S+N L ++ NLK L+L+ N+
Sbjct: 55 ATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIK 113
Query: 373 CGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSGNFLNTVVS 420
L EL L N L+ S++ L G+ L ++
Sbjct: 114 GLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGHELPPPIA 161
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (92), Expect = 5e-04
Identities = 31/132 (23%), Positives = 46/132 (34%), Gaps = 8/132 (6%)
Query: 198 PSLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSY 257
S LDL G + L +LN + + L N + +++LS
Sbjct: 22 GSQQALDLKGLRSDPD------LVAQNIDVVLNRR-SSMAATLRIIEENIPELLSLNLSN 74
Query: 258 NLLSGEIPASFVADSSGSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFP 317
N L S + + +LK L+LS N LD + L + L N LS T
Sbjct: 75 NRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRD 133
Query: 318 ASLKNCQLLETL 329
S + E
Sbjct: 134 QSTYISAIRERF 145
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (91), Expect = 8e-04
Identities = 25/125 (20%), Positives = 43/125 (34%), Gaps = 9/125 (7%)
Query: 311 LSGTEFPASLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFAG-EIPPEL 369
L G L + LN + + + L L+L++N+ + +
Sbjct: 29 LKGLRSDPDLVAQNIDVVLNRRSSMAA--TLRIIEENIPELLSLNLSNNRLYRLDDMSSI 86
Query: 370 GQACGTLRELDLSSNRLTGELPSTFASCSSLHSLNLGSNMLSG------NFLNTVVSKIS 423
Q L+ L+LS N L E L L L N LS +++ + +
Sbjct: 87 VQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFP 146
Query: 424 SLIYL 428
L+ L
Sbjct: 147 KLLRL 151
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (89), Expect = 0.001
Identities = 18/97 (18%), Positives = 34/97 (35%), Gaps = 3/97 (3%)
Query: 707 FTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGH--IPDSFGGLKAIGVL 764
+ L+ + + TL ++ L LNL +N+L + + +L
Sbjct: 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96
Query: 765 DLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPS 801
+LS N + L +L + N+LS
Sbjct: 97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRD 133
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.003
Identities = 41/202 (20%), Positives = 72/202 (35%), Gaps = 20/202 (9%)
Query: 423 SSLIYLYVPFNNISGPVPLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLP 482
+ + + N++ V + + Q+ L G G L +I
Sbjct: 18 AEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGV---EYLNNLTQINFS 70
Query: 483 NNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGI 542
NN L+ PL+ + ++ + ++I L NL++L
Sbjct: 71 NNQLTDITPLKNLTKLVDILMNNNQI-------ADITPLANLTNLTGLTLFNNQITDIDP 123
Query: 543 CVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQL 602
N NL L L++N ++ S + L SSNQ+T P + NL L L +
Sbjct: 124 LKNLTNLNRLELSSNTISDISALSGLTSLQQLNF--SSNQVTDLKP--LANLTTLERLDI 179
Query: 603 GNNSLTGQVPQGLGKCRSLVWL 624
+N ++ L K +L L
Sbjct: 180 SSNKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.003
Identities = 21/189 (11%), Positives = 58/189 (30%), Gaps = 12/189 (6%)
Query: 571 TNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNN 630
+ L +T + +L ++ LQ + G+ +L ++ ++N
Sbjct: 18 AEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQ 73
Query: 631 LSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMV 690
L+ P + + ++ + N + ++ +
Sbjct: 74 LTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGL------TLFNNQITDIDPLKNL 127
Query: 691 HSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGH 750
+ + + +G L+++S T + +L L+ L++ NK++
Sbjct: 128 TNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD- 186
Query: 751 IPDSFGGLK 759
L
Sbjct: 187 -ISVLAKLT 194
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1237 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.97 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.97 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.96 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.96 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.96 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.95 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.95 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.9 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.89 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.88 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.88 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.88 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.87 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.86 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.86 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.85 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.84 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.83 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.63 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.55 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.51 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.44 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.44 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.08 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.94 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.87 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.65 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 98.63 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.61 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 98.58 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.37 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.0 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.86 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.63 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.02 Aligned_cols=250 Identities=27% Similarity=0.396 Sum_probs=206.1
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEEEEEC
Q ss_conf 89998842143477089999988-99999999930225768799999999987048897324111588498689999954
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
++|++.+.||+|+||+||+|++. ++..||+|++........+.+.+|++++++++||||+++++++.+.+..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf 05388789812858299999998999899999984301727999999999998679998805857798899989999703
Q ss_pred CCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEECCCC
Q ss_conf 68887899963213999866899999999999999999772699991642889897566899956996404642205678
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~~~~~~ 1086 (1237)
++|+|.+++.. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 100 ~gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 100 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp TTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC
T ss_conf 79808988641------5999999999999999999999987---97226776888688789968642515641321366
Q ss_pred CCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 61132012567876780122766667412008799999999939999999998997218899999853101122359321
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1087 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
. ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.... ... .......... +.+
T Consensus 171 ~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~-~~~~~~~~~~------~~~ 236 (293)
T d1yhwa1 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-----PLR-ALYLIATNGT------PEL 236 (293)
T ss_dssp C--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHH-HHHHHHHHCS------CCC
T ss_pred C--CCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCC-----HHH-HHHHHHHCCC------CCC
T ss_conf 6--4444444777368266447998801203137299999804889989979-----999-9999985799------988
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 4899979999999999986123499999999999999
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 1203 (1237)
..+ ......+.+++.+||+.||++|||+.+++++
T Consensus 237 ~~~---~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 237 QNP---EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SSG---GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCC---CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 885---5379999999999866996689099999649
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.99 Aligned_cols=263 Identities=28% Similarity=0.452 Sum_probs=208.4
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEEEE
Q ss_conf 28999884214347708999998899999999930225--7687999999999870488973241115884986899999
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 927 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
.++|++.+.||+|+||+||+|+++ ..||||++.... ....+.|.+|++++++++||||+++++++. .+..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEEEEE
T ss_conf 451899889830788589999999--98999999734699899999999999998479987864567971-558999996
Q ss_pred ECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEECC
Q ss_conf 54688878999632139998668999999999999999997726999916428898975668999569964046422056
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~~~~ 1084 (1237)
|+++|+|.+++.... ..+++..+..++.|+++||+|||+. +||||||||+|||++.++.+||+|||+|+....
T Consensus 84 y~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp CCCEEEHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred CCCCCCHHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCHHHEEECCCCCEEECCCCCEEECCC
T ss_conf 589988899985235----7899999999999999998887509---995161478997981899788750022133355
Q ss_pred CCCCEEEECCCCCCCCCCCCCCCCC---CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCC
Q ss_conf 7861132012567876780122766---6674120087999999999399999999989972188999998531011223
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQSF---RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161 (1237)
Q Consensus 1085 ~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1161 (1237)
...........||+.|||||++.+. .++.++||||||+++|||++|+.||..... ............
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~-----~~~~~~~~~~~~----- 226 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-----RDQIIFMVGRGY----- 226 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHHHTS-----
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHHCCC-----
T ss_conf 6776312566557431799999505689999531516359999999978899899896-----999999996588-----
Q ss_pred CCCCCC-CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCC
Q ss_conf 593214-899979999999999986123499999999999999983001658
Q 000889 1162 LDPELT-MQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTE 1212 (1237)
Q Consensus 1162 ~~~~l~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~ 1212 (1237)
..+.+. .....+ ..+.+++.+||+.+|++|||+.++++.|+.+....+
T Consensus 227 ~~p~~~~~~~~~~---~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 227 LSPDLSKVRSNCP---KAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp CCCCGGGSCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCCCCHHCCCCCH---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCC
T ss_conf 8986000365554---999999999758897689299999999999997098
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.57 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=208.6
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEEEEECC
Q ss_conf 89998842143477089999988999999999302257687999999999870488973241115884986899999546
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMK 1007 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 1007 (1237)
++|++.+.||+|+||+||+|++.++..||||++.. .....++|.+|++++++++||||++++|++...+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCS-SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECC-CCCCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf 99588889820888299999988999999999878-86768999999999996689975653524315993379998369
Q ss_pred CCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEECCCCC
Q ss_conf 88878999632139998668999999999999999997726999916428898975668999569964046422056786
Q 000889 1008 WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDT 1087 (1237)
Q Consensus 1008 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~~~~~~~ 1087 (1237)
+|+|.+++.... ..+++..+..++.|++.||+|+|+. +|+||||||+||+++.++.+||+|||+|+.......
T Consensus 84 ~g~L~~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 84 HGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCHHHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCHHHEEECCCCCEEECCCCHHEECCCCCC
T ss_conf 991899752013----4788999999999999987765316---431044315326666887768655321002368873
Q ss_pred CEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 11320125678767801227666674120087999999999399999999989972188999998531011223593214
Q 000889 1088 HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELT 1167 (1237)
Q Consensus 1088 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1167 (1237)
. ......||+.|+|||++.+..++.++||||||+++|||++++.|+... ............... ...+
T Consensus 157 ~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~-----~~~~~~~~~i~~~~~---~~~p--- 224 (263)
T d1sm2a_ 157 T-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-----RSNSEVVEDISTGFR---LYKP--- 224 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-----CCHHHHHHHHHHTCC---CCCC---
T ss_pred E-EECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCC-----CCHHHHHHHHHHCCC---CCCC---
T ss_conf 3-504300176667857860799984033210599999998789888778-----999999999980688---8995---
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 899979999999999986123499999999999999983001
Q 000889 1168 MQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQV 1209 (1237)
Q Consensus 1168 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~ 1209 (1237)
...+ .++.+++.+||+.+|++|||+.+++++|+++..
T Consensus 225 --~~~~---~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 --RLAS---THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp --TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf --4367---999999999765797689199999999999985
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=368.12 Aligned_cols=260 Identities=25% Similarity=0.425 Sum_probs=206.9
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC-C---CEEEEEEECCCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEE
Q ss_conf 899988421434770899999889-9---9999999302257-6879999999998704889732411158849868999
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD-G---SVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 1002 (1237)
++|++.+.||+|+||+||+|+++. + ..||||++..... ...+.|.+|++++++++|||||+++|++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 04278569802788299999995799788999999978445989999999999999857998886189999628877999
Q ss_pred EEECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEE
Q ss_conf 99546888789996321399986689999999999999999977269999164288989756689995699640464220
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~~ 1082 (1237)
||||++|+|.+++.... ..+++..+..++.|+++||+|||+. +++||||||+|||++.++.+||+|||+|+..
T Consensus 106 ~Ey~~~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EECCTTEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEECCCCCCEEEECCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCCEEC
T ss_conf 97227985300210456----7999999999999999988988527---9835761504489889991998884431575
Q ss_pred CCCCCCE---EEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 5678611---3201256787678012276666741200879999999993-99999999989972188999998531011
Q 000889 1083 NALDTHL---SVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158 (1237)
Q Consensus 1083 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1158 (1237)
....... ......|++.|||||++.+..++.++||||||+++|||+| |+.||..... ...........
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~------~~~~~~i~~~~-- 250 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN------QDVINAIEQDY-- 250 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTTC--
T ss_pred CCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH------HHHHHHHHCCC--
T ss_conf 6777765365025666883003878883699786121445357899998679999999999------99999997378--
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 22359321489997999999999998612349999999999999998300165
Q 000889 1159 NEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDT 1211 (1237)
Q Consensus 1159 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 1211 (1237)
+++.+...+ ..+.+++.+||+.+|++|||+.++++.|+++..+.
T Consensus 251 ------~~~~~~~~~---~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 251 ------RLPPPMDCP---SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp ------CCCCCTTCC---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ------CCCCCCCCH---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCH
T ss_conf ------899974226---99999999975879768929999999999984186
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.77 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=207.8
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEEEEECC
Q ss_conf 89998842143477089999988999999999302257687999999999870488973241115884986899999546
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMK 1007 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 1007 (1237)
++|++.+.||+|+||.||+|+++++..||||++.. .....+.|.+|++++++++||||++++|++. .+..++||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECT-TSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECC-CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEC-CCCEEEEEEECC
T ss_conf 99388679810798289999999999999999864-7688899999999998679998857873104-597699999578
Q ss_pred CCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEECCCCC
Q ss_conf 88878999632139998668999999999999999997726999916428898975668999569964046422056786
Q 000889 1008 WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDT 1087 (1237)
Q Consensus 1008 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~~~~~~~ 1087 (1237)
+|+|.+++..... ..+++..+.+++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+|+......
T Consensus 91 ~g~L~~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~- 163 (272)
T d1qpca_ 91 NGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE- 163 (272)
T ss_dssp TCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-
T ss_pred CCCHHHHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCEEECCCCCEEECCCCC-
T ss_conf 9828888751478---9887889999999999999999748---95467564225156202440423410147735886-
Q ss_pred CEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 11320125678767801227666674120087999999999399999999989972188999998531011223593214
Q 000889 1088 HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELT 1167 (1237)
Q Consensus 1088 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1167 (1237)
........|++.|||||++.+..++.++||||||+++|||+||+.|+.... ............. .+.
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-----~~~~~~~~i~~~~------~~~-- 230 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQNLERGY------RMV-- 230 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHHHTTC------CCC--
T ss_pred CCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHHHHHCC------CCC--
T ss_conf 442035677444458289837999824564525799999996898888888-----9999999997068------888--
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCC
Q ss_conf 899979999999999986123499999999999999983001658
Q 000889 1168 MQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTE 1212 (1237)
Q Consensus 1168 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~ 1212 (1237)
.+...+ ..+.+++.+||+.+|++|||+.++++.|+++...+|
T Consensus 231 ~p~~~~---~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftste 272 (272)
T d1qpca_ 231 RPDNCP---EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (272)
T ss_dssp CCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred CCCCCH---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCC
T ss_conf 965571---999999999758897689399999998611321379
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.27 Aligned_cols=253 Identities=25% Similarity=0.340 Sum_probs=203.7
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEEEEE
Q ss_conf 89998842143477089999988-99999999930225-76879999999998704889732411158849868999995
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
++|++.+.||+|+||+||+|+++ ++..||+|++.... ....+.+.+|++++++++||||+++++++.++...++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEEC
T ss_conf 46089989721748099999999999799999984566412799999999999857998884696540467436798864
Q ss_pred CCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEECCC
Q ss_conf 46888789996321399986689999999999999999977269999164288989756689995699640464220567
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~~~~~ 1085 (1237)
+++|+|.+++... ..+++..++.++.|++.|++|||+. +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ~~gg~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 85 CSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred CCCCCHHHHHHCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECCC
T ss_conf 5898089997537-----9999999999999999999999975---9835754689978878998798323142240468
Q ss_pred CCCEEEECCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 86113201256787678012276666-74120087999999999399999999989972188999998531011223593
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQSFRC-TTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDP 1164 (1237)
Q Consensus 1086 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1164 (1237)
.........+||+.|||||++.+..+ +.++||||+|+++|||++|+.||....... ..+... ...... ..+
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~----~~~~~~-~~~~~~---~~~ 228 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC----QEYSDW-KEKKTY---LNP 228 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS----HHHHHH-HTTCTT---STT
T ss_pred CCCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHH----HHHHHH-HCCCCC---CCC
T ss_conf 865311132557474287286189999971016173799999982997888898599----999998-638887---886
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 214899979999999999986123499999999999999
Q 000889 1165 ELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1165 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 1203 (1237)
. ......+.+++.+|++.||++|||+.+++++
T Consensus 229 -~------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 229 -W------KKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp -G------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -C------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -4------4699999999999767996689099999619
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.69 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=203.3
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEEEEEC
Q ss_conf 89998842143477089999988-99999999930225768799999999987048897324111588498689999954
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
+.|++.+.||+|+||.||+|++. ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980099589999627
Q ss_pred CCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEECCCC
Q ss_conf 68887899963213999866899999999999999999772699991642889897566899956996404642205678
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~~~~~~ 1086 (1237)
++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 92 AGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp TTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred CCCCHHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEECCHHHEEECCCCCEEEEECHHHHCCCCCC
T ss_conf 9981889998628----9999999999999999999999988---98871407003148789998997161230357786
Q ss_pred CCEEEECCCCCCCCCCCCCCC-----CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCC
Q ss_conf 611320125678767801227-----666674120087999999999399999999989972188999998531011223
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQ-----SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161 (1237)
Q Consensus 1087 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1161 (1237)
.......||+.|||||++. +..++.++||||+||++|||++|+.||..... ... ... ..... .
T Consensus 165 --~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~---~~~--~~~-i~~~~-~--- 232 (288)
T d2jfla1 165 --QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP---MRV--LLK-IAKSE-P--- 232 (288)
T ss_dssp --HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG---GGH--HHH-HHHSC-C---
T ss_pred --CCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCH---HHH--HHH-HHCCC-C---
T ss_conf --41001025626479999832025788888066578789999998208899999899---999--999-97079-9---
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 593214899979999999999986123499999999999999
Q 000889 1162 LDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1162 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 1203 (1237)
+.+..+ ......+.+++.+||+.||++|||+.|++++
T Consensus 233 --~~~~~~---~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 233 --PTLAQP---SRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp --CCCSSG---GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --CCCCCC---CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --877765---6699999999999766996689199999629
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.51 Aligned_cols=265 Identities=25% Similarity=0.386 Sum_probs=205.6
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEEEE
Q ss_conf 289998842143477089999988-999999999302257-687999999999870488973241115884986899999
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 927 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
.++|++.+.||+|+||+||+|++. ++..||+|++..... .....+.+|++++++++||||+++++++.+....++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf 56888978971277809999999899969999998754097899999999999986799999949999998999999997
Q ss_pred ECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEEC
Q ss_conf 5468887899963213999866899999999999999999772-699991642889897566899956996404642205
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH-SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~~~ 1083 (1237)
|+++|+|.+++... ..+++..+..++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||+|+...
T Consensus 85 y~~gg~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp CCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred CCCCCCHHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEEEECCCCCCCC
T ss_conf 67998689987424-----99999999999999999999999859---99714457799468789989995487762567
Q ss_pred CCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHH----------HH
Q ss_conf 67861132012567876780122766667412008799999999939999999998997218899999----------85
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQ----------LH 1153 (1237)
Q Consensus 1084 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~----------~~ 1153 (1237)
... ....+||+.|||||++.+..++.++||||+||++|||++|+.||.+............... ..
T Consensus 157 ~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 157 DSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp HHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred CCC----CCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCC
T ss_conf 886----2111377141194687589989488899899999999988899899887899999988751775457742123
Q ss_pred ---------HH-----------CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHC
Q ss_conf ---------31-----------011223593214899979999999999986123499999999999999--9830
Q 000889 1154 ---------RE-----------KRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM--FKEL 1207 (1237)
Q Consensus 1154 ---------~~-----------~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~l 1207 (1237)
.. ..+.....+..+. .....++.+++.+|+..||++|||+.|++++ +++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS----GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCCB----TTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCC
T ss_conf 33221111222354134778876650268766764----4489999999999868994679089999609864769
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.42 Aligned_cols=259 Identities=24% Similarity=0.378 Sum_probs=208.6
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCC------CEEEEEEECCC-CCCCHHHHHHHHHHHHHC-CCCCCCCCCCEEEECCEE
Q ss_conf 8999884214347708999998899------99999993022-576879999999998704-889732411158849868
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRDG------SVVAIKKLIHV-TGQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEER 999 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~~~------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 999 (1237)
++|++.+.||+|+||+||+|++... ..||+|++... .......+.+|+.+++++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEE
T ss_conf 99397019830788199999985788554204999999663358789999999999999715899686877888629958
Q ss_pred EEEEEECCCCCHHHHHHHHHCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCC
Q ss_conf 9999954688878999632139------------------9986689999999999999999977269999164288989
Q 000889 1000 LLVYEYMKWGSLESVLHDRAKG------------------GGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSS 1061 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~ 1061 (1237)
++|||||++|+|.++++..... ....+++..++.++.|+++||+|||+. +|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHH
T ss_conf 9999727999599999862577751022100001222001257789999999999999999999739---9050527032
Q ss_pred CEEECCCCCEEEEECCCCEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCC
Q ss_conf 75668999569964046422056786113201256787678012276666741200879999999993-99999999989
Q 000889 1062 NVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFG 1140 (1237)
Q Consensus 1062 NIll~~~~~vki~DfGla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~p~~~~~~~ 1140 (1237)
||+++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||++ |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred CCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCCHH
T ss_conf 14434598289851422220457786156234357876578388727999963303000399999983899999998989
Q ss_pred CCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 97218899999853101122359321489997999999999998612349999999999999998
Q 000889 1141 DDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFK 1205 (1237)
Q Consensus 1141 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 1205 (1237)
..+.. . .... ..+ ..+...+ ..+.+++.+||+.+|++|||+.+++++|.
T Consensus 274 --~~~~~---~-~~~~-----~~~--~~p~~~~---~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 --ANFYK---L-IQNG-----FKM--DQPFYAT---EEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp --HHHHH---H-HHTT-----CCC--CCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --HHHHH---H-HHCC-----CCC--CCCCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf --99999---9-8569-----989--9887678---99999999975889668939999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=360.55 Aligned_cols=259 Identities=24% Similarity=0.387 Sum_probs=209.2
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEEEEEC
Q ss_conf 89998842143477089999988-99999999930225768799999999987048897324111588498689999954
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
++|++.+.||+|+||+||+|++. ++..||+|++.. .....+++.+|++++++++||||+++++++.+++..++||||+
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCT-TCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECC-CCCHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEEECC
T ss_conf 993986598208880899999999996999999777-6103999999999998679998826775274578547876314
Q ss_pred CCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEECCCC
Q ss_conf 68887899963213999866899999999999999999772699991642889897566899956996404642205678
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~~~~~~ 1086 (1237)
++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 96 ~~g~l~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 96 TYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp TTCBHHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred CCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEEECCCCC
T ss_conf 6760677753035---54157999999999999978889878---93057604576899899928983244546537887
Q ss_pred CCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 61132012567876780122766667412008799999999939999999998997218899999853101122359321
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1087 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
........|++.|+|||++.+..++.++||||||+++|||++|+.||.... ............. .+..
T Consensus 170 -~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~-----~~~~~~~~i~~~~------~~~~ 237 (287)
T d1opja_ 170 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVYELLEKDY------RMER 237 (287)
T ss_dssp -SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC-----CHHHHHHHHHTTC------CCCC
T ss_pred -CEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHHCCC------CCCC
T ss_conf -221035566546669278727999810430217899999986799887742-----5999999985588------8888
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 48999799999999999861234999999999999999830016
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVD 1210 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 1210 (1237)
+...+ ..+.+++.+||+.||++|||+.++++.|+.+..+
T Consensus 238 --~~~~~---~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 238 --PEGCP---EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp --CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred --CCCCH---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf --74330---9999999997577976893999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=356.69 Aligned_cols=253 Identities=21% Similarity=0.313 Sum_probs=205.2
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEEEEE
Q ss_conf 289998842143477089999988-9999999993022576879999999998704889732411158849868999995
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 927 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
.++|++.+.||+|+||.||+|++. ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 65758988984076819999998899989999998452431699999999999867997999299999989999999985
Q ss_pred CCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEEECCCCEEEC
Q ss_conf 4688878999632139998668999999999999999997726999916428898975668--99956996404642205
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLD--ENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~--~~~~vki~DfGla~~~~ 1083 (1237)
|++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++ .++.+||+|||+|+...
T Consensus 105 ~~gg~L~~~l~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 105 MSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp CCSCBHHHHHTCT----TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCEEEEECHHHEEECCCCCCEEEEEECCHHEECC
T ss_conf 7998899999762----37899999999999999999999756---9760001546736416889869995452104425
Q ss_pred CCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCC
Q ss_conf 67861132012567876780122766667412008799999999939999999998997218899999853101122359
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1084 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
.... .....||+.|||||++.+..++.++||||+||++|||++|+.||.+.. . ............ ...
T Consensus 178 ~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~-~~~~~~i~~~~~---~~~ 245 (350)
T d1koaa2 178 PKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-----D-DETLRNVKSCDW---NMD 245 (350)
T ss_dssp TTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-----H-HHHHHHHHHTCC---CSC
T ss_pred CCCC---CCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC-----H-HHHHHHHHHCCC---CCC
T ss_conf 6543---200068624218899758998726765546599999985989989979-----9-999999984788---989
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 3214899979999999999986123499999999999999
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 1203 (1237)
.... ......+.+++.+|+..||++|||+.+++++
T Consensus 246 ~~~~-----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 246 DSAF-----SGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CGGG-----GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCC-----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 4223-----5899999999999756896679089998629
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.57 Aligned_cols=246 Identities=27% Similarity=0.434 Sum_probs=203.5
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCC---CCCCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEEE
Q ss_conf 89998842143477089999988-9999999993022---5768799999999987048897324111588498689999
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHV---TGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
++|++.+.||+|+||.||+|+++ ++..||+|++... .......+.+|++++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred EECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEEC
Q ss_conf 95468887899963213999866899999999999999999772699991642889897566899956996404642205
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~~~ 1083 (1237)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+...
T Consensus 86 Ey~~~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 86 EYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp ECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred EECCCCCHHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCCEECCCCCEEECCCCEEEECC
T ss_conf 504798589887504-----8999999999999999999999988---94652202344146689987115556335448
Q ss_pred CCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCC
Q ss_conf 67861132012567876780122766667412008799999999939999999998997218899999853101122359
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1084 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
... .....||+.|||||++.+..++.++||||+||++|||++|+.||.... ..........
T Consensus 158 ~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~~--------- 218 (263)
T d2j4za1 158 SSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT------YQETYKRISR--------- 218 (263)
T ss_dssp CCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHT---------
T ss_pred CCC----CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC------HHHHHHHHHC---------
T ss_conf 885----235578876349999758998931440467599999832999988899------9999999971---------
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 3214899979999999999986123499999999999999
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 1203 (1237)
.....+...+ ..+.+++.+|+++||++|||+.+++++
T Consensus 219 ~~~~~p~~~s---~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 219 VEFTFPDFVT---EGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp TCCCCCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCCCCCCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8999986689---999999999764797689099999719
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.73 Aligned_cols=254 Identities=22% Similarity=0.379 Sum_probs=210.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEEEEECC
Q ss_conf 89998842143477089999988999999999302257687999999999870488973241115884986899999546
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMK 1007 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 1007 (1237)
++|++.+.||+|+||+||+|+++++..||||++.. .....++|.+|+.++++++||||++++|++.+....++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~-~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEES-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECC-CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCC
T ss_conf 99799689820788399999988998999999874-75778999999999996689860158899850781699997048
Q ss_pred CCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEECCCCC
Q ss_conf 88878999632139998668999999999999999997726999916428898975668999569964046422056786
Q 000889 1008 WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDT 1087 (1237)
Q Consensus 1008 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~~~~~~~ 1087 (1237)
+|+|..++.... ..+++..+.+++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+|+.......
T Consensus 83 ~g~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 83 NGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TEEHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCCHHHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCC
T ss_conf 993888641024----6776899999999999999987546---843466541358876998479886144202357872
Q ss_pred CEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 113201256787678012276666741200879999999993-9999999998997218899999853101122359321
Q 000889 1088 HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1088 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
. ......|++.|+|||++.+..++.++||||||+++|||+| |+.||..... ........... ..
T Consensus 156 ~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~------~~~~~~i~~~~------~~-- 220 (258)
T d1k2pa_ 156 T-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN------SETAEHIAQGL------RL-- 220 (258)
T ss_dssp C-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH------HHHHHHHHTTC------CC--
T ss_pred E-EECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCH------HHHHHHHHHCC------CC--
T ss_conf 2-524657887757807863799885210336432467397559999889999------99999998079------78--
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf 48999799999999999861234999999999999999830
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKEL 1207 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l 1207 (1237)
..+...+ ..+.+++.+||+.+|++|||+.+++++|.++
T Consensus 221 ~~p~~~~---~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 221 YRPHLAS---EKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCTTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf 9965465---9999999997668976893999999874188
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=354.75 Aligned_cols=253 Identities=21% Similarity=0.290 Sum_probs=204.6
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEEEEE
Q ss_conf 289998842143477089999988-9999999993022576879999999998704889732411158849868999995
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 927 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
.++|++.+.||+|+||.||+|++. ++..||+|++..........+.+|++++++++||||+++++++.+++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 40359989993177829999999899979999998872646799999999999867997989199999989999999982
Q ss_pred CCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEEECCCCEEEC
Q ss_conf 4688878999632139998668999999999999999997726999916428898975668--99956996404642205
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLD--ENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~--~~~~vki~DfGla~~~~ 1083 (1237)
|++|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++ .++.+||+|||+|+...
T Consensus 108 ~~gg~L~~~~~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 108 LSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp CCCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred CCCCHHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCCCCCCCCEEEEEECCCCEECC
T ss_conf 8998088889863----89989999999999999999999977---9265131445531134678848995256303437
Q ss_pred CCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCC
Q ss_conf 67861132012567876780122766667412008799999999939999999998997218899999853101122359
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1084 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
.... .....|++.|+|||++.+..++.++||||+||++|||++|+.||.+.. ... ........ ... ..
T Consensus 181 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~~~-~~~~i~~~-~~~--~~ 248 (352)
T d1koba_ 181 PDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-----DLE-TLQNVKRC-DWE--FD 248 (352)
T ss_dssp TTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-----HHH-HHHHHHHC-CCC--CC
T ss_pred CCCC---EEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCC-----HHH-HHHHHHHC-CCC--CC
T ss_conf 8872---010047645348999747998976333898999999996889989979-----999-99999847-889--89
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 3214899979999999999986123499999999999999
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 1203 (1237)
... ....+ ..+.+++.+|++.||++|||+.+++++
T Consensus 249 ~~~--~~~~s---~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 249 EDA--FSSVS---PEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp SST--TTTSC---HHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCC--CCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 300--24799---999999999756996689189999609
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.89 Aligned_cols=250 Identities=21% Similarity=0.291 Sum_probs=206.8
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCC---CCCCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEEE
Q ss_conf 89998842143477089999988-9999999993022---5768799999999987048897324111588498689999
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHV---TGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
++|++.+.||+|+||.||+|++. ++..||+|++... .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred EECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEEC
Q ss_conf 95468887899963213999866899999999999999999772699991642889897566899956996404642205
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~~~ 1083 (1237)
||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+|+...
T Consensus 88 Ey~~gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ECCCCCCHHHHHHCC-----CCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCCCCCCCCCCCEEEECCCCCCEECC
T ss_conf 704898777765315-----9999999999999999999762165---08847677412366888538860321024225
Q ss_pred CCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCC
Q ss_conf 67861132012567876780122766667412008799999999939999999998997218899999853101122359
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1084 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
............||+.|||||++.+..++.++||||+||++|||++|+.||.... .. ......... .
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~~-~~~~~i~~~-~------ 226 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-----EY-LIFQKIIKL-E------ 226 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HH-HHHHHHHTT-C------
T ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCC-----HH-HHHHHHHCC-C------
T ss_conf 6776433355567755258440026898966623045699999803889989959-----99-999999718-9------
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 3214899979999999999986123499999999999999
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 1203 (1237)
..++ .... ..+.+++.+|+..||++|||+.|+.++
T Consensus 227 ~~~p--~~~s---~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 227 YDFP--EKFF---PKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp CCCC--TTCC---HHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CCCC--CCCC---HHHHHHHHHHCCCCHHHCCCHHHHCCC
T ss_conf 9998--5479---999999999855797689197897377
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.30 Aligned_cols=261 Identities=22% Similarity=0.379 Sum_probs=206.5
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCC-----CEEEEEEECCCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEE
Q ss_conf 8999884214347708999998899-----9999999302257-687999999999870488973241115884986899
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRDG-----SVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLL 1001 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 1001 (1237)
..|+..++||+|+||.||+|.++.. ..||||++..... ....+|.+|++++++++||||++++|++.+....++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf 99686159811779099999996899878799999998844596899999999999985689878323677833880389
Q ss_pred EEEECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEE
Q ss_conf 99954688878999632139998668999999999999999997726999916428898975668999569964046422
Q 000889 1002 VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~ 1081 (1237)
||||+.++++.+++.... ..+++..+..++.|++.|++|||+. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 87 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEECCCCCCHHHHHCCC----CCCCHHHHHHHHHHHHHHHHHCCCC---CCCCCCCCCCEEEECCCCEEEECCCCHHHC
T ss_conf 997213574022210234----5420899999999999854121212---342576564427888998499845510300
Q ss_pred ECCCCC-CEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCC
Q ss_conf 056786-1132012567876780122766667412008799999999939999999998997218899999853101122
Q 000889 1082 VNALDT-HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINE 1160 (1237)
Q Consensus 1082 ~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1160 (1237)
...... ........||+.|||||++.+..++.++||||||+++|||++++.|+.... .............
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-----~~~~~~~~i~~~~---- 230 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-----SNHEVMKAINDGF---- 230 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHHHTTC----
T ss_pred CCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCC-----CHHHHHHHHHCCC----
T ss_conf 3578765267426777734348888704999973556344898999996798865568-----9999999986357----
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 359321489997999999999998612349999999999999998300165
Q 000889 1161 ILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDT 1211 (1237)
Q Consensus 1161 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 1211 (1237)
.+. .+...+ ..+.+++.+||+.+|++|||+.++++.|+++....
T Consensus 231 --~~~--~~~~~~---~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 231 --RLP--TPMDCP---SAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp --CCC--CCTTCB---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred --CCC--CCHHHH---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf --899--850457---99999999977679768939999999999986695
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=353.63 Aligned_cols=252 Identities=25% Similarity=0.342 Sum_probs=203.0
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEEEE
Q ss_conf 289998842143477089999988-99999999930225-7687999999999870488973241115884986899999
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 927 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
.+.|++.+.||+|+||+||+|+++ ++..||+|++.... ......+.+|++++++++||||+++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf 66669988994065839999999999989999998157731289999999999986799899919899998998889885
Q ss_pred ECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEEECCCCEE
Q ss_conf 54688878999632139998668999999999999999997726999916428898975668---999569964046422
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLD---ENFEARVSDFGMARL 1081 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~---~~~~vki~DfGla~~ 1081 (1237)
||+||+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++. +++.+||+|||+|+.
T Consensus 88 ~~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 88 LVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCSCBHHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred CCCCCCHHHHHHCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---EEEEEEECCCCEEECCCCCCCEEEEECCCEEEE
T ss_conf 26898488865303-----6788789999999999998752413---055687046300110468882499831543587
Q ss_pred ECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCC
Q ss_conf 05678611320125678767801227666674120087999999999399999999989972188999998531011223
Q 000889 1082 VNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161 (1237)
Q Consensus 1082 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1161 (1237)
..... ......||+.|||||++.+..++.++||||+||++|||++|+.||.... ....+..........
T Consensus 160 ~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~~~~~~~i~~~~~~~--- 228 (307)
T d1a06a_ 160 EDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN-----DAKLFEQILKAEYEF--- 228 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHTTCCCC---
T ss_pred CCCCC---EEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHCCCCCC---
T ss_conf 25897---0440032842259188737999807873451599999985979999989-----999999986168777---
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 593214899979999999999986123499999999999999
Q 000889 1162 LDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1162 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 1203 (1237)
..+.....+ ..+.+++.+|+++||++|||+.|++++
T Consensus 229 ---~~~~~~~~s---~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 229 ---DSPYWDDIS---DSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ---CTTTTTTSC---HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---CCCCCCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---876666789---999999999760897579189998629
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.07 Aligned_cols=256 Identities=24% Similarity=0.371 Sum_probs=202.2
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCC--CCHHHHHHHHHHHHHCCCCCCCCCCCEEEE--CCEEEEE
Q ss_conf 89998842143477089999988-999999999302257--687999999999870488973241115884--9868999
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG--QGDREFMAEMETIGKIKHRNLVPLLGYCKI--GEERLLV 1002 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 1002 (1237)
++|++.+.||+|+||+||+|+++ ++..||+|++..... ...+.+.+|++++++++||||+++++++.+ ....|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 33799679830889199999999999799999987465797999999999999997789998248999991789989999
Q ss_pred EEECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCCCCCEEECCCCCEEEEECCCCE
Q ss_conf 99546888789996321399986689999999999999999977269--9991642889897566899956996404642
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC--IPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1080 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dikp~NIll~~~~~vki~DfGla~ 1080 (1237)
||||++|+|.+++...... ...+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|||+|+
T Consensus 84 mEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 84 MEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EECCCCCCHHHHHHHCCCC-CCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEE
T ss_conf 9568999389999851545-789999999999999999999999716778878858676542574788857980010003
Q ss_pred EECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCC
Q ss_conf 20567861132012567876780122766667412008799999999939999999998997218899999853101122
Q 000889 1081 LVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINE 1160 (1237)
Q Consensus 1081 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1160 (1237)
....... ......||+.|||||++.+..++.++||||+|+++|||++|+.||..... ....... ......
T Consensus 163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~------~~~~~~i-~~~~~~- 232 (269)
T d2java1 163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KELAGKI-REGKFR- 232 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHH-HHTCCC-
T ss_pred ECCCCCC--CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCH------HHHHHHH-HCCCCC-
T ss_conf 2245777--55667788232799998399999389887527899998018899899899------9999999-718998-
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 3593214899979999999999986123499999999999999
Q 000889 1161 ILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1161 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 1203 (1237)
.++ ...+ .++.+++.+||+.||++|||+.+++++
T Consensus 233 ----~~~--~~~s---~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 233 ----RIP--YRYS---DELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp ----CCC--TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----CCC--CCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf ----897--4359---999999999767995579189999729
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.95 Aligned_cols=257 Identities=25% Similarity=0.369 Sum_probs=203.1
Q ss_pred CCCCCC-EECCCCCEEEEEEEECC---CCEEEEEEECCCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEEE
Q ss_conf 999884-21434770899999889---99999999302257-68799999999987048897324111588498689999
Q 000889 929 GFSADS-MIGSGGFGEVYKAQLRD---GSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 929 ~~~~~~-~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
+|.+.. .||+|+||.||+|.++. +..||||++..... ...+.|.+|++++++++||||++++|++. .+..++||
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~~lvm 87 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVM 87 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEE
T ss_pred CEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEC-CCEEEEEE
T ss_conf 71887848730608099999996089768999999882039789999999999998679988806865603-68079999
Q ss_pred EECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEEC
Q ss_conf 95468887899963213999866899999999999999999772699991642889897566899956996404642205
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~~~ 1083 (1237)
||+++|+|.+++... ...+++..+.+++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 88 E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp ECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EECCCCCHHHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEECCCHHHHCCC
T ss_conf 807899689975212----56999999999999999987899868---81057676466045468854203313421155
Q ss_pred CCCCCE-EEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCC
Q ss_conf 678611-3201256787678012276666741200879999999993-99999999989972188999998531011223
Q 000889 1084 ALDTHL-SVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161 (1237)
Q Consensus 1084 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1161 (1237)
...... ......||+.|+|||++.+..++.++||||||+++|||++ |+.||..... ... ........+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~---~~~i~~~~~---- 230 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEV---MAFIEQGKR---- 230 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHH---HHHHHTTCC----
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCH---HHH---HHHHHCCCC----
T ss_conf 4343211356211374335868872799995412322017899999389999999799---999---999981899----
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 5932148999799999999999861234999999999999999830016
Q 000889 1162 LDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVD 1210 (1237)
Q Consensus 1162 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 1210 (1237)
+. .+...+ ..+.+++.+||+.+|++|||+.++.+.|+.+...
T Consensus 231 --~~--~p~~~~---~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 231 --ME--CPPECP---PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp --CC--CCTTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CC--CCCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf --99--997678---9999999997577976890999999999999998
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.64 Aligned_cols=264 Identities=27% Similarity=0.377 Sum_probs=212.2
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEEEEECC
Q ss_conf 89998842143477089999988999999999302257687999999999870488973241115884986899999546
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMK 1007 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 1007 (1237)
++|++.+.||+|+||.||+|+++++..||+|++.. .....+.|.+|+.++++++|||||+++|++. .+..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCT-TSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECC-CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCCEEEEEEECC
T ss_conf 99798469930798099999999999999999880-4488899999999998666678868999982-397599999447
Q ss_pred CCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEECCCCC
Q ss_conf 88878999632139998668999999999999999997726999916428898975668999569964046422056786
Q 000889 1008 WGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDT 1087 (1237)
Q Consensus 1008 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~~~~~~~ 1087 (1237)
+|+|..++..... ..++|..++.++.|++.|++|||+. +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 95 ~g~l~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 95 KGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp TCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCCHHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHHH---HEECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCC
T ss_conf 9943542000035---5305999999999999999987541---143353123079998999299844255542568873
Q ss_pred CEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 11320125678767801227666674120087999999999399999999989972188999998531011223593214
Q 000889 1088 HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPELT 1167 (1237)
Q Consensus 1088 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1167 (1237)
.......|++.|+|||++....++.++||||||+++|||++|+.|+.... ............. ...
T Consensus 169 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-----~~~~~~~~i~~~~------~~~-- 234 (285)
T d1fmka3 169 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-----VNREVLDQVERGY------RMP-- 234 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHHHTTC------CCC--
T ss_pred -EEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCC-----CHHHHHHHHHHCC------CCC--
T ss_conf -35245455665458089837998917741323589999986899999888-----8999999998268------999--
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 8999799999999999861234999999999999999830016589998
Q 000889 1168 MQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGDSL 1216 (1237)
Q Consensus 1168 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~~~~ 1216 (1237)
.+...+ ..+.+++.+||+.+|++||++.+|++.|++.....++...
T Consensus 235 ~~~~~~---~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~ 280 (285)
T d1fmka3 235 CPPECP---ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280 (285)
T ss_dssp CCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCC
T ss_pred CCCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCCCCCCC
T ss_conf 983237---9999999997566975891999999987666238999999
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.13 Aligned_cols=249 Identities=23% Similarity=0.378 Sum_probs=199.4
Q ss_pred CEECCCCCEEEEEEEECC---CCEEEEEEECCCCCC--CHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEEEEECCC
Q ss_conf 421434770899999889---999999993022576--879999999998704889732411158849868999995468
Q 000889 934 SMIGSGGFGEVYKAQLRD---GSVVAIKKLIHVTGQ--GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKW 1008 (1237)
Q Consensus 934 ~~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 1008 (1237)
+.||+|+||.||+|.++. +..||+|++...... ..+.+.+|++++++++||||++++|++. .+..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEC-CCCEEEEEECCCC
T ss_conf 783458782999999816973859999998801089899999999999998679989852777750-5977999974788
Q ss_pred CCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEECCCCCC
Q ss_conf 88789996321399986689999999999999999977269999164288989756689995699640464220567861
Q 000889 1009 GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALDTH 1088 (1237)
Q Consensus 1009 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~~~~~~~~ 1088 (1237)
|+|.++++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||+|+........
T Consensus 92 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 92 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CCHHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCC
T ss_conf 9689997522-----5789999999999999997668747---9556777611310235675123413453313432344
Q ss_pred E-EEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 1-3201256787678012276666741200879999999993-9999999998997218899999853101122359321
Q 000889 1089 L-SVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPEL 1166 (1237)
Q Consensus 1089 ~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1166 (1237)
. ......||+.|||||++.+..++.++||||||+++|||++ |+.||..... ........... ++
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~------~~~~~~i~~~~--------~~ 229 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------SEVTAMLEKGE--------RM 229 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTTC--------CC
T ss_pred CCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCH------HHHHHHHHCCC--------CC
T ss_conf 32244567784203916653799984344303403132896589999999899------99999998289--------99
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf 489997999999999998612349999999999999998300
Q 000889 1167 TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208 (1237)
Q Consensus 1167 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 1208 (1237)
..+...+ ..+.+++.+||+.||++|||+.++.+.|+...
T Consensus 230 ~~p~~~~---~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 230 GCPAGCP---REMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CCCTTCC---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHH
T ss_conf 9986567---99999999975889768909899999852887
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.74 Aligned_cols=258 Identities=24% Similarity=0.415 Sum_probs=207.7
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC-CC----EEEEEEECCC-CCCCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEE
Q ss_conf 899988421434770899999889-99----9999993022-57687999999999870488973241115884986899
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD-GS----VVAIKKLIHV-TGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLL 1001 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 1001 (1237)
.+|++.+.||+|+||+||+|++.. ++ .||+|++... .....+++.+|++++++++||||++++|++.+ +..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEE
T ss_conf 99978319820899299999995899889899999996513497999999999999986799888158999961-98369
Q ss_pred EEEECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEE
Q ss_conf 99954688878999632139998668999999999999999997726999916428898975668999569964046422
Q 000889 1002 VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~ 1081 (1237)
++|++.+|+|.+++... ...+++..+++++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+|+.
T Consensus 88 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEECCTTCBHHHHHHHT----SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred EEEECCCCCCCCCCCCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCHHHCCEECCCCCEEEECCCCCEE
T ss_conf 99842687401011133----45799999999999999999999876---950476212031167998758602552223
Q ss_pred ECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCCCCHHHHHHHHHHHHCCCCC
Q ss_conf 056786113201256787678012276666741200879999999993-9999999998997218899999853101122
Q 000889 1082 VNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINE 1160 (1237)
Q Consensus 1082 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1160 (1237)
..............||+.|+|||++.++.++.++||||||+++|||+| |..||..... ..+... .....+
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~---~~~~~~---i~~~~~--- 231 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSI---LEKGER--- 231 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG---GGHHHH---HHHTCC---
T ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHH---HHCCCC---
T ss_conf 35444532236510586446708874699983565440799999999779999999998---999999---975998---
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 35932148999799999999999861234999999999999999830016
Q 000889 1161 ILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVD 1210 (1237)
Q Consensus 1161 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 1210 (1237)
++.+...+ ..+.+++.+||+.+|++|||+.+++++|..+..+
T Consensus 232 -----~~~p~~~~---~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 232 -----LPQPPICT---IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp -----CCCCTTBC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -----CCCCCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf -----99985568---9999999984789934691999999999998758
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.74 Aligned_cols=249 Identities=20% Similarity=0.293 Sum_probs=204.6
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCC---CCCCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEE
Q ss_conf 289998842143477089999988-9999999993022---576879999999998704889732411158849868999
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHV---TGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 927 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 1002 (1237)
.++|++.+.||+|+||.||+|+.+ ++..||+|++.+. .....+.+.+|++++++++||||+++++++.+....|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867999887787640356421110
Q ss_pred EEECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEE
Q ss_conf 99546888789996321399986689999999999999999977269999164288989756689995699640464220
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~~ 1082 (1237)
|||+++|+|.+++... ..+++..++.++.|++.|++|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 84 ~ey~~gg~L~~~~~~~-----~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EECCCCCCHHHHHHCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEEEECCCCCCC
T ss_conf 0035798605555325-----6775999999999996521134315---9622464777847658998888205652003
Q ss_pred CCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCC
Q ss_conf 56786113201256787678012276666741200879999999993999999999899721889999985310112235
Q 000889 1083 NALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162 (1237)
Q Consensus 1083 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1162 (1237)
..... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ........ ...
T Consensus 156 ~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~------~~~~~~i~-~~~----- 221 (337)
T d1o6la_ 156 ISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELIL-MEE----- 221 (337)
T ss_dssp CCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HCC-----
T ss_pred CCCCC--CCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCH------HHHHHHHH-CCC-----
T ss_conf 56786--20551008899666650489888333102230678899878999999699------99999985-289-----
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHH
Q ss_conf 9321489997999999999998612349999999-----9999999
Q 000889 1163 DPELTMQTSDETELYQYLRISFECLDDRPFKRPT-----MIQVMAM 1203 (1237)
Q Consensus 1163 ~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~ 1203 (1237)
..++ .... .++.+++.+|+++||.+|++ +.+++++
T Consensus 222 -~~~p--~~~s---~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 222 -IRFP--RTLS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -CCCC--TTSC---HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CCCC--CCCC---HHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCC
T ss_conf -9898--6689---99999998666389344225652349999729
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.80 Aligned_cols=245 Identities=24% Similarity=0.367 Sum_probs=193.1
Q ss_pred CCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCCCCCCCEEEE----CCEEEEEE
Q ss_conf 98842143477089999988-99999999930225--7687999999999870488973241115884----98689999
Q 000889 931 SADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKI----GEERLLVY 1003 (1237)
Q Consensus 931 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 1003 (1237)
+..+.||+|+||+||+|++. ++..||+|++.... ....+.+.+|++++++++||||+++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred EECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC--EEECCCCCCCEEEC-CCCCEEEEECCCCE
Q ss_conf 9546888789996321399986689999999999999999977269999--16428898975668-99956996404642
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPH--IIHRDMKSSNVLLD-ENFEARVSDFGMAR 1080 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dikp~NIll~-~~~~vki~DfGla~ 1080 (1237)
||+++|+|.+++... ..+++..+..++.|+++||+|||++ + |+||||||+|||++ .++.+||+|||+|+
T Consensus 92 E~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred ECCCCCCHHHHHHCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEECCCCHHHCEEECCCCCEEEEECCCCE
T ss_conf 578989489997513-----5546999999999999999999978---99799687674351166799988980057654
Q ss_pred EECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCC
Q ss_conf 20567861132012567876780122766667412008799999999939999999998997218899999853101122
Q 000889 1081 LVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINE 1160 (1237)
Q Consensus 1081 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1160 (1237)
...... .....||+.|||||++.+ .++.++||||+|+++|||++|+.||.... ..............
T Consensus 164 ~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~-----~~~~~~~~i~~~~~--- 230 (270)
T d1t4ha_ 164 LKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----NAAQIYRRVTSGVK--- 230 (270)
T ss_dssp GCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SHHHHHHHHTTTCC---
T ss_pred ECCCCC----CCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHHHHCCCC---
T ss_conf 236876----677553813008988478-99986711007999999987889998765-----59999999973899---
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 3593214899979999999999986123499999999999999
Q 000889 1161 ILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1161 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 1203 (1237)
.+.+... .. .++.+++.+||+++|++|||+.|++++
T Consensus 231 --~~~~~~~--~~---~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 231 --PASFDKV--AI---PEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp --CGGGGGC--CC---HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --CCCCCCC--CC---HHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --8656755--78---999999999763797589299999677
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.71 Aligned_cols=252 Identities=22% Similarity=0.290 Sum_probs=203.1
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCC------CCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEE
Q ss_conf 289998842143477089999988-999999999302257------6879999999998704889732411158849868
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG------QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEER 999 (1237)
Q Consensus 927 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 999 (1237)
.++|++.+.||+|+||+||+|+++ ++..||+|++..... ...+.+.+|++++++++||||+++++++.+....
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999979989
Q ss_pred EEEEEECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CEEEEE
Q ss_conf 9999954688878999632139998668999999999999999997726999916428898975668999----569964
Q 000889 1000 LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENF----EARVSD 1075 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~----~vki~D 1075 (1237)
++|||||++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+|++|
T Consensus 89 ~iv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEECCCCCCCCCHHCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEEECCCCCCCCEEECC
T ss_conf 9999867786431001035-----6421557899999999998766625---4221133301279825898666469643
Q ss_pred CCCCEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 04642205678611320125678767801227666674120087999999999399999999989972188999998531
Q 000889 1076 FGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE 1155 (1237)
Q Consensus 1076 fGla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1155 (1237)
||+|+....... .....|++.|+|||++.+..++.++||||+|+++|||++|+.||.+.. ....+ ......
T Consensus 161 fG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~~~~~-~~i~~~ 231 (293)
T d1jksa_ 161 FGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----KQETL-ANVSAV 231 (293)
T ss_dssp CTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHH-HHHHTT
T ss_pred HHHHHHCCCCCC---CCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC-----HHHHH-HHHHHC
T ss_conf 344210577763---122477774309999818999976652214099999970889988999-----99999-999816
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 011223593214899979999999999986123499999999999999
Q 000889 1156 KRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1156 ~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 1203 (1237)
.. ........ . ....+.+++.+||+.||++|||+.+++++
T Consensus 232 -~~--~~~~~~~~--~---~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 232 -NY--EFEDEYFS--N---TSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp -CC--CCCHHHHT--T---SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CC--CCCCHHCC--C---CCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -88--88701047--8---89999999999863896689199999619
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=349.08 Aligned_cols=245 Identities=28% Similarity=0.398 Sum_probs=196.7
Q ss_pred CCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCC---HHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEEEE
Q ss_conf 9998842143477089999988-99999999930225768---7999999999870488973241115884986899999
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQG---DREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 929 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
.|+..+.||+|+||.||+|++. ++..||+|++....... .+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
T ss_conf 56762797018880999999989993999999844443588999999999999997789998238999998998899998
Q ss_pred ECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEECC
Q ss_conf 54688878999632139998668999999999999999997726999916428898975668999569964046422056
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~~~~ 1084 (1237)
||++|++..++... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 96 ~~~~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp CCSEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ECCCCCHHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCCCEEEECCCCCEEEEECCCCCCCCC
T ss_conf 06999457899737-----9999999999999999999999868---976667884217987999789844365334677
Q ss_pred CCCCEEEECCCCCCCCCCCCCCCC---CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCC
Q ss_conf 786113201256787678012276---66674120087999999999399999999989972188999998531011223
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQS---FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161 (1237)
Q Consensus 1085 ~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1161 (1237)
. ....||+.|||||++.+ ..++.++||||+||++|||++|+.||.... ....... .... .
T Consensus 168 ~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~-----~~~~~~~-i~~~-~---- 230 (309)
T d1u5ra_ 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYH-IAQN-E---- 230 (309)
T ss_dssp B------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHH-HHHS-C----
T ss_pred C------CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHH-HHHC-C----
T ss_conf 8------73134766368899834678886721454558999999987889999979-----9999999-9828-9----
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 593214899979999999999986123499999999999999
Q 000889 1162 LDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1162 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 1203 (1237)
.+.+.. ...+ ..+.+++.+||+.||++|||+.+++++
T Consensus 231 -~~~~~~-~~~s---~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 231 -SPALQS-GHWS---EYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp -CCCCSC-TTSC---HHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -CCCCCC-CCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf -998887-8889---999999999773796579189999719
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=349.29 Aligned_cols=263 Identities=27% Similarity=0.429 Sum_probs=210.5
Q ss_pred HHCCCCCCCEECCCCCEEEEEEEEC------CCCEEEEEEECCCCCC-CHHHHHHHHHHHHHCCCCCCCCCCCEEEECCE
Q ss_conf 8289998842143477089999988------9999999993022576-87999999999870488973241115884986
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLR------DGSVVAIKKLIHVTGQ-GDREFMAEMETIGKIKHRNLVPLLGYCKIGEE 998 (1237)
Q Consensus 926 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 998 (1237)
..++|++.+.||+|+||+||+|+++ ++..||||++...... ..+++.+|++++++++||||+++++++.....
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCCCC
T ss_conf 98893886798207883999999888765778829999998821085799999999999996689976552466605980
Q ss_pred EEEEEEECCCCCHHHHHHHHHC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCC
Q ss_conf 8999995468887899963213-------------------999866899999999999999999772699991642889
Q 000889 999 RLLVYEYMKWGSLESVLHDRAK-------------------GGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMK 1059 (1237)
Q Consensus 999 ~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik 1059 (1237)
.+++|||+++|+|.++++.... .....+++..+..++.|++.||+|||+. ++||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC---CEEEEEEC
T ss_conf 389998158992999998527554210000111001210346788989999999999999985541357---86854884
Q ss_pred CCCEEECCCCCEEEEECCCCEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC-CCCCCCC
Q ss_conf 897566899956996404642205678611320125678767801227666674120087999999999399-9999999
Q 000889 1060 SSNVLLDENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGK-RPIDPSE 1138 (1237)
Q Consensus 1060 p~NIll~~~~~vki~DfGla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~-~p~~~~~ 1138 (1237)
|+||+++.++.+||+|||+|+...............|++.|+|||++.+..++.++||||||+++|||++|. +||....
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCCCCC
T ss_conf 01168989992898331442113677641115777767676798997268898056302523629999806899999989
Q ss_pred CCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf 8997218899999853101122359321489997999999999998612349999999999999998300
Q 000889 1139 FGDDNNLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208 (1237)
Q Consensus 1139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 1208 (1237)
......... .+.. +. .+...+ .++.+++.+||+.+|++||||.+|++.|+++.
T Consensus 248 ------~~e~~~~v~-~~~~-----~~--~p~~~~---~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 ------HEEVIYYVR-DGNI-----LA--CPENCP---LELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp ------HHHHHHHHH-TTCC-----CC--CCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ------HHHHHHHHH-CCCC-----CC--CCCCCH---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf ------999999997-3997-----88--873252---99999999974889657939999999999842
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.23 Aligned_cols=270 Identities=24% Similarity=0.344 Sum_probs=205.6
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHH--HHHHHHHCCCCCCCCCCCEEEECC----EEEE
Q ss_conf 8999884214347708999998899999999930225768799999--999987048897324111588498----6899
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMA--EMETIGKIKHRNLVPLLGYCKIGE----ERLL 1001 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~l~~~~~~~~----~~~l 1001 (1237)
.+|.+.+.||+|+||.||+|++. +..||||++... ..+.+.. |+..+.+++||||+++++++.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEEC-CEEEEEEEECCC---CHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 68999889820788199999999-989999998720---04679999999999627998683268899837986048999
Q ss_pred EEEECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCEEECCCCCCCEEECCCCCEEEEEC
Q ss_conf 999546888789996321399986689999999999999999977269-----999164288989756689995699640
Q 000889 1002 VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC-----IPHIIHRDMKSSNVLLDENFEARVSDF 1076 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~Dikp~NIll~~~~~vki~Df 1076 (1237)
||||+++|+|.++++. ..++|..+.+++.|+|.|++|+|+.. .++|+||||||+|||++.++.+||+||
T Consensus 79 v~Ey~~~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEECCCCCCHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEEC
T ss_conf 9964669898999865------8999899999999999999998876652046898661531731357868877688763
Q ss_pred CCCEEECCCCCCE--EEECCCCCCCCCCCCCCCCC------CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCC-----
Q ss_conf 4642205678611--32012567876780122766------6674120087999999999399999999989972-----
Q 000889 1077 GMARLVNALDTHL--SVSTLAGTPGYVPPEYYQSF------RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDN----- 1143 (1237)
Q Consensus 1077 Gla~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~------~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~----- 1143 (1237)
|+++......... ......||+.|+|||++.+. .++.++||||||+++|||++|..||.........
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCC
T ss_conf 86623467776200135525035476782210565454677767501220159999999628998876631124101225
Q ss_pred ---HHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf ---18899999853101122359321489997999999999998612349999999999999998300165
Q 000889 1144 ---NLVGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDT 1211 (1237)
Q Consensus 1144 ---~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~ 1211 (1237)
......... ......++.++...........+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 233 ~~~~~~~~~~~~----~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 233 PSDPSVEEMRKV----VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CSSCCHHHHHHH----HTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHH----HHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf 564309999998----7502468887765577689999999999976069858959999999999888865
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=345.02 Aligned_cols=245 Identities=23% Similarity=0.343 Sum_probs=202.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCC---CCCCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEEE
Q ss_conf 89998842143477089999988-9999999993022---5768799999999987048897324111588498689999
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHV---TGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
++|++.+.||+|+||+||+|+++ ++..||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred EECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEEC
Q ss_conf 95468887899963213999866899999999999999999772699991642889897566899956996404642205
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~~~ 1083 (1237)
||++||++..++... ..+++..++.++.|++.|++|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 84 E~~~gg~l~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 84 DYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp CCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EECCCCCCCCCCCCC-----CCCCCCHHHHHHHHHHHHHHHHCCC---CEECCCCCCHHEEECCCCCEEEECCCCCEEEC
T ss_conf 503786322343222-----2111007999999998765541247---67705568105038689988983175216712
Q ss_pred CCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCC
Q ss_conf 67861132012567876780122766667412008799999999939999999998997218899999853101122359
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1084 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
... ....||+.|||||++.+..++.++||||+||++|||++|+.||.... ........... .
T Consensus 156 ~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~~-~------ 217 (316)
T d1fota_ 156 DVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------TMKTYEKILNA-E------ 217 (316)
T ss_dssp SCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHC-C------
T ss_pred CCC-----CCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCC------HHHHHHHHHCC-C------
T ss_conf 456-----43457634359999838999804304653336899975989999969------99999999708-9------
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 32148999799999999999861234999999-----99999999
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRP-----TMIQVMAM 1203 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 1203 (1237)
..+ +...+ ..+.+++.+|+.++|.+|+ |+.+++++
T Consensus 218 ~~~--p~~~s---~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 LRF--PPFFN---EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CCC--CTTSC---HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCC--CCCCC---HHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf 889--97789---99999999995449976664310219999819
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=345.41 Aligned_cols=245 Identities=22% Similarity=0.269 Sum_probs=202.5
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCC---CCCCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEEE
Q ss_conf 89998842143477089999988-9999999993022---5768799999999987048897324111588498689999
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHV---TGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 1003 (1237)
++|++.+.||+|+||.||+|+++ ++..||+|++... .....+.+.+|+++++.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred EECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEEC
Q ss_conf 95468887899963213999866899999999999999999772699991642889897566899956996404642205
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVN 1083 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~~~ 1083 (1237)
||+.+|+|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+...
T Consensus 121 e~~~~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCCCCCCHHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHCCCCCCCCEEEEECEEEEECC
T ss_conf 233466226667515-----8989999999999999989999859---98617679999360778978861010333225
Q ss_pred CCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCC
Q ss_conf 67861132012567876780122766667412008799999999939999999998997218899999853101122359
Q 000889 1084 ALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILD 1163 (1237)
Q Consensus 1084 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1163 (1237)
... ....||+.|||||++.+..++.++||||+||++|||++|+.||.... ........... ..
T Consensus 193 ~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~~-~~----- 255 (350)
T d1rdqe_ 193 GRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIVSG-KV----- 255 (350)
T ss_dssp SCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHC-CC-----
T ss_pred CCC-----CCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC------HHHHHHHHHCC-CC-----
T ss_conf 666-----43367635678899717998853311450078999975889989959------99999998617-98-----
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 32148999799999999999861234999999-----99999999
Q 000889 1164 PELTMQTSDETELYQYLRISFECLDDRPFKRP-----TMIQVMAM 1203 (1237)
Q Consensus 1164 ~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 1203 (1237)
.. +...+ ..+.+++.+|+..||.+|+ |+.+++++
T Consensus 256 -~~--p~~~s---~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 256 -RF--PSHFS---SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -CC--CTTCC---HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CC--CCCCC---HHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCC
T ss_conf -89--76689---99999999983409986065534549999719
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=342.87 Aligned_cols=250 Identities=25% Similarity=0.337 Sum_probs=197.7
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC---CCCHHHHHHH---HHHHHHCCCCCCCCCCCEEEECCEE
Q ss_conf 289998842143477089999988-99999999930225---7687999999---9998704889732411158849868
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT---GQGDREFMAE---METIGKIKHRNLVPLLGYCKIGEER 999 (1237)
Q Consensus 927 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~ 999 (1237)
-++|++.+.||+|+||.||+|++. ++..||+|++.... ......+.+| +++++.++||||+++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf 77685101884288909999999999979999998458754266799999999999998508998588999999989988
Q ss_pred EEEEEECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 99999546888789996321399986689999999999999999977269999164288989756689995699640464
Q 000889 1000 LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMA 1079 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla 1079 (1237)
|+||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|
T Consensus 83 ~ivmE~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla 154 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA 154 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred EEEEEECCCCCHHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCEEECCCEEEECCCCCEEEEEECEE
T ss_conf 9999914898389998732-----5532789999999999999999977---9622044422167858896798220102
Q ss_pred EEECCCCCCEEEECCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 22056786113201256787678012276-66674120087999999999399999999989972188999998531011
Q 000889 1080 RLVNALDTHLSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158 (1237)
Q Consensus 1080 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1158 (1237)
+...... .....||+.|+|||++.. ..++.++||||+||++|||++|+.||......+ .......
T Consensus 155 ~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~~~~------- 220 (364)
T d1omwa3 155 CDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDRM------- 220 (364)
T ss_dssp EECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC---HHHHHHH-------
T ss_pred EECCCCC----CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHH-------
T ss_conf 3337886----4331134554216876038999844104677899999985999888899899---9999986-------
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHH
Q ss_conf 22359321489997999999999998612349999999-----9999999
Q 000889 1159 NEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPT-----MIQVMAM 1203 (1237)
Q Consensus 1159 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~ 1203 (1237)
........+...+ ..+.+++.+|+++||++||| +.+++++
T Consensus 221 --~~~~~~~~~~~~s---~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 221 --TLTMAVELPDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp --SSSCCCCCCSSSC---HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred --CCCCCCCCCCCCC---HHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCC
T ss_conf --0468887887789---99999999985669888088743579999749
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.46 Aligned_cols=262 Identities=26% Similarity=0.438 Sum_probs=207.0
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCC-C--EEEEEEECCC-CCCCHHHHHHHHHHHHHC-CCCCCCCCCCEEEECCEEEEE
Q ss_conf 8999884214347708999998899-9--9999993022-576879999999998704-889732411158849868999
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRDG-S--VVAIKKLIHV-TGQGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~~~-~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 1002 (1237)
++|++.+.||+|+||.||+|+++++ . .||||++... .....+.+.+|+++++++ +||||++++|++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EEECCCCCHHHHHHHHH-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCE
Q ss_conf 99546888789996321-----------3999866899999999999999999772699991642889897566899956
Q 000889 1003 YEYMKWGSLESVLHDRA-----------KGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEA 1071 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~v 1071 (1237)
|||+++|+|.++++... ......+++..+.+++.|++.|+.|+|+. +++||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCCE
T ss_conf 980289869999864035555512310123457899999999999999998766308---95455505204898688763
Q ss_pred EEEECCCCEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC-CCCCCCCCCCCHHHHHHH
Q ss_conf 9964046422056786113201256787678012276666741200879999999993999-999999899721889999
Q 000889 1072 RVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKR-PIDPSEFGDDNNLVGWAK 1150 (1237)
Q Consensus 1072 ki~DfGla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~-p~~~~~~~~~~~~~~~~~ 1150 (1237)
||+|||+|+....... .....|+..|+|||.+.+..++.++||||||+++|||++|.. ||.... ......
T Consensus 167 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------~~~~~~ 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAELYE 237 (309)
T ss_dssp EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHH
T ss_pred EECCCCCCCCCCCCCC---CCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCC------HHHHHH
T ss_conf 8743443224442234---5530137755553875269999622153138899999836899999999------999999
Q ss_pred HHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCC
Q ss_conf 98531011223593214899979999999999986123499999999999999983001658
Q 000889 1151 QLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTE 1212 (1237)
Q Consensus 1151 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~ 1212 (1237)
...... .+.. +...+ ..+.+++.+||+.||++|||+.+++++|+++.....
T Consensus 238 ~i~~~~------~~~~--~~~~~---~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 238 KLPQGY------RLEK--PLNCD---DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp HGGGTC------CCCC--CTTBC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHHHCC------CCCC--CCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCC
T ss_conf 998268------8888--76678---999999999767896689499999999999986186
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.59 Aligned_cols=263 Identities=24% Similarity=0.390 Sum_probs=204.7
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC------CCEEEEEEECCCCC-CCHHHHHHHHHHHHHC-CCCCCCCCCCEEEEC-CE
Q ss_conf 899988421434770899999889------99999999302257-6879999999998704-889732411158849-86
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD------GSVVAIKKLIHVTG-QGDREFMAEMETIGKI-KHRNLVPLLGYCKIG-EE 998 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~ 998 (1237)
++|++.+.||+|+||.||+|++.. ++.||+|++..... ...+.+.+|...+.++ +|+||+.+++++... ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCE
T ss_conf 99798449841678399999986777555783999999860017178999999999988614998499741154047975
Q ss_pred EEEEEEECCCCCHHHHHHHHHCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC
Q ss_conf 89999954688878999632139-----------9986689999999999999999977269999164288989756689
Q 000889 999 RLLVYEYMKWGSLESVLHDRAKG-----------GGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE 1067 (1237)
Q Consensus 999 ~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~ 1067 (1237)
.++|||||++|+|.++++..... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECC
T ss_conf 7999984589929999985366666532220233214689999999999999999988737---9717867731065779
Q ss_pred CCCEEEEECCCCEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC-CCCCCCCCCCCCHHH
Q ss_conf 9956996404642205678611320125678767801227666674120087999999999399-999999989972188
Q 000889 1068 NFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGK-RPIDPSEFGDDNNLV 1146 (1237)
Q Consensus 1068 ~~~vki~DfGla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~-~p~~~~~~~~~~~~~ 1146 (1237)
++.+||+|||+|+...............||+.|||||++.+..++.++||||||+++|||++|. .||...... ..+
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--~~~- 246 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEF- 246 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--HHH-
T ss_pred CCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHH--HHH-
T ss_conf 98289845752001135665222475166721020368646889966322136789999986889999899989--999-
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 999998531011223593214899979999999999986123499999999999999983001
Q 000889 1147 GWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQV 1209 (1237)
Q Consensus 1147 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~ 1209 (1237)
......... +.. +...+ .++.+++.+||+.||++|||+.+++++|+++..
T Consensus 247 --~~~~~~~~~------~~~--~~~~~---~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 247 --CRRLKEGTR------MRA--PDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp --HHHHHHTCC------CCC--CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHCCCC------CCC--CCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf --999963898------888--86578---999999999767796679199999999979986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.19 Aligned_cols=261 Identities=26% Similarity=0.414 Sum_probs=205.2
Q ss_pred CCEECCCCCEEEEEEEECCC----CEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCEEEE-CCEEEEEEEEC
Q ss_conf 84214347708999998899----999999930225-7687999999999870488973241115884-98689999954
Q 000889 933 DSMIGSGGFGEVYKAQLRDG----SVVAIKKLIHVT-GQGDREFMAEMETIGKIKHRNLVPLLGYCKI-GEERLLVYEYM 1006 (1237)
Q Consensus 933 ~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 1006 (1237)
.++||+|+||+||+|++..+ ..||||++.... ....++|.+|++++++++||||++++|++.. +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEECCCC
Q ss_conf 68887899963213999866899999999999999999772699991642889897566899956996404642205678
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~~~~~~ 1086 (1237)
++|+|.+++.... ...++..+.+++.|++.|+.|+|+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 112 ~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ECCCHHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCC
T ss_conf 0674144210134----5404899999999988765200336---76257766875767799988991065232255665
Q ss_pred CC--EEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 61--1320125678767801227666674120087999999999399999999989972188999998531011223593
Q 000889 1087 TH--LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDP 1164 (1237)
Q Consensus 1087 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1164 (1237)
.. .......|++.|+|||++.+..++.++||||||+++|||++|+.||...... .. +........+
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~---~~~~i~~g~~------- 252 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FD---ITVYLLQGRR------- 252 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHTTCC-------
T ss_pred CCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCH--HH---HHHHHHCCCC-------
T ss_conf 55310025655564556768874379997457466199999999789999888999--99---9999980898-------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 2148999799999999999861234999999999999999830016589998
Q 000889 1165 ELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGDSL 1216 (1237)
Q Consensus 1165 ~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~~~~ 1216 (1237)
...+...+ ..+.+++.+||+.||++||++.+++++|+++......+..
T Consensus 253 -~~~p~~~~---~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~~ 300 (311)
T d1r0pa_ 253 -LLQPEYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 300 (311)
T ss_dssp -CCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCB
T ss_pred -CCCCCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHHHHC
T ss_conf -89964475---9999999997688976893999999999999975201212
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=336.63 Aligned_cols=261 Identities=24% Similarity=0.351 Sum_probs=207.7
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCC---HHHHHHHHHHHHHCCCCCCCCCCCEEEECC----E
Q ss_conf 289998842143477089999988-99999999930225768---799999999987048897324111588498----6
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQG---DREFMAEMETIGKIKHRNLVPLLGYCKIGE----E 998 (1237)
Q Consensus 927 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 998 (1237)
.++|++.+.||+|+||.||+|++. +++.||+|++......+ .+.+.+|+++++.++||||+++++++.... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred EEEEEEECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf 89999954688878999632139998668999999999999999997726999916428898975668999569964046
Q 000889 999 RLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1078 (1237)
Q Consensus 999 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGl 1078 (1237)
.|+||||++|++|.+++... ..+++..++.++.|++.|++|||+. +|+||||||+||+++.++..+++|||.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTT
T ss_pred EEEEEECCCCCEEHHHHCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCEEEHHHH
T ss_conf 99999778898710112035-----8999999999999999999999857---952763467556657543201003444
Q ss_pred CEEECCCC-CCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 42205678-61132012567876780122766667412008799999999939999999998997218899999853101
Q 000889 1079 ARLVNALD-THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKR 1157 (1237)
Q Consensus 1079 a~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1157 (1237)
+....... .........||+.|||||++.+..++.++||||+|+++|||++|+.||.... . ............
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~-~~~~~~~~~~~~ 231 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-----P-VSVAYQHVREDP 231 (277)
T ss_dssp CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----H-HHHHHHHHHCCC
T ss_pred HHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCC-----H-HHHHHHHHHCCC
T ss_conf 3221235443333464257624369999839999966320265289999976979989969-----9-999999984699
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHHCCC
Q ss_conf 12235932148999799999999999861234999999-99999999983001
Q 000889 1158 INEILDPELTMQTSDETELYQYLRISFECLDDRPFKRP-TMIQVMAMFKELQV 1209 (1237)
Q Consensus 1158 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~eil~~L~~l~~ 1209 (1237)
.. +.. .....+ ..+.+++.+|+++||.+|| |+.++.+.|.++..
T Consensus 232 ~~----~~~-~~~~~s---~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 232 IP----PSA-RHEGLS---ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp CC----GGG-TSSSCC---HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred CC----CCH-HCCCCC---HHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHHC
T ss_conf 99----710-034789---9999999998667976777399999999999758
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.49 Aligned_cols=253 Identities=20% Similarity=0.248 Sum_probs=202.9
Q ss_pred HHCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEEEE
Q ss_conf 8289998842143477089999988-999999999302257687999999999870488973241115884986899999
Q 000889 926 ATNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 926 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
..++|++.+.||+|+||+||+|++. ++..||+|.+... ..+...+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
T ss_conf 701058878983177839999999899969999997578-6659999999999985799798909899988998899995
Q ss_pred ECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEEEECCCCEEE
Q ss_conf 546888789996321399986689999999999999999977269999164288989756689--995699640464220
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE--NFEARVSDFGMARLV 1082 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~--~~~vki~DfGla~~~ 1082 (1237)
||+||+|.+++... +..+++..++.++.|+++|+.|||+. +|+||||||+|||++. ...+|++|||+++..
T Consensus 82 ~~~gg~L~~~i~~~----~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 82 FISGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred CCCCCCHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEEECCCCHHHCC
T ss_conf 38998088998753----89999999999999999999999876---997513554443443788518997644111003
Q ss_pred CCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCC
Q ss_conf 56786113201256787678012276666741200879999999993999999999899721889999985310112235
Q 000889 1083 NALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162 (1237)
Q Consensus 1083 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1162 (1237)
..... .....+++.|+|||...+..++.++||||+||++|+|++|+.||.... . ........... . ..
T Consensus 155 ~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~-----~-~~~~~~i~~~~-~--~~ 222 (321)
T d1tkia_ 155 KPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-----N-QQIIENIMNAE-Y--TF 222 (321)
T ss_dssp CTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-----H-HHHHHHHHHTC-C--CC
T ss_pred CCCCC---CCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCC-----H-HHHHHHHHHCC-C--CC
T ss_conf 46775---321223322234021048777840113027999999982899999989-----9-99999998389-9--98
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 93214899979999999999986123499999999999999
Q 000889 1163 DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1163 ~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 1203 (1237)
+..... . ...++.+++.+|+..||++|||+.|++++
T Consensus 223 ~~~~~~--~---~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 223 DEEAFK--E---ISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CHHHHT--T---SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CHHHCC--C---CCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 802236--7---89999999999866996689099999639
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.06 Aligned_cols=252 Identities=22% Similarity=0.273 Sum_probs=197.5
Q ss_pred HCCCCCC-CEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHC-CCCCCCCCCCEEEE----CCEE
Q ss_conf 2899988-42143477089999988-9999999993022576879999999998704-88973241115884----9868
Q 000889 927 TNGFSAD-SMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKI-KHRNLVPLLGYCKI----GEER 999 (1237)
Q Consensus 927 ~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~ 999 (1237)
.++|++. ++||+|+||.||+|++. ++..||+|++.. ...+.+|+.++.++ +||||+++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf 14879810796545486999999889998999999897-----4779999999998669999782989995034689789
Q ss_pred EEEEEECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEEEC
Q ss_conf 99999546888789996321399986689999999999999999977269999164288989756689---995699640
Q 000889 1000 LLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE---NFEARVSDF 1076 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~---~~~vki~Df 1076 (1237)
|+|||||+||+|.+++..+. ...+++..++.++.|++.|++|||+. +|+||||||+||+++. .+.+||+||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEECCCCCCHHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 99997789984999998627---87757999999999999999999976---9864441002201135555663113545
Q ss_pred CCCEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 46422056786113201256787678012276666741200879999999993999999999899721889999985310
Q 000889 1077 GMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREK 1156 (1237)
Q Consensus 1077 Gla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1156 (1237)
|+|+....... .....||+.|||||++.+..++.++||||+||++|+|++|+.||.......... ..
T Consensus 159 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~------- 225 (335)
T d2ozaa1 159 GFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GM------- 225 (335)
T ss_dssp TTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------------
T ss_pred CEEEECCCCCC---CCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHH---HH-------
T ss_conf 51233368886---432267756379277748988888888764516778865889988988778899---99-------
Q ss_pred CCCCCCCCCCCCCCCC-HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 1122359321489997-9999999999986123499999999999999
Q 000889 1157 RINEILDPELTMQTSD-ETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1157 ~~~~~~~~~l~~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 1203 (1237)
...+.......+... ......+.+++.+|++.||++|||+.+++++
T Consensus 226 -~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 226 -KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ---CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -HHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -99985388888985434699999999999756996579099999709
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.95 Aligned_cols=252 Identities=26% Similarity=0.419 Sum_probs=204.5
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCEEEEC-CEEEEEEEEC
Q ss_conf 899988421434770899999889999999993022576879999999998704889732411158849-8689999954
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIG-EERLLVYEYM 1006 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~ 1006 (1237)
++|++.+.||+|+||.||+|+++ +..||||++.. ....+.+.+|++++++++||||++++|++.+. +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECC--HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECC
T ss_conf 99488579820798089999999-90999999885--7779999999999986789898549878872389289999636
Q ss_pred CCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEECCCC
Q ss_conf 68887899963213999866899999999999999999772699991642889897566899956996404642205678
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~~~~~~ 1086 (1237)
++|+|.+++..... ..+++..+++++.|++.|+.|||+. +++||||||+||+++.++.+|++|||+++......
T Consensus 84 ~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 84 AKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp TTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCHHHHHHHCCC---CCCCHHHHHHHHHHHHHHCCCCCCC---CEECCCCCHHHHEECCCCCEEECCCCCCEECCCCC
T ss_conf 99989999874578---8889999999999998523211337---65536665676014689977632456003447877
Q ss_pred CCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 6113201256787678012276666741200879999999993-999999999899721889999985310112235932
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEILDPE 1165 (1237)
Q Consensus 1087 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1165 (1237)
....++..|+|||++.+..++.++||||||+++|||++ |+.||.... ........ ... ..+.
T Consensus 158 -----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~---~~~~~~~i---~~~------~~~~ 220 (262)
T d1byga_ 158 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPRV---EKG------YKMD 220 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC---GGGHHHHH---TTT------CCCC
T ss_pred -----CCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC---HHHHHHHH---HCC------CCCC
T ss_conf -----655666467781787279888588777579999999978999999999---99999999---808------9999
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 148999799999999999861234999999999999999830016
Q 000889 1166 LTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVD 1210 (1237)
Q Consensus 1166 l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 1210 (1237)
.+. ..+ ..+.+++.+||+.||.+|||+.+++++|++++..
T Consensus 221 ~~~--~~~---~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 221 APD--GCP---PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CCT--TCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC--CCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 976--579---9999999997566976893999999999999867
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.13 Aligned_cols=262 Identities=26% Similarity=0.392 Sum_probs=209.9
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC--------CCEEEEEEECCCCC-CCHHHHHHHHHHHHHC-CCCCCCCCCCEEEECC
Q ss_conf 899988421434770899999889--------99999999302257-6879999999998704-8897324111588498
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD--------GSVVAIKKLIHVTG-QGDREFMAEMETIGKI-KHRNLVPLLGYCKIGE 997 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 997 (1237)
++|++.+.||+|+||.||+|+... +..||+|++..... ....++.+|...+.++ +||||+++++++.++.
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCCC
T ss_conf 99697009851678289999985787555667549999998811286889999999999998139996973465220188
Q ss_pred EEEEEEEECCCCCHHHHHHHHHCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC
Q ss_conf 689999954688878999632139-----------998668999999999999999997726999916428898975668
Q 000889 998 ERLLVYEYMKWGSLESVLHDRAKG-----------GGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLD 1066 (1237)
Q Consensus 998 ~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~ 1066 (1237)
..++||||+++|+|.+++..+... ....+++..+++++.|++.||+|||+. ++|||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred EEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCEEEC
T ss_conf 68999973699909999986067764322233457434679999999999999999876637---978630221022454
Q ss_pred CCCCEEEEECCCCEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCCCCHH
Q ss_conf 999569964046422056786113201256787678012276666741200879999999993-9999999998997218
Q 000889 1067 ENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNL 1145 (1237)
Q Consensus 1067 ~~~~vki~DfGla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~p~~~~~~~~~~~~ 1145 (1237)
.++.+||+|||+++...............+++.|+|||++.++.++.++||||||+++|||++ |..||..... .
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---~-- 244 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---E-- 244 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---H--
T ss_pred CCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCH---H--
T ss_conf 78976762211101135555543146678884663266751798882555477588888740179898999999---9--
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 8999998531011223593214899979999999999986123499999999999999983001
Q 000889 1146 VGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQV 1209 (1237)
Q Consensus 1146 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~ 1209 (1237)
.......... .+.. +...+ ..+.+++.+||+.+|++|||+.++++.|+++..
T Consensus 245 -~~~~~i~~~~------~~~~--p~~~~---~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 245 -ELFKLLKEGH------RMDK--PSNCT---NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -HHHHHHHTTC------CCCC--CSSCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHCCC------CCCC--CCCCH---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf -9999997288------8898--74352---999999999766797679399999999988860
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.85 Aligned_cols=264 Identities=27% Similarity=0.416 Sum_probs=209.6
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC------CCCEEEEEEECCCCC-CCHHHHHHHHHHHHHC-CCCCCCCCCCEEEECCEE
Q ss_conf 89998842143477089999988------999999999302257-6879999999998704-889732411158849868
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR------DGSVVAIKKLIHVTG-QGDREFMAEMETIGKI-KHRNLVPLLGYCKIGEER 999 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 999 (1237)
++|++.+.||+|+||.||+|++. .+..||||++..... .....+.+|+.+++.+ +||||+++++++.+....
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf 99698549820688299999980664477886999999874248779999999999987626999887899898319978
Q ss_pred EEEEEECCCCCHHHHHHHHHC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC
Q ss_conf 999995468887899963213-------------9998668999999999999999997726999916428898975668
Q 000889 1000 LLVYEYMKWGSLESVLHDRAK-------------GGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLD 1066 (1237)
Q Consensus 1000 ~lv~e~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~ 1066 (1237)
++|||||++|+|.++++.... .....+++..+.+++.|++.|++|||++ +++||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCCC
T ss_conf 99997379987999998535665444445332223345889999999999999999988757---926662410210000
Q ss_pred CCCCEEEEECCCCEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCC-CCCCCCCCCCHH
Q ss_conf 9995699640464220567861132012567876780122766667412008799999999939999-999998997218
Q 000889 1067 ENFEARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRP-IDPSEFGDDNNL 1145 (1237)
Q Consensus 1067 ~~~~vki~DfGla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p-~~~~~~~~~~~~ 1145 (1237)
.++.+|++|||.++...............|++.|+|||++.+..++.++||||||+++|||++++.| |...... ..+
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~--~~~ 257 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--SKF 257 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--HHH
T ss_pred CCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHH--HHH
T ss_conf 257521023401023367886158620135968767788617999974001025899999985899887789989--999
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 89999985310112235932148999799999999999861234999999999999999830016
Q 000889 1146 VGWAKQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVD 1210 (1237)
Q Consensus 1146 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 1210 (1237)
.... ... ..+. .+...+ ..+.+++.+||+.||++|||+.++++.|+++..+
T Consensus 258 ~~~i----~~~-----~~~~--~~~~~~---~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 258 YKMI----KEG-----FRML--SPEHAP---AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHH----HHT-----CCCC--CCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHH----HCC-----CCCC--CCCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf 9998----668-----9889--854365---9999999997577965792999999999876534
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.21 Aligned_cols=257 Identities=25% Similarity=0.385 Sum_probs=204.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC----CCEEEEEEECCCCCC-CHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEE
Q ss_conf 899988421434770899999889----999999993022576-879999999998704889732411158849868999
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD----GSVVAIKKLIHVTGQ-GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 1002 (1237)
++|++.+.||+|+||.||+|++.. +..||+|++...... ..+.+.+|++++++++||||++++|++. .+..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEEE
T ss_conf 996987799307882999999936996449999999365668799999999999998689999856988995-3747999
Q ss_pred EEECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEE
Q ss_conf 99546888789996321399986689999999999999999977269999164288989756689995699640464220
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~~ 1082 (1237)
|||+++|++.+++.... ..+++..++.++.|+++||.|||+. +++||||||+||+++.++.+||+|||+|+..
T Consensus 86 ~E~~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEECCCCCHHHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCHHHEEECCCCCEEECCCHHHEEC
T ss_conf 98406980776542247----8999999999999998775230226---7441410265532067896787650342133
Q ss_pred CCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCC
Q ss_conf 56786113201256787678012276666741200879999999993-99999999989972188999998531011223
Q 000889 1083 NALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRINEI 1161 (1237)
Q Consensus 1083 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1161 (1237)
..... .......||+.|+|||++.+..++.++||||||+++|||++ |..||..... .... ........
T Consensus 159 ~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~---~~~~---~~i~~~~~---- 227 (273)
T d1mp8a_ 159 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVI---GRIENGER---- 227 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHH---HHHHTTCC----
T ss_pred CCCCC-EECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH---HHHH---HHHHCCCC----
T ss_conf 67762-3305400583103266751699887452444247899998269999888999---9999---99981899----
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 5932148999799999999999861234999999999999999830016
Q 000889 1162 LDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVD 1210 (1237)
Q Consensus 1162 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~ 1210 (1237)
+ +.+...+ ..+.+++.+||+.||++|||+.++++.|+++..+
T Consensus 228 --~--~~~~~~~---~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 228 --L--PMPPNCP---PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp --C--CCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --C--CCCCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf --9--8987779---9999999997687976892999999999999778
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.19 Aligned_cols=257 Identities=23% Similarity=0.369 Sum_probs=203.2
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC--C--CEEEEEEECCCC---CCCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEE
Q ss_conf 899988421434770899999889--9--999999930225---768799999999987048897324111588498689
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRD--G--SVVAIKKLIHVT---GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERL 1000 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~~--~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 1000 (1237)
++|++.+.||+|+||.||+|++.. + ..||+|++.... ....+.|.+|++++++++||||++++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHH
T ss_conf 891997898038883999999988999079999999983555798999999999999986899998789877740-1001
Q ss_pred EEEEECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCE
Q ss_conf 99995468887899963213999866899999999999999999772699991642889897566899956996404642
Q 000889 1001 LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1080 (1237)
Q Consensus 1001 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~ 1080 (1237)
+||||+++|++.+++.... ..+++..+.+++.|++.||.|||+. +|+||||||+||+++.++.+|++|||+++
T Consensus 87 lv~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEECCCCHHHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECHHHHCCCCCCCEEECCCHHHH
T ss_conf 1465423861254442126----8999999999999999999875217---87520566888156556543325611555
Q ss_pred EECCCCCCE-EEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 205678611-3201256787678012276666741200879999999993-99999999989972188999998531011
Q 000889 1081 LVNALDTHL-SVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLS-GKRPIDPSEFGDDNNLVGWAKQLHREKRI 1158 (1237)
Q Consensus 1081 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1158 (1237)
......... ......|+..|+|||++.+..++.++||||||+++|||++ |+.||..... ...........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~------~~~~~~i~~~~-- 231 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEG-- 231 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSC--
T ss_pred HCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH------HHHHHHHHHCC--
T ss_conf 3035887526547632573107999983799994215661489999999689999999699------99999998479--
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf 22359321489997999999999998612349999999999999998300
Q 000889 1159 NEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQ 1208 (1237)
Q Consensus 1159 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~ 1208 (1237)
.. ++.+...+ ..+.+++.+||+.||++|||+.++.+.|++.+
T Consensus 232 ---~~--~~~~~~~~---~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 232 ---ER--LPRPEDCP---QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp ---CC--CCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ---CC--CCCCCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHCC
T ss_conf ---99--99854453---99999999976889667929999999999649
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.66 Aligned_cols=262 Identities=23% Similarity=0.345 Sum_probs=208.1
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC------CCCEEEEEEECCCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEE
Q ss_conf 89998842143477089999988------999999999302257-68799999999987048897324111588498689
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR------DGSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERL 1000 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 1000 (1237)
++|++.+.||+|+||+||+|.++ .+..||||++..... .....+.+|++++++++||||++++|++...+..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEE
T ss_conf 99188359820788189999987864477896899999870128689999999999999769998841254784288106
Q ss_pred EEEEECCCCCHHHHHHHHHC-----CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEE
Q ss_conf 99995468887899963213-----9998668999999999999999997726999916428898975668999569964
Q 000889 1001 LVYEYMKWGSLESVLHDRAK-----GGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSD 1075 (1237)
Q Consensus 1001 lv~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~D 1075 (1237)
+||||+++|+|.+++..... .....+++..+.+++.|+++||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECEECCCCEEECCCCEEEEEE
T ss_conf 77760489988999875033211344468879999999999999999987647---965432867754035996499942
Q ss_pred CCCCEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC-CCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 04642205678611320125678767801227666674120087999999999399-99999998997218899999853
Q 000889 1076 FGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGK-RPIDPSEFGDDNNLVGWAKQLHR 1154 (1237)
Q Consensus 1076 fGla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~ 1154 (1237)
||+|+...............|++.|+|||.+.+..++.++||||||+++|||++|. .||... ...........
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~------~~~~~~~~i~~ 250 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL------SNEQVLRFVME 250 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS------CHHHHHHHHHT
T ss_pred CCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC------CHHHHHHHHHH
T ss_conf 454202357763031340231632378888736998833344437899999996899999998------99999999980
Q ss_pred HCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 1011223593214899979999999999986123499999999999999983001
Q 000889 1155 EKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQV 1209 (1237)
Q Consensus 1155 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~ 1209 (1237)
... +..+...+ ..+.+++.+||+.+|++|||+.++++.|++...
T Consensus 251 ~~~--------~~~p~~~~---~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 251 GGL--------LDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TCC--------CCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCC--------CCCCCCCH---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf 888--------88863353---999999999757796589399999999787617
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.16 Aligned_cols=247 Identities=26% Similarity=0.386 Sum_probs=199.6
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCC---CCCCHHHHHHHHHHHH-HCCCCCCCCCCCEEEECCEEEEE
Q ss_conf 89998842143477089999988-9999999993022---5768799999999987-04889732411158849868999
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHV---TGQGDREFMAEMETIG-KIKHRNLVPLLGYCKIGEERLLV 1002 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 1002 (1237)
++|++.+.||+|+||+||+|++. +++.||+|++.+. .....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEE
Q ss_conf 99546888789996321399986689999999999999999977269999164288989756689995699640464220
Q 000889 1003 YEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLV 1082 (1237)
Q Consensus 1003 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~~ 1082 (1237)
|||+++|+|.++++.. ..+++..+..++.|++.||+|||+. +++||||||+|||++.++.+|++|||+|+..
T Consensus 82 mEy~~~g~L~~~i~~~-----~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEECCCCCHHHHHHCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCEEECCCCCEECCCCCHHHHC
T ss_conf 7503798089986404-----7899999999999999999999868---9340347654044448996301555302323
Q ss_pred CCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCC
Q ss_conf 56786113201256787678012276666741200879999999993999999999899721889999985310112235
Q 000889 1083 NALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL 1162 (1237)
Q Consensus 1083 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1162 (1237)
..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+... ........ ..
T Consensus 154 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~-~~------ 218 (320)
T d1xjda_ 154 MLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------EELFHSIR-MD------ 218 (320)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HC------
T ss_pred CCCCC--CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHH-CC------
T ss_conf 56653--34545787776899998279988323201122789898738899999899------99999997-18------
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf 932148999799999999999861234999999999-9999
Q 000889 1163 DPELTMQTSDETELYQYLRISFECLDDRPFKRPTMI-QVMA 1202 (1237)
Q Consensus 1163 ~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-eil~ 1202 (1237)
.+.++ ...+ ..+.+++.+|+.++|++||++. ++++
T Consensus 219 ~~~~p--~~~s---~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 NPFYP--RWLE---KEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCCCC--TTSC---HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCCC--CCCC---HHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf 99897--5679---999999999654489878388999980
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=328.85 Aligned_cols=252 Identities=23% Similarity=0.361 Sum_probs=200.5
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCC---------HHHHHHHHHHHHHCC-CCCCCCCCCEEEE
Q ss_conf 289998842143477089999988-99999999930225768---------799999999987048-8973241115884
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQG---------DREFMAEMETIGKIK-HRNLVPLLGYCKI 995 (1237)
Q Consensus 927 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 995 (1237)
.++|++.+.||+|+||+||+|++. +++.||+|++....... .+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCEEEEEEEECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEE
Q ss_conf 98689999954688878999632139998668999999999999999997726999916428898975668999569964
Q 000889 996 GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSD 1075 (1237)
Q Consensus 996 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~D 1075 (1237)
++..|+||||+++|+|.++++.. ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~D 153 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 153 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred CCCEEEEEECCCCCHHHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECC
T ss_conf 76059999768986689999865-----9999999999999999999999875---994323462548986899838712
Q ss_pred CCCCEEECCCCCCEEEECCCCCCCCCCCCCCCC------CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHH
Q ss_conf 046422056786113201256787678012276------66674120087999999999399999999989972188999
Q 000889 1076 FGMARLVNALDTHLSVSTLAGTPGYVPPEYYQS------FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWA 1149 (1237)
Q Consensus 1076 fGla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~ 1149 (1237)
||+++....... .....||+.|+|||.+.+ ..++.++||||+|+++|||++|+.||.... .... .
T Consensus 154 FG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~-----~~~~-~ 224 (277)
T d1phka_ 154 FGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-----QMLM-L 224 (277)
T ss_dssp CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHH-H
T ss_pred CHHEEECCCCCC---EEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCC-----HHHH-H
T ss_conf 403167268872---134524678889888605344567889923318565602310322888988999-----9999-9
Q ss_pred HHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 998531011223593214899979999999999986123499999999999999
Q 000889 1150 KQLHREKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1150 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 1203 (1237)
.... ..... ...+.. .....++.+++.+|++++|++|||+.+++++
T Consensus 225 ~~i~-~~~~~-~~~~~~------~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 225 RMIM-SGNYQ-FGSPEW------DDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHH-HTCCC-CCTTTG------GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHH-HCCCC-CCCCCC------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 9998-18988-898543------4689999999999765896689199999739
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.34 Aligned_cols=262 Identities=24% Similarity=0.338 Sum_probs=199.0
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEEEE
Q ss_conf 89998842143477089999988-99999999930225--7687999999999870488973241115884986899999
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
++|++.+.||+|+||+||+|++. ++..||+|++.... ....+.+.+|++++++++||||+++++++.++...++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred ECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEECC
Q ss_conf 54688878999632139998668999999999999999997726999916428898975668999569964046422056
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~~~~ 1084 (1237)
|+.+ ++.+++.... ...+++..+..++.|++.||.|||+. +||||||||+|||++.++.+|++|||.|+....
T Consensus 82 ~~~~-~~~~~~~~~~---~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp CCSE-EHHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ECCC-CHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCHHEEECCCCCCEECCCCCCEECCC
T ss_conf 2377-4455544202---56888899999999999999986528---899213571140113467621035786134368
Q ss_pred CCCCEEEECCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCC-
Q ss_conf 78611320125678767801227666-6741200879999999993999999999899721889999985310112235-
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQSFR-CTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKRINEIL- 1162 (1237)
Q Consensus 1085 ~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1162 (1237)
.. .......|++.|+|||++.... ++.++||||+|+++|+|++|+.||.+.. ....+...........+..
T Consensus 155 ~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~-----~~~~~~~i~~~~~~~~~~~~ 227 (298)
T d1gz8a_ 155 PV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS-----EIDQLFRIFRTLGTPDEVVW 227 (298)
T ss_dssp CS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCCTTTS
T ss_pred CC--CCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCC-----HHHHHHHHHHHCCCCCHHHC
T ss_conf 86--410010365215411221366577742210333313427966879989889-----99999999983289833314
Q ss_pred ---------CCCCCC-CCCCH-----HHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ---------932148-99979-----999999999986123499999999999999
Q 000889 1163 ---------DPELTM-QTSDE-----TELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1163 ---------~~~l~~-~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 1203 (1237)
...... ..... .....+.+++.+|+..||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 44222421243454322220444166789999999999763995579189999678
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.01 Aligned_cols=259 Identities=24% Similarity=0.293 Sum_probs=193.2
Q ss_pred CCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCC-----HHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEEEEEC
Q ss_conf 842143477089999988-99999999930225768-----799999999987048897324111588498689999954
Q 000889 933 DSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQG-----DREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 1006 (1237)
Q Consensus 933 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 1006 (1237)
.++||+|+||+||+|+++ +++.||+|++....... .+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHH
T ss_conf 63851272829999999999969999998420212456799999999999998679999868985422587402204553
Q ss_pred CCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEECCCC
Q ss_conf 68887899963213999866899999999999999999772699991642889897566899956996404642205678
Q 000889 1007 KWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNALD 1086 (1237)
Q Consensus 1007 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~~~~~~ 1086 (1237)
.++++..+... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 83 ~~~~~~~~~~~-----~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 83 ETDLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp SEEHHHHHTTC-----CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred CCHHHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCC
T ss_conf 45077655412-----66778999999999999999886316---35503577625885377841146576100057875
Q ss_pred CCEEEECCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHH--HCCCCCCCC
Q ss_conf 61132012567876780122766-667412008799999999939999999998997218899999853--101122359
Q 000889 1087 THLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR--EKRINEILD 1163 (1237)
Q Consensus 1087 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 1163 (1237)
.......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+......... .........
T Consensus 155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~--~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 155 --RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp --CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCTTTSSSTTS
T ss_pred --CCCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHH--HHHHHHHHHCCCCCHHHCCCHHC
T ss_conf --54330204733363999726778880564363042899998596999999999--99999998518997254521000
Q ss_pred ----CCCCC-CCCCH-----HHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ----32148-99979-----999999999986123499999999999999
Q 000889 1164 ----PELTM-QTSDE-----TELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1164 ----~~l~~-~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 1203 (1237)
..... +.... .....+.+++.+|++.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 21344303478988678565689999999999763894569089999679
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=320.93 Aligned_cols=276 Identities=16% Similarity=0.199 Sum_probs=216.0
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCC-CCCCCCCCEEEECCEEEEEEE
Q ss_conf 289998842143477089999988-999999999302257687999999999870488-973241115884986899999
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKH-RNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 927 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 1004 (1237)
.++|++.+.||+|+||+||+|++. +++.||+|.+.... ....+.+|++.++.+.| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 980699799841788299999998899799999975025--829999999999996489998779999601881179999
Q ss_pred ECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCEEEEECCCC
Q ss_conf 546888789996321399986689999999999999999977269999164288989756689-----995699640464
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE-----NFEARVSDFGMA 1079 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~-----~~~vki~DfGla 1079 (1237)
|+ +++|.++++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++. ++.+|++|||+|
T Consensus 82 ~~-~~~l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EC-CCCHHHHHHHHC----CCHHHHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEECCCCCCCCCCEEECCCCEE
T ss_conf 64-888799997520----3110689999999999999999977---966266771315234754344795687236605
Q ss_pred EEECCCCCC-----EEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 220567861-----132012567876780122766667412008799999999939999999998997218899999853
Q 000889 1080 RLVNALDTH-----LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR 1154 (1237)
Q Consensus 1080 ~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1154 (1237)
+........ .......||+.|||||++.+..++.++||||+|+++|||++|+.||.+..................
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred EECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCC
T ss_conf 77146766541110246762775102679896488888699989831999999869876788530219999999970567
Q ss_pred HCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCH
Q ss_conf 10112235932148999799999999999861234999999999999999830016589998956722
Q 000889 1155 EKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGDSLDSFSLK 1222 (1237)
Q Consensus 1155 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~~~~~~~~~~ 1222 (1237)
.....+. .+ ..+ .++.+++..|++.+|++||++..+.+.++++.........+.++|.
T Consensus 234 ~~~~~~l-~~------~~p---~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~ 291 (293)
T d1csna_ 234 STPLREL-CA------GFP---EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN 291 (293)
T ss_dssp HSCHHHH-TT------TSC---HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred CCCHHHH-CC------CCC---HHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCC
T ss_conf 9995896-57------998---9999999998439930085999999999999997599999998989
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=320.70 Aligned_cols=276 Identities=20% Similarity=0.226 Sum_probs=206.2
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCC-CCCEEEECCEEEEEEE
Q ss_conf 289998842143477089999988-99999999930225768799999999987048897324-1115884986899999
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVP-LLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 927 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e 1004 (1237)
.++|++.+.||+|+||.||+|++. ++..||+|.+.... ...++..|+++++.++|++++. +.++..+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHC--CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEE
T ss_conf 888999689850788099999998899899999972100--588899999999970389960179999951987789998
Q ss_pred ECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEEECCCCEE
Q ss_conf 546888789996321399986689999999999999999977269999164288989756689---99569964046422
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE---NFEARVSDFGMARL 1081 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~---~~~vki~DfGla~~ 1081 (1237)
|+. +++.+.+... ...+++..+..++.|++.||+|||++ +|+||||||+||+++. +..+|++|||+|+.
T Consensus 84 ~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 84 LLG-PSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp CCC-CBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred ECC-CCHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHCCCCCCCCCCEEEEECCCCCEE
T ss_conf 738-7133324430----68876899999999999999999979---944266787660643357776156504675134
Q ss_pred ECCCCCC-----EEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 0567861-----13201256787678012276666741200879999999993999999999899721889999985310
Q 000889 1082 VNALDTH-----LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREK 1156 (1237)
Q Consensus 1082 ~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1156 (1237)
....... .......||+.|||||++.+..++.++||||||+++|||++|+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred CCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCC
T ss_conf 25544554100013577678735329999918998983218861778999984987665530577999999852356789
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCH
Q ss_conf 112235932148999799999999999861234999999999999999830016589998956722
Q 000889 1157 RINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAMFKELQVDTEGDSLDSFSLK 1222 (1237)
Q Consensus 1157 ~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~~~~~~~~~~ 1222 (1237)
..... . ...+ .++.+++.+||+.+|++||++.++.+.|+.+.........+.++|.
T Consensus 236 ~~~~~-~------~~~p---~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~ 291 (299)
T d1ckia_ 236 PIEVL-C------KGYP---SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 291 (299)
T ss_dssp CHHHH-T------TTSC---HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHH
T ss_pred CHHHH-C------CCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCCCCCCCCCCCH
T ss_conf 83575-3------4788---9999999998439955791999999999999997699978893854
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.79 Aligned_cols=273 Identities=23% Similarity=0.289 Sum_probs=199.3
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEEEECC----EEE
Q ss_conf 289998842143477089999988-999999999302257-68799999999987048897324111588498----689
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG-QGDREFMAEMETIGKIKHRNLVPLLGYCKIGE----ERL 1000 (1237)
Q Consensus 927 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 1000 (1237)
+.+|++.+.||+|+||+||+|++. ++..||||++..... ...+.+.+|++++++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 89859978994064809999999999949999998031095899999999999997689898858889950564554149
Q ss_pred EEEEECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCE
Q ss_conf 99995468887899963213999866899999999999999999772699991642889897566899956996404642
Q 000889 1001 LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMAR 1080 (1237)
Q Consensus 1001 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~ 1080 (1237)
++++++.+|+|.+++.. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 87 ~l~~~~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp EEEEECCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEECCCCHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEE
T ss_conf 99996259865664405------8999999999999999999999978---98677787643788799977875457056
Q ss_pred EECCCCCC-EEEECCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-
Q ss_conf 20567861-1320125678767801227-66667412008799999999939999999998997218899999853101-
Q 000889 1081 LVNALDTH-LSVSTLAGTPGYVPPEYYQ-SFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKR- 1157 (1237)
Q Consensus 1081 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~-~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 1157 (1237)
........ .......|++.|+|||++. +..++.++||||+|+++|||++|+.||......+. .............
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~--~~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--LNHILGILGSPSQE 235 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHH
T ss_pred ECCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHH--HHHHHHHCCCCCHH
T ss_conf 5047776410101102652000387860478887410100467013377669799788888999--99876520699756
Q ss_pred -C---------CCCCCCCCCCCCCCH----HHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHCCCC
Q ss_conf -1---------223593214899979----999999999986123499999999999999--9830016
Q 000889 1158 -I---------NEILDPELTMQTSDE----TELYQYLRISFECLDDRPFKRPTMIQVMAM--FKELQVD 1210 (1237)
Q Consensus 1158 -~---------~~~~~~~l~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~l~~~ 1210 (1237)
. ............... ....++.+++.+|+..||.+|||+.+++++ +++....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred HHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCCC
T ss_conf 642343322220244677557787778378999999999999764895679089998619865558897
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.69 Aligned_cols=268 Identities=25% Similarity=0.324 Sum_probs=200.5
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCC--CCHHHHHHHHHHHHHCCCCCCCCCCCEEEECC------
Q ss_conf 289998842143477089999988-999999999302257--68799999999987048897324111588498------
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG--QGDREFMAEMETIGKIKHRNLVPLLGYCKIGE------ 997 (1237)
Q Consensus 927 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 997 (1237)
.++|++.+.||+|+||+||+|++. +++.||+|++..... ...+.+.+|++++++++||||+++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf 77189988980177819999999999989999998522259699999999999998668987547999863576555541
Q ss_pred EEEEEEEECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf 68999995468887899963213999866899999999999999999772699991642889897566899956996404
Q 000889 998 ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFG 1077 (1237)
Q Consensus 998 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfG 1077 (1237)
..++||||+ +.+|..+.+. ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+|++|||
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEEECC-CCCHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHCCCCCCCCCCCCC
T ss_conf 599998405-5218999874------0226999999999999999998737---87645668511112100122113431
Q ss_pred CCEEECCCCCCEEEECCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHH---
Q ss_conf 6422056786113201256787678012276-666741200879999999993999999999899721889999985---
Q 000889 1078 MARLVNALDTHLSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLH--- 1153 (1237)
Q Consensus 1078 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--- 1153 (1237)
+|+..... .....|++.|+|||++.+ ..++.++||||+||++|+|++|+.||...... ..+........
T Consensus 167 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 167 LARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL--DQLKEIMKVTGTPP 239 (346)
T ss_dssp TCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCC
T ss_pred CEECCCCC-----CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHH--HHHHHHHHCCCCCC
T ss_conf 02206876-----310245533358899817878996501030038999999786998889768--99999985037884
Q ss_pred --------------HHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHCCCCCCC
Q ss_conf --------------31011223593214899979999999999986123499999999999999--9830016589
Q 000889 1154 --------------REKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM--FKELQVDTEG 1213 (1237)
Q Consensus 1154 --------------~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~l~~~~~~ 1213 (1237)
......+.....+.... ......+.+++.+|+..||.+|||+.+++++ ++++....+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~ 313 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASIL--TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDE 313 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTC--TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-----
T ss_pred HHHHHHHCCHHHHHHHCCCCCCCCCCHHHHC--CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCCCCCC
T ss_conf 8888653000344331157866655667755--6899999999999772995579299999639623758776646
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=324.15 Aligned_cols=264 Identities=23% Similarity=0.312 Sum_probs=200.0
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEEEEE
Q ss_conf 8999884214347708999998899999999930225--76879999999998704889732411158849868999995
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVT--GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEY 1005 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 1005 (1237)
++|++.++||+|+||+||+|++++++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEECCC
Q ss_conf 46888789996321399986689999999999999999977269999164288989756689995699640464220567
Q 000889 1006 MKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNAL 1085 (1237)
Q Consensus 1006 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~~~~~ 1085 (1237)
+.++.+..+.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||.|......
T Consensus 82 ~~~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred EHHHHHHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHCCC---CEEECCCCCCEEEECCCCCEEECCCCCCEECCCC
T ss_conf 0045678998604-----7751445689999999999986057---4882678775056868997873236643011467
Q ss_pred CCCEEEECCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHH--CC---CC
Q ss_conf 861132012567876780122766-6674120087999999999399999999989972188999998531--01---12
Q 000889 1086 DTHLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHRE--KR---IN 1159 (1237)
Q Consensus 1086 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~---~~ 1159 (1237)
.. ......+++.|+|||.+.+. .++.++||||+|+++|||++|+.||..... ...+.......... .. ..
T Consensus 154 ~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 154 VR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE--ADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTTTSTTGG
T ss_pred CC--CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCH--HHHHHHHHHHHCCCCHHHCCCHH
T ss_conf 65--410102431101378871788888410021117589999779799898898--99999999863899711042123
Q ss_pred CC--CCCCCCC------CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 23--5932148------99979999999999986123499999999999999
Q 000889 1160 EI--LDPELTM------QTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1160 ~~--~~~~l~~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 1203 (1237)
.. ....... ..........+.+++.+|++.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 3322143333356764666512589999999999866896689099998569
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.55 Aligned_cols=266 Identities=27% Similarity=0.310 Sum_probs=192.4
Q ss_pred CCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCEEEEC------CEEEE
Q ss_conf 9998842143477089999988-9999999993022576879999999998704889732411158849------86899
Q 000889 929 GFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIG------EERLL 1001 (1237)
Q Consensus 929 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 1001 (1237)
+|+..++||+|+||+||+|++. +++.||+|++..... ...+|++++++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 76751698217683999999999997999999881606----89999999986689898738789974476577318999
Q ss_pred EEEECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEECCCCE
Q ss_conf 99954688878999632139998668999999999999999997726999916428898975668999-56996404642
Q 000889 1002 VYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENF-EARVSDFGMAR 1080 (1237)
Q Consensus 1002 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~-~vki~DfGla~ 1080 (1237)
||||++++.+..+.+.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++
T Consensus 97 v~Ey~~~~~~~~l~~~~~~--~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEECCSEEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEECCCCCCHHHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEEECCCCCEEEECCCCHH
T ss_conf 9841688607888863103--68999999999999999999999866---876457886037873589711673366054
Q ss_pred EECCCCCCEEEECCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHH-------
Q ss_conf 2056786113201256787678012276-66674120087999999999399999999989972188999998-------
Q 000889 1081 LVNALDTHLSVSTLAGTPGYVPPEYYQS-FRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQL------- 1152 (1237)
Q Consensus 1081 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~------- 1152 (1237)
....... .....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+.......
T Consensus 172 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~--~~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 172 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTREQ 246 (350)
T ss_dssp ECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH--HHHHHHHHHHCCCCHHH
T ss_pred HCCCCCC---CCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHH--HHHHHHHHHHCCCHHHH
T ss_conf 4047765---320025555568277640468882100024652778550287998987999--99999999748981776
Q ss_pred ----HH---HCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHCCC
Q ss_conf ----53---1011223593214899979999999999986123499999999999999--983001
Q 000889 1153 ----HR---EKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM--FKELQV 1209 (1237)
Q Consensus 1153 ----~~---~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~l~~ 1209 (1237)
.. .............. ........++.+++.+|+..||++|||+.|++++ ++++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGG-TSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred HHHHCCCHHHCCCCCCCCCCHHH-HCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 54306210110355445674444-315689999999999976589557929999966984524667
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.29 Aligned_cols=241 Identities=24% Similarity=0.399 Sum_probs=193.9
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCC------CHHHHHHHHHHHHHCC--CCCCCCCCCEEEECC
Q ss_conf 289998842143477089999988-9999999993022576------8799999999987048--897324111588498
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQ------GDREFMAEMETIGKIK--HRNLVPLLGYCKIGE 997 (1237)
Q Consensus 927 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 997 (1237)
.++|++.+.||+|+||+||+|++. ++..||+|++...... ....+.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred EEEEEEEECCC-CCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-CCCEEEEE
Q ss_conf 68999995468-88789996321399986689999999999999999977269999164288989756689-99569964
Q 000889 998 ERLLVYEYMKW-GSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDE-NFEARVSD 1075 (1237)
Q Consensus 998 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~-~~~vki~D 1075 (1237)
..++||||+.+ +++.+++... ..+++..++.++.|+++||+|||+. +|+||||||+||+++. ++.+||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECC
T ss_pred EEEEEEEECCCCCHHHHHHHCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCEEEECC
T ss_conf 6899998336862289998615-----8999999999999999999999877---9755667611147744788489775
Q ss_pred CCCCEEECCCCCCEEEECCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 046422056786113201256787678012276666-7412008799999999939999999998997218899999853
Q 000889 1076 FGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRC-TTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR 1154 (1237)
Q Consensus 1076 fGla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1154 (1237)
||+|+...... .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... ....
T Consensus 155 FG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~ 218 (273)
T d1xwsa_ 155 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIR 218 (273)
T ss_dssp CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHH
T ss_pred CCCCEECCCCC----CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH------------HHHH
T ss_conf 46535324445----5665658774799998489978865332554034536756889988736------------7761
Q ss_pred HCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 1011223593214899979999999999986123499999999999999
Q 000889 1155 EKRINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1155 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 1203 (1237)
. .. ...+ ..+ .++.+++.+|+..||++|||+.|++++
T Consensus 219 ~-~~--~~~~------~~s---~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 219 G-QV--FFRQ------RVS---SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp C-CC--CCSS------CCC---HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred C-CC--CCCC------CCC---HHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 5-44--7787------799---999999999760897589399998539
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=318.73 Aligned_cols=266 Identities=23% Similarity=0.332 Sum_probs=194.3
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-C-CCEEEEEEECCCCC--CCHHHHHHHHHHHHHC---CCCCCCCCCCEEEE----
Q ss_conf 289998842143477089999988-9-99999999302257--6879999999998704---88973241115884----
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-D-GSVVAIKKLIHVTG--QGDREFMAEMETIGKI---KHRNLVPLLGYCKI---- 995 (1237)
Q Consensus 927 ~~~~~~~~~ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 995 (1237)
.++|++.+.||+|+||+||+|++. + ++.||+|++..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred -CCEEEEEEEECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEE
Q ss_conf -9868999995468887899963213999866899999999999999999772699991642889897566899956996
Q 000889 996 -GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVS 1074 (1237)
Q Consensus 996 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~ 1074 (1237)
....+++|||++++.+....... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCEEEEEEEECCCCCHHHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEECCCCCEEEC
T ss_conf 674699999740587144444303----78999899999999999999999758---89835798627898589975421
Q ss_pred ECCCCEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 40464220567861132012567876780122766667412008799999999939999999998997218899999853
Q 000889 1075 DFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHR 1154 (1237)
Q Consensus 1075 DfGla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 1154 (1237)
|||.++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+.........
T Consensus 159 dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~ 233 (305)
T d1blxa_ 159 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGL 233 (305)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCC
T ss_pred CHHHHHHHCCCC---CCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHHCC
T ss_conf 000101100234---577765485114831001798881110003289999998787998998989--999999984079
Q ss_pred HC--CCC-----------CCCCCCC-CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHC
Q ss_conf 10--112-----------2359321-4899979999999999986123499999999999999--9830
Q 000889 1155 EK--RIN-----------EILDPEL-TMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM--FKEL 1207 (1237)
Q Consensus 1155 ~~--~~~-----------~~~~~~l-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~l 1207 (1237)
.. ... ....... ....... ..+.+++.+|+++||++|||+.|++++ ++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s---~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID---ELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCC---HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 961105321111033302234564544044589---999999999874896679189999669634075
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=314.64 Aligned_cols=266 Identities=22% Similarity=0.287 Sum_probs=196.5
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCC--CCCCHHHHHHHHHHHHHCCCCCCCCCCCEEEE--------
Q ss_conf 289998842143477089999988-9999999993022--57687999999999870488973241115884--------
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHV--TGQGDREFMAEMETIGKIKHRNLVPLLGYCKI-------- 995 (1237)
Q Consensus 927 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 995 (1237)
.++|++.+.||+|+||+||+|++. +++.||||++... .......+.+|++++++++|||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred CCEEEEEEEECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEE
Q ss_conf 98689999954688878999632139998668999999999999999997726999916428898975668999569964
Q 000889 996 GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSD 1075 (1237)
Q Consensus 996 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~D 1075 (1237)
....++||||+.++.+...... ...++...++.++.|++.|+.|||+. +|+||||||+||+++.++.+|++|
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~-----~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~d 160 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD 160 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred CCEEEEEEECCCCCCCCHHHHC-----CCCCCCHHHHHHHHHHHHHHHHHCCC---CEEECCCCCHHEEECCCCCEEEEE
T ss_conf 7638999853578741012220-----34433089999999999999885229---988567672220366899687631
Q ss_pred CCCCEEECCCCC--CEEEECCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 046422056786--1132012567876780122766-6674120087999999999399999999989972188999998
Q 000889 1076 FGMARLVNALDT--HLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQL 1152 (1237)
Q Consensus 1076 fGla~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 1152 (1237)
||+++....... ........||+.|+|||++.+. .++.++||||+|+++|||++|+.||.+... ..........
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~---~~~~~~i~~~ 237 (318)
T d3blha1 161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE---QHQLALISQL 237 (318)
T ss_dssp CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHH
T ss_pred CCEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCH---HHHHHHHHHH
T ss_conf 3500223554443211356602497874289970799989178700678646617448799899899---9999999984
Q ss_pred HHH---CCCCCCCC-------CCCCCCCCCH-H------HHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 531---01122359-------3214899979-9------99999999986123499999999999999
Q 000889 1153 HRE---KRINEILD-------PELTMQTSDE-T------ELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1153 ~~~---~~~~~~~~-------~~l~~~~~~~-~------~~~~l~~li~~cl~~dP~~RPt~~eil~~ 1203 (1237)
... ........ .......... . ....+.+++.+|++.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 18998255344320344433201334455503340444599899999999873896589099999749
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=314.50 Aligned_cols=253 Identities=23% Similarity=0.312 Sum_probs=199.7
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC----CCCEEEEEEECCCC----CCCHHHHHHHHHHHHHCCC-CCCCCCCCEEEECCE
Q ss_conf 89998842143477089999988----99999999930225----7687999999999870488-973241115884986
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR----DGSVVAIKKLIHVT----GQGDREFMAEMETIGKIKH-RNLVPLLGYCKIGEE 998 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 998 (1237)
++|++.+.||+|+||+||+|+.. ++..||+|.+.... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEEECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf 89999954688878999632139998668999999999999999997726999916428898975668999569964046
Q 000889 999 RLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1078 (1237)
Q Consensus 999 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGl 1078 (1237)
.+++|||+.+|+|.+++... ..+.+..+..++.|++.|++|+|+. +++||||||+||+++.++.+||+|||+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred EEEEEECCCCCHHHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCCCCEEECCCCCEEEEECCC
T ss_conf 00123123411799998730-----4543788888899999999885149---989654773201246999888741320
Q ss_pred CEEECCCCCCEEEECCCCCCCCCCCCCCCCC--CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 4220567861132012567876780122766--66741200879999999993999999999899721889999985310
Q 000889 1079 ARLVNALDTHLSVSTLAGTPGYVPPEYYQSF--RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREK 1156 (1237)
Q Consensus 1079 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1156 (1237)
|+.+...... ......|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+.. ..........
T Consensus 176 a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~--~~i~~~~~~~- 251 (322)
T d1vzoa_ 176 SKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS- 251 (322)
T ss_dssp EEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHC-
T ss_pred HHHHCCCCCC-CCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHCCCC-
T ss_conf 2220344443-22122233333106876057768871325177779999997689998888777799--9999833568-
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 112235932148999799999999999861234999999-----99999999
Q 000889 1157 RINEILDPELTMQTSDETELYQYLRISFECLDDRPFKRP-----TMIQVMAM 1203 (1237)
Q Consensus 1157 ~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 1203 (1237)
.+.. +.... ..+.+++.+|+.++|++|| |+.|++++
T Consensus 252 ------~~~~--~~~~s---~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 252 ------EPPY--PQEMS---ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp ------CCCC--CTTSC---HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ------CCCC--CCCCC---HHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCC
T ss_conf ------9988--65479---99999999974458988199974509999749
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=311.49 Aligned_cols=258 Identities=21% Similarity=0.271 Sum_probs=193.9
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCC-CCCCCCCCCEEEEC--CEEEEEE
Q ss_conf 89998842143477089999988-99999999930225768799999999987048-89732411158849--8689999
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIK-HRNLVPLLGYCKIG--EERLLVY 1003 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 1003 (1237)
++|++.++||+|+||+||+|++. +++.||+|++.. ...+.+.+|+++++.++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf 671897898317481999999889997999999888---99999999999998515799876799999816877126888
Q ss_pred EECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC-CCEEEEECCCCEEE
Q ss_conf 95468887899963213999866899999999999999999772699991642889897566899-95699640464220
Q 000889 1004 EYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDEN-FEARVSDFGMARLV 1082 (1237)
Q Consensus 1004 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~-~~vki~DfGla~~~ 1082 (1237)
||+++++|..+. +.+++..++.++.|++.||+|||++ +|+||||||+|||++.+ ..+|++|||+|+..
T Consensus 112 e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 112 EHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp ECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EECCCCCHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEECCCCCCEEC
T ss_conf 631798589974--------6899999999999999999887643---34434564412377489983664156542664
Q ss_pred CCCCCCEEEECCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHH--------H
Q ss_conf 567861132012567876780122766-6674120087999999999399999999989972188999998--------5
Q 000889 1083 NALDTHLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQL--------H 1153 (1237)
Q Consensus 1083 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--------~ 1153 (1237)
..... .....+|+.|+|||.+.+. .++.++||||+|+++|||++|+.||........ ......... .
T Consensus 181 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~-~~~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 181 HPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYI 256 (328)
T ss_dssp CTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHH
T ss_pred CCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHH-HHHHHHHHHCCCHHHHHH
T ss_conf 68874---44322486424761026888888452323354555876048899988760189-999999987884155555
Q ss_pred HH------CCCCCCCC-------CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 31------01122359-------3214899979999999999986123499999999999999
Q 000889 1154 RE------KRINEILD-------PELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1154 ~~------~~~~~~~~-------~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 1203 (1237)
.. ........ ..............++.+++.+|+..||++|||+.|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 422544474300000333433112115521124489999999999866995689089999649
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=307.94 Aligned_cols=261 Identities=23% Similarity=0.279 Sum_probs=197.2
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCC--CCHHHHHHHHHHHHHCCCCCCCCCCCEEEE------CC
Q ss_conf 289998842143477089999988-999999999302257--687999999999870488973241115884------98
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG--QGDREFMAEMETIGKIKHRNLVPLLGYCKI------GE 997 (1237)
Q Consensus 927 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 997 (1237)
.++|++.++||+|+||+||+|++. ++..||||++..... .....+.+|+.++++++||||+++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCC
T ss_conf 37759988962175859999999999989999998823369799999999999998648987648998970256434576
Q ss_pred EEEEEEEECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf 68999995468887899963213999866899999999999999999772699991642889897566899956996404
Q 000889 998 ERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFG 1077 (1237)
Q Consensus 998 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfG 1077 (1237)
..|+||||+.++ +.+.+. ..+++..++.++.|++.|+.|||+. ||+||||||+|||++.++.+|++|||
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp EEEEEEECCSEE-HHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred EEEEEEECCCHH-HHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCEEEECHH
T ss_conf 269998414467-787650-------3899999999999999999886522---11245677632113654431320102
Q ss_pred CCEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHH-----
Q ss_conf 642205678611320125678767801227666674120087999999999399999999989972188999998-----
Q 000889 1078 MARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQL----- 1152 (1237)
Q Consensus 1078 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~----- 1152 (1237)
+++..... .......+|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.... ..........
T Consensus 165 ~~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~--~~~~~i~~~~~~~~~ 239 (355)
T d2b1pa1 165 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI--DQWNKVIEQLGTPCP 239 (355)
T ss_dssp C------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCH
T ss_pred HHHCCCCC---CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHH--HHHHHHHHHCCCCCH
T ss_conf 32114666---5533221465555813314777787743335662578986598998889778--899999972058987
Q ss_pred -------------HHHC-CC-----CCCCCCCCCCCCC--CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -------------5310-11-----2235932148999--79999999999986123499999999999999
Q 000889 1153 -------------HREK-RI-----NEILDPELTMQTS--DETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1153 -------------~~~~-~~-----~~~~~~~l~~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 1203 (1237)
.... .. ............. .......+.+++.+|+..||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 999876566777764175435666421264333543210133379999999999876994579089999669
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=306.09 Aligned_cols=264 Identities=22% Similarity=0.298 Sum_probs=199.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCC--CCHHHHHHHHHHHHHCCCCCCCCCCCEEEECCEEEEEEE
Q ss_conf 89998842143477089999988-999999999302257--687999999999870488973241115884986899999
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTG--QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
++|++.+.||+|+||+||+|++. ++..||||++..... .....+.+|+.+++.++||||+++++++.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred ECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEECC
Q ss_conf 54688878999632139998668999999999999999997726999916428898975668999569964046422056
Q 000889 1005 YMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGMARLVNA 1084 (1237)
Q Consensus 1005 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~~~~ 1084 (1237)
++.++++..+++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+|++|||.|+....
T Consensus 82 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 82 FCDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSEEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ECCCCCCCCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHHCC---CEEEECCCCCCCCCCCCCCEEEEECCHHHCCCC
T ss_conf 02332221121235-----6540367899999999998774339---986001467612113378266520460110468
Q ss_pred CCCCEEEECCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCC------
Q ss_conf 78611320125678767801227666-67412008799999999939999999998997218899999853101------
Q 000889 1085 LDTHLSVSTLAGTPGYVPPEYYQSFR-CTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKR------ 1157 (1237)
Q Consensus 1085 ~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 1157 (1237)
.... .....+++.|+|||++.+.. ++.++||||+||++|||++|+.||.... +................
T Consensus 154 ~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 154 PVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp CCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCTT
T ss_pred CCCC--CEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCC--CHHHHHHHHHHHCCCCCHHHHHH
T ss_conf 8751--0010344310146675069888804440265418899851899998899--99999999986118997355134
Q ss_pred ---CCCC-----CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ---1223-----593214899979999999999986123499999999999999
Q 000889 1158 ---INEI-----LDPELTMQTSDETELYQYLRISFECLDDRPFKRPTMIQVMAM 1203 (1237)
Q Consensus 1158 ---~~~~-----~~~~l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 1203 (1237)
.... .................+.+++.+|+++||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 432221133444544310433065689999999999864996689099999649
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=307.61 Aligned_cols=264 Identities=24% Similarity=0.303 Sum_probs=196.7
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCC--CHHHHHHHHHHHHHCCCCCCCCCCCEEEEC-----CE
Q ss_conf 289998842143477089999988-9999999993022576--879999999998704889732411158849-----86
Q 000889 927 TNGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQ--GDREFMAEMETIGKIKHRNLVPLLGYCKIG-----EE 998 (1237)
Q Consensus 927 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 998 (1237)
.++|++.+.||+|+||+||+|++. +++.||+|++...... ..+.+.+|++++++++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf 98718888983178839999999999979999998820028689999999999998668987425999996346456686
Q ss_pred EEEEEEECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf 89999954688878999632139998668999999999999999997726999916428898975668999569964046
Q 000889 999 RLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEARVSDFGM 1078 (1237)
Q Consensus 999 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vki~DfGl 1078 (1237)
.+++++++.+|+|.+++.. ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+|++|||.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred EEEEEEEECCCCHHHHCCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCH
T ss_conf 4999996258862320022------4530999999999999999999738---876516677633455432200132100
Q ss_pred CEEECCCCCCEEEECCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 4220567861132012567876780122766-667412008799999999939999999998997218899999853101
Q 000889 1079 ARLVNALDTHLSVSTLAGTPGYVPPEYYQSF-RCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLVGWAKQLHREKR 1157 (1237)
Q Consensus 1079 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1157 (1237)
|...... .....|++.|+|||+..+. .++.++||||+|+++|+|++|+.||.+... .............
T Consensus 168 a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~-----~~~~~~i~~~~~~ 237 (348)
T d2gfsa1 168 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-----IDQLKLILRLVGT 237 (348)
T ss_dssp --CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCC
T ss_pred HCCCCCC-----CCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHHHCCC
T ss_conf 0125754-----44434543555835533775678551243205899999768899788988-----9999999973079
Q ss_pred C-CC------------CCCCCCCCCCCCH-----HHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHCCC
Q ss_conf 1-22------------3593214899979-----999999999986123499999999999999--983001
Q 000889 1158 I-NE------------ILDPELTMQTSDE-----TELYQYLRISFECLDDRPFKRPTMIQVMAM--FKELQV 1209 (1237)
Q Consensus 1158 ~-~~------------~~~~~l~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~l~~ 1209 (1237)
. .+ ............. .....+.+++.+|+..||++|||+.|++++ +.+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred CCHHHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 975773200102445444303557875556626789999999999977588345938999855995487999
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=280.99 Aligned_cols=265 Identities=18% Similarity=0.182 Sum_probs=191.6
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCC-----------CCCCCCCCCEEEE
Q ss_conf 89998842143477089999988-99999999930225768799999999987048-----------8973241115884
Q 000889 928 NGFSADSMIGSGGFGEVYKAQLR-DGSVVAIKKLIHVTGQGDREFMAEMETIGKIK-----------HRNLVPLLGYCKI 995 (1237)
Q Consensus 928 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 995 (1237)
++|++.++||+|+||+||+|++. +++.||||++.... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 85799899750778189999999999799999983431-33689999999999840145555542276764789987631
Q ss_pred --CCEEEEEEEECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCC---
Q ss_conf --9868999995468887899963213999866899999999999999999772-6999916428898975668999---
Q 000889 996 --GEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHH-SCIPHIIHRDMKSSNVLLDENF--- 1069 (1237)
Q Consensus 996 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dikp~NIll~~~~--- 1069 (1237)
....+++++++..+........... ...+++..++.++.|++.|++|||+ . +|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred CCCCCEEEEEEECCCCCCCCCCCCCCC--CCCCCHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCCC
T ss_conf 256520234320003542000001223--467868999999999999988876405---864656770570563057656
Q ss_pred ---CEEEEECCCCEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHH
Q ss_conf ---56996404642205678611320125678767801227666674120087999999999399999999989972188
Q 000889 1070 ---EARVSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILLELLSGKRPIDPSEFGDDNNLV 1146 (1237)
Q Consensus 1070 ---~vki~DfGla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el~tg~~p~~~~~~~~~~~~~ 1146 (1237)
.++++|||.|...... .....|++.|+|||++.+..++.++||||+|+++++|++|+.||............
T Consensus 167 ~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CCCEEEEEECCCCCCCCCC-----CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHH
T ss_conf 4430567531442123445-----42236652105713214667776432012378999998788998987554321026
Q ss_pred ----HHHHHHHH--------HCC---------CCCCCCCC---------CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf ----99999853--------101---------12235932---------1489997999999999998612349999999
Q 000889 1147 ----GWAKQLHR--------EKR---------INEILDPE---------LTMQTSDETELYQYLRISFECLDDRPFKRPT 1196 (1237)
Q Consensus 1147 ----~~~~~~~~--------~~~---------~~~~~~~~---------l~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 1196 (1237)
........ ... ........ .............+.+++.+|+..||++|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC
T ss_conf 89999999837998788624532200013201220243235776444210001567435899999999987799457908
Q ss_pred HHHHHHH
Q ss_conf 9999999
Q 000889 1197 MIQVMAM 1203 (1237)
Q Consensus 1197 ~~eil~~ 1203 (1237)
+.|++++
T Consensus 322 a~e~L~H 328 (362)
T d1q8ya_ 322 AGGLVNH 328 (362)
T ss_dssp HHHHHTC
T ss_pred HHHHHCC
T ss_conf 9999669
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=9.8e-45 Score=273.15 Aligned_cols=81 Identities=27% Similarity=0.565 Sum_probs=60.7
Q ss_pred CCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCE--EEEEECCCC---CCEEEEECCCCCCCCCC-CCCCCCCCCC
Q ss_conf 79913599999961015678999875455689999830--343132799---81569742899987752-2122358998
Q 000889 54 SGGNEELTILMAFKQSSIGSDPNGYLANWTADALTPCS--WQGVSCSLN---SHVTSLNLNNSGLSGSL-NLTTLTALPY 127 (1237)
Q Consensus 54 ~~~~~~~~all~~k~~~~~~~~~~~l~sW~~~~~~~c~--W~gv~c~~~---~~v~~L~L~~~~l~~~~-~~~~l~~l~~ 127 (1237)
-|.++|++||++||+++ .|| ..++||.. ..|||. |.||+|+.. .||++|+|+++++.|.. .+..+.++++
T Consensus 2 ~c~~~e~~aLl~~k~~~--~~~-~~l~sW~~-~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~ 77 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDL--GNP-TTLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPY 77 (313)
T ss_dssp CSCHHHHHHHHHHHHHT--TCC-GGGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred CCCHHHHHHHHHHHHHC--CCC-CCCCCCCC-CCCCCCCCCCCEEEECCCCCEEEEEEECCCCCCCCCCCCCHHHHCCCC
T ss_conf 98989999999999977--999-86778899-999988948896974899947988998989988888879847846753
Q ss_pred CCEEECCC-CCC
Q ss_conf 79488548-978
Q 000889 128 LEHLNLQG-NSF 138 (1237)
Q Consensus 128 L~~L~Ls~-n~l 138 (1237)
|++|+|++ |.+
T Consensus 78 L~~L~Ls~~N~l 89 (313)
T d1ogqa_ 78 LNFLYIGGINNL 89 (313)
T ss_dssp CSEEEEEEETTE
T ss_pred CCCCCCCCCCCC
T ss_conf 352020265433
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=8.5e-43 Score=261.91 Aligned_cols=259 Identities=36% Similarity=0.588 Sum_probs=217.0
Q ss_pred CCCEECCCCCCCCC--CCCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCE
Q ss_conf 55475256873446--7894245876756145122-55657456542246888558982565323435632125798668
Q 000889 499 NLKTIDLSFNSLAG--PVPSEIWSLPNLSDLVMWA-NNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLW 575 (1237)
Q Consensus 499 ~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 575 (1237)
.++.|+|++|.+++ .+|..++++++|++|++++ |++.|.+|..+ .++++|++|+|++|++.+..+..+..+..|+.
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i-~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAI-AKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGG-GGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEECCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCC
T ss_conf 98899898998888887984784675335202026543330024311-45420011020356434433222220111001
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCC-CEEECCCCCCCCCCCHHHHHHCCCCCCCCCCCC
Q ss_conf 9900550112489232283456617815773534799788788989-899778971445789467730165467644575
Q 000889 576 VSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSL-VWLDLNSNNLSGPLPSELANQAGVVMPGIVSGK 654 (1237)
Q Consensus 576 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~~~~ 654 (1237)
+++++|++.+.+|.+++.++.++.+++++|.+.+.+|..+..+.++ +.+++++|++++..|..+.++
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l------------ 197 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL------------ 197 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGC------------
T ss_pred CCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------------
T ss_conf 11122455556851220674000000235533562031214431123231022464353324332222------------
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEECCCEEEEECCCCCEEEEECCCCCCCCCCCCCCCCC
Q ss_conf 31011157986435899742114787653579865467787420026202332169933399966896886688000289
Q 000889 655 QFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSL 734 (1237)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l 734 (1237)
....++++.+...+.+|..++.+
T Consensus 198 ---------------------------------------------------------~~~~l~l~~~~~~~~~~~~~~~~ 220 (313)
T d1ogqa_ 198 ---------------------------------------------------------NLAFVDLSRNMLEGDASVLFGSD 220 (313)
T ss_dssp ---------------------------------------------------------CCSEEECCSSEEEECCGGGCCTT
T ss_pred ---------------------------------------------------------CCCCCCCCCCCCCCCCCCCCCCC
T ss_conf ---------------------------------------------------------22233333343322222222222
Q ss_pred CCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 88859992584023322231245557768847787467878775457443461202366233468999877765887656
Q 000889 735 NYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGIIPSGGQLTTFPASRYE 814 (1237)
Q Consensus 735 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~ 814 (1237)
++++.+++++|.+.+.+| .++.+++|+.|||++|+++|.+|.++..+++|++|+|++|+++|.+|..+.++++..+.+.
T Consensus 221 ~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~ 299 (313)
T d1ogqa_ 221 KNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYA 299 (313)
T ss_dssp SCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTC
T ss_pred CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHC
T ss_conf 221112222222222222-2224554444447657066608768847999998979588351668986667998978868
Q ss_pred CCCCCCCCCCCCCC
Q ss_conf 89887799998898
Q 000889 815 NNSGLCGLPLLPCS 828 (1237)
Q Consensus 815 ~n~~~~~~p~~~c~ 828 (1237)
+|..+||.|+++|.
T Consensus 300 ~N~~l~g~plp~c~ 313 (313)
T d1ogqa_ 300 NNKCLCGSPLPACT 313 (313)
T ss_dssp SSSEEESTTSSCCC
T ss_pred CCCCCCCCCCCCCC
T ss_conf 89500198988989
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=2.4e-36 Score=224.39 Aligned_cols=191 Identities=30% Similarity=0.427 Sum_probs=109.1
Q ss_pred CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCC
Q ss_conf 45876756145122556574565422468885589825653234356321257986689900550112489232283456
Q 000889 518 IWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKL 597 (1237)
Q Consensus 518 ~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 597 (1237)
+..++++..+++++|.+.+..|. ...++|+.|++++|.++. + ..+..+++|+.|++++|++++.. .++.+++|
T Consensus 193 ~~~l~~~~~l~l~~n~i~~~~~~---~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L 265 (384)
T d2omza2 193 LAKLTNLESLIATNNQISDITPL---GILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--PLSGLTKL 265 (384)
T ss_dssp GGGCTTCSEEECCSSCCCCCGGG---GGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTC
T ss_pred CCCCCCCCEEECCCCCCCCCCCC---CCCCCCCEEECCCCCCCC-C-CHHHCCCCCCHHCCCCCCCCCCC--CCCCCCCC
T ss_conf 02235323330357744787864---445778788887777789-6-13432565341004467447877--53554668
Q ss_pred CEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf 61781577353479978878898989977897144578946773016546764457531011157986435899742114
Q 000889 598 AILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFE 677 (1237)
Q Consensus 598 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (1237)
+.|++++|.+++. + .+..++.++.++++.|.+.+ ++ .
T Consensus 266 ~~L~l~~~~l~~~-~-~~~~~~~l~~l~~~~n~l~~-~~-~--------------------------------------- 302 (384)
T d2omza2 266 TELKLGANQISNI-S-PLAGLTALTNLELNENQLED-IS-P--------------------------------------- 302 (384)
T ss_dssp SEEECCSSCCCCC-G-GGTTCTTCSEEECCSSCCSC-CG-G---------------------------------------
T ss_pred CEEECCCCCCCCC-C-CCCCCCCCCCCCCCCCCCCC-CC-C---------------------------------------
T ss_conf 7754567445787-7-32356522223323233333-22-1---------------------------------------
Q ss_pred CCCCCCCCCCCCCCCCCCCCEECCCEEEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCC
Q ss_conf 78765357986546778742002620233216993339996689688668800028988859992584023322231245
Q 000889 678 GIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGG 757 (1237)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~ 757 (1237)
+....+++.|++++|++++.. .+..+++|++|++++|+++ .++ .+..
T Consensus 303 -----------------------------~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~-~l~-~l~~ 349 (384)
T d2omza2 303 -----------------------------ISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVS-DVS-SLAN 349 (384)
T ss_dssp -----------------------------GGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCC-CCG-GGGG
T ss_pred -----------------------------CCHHCCCCEEECCCCCCCCCC--CCCCCCCCCEEECCCCCCC-CCH-HHCC
T ss_conf -----------------------------000024676777788778984--5366898898989899899-974-6708
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCCEECCCC
Q ss_conf 557768847787467878775457443461202366
Q 000889 758 LKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNN 793 (1237)
Q Consensus 758 l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N 793 (1237)
+++|+.|++++|++++..| +..+++|+.|++++|
T Consensus 350 l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 350 LTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCEEECCCCCCCCCHH--HCCCCCCCEEECCCC
T ss_conf 9999989897995899800--003999999639789
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=4.7e-35 Score=216.91 Aligned_cols=54 Identities=26% Similarity=0.427 Sum_probs=29.2
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 3339996689688668800028988859992584023322231245557768847787
Q 000889 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHN 769 (1237)
Q Consensus 712 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ls~N 769 (1237)
+|+.|++++|+++ .++ .++.+++|++|++++|++++..| +.++++|+.|++++|
T Consensus 330 ~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 330 KLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp TCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCEEECCCCCCC-CCH-HHCCCCCCCEEECCCCCCCCCHH--HCCCCCCCEEECCCC
T ss_conf 8898989899899-974-67089999989897995899800--003999999639789
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.6e-32 Score=200.97 Aligned_cols=182 Identities=25% Similarity=0.344 Sum_probs=84.2
Q ss_pred CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCEECCCCCEEEECCCCCCCCCCCCCEECCCCCCCC--CCCCCC
Q ss_conf 866777787759986388475558999999998743451012585111014622226665547525687344--678942
Q 000889 440 PLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLA--GPVPSE 517 (1237)
Q Consensus 440 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~--~~~p~~ 517 (1237)
+..|.++++|+.|++++|+++. +|..+ .+.+..|.+.+|.+....+..+.....+..++...|... ...+..
T Consensus 72 ~~~f~~l~~L~~L~l~~n~l~~-l~~~~-----~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~ 145 (305)
T d1xkua_ 72 PGAFAPLVKLERLYLSKNQLKE-LPEKM-----PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGA 145 (305)
T ss_dssp TTTTTTCTTCCEEECCSSCCSB-CCSSC-----CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTG
T ss_pred HHHHHCCCCCCEECCCCCCCCC-CCCCH-----HHHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 5665279855783156875676-76400-----11132321024610234444540133110000123333346777642
Q ss_pred CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCC
Q ss_conf 45876756145122556574565422468885589825653234356321257986689900550112489232283456
Q 000889 518 IWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKL 597 (1237)
Q Consensus 518 ~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 597 (1237)
+..+++|+.+++.+|.+. .+|... .++|+.|++++|......+..+..++.++.|++++|++.+..+.++.++++|
T Consensus 146 ~~~l~~L~~l~l~~n~l~-~l~~~~---~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L 221 (305)
T d1xkua_ 146 FQGMKKLSYIRIADTNIT-TIPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL 221 (305)
T ss_dssp GGGCTTCCEEECCSSCCC-SCCSSC---CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTC
T ss_pred CCCCCCCCCCCCCCCCCC-CCCCCC---CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 234565671203467745-167101---7766789897886778882676413413301544553322234543344332
Q ss_pred CEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 61781577353479978878898989977897144
Q 000889 598 AILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLS 632 (1237)
Q Consensus 598 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 632 (1237)
+.|+|++|.++ .+|++|..+++|+.|+|++|+++
T Consensus 222 ~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 222 RELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp CEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred EEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCC
T ss_conf 24302554002-46311033467898989898657
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.3e-32 Score=200.32 Aligned_cols=244 Identities=26% Similarity=0.339 Sum_probs=104.8
Q ss_pred CCEECCCCCEEEECCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 45101258511101462222666554752568734467894245876756145122556574565422468885589825
Q 000889 476 LEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILN 555 (1237)
Q Consensus 476 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls 555 (1237)
++.|++++|+++...+..|.++++|+.|++++|.+....|..|..+++|+.|++++|+++ .+|...+ ..+..|++.
T Consensus 33 l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~~---~~l~~L~~~ 108 (305)
T d1xkua_ 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP---KTLQELRVH 108 (305)
T ss_dssp CCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC---TTCCEEECC
T ss_pred CCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCCCCCCC-CCCCCHH---HHHHHHHCC
T ss_conf 798978499189869657604656523112344344523566527985578315687567-6764001---113232102
Q ss_pred CCCCCCCCCCCCCCCCCCCEEEEECCCC--CCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 6532343563212579866899005501--12489232283456617815773534799788788989899778971445
Q 000889 556 NNHLTGAIPKSIASCTNMLWVSLSSNQL--TGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLSG 633 (1237)
Q Consensus 556 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l--~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 633 (1237)
+|.+....+..+.....+..++...|.. ....+..+..+++|+.+++++|.+. .+|..+ +++|+.|++++|...+
T Consensus 109 ~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~ 185 (305)
T d1xkua_ 109 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITK 185 (305)
T ss_dssp SSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCE
T ss_pred CCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCC--CCCCCEEECCCCCCCC
T ss_conf 4610234444540133110000123333346777642234565671203467745-167101--7766789897886778
Q ss_pred CCCHHHHHHCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEECCCEEEEECCCCCE
Q ss_conf 78946773016546764457531011157986435899742114787653579865467787420026202332169933
Q 000889 634 PLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTFTTNGSL 713 (1237)
Q Consensus 634 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 713 (1237)
..+..+.+ ...+
T Consensus 186 ~~~~~~~~--------------------------------------------------------------------~~~l 197 (305)
T d1xkua_ 186 VDAASLKG--------------------------------------------------------------------LNNL 197 (305)
T ss_dssp ECTGGGTT--------------------------------------------------------------------CTTC
T ss_pred CCHHHHHC--------------------------------------------------------------------CCCC
T ss_conf 88267641--------------------------------------------------------------------3413
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC-------CCCCCCCCC
Q ss_conf 3999668968866880002898885999258402332223124555776884778746787877-------545744346
Q 000889 714 IYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPG-------SLGGLSFLS 786 (1237)
Q Consensus 714 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-------~~~~l~~L~ 786 (1237)
+.|++++|.+.+..+..+..+++|++|+|++|+++ .+|.+|..+++|+.|+|++|+|+ .++. ....++.|+
T Consensus 198 ~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~~~~~~~~~~~L~ 275 (305)
T d1xkua_ 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYS 275 (305)
T ss_dssp CEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCCTTSSSCSSCCTTSCCCS
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCHHCCCCCCC
T ss_conf 30154455332223454334433224302554002-46311033467898989898657-63810026721002158889
Q ss_pred CEECCCCCCC
Q ss_conf 1202366233
Q 000889 787 DLDVSNNNLS 796 (1237)
Q Consensus 787 ~l~l~~N~l~ 796 (1237)
.+++++|++.
T Consensus 276 ~L~L~~N~~~ 285 (305)
T d1xkua_ 276 GVSLFSNPVQ 285 (305)
T ss_dssp EEECCSSSSC
T ss_pred EEECCCCCCC
T ss_conf 7889899576
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-32 Score=199.24 Aligned_cols=88 Identities=23% Similarity=0.218 Sum_probs=28.4
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 68885589825653234356321257986689900550112489232283456617815773534799788788989899
Q 000889 545 NGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWL 624 (1237)
Q Consensus 545 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 624 (1237)
++++|++|++++|.+....+..+...++|+.+++++|++++..+..|..+++|+.|++++|++.+..+..|..+++|+.+
T Consensus 103 ~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l 182 (284)
T d1ozna_ 103 GLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182 (284)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHH
T ss_conf 01027787568854432013533200012110200143144580574043405022314176566256665465634131
Q ss_pred ECCCCCCC
Q ss_conf 77897144
Q 000889 625 DLNSNNLS 632 (1237)
Q Consensus 625 ~L~~N~l~ 632 (1237)
++++|+++
T Consensus 183 ~l~~N~l~ 190 (284)
T d1ozna_ 183 LLHQNRVA 190 (284)
T ss_dssp ECCSSCCC
T ss_pred HHHHCCCC
T ss_conf 42114346
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.8e-31 Score=195.99 Aligned_cols=136 Identities=24% Similarity=0.309 Sum_probs=54.5
Q ss_pred CCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCE
Q ss_conf 66655475256873446789424587675614512255657456542246888558982565323435632125798668
Q 000889 496 SCKNLKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLW 575 (1237)
Q Consensus 496 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 575 (1237)
++++|+.|++++|.+....+..+...++|+.+++++|.++ .++...|...++|+.|++++|++.+..+..|.++++|+.
T Consensus 103 ~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~-~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~ 181 (284)
T d1ozna_ 103 GLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR 181 (284)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred CCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCC-CCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCH
T ss_conf 0102778756885443201353320001211020014314-458057404340502231417656625666546563413
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 990055011248923228345661781577353479978878898989977897144
Q 000889 576 VSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLS 632 (1237)
Q Consensus 576 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 632 (1237)
+++++|++++..|..|..+++|+.|++++|.+.+..+..|+.+++|+.|++++|++.
T Consensus 182 l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp EECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred HHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
T ss_conf 142114346628167665320002333335221000002355465688981199887
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2e-29 Score=184.09 Aligned_cols=177 Identities=25% Similarity=0.242 Sum_probs=93.0
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 85589825653234356321257986689900550112489232283456617815773534799788788989899778
Q 000889 548 NLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLN 627 (1237)
Q Consensus 548 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 627 (1237)
++++|+|++|.+++..+.+|.++++|+.|+|++|+++ .+| .++.+++|+.|+|++|+++ ..+..+..+++|+.|+++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~ 108 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred CCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCC-CCC-CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCC
T ss_conf 8898988499289859778634565522135665444-431-1111223211111222221-111121222222222222
Q ss_pred CCCCCCCCCHHHHHHCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEECCCEEEEE
Q ss_conf 97144578946773016546764457531011157986435899742114787653579865467787420026202332
Q 000889 628 SNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPERLEGFPMVHSCPSTRIYTGMTMYTF 707 (1237)
Q Consensus 628 ~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 707 (1237)
+|++.+..+.. +
T Consensus 109 ~~~~~~~~~~~--------------------------------------------------------------------~ 120 (266)
T d1p9ag_ 109 FNRLTSLPLGA--------------------------------------------------------------------L 120 (266)
T ss_dssp SSCCCCCCSST--------------------------------------------------------------------T
T ss_pred CCCCCEEECCC--------------------------------------------------------------------C
T ss_conf 23110110011--------------------------------------------------------------------2
Q ss_pred CCCCCEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 16993339996689688668800028988859992584023322231245557768847787467878775457443461
Q 000889 708 TTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSD 787 (1237)
Q Consensus 708 ~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~ 787 (1237)
....++..|++++|.+....+..+..+++|+.+++++|++++..+..|..+++|+.|||++|+|+ .+|..+..+++|+.
T Consensus 121 ~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~ 199 (266)
T d1p9ag_ 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPF 199 (266)
T ss_dssp TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSE
T ss_pred CCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCCE
T ss_conf 22211112212434210221233322111000000015652237200134212423430139785-56866777888999
Q ss_pred EECCCCCCC
Q ss_conf 202366233
Q 000889 788 LDVSNNNLS 796 (1237)
Q Consensus 788 l~l~~N~l~ 796 (1237)
|+|++|++.
T Consensus 200 L~L~~Np~~ 208 (266)
T d1p9ag_ 200 AFLHGNPWL 208 (266)
T ss_dssp EECCSCCBC
T ss_pred EEECCCCCC
T ss_conf 983699987
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.6e-28 Score=176.85 Aligned_cols=178 Identities=26% Similarity=0.231 Sum_probs=100.4
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEE
Q ss_conf 75614512255657456542246888558982565323435632125798668990055011248923228345661781
Q 000889 523 NLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQL 602 (1237)
Q Consensus 523 ~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 602 (1237)
+++.|++++|+++ .+|...|.++++|++|+|++|+++. +| .+..+++|+.|+|++|+++ ..+..+..+++|+.|++
T Consensus 32 ~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 32 DTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp TCCEEECTTSCCS-EEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred CCCEEECCCCCCC-CCCHHHHHCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCC
T ss_conf 8898988499289-8597786345655221356654444-31-1111223211111222221-11112122222222222
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 57735347997887889898997789714457894677301654676445753101115798643589974211478765
Q 000889 603 GNNSLTGQVPQGLGKCRSLVWLDLNSNNLSGPLPSELANQAGVVMPGIVSGKQFAFVRNEGGTACRGAGGLVEFEGIRPE 682 (1237)
Q Consensus 603 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 682 (1237)
++|.+.+..+..+..+.+++.|++++|.+. .+|...
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~-~l~~~~------------------------------------------- 143 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGL------------------------------------------- 143 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCC-CCCTTT-------------------------------------------
T ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCC-EECCCC-------------------------------------------
T ss_conf 223110110011222211112212434210-221233-------------------------------------------
Q ss_pred CCCCCCCCCCCCCCCEECCCEEEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 35798654677874200262023321699333999668968866880002898885999258402332223124555776
Q 000889 683 RLEGFPMVHSCPSTRIYTGMTMYTFTTNGSLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIG 762 (1237)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 762 (1237)
+..+..++.+++++|++++..+..|..+++|++|+|++|+++ .+|+.+..+++|+
T Consensus 144 ------------------------~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~ 198 (266)
T d1p9ag_ 144 ------------------------LTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLP 198 (266)
T ss_dssp ------------------------TTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCS
T ss_pred ------------------------CCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCC
T ss_conf ------------------------322111000000015652237200134212423430139785-5686677788899
Q ss_pred EEECCCCCCCC
Q ss_conf 88477874678
Q 000889 763 VLDLSHNNFQG 773 (1237)
Q Consensus 763 ~L~ls~N~l~~ 773 (1237)
.|+|++|.+..
T Consensus 199 ~L~L~~Np~~C 209 (266)
T d1p9ag_ 199 FAFLHGNPWLC 209 (266)
T ss_dssp EEECCSCCBCC
T ss_pred EEEECCCCCCC
T ss_conf 99836999878
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7e-32 Score=198.43 Aligned_cols=64 Identities=17% Similarity=0.115 Sum_probs=30.3
Q ss_pred CCCEEECCCCCCCCCCCHHHHHCCCCCCEECCCCCCCCC--CCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 879488548978845412332017556652454773368--8551000136885556983487667
Q 000889 127 YLEHLNLQGNSFSAGDLSTSKTSSCSLVTMDLSSNNITG--SLPGRSFLLSCDRLSYVNLSHNSIS 190 (1237)
Q Consensus 127 ~L~~L~Ls~n~l~~~~~~~~~~~~~~L~~L~Ls~n~l~~--~~~~~~~l~~~~~L~~L~ls~n~l~ 190 (1237)
.|+.||+++|++++.++......+.+++.|+|++|+++. ......++..+++|+.|++++|.|+
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~ 68 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCH
T ss_pred CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCC
T ss_conf 877798208958868999999767799999828999988999999999853999888979598597
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.3e-31 Score=196.84 Aligned_cols=63 Identities=17% Similarity=0.220 Sum_probs=35.2
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHH---HHHCCCCCCEECCCCCCCC
Q ss_conf 15697428999877522122358998794885489788454123---3201755665245477336
Q 000889 102 HVTSLNLNNSGLSGSLNLTTLTALPYLEHLNLQGNSFSAGDLST---SKTSSCSLVTMDLSSNNIT 164 (1237)
Q Consensus 102 ~v~~L~L~~~~l~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~---~~~~~~~L~~L~Ls~n~l~ 164 (1237)
.+..||++++.+++......+..+++++.|+|++|++++.++.+ .+..+++|++|||++|.++
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~ 68 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCH
T ss_pred CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCC
T ss_conf 877798208958868999999767799999828999988999999999853999888979598597
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.95 E-value=2.3e-24 Score=154.68 Aligned_cols=57 Identities=28% Similarity=0.367 Sum_probs=25.5
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC
Q ss_conf 333999668968866880002898885999258402332223124555776884778746787877
Q 000889 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPG 777 (1237)
Q Consensus 712 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 777 (1237)
+|++|++++|+++ .+|+. +++|+.|+|++|+++ .+|.. +++|+.|++++|+++ .+|.
T Consensus 285 ~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~ 341 (353)
T d1jl5a_ 285 SLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD 341 (353)
T ss_dssp TCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred CCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCC
T ss_conf 8898979799168-35665---487998989999687-54532---288898987699189-7776
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.95 E-value=4.2e-24 Score=153.20 Aligned_cols=57 Identities=28% Similarity=0.320 Sum_probs=28.2
Q ss_pred CCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCC
Q ss_conf 98885999258402332223124555776884778746787877545744346120236623346
Q 000889 734 LNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNLSGI 798 (1237)
Q Consensus 734 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 798 (1237)
+++|++|+|++|+++ .+|.. +++|+.|++++|+|+ .+|.. +++|++|++++|++...
T Consensus 283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~~l 339 (353)
T d1jl5a_ 283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLREF 339 (353)
T ss_dssp CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSSC
T ss_pred CCCCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCCCC
T ss_conf 898898979799168-35665---487998989999687-54532---28889898769918977
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=2.8e-26 Score=165.89 Aligned_cols=170 Identities=16% Similarity=0.110 Sum_probs=119.3
Q ss_pred CCCCEECCCCCEEEEEEEECCCCEEEEEEECCCCCC-----C-------------HHHHHHHHHHHHHCCCCCCCCCCCE
Q ss_conf 988421434770899999889999999993022576-----8-------------7999999999870488973241115
Q 000889 931 SADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQ-----G-------------DREFMAEMETIGKIKHRNLVPLLGY 992 (1237)
Q Consensus 931 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~-------------~~~~~~E~~~l~~l~h~niv~l~~~ 992 (1237)
.+.++||+|+||+||+|++.+++.||+|.+...... . ......|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 22778024856599999979999999999860443466655656300088899999977899999998169991449986
Q ss_pred EEECCEEEEEEEECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEE
Q ss_conf 88498689999954688878999632139998668999999999999999997726999916428898975668999569
Q 000889 993 CKIGEERLLVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSCIPHIIHRDMKSSNVLLDENFEAR 1072 (1237)
Q Consensus 993 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIll~~~~~vk 1072 (1237)
. ..+++|||+++..+. .++......++.|++++++|||+. +++||||||+|||++++ .++
T Consensus 83 ~----~~~lvme~~~~~~~~------------~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 83 E----GNAVLMELIDAKELY------------RVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp E----TTEEEEECCCCEEGG------------GCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEE
T ss_pred C----CCEEEEEEECCCCCC------------CHHHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHEEEECC-CEE
T ss_conf 2----888999950456542------------001578999999999999998268---88983689036114289-899
Q ss_pred EEECCCCEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 96404642205678611320125678767801227666674120087999999
Q 000889 1073 VSDFGMARLVNALDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVILL 1125 (1237)
Q Consensus 1073 i~DfGla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ 1125 (1237)
++|||.|............. .+... -.+. ....|+.++|+||..--+.
T Consensus 143 liDFG~a~~~~~~~~~~~l~---rd~~~-~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 143 IIDFPQSVEVGEEGWREILE---RDVRN-IITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp ECCCTTCEETTSTTHHHHHH---HHHHH-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred EEECCCCCCCCCCCCHHHHH---HHHHH-HHHH-HCCCCCCCCCHHHHHHHHH
T ss_conf 98778843089987099998---77999-9999-7578998446899999874
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.8e-23 Score=149.52 Aligned_cols=79 Identities=20% Similarity=0.128 Sum_probs=38.5
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCCCEE-EECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEC
Q ss_conf 33399966896886688000289888599-92584023322231245557768847787467878775457443461202
Q 000889 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVL-NLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDV 790 (1237)
Q Consensus 712 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L-~L~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l 790 (1237)
.+..|++++|.++ .++.......+++.+ .+++|+++...+..|.++++|+.||+++|+++...+..+..++.|+.+++
T Consensus 154 ~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 154 ESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp SCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred CCEEEECCCCCCC-CCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCCCCC
T ss_conf 1001220012333-322222220111012123543246424788668999998989799289459779737713414767
Q ss_pred C
Q ss_conf 3
Q 000889 791 S 791 (1237)
Q Consensus 791 ~ 791 (1237)
.
T Consensus 233 ~ 233 (242)
T d1xwdc1 233 Y 233 (242)
T ss_dssp E
T ss_pred C
T ss_conf 8
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=1.2e-22 Score=144.76 Aligned_cols=85 Identities=25% Similarity=0.264 Sum_probs=38.3
Q ss_pred CCCEEECCCCCCCCCHHHHCCCCCCCCCCEEECCCCCCCCHHHHHCCCCCCCCEEECCCCCCCCCCCHHHHHCCCCCCCE
Q ss_conf 51199868997997212210123788888898337989842321002498756897645545674320111025897249
Q 000889 199 SLLQLDLSGNQISDSALLTYSLSNCQNLNLLNFSDNKLPGKLNATSVNCKSISTIDLSYNLLSGEIPASFVADSSGSLKY 278 (1237)
Q Consensus 199 ~L~~L~Ls~n~I~~~~~~~~~l~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~L~~ 278 (1237)
.|++||+++|.+++.++... +..|++|++|+|++|.+++.....++.+++|++|++++|.-.++.....+...+++|++
T Consensus 47 ~L~~LdLs~~~i~~~~l~~l-~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 47 RVQHMDLSNSVIEVSTLHGI-LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp CCCEEECTTCEECHHHHHHH-HTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCEEECCCCCCCHHHHHHH-HHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCC
T ss_conf 78878898984577799999-97487765145234679867899985189975715100134123554036578874356
Q ss_pred EECCCC
Q ss_conf 967788
Q 000889 279 LDLSHN 284 (1237)
Q Consensus 279 L~Ls~N 284 (1237)
|++++|
T Consensus 126 L~ls~c 131 (284)
T d2astb2 126 LNLSWC 131 (284)
T ss_dssp EECCCC
T ss_pred CCCCCC
T ss_conf 522453
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=7.9e-22 Score=139.96 Aligned_cols=169 Identities=21% Similarity=0.198 Sum_probs=62.6
Q ss_pred CCCCCCCEEECCCC-CCCCHH-HHHCCCCCCCCEEECCCCC-CCCCCCHHHHHCCCCCCCEEECCCC--CCCCCCCCCCC
Q ss_conf 37888888983379-898423-2100249875689764554-5674320111025897249967788--67897664444
Q 000889 221 SNCQNLNLLNFSDN-KLPGKL-NATSVNCKSISTIDLSYNL-LSGEIPASFVADSSGSLKYLDLSHN--NFTGKFSNLDF 295 (1237)
Q Consensus 221 ~~~~~L~~L~Ls~n-~l~~~~-~~~~~~~~~L~~L~Ls~n~-l~~~~~~~~~~~~~~~L~~L~Ls~N--~l~~~~~~~~~ 295 (1237)
..+++|++|++++| .+++.. ......|++|++|++++|. +++..........+++|+.|+++++ .+++......+
T Consensus 92 ~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~ 171 (284)
T d2astb2 92 AKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLV 171 (284)
T ss_dssp TTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHH
T ss_pred HCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHCCCCCCCCHHHHCCCCCCCCCCCCCCCC
T ss_conf 51899757151001341235540365788743565224533233322000100011111012213554244444343423
Q ss_pred CCCCCCCEEECCCC-CCCCCCCCHHHCCCCCCEEEEECCC-CCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCHHHHHHC
Q ss_conf 67799756631576-4347556101002464019992277-457997333330378886996578747799954676514
Q 000889 296 GRCGNLSVITLSQN-GLSGTEFPASLKNCQLLETLNMSHN-ALQGGIPGFLLGSFRNLKQLSLAHNQFAGEIPPELGQAC 373 (1237)
Q Consensus 296 ~~l~~L~~L~L~~n-~l~~~~~~~~l~~l~~L~~L~Ls~n-~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~i~~~l~~~~ 373 (1237)
..+++|++|++++| .+++.. ...+..+++|++|++++| .+++..... ++.+++|+.|++++| +++.....+...+
T Consensus 172 ~~~~~L~~L~L~~~~~itd~~-~~~l~~~~~L~~L~L~~C~~i~~~~l~~-L~~~~~L~~L~l~~~-~~d~~l~~l~~~l 248 (284)
T d2astb2 172 RRCPNLVHLDLSDSVMLKNDC-FQEFFQLNYLQHLSLSRCYDIIPETLLE-LGEIPTLKTLQVFGI-VPDGTLQLLKEAL 248 (284)
T ss_dssp HHCTTCSEEECTTCTTCCGGG-GGGGGGCTTCCEEECTTCTTCCGGGGGG-GGGCTTCCEEECTTS-SCTTCHHHHHHHS
T ss_pred CCCCCCCCCCCCCCCCCCCHH-HHHHCCCCCCCEEECCCCCCCCHHHHHH-HHCCCCCCEEEEECC-CCHHHHHHHHHHC
T ss_conf 232221235532234778303-3332135768779899999787378999-726999898964488-8989999999768
Q ss_pred CCCCEEECCCCCCCCCCCCCCC
Q ss_conf 8796797545767898995734
Q 000889 374 GTLRELDLSSNRLTGELPSTFA 395 (1237)
Q Consensus 374 ~~L~~L~Ls~N~l~~~~~~~l~ 395 (1237)
++|+ +..+.++...+..++
T Consensus 249 p~L~---i~~~~ls~~~~~~~~ 267 (284)
T d2astb2 249 PHLQ---INCSHFTTIARPTIG 267 (284)
T ss_dssp TTSE---ESCCCSCCTTCSSCS
T ss_pred CCCC---CCCCCCCCCCCCCCC
T ss_conf 4366---168658777788547
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=3.5e-22 Score=142.06 Aligned_cols=133 Identities=15% Similarity=0.136 Sum_probs=54.5
Q ss_pred CCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCEEEE
Q ss_conf 547525687344678942458767561451225565745654224688855898256-5323435632125798668990
Q 000889 500 LKTIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNN-NHLTGAIPKSIASCTNMLWVSL 578 (1237)
Q Consensus 500 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L 578 (1237)
+++|++++|.++...+..|.++++|++|++++|.+...++...|..++.++++.+.. |.+....+..|.++++|+.+++
T Consensus 31 l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l 110 (242)
T d1xwdc1 31 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLI 110 (242)
T ss_dssp CSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEE
T ss_pred CCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 89998769918964966861464323211022112420100112222222221111123432222221222222222234
Q ss_pred ECCCCCCCCCC-CCCCCCCCCEEEECCCCCCCCCCCCCCCCC-CCCEEECCCCCCC
Q ss_conf 05501124892-322834566178157735347997887889-8989977897144
Q 000889 579 SSNQLTGEIPA-GIGNLVKLAILQLGNNSLTGQVPQGLGKCR-SLVWLDLNSNNLS 632 (1237)
Q Consensus 579 s~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~ 632 (1237)
++|++....+. .+..+..+..+...++.+....+..+..++ .++.|++++|+++
T Consensus 111 ~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 111 SNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp ESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred CHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC
T ss_conf 21111255433322211112222222121112222222222331001220012333
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.88 E-value=4.9e-22 Score=141.17 Aligned_cols=16 Identities=19% Similarity=0.281 Sum_probs=5.4
Q ss_pred CCCCCCCEEECCCCCC
Q ss_conf 4555776884778746
Q 000889 756 GGLKAIGVLDLSHNNF 771 (1237)
Q Consensus 756 ~~l~~L~~L~ls~N~l 771 (1237)
..+++|+.|++++|++
T Consensus 192 ~~l~~L~~L~Ls~N~l 207 (227)
T d1h6ua2 192 ASLPNLIEVHLKNNQI 207 (227)
T ss_dssp GGCTTCCEEECTTSCC
T ss_pred CCCCCCCEEECCCCCC
T ss_conf 4799999897959968
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.87 E-value=2e-22 Score=143.50 Aligned_cols=45 Identities=16% Similarity=0.098 Sum_probs=26.7
Q ss_pred CCCCCCCCCCCEEECCCCCCCCCCCHHH---HHCCCCCCEECCCCCCC
Q ss_conf 1223589987948854897884541233---20175566524547733
Q 000889 119 LTTLTALPYLEHLNLQGNSFSAGDLSTS---KTSSCSLVTMDLSSNNI 163 (1237)
Q Consensus 119 ~~~l~~l~~L~~L~Ls~n~l~~~~~~~~---~~~~~~L~~L~Ls~n~l 163 (1237)
...+.....|+.|+|++|.+++.++..+ +..+.+|+.++++++..
T Consensus 24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~ 71 (344)
T d2ca6a1 24 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71 (344)
T ss_dssp SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCT
T ss_pred HHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCC
T ss_conf 999963899788978498377899999999998589988888877754
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.86 E-value=4.9e-22 Score=141.19 Aligned_cols=17 Identities=29% Similarity=0.214 Sum_probs=7.2
Q ss_pred HHCCCCCCEECCCCCCC
Q ss_conf 20175566524547733
Q 000889 147 KTSSCSLVTMDLSSNNI 163 (1237)
Q Consensus 147 ~~~~~~L~~L~Ls~n~l 163 (1237)
+..+.++++|+|++|.+
T Consensus 27 L~~~~~l~~L~Ls~n~i 43 (344)
T d2ca6a1 27 LLEDDSVKEIVLSGNTI 43 (344)
T ss_dssp HHHCSCCCEEECTTSEE
T ss_pred HHHCCCCCEEECCCCCC
T ss_conf 96389978897849837
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.86 E-value=1.4e-21 Score=138.56 Aligned_cols=128 Identities=24% Similarity=0.307 Sum_probs=60.0
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECC
Q ss_conf 75256873446789424587675614512255657456542246888558982565323435632125798668990055
Q 000889 502 TIDLSFNSLAGPVPSEIWSLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSN 581 (1237)
Q Consensus 502 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 581 (1237)
.++.+++.++ .+|..+. +++++|++++|+++..++...|..+++|+.|+|++|.+....+..+..+++|+.|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEECCCCC-CCCCCCC--CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCC
T ss_conf 9997089967-0298989--787889848987755302002578762721301363221212122211222210100355
Q ss_pred CCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 011248923228345661781577353479978878898989977897144
Q 000889 582 QLTGEIPAGIGNLVKLAILQLGNNSLTGQVPQGLGKCRSLVWLDLNSNNLS 632 (1237)
Q Consensus 582 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 632 (1237)
+++...|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++.
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred CCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCC
T ss_conf 344349799807974655245774535359778568753342000364434
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.85 E-value=4.5e-21 Score=135.59 Aligned_cols=73 Identities=29% Similarity=0.393 Sum_probs=29.3
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEECC
Q ss_conf 3399966896886688000289888599925840233222312455577688477874678787754574434612023
Q 000889 713 LIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVS 791 (1237)
Q Consensus 713 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~ 791 (1237)
++.++++.|.+++ +..+..+++|+.+++++|++++ +++ +..+++|+.|++++|+++ .+| .+..+++|+.|+++
T Consensus 136 l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~~-l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 136 LESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELF 208 (210)
T ss_dssp CCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEE
T ss_pred CCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC-CCC-CCCCCCCCEEECCCCCCC-CCH-HHCCCCCCCEEECC
T ss_conf 2221122233345--4310001332100134643025-645-367898999989799899-872-11699998999711
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.84 E-value=3.3e-21 Score=136.34 Aligned_cols=81 Identities=21% Similarity=0.215 Sum_probs=32.2
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEECC
Q ss_conf 33399966896886688000289888599925840233222312455577688477874678787754574434612023
Q 000889 712 SLIYLDLSYNSLSGTLPENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVS 791 (1237)
Q Consensus 712 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~ 791 (1237)
+|+.|+|++|++++..|..|..+++|++|+|++|.+....+ ...-...++.+.+..|.+....|..+.+ ++.++++
T Consensus 103 ~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~p~~l~~---~~l~~L~ 178 (192)
T d1w8aa_ 103 QLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPSKVRD---VQIKDLP 178 (192)
T ss_dssp TCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCSSTTTTT---SBGGGSC
T ss_pred CCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCC-HHHHHHHHHHHCCCCCCEEECCCHHHCC---CEEEECC
T ss_conf 46552457745353597785687533420003644343530-2777642354035689827689843369---8861448
Q ss_pred CCCCC
Q ss_conf 66233
Q 000889 792 NNNLS 796 (1237)
Q Consensus 792 ~N~l~ 796 (1237)
.|.+.
T Consensus 179 ~n~l~ 183 (192)
T d1w8aa_ 179 HSEFK 183 (192)
T ss_dssp TTTCC
T ss_pred HHHCC
T ss_conf 75575
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.83 E-value=1.5e-20 Score=132.54 Aligned_cols=16 Identities=31% Similarity=0.497 Sum_probs=5.4
Q ss_pred CCCCCCCEEECCCCCC
Q ss_conf 4555776884778746
Q 000889 756 GGLKAIGVLDLSHNNF 771 (1237)
Q Consensus 756 ~~l~~L~~L~ls~N~l 771 (1237)
+++++|+.|++++|++
T Consensus 169 ~~l~~L~~L~ls~N~i 184 (199)
T d2omxa2 169 ANLTTLERLDISSNKV 184 (199)
T ss_dssp TTCTTCCEEECCSSCC
T ss_pred CCCCCCCEEECCCCCC
T ss_conf 6799899997879979
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=5.5e-16 Score=105.98 Aligned_cols=130 Identities=23% Similarity=0.243 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCEECCCCCEEEECCCCCCCCCCCCCEECCCCCCCCCCCCCCCC
Q ss_conf 86677778775998638847555899999999874345101258511101462222666554752568734467894245
Q 000889 440 PLSLTNCTQLRVLDLSSNGFTGTIPSGFCSPPNFPALEKIVLPNNYLSGTVPLELGSCKNLKTIDLSFNSLAGPVPSEIW 519 (1237)
Q Consensus 440 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~ 519 (1237)
...+.++.++++|+|++|+|+ .++..+..+++|+.|++++|.++.. +.+.
T Consensus 11 ~~~~~n~~~lr~L~L~~n~I~----------------------------~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~ 60 (162)
T d1a9na_ 11 AAQYTNAVRDRELDLRGYKIP----------------------------VIENLGATLDQFDAIDFSDNEIRKL--DGFP 60 (162)
T ss_dssp SCEEECTTSCEEEECTTSCCC----------------------------SCCCGGGGTTCCSEEECCSSCCCEE--CCCC
T ss_pred HHHCCCCCCCCEEECCCCCCC----------------------------CCCCCCCCCCCCCEEECCCCCCCCC--CCCC
T ss_conf 175168574848978899788----------------------------6576200414599898979978764--7744
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC-CCCCCCCCCCEEEEECCCCCCCCCC----CCCCC
Q ss_conf 876756145122556574565422468885589825653234356-3212579866899005501124892----32283
Q 000889 520 SLPNLSDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIP-KSIASCTNMLWVSLSSNQLTGEIPA----GIGNL 594 (1237)
Q Consensus 520 ~l~~L~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l 594 (1237)
.+++|+.|++++|++. .++..++..+++|+.|++++|.+..... ..+..+++|+.|++++|.++ ..|. .+..+
T Consensus 61 ~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~l 138 (162)
T d1a9na_ 61 LLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKV 138 (162)
T ss_dssp CCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHC
T ss_pred CCCCHHHHHCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCHHHCCCCCCC-CCCCHHHHHHHHC
T ss_conf 5761306431021345-7776322334534434203000166542110013653206640799634-5610699999878
Q ss_pred CCCCEEE
Q ss_conf 4566178
Q 000889 595 VKLAILQ 601 (1237)
Q Consensus 595 ~~L~~L~ 601 (1237)
++|++||
T Consensus 139 p~L~~LD 145 (162)
T d1a9na_ 139 PQVRVLD 145 (162)
T ss_dssp TTCSEET
T ss_pred CCCCEEC
T ss_conf 9958337
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.55 E-value=1.9e-16 Score=108.75 Aligned_cols=41 Identities=29% Similarity=0.439 Sum_probs=14.9
Q ss_pred HHCCCCCCEEEEECCCCCCCCCCHHHHCCCCCCCEEECCCCCCC
Q ss_conf 10024640199922774579973333303788869965787477
Q 000889 319 SLKNCQLLETLNMSHNALQGGIPGFLLGSFRNLKQLSLAHNQFA 362 (1237)
Q Consensus 319 ~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~ 362 (1237)
.+..+++|+.|+|++|.|+ .++. +..+++|+.|++++|.++
T Consensus 43 sl~~L~~L~~L~Ls~n~I~-~i~~--l~~l~~L~~L~Ls~N~i~ 83 (198)
T d1m9la_ 43 TLSTLKACKHLALSTNNIE-KISS--LSGMENLRILSLGRNLIK 83 (198)
T ss_dssp HHHHTTTCCEEECSEEEES-CCCC--HHHHTTCCEEECCEEEEC
T ss_pred HHHCCCCCCEEECCCCCCC-CCCC--CCCCCCCCCHHHCCCCCC
T ss_conf 7762604615199446899-8644--247825357341353432
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.51 E-value=4.3e-14 Score=94.99 Aligned_cols=102 Identities=29% Similarity=0.337 Sum_probs=0.0
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEECC
Q ss_conf 61451225565745654224688855898256532343563212579866899005501124892322834566178157
Q 000889 525 SDLVMWANNLTGEIPEGICVNGGNLETLILNNNHLTGAIPKSIASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGN 604 (1237)
Q Consensus 525 ~~L~L~~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 604 (1237)
+.|++++|+++ .++. +..+++|++|++++|.++ .+|..+..+++|+.|++++|+++ .+|. ++.+++|+.|++++
T Consensus 1 R~L~Ls~n~l~-~l~~--l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~-~~~l~~L~~L~l~~ 74 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCN 74 (124)
T ss_dssp SEEECTTSCCS-SCCC--GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCS
T ss_pred CEEECCCCCCC-CCCC--CCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCC-CCCC-CCCCCCCCEEECCC
T ss_conf 98986899898-8710--105898898979787168-65215655431354532432112-3574-12335557688889
Q ss_pred CCCCCCCC-CCCCCCCCCCEEECCCCCCC
Q ss_conf 73534799-78878898989977897144
Q 000889 605 NSLTGQVP-QGLGKCRSLVWLDLNSNNLS 632 (1237)
Q Consensus 605 N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 632 (1237)
|+++.... ..+..+++|+.|++++|+++
T Consensus 75 N~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 75 NRLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred CCCCCCCCCHHHCCCCCCCEEECCCCCCC
T ss_conf 86588888256537999999989799688
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=2.1e-13 Score=90.99 Aligned_cols=42 Identities=17% Similarity=0.163 Sum_probs=13.8
Q ss_pred CCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 125798668990055011248923228345661781577353
Q 000889 567 IASCTNMLWVSLSSNQLTGEIPAGIGNLVKLAILQLGNNSLT 608 (1237)
Q Consensus 567 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 608 (1237)
|.++++|+.|+|++|+|+...|..|..+++|+.|+|++|+++
T Consensus 52 f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~ 93 (156)
T d2ifga3 52 LRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE 93 (156)
T ss_dssp SCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred HCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCC
T ss_conf 256666672162021247742011124554333322678785
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=5.1e-13 Score=88.76 Aligned_cols=66 Identities=26% Similarity=0.240 Sum_probs=26.6
Q ss_pred CCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEECCCCCC
Q ss_conf 0002898885999258402332223124555776884778746787877545744346120236623
Q 000889 729 ENFGSLNYLQVLNLGHNKLTGHIPDSFGGLKAIGVLDLSHNNFQGSIPGSLGGLSFLSDLDVSNNNL 795 (1237)
Q Consensus 729 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l 795 (1237)
..|.++++|+.|+|++|+++...|..|..+++|+.|||++|+++ .+|........|+.|+|++|++
T Consensus 50 ~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 50 RDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115 (156)
T ss_dssp GGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCC
T ss_pred HHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCC-CCCHHHHCCCCCCCCCCCCCCC
T ss_conf 12256666672162021247742011124554333322678785-1574563353212433579863
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.08 E-value=1.4e-09 Score=68.74 Aligned_cols=149 Identities=13% Similarity=0.034 Sum_probs=99.1
Q ss_pred HHHHHHCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCC-CCCCCCCCCEEEECCEEE
Q ss_conf 9999828999884214347708999998899999999930225768799999999987048-897324111588498689
Q 000889 922 HLLEATNGFSADSMIGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIK-HRNLVPLLGYCKIGEERL 1000 (1237)
Q Consensus 922 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 1000 (1237)
++......|+..+..+.++.+.||+.... +..+++|+...........+.+|...++.+. +-.+.+++++...++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHHHCEEEEECCCCCCCCCEEEEEEC-CCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEE
T ss_conf 99975135279976789987718999908-98699998488765325569999999998760699872899975089649
Q ss_pred EEEEECCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------
Q ss_conf 9999546888789996321399986689999999999999999977269-------------------------------
Q 000889 1001 LVYEYMKWGSLESVLHDRAKGGGTKLDWAARKKIAIGSARGLAFLHHSC------------------------------- 1049 (1237)
Q Consensus 1001 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------- 1049 (1237)
+||++++|.++.+..... . ....++.++++.++.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~-------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE-------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEECCSSEEHHHHTTTC-------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEECCCCCCCCCCCCC-------C---CHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_conf 999860433435433440-------2---699999989999999855684214357644656555778998776555543
Q ss_pred -------------------------CCCEEECCCCCCCEEECCCCCEEEEECCCCEE
Q ss_conf -------------------------99916428898975668999569964046422
Q 000889 1050 -------------------------IPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081 (1237)
Q Consensus 1050 -------------------------~~~ivH~Dikp~NIll~~~~~vki~DfGla~~ 1081 (1237)
.+.++|+|+.+.||+++++..+.++||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 033232005799999999844986781789860047642364996599960231441
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.94 E-value=3.2e-10 Score=72.44 Aligned_cols=40 Identities=23% Similarity=0.254 Sum_probs=17.8
Q ss_pred CCCCCEEECCCCCCCCCHH--HHCCCCCCCCCCEEECCCCCC
Q ss_conf 9951199868997997212--210123788888898337989
Q 000889 197 GPSLLQLDLSGNQISDSAL--LTYSLSNCQNLNLLNFSDNKL 236 (1237)
Q Consensus 197 ~~~L~~L~Ls~n~I~~~~~--~~~~l~~~~~L~~L~Ls~n~l 236 (1237)
++.|++|+|++|.|++.|. ++.++..++.|++|++++|.+
T Consensus 71 n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~ 112 (167)
T d1pgva_ 71 SPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQ 112 (167)
T ss_dssp CSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSS
T ss_pred CCCCCCEEEEHHHCCHHHHHHHHHHHHHCCCCCEEECCCCCC
T ss_conf 234330033010214599999999998489389877887768
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.87 E-value=6.5e-10 Score=70.67 Aligned_cols=14 Identities=0% Similarity=0.370 Sum_probs=4.7
Q ss_pred CCCCCEEECCCCCC
Q ss_conf 88888898337989
Q 000889 223 CQNLNLLNFSDNKL 236 (1237)
Q Consensus 223 ~~~L~~L~Ls~n~l 236 (1237)
.+.|+.|+|++|.+
T Consensus 43 n~~L~~L~Ls~n~l 56 (167)
T d1pgva_ 43 SKHIEKFSLANTAI 56 (167)
T ss_dssp CSCCCEEECTTSCC
T ss_pred CCCCCEEECCCCCC
T ss_conf 77645401201562
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.65 E-value=7.9e-08 Score=58.54 Aligned_cols=144 Identities=14% Similarity=0.051 Sum_probs=83.4
Q ss_pred EECCCCC-EEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCC--CCCCCCCCCEEEECCEEEEEEEECCCCCH
Q ss_conf 2143477-08999998899999999930225768799999999987048--89732411158849868999995468887
Q 000889 935 MIGSGGF-GEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIK--HRNLVPLLGYCKIGEERLLVYEYMKWGSL 1011 (1237)
Q Consensus 935 ~ig~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL 1011 (1237)
.+..|.. +.||+.....+..+++|..... ....+..|...++.+. .-.+.+++++..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCC---CHHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf 767865477589999389878999958966---77689999999999986599988613222456615999874413554
Q ss_pred HHH--------------HHHHHCC--CCCC--CCHHHHHHHHH--------------------HHHHHHHHHHHCC----
Q ss_conf 899--------------9632139--9986--68999999999--------------------9999999977269----
Q 000889 1012 ESV--------------LHDRAKG--GGTK--LDWAARKKIAI--------------------GSARGLAFLHHSC---- 1049 (1237)
Q Consensus 1012 ~~~--------------l~~~~~~--~~~~--l~~~~~~~i~~--------------------~ia~gL~yLH~~~---- 1049 (1237)
.+. +..-... .... -.......-.. .....+..+....
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 32212689999999999998736885448875541246889999998754110113401121379999999987187657
Q ss_pred CCCEEECCCCCCCEEECCCCCEEEEECCCCEE
Q ss_conf 99916428898975668999569964046422
Q 000889 1050 IPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081 (1237)
Q Consensus 1050 ~~~ivH~Dikp~NIll~~~~~vki~DfGla~~ 1081 (1237)
.+.++|+|+.|.||+++.+..+.|+||+.+..
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 95678678887635773796589998533265
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.63 E-value=4e-09 Score=66.12 Aligned_cols=22 Identities=27% Similarity=0.315 Sum_probs=9.9
Q ss_pred CCCCCCCCEEECCC-CCCCCCCC
Q ss_conf 35899879488548-97884541
Q 000889 122 LTALPYLEHLNLQG-NSFSAGDL 143 (1237)
Q Consensus 122 l~~l~~L~~L~Ls~-n~l~~~~~ 143 (1237)
..+.+.|++|+|++ +.+++.++
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~ 35 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTL 35 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHH
T ss_pred HHCCCCCCEEECCCCCCCCHHHH
T ss_conf 95599986887689999898999
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.61 E-value=5.2e-09 Score=65.42 Aligned_cols=123 Identities=23% Similarity=0.119 Sum_probs=0.0
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCEEEEECCCCCCCCCC-HHHHCCCCCCC
Q ss_conf 97249967788678976644446779975663157643475561010024640199922774579973-33330378886
Q 000889 274 GSLKYLDLSHNNFTGKFSNLDFGRCGNLSVITLSQNGLSGTEFPASLKNCQLLETLNMSHNALQGGIP-GFLLGSFRNLK 352 (1237)
Q Consensus 274 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~-~~~~~~l~~L~ 352 (1237)
...+.|+++.+.... .+..+..+..+....+.. ..++.....++.|++|+|++|+|++..+ ...+..+++|+
T Consensus 22 ~~~~~Ldls~l~~~~-----~l~~~~~~~~l~~~~~~~--~~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~ 94 (162)
T d1koha1 22 GSQQALDLKGLRSDP-----DLVAQNIDVVLNRRSSMA--ATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLK 94 (162)
T ss_dssp SSSCCBCCCCCSSCT-----TTTTTTCCCCTTSHHHHH--HHHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCC
T ss_pred HHHCEEECCCCCCCC-----HHHHCCCHHHCCHHHHHH--HHHHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCC
T ss_conf 330865343598982-----155466401122555676--6607889748787886377766667731588986588561
Q ss_pred EEECCCCCCCCCCCHHHHHHCCCCCEEECCCCCCCCCCCCC-------CCCCCCCCEEE
Q ss_conf 99657874779995467651487967975457678989957-------34666565420
Q 000889 353 QLSLAHNQFAGEIPPELGQACGTLRELDLSSNRLTGELPST-------FASCSSLHSLN 404 (1237)
Q Consensus 353 ~L~L~~n~l~~~i~~~l~~~~~~L~~L~Ls~N~l~~~~~~~-------l~~l~~L~~L~ 404 (1237)
.|++++|.++ .++.-..-...+|+.+++++|.+....... +..+++|+.||
T Consensus 95 ~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 95 ILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred CCCCCCCCCC-CCHHHHHHHCCCCCEEECCCCCCCCCCCCCHHHHHHHHHHCCCCCEEC
T ss_conf 0004357213-423442220331042664899767676661569999999889978799
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.58 E-value=1.9e-08 Score=62.20 Aligned_cols=18 Identities=6% Similarity=0.097 Sum_probs=7.5
Q ss_pred CCCCCCCCEEECCCCCCC
Q ss_conf 237888888983379898
Q 000889 220 LSNCQNLNLLNFSDNKLP 237 (1237)
Q Consensus 220 l~~~~~L~~L~Ls~n~l~ 237 (1237)
+..++.|+.|+|++|.++
T Consensus 42 l~~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 42 LKTNTYVKKFSIVGTRSN 59 (166)
T ss_dssp HTTCCSCCEEECTTSCCC
T ss_pred HHCCCCCCEEECCCCCCC
T ss_conf 841982574301589611
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.37 E-value=7.3e-06 Score=47.11 Aligned_cols=77 Identities=14% Similarity=0.087 Sum_probs=49.5
Q ss_pred CCEECCCCCEEEEEEEECC-CCEEEEEEECCCC-------CCCHHHHHHHHHHHHHCC-C--CCCCCCCCEEEECCEEEE
Q ss_conf 8421434770899999889-9999999930225-------768799999999987048-8--973241115884986899
Q 000889 933 DSMIGSGGFGEVYKAQLRD-GSVVAIKKLIHVT-------GQGDREFMAEMETIGKIK-H--RNLVPLLGYCKIGEERLL 1001 (1237)
Q Consensus 933 ~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l 1001 (1237)
.+.||.|....||++...+ +..+++|.-.... .....+...|.+.++.+. + ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998--5988779
Q ss_pred EEEECCCCCH
Q ss_conf 9995468887
Q 000889 1002 VYEYMKWGSL 1011 (1237)
Q Consensus 1002 v~e~~~~gsL 1011 (1237)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEECCCCCCC
T ss_conf 8713577653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.00 E-value=0.00011 Score=40.36 Aligned_cols=140 Identities=13% Similarity=0.078 Sum_probs=78.3
Q ss_pred CCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCC--CCCCCC-----EEEECCEEEEEEEECCCCCH
Q ss_conf 47708999998899999999930225768799999999987048897--324111-----58849868999995468887
Q 000889 939 GGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKHRN--LVPLLG-----YCKIGEERLLVYEYMKWGSL 1011 (1237)
Q Consensus 939 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~-----~~~~~~~~~lv~e~~~~gsL 1011 (1237)
+..-.||+++..+|..+++|.... .....+++..|...+..+.... ++.... .....+..+.++++++|..+
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp-~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRP-ERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECT-TTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred CCCCEEEEEECCCCCEEEEEEECC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCC
T ss_conf 612026999838999799998478-7788999999999999998559987875206898056653479999865277688
Q ss_pred H-----HH---------HHHHHC----CCCCCCCHH----------------------HHHHHHHHHHHHHHHH-HHCCC
Q ss_conf 8-----99---------963213----999866899----------------------9999999999999997-72699
Q 000889 1012 E-----SV---------LHDRAK----GGGTKLDWA----------------------ARKKIAIGSARGLAFL-HHSCI 1050 (1237)
Q Consensus 1012 ~-----~~---------l~~~~~----~~~~~l~~~----------------------~~~~i~~~ia~gL~yL-H~~~~ 1050 (1237)
. .+ ++.... ......++. .....+..+...+.-. .+...
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 99999999998999999886303578655677897887665689998747699889899999999999999984545687
Q ss_pred CCEEECCCCCCCEEECCCCCEEEEECCCCEE
Q ss_conf 9916428898975668999569964046422
Q 000889 1051 PHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081 (1237)
Q Consensus 1051 ~~ivH~Dikp~NIll~~~~~vki~DfGla~~ 1081 (1237)
.+++|+|+.+.|||++++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 120247888042878389--35886520146
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.86 E-value=5.5e-05 Score=42.05 Aligned_cols=72 Identities=17% Similarity=0.156 Sum_probs=46.9
Q ss_pred CEECCCCCEEEEEEEECCC--------CEEEEEEECCCCCCCHHHHHHHHHHHHHCC-CCCCCCCCCEEEECCEEEEEEE
Q ss_conf 4214347708999998899--------999999930225768799999999987048-8973241115884986899999
Q 000889 934 SMIGSGGFGEVYKAQLRDG--------SVVAIKKLIHVTGQGDREFMAEMETIGKIK-HRNLVPLLGYCKIGEERLLVYE 1004 (1237)
Q Consensus 934 ~~ig~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 1004 (1237)
+.++.|-.-.+|++...++ ..|.++..- .........+|..+++.+. +.-.+++++++. + .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g--~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF--NPETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC--SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC--CCCHHHHHHHHHHHHHHHHHCCCCCEEEEECC--C--CEEEE
T ss_conf 991785334348999688775445789817999659--96116589999999999975799980899818--9--56999
Q ss_pred ECCCCCH
Q ss_conf 5468887
Q 000889 1005 YMKWGSL 1011 (1237)
Q Consensus 1005 ~~~~gsL 1011 (1237)
|++|..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EECCCCC
T ss_conf 7345548
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.63 E-value=0.00095 Score=34.84 Aligned_cols=161 Identities=12% Similarity=0.068 Sum_probs=85.4
Q ss_pred CCHHHHHHHHCCCCCCCE-----ECCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCC-----CCCC
Q ss_conf 698899998289998842-----143477089999988999999999302257687999999999870488-----9732
Q 000889 918 LTFAHLLEATNGFSADSM-----IGSGGFGEVYKAQLRDGSVVAIKKLIHVTGQGDREFMAEMETIGKIKH-----RNLV 987 (1237)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~-----ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-----~niv 987 (1237)
++..++.....+|.+.+. |..|.--+.|+.+..++ .+++|...... ...+...|++++..+.. |..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCC-CEEEEECCCCC--CHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 8999999999867999856852378885267389997897-28999807899--98899999999875430255545564
Q ss_pred CCCC---EEEECCEEEEEEEECCCCCHHH--------------HHHHHHCCC--C--CCCC------------------H
Q ss_conf 4111---5884986899999546888789--------------996321399--9--8668------------------9
Q 000889 988 PLLG---YCKIGEERLLVYEYMKWGSLES--------------VLHDRAKGG--G--TKLD------------------W 1028 (1237)
Q Consensus 988 ~l~~---~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~~--~--~~l~------------------~ 1028 (1237)
...+ +.........++.+..+..... .++...... . .... .
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred EECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCC
T ss_conf 10489762134125502453114655333204678888899876454443202453101110120024567777653114
Q ss_pred HHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCCEEEEECCCCEE
Q ss_conf 9999999999999999772-6999916428898975668999569964046422
Q 000889 1029 AARKKIAIGSARGLAFLHH-SCIPHIIHRDMKSSNVLLDENFEARVSDFGMARL 1081 (1237)
Q Consensus 1029 ~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dikp~NIll~~~~~vki~DfGla~~ 1081 (1237)
......+......+...+. ....+++|+|+.++||+++.+...-++||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 127999999987642048554545033378636564020454126742221236
|